Record O
date O
: O
2077-03-31 I-DATE
Notre I-LOCATION
Dame I-LOCATION
Nursing I-LOCATION
Home I-LOCATION
1410 I-LOCATION
Madera I-LOCATION
Circle I-LOCATION
POTTS O
, O
WILLIAM I-NAME
Hyannis I-LOCATION
, O
NV I-LOCATION
21113 I-LOCATION
10916758 I-ID
( O
391 O
) O
643-6925 I-CONTACT
03/31/2077 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Potts I-NAME
is O
a O
60-year-old O
male O
who O
comes O
for O
annual O
review O
and O
follow O
up O
of O
medical O
problems O
. O
 
1 O
. O
 
Hypertension O
. O
 
No O
chest O
pain O
, O
shortness O
of O
breath O
, O
or O
pedal O
edema O
. O
 
2 O
. O
 
Hypercholesterolemia O
. O
 
Recent O
fasting O
lipid O
analysis O
shows O
total O
cholesterol O
of O
118 O
, O
triglycerides O
of O
121 O
, O
LDL O
61 O
, O
HDL O
33 O
. O
 
3 O
. O
 
Coronary O
artery O
disease O
status O
post O
CABG O
2070 I-DATE
. O
 
He O
has O
a O
stable O
pattern O
of O
dyspnea O
with O
exercise O
. O
 
No O
significant O
chest O
pain O
. O
 
4 O
. O
 
Prostate O
CA O
. O
 
He O
has O
begun O
prostatic O
brachytherapy O
four O
months O
ago O
. O
 
5 O
. O
 
Depression O
. O
 
He O
needs O
to O
arrange O
follow O
up O
with O
our O
counseling O
department O
. O
 
6 O
. O
 
Benign O
prostatic O
hypertrophy O
and O
bladdre O
outlet O
obstruction O
. O
 
He O
is O
going O
to O
undergo O
further O
evaluation O
. O
 
He O
has O
responded O
well O
to O
medical O
therapy O
. O
 
MEDICATIONS O
: O
Aspirin O
81 O
mg O
daily O
, O
atenolol O
50 O
mg O
daily O
, O
diltiazem O
180 O
mg O
daily O
, O
fluoxetine O
20 O
mg O
daily O
, O
folic O
acid O
1 O
mg O
daily O
, O
Lipitor O
20 O
mg O
daily O
, O
Naprosyn O
500 O
mg O
b.i.d O
. O
 
p.r.n. O
, O
terazosin O
5 O
mg O
b.i.d. O
, O
nitroglycerin O
p.r.n O
. O
 
ALLERGIES O
: O
Sulfa O
medications O
. O
 
HABITS O
: O
He O
denies O
tobacco O
or O
drug O
use O
and O
drinks O
rarely O
. O
 
FAMILY O
HISTORY O
: O
Unchanged O
. O
 
SOCIAL O
HISTORY O
: O
Unchanged O
. O
 
REVIEW O
OF O
SYMPTOMS O
: O
Notable O
for O
slightly O
worsening O
back O
pain O
, O
which O
he O
has O
had O
for O
all O
his O
life O
since O
trauma O
as O
a O
youth O
. O
 
The O
pain O
is O
most O
noticeable O
after O
standing O
for O
a O
long O
period O
of O
time O
. O
 
No O
nocturnal O
back O
pain O
. O
 
No O
significant O
weight O
change O
, O
febrile O
signs O
or O
symptoms O
, O
headache O
, O
blurred O
vision O
, O
tinnitus O
, O
chest O
pain O
, O
cough O
, O
shortness O
of O
breath O
, O
nausea O
, O
abdominal O
pain O
, O
nightsweats O
, O
diarrhea O
, O
dysuria O
, O
skin O
rash O
, O
bruising O
, O
joint O
pain O
, O
or O
focal O
weakness O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
108/60 O
, O
weight O
224 O
pounds O
, O
height O
69 O
inches O
. O
 
BMI O
33.1 O
. O
 
Skin O
exam O
: O
No O
rash O
. O
 
Head O
and O
neck O
normal O
. O
 
Chest O
: O
Clear O
to O
percussion O
and O
auscultation O
. O
 
Cardiovascular O
exam O
: O
S4 O
. O
 
No O
extra O
sounds O
or O
murmurs O
. O
 
Pedal O
pulses O
1+ O
bilaterally O
. O
 
Abdominal O
exam O
: O
No O
masses O
, O
tenderness O
, O
or O
organomegaly O
. O
 
Stool O
guaiac O
negative O
. O
 
GU O
exam O
: O
Both O
testes O
are O
without O
masses O
or O
tenderness O
. O
 
Prostate O
not O
significantly O
palpable O
. O
 
Lymph O
exam O
: O
No O
axillary O
or O
cervical O
lymphadenopathy O
. O
 
Musculoskeletal O
exam O
grossly O
intact O
. O
 
Bilateral O
pes O
planus O
. O
 
Neuro O
exam O
grossly O
intact O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Hypertension O
. O
 
Stable O
. O
 
2 O
. O
 
Hypercholesterolemia O
. O
 
Adequate O
LDL O
treatment O
. O
 
3 O
. O
 
Coronary O
artery O
disease O
. O
 
Symptomatically O
stable O
though O
I O
wish O
he O
had O
better O
exercise O
tolerance O
. O
 
Will O
follow O
. O
 
4 O
. O
 
Prostate O
CA O
. O
 
Under O
treatment O
. O
 
5 O
. O
 
Depression O
. O
 
I O
encouraged O
him O
to O
follow O
up O
with O
our O
counseling O
department O
. O
 
6 O
. O
 
Prostatic O
hypertrophy O
and O
outlet O
obstruction O
. O
 
He O
has O
follow O
up O
arranged O
with O
Dr. O
Uren I-NAME
. O
 
7 O
. O
 
Low O
HDL O
. O
 
I O
will O
initiate O
treatment O
with O
Tricor O
. O
 
Previous O
trials O
with O
niacin O
failed O
. O
 
8 O
. O
 
Pes O
planus O
. O
 
Not O
symptomatically O
a O
problem O
. O
 
9 O
. O
 
Low O
back O
pain O
. O
 
The O
pattern O
has O
been O
stable O
. O
 
Will O
not O
further O
intervene O
. O
 
10 O
. O
 
Obesity O
. O
 
I O
discussed O
with O
him O
the O
need O
to O
reduce O
weight O
but O
it O
has O
been O
stable O
for O
some O
time O
. O
 
11 O
. O
 
Adult O
health O
maintenance O
. O
 
Tetanus O
up-to-date O
. O
 
He O
has O
had O
endoscopy O
. O
 
Guaiac O
cards O
given O
. O
 
Screening O
blood O
work O
up-to-date O
. O
 
______________________________ O
Matthew I-NAME
H I-NAME
Wyatt I-NAME
, O
M.D O
. O
 
eScription O
document:2-4489673 O
EMS O
DD O
: O
03/31/77 I-DATE
DT O
: O
03/31/77 I-DATE
DV O
: O
03/31/77 I-DATE
 
Record O
date O
: O
2080-03-09 I-DATE
Notre I-LOCATION
Dame I-LOCATION
Nursing I-LOCATION
Home I-LOCATION
6250 I-LOCATION
Madera I-LOCATION
Circle I-LOCATION
POTTS O
, O
WILLIAM I-NAME
Hyannis I-LOCATION
, O
NV I-LOCATION
21113 I-LOCATION
10916758 I-ID
( O
391 O
) O
643-6925 I-CONTACT
03/09/2080 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Potts I-NAME
is O
a O
65-year-old O
male O
who O
comes O
in O
for O
followup O
of O
chronic O
kidney O
disease O
and O
other O
medical O
problems O
. O
 
1 O
. O
 
Chronic O
kidney O
disease O
. O
 
Creatinine O
stable O
at O
1.42 O
. O
 
He O
is O
on O
no O
ACE O
inhibitor O
. O
 
2 O
. O
 
Borderline O
diabetes O
mellitus O
. O
 
He O
is O
not O
currently O
treated O
. O
 
However O
, O
A1c O
recently O
6.6 O
. O
 
3 O
. O
 
Low O
HDL O
. O
 
Recent O
fasting O
lipid O
analysis O
showed O
total O
cholesterol O
121 O
, O
triglycerides O
74 O
, O
LDL O
85 O
, O
and O
HDL O
21 O
. O
 
4 O
. O
 
History O
of O
prostate O
cancer O
. O
 
PSA O
less O
than O
assay O
. O
 
MEDICATIONS O
: O
Albuterol O
q.i.d O
. O
 
p.r.n. O
, O
atenolol O
50 O
mg O
p.o O
. O
 
daily O
, O
diltiazem O
180 O
mg O
p.o O
. O
 
daily O
, O
Flomax O
0.8 O
mg O
daily O
, O
Flonase O
2 O
sprays O
b.i.d. O
, O
folic O
acid O
2 O
mg O
b.i.d. O
, O
Lipitor O
40 O
mg O
p.o O
. O
 
daily O
, O
Plavix O
75 O
mg O
p.o O
. O
 
daily O
, O
and O
TriCor O
200 O
mg O
p.o O
. O
 
daily O
. O
 
REVIEW O
OF O
SYMPTOMS O
: O
No O
significant O
weight O
change O
, O
febrile O
signs O
or O
symptoms O
, O
headache O
, O
blurred O
vision O
, O
tinnitus O
, O
chest O
pain O
, O
cough O
, O
shortness O
of O
breath O
, O
nausea O
, O
abdominal O
pain O
, O
nightsweats O
, O
diarrhea O
, O
dysuria O
, O
polyuria O
, O
skin O
rash O
, O
bruising O
, O
joint O
pain O
, O
or O
focal O
weakness O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
100/60 O
, O
weight O
226 O
pounds O
, O
heart O
rate O
68 O
and O
regular O
. O
 
Chest O
: O
Clear O
to O
percussion O
and O
auscultation O
. O
 
Extremities O
: O
No O
edema O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Chronic O
kidney O
disease O
. O
 
This O
remains O
stable O
. O
 
However O
, O
he O
should O
be O
on O
an O
ACE O
inhibitor O
. O
 
I O
will O
initiate O
lisinopril O
10 O
mg O
p.o O
. O
 
daily O
, O
substituted O
for O
diltiazem O
. O
 
2 O
. O
 
Borderline O
glucose O
tolerance O
. O
 
The O
patient O
will O
return O
for O
2 O
hour O
glucose O
tolerance O
test O
. O
 
3 O
. O
 
Low O
HDL O
. O
 
Remains O
quite O
low O
in O
the O
setting O
of O
coronary O
artery O
disease O
despite O
treatment O
. O
 
We O
will O
continue O
TriCor O
. O
 
4 O
. O
 
History O
of O
prostate O
cancer O
. O
 
No O
evidence O
of O
recurrence O
. O
 
5 O
. O
 
Hypertension O
. O
 
Good O
control O
. O
 
Substitute O
lisinopril O
for O
diltiazem O
as O
noted O
above O
. O
 
______________________________ O
Matthew I-NAME
H I-NAME
Wyatt I-NAME
, O
M.D. O
, O
M.Sc O
. O
 
eScription O
document:6-0114243 O
CSSten O
Tel O
DD O
: O
03/09/80 I-DATE
DT O
: O
03/09/80 I-DATE
DV O
: O
03/09/80 I-DATE
 
Record O
date O
: O
2078-05-31 I-DATE
VASCULAR O
SURGERY O
H O
& O
P O
Ulysses I-NAME
Richard I-NAME
8913196 I-ID
May I-DATE
31 O
, O
2078 I-DATE
Service O
: O
Mosley I-NAME
Attending O
: O
Snyder I-NAME
Fellow O
: O
Allison I-NAME
Senior O
: O
Fulton I-NAME
Junior O
: O
Benitez I-NAME
Mr O
Richard I-NAME
is O
an O
85 I-AGE
year O
old O
gentleman O
with O
a O
long-standing O
history O
of O
peripheral O
vascular O
disease O
who O
presents O
with O
progressive O
rest O
pain O
and O
ischemic O
ulceration O
of O
his O
right O
foot O
. O
 
He O
underwent O
angiography O
, O
but O
no O
lesions O
amenable O
to O
percutaneous O
intervention O
were O
identified O
. O
 
He O
presents O
now O
in O
anticipation O
of O
a O
distal O
bypass O
procedure O
. O
 
PMH O
: O
CAD O
HTN O
CRI O
( O
Cr O
1.8 O
at O
baseline O
) O
DM O
PVD O
s/p O
left O
fem-pop O
( O
failed O
) O
and O
redo O
left O
fem-pop-peroneal O
CAS O
s/p O
endarterectomy O
CHF O
Atrial O
Fibrillation O
Nephrolithiasis O
Spinal O
Stenosis O
Meds O
: O
Norvasc O
10 O
Glyburide O
10 O
BID O
Labetalol O
200 O
BID O
Lisinopril O
10 O
BID O
ASA O
325 O
Plavix O
75 O
Doxazosin O
4 O
Aciphex O
20 O
BID O
Zocor O
20 O
NitroDur O
0.2mg/hr O
Ativan O
0.5 O
PRN O
Lasix O
40 O
PRN O
Vicodin O
PRN O
Tylenol O
PRN O
Zantac O
PRN O
Coumadin O
Allergies O
: O
ASA O
SH O
: O
never O
smoked O
, O
widower O
PE O
: O
Afebrile O
75SR O
132/52 O
94 O
% O
RA O
NAD O
Chest O
CTAB O
Heart O
Irreg O
, O
II/VI O
SEM O
Abd O
soft O
RLE O
with O
ischemic O
, O
but O
clean O
ulceration O
. O
 
LLE O
warm O
without O
lesions O
Vasc O
: O
Car O
Rad O
Fem O
Pop O
DP O
PT O
R O
2+ O
2+ O
1+ O
- O
- O
- O
L O
2+ O
2+ O
2+ O
1+ O
D O
1+ O
EKG O
Afeb O
PVR O
pulsatile O
on O
L O
, O
flat O
on O
R O
CXR O
No O
acute O
processes O
Impression O
: O
RLE O
limb O
ischemia O
Plan O
: O
OR O
in O
AM O
for O
Fem-distal O
bypass O
IV O
Heparin O
overnight O
Consent O
obtained O
Richard I-NAME
Benitez I-NAME
, O
MD O
, O
MPH O
Resident O
in O
Surgery O
 
Record O
date O
: O
2078-07-26 I-DATE
Plastic O
Surgery O
Consult O
Note O
Patient O
: O
Richard O
, O
Ulysses I-NAME
MRN O
# O
: O
8913196 I-ID
Date O
of O
Consult O
: O
7/26/78 I-DATE
Chief O
Complaint O
: O
Open O
surgical O
wound O
right O
leg O
HPI O
: O
85 I-AGE
yo O
WM O
w/ O
multiple O
medical O
problems O
presents O
s/p O
right O
common O
femoral O
to O
anterior O
tibial O
bypass O
with O
failure O
of O
his O
right O
lower O
leg O
surgical O
wound O
to O
close O
. O
 
He O
has O
peripheral O
vascular O
disease O
with O
a O
prior O
left O
femoral-tibial O
bypass O
graft O
. O
 
He O
initially O
presented O
to O
the O
vascular O
surgery O
clinic O
with O
an O
ischemic O
ulceration O
in O
the O
right O
foot O
. O
 
There O
were O
no O
lesions O
amenable O
to O
percutaneous O
intervention O
and O
he O
underwent O
right O
common O
femoral O
artery O
to O
distal O
anterior O
tibial O
artery O
in O
situ O
saphenous O
vein O
bypass O
graft O
on O
6/01/78 I-DATE
. O
 
He O
was O
discharged O
to O
an O
acute O
rehabilitation O
facility O
on O
6/07 I-DATE
where O
he O
reports O
initially O
doing O
well O
. O
 
The O
patient O
was O
readmitted O
in O
early O
June I-DATE
because O
of O
fevers O
. O
 
No O
source O
of O
the O
fevers O
were O
determined O
but O
he O
was O
started O
on O
an O
empiric O
regimen O
of O
antibiotics O
. O
 
During O
that O
admission O
, O
every O
other O
staple O
in O
his O
wound O
was O
removed O
. O
 
The O
patient O
came O
back O
to O
clinic O
where O
all O
of O
his O
sutures O
were O
removed O
. O
 
The O
surgical O
site O
over O
the O
lower O
leg O
never O
completely O
healed O
and O
the O
open O
area O
was O
treated O
with O
daily O
dressing O
changes O
. O
 
He O
was O
seen O
in O
clinic O
for O
follow-up O
today O
where O
his O
wound O
was O
again O
noted O
to O
be O
open O
in O
proximity O
to O
the O
graft O
. O
 
Plastic O
surgery O
is O
consulted O
regarding O
closure O
options O
. O
 
PMH/PSH O
: O
1 O
. O
 
CAD O
2 O
. O
 
HTN O
3 O
. O
 
CRI O
( O
Cr O
1.8 O
at O
baseline O
) O
4 O
. O
 
DM O
5 O
. O
 
PVD O
s/p O
left O
fem-pop O
( O
failed O
) O
, O
redo O
left O
fem-pop-peroneal O
, O
right O
fem-AT O
CAS O
, O
s/p O
endarterectomy O
6 O
. O
 
CHF O
7 O
. O
 
Atrial O
Fibrillation O
8 O
. O
 
Nephrolithiasis O
9 O
. O
 
Spinal O
Stenosis O
Allergies O
: O
ASA O
( O
GI O
intolerance O
) O
Meds O
: O
1 O
. O
 
Aspirin O
81 O
mg O
p.o O
. O
 
every O
day O
. O
 
2 O
. O
 
Albuterol O
nebulizer O
2.5 O
mg O
nebulized O
q4 O
hours O
prn O
wheeze O
. O
 
3 O
. O
 
Norvasc O
10 O
mg O
p.o O
. O
 
bid O
. O
 
4 O
. O
 
Colace O
100 O
mg O
p.o O
. O
 
bid O
. O
 
5 O
. O
 
Doxazosin O
2 O
mg O
p.o O
. O
 
qhs O
. O
 
6 O
. O
 
Lexapro O
10 O
mg O
p.o O
. O
 
every O
day O
. O
 
7 O
. O
 
Nexium O
40 O
mg O
p.o O
. O
 
every O
day O
. O
 
8 O
. O
 
Glyburide O
5 O
mg O
p.o O
. O
 
bid O
before O
breakfast O
and O
before O
supper O
. O
 
9 O
. O
 
Vicodin O
1 O
tab O
p.o O
. O
 
q4 O
hours O
prn O
pain O
. O
 
10 O
. O
 
Sliding O
scale O
insulin O
. O
 
11 O
. O
 
Atrovent O
0.5 O
mg O
nebs O
qid O
prn O
wheeze O
. O
 
12 O
. O
 
Ativan O
0.5 O
to O
1 O
mg O
p.o O
. O
 
bid O
prn O
anxiety O
. O
 
13 O
. O
 
Lopressor O
12.5 O
mg O
p.o O
. O
 
bid O
. O
 
14 O
. O
 
Multivitamin O
1 O
tab O
p.o O
. O
 
every O
day O
. O
 
15 O
. O
 
Nitro-Dur O
patch O
0.2 O
mg O
per O
hour O
transdermal O
every O
day O
. O
 
16 O
. O
 
SENNA O
2 O
tabs O
p.o O
. O
 
bid O
. O
 
17 O
. O
 
Silvadene O
one O
application O
topically O
bid O
to O
wound O
. O
 
18 O
. O
 
Zocor O
20 O
mg O
every O
day O
. O
 
19 O
. O
 
Coumadin O
5 O
mg O
p.o O
. O
 
qpm O
. O
 
Vitals O
: O
T O
: O
96.9 O
, O
HR O
: O
75 O
, O
BP O
: O
179/78 O
, O
RR O
: O
18 O
, O
O2 O
sat O
: O
96 O
% O
RA O
Physical O
Examination O
: O
General O
: O
Alert O
, O
oriented O
, O
NAD O
, O
good O
historian O
Lower O
extremities O
: O
Multiple O
well-healed O
incisions O
. O
 
On O
the O
right O
lower O
extremity O
, O
there O
is O
an O
incision O
from O
the O
groin O
to O
the O
foot O
. O
 
It O
is O
well-healed O
with O
the O
exception O
of O
a O
5 O
x O
2 O
cm O
area O
over O
the O
lower O
third O
of O
the O
leg O
just O
medial O
to O
the O
tibia O
. O
 
The O
graft O
is O
palpable O
just O
lateral O
to O
the O
area O
. O
 
The O
base O
of O
the O
wound O
appears O
to O
have O
granulation O
tissue O
. O
 
No O
odor O
. O
 
There O
is O
minimal O
erythema O
and O
tenderness O
around O
the O
site O
. O
 
Distal O
pulses O
palpable O
. O
 
Foot O
warm O
and O
well-perfused O
but O
with O
no O
sensation O
below O
the O
ankle O
. O
 
There O
are O
other O
venous O
stasis O
ulcers O
in O
various O
stages O
of O
healing O
. O
 
The O
great O
toe O
has O
an O
ulcer O
with O
overlying O
eschar O
. O
 
Relevant O
Laboratory O
Values O
: O
Pending O
Assessment O
: O
85 I-AGE
yo O
WM O
w/ O
multiple O
medical O
comorbidities O
presents O
with O
need O
for O
wound O
coverage O
of O
a O
right O
saphenous O
vein O
bypass O
graft O
. O
 
This O
may O
be O
amenable O
to O
local O
flap O
coverage O
. O
 
Recommendations O
: O
-Tentative O
plan O
wound O
debridement/possible O
flap O
closure O
this O
week O
-Will O
discuss O
with O
Dr. O
Ring I-NAME
( O
covering O
for O
Dr. O
Velasco I-NAME
) O
and O
plan O
to O
assist O
with O
closure O
. O
 
-Preoperative O
labs O
and O
studies O
pending O
. O
 
-Continue O
daily O
dressing O
changes O
for O
now O
. O
 
The O
patient O
was O
discussed O
with O
Dr. O
Uriah I-NAME
Wills I-NAME
. O
 
James I-NAME
Kopp I-NAME
, O
M.D O
. O
 
PH I-LOCATION
Surgery O
, O
Pager O
# O
: O
79920 I-CONTACT
 
Record O
date O
: O
2078-09-06 I-DATE
Vascular O
Surgery O
H O
& O
P O
Date O
09/06/78 I-DATE
Name O
: O
Richard O
, O
Ulysses I-NAME
Medical O
Record O
: O
8913196 I-ID
Attending O
: O
Snyder I-NAME
History O
of O
Present O
Illness O
: O
Mr O
Ulysses I-NAME
is O
an O
85 I-AGE
yom O
with O
h/p O
PVD O
s/p O
multiple O
bilateral O
lower O
extremity O
revascularizations O
and O
a O
non-healing O
wound O
on O
the O
RLE O
. O
 
Most O
recently O
, O
he O
had O
undergone O
Rle O
necrotic O
ulcer O
debridement O
( O
07/78 I-DATE
) O
, O
R O
CFA O
to O
distal O
anterior O
tibial O
BPG O
on O
05/78 I-DATE
. O
 
The O
wound O
was O
overlying O
the O
BPG O
. O
 
He O
was O
made O
NWB O
on O
R O
, O
with O
VAC O
dressing O
applied O
to O
the O
wound O
to O
be O
changed O
twice O
weekly O
. O
 
He O
has O
been O
followed O
in O
clinic O
. O
 
Though O
he O
was O
noted O
to O
have O
good O
granulation O
tissue O
during O
his O
hospitalization O
one O
month O
ago O
, O
recently O
his O
wound O
has O
been O
concerning O
for O
non-healing O
. O
 
In O
clinic O
, O
his O
RLE O
is O
ischemic O
, O
and O
there O
is O
a O
concern O
for O
wound O
infection O
. O
 
The O
patient O
reports O
that O
the O
proximal O
aspect O
of O
his O
wound O
had O
pregressive O
breakdown O
over O
the O
past O
2-3 O
weeks O
, O
with O
associated O
increase O
in O
pain O
, O
especially O
with O
VAC O
changes O
. O
 
He O
says O
that O
he O
could O
no O
longer O
feel O
a O
palpable O
graft O
pulse O
as O
he O
could O
just O
after O
the O
surgery O
. O
 
His O
foot O
became O
increasingly O
discolored O
, O
and O
his O
toe O
became O
necrotic O
after O
some O
minor O
trauma O
without O
response O
to O
silvadene O
. O
 
No O
fevers O
, O
chills O
, O
nausea O
, O
vomiting O
. O
 
Past O
Medical O
History O
: O
CAD O
, O
Htn O
, O
CRI O
( O
Cr O
1.8 O
at O
baseline O
) O
, O
DM O
, O
PVD O
, O
Carotid O
Stenosis O
s/p O
R O
CEA O
3/73 I-DATE
, O
CHF O
, O
AF O
, O
Nephrolithiasis O
, O
Spinal O
Stenosis O
Past O
Surgical O
History O
: O
RLE O
wound O
debridement O
2078 I-DATE
R O
CFA O
to O
distal O
anterior O
tibial O
in-situ O
saphenous O
BPG O
2078 I-DATE
L O
fem/pop/peroneal O
BPG O
redo O
2074 I-DATE
L O
fem/pop O
BPG O
2073 I-DATE
R O
CEA O
Allergies O
: O
ASA O
GI O
intolerance O
Medications O
: O
Lasix O
40 O
po O
qd O
Ipatropium O
inh O
Norvasc O
10 O
bid O
KCL O
20 O
QD O
Zocor O
20 O
mg O
po O
qhs O
Fentanyl O
patch O
Doxazosin O
2mg O
po O
qhs O
Nitroglycerine O
patch O
0.2mg/h O
Lopressor O
12.5 O
po O
bid O
Nexium O
40 O
mg O
po O
qd O
Lexapro O
10 O
mg O
po O
qd O
ASA O
325 O
mg O
po O
qd O
Glyburide O
5mg O
po O
qd O
Percocet O
prn O
Ativan O
0.5 O
mg O
po O
bid O
prn O
Social O
history O
: O
Denies O
tobacco O
use O
in O
past O
or O
currently O
. O
 
Alcohol O
1 O
glass O
wine O
every O
few O
weeks O
. O
 
Physical O
Exam O
: O
T= O
97.9 O
P=101 O
BP= O
131/70 O
RR= O
16 O
96 O
% O
RA O
CV O
: O
reg O
Pulm O
: O
clear O
Pulses O
: O
Femoral O
L O
: O
1+ O
R O
: O
1+ O
Pop O
L O
: O
1+ O
R O
: O
1+ O
DP O
: O
L O
: O
np O
R O
: O
np O
PT O
L O
: O
np O
R O
: O
np O
RLE O
cool O
~15cm O
below O
knee O
, O
wound O
of O
medial O
leg O
, O
with O
erythema O
and O
breakdown O
healed O
medial O
saphenous O
harvest O
wound O
foot O
dusky O
, O
poor O
cap O
refill O
, O
necrotic O
1st O
toe O
LLE O
warm O
, O
healed O
medial O
saphenous O
harvest O
wound O
, O
OK O
cap O
refill O
Recent O
studies O
: O
Labs O
: O
Pending O
CXR O
: O
pending O
Impression/Plan O
: O
Ischemic O
RLE O
Admit O
to O
Vascular O
Service O
, O
Dr. O
Matthew I-NAME
Snyder I-NAME
attending O
Send O
wound O
culture O
, O
start O
vancomycin O
empirically O
Plan O
for O
R O
BKA O
on O
09/08 I-DATE
This O
has O
been O
discussed O
with O
Dr. O
Jackson I-NAME
Roth I-NAME
, O
Vascular O
Surgery O
Fellow O
_________________________________________ O
Julia I-NAME
Jorgenson I-NAME
, O
MD O
, O
Vascular O
surgery O
, O
Junior O
Resident O
Pager O
# O
04873 I-CONTACT
 
Record O
date O
: O
2094-08-11 I-DATE
CARDIOLOGY O
COQUILLE I-LOCATION
VALLEY I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
Evaluation O
for O
cardiac O
catheterization O
with O
Dr. O
Irvin I-NAME
Vitale I-NAME
. O
 
Interval O
History O
: O
Multiple O
risk O
factors O
for O
CAD O
including O
DM O
, O
HTN O
, O
CRI O
. O
 
Now O
with O
complaints O
of O
exertional O
dyspnea O
and O
fatigue O
. O
 
Progressed O
and O
she O
was O
evaluated O
by O
Bonnie I-NAME
Eaves I-NAME
. O
 
8/25 I-DATE
Bruce O
protocol O
was O
postive O
at O
9 O
minutes O
, O
64 O
% O
PMHR O
. O
 
Complaints O
of O
dyspnea O
. O
 
EKG O
with O
borderline O
changes O
. O
 
Nuclear O
images O
with O
moderate O
sized O
defect O
of O
anteroapical O
zone O
with O
partial O
reperfusion O
. O
 
Some O
scar O
. O
 
Mild O
LV O
dysfunction O
with O
EF O
45-50 O
% O
and O
apical O
dyskinesis O
. O
 
Arranged O
for O
elective O
cardiac O
catheterization O
with O
Dr O
Vitale I-NAME
. O
 
Past O
medical O
history O
: O
CVA O
of O
left O
PCA O
territory O
2093 I-DATE
. O
 
No O
residual O
. O
 
Rx O
with O
ASA O
, O
folate O
, O
niaspan O
IDDM O
diagnosed O
30 O
yrs O
ago O
CRI O
with O
creat O
baseline O
3.7 O
( O
followed O
by O
Orlando I-NAME
Ernst I-NAME
) O
and O
recent O
eval O
by O
Dr O
Ratliff I-NAME
for O
transplant O
. O
 
+proteinuria O
with O
nephrotic O
syndrome O
. O
 
Donor O
kidney O
lined O
up O
. O
 
HTN O
High O
cholesterol O
Diabetic O
retinopathy O
Anemia O
Medications O
: O
Toprol O
25 O
QD O
Diovan O
160 O
QD O
Norvasc O
10 O
QD O
Lasix O
80 O
QD O
Plavix O
75 O
QD O
ASA O
81 O
QD O
MVI O
Insulin O
pump O
Vytorin O
QD O
Family O
history O
: O
Mom O
A O
& O
W O
in O
her O
60 O
's O
with O
HTN O
. O
 
Dad O
A O
& O
W O
. O
 
Social O
history O
: O
Works O
as O
Patternmaker I-PROFESSION
at O
IMN I-LOCATION
. O
 
volunteer I-PROFESSION
firefighter I-PROFESSION
. O
 
Single O
and O
lives O
with O
her O
parents O
. O
 
Never O
smoked O
. O
 
No O
ETOH O
. O
 
Review O
of O
systems O
: O
no O
peripheral O
edema O
currently O
( O
but O
had O
it O
in O
the O
past O
) O
. O
 
No O
fever O
, O
chills O
, O
sweating O
. O
 
Problems O
with O
gastroparesis O
and O
is O
planning O
to O
have O
a O
gastric O
pacemaker O
inserted O
( O
has O
been O
having O
delayed O
spikes O
in O
insulin O
) O
. O
 
Physical O
examination O
: O
-BP O
: O
150/100 O
L O
154-90 O
R O
-Pulse O
: O
70 O
-resp O
. O
 
rate O
: O
16 O
-weight O
: O
153 O
-BMI O
: O
-General O
appearance O
: O
No O
acute O
distress O
. O
 
-Skin O
: O
No O
rashes O
, O
anicteric O
. O
 
-Heent O
: O
Unremarkable O
-Neck O
: O
Carotids O
2+ O
without O
bruits O
. O
 
JVP O
no O
jugular O
venous O
distention O
-Chest O
: O
Clear O
to O
auscultation O
and O
percussion O
. O
 
-Cardiac O
: O
Left O
ventricular O
impulse O
discrete O
and O
nondisplaced O
. O
 
Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
with O
no O
S3 O
or O
S4 O
. O
 
There O
were O
no O
murmurs O
, O
clicks O
or O
rubs O
. O
 
-Abdomen O
: O
Normal O
bowel O
sounds O
, O
soft O
and O
nontender O
, O
with O
no O
hepatosplenomegaly O
or O
masses O
appreciated O
. O
 
-Extremities O
: O
No O
cyanosis O
, O
clubbing O
or O
edema O
. O
 
2+ O
femoral O
pulses O
without O
bruits O
. O
 
2+ O
pedal O
pulses O
. O
 
-Neuro O
: O
A O
& O
O O
x3 O
, O
CN O
2-12 O
grossly O
intact O
. O
 
Reflexes O
2+ O
and O
symmetric O
x O
4 O
extremities O
. O
 
Toes O
B O
downgoing O
. O
 
EKG O
: O
Selected O
recent O
labs O
: O
8/4/94 I-DATE
: O
WBC O
7.1 O
, O
Crit O
35.2 O
, O
Plts O
274 O
. O
 
INR O
0.9 O
. O
 
Na O
139 O
, O
K O
4.3 O
, O
Creat O
3.4 O
. O
 
AST/ALT O
39-30 O
. O
 
Assessment O
and O
plan O
: O
40 I-AGE
y.o O
. O
 
with O
multiple O
risk O
factors O
for O
CAD O
. O
 
HTN O
, O
high O
chol O
, O
IDDM O
. O
 
Now O
with O
progressive O
angina O
and O
a O
positive O
ETT O
. O
 
Plan O
for O
cath O
. O
 
She O
will O
probably O
end O
up O
on O
dialysis O
given O
severe O
renal O
failure O
. O
 
Pretreated O
with O
musomyst O
. O
 
Give O
bicarb O
in O
holding O
room O
. O
 
Impression O
: O
Further O
plan O
per O
Dr O
Vitale I-NAME
and O
Dr O
Rollins I-NAME
. O
 
Follow O
up O
with O
Dr O
Bonnie I-NAME
Eaves I-NAME
. O
 
Frances I-NAME
Travis I-NAME
Potts I-NAME
NP O
23119 I-CONTACT
Signed O
electronically O
by O
Frances I-NAME
T I-NAME
Potts I-NAME
NP O
on O
Aug I-DATE
11 O
, O
2094 I-DATE
 
Record O
date O
: O
2094-12-26 I-DATE
CARDIOLOGY O
COQUILLE I-LOCATION
VALLEY I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
NSTEMI O
Interval O
History O
: O
Multiple O
risk O
factors O
for O
CAD O
including O
DM O
, O
HTN O
, O
CRI O
. O
 
Developed O
complaints O
of I-DATE
exertional O
dyspnea O
and O
fatigue O
during O
the O
spring I-DATE
of I-DATE
2094 I-DATE
. O
 
Progressed O
and O
she O
was O
evaluated O
by O
Bonnie I-NAME
Eaves I-NAME
. O
 
Bruce O
protocol O
was O
postive O
at O
9 O
minutes O
, O
64 O
% O
PMHR O
. O
 
Complaints O
of I-DATE
dyspnea O
. O
 
EKG O
with O
borderline O
changes O
. O
 
Nuclear O
images O
with O
moderate O
sized O
defect O
of I-DATE
anteroapical O
zone O
with O
partial O
reperfusion O
. O
 
Some O
scar O
. O
 
Mild O
LV O
dysfunction O
with O
EF O
45-50 O
% O
and O
apical O
dyskinesis O
. O
 
8/2094 I-DATE
Admitted O
to O
CVH I-LOCATION
for O
elective O
cath O
. O
 
Cath O
with O
Dr O
Vitale I-NAME
found O
nl O
LM O
. O
 
99 O
% O
subtotal O
LAD O
with O
TIMI O
I O
flow O
. O
 
Circ O
was O
patent O
. O
 
RCA O
with O
proximal O
30 O
% O
lesions O
and O
mid O
80 O
% O
lesion O
. O
 
Nl O
LV O
gram O
. O
 
Treated O
with O
PTCA O
and O
stent O
to O
mid O
LAD O
with O
mini-vision O
non-drug-eluding O
stent O
( O
2.5 O
X O
18 O
mm O
) O
. O
 
Excellent O
results O
. O
 
Distal O
LAD O
with O
residual O
diffuse O
30-40 O
% O
lesion O
. O
 
Plan O
to O
return O
for O
staged O
intervention O
to O
RCA O
. O
 
9/29/2094 I-DATE
she O
was O
readmitted O
for O
elective O
RCA O
PCI O
. O
 
A O
relook O
at O
her O
LAD O
stent O
found O
> O
90 O
% O
restenosis O
to O
proximal O
edge O
of I-DATE
LAD O
stent O
. O
 
Treated O
with O
2.75 O
X O
12 O
mm O
TAXUS O
stent O
. O
 
Tolerated O
procedure O
well O
. O
 
Discharged O
the O
following O
day O
with O
creat O
3.3 O
. O
 
Plan O
was O
to O
again O
return O
for O
RCA O
PCI O
. O
 
10/94 I-DATE
Cath O
: O
patent O
LAD O
stents O
. O
 
Mid O
RCA O
lesion O
treated O
with O
2.5 O
X O
13 O
mm O
cypher O
stent O
. O
 
Discharge O
delayed O
for O
neurologic O
changes O
( O
LOC O
and O
unresponsive O
) O
but O
EEG O
, O
CNIS O
, O
CT O
, O
all O
without O
new O
infarct O
( O
old O
PCA O
CVA O
) O
. O
 
12/25 I-DATE
Developed O
SOB O
and O
arrived O
in O
EW O
at O
SMM I-LOCATION
with O
chest O
pain O
. O
 
EKG O
without O
changes O
. O
 
Trop O
+/- O
but O
continued O
to O
have O
chest O
pain O
. O
 
Given O
previous O
stents O
, O
she O
was O
transferred O
urgently O
to O
CVH I-LOCATION
for O
cath O
. O
 
Past O
medical O
history O
: O
CVA O
of I-DATE
left O
PCA O
territory O
2093 I-DATE
. O
 
No O
residual O
. O
 
Rx O
with O
ASA O
, O
folate O
, O
niaspan O
Complete O
neurologic O
evaluation O
in O
LOC O
in O
10/94 I-DATE
and O
previously O
in O
2093 I-DATE
IDDM O
diagnosed O
30 O
yrs O
ago O
on O
insulin O
pump O
CRI O
with O
creat O
baseline O
3.7 O
( O
followed O
by O
Orlando I-NAME
Ernst I-NAME
) O
and O
recent O
eval O
by O
Dr O
Ratliff I-NAME
for O
transplant O
. O
 
+proteinuria O
with O
nephrotic O
syndrome O
. O
 
Donor O
kidney O
( O
sister O
) O
lined O
up O
. O
 
No O
date O
for O
transplant O
made O
... O
needs O
to O
complete O
Plavix O
course O
first O
. O
 
HTN O
High O
cholesterol O
Diabetic O
retinopathy O
Anemia O
Medications O
( O
Confirmed O
) O
: O
Colace O
100 O
mg O
po O
qd O
Diovan O
160mg O
po O
qd O
Epogen O
10000u O
sc O
sundays I-DATE
erythromycin O
333mg O
po O
TID O
folic O
acid O
1 O
mg O
po O
qd O
Insulin O
pump O
iron O
supplement O
325mg O
po O
am O
isosorbide O
dinitrate O
Lasix O
80 O
mg O
po O
qd O
multivitamins O
1 O
tab O
po O
qd O
Niaspan O
1000mg O
SR O
po O
qhs O
Norvasc O
5mg O
po O
q O
pm O
Phoslo O
and O
vitamin O
B O
1 O
Plavix O
75mg O
po O
qd O
Toprol O
XL O
25 O
mg O
po O
qd O
Vytorin O
10mg/80mg O
po O
qhs O
Allergies O
: O
No O
known O
drug O
allergy O
Family O
history O
: O
Mom O
A O
& O
W O
in O
her O
60 O
's O
with O
HTN O
. O
 
Dad O
A O
& O
W O
. O
 
Sister O
is O
planning O
to O
be O
donor O
kidney O
. O
 
Other O
sister O
is O
back-up O
donor O
. O
 
Social O
history O
: O
Works O
as O
Patternmaker I-PROFESSION
at O
IMN I-LOCATION
. O
 
volunteer I-PROFESSION
firefighter I-PROFESSION
. O
 
Single O
and O
lives O
with O
her O
parents O
. O
 
Never O
smoked O
. O
 
No O
ETOH O
. O
 
Review O
of I-DATE
systems O
: O
no O
peripheral O
edema O
currently O
( O
but O
had O
it O
in O
the O
past O
) O
. O
 
No O
fever O
, O
chills O
, O
sweating O
. O
 
Problems O
with O
gastroparesis O
and O
is O
planning O
to O
have O
a O
gastric O
pacemaker O
inserted O
( O
has O
been O
having O
delayed O
spikes O
in O
insulin O
) O
. O
 
Physical O
examination O
: O
-BP O
: O
110/50 O
-Pulse O
: O
70 O
-resp O
. O
 
rate O
: O
16 O
-weight O
: O
153 O
-General O
appearance O
: O
No O
acute O
distress O
. O
 
-Skin O
: O
No O
rashes O
, O
anicteric O
. O
 
-Heent O
: O
Unremarkable O
-Neck O
: O
Carotids O
2+ O
without O
bruits O
. O
 
JVP O
no O
jugular O
venous O
distention O
-Chest O
: O
Clear O
to O
auscultation O
and O
percussion O
. O
 
-Cardiac O
: O
Left O
ventricular O
impulse O
discrete O
and O
nondisplaced O
. O
 
Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
with O
no O
S3 O
or O
S4 O
. O
 
There O
were O
no O
murmurs O
, O
clicks O
or O
rubs O
. O
 
-Abdomen O
: O
Normal O
bowel O
sounds O
, O
soft O
and O
nontender O
, O
with O
no O
hepatosplenomegaly O
or O
masses O
appreciated O
. O
 
-Extremities O
: O
No O
cyanosis O
, O
clubbing O
or O
edema O
. O
 
2+ O
femoral O
pulses O
without O
bruits O
. O
 
2+ O
pedal O
pulses O
. O
 
-Neuro O
: O
A O
& O
O O
x3 O
, O
CN O
2-12 O
grossly O
intact O
. O
 
Reflexes O
2+ O
and O
symmetric O
x O
4 O
extremities O
. O
 
Toes O
B O
downgoing O
. O
 
Selected O
recent O
labs O
: O
K O
4.4 O
, O
Creat O
4.2 O
. O
 
WBC O
7.5 O
, O
Creat O
35.8 O
, O
Plts O
401 O
. O
 
INR O
0.9 O
Assessment O
and O
plan O
: O
40 I-AGE
y.o O
. O
 
with O
multiple O
risk O
factors O
for O
CAD O
. O
 
HTN O
, O
high O
chol O
, O
IDDM O
. O
 
Previous O
LAD O
stent O
with O
restenosis O
. O
 
Then O
second O
LAD O
stent O
and O
finally O
RCA O
stent O
. O
 
Now O
with O
admit O
for O
NSTEMI O
. O
 
Transferred O
for O
urgent O
cath O
. O
 
Plan O
for O
eventual O
renal O
transplant O
at O
CVH I-LOCATION
( O
had O
been O
waiting O
for O
Plavix O
to O
be O
completed O
) O
. O
 
Pre-treated O
with O
mucomyst O
. O
 
Given O
her O
previous O
restenosis O
, O
and O
the O
fact O
that O
further O
Plavix O
courses O
are O
postponing O
her O
renal O
transplant O
.... O
she O
would O
be O
best O
served O
with O
CABG O
if O
she O
has O
restenosis O
. O
 
Further O
plan O
per O
Dr O
Rollins I-NAME
Follow O
up O
with O
Dr O
Eaves I-NAME
Frances I-NAME
Travis I-NAME
Potts I-NAME
NP O
Changes O
to O
Medications O
this O
visit O
Diovan O
160mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
Lasix O
80 O
mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
Toprol O
XL O
25 O
mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
just O
increased O
to O
50 O
Norvasc O
5mg O
po O
q O
pm O
Start O
: O
09/28/2094 I-DATE
Plavix O
75mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
Niaspan O
1000mg O
SR O
po O
qhs O
Start O
: O
09/28/2094 I-DATE
Vytorin O
10mg/80mg O
po O
qhs O
Start O
: O
09/28/2094 I-DATE
folic O
acid O
1 O
mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
Epogen O
10000u O
sc O
sundays I-DATE
Start O
: O
09/28/2094 I-DATE
multivitamins O
1 O
tab O
po O
qd O
Start O
: O
09/28/2094 I-DATE
iron O
supplement O
325mg O
po O
am O
Start O
: O
09/28/2094 I-DATE
Colace O
100 O
mg O
po O
qd O
Start O
: O
09/28/2094 I-DATE
isosorbide O
dinitrate O
Start O
: O
09/28/2094 I-DATE
erythromycin O
333mg O
po O
TID O
Start O
: O
09/28/2094 I-DATE
for O
gastroparesis O
Phoslo O
and O
vitamin O
B O
1 O
Start O
: O
09/28/2094 I-DATE
Insulin O
pump O
Signed O
electronically O
by O
Frances I-NAME
T I-NAME
Potts I-NAME
NP O
on O
Dec I-DATE
26 O
, O
2094 I-DATE
 
Record O
date O
: O
2095-07-16 I-DATE
Transplant O
Surgery O
Admit O
Note O
Surgical O
Attending O
: O
Dr. O
John I-NAME
Escamilla I-NAME
Fellow O
: O
Dr. O
Robert I-NAME
Ivy I-NAME
Senior O
Resident O
: O
Dr. O
Zachary I-NAME
Terrell I-NAME
Intern O
: O
Dr. O
Victor I-NAME
L. I-NAME
Bonilla I-NAME
MRN O
: O
0658969 I-ID
Pt O
Name O
: O
Fagan O
, O
Joanne I-NAME
Date O
of O
admission O
: O
7/16/95 I-DATE
RFA O
: O
Living-related O
renal O
transplant O
( O
from O
sister O
) O
HPI O
: O
The O
patient O
is O
a O
41 I-AGE
year O
old O
woman O
with O
ESRD O
2/2 O
DM O
nephropathy O
here O
for O
living-related O
renal O
transplant O
this O
morning O
. O
 
She O
continues O
to O
make O
urine O
and O
her O
disease O
has O
not O
been O
complicated O
by O
UTI O
or O
voiding O
dysfunction O
. O
 
Her O
past O
medical O
history O
is O
significant O
for O
CV O
disease O
she O
has O
had O
3 O
cardiac O
stents O
placed O
since O
2094 I-DATE
and O
suffered O
an O
ischemic O
stroke O
in O
2089 I-DATE
for O
which O
she O
takes O
Plavix O
. O
 
This O
morning O
, O
she O
denies O
fever O
, O
chills O
, O
N/V/D O
, O
SOB O
, O
dyspnea O
, O
burning O
on O
urination O
, O
or O
any O
other O
symptoms O
. O
 
PAST O
MEDICAL/SURGICAL O
HISTORY O
: O
IDDM O
diagnosed O
30 O
yrs O
ago O
CAD O
: O
8/94 I-DATE
stent O
to O
mid O
LAD O
, O
9/94 I-DATE
restenosis O
of O
LAD O
taxus O
sten O
to O
LADt O
, O
RCA O
stent O
10/94 I-DATE
12/94 I-DATE
: O
dyspnea O
40 O
% O
in-stent O
restenosis O
of O
LAD O
. O
 
RCA O
stent O
patent O
. O
 
with O
Cypher O
stents O
( O
2 O
) O
to O
RCA O
( O
prox O
and O
distal O
) O
. O
 
Recent O
TTE O
: O
EF O
77 O
% O
Recent O
stress O
test O
: O
8 O
mets O
, O
mild O
anterior O
ischemia O
CVA O
of O
left O
PCA O
territory O
2093 I-DATE
. O
 
No O
residual O
. O
 
Rx O
with O
ASA O
, O
folate O
, O
niaspan O
CKD O
HTN O
High O
cholesterol O
Diabetic O
retinopathy O
Anemia O
MEDICATIONS O
: O
Lasix O
80 O
mg O
qday O
Toprol O
25 O
mg O
qam O
Vytorin O
5/40 O
mg O
qpm O
Niaspan O
1000 O
mg O
qpm O
Folic O
Acid O
1 O
mg O
qdayEpogen O
10,000 O
U O
q O
Sunday I-DATE
Vitamin O
B12 O
500 O
mg O
qam O
Vitamin O
B6 O
100 O
mg O
qam O
Colace O
prn O
Isosorbide O
30 O
mg O
qam O
Insulin O
pump O
at O
1U/hr O
( O
= O
NPH O
12 O
U O
qam O
as O
per O
Dr. O
Valenti I-NAME
) O
Sodium O
bicarbonate O
650 O
mg O
tid O
Diovan O
160 O
mg O
qd O
( O
held O
) O
Norvasc O
5 O
mg O
qd O
( O
held O
) O
Plavix O
75 O
mg O
qd O
( O
held O
) O
ASA O
325 O
mg O
qd O
( O
held O
) O
ALLERGIES O
: O
NKDA/NKA O
SOCIAL O
HISTORY O
: O
seamstress I-PROFESSION
, O
lives O
with O
parents O
( O
single O
) O
. O
 
Tobacco O
: O
negative O
EtOH O
: O
negative O
Other O
drugs O
: O
FAMILY O
HISTORY O
: O
Father O
: O
HTN O
Mother O
: O
HTN O
, O
hyperlipidemia O
Maternal O
grandmother O
: O
CVA O
in O
her O
60 O
's O
, O
CAD O
, O
HTN O
- O
deceased O
at O
age O
70 I-AGE
Siblings O
: O
all O
alive O
and O
well- O
no O
DM O
, O
CAD O
, O
CVA O
ROS O
: O
As O
per O
HPI O
. O
 
PHYSICAL O
EXAM O
: O
Gen O
: O
appears O
well O
, O
in O
NAD O
VS O
: O
pending O
HEENT O
: O
NCAT O
, O
PERRLA O
, O
OC/OP O
clear O
, O
sclerae O
anicteric O
Pulm O
: O
CTAB O
Cardiac O
: O
RRR O
, O
no O
M/R/G O
Abd O
: O
soft O
, O
NT/ND O
, O
BS+ O
Ext O
: O
WWP O
, O
no O
LE O
edema O
. O
 
2+ O
DP/PT O
pulses O
LABS O
: O
U/A O
: O
negative O
Serologies O
: O
CMV O
NEG O
HBsAb O
POS O
HBsAg O
NEG O
HBcAb O
HCV O
NEG O
EBV O
VZV O
HIV O
NEG O
IMAGING O
: O
CXR O
: O
clear O
A/P O
: O
41 I-AGE
year O
old O
woman O
with O
diabetic O
nephropathy-induced O
ESRD O
here O
this O
morning O
for O
living-related O
renal O
transplant O
from O
sister O
. O
 
Cellcept O
in O
the O
AM O
, O
no O
thymoglobulin O
to O
the O
OR O
today O
Victor I-NAME
L. I-NAME
Bonilla I-NAME
, O
MD O
, O
PhD O
Pager O
76006 I-CONTACT
 
Record O
date O
: O
2096-05-28 I-DATE
CARDIOLOGY O
COQUILLE I-LOCATION
VALLEY I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
42 I-AGE
y.o O
. O
 
s/p O
cath O
with O
no O
progression O
of O
CAD O
Interval O
History O
: O
Please O
refer O
to O
detailed O
Cardiology O
admit O
note O
, O
reviewed O
and O
agreed O
with O
, O
briefly O
here O
: O
-- O
08/11/2094 I-DATE
Vision O
stent O
to O
LAD O
. O
 
-- O
09/29/2094 I-DATE
elective O
relook O
, O
LAD O
ISR O
-- O
> O
Taxus O
stent O
2.75 O
x O
12 O
mm O
. O
 
-- O
10/06/2094 I-DATE
Cypher O
stent O
2.5 O
x O
13 O
mm O
to O
the O
mid O
right O
coronary O
artery O
. O
 
-- O
12/25/2094 I-DATE
RCA O
with O
Cypher O
stent O
3 O
x O
13 O
mm O
and O
Cypher O
stent O
2.5 O
x O
18 O
mm O
. O
 
-- O
7/2095 I-DATE
Renal O
transplant O
at O
CVH I-LOCATION
. O
 
Donor O
is O
sister O
( O
live O
donor O
transplant O
) O
. O
 
-- O
2/5/96 I-DATE
RCA O
with O
two O
stents O
( O
DES O
) O
placed O
at O
OSH O
. O
 
-- O
3/2096 I-DATE
ETT O
to O
6+ O
minutes O
( O
61 O
% O
MPHR O
) O
. O
 
EF O
70 O
% O
. O
 
Small O
anteroapical O
defect O
with O
partial O
reperfusion O
( O
small O
) O
. O
 
Septal O
DK O
. O
 
Had O
done O
well O
until O
the O
past O
few O
weeks O
. O
 
Complaints O
of O
SOB O
and O
fatigue O
. O
 
5/27 I-DATE
Admitted O
to O
Ripley I-LOCATION
Clinic I-LOCATION
with O
SOB O
. O
 
Ruled O
out O
. O
 
Had O
episode O
of O
LOC O
( O
has O
done O
in O
past O
at O
CVH I-LOCATION
) O
. O
 
Head O
CT O
negative O
. O
 
She O
has O
been O
listed O
for O
pancreatic O
transplant O
Cath O
today O
revealing O
: O
Coronary O
angiography O
: O
Mild O
to O
moderate O
stenosis O
of O
LAD O
. O
 
Severe O
ostial O
right O
PDA O
disease O
. O
 
Patent O
stents O
in O
the O
LAD O
and O
RCA O
. O
 
Left O
ventriculography O
: O
preserved O
systolic O
function O
with O
no O
MR. O
No O
hemodynamically O
significant O
gradient O
across O
the O
aortic O
valve O
with O
catheter O
pull-back O
. O
 
Past O
medical O
history O
: O
CAD O
as O
above O
with O
multiple O
PCIs O
CVA O
in O
2093 I-DATE
without O
residual O
. O
 
Neuro O
events O
( O
neg O
TIA O
or O
CVA O
or O
Sz O
) O
post O
cath O
. O
 
IDDM O
on O
insulin O
pump O
times O
4yrs O
, O
pt O
states O
glucose O
has O
not O
been O
< O
200 O
over O
the O
past O
Renal O
transplant O
HTN O
High O
cholesterol O
Diabetic O
retinopathy O
Anemia O
Medications O
( O
Confirmed O
) O
: O
aspirin O
325 O
mg O
PO O
QD O
Cellcept O
1000mg O
po O
QD O
Colace O
100mg O
po O
BID O
folic O
acid O
1 O
mg O
PO O
QD O
Imdur O
30 O
mg O
PO O
QD O
insulin O
isosorbide O
dinitrate O
30 O
mg O
QD O
Lasix O
20 O
mg O
po O
daily O
lisinopril O
5 O
mg O
po O
daily O
Plavix O
75 O
mg O
PO O
QD O
Prilosec O
20mg O
po O
daily O
Prograf O
2 O
mg O
2 O
mg O
oral O
twice O
a O
day O
Toprol O
XL O
50 O
mg O
PO O
QD O
Vytorin O
5/40 O
mg O
PO O
QD O
Family O
history O
: O
Mom O
A O
& O
W O
in O
her O
60 O
's O
with O
HTN O
. O
 
Dad O
A O
& O
W O
. O
 
Other O
sister O
is O
back-up O
donor O
. O
 
Social O
history O
: O
The O
patient O
is O
single O
and O
lives O
with O
her O
parents O
. O
 
She O
has O
two O
sisters O
who O
live O
nearby O
. O
 
She O
is O
a O
Patternmaker I-PROFESSION
at O
the O
Ion I-LOCATION
Media I-LOCATION
Networks I-LOCATION
in O
Erwin I-LOCATION
. O
 
Review O
of O
systems O
: O
Neuro O
symptoms O
follow O
cath O
in O
past O
( O
at O
least O
twice O
) O
. O
 
Unresponsive O
and O
unable O
to O
speak O
. O
 
Neuro O
evaluation O
and O
CT O
both O
times O
. O
 
EEGs O
negative O
. O
 
Glucose O
was O
normal O
. O
 
Physical O
examination O
: O
-Pulse O
: O
64 O
-resp O
. O
 
rate O
: O
16 O
-weight O
: O
153 O
-General O
: O
Comfortable O
appearing O
white O
female O
in O
no O
acute O
distress O
-Skin O
: O
No O
rashes O
, O
anicteric O
. O
 
-HEENT O
: O
Unremarkable O
-Neck O
: O
Supple O
. O
 
No O
thyromegaly O
. O
 
Carotids O
2+ O
with O
possible O
soft O
bruit O
bilaterally O
-Chest O
: O
Clear O
-Cardiac O
: O
No O
JVD O
. O
 
PMI O
not O
displaced O
. O
 
2/6 O
SEM O
at O
base/RSB O
. O
 
No O
rub O
. O
 
-Abdomen O
: O
Bowel O
sounds O
present O
. O
 
No O
hepatosplenomegaly O
. O
 
No O
masses O
or O
tenderness O
-Extremities O
: O
left O
groin O
no O
ooze O
, O
no O
hematoma O
, O
+2 O
dp O
and O
pt O
, O
right O
groin O
attempted O
canulization O
, O
no O
ooze O
, O
no O
hematoma O
-Neuro O
: O
A O
& O
O O
x3 O
, O
CN O
2-12 O
grossly O
intact O
. O
 
-BP O
: O
170/64 O
Selected O
recent O
labs O
: O
WBC O
12.6 O
, O
Crit O
36.9 O
, O
Plts O
216 O
. O
 
INR O
1.1 O
. O
 
Na O
134 O
, O
K O
4.5 O
, O
BUN O
21 O
. O
 
Creat O
1.2 O
. O
 
Assessment O
and O
plan O
: O
The O
patient O
is O
a O
41-year-old O
white O
female O
with O
a O
history O
of O
insulin-dependent O
diabetes O
mellitus O
with O
renal O
transplant O
in O
2095 I-DATE
. O
 
Previous O
PCIs O
to O
RCA O
and O
LAD O
with O
several O
DES O
. O
 
Now O
with O
recurrent O
angina O
. O
 
Cath O
today O
with O
no O
progression O
of O
disease O
-continue O
current O
medications O
-IVF O
overnight O
-patient O
to O
adjust O
insulin O
pump O
as O
indicated O
-plan O
for O
d/c O
in O
am O
-further O
plans O
per O
Dr O
Rollins I-NAME
Francisca I-NAME
Kline I-NAME
NP O
Changes O
to O
Medications O
this O
visit O
insulin O
pump O
Patient O
adjusts O
her O
insulin O
pump O
independently O
lisinopril O
10 O
mg O
po O
daily O
Start O
: O
05/28/2096 I-DATE
Cellcept O
1000mg O
po O
bid O
Start O
: O
05/28/2096 I-DATE
Vytorin O
10/80 O
PO O
QD O
Francisca I-NAME
Kline I-NAME
, O
RN O
Transcribed O
by O
: O
Francisca I-NAME
Kline I-NAME
Signed O
electronically O
by O
Francisca I-NAME
Kline I-NAME
, O
RN O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2098-10-11 I-DATE
CARDIOLOGY O
COQUILLE I-LOCATION
VALLEY I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
45 I-AGE
y O
o O
seamstress I-PROFESSION
with O
h/o O
CAD O
, O
renal O
transplant O
, O
CVA O
, O
here O
for O
cardiology O
FU O
after O
having O
been O
inactivated O
from O
pancreas O
transplant O
list O
. O
 
Interval O
History O
: O
Ms. O
Fagan I-NAME
notes O
that O
she O
is O
doing O
very O
well O
. O
 
She O
does O
not O
have O
any O
chest O
pain O
and O
only O
rare O
dyspnea O
. O
 
She O
has O
not O
had O
any O
dizziness O
and O
lightheadedness O
. O
 
She O
had O
previously O
been O
on O
the O
CVH I-LOCATION
pancreas O
transplant O
list O
and O
had O
full O
cardiac O
workup O
including O
recent O
dobutamine O
echo O
which O
revealed O
normal O
LV O
function O
and O
no O
ischemia O
. O
 
However O
, O
there O
was O
concern O
about O
her O
extensive O
visceral O
and O
iliac O
vascular O
calcification O
by O
CT O
which O
rendered O
her O
high O
surgical O
risk O
. O
 
She O
is O
understandably O
upset O
about O
this O
reclassification O
and O
is O
here O
today O
for O
an O
overview O
of O
her O
cardiac O
status O
. O
 
Past O
medical O
history O
: O
IDDM O
for O
many O
years O
for O
which O
she O
is O
on O
an O
insulin O
pump O
. O
 
She O
now O
also O
has O
a O
continuous O
glucometer O
as O
she O
has O
had O
a O
h/o O
recurrent O
hypoglycemic O
episodes O
CAD O
- O
s/p O
PCI O
LAD O
8/94 I-DATE
with O
subsequent O
DES O
to O
mid O
RCA O
and O
restent O
proximal O
edge O
of O
LAD O
stent O
9/94 I-DATE
. O
 
12/94 I-DATE
RCA O
stenting O
. O
 
Repeat O
RCA O
stenting O
2/96 I-DATE
. O
 
70 O
% O
OMB2 O
detected O
. O
 
Subsequent O
cath O
no O
change O
. O
 
No O
ischemia O
by O
9/98 I-DATE
dobutamine O
Echo O
Small O
anteroapical O
defect O
with O
partial O
reperfusion O
by O
8/97 I-DATE
nuclear O
, O
unchanged O
LVEF O
75 O
% O
h/o O
CHF O
s/p O
renal O
transplant O
with O
Cr O
1.1-1.2 O
Hypercholesterolemia O
h/o O
L O
temporal-occipital O
CVA O
2093 I-DATE
with O
subsequent O
agraphia O
and O
inability O
to O
read O
which O
has O
resolved O
. O
 
Diabetic O
retinopathy O
s/p O
R O
wrist O
fx O
2/96 I-DATE
s/p O
L O
foot O
fx O
with O
surgery O
5/97 I-DATE
for O
nonhealing O
and O
wound O
infection O
Changes O
to O
Allergies O
reglan O
- O
reaction O
: O
GI O
Intolerance O
[ O
reviewed O
] O
Family O
history O
: O
Mother O
with O
HTN O
, O
cancerdiabetes O
. O
 
Father O
afib O
. O
 
Grandmother O
CVA O
. O
 
Social O
history O
: O
The O
patient O
is O
single O
and O
lives O
with O
her O
parents O
. O
 
She O
is O
a O
Patternmaker I-PROFESSION
at O
the O
Ion I-LOCATION
Media I-LOCATION
Networks I-LOCATION
in O
Erwin I-LOCATION
. O
 
Review O
of O
systems O
: O
No O
fever O
, O
chills O
or O
sweats O
. O
 
No O
nausea O
vomiting O
or O
diarrhea O
. O
 
No O
cough O
or O
respiratory O
sxs O
. O
 
No O
abdominal O
pain O
. O
 
No O
headaches O
or O
neurologic O
sxs O
. O
 
Remainder O
of O
ros O
negative O
except O
as O
described O
in O
HPI O
. O
 
Physical O
examination O
: O
-BMI O
: O
24.2 O
Normal O
, O
low O
risk O
-Pulse O
: O
73 O
-resp O
. O
 
rate O
: O
12 O
-height O
: O
66.25 O
in O
. O
 
-weight O
: O
151 O
lbs O
. O
 
-General O
: O
Well-appearing O
middle O
aged O
white O
female O
in O
no O
apparent O
distress O
. O
 
Skin O
is O
warm O
and O
dry O
. O
 
HEENT O
examination O
is O
within O
normal O
limits O
. O
 
Neck O
is O
without O
jugular O
venous O
distention O
. O
 
Carotids O
are O
2 O
bilaterally O
without O
bruits O
. O
 
There O
is O
no O
lymphadenopathy O
. O
 
Lungs O
are O
clear O
without O
wheezes O
or O
rhonchi O
. O
 
Cardiac O
exam O
reveals O
a O
nondisplaced O
PMI O
S1-S2 O
regular O
rhythm O
with O
no O
murmur O
, O
rub O
or O
gallop O
. O
 
Abdomen O
is O
soft O
and O
nontender O
with O
positive O
bowel O
sounds O
. O
 
Extremities O
are O
without O
peripheral O
edema O
. O
 
Distal O
pulses O
are O
2 O
bilaterally O
. O
 
There O
is O
no O
clubbing O
or O
cyanosis O
. O
 
Neuro O
exam O
is O
grossly O
nonfocal O
. O
 
NS O
-BP O
: O
106 O
66 O
( O
l O
) O
EKG O
: O
NSR O
at O
73 O
. O
 
LVH O
by O
voltage O
. O
 
Septal O
infarct O
- O
age O
indeterminate O
. O
 
No O
change O
compared O
with O
7/11/98 I-DATE
. O
 
Selected O
recent O
labs O
: O
Lipid/Thyroid O
Date O
 
Record O
date O
: O
2097-06-09 I-DATE
Renal O
Consult O
Note O
Quinton I-NAME
Delong I-NAME
, O
M.D O
. O
 
CC/ID O
: O
Asked O
to O
assit O
in O
the O
mangement O
of O
Lori I-NAME
Stevens I-NAME
with O
hypertension O
, O
nausea O
and O
vomiting O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
She O
is O
a O
62 I-AGE
year O
old O
lady O
with O
ESRD O
who O
has O
been O
admitted O
in O
the O
past O
with O
nausea O
, O
vomiting O
and O
severe O
hypertension O
. O
 
She O
was O
treated O
with O
BP O
medications O
. O
 
She O
has O
had O
a O
CT O
scan O
and O
is O
seen O
in O
dialysis O
. O
 
She O
is O
stable O
on O
dialysis O
currently O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
1 O
. O
 
Diabetes O
Mellitus O
x O
many O
years O
. O
 
2 O
. O
 
History O
of O
hypertension O
x O
many O
years O
. O
 
3 O
. O
 
History O
of O
GI O
bleeding O
. O
 
4 O
. O
 
ESRD O
secondary O
to O
DM O
on O
HD O
x O
years O
. O
 
On O
HD O
Mon/Wed/Fri O
. O
 
5 O
. O
 
CAD O
s/p O
NSTEMI O
. O
 
6 O
. O
 
Meningitis O
in O
the O
past O
. O
 
( O
Viral O
) O
MEDICATIONS O
Unavailable O
SOCIAL O
HISTORY O
: O
Lives O
in O
Nursing O
Home O
. O
 
PHYSICAL O
EXAMINATION O
: O
BP O
: O
159/70 O
P O
: O
72 O
R O
: O
16 O
T=97 O
SKIN O
: O
No O
rash O
HEENT O
: O
Anicteric O
NECK O
: O
Supple O
. O
 
JVP= O
6 O
cm O
CHEST O
: O
Left O
base O
crackles O
& O
gt O
; O
right O
COR O
: O
S1 O
S2 O
ABD O
: O
Benign O
. O
 
No O
HSM O
EXT O
: O
No O
edema O
Labs O
: O
Plasma O
Sodium O
136 O
( O
135-145 O
) O
mmol/LPlasma O
Potassium O
3.9 O
( O
3.4-4.8 O
) O
mmol/LPlasma O
Chloride O
91 O
L O
( O
100-108 O
) O
mmol/LPlasma O
Carbon O
Dioxide O
29.1 O
( O
23.0-31.9 O
) O
mmol/LPlasma O
Anion O
GAP O
16 O
H O
( O
3-15 O
) O
mmol/LCalcium O
10.0 O
( O
8.5-10.5 O
) O
mg/dlPhosphorus O
4.6 O
H O
( O
2.6-4.5 O
) O
mg/dlMagnesium O
2.0 O
( O
1.4-2.0 O
) O
meq/LPlasma O
Urea O
Nitrogen O
50 O
H O
( O
8-25 O
) O
mg/dlPlasma O
Creatinine O
3.93 O
H O
( O
0.60-1.50 O
) O
mg/dleGFR O
12 O
mL/min/1.73m2Plasma O
Glucose O
132 O
H O
( O
70-110 O
) O
mg/dlTotal O
Protein O
8.0 O
( O
6.0-8.3 O
) O
g/dlAlbumin O
3.6 O
( O
3.3-5.0 O
) O
g/dlGlobulin O
4.4 O
H O
( O
2.6-4.1 O
) O
g/dlDirect O
Bilirubin O
0.2 O
( O
0-0.4 O
) O
mg/dlTotal O
Bilirubin O
0.4 O
( O
0.0-1.0 O
) O
mg/dlAlkaline O
Phosphatase O
345 O
H O
( O
30-100 O
) O
U/LTransaminase-SGPT O
9 O
( O
7-30 O
) O
U/LAmylase O
54 O
( O
3-100 O
) O
units/LTransaminase-SGOT O
19 O
( O
9-32 O
) O
U/LLipase O
18 O
( O
13-60 O
) O
U/L O
WBC O
15.9 O
H O
( O
4.5-11.0 O
) O
th/cmmHCT O
39.0 O
( O
36.0-46.0 O
) O
% O
HGB O
12.4 O
( O
12.0-16.0 O
) O
gm/dlRBC O
4.39 O
( O
4.00-5.20 O
) O
mil/cmmPLT O
558 O
H O
( O
150-400 O
) O
th/cummMCV O
89 O
( O
80-100 O
) O
flMCH O
28.2 O
( O
26.0-34.0 O
) O
pg/rbcMCHC O
31.9 O
( O
31.0-37.0 O
) O
g/dlRDW O
20.9 O
H O
( O
11.5-14.5 O
) O
% O
Poly O
82 O
H O
( O
40-70 O
) O
% O
Lymphs O
8 O
L O
( O
22-44 O
) O
% O
Monos O
4 O
( O
4-11 O
) O
% O
EOS O
6 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
Absolute O
Neuts O
13.18 O
H O
( O
1.8-7.7 O
) O
th/cmmAbsolute O
Lymphs O
1.20 O
( O
1.0-4.8 O
) O
th/cmmAbsolute O
Monos O
0.58 O
( O
0.2-1.2 O
) O
th/mm3Absolute O
EOS O
0.88 O
H O
( O
0.1-0.3 O
) O
th/cmmAbsolute O
Basos O
0.02 O
( O
0.0-0.3 O
) O
th/cmmAniso O
2+ O
H O
( O
None O
) O
Hypo O
3+ O
H O
( O
None O
) O
Macrocytes O
None O
( O
None O
) O
Microcytes O
1+ O
H O
( O
None O
) O
IMPRESSION O
: O
Ms. O
Stevens I-NAME
is O
a O
64 I-AGE
year O
old O
lady O
with O
ESRD O
admitted O
with O
hypertension O
and O
nausea O
as O
well O
as O
vomiting O
. O
 
She O
was O
quite O
hypertensive O
and O
I O
would O
wonder O
about O
the O
effect O
of O
BP O
. O
 
She O
also O
looks O
fluid O
overloaded O
. O
 
PLAN O
: O
HD O
x O
3 O
1/4 O
hours O
, O
2 O
K O
, O
2.5 O
Ca O
Negative O
3 O
liters O
Needs O
Medication O
clarification O
and O
good O
BP O
control O
. O
 
Quinton I-NAME
Delong I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2097-12-01 I-DATE
RENAL O
CONSULT O
NOTE O
AUTHOR/FELLOW O
& O
# O
8211 O
; O
Morrison I-NAME
ATTENDING O
& O
# O
8211 O
; O
Ingle I-NAME
Consult O
indication O
& O
# O
8211 O
; O
Pt O
with O
ESRD O
, O
consulted O
for O
HD O
needs O
HPI O
& O
# O
8211 O
; O
64 I-AGE
yo O
F O
with O
ho O
ESRD O
due O
to O
DM O
on O
HD O
TTS O
, O
Type O
2 O
DM O
, O
CVA O
, O
prior O
GI O
bleeds O
- O
& O
gt O
; O
admitted O
for O
probable O
PNA O
and O
colitis O
- O
& O
gt O
; O
consulted O
for O
HD O
needs O
. O
 
Recently O
admitted O
8/27-8/30/97 O
for O
HTN O
urgency O
, O
N/V O
, O
and O
CT O
findings O
of O
asc O
colon O
thickening O
suggestive O
of O
colitis O
. O
 
BP O
controlled O
with O
IV O
and O
oral O
medications O
and O
UF O
on O
HD O
. O
 
Was O
seen O
by O
GI O
consult O
who O
felt O
that O
CT O
findings O
were O
an O
artifact O
in O
context O
of O
volume O
overload O
. O
 
Cdif O
toxin O
x O
1 O
negative O
, O
was O
also O
given O
ivermectin O
for O
positive O
stronyloides O
serology O
. O
 
Was O
d/c O
& O
# O
8217 O
; O
ed O
on O
vanc O
x O
2 O
weeks O
with O
HD O
for O
sacral O
decub O
ulcer O
. O
 
Admitted O
from O
NGH I-LOCATION
with O
N/V O
, O
abd O
pain O
. O
 
In O
ER O
, O
had O
BP O
204/99 O
, O
nl O
HR O
, O
RR O
, O
and O
was O
afebrile O
. O
 
Had O
CT O
a/p O
with O
contrast O
showing O
resolution O
of O
asc O
colon O
thickening O
, O
now O
with O
sigmoid/rectal O
thickening O
concerning O
for O
infectious O
colitis O
, O
also O
with O
LLL O
opacity O
possible O
pna O
; O
cdif O
x O
1 O
negative O
. O
 
Per O
ER O
notes O
, O
had O
bloody O
BM O
overnight O
. O
 
Received O
vanc O
1 O
g O
, O
cefepime O
1 O
g O
, O
and O
flagyl O
500 O
mg. O
Pt O
currently O
endorses O
abd O
pain O
localized O
to O
LLQ O
; O
denies O
melena O
, O
hematochezia O
. O
 
Has O
had O
N/V O
x O
1 O
day O
, O
no O
hematemsis O
. O
 
Denies O
fevers O
, O
dyspnea O
, O
cough O
, O
chest O
pain O
, O
rash O
. O
 
Makes O
small O
amt O
of O
urine O
, O
no O
dysuria O
. O
 
All O
other O
ROS O
evaluated O
and O
found O
to O
be O
negative O
. O
 
PMH O
& O
# O
8211 O
; O
1 O
. O
 
ESRD O
since O
2096 I-DATE
- O
etiology O
presumed O
DM O
- O
access O
= O
L O
brachiocephalic O
AVF O
2 O
. O
 
Chronic O
decubitus O
ulcers O
3 O
. O
 
Type O
II O
DM O
4 O
. O
 
Prior O
GI O
bleeding O
- O
no O
prior O
endoscopy O
report O
from O
MH O
5 O
. O
 
CVA O
12/96 I-DATE
, O
previous O
PEG O
tube O
now O
removed O
6 O
. O
 
Cataracts O
7 O
. O
 
Hypertension O
( O
intermittently O
difficult O
to O
control O
) O
8 O
. O
 
Past O
TTE O
7/97 I-DATE
Mild O
AI O
, O
TR O
, O
PI O
, O
LVSF O
68 O
, O
R O
PA O
dilation O
, O
RV O
no O
diln/hypokinesis O
Medications O
: O
( O
taken O
from O
NGH I-LOCATION
list O
) O
phoslo O
1 O
tab O
po O
tidac O
labetaolol O
200 O
tid O
, O
am O
dose O
held O
HD O
days O
lisinopril O
30 O
qday O
renocaps O
1 O
tab O
po O
qday O
MOM O
maalox O
oxycodone O
compazine O
supp O
tyl O
prn O
albuterol O
ipratropium O
cholestyramine O
powder O
omeprazole O
40 O
qday O
70/30 O
4 O
am O
3 O
pm O
acetaminophen O
prn O
ALL O
& O
# O
8211 O
; O
nkda O
FH/SH O
& O
# O
8211 O
; O
lives O
in O
nursing O
facility O
reports O
that O
dtr O
lives O
nearby O
PEX O
& O
# O
8211 O
; O
187/57 O
89 O
at O
start O
of O
HD O
gen O
pleasant O
, O
able O
to O
answer O
questions O
appropriately O
jvp O
JVP O
~14 O
cm O
at O
45 O
degrees O
pulm O
cta O
b O
, O
no O
wrr O
cv O
rrr O
, O
systolic O
murmur O
heard O
throughout O
precordium O
gi O
+ O
bs O
, O
+ O
distn O
, O
TTP O
in O
LLQ O
only O
, O
no O
reb/rig/guarding O
extrem O
no O
edema O
, O
LUE O
AVF O
with O
good O
thrill/bruit O
LABS O
& O
# O
8211 O
; O
cbc O
11.4 O
, O
hb O
13.5 O
, O
plt O
285 O
na O
137 O
, O
k O
5.4 O
, O
cl O
89 O
, O
bicarb O
26.2 O
, O
bun O
61 O
, O
cr O
4.99 O
, O
gluc O
196 O
, O
ca O
10.5 O
, O
mg O
1.9 O
, O
phos O
4.1 O
vit O
d O
20 O
8/27/97 I-DATE
alb O
4.2 O
fe O
50 O
, O
tibc O
204 O
, O
ferritin O
878 O
8/27 I-DATE
inr O
1.1 O
pth O
115 O
8/27 I-DATE
CT O
A/P O
WITH O
IV O
CONTRAST O
12/1 I-DATE
Patchy O
LLL O
consolidation O
, O
B O
effusions O
( O
pleural O
) O
CM O
Periportal O
edema O
, O
tr O
ascites O
Atrophic O
pancreas O
, O
stable O
low O
attenuation O
lesion O
at O
head O
Stable O
nonobstructing O
R O
lower O
pole O
renal O
calculi O
measuring O
approximately O
3 O
to O
4 O
mm O
Uterine O
fibroids O
Nonspecific O
thickening O
of O
bladder O
wall O
Vascular O
calcification O
G O
tube O
removal O
with O
thickening O
at O
site O
Resolution O
of O
asc O
colon O
thickening O
, O
new O
mild O
to O
moderate O
diffuse O
sigmoid O
colon O
and O
rectal O
thickening O
, O
no O
obstruction O
Diffuse O
soft O
tissue O
edema O
CXR O
LLL O
opacity O
, O
small O
R O
effn O
, O
int O
edema O
IMPRESSION O
- O
1 O
. O
 
ESRD O
- O
HD O
today O
3 O
hrs O
( O
12/97 I-DATE
was O
undergoing O
2.5 O
hr O
HD O
runs O
, O
but O
9/97 I-DATE
was O
undergoing O
3 O
hr O
runs O
; O
will O
measure O
URR O
and O
Kt/V O
) O
, O
2K/2.5Ca O
, O
3L O
UF O
, O
no O
EPO O
, O
zemplar O
1 O
mcg O
. O
 
No O
heparin O
with O
HD O
given O
possible O
GI O
bleed O
. O
 
2 O
. O
 
ACCESS O
& O
# O
8211 O
; O
During O
8/97 I-DATE
admission O
, O
was O
to O
undergo O
fistulogram O
but O
per O
notes O
from O
last O
9/97 I-DATE
admission O
AVF O
was O
functioning O
well O
. O
 
Good O
thrill/bruit O
on O
exam O
. O
 
Place O
sign O
over O
bed O
indicating O
no O
BP's/IV's/blood O
draws O
from O
LUE O
. O
 
3 O
. O
 
ANEMIA O
& O
# O
8211 O
; O
Hb O
currently O
high O
, O
but O
per O
ER O
notes O
had O
bloody O
stool O
overnight O
( O
per O
signout O
from O
current O
ER O
nurse O
and O
resident O
, O
no O
recurrence O
of O
hematochezia O
) O
, O
has O
not O
had O
sufficient O
time O
to O
equilibrate O
. O
 
Will O
hold O
EPO O
for O
now O
, O
would O
consider O
serial O
CBC O
's O
. O
 
Consider O
GI O
consult O
given O
hematochezia O
, O
sigmoid O
c/rectal O
thickening O
on O
CT O
; O
distribution O
of O
colon O
involvement O
not O
in O
watershed O
area O
, O
but O
given O
extensive O
atherosclerotic O
disease O
, O
ischemic O
colitis O
possible O
in O
addition O
to O
infectious O
etiologies O
. O
 
4 O
. O
 
MINERALS O
& O
# O
8211 O
; O
Phos O
at O
goal O
, O
on O
phoslo O
1 O
tab O
po O
tidac O
. O
 
PTH O
below O
goal O
, O
will O
give O
low O
dose O
zemplar O
1 O
mcg O
IV O
. O
 
VIt O
25oh O
D O
low O
8/27/97 I-DATE
, O
may O
have O
already O
received O
course O
of O
ergo O
, O
will O
repeat O
levels O
and O
if O
& O
lt O
; O
30 O
, O
will O
need O
addtl O
course O
ergocalciferol O
. O
 
5 O
. O
 
VOLUME/HTN O
& O
# O
8211 O
; O
Pt O
with O
elevated O
BP O
, O
volume O
up O
on O
exam O
; O
CT O
study O
also O
demonstrates O
pleural O
effusions O
, O
mild O
ascites O
, O
and O
diffuse O
soft O
tissue O
edema O
. O
 
Pre-HD O
wt O
not O
obtained O
, O
will O
aim O
for O
3L O
UF O
( O
EDW O
48 O
kg O
) O
. O
 
6 O
. O
 
NUTRITION O
& O
# O
8211 O
; O
1.5L O
fluid O
restrict O
, O
2g O
K O
restrict O
, O
continue O
nephrocaps O
. O
 
Continue O
labetalol O
and O
lisinopril O
. O
 
7 O
. O
 
HEMATOCHEZIA O
- O
See O
# O
3 O
. O
 
8 O
. O
 
LUNG O
OPACITY O
- O
Received O
vanc O
and O
cefepime O
for O
possible O
pna O
in O
ER O
prior O
to O
arrival O
on O
HD O
. O
 
Vanc O
not O
given O
on O
HD O
. O
 
Would O
give O
addtl O
dose O
of O
cefepime O
1 O
g O
today O
after O
HD O
. O
 
Blood O
cx O
's O
x O
2 O
drawn O
on O
HD O
. O
 
Pt O
to O
be O
discussed O
with O
Dr. O
Ingle I-NAME
. O
 
Thelma I-NAME
Morrison I-NAME
, O
renal O
fellow O
, O
pager O
96794 I-CONTACT
Renal O
Staff O
Addendum O
Patient O
seen O
and O
examined O
on O
dialysis O
. O
 
Discussed O
with O
Renal O
Fellow O
. O
 
Agree O
with O
details O
per O
her O
note O
. O
 
Admitted O
with O
nausea O
vomiting O
abdominal O
pain O
and O
accelerated O
hypertension O
. O
 
Initial O
evaluation O
notable O
for O
pulmonary O
infiltrate O
and O
colonic O
thickening O
with O
mildly O
elevated O
WBC O
cnt O
. O
 
On O
exam O
Afebrile O
with O
BP O
initially O
180 O
decreasing O
to O
110 O
on O
dialysis O
. O
 
Chest O
exam O
notable O
for O
crackles O
with O
O2 O
sat O
97 O
% O
. O
 
Is O
not O
in O
overt O
CHF O
although O
appears O
volume O
overloaded O
with O
peripheral O
edema O
. O
 
Abdominal O
exam O
benign O
despite O
CT O
findings O
. O
 
Labs O
showing O
hyperkalemia O
. O
 
Dialysis O
: O
3 O
hrs O
2K O
bath O
Ultrafiltration O
: O
2L O
Anemia O
management O
: O
Epogen O
on O
hold O
due O
t O
dialysis O
CVD O
: O
optimize O
dry O
wt O
and O
anti-hypertensives O
ID O
: O
broadly O
covered O
with O
Vancomycin O
and O
Cefeopime O
; O
r/o O
C O
diff O
John I-NAME
Ingle I-NAME
MD O
. O
 
Record O
date O
: O
2098-02-12 I-DATE
RENAL O
CONSULT O
NOTE O
ATTENDING O
& O
# O
8211 O
; O
Dr. O
John I-NAME
Ingle I-NAME
DOA O
& O
# O
8211 O
; O
02/12/98 I-DATE
Consult O
indication O
- O
Pt O
with O
ESRD O
, O
consulted O
for O
HD O
needs O
from O
ED O
department O
HPI O
- O
64 I-AGE
yo O
F O
with O
ho O
ESRD O
due O
to O
DM O
on O
HD O
TTS O
, O
Type O
2 O
DM O
, O
CVA O
, O
prior O
GI O
bleeds O
- O
& O
gt O
; O
admitted O
with O
nausea O
and O
vomiting O
and O
abdo O
distention O
. O
 
Very O
difficult O
history O
in O
ED O
as O
limited O
English O
and O
orevious O
dysphasia O
from O
CVA O
. O
 
Recently O
admitted O
12/1-12/10/97 O
for O
N/V/abd O
pain O
. O
 
CT O
abdomen O
demonstrated O
thickened O
sigmoid O
colon/rectum O
. O
 
Underwent O
colonoscopy O
demonstrating O
polyp O
- O
& O
gt O
; O
high O
grade O
dysplasia/adenoca O
on O
path O
. O
 
CT O
pancreas O
protocol O
demonstrated O
low O
density O
foci O
in O
the O
head O
and O
uncinate O
process O
unchanged O
since O
1/96 I-DATE
. O
 
Had O
blood O
cx O
positive O
for O
stenotrophomonas O
( O
cefepime O
resistant O
) O
, O
e O
faecium O
, O
and O
achromobacter O
, O
briefly O
received O
cefepime O
, O
surveillance O
cx O
& O
# O
8217 O
; O
s O
negative O
, O
and O
abx O
were O
d/c O
& O
# O
8217 O
; O
ed O
. O
 
PMH O
- O
1 O
. O
 
ESRD O
since O
2096 I-DATE
- O
etiology O
presumed O
DM O
- O
access O
= O
L O
brachiocephalic O
AVF O
2 O
. O
 
Chronic O
decubitus O
ulcers O
3 O
. O
 
Type O
II O
DM O
4 O
. O
 
Prior O
GI O
bleeding O
- O
no O
prior O
endoscopy O
report O
from O
MH O
5 O
. O
 
CVA O
12/96 I-DATE
, O
previous O
PEG O
tube O
now O
removed O
6 O
. O
 
Cataracts O
7 O
. O
 
Hypertension O
8 O
. O
 
Past O
TTE O
7/97 I-DATE
Mild O
AI O
, O
TR O
, O
PI O
, O
LVSF O
68 O
, O
R O
PA O
dilation O
, O
RV O
no O
diln/hypokinesis O
9 O
. O
 
Stage O
I-II O
colon O
cancer O
Medications O
( O
from O
last O
discharge O
) O
: O
Heparin O
5000 O
UNITS O
SC O
TIDAlbuterol O
Nebulizer O
2.5 O
MG O
NEB O
Q6H O
prnCalcium O
Acetate O
( O
1 O
Gelcap=667 O
Mg O
) O
667 O
MG O
PO O
TIDCholestyramine O
Resin O
Dried O
4 O
GM O
PO O
BIDLisinopril O
40 O
MG O
PO O
QDNephrocaps O
1 O
CAPSULE O
PO O
QDOmeprazole O
40 O
MG O
PO O
BIDOndansetron O
Hcl O
( O
Non O
Chemo O
) O
( O
Zofran O
( O
Non O
Chemo O
) O
) O
4 O
MG O
IV O
Q8H O
prnAcetaminophen O
( O
Tylenol O
) O
650 O
MG O
PO O
Q6H O
prnInsulin O
Regular O
Inj O
SC O
AC O
( O
Sliding O
Scale O
) O
Labetalol O
Hcl O
300 O
MG O
PO O
TIDAcetylsalicylic O
Acid O
( O
Aspirin O
) O
81 O
MG O
PO O
QDInsulin O
Glargine O
( O
Lantus O
) O
5 O
UNITS O
SC O
QHSAmlodipine O
10 O
MG O
PO O
QPMHydralazine O
Hcl O
10 O
MG O
PO O
QID O
prn O
Allergies O
: O
NKDA O
FH/SH O
- O
Lives O
in O
nursing O
facility O
No O
alcohol O
, O
no O
illicitr O
Daughter O
lives O
nearby O
EXAM O
: O
BP O
193/69 O
HR O
62 O
T O
98F O
Hands O
: O
no O
clubbing O
H+N O
: O
no O
elevated O
JVP O
, O
erythema O
and O
injection O
elft O
eye O
? O
 
conjunctivitis O
, O
no O
nodes O
CVS O
: O
normal O
S1 O
and O
S2 O
, O
no O
added.murmurs/rubs O
heard O
Chest O
: O
dull O
right O
abse O
, O
creps O
bibasally O
Abdo O
: O
SNT O
, O
distended O
, O
BS O
present O
Legs O
: O
no O
odema O
, O
Calves O
soft O
LABS O
: O
Results02/12/2098 O
NA O
139 O
, O
K O
6.2 O
( O
H O
) O
, O
CL O
94 O
( O
L O
) O
, O
CO2 O
29.2 O
, O
BUN O
37 O
( O
H O
) O
, O
CRE O
3.47 O
( O
H O
) O
02/12/2098 I-DATE
NA O
135 O
, O
K O
6.6 O
( O
H O
) O
, O
CL O
93 O
( O
L O
) O
, O
CO2 O
26.1 O
, O
BUN O
38 O
( O
H O
) O
, O
CRE O
3.56 O
( O
H O
) O
02/12/2098 I-DATE
CA O
10.102/12/2098 O
CA O
9.9 O
, O
ALB O
4.2 O
, O
LIPS O
2202/12/2098 O
aPO2 O
96 O
, O
aPCO2 O
52 O
( O
H O
) O
, O
aPH O
7.40 O
, O
K-PL O
5.2 O
( O
H O
) O
02/12/2098 I-DATE
ALT/SGPT O
32 O
( O
H O
) O
, O
AST/SGOT O
87 O
( O
H O
) O
, O
ALKP O
233 O
( O
H O
) O
, O
TBILI O
0.502/12/2098 O
WBC O
9.6 O
, O
HGB O
13.7 O
, O
PLT O
29702/12/2098 O
PT-INR O
1.2 O
A/PLAN O
: O
Nausea+Vomiting O
Concerning O
in O
light O
of O
history O
of O
colon O
ca O
, O
but O
did O
not O
appear O
to O
have O
large O
intraluminal O
lesion O
from O
what O
I O
can O
see O
. O
 
Note O
plan O
for O
CT O
tonight O
per O
ED O
management O
ESKD O
K O
from O
ABG O
was O
5.2 O
No O
immediate O
need O
to O
dialyse O
tonight O
Will O
schedule O
for O
HD O
first O
shift O
tomorrow O
Treat O
K O
medically O
overnight O
as O
needed O
; O
please O
limit O
IV O
fluids O
Anaemia O
Hb O
above O
target O
, O
hold O
EPO O
for O
now O
Bone O
Please O
check O
phosphate O
and O
iPTH O
Will O
dose O
adjust O
binders O
and O
Vit O
based O
on O
results O
HTN O
Need O
to O
assess O
complaince O
with O
meds O
Consider O
prn O
iv O
labetalol O
as O
needed O
for O
severe O
HTN O
Perhaps O
add O
nitrate O
if O
needed O
for O
longer-term O
management O
Pleural O
effusions O
Consider O
tapping O
if O
not O
done O
recently O
in O
light O
of O
malignancy O
in O
history O
Calvin I-NAME
Stanley I-NAME
Tripp I-NAME
Renal O
Fellow O
# O
94122 I-CONTACT
Renal O
Staff O
Addendum O
Patient O
seen O
and O
examined O
on O
dialysis O
. O
 
Case O
discussed O
with O
Fellow O
. O
 
Note O
appreciated O
. O
 
- O
presents O
with O
nausea O
and O
vomiting O
- O
abd O
CT O
shows O
: O
increasing O
size O
colonic O
neoplasm O
right O
sided O
colitis O
markedly O
distended O
bladder O
- O
BP O
poorly O
controlled O
- O
Hyperkalemia O
- O
Hypoglycemia O
REC O
1 O
. O
 
Dialysis O
3hrs O
2K O
2.5Ca O
2 O
. O
 
UF O
2L O
3 O
. O
 
AVG O
access O
4 O
. O
 
Epogen O
and O
Zemplar O
pre O
outpatient O
regimen O
5 O
. O
 
Straight O
cath O
bladder O
and O
send O
off O
urine O
culture O
: O
Retention O
of O
urine O
and O
UTI O
might O
explain O
her O
prsentation O
6 O
. O
 
Surgical O
f/u O
re O
colon O
neoplasm O
: O
she O
is O
a O
high O
risk O
surgical O
candidate O
7 O
. O
 
D10W O
IV O
while O
NPO O
; O
RISS O
8 O
. O
 
Resume O
po O
BP O
meds O
. O
 
( O
no O
hold O
on O
dialysis O
days O
) O
John I-NAME
Ingle I-NAME
MD O
. O
 
Record O
date O
: O
2098-11-02 I-DATE
MERCED I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
ATTENDING O
ADMISSION O
NOTE O
PATIENT O
: O
Stevens O
, O
Lori I-NAME
MRN O
: O
8593546 I-ID
ADMIT O
DATE O
: O
11/2/2098 I-DATE
TIME O
: O
6 O
pm O
PCP O
: O
Dr. O
Iyan I-NAME
Winston I-NAME
CONTACT O
: O
Daughter O
, O
Sally I-NAME
, O
at O
011-053-5691 I-CONTACT
Code O
status O
: O
DNR/DNI O
Source O
: O
Patient O
, O
patient O
record O
CC O
: O
hypotension O
HPI O
: O
65 I-AGE
y/o O
F I-DATE
with O
colon O
cancer O
( O
known O
, O
surgery/GI O
refuse O
to O
proceduralize O
) O
, O
ESRD O
on O
HD O
( O
M/W/F O
) O
, O
CVA O
c/b O
severe O
residual O
speech/cognitive O
deficits O
, O
HTN O
, O
recurrent O
GIB O
who O
presents O
with O
hypotension O
. O
 
She O
was O
en O
route O
to O
her O
normal O
dialysis O
session O
, O
and O
EMT O
took O
BP O
that O
was O
80s/40s O
, O
brought O
to O
LCH I-LOCATION
ED O
for O
evaluation O
. O
 
Notably O
recently O
admitted O
to O
Santa I-LOCATION
Rosa I-LOCATION
on O
9/10/2098 I-DATE
for O
hematemesis/hematochezia O
, O
but O
no O
intervention O
done O
. O
 
No O
report O
of O
recent O
GI O
bleeding O
. O
 
In O
ED O
, O
initial O
BP O
in O
80s/30s O
, O
got O
1.5 O
liters O
of O
IV O
fluid O
, O
came O
up O
to O
90s/50s O
. O
 
Also O
was O
on O
4-5 O
liters O
of O
oxygen O
with O
sat O
95 O
% O
. O
 
Blood O
and O
urine O
cultures O
sent O
, O
Vancomycin O
and O
Cefepime O
given O
. O
 
Daughter O
was O
contacted O
, O
who O
states O
patient O
is O
definitely O
DNR/DNI O
and O
no O
invasive O
interventions O
are O
to O
be O
done O
( O
including O
central O
lines O
, O
surgery O
, O
etc O
. O
) O
 
Bedside O
ultrasounds O
revealed O
known O
pleural O
effusions O
, O
pericardial O
effusion O
without O
signs O
of O
tamponade O
, O
and O
hypoechoic O
material O
in O
bladder O
suspicious O
for O
abscess/infection O
. O
 
CT O
abdomen O
done O
, O
was O
notable O
for O
bladder O
wall O
thickening O
potentially O
c/w O
cystitis O
, O
a O
new O
moderate O
sized O
pericardial O
effusion O
, O
and O
rectal O
wall O
thickening O
c/w O
proctitis O
. O
 
After O
CT O
, O
Foley O
placed O
with O
reported O
return O
of O
400-500 O
cc O
of O
frank O
pus O
. O
 
Labs O
notable O
for O
K O
5.0 O
, O
BUN/Cr O
39/4.02 O
, O
WBC O
count O
7.7 O
. O
 
Patient O
seen O
in O
ED O
& O
# O
8211 O
; O
BP O
80s/40s O
, O
but O
arousable O
and O
able O
to O
answer O
simple O
questions O
. O
 
Denies O
any O
complaints O
, O
including O
pain O
, O
dyspnea O
, O
nausea O
, O
with O
one-word O
answers O
. O
 
When O
daughter O
subsequently O
arrives O
, O
she O
confirms O
desire O
for O
no O
invasive O
procedures O
, O
lines O
, O
surgeries O
, O
or O
ICU O
level O
care O
. O
 
She O
does O
add O
that O
patient O
was O
at O
Levi I-LOCATION
Hospital I-LOCATION
two O
weeks O
ago O
, O
treated O
for O
& O
# O
8220 O
; O
lung O
infection. O
& O
# O
8221 O
; O
Uncertain O
of O
specifics O
. O
 
ROS O
15-point O
ROS O
as O
above O
; O
limited O
by O
mental O
status O
. O
 
MEDICAL I-LOCATION
HISTORY O
1 O
& O
# O
8211 O
; O
Recurrent O
GIB O
& O
# O
8211 O
; O
s/p O
EGD/colo O
showing O
multiple O
duodenal/colonic O
polyps O
( O
12/2097 I-DATE
) O
, O
here O
with O
GI O
bleed O
in O
September I-DATE
, O
no O
workup O
pursued O
as O
thought O
to O
be O
major O
cardiac O
risk O
. O
 
2 O
& O
# O
8211 O
; O
Colon O
Ca O
- O
Pt O
seen O
by O
surgery O
and O
is O
not O
a O
surgical O
candidate O
2/2 O
multiple O
medical O
comorbidities O
. O
 
3 O
& O
# O
8211 O
; O
ESRD O
since O
2096 I-DATE
( O
HD O
: O
M/W/F O
) O
-Access O
L O
brachiocephalic O
AVF O
-Presumed O
2/2 O
longstanding O
DM O
4 O
& O
# O
8211 O
; O
DM2 O
& O
# O
8211 O
; O
On O
SSI O
2/2 O
frequent O
hypoglycemia O
episodes O
on O
long O
acting O
insulin O
5 O
& O
# O
8211 O
; O
Chronic O
decubitus O
ulcers O
presumed O
2/2 O
immobility O
6 O
& O
# O
8211 O
; O
HTN O
7 O
& O
# O
8211 O
; O
CVA O
( O
12/2096 I-DATE
) O
& O
# O
8211 O
; O
c/b O
significant O
residual O
speech/cognitive O
deficits O
8 O
& O
# O
8211 O
; O
Gastroparesis O
& O
# O
8211 O
; O
presumed O
2/2 O
longstanding O
DM O
. O
 
s/p O
gastric O
emptying O
study O
2/2098 I-DATE
9 O
- O
Cataracts O
10 O
& O
# O
8211 O
; O
history O
of O
NSTEMI O
per O
some O
prior O
notes O
MEDICATIONS O
ON O
ADMISSION O
: O
from O
discharge O
med O
list O
in O
September I-DATE
; O
have O
requested O
current O
med O
list O
from O
NGH I-LOCATION
. O
 
Amlodipine O
10 O
MG O
PO O
QPM O
Cholestyramine O
Resin O
Dried O
4 O
GM O
PO O
BID O
( O
last O
dose O
: O
09/14/98 I-DATE
09:00 O
am O
) O
Hydralazine O
Hcl O
50 O
MG O
PO O
Q6H O
( O
last O
dose O
: O
09/14/98 I-DATE
12:40 O
am O
) O
Irbesartan O
( O
Avapro O
) O
150 O
MG O
PO O
QD O
Labetalol O
Hcl O
300 O
MG O
PO O
TID O
( O
last O
dose O
: O
09/13/98 I-DATE
08:20 O
pm O
) O
Simvastatin O
40 O
MG O
PO O
QPM O
( O
last O
dose O
: O
09/13/98 I-DATE
08:00 O
pm O
) O
Albuterol O
Nebulizer O
Solution O
2.5 O
MG O
NEB O
Q6H O
prn O
Calcium O
Acetate O
( O
1 O
Gelcap=667 O
Mg O
) O
667 O
MG O
PO O
TID O
( O
last O
dose O
: O
09/14/98 I-DATE
12:30 O
pm O
) O
Docusate O
Sodium O
( O
Colace O
) O
100 O
MG O
PO O
TID O
( O
last O
dose O
: O
09/14/98 I-DATE
12:30 O
pm O
) O
Omeprazole O
40 O
MG O
PO O
QD O
( O
last O
dose O
: O
09/14/98 I-DATE
09:00 O
am O
) O
Polyethylene O
Glycol O
( O
Miralax O
) O
17 O
GM O
PO O
QD O
prn O
Sennosides O
( O
Senna O
Tablets O
) O
2 O
TAB O
PO O
BID O
prn O
Sevelamer O
( O
Renagel O
) O
400 O
MG O
PO O
AC O
( O
last O
dose O
: O
09/14/98 I-DATE
12:30 O
pm O
) O
Divalproex O
Sodium O
( O
Depakote O
) O
250 O
MG O
PO O
QHS O
Insulin O
Regular O
Inj O
SC O
AC O
( O
Sliding O
Scale O
) O
If O
BS O
& O
lt O
; O
= O
200 O
give O
0 O
Units O
For O
BS O
from O
201 O
to O
250 O
give O
4 O
Units O
For O
BS O
from O
251 O
to O
300 O
give O
6 O
Units O
For O
BS O
from O
301 O
to O
350 O
give O
8 O
Units O
For O
BS O
from O
351 O
to O
400 O
give O
10 O
Units O
For O
BS O
= O
& O
gt O
; O
401 O
give O
12 O
Units O
and O
call O
responding O
clinician O
Donepezil O
Hcl O
( O
Aricept O
) O
5 O
MG O
PO O
QHS O
Erythromycin O
Ethylsuccinate O
200 O
Mg/5 O
Ml O
200 O
MG O
PO O
AC O
Nephrocaps O
1 O
CAPSULE O
PO O
QD O
Acetylsalicylic O
Acid O
81 O
MG O
PO O
QD O
ALLERGIES O
: O
NKDA O
FAMILY O
HISTORY O
( O
from O
past O
notes O
) O
: O
Mother O
with O
breast O
cancer O
, O
father O
with O
lung O
cancer O
. O
 
No O
FH O
of O
DM O
. O
 
No O
FH O
of O
intrinsic O
renal O
disease O
. O
 
SOCIAL O
HISTORY O
Lives O
in O
Wheatland I-LOCATION
Manor I-LOCATION
, O
has O
one O
daughter O
. O
 
Per O
prior O
notes O
, O
no O
tobacco O
, O
alcohol O
, O
illicits O
. O
 
Daughter O
& O
# O
8217 O
; O
s O
contact O
info O
: O
Sally I-NAME
, O
home O
011-053-5691 I-CONTACT
, O
cell O
544-761-0912 I-CONTACT
Wheatland I-LOCATION
Manor I-LOCATION
: O
154-734-1487 I-CONTACT
, O
x557 O
( O
4th O
floor O
) O
PHYSICAL O
EXAM O
VITALS O
: O
T O
: O
97.4 O
HR O
: O
60s O
BP O
: O
80-90/30s-40s O
RR O
: O
O2Sat O
: O
95 O
% O
, O
currently O
on O
4.5 O
liters O
GEN O
& O
# O
8217 O
; O
L O
: O
somnolent O
but O
arousable O
, O
alert O
to O
hospital O
, O
but O
not O
month O
and O
year O
, O
knows O
daughter O
& O
# O
8217 O
; O
s O
name O
SKIN O
: O
no O
rashes O
noted O
HEENT O
: O
essentially O
normocephalic O
, O
atraumatic O
, O
no O
facial O
droop O
noted O
NECK O
: O
supple O
HEART O
: O
regular O
, O
difficult O
to O
localize O
systolic O
murmur O
heard O
LUNG O
: O
Decreased O
breath O
sounds O
globally O
, O
but O
no O
discrete O
crackles/wheezes O
heard O
ABD O
: O
hypoactive O
bowel O
sounds O
; O
is O
diffusely O
tender O
. O
 
Fluid O
wave O
does O
appear O
to O
be O
present O
. O
 
RECTAL O
: O
not O
performed O
at O
this O
time O
. O
 
EXT O
: O
does O
not O
appear O
to O
be O
able O
to O
move O
lower O
extremities O
significantly O
on O
own O
. O
 
NEURO O
: O
as O
above O
; O
LABORATORY O
STUDIES O
of O
note O
: O
Hct O
33 O
, O
platelets O
481 O
, O
WBC O
7.7 O
with O
unremarkable O
diff O
Na O
136 O
, O
K O
5.0 O
, O
bicarb O
31 O
, O
BUN/Cr O
39/4.02 O
Lactate O
1.2 O
UA O
with O
over O
100 O
WBCs O
. O
 
MICROBIOLOGY O
Blood O
and O
urine O
cultures O
pending O
RADIOLOGY O
Abdominal O
CT O
IMPRESSION O
: O
1 O
. O
 
New O
moderate-sized O
pericardial O
effusion O
with O
pericardial O
enhancement O
which O
may O
be O
due O
to O
pericarditis O
or O
pericardial O
metastatic O
disease O
. O
 
2 O
. O
 
Rectal O
wall O
thickening O
with O
fecal O
impaction O
, O
consistent O
with O
proctitis O
, O
possibly O
due O
to O
venous O
stasis O
. O
 
3 O
. O
 
Thickened O
urinary O
bladder O
wall O
with O
irregularity O
and O
enhancement O
consistent O
with O
cystitis O
. O
 
4 O
. O
 
Slight O
increase O
in O
moderate O
ascites O
since O
4/2/98 I-DATE
. O
 
5 O
. O
 
Distended O
urinary O
bladder O
with O
unchanged O
bladder O
wall O
thickening O
. O
 
Also O
noted O
are O
moderate O
bilateral O
pleural O
effusions O
. O
 
CXR O
: O
IMPRESSION O
: O
Pulmonary O
edema O
with O
large O
left O
effusion O
small O
right O
effusion O
. O
 
TTE O
: O
MITRAL O
VALVE O
There O
is O
calcification O
of O
the O
posterior O
mitral O
annulus O
. O
 
There O
is O
no O
evidence O
of O
mitral O
valve O
prolapse O
. O
 
There O
is O
trace O
mitral O
regurgitation O
by O
color O
and O
spectral O
Doppler O
. O
 
There O
is O
a O
calcified O
papillary O
muscle O
tip O
. O
 
LEFT O
ATRIUM O
The O
left O
atrium O
is O
elongated O
. O
 
The O
antero-posterior O
left O
atrial O
dimension O
is O
38 O
mm O
( O
normal O
range O
: O
up O
to O
38 O
mm O
) O
. O
 
The O
medial-lateral O
left O
atrial O
dimension O
is O
42 O
mm O
( O
normal O
range O
: O
up O
to O
49 O
mm O
) O
. O
 
The O
superior-inferior O
left O
atrial O
dimension O
is O
56 O
mm O
( O
normal O
range O
: O
up O
to O
53 O
mm O
) O
. O
 
AORTIC O
VALVE O
, O
AORTA O
, O
LVOT O
Multiple O
aortic O
leaflets O
are O
thickened O
but O
there O
is O
no O
stenosis O
. O
 
The O
aortic O
valve O
is O
tricuspid O
. O
 
There O
is O
evidence O
of O
mild O
aortic O
insufficiency O
by O
color O
and O
spectral O
Doppler O
. O
 
The O
aortic O
diameter O
at O
the O
sinuses O
of O
Valsalva O
is O
29 O
mm O
( O
normal O
: O
less O
than O
40mm O
) O
. O
 
The O
ascending O
aorta O
diameter O
above O
the O
sinotubular O
junction O
is O
28 O
mm O
( O
normal O
: O
less O
than O
or O
equal O
to O
36mm O
) O
. O
 
LEFT O
VENTRICLE O
The O
left O
ventricular O
cavity O
size O
is O
normal O
. O
 
The O
left O
ventricular O
systolic O
function O
is O
within O
normal O
limits O
. O
 
There O
is O
symmetric O
left O
ventricular O
hypertrophy O
. O
 
There O
are O
no O
obvious O
segmental O
wall O
motion O
abnormalities O
. O
 
The O
estimated O
ejection O
fraction O
is O
66 O
% O
. O
 
LVEF O
was O
measured O
by O
the O
single O
dimension O
method O
. O
 
TRICUSPID O
VALVE O
- O
IVC O
, O
SVC O
There O
is O
color O
and O
spectral O
Doppler O
evidence O
of O
mild O
tricuspid O
insufficiency O
. O
 
The O
inferior O
vena O
cava O
is O
dilated O
. O
 
There O
is O
no O
phasic O
collapse O
of O
the O
IVC O
noted O
. O
 
PULMONARY O
VALVE O
, O
INFUND. O
, O
P.A O
. O
 
There O
is O
evidence O
of O
mild O
pulmonary O
insufficiency O
by O
color O
and O
spectral O
Doppler O
. O
 
The O
RV O
systolic O
pressure O
was O
estimated O
from O
the O
regurgitant O
tricuspid O
velocity O
( O
assuming O
an O
RA O
pressure O
of O
10mmHg O
) O
. O
 
The O
estimated O
RV O
systolic O
pressure O
is O
41 O
mmHg O
. O
 
RIGHT O
VENTRICLE O
The O
right O
ventricle O
is O
not O
dilated O
. O
 
There O
is O
right O
ventricular O
hypertrophy O
. O
 
The O
right O
ventricular O
systolic O
function O
is O
within O
normal O
limits O
. O
 
INTERATRIAL O
SEPTUM O
, O
INTERVENTRICULAR O
SEPTUM O
There O
is O
no O
evidence O
of O
a O
patent O
foramen O
ovale O
by O
Doppler O
. O
 
PERICARDIAL O
DISEASE O
AND O
EXTRACARDIAC O
MASSES O
There O
is O
a O
small O
circumferential O
pericardial O
effusion O
. O
 
There O
is O
no O
echocardiographic O
evidence O
of O
tamponade O
. O
 
There O
are O
intrapericardial O
fibrinous O
strands O
. O
 
There O
is O
evidence O
of O
a O
large O
pleural O
effusion O
. O
 
There O
is O
ascites O
. O
 
CONCLUSIONS O
Compared O
to O
the O
study O
of O
3/18/98 I-DATE
, O
a O
small O
circumferential O
pericardial O
effusion O
is O
now O
noted O
, O
and O
the O
measured O
RVSP O
has O
decreased O
( O
55 O
mm O
Hg O
previously O
) O
. O
 
LVH O
and O
RVH O
have O
appeared O
. O
 
EKG O
: O
EKG O
reviewed O
& O
# O
8211 O
; O
notable O
for O
low O
voltages O
, O
normal O
intervals O
, O
no O
significant O
ST O
changes O
compared O
to O
prior O
ASSESSMENT O
& O
amp O
; O
PLAN O
65F O
with O
colon O
cancer O
( O
but O
not O
candidate O
for O
intervention O
) O
, O
CVA O
with O
residual O
speech/cognitive O
deficits O
, O
recurrent O
GI O
bleeds O
, O
HTN O
, O
p/w O
hypotension O
. O
 
Suspect O
likely O
UTI O
as O
source O
given O
frank O
pyuria O
. O
 
Can O
& O
# O
8217 O
; O
t O
rule O
out O
SBP O
in O
setting O
of O
ascites O
and O
abdominal O
pain O
, O
but O
seems O
less O
likely O
. O
 
Does O
have O
bilateral O
pleural O
effusions O
, O
but O
these O
are O
chronic O
and O
without O
other O
signs O
of O
empyema O
, O
and O
small O
pericardial O
effusion O
with O
no O
signs O
of O
tamponade O
. O
 
Goals O
of O
care O
are O
decidedly O
conservative O
. O
 
Shock O
, O
likely O
2/2 O
urosepsis O
: O
Foley O
placed O
, O
purulent O
material O
returned O
. O
 
Culture O
pending O
. O
 
Got O
Vanc O
1 O
gm O
in O
ED O
at O
approximately O
noon O
, O
2 O
gm O
cefepime O
at O
noon O
. O
 
-continue O
cefepime O
1 O
gm O
daily O
-vanc O
1 O
gm O
with O
HD O
-consider O
diagnostic O
paracentesis O
tonight O
( O
daughter O
said O
this O
procedure O
seems O
reasonable O
) O
, O
but O
would O
be O
of O
limited O
value O
given O
diagnostic O
only O
and O
more O
likely O
source O
of O
UTI O
-with O
finding O
of O
proctitis O
on O
CT O
, O
will O
add O
IV O
flagyl O
Hypoxia O
, O
bilateral O
pleural O
effusions O
: O
on O
4-5 O
L O
, O
suspect O
fluid O
overload O
as O
culprit O
-could O
consider O
therapeutic O
thoracentesis O
if O
this O
would O
allow O
more O
aggressive O
fluid O
resuscitation O
, O
but O
should O
discuss O
with O
daughter O
first O
ESRD O
: O
renal O
following O
, O
will O
consider O
HD O
tomorrow O
, O
pending O
labs/hemodynamics O
h/o O
GI O
bleeds O
: O
hct O
seems O
stable O
without O
evidence O
for O
bleed O
as O
cause O
of O
shock O
, O
but O
follow O
Hct O
in O
AM O
DM O
: O
SSI O
HTN O
: O
holding O
anti-hypertensives O
Goals O
of O
care O
: O
as O
above O
, O
no O
surgeries/invasive O
interventions/ICU O
level O
care O
Med O
recon O
: O
PAML O
created O
from O
last O
discharge O
med O
list O
; O
have O
requested O
current O
med O
list O
from O
NGH I-LOCATION
, O
not O
yet O
received O
by O
fax O
FEN O
: O
-boluses O
tonight O
as O
needed O
-follow O
lytes O
-NPO O
for O
now O
given O
mental O
status O
, O
active O
resuscitation O
PPX O
: O
-GI O
: O
continue O
omeprazole O
if O
awake O
enough O
to O
take O
POs O
-DVT O
: O
subq O
heparin O
-BOWEL O
: O
docusate/senna O
Code O
Status O
: O
DNR/DNI O
( O
Discussed O
with O
patient O
& O
# O
8217 O
; O
s O
daughter/HCP O
. O
) O
 
__________________________________ O
Quenton I-NAME
Stark I-NAME
, O
MD O
MMC/Team O
4 O
Pager O
# O
00138 I-CONTACT
 
Record O
date O
: O
2061-10-13 I-DATE
October I-DATE
13 O
, O
2061 I-DATE
Philip I-NAME
Stanley I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
Donnellson I-LOCATION
Community I-LOCATION
Clinic I-LOCATION
RE O
: O
Shilpa I-NAME
Pickett I-NAME
MR O
# O
129-53-47-3 I-ID
Dear O
Philip I-NAME
: O
I O
had O
the O
pleasure O
of O
seeing O
Shilpa I-NAME
Pickett I-NAME
in O
Cardiovascular O
Clinic I-LOCATION
today O
. O
 
Since O
her O
discharge O
from O
the O
hospital O
in O
September I-DATE
, O
she O
has O
noticed O
that O
she O
is O
fatigue O
with O
exertion O
but O
has O
had O
no O
chest O
pressure O
and O
no O
exertional O
diaphoresis O
, O
nausea O
, O
or O
jaw O
pain O
. O
 
She O
does O
note O
occasional O
lightheadedness O
throughout O
the O
day O
, O
this O
is O
not O
related O
to O
position O
or O
going O
from O
sitting O
to O
standing O
position O
. O
 
As O
you O
are O
aware O
, O
her O
MIBI O
test O
showed O
very O
small O
amount O
of O
ischemia O
almost O
undetectable O
in O
amount O
. O
 
Her O
medical O
regimen O
includes O
Lasix O
40 O
mg O
po O
q.d. O
, O
Lisinopril O
20 O
mg O
po O
q.d. O
, O
125 O
mg O
of O
hydrochlorothiazide O
b.i.d O
. O
 
Of O
note O
, O
she O
was O
taking O
an O
additional O
Lisinopril O
at O
20 O
mg O
po O
b.i.d O
. O
 
Labetalol O
200 O
mg O
b.i.d. O
, O
Isordil O
40 O
t.i.d. O
, O
Prilosec O
20 O
mg O
po O
q.d. O
, O
Cisapride O
10 O
mg O
po O
q.d. O
, O
simvastatin O
10 O
mg O
po O
q.d. O
, O
aspirin O
325 O
mg O
po O
q.d O
. O
 
On O
physical O
exam O
, O
her O
blood O
pressure O
is O
140/90 O
right O
and O
left O
arm O
seated O
, O
heart O
rate O
is O
77 O
and O
irregular O
, O
respiratory O
rate O
is O
12 O
. O
 
There O
is O
no O
increase O
in O
jugular O
venous O
pressure O
. O
 
Carotids O
are O
free O
of O
bruits O
. O
 
Lungs O
are O
clear O
to O
auscultation O
throughout O
. O
 
Cardiac O
exam O
is O
notable O
for O
distant O
heart O
sounds O
with O
no O
S3 O
, O
S4 O
. O
 
Abdomen O
is O
soft O
and O
nontender O
. O
 
The O
extremities O
are O
free O
of O
edema O
. O
 
Electrocardiogram O
is O
normal O
sinus O
rhythm O
with O
left O
bundle O
branch O
block O
unchanged O
from O
prior O
electrocardiograms O
. O
 
In O
summary O
, O
Shilpa I-NAME
Pickett I-NAME
certainly O
has O
cardiovascular O
risk O
factors O
of O
sedentary O
lifestyle O
, O
diabetes O
, O
high O
cholesterol O
and O
increase O
in O
weight O
. O
 
We O
will O
be O
rechecking O
her O
lipid O
profile O
today O
. O
 
She O
reports O
to O
me O
that O
she O
has O
absolutely O
no O
appetite O
for O
the O
foods O
she O
usually O
eats O
and O
has O
occasionally O
had O
trouble O
eating O
. O
 
She O
notes O
no O
dysphoria O
and O
no O
other O
signs O
or O
symptoms O
of O
depression O
. O
 
She O
has O
had O
no O
change O
in O
her O
hair O
or O
skin O
. O
 
For O
the O
Pickett I-NAME
, O
Shilpa I-NAME
MR O
# O
129-53-47-3 I-ID
-2- O
October I-DATE
13 O
, O
2061 I-DATE
moment O
, O
I O
will O
be O
reviewing O
her O
SMA O
20 O
for O
evidence O
of O
liver O
dysfunction O
but O
would O
strongly O
consider O
both O
depression O
and O
hyperthyroidism O
for O
further O
workup O
of O
this O
loss O
of O
appetite O
. O
 
It O
is O
certainly O
a O
pleasure O
for O
me O
to O
participate O
in O
Shilpa I-NAME
Pickett I-NAME
' O
care O
. O
 
Let O
me O
know O
if O
there O
are O
any O
questions O
or O
issues O
I O
can O
be O
of O
help O
with O
. O
 
Sincerely O
, O
Leona I-NAME
Xiques I-NAME
, O
M.D O
. O
 
Second I-LOCATION
Alabama I-LOCATION
Hospital I-LOCATION
78 I-LOCATION
Parkhurst I-LOCATION
Drive I-LOCATION
Ladysmith I-LOCATION
, O
TN I-LOCATION
47657 I-LOCATION
DD O
: O
10/13/61 I-DATE
DT O
: O
10/14/61 I-DATE
DV O
: O
10/13/61 I-DATE
/maynard O
* O
* O
* O
* O
* O
* O
* O
* O
Approved O
but O
not O
reviewed O
by O
Attending O
Provider O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2062-07-29 I-DATE
DONELLSON I-LOCATION
EMERGENCY O
DEPT O
VISIT O
PICKETT O
, O
SHILPA O
129-53-47-3 I-ID
VISIT O
DATE O
: O
07/29/62 I-DATE
PRESENTING O
COMPLAINT O
: O
Syncope O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Seventy-year-old O
female O
with O
diabetes O
, O
hypertension O
, O
coronary O
artery O
disease O
complaining O
about O
syncopal O
episode O
today O
. O
 
The O
patient O
states O
that O
over O
the O
last O
couple O
of O
weeks O
she O
has O
had O
increased O
chest O
palpitations O
and O
two O
weeks O
ago O
was O
given O
an O
event O
monitor O
which O
he O
has O
intermittently O
worn O
saying O
it O
is O
difficult O
to O
wear O
during O
the O
heat O
wave O
. O
 
This O
a.m. O
the O
patient O
had O
a O
syncopal O
episode O
while O
watching O
a O
disagreement O
between O
her O
two O
grandchildren O
. O
 
The O
patient O
states O
had O
no O
chest O
pain O
, O
dizziness O
, O
nausea O
, O
or O
vomiting O
. O
 
The O
patient O
fell O
to O
the O
floor O
and O
awoke O
, O
denies O
incontinence O
or O
tongue O
biting O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
diabetes O
, O
coronary O
artery O
disease O
, O
CVA O
. O
 
MEDICATIONS O
: O
Aspirin O
, O
Lasix O
, O
Lopressor O
, O
Isordil O
, O
insulin O
, O
lisinopril O
, O
Colace O
, O
nitroglycerin O
sublingual O
, O
Cisapride O
, O
Prilosec O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
Well O
developed O
, O
well O
nourished O
female O
with O
a O
Glasgow O
Coma O
Scale O
of O
15 O
. O
 
HEENT O
normocephalic O
, O
atraumatic O
. O
 
Neck O
supple O
without O
spinal O
tenderness O
. O
 
Heart O
regular O
rate O
and O
rhythm O
, O
positive O
2/6 O
systolic O
ejection O
murmur O
. O
 
Chest O
is O
clear O
. O
 
Abdomen O
is O
soft O
, O
nontender O
, O
positive O
bowel O
sounds O
. O
 
Extremities O
without O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
Neuro O
alert O
and O
oriented O
times O
three O
, O
good O
motor O
strength O
throughout O
, O
sensory O
intact O
, O
no O
focality O
. O
 
FINAL O
DIAGNOSIS O
: O
Syncopal O
episode O
most O
likely O
cardiac O
in O
origin O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Will O
admit O
to O
monitor O
and O
rule O
out O
for O
MI O
. O
 
The O
patient O
was O
admitted O
in O
stable O
condition O
. O
 
___________________________________ O
IE615/5791 I-ID
LINDA I-NAME
ANDREWS I-NAME
, O
M.D O
. O
 
LA06 I-NAME
D:07/29/62 O
T:07/30/62 O
Dictated O
by O
: O
LINDA I-NAME
ANDREWS I-NAME
, O
M.D O
. O
 
LA06 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2063-03-20 I-DATE
EASLEY I-LOCATION
BAPTIST I-LOCATION
HOSPITAL I-LOCATION
Pickett I-NAME
, O
Silpa I-NAME
12953473 I-ID
03-20-63 I-DATE
CHIEF O
COMPLAINT O
: O
Ms. O
Pickett I-NAME
comes O
to O
the O
Easley I-LOCATION
Baptist I-LOCATION
Hospital I-LOCATION
with O
numerous O
complaints O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
She O
states O
that O
she O
has O
not O
been O
feeling O
well O
since O
her O
upper O
respiratory O
tract O
infection O
. O
 
She O
had O
the O
flu O
in O
January I-DATE
and O
then O
developed O
another O
upper O
respiratory O
tract O
infection O
a O
couple O
of O
weeks O
ago O
. O
 
She O
states O
that O
this O
has O
severely O
debilitated O
her O
. O
 
She O
is O
complaining O
of O
occasional O
nonproductive O
cough O
, O
post O
nasal O
drip O
, O
and O
occasional O
dull O
headache O
. O
 
However O
, O
her O
main O
concern O
is O
her O
stomach O
and O
her O
back O
. O
 
Ms. O
Pickett I-NAME
continues O
to O
have O
postprandial O
nausea O
and O
discomfort O
in O
her O
epigastrium O
, O
particularly O
after O
eating O
. O
 
This O
is O
different O
than O
her O
reflux O
disease O
, O
which O
she O
feels O
is O
under O
fairly O
good O
control O
, O
with O
the O
Prilosec-Propulsid O
combination O
. O
 
She O
is O
describing O
some O
anorexia O
, O
although O
she O
has O
not O
lost O
any O
weight O
. O
 
She O
has O
not O
had O
any O
alterations O
in O
her O
bowel O
movements O
. O
 
She O
has O
not O
been O
constipated O
or O
had O
diarrhea O
. O
 
She O
wonders O
whether O
this O
could O
be O
in O
gallbladder O
. O
 
In O
addition O
, O
she O
is O
continuing O
to O
have O
some O
back O
pain O
with O
radiation O
down O
her O
left O
leg O
in O
the O
L5/S1 O
distribution O
. O
 
She O
had O
one O
epidural O
steroid O
injection O
but O
was O
due O
to O
go O
back O
. O
 
Given O
her O
upper O
respiratory O
tract O
infection O
, O
this O
was O
postponed O
. O
 
She O
is O
not O
having O
any O
heart O
symptoms O
or O
shortness O
of O
breath O
. O
 
Her O
sugars O
have O
been O
under O
good O
control O
, O
ranging O
between O
111 O
and O
143 O
. O
 
Her O
blood O
pressure O
is O
152/70 O
today O
, O
with O
a O
pulse O
of O
70 O
. O
 
She O
is O
saturating O
well O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
exam O
, O
lungs O
were O
clear O
to O
auscultation O
. O
 
There O
was O
no O
JVD O
. O
 
Heart O
: O
regular O
rate O
and O
rhythm O
with O
positive O
S4 O
, O
? O
 
S3 O
with O
no O
significant O
murmur O
. O
 
Abdomen O
was O
soft O
, O
nondistended O
, O
with O
some O
mild O
tenderness O
without O
rebound O
or O
guarding O
over O
the O
right O
upper O
quadrant O
. O
 
Abdomen O
was O
somewhat O
bloated O
per O
patient O
and O
diffusely O
tender O
. O
 
Extremities O
revealed O
some O
mild O
pedal O
edema O
left O
greater O
than O
right O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
A O
seventy-one-year-old O
woman O
with O
multiple O
medical O
issues O
, O
including O
coronary O
artery O
disease O
, O
CHF O
, O
diabetes O
, O
hypertension O
, O
and O
cerebrovascular O
disease O
. O
 
She O
came O
in O
today O
for O
discussion O
of O
her O
ongoing O
lumbar O
radiculopathic O
pain O
as O
well O
as O
her O
abdominal O
complaint O
. O
 
With O
regard O
to O
her O
back O
pain O
, O
she O
wanted O
a O
prescription O
for O
Tylenol O
with O
codeine O
, O
which O
has O
helped O
in O
the O
past O
. O
 
I O
gave O
her O
a O
prescription O
. O
 
I O
warned O
her O
about O
the O
possible O
side O
effects O
of O
constipation O
. O
 
She O
should O
contact O
the O
pain O
clinic O
as O
soon O
as O
she O
feels O
able O
, O
for O
a O
repeat O
epidural O
steroid O
injection O
. O
 
With O
regard O
to O
her O
abdominal O
complaints O
, O
the O
bubbling O
in O
her O
chest O
, O
postprandial O
nausea O
and O
anorexia O
could O
certainly O
be O
due O
to O
gallbladder O
disease O
. O
 
Unclear O
contribution O
from O
her O
reflux O
. O
 
Dr. O
Mario I-NAME
Robison I-NAME
recommended O
elective O
cholecystectomy O
. O
 
Given O
the O
fact O
that O
Ms. O
Pickett I-NAME
is O
being O
more O
and O
more O
bothered O
by O
these O
symptoms O
, O
it O
may O
be O
reasonable O
to O
EASLEY I-LOCATION
BAPTIST I-LOCATION
HOSPITAL I-LOCATION
Pickett I-NAME
, O
Silpa I-NAME
12953473 I-ID
03-20-63 I-DATE
page O
2 O
consider O
her O
for O
the O
surgery O
. O
 
I O
have O
asked O
her O
to O
call O
Dr. O
Xiques I-NAME
and O
make O
an O
appointment O
to O
discuss O
her O
cardiovascular O
risk O
so O
that O
she O
can O
make O
an O
informed O
decision O
about O
the O
surgery O
. O
 
She O
is O
otherwise O
up O
to O
date O
with O
her O
issues O
and O
doing O
relatively O
well O
from O
a O
cardiovascular O
and O
diabetic O
perspective O
. O
 
She O
would O
probably O
do O
better O
with O
lower O
blood O
pressure O
. O
 
We O
could O
consider O
increasing O
her O
Imdur O
. O
 
I O
plan O
to O
follow O
up O
with O
her O
in O
a O
few O
weeks O
time O
. O
 
_________________________ O
Una I-NAME
Romano I-NAME
, O
M.D O
. O
 
LL I-NAME
: O
OB:6245 O
DD:03-20-63 O
DT:03-20-63 O
DV:03-20-63 O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2064-10-05 I-DATE
DONELLSON I-LOCATION
EMERGENCY O
DEPT O
VISIT O
PICKETT O
, O
SHILPA O
129-53-47-3 I-ID
VISIT O
DATE O
: O
10/05/64 I-DATE
Please O
see O
the O
resident O
's O
handwritten O
note O
for O
additional O
complete O
details O
. O
 
I O
also O
saw O
the O
patient O
to O
supervise O
the O
resident O
's O
care O
. O
 
PRESENTING O
COMPLAINT O
: O
Chest O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
A O
73-year-old O
woman O
with O
known O
coronary O
disease O
with O
cardiac O
catheterization O
and O
three-vessel O
disease O
in O
2062 I-DATE
, O
and O
a O
positive O
exercise O
tolerance O
test O
in O
2063 I-DATE
. O
 
She O
was O
with O
relatively O
stable O
symptoms O
until O
early O
this O
morning O
when O
she O
had O
increase O
in O
chest O
tightness O
and O
dyspnea O
on O
exertion O
. O
 
She O
has O
actually O
been O
stuttering O
on O
and O
off O
for O
18-24 O
hours O
, O
and O
she O
came O
to O
the O
emergency O
department O
in O
the O
earl O
morning O
hours O
for O
evaluation O
of O
this O
problem O
. O
 
She O
is O
presently O
pain O
free O
after O
having O
received O
nitrates O
in O
the O
emergency O
department O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
Noted O
on O
handwritten O
emergency O
department O
record O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
Patient O
is O
presently O
comfortable O
in O
no O
respiratory O
distress O
. O
 
HEART O
: O
No O
murmurs O
or O
gallops O
. O
 
Pulses O
are O
equal O
and O
symmetric O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
bilaterally O
. O
 
LABORATORY O
EVALUATION O
: O
Electrocardiogram O
shows O
left O
bundle O
branch O
pattern O
which O
is O
old O
. O
 
Her O
cardiac O
markers O
are O
positive O
for O
troponin O
I O
of O
0.32 O
. O
 
FINAL O
DIAGNOSIS O
: O
Acute O
coronary O
insufficiency O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Patient O
is O
presently O
comfortable O
and O
will O
be O
admitted O
to O
cardiology O
service O
. O
 
___________________________________ O
LR676/41602 I-ID
ADAM I-NAME
OLDHAM I-NAME
, O
M.D O
. O
 
AO66 I-NAME
D:10/05/64 O
T:10/05/64 O
Dictated O
by O
: O
ADAM I-NAME
OLDHAM I-NAME
, O
M.D O
. O
 
AO66 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2069-06-27 I-DATE
EDVISIT^12953473^PICKETT O
, O
SHILPA^06/27/69^RICO O
, O
WILLARD I-NAME
The O
patient O
was O
seen O
with O
Dr. O
Mueller I-NAME
. O
 
I O
confirmed O
her O
history O
and O
physical O
. O
 
I O
also O
interviewed O
and O
examined O
the O
patient O
. O
 
Please O
see O
her O
note O
for O
more O
details O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
77-year-old O
female O
with O
a O
several-week O
history O
of O
nausea O
, O
vomiting O
, O
abdominal O
pain O
, O
which O
has O
worsened O
over O
the O
past O
3 O
days O
, O
per O
the O
patient O
and O
her O
son O
. O
 
These O
episodes O
are O
`` O
gassy O
feeling O
'' O
in O
the O
epigastrium O
associated O
with O
nausea O
and O
vomiting O
and O
lightheadedness O
. O
 
No O
chest O
pain O
, O
no O
shortness O
of O
breath O
. O
 
Of O
note O
, O
the O
patient O
has O
a O
history O
of O
coronary O
artery O
disease O
with O
atypical O
symptoms O
. O
 
She O
has O
also O
had O
a O
history O
of O
pancreatitis O
. O
 
PHYSICAL O
EXAMINATION O
: O
She O
is O
awake O
and O
alert O
, O
in O
no O
distress O
at O
this O
time O
. O
 
Afebrile O
with O
a O
pulse O
of O
62 O
, O
blood O
pressure O
140/60 O
, O
and O
O2 O
sat O
100 O
% O
on O
room O
air O
. O
 
Neck O
is O
supple O
with O
no O
signs O
of O
meningismus O
. O
 
Head O
is O
atraumatic O
. O
 
Moist O
mucous O
membranes O
. O
 
Lungs O
are O
clear O
to O
auscultation O
bilaterally O
. O
 
Heart O
has O
regular O
rate O
and O
rhythm O
. O
 
Abdomen O
is O
soft O
with O
mild O
epigastric O
tenderness O
to O
palpation O
. O
 
No O
guarding O
or O
rebound O
on O
my O
exam O
. O
 
Extremities O
are O
warm O
and O
well O
perfused O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
's O
IV O
access O
was O
established O
. O
 
Labs O
were O
drawn O
revealing O
white O
count O
of O
8 O
, O
hematocrit O
of O
39 O
. O
 
BUN O
and O
creatinine O
of O
36 O
and O
1.5 O
, O
which O
is O
normal O
for O
the O
patient O
. O
 
LFTs O
are O
normal O
. O
 
Lipase O
is O
slightly O
elevated O
at O
67 O
. O
 
Troponin O
less O
than O
assay O
. O
 
Urinalysis O
25-30 O
white O
cells O
. O
 
The O
patient O
's O
EKG O
was O
left O
bundle-branch O
block O
, O
which O
is O
unchanged O
. O
 
KUB O
shows O
no O
air O
fluid O
levels O
. O
 
This O
patient O
has O
a O
possible O
mild O
pancreatitis O
as O
well O
as O
a O
mild O
urinary O
tract O
infection O
. O
 
In O
addition O
, O
she O
has O
multiple O
cardiac O
risk O
factors O
and O
an O
EKG O
, O
which O
will O
not O
allow O
for O
conventional O
cardiac O
stress O
testing O
. O
 
She O
will O
be O
admitted O
the O
hospital O
for O
enzymatic O
rule O
out O
MI O
with O
a O
possible O
necessity O
to O
have O
a O
stress O
MIBI O
as O
well O
as O
to O
give O
IV O
antibiotics O
for O
urinary O
tract O
infection O
and O
hydration O
and O
serial O
exams O
for O
her O
probable O
pancreatitis O
. O
 
The O
patient O
was O
admitted O
to O
the O
floor O
in O
stable O
condition O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
______________________________ O
RICO O
, O
WILLARD I-NAME
MD O
D O
: O
06/28/69 I-DATE
T O
: O
06/28/69 I-DATE
Dictated O
By O
: O
RICO O
, O
WILLARD I-NAME
eScription O
document:3-4025432 O
BF O
 
Record O
date O
: O
2074-09-03 I-DATE
HSP I-LOCATION
Cardiovascular O
Division O
CVD O
MR8 O
99 I-LOCATION
Fitzpatrick I-LOCATION
Circle I-LOCATION
SERGIO-STEVEN O
, O
FRANCESCA I-NAME
Adrian I-LOCATION
, O
TN I-LOCATION
13467 I-LOCATION
80780896 I-ID
( O
433 O
) O
758-3431 I-CONTACT
09/03/74 I-DATE
REFERRING O
PHYSICIAN O
: O
Armando I-NAME
Newton I-NAME
, O
M.D O
. O
 
Mrs. O
Francesca I-NAME
Sergio-Steven I-NAME
is O
a O
72-year-old O
Hispanic O
female O
who O
presents O
with O
a O
new-onset O
acute O
MI O
. O
 
She O
has O
no O
known O
prior O
manifestations O
of O
coronary O
disease O
, O
but O
has O
a O
long O
history O
of O
insulin-dependent O
diabetes O
mellitus O
and O
hypertension O
. O
 
She O
had O
been O
in O
her O
usual O
state O
of O
health O
until O
about O
2 O
weeks O
ago O
, O
when O
she O
began O
to O
have O
episodes O
of O
chest O
discomfort O
. O
 
She O
has O
only O
had O
two O
such O
episodes O
until O
the O
morning O
of O
admission O
, O
when O
she O
developed O
severe O
episode O
of O
chest O
pain O
at O
rest O
associated O
with O
shortness O
of O
breath O
. O
 
She O
presented O
to O
the O
emergency O
room O
here O
where O
she O
was O
found O
to O
have O
new-onset O
ST-segment O
elevation O
in O
the O
inferior O
leads O
with O
a O
coving O
morphology O
involving O
the O
lateral O
leads O
as O
well O
. O
 
There O
was O
also O
poor O
R-wave O
progression O
V1 O
through O
V3 O
. O
 
She O
was O
taken O
urgently O
to O
the O
cardiac O
catheterization O
laboratory O
, O
where O
she O
was O
found O
to O
have O
a O
markedly O
elevated O
wedge O
pressure O
at O
30 O
mmHg O
with O
a O
normal O
cardiac O
index O
and O
blood O
pressure O
. O
 
She O
had O
mid O
inferior O
wall O
and O
lateral O
wall O
akinesis O
initially O
with O
3+ O
mitral O
regurgitation O
. O
 
There O
was O
severe O
diffuse O
coronary O
disease O
with O
diffuse O
LAD O
disease O
and O
total O
occlusion O
of O
the O
proximal O
circumflex O
. O
 
The O
right O
coronary O
artery O
was O
small O
with O
a O
70 O
% O
proximal O
stenosis O
. O
 
The O
occluded O
circumflex O
was O
crossed O
with O
a O
wire O
and O
was O
stented O
with O
a O
Cypher O
drug-eluting O
stent O
. O
 
She O
had O
an O
excellent O
result O
with O
the O
wedge O
also O
decreasing O
to O
20 O
mmHg O
. O
 
She O
had O
an O
estimated O
70 O
% O
ejection O
fraction O
despite O
the O
inferior O
and O
lateral O
akinesis O
. O
 
Cardiac O
index O
was O
2.5 O
with O
SVR O
of O
1739 O
. O
 
She O
was O
then O
brought O
to O
the O
coronary O
care O
unit O
for O
further O
evaluation O
. O
 
Her O
past O
medical O
history O
is O
notable O
for O
hypertension O
for O
which O
she O
takes O
lisinopril O
40 O
mg O
q.d O
. O
 
and O
atenolol O
50 O
mg O
q.d O
. O
 
She O
also O
has O
insulin-dependent O
diabetes O
mellitus O
and O
takes O
insulin O
. O
 
Past O
medical O
history O
is O
also O
notable O
for O
a O
hysterectomy O
. O
 
Social O
history O
is O
notable O
for O
no O
cigarette O
or O
alcohol O
use O
. O
 
She O
is O
from O
Paraguay I-LOCATION
and O
has O
recently O
arrived O
in O
this O
country O
. O
 
Review O
of O
systems O
show O
no O
fever O
, O
chills O
, O
nausea O
, O
or O
vomiting O
. O
 
On O
exam O
, O
she O
is O
comfortable O
with O
a O
blood O
pressure O
initially O
160/80 O
with O
a O
heart O
rate O
of O
70 O
and O
regular O
. O
 
Followup O
pressure O
125/80 O
with O
a O
heart O
rate O
of O
72 I-AGE
beats O
per O
minute O
. O
 
Head O
and O
neck O
were O
unremarkable O
. O
 
Chest O
is O
clear O
. O
 
Cardiac O
exam O
shows O
no O
jugular O
venous O
distention O
at O
30 O
degrees O
. O
 
PMI O
is O
normal O
. O
 
S1 O
and O
S2 O
were O
normal O
with O
a O
physiological O
split O
. O
 
There O
is O
an O
S4 O
and O
a O
1/6 O
systolic O
ejection O
murmur O
as O
well O
as O
a O
1 O
to O
2/6 O
holosystolic O
murmur O
and O
mitral O
regurgitation O
at O
the O
left O
lower O
sternal O
border O
. O
 
There O
is O
no O
S3 O
. O
 
Abdominal O
exam O
was O
unremarkable O
without O
organomegaly O
. O
 
Bowel O
sounds O
are O
normal O
. O
 
Extremities O
showed O
no O
edema O
or O
cyanosis O
. O
 
Calf O
site O
is O
clean O
without O
bruits O
. O
 
Distal O
pulse O
is O
decreased O
but O
palpable O
. O
 
Her O
resting O
12-lead O
electrocardiogram O
shows O
evidence O
of O
her O
evolving O
inferolateral O
MI O
. O
 
Other O
lab O
values O
included O
creatinine O
1.0 O
with O
normal O
electrolytes O
, O
hematocrit O
is O
44.4 O
% O
, O
white O
blood O
cell O
count O
3.8 O
with O
platelets O
322,000 O
. O
 
Liver O
function O
tests O
are O
normal O
. O
 
A O
portable O
chest O
x-ray O
shows O
pulmonary O
edema O
. O
 
Mrs. O
Sergio-Steven I-NAME
clearly O
has O
evidence O
of O
an O
inferoposterior O
MI O
initially O
with O
a O
very O
high O
filling O
pressure O
and O
pulmonary O
edema O
and O
mitral O
regurgitation O
. O
 
She O
has O
had O
her O
circumflex O
, O
which O
is O
a O
very O
large O
vessel O
, O
well O
treated O
now O
with O
a O
drug-eluting O
stent O
, O
and O
her O
wedge O
has O
come O
down O
, O
and O
her O
mitral O
regurgitation O
is O
substantially O
improved O
. O
 
At O
this O
point O
, O
we O
will O
bring O
her O
to O
the O
coronary O
care O
unit O
for O
careful O
management O
with O
aspirin O
, O
Plavix O
, O
heparin O
, O
continue O
the O
Integrilin O
, O
as O
well O
as O
Lasix O
and O
nitrates O
. O
 
We O
will O
plan O
to O
initiate O
afterload O
reduction O
as O
soon O
as O
tolerated O
, O
and O
also O
plan O
beta-blockade O
to O
limit O
her O
myocardial O
oxygen O
demands O
. O
 
She O
certainly O
has O
co-existent O
quite O
substantial O
coronary O
disease O
including O
primarily O
the O
right O
coronary O
artery O
degree O
and O
to O
some O
degree O
the O
LAD O
. O
 
At O
this O
point O
, O
if O
she O
were O
to O
have O
developed O
recurrent O
ischemia O
, O
we O
would O
proceed O
to O
consideration O
of O
bypass O
surgery O
. O
 
______________________________ O
Yakov I-NAME
Ferris I-NAME
, O
MD O
Dictated O
By O
: O
Yakov I-NAME
Ferris I-NAME
eScription O
document:5-4672574 O
BFFocus O
DD O
: O
09/03/74 I-DATE
DT O
: O
09/03/74 I-DATE
DV O
: O
09/03/74 I-DATE
 
Record O
date O
: O
2074-12-09 I-DATE
Francesca I-NAME
is O
a O
72 I-AGE
y/o O
woman O
here O
for O
f/u O
abnormal O
lab O
tests O
done O
11/21 I-DATE
. O
 
Feels O
ok O
. O
 
Problems O
DM O
HTN O
Hysterectomy O
Coronary O
artery O
disease O
: O
CABG-9/74 O
Medications O
Colace O
( O
DOCUSATE O
SODIUM O
) O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
BID O
Nystatin O
SUSPENSION O
( O
MOUTHWASH O
) O
5 O
ML O
SWISH O
& O
SPIT O
QID O
Lisinopril O
40 O
MG O
PO O
QD O
Lantus O
( O
INSULIN O
GLARGINE O
) O
30 O
UNITS O
SC O
QHS O
Lipitor O
( O
ATORVASTATIN O
) O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Protonix O
( O
PANTOPRAZOLE O
) O
40 O
MG O
( O
40MG O
TABLET O
DR O
take O
1 O
) O
PO O
QD O
Amiodarone O
400 O
MG O
( O
200MG O
TABLET O
take O
2 O
) O
PO O
BID O
Furosemide O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
BID O
Ntg O
1/150 O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
MG O
) O
) O
1 O
TAB O
SL O
x1 O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Mg O
OXIDE O
( O
MAGNESIUM O
OXIDE O
) O
800 O
MG O
( O
400MG O
TABLET O
take O
2 O
) O
PO O
BID O
Toprol O
XL O
( O
METOPROLOL O
SUCCINATE O
EXTENDED O
RELEASE O
) O
100MG O
TAB.SR O
24H O
PO O
QD O
Asa O
( O
ACETYLSALICYLIC O
ACID O
) O
81MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Allergies O
NKA O
Takes O
meds O
. O
 
Home O
glu80-300 O
. O
 
The O
more O
she O
eats O
the O
lower O
her O
blood O
sugar O
. O
 
Endocrine O
: O
No O
polydipsia O
, O
polyuria O
, O
polyphagia O
, O
weight O
change O
, O
sweats O
, O
heat O
intolerance O
. O
 
Cor- O
No O
chest O
pain O
. O
 
No O
SOB O
. O
 
No O
palpitations O
. O
 
No O
lighthead O
. O
 
No O
PND O
. O
 
No O
orthopnea O
. O
 
No O
claudication O
. O
 
No O
edema O
. O
 
Pulm- O
No O
cough O
. O
 
No O
wheeze O
. O
 
No O
SOB O
. O
 
GI- O
No O
nausea O
. O
 
No O
vomitting O
. O
 
No O
dyspepsia O
. O
 
No O
reflux O
. O
 
No O
abdo O
pain O
. O
 
No O
diarrhea O
. O
 
No O
constipation O
. O
 
No O
melena O
. O
 
No O
BRBPR O
. O
 
GU- O
no O
hematuria O
; O
no O
dysuria O
; O
no O
frequency O
; O
no O
urgency O
; O
no O
incontinence O
. O
 
no O
vaginal O
dc O
or O
itch O
. O
 
No O
dyspareunia O
. O
 
No O
abnormal O
bleeding O
. O
 
Constitutional O
: O
No O
weight O
loss O
. O
 
No O
fevers O
. O
 
NO O
chills O
. O
 
NO O
night O
sweats O
. O
 
No O
fatigue O
. O
 
NO O
pain O
. O
 
Going O
to O
Paraguay I-LOCATION
12/13 I-DATE
for O
3 O
months O
. O
 
Vital O
Signs O
BP O
126/78 O
, O
P O
68 O
, O
Wt O
133 O
lb O
WD O
, O
WN O
, O
NAD O
. O
 
M O
& O
T- O
lips O
and O
gums O
unremarkable O
. O
 
Good O
dentition O
. O
 
Moist O
; O
no O
erythema O
; O
no O
exudate O
; O
no O
lesions O
Neck- O
supple O
. O
 
No O
JVD O
. O
 
No O
bruit O
. O
 
No O
LAN O
. O
 
No O
thyromegaly O
Pulm- O
NO O
accessory O
muscle O
use O
. O
 
Percussion- O
normal O
. O
 
Palpation-normal O
. O
 
Auscultation-clear O
. O
 
Cor- O
reg O
rhyhm O
. O
 
S1S2 O
normal O
. O
 
No O
gallop O
. O
 
No O
rub O
. O
 
NO O
murmer O
. O
 
Abdo- O
normal O
BS O
; O
soft O
with O
no O
HSM O
. O
 
No O
mass O
. O
 
No O
tenderness O
Ext- O
skin O
intact O
. O
 
DP-trace O
. O
 
NO O
edema O
. O
 
Monofilament O
intact O
. O
 
ASS O
: O
DM.CAD O
. O
 
AbnormalCMP O
. O
 
P- O
Repeat O
CMP O
. O
 
Information O
given O
for O
her O
MD O
in O
DR. O
f/u O
when O
she O
returns O
in O
3-4 O
months O
. O
 
Record O
date O
: O
2075-07-03 I-DATE
EDVISIT^80780896^SERGIO-STEVEN O
, O
FRANCESCA^07/03/75^VARNER O
, O
FALLON I-NAME
The O
patient O
was O
seen O
in O
conjunction O
with O
the O
resident O
, O
Dr. O
Vue I-NAME
. O
 
Resident O
's O
note O
was O
reviewed O
. O
 
The O
patient O
was O
seen O
and O
examined O
by O
me O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Briefly O
, O
this O
is O
a O
73-year-old O
woman O
with O
extensive O
cardiac O
history O
of O
hypertension O
and O
coronary O
artery O
disease O
, O
IMI O
with O
any O
EF O
40 O
% O
, O
history O
of O
V-TACH O
, O
high O
cholesterol O
, O
insulin-dependent O
diabetes O
, O
and O
status O
post O
AICD O
cardiac O
catheterization O
and O
in O
the O
past O
. O
 
The O
patient O
was O
in O
the O
Emergency O
Department O
today O
visiting O
a O
family O
member O
. O
 
She O
was O
completely O
asymptomatic O
, O
but O
had O
her O
blood O
pressure O
taken O
which O
showed O
a O
pressure O
of O
190/98 O
. O
 
The O
patient O
states O
that O
she O
usually O
takes O
9 O
cardiac O
and O
antihypertensive O
medicines O
but O
the O
prescriptions O
has O
run O
out O
and O
so O
for O
the O
past O
week O
or O
so O
, O
she O
has O
been O
taking O
only O
4 O
of O
the O
9 O
. O
 
She O
is O
unable O
to O
say O
exactly O
which O
ones O
. O
 
She O
denies O
any O
headache O
, O
visual O
changes O
, O
chest O
pain O
, O
shortness O
of O
breath O
, O
palpitations O
, O
dizziness O
, O
or O
lightheadedness O
. O
 
Her O
husband O
is O
the O
one O
in O
the O
Emergency O
Department O
today O
and O
that O
is O
causing O
her O
some O
stress O
. O
 
Denies O
any O
rash O
, O
joint O
pain O
, O
back O
pain O
, O
polyuria O
, O
or O
polydipsia O
. O
 
Please O
see O
the O
resident O
's O
note O
for O
details O
of O
the O
patient O
's O
past O
medical O
history O
, O
surgical O
history O
, O
family O
history O
, O
review O
of O
systems O
, O
and O
physical O
exam O
. O
 
PHYSICAL O
EXAMINATION O
: O
She O
is O
awake O
, O
alert O
, O
in O
no O
distress O
with O
no O
complaints O
. O
 
Has O
a O
repeat O
blood O
pressure O
of O
190/95 O
and O
saturating O
99 O
% O
on O
room O
air O
with O
a O
pulse O
of O
70 O
. O
 
Exam O
is O
remarkable O
for O
a O
systolic O
ejection O
murmur O
at O
the O
right O
upper O
sternal O
border O
of O
3/6 O
. O
 
No O
JVD O
, O
with O
good O
and O
equal O
pulses O
. O
 
Abdomen O
is O
soft O
and O
nontender O
. O
 
She O
has O
no O
papilledema O
and O
fundal O
exam O
is O
clear O
. O
 
Neurologically O
, O
she O
is O
oriented O
x3 O
with O
normal O
mood O
and O
affect O
. O
 
IMAGING O
STUDIES O
: O
EKG O
shows O
first-degree O
AV O
block O
with O
an O
old O
LAD O
. O
 
This O
is O
considered O
normal O
for O
this O
patient O
and O
is O
unchanged O
from O
before O
. O
 
Urinary O
dip O
is O
negative O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
's O
usual O
pharmacy O
is O
contacted O
. O
 
Correct O
doses O
of O
her O
medications O
are O
obtained O
and O
refills O
for O
2 O
weeks O
were O
given O
. O
 
She O
is O
told O
to O
follow O
up O
with O
her O
primary O
care O
physician O
within O
2 O
weeks O
. O
 
She O
says O
she O
will O
be O
able O
to O
do O
that O
and O
remains O
asymptomatic O
throughout O
her O
Emergency O
Department O
stay O
. O
 
At O
one O
point O
during O
her O
stay O
, O
her O
blood O
pressure O
went O
up O
to O
as O
high O
as O
209/98 O
, O
however O
, O
on O
my O
last O
recheck O
, O
just O
prior O
to O
the O
patient O
leaving O
, O
the O
pressure O
was O
185/90 O
. O
 
The O
patient O
's O
primary O
care O
physician O
was O
contacted O
about O
this O
and O
agrees O
to O
follow O
up O
with O
the O
patient O
within O
3 O
days O
. O
 
DISPOSITION O
: O
The O
patient O
is O
discharged O
home O
in O
satisfactory O
condition O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
PRIMARY O
DIAGNOSIS O
: O
Hypertension O
. O
 
______________________________ O
VARNER O
, O
FALLON I-NAME
M.D O
. O
 
D O
: O
07/03/75 I-DATE
T O
: O
07/03/75 I-DATE
Dictated O
By O
: O
VARNER O
, O
FALLON I-NAME
eScription O
document:1-0201766 O
BF O
 
Record O
date O
: O
2076-06-22 I-DATE
Reason O
for O
Visit O
Francesca I-NAME
is O
a O
74 I-AGE
y/o O
woman O
here O
for O
evaluation O
of O
HTN O
, O
cardiac O
and O
DM O
treatment O
. O
 
Problems O
DM O
HTN O
Hysterectomy O
Coronary O
artery O
disease O
: O
CABG-9/74 O
Medications O
Ntg O
1/150 O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
Mg O
) O
) O
1 O
TAB O
SL O
x1 O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
81MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Humulin O
N O
UNITS O
SC O
QAM O
and O
before O
bed O
, O
20 O
units O
AM O
, O
30 O
units O
HS O
FUROSEMIDE O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
BID O
CAPTOPRIL O
25MG O
TABLET O
PO O
TID O
x O
30 O
days O
Lipitor O
( O
ATORVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
x O
14 O
days O
Toprol O
Xl O
( O
METOPROLOL O
Succinate O
Extended O
Release O
) O
100MG O
TAB.SR O
24H O
PO O
QD O
x O
14 O
days O
Allergies O
NKA O
Narrative O
History O
Takes O
meds O
. O
 
No O
SEs O
. O
 
Nocturia O
x O
1 O
; O
polys-0 O
; O
Eyes- O
no O
complaints O
. O
 
Last O
exam O
-none O
. O
 
Feet- O
no O
pain O
, O
numbness O
, O
burning O
. O
 
Cor- O
No O
chest O
pain O
. O
 
No O
SOB O
. O
 
No O
palpitations O
. O
 
When O
gets O
up O
from O
bed O
, O
has O
lighthead O
. O
 
No O
PND O
. O
 
No O
orthopnea O
. O
 
No O
claudication O
. O
 
No O
edema O
. O
 
GI- O
No O
nausea O
. O
 
No O
vomitting O
. O
 
No O
dyspepsia O
. O
 
No O
reflux O
. O
 
No O
abdo O
pain O
. O
 
No O
diarrhea O
. O
 
No O
constipation O
. O
 
No O
melena O
. O
 
No O
BRBPR O
. O
 
Neuro- O
No O
headache O
. O
 
No O
vision O
change O
. O
 
NO O
hearing O
change O
. O
 
No O
numbness O
. O
 
No O
tingling O
. O
 
No O
loss O
of O
strength O
. O
 
No O
seizures O
. O
 
No O
loss O
of O
balance O
. O
 
ETOH/drugs- O
no O
Cigs- O
no O
Diet-no O
Exercise-no O
Home O
glu- O
machine O
not O
working O
well O
. O
 
Hypoglycemia-no O
Other O
complaints-no O
Sleep- O
ok. O
Not O
depressed O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
146/84 O
PULSE O
80 O
WEIGHT O
143.5 O
lb O
Exam O
NAD O
, O
WD O
, O
WN O
Eyes- O
conj O
& O
sclera O
not O
injected O
EOMI O
, O
PERLA O
M O
& O
T- O
lips O
and O
gums O
unremarkable O
. O
 
Moist O
no O
erythema O
; O
no O
exudate O
; O
no O
lesions O
Neck- O
supple O
. O
 
No O
JVD O
. O
 
No O
bruit O
. O
 
No O
LAN O
. O
 
No O
thyromegaly O
Cor- O
reg O
rhyhm O
. O
 
S1S2 O
normal O
. O
 
No O
gallop O
. O
 
No O
rub O
. O
 
NO O
murmer O
. O
 
Pulm- O
NO O
accessory O
muscle O
use O
. O
 
Percussion- O
normal O
. O
 
Palpation-normal O
. O
 
Auscultation-clear O
. O
 
Abdo- O
normal O
BS O
; O
soft O
with O
no O
HSM O
. O
 
No O
mass O
. O
 
No O
tenderness O
Ext/ O
feet O
: O
no O
edema O
; O
DP O
Pulses O
absent O
. O
 
Skin O
intact O
. O
 
Monofilament O
absent O
. O
 
Results O
05/26/2076 I-DATE
NA O
142 O
, O
K O
3.6 O
( O
# O
) O
, O
CL O
100 O
, O
CO2 O
34 O
( O
* O
) O
, O
BUN O
13 O
, O
CRE O
1.3 O
, O
EGFR O
43 O
[ O
1 O
] O
, O
GLU O
93 O
( O
# O
) O
[ O
1 O
] O
RESULT O
COMMENT O
: O
( O
Abnormal O
if O
Assessment O
DM- O
poor O
control O
Asymp O
CAD O
HTN- O
elevted O
today O
but O
has O
been O
fine O
. O
 
Disposition O
and O
Plans O
Cont O
meds O
but O
increase O
PM O
insulin O
to O
30 O
units O
. O
 
RTC O
3 O
month O
or O
PRN O
. O
 
______________________________ O
Armando I-NAME
Brian I-NAME
Nettles I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2077-03-31 I-DATE
EDVISIT^80780896^SERGIO O
STEVEN O
, O
FRANCESCA^03/31/77^DELACRUZ O
, O
ARMANDO I-NAME
I O
evaluated O
this O
patient O
independently O
and O
concur O
with O
findings O
as O
noted O
on O
the O
medical O
record O
, O
supervised O
the O
care O
as O
provided O
by O
the O
residents O
in O
the O
Emergency O
Department O
. O
 
CHIEF O
COMPLAINT O
: O
In O
brief O
, O
this O
is O
a O
74-year-old O
female O
with O
complaint O
of O
worsening O
renal O
function O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
patient O
is O
a O
74-year-old O
female O
with O
a O
history O
of O
hypertension O
, O
diabetes O
of O
type O
2 O
, O
and O
diabetic O
neuropathy O
, O
followed O
by O
her O
primary O
care O
physician O
, O
Dr. O
Nettles I-NAME
and O
has O
had O
worsening O
a O
diabetic O
control O
and O
poor O
p.o O
. O
 
intake O
. O
 
The O
patient O
has O
had O
switched O
recently O
captopril O
dosing O
and O
also O
insulin O
dosing O
per O
Dr. O
Nettles I-NAME
. O
 
She O
has O
been O
eating O
and O
drinking O
well O
and O
has O
no O
specific O
complaints O
of O
fever O
, O
chills O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
or O
additional O
symptoms O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
diabetes O
, O
hypercholesterolemia O
, O
and O
diabetic O
neuropathy O
. O
 
SOCIAL O
HISTORY O
: O
Negative O
for O
drugs O
, O
alcohol O
, O
or O
tobacco O
. O
 
FAMILY O
HISTORY O
: O
Noncontributory O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
CABG O
in O
09/2074 I-DATE
and O
pacemaker O
placement O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Significant O
for O
complaint O
of O
worsening O
renal O
function O
but O
no O
additional O
symptoms O
. O
 
All O
other O
systems O
are O
reviewed O
and O
are O
negative O
as O
noted O
on O
the O
medical O
record O
. O
 
MEDICATIONS O
: O
Numerous O
. O
 
Please O
see O
the O
medical O
record O
. O
 
ALLERGIES O
: O
None O
. O
 
PHYSICAL O
EXAMINATION O
: O
Awake O
, O
alert O
, O
and O
oriented O
female O
in O
no O
apparent O
distress O
. O
 
Vital O
signs O
are O
as O
noted O
in O
the O
medical O
record O
. O
 
I O
examined O
this O
patient O
, O
and O
agree O
with O
physical O
exam O
findings O
as O
noted O
on O
the O
medical O
record O
. O
 
Please O
refer O
to O
the O
chart O
. O
 
ASSESSMENT O
AND O
MEDICAL O
DECISION O
MAKING O
: O
This O
is O
a O
74-year-old O
female O
with O
worsening O
prerenal O
azotemia O
; O
probably O
dehydration O
, O
and O
worsening O
renal O
function O
and O
noted O
to O
have O
BUN O
in O
the O
50 O
and O
creatinine O
of O
2.4 O
. O
 
PLAN O
: O
We O
discussed O
this O
case O
with O
her O
physician O
, O
Dr. O
Nettles I-NAME
who O
suggest O
Benson I-LOCATION
admission O
, O
discuss O
this O
with O
Benson I-LOCATION
. O
 
They O
will O
agree O
to O
accept O
the O
patient O
for O
IV O
hydration O
and O
following O
the O
renal O
function O
. O
 
PRIMARY O
DIAGNOSIS O
: O
Dehydration O
. O
 
SECONDARY O
DIAGNOSIS O
: O
Acute O
renal O
insufficiency O
. O
 
THIRD O
DIAGNOSIS O
: O
Diabetes O
mellitus O
. O
 
______________________________ O
DELACRUZ O
, O
ARMANDO I-NAME
M.D O
. O
 
D O
: O
03/31/77 I-DATE
T O
: O
03/31/77 I-DATE
Dictated O
By O
: O
DELACRUZ O
, O
ARMANDO I-NAME
eScription O
document:6-0689198 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2082-06-29 I-DATE
Narrative O
History O
The O
patient O
is O
here O
today O
for O
the O
following O
issues O
: O
1 O
. O
 
Patient O
is O
scheduled O
for O
gastric O
bypass O
surgery O
July I-DATE
22nd I-DATE
. O
 
She O
is O
leaving O
for O
vacation O
. O
 
She O
wants O
to O
make O
sure O
she O
is O
cleared O
for O
her O
surgery O
2 O
. O
 
Patient O
completed O
Vit O
. O
 
D O
supplementation O
and O
her O
new O
VIT O
D O
level O
is O
49 O
( O
up O
from O
9 O
) O
. O
 
3 O
. O
 
Patient O
complaining O
of O
persistent O
chest O
pain O
- O
she O
saw O
Dr. O
Uzzell I-NAME
who O
feels O
she O
is O
cleared O
for O
surgery O
from O
a O
cardiac O
perspective O
. O
 
4 O
. O
 
Patient O
has O
persistednt O
recurrent O
LE O
edema O
. O
 
5 O
. O
 
She O
complaining O
of O
occasional O
shortness O
of O
breath O
and O
has O
a O
pulmonary O
appointment O
in O
July I-DATE
prior O
to O
her O
surgery O
. O
 
6 O
. O
 
Patient O
saw O
Dr. O
Newkirk I-NAME
who O
is O
still O
awaiting O
some O
bloodwork O
but O
feels O
she O
is O
cleared O
for O
surgery O
. O
 
Her O
hct O
most O
recently O
was O
35.6 O
7 O
. O
 
OSA O
- O
feels O
she O
does O
awake O
in O
the O
middle O
of O
the O
night O
with O
sob O
. O
 
8 O
. O
 
Patient O
gets O
an O
occasional O
leg O
cramp O
on O
the O
right O
- O
question O
related O
to O
LBP O
. O
 
K+ O
normal O
on O
June I-DATE
23rd I-DATE
. O
 
Will O
follow O
up O
after O
surgery O
. O
 
No O
weakness O
or O
numbness O
. O
 
Problems O
Diabetes O
mellitus O
S/P O
Abortion O
SPONTANEOUS O
4/80 I-DATE
Chlamydia O
CERVICITIS-TREATED O
H/O O
Abnormal O
pap O
test O
Positive O
PPD O
NEG O
CXR O
PARONYCHIAL O
INFECTION O
LEFT O
HAND O
78 I-DATE
Ectopic O
pregnancy O
74 I-DATE
Coronary O
artery O
disease O
Anemia O
Shortness O
of O
breath O
Hypertension O
Gastroesophageal O
reflux O
disease O
Elevated O
cholesterol O
Hyperthyroidism O
Obesity O
Review O
of O
Systems O
Unless O
mentioned O
in O
the O
history O
above O
the O
following O
ROS O
were O
asked O
and O
are O
negative O
: O
Constitutional O
, O
Respiratory O
, O
Cardiac O
, O
GI O
( O
above O
) O
, O
Heme O
( O
above O
) O
, O
Endocrine O
, O
GYN O
, O
Musculoskeletal O
, O
Psych O
, O
and O
Neuro O
. O
 
Medications O
ATENOLOL O
100MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ASA O
( O
ACETYLSALICYLIC O
ACID O
) O
325MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LIPITOR O
( O
ATORVASTATIN O
) O
20MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
INSULIN O
70/30 O
( O
HUMAN O
) O
SEE O
BELOW O
SC O
5ID O
IMDUR O
( O
ISOSORBIDE O
MONONIT O
. O
 
( O
SR O
) O
) O
30MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
NEXIUM O
( O
ESOMEPRAZOLE O
) O
40MG O
1 O
Capsule O
( O
s O
) O
PO O
BID O
KLONOPIN O
( O
CLONAZEPAM O
) O
0.5MG O
1 O
Tablet O
( O
s O
) O
PO O
TID O
ZESTRIL O
( O
LISINOPRIL O
) O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ZANTAC O
( O
RANITIDINE O
HCL O
) O
300MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
VITAMIN O
D O
( O
ERGOCALCIFEROL O
) O
50000 O
U O
IM O
q72 O
HOURS O
36 O
day O
( O
s O
) O
MECLIZINE O
HCL O
25MG O
1 O
Tablet O
( O
s O
) O
PO O
TID O
7 O
day O
( O
s O
) O
Allergies O
NKDA O
Physical O
Exam O
120/80 O
GENERAL O
: O
obese O
female O
EXT O
: O
No O
edema O
LABS O
reviewed O
. O
 
Assessment O
and O
Plan O
1 O
. O
 
Gastric O
Bypass O
- O
Will O
proceed O
to O
preop O
evaluation O
and O
hopeful O
surgery O
on O
July I-DATE
22nd I-DATE
. O
 
Dr. O
Rivers I-NAME
will O
be O
consulted O
to O
assist O
with O
sugar O
management O
. O
 
2 O
. O
 
Vit O
D O
deficiency O
- O
Corrected O
with O
Vit O
D O
supplementation O
. O
 
3 O
. O
 
LE O
edema O
will O
likely O
improve O
with O
weight O
loss O
. O
 
Follow O
up O
after O
surgery O
. O
 
4 O
. O
 
CAD O
- O
followed O
by O
Dr. O
Uzzell I-NAME
5. O
shortness O
of O
breath O
- O
Likely O
mostly O
secondary O
to O
deconditioning O
and O
weight O
but O
will O
be O
evaluated O
by O
pulmonary O
. O
 
6 O
. O
 
OSA O
- O
sees O
pulmonary O
in O
July I-DATE
. O
 
appointment O
time O
35 O
minutes O
- O
Discussed O
with O
patient O
at O
lenght O
surgery O
and O
what O
to O
expect O
after O
. O
 
She O
seems O
motivated O
to O
lose O
weight O
. O
 
Record O
date O
: O
2083-03-08 I-DATE
Narrative O
History O
The O
patient O
is O
here O
today O
for O
the O
following O
issues O
: O
1 O
. O
 
Patient O
's O
father O
recently O
died O
- O
massive O
MI O
. O
 
Klonipin O
has O
been O
helping O
patient O
at O
night O
. O
 
She O
tried O
it O
during O
the O
day O
but O
too O
sleepy O
. O
 
2 O
. O
 
She O
has O
had O
persistent O
chest O
pain O
and O
sob O
since O
Father O
's O
dealth O
. O
 
She O
tried O
SLNTG O
without O
improvement O
. O
 
HAs O
have O
also O
returned O
. O
 
Pain O
not O
worse O
with O
exertion O
. O
 
3 O
. O
 
Patient O
asking O
about O
IUD O
removal O
. O
 
4 O
. O
 
Patient O
has O
lost O
90 O
pounds O
so O
far O
. O
 
Appetite O
is O
down O
and O
smaller O
portions O
. O
 
5 O
. O
 
Diabetes O
- O
Dr. O
Rivers I-NAME
started O
glucophage O
825 O
BID O
but O
she O
does O
n't O
take O
it O
all O
the O
time O
. O
 
6 O
. O
 
She O
admits O
to O
not O
taking O
her O
lipitor O
- O
worrries O
it O
had O
some O
effect O
on O
her O
vision O
. O
 
Problems O
Diabetes O
mellitus O
S/P O
Abortion O
: O
SPONTANEOUS O
4/80 I-DATE
Chlamydia O
: O
CERVICITIS-TREATED O
H/O O
Abnormal O
pap O
test O
: O
'76 I-DATE
S/P O
COLPOSCOPY O
IN O
PAST O
; O
RECENT O
PAP O
NORMAL O
Positive O
PPD O
: O
NEG O
CXR O
PARONYCHIAL O
INFECTION O
: O
LEFT O
HAND O
78 I-DATE
Ectopic O
pregnancy O
: O
74 I-DATE
Coronary O
artery O
disease O
Anemia O
Shortness O
of O
breath O
Hypertension O
Gastroesophageal O
reflux O
disease O
Elevated O
cholesterol O
Hyperthyroidism O
Obesity O
Medications O
ATENOLOL O
100MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Klonopin O
( O
CLONAZEPAM O
) O
0.5MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
TID O
Lipitor O
( O
ATORVASTATIN O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Imdur O
( O
ISOSORBIDE O
MONONIT O
. O
 
( O
SR O
) O
) O
30MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Nexium O
( O
ESOMEPRAZOLE O
) O
40MG O
, O
1 O
Capsule O
( O
s O
) O
PO O
QD O
Allergies O
NKDA O
Review O
of O
Systems O
Unless O
mentioned O
in O
the O
history O
above O
the O
following O
ROS O
were O
asked O
and O
are O
negative O
: O
Constitutional O
, O
Respiratory O
, O
Cardiac O
, O
GI O
, O
Endocrine O
, O
GYN O
, O
Musculoskeletal O
, O
Psych O
- O
no O
SI O
. O
 
Vital O
signs O
BP O
120/75 O
, O
Wt O
228 O
lb O
Physical O
Exam O
108/70 O
GENERAL O
: O
Healthy O
appearing O
overweight O
female O
NECK O
: O
No O
thyromegaly O
, O
no O
nodes O
CHEST O
Clear O
lungs O
, O
NL O
frame O
COR O
: O
RRR O
, O
NL O
S1S2 O
, O
no O
murmur O
, O
rubs O
, O
or O
gallops O
. O
 
BIMAN O
c O
no O
adnexal O
masses O
, O
no O
CMT O
EXT O
: O
No O
edema O
NEURO O
: O
NL O
MS O
, O
NL O
gait O
Labs O
reviewed O
EKG O
done O
and O
unchanged O
from O
8/82 I-DATE
Assessment O
and O
Plan O
1 O
. O
 
Chest O
pain O
, O
Headaches O
and O
shortness O
of O
breath O
- O
No O
evidence O
of O
USA O
. O
 
All O
likely O
secondary O
to O
anxiety O
and O
grief O
over O
father O
's O
death O
. O
 
Patient O
reassured O
. O
 
Will O
continue O
cardiac O
medications O
. O
 
Return O
to O
cardiac O
rehab O
on O
Thursday I-DATE
. O
 
Will O
add O
.5mg O
klonipin O
during O
the O
day O
as O
needed O
. O
 
Continue O
1mg O
klonipin O
at O
night O
. O
 
Patient O
declines O
psychotherapy O
. O
 
Also O
, O
will O
restart O
nexium O
as O
some O
of O
chest O
pain O
may O
be O
recurrence O
of O
reflux O
. O
 
2 O
. O
 
DM O
- O
Encouraged O
patient O
to O
take O
glucophage O
as O
prescribed O
. O
 
She O
is O
worried O
she O
will O
always O
have O
DM O
. O
 
Discussed O
with O
patient O
importance O
of O
controlling O
BSs O
now O
and O
losing O
remaining O
weight O
. O
 
She O
will O
continue O
to O
monitor O
home O
FSBS O
. O
 
3 O
. O
 
Obesity O
- O
Impressive O
90 O
pound O
weight O
loss O
. O
 
Patient O
very O
encourage O
. O
 
Continue O
with O
smaller O
meals O
. O
 
4 O
. O
 
Hyperlipidemia O
- O
Patient O
will O
restart O
lipitor O
. O
 
Follow O
up O
fasting O
cholesterol O
and O
SGOT O
. O
 
5 O
. O
 
CAD O
- O
Continue O
Imdur O
, O
aspirin O
and O
lipitor O
. O
 
Cardiac O
rehab O
. O
 
Follow O
up O
if O
new O
chest O
pain O
. O
 
6 O
. O
 
IUD O
- O
Discussed O
briefly O
. O
 
Stressed O
importance O
of O
no O
pregnancies O
with O
CAD O
. O
 
She O
wants O
to O
rediscuss O
at O
end O
of O
year O
. O
 
7 O
. O
 
History O
of O
hyperthyroidism O
- O
Recheck O
. O
 
Record O
date O
: O
2085-10-30 I-DATE
Narrative O
History O
The O
patient O
is O
here O
today O
for O
the O
following O
issues O
: O
1 O
. O
 
Patient O
is O
pregnant O
. O
 
No O
bleeding O
or O
cramping O
. O
 
Followed O
by O
Dr. O
Kilgore I-NAME
. O
 
She O
did O
not O
intend O
to O
get O
pregnant O
again O
but O
would O
like O
to O
keep O
this O
pregnancy O
. O
 
2 O
. O
 
Labs O
in O
past O
indicated O
hyperthyroidism O
. O
 
This O
is O
being O
followed O
by O
endocrine O
. O
 
No O
palpitations O
. O
 
3 O
. O
 
DM O
- O
Has O
not O
been O
taking O
insulin O
since O
birth O
of O
son O
. O
 
HgA1C O
> O
10 O
. O
 
She O
will O
be O
seen O
by O
Endocrine O
today O
. O
 
4 O
. O
 
Followed O
by O
Dr. O
Uzzell I-NAME
for O
CAD O
. O
 
No O
chest O
pain O
. O
 
On O
atenolol O
, O
aspirin O
and O
imdur O
. O
 
Problems O
Diabetes O
mellitus O
S/P O
Abortion O
: O
SPONTANEOUS O
4/80 I-DATE
Chlamydia O
: O
CERVICITIS-TREATED O
H/O O
Abnormal O
pap O
test O
: O
'76 I-DATE
S/P O
COLPOSCOPY O
IN O
PAST O
; O
RECENT O
PAP O
NORMAL O
Positive O
PPD O
: O
NEG O
CXR O
PARONYCHIAL O
INFECTION O
: O
LEFT O
HAND O
78 I-DATE
Ectopic O
pregnancy O
: O
74 I-DATE
Coronary O
artery O
disease O
Anemia O
Shortness O
of O
breath O
Hypertension O
Gastroesophageal O
reflux O
disease O
Elevated O
cholesterol O
Hyperthyroidism O
Obesity O
Review O
of O
Systems O
Unless O
mentioned O
in O
the O
history O
above O
the O
following O
ROS O
were O
asked O
and O
are O
negative O
: O
Constitutional O
, O
Respiratory O
, O
Cardiac O
, O
GI O
, O
Endocrine O
, O
Musculoskeletal O
. O
 
Medications O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Natalcare O
Plus O
1TAB O
PO O
qd O
ATENOLOL O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Imdur O
( O
ISOSORBIDE O
MONONIT O
. O
 
( O
SR O
) O
) O
30MG O
TABLET O
CR O
24HR O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Allergies O
NKA O
Social O
History O
NP I-PROFESSION
in O
Laplace I-LOCATION
- O
waiting O
for O
researcher I-PROFESSION
job O
. O
 
Son O
born O
in O
2085 I-DATE
name O
Uri I-NAME
, O
older O
child O
Vital O
Signs O
BLOOD O
PRESSURE O
122/70 O
WEIGHT O
220 O
lb O
AGE O
32y5.7m I-AGE
Physical O
Exam O
GENERAL O
: O
Healthy O
appearing O
Labs O
reviewed O
. O
 
Assessment O
and O
Plan O
1 O
. O
 
Pregnancy O
- O
Counseled O
patient- O
especially O
on O
need O
to O
control O
sugars O
. O
 
Limited O
weight O
gain O
. O
 
She O
will O
discuss O
with O
ob O
and O
cardiology O
when O
to O
stop O
aspirin O
. O
 
She O
will O
likely O
be O
induced O
early O
. O
 
2 O
. O
 
Hyperthyroidism O
- O
Denies O
symptoms- O
repeat O
today O
Follow O
up O
with O
Dr. O
Kirkpatrick I-NAME
. O
 
3 O
. O
 
DM O
- O
Followed O
by O
diabetes O
clinic O
. O
 
HgA1C O
> O
10 O
. O
 
Will O
need O
to O
restart O
insulin O
- O
counseled O
. O
 
4 O
. O
 
CAD O
- O
On O
atenolol O
, O
asa O
, O
imdur O
. O
 
Followed O
by O
Dr. O
Uzzell I-NAME
. O
 
25 O
minutes O
spent O
with O
the O
patient O
- O
the O
majority O
counseling O
on O
above O
. O
 
Record O
date O
: O
2087-09-15 I-DATE
CARDIOLOGY O
SAINT I-LOCATION
VINCENT I-LOCATION
HOSPITAL I-LOCATION
Interval O
History O
: O
Since O
last O
seen O
, O
Ursula I-NAME
notes O
that O
her O
weight O
continues O
to O
rise O
, O
and O
with O
this O
, O
her O
angina O
is O
clearly O
worse O
. O
 
She O
has O
stable O
symptoms O
, O
nothing O
to O
suggest O
an O
ACS O
, O
but O
she O
's O
dyspneic O
with O
exertion O
and O
takes O
nitro O
occasionally O
. O
 
Medications O
: O
Atenolol O
100 O
mg O
qd O
, O
Aspirin O
81 O
mg. O
qd O
, O
Imdur O
30 O
mg. O
, O
Lipitor O
20 O
mg O
qd O
, O
glucophage O
Physical O
examination O
: O
Reveals O
her O
to O
be O
obese O
weighing O
231 O
lbs O
. O
 
Her O
BP O
is O
120/ O
palp O
in O
her O
left O
arm O
and O
her O
heart O
rate O
is O
80 O
. O
 
Her O
lungs O
are O
clear O
throughout O
. O
 
Her O
apical O
impulse O
is O
non-displaced O
with O
a O
regular O
rate O
and O
rhythm O
, O
a O
normal O
S1 O
and O
S2 O
, O
but O
no O
S3 O
or O
S4 O
. O
 
There O
is O
a O
grade O
1 O
MR O
murmur O
noted O
. O
 
There O
is O
no O
jugular O
venous O
distention O
and O
carotid O
pulses O
are O
2+ O
bilaterally O
with O
soft O
bilateral O
bruits O
. O
 
Her O
abdomen O
is O
morbidly O
obese O
. O
 
Her O
extremities O
are O
notable O
for O
trace O
lower O
extremity O
edema O
. O
 
EKG O
: O
NSR O
with O
an O
old O
IPMI O
. O
 
She O
also O
has O
non O
specific O
STT O
wave O
abnormalities O
. O
 
When O
compared O
to O
a O
previous O
tracing O
there O
is O
no O
change O
. O
 
Impression O
: O
1.CAD O
, O
s/p O
cath O
and O
stenting O
: O
her O
angina O
is O
clearly O
related O
to O
her O
weight O
going O
up O
again O
; O
I O
worry O
about O
this O
, O
and O
wonder O
if O
she O
should O
have O
another O
weight O
loss O
surgery O
. O
 
For O
the O
meantime O
, O
I O
will O
increase O
Imdur O
to O
60 O
mg O
qd O
, O
and O
consider O
an O
increase O
in O
atenolol O
. O
 
Umberto I-NAME
M. I-NAME
Uzzell I-NAME
, O
MD O
pager O
# O
12472 I-CONTACT
Signed O
electronically O
by O
Umberto I-NAME
M. I-NAME
Uzzell I-NAME
, O
MD O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2089-04-05 I-DATE
CARDIOLOGY O
SAINT I-LOCATION
VINCENT I-LOCATION
HOSPITAL I-LOCATION
Interval O
History O
: O
Ursula I-NAME
is O
seen O
in O
the O
Cardiology O
office O
for O
a O
followup O
visit O
. O
 
Since O
last O
seen O
, O
she O
notes O
a O
number O
of O
somewhat O
concerning O
symptoms O
. O
 
First O
of O
all O
, O
she O
is O
noting O
some O
mid O
sternal O
chest O
discomfort O
with O
exertion O
. O
 
She O
associates O
this O
with O
back O
pain O
related O
to O
a O
remote O
back O
injury O
, O
but O
nonetheless O
with O
exertions O
she O
develops O
some O
degree O
of O
mid O
sternal O
chest O
discomfort O
, O
non O
radiating O
, O
associated O
may O
be O
with O
some O
shortness O
of O
breath O
. O
 
She O
has O
not O
used O
any O
nitroglycerin O
for O
it O
. O
 
It O
gets O
better O
when O
she O
rests O
. O
 
She O
denies O
palpitations O
, O
PND O
, O
or O
orthopnea O
. O
 
Her O
sugars O
are O
out O
of O
control O
. O
 
Her O
weight O
is O
down O
, O
nonetheless O
. O
 
Physical O
examination O
: O
-Pulse O
: O
80 O
-BP O
: O
130/85 O
-weight O
: O
206 O
lbs O
. O
 
-General O
: O
Overweight O
. O
 
Well O
appearing O
. O
 
-Skin O
: O
No O
rashes O
. O
 
Anicteric O
. O
 
-Heent O
: O
Unremarkable O
. O
 
-Neck O
: O
JVP O
less O
than O
5 O
, O
possible O
venous O
hums O
bilaterally O
. O
 
Carotids O
without O
bruits O
. O
 
-Chest O
: O
Clear O
to O
auscultation O
and O
percussion O
. O
 
-Cardiac O
: O
Apical O
impulse O
nondisplaced O
and O
discrete O
. O
 
Regular O
rate O
and O
rhythm O
. O
 
Normal O
S1 O
and O
split O
S2 O
. O
 
Soft O
S4 O
gallop O
. O
 
-Abdomen O
: O
Obese O
, O
soft O
, O
nontender O
, O
and O
nondistended O
without O
hepatosplenomegaly O
, O
bruits O
, O
dilated O
aorta O
. O
 
-Extremities O
: O
No O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
Procedures O
: O
Electrocardiogram O
normal O
sinus O
rhythm O
IVCD O
, O
old O
IMI O
. O
 
In O
addition O
, O
she O
has O
nonspecific O
ST O
and O
T-wave O
changes O
. O
 
Compared O
there O
is O
no O
important O
change O
. O
 
Impression O
: O
1 O
. O
 
Coronary O
artery O
disease O
status O
post O
multiple O
PCIs O
. O
 
Ursula I-NAME
has O
the O
return O
of O
chest O
symptoms O
which O
are O
suggestive O
for O
angina O
. O
 
I O
will O
refer O
her O
for O
an O
exercise O
tolerance O
test O
to O
better O
evaluate O
this O
. O
 
I O
will O
continue O
on O
the O
current O
medication O
program O
. O
 
2 O
. O
 
Hypertension O
. O
 
Her O
blood O
pressure O
is O
a O
bit O
elevated O
. O
 
Given O
her O
diabetes O
, O
I O
think O
it O
is O
prudent O
to O
add O
an O
ACE O
inhibitor O
. O
 
Accordingly O
, O
lisinopril O
2.5 O
mg O
QD O
was O
added O
to O
her O
program O
. O
 
3 O
. O
 
Lipids O
will O
be O
checked O
. O
 
I O
strongly O
suspect O
that O
her O
LDL O
is O
not O
well O
suppressed O
. O
 
Our O
goal O
LDL O
in O
this O
case O
is O
less O
than O
70 O
mg/dL O
. O
 
Umberto I-NAME
Uzzell I-NAME
, O
MD O
Signed O
electronically O
by O
Umberto I-NAME
Uzzell I-NAME
, O
MD O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2067-09-05 I-DATE
Internal O
Medicine O
Vance I-NAME
, O
Jennifer I-NAME
54266003 I-ID
9-5-67 I-DATE
CHIEF O
COMPLAINT O
: O
Ms. O
Vance I-NAME
is O
a O
45 I-AGE
year O
old O
woman O
with O
diabetes O
, O
porphyria O
and O
coronary O
artery O
disease O
, O
who O
came O
in O
today O
for O
annual O
visit O
. O
 
HPI O
: O
1 O
. O
 
Pain O
in O
right O
hand O
. O
 
The O
patient O
has O
a O
Dupuytren O
's O
contraction O
in O
the O
right O
hand O
. O
 
She O
did O
have O
one O
in O
the O
left O
hand O
for O
which O
she O
had O
surgery O
in O
June O
, O
2064 I-DATE
. O
 
The O
surgery O
was O
performed O
by O
Dr. O
Peter I-NAME
Vandenberg I-NAME
. O
 
At O
that O
time O
, O
she O
also O
had O
an O
ulnar O
nerve O
decompression O
. O
 
She O
had O
trigger O
fingers O
in O
the O
left O
index O
and O
ring O
finger O
as O
well O
, O
which O
were O
repaired O
. O
 
She O
is O
a O
Transport I-PROFESSION
Operations I-PROFESSION
Supervisor I-PROFESSION
that O
uses O
her O
hands O
extensively O
and O
is O
very O
concerned O
about O
the O
pain O
in O
her O
right O
hand O
. O
 
2 O
. O
 
Diabetes O
mellitus O
. O
 
She O
only O
rarely O
checks O
her O
blood O
sugars O
. O
 
They O
tend O
to O
run O
about O
160 O
. O
 
She O
has O
had O
diabetes O
for O
28 O
years O
. O
 
She O
takes O
NPH O
insulin O
25 O
units O
sub O
q O
q.a.m O
. O
 
and O
CGI O
10 O
units O
sub O
q O
q.a.m O
. O
 
She O
is O
not O
on O
an O
evening O
dose O
. O
 
Her O
last O
ophthalmology O
visit O
was O
in O
6/66 I-DATE
. O
 
She O
denies O
any O
problems O
with O
peripheral O
neuropathy O
. O
 
3 O
. O
 
Coronary O
artery O
disease O
. O
 
She O
is O
status O
post O
single O
vessel O
CABG O
in O
9/61 I-DATE
for O
isolated O
lesion O
. O
 
Since O
then O
she O
has O
had O
no O
angina O
. O
 
She O
has O
been O
on O
no O
medications O
for O
coronary O
artery O
disease O
since O
2063 I-DATE
. O
 
4 O
. O
 
Left O
breast O
lesion O
. O
 
She O
was O
found O
to O
have O
a O
breast O
mass O
in O
12/66 I-DATE
and O
underwent O
wire O
localization O
and O
biopsy O
. O
 
At O
that O
time O
, O
she O
had O
micro O
calcifications O
on O
her O
mammogram O
at O
that O
time O
. O
 
The O
past O
report O
revealed O
atypical O
ductal O
hyperplasia O
only O
. O
 
CURRENT O
MEDICATIONS O
: O
NPH O
insulin O
25 O
units O
sub O
q O
q.a.m. O
, O
CGI O
10 O
units O
sub O
q O
q.a.m. O
, O
Tylenol O
p.r.n. O
, O
aspirin O
85 O
mg O
PO O
q.d O
. O
 
PHYSICAL O
EXAM O
: O
Blood O
pressure O
114/50 O
. O
 
Weight O
111.5 O
lbs O
. O
 
General O
appearance O
: O
healthy O
appearing O
middle O
aged O
woman O
in O
no O
acute O
distress O
. O
 
HEENT O
: O
no O
retinopathy O
was O
noted O
on O
my O
exam O
. O
 
Neck O
: O
no O
thyromegaly O
. O
 
Chest O
is O
clear O
to O
P O
& O
A O
. O
 
She O
has O
sternotomy O
scars O
present O
. O
 
Cardiac O
: O
normal O
S1 O
, O
S2 O
. O
 
Breasts O
: O
right O
breast O
is O
normal O
, O
left O
breast O
reveals O
surgical O
incisional O
scars O
at O
12:00 O
and O
3:00 O
O'clock O
. O
 
She O
does O
have O
a O
firm O
mass O
below O
the O
incisional O
scar O
at O
3:00 O
P.M. O
Abdomen O
: O
midline O
scar O
in O
the O
lower O
abdomen O
is O
evident O
from O
her O
C O
section O
. O
 
No O
hepatosplenomegaly O
. O
 
Extremities O
: O
no O
edema O
. O
 
Pelvic O
exam O
: O
external O
genitalia O
are O
normal O
. O
 
Vagina O
, O
cervix O
, O
fundus O
, O
adnexae O
all O
normal O
. O
 
IMPRESSION O
: O
1 O
. O
 
Painful O
right O
hand O
. O
 
The O
patient O
was O
referred O
back O
to O
Dr. O
Peter I-NAME
Vandenberg I-NAME
for O
evaluation O
for O
surgery O
. O
 
2 O
. O
 
Diabetes O
mellitus O
. O
 
I O
asked O
the O
patient O
to O
keep O
track O
of O
her O
blood O
sugars O
for O
then O
next O
month O
and O
to O
return O
to O
see O
me O
. O
 
I O
also O
checked O
a O
BUN O
and O
creatinine O
as O
well O
as O
a O
urine O
micro O
albumen O
. O
 
We O
checked O
her O
annual O
cholesterol O
. O
 
Her O
previous O
cholesterol O
was O
done O
5/66 I-DATE
and O
was O
203 O
. O
 
She O
was O
referred O
to O
Dr. O
Nava I-NAME
for O
a O
good O
retinal O
exam O
. O
 
INDIANOLA I-LOCATION
VALLEY I-LOCATION
CENTER I-LOCATION
Vance I-NAME
, O
Jennifer I-NAME
Page O
2 O
54266003 I-ID
9-5-67 I-DATE
3 O
. O
 
Status O
post O
CABG O
. O
 
I O
started O
her O
on O
atenolol O
25 O
mg O
PO O
q.d O
. O
 
given O
that O
she O
does O
have O
coronary O
artery O
disease O
, O
and O
there O
is O
a O
question O
as O
to O
whether O
or O
not O
she O
had O
an O
MI O
in O
2061 I-DATE
, O
which O
she O
will O
return O
in O
one O
month O
for O
blood O
pressure O
check O
and O
also O
to O
review O
her O
blood O
sugars O
. O
 
_________________________ O
Vester I-NAME
Light I-NAME
, O
M.D O
. O
 
WV I-NAME
: O
AV:8176 O
DD:9-5-67 O
DT:9-6-67 O
DV:9-5-67 O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2069-07-18 I-DATE
July I-DATE
18 O
, O
2069 I-DATE
Vester I-NAME
Light I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
Barton I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
RE O
: O
Jennifer I-NAME
Vance I-NAME
MR O
# O
542-66-00-3 I-ID
Dear O
Vester I-NAME
: O
Mrs. O
Vance I-NAME
presents O
to O
the O
office O
today O
for O
general O
cardiac O
evaluation O
. O
 
As O
her O
history O
is O
well O
known O
to O
you O
, O
I O
will O
repeat O
it O
briefly O
for O
our O
records O
. O
 
Mrs. O
Vance I-NAME
is O
a O
47-year-old O
woman O
with O
a O
history O
of I-DATE
variegata O
porphyria O
, O
insulin O
dependent O
diabetes O
and O
significant O
coronary O
artery O
disease O
. O
 
In O
2061 I-DATE
, O
after O
a O
four O
to O
five O
day O
history O
of I-DATE
retrosternal O
chest O
discomfort O
, O
she O
was O
admitted O
to O
the O
Barton I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
where O
coronary O
angiography O
revealed O
a O
95 O
% O
proximal O
left O
anterior O
descending O
artery O
stenosis O
. O
 
She O
underwent O
balloon O
angioplasty O
of I-DATE
her O
LAD O
times O
two O
with O
inadequate O
results O
. O
 
She O
therefore O
was O
taken O
electively O
for O
coronary O
artery O
bypass O
graft O
surgery O
with O
placement O
of I-DATE
a O
left O
internal O
mammary O
artery O
to O
her O
LAD O
. O
 
She O
subsequently O
continued O
to O
have O
chest O
discomfort O
and O
underwent O
repeat O
cardiac O
catheterization O
in O
May I-DATE
of I-DATE
2063 I-DATE
at O
which O
time O
coronary O
angiography O
revealed O
a O
60 O
% O
stenosis O
in O
the O
proximal O
left O
anterior O
descending O
artery O
and O
a O
50 O
% O
stenosis O
in O
the O
mid O
right O
coronary O
artery O
. O
 
The O
catheterization O
report O
does O
not O
indicate O
the O
status O
of I-DATE
her O
left O
internal O
mammary O
artery O
graft O
. O
 
Since O
then O
, O
she O
has O
continued O
to O
have O
episodes O
of I-DATE
intermittent O
abdominal O
discomfort O
. O
 
She O
recently O
has O
undergone O
an O
extensive O
evaluation O
by O
the O
gastroenterology O
service O
for O
her O
abdominal O
pain O
without O
specific O
pathology O
being O
discovered O
. O
 
Trials O
of I-DATE
H2 O
blockers O
and O
proton O
pump O
inhibitors O
have O
been O
ineffective O
. O
 
In O
November I-DATE
of I-DATE
2068 I-DATE
, O
she O
underwent O
a O
Bruce O
protocol O
stress O
test O
exercising O
for O
eight O
minutes O
to O
a O
peak O
heart O
rate O
of I-DATE
131 O
, O
peak O
blood O
pressure O
of I-DATE
188/82 O
stopping O
because O
of I-DATE
fatigue O
. O
 
She O
had O
no O
ischemic O
changes O
on O
electrocardiogram O
. O
 
Over O
the O
past O
two O
weeks O
however O
, O
she O
has O
noticed O
that O
her O
chronic O
abdominal O
pain O
syndrome O
( O
which O
she O
often O
describes O
as O
feeling O
like O
indigestion O
) O
now O
includes O
radiation O
to O
her O
left O
shoulder O
. O
 
The O
pain O
is O
not O
exacerbated O
by O
position O
, O
time O
of I-DATE
day O
or O
any O
particular O
activity O
. O
 
The O
pain O
does O
not O
awaken O
her O
from O
sleep O
nor O
does O
it O
occur O
at O
rest O
. O
 
Of O
note O
, O
her O
lipid O
profile O
from O
October I-DATE
2068 I-DATE
indicates O
a O
cholesterol O
of I-DATE
229 O
, O
triglyceride O
of I-DATE
68 O
, O
HDL O
51 O
, O
LDL O
of I-DATE
164 O
. O
 
Vance I-NAME
, O
Jennifer I-NAME
MR O
# O
542-66-00-3 I-ID
-2- O
July I-DATE
18 O
, O
2069 I-DATE
Past O
medical O
history O
is O
notable O
for O
variegata O
porphyria O
, O
insulin O
dependent O
diabetes O
, O
right O
hand O
carpal O
tunnel O
syndrome O
, O
Dupuytren's O
contracture O
and O
tendinitis O
and O
hypertension O
. O
 
Medications O
at O
Present O
: O
Enteric O
coated O
aspirin O
one O
tab O
po O
q.d. O
, O
NPH O
insulin O
25 I-AGE
units O
sub O
q O
qAM O
, O
CZI O
10 O
units O
sub O
q O
qAM O
. O
 
Allergies O
: O
None O
. O
 
Cigarettes O
- O
none O
. O
 
Ethanol O
- O
social O
. O
 
Family O
history O
is O
notable O
for O
her O
father O
dying O
from O
carcinoma O
, O
mother O
dying O
of I-DATE
colon O
cancer O
, O
question O
coronary O
disease O
, O
one O
brother O
having O
a O
myocardial O
infarction O
at O
age O
25 I-AGE
, O
another O
brother O
dying O
from O
melanoma O
age O
36 I-AGE
. O
 
The O
rest O
of I-DATE
her O
siblings O
and O
children O
have O
not O
heart O
disease O
. O
 
Physical O
exam O
reveals O
a O
delightful O
woman O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
right O
arm O
sitting O
110/64 O
, O
heart O
rate O
85 O
and O
regular O
, O
respirations O
12 O
and O
unlabored O
, O
weight O
104 O
pounds O
. O
 
The O
neck O
is O
supple O
. O
 
JVP O
flat O
. O
 
Carotids O
are O
2+ O
with O
bilateral O
soft O
right O
greater O
than O
left O
bruits O
. O
 
Chest O
is O
clear O
. O
 
Cardiac O
exam O
shows O
a O
normal O
S1 O
, O
physiologically O
split O
S2 O
and O
a O
I/VI O
systolic O
ejection O
murmur O
radiating O
from O
the O
apex O
to O
the O
base O
, O
no O
significant O
diastolic O
murmur O
. O
 
The O
abdomen O
is O
benign O
. O
 
Extremities O
reveal O
no O
appreciable O
edema O
. O
 
Peripheral O
pulses O
are O
intact O
. O
 
Electrocardiogram O
shows O
sinus O
rhythm O
at O
a O
rate O
of I-DATE
85 O
. O
 
PR O
interval O
of I-DATE
.12 O
, O
QRS O
.06 O
, O
QT O
.36 O
, O
axis O
85 O
degrees O
. O
 
There O
are O
minor O
nonspecific O
ST-T O
wave O
changes O
. O
 
Impression O
: O
Mrs. O
Vance I-NAME
is O
a O
47-year-old O
woman O
with O
a O
history O
of I-DATE
variegata O
porphyria O
, O
insulin O
dependent O
diabetes O
, O
hypertension O
and O
dyslipidemia O
with O
known O
coronary O
artery O
disease O
. O
 
She O
has O
had O
a O
retrosternal O
chest O
pain O
syndrome O
for O
the O
past O
several O
years O
and O
her O
most O
recent O
stress O
test O
approximately O
one O
year O
ago O
did O
not O
show O
significant O
provokable O
ischemia O
. O
 
Nonetheless O
, O
I O
am O
concerned O
that O
her O
clinical O
presentation O
may O
still O
represent O
recurrent O
ischemia O
. O
 
I O
therefore O
have O
scheduled O
her O
for O
an O
exercise O
MIBI O
stress O
test O
and O
I O
will O
obtain O
both O
an O
echocardiogram O
and O
carotid O
noninvasive O
studies O
. O
 
In O
light O
of I-DATE
her O
significant O
dyslipidemia O
and O
insulin O
dependent O
diabetes O
, O
I O
strongly O
recommend O
beginning O
aggressive O
antilipemic O
pharmacologic O
therapy O
. O
 
Unless O
her O
variegata O
porphyria O
precludes O
the O
use O
of I-DATE
atorvastatin O
, O
I O
would O
begin O
this O
at O
10 O
mg O
po O
q.d O
. O
 
I O
would O
target O
her O
LDL O
cholesterol O
to O
less O
than O
90 O
. O
 
In O
addition O
, O
I O
have O
started O
her O
on O
atenolol O
at O
25 I-AGE
mg O
po O
q.d O
. O
 
and O
I O
would O
consider O
beginning O
an O
ACE O
inhibitor O
again O
if O
her O
porphyria O
does O
not O
Vance I-NAME
, O
Jennifer I-NAME
MR O
# O
542-66-00-3 I-ID
-3- O
July I-DATE
18 O
, O
2069 I-DATE
preclude O
this O
. O
 
She O
understands O
that O
if O
she O
has O
evidence O
for O
significant O
provokable O
ischemia O
that O
I O
would O
strongly O
encourage O
her O
to O
undergo O
repeat O
coronary O
angiography O
. O
 
Thank O
you O
very O
much O
for O
allowing O
me O
to O
assist O
in O
her O
care O
. O
 
Sincerely O
yours O
, O
Timothy I-NAME
Quarterman I-NAME
, O
M.D O
. O
 
DD O
: O
07/18/69 I-DATE
DT O
: O
07/28/ I-DATE
DV O
: O
07/18/69 I-DATE
/riggs O
cc O
: O
John I-NAME
Koontz I-NAME
, O
M.D O
. O
 
Kearney I-LOCATION
Urology I-LOCATION
Center I-LOCATION
49 I-LOCATION
Buswell I-LOCATION
St I-LOCATION
Minerva I-LOCATION
, O
TN I-LOCATION
41694 I-LOCATION
cc O
: O
Vincent I-NAME
Veal I-NAME
, O
M.D O
. O
 
Gastroenterology O
Division O
- O
BMH I-LOCATION
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2070-06-10 I-DATE
June I-DATE
11 O
, O
2070 I-DATE
Wanda I-NAME
Koontz I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
Barton I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
12 I-LOCATION
Batchelder I-LOCATION
Street I-LOCATION
Minerva I-LOCATION
, O
TN I-LOCATION
41694 I-LOCATION
Re O
: O
Jennifer I-NAME
Vance I-NAME
MR O
# O
542-66-00-3 I-ID
Dear O
Wanda I-NAME
: O
Mrs. O
Vance I-NAME
returns O
for O
routine O
follow O
up O
. O
 
At O
the O
present O
time O
, O
she O
continues O
to O
complain O
of O
exertional O
angina O
, O
and O
states O
that O
she O
is O
willing O
to O
consider O
undergoing O
cardiac O
catheterization O
. O
 
As O
you O
know O
, O
I O
had O
suggested O
this O
to O
her O
last O
November I-DATE
. O
 
She O
continues O
now O
on O
a O
regimen O
of O
Atenolol O
25 O
mg O
p.o O
. O
 
q.d. O
, O
Paxil O
20 O
mg O
p.o O
. O
 
q.d. O
, O
Humalog O
10 O
units O
sub.q O
. O
 
q.a.m. O
, O
NPH O
25 O
units O
sub.q O
. O
 
q.a.m. O
, O
sliding O
scale O
CZI O
throughout O
the O
day O
, O
isosorbide O
mononitrate O
60 O
mg O
p.o O
. O
 
q.d. O
, O
Pravastatin O
20 O
mg O
p.o O
. O
 
q.d. O
, O
Flonase O
, O
Neurontin O
300 O
mg O
p.o O
. O
 
b.i.d. O
, O
and O
Celexa O
. O
 
Physical O
exam O
reveals O
a O
thin O
woman O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
right O
arm O
sitting O
92/60 O
, O
heart O
rate O
75 O
and O
regular O
. O
 
Respirations O
12 I-LOCATION
and O
unlabored O
. O
 
Weight O
109 O
pounds O
. O
 
This O
is O
one O
pound O
above O
her O
weight O
of O
six O
months O
ago O
. O
 
The O
neck O
is O
supple O
. O
 
JVP O
is O
flat O
. O
 
Carotids O
with O
continuing O
right O
greater O
than O
left O
bruits O
. O
 
Chest O
is O
clear O
. O
 
Cardiac O
exam O
reveals O
a O
normal O
, O
physiologically O
split O
S2 O
, O
and O
a O
soft O
systolic O
ejection O
murmur O
radiating O
from O
the O
apex O
to O
the O
base O
. O
 
No O
significant O
diastolic O
murmur O
. O
 
The O
abdomen O
is O
benign O
. O
 
Extremities O
are O
without O
edema O
. O
 
The O
pulses O
are O
intact O
. O
 
Electrocardiogram O
shows O
a O
sinus O
rhythm O
at O
a O
rate O
of O
75 O
, O
PR O
interval O
.12 O
, O
QRS O
.08 O
, O
QT O
.34 O
, O
axis O
75 O
degrees O
. O
 
There O
are O
lateral O
ST O
and O
T O
wave O
changes O
compatible O
with O
strain O
or O
ischemia O
. O
 
Compared O
to O
her O
last O
electrocardiogram O
, O
there O
has O
been O
no O
significant O
change O
. O
 
Impression O
: O
Ms. O
Vance I-NAME
is O
a O
48-year-old O
woman O
with O
a O
history O
of O
variegata O
porphyria O
, O
insulin O
dependent O
diabetes O
, O
and O
significant O
Jennifer I-NAME
Vance I-NAME
MR O
# O
542-66-00-3 I-ID
June I-DATE
10 O
, O
2070 I-DATE
-2- O
coronary O
artery O
disease O
. O
 
She O
is O
status O
post O
intramammary O
artery O
graft O
to O
her O
LAD O
, O
after O
developing O
restenosis O
at O
the O
site O
of O
a O
balloon O
LAD O
angioplasty O
. O
 
The O
results O
of O
the O
catheterization O
will O
determine O
subsequent O
therapeutic O
recommendations O
. O
 
She O
will O
have O
her O
insulin O
dose O
on O
the O
morning O
of O
her O
scheduled O
catheterization O
. O
 
Thank O
you O
very O
much O
for O
allowing O
me O
to O
assist O
in O
her O
care O
. O
 
Sincerely O
yours O
, O
Timothy I-NAME
E. I-NAME
Quarterman I-NAME
, O
M.D O
. O
 
/quintal O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2071-01-12 I-DATE
Problems O
IDDM O
COR O
ART O
DIS O
MI O
PORPHYRIA O
PAST O
SMOKER O
QUIT O
2061 I-DATE
; O
1/2 O
PPD O
X O
15 O
YEARS O
S/P O
SURGERY O
LEFT O
HAND O
, O
REPAIR O
DUPYTRENS O
CONTRACTURE O
History O
of O
Present O
Illness O
Jennifer I-NAME
comes O
in O
doing O
well O
. O
 
She O
has O
had O
little O
chest O
pain O
and O
has O
required O
few O
nitros O
. O
 
No O
chest O
pain O
at O
rest O
or O
shortness O
of O
breath O
. O
 
She O
continues O
to O
have O
significant O
discomfort O
from O
her O
DM O
neuropathy O
. O
 
She O
has O
been O
taking O
neurontin O
and O
has O
noticed O
an O
improvement O
in O
this O
, O
but O
the O
pain O
does O
continue O
to O
be O
problematic O
. O
 
She O
saw O
Pearline I-NAME
Rush I-NAME
in O
neurology O
who O
felt O
that O
she O
was O
not O
likely O
to O
be O
having O
seizures O
, O
but O
planned O
an O
EEG O
and O
MRI O
to O
r/o O
any O
structural O
disease O
. O
 
Seen O
in O
GYN O
for O
embx O
which O
was O
negative O
for O
hyperplasia O
. O
 
Has O
not O
had O
her O
period O
for O
3 O
months O
. O
 
Seen O
in O
ED O
with O
a O
tick O
bite O
. O
 
No O
rashes O
or O
joint O
symptoms O
. O
 
Past O
Medical O
History O
See O
problem O
list O
Medications O
TYLENOL O
PO O
PRN O
ASPIRIN O
81MG O
PO O
QD O
* O
HUMULOG O
Variable O
qid O
CELEXA O
( O
CITALOPRAM O
) O
40MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
SYNALAR O
0.025 O
% O
CREAM O
( O
FLUOCINOLONE O
0.025 O
% O
... O
TOP O
BID O
FLONASE O
( O
FLUTICASONE O
NASAL O
SPRAY O
) O
2SPRAY O
INH O
each O
nostril O
qd O
IMDUR O
( O
ISOSORBIDE O
MONONIT O
. O
 
( O
SR O
) O
) O
60MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
NPH O
INSULIN O
25UNITS/3units O
SC O
QAM/qpm O
LOPRESSOR O
25MG O
PO O
QD O
TNG O
0.4 O
MG O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
MG O
) O
) O
1TAB O
SL O
Q5 O
MIN O
X O
3 O
NEURONTIN O
( O
GABAPENTIN O
) O
300MG O
2 O
Capsule O
( O
s O
) O
PO O
TID O
PRAVACHOL O
( O
PRAVASTATIN O
) O
40MG O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PLAVIX O
( O
CLOPIDOGREL O
) O
75MG O
PO O
QD O
NEXIUM O
( O
ESOMEPRAZOLE O
) O
20MG O
PO O
QD O
Allergies O
TEGRETOL O
( O
CARBAMAZEPINE O
) O
porphyria O
ELAVIL O
( O
AMITRIPTYLINE O
HCL O
) O
porphyria O
Morphine O
Rash O
VARIEGATE O
PORPHYRIA O
CHECK O
LONGMONT I-LOCATION
FOR O
LIST O
OF O
DRUGS O
; O
INCLUDES O
SULFA O
, O
BARBITUATES O
, O
MEPROBAMATE O
, O
VALPROATE O
, O
GRISEOFULVIN O
, O
ERGOTS O
, O
STEROIDS O
Family O
History O
Mother O
, O
sister O
, O
brother O
, O
nephew O
DM O
Mother O
Porphyria O
Sister O
Porphyria O
Social O
History O
Formerly O
worked O
as O
an O
Transport I-PROFESSION
Operations I-PROFESSION
Supervisor I-PROFESSION
. O
 
Married O
with O
1 O
son O
. O
 
No O
tob O
. O
 
No O
etoh O
. O
 
Review O
of O
Systems O
No O
sob/worsening O
cp O
Vital O
Signs O
Blood O
Pressure O
: O
128/68 O
Weight O
: O
107 O
Pounds O
Physical O
Exam O
Disposition O
and O
Plans O
1 O
. O
 
CAD O
- O
Follow O
closely O
. O
 
Continue O
current O
regimen O
. O
 
2 O
. O
 
DM O
- O
poor O
control O
. O
 
Very O
brittle O
. O
 
Recently O
seen O
by O
Dr. O
Nelson I-NAME
. O
 
3 O
. O
 
Cholesterol O
- O
last O
LDL O
< O
100 O
. O
 
Pravachol O
increased O
to O
40mg O
. O
 
4 O
. O
 
Menorrhagia O
- O
currently O
not O
an O
issue O
. O
 
5 O
. O
 
DM O
neuropathy O
- O
will O
increase O
neurontin O
to O
600 O
mg O
tid O
. O
 
6 O
. O
 
HM O
up O
to O
date O
Return O
to O
Clinic O
in O
4 O
months O
. O
 
cc O
: O
John I-NAME
Koontz I-NAME
, O
MD O
; O
Timothy I-NAME
Quarterman I-NAME
, O
MD O
______________________________ O
Wanda I-NAME
Andrea I-NAME
Koontz I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2073-05-10 I-DATE
LUH I-LOCATION
Cardiovascular O
Division O
CVD O
ER8 O
92 I-LOCATION
Batchelder I-LOCATION
Street I-LOCATION
VANCE O
, O
JENNIFER I-NAME
Minerva I-LOCATION
, O
TN I-LOCATION
41694 I-LOCATION
54266003 I-ID
( O
727 O
) O
859-7945 I-CONTACT
05/10/73 I-DATE
Wanda I-NAME
A. I-NAME
Koontz I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
Associates O
Barton I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
70 I-LOCATION
Batchelder I-LOCATION
Street I-LOCATION
Minerva I-LOCATION
, O
TN I-LOCATION
41694 I-LOCATION
Dear O
Wanda I-NAME
: O
Mr. O
Vance I-NAME
returns O
for O
followup O
. O
 
Since O
last O
seen O
, O
she O
apparently O
was O
recently O
seen O
in O
the O
walk-in O
clinic O
in O
your O
office O
complaining O
of O
profound O
fatigue O
and O
depression O
. O
 
She O
wonders O
if O
she O
was O
having O
a O
flare O
of O
her O
porphyria O
. O
 
Apparently O
, O
her O
examination O
at O
that O
time O
was O
relatively O
benign O
, O
and O
no O
specific O
new O
findings O
were O
noted O
. O
 
After O
talking O
with O
Dr. O
Vogt I-NAME
at O
that O
office O
visit O
, O
she O
felt O
modestly O
improved O
, O
and O
over O
the O
past O
few O
weeks O
feels O
that O
her O
energy O
level O
has O
returned O
to O
its O
baseline O
. O
 
Lab O
studies O
obtained O
at O
that O
time O
revealed O
creatinine O
0.9 O
, O
glucose O
elevated O
at O
236 O
, O
hematocrit O
of O
43 O
, O
with O
a O
white O
count O
10 O
. O
 
As O
no O
specific O
pathology O
was O
noted O
, O
she O
was O
sent O
home O
without O
any O
change O
in O
her O
medical O
regimen O
. O
 
Currently O
, O
she O
continues O
on O
Lantus O
insulin O
20 O
units O
subcutaneous O
. O
 
q.p.m. O
, O
Celexa O
40 O
mg O
p.o O
. O
 
q.d. O
, O
enteric-coated O
aspirin O
81 O
mg O
p.o O
. O
 
q.d. O
, O
Flonase O
1-2 O
puffs O
p.o O
. O
 
q.d. O
, O
isosorbide O
mononitrate O
60 O
mg O
p.o O
. O
 
q.d. O
, O
Neurontin O
600 O
mg O
p.o O
. O
 
t.i.d. O
, O
nitroglycerin O
p.r.n O
. O
 
which O
she O
has O
not O
had O
to O
take O
, O
lisinopril O
10 O
mg O
p.o O
. O
 
q.d. O
, O
furosemide O
20 O
mg O
p.o O
. O
 
q.d. O
, O
and O
p.r.n O
. O
 
Motrin O
. O
 
Physical O
exam O
reveals O
a O
thin O
woman O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
right O
arm O
sitting O
105/78 O
, O
heart O
rate O
70 I-LOCATION
and O
regular O
, O
respirations O
14 O
and O
unlabored O
, O
and O
weight O
is O
pending O
. O
 
The O
neck O
is O
supple O
. O
 
JVP O
is O
flat O
. O
 
Carotids O
are O
2+ O
with O
very O
soft O
bilateral O
referred O
murmurs O
. O
 
Chest O
is O
clear O
. O
 
Cardiac O
exam O
shows O
normal O
S1 O
, O
physiologically O
split O
S2 O
with O
1/6 O
systolic O
ejection O
murmur O
radiating O
from O
the O
apex O
to O
the O
base O
, O
and O
a O
1-2/6 O
holosystolic O
murmur O
radiating O
from O
the O
apex O
to O
the O
axilla O
. O
 
No O
significant O
diastolic O
murmur O
or O
rub O
. O
 
The O
abdomen O
is O
benign O
. O
 
Extremities O
reveal O
trace O
bipedal O
edema O
. O
 
Peripheral O
pulses O
are O
diminished O
but O
detectable O
. O
 
Electrocardiogram O
is O
pending O
. O
 
Impression O
: O
Ms. O
Vance I-NAME
remains O
relatively O
stable O
from O
a O
cardiovascular O
perspective O
. O
 
However O
, O
as O
you O
know O
, O
her O
last O
echocardiogram O
did O
show O
evidence O
of O
at O
least O
moderate O
mitral O
regurgitation O
with O
significantly O
reduced O
left O
ventricular O
systolic O
function O
. O
 
She O
has O
made O
it O
quite O
clear O
that O
under O
no O
circumstances O
would O
she O
consider O
repeat O
cardiac O
surgery O
to O
treat O
her O
valvular O
heart O
disease O
. O
 
Nonetheless O
, O
I O
think O
it O
would O
be O
helpful O
for O
her O
to O
undergo O
repeat O
echocardiogram O
to O
help O
gauge O
the O
current O
status O
of O
her O
left O
ventricle O
and O
degree O
of O
regurgitation O
, O
which O
may O
allow O
for O
additional O
modifications O
to O
her O
therapeutic O
regimen O
. O
 
Beyond O
this O
, O
her O
condition O
is O
actually O
relatively O
stable O
from O
a O
cardiovascular O
standpoint O
. O
 
I O
have O
not O
further O
altered O
her O
medical O
regimen O
. O
 
Thank O
you O
very O
much O
for O
allowing O
me O
to O
assist O
in O
her O
care O
. O
 
Sincerely O
yours O
, O
______________________________ O
Timothy I-NAME
Quarterman I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Timothy I-NAME
Quarterman I-NAME
eScription O
document:6-0437424 O
GFFocus O
CC O
: O
John I-NAME
Koontz I-NAME
MD O
489 I-LOCATION
MONICA I-LOCATION
STREET I-LOCATION
MINERVA I-LOCATION
, O
TN I-LOCATION
41694 I-LOCATION
DD O
: O
05/10/73 I-DATE
DT O
: O
05/11/73 I-DATE
DV O
: O
05/10/73 I-DATE
 
Record O
date O
: O
2091-07-02 I-DATE
CARDIOLOGY O
BEAUREGARD I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
Nathan I-NAME
J I-NAME
Fernandes I-NAME
M.D O
. O
 
College I-LOCATION
Station I-LOCATION
, O
NC I-LOCATION
22169 I-LOCATION
Dear O
Dr. O
Fernandes I-NAME
: O
Dr. O
Nunes I-NAME
and O
I O
had O
the O
pleasure O
to O
see O
your O
patient O
, O
Mr. O
Christian I-NAME
Mullen I-NAME
, O
this O
morning O
in O
the O
office O
for O
a O
routine O
vascular O
followup O
. O
 
It O
has O
been O
nearly O
18 O
months O
since O
his O
last O
visit O
here O
and O
in O
the O
interim O
time O
, O
has O
been O
having O
discomfort O
involving O
both O
of O
his O
hips O
, O
thighs O
, O
and O
calves O
. O
 
As O
you O
well O
know O
, O
Mr. O
Mullen I-NAME
is O
a O
delightful O
69-year-old O
gentleman O
with O
history O
of O
hypertension O
, O
hyperlipidemia O
, O
coronary O
artery O
disease O
, O
type O
2 O
diabetes O
mellitus O
, O
and O
peripheral O
arterial O
disease O
who O
previously O
underwent O
left O
common O
femoral O
and O
left O
popliteal O
artery O
revascularization O
November I-DATE
2088 I-DATE
followed O
by O
right O
external O
, O
right O
internal O
, O
and O
right O
common O
femoral O
artery O
revascularization O
in O
February I-DATE
2089 I-DATE
. O
 
Despite O
the O
technical O
success O
of O
both O
procedures O
, O
he O
continued O
to O
have O
bilateral O
hip O
claudication O
symptoms O
. O
 
When O
we O
had O
last O
evaluated O
him O
in O
November I-DATE
2089 I-DATE
, O
we O
had O
considered O
moving O
forward O
with O
CT O
angiography O
to O
assess O
the O
patency O
of O
his O
aorto-iliac O
anatomy O
. O
 
At O
the O
time O
, O
he O
favored O
moving O
on O
a O
conservative O
course O
with O
improved O
walking O
regimen O
and O
weight O
loss O
. O
 
Unfortunately O
, O
despite O
these O
measures O
, O
he O
feels O
quite O
disabled O
and O
limited O
by O
his O
claudication O
symptoms O
. O
 
Symptoms O
are O
noticeable O
between O
20 O
and O
50 O
yards O
distance O
occurring O
in O
the O
hip O
area O
as O
well O
as O
extending O
down O
in O
to O
his O
thigh O
and O
occasionally O
the O
calves O
. O
 
Symptoms O
resolve O
with O
sitting O
and O
resting O
for O
approximately O
2.5 O
minutes O
. O
 
He O
notes O
that O
symptoms O
will O
improve O
with O
standing O
still O
however O
sitting O
symptoms O
resolve O
much O
quicker O
. O
 
He O
does O
not O
necessarily O
notice O
any O
change O
with O
inclines O
or O
going O
up O
stairs O
; O
in O
fact O
, O
he O
is O
actually O
able O
to O
climb O
18 O
stairs O
to O
his O
office O
without O
limitation O
. O
 
From O
the O
cardiac O
perspective O
, O
Mr. O
Mullen I-NAME
has O
been O
free O
of O
any O
symptoms O
of O
exertional O
chest O
tightness O
, O
pressure O
, O
or O
shortness O
of O
breath O
. O
 
We O
understand O
that O
you O
are O
following O
him O
in O
closely O
in O
this O
regard O
and O
now O
requesting O
up O
coming O
chemical O
stress O
test O
given O
that O
has O
been O
nearly O
10 O
years O
from O
his O
coronary O
artery O
bypass O
surgery O
. O
 
Past O
medical O
history O
: O
Hypertension O
. O
 
Hyperlipidemia O
. O
 
CAD O
. O
 
PAD O
. O
 
Prior O
tobacco O
use O
. O
 
Obesity O
. O
 
Type O
2 O
diabetes O
mellitus O
. O
 
Depressive O
disorder O
. O
 
Cervical O
spine O
disease O
. O
 
Congenital O
hypospadias O
. O
 
Prostatitis O
. O
 
Hemorrhoids O
. O
 
Colonic O
polyps O
. O
 
Chronic O
normocytic O
anemia O
. O
 
Medications O
( O
Confirmed O
) O
: O
aspirin O
325 O
mg O
qd O
Atacand O
15 O
mg O
qd O
doxepin O
glyburide O
Lipitor O
80 O
mg O
qd O
Lopid O
600 O
mg O
BID O
Toprol O
XL O
50 O
mg O
qd O
Wellbutrin O
Physical O
examination O
: O
-Pulse O
: O
66 O
and O
regular O
-General O
: O
Mr. O
Mullen I-NAME
is O
well O
appearing O
in O
no O
apparent O
distress O
-Heent O
: O
Benign O
-Neck O
: O
Carotids O
are O
2+ O
without O
bruits O
-Chest O
: O
Lungs O
are O
clear O
to O
auscultation O
bilaterally O
without O
any O
wheezes O
, O
rhonchi O
, O
or O
rubs O
-Cardiac O
: O
Discloses O
regular O
rhythm O
with O
a O
rate O
of O
approximately O
66 O
beats O
per O
minute O
. O
 
S1 O
and O
S2 O
. O
 
There O
is O
no O
murmur O
, O
rub O
, O
or O
gallop O
-Abdomen O
: O
Obese O
, O
nontender O
, O
and O
nondistended O
. O
 
There O
are O
no O
masses O
or O
bruits O
appreciated O
-Extremities O
: O
Reveals O
1+ O
right O
femoral O
pulse O
with O
audible O
bruits O
. O
 
Trace O
to O
1+ O
left O
femoral O
pulse O
with O
audible O
bruit O
. O
 
Distal O
pulses O
are O
1+ O
without O
any O
evidence O
of O
edema O
, O
skin O
breakdown O
, O
or O
ulceration O
-BP O
: O
145/80 O
on O
the O
right O
Other O
Data O
: O
Three-vessel O
coronary O
artery O
bypass O
surgery O
2082 I-DATE
. O
 
Status O
post O
C6-C7 O
disk O
surgery O
2079 I-DATE
. O
 
Hypospadias O
repair O
in O
childhood O
. O
 
Assessment O
and O
plan O
: O
Mr. O
Christian I-NAME
Mullen I-NAME
is O
a O
delightful O
69-year-old O
gentleman O
with O
history O
of O
coronary O
artery O
disease O
, O
hypertension O
, O
hyperlipidemia O
, O
type O
2 O
diabetes O
mellitus O
, O
peripheral O
arterial O
disease O
with O
prior O
bilateral O
aortoiliac O
revascularization O
here O
for O
a O
vascular O
followup O
with O
symptoms O
of O
bilateral O
hip O
, O
buttock O
, O
thigh O
, O
and O
claudication O
. O
 
Mr. O
Mullen I-NAME
's O
symptoms O
at O
present O
are O
suggestive O
of O
vascular O
claudication O
and O
in O
the O
sense O
that O
they O
are O
exertionally O
related O
. O
 
Interestingly O
, O
he O
has O
had O
these O
symptoms O
dating O
back O
to O
immediately O
following O
his O
revascularization O
procedures O
in O
2088 I-DATE
and O
2089 I-DATE
. O
 
On O
examination O
today O
, O
his O
femoral O
pulses O
are O
certainly O
not O
robust O
and O
may O
suggest O
the O
presence O
of O
restenosis O
. O
 
We O
discussed O
with O
Mr. O
Mullen I-NAME
the O
potential O
of O
going O
forward O
with O
lower O
extremity O
noninvasive O
studies O
; O
however O
, O
these O
revealed O
supra-normal O
ABIs O
in O
the O
past O
secondary O
to O
his O
diabetes O
. O
 
Likewise O
, O
we O
discussed O
the O
possibility O
of O
moving O
forward O
with O
a O
non-invasive O
imaging O
study O
i.e O
. O
 
CT O
angiogram O
; O
however O
, O
this O
would O
not O
provide O
the O
option O
of O
therapeutic O
intervention O
if O
indeed O
narrowings O
were O
noted O
. O
 
Accordingly O
, O
Mr. O
Mullen I-NAME
is O
in O
favor O
of O
proceeding O
forward O
with O
diagnostic O
peripheral O
angiography O
plus/minus O
therapeutic O
intervention O
if O
restenosis O
of O
his O
aortoiliac O
segments O
are O
noted O
. O
 
It O
is O
indeed O
possible O
that O
there O
is O
a O
contributing O
factor O
of O
spinal O
stenosis O
in O
that O
Mr. O
Mullen I-NAME
's O
symptoms O
are O
relieved O
more O
quickly O
in O
the O
sitting O
position O
. O
 
Likewise O
, O
he O
has O
noted O
improvement O
upon O
leaning O
forward O
and O
against O
a O
tree O
. O
 
We O
understand O
that O
Mr. O
Mullen I-NAME
is O
being O
considered O
for O
an O
upcoming O
chemical O
stress O
test O
to O
assess O
the O
patency O
for O
any O
silent O
coronary O
ischemia O
. O
 
He O
is O
quite O
reticent O
to O
go O
forward O
with O
the O
chemical O
stress O
test O
though O
we O
did O
broach O
the O
subject O
of O
performing O
coronary O
catheterization O
at O
the O
time O
of O
his O
peripheral O
angiogram O
given O
that O
we O
are O
actually O
going O
to O
be O
in O
there O
. O
 
He O
has O
actually O
requested O
this O
as O
opposed O
to O
going O
forward O
with O
the O
chemical O
stress O
test O
. O
 
With O
your O
permission O
, O
we O
will O
perform O
both O
coronary O
catheterization O
to O
assess O
the O
patency O
of O
his O
grafts O
in O
addition O
to O
his O
peripheral O
angiogram O
plus/minus O
therapeutic O
intervention O
of O
his O
lower O
extremities O
. O
 
Paramount O
to O
his O
ongoing O
cardiovascular O
fitness O
, O
we O
certainly O
recommend O
blood O
pressure O
of O
130/80 O
or O
below O
and O
LDL O
cholesterol O
70 O
or O
below O
and O
ongoing O
exercise O
and O
weight O
loss O
. O
 
We O
will O
plan O
to O
schedule O
his O
procedure O
in O
the O
upcoming O
weeks O
and O
he O
is O
to O
notify O
us O
if O
symptoms O
are O
progressed O
in O
the O
interim O
time O
. O
 
Changes O
to O
Medications O
this O
visit O
glyburide O
Toprol O
XL O
50 O
mg O
qd O
Atacand O
15 O
mg O
qd O
Lipitor O
80 O
mg O
qd O
Lopid O
600 O
mg O
BID O
aspirin O
325 O
mg O
qd O
Wellbutrin O
doxepin O
Thank O
you O
for O
allowing O
us O
to O
participate O
in O
his O
care O
. O
 
If O
you O
indeed O
have O
any O
questions O
regarding O
his O
visit O
here O
today O
or O
upcoming O
procedure O
, O
please O
do O
not O
hesitate O
to O
contact O
us O
. O
 
Sincerely O
, O
Sharon I-NAME
Oglesby I-NAME
PA O
I O
saw O
this O
patient O
and O
personally O
obtained O
the O
history O
of O
present O
illness O
. O
 
I O
also O
reviewed O
and O
confirmed O
the O
PMH O
, O
medications O
, O
social O
and O
family O
history O
, O
and O
detailed O
ROS O
. O
 
I O
personally O
performed O
a O
comprehensive O
cardiovascular O
examination O
, O
including O
assessment O
of O
VS O
; O
auscultation O
of O
carotid O
arteries O
, O
lungs O
, O
heart O
, O
and O
abdomen O
; O
palpation O
of O
carotid O
arteries O
, O
evaluation O
of O
jugular O
venous O
pressure O
, O
palpation O
of O
abdominal O
aorta O
and O
lower O
extremity O
pulses O
and O
perfusion O
, O
and O
neurologic O
examination O
for O
focal O
deficits O
. O
 
I O
interpreted O
the O
EKG O
and O
other O
pertinent O
laboratory O
data O
. O
 
I O
discussed O
findings O
with O
the O
patient O
and O
personally O
developed O
the O
management O
strategy O
and O
plans O
. O
 
My O
findings O
and O
plans O
are O
elaborated O
on O
the O
note O
above O
, O
with O
which O
I O
concur O
. O
 
Guy I-NAME
Nunes I-NAME
M.D O
. O
 
Guyton I-NAME
Nunes I-NAME
, O
MD O
pager O
# O
53530 I-CONTACT
Signed O
electronically O
by O
Sharon I-NAME
Oglesby I-NAME
, O
PA O
; O
Guyton I-NAME
Nunes I-NAME
, O
MD O
pager O
# O
53530 I-CONTACT
Document O
Status O
: O
Final O
 
Record O
date O
: O
2093-04-13 I-DATE
CARDIOLOGY O
BEAUREGARD I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
Steven I-NAME
N I-NAME
Cooper I-NAME
M.D O
. O
 
8 I-LOCATION
Riverview I-LOCATION
Avenue I-LOCATION
, O
Suite O
185 O
, O
College I-LOCATION
Station I-LOCATION
, O
NC I-LOCATION
22169 I-LOCATION
Dear O
Dr. O
Cooper I-NAME
: O
I O
had O
the O
pleasure O
of O
seeing O
your O
patient O
, O
Christian I-NAME
Mullen I-NAME
today O
in O
the O
office O
in O
followup O
for O
his O
peripheral O
artery O
disease O
, O
as O
well O
as O
his O
coronary O
disease O
. O
 
I O
permanently O
follow O
him O
for O
PAD O
, O
as O
I O
know O
he O
follows O
with O
Dr. O
Fernandes I-NAME
for O
his O
coronary O
disease O
. O
 
Regarding O
his O
peripheral O
disease O
, O
he O
is O
status O
post O
left O
common O
femoral O
endarterectomy O
, O
performed O
at O
my O
request O
by O
Dr. O
Fredrick I-NAME
Xa I-NAME
couple O
of O
years O
ago O
. O
 
This O
alleviated O
some O
of O
his O
left O
leg O
claudication O
, O
though O
he O
still O
has O
some O
residual O
symptoms O
in O
that O
left O
calf O
. O
 
The O
right O
calf O
is O
what O
bothers O
him O
more O
, O
with O
symptoms O
that O
are O
earlier O
in O
onset O
. O
 
They O
occurred O
about O
100 O
yards O
of O
walking O
on O
the O
flat O
. O
 
While O
Chris I-NAME
is O
affected O
by O
this O
, O
it O
does O
not O
preclude O
him O
from O
doing O
his O
usual O
activities O
of O
daily O
living O
. O
 
He O
also O
continues O
to O
travel O
( O
on O
his O
way O
to O
Bogalusa I-LOCATION
with O
Brad I-NAME
Fair I-NAME
, O
his O
partner O
, O
next O
week O
) O
, O
and O
also O
continues O
to O
work O
actively O
. O
 
The O
biggest O
problem O
with O
his O
claudication O
is O
that O
it O
prevents O
him O
from O
being O
physically O
active O
enough O
to O
lose O
enough O
weight O
. O
 
As O
he O
says O
, O
he O
put O
on O
about O
80 O
pounds O
after O
his O
coronary O
bypass O
graft O
in O
2082 I-DATE
, O
and O
he O
has O
had O
trouble O
losing O
the O
weight O
. O
 
He O
is O
considering O
weight O
reduction O
surgery O
, O
but O
has O
not O
made O
a O
decision O
about O
this O
yet O
. O
 
He O
is O
struggling O
with O
the O
decision O
. O
 
I O
would O
support O
him O
either O
way O
in O
this O
regard O
, O
encouraging O
him O
to O
lose O
weight O
however O
he O
can O
do O
so O
. O
 
In O
terms O
of O
his O
lower O
extremities O
, O
his O
exam O
demonstrates O
diminished O
pulses O
( O
absent O
to O
palpation O
) O
in O
both O
ankles O
, O
but O
they O
are O
audible O
by O
Doppler O
. O
 
Both O
feet O
are O
well O
perfused O
, O
with O
good O
capillary O
refill O
. O
 
He O
has O
no O
ulcers O
or O
gangrene O
. O
 
From O
a O
cardiac O
standpoint O
, O
Chris I-NAME
is O
doing O
well O
. O
 
He O
denies O
significant O
dyspnea O
or O
chest O
discomfort O
, O
although O
he O
is O
limited O
in O
terms O
of O
walking O
because O
of O
his O
legs O
. O
 
It O
has O
been O
11 O
years O
since O
his O
bypass O
operation O
, O
and O
I O
think O
it O
would O
be O
reasonable O
to O
do O
a O
stress O
test O
on O
him O
to O
make O
certain O
that O
there O
is O
no O
evidence O
of O
silent O
ischemia O
. O
 
While O
this O
might O
be O
controversial O
, O
as O
to O
whether O
to O
do O
a O
stress O
test O
or O
not O
, O
my O
own O
gut O
feeling O
is O
that O
it O
is O
probably O
the O
right O
time O
in O
this O
patient O
with O
significant O
risk O
factors O
and O
limitations O
on O
the O
basis O
of O
his O
lower O
extremity O
disease O
. O
 
He O
requests O
specifically O
we O
do O
this O
study O
here O
, O
so O
I O
will O
take O
the O
liberty O
of O
ordering O
an O
adenosine O
MIBI O
, O
and O
certainly O
will O
forward O
you O
the O
results O
. O
 
Otherwise O
, O
Chris I-NAME
is O
doing O
great O
. O
 
We O
will O
continue O
to O
work O
on O
risk O
factor O
modification O
and O
I O
will O
see O
him O
again O
in O
six O
months O
. O
 
We O
will O
also O
order O
an O
exercise O
ABI O
and O
duplex O
of O
his O
lower O
extremities O
to O
assess O
where O
we O
stand O
at O
the O
present O
time O
. O
 
If O
his O
symptoms O
progress O
to O
the O
point O
where O
they O
are O
more O
disabling O
, O
then O
we O
would O
consider O
further O
evaluation O
. O
 
Otherwise O
, O
as O
long O
as O
his O
symptoms O
remain O
stable O
and O
his O
lifestyle O
is O
not O
terribly O
limited O
, O
we O
will O
continue O
the O
same O
. O
 
Other O
Data O
: O
I O
saw O
him O
today O
with O
Vernon I-NAME
Galvan I-NAME
, O
one O
of O
my O
cardiovascular O
fellows O
, O
who O
have O
written O
a O
detailed O
note O
. O
 
We O
will O
send O
this O
along O
to O
you O
as O
well O
. O
 
Thanks O
again O
. O
 
Best O
personal O
regards O
, O
Guyton I-NAME
Nunes I-NAME
MD O
cc O
: O
Nathan I-NAME
Fernandes I-NAME
M.D O
. O
 
; O
Vernon I-NAME
X I-NAME
Galvan I-NAME
M.D O
. O
 
; O
V O
Signed O
electronically O
by O
Guyton I-NAME
Nunes I-NAME
, O
MD O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2093-12-27 I-DATE
CARDIOLOGY O
BEAUREGARD I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
73 I-AGE
yo O
male O
admitted O
via O
CCL O
s/p O
PTA O
to O
right O
profunda O
and O
CFA O
and O
stenting O
to O
right O
CIA O
and O
right O
EIA O
Interval O
History O
: O
Mr. O
Mullen I-NAME
is O
a O
73 I-AGE
yo O
male O
with O
an O
extensive O
history O
of O
coronary O
artery O
disease O
( O
bypass O
surgery O
in O
2082 I-DATE
) O
peripheral O
arterial O
disease O
, O
hypertension O
, O
hyperlipidemia O
, O
diabetes O
, O
and O
obesity O
, O
His O
PVD O
includes O
: O
Left O
Common O
femoral O
and O
left O
popliteal O
artery O
revascularization O
in O
11/88 I-DATE
. O
 
He O
received O
stent O
Medtronic O
Bridge O
Assurant O
to O
Left O
CIA O
. O
 
He O
then O
had O
right O
external O
, O
right O
internal O
, O
and O
right O
common O
femoral O
artery O
revascularization O
in O
2/89 I-DATE
. O
 
Right O
CFA O
received O
15 O
mm O
Express O
stent O
Patient O
now O
with O
claudication O
in O
his O
right O
calf O
after O
ambulating O
only O
50 O
yards O
or O
so O
. O
 
Six O
months O
ago O
he O
was O
able O
to O
ambulate O
for O
over O
a O
100 O
yards O
without O
significant O
claudication O
symptoms O
. O
 
He O
does O
not O
describe O
any O
rest O
pain O
or O
ulceration O
in O
his O
right O
leg O
. O
 
He O
does O
get O
some O
claudication O
in O
his O
left O
leg O
, O
although O
this O
is O
fairly O
minor O
compared O
to O
the O
right O
leg O
. O
 
He O
denies O
chest O
pain/angina O
nor O
any O
significant O
shortness O
of O
breath O
, O
orthopnea O
, O
paroxysmal O
nocturnal O
dyspnea O
, O
LEE O
, O
palpitations O
or O
presyncopal O
or O
syncopal O
symptoms O
. O
 
12/23 I-DATE
- O
LE O
CTA O
showing O
: O
Patent O
distal O
aortoiliac O
system O
; O
Extensive O
, O
severe O
atherosclerotic O
calcification O
of O
aorta O
, O
pelvic O
and O
lower O
extremity O
arteries O
; O
On O
the O
right O
: O
Patent O
arterial O
tree O
; O
On O
the O
left O
: O
Patent O
arterial O
tree O
; O
No O
evidence O
of O
thrombosis O
of O
pelvic O
veins O
, O
femoral O
or O
popliteal O
veins O
bilaterally O
. O
 
Patient O
is O
admitted O
now O
for O
angiogram O
12/27/93 I-DATE
SDA O
to O
CCL O
with O
preliminary O
results O
showing O
: O
All O
vessels O
very O
heavily O
calcified.1 O
) O
Abd O
. O
 
Aorta O
calcified O
with O
plaque O
, O
but O
non-obstructive O
2 O
) O
Lt O
renal O
has O
approx O
50 O
% O
stenosis O
3 O
) O
Lt O
common O
iliac O
has O
35-50 O
% O
stenosis O
, O
non-flow O
limiting O
4 O
) O
Rt O
side O
: O
Common O
iliac O
- O
70 O
% O
eccentric O
calcified O
plaque O
prox O
vessel O
; O
ulcerated O
plaque O
distal O
vessel O
. O
 
Internal O
iliac O
- O
65-70 O
% O
stenosis O
mid O
vessel O
External O
iliac O
- O
serial O
50 O
% O
stenoses O
, O
eccentric O
and O
calcified O
COmmon O
femoral O
and O
profunda- O
both O
severely O
narrowed O
with O
heavily O
calcified O
plaque O
, O
extending O
into O
prox O
Profunda O
and O
prox O
SFA O
. O
 
SFA O
- O
serial O
stenoses O
( O
prox O
90 O
% O
, O
focal O
mid-90 O
% O
, O
and O
distal O
diffuse O
calcific/exophytic/coral O
reef O
stenosis O
in O
adductor O
canal O
( O
75 O
% O
) O
. O
 
Pop O
- O
patent O
Infrapop- O
trifurcation O
patent O
. O
 
AT O
arises O
at O
knee O
joint O
and O
is O
patent O
to O
ankle O
. O
 
TPT O
patent O
, O
but O
PT O
is O
threadlike O
and O
small O
caliber O
. O
 
does O
not O
go O
to O
ankle O
; O
Peroneal O
patent O
at O
least O
half O
way O
down O
to O
ankle O
Patient O
underwent O
successful O
balloon O
inflation O
and O
revasc O
of O
Rt O
leg O
with O
PTA O
alone O
, O
up O
to O
6mm O
balloons O
. O
 
Successful O
balloon O
inflation O
iand O
revasc O
of O
Rt O
profunda O
and O
Common O
Femoral O
artery O
with O
PTA O
and O
kissing O
balloon O
into O
profunda O
. O
 
Successful O
revasc O
of O
Rt O
External O
iliac O
and O
Rt O
Common O
Iliac O
with O
PTA/stents O
. O
 
Past O
medical O
history O
: O
CAD O
-- O
2082 I-DATE
CABG O
x O
3 O
-- O
10/9/91 I-DATE
LIMA O
to O
LAD O
patent O
; O
mod O
LAD O
stenosis O
beyond O
graft O
; O
SVT O
to O
OM O
patent O
; O
SVG O
to O
RCA O
occl O
@ O
origin O
-- O
10/91 I-DATE
rota-stenting O
of O
mid O
RCA O
99 O
% O
-- O
& O
gt O
; O
0 O
% O
Hypertension O
. O
 
Hyperlipidemia O
. O
 
PAD O
-- O
11/88 I-DATE
left O
common O
femoral O
and O
left O
popliteal O
artery O
revasc O
; O
stent O
Medtronic O
bridge O
Assurant O
ot O
left O
common O
iliac O
art O
-- O
2/89 I-DATE
right O
external O
and O
internal O
and O
right O
common O
femoral O
artery O
revasc O
; O
stent O
to O
right O
common O
femoral O
art O
Obesity O
. O
 
Type O
2 O
diabetes O
mellitus O
( O
2/2089 I-DATE
HgbA1c O
-- O
6.50 O
) O
Depressive O
disorder O
, O
none O
x O
20 O
years O
, O
no O
hospitalization O
or O
harm O
to O
self O
Cervical O
spine O
disease O
s/p O
C6-C7 O
disk O
surgery O
2079 I-DATE
Congenital O
hypospadias O
. O
 
Prostatitis- O
since O
age O
30 I-AGE
, O
takes O
antibiotic O
daily O
. O
 
Hemorrhoids O
. O
 
Colonic O
polyps O
. O
 
Chronic O
normocytic O
anemia O
. O
 
Beginning O
of O
cataracts O
Medications O
: O
EcASA O
325 O
mg O
daily O
NPH O
68 O
u O
qpm O
about O
9pm O
Atacand O
16 O
mg O
daily O
Glyburide O
3 O
mg O
bid O
Metroprolol O
25 O
mg O
tid O
( O
patient O
takes O
75 O
mg O
daily O
) O
Norvasc O
5 O
mg O
daily O
Januvia O
100 O
mg O
daily O
Bactrim O
SS O
1 O
tab O
daily O
Crestor O
20 O
mg O
daily O
Pristiq O
50 O
mg O
daily O
Mirtazapine O
7.5 O
mg O
qhs O
Social O
history O
: O
Married O
, O
glazier I-PROFESSION
, O
3 O
grown O
adult O
children O
Tob O
: O
quit O
2071 I-DATE
smoked O
3 O
packs O
of O
cigarettes O
per O
day O
for O
approximately O
30 I-AGE
years O
Exercise O
: O
Negative O
for O
any O
regular O
exercise O
b/c O
of O
claudication O
ETOH O
: O
1 O
beer O
a O
week O
Negative O
for O
illicit O
drug O
use O
. O
 
Review O
of O
systems O
: O
+ O
claudication O
as O
above O
denies O
headache O
, O
seizures O
, O
stroke O
, O
syncope O
, O
visual O
changes O
, O
asthma O
, O
COPD O
, O
recent O
fever O
, O
recent O
URI O
, O
PUD O
, O
GERD O
, O
Hematemesis O
, O
BRBPR O
, O
weight O
changes O
, O
LEE O
, O
blood O
clots O
Physical O
examination O
: O
-BMI O
: O
38.9 O
Obese O
, O
high O
risk O
-Pulse O
: O
65 O
-resp O
. O
 
rate O
: O
16 O
-height O
: O
72 O
in O
. O
 
-weight O
: O
286 O
lbs O
. O
 
-General O
: O
well O
appearing O
male O
, O
No O
acute O
distress O
. O
 
-Neck O
: O
Carotids O
2+ O
without O
bruits O
. O
 
JVP O
not O
appreciated O
-Chest O
: O
Clear O
ant/lat O
-Cardiac O
: O
distant O
HS O
, O
RRR O
, O
normal O
S1S2 O
, O
no O
M/R/G O
-Abdomen O
: O
Round O
, O
NT O
, O
+ O
BS O
no O
masses O
appreciated O
-Extremities O
: O
no O
C/C/E O
left O
groin O
- O
art O
sheaths O
inplace O
, O
no O
obvious O
hematoma O
or O
ooze O
, O
dop O
DP O
, O
dop O
PT O
feet O
warm O
-Neuro O
: O
Alert O
and O
oriented O
times O
3. O
speech O
clear O
. O
 
strengths O
equal O
through O
out O
, O
grossly O
non O
focal O
-BP O
: O
132/56 O
Assessment O
and O
plan O
: O
73 I-AGE
yo O
male O
with O
H/O O
cardiovascular O
disease O
now O
with O
right O
LE O
claudication O
admitted O
now O
s/p O
PTA O
to O
Rt O
profunda O
and O
Common O
Femoral O
artery O
with O
PTA O
and O
kissing O
balloon O
into O
profunda O
. O
 
and O
stenting O
to O
Rt O
External O
iliac O
and O
Rt O
Common O
Iliac O
. O
 
- O
sheath O
removal O
tonight O
- O
cont O
ASA O
and O
Plavix O
- O
cont O
present O
medications O
presently O
BP O
and O
HR O
well O
controlled O
- O
check O
fasting O
lipids O
and O
LFTs O
DM O
- O
cont O
NPH O
, O
Glyburide O
, O
and O
Januvia O
- O
follow O
FS O
BS O
- O
SS O
Insulin O
PRN O
- O
Hga1c O
as O
out O
patient O
Depression O
- O
cont O
Mirtazepine O
and O
Pristiq O
further O
plans O
per O
Nunes I-NAME
Frances I-NAME
Teresa I-NAME
Quevedo I-NAME
, O
NP O
Transcribed O
by O
: O
Frances I-NAME
Teresa I-NAME
Quevedo I-NAME
Signed O
electronically O
by O
Frances I-NAME
Teresa I-NAME
Quevedo I-NAME
, O
NP O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2094-12-27 I-DATE
CARDIOLOGY O
BEAUREGARD I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
RE O
: O
Follow-up O
of O
coronary O
and O
peripheral O
arterial O
disease O
. O
 
Dear O
Dr. O
Cooper I-NAME
: O
I O
had O
the O
pleasure O
of O
seeing O
Christian I-NAME
Mullen I-NAME
in O
the O
office O
today O
with O
Dr. O
Nunes I-NAME
. O
 
As O
you O
know O
he O
has O
an O
extensive O
coronary O
and O
peripheral O
arterial O
disease O
history O
. O
 
He O
last O
underwent O
intervention O
on O
his O
right O
leg O
vessels O
in O
December I-DATE
2093 I-DATE
. O
 
He O
underwent O
PTA/Stenting O
of O
the O
right O
external O
and O
common O
iliac O
arteries O
and O
PTA O
of O
the O
right O
common O
femoral/Profunda O
arteries O
. O
 
As O
you O
know O
, O
he O
previously O
has O
had O
patch O
endarterectomy O
of O
his O
left O
common O
femoral O
and O
common O
iliac O
and O
popliteal O
stenting O
on O
the O
left O
. O
 
He O
previously O
has O
undergone O
CABG O
in O
2082 I-DATE
with O
repeat O
angio O
in O
2091 I-DATE
showing O
patent O
IMA O
to O
LAD O
graft O
, O
patent O
SVG-OM1 O
graft O
, O
and O
occluded O
grafts O
to O
OM2 O
and O
RCA O
. O
 
He O
underwent O
rotastenting O
of O
his O
native O
RCA O
with O
a O
BMS O
at O
that O
time O
. O
 
Additionally O
, O
he O
has O
asymptomatic O
moderate O
RICA O
stenosis O
with O
mild O
LICA O
stenosis O
. O
 
He O
returns O
today O
for O
review O
. O
 
He O
remains O
in O
reasonable O
health O
. O
 
He O
is O
still O
struggling O
to O
lose O
weight O
and O
is O
interested O
in O
bariatric O
surgery O
. O
 
He O
has O
limiting O
bilateral O
claudication O
worse O
since O
his O
last O
visit O
, O
on O
each O
side O
. O
 
He O
also O
has O
dyspnea O
on O
exertion O
but O
does O
not O
describe O
angina O
. O
 
However O
, O
it O
is O
now O
3 O
years O
since O
his O
last O
nulcear O
perfusion O
study O
. O
 
He O
does O
not O
report O
any O
neurovascular O
symptoms O
. O
 
Past O
medical O
history O
: O
CAD O
-- O
2082 I-DATE
CABG O
x O
3 O
-- O
10/9/91 I-DATE
LIMA O
to O
LAD O
patent O
; O
mod O
LAD O
stenosis O
beyond O
graft O
; O
SVT O
to O
OM O
patent O
; O
SVG O
to O
RCA O
occl O
@ O
origin O
-- O
10/91 I-DATE
rota-stenting O
of O
mid O
RCA O
99 O
% O
-- O
& O
gt O
; O
0 O
% O
Hypertension O
. O
 
Hyperlipidemia O
. O
 
PAD O
-- O
11/88 I-DATE
left O
common O
femoral O
and O
left O
popliteal O
artery O
revasc O
; O
stent O
Medtronic O
bridge O
Assurant O
ot O
left O
common O
iliac O
art O
-- O
2/89 I-DATE
right O
external O
and O
internal O
and O
right O
common O
femoral O
artery O
revasc O
; O
stent O
to O
right O
common O
femoral O
art O
Obesity O
. O
 
Type O
2 O
diabetes O
mellitus O
( O
2/2089 I-DATE
HgbA1c O
-- O
6.50 O
) O
Depressive O
disorder O
, O
none O
x O
20 O
years O
, O
no O
hospitalization O
or O
harm O
to O
self O
Cervical O
spine O
disease O
s/p O
C6-C7 O
disk O
surgery O
2079 I-DATE
Congenital O
hypospadias O
. O
 
Prostatitis- O
since O
age O
30 I-AGE
, O
takes O
antibiotic O
daily O
. O
 
Hemorrhoids O
. O
 
Colonic O
polyps O
. O
 
Chronic O
normocytic O
anemia O
. O
 
Beginning O
of O
cataracts O
Medications O
: O
EcASA O
325 O
mg O
daily O
NPH O
68 O
u O
qpm O
about O
9pm O
Atacand O
16 O
mg O
daily O
Glyburide O
3 O
mg O
bid O
Metroprolol O
25 O
mg O
tid O
( O
patient O
takes O
75 O
mg O
daily O
) O
Norvasc O
5 O
mg O
daily O
Januvia O
100 O
mg O
daily O
Bactrim O
SS O
1 O
tab O
daily O
Crestor O
20 O
mg O
daily O
Pristiq O
50 O
mg O
daily O
Mirtazapine O
7.5 O
mg O
qhs O
Changes O
to O
Allergies O
Fentanyl O
- O
reaction O
: O
see O
comment O
( O
nausea O
and O
vomiting O
during O
11/23/2088 I-DATE
catheterization O
) O
[ O
reviewed O
] O
NKA O
: O
No O
Known O
Allergies O
- O
reaction O
: O
see O
comment O
( O
No O
known O
allergies O
to O
shellfish O
, O
iodine O
, O
or O
contrast O
media O
) O
[ O
reviewed O
] O
Penicillins O
- O
reaction O
: O
Rash O
[ O
reviewed O
] O
Family O
history O
: O
Positive O
for O
CVD O
and O
DM O
. O
 
Social O
history O
: O
Married O
, O
glazier I-PROFESSION
, O
3 O
grown O
adult O
children O
Tob O
: O
quit O
2071 I-DATE
smoked O
3 O
packs O
of O
cigarettes O
per O
day O
for O
approximately O
30 I-AGE
years O
Exercise O
: O
Negative O
for O
any O
regular O
exercise O
b/c O
of O
claudication O
ETOH O
: O
1 O
beer O
a O
week O
Negative O
for O
illicit O
drug O
use O
. O
 
Physical O
examination O
: O
-Pulse O
: O
77 O
-General O
: O
No O
acute O
distress O
. O
 
-Skin O
: O
No O
rashes O
, O
anicteric O
. O
 
-Heent O
: O
Unremarkable O
-Neck O
: O
Carotids O
2+ O
without O
bruits O
. O
 
JVP O
no O
jugular O
venous O
distention O
. O
 
-Chest O
: O
Clear O
to O
auscultation O
and O
percussion O
. O
 
-Cardiac O
: O
Left O
ventricular O
impulse O
discrete O
and O
nondisplaced O
. O
 
Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
with O
no O
S3 O
or O
S4 O
. O
 
There O
were O
no O
murmurs O
, O
clicks O
or O
rubs O
. O
 
-Abdomen O
: O
Normal O
bowel O
sounds O
, O
soft O
and O
nontender O
, O
with O
no O
hepatosplenomegaly O
or O
masses O
appreciated O
. O
 
-Extremities O
: O
No O
cyanosis O
, O
clubbing O
or O
edema O
. O
 
2+ O
femoral O
pulses O
with O
bruits O
. O
 
Doppler O
+ O
right O
DP/ O
PT O
biphasic O
signal O
, O
doppler O
( O
+ O
) O
left O
DP/PT O
monophasic O
signal O
-BP O
: O
130/60 O
Bilaterally O
EKG O
: O
NSR O
( O
73 O
) O
, O
normal O
axis O
, O
IVCD O
, O
no O
acute O
ischemic O
changes O
. O
 
Impression O
: O
Mr O
Mullen I-NAME
is O
a O
74 I-AGE
year O
old O
gentleman O
with O
extensive O
PAD O
andCAD O
now O
limited O
again O
with O
recurrent O
intermittent O
claudication O
. O
 
He O
is O
now O
also O
3 O
years O
since O
his O
last O
perfusion O
study O
for O
coronary O
ischemia O
. O
 
Finally O
, O
he O
warrants O
repeat O
duplex O
of O
his O
carotids O
. O
 
Assessment O
and O
plan O
: O
1 O
. O
 
CAD- O
will O
continue O
current O
medication O
regimen O
and O
arrange O
Nuclear O
Adenosine O
MIBI O
stress O
test O
. O
 
2 O
. O
 
PAD- O
worsening O
claudication O
, O
will O
review O
angiographic O
images O
and O
plan O
for O
repeat O
catheterization O
to O
re-intervene O
. O
 
3 O
. O
 
Carotid O
disease O
; O
currently O
asymptomatic O
, O
will O
repeat O
CANIs O
. O
 
Medication O
List O
CONFIRMED O
- O
aspirin O
325 O
mg O
daily O
- O
Bactrim O
1 O
mg O
daily O
- O
bupropion O
150 O
mg O
daily O
- O
candesartan O
16 O
mg O
daily O
- O
Colace O
100 O
mg O
BID O
- O
Colace O
BID O
100 O
- O
Crestor O
dose O
unknown O
- O
doxepin O
- O
gemfibrozil O
600 O
mg O
BID O
- O
glyburide O
2.5 O
mg O
daily O
- O
insulin O
- O
Lipitor O
80 O
mg O
daily O
- O
metoprolol O
tartrate O
75 O
mg O
daily O
- O
sitagliptin O
dose O
unknown O
UNCONFIRMED O
- O
Toprol O
XL O
50 O
mg O
daily O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
REMOVED O
- O
Avandia O
8 O
mg O
daily O
- O
clopidogrel O
bisulfate O
75 O
mg O
daily O
Thanks O
for O
allowing O
us O
to O
participate O
in O
his O
care O
. O
 
Best O
personal O
regards O
, O
Nicholas I-NAME
B I-NAME
Fuchs I-NAME
MD O
I O
saw O
this O
patient O
and O
confirmed O
the O
history O
of O
present O
illness O
, O
PMH O
, O
medications O
, O
and O
ROS O
. O
 
I O
also O
confirmed O
the O
cardiovascular O
examination O
and O
interpreted O
the O
pertinent O
laboratory O
data O
. O
 
I O
discussed O
findings O
with O
the O
patient O
and O
developed O
the O
management O
strategy O
. O
 
My O
findings O
and O
plans O
are O
elaborated O
on O
the O
note O
above O
. O
 
Issues:1 O
) O
12 O
years O
out O
from O
CABG O
. O
 
He O
is O
experiencing O
increasing O
DOE O
, O
which O
is O
likely O
due O
to O
his O
weight O
and O
other O
factors O
. O
 
but O
I O
am O
concerned O
that O
we O
make O
certain O
his O
myocardial O
perfusion O
is O
OK. O
Will O
order O
Stress O
MIBI.2 O
) O
PAD- O
claudicating O
L O
& O
gt O
; O
R O
leg O
... O
calf O
. O
 
Rutherford O
2 O
. O
 
Disabling O
. O
 
Has O
signif O
disease O
previously O
treated O
. O
 
Will O
review O
films O
and O
consider O
repeat O
CTA O
to O
decide O
whether O
he O
warrants O
relook O
and O
repeat O
intervention O
. O
 
He O
is O
s/p O
CFA/Profunda O
endarterectomy.3 O
) O
Weight O
- O
will O
provide O
him O
names O
of O
Bariatric O
surgeons O
here O
at O
BMH.4 O
) O
Carotids O
- O
asymptomatic O
. O
 
repeating O
CNI's O
Guyton I-NAME
Nunes I-NAME
, O
MD O
pager O
# O
53530 I-CONTACT
Signed O
electronically O
by O
Nicholas I-NAME
B. I-NAME
Fuchs I-NAME
, O
MD O
; O
Guyton I-NAME
Nunes I-NAME
, O
MD O
pager O
# O
53530 I-CONTACT
Document O
Status O
: O
Final O
 
Record O
date O
: O
2078-08-20 I-DATE
New O
office O
visit O
Referring O
Physician O
: O
Dr. O
Ebert I-NAME
BMC I-LOCATION
PCP O
: O
Dr.Bryan O
Edmondson I-NAME
BMC I-LOCATION
CHIEF O
PAIN O
COMPLAINT O
: O
`` O
I O
have O
pain O
in O
the O
back O
radiating O
down O
my O
legs O
. O
'' O
 
PAIN O
HISTORY O
: O
The O
patient O
's O
pain O
started O
spontaneously O
about O
two O
years O
ago O
. O
 
It O
is O
located O
in O
the O
lower O
back O
, O
radiating O
to O
the O
back O
of O
the O
legs O
, O
to O
the O
level O
of O
the O
knees O
. O
 
The O
pain O
is O
brought O
on O
by O
walking O
and O
made O
better O
by O
stopping O
or O
sitting O
down O
. O
 
Bending O
over O
forward O
also O
helps O
the O
pain O
. O
 
There O
is O
no O
numbness O
or O
weakness O
associated O
with O
the O
pain O
. O
 
The O
pain O
is O
better O
at O
night O
than O
during O
the O
day O
. O
 
The O
patient O
has O
separate O
pain O
complaint O
, O
which O
is O
burning O
pain O
in O
her O
feet O
, O
is O
worse O
at O
night O
than O
during O
the O
day O
. O
 
Patient O
denies O
bowel O
or O
bladder O
changes O
. O
 
The O
patient O
has O
tried O
Celebrex O
, O
Vioxx O
and O
Motrin O
but O
has O
not O
found O
any O
relief O
for O
her O
pain O
. O
 
She O
currently O
does O
not O
take O
any O
pain O
medications O
. O
 
She O
denies O
a O
history O
of O
heartburn O
, O
gastric O
or O
duodenal O
ulcers O
or O
GI O
bleeds O
. O
 
She O
has O
trouble O
falling O
asleep O
and O
staying O
asleep O
because O
of O
the O
burning O
pain O
in O
her O
feet O
. O
 
She O
is O
being O
referred O
to O
us O
by O
Dr. O
Ebert I-NAME
from O
Neurosurgery O
after O
an O
MRI O
scan O
showed O
spinal O
stenosis O
at O
L5-S1 O
and O
at O
L4-5 O
as O
well O
as O
spondylolithiasis O
between O
L4 O
and O
L5 O
. O
 
She O
had O
been O
reluctant O
to O
undergo O
surgery O
and O
was O
therefore O
referred O
to O
see O
if O
epidural O
steroid O
injections O
could O
help O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Diabetes O
, O
hypertension O
, O
coronary O
artery O
disease O
with O
myocardial O
infarction O
four O
years O
ago O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Coronary O
stent O
placement O
times O
two O
in O
December I-DATE
2074 I-DATE
. O
 
CURRENT O
MEDICATIONS O
: O
Metformin O
500 O
mg O
q. O
day O
, O
Monopril O
40 O
mg O
q. O
day O
, O
baby O
aspirin O
81 O
mg O
q. O
day O
, O
HCTZ O
12.5 O
mg O
q. O
day O
, O
Norvasc O
5 O
mg O
q. O
day O
and O
Pravachol O
20 O
mg O
q. O
day O
. O
 
Social O
History O
: O
She O
does O
not O
smoke O
, O
does O
smoke O
, O
does O
not O
drink O
and O
does O
not O
use O
drugs O
. O
 
She O
came O
from O
Bermuda I-LOCATION
four O
years O
ago O
. O
 
She O
is O
married O
and O
retired O
. O
 
Allergies O
: O
NKDA O
Review O
of O
systems O
: O
Constitutional O
: O
Denies O
fever O
, O
recent O
weight O
change O
, O
fatigue O
, O
or O
anxiety O
. O
 
Neurological O
: O
Denies O
confusion O
, O
double O
vision O
, O
light-headedness O
. O
 
HEENT O
: O
No O
symptoms O
. O
 
Respiratory O
: O
Non-smoker O
. O
 
No O
dyspnea O
, O
bronchospasm O
, O
cough O
, O
COPD O
. O
 
Cardiac O
: O
No O
, O
palpitations O
, O
syncope O
. O
 
Gastrointestinal O
: O
Denies O
N O
& O
V O
, O
heartburn O
, O
constipation O
, O
diarrhea O
, O
bleeding O
. O
 
Renal O
: O
No O
history O
of O
renal O
problems O
. O
 
No O
dysuria O
, O
urgency O
or O
frequency O
. O
 
Skin O
: O
No O
recent O
changes O
. O
 
Musculoskeletal O
: O
Denies O
muscle O
pain O
, O
positive O
for O
leg O
cramps O
cramps O
, O
arthritis O
. O
 
Hematologic O
: O
Pt O
denies O
spontaneous O
nose O
bleeds O
or O
easy O
bruising O
. O
 
Physical O
examination O
: O
Vital O
signs O
BP O
145/60 O
, O
P O
56 O
, O
VAS O
SCORE O
8/10 O
HEENT O
: O
Normal O
. O
 
Lungs O
: O
CTA O
( O
B O
) O
Heart O
: O
RRR O
, O
S1 O
, O
S2 O
, O
no O
murmurs O
Abdomen O
: O
Soft O
, O
non-tender O
, O
bowel O
sounds O
present O
Extremities O
: O
No O
cyanosis O
, O
clubbing O
or O
edema O
. O
 
Targeted O
examination O
showed O
an O
age O
appropriate O
woman O
in O
no O
apparent O
distress O
. O
 
Mental O
Status O
: O
She O
was O
fully O
awake O
and O
alert O
. O
 
Her O
mood O
was O
appropriate O
. O
 
There O
was O
mild O
sensory O
loss O
in O
a O
stocking O
distribution O
over O
the O
lets O
as O
well O
as O
in O
a O
glove O
distribution O
over O
the O
hands O
. O
 
There O
was O
no O
frank O
allodynia O
of O
the O
feet O
. O
 
Patellar O
and O
ankle O
reflexes O
were O
retained O
. O
 
Toe O
response O
was O
flexor O
. O
 
The O
patient O
could O
walk O
, O
including O
heel O
and O
toe O
walk O
. O
 
There O
was O
no O
pain O
on O
straight O
leg O
raising O
. O
 
There O
was O
no O
local O
tenderness O
over O
the O
back O
, O
however O
, O
a O
moderate O
degree O
of O
muscle O
spasm O
over O
the O
lower O
back O
. O
 
IMPRESSION O
: O
1 O
. O
 
Spinal O
stenosis O
. O
 
2 O
. O
 
Diabetic O
neuropathy O
. O
 
PLAN O
: O
1 O
. O
 
Start O
Neurontin O
with O
a O
target O
dose O
of O
300 O
mg O
t.i.d O
. O
 
for O
now O
. O
 
If O
tolerated O
, O
we O
will O
increase O
to O
600 O
mg O
t.i.d O
. O
 
2 O
. O
 
One O
week O
after O
Neurontin O
, O
start O
Zanaflex O
2 O
mg O
p.o O
. O
 
q.h.s O
. O
 
to O
be O
titrate O
up O
to O
4 O
mg O
after O
one O
week O
. O
 
3 O
. O
 
Lumbar O
epidural O
steroid O
injection O
at O
L4-5 O
or O
L5-S1 O
. O
 
If O
treatment O
with O
injections O
is O
unsuccessful O
, O
we O
will O
ask O
the O
patient O
to O
be O
reevaluate O
by O
Neurosurgery O
. O
 
Ila I-NAME
Easter I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2079-04-22 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
BROADLAWNS I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
Reason O
for O
visit O
elevated O
B/P O
History O
of O
present O
illness O
Seen O
in O
ER O
for O
HTN.yesterday O
224/105 O
Per O
dau O
TX O
w/ O
IV O
lopressor O
x O
4 O
doses O
, O
betalol O
& O
NTG O
Today O
B/P O
210/90 O
this O
AM O
Meds O
not O
changed O
. O
 
No O
ha O
, O
no O
chest O
pain O
, O
no O
SOB O
, O
no O
blurred O
vision O
. O
 
Change O
in O
therapies O
and O
Renewals O
Norvasc O
5mg O
po O
qd O
QTY:30 O
Refills:3 O
Start O
: O
3/12/2075 I-DATE
Assessment O
and O
plan O
HTN O
Discussed O
w/ O
Dr O
Edmondson I-NAME
by O
phone O
. O
 
Will O
add O
Norvasc O
5 O
mg O
qd O
Advised O
family O
. O
 
Called O
to O
pharm O
Disposition O
Appt O
w/ O
Dr O
Edmondson I-NAME
4/28/79 I-DATE
Addendum O
I O
was O
present O
during O
key O
portions O
of O
the O
evaluation O
of O
the O
patient O
and O
agree O
with O
Noreen I-NAME
Dotson I-NAME
's O
findings O
and O
plan O
as O
written O
. O
 
Bryan I-NAME
Edmondson I-NAME
Signed O
electronically O
by O
Noreen I-NAME
O I-NAME
Dotson I-NAME
RN O
on O
Apr I-DATE
22 O
, O
2079 I-DATE
Bryan I-NAME
Edmondson I-NAME
MD O
on O
Aug I-DATE
20 O
, O
2079 I-DATE
 
Record O
date O
: O
2080-01-26 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
BROADLAWNS I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
History O
of O
present O
illness O
This O
is O
an O
81-year-old O
black O
female O
with O
hypertension O
, O
type O
2 O
diabetes O
mellitus O
, O
coronary O
artery O
disease O
, O
and O
paroxysmal O
atrial O
fibrillation O
who O
is O
here O
for O
followup O
. O
 
The O
patient O
feels O
generally O
well O
. O
 
Her O
only O
complaint O
is O
difficulty O
sleeping O
. O
 
She O
wakes O
up O
at O
night O
. O
 
She O
does O
not O
sleep O
soundly O
. O
 
She O
denies O
any O
orthopnea O
or O
PND O
. O
 
No O
chest O
pain O
. O
 
No O
back O
pain O
. O
 
She O
had O
a O
history O
of O
low O
back O
pain O
secondary O
to O
spinal O
stenosis O
; O
however O
, O
her O
pain O
has O
not O
been O
a O
problem O
lately O
. O
 
She O
denies O
any O
palpitations O
, O
lightheadedness O
, O
or O
shortness O
of O
breath O
. O
 
Change O
in O
therapies O
and O
Renewals O
Norvasc O
5 O
mg O
1 O
tab O
qd O
aspirin O
325 O
mg O
1 O
tab O
qd O
Glucophage O
500 O
mg O
bid O
hydrochlorothiazide O
25 O
mg O
QD O
ibuprofen O
800 O
mg O
tid O
Isordil O
40 O
mg O
tid O
fosinopril O
40 O
mg O
QD O
metoprolol O
50 O
mg O
BID O
Pravachol O
20 O
mg O
QD O
Physical O
examination O
Blood O
pressure O
170/80 O
Weight O
179 O
pounds O
General O
appearance O
Overweight O
in O
no O
acute O
distress O
Skin O
Clear O
Heent O
Eyes O
, O
nonicteric O
Nodes O
Normal O
Chest O
Lungs O
are O
clear O
Cor O
Regular O
rhythm O
. O
 
S1 O
and O
S2 O
are O
normal O
. O
 
No O
murmur O
, O
S3 O
, O
or O
S4 O
Abdomen O
Soft O
and O
nontender O
. O
 
No O
masses O
Extrem O
No O
edema O
Assessment O
and O
plan O
Coronary O
artery O
disease O
. O
 
Stable O
. O
 
Continue O
present O
medications O
. O
 
Hypertension O
. O
 
Systolic O
a O
little O
high O
today O
. O
 
We O
will O
not O
change O
her O
medicine O
right O
now O
. O
 
Her O
blood O
pressure O
has O
been O
satisfactory O
in O
the O
past O
. O
 
Degenerative O
arthritis O
with O
low O
back O
pain O
. O
 
Stable O
and O
asymptomatic O
. O
 
Continue O
ibuprofen O
PRN O
. O
 
Paroxysmal O
atrial O
fibrillation O
. O
 
Asymptomatic O
. O
 
Pulse O
is O
regular O
today O
. O
 
No O
change O
in O
treatment O
. O
 
Diabetes O
. O
 
Continue O
Glucophage O
. O
 
Check O
hemoglobin O
A1c O
. O
 
Insomnia O
. O
 
Trial O
of O
trazodone O
50 O
mg O
QHS O
PRN O
. O
 
Disposition O
Return O
in O
three O
months O
. O
 
Note O
transcribed O
by O
outside O
service O
Transcription O
errors O
may O
be O
present O
. O
 
Signed O
electronically O
by O
Edmondson O
, O
Bryan I-NAME
on O
Feb I-DATE
2 O
, O
2080 I-DATE
 
Record O
date O
: O
2082-06-23 I-DATE
CARDIOLOGY O
BROADLAWNS I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
Reason O
for O
visit O
: O
Mrs O
Vanmeter I-NAME
presents O
for O
routine O
follow O
up O
of O
her O
CAD O
, O
HTN O
and O
hyperlipidemia O
Interval O
History O
: O
She O
presents O
stating O
that O
she O
is O
getting O
along O
reasonably O
well O
. O
 
Her O
main O
problem O
is O
burning O
in O
her O
legs O
and O
feet O
, O
also O
present O
in O
her O
hands O
. O
 
She O
also O
reports O
an O
increased O
frequency O
of O
her O
chest O
tightness O
, O
occuring O
mainly O
at O
night O
, O
sometimes O
before O
going O
to O
sleep O
, O
sometimes O
durign O
the O
night O
. O
 
This O
is O
responsive O
to O
1 O
SL O
TNG O
typically O
, O
although O
sometimes O
is O
goes O
away O
without O
intervention O
. O
 
She O
denies O
SOB O
, O
PND O
, O
orthopnea O
, O
presycope O
or O
syncope O
. O
 
She O
has O
intermittant O
mild O
LE O
edema O
. O
 
She O
occasionally O
has O
palpitations O
, O
lasting O
~ O
5 O
minutes O
, O
resolving O
spontaneously O
. O
 
She O
can O
not O
relate O
them O
to O
any O
time O
of O
day O
or O
activity O
, O
and O
they O
are O
not O
associated O
w/ O
lightheadedness O
or O
CP O
. O
 
Recently O
she O
called O
me O
w/ O
complaints O
of O
increased O
LE O
edema O
. O
 
This O
is O
minor O
on O
exam O
. O
 
Her O
echo O
showed O
preserved O
LV O
function O
and O
no O
significnat O
valvular O
disease O
. O
 
Past O
medical O
history O
: O
CAD O
s/p O
IMI O
in O
2074 I-DATE
, O
s/p O
stent O
placement O
x2 O
in O
2074 I-DATE
. O
 
HTN O
PAF O
Type O
2 O
DM O
Sciatica O
Hyperlipidemia O
GERD O
Glaucoma O
Multinodular O
goiter O
Medications O
( O
Confirmed O
) O
: O
acetaminophen O
and O
codeine O
( O
tylenol O
with O
codeine O
# O
3 O
) O
tablets O
Alphagan O
P O
0.15 O
% O
x O
1 O
drop O
ou O
bid O
aspirin O
81 O
mg O
QD O
fosinopril O
Glucophage O
500 O
mg O
bid O
Isordil O
40 O
mg O
tid O
Removed O
- O
lisinopril O
40 O
mg O
qd O
Lopressor O
25 O
mg O
1/2 O
bid O
nitroglycerin O
Norvasc O
5 O
mg O
1/2 O
qd O
Pravachol O
20 O
mg O
qd O
Trusopt O
1 O
drop O
od O
daily O
Tylenol O
325mg O
x O
2 O
tabs O
po O
q4-6h O
PRN O
pain O
Allergies O
: O
No O
known O
drug O
allergy O
Family O
history O
: O
Mother O
died O
in O
her O
early O
60s I-AGE
of O
`` O
heart O
problems O
'' O
, O
not O
otherwise O
specified O
. O
 
Father O
in O
mid O
50s I-AGE
with O
`` O
kidney O
problems O
'' O
. O
 
Social O
history O
: O
She O
is O
married O
, O
retired O
, O
comes O
originally O
from O
Bermuda I-LOCATION
. O
 
Has O
several O
children/grandchildren O
who O
help O
with O
her O
medical O
issues O
. O
 
She O
does O
not O
smoke O
or O
drink O
alcohol O
. O
 
Review O
of O
systems O
: O
Otherwise O
negative O
in O
detail O
. O
 
Physical O
examination O
: O
-BMI O
: O
32.6 O
Obese O
, O
high O
risk O
-Pulse O
: O
57 O
-resp O
. O
 
rate O
: O
18 O
-height O
: O
61 O
in O
. O
 
-weight O
: O
172 O
lbs O
. O
 
-General O
appearance O
: O
No O
acute O
distress O
. O
 
-Skin O
: O
No O
rashes O
, O
anicteric O
. O
 
-HEENT O
: O
Unremarkable O
-Neck O
: O
Carotids O
2+ O
without O
bruits O
. O
 
JVP O
no O
jugular O
venous O
distention O
-Chest O
: O
Clear O
to O
auscultation O
and O
percussion O
. O
 
-Cardiac O
: O
Left O
ventricular O
impulse O
discrete O
and O
nondisplaced O
. O
 
Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
with O
no O
S3 O
or O
S4 O
. O
 
There O
were O
no O
murmurs O
, O
clicks O
or O
rubs O
. O
 
-Abdomen O
: O
Normal O
bowel O
sounds O
, O
soft O
and O
nontender O
, O
with O
no O
hepatosplenomegaly O
or O
masses O
appreciated O
. O
 
-Extremities O
: O
No O
cyanosis O
, O
clubbing O
or O
edema O
. O
 
2+ O
pedal O
pulses O
. O
 
Mild O
fullness O
over O
the O
dorsum O
of O
the O
left O
foot O
. O
 
LLE O
varicosities O
. O
 
-BP O
: O
130/65 O
EKG O
: O
SB O
. O
 
52 O
. O
 
Old O
Inf O
apical O
MI O
. O
 
No O
change O
from O
the O
prior O
. O
 
Selected O
recent O
labs O
: O
Metabolic O
Date O
NA O
K O
CL O
CO2 O
BUN O
CRE O
GLU O
CA O
PHOS O
MG O
05/18/82 I-DATE
142 O
4.1 O
105 O
26.1 O
27 O
1.3 O
107 O
9.4 O
11/14/79 I-DATE
3.4 O
04/21/79 I-DATE
1.7 O
Date O
URIC O
05/18/82 I-DATE
6.8 O
11/14/79 I-DATE
04/21/79 I-DATE
Lipid/Thyroid O
Date O
CHOL O
TRIG O
HDL O
LDL O
TSH O
T3 O
T4 O
10/08/81 I-DATE
133 O
66 O
53 O
67 O
01/14/81 I-DATE
0.54 O
05/23/78 I-DATE
109 O
10.1 O
Hematology O
Date O
HCT O
WBC O
PLT O
12/22/80 I-DATE
32.9 O
6.4 O
323 O
Immunology O
Date O
HGBA1C O
05/18/82 I-DATE
6.70 O
Assessment O
and O
plan O
: O
Mrs. O
Vanmeter I-NAME
presents O
today O
stating O
that O
she O
continues O
to O
have O
some O
mild O
nighttime O
chest O
discomfort O
, O
responsive O
to O
SL O
TNG O
. O
 
Her O
last O
stress O
test O
was O
in O
January I-DATE
2082 I-DATE
and O
was O
without O
ischemia O
with O
a O
posterobasal O
scar O
( O
Adeno O
MIBI O
) O
. O
 
A O
recent O
echo O
in O
June I-DATE
2081 I-DATE
done O
to O
evaluate O
increased O
LE O
edema O
was O
normal O
. O
 
Problems O
: O
Coronary O
artery O
disease O
- O
She O
reports O
an O
increased O
frequency O
of O
her O
nighttime O
CP O
and O
takes O
SL O
TNG O
when O
with O
good O
relief O
. O
 
Takes O
it O
about O
once/month O
. O
 
These O
episodes O
only O
occur O
at O
night O
when O
she O
is O
in O
bed O
. O
 
Her O
echo O
showed O
preserved O
LV O
function O
and O
no O
significnat O
valvular O
disease O
. O
 
A O
repeat O
adenosine O
MIBI O
was O
negative O
for O
recurrent O
ischemia O
with O
an O
inferobasal O
scar O
and O
LVEF O
54 O
% O
. O
 
I O
advised O
her O
to O
take O
an O
H2 O
blocker O
before O
bedtime O
and O
if O
symptoms O
do O
n't O
improve O
, O
seek O
a O
workup O
with O
her O
PCP O
. O
 
Hyperlipidemia O
- O
Her O
last O
lipid O
profile O
showed O
that O
her O
LDL O
was O
in O
range O
at O
67 O
, O
and O
her O
TG O
were O
normal O
! O
 
I O
advised O
her O
about O
the O
metabolic O
syndrome O
and O
the O
importance O
of O
careful O
diabetic O
control O
as O
well O
as O
regular O
exercise O
. O
 
Continue O
her O
present O
dose O
of O
statin O
. O
 
HTN O
- O
Her O
BP O
is O
well-controlled O
today O
. O
 
Continue O
her O
current O
regimen O
. O
 
Changes O
to O
Medications O
this O
visit O
Glucophage O
500 O
mg O
bid O
half O
a O
tab O
lisinopril O
40 O
mg O
qd O
End O
: O
6/23/2082 I-DATE
- O
Inactivated O
fosinopril O
40 O
mg O
QD O
QTY:90 O
Refills:1 O
year O
Start O
: O
11/21/2072 I-DATE
Norvasc O
5 O
mg O
1/2 O
qd O
half O
a O
tab O
nitroglycerin O
0.4 O
mg O
sl O
PRN O
QTY:100 O
Refills:3 O
Start O
: O
08/20/2078 I-DATE
Isordil O
40 O
mg O
tid O
Lopressor O
25 O
mg O
1/2 O
bid O
half O
a O
tab O
aspirin O
81 O
mg O
QD O
acetaminophen O
and O
codeine O
( O
tylenol O
with O
codeine O
# O
3 O
) O
tablets O
1-2 O
tabs O
po O
q O
4-6 O
hours O
PRN O
pain O
QTY:100 O
Refills:1 O
Start O
: O
04/14/2081 I-DATE
Pravachol O
20 O
mg O
qd O
Trusopt O
1 O
drop O
od O
daily O
Alphagan O
P O
0.15 O
% O
x O
1 O
drop O
ou O
bid O
Tylenol O
325mg O
x O
2 O
tabs O
po O
q4-6h O
PRN O
pain O
Disposition O
: O
6 O
months O
with O
me O
Barbara I-NAME
T. I-NAME
Sandoval I-NAME
, O
MD O
pager O
# O
19360 I-CONTACT
cc O
: O
Dr. O
Bryan I-NAME
Edmondson I-NAME
Document O
Status O
: O
Preliminary O
 
Record O
date O
: O
2066-11-14 I-DATE
Chief O
Complaint O
Dyspnea O
and O
exertional O
chest O
discomfort O
History O
of O
Present O
Illness O
Patient O
is O
a O
59-year-old O
Chadian I-LOCATION
gentleman O
with O
multiple O
medical O
problems O
including O
DM O
and O
HTN O
and O
ESRF O
, O
recently O
started O
on O
hemodialysis O
who O
is O
admitted O
for O
right O
and O
left O
heart O
cath O
prior O
to O
MVR/CABG/MAZE O
. O
 
Pt O
presented O
1 O
year O
ago O
with O
complaints O
of O
increased O
abd O
girth O
, O
lower O
ext O
edema O
, O
and O
worsening O
DOE O
. O
 
Cardiac O
ultrasound O
at O
that O
time O
revealed O
severe O
mitral O
regurgitation O
secondary O
to O
diffuse O
ventricular O
dilation O
and O
papillary O
muscle O
displacement O
with O
ejection O
fraction O
36 O
% O
. O
 
He O
denied O
CP O
, O
PND O
and O
orthopnea O
at O
the O
time O
and O
adenoMibi O
showed O
inferior O
thinning O
which O
might O
be O
consistent O
with O
a O
prior O
( O
silent O
) O
IMI O
without O
evidence O
of O
ongoing O
ischemia O
. O
 
He O
refused O
further O
work-up O
or O
intervention O
until O
recently O
. O
 
He O
presents O
now O
for O
cath O
and O
surgery O
. O
 
Review O
of O
Systems O
As O
in O
HPI O
, O
additionally O
; O
- O
General O
: O
no O
weight O
loss/gain O
- O
ID O
: O
no O
fever O
chills O
- O
Derm O
: O
no O
rash O
pruritus O
- O
Gastrointestinal O
: O
no O
nausea O
dysphagia O
vomiting O
dyspesia O
- O
Respiratory O
: O
no O
dysnpnea O
wheezing O
- O
Neuorologic O
: O
no O
weakness O
numbness/tingling O
seizures O
syncope O
- O
Hematologic O
: O
no O
excessive O
bruising O
, O
bleeding O
- O
MSK O
no O
joint O
pain O
swelling O
Problems O
Neuropathy O
Nephropathy O
: O
cr O
. O
 
2.6 O
. O
 
3.3 O
gm O
proteinuria O
Hemodialysis O
for O
the O
past O
2 O
months O
. O
 
Mature O
L O
fistula O
. O
 
problems O
with O
fistula O
last O
week O
Hyperlipidemia O
Hypertension O
Previously O
reasonably O
controlled O
on O
meds O
. O
 
Greatly O
Improved O
after O
start O
of O
dialysis O
Obesity O
Diabetes O
mellitus O
: O
type O
2 O
Noncompliance O
: O
poor O
compliance O
repeated O
noncompliance O
, O
frequently O
, O
but O
not O
always O
, O
due O
to O
financial O
constraints O
and O
language O
barrier O
Basal O
cell O
carcinoma O
: O
carcinoma O
of O
skin O
left O
cheek O
Lower O
extremity O
ulcer O
: O
DIABETIC O
FOOT O
ULCER O
. O
 
L O
Foot O
Abscess O
: O
Rt O
shin O
2062 I-DATE
Back O
: O
11/64 I-DATE
. O
 
S/P O
I O
& O
D O
Mitral O
valve O
insufficiency O
: O
severe O
, O
with O
cardiomyopathy O
and O
EF O
36 O
% O
Colonic O
polyps O
: O
tubulovillious O
adenoma O
11/65 I-DATE
. O
 
Needs O
repeat O
scope O
11/66 I-DATE
Social O
History O
Married O
with O
2 O
daughters O
. O
 
Lives O
in O
De I-LOCATION
Soto I-LOCATION
and O
assists O
in O
care O
of O
his O
grandchildren O
. O
 
He O
has O
been O
unable O
to O
work O
due O
to O
his O
chronic O
medical O
conditions O
and O
is O
exceptionally O
limited O
financially O
. O
 
He O
worked O
( O
his O
wife O
works O
) O
in O
visual I-PROFESSION
art I-PROFESSION
. O
 
Medications O
Aspirin O
Buffered O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Toprol O
Xl O
( O
METOPROLOL O
Succinate O
Extended O
Release O
) O
100 O
MG O
( O
100MG O
TAB.SR O
24H O
take O
1 O
) O
PO O
QD O
Ferrous O
Sulfate O
325 O
MG O
( O
325 O
( O
65 O
) O
MG O
TABLET O
take O
1 O
) O
PO O
TID O
Aranesp O
( O
DARBEPOETIN O
Alfa O
) O
60MCG/.3ML O
DISP O
SYRIN O
ML O
SC O
QWeek O
Lipitor O
( O
ATORVASTATIN O
) O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
QD O
Zetia O
( O
EZETIMIBE O
) O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Norvasc O
( O
AMLODIPINE O
) O
15 O
MG O
PO O
QD O
Ca O
Acetate O
( O
CALCIUM O
Acetate O
( O
1 O
Tablet=667 O
Mg O
) O
) O
1334 O
MG O
( O
667MG O
TABLET O
take O
2 O
) O
PO O
TID O
x O
30 O
days O
, O
take O
with O
meals O
; O
if O
snack O
inbetween O
meals O
take O
one O
extra O
pill O
LISINOPRIL O
10MG O
TABLET O
PO O
QD O
, O
Evening O
Qpm O
Insulin O
70/30 O
( O
HUMAN O
) O
Variable O
( O
70-30 O
U/ML O
VIAL O
) O
SC O
Physical O
Exam O
General O
: O
mildly O
obese O
adult O
male O
, O
dishevelled O
Integument O
: O
Warm O
and O
dry O
HEENT O
: O
Moist O
mucous O
membranes O
, O
edentulous O
Neck O
: O
Supple O
, O
no O
thryomegaly O
, O
carotids O
Chest O
: O
Lungs O
clear O
to O
auscultation O
and O
percussion O
Cardiac O
: O
apical O
impulse O
, O
Normal O
S1 O
, O
S2 O
III O
HSM O
murmer O
, O
S3 O
gallop O
Abdomen O
: O
soft O
, O
nondistended O
, O
normal O
bowel O
sounds O
Ext O
: O
External O
Labs O
Lab O
Results O
For O
: O
Ogrady O
, O
Ulysses O
Test O
IMC I-LOCATION
11/08/2066 I-DATE
13:37 O
WBC O
12.5 O
( O
H O
) O
RBC O
4.36 O
( O
L O
) O
HGB O
12.7 O
( O
L O
) O
HCT O
38.2 O
( O
L O
) O
MCV O
88 O
MCH O
29.1 O
MCHC O
33.2 O
PLT O
329 O
RDW O
15.6 O
( O
H O
) O
PT O
13.8 O
( O
H O
) O
PT-INR O
1.2 O
( O
T O
) O
PTT O
NA O
137 O
K O
4.8 O
CL O
98 O
( O
L O
) O
CO2 O
26.6 O
BUN O
42 O
( O
H O
) O
CRE O
5.6 O
( O
H O
) O
GLU O
130 O
( O
H O
) O
Nov I-DATE
08 I-DATE
LEFT O
FOREARM O
RADIOCEPHALIC O
AV O
FISTULA O
WITH O
MARKED O
STENOSIS O
WITHIN O
THE O
VENOUS O
OUTFLOW O
JUST O
BEYOND O
THE O
AV O
ANASTOMOSIS O
SUCCESSFULLY O
TREATED O
WITH O
ANGIOPLASTY O
. O
 
CXR O
8/18/66 I-DATE
REPORT O
: O
No O
prior O
: O
Findings O
: O
The O
lungs O
are O
clear O
however O
there O
is O
some O
cephalization O
of O
blood O
flow O
. O
 
The O
cardiac O
shadow O
is O
at O
the O
upper O
limits O
of O
normal O
. O
 
The O
bony O
thorax O
demonstrates O
degenerative O
changes O
. O
 
Impression O
: O
Cephalization O
of O
blood O
flow O
and O
cardiomegaly O
Assessment O
58-year-old O
Chadian I-LOCATION
gentleman O
with O
multiple O
medical O
problems O
including O
DM O
, O
HTN O
and O
ESRF O
on O
dialysis O
. O
 
In O
addition O
he O
has O
ischemic O
cardiomyopathy O
complicated O
by O
severe O
mitral O
regurgitation O
. O
 
He O
has O
been O
reluctant O
to O
consider O
surgery O
in O
the O
past O
but O
in O
the O
face O
of O
worsening O
symptoms O
has O
now O
agreed O
to O
proceed O
. O
 
Plan O
1 O
. O
 
Admit O
for O
right O
and O
left O
heart O
cath O
with O
cors O
. O
 
2 O
. O
 
Pt O
schedulled O
for O
dialysis O
on O
Friday I-DATE
please O
notify O
Dr O
Mcdaniel I-NAME
of O
his O
arrival O
. O
 
3 O
. O
 
CABG/MVR/MAZE O
schedulled O
for O
Thursday I-DATE
 
Record O
date O
: O
2067-08-02 I-DATE
60 I-AGE
year O
old O
gentleman O
presents O
for O
follow-up O
of O
right O
lower O
extremity O
foot O
ulcer O
. O
 
It O
would O
appear O
that O
two O
weeks O
prior O
, O
the O
patient O
sustained O
a O
burn O
to O
the O
right O
lower O
extremity O
while O
walking O
on O
a O
hot O
sandy O
beach O
. O
 
He O
has O
been O
followed O
regularly O
by O
a O
podiatrist O
Dr. O
Sanchez I-NAME
, O
who O
has O
attempted O
debridement O
of O
lesion O
. O
 
He O
also O
asked O
that O
the O
patient O
receive O
vancomycin O
at O
the O
time O
of O
his O
dialysis O
. O
 
In O
the O
setting O
of O
four O
compliance O
and O
poor O
wound O
healing O
, O
the O
patient O
was O
admitted O
for O
48 O
hours O
to O
the O
Northport I-LOCATION
Veterans I-LOCATION
Hospital I-LOCATION
. O
 
Records O
are O
not O
immediately O
available O
but O
it O
would O
appear O
that O
he O
received O
intravenous O
antibiotics O
at O
that O
time O
. O
 
He O
was O
discharged O
without O
clear O
follow-up O
. O
 
The O
patient O
presents O
to O
my O
office O
with O
his O
foot O
unwrapped O
and O
undressed O
. O
 
He O
has O
been O
ambulating O
on O
the O
wound O
. O
 
He O
reports O
that O
it O
appears O
less O
red O
and O
has O
less O
drainage O
than O
at O
his O
initial O
presentation O
. O
 
He O
reports O
no O
pain O
. O
 
Having O
spoken O
with O
his O
podiatrist O
, O
it O
would O
appear O
that O
the O
patient O
has O
been O
noncompliant O
with O
leg O
elevation O
and O
dressing O
overall O
. O
 
Review O
of O
systems O
is O
otherwise O
negative O
. O
 
Past O
Medical I-LOCATION
History O
: O
Neuropathy O
Nephropathy O
: O
cr O
. O
 
2.6 O
. O
 
3.3 O
gm O
proteinuria O
. O
 
Currently O
on O
hemodialysis O
Hyperlipidemia O
Hypertension O
Obesity O
Diabetes O
mellitus O
: O
type O
2 O
Noncompliance O
: O
poor O
compliance O
Basal O
cell O
carcinoma O
: O
carcinoma O
of O
skin O
left O
cheek O
Lower O
extremity O
ulcer O
: O
DIABETIC O
FOOT O
ULCER O
. O
 
L O
Foot O
Abscess O
: O
Rt O
shin O
2062Back O
: O
11/64 I-DATE
. O
 
S/P O
I O
& O
D O
Mitral O
valve O
insufficiency O
: O
severe O
, O
with O
cardiomyopathy O
and O
EF O
36 O
% O
Colonic O
polyps O
: O
tubulovillious O
adenoma O
11/65 I-DATE
. O
 
Needs O
repeat O
scope O
11/66 I-DATE
FH O
Uncoded O
Information O
: O
Comments O
: O
Noncontributory O
Allergies O
NKA O
Medications O
Aspirin O
BUFFERED O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Nephrocaps O
1 O
CAPSULE O
PO O
QD O
x O
90 O
days O
Ca O
ACETATE O
( O
CALCIUM O
ACETATE O
( O
1 O
TABLET=667 O
MG O
) O
) O
1334 O
MG O
( O
667MG O
TABLET O
take O
2 O
) O
PO O
TID O
x O
30 O
days O
, O
take O
with O
meals O
; O
if O
snack O
inbetween O
meals O
take O
one O
extra O
pill O
Lipitor O
( O
ATORVASTATIN O
) O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
QD O
Zetia O
( O
EZETIMIBE O
) O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Toprol O
XL O
( O
METOPROLOL O
SUCCINATE O
EXTENDED O
RELEASE O
) O
100 O
MG O
( O
100MG O
TAB.SR O
24H O
take O
1 O
) O
PO O
QD O
Lisinopril O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
, O
Evening O
Qpm O
Insulin O
70/30 O
( O
HUMAN O
) O
Variable O
( O
70-30 O
U/ML O
VIAL O
) O
SC O
, O
45 O
am O
, O
Pm O
Physical O
exam O
: O
In O
no O
acute O
distress O
. O
 
Blood O
pressure O
is O
100/58 O
. O
 
Weight O
is O
236 O
. O
 
Pulse O
is O
70 O
and O
regular.HEENT O
: O
Pupils O
equal O
round O
reactive O
to O
light O
. O
 
Extraocular O
motions O
intact O
. O
 
Oropharynx O
moist O
without O
erythema O
or O
exudate O
. O
 
Neck O
: O
Supple O
without O
JVD O
, O
lymphadenopathy O
, O
or O
thyromegaly O
. O
 
Chest O
: O
Clear O
to O
auscultation O
bilaterally O
without O
wheezes O
or O
rhonchi O
or O
rhales O
. O
 
Cardiac O
: O
Regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
without O
murmurs O
rubs O
or O
gallops O
. O
 
Extremities O
: O
Right O
lower O
extremity O
with O
a O
1.6 O
cm O
x O
1.6 O
cm O
black O
eschar O
to O
be O
great O
toe O
. O
 
Lesion O
is O
soft O
. O
 
It O
is O
unclear O
if O
there O
is O
significant O
tracking O
beneath O
the O
surface O
. O
 
A O
3 O
cm O
x O
2 O
cm O
flat O
based O
ulcer O
with O
surrounding O
callus O
formation O
is O
noted O
to O
be O
ball O
of O
the O
right O
foot O
with O
some O
granulation O
and O
no O
drainage O
. O
 
A O
collar O
is O
noted O
. O
 
No O
surrounding O
erythema O
is O
appreciated O
. O
 
Dorsalis O
pedis O
and O
posterior O
tibial O
pulses O
are O
palpable O
but O
clearly O
diminished O
. O
 
Assessment O
and O
plan O
: O
This O
is O
a O
60 I-AGE
year O
old O
gentleman O
with O
multiple O
medical O
issues O
including O
end-stage O
renal O
disease O
my O
for O
regurgitation O
, O
congestive O
heart O
failure O
, O
severe O
peripheral O
neuropathy O
, O
diabetes O
. O
 
Present O
in O
with O
two O
large O
altars O
to O
the O
right O
lower O
extremity O
. O
 
He O
is O
status O
post O
hospitalization O
and O
some O
debridement O
and O
appears O
to O
have O
had O
little O
overall O
improvement O
in O
clinical O
status O
. O
 
I O
will O
proceed O
with O
an O
aggressive O
outpatient O
treatment O
plan O
however O
I O
suspect O
that O
he O
will O
need O
inpatient O
admission O
once O
again O
if O
significant O
improvement O
is O
not O
rapidly O
obtained O
. O
 
A O
referral O
has O
been O
made O
to O
the O
Island I-LOCATION
Medical I-LOCATION
Center I-LOCATION
wound O
clinic O
for O
this O
Tuesday I-DATE
. O
 
Visiting O
nurse O
has O
been O
arranged O
for O
his O
home O
for O
wound O
care O
in O
the O
interim O
. O
 
He O
is O
advised O
to O
avoid O
all O
weight-bearing O
and O
to O
keep O
his O
foot O
dressed O
at O
all O
times O
. O
 
I O
have O
explained O
to O
the O
patient O
that O
he O
is O
at O
risk O
of O
amputation O
of O
at O
least O
his O
right O
great O
toe O
should O
his O
healing O
not O
improve O
. O
 
With O
regards O
to O
his O
other O
medical O
issues O
, O
he O
continues O
on O
dialysis O
. O
 
I O
have O
asked O
for O
a O
hemoglobin O
A1c O
and O
fasting O
cholesterol O
to O
be O
drawn O
at O
the O
time O
of O
his O
dialysis O
tomorrow O
. O
 
I O
'll O
see O
the O
patient O
on O
Tuesday I-DATE
. O
 
His O
blood O
pressure O
is O
appropriately O
controlled O
and O
he O
is O
no O
stigmata O
of O
congestive O
heart O
failure O
At O
today O
's O
visit O
, O
the O
patient O
's O
wound O
was O
dressed O
and O
cleaned O
the O
our O
nursing O
staff O
 
Record O
date O
: O
2069-04-16 I-DATE
Patient O
Name O
: O
OGRADY O
, O
ULYSSES O
[ O
0937884 I-ID
( O
IMC I-LOCATION
) O
] O
Date O
of O
Visit O
: O
04/16/2069 I-DATE
Renal O
Staff O
Patient O
seen O
and O
examined O
on O
dialysis O
. O
 
Agree O
with O
details O
per O
Fellow O
Note O
. O
 
62 I-AGE
year O
old O
man O
referred O
to O
ED O
after O
missing O
dialysis O
yesterday O
and O
noted O
to O
be O
mentally O
confused O
. O
 
On O
presentation O
he O
was O
hyperkalemic O
to O
7.4 O
. O
 
He O
has O
been O
evaluated O
in O
ED O
setting O
with O
negative O
head O
CT O
and O
LP O
. O
 
Family O
reports O
h/o O
poor O
compliance O
and O
self O
care O
deficit O
. O
 
PMH/PSH O
: O
ESRD O
, O
presumed O
from O
HTN/DM O
, O
TTS O
, O
LUE O
AVF O
; O
initiated O
dialysis O
in O
2067 I-DATE
; O
has O
left O
arm O
AVF O
; O
HD O
at O
Eureka I-LOCATION
Springs I-LOCATION
Hospital I-LOCATION
- O
Dr O
Allan I-NAME
Jester I-NAME
is O
attending O
NephrologistHyperlipidemia O
Hypertension O
Obesity O
Diabetes O
mellitus O
: O
type O
2 O
, O
with O
tripothyNoncompliance O
Basal O
cell O
carcinoma O
: O
carcinoma O
of O
skin O
left O
cheekLower O
extremity O
ulcer O
: O
DIABETIC O
FOOT O
ULCER O
. O
 
L O
FootAbscess O
: O
Rt O
shin O
2062Back O
: O
11/64 I-DATE
. O
 
S/P O
I O
& O
amp O
; O
DMitral O
valve O
insufficiency O
: O
severe O
, O
with O
cardiomyopathy O
and O
EF O
36 O
% O
Colonic O
polyps O
: O
tubulovillious O
adenoma O
11/65 I-DATE
. O
 
Needs O
repeat O
scope O
11/66 I-DATE
Medications O
Insulin O
variable O
dosing O
Reportedly O
not O
taking O
other O
meds O
SOCIAL O
Lives O
in O
De I-LOCATION
Soto I-LOCATION
with O
Wife O
and O
Daughter O
ROS O
As O
detailed O
. O
 
He O
also O
has O
been O
c/o O
dizziness O
and O
weakness O
after O
dialysis O
, O
which O
was O
the O
main O
reason O
he O
refused O
to O
go O
for O
HD O
yesterday O
. O
 
No O
additional O
hx O
is O
available O
, O
no O
known O
sick O
contact O
per O
wife O
. O
 
When O
he O
was O
in O
ED O
, O
he O
was O
noted O
to O
have O
LGF O
100.4 O
, O
hypertensive O
and O
tachycardic O
. O
 
He O
is O
waiting O
for O
head O
CT O
and O
possible O
LP O
. O
 
EXAM O
T O
100.4 O
, O
P O
110 O
, O
BP O
150/80 O
, O
R O
26 O
, O
SO2 O
94 O
% O
( O
4L O
) O
NAD O
, O
limited O
cooperation O
with O
exam O
, O
A+O O
x2 O
CV O
: O
tachy/reg O
, O
no O
rubs O
CHEST O
: O
CTA O
ant O
ABD O
: O
soft O
, O
NT/ND/NABS O
EXT O
: O
1+ O
edema O
Neuro O
: O
nonfocal-limited O
exam O
DATAEKG O
is O
not O
available O
for O
review O
, O
but O
no O
acute O
ischemic O
changes O
and O
no O
widened O
QRS/peaked O
T O
wave O
per O
ED O
. O
 
PCXR O
: O
poor O
penetration O
, O
but O
no O
acute O
process O
Head O
CT O
IMPRESSION O
: O
1 O
. O
 
No O
hemorrhage O
, O
mass O
lesion O
, O
or O
evidence O
of O
acute O
territorial O
infarction O
. O
 
2 O
. O
 
Extensive O
nonspecific O
periventricular O
, O
deep O
, O
and O
subcortical O
white O
matter O
changes O
are O
likely O
sequela O
from O
chronic O
microangiopathic O
disease O
. O
 
3 O
. O
 
Old O
lacunar O
infarctions O
in O
the O
left O
caudate O
head O
and O
right O
caudate-anterior O
corona O
radiata O
. O
 
Evaluation O
for O
acute O
ischemia O
is O
limited O
in O
the O
areas O
of O
extensive O
white O
matter O
disease O
. O
 
Brain O
MRI O
with O
diffusion-weighted O
imaging O
is O
more O
sensitive O
in O
assessing O
for O
acute O
ischemia O
and O
should O
be O
obtained O
as O
clinically O
indicated O
. O
 
UA-SED-RBC O
20-50 O
( O
0-2 O
) O
/hpfUA-SED-WBC O
5-10 O
( O
0-2 O
) O
/hpfUA-SED-Bacteria O
Many O
( O
NEG O
) O
/hpf O
WBC O
20.7 O
H O
( O
4.5-11.0 O
) O
th/cmmHCT O
33.6 O
L O
( O
41.0-53.0 O
) O
% O
HGB O
11.3 O
L O
( O
13.5-17.5 O
) O
gm/dlRBC O
3.77 O
L O
( O
4.50-5.90 O
) O
mil/cmmPLT O
239 O
( O
150-400 O
) O
th/cumm O
Plasma O
Sodium O
133 O
L O
( O
135-145 O
) O
mmol/LPlasma O
Potassium O
7.4 O
H O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
94 O
L O
( O
100-108 O
) O
mmol/LPlasma O
Carbon O
Dioxide O
18.1 O
L O
( O
23.0-31.9 O
) O
mmol/LPlasma O
Anion O
GAP O
21 O
H O
( O
3-15 O
) O
mmol/LCalcium O
9.6 O
( O
8.5-10.5 O
) O
mg/dlPhosphorus O
7.3 O
H O
( O
2.6-4.5 O
) O
mg/dlMagnesium O
2.2 O
H O
( O
1.4-2.0 O
) O
meq/LPlasma O
Urea O
Nitrogen O
68 O
H O
( O
8-25 O
) O
mg/dlPlasma O
Creatinine O
9.18 O
H O
( O
0.60-1.50 O
) O
mg/dlAlbumin O
4.6 O
( O
3.3-5.0 O
) O
g/dlDirect O
Bilirubin O
0.5 O
H O
( O
0-0.4 O
) O
mg/dlTotal O
Bilirubin O
1.1 O
H O
( O
0.0-1.0 O
) O
mg/dlA+P O
1 O
. O
 
ESRD O
, O
with O
hyperkalemia O
2 O
. O
 
AMS O
, O
found O
down O
s/p O
LP O
with O
results O
pending O
and O
extensive O
CNS O
white O
matter O
changes O
3 O
. O
 
Medical O
noncompliance O
4 O
. O
 
Leukocytosis O
with O
infected O
leg O
ulcer O
and O
? O
 
cellulitis O
5 O
. O
 
Pyuria O
- O
Dialysis O
3 O
hrs O
1K O
, O
2.5Ca O
- O
UF O
2L O
- O
AVF O
access O
- O
Hold O
Epogen O
today O
- O
F/U O
LP O
results O
- O
Blood O
Cultures O
on O
dialysis O
; O
wound O
culture O
, O
urine O
culture O
- O
Vancomycin O
1g O
post O
dialysis O
; O
Levofloxacin O
500mg O
qod O
- O
cycle O
cardiac O
enzymes O
- O
Review O
outpatient O
medication O
regimen O
____________________________________ O
Kenneth I-NAME
DUSTIN I-NAME
Mcdaniel I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2069-10-07 I-DATE
IMC I-LOCATION
Odem I-LOCATION
IM O
Attending O
Medicine O
Consult O
NotePt O
: O
Ulysses I-NAME
OgradyIMC O
# O
0937884Date O
: O
10/07/69 I-DATE
Time O
: O
12:15pmPCP O
: O
Paul I-NAME
Jaramillo I-NAME
, O
MD O
Pager O
# O
52666 I-CONTACT
HPI O
: O
Asked O
to O
see O
patient O
by O
surgical O
team O
in O
consultation O
for O
is O
multiple O
medical O
issues O
. O
 
I O
have O
served O
as O
his O
PCP O
for O
eight O
years O
. O
 
Pt O
seen O
and O
examined O
. O
 
Case O
discussed O
in O
detail O
. O
 
This O
is O
a O
62 I-AGE
y/o O
male O
with O
multiple O
medical O
issues O
last O
admitted O
in O
September I-DATE
for O
increased O
falls O
, O
found O
to O
have O
a O
small O
stroke O
in O
addition O
to O
his O
likely O
vascular O
dementia O
. O
 
Readmitted O
last O
week O
in O
the O
setting O
of O
Purulent O
L O
foot O
ulcer/ O
S/P O
debridement O
and O
later O
TMA O
. O
 
He O
has O
a O
long O
history O
well O
documented O
in O
the O
electronic O
medical O
record O
which O
is O
notable O
for O
poor O
compliance O
with O
medication O
and O
follow-up O
. O
 
At O
baseline O
, O
patient O
has O
declined O
further O
cardiology O
workup O
for O
his O
severe O
mitral O
regurgitation O
and O
cardiomyopathy O
, O
has O
declined O
treatment O
for O
his O
hyperlipidemia O
and O
takes O
his O
blood O
pressure O
medications O
with O
less O
than O
25 O
% O
compliance O
. O
 
At O
the O
time O
of O
his O
last O
admission O
, O
he O
was O
actually O
admitted O
to O
a O
nursing O
home O
with O
plans O
for O
long O
term O
placement O
. O
 
The O
patient O
's O
wound O
has O
currently O
not O
been O
closed O
. O
 
He O
has O
a O
vac O
dressing O
in O
place O
. O
 
He O
has O
been O
attending O
dialysis O
per O
schedule O
of O
nephrology O
. O
 
Current O
hospital O
course O
has O
been O
complicated O
by O
increased O
agitation O
and O
last O
evening O
, O
self O
limited O
substernal O
chest O
pain O
and O
dyspnea O
. O
 
This O
resolved O
spontaneously O
. O
 
He O
has O
also O
been O
intermittently O
refusing O
his O
medications O
and O
has O
been O
attempting O
to O
ambulate O
. O
 
This O
AM O
. O
 
the O
patient O
actually O
denies O
ever O
experiencing O
chest O
pain O
. O
 
He O
also O
only O
recalls O
his O
foot O
pain O
with O
repeated O
prompting O
. O
 
He O
denies O
any O
pain O
, O
dyspnea O
ROS O
otherwise O
negative. O
, O
Past O
Medical O
History O
: O
Neuropathy O
Nephropathy O
: O
cr O
. O
 
2.6 O
. O
 
3.3 O
gm O
proteinuria O
. O
 
Currently O
on O
hemodialysisHyperlipidemia O
Hypertension O
Obesity O
Diabetes O
mellitus O
: O
type O
2Noncompliance O
: O
poor O
complianceBasal O
cell O
carcinoma O
: O
carcinoma O
of O
skin O
left O
cheekLower O
extremity O
ulcer O
: O
DIABETIC O
FOOT O
ULCER O
. O
 
L O
FootAbscess O
: O
Rt O
shin O
2062 I-DATE
Back O
: O
11/64 I-DATE
. O
 
S/P O
I O
& O
amp O
; O
DMitral O
valve O
insufficiency O
: O
severe O
, O
with O
cardiomyopathy O
and O
EF O
36 O
% O
Colonic O
polyps O
: O
tubulovillious O
adenoma O
11/65 I-DATE
. O
 
CAD O
: O
cath O
in O
2066 I-DATE
showed O
occluded O
mid O
LAD O
with O
collaterals O
. O
 
Stress O
test O
showed O
mid-distal O
anterior O
wall O
and O
apical O
ischemia O
. O
 
- O
Cardiomyopathy O
with O
EF=36 O
% O
, O
severe O
mitral O
regurg O
not O
on O
any O
SBE O
ppx O
Medications O
: O
As O
prescribed O
: O
Olanzapine O
5mg O
BID O
SQ O
Hepatin O
Toprol O
XL O
, O
50mg O
Lisinopril O
40mg O
po O
qd O
Vancomycin O
: O
dosed O
at O
dialysis O
RISS O
Oxycodone O
prn O
Simvastatin O
Levofloxacin O
Fluoxetine O
Nephocaps O
Calcium O
acetate O
. O
 
Allergies O
: O
NKDA O
Social O
History/FH O
per O
Surgical O
notes O
. O
 
Pt O
is O
a O
nonsmoker O
. O
 
No O
ETOH O
or O
Drug O
use O
hx O
. O
 
Formerly O
lived O
with O
daughter O
. O
 
Emigrated O
to O
tajikistan I-LOCATION
many O
years O
prior O
but O
still O
primarily O
speaks O
Chad I-LOCATION
. O
 
Examination O
: O
Modestly O
confused O
but O
not O
agitated O
. O
 
Does O
recognize O
PCP O
. O
 
Does O
not O
know O
date O
or O
time O
. O
 
Does O
not O
clearly O
know O
why O
he O
is O
hospitalized O
. O
 
VITALS O
: O
99.0 O
hr O
80-101 O
R O
BP O
150/76 O
.GEN O
& O
# O
8217 O
; O
L O
NAD O
, O
AO O
X O
2 O
( O
& O
# O
8220 O
; O
Superior I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
) O
HEENT O
MMM O
, O
no O
scleral O
icterus O
, O
no O
pale O
conjunctiva O
. O
 
No O
roth O
spots O
. O
 
NECK O
supple O
, O
no O
thyromegaly O
, O
no O
LAD O
, O
no O
carotid O
bruits O
. O
 
+ O
10cm O
JVOP O
Heart O
: O
RRR O
, O
no O
m/r/gLUNG O
: O
Bibasilar O
crackles O
. O
 
No O
wheezeABD O
: O
Soft O
, O
non-tender O
, O
obese O
, O
NABS O
. O
 
No O
HSM O
. O
 
No O
masses O
, O
no O
rebound O
. O
 
EXT O
: O
RLE O
in O
Vac O
dressing O
. O
 
Wound O
open O
without O
surrounding O
erythema.NEURO O
: O
AO O
x O
3 O
; O
alert O
; O
CN O
II-XII O
grossly O
intact O
; O
Motor O
: O
5/5 O
B O
UE/LE O
; O
sensation O
dinished O
to O
light O
tough O
, O
proprioception O
. O
 
Full O
neurologic O
eval O
per O
neurology O
assessment O
Data O
: O
Date/Time O
NA O
K O
CL O
CO2 O
10/07/2069 I-DATE
136 O
4.4 O
100 O
24.5 O
10/07/2069 I-DATE
138 O
4.7 O
100 O
26.4 O
10/06/2069 I-DATE
136 O
4.7 O
99 O
( O
L O
) O
26.6 O
10/06/2069 I-DATE
136 O
4.2 O
98 O
( O
L O
) O
Date/Time O
BUN O
CRE O
EGFR O
GLU O
10/07/2069 I-DATE
35 O
( O
H O
) O
6.64 O
( O
H O
) O
9 O
[ O
1 O
] O
124 O
( O
H O
) O
10/07/2069 I-DATE
35 O
( O
H O
) O
6.38 O
( O
H O
) O
9 O
[ O
2 O
] O
106 O
10/06/2069 I-DATE
34 O
( O
H O
) O
6.33 O
( O
H O
) O
10 O
[ O
3 O
] O
141 O
( O
H O
) O
Date/Time O
ANION O
10/07/2069 I-DATE
12 O
10/07/2069 I-DATE
12 O
10/06/2069 I-DATE
10 O
Date/Time O
CA O
PHOS O
MG O
ALB O
10/07/2069 I-DATE
8.5 O
5.0 O
( O
H O
) O
2.0 O
3.0 O
( O
L O
) O
10/07/2069 I-DATE
8.5 O
4.8 O
( O
H O
) O
2.0 O
10/06/2069 I-DATE
8.7 O
10/06/2069 I-DATE
8.4 O
( O
L O
) O
4.0 O
2.0 O
3.4 O
Date/Time O
25 O
OH-VITD O
10/02/2069 I-DATE
23 O
( O
L O
) O
[ O
13 O
] O
Date/Time O
CK O
CK-MB O
CKMBRI O
TROP-T O
10/07/2069 I-DATE
25 O
( O
L O
) O
2.7 O
SEE O
DETAIL O
[ O
14 O
] O
0.07 O
10/06/2069 I-DATE
32 O
( O
L O
) O
2.8 O
SEE O
DETAIL O
[ O
15 O
] O
0.08 O
Date/Time O
FE O
TIBC O
FER O
10/02/2069 I-DATE
23 O
( O
L O
) O
156 O
( O
L O
) O
501 O
( O
H O
) O
Date/Time O
PTH O
10/02/2069 I-DATE
66 O
( O
H O
) O
Date/Time O
WBC O
RBC O
HGB O
HCT O
10/07/2069 I-DATE
13.9 O
( O
H O
) O
3.42 O
( O
L O
) O
9.7 O
( O
L O
) O
29.4 O
( O
L O
) O
10/07/2069 I-DATE
16.4 O
( O
H O
) O
3.34 O
( O
L O
) O
9.6 O
( O
L O
) O
29.2 O
( O
L O
) O
10/06/2069 I-DATE
14.6 O
( O
H O
) O
3.58 O
( O
L O
) O
10.0 O
( O
L O
) O
31.2 O
( O
L O
) O
Date/Time O
MCV O
MCH O
MCHC O
PLT O
10/07/2069 I-DATE
86 O
28.2 O
32.9 O
372 O
10/07/2069 I-DATE
88 O
28.8 O
32.9 O
372 O
10/06/2069 I-DATE
87 O
28.0 O
32.1 O
Date/Time O
RETIC O
10/02/2069 I-DATE
1.6 O
Date/Time O
PT O
PT-INR O
PTT O
10/07/2069 I-DATE
17.6 O
( O
H O
) O
1.6 O
30.6 O
10/01/2069 I-DATE
17.3 O
( O
H O
) O
1.6 O
29.2 O
[ O
21 O
] O
Date/Time O
HBV-SAB O
HBV-SAG O
HCVAB O
10/02/2069 I-DATE
EQUIVOCAL O
Non-Reactive O
Non-Reactive O
Date/Time O
VANC O
TR-VANC O
10/07/2069 I-DATE
13.2 O
[ O
22 O
] O
10/04/2069 I-DATE
38.6 O
[ O
23 O
] O
Specimen O
Type O
: O
BLOOD O
CULTURE O
Few O
POLYS O
, O
Few O
MONONUCLEAR O
CELLS O
, O
Abundant O
GRAM O
NEGATIVE O
RODS O
, O
Rare O
LARGE O
GRAM O
POSITIVE O
RODS O
Wound O
Culture O
- O
Final O
Reported O
: O
06-Oct-69 I-DATE
14:55 O
Specimen O
received O
from O
OR O
Abundant O
KLEBSIELLA O
PNEUMONIAE O
RAPID O
MIC O
METHOD O
Antibiotic O
Interpretation O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
Amikacin O
Susceptible O
Ampicillin O
Resistant O
Aztreonam O
Susceptible O
Cefazolin O
Susceptible O
Cefepime O
Susceptible O
Ceftriaxone O
Susceptible O
Ciprofloxacin O
Susceptible O
Gentamicin O
Susceptible O
Levofloxacin O
Susceptible O
Piperacillin O
Resistant O
Trimethoprim/Sulfamethoxazole O
Susceptible O
Abundant O
PSEUDOMONAS O
AERUGINOSA O
DISK O
METHOD O
Antibiotic O
Interpretation O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
Aztreonam O
Susceptible O
Cefepime O
Susceptible O
Gentamicin O
Susceptible O
Levofloxacin O
Susceptible O
Piperacillin/Tazobactam O
Susceptible O
Ticarcillin O
Susceptible O
Tobramycin O
Susceptible O
Abundant O
MORGANELLA O
MORGANII O
SUBSPECIES O
MORGANII O
RAPID O
MIC O
METHOD O
Antibiotic O
Interpretation O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
Amikacin O
Susceptible O
Ampicillin O
Resistant O
Aztreonam O
Susceptible O
Cefazolin O
Resistant O
Cefepime O
Susceptible O
Ceftriaxone O
Susceptible O
Ciprofloxacin O
Susceptible O
Gentamicin O
Susceptible O
Levofloxacin O
Susceptible O
Piperacillin O
Susceptible O
Trimethoprim/Sulfamethoxazole O
Susceptible O
Anaerobic O
Culture O
- O
Preliminary O
Reported O
: O
06-Oct-69 I-DATE
11:48 O
Specimen O
received O
from O
OR O
NO O
ANAEROBES O
ISOLATED O
SO O
FAR O
EKG O
: O
NSR O
@ O
90 O
, O
incomplete O
RBBB O
, O
L O
anterior O
fascicular O
block O
; O
QTC O
495 O
ms. O
Assessment/Plan O
In O
summary,62 O
y/o O
male O
with O
multiple O
medical O
issues O
as O
outlined O
in O
this O
and O
many O
other O
notes O
. O
 
Presenting O
with O
necrotic O
foot O
infection O
, O
polymicrobial O
. O
 
S/P O
Rt O
TMA O
. O
 
Mildly O
delerious O
and O
certainly O
off O
from O
a O
baseline O
that O
was O
tenuous O
to O
start O
. O
 
By O
issue O
: O
1 O
) O
CAD O
: O
The O
patient O
does O
have O
CAD O
, O
MR O
and O
cardiomyopathy O
that O
are O
really O
not O
amenable O
to O
intervention O
, O
given O
patient O
noncompliance O
. O
 
The O
best O
goal O
at O
present O
is O
going O
to O
be O
continued O
medical O
management O
. O
 
If O
BP O
allows O
, O
could O
increase O
toprol O
XL O
, O
although O
I O
suspect O
that O
this O
will O
not O
be O
an O
option O
. O
 
In O
addition O
, O
would O
aim O
to O
keep O
even O
at O
dialysis O
. O
 
Certainly O
, O
cycle O
CKs O
and O
troponin O
and O
follow O
sx O
. O
 
I O
will O
defer O
to O
Dr. O
Shah I-NAME
, O
but O
I O
do O
n't O
see O
clear O
benefit O
for O
cardiac O
cath O
, O
especially O
as O
we O
are O
not O
going O
to O
proceed O
to O
valve O
repair O
at O
this O
juncture O
. O
 
If O
he O
were O
to O
become O
more O
compliant O
, O
this O
might O
be O
another O
consideration O
and O
as O
he O
is O
now O
a O
CT I-LOCATION
resident O
, O
perhaps O
this O
will O
be O
a O
future O
consideration O
. O
 
2 O
) O
Delirium O
: O
He O
does O
have O
a O
very O
tenuous O
baseline O
and O
has O
significant O
vascular O
dementia O
to O
start O
. O
 
He O
is O
off O
of O
this O
baseline O
, O
likely O
reflecting O
sundowning O
, O
medications O
and O
underlying O
metabolic O
processes O
. O
 
Please O
d/c O
medications O
that O
might O
be O
contributing O
to O
sx O
. O
 
Fluoxetine O
can O
be O
held O
for O
now O
as O
it O
was O
only O
started O
3 O
weeks O
prior O
. O
 
Might O
hold O
ranitidine O
as O
well O
. O
 
Haldol O
is O
d/cd O
in O
the O
setting O
of O
his O
prolonged O
QTc O
. O
 
Currently O
on O
olanzapine O
. O
 
Would O
continue O
to O
follow O
QTc O
closely O
and O
would O
d/c O
this O
med O
as O
well O
is O
still O
prolonged O
. O
 
Please O
send O
urine O
culture O
and O
surveillance O
blood O
cultures O
. O
 
3 O
) O
Infection O
: O
Appreciate O
excellent O
surgical O
management O
of O
patient O
's O
wound O
. O
 
Levofloxacin O
has O
been O
d/cd O
2nd O
to O
concerns O
for O
altered O
mental O
status O
. O
 
All O
bacteria O
are O
sensitive O
to O
aztreonam O
so O
perhaps O
this O
would O
be O
a O
reasonable O
alternative O
. O
 
Would O
seek O
ID O
input O
to O
the O
end O
. O
 
Wound O
care O
per O
vascular O
with O
plans O
for O
D/C O
when O
stable O
and O
return O
for O
closure O
in O
the O
future O
. O
 
4 O
) O
ESRD O
: O
Patient O
HAD O
dialysis O
today O
. O
 
Recs O
per O
nephrology O
3 O
) O
DM O
: O
HgA1c O
was O
at O
target O
. O
 
Please O
cover O
as O
needed O
with O
RISS O
for O
now O
. O
 
5 O
) O
Competency O
: O
certainly O
not O
able O
to O
make O
informed O
decisions O
at O
this O
time O
. O
 
Please O
confirm O
that O
his O
daughter O
is O
his O
HCP O
. O
 
Would O
try O
to O
use O
a O
Chadian I-LOCATION
interpreter O
and O
not O
daughters O
if O
at O
all O
possible O
. O
 
Thanks O
, O
____________________________________Paul O
Anthony I-NAME
Jaramillo I-NAME
, O
M.D.Pager O
# O
52666.Sheila O
Strong I-NAME
to O
cover O
for O
Thursday I-DATE
and O
Friday I-DATE
 
Record O
date O
: O
2069-03-26 I-DATE
Problems O
Diabetes O
mellitus O
Taking O
meds O
below O
, O
HbA1C O
not O
incontrol O
at O
last O
measure O
. O
 
Hypertension O
On O
meds O
below O
, O
feels O
tired O
. O
 
Coronary O
artery O
disease O
No O
chest O
pain O
. O
 
Had O
both O
exercise O
stress O
test O
and O
dobutamine O
echo O
showing O
borderline O
inferior O
thinning O
. O
 
Seeing O
Dr. O
Ily I-NAME
Light I-NAME
. O
 
Had O
episode O
of O
A O
flutter O
last O
month O
in O
setting O
of O
chest O
pain O
and O
snow O
shovelling O
. O
 
Easily O
converted O
in O
hospital O
. O
 
Now O
on O
Coumadin O
for O
another O
2 O
wks O
. O
 
Atrial O
flutter O
: O
Converted O
to O
NSR O
See O
above O
. O
 
Hyperlipidemia O
: O
Syndrome O
X O
Low O
HDL O
, O
high O
triglycerides O
, O
abd O
obesity O
, O
Type O
2 O
DM O
. O
 
Now O
starting O
to O
exercise O
regularly O
and O
diet O
. O
 
Medications O
ALLOPURINOL O
300MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Potassium O
Citrate O
1020 O
MG O
PO O
TID O
PRN O
kidney O
stones O
: O
Takes O
usually O
for O
4 O
days O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
81MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Viagra O
( O
SILDENAFIL O
) O
100MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
x1 O
Zestril O
( O
LISINOPRIL O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Micronase O
( O
GLYBURIDE O
) O
5MG O
, O
1.5 O
Tablet O
( O
s O
) O
PO O
BID O
x O
30 O
day O
( O
s O
) O
Glucophage O
( O
METFORMIN O
) O
1000MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
day O
( O
s O
) O
ATENOLOL O
50MG O
, O
1.5 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Coumadin O
( O
WARFARIN O
Sodium O
) O
5MG O
, O
1.5 O
Tablet O
( O
s O
) O
PO O
QPM O
x O
30 O
day O
( O
s O
) O
Lopid O
( O
GEMFIBROZIL O
) O
600MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
30 O
day O
( O
s O
) O
Narrative O
History O
Here O
for O
monitoring O
of O
above O
. O
 
Got O
event O
monitor O
from O
Ilya I-NAME
Light I-NAME
for O
occ O
palps O
. O
 
Past O
Medical O
History O
L O
Bell O
's O
2064 I-DATE
saw O
Dr. O
Quint I-NAME
, O
L O
eye O
still O
tears O
. O
 
Umbilical O
hernia O
. O
 
Saw O
Dr. O
Umstead I-NAME
, O
said O
to O
just O
watch O
it O
. O
 
Records O
received O
from O
Dr. O
Alcala I-NAME
via O
Dr. O
Adams I-NAME
. O
 
2064 I-DATE
value O
for O
HbA1C O
was O
9.1 O
, O
BP O
10/31/64 I-DATE
was O
190/105 O
. O
 
EKG O
WNL O
. O
 
Records O
from O
Dr. O
Quint I-NAME
and O
Dr. O
Faust I-NAME
re O
Bell O
's O
and O
stones O
. O
 
On O
Urocit O
and O
allopurinol O
. O
 
Health O
Maintenance O
Cholesterol O
02/23/2069 I-DATE
182 O
DESIRABLE O
: O
< O
200 O
Rectal O
exam O
03/22/2068 I-DATE
Prostate O
normal O
size O
and O
consistency O
. O
 
No O
masses O
or O
tenderness O
. O
 
M-alb/creat O
ratio O
03/25/2068 I-DATE
120.5 O
PERFORMED O
AT O
HOLLY I-LOCATION
MANOR I-LOCATION
NURSING I-LOCATION
HOME I-LOCATION
( O
NOTE O
) O
Reference O
Range O
: O
< O
30.0 O
mg/g O
creatinine O
EKG O
03/02/2069 I-DATE
RBBB O
, O
otherwise O
normal O
UA-Protein O
04/16/2066 I-DATE
NEGATIVE O
Ophthal O
Exam O
07/03/2067 I-DATE
Done O
elsewhere O
HBA1C O
03/23/2068 I-DATE
10.30 O
Microalbumin O
03/25/2068 I-DATE
20.0 O
PERFORMED O
AT O
HOLLY I-LOCATION
MANOR I-LOCATION
NURSING I-LOCATION
HOME I-LOCATION
( O
NOTE O
) O
Reference O
Range O
: O
Random O
urine O
< O
2.0 O
mg/dL O
24 O
hr O
urine O
< O
300 O
mg/24 O
hr O
Allergies O
Penicillins O
- O
Rash O
: O
2061 I-DATE
. O
 
Social O
History O
Married O
. O
 
Lives O
with O
wife O
. O
 
Sexually O
active O
, O
usually O
needs O
Viagra O
. O
 
Communications I-PROFESSION
senior I-PROFESSION
manager I-PROFESSION
, O
marketing I-PROFESSION
, O
worked O
for O
Brinker I-LOCATION
International I-LOCATION
, O
now O
Facebook I-LOCATION
. O
 
Then O
Twitter I-LOCATION
. O
 
Now O
about O
to O
start O
job O
as O
securities I-PROFESSION
investment I-PROFESSION
dealer I-PROFESSION
. O
 
Review O
of O
Systems O
General O
- O
Neg O
Eyes O
- O
see O
above O
Ears O
- O
ext O
ear O
infs O
from O
swimming O
, O
wears O
wax O
earplugs O
Mouth O
- O
Neg O
Heart O
and O
Lungs O
- O
Had O
chest O
pain O
, O
stress O
test O
done O
at O
Delnor I-LOCATION
, O
2067 I-DATE
, O
neg O
. O
 
Occ O
feels O
skipped O
beat O
. O
 
Adm O
in O
Feb I-DATE
2069 I-DATE
for O
A O
flutter O
, O
see O
above O
. O
 
GI O
- O
Neg O
GU O
- O
impotence O
, O
needs O
Viagra O
. O
 
Musc-skel O
- O
elbows O
bother O
him O
at O
times O
, O
after O
lifting O
. O
 
Skin O
- O
legs O
stasis O
dermatitis O
, O
has O
cream O
that O
helps O
. O
 
Steroid O
. O
 
Neuro O
- O
Bell O
's O
in O
past O
. O
 
Emotional O
- O
Neg O
Endocrine O
- O
DM O
Hematologic O
- O
Neg O
Vital O
Signs O
BLOOD O
PRESSURE O
130/70 O
PULSE O
80 O
TEMPERATURE O
97.8 O
WEIGHT O
263 O
lb O
Physical O
Exam O
Skin O
- O
stasis O
dermatitis O
changes O
, O
tr O
edema O
both O
lower O
legs O
. O
 
Neck O
- O
no O
adenopathy O
, O
thy O
normal O
, O
carotids O
2+ O
without O
bruit O
. O
 
JVP O
< O
5 O
cm O
. O
 
Lungs O
- O
clear O
to O
P O
& O
A O
. O
 
Heart O
- O
S1S2 O
normal O
, O
no O
murmur O
, O
rub O
, O
gallop O
. O
 
Abd O
- O
BS O
normal O
. O
 
No O
LSKK O
, O
masses O
, O
hernias O
, O
tenderness O
, O
aneurysm O
. O
 
Feet O
- O
no O
sores O
. O
 
Assessment O
DM O
- O
not O
well O
controlled O
in O
past O
. O
 
CAD O
- O
stable O
. O
 
Atr O
flutter O
- O
resolved O
. O
 
PVCs O
. O
 
Hchol O
. O
 
Counseling O
On O
DM O
care O
, O
importance O
of O
controlling O
blood O
sugar O
, O
wt O
reduction O
, O
need O
for O
regular O
follow-up O
to O
work O
on O
controlling O
above O
. O
 
Plan O
Ret O
1 O
mo O
. O
 
PT/INR O
, O
lipids O
, O
AST O
, O
HbA1C O
. O
 
Continue O
above O
meds O
. O
 
Record O
date O
: O
2070-02-14 I-DATE
Patient O
Name O
: O
VERA O
, O
XANDER O
N I-NAME
[ O
2152363 I-ID
( O
BMH I-LOCATION
) O
] O
Problems O
Diabetes O
mellitus O
On O
meds O
below O
. O
 
Missed O
earlier O
appointment O
. O
 
Last O
fasting O
sugar O
was O
140 O
. O
 
Hypertension O
On O
meds O
below O
, O
no O
side O
effects O
. O
 
Kidney O
stone O
: O
Uric O
acid O
No O
episodes O
of O
colic O
. O
 
Has O
small O
stones O
on O
CT O
one O
year O
ago O
. O
 
Atrial O
flutter O
: O
Converted O
to O
NSR O
No O
symptomatic O
palpitations O
. O
 
No O
chest O
pains O
. O
 
Off O
Coumadin O
. O
 
Hyperlipidemia O
: O
Syndrome O
X O
Taking O
statin O
and O
fibrate O
, O
no O
myalgias O
, O
weakness O
, O
abdominal O
pain O
or O
anorexia O
. O
 
Medications O
Zestril O
( O
LISINOPRIL O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
ALLOPURINOL O
300MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
81MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Glucophage O
( O
METFORMIN O
) O
1000MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
day O
( O
s O
) O
ATENOLOL O
50MG O
, O
1.5 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Lopid O
( O
GEMFIBROZIL O
) O
600MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
day O
( O
s O
) O
GLYBURIDE O
5MG O
, O
2 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
day O
( O
s O
) O
OMEPRAZOLE O
20MG O
, O
1 O
Capsule O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Urocit-k O
( O
POTASSIUM O
Citrate O
) O
10MEQ O
, O
1 O
Tablet O
( O
s O
) O
PO O
TID O
x O
30 O
day O
( O
s O
) O
PRN O
kidney O
stone O
Pravachol O
( O
PRAVASTATIN O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
x O
90 O
day O
( O
s O
) O
Valisone O
0.1 O
% O
( O
BETAMETHASONE O
Valerate O
0.1 O
% O
) O
LOTION O
TOP O
BID O
x O
90 O
day O
( O
s O
) O
Avandia O
( O
ROSIGLITAZONE O
) O
4MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
90 O
day O
( O
s O
) O
Tng O
0.4 O
Mg O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
Mg O
) O
) O
1 O
TAB O
SL O
x1 O
x O
90 O
day O
( O
s O
) O
PRN O
chest O
pain O
Narrative O
History O
Has O
seen O
urologist O
for O
erectile O
dysfunction O
since O
last O
visit O
. O
 
Is O
taking O
injections O
for O
impotence O
now O
. O
 
Past O
Medical O
History O
L O
Bell O
's O
2064 I-DATE
saw O
Dr. O
Quint I-NAME
, O
L O
eye O
still O
tears O
. O
 
Umbilical O
hernia O
. O
 
Saw O
Dr. O
Umstead I-NAME
, O
said O
to O
just O
watch O
it O
. O
 
On O
Urocit O
K O
and O
allopurinol O
. O
 
Takes O
former O
only O
when O
he O
is O
having O
a O
stone O
passage O
problem O
, O
because O
it O
upsets O
his O
stomach O
. O
 
CAD O
found O
in O
May I-DATE
. O
 
DM O
recently O
diagnosed O
. O
 
Longstanding O
Hchol O
on O
two O
drugs O
now O
. O
 
HT O
, O
good O
control O
. O
 
GERD O
, O
controlled O
on O
omeprazole O
. O
 
Stasis O
dermatitis O
, O
ankles O
. O
 
T. O
pedis O
with O
nail O
involvement O
. O
 
Health O
Maintenance O
EKG O
03/02/2069 I-DATE
RBBB O
, O
otherwise O
normal O
Ophthal O
Exam O
04/16/2069 I-DATE
No O
diabetic O
complications O
Done O
elsewhere O
Colonoscopy O
06/20/2068 I-DATE
Normal O
Cholesterol O
07/17/2069 I-DATE
164 O
M-alb/creat O
ratio O
03/25/2068 I-DATE
120.5 O
PERFORMED O
AT O
HOLLY I-LOCATION
MANOR I-LOCATION
NURSING I-LOCATION
HOME I-LOCATION
( O
NOTE O
) O
Reference O
Range O
: O
< O
30.0 O
mg/g O
creatinine O
UA-Protein O
04/16/2066 I-DATE
NEGATIVE O
HBA1C O
07/18/2069 I-DATE
9.50 O
Triglycerides O
07/17/2069 I-DATE
142 O
Cholesterol-LDL O
07/17/2069 I-DATE
104 O
Microalbumin O
03/25/2068 I-DATE
20.0 O
PERFORMED O
AT O
HOLLY I-LOCATION
MANOR I-LOCATION
NURSING I-LOCATION
HOME I-LOCATION
( O
NOTE O
) O
Reference O
Range O
: O
Random O
urine O
< O
2.0 O
mg/dL O
24 O
hr O
urine O
< O
300 O
mg/24 O
hr O
Hct O
( O
Hematocrit O
) O
02/22/2069 I-DATE
40.2 O
Cholesterol-HDL O
07/17/2069 I-DATE
32 O
Hgb O
( O
Hemoglobin O
) O
02/22/2069 I-DATE
13.8 O
Rectal O
exam O
03/22/2068 I-DATE
Prostate O
normal O
size O
and O
consistency O
. O
 
No O
masses O
or O
tenderness O
. O
 
Review O
of O
Systems O
General O
-obese O
, O
has O
not O
been O
able O
to O
lose O
weight O
. O
 
Heart O
and O
Lungs O
-see O
above O
. O
 
GI O
-heartburn O
, O
improved O
with O
omeprazole O
. O
 
GU O
-erectile O
dysfunction O
, O
history O
of O
kidney O
stones O
, O
none O
recently O
. O
 
Skin O
-feet O
much O
improved O
, O
seen O
podiatrist O
. O
 
Neuro O
- O
Neg O
Endocrine O
- O
AODM O
Habits O
Tob O
- O
Alc O
- O
Exercise O
- O
Vital O
Signs O
BLOOD O
PRESSURE O
140/80 O
TEMPERATURE O
97.5 O
F O
PULSE O
66 O
Physical O
Exam O
Lungs O
- O
clear O
to O
P O
& O
A O
. O
 
Heart O
- O
S1S2 O
normal O
, O
no O
murmur O
, O
rub O
, O
gallop O
. O
 
Abd O
- O
BS O
normal O
. O
 
No O
LSKK O
, O
masses O
, O
hernias O
, O
tenderness O
, O
aneurysm O
. O
 
Rectal O
- O
pros O
1+ O
, O
normal O
consistency O
, O
no O
masses O
or O
Feet O
- O
no O
edema O
or O
sores O
. O
 
Position O
, O
light O
touch O
intact O
. O
 
Assessment O
DM O
, O
fair O
control O
. O
 
Hchol O
. O
 
HT O
. O
 
GERD O
. O
 
Erectile O
dysfunction O
. O
 
Kidney O
stone O
. O
 
A O
flutter O
, O
no O
symptomatic O
recurrences O
since O
August I-DATE
. O
 
Plan O
Fasting O
lipids O
, O
CK O
, O
AST O
, O
HbA1C O
, O
chem O
8 O
, O
Ret O
3 O
mos O
. O
 
Continue O
above O
meds O
. O
 
All O
meds O
renewed O
. O
 
______________________________ O
Xavier I-NAME
Tristan I-NAME
Huerta I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2071-01-30 I-DATE
CARDIOLOGY O
BETHESDA I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
Xavier I-NAME
T I-NAME
Huerta I-NAME
M.D O
. O
 
BMH I-LOCATION
Health O
Associates O
583 I-LOCATION
Appaloosa I-LOCATION
Place I-LOCATION
CHESTERTOWN I-LOCATION
, O
NY I-LOCATION
91987 I-LOCATION
Dear O
Dr. O
Huerta I-NAME
: O
Reason O
for O
visit O
: O
Today O
, O
I O
had O
the O
pleasure O
of O
seeing O
Irving I-NAME
Vera I-NAME
in O
Cardiology O
clinic O
. O
 
He O
is O
a O
former O
patient O
of O
Dr. O
Ilya I-NAME
Light I-NAME
. O
 
He O
is O
a O
59-year-old O
man O
with O
diabetes O
type O
2 O
, O
hypertension O
, O
hypercholesterolemia O
, O
and O
mild O
coronary O
artery O
disease O
who O
had O
a O
brief O
episode O
of O
atrial O
flutter O
in O
2069 I-DATE
. O
 
He O
presented O
in O
2069 I-DATE
with O
chest O
pain O
and O
rapid O
heart O
rate O
following O
snow O
shoveling O
. O
 
He O
was O
found O
to O
be O
in O
atrial O
flutter O
with O
a O
rapid O
ventricular O
response O
. O
 
He O
was O
cardioverted O
two O
days O
later O
and O
has O
remained O
in O
sinus O
rhythm O
since O
then O
. O
 
Echocardiogram O
performed O
on O
02/22/2069 I-DATE
showed O
normal O
ejection O
fraction O
of O
72 O
% O
, O
borderline O
left O
atrium O
at O
43 O
mm O
, O
and O
no O
significant O
valvular O
abnormalities O
. O
 
Stress O
test O
performed O
on O
03/16/2069 I-DATE
showed O
5 O
minutes O
of O
exercise O
, O
7 O
METS O
, O
and O
a O
peak O
double O
product O
of O
22 O
, O
000 O
. O
 
He O
had O
no O
EKG O
changes O
, O
and O
a O
small O
mild O
posterobasilar O
defect O
suggestive O
of O
a O
very O
limited O
area O
of O
mild O
ischemia O
. O
 
The O
patient O
has O
been O
managed O
medically O
since O
then O
. O
 
He O
has O
used O
an O
event O
monitor O
and O
since O
then O
has O
not O
had O
any O
subsequent O
episodes O
of O
atrial O
flutter O
or O
fibrillation O
. O
 
The O
patient O
has O
been O
doing O
well O
over O
the O
past O
several O
months O
. O
 
Currently O
, O
he O
exercises O
once O
or O
twice O
a O
week O
by O
swimming O
30 O
minutes O
in O
a O
pool O
. O
 
A O
few O
months O
ago O
, O
he O
was O
exercising O
almost O
everyday O
. O
 
His O
weight O
has O
been O
up O
and O
down O
. O
 
He O
does O
not O
complain O
of O
any O
chest O
pain O
, O
shortness O
of O
breath O
, O
or O
other O
symptoms O
. O
 
Occasionally O
in O
the O
morning O
when O
he O
takes O
his O
pulse O
, O
he O
notices O
a O
skipped O
beat O
. O
 
I O
have O
reassured O
him O
that O
this O
is O
not O
a O
cause O
for O
concern O
. O
 
Past O
medical O
history O
: O
Diabetes O
, O
hypertension O
, O
hypercholesterolemia O
, O
atrial O
flutter O
as O
above O
, O
coronary O
artery O
disease O
as O
above O
, O
Bell O
's O
palsy O
with O
residual O
left O
eye O
tearing O
, O
kidney O
stones O
, O
and O
glaucoma O
. O
 
Current O
Medications O
: O
lisinopril O
20 O
mg O
QD O
Glucophage O
1 O
g O
BID O
glyburide O
10 O
mg O
BID O
atenolol O
50 O
mg O
QAM O
; O
Dir O
: O
and O
25 O
mg O
QPM O
Lopid O
600 O
mg O
BID O
allopurinol O
300 O
mg O
QD O
omeprazole O
20 O
mg O
QD O
aspirin O
81 O
mg O
QD O
Pravachol O
80 O
mg O
QD O
Avandia O
8 O
mg O
QD O
Allergies O
: O
Penicillin O
allergy O
Penicillin O
and O
erythromycin O
, O
causing O
rash O
. O
 
Family O
history O
: O
Not O
significant O
for O
coronary O
artery O
disease O
. O
 
Social O
history O
: O
Former O
tobacco O
user O
, O
works O
part O
time O
in O
securities I-PROFESSION
. O
 
Review O
of O
systems O
: O
As O
above O
, O
otherwise O
negative O
. O
 
Physical O
examination O
: O
-Pulse O
: O
60 O
-General O
: O
Obese O
talkative O
man O
in O
no O
distress O
-Chest O
: O
Lungs O
are O
clear O
bilaterally O
-Cardiac O
: O
JVP O
is O
7 O
cm O
with O
normal O
waveform O
. O
 
PMI O
is O
discrete O
and O
nondisplaced O
. O
 
Regular O
rate O
and O
rhythm O
with O
normal O
S1 O
and O
S2 O
. O
 
Soft O
2/6 O
holosystolic O
murmur O
heard O
at O
the O
lower O
left O
sternal O
border O
-Abdomen O
: O
Obese O
and O
tender O
-Extremities O
: O
Have O
trace O
edema O
with O
chronic O
venous O
stasis O
changes O
Selected O
recent O
labs O
: O
On O
06/18/2070 I-DATE
, O
total O
cholesterol O
168 O
, O
triglycerides O
104 O
, O
HDL O
38 O
, O
and O
LDL O
109 O
. O
 
His O
Pravachol O
dose O
has O
been O
increased O
since O
this O
time O
. O
 
Assessment O
and O
plan O
: O
This O
is O
a O
59-year-old O
man O
with O
metabolic O
syndrome O
, O
diabetes O
type O
2 O
, O
hyperlipidemia O
, O
hypertension O
, O
obesity O
, O
and O
mild O
coronary O
artery O
disease O
that O
has O
been O
medically O
managed O
. O
 
He O
is O
doing O
well O
. O
 
He O
had O
an O
episode O
of O
atrial O
flutter O
for O
two O
days O
in O
2069 I-DATE
but O
has O
not O
had O
any O
repeat O
episodes O
. O
 
He O
is O
currently O
not O
anticoagulated O
. O
 
Given O
new O
recommendations O
, O
his O
target O
LDL O
should O
be O
less O
than O
70 O
. O
 
He O
is O
due O
for O
a O
fasting O
lipid O
profile O
in O
one O
week O
. O
 
If O
his O
LDL O
is O
not O
below O
70 O
, O
then O
he O
should O
either O
be O
switched O
to O
Lipitor O
80 O
mg O
day O
or O
Zetia O
should O
be O
added O
to O
his O
present O
regimen O
. O
 
He O
is O
slightly O
hypertensive O
today O
with O
a O
blood O
pressure O
of O
140/75 O
. O
 
The O
patient O
will O
check O
his O
blood O
pressure O
at O
home O
since O
he O
is O
somewhat O
anxious O
male O
. O
 
In O
the O
office O
today O
, O
if O
his O
blood O
pressure O
remains O
elevated O
, O
then O
I O
will O
increase O
his O
lisinopril O
to O
30 O
mg O
a O
day O
. O
 
Otherwise O
, O
he O
is O
doing O
very O
well O
without O
any O
cardiac O
symptoms O
. O
 
Changes O
to O
Medications O
this O
visit O
lisinopril O
20 O
mg O
QD O
Glucophage O
1 O
g O
BID O
glyburide O
10 O
mg O
BID O
atenolol O
50 O
mg O
QAM O
and O
25 O
mg O
QPM O
Lopid O
600 O
mg O
BID O
allopurinol O
300 O
mg O
QD O
omeprazole O
20 O
mg O
QD O
aspirin O
81 O
mg O
QD O
Pravachol O
80 O
mg O
QD O
Avandia O
8 O
mg O
QD O
Thank O
you O
for O
allowing O
me O
to O
participate O
in O
the O
care O
of O
this O
patient O
. O
 
If O
you O
have O
any O
questions O
, O
please O
feel O
free O
to O
contact O
me O
. O
 
Steven I-NAME
Vega I-NAME
MD O
Signed O
electronically O
by O
Steven I-NAME
Vega I-NAME
MD O
on O
Feb I-DATE
3 O
, O
2071 I-DATE
 
Record O
date O
: O
2072-11-16 I-DATE
Internal O
Medicine O
JAR O
ADMIT O
NOTE O
Name O
: O
Xander I-NAME
Vera I-NAME
MR O
# O
: O
2152363 I-ID
Date O
of O
admission O
: O
11/16/2072 I-DATE
Attending O
: O
Hodges I-NAME
Cards O
Fellow O
: O
Steven I-NAME
Vega I-NAME
PCP O
: O
Dr. O
Xavier I-NAME
Huerta I-NAME
Code O
: O
FULL O
CC O
: O
SOB O
, O
LE O
edema O
HPI O
: O
60M O
with O
obesity O
, O
DM2 O
, O
HTN O
, O
hyperlipidemia O
, O
and O
stress O
test O
in O
2069 I-DATE
with O
mild O
posterobasal O
reversible O
defect O
managed O
medically O
sent O
to O
ED O
by O
PCP O
for O
LE O
edema O
and O
SOB O
. O
 
The O
patient O
reports O
several O
days O
of O
increasing O
LLE O
swelling O
and O
erythema O
. O
 
He O
presented O
to O
his O
PCP O
with O
a O
chief O
complaint O
of O
SOB O
, O
although O
he O
currently O
denies O
that O
. O
 
He O
has O
also O
apparently O
had O
intermittent O
left-sided O
chest O
pressure O
x O
1 O
day O
, O
which O
he O
also O
denies O
. O
 
+fevers O
at O
home O
to O
101 O
. O
 
No O
cough O
. O
 
No O
nausea/vomiting/diarrhea O
. O
 
No O
abdominal O
pain O
. O
 
No O
urinary O
symptoms O
. O
 
In O
ED O
: O
Febrile O
to O
103 O
. O
 
HR O
in O
90s O
. O
 
BP O
91-175/46-81 O
, O
R20s O
, O
95-100 O
% O
RA O
. O
 
EKG O
with O
baseline O
RBBB O
. O
 
Tn+ O
at O
0.44 O
. O
 
LENIs O
negative O
for O
DVT O
. O
 
CT O
PE O
negative O
for O
PE/DVT O
. O
 
Started O
on O
IV O
heparin O
. O
 
Vanco O
and O
levo O
. O
 
Mucomyst O
x1 O
dose O
. O
 
ASA O
325 O
. O
 
Lopressor O
25po O
. O
 
NSx O
1L O
. O
 
PMH O
: O
CAD O
-- O
3/69 I-DATE
ETT O
mibi O
METS O
7 O
, O
ECG O
non-dx O
due O
to O
submax O
HR O
, O
small O
, O
mild O
posterobasal O
defect O
which O
improves O
at O
rest O
suggestive O
for O
a O
very O
limited O
area O
of O
mild O
ischemia O
-- O
2/69 I-DATE
TTE O
EF O
72 O
% O
, O
no O
WMA O
, O
no O
valvular O
abnormalities O
, O
RVSP O
27 O
Diabetes O
mellitus O
type O
2 O
: O
7/72 I-DATE
HbA1c O
6.10 O
, O
+microalbuminuria O
, O
mild O
retinopathy O
Hypertension O
Hyperlipidemia O
: O
8/72 I-DATE
chol O
169 O
, O
Tgl O
67 O
, O
hdl O
37 O
, O
ldl O
119 O
Obesity O
OSA- O
recently O
started O
on O
home O
CPAP O
at O
12cmH20 O
H/o O
atrial O
flutter O
sp O
DCCV O
2069 I-DATE
, O
no O
anticoagulation O
RBBB O
Rectal O
bleeding O
: O
felt O
to O
be O
due O
to O
hemorrhoids O
Anemia O
: O
colonoscopy O
2068 I-DATE
wnl O
; O
6/72 I-DATE
Fe O
47 O
, O
TIBC O
464 O
, O
10 O
% O
sat O
, O
ferritin O
38 O
, O
b12 O
nl O
; O
7/72 I-DATE
bilis O
and O
SPEP O
normal O
; O
8/72 I-DATE
epo O
elevated O
Nephrolithiasis O
: O
uric O
acid O
Glaucoma O
Bells O
palsy O
Stasis O
dermatitis O
Tinea O
pedis O
Medications O
on O
admission O
( O
confirmed O
with O
patient O
) O
: O
Allopurinol O
300MG O
PO O
QD O
Asa O
81MG O
PO O
QD O
Atenolol O
75MG O
PO O
QD O
Avandia O
( O
ROSIGLITAZONE O
) O
8MG O
TABLET O
PO O
QD O
Clobetasol O
PROPIONATE O
0.05 O
% O
0.05 O
% O
CREAM O
( O
GM O
) O
TOP O
BID O
Glucophage O
( O
METFORMIN O
) O
1000MG O
PO O
BID O
Glyburide O
10MG O
TABLET O
PO O
BID O
Lopid O
( O
GEMFIBROZIL O
) O
600MG O
TABLET O
PO O
BID O
Multivitamin O
W/IRON O
1 O
TAB O
PO O
QD O
Omeprazole O
20MG O
CAPSULE O
CR O
PO O
QD O
Vytorin O
( O
80 O
simvastatin/10 O
zetia O
) O
PO O
QD O
Tng O
0.4 O
MG O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
MG O
) O
) O
1 O
TAB O
SL O
x1 O
PRN O
chest O
pain O
Urocit-k O
( O
POTASSIUM O
CITRATE O
) O
10MEQ O
TABLET O
CR O
PO O
TID O
PRN O
kidney O
stone O
Valisone O
0.1 O
% O
( O
BETAMETHASONE O
VALERATE O
0.1 O
% O
) O
LOTION O
TOP O
BID O
Vitamin O
B12 O
( O
CYANOCOBALAMIN O
) O
1000 O
MCG O
PO O
QD O
Zestril O
( O
LISINOPRIL O
) O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ALL O
: O
penicillins O
, O
erythromycins O
, O
tape O
rash O
SH O
: O
Married O
with O
5 O
adult O
children O
. O
 
Works O
in O
communications I-PROFESSION
. O
 
Denies O
tobacco/etoh/illicits O
. O
 
FH O
: O
Father O
with O
HTN O
, O
arrhythmia O
. O
 
Mother O
with O
DM O
, O
CAD O
. O
 
Sister O
and O
daugther O
w/ITP O
. O
 
Physical O
Exam O
: O
V O
: O
T O
99.2 O
, O
P72 O
, O
R18 O
, O
112/54 O
, O
98 O
% O
4L O
Gen O
: O
lying O
with O
eyes O
closed O
HEENT O
: O
PERRL O
, O
EOMI O
, O
OP O
clear O
, O
thick O
neck O
Neck O
: O
Supple O
, O
no O
thyromegaly O
, O
no O
carotid O
bruits O
, O
JVP O
8cm O
Nodes O
: O
No O
cervical O
or O
supraclavicular O
LAN O
Cor O
: O
RRR O
, O
nl O
S1 O
, O
S2 O
. O
 
No O
m/r/g O
. O
 
Distant O
heart O
sounds O
Chest O
: O
CTAB O
Abdomen O
: O
S/NT/ND O
, O
+BS O
. O
 
No O
HSM O
Ext O
: O
marked O
LLE O
erythema O
with O
warmth O
, O
2+ O
pitting O
edema O
; O
2+ O
pedal O
pulses O
bilat O
; O
chronic O
venous O
stasis O
Neuro O
: O
AAOx3 O
, O
CNII-XII O
intact O
, O
muscle O
strength/sensation O
intact O
Labs O
and O
Studies O
: O
Na O
137 O
, O
K O
3.7 O
, O
Cl O
107 O
, O
CO2 O
23.8 O
, O
BUN O
27 O
, O
Cr O
1.5 O
( O
baseline O
1.3-1.4 O
) O
, O
glu O
85 O
WBC O
15.2 O
w/ O
96 O
% O
polys O
, O
Hct O
30.6 O
( O
baseline O
33 O
) O
, O
MCV O
82 O
, O
RDW O
15.8 O
, O
Plt O
229 O
CK-MB O
, O
Tn-I O
POSITIVE O
at O
kiosk O
# O
1 O
CK O
347 O
, O
CK-MB O
11.5 O
, O
CKMBRI O
3.3 O
, O
Tn-T O
0.44 O
# O
2 O
CK O
663 O
, O
CK-MB O
15.7 O
, O
CKMBRI O
2.4 O
, O
Tn-T O
1.07 O
INR O
1.4 O
, O
PTT O
32.9 O
CXR O
: O
2 O
views O
, O
no O
pneumonia O
or O
CHF O
LENIs O
: O
no O
DVT O
bilaterally O
PECT O
: O
negative O
for O
PE/DVT O
UA O
: O
SG O
> O
1.030 O
, O
2+blood O
, O
3+protein O
, O
nit O
neg O
, O
0-5 O
RBC O
, O
3-5 O
WBC O
, O
few O
bact O
Blood O
cultures O
: O
gram O
+cocci O
in O
pairs O
and O
chains O
2/2 O
bottles O
EKG O
: O
NSR O
at O
74bpm O
, O
baseline O
RBBB O
, O
no O
ischemic O
changes O
A/P O
: O
60 I-AGE
yo O
man O
with O
metabolic O
syndrome O
presents O
with O
LLE O
edema O
and O
SOB O
with O
+troponin O
. O
 
Initially O
concerning O
for O
PE O
but O
ruled O
out O
with O
LENIs/CT O
scan O
. O
 
He O
does O
have O
a O
severe O
LLE O
cellulitis O
now O
with O
bacteremia O
likely O
due O
to O
strep O
. O
 
His O
cardiac O
enzymes O
continue O
to O
increase O
suggesting O
ongoing O
myocardial O
damage O
either O
from O
silent O
cardiac O
ischemia O
or O
demand O
from O
fever/tachycardia O
. O
 
Could O
also O
consider O
endomyocarditis O
secondary O
to O
bactermia O
. O
 
ISCHEMIA O
-cont O
ASA O
, O
BB O
, O
heparin O
, O
statin O
-plan O
for O
cardiac O
cath O
to O
r/o O
flow-limiting O
CAD O
, O
although O
likely O
delayed O
due O
to O
bactermia O
-check O
TTE O
r/o O
endocarditis O
-cont O
to O
cycle O
cardiac O
enzymes O
-follow O
EKGs O
BACTEREMIA O
-Likely O
seeded O
blood O
stream O
from O
cellulitis O
due O
to O
strep O
, O
must O
also O
consider O
enterococcus O
-Minimal O
response O
to O
vanco O
overnight O
-gentamicin O
x O
1 O
dose O
to O
cover O
anaerobes/GN O
-consider O
VRE O
, O
? O
source O
-surveillance O
cultures O
-TTE O
as O
above O
DM O
-hold O
oral O
hypoglycemics O
for O
now O
-RISS O
coverage O
RENAL O
INSUFFICIENCY O
-creatinine O
mildly O
above O
baseline O
-high O
risk O
for O
contrast O
nephropathy O
given O
DM O
and O
underlying O
renal O
insufficiency O
-continue O
mucomyst O
and O
bicarb O
, O
especially O
with O
upcoming O
cath O
-follow O
renal O
function O
NUTRITION O
-cardiac O
, O
diabetic O
diet O
PPX O
-nexium O
, O
anticoagulation O
FULL O
CODE O
___________________________________________________________ O
Edan I-NAME
I. I-NAME
Frederick I-NAME
, O
MD O
Pager O
00212 I-CONTACT
PGY-2 O
Medicine O
 
Record O
date O
: O
2073-02-07 I-DATE
Internal O
Medicine O
JAR O
Admit O
Note O
Pt O
: O
Xander I-NAME
Vera I-NAME
MR O
# O
: O
2152363 I-ID
Date O
of O
Admission O
: O
2/7/73 I-DATE
Attending O
: O
Alton I-NAME
Uher I-NAME
PCP O
: O
Richard O
Huerta I-NAME
Contact O
: O
Molly I-NAME
Vera I-NAME
( O
Wife O
) O
371-514-1494 I-CONTACT
Code O
: O
Full O
Code O
CC/RFA O
: O
Pt O
is O
a O
61-year-old O
man O
w/ O
CAD O
, O
DM O
, O
HTN O
hypercholesterolemia O
and O
recurrent O
atrial O
flutter O
admitted O
for O
atrial O
flutter O
ablation O
. O
 
HPI O
: O
Pt O
s O
cardiac O
hx O
begins O
in O
2069 I-DATE
when O
he O
presented O
with O
chest O
pain O
and O
palpitations O
while O
shoveling O
snow O
and O
was O
found O
to O
be O
in O
atrial O
flutter O
. O
 
Pt O
was O
subsequently O
cardioverted O
to O
NSR O
. O
 
Pt O
did O
well O
post O
cardioversion O
. O
 
He O
was O
suffered O
NSTEMI O
in O
11/72 I-DATE
in O
the O
setting O
of O
bactermia O
and O
Streptococcal O
cellulitis O
. O
 
Coronary O
angiography O
showed O
diffuse O
non-critical O
disease O
; O
decision O
was O
made O
to O
manage O
CAD O
medically O
. O
 
Pt O
was O
found O
to O
be O
in O
atrial O
flutter O
on O
follow O
up O
visit O
with O
cardiology O
. O
 
He O
was O
referred O
to O
Dr. O
Uher I-NAME
in O
appx O
two O
weeks O
prior O
to O
admission O
, O
who O
recommended O
radiofrequency O
ablation O
of O
atrial O
flutter O
. O
 
Pt O
underwent O
radiofrequency O
ablation O
of O
atrial O
flutter O
on O
2/7/73 I-DATE
. O
 
The O
procedure O
was O
was O
successful O
and O
the O
patient O
was O
transferred O
to O
the O
floor O
in O
normal O
sinus O
rhythm O
. O
 
He O
has O
no O
complaints O
and O
specifically O
reports O
no O
CP/SOB/palpitations O
. O
 
PMH O
: O
Coronary O
artery O
disease O
Diabetes O
Hypertension O
Hypercholesterolemia O
Atrial O
flutter O
. O
 
Hx O
Bell O
s O
palsy O
: O
residual O
left O
eye O
tearing O
thought O
to O
be O
due O
to O
aberrant O
reinnervation O
Kidney O
stones O
Glaucoma O
Mild O
renal O
failure O
Cardiac O
Hx/Risk O
Factors O
: O
Echocardiogram O
( O
11/72 I-DATE
) O
: O
EF O
71 O
% O
; O
left O
ventricular O
function O
normal O
with O
symmetric O
hypertrophy O
; O
minimal O
valvular O
disease O
Stress O
Test O
( O
3/69 I-DATE
) O
: O
normal O
exercise O
capacity O
( O
METS O
achieved O
= O
7 O
. O
 
) O
; O
ECG O
response O
to O
stress O
was O
nondiagnostic O
for O
ischemia O
; O
myocardial O
perfusion O
scan O
show O
a O
small O
, O
mild O
posterobasal O
defect O
which O
improves O
at O
rest O
suggestive O
for O
a O
very O
limited O
area O
of O
mild O
ischemia O
Cardiac O
Catheterization O
( O
11/72 I-DATE
) O
: O
Diffuse O
mild O
to O
moderate O
CAD O
: O
LMCA O
- O
20 O
% O
plaque O
; O
LAD O
- O
diffuse O
plaque O
; O
LCx O
- O
Diffuse O
plque O
in O
a O
small O
AV O
groove O
artery O
; O
RCA O
- O
patent O
proximally O
; O
calcified O
; O
Occluded O
right O
after O
take O
off O
of O
PDA O
, O
distal O
branches O
fill O
by O
collats O
from O
L O
Meds O
on O
Admission O
: O
1 O
. O
 
Atenolol O
PO O
50 O
MG O
BID O
2 O
. O
 
Lisinopril O
PO O
20 O
MG O
QD O
3 O
. O
 
Metformin O
PO O
1000 O
MG O
BID O
4 O
. O
 
Glimepiride O
PO O
1 O
MG O
QD O
5 O
. O
 
Rosiglitazone O
( O
Avandia O
) O
PO O
8 O
MG O
QD O
6 O
. O
 
Gemfibrozil O
( O
Lopid O
) O
PO O
600 O
MG O
BID O
7 O
. O
 
Ezetimibe O
And O
Simvastatin O
( O
Vytorin O
) O
po O
10mg/80mg O
qhs O
8 O
. O
 
Allopurinol O
300 O
mg O
QD O
9 O
. O
 
Furosemide O
PO O
20 O
MG O
QOD O
10 O
. O
 
Omeprazole O
PO O
20 O
MG O
QD O
11 O
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
PO O
81 O
MG O
QD O
12 O
. O
 
Cyanocobalamin O
( O
Vitamin O
B12 O
) O
PO O
1000 O
MCG O
QD O
13 O
. O
 
Coumadin O
( O
Warfarin O
Sodium O
) O
PO O
QPM O
14 O
. O
 
Ferrous O
Sulfate O
PO O
325 O
MG O
QD O
All O
: O
Clindamycin O
rash O
Azithromycin O
rash O
Erythromycin O
rash O
SHx O
: O
Pt O
lives O
with O
his O
wife O
in O
Guatemala I-LOCATION
City I-LOCATION
. O
 
He O
has O
five O
children O
. O
 
Former O
communications I-PROFESSION
manager I-PROFESSION
; O
currently O
works O
part O
time O
in O
securities I-PROFESSION
Tob O
: O
minimal O
past O
use O
EtOH O
: O
1 O
drink/wk O
Illicits O
: O
none O
FHx O
: O
Mother O
: O
CAD O
s/p O
CABG O
ROS O
: O
Ten O
point O
review O
of O
systems O
negative O
except O
as O
noted O
in O
HPI O
. O
 
Exam O
: O
Pt O
is O
a O
well O
appearing O
middle-aged O
man O
lying O
comfortably O
in O
bed O
VS O
: O
T- O
97 O
, O
HR- O
95 O
, O
BP- O
141/63 O
, O
RR- O
18 O
HEENT O
: O
MMM O
, O
w/o O
exudates O
. O
 
Neck O
: O
supple O
, O
NT O
, O
full O
ROM O
Chest O
: O
CTAB O
; O
no O
crackles O
, O
no O
wheezes O
CV O
: O
RRR O
; O
normal O
S1S2 O
, O
no O
m/r/g O
appreciated O
; O
JVP O
7cm O
; O
2+ O
carotids O
without O
bruit O
; O
2+ O
radial O
and O
DP O
pulses O
; O
R O
groin O
dressing O
w/ O
small O
amount O
of O
blood O
, O
pulse O
2+ O
, O
no O
obvious O
hematoma O
Abd O
: O
bruising O
across O
lower O
abdomen O
, O
NABS O
; O
soft O
, O
non-tender O
, O
distended O
; O
no O
organomegaly O
Nodes O
: O
no O
cervical O
LAD O
Extr O
: O
1+ O
bilateral O
lower O
extremity O
edema O
to O
knees O
with O
chronic O
erythematous O
skin O
changes O
, O
non O
tender O
Neuro O
: O
AOx3 O
, O
MS O
nl O
, O
CN O
II O
through O
XII O
intact O
, O
motor O
and O
sensory O
nonfocal O
EKG O
: O
NSR O
, O
RBBB O
________________________________________________________________________________ O
I/P O
: O
61M O
w/ O
CAD O
, O
DM O
, O
HTN O
, O
hyperlipidemia O
and O
atrial O
flutter O
s/p O
flutter O
ablation O
Atrial O
flutter O
: O
NSR O
s/p O
ablation O
Groin O
check O
every O
four O
hours O
; O
monitor O
for O
signs O
of O
tamponade O
; O
anticoagulation O
with O
Heparin/Coumadin O
bridge O
Ischemia O
Continue O
ASA O
, O
Atenolol O
HTN O
Continue O
Lisinopril O
DM O
Continue O
Metformin O
, O
Avandia O
, O
Glimepiride O
Hyperlipidemia O
Continue O
Gemfibrozil O
Nutrition O
: O
Cardiac O
Diet O
Therapists O
: O
None O
Access O
: O
Peripheral O
IV O
fluids O
: O
None O
Telemetry O
: O
Continuous O
Prophylaxis O
: O
Heparin O
/Coumadin O
, O
Nexium O
Code O
status O
: O
Full O
Code O
_______________________________ O
Andrew I-NAME
Kendrick I-NAME
, O
M.D O
. O
 
( O
pager O
# O
99225 I-CONTACT
) O
 
Record O
date O
: O
2088-06-26 I-DATE
Personal O
Data O
and O
Overall O
Health O
66 I-AGE
year O
old O
white O
female O
scheduled O
for O
surgery O
on O
July I-DATE
1st I-DATE
. O
 
Chief O
Complaint O
The O
patient O
is O
scheduled O
for O
bone-muscle O
graft O
from O
the O
fibula O
to O
the O
right O
arm O
. O
 
History O
of O
Present O
Illness O
The O
patient O
complains O
of O
a O
nonunion O
fx O
of O
the O
right O
arm O
in O
January I-DATE
2087 I-DATE
. O
 
Past O
Surgical O
History O
Prior O
surgery O
includes O
: O
10 O
procedurews O
on O
the O
right O
arm O
, O
colectomy O
, O
brain O
tumor O
. O
 
General O
anesthesia O
for O
all O
procedures O
without O
problems O
. O
 
Family O
History O
There O
in O
no O
family O
history O
of O
adverse O
reactions O
to O
general O
anesthesia O
. O
 
Past O
Medical O
History O
Current O
medical O
problems O
include O
: O
diabetes O
mellitus O
, O
pituitary O
adenoma O
, O
CAD O
, O
meningitis O
, O
fibromyalgia O
, O
severe O
fatty O
liver O
; O
see O
attached O
problem O
list O
. O
 
Social O
History O
Smoking O
: O
stopped O
15 O
years O
ago O
. O
 
Alcohol O
use O
: O
no O
history O
of O
excessive O
use O
Substance O
abuse O
: O
none O
Review O
of O
Systems O
Medications O
: O
Prilosec O
Vasotec O
Serzone O
Diflucan O
Lipitor O
Reglan O
Bactrim O
Synthroid O
Permpro O
Prednisone O
2.5 O
mg O
QD O
Valium O
Lancet O
Humulin O
NPH O
20 O
units O
BID O
Allergies O
: O
none O
Cardiovascular O
: O
no O
history O
of O
hypertension O
, O
no O
MI O
; O
hx O
of O
well O
controlled O
angina O
, O
uses O
NTG O
rarely O
, O
very O
little O
exercise O
, O
no O
ankle O
edema O
, O
syncope O
. O
 
Respiratory O
: O
no O
history O
of O
asthma O
or O
chronic O
lung O
disease O
; O
denies O
unusual O
shortness O
of O
breath O
; O
recent O
productive O
cough O
following O
URI O
, O
started O
on O
Levaquin O
. O
 
Neurological O
: O
hx O
of O
pituitary O
adenoma O
with O
hypophysectomy O
in O
2081 I-DATE
, O
no O
stroke O
Gastrointestinal O
: O
no O
history O
of O
PUD O
; O
denies O
reflux O
but O
is O
on O
Prilosec O
Hepatobiliary O
: O
history O
of O
liver O
disease O
with O
fatty O
liver O
, O
LFTs O
are O
normal O
at O
this O
time O
except O
for O
hypoalbuminemia O
; O
denies O
jaundice O
or O
hepatitis O
Renal/Genitourinary O
: O
no O
history O
of O
renal O
failure O
; O
denies O
hematuria O
, O
dysuria O
, O
obstructive O
uropathy O
Musculoskeletal O
: O
see O
PI O
Endocrine/metabolic O
: O
history O
of O
diabetes O
since O
hypophysectomy O
in O
2081 I-DATE
, O
BS O
~ O
100-150 O
; O
endocrinopathy O
with O
pan O
hypopit O
, O
T4 O
is O
low O
. O
 
Heme/Onc O
: O
no O
history O
of O
bleeding O
, O
blood O
diseases O
; O
no O
history O
of O
malignancy O
, O
chemotherapy O
, O
or O
radiation O
therapy O
Psychiatric O
: O
no O
significant O
psychiatric O
problems O
Exam O
Ht O
: O
68 O
'' O
Wt O
: O
224 O
# O
BP O
: O
106/58 O
P O
: O
88 O
SaO2 O
: O
98 O
% O
HEEN O
& O
T O
: O
good O
range O
of O
motion O
, O
no O
masses O
, O
neck O
veins O
flat O
, O
no O
bruits O
Airway O
: O
Mallampatti O
Class O
I O
or O
II O
Teeth O
: O
dentures O
Lungs O
: O
coarse O
rhonchi O
bilaterally O
Heart O
: O
regular O
rhythm O
, O
no O
murmurs O
, O
S1=S2 O
, O
no O
gallop O
Abdomen O
: O
not O
examined O
Extremities O
: O
not O
examined O
Assessment O
ASA O
Physical O
Status O
: O
III O
Well O
prepared O
for O
surgery O
; O
subacute O
respiratory O
infection O
is O
being O
treated O
with O
Levaquin O
. O
 
Consider O
delaying O
surgery O
if O
not O
improved O
by O
time O
of O
surgery O
. O
 
Plan O
Proposed O
Anesthetic O
: O
general O
anesthesia O
Monitors O
: O
standard O
Pain O
Management O
: O
IVPCA O
Autologous O
blood O
: O
none O
Premedication O
: O
none O
Usual O
Medications O
: O
take O
on O
day O
of O
surgery O
Medications O
to O
be O
held O
on O
day O
of O
surgery O
: O
none O
Diabetic O
medications O
: O
10 O
units O
NPH O
on O
am O
of O
surgery O
NSAIDS O
: O
avoid O
for O
3 O
days O
before O
surgery O
Aspirin O
: O
avoid O
for O
7 O
days O
before O
surgery O
NPO O
: O
after O
midnight O
Consider O
steroid O
supplement O
. O
 
Consider O
insulin O
infusion O
. O
 
External O
Labs O
She O
has O
had O
a O
stress O
test O
. O
 
I O
will O
try O
to O
get O
results O
from O
PCP O
. O
 
Attending O
Anesthesiologist O
Reassessment O
Note O
I O
have O
reviewed O
this O
preanesthetic O
assessment O
and O
concur O
with O
the O
assessment O
and O
recommended O
plan O
with O
the O
following O
exceptions O
: O
______________________________ O
Hunt O
, O
Xavier I-NAME
I. I-NAME
, O
MD O
 
Record O
date O
: O
2090-10-07 I-DATE
NAME O
: O
Olivo O
, O
Kimberly I-NAME
MRN O
: O
3299811 I-ID
INITIAL O
VISIT O
This O
is O
a O
69-year-old O
white O
female O
coming O
for O
her O
fu O
visit O
. O
 
The O
patient O
has O
a O
history O
of O
type O
II O
diabetes O
mellitus O
and O
pituitary O
adenoma O
and O
recently O
was O
hospitalized O
at O
American I-LOCATION
Legion I-LOCATION
Hospital I-LOCATION
with O
general O
malaise O
syndrome O
and O
back/chest O
pain O
. O
 
Initially O
the O
patient O
was O
seen O
at O
Neligh I-LOCATION
Clinic I-LOCATION
and O
cardiac O
ischemia O
was O
ruled O
out O
. O
 
She O
was O
found O
to O
have O
a O
blood O
pressure O
of O
250 O
systolic O
at O
Neligh I-LOCATION
Clinic I-LOCATION
associated O
with O
persistent O
headaches O
. O
 
She O
was O
transferred O
to O
American I-LOCATION
Legion I-LOCATION
Hospital I-LOCATION
after O
being O
found O
collapsed O
on O
the O
floor O
of O
the O
hospital O
bathroom O
. O
 
She O
was O
transferred O
to O
the O
Intensive O
Care O
Unit O
at O
Neligh I-LOCATION
Clinic I-LOCATION
and O
treated O
for O
tonic-clonic O
convulsions O
with O
diazepam O
and O
lorazepam O
. O
 
She O
also O
suffered O
a O
urinary O
tract O
infection O
in O
hospital O
, O
treated O
with O
Cipro O
. O
 
She O
was O
transferred O
to O
the O
American I-LOCATION
Legion I-LOCATION
Hospital I-LOCATION
on O
October I-DATE
02 O
, O
2089 I-DATE
, O
at O
which O
time O
she O
was O
awake O
but O
unable O
to O
give O
a O
history O
. O
 
On O
admission O
to O
American I-LOCATION
Legion I-LOCATION
Hospital I-LOCATION
she O
had O
a O
blood O
pressure O
of O
127/70 O
, O
pulse O
was O
80 O
, O
and O
temperature O
was O
99.3 O
. O
 
She O
had O
a O
myxedematous O
face O
and O
was O
obese O
. O
 
She O
was O
cardiovascularly O
stable O
. O
 
Neurologically O
, O
she O
was O
able O
to O
move O
all O
four O
extremities O
with O
good O
strength O
and O
symmetrical O
reflexes O
. O
 
Cranial O
nerves O
intact O
. O
 
Initially O
, O
the O
impression O
was O
that O
patient O
suffered O
seizure O
secondary O
to O
elevated O
blood O
pressure O
. O
 
Most O
likely O
, O
she O
suffered O
hypertensive O
encephalopathy O
. O
 
Patient O
underwent O
neurologic O
evaluation O
including O
MRA O
of O
the O
brain O
, O
lumbar O
puncture O
, O
both O
of O
which O
were O
negative O
. O
 
Electroencephalogram O
was O
performed O
and O
showed O
no O
epileptiform O
foci O
and O
diffuse O
temporal O
slowing O
bilaterally O
. O
 
The O
patient's O
alertness O
and O
responsiveness O
increased O
gradually O
during O
the O
hospital O
stay O
. O
 
She O
had O
an O
episode O
of O
chest O
pain O
which O
was O
associated O
with O
some O
ST O
flattening O
in O
the O
lateral O
leads O
. O
 
Acute O
cardiac O
event O
was O
ruled O
out O
. O
 
The O
patient O
underwent O
a O
course O
of O
physical O
therapy O
and O
then O
, O
finally O
, O
was O
transferred O
to O
a O
rehabilitation O
facility O
. O
 
A O
specific O
cause O
of O
the O
patient O
's O
seizure O
was O
not O
found O
although O
it O
was O
assumed O
that O
this O
might O
have O
been O
provoked O
by O
the O
hypertensive O
encephalopathy O
associated O
with O
use O
of O
ciprofloxacin O
for O
the O
treatment O
of O
the O
UTI O
which O
could O
have O
lowered O
her O
threshold O
for O
seizure O
activity O
. O
 
Upon O
discharge O
, O
the O
patient O
was O
in O
stable O
condition O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Remarkable O
for O
seizure O
, O
type O
II O
diabetes O
mellitus O
, O
panhypopituitarism O
secondary O
to O
pituitary O
surg O
, O
hypertension O
, O
right O
arm O
bone O
tumor O
excision O
associated O
with O
right O
radial O
neuropathy O
, O
and O
hyperlipidemia O
. O
 
MEDICATIONS O
: O
See O
LMR O
. O
 
FAMILY O
HISTORY O
: O
Negative O
. O
 
SOCIAL O
HISTORY O
: O
Denies O
alcohol O
intake O
, O
smoking O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Denies O
visual O
or O
hearing O
disturbance O
, O
headaches O
, O
weakness O
, O
numbness O
, O
seizure O
activity O
, O
chest O
pain O
, O
palpitations O
, O
syncope O
, O
dyspnea O
, O
wheezing O
, O
cough O
, O
coryza O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
constipation O
, O
abdominal O
pain O
. O
 
Positive O
for O
mild O
nocturia O
with O
no O
dysuria O
. O
 
No O
polydipsia O
. O
 
Positive O
mild O
paresthesias O
right O
upper O
extremity O
. O
 
Occasional O
mid-morning O
reactions O
. O
 
Home O
blood O
glucose O
monitoring O
b.i.d O
. O
 
with O
most O
glucose O
readings O
between O
100 O
and O
200 O
. O
 
Positive O
mild O
tiredness O
without O
any O
hoarseness O
, O
heat O
or O
cold O
intolerance O
. O
 
Mild O
arthralgia O
. O
 
No O
bleeding O
, O
rash O
, O
pruritus O
. O
 
Diet O
: O
Low O
salt O
. O
 
Mets O
2-3 O
. O
 
ALLERGIES O
: O
Sulfa O
, O
codeine O
, O
morphine O
. O
 
PHYSICAL O
EXAM O
: O
General O
appearance O
: O
Well-developed O
, O
well-nourished O
. O
 
Vital O
signs O
: O
Blood O
pressure O
130/80 O
, O
respiratory O
rate O
18 O
, O
heart O
rate O
76 O
, O
temperature O
afebrile O
. O
 
HEENT O
exam O
: O
No O
exophthalmos O
, O
no O
lid O
lag O
, O
equally O
reactive O
pupils O
, O
difficult O
to O
visualize O
fundi O
; O
pharynx O
clear O
; O
ears O
clear O
. O
 
Neck O
: O
No O
JVD O
, O
no O
bruits O
, O
thyroid O
within O
normal O
limits O
. O
 
Chest O
: O
Clear O
, O
no O
rales O
or O
wheezes O
. O
 
Heart O
sounds O
normal O
. O
 
No O
murmurs O
. O
 
Abdomen O
: O
Soft O
, O
nontender O
, O
no O
organomegaly O
. O
 
Extremities O
: O
No O
edema O
. O
 
Neuro O
: O
Awake O
and O
alert O
although O
at O
times O
forgets O
details O
of O
past O
history O
; O
no O
focal O
neurologic O
signs O
. O
 
A/P O
: O
1 O
. O
 
Type O
II O
diabetes O
mellitus.good O
control O
. O
 
Plan O
- O
Continue O
diet O
. O
 
2 O
. O
 
Panhypopituitarism O
secondary O
to O
pituitary O
surgery O
for O
pituitary O
adenoma O
. O
 
Need O
to O
obtain O
record O
from O
surgeon O
for O
details O
on O
what O
type O
of O
tumor O
this O
was O
. O
 
Patient O
on O
replacement O
therapy O
with O
levothyroxine O
and O
prednisone O
. O
 
She O
will O
continue O
both O
with O
the O
understanding O
that O
should O
she O
become O
sick O
for O
whatever O
reason O
she O
needs O
to O
double O
or O
triple O
dose O
her O
prednisone O
and O
contact O
me O
. O
 
She O
needs O
to O
wear O
a O
bracelet O
for O
this O
as O
well O
as O
for O
her O
diabetes O
. O
 
3 O
. O
 
Seizure O
disorder O
, O
? O
 
etiology O
. O
 
She O
saw O
the O
neurologist O
; O
she O
will O
need O
to O
remain O
on O
anti-seizure O
medications O
. O
 
4 O
. O
 
Hyperlipidemia O
: O
Plan O
- O
Check O
fast O
lipid O
profile O
. O
 
Discussed O
with O
Dr O
Xavier I-NAME
; O
P O
: O
: O
lipitor O
10 O
mg O
/d O
. O
 
5 O
Cryptogenic O
cirrhosis O
, O
LFT O
ok O
; O
discussed O
with O
Dr O
Xavier I-NAME
; O
no O
absolute O
contraindication O
to O
lipitor O
. O
 
6 O
? O
 
CAD O
x O
family O
; O
no O
clear O
documet O
; O
P O
: O
adenosine O
MIBI O
since O
pt O
is O
diabetic O
and O
unable O
to O
perform O
exercis O
eETT O
. O
 
WT O
loss O
? O
 
etiol O
; O
ct O
abd O
neg O
and O
cxr O
neg O
; O
P O
: O
colonoscopy O
. O
 
refuses O
vaccines O
To O
follow O
up O
in O
2 O
months O
. O
 
Isaac I-NAME
Ng I-NAME
, O
M.D O
. O
 
IN/rowe/yeater O
 
Record O
date O
: O
2091-12-16 I-DATE
Team O
D O
Intern O
Admission O
Note O
Patient O
Name O
Here O
: O
Olivo O
, O
Kimberly I-NAME
MR O
# O
3299811 I-ID
Location O
: O
Suite O
53-02Q O
Date O
of O
Admission O
: O
December I-DATE
15 O
, O
2091 I-DATE
PCP O
: O
Isaac I-NAME
Ng I-NAME
ID/CC O
: O
Change O
in O
mental O
status O
HPI O
: O
70 I-AGE
y/o O
Female O
with O
PMHx O
significant O
for O
Pituitary O
adenoma O
s/p O
resection O
, O
cryptogenic O
cirrhosis O
, O
presenting O
with O
confusion O
for O
the O
past O
3 O
days O
. O
 
Patient O
confused O
and O
unable O
to O
give O
history O
at O
time O
of O
admission O
. O
 
As O
per O
son O
and O
daughter O
, O
they O
have O
noticed O
increasing O
confusion O
and O
inappropriate O
behavior O
over O
the O
past O
3 O
days O
. O
 
They O
report O
that O
she O
has O
woken O
up O
in O
the O
middle O
of O
the O
night O
c/o O
feeling O
weak O
and O
confused O
. O
 
The O
first O
two O
nights O
, O
her O
son O
treated O
her O
initially O
with O
increasing O
lactulose O
administration O
when O
she O
would O
wake O
up O
at O
night O
( O
although O
it O
is O
unclear O
whether O
she O
had O
any O
increase O
in O
her O
stool O
) O
and O
he O
reports O
that O
she O
would O
behave O
better O
during O
the O
day O
. O
 
On O
the O
night O
prior O
to O
administration O
, O
the O
patient O
urinated O
in O
her O
bed O
at O
night O
and O
called O
her O
daughter O
on O
the O
phone O
in O
the O
middle O
of O
the O
night O
. O
 
She O
also O
forgot O
the O
names O
of O
her O
grandchildren O
. O
 
The O
son O
became O
worried O
about O
her O
behavior O
, O
contacted O
her O
PCP O
, O
and O
brought O
her O
to O
the O
ALH I-LOCATION
ED O
. O
 
The O
family O
reports O
that O
she O
experienced O
similar O
behavior O
prior O
to O
grand-mal O
seizures O
that O
were O
a O
consequence O
of O
uncontrolled O
hypertension O
about O
2 O
yrs O
ago O
. O
 
She O
also O
suffers O
from O
chronic O
UTI O
's O
and O
often O
becomes O
confused O
during O
times O
of O
infection O
. O
 
ED O
Course O
: O
Vitals O
T O
98.2 O
, O
HR O
64 O
, O
BP O
215 O
, O
115 O
, O
RR O
24 O
, O
Sa02 O
100 O
% O
NRB O
. O
 
Blood O
Pressure O
: O
Treated O
with O
labetalol O
10 O
mg O
IV O
x O
1 O
, O
Hydral O
10 O
mg O
IV O
x O
1 O
, O
decreased O
to O
176/74 O
. O
 
Hyponatremia O
: O
NS O
x O
1 O
L O
PMH O
: O
Pituitary O
adenoma O
2080 I-DATE
s/p O
resection O
, O
XRT O
Diabetes O
mellitus O
Type O
II O
- O
On O
Humulin O
15/15 O
Hypertension O
- O
on O
Avapro O
, O
allergy O
to O
Ace-I O
Angina O
pectoris O
- O
negative O
stress O
Seizure O
- O
According O
to O
discharge O
summaries O
in O
YPZ O
, O
patient O
had O
two O
episodes O
of O
general O
tonic-clonic O
seizures O
at O
OSH O
prior O
to O
transfer O
to O
ALH I-LOCATION
. O
 
Extensive O
neuro O
work-up O
at O
ALH I-LOCATION
including O
MRI/MRA O
, O
carotid O
non-invasives O
, O
TCVs O
, O
EEG O
, O
LP O
revealed O
no O
definitive O
etiology O
of O
seizure O
but O
thought O
to O
be O
likely O
related O
to O
her O
uncontrolled O
hypertension O
with O
systolic O
BP O
250 O
's O
, O
her O
morbid O
state O
in O
setting O
of O
UTI O
, O
and O
lower O
seizure O
threshold O
with O
ciprofloxacin O
. O
 
Hyperlipidemia O
- O
was O
on O
zocor O
, O
recently O
switched O
to O
zetia O
, O
? O
myositis O
Hypothyroid O
- O
central O
, O
secondary O
to O
pituitary O
XRT O
Arthritis O
Cryptogenic O
cirrhosis O
- O
HIV O
, O
HBV O
, O
HCV O
negative O
( O
4/90 I-DATE
) O
, O
ANA O
negative O
, O
Anti-mitochondrial O
Ab O
negative O
, O
no O
evidence O
of O
hemachromatosis O
, O
alpha-1-antitrypsin O
deficiency O
or O
Wilson O
's O
disease O
on O
biopsy O
, O
findings O
consistent O
with O
NASH O
. O
 
Medications O
: O
Avapro O
75MG O
1 O
QD O
Cabergoline O
0.25 O
QWEEK O
Humulin O
15 O
bid O
Kcl O
slow O
release O
20MEQ O
1 O
QD O
Lactulose O
30 O
TID O
Levothyroxine O
sodium O
100MCG O
Macrodantin O
100MG O
1 O
QD O
Nortriptyline O
hcl O
25MG O
1 O
HS O
Prednisone O
2.5 O
QD O
Prempro O
0.625 O
QD O
Serax O
15MG O
1 O
QHS O
Zoloft O
75MG O
QD O
Allergies O
: O
Sulfa O
drugs O
Codeine O
Lisinopril O
SH O
: O
Lives O
in O
Ardmore I-LOCATION
with O
son O
. O
 
Husband O
died O
3 O
years O
ago O
. O
 
Three O
children O
. O
 
Tob O
: O
1 O
ppd O
x O
many O
years O
EtOH O
: O
Denies O
Illicits O
: O
Denies O
Exam O
: O
VS O
: O
General O
: O
NAD O
, O
extrapyramidal O
movements O
, O
responding O
to O
commands O
. O
 
HEENT O
: O
NC/AT O
, O
Right O
pupil O
w/minimal O
proptosis O
and O
unreactive O
to O
light O
, O
left O
pupil O
RRLA O
, O
anicteric O
. O
 
EOMI O
. O
 
OP O
w/ O
MMM O
, O
Skin O
: O
No O
rashes O
Neck O
: O
Supple O
, O
full O
ROM O
, O
2+ O
carotids O
w/o O
bruits O
, O
no O
thyromegaly O
or O
nodules O
, O
no O
nodes O
Chest O
: O
CTA O
b/l O
, O
coarse O
upper O
airway O
sounds O
CVS O
: O
RRR O
nl O
S1 O
S2 O
, O
no O
m/r/g O
Abd O
: O
nl O
BS O
, O
soft O
, O
non-tender O
, O
no O
HSM O
, O
no O
fluid O
wave O
, O
no O
fluid O
shift O
Extr O
: O
no O
c/c/e O
2+ O
DP O
's O
bilaterally O
Neuro O
: O
Oriented O
to O
person O
and O
place O
. O
 
Somnolent O
but O
arousable O
. O
 
Able O
to O
follow O
simple O
commands O
. O
 
Muscle O
strength O
5/5 O
except O
RUE O
where O
limited O
by O
prior O
surgery O
. O
 
DATA O
: O
Sodium O
( O
Stat O
Lab O
) O
125 O
L O
( O
135-145 O
) O
mmol/L O
Potassium O
( O
Stat O
Lab O
) O
3.8 O
( O
3.4-4.8 O
) O
mmol/L O
Chloride O
( O
Stat O
Lab O
) O
98 O
L O
( O
100-108 O
) O
mmol/L O
CO2 O
( O
Stat O
Lab O
) O
25.8 O
( O
23.0-31.9 O
) O
mmol/L O
BUN O
( O
Stat O
Lab O
) O
7 O
L O
( O
8-25 O
) O
mg/dl O
Creatinine O
( O
Stat O
Lab O
) O
0.6 O
( O
0.6-1.5 O
) O
mg/dl O
Glucose O
( O
Stat O
Lab O
) O
128 O
H O
( O
70-110 O
) O
mg/dl O
Calcium O
8.8 O
( O
8.5-10.5 O
) O
mg/dl O
Phosphorus O
1.9 O
L O
( O
2.6-4.5 O
) O
mg/dl O
Magnesium O
1.5 O
( O
1.4-2.0 O
) O
meq/L O
Total O
Protein O
6.2 O
( O
6.0-8.3 O
) O
g/dl O
Albumin O
3.4 O
( O
3.3-5.0 O
) O
g/dl O
Globulin O
2.8 O
( O
2.6-4.1 O
) O
g/dl O
Direct O
Bilirubin O
0.2 O
( O
0-0.4 O
) O
mg/dl O
Total O
Bilirubin O
0.5 O
( O
0-1.0 O
) O
mg/dl O
Alkaline O
Phosphatase O
75 O
( O
30-100 O
) O
U/L O
Transaminase-SGPT O
12 O
( O
7-30 O
) O
U/L O
Amylase O
25 O
( O
3-100 O
) O
units/L O
Lipase O
2.7 O
( O
1.3-6.0 O
) O
U/dl O
Transaminase-SGOT O
18 O
( O
9-32 O
) O
U/L O
Creatine O
Kinase O
Isoenz O
NEGATIVE O
( O
NEG O
) O
Troponin-I O
NEGATIVE O
( O
NEG O
) O
Nortriptyline O
< O
50 O
mcg/L O
Desmethylsertraline O
PRESENT O
mcg/L O
Sertraline O
< O
50 O
mcg/L O
REF O
. O
 
RANGE O
: O
40-160 O
WBC O
5.5 O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
37.0 O
( O
36.0-46.0 O
) O
% O
HGB O
13.3 O
( O
12.0-16.0 O
) O
gm/dl O
RBC O
4.21 O
( O
4.00-5.20 O
) O
mil/cmm O
PLT O
187 O
( O
150-350 O
) O
th/cumm O
MCV O
88 O
( O
80-100 O
) O
fl O
MCH O
31.6 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
36.0 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
12.4 O
( O
11.5-14.5 O
) O
% O
Superstat O
PT O
12.9 O
( O
11.1-13.1 O
) O
sec O
Superstat O
PT-INR O
1.1 O
Superstat O
APTT O
30.7 O
( O
22.1-35.1 O
) O
sec O
Poly O
65 O
( O
40-70 O
) O
% O
Lymphs O
28 O
( O
22-44 O
) O
% O
Monos O
4 O
( O
4-11 O
) O
% O
EOS O
3 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
UA-Specific O
Gravity O
1.025 O
( O
1.001-1.035 O
) O
UA-pH O
7.0 O
( O
5.0-9.0 O
) O
UA-WBC O
Screen O
NEGATIVE O
( O
NEG O
) O
UA-Nitrite O
NEGATIVE O
( O
NEG O
) O
UA-Albumin O
( O
NEG O
) O
2+SAMPLE O
SENT O
TO O
HEME O
LAB O
FOR O
ADDITIONAL O
TESTING O
UA-Glucose O
NEGATIVE O
( O
NEG O
) O
UA-Ketones O
NEGATIVE O
( O
NEG O
) O
UA-Occult O
Blood O
NEGATIVE O
( O
NEG O
) O
CXR O
: O
no O
acute O
cardiopulmonary O
process O
HEAD O
CT O
: O
CT O
HEAD O
WITHOUT O
CONTRAST O
History O
: O
Mental O
status O
change O
. O
 
Right O
sided O
weakness O
. O
 
Hypertension O
. O
 
Procedure O
: O
Contiguous O
axial O
images O
of O
the O
head O
were O
performed O
from O
the O
skull O
base O
to O
the O
vertex O
without O
intravenous O
contrast O
. O
 
Bone O
and O
soft-tissue O
windows O
were O
reviewed O
. O
 
Comparison O
: O
MRI O
dated O
7/16/91 I-DATE
Findings O
: O
The O
cerebral O
parenchyma O
, O
posterior O
fossa O
, O
basal O
cisterns O
and O
ventricular O
system O
appear O
normal O
. O
 
There O
is O
no O
evidence O
of O
any O
mass O
or O
mass O
effect O
. O
 
There O
is O
no O
evidence O
of O
acute O
infarction O
although O
this O
would O
be O
better O
assessed O
by O
MR O
with O
diffusion O
. O
 
There O
is O
no O
evidence O
of O
parenchymal O
or O
extra-axial O
hemorrhage O
. O
 
A O
right O
frontal O
mucocele O
has O
enlarged O
since O
the O
previous O
exam O
. O
 
It O
extends O
into O
the O
right O
orbit O
resulting O
in O
proptosis O
. O
 
There O
are O
bilateral O
lens O
implants O
. O
 
IMPRESSION O
: O
No O
acute O
intracranial O
hemorrhage O
. O
 
Enlarging O
right O
frontal O
mucocele O
which O
causes O
right O
proptosis O
. O
 
Pituitary O
MRI O
: O
( O
7/91 I-DATE
) O
No O
evidence O
of O
recurrent O
pituitary O
adenoma O
. O
 
Interval O
increase O
in O
the O
size O
of O
an O
expansile O
lesion O
within O
the O
right O
ethmoid O
bed O
, O
with O
increased O
extension O
into O
the O
right O
orbit O
. O
 
The O
lesion O
contacts O
the O
right O
globe O
. O
 
This O
lesion O
most O
likely O
represents O
a O
mucocele O
. O
 
EKG O
: O
NSR O
@ O
73 O
, O
normal O
axis O
, O
normal O
intervals O
, O
biphasic O
t O
wave O
v2 O
, O
no O
sttw O
changes O
. O
 
ALH I-LOCATION
Cardiology O
25-Oct-2090 I-DATE
13:00 O
DURATION O
@ O
MAX O
DOSE O
( O
min O
: O
sec O
) O
5:00 O
HR O
( O
REST= O
> O
MAX O
) O
57 O
= O
> O
76 O
( O
50 O
% O
PREDICTED O
) O
BP O
( O
INITIAL= O
> O
PEAK O
) O
146/60 O
= O
> O
146/60 O
( O
MINIMUM O
= O
114/52 O
) O
PEAK O
DOUBLE O
PRODUCT O
: O
11096 O
ENDPOINT O
( O
S O
) O
: O
The O
protocol O
was O
completed O
. O
 
Chest O
pain O
did O
not O
occur O
. O
 
The O
baseline O
cardiac O
rhythm O
was O
normal O
sinus O
rhythm O
. O
 
The O
rest O
electrocardiogram O
revealed O
nonspecific O
ST O
segment O
and O
T-wave O
abnormalities O
. O
 
Small O
inferior O
q O
's O
. O
 
No O
ST O
segment O
changes O
were O
observed O
during O
this O
test O
. O
 
Negative O
for O
ischemia O
. O
 
However O
, O
the O
sensitivity O
of O
Adenosine-induced O
ST O
segment O
changes O
for O
detecting O
significant O
CAD O
is O
limited O
. O
 
SCAN O
RESULTS O
: O
The O
left O
ventricle O
is O
normal O
in O
size O
. O
 
Regional O
left O
ventricular O
perfusion O
is O
normal O
. O
 
The O
left O
ventricular O
ejection O
fraction O
was O
77 O
% O
on O
the O
stress O
study O
. O
 
Regional O
wall O
motion O
was O
normal O
on O
the O
stress O
study O
. O
 
CONCLUSIONS O
: O
The O
ECG O
response O
to O
pharmacological O
stress O
was O
negative O
for O
ischemia O
. O
 
The O
myocardial O
scans O
are O
within O
normal O
limits O
and O
do O
not O
demonstrate O
evidence O
of O
myocardial O
ischemia O
or O
infarction O
. O
 
ALH I-LOCATION
CARDIAC O
ULTRASOUND O
11-May-2087 I-DATE
Serial O
# O
732087 I-ID
Final O
( O
normal O
) O
( O
Completed O
only O
if O
abn O
. O
) O
 
MITRAL O
VALVE O
NORM O
AO O
29 O
mm O
. O
 
( O
24-39mm O
) O
SEGMENT O
BASE O
MID O
APEX O
LEFT O
ATRIUM O
NORM O
AV O
. O
 
AO O
. O
 
LVOT O
ABN O
LA O
38 O
mm O
. O
 
( O
25-38mm O
) O
anterior O
LEFT O
VENT O
. O
 
NORM O
ant.sep O
. O
 
TV O
. O
 
RA O
. O
 
VC O
. O
 
NORM O
LVID O
44 O
mm O
. O
 
( O
37-53mm O
) O
mid.sep O
. O
 
PV O
. O
 
INF O
. O
 
PA. O
ABN O
inf.sep O
. O
 
RIGHT O
VENT O
. O
 
NORM O
PWT O
11 O
mm O
. O
 
( O
7-11mm O
) O
inferior O
IAS O
. O
 
IVS O
. O
 
NORM O
inf.pos O
. O
 
COMPLEX O
CHD O
NORM O
IVS O
11 O
mm O
. O
 
( O
7-11mm O
) O
pos.lat O
. O
 
CORONARIES O
UV O
lateral O
PERICARDIUM O
NORM O
EF O
75 O
% O
( O
> O
50 O
% O
) O
MITRAL O
VALVE O
There O
is O
trace O
to O
mild O
mitral O
regurgitation O
by O
color O
and O
spectral O
Doppler O
. O
 
LEFT O
ATRIUM O
There O
is O
no O
evidence O
of O
left O
atrial O
dilatation O
. O
 
AORTIC O
VALVE O
, O
AORTA O
, O
LVOT O
Multiple O
aortic O
leaflets O
are O
thickened O
but O
there O
is O
no O
stenosis O
. O
 
There O
is O
no O
evidence O
of O
aortic O
insufficiency O
by O
color O
and O
spectral O
Doppler O
. O
 
LEFT O
VENTRICLE O
The O
left O
ventricular O
size O
and O
systolic O
function O
are O
within O
normal O
limits O
. O
 
There O
are O
no O
obvious O
segmental O
wall O
motion O
abnormalities O
. O
 
The O
estimated O
ejection O
fraction O
is O
75 O
% O
. O
 
TRICUSPID O
VALVE O
- O
IVC O
, O
SVC O
There O
is O
color O
and O
spectral O
Doppler O
evidence O
of O
mild O
tricuspid O
insufficiency O
. O
 
There O
is O
a O
prominent O
Eustachian O
valve O
. O
 
PULMONARY O
VALVE O
, O
INFUND. O
, O
P.A O
. O
 
Color O
and O
spectral O
Doppler O
study O
c/w O
trace O
pulmonary O
insufficiency O
. O
 
The O
RV O
systolic O
pressure O
estimated O
from O
the O
regurgitant O
tricuspid O
velocity O
is O
53 O
mmHg O
( O
assuming O
an O
RA O
pressure O
of O
10mmHg O
) O
. O
 
RIGHT O
VENTRICLE O
The O
right O
ventricle O
is O
not O
dilated O
. O
 
The O
right O
ventricular O
systolic O
function O
is O
within O
normal O
limits O
. O
 
PERICARDIAL O
DISEASE O
AND O
EXTRACARDIAC O
MASSES O
Echo O
free O
space O
between O
visceral O
& O
parietal O
pericardium O
is O
c/w O
pericardial O
fat O
. O
 
TEST O
TYPE O
: O
CAROTID O
ULTRASOUND O
10/2089 I-DATE
FINDINGS O
No O
carotid O
bruits O
are O
heard O
. O
 
Blood O
flow O
velocity O
is O
within O
normal O
limits O
in O
the O
common O
, O
internal O
, O
external O
carotid O
, O
and O
extracranial O
vertebral O
arteries O
, O
bilaterally O
. O
 
Ophthalmic O
artery O
flow O
is O
normal O
in O
direction O
, O
via O
the O
transorbital O
approach O
, O
bilaterally O
. O
 
Ultrasound O
visualization O
of O
the O
bifurcations O
is O
good O
. O
 
There O
is O
dense O
plaque O
visualized O
in O
each O
bifurcation O
. O
 
Plaque O
does O
not O
alter O
flow O
in O
either O
vessel O
. O
 
IMPRESSIONS O
: O
1 O
. O
 
MINIMAL O
DISEASE O
OF O
BOTH O
CAROTID O
ARTERY O
BIFURCATION O
. O
 
LIVER O
, O
BIOPSY O
: O
( O
11/2089 I-DATE
) O
NOTE O
: O
There O
is O
established O
cirrhosis O
, O
confirmed O
on O
trichrome O
stain O
. O
 
There O
is O
a O
mild O
to O
moderate O
mixed O
portal O
tract O
inflammatory O
infiltrate O
, O
composed O
of O
lymphocytes O
, O
plasma O
cells O
, O
and O
eosinophils O
. O
 
There O
is O
no O
interface O
or O
lobular O
activity O
. O
 
There O
is O
mild O
macrovesicular O
steatosis O
. O
 
There O
are O
scattered O
glycogenated O
nuclei O
in O
periportal O
hepatocytes O
, O
consistent O
with O
diabetes O
and/or O
obesity O
. O
 
There O
is O
mild O
periportal O
edema O
and O
copper O
deposition O
, O
consistent O
with O
chronic O
cholestasis O
. O
 
There O
is O
no O
Mallory O
's O
hyaline O
. O
 
There O
is O
no O
evidence O
of O
hemachromatosis O
, O
alpha-1-antitrypsin O
deficiency O
or O
Wilson O
's O
disease O
based O
on O
iron O
, O
PAS/D O
, O
and O
copper O
stains O
, O
respectively O
. O
 
The O
inflammatory O
infiltrate O
is O
not O
ductulocentric O
, O
and O
there O
is O
minimal O
bile O
duct O
damage O
. O
 
Immunostains O
for O
cytokeratins O
7 O
and O
19 O
highlight O
bile O
ductular O
reduplication O
, O
but O
there O
is O
no O
ductopenia O
. O
 
The O
findings O
of O
cirrhosis O
are O
not O
specific O
, O
but O
are O
compatible O
with O
end-stage O
non-alcoholic O
steatohepatitis O
( O
NASH O
) O
. O
 
___________________________________________ O
ASSESSMENT O
AND O
PLAN O
: O
70 I-AGE
y/o O
female O
with O
PMHx O
sig O
for O
pituitary O
adenoma O
s/p O
resection O
, O
cryptogenic O
cirrhosis O
, O
hypothyroidism O
, O
htn O
, O
DM O
, O
who O
presents O
with O
increasing O
confusion O
and O
depressed O
mental O
status O
. O
 
1 O
. O
 
Change O
in O
mental O
status O
1 O
. O
 
Hyponatremia O
- O
Euvolemic O
by O
exam O
, O
Serum O
sodium O
125 O
, O
Serum O
Osm O
262 O
, O
Urine O
sodium O
126 O
, O
Urine O
Osm O
387 O
. O
 
Consistent O
with O
SIADH O
( O
euvolemic O
hypotonic O
hyponatremia O
, O
Uosm O
> O
100 O
, O
Una O
> O
20 O
) O
. O
 
Will O
place O
on O
fluid O
restriction O
, O
follow O
correction O
rate O
slowly O
. O
 
Past O
Na O
levels O
: O
130 O
( O
10/91 I-DATE
) O
, O
135 O
( O
6/91 I-DATE
) O
, O
133 O
( O
1/91 I-DATE
) O
. O
 
Other O
etiologies O
: O
diuretics O
, O
polydipsia O
, O
adrenal O
insufficiency O
, O
hypoaldo O
, O
third-spacing O
less O
likely O
. O
 
2 O
. O
 
Hepatic O
encephalopathy O
- O
known O
cirrhosis O
, O
on O
home O
standing O
lactulose O
. O
 
By O
exam O
, O
no O
asterixis O
. O
 
Abdomen O
obese O
but O
no O
obvious O
fluid O
collection O
. O
 
Somewhat O
tender O
, O
no O
peritoneal O
signs O
. O
 
Will O
schedule O
for O
Abdominal O
U/S O
to O
r/o O
ascites O
. O
 
Low O
suspicion O
for O
SBP O
, O
will O
hold O
off O
prophylaxis O
antibiotics O
. O
 
3 O
. O
 
Hypertensive O
encephalopthy O
- O
history O
of O
mental O
status O
changes O
and O
seizures O
with O
elevated O
blood O
pressures O
in O
the O
past O
. O
 
Extremely O
hypertensive O
upon O
presentation O
to O
the O
ED O
. O
 
Will O
continue O
to O
titrate O
up O
beta-blocker O
as O
tolerated O
, O
MAP O
goal O
reduction O
of O
25 O
% O
obtained O
, O
will O
continue O
to O
lower O
with O
PO O
agents O
. O
 
Consider O
MRI O
to O
look O
for O
PLE O
changes O
. O
 
4 O
. O
 
Infection O
- O
history O
of O
chronic O
UTIs O
. O
 
U/A O
negative O
, O
CXR O
negative O
. O
 
Will O
send O
blood O
cx O
and O
urine O
cx O
to O
complete O
fever O
work-up O
. O
 
5 O
. O
 
Standard O
work-up O
- O
TSH O
, O
RPR O
, O
B12 O
, O
Folate O
, O
cortisol O
2 O
. O
 
Diabetes O
- O
Finger O
sticks O
with O
sliding O
scale O
insulin O
coverage O
QID O
3 O
. O
 
Hypothyroidism O
- O
check O
TSH O
, O
T4 O
, O
T3 O
. O
 
Recent O
adjustment O
to O
synthroid O
dose O
. O
 
4 O
. O
 
Prolactinoma O
- O
Check O
prolactin O
level O
, O
have O
patient O
bring O
in O
home O
cabergoline O
for O
weekly O
dose O
. O
 
_________________________________ O
Taquan I-NAME
Q. I-NAME
Cantu I-NAME
, O
MD O
Pager O
# O
30547 I-CONTACT
 
Record O
date O
: O
2097-06-29 I-DATE
AMERICAN I-LOCATION
LEGION I-LOCATION
HOSPITAL I-LOCATION
NEUROCRITICAL O
RESIDENT O
ADMIT O
NOTE O
Name O
: O
Ollivo O
, O
Kimberly I-NAME
MRN O
: O
3299811 I-ID
Date O
: O
6/29/97 I-DATE
Time O
of O
Exam O
: O
5:20 O
p.m. O
NICU O
day O
: O
1 O
Critically O
ill O
secondary O
to O
: O
R. O
BG/thalamus O
hemorrhage O
with O
IVH O
extension O
, O
with O
potential O
for O
fatal O
neurologic O
deterioration O
Critical O
Care O
Min O
: O
35 O
min O
History O
: O
Ms. O
Olivo I-NAME
is O
a O
75-year-old O
RHW O
with O
DM O
, O
HTN O
and O
dementia O
, O
LSW O
at O
11:00 O
a.m. O
, O
then O
found O
by O
son O
at O
1:45 O
pm O
to O
be O
less O
responsive O
with O
left-sided O
weakness O
. O
 
BP O
was O
200/96 O
when O
EMS O
arrived O
. O
 
Here O
her O
SBP O
was O
in O
the O
220s O
with O
heart O
rate O
in O
the O
50-60s O
. O
 
Her O
initial O
exam O
revealed O
somnolence O
, O
but O
able O
to O
follow O
some O
very O
simple O
commands O
like O
squeezing O
hand O
, O
nodding O
head O
; O
she O
had O
right O
gaze O
deviation O
, O
left O
hemianopsia O
, O
left O
facial O
palsy O
, O
left O
arm O
and O
leg O
plegia O
, O
right O
arm O
and O
leg O
paresis O
, O
and O
dysarthria O
. O
 
She O
received O
10 O
mg O
of O
hydralazine O
for O
her O
SBP O
greater O
than O
220 O
. O
 
CT O
revealed O
a O
right O
basal O
ganglia/thalamic O
hemorrhage O
with O
intraventricular O
extension O
including O
casting O
of O
the O
4th O
ventricle O
, O
7 O
mm O
mls O
to O
the O
left O
, O
contrast O
extravasation O
suggestive O
of O
active O
hemorrhage O
but O
no O
evidence O
of O
any O
vascular O
abnormality O
. O
 
She O
was O
intubated O
for O
worsening O
mental O
status O
and O
had O
an O
a-line O
placed O
for O
Bp O
monitoring O
and O
management O
. O
 
At O
baseline O
, O
Ms. O
Olivo I-NAME
is O
wheelchair-bound O
, O
according O
to O
her O
daughter O
, O
due O
to O
her O
neuropathy O
. O
 
She O
is O
dependent O
for O
all O
of O
her O
ADLs O
and O
has O
a O
home O
health O
aide O
. O
 
PMHx O
: O
DM O
, O
HTN O
, O
dementia O
, O
h/o O
sz O
d/o O
not O
on O
AED O
now O
, O
Pituitary O
adenoma O
, O
s/p O
hypophysectomy O
, O
hypothyroidism O
, O
COPD O
, O
dyslipidemia O
, O
obesity O
, O
fatty O
liver O
, O
fibromyalgia O
, O
arthritis O
, O
depression O
, O
anxiety O
, O
meningitis O
, O
Rt O
humerus O
fx/osteo/nonunion O
, O
Cirrhosis O
or O
unclear O
etiology O
with O
hyperammonemia O
, O
Neuropathy O
with O
paresthesias O
, O
presumably O
due O
to O
diabetes O
Home O
meds O
: O
Mirtazapine O
15 O
mg O
daily O
, O
Namenda O
10 O
mg O
daily O
, O
Potassium O
supplementation O
20 O
meq O
daily O
, O
Levothyroxine O
100 O
mcg O
daily O
, O
Metoprolol O
( O
unclear O
if O
metoprolol O
succinate O
or O
tartrate O
) O
25 O
mg O
daily O
, O
Prednisone O
2.5 O
mg O
daily O
, O
MVI O
All O
: O
Morphine O
( O
Unknown O
) O
Codeine O
( O
Unknown O
) O
ACE O
Inhibitor O
( O
Unknown O
) O
LISINOPRIL O
( O
cough O
) O
CIPROFLOXACIN O
HCL O
( O
dec O
effects O
of O
sz O
med O
) O
ATORVASTATIN O
( O
abnormal O
LFT O
) O
SH O
: O
Lives O
with O
her O
son O
in O
Ardmore I-LOCATION
. O
 
Has O
two O
sons O
and O
a O
daughter O
. O
 
Daughter O
, O
Yolanda I-NAME
, O
is O
the O
HCP O
( O
817-638-1328 I-CONTACT
) O
and O
primary O
caregiver O
. O
 
She O
quit O
smoking O
16 O
years O
ago O
. O
 
24 O
hour O
events O
: O
admitted O
to O
NICU O
Flowsheet O
Data O
: O
VS O
: O
Tm O
HR O
52-70 O
SR O
SBP O
223/90 O
& O
# O
224 O
; O
148/53 O
MAP O
RR O
19 O
O2 O
sat O
100 O
% O
on O
FiO2 O
1.0 O
CVP O
ICP O
CPP O
ICU O
Titrateable O
Drips O
: O
propofol O
Vent O
Settings O
: O
AC O
f12 O
PEEP O
5.0 O
FiO2 O
1.0 O
PC O
12 O
TBB O
: O
since O
MN O
EVD O
output O
: O
Maintenance O
IVF O
: O
D5NS O
Nutrition O
: O
npo O
IVF O
: O
D5NS O
FSBG O
: O
Lines O
: O
L. O
Rad O
art O
line O
Significant O
Medications O
: O
propofol O
, O
RISS O
, O
peridex O
, O
synthroid O
, O
lactulose O
Significant O
LABS O
: O
INR O
1.1 O
Plt O
273 O
Physical O
Exam O
Cardio O
: O
S1 O
, O
S2 O
, O
reg O
Pulm O
: O
CTAB O
Abd O
: O
soft O
, O
hypoactive O
bowel O
sounds O
Skin O
: O
erthematous O
lesions O
with O
centers O
of O
white O
rash O
in O
skin O
folds O
: O
neck O
, O
under O
breasts O
Ortho O
: O
R. O
arm O
fracture O
( O
old O
) O
Neuro O
Exam O
: O
Off O
sedation O
& O
# O
8211 O
; O
no O
verbal O
response O
to O
noxious O
stimuli O
, O
intermittently O
extensor O
postures O
; O
minimally O
reactive O
small O
pupils O
, O
midline O
gaze O
in O
primary O
position O
, O
able O
to O
x-midline O
, O
no O
BTT O
, O
+ O
R. O
corneal O
brisk O
vs. O
L. O
, O
grimace O
to O
nasal O
tickle O
better O
on O
the O
L. O
than O
on O
the O
R. O
, O
R. O
UE O
slight O
w/d O
to O
deep O
noxious O
stim O
, O
plegic O
in O
LUE. O
, O
w/d O
briskly O
in O
the O
L. O
LE O
vs. O
RLE O
, O
toes O
up O
b/l O
Imaging/Studies/TCD O
: O
Head O
CT/A O
( O
6/29 I-DATE
) O
: O
Prelim O
read O
shows O
a O
right O
basal O
ganglia/thalamic O
hemorrhage O
( O
1.87 O
cm O
x O
4.5 O
cm O
in O
largest O
dimension O
) O
with O
intraventricular O
extension O
including O
casting O
of O
the O
4th O
ventricle O
, O
and O
mls O
of O
7 O
mm O
to O
the O
left O
. O
 
CTA O
showed O
at O
least O
3 O
spot O
signs O
indicating O
active O
hemorrhage O
but O
no O
evidence O
of O
any O
vascular O
abnormality O
. O
 
Assessment O
: O
Olivo I-NAME
is O
a O
75-year-old O
right-handed O
woman O
with O
diabetes O
mellitus O
, O
HTN O
and O
dementia O
, O
and O
found O
with O
a O
~ O
11 O
cc O
R. O
BG/thalamic O
bleed O
with O
pan-ventricular O
extension O
with O
casted O
3rd O
and O
4th O
ventricles O
, O
and O
mild O
midline O
shift O
. O
 
The O
etiology O
appears O
to O
be O
hypertensive O
in O
nature O
; O
CTA O
was O
negative O
for O
a O
vascular O
anomaly O
. O
 
A O
mass O
lesion O
can O
not O
be O
excluded O
at O
this O
time O
however O
, O
and O
will O
need O
an O
MRI O
. O
 
Her O
prognosis O
is O
somewhat O
difficult O
to O
articulate O
at O
this O
time O
using O
the O
conventional O
FUNC O
( O
8 O
) O
and O
ICH O
( O
2 O
) O
scores O
given O
her O
clinical O
status O
and O
medical O
comorbidities O
. O
 
Plan O
: O
Neuro O
: O
ICH O
with O
IVH O
, O
prior O
h/o O
sz O
d/o O
not O
AEDs O
now O
-Serial O
neuro O
exams O
-repeat O
I-HCT O
in O
6 O
h O
( O
at O
9:45 O
p.m. O
) O
, O
24 O
h O
( O
6/30/97 I-DATE
at O
3:45 O
p.m. O
) O
, O
and O
STAT O
with O
exam O
change O
-SBP O
goal O
& O
lt O
; O
140 O
mm O
Hg O
-A-line O
-propofol O
for O
BP O
control O
-HOB O
& O
gt O
; O
30 O
degrees O
-no O
antiplatelet O
or O
anticoagulants O
-labetalol O
prn O
, O
nicardipine O
prn O
-no O
need O
for O
AEDs O
unless O
declares O
self O
with O
new O
sz O
( O
has O
been O
stably O
off O
AEDs O
for O
prior O
h/o O
Sz O
d/o O
) O
-MRI O
to O
r/o O
underlying O
mass O
lesion O
when O
able O
-N. O
Surg O
c/s O
appreciated O
for O
EVD O
placement O
Pulm O
: O
-intubated O
-wean O
as O
tolerated O
-daily O
CXR O
while O
intubated O
CV O
: O
HTN O
, O
HL O
, O
angina O
-BP O
control O
as O
above O
-Tn O
x O
3 O
-SBP O
goal O
& O
lt O
; O
140 O
mm O
Hg O
RENAL O
: O
-foley O
, O
strict O
I/O O
-no O
hypotonic O
fluids O
-D5 O
NS O
for O
now O
-trend O
UOP O
, O
Cr O
-renoprotection O
for O
iv O
contrast O
-replete O
lytes O
ID O
: O
-follow O
U/A O
, O
temp O
, O
WBC O
-nystatin O
for O
crural O
dermatophytosis O
GI/Nutrition O
: O
Cirrhosis O
-daily O
LFTs O
, O
NH3 O
-lactulose O
at O
home O
dose O
-npo O
-IV O
fluids O
for O
now O
Heme O
: O
-trend O
CBC O
-type O
and O
hold O
-no O
antiplatelet O
or O
anticoagulation O
for O
now O
Endo O
: O
DM O
, O
hypothyroid O
-synthroid O
-Fsg O
q6h O
-RISS O
Skin O
: O
-Nystatin O
-turn O
and O
position O
q2h O
Ortho O
: O
-Old O
R. O
arm O
fx O
per O
family O
-baseline O
R. O
elbow O
XRay O
pending O
Prophy O
: O
DVT O
teds O
& O
amp O
; O
boots O
, O
fragmin O
if O
repeat O
CT O
stable O
in O
48 O
h O
Sz O
- O
GI O
PPI O
VAP O
peridex O
Restraints O
- O
CODE/Dispo O
: O
FULL/ICU O
-continue O
code O
status O
discussion O
with O
the O
family O
_______________________________ O
Yuval I-NAME
Xaysana I-NAME
, O
M.D. O
, O
Ph.D. O
Neurology O
Resident O
 
Record O
date O
: O
2079-02-28 I-DATE
DOUGLAS I-LOCATION
EMERGENCY O
DEPT O
VISIT O
DODD O
, O
STEVEN O
350-93-05-3 I-ID
VISIT O
DATE O
: O
02/28/79 I-DATE
This O
patient O
was O
evaluated O
in O
conjunction O
with O
a O
resident O
and O
I O
confirmed O
the O
history O
and O
physical O
findings O
as O
documented O
in O
the O
handwritten O
record O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
patient O
is O
a O
63 I-AGE
year O
old O
gentleman O
with O
underlying O
diabetes O
and O
congestive O
failure O
as O
well O
as O
extensive O
coronary O
artery O
disease O
now O
presenting O
with O
worsening O
fatigue O
and O
shortness O
of O
breath O
over O
the O
preceding O
few O
days O
. O
 
PHYSICAL O
EXAMINATION O
: O
Physical O
examination O
is O
suggestive O
of O
congestive O
failure O
. O
 
LABORATORY O
EVALUATION O
: O
Electrolytes O
are O
normal O
. O
 
Electrocardiogram O
shows O
no O
definite O
ischemic O
change O
. O
 
Chest O
x-ray O
is O
a O
limited O
study O
due O
to O
body O
habitus O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
treated O
with O
diuretics O
and O
ultimately O
admitted O
to O
the O
hospital O
for O
further O
care O
. O
 
FINAL O
DIAGNOSIS O
: O
Congestive O
heart O
failure O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
was O
admitted O
to O
the O
hospital O
in O
stable O
condition O
. O
 
___________________________________ O
TO761/1620 I-ID
VIRGIL I-NAME
L. I-NAME
IVERY I-NAME
, O
M.D O
. O
 
VI65 I-NAME
D:02/28/79 O
T:02/28/79 O
Dictated O
by O
: O
VIRGIL I-NAME
L. I-NAME
IVERY I-NAME
, O
M.D O
. O
 
VI65 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2079-09-28 I-DATE
DOUGLAS I-LOCATION
EMERGENCY O
DEPT O
VISIT O
DODD O
, O
STEVEN O
350-93-05-3 I-ID
VISIT O
DATE O
: O
09/28/79 I-DATE
The O
patient O
was O
interviewed O
and O
examined O
by O
me O
as O
well O
as O
by O
the O
resident O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
In O
brief O
, O
this O
is O
a O
64-year-old O
gentleman O
with O
morbid O
obesity O
. O
 
He O
is O
on O
CPAP O
. O
 
He O
has O
CHF O
, O
hypertension O
, O
chronic O
renal O
insufficiency O
, O
triple O
bypass O
, O
and O
diabetes O
. O
 
He O
had O
three O
episodes O
of O
chest O
pain O
which O
woke O
him O
up O
from O
CPAP O
last O
last O
night O
. O
 
Each O
episode O
reminded O
him O
of O
his O
typical O
angina O
, O
but O
the O
last O
time O
he O
had O
it O
was O
in O
May I-DATE
. O
 
Those O
three O
episodes O
were O
resolved O
with O
one O
sublingual O
nitroglycerin O
. O
 
He O
woke O
up O
today O
and O
thought O
he O
needed O
to O
be O
evaluated O
. O
 
He O
is O
also O
complaining O
of O
low O
grade O
temperature O
. O
 
He O
has O
recently O
been O
receiving O
VNA O
services O
as O
a O
result O
of O
a O
left O
foot O
ulcer O
as O
a O
result O
of O
an O
oxygen O
tank O
burn O
. O
 
His O
VNA O
came O
to O
visit O
him O
today O
and O
found O
that O
he O
had O
some O
crackles O
in O
his O
lungs O
with O
a O
temperature O
and O
was O
concerned O
about O
a O
pneumonia O
. O
 
Please O
see O
the O
resident O
's O
note O
for O
details O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
He O
denies O
chest O
pain O
now O
. O
 
No O
shortness O
of O
breath O
now O
. O
 
He O
states O
that O
his O
foot O
appears O
to O
be O
getting O
better O
. O
 
MEDICATIONS O
: O
Atenolol O
, O
aspirin O
, O
isosorbide O
, O
Lasix O
, O
Glyburide O
, O
Lipitor O
, O
and O
Lorazepam O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
APPEARANCE O
: O
The O
patient O
is O
a O
morbidly O
obese O
gentleman O
. O
 
VITAL O
SIGNS O
: O
Temperature O
100.2 O
, O
pulse O
62 O
, O
respiratory O
rate O
18 O
, O
blood O
pressure O
173/74 O
. O
 
O2 O
saturation O
is O
99 O
% O
. O
 
LUNGS O
: O
He O
has O
rales O
at O
the O
right O
base O
. O
 
Unable O
to O
assess O
JVD O
. O
 
ABDOMEN O
: O
He O
is O
obese O
with O
active O
bowel O
sounds O
. O
 
EXTREMITIES O
: O
Distal O
left O
foot O
lateral O
ulcer O
is O
dry O
, O
necrotic O
, O
without O
surrounding O
edema O
or O
tenderness O
. O
 
LABORATORY O
EVALUATION O
: O
His O
white O
count O
here O
is O
14 O
. O
 
His O
BUN O
and O
creatinine O
are O
25 O
and O
2.4 O
, O
which O
is O
his O
baseline O
. O
 
CK O
is O
28 O
, O
troponin O
pending O
. O
 
INR O
is O
1.2 O
. O
 
EKG O
shows O
no O
changes O
from O
prior O
. O
 
Chest O
x-ray O
shows O
right O
pleural O
effusion O
with O
question O
right O
paratracheal O
mass O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
His O
care O
was O
discussed O
with O
the O
Christus I-LOCATION
Spohn I-LOCATION
cardiology O
. O
 
FINAL O
DIAGNOSIS O
: O
Unstable O
angina O
pectoris O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
He O
is O
going O
to O
be O
treated O
with O
antibiotics O
, O
aspirin O
, O
Lopressor O
, O
and O
admitted O
to O
the O
hospital O
for O
a O
rule O
out O
. O
 
Condition O
on O
admission O
is O
stable O
. O
 
He O
will O
be O
presumptively O
treated O
for O
a O
pneumonia O
on O
the O
right O
side O
. O
 
___________________________________ O
QQ632/54034 I-ID
FREDA I-NAME
F. I-NAME
PELLETIER I-NAME
, O
M.D O
. O
 
FP00 I-NAME
D:09/28/79 O
T:09/28/79 O
Dictated O
by O
: O
FREDA I-NAME
F. I-NAME
PELLETIER I-NAME
, O
M.D O
. O
 
FP00 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2080-08-08 I-DATE
EDVISIT^35093053^Dodd O
, O
Steven^08/08/80^DURHAM O
, O
DENA I-NAME
CHRISTENA I-NAME
CHIEF O
COMPLAINT O
: O
Chest O
pain O
. O
 
I O
confirm O
that O
I O
have O
seen O
and O
evaluated O
this O
patient O
, O
reviewed O
the O
resident O
's O
documentation O
, O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
65-year-old O
gentleman O
with O
a O
history O
of O
coronary O
artery O
disease O
who O
is O
transferred O
here O
from O
an O
outlying O
institution O
after O
an O
episode O
of O
left O
chest O
radiated O
to O
his O
arm O
that O
awoke O
him O
from O
sleep O
at O
about O
11 O
o'clock O
. O
 
This O
resolved O
after O
some O
sublingual O
nitroglycerin O
at O
the O
hospital O
but O
was O
associated O
with O
some O
diaphoresis O
. O
 
He O
can O
not O
tell O
if O
it O
is O
like O
his O
previous O
coronary O
pain O
or O
not O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Negative O
for O
nausea O
, O
vomiting O
, O
diarrhea O
, O
abdominal O
pain O
, O
fever O
, O
or O
chills O
. O
 
Otherwise O
, O
negative O
. O
 
PAST O
MEDICAL O
HISTORY O
, O
MEDICATIONS O
, O
ALLERGIES O
, O
SOCIAL O
, O
AND O
FAMILY O
HISTORY O
: O
As O
per O
the O
chart O
. O
 
PHYSICAL O
EXAMINATION O
: O
Shows O
a O
well-developed O
morbidly O
obese O
gentleman O
snoring O
in O
the O
bed O
in O
no O
acute O
distress O
. O
 
He O
is O
asymptomatic O
when O
I O
see O
him O
and O
complaining O
of O
being O
tired O
. O
 
HEENT O
is O
normocephalic O
, O
atraumatic O
. O
 
Oropharynx O
is O
unremarkable O
. O
 
Neck O
is O
supple O
. O
 
Chest O
is O
clear O
. O
 
Abdomen O
is O
morbidly O
obese O
, O
soft O
, O
and O
nontender O
. O
 
Extremities O
are O
without O
cyanosis O
, O
clubbing O
, O
or O
edema O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
has O
an O
EKG O
, O
an O
abnormal O
but O
unchanged O
in O
comparison O
with O
previously O
. O
 
He O
had O
a O
total O
troponin O
here O
of O
0.99 O
equal O
to O
the O
0.1 O
at O
the O
outlying O
institution O
. O
 
His O
MB O
is O
8 O
with O
a O
CK O
of O
242 O
. O
 
His O
creatinine O
is O
also O
4.5 O
. O
 
PLAN O
: O
Admission O
to O
the O
hospital O
for O
further O
evaluation O
. O
 
DIAGNOSIS O
: O
Non-Q-wave O
, O
non-ST-elevation O
myocardial O
infarction O
. O
 
DISPOSITION O
: O
The O
patient O
is O
admitted O
for O
further O
care O
. O
 
______________________________ O
DURHAM O
, O
DENA I-NAME
CHRISTENA I-NAME
M.D O
. O
 
D O
: O
08/08/80 I-DATE
T O
: O
08/08/80 I-DATE
Dictated O
By O
: O
DURHAM O
, O
DENA I-NAME
CHRISTENA I-NAME
eScription O
document:5-0405500 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2080-09-20 I-DATE
EDVISIT^35093053^Dodd O
, O
Steven^09/20/80^FARMER O
, O
F. I-NAME
KELLY I-NAME
TIME O
OF O
DICTATION O
: O
6:40 O
a.m. O
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
patient O
is O
a O
65-year-old O
male O
who O
presents O
to O
Douglas I-LOCATION
Community I-LOCATION
Hospital I-LOCATION
Department O
of O
Emergency O
Medicine O
with O
complaints O
of O
chest O
pain O
. O
 
The O
chest O
pain O
is O
midsternal O
pressure O
type O
in O
sensation O
and O
not O
associated O
with O
nausea O
or O
vomiting O
. O
 
He O
is O
awake O
and O
alert O
in O
the O
ED O
and O
noted O
to O
be O
in O
mild O
distress O
. O
 
This O
patient O
is O
a O
morbidly O
obese O
male O
and O
weighs O
approximately O
400 O
pounds O
. O
 
The O
resident O
's O
note O
was O
reviewed O
. O
 
The O
patient O
was O
interviewed O
. O
 
The O
patient O
was O
examined O
by O
me O
. O
 
I O
concur O
with O
the O
workup O
and O
evaluation O
of O
the O
patient O
in O
the O
ED O
. O
 
For O
more O
detailed O
note O
on O
this O
patient O
, O
please O
review O
the O
resident O
's O
note O
. O
 
Please O
review O
the O
resident O
's O
note O
for O
past O
medical O
history O
, O
surgical O
history O
, O
review O
of O
systems O
, O
medications O
, O
allergies O
, O
family O
history O
, O
and O
social O
history O
. O
 
PHYSICAL O
EXAMINATION O
: O
HEENT O
: O
Normocephalic O
, O
atraumatic O
. O
 
Pupils O
were O
equal O
, O
round O
, O
and O
reactive O
. O
 
Fundi O
were O
benign O
. O
 
Neck O
was O
supple O
. O
 
Chest O
was O
clear O
to O
auscultation O
and O
percussion O
. O
 
I O
noted O
no O
rales O
, O
wheezes O
, O
or O
rhonchi O
. O
 
Heart O
noted O
a O
normal O
S1 O
, O
S2 O
. O
 
No O
S3 O
, O
S4 O
. O
 
No O
murmur O
. O
 
Abdomen O
was O
protruding O
. O
 
It O
was O
nontender O
. O
 
I O
noted O
no O
masses O
or O
guarding O
. O
 
His O
extremities O
were O
positive O
for O
1+ O
pitting O
edema O
. O
 
Neurologically O
, O
he O
was O
awake O
, O
alert O
, O
and O
able O
to O
follow O
all O
commands O
. O
 
Negative O
Babinski O
. O
 
LABORATORY O
DATA O
: O
He O
had O
a O
white O
count O
of O
7 O
and O
hematocrit O
of O
34 O
. O
 
Normal O
serum O
electrolytes O
except O
for O
a O
creatinine O
of O
4.6 O
with O
a O
BUN O
of O
57 O
as O
well O
as O
a O
glucose O
of O
213 O
and O
as O
well O
as O
sodium O
of O
130 O
. O
 
His O
troponin O
I O
was O
0.69 O
. O
 
His O
CK O
was O
140 O
. O
 
His O
CK-MB O
was O
6.4 O
. O
 
His O
PT O
was O
15 O
, O
PTT O
was O
34 O
, O
and O
INR O
was O
1.1 O
. O
 
Chest O
x-ray O
noted O
increased O
markings O
but O
not O
consistent O
with O
congestive O
failure O
. O
 
His O
EKG O
noted O
a O
normal O
sinus O
rhythm O
with O
a O
nonspecific O
interventricular O
block O
. O
 
DIAGNOSTIC O
IMPRESSION O
IN O
THE O
EMERGENCY O
DEPARTMENT O
: O
Acute O
coronary O
syndrome O
. O
 
The O
patient O
had O
an O
IV O
placed O
. O
 
He O
was O
given O
Lopressor O
, O
heparin O
, O
and O
morphine O
for O
his O
chest O
pain O
, O
and O
admitted O
to O
the O
Internal O
Medicine O
Service O
for O
further O
workup O
and O
evaluation O
of O
his O
chest O
pain O
. O
 
______________________________ O
FARMER O
, O
F. I-NAME
KELLY I-NAME
M.D O
. O
 
D O
: O
09/21/80 I-DATE
T O
: O
09/21/80 I-DATE
Dictated O
By O
: O
FARMER O
, O
F. I-NAME
KELLY I-NAME
eScription O
document:7-5881990 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2081-03-02 I-DATE
EDVISIT^35093053^Dodd O
, O
Steven^03/02/81^CHURCH O
, O
XION I-NAME
I O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
The O
Medical O
Intensive O
Care O
Unit O
team O
, O
the O
senior O
admitting O
resident O
, O
and O
other O
members O
of O
the O
medical O
staff O
. O
 
Please O
refer O
to O
the O
resident O
's O
chart O
for O
details O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Briefly O
, O
Mr. O
Dodd I-NAME
is O
a O
65-year-old O
man O
with O
congestive O
heart O
failure O
and O
multiple O
other O
medical O
problems O
, O
who O
was O
brought O
in O
by O
ambulance O
in O
respiratory O
distress O
. O
 
We O
found O
him O
to O
be O
in O
near O
respiratory O
failure O
. O
 
He O
was O
treated O
with O
bilevel O
positive O
airway O
pressure O
ventilation O
as O
well O
as O
morphine O
, O
aspirin O
, O
Lasix O
, O
and O
nitroglycerin O
. O
 
He O
had O
a O
dramatic O
improvement O
. O
 
Further O
details O
are O
in O
the O
resident's O
chart O
. O
 
PRIMARY O
DIAGNOSIS O
: O
Congestive O
heart O
failure O
exacerbation O
with O
incipient O
respiratory O
failure O
. O
 
SECONDARY O
DIAGNOSIS O
: O
Acute O
on O
chronic O
renal O
insufficiency O
. O
 
THIRD O
DIAGNOSIS O
: O
Urinary O
tract O
infection O
. O
 
PLAN O
: O
Antibiotic O
treatment O
. O
 
Continued O
bilevel O
positive O
airway O
pressure O
ventilation O
, O
admission O
to O
the O
Medical O
Intensive O
Care O
Unit O
. O
 
CRITICAL O
CARE O
TIME O
: O
35 O
minutes O
. O
 
CONDITION O
: O
Fair O
. O
 
______________________________ O
CHURCH O
, O
XION I-NAME
M.D O
. O
 
D O
: O
03/02/81 I-DATE
T O
: O
03/02/81 I-DATE
Dictated O
By O
: O
CHURCH O
, O
XION I-NAME
eScription O
document:6-1192641 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2088-03-06 I-DATE
RHINELAND I-LOCATION
EMERGENCY O
DEPT O
VISIT O
PIERRE I-NAME
, O
EDEN O
241-52-56-3 I-ID
VISIT O
DATE O
: O
03/06/88 I-DATE
The O
patient O
was O
evaluated O
by O
me O
with O
a O
resident O
. O
 
The O
resident O
's O
history O
was O
reviewed O
and O
the O
patient O
interviewed O
and O
examined O
. O
 
Briefly O
, O
history O
is O
as O
follows O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
patient O
is O
a O
72 I-AGE
year-old O
female O
complaining O
of O
chest O
tightness O
lasting O
approximately O
30 O
minutes O
after O
climbing O
stairs O
at O
home O
. O
 
She O
reports O
she O
has O
been O
having O
increasing O
bouts O
of O
shortness O
of O
breath O
over O
the O
preceding O
week O
. O
 
She O
denies O
diaphoresis O
, O
palpitations O
or O
radiations O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
There O
is O
chest O
pain O
, O
as O
noted O
above O
, O
and O
shortness O
of O
breath O
, O
as O
noted O
above O
. O
 
All O
other O
systems O
are O
negative O
except O
as O
noted O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Previous O
myocardial O
infarction O
and O
hypothyroidism O
. O
 
MEDICATIONS O
: O
See O
nursing O
note O
. O
 
ALLERGIES O
: O
Morphine O
sulfate O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
The O
patient O
is O
a O
past O
smoker O
and O
a O
nondrinker O
who O
lives O
alone O
. O
 
Family O
history O
is O
noncontributory O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
Awake O
, O
alert O
and O
in O
no O
acute O
distress O
. O
 
VITAL O
SIGNS O
: O
Stable O
and O
normal O
. O
 
HEENT O
: O
Benign O
. O
 
NECK O
: O
Supple O
. O
 
LUNGS O
: O
Breath O
sounds O
showed O
left O
lower O
lobar O
rales O
and O
rhonchi O
. O
 
HEART O
: O
Regular O
rate O
and O
rhythm O
. O
 
ABDOMEN O
: O
Soft O
and O
non-tender O
. O
 
LABORATORY O
EVALUATION O
: O
Electrolytes O
were O
normal O
. O
 
Cardiac O
enzymes O
were O
negative O
. O
 
CBC O
was O
normal O
. O
 
EKG O
showed O
sinus O
rhythm O
with O
nonspecific O
ST-T O
wave O
changes O
. O
 
Chest O
x-ray O
showed O
mild O
cardiomegaly O
without O
other O
abnormality O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
treated O
with O
aspirin O
, O
beta O
blockers O
, O
and O
oxygen O
. O
 
Ultimately O
she O
was O
admitted O
to O
the O
hospital O
for O
definitive O
evaluation O
and O
further O
care O
following O
consultation O
with O
the O
DHD I-LOCATION
cardiologist O
. O
 
See O
resident O
's O
note O
for O
further O
details O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Admitted O
in O
stable O
condition O
. O
 
___________________________________ O
FT188/35814 I-ID
ORLANDO I-NAME
R. I-NAME
PIERRE I-NAME
, O
M.D O
. O
 
OP63 I-NAME
D:03/07/88 O
T:03/07/88 O
Dictated O
by O
: O
ORLANDO I-NAME
R. I-NAME
PIERRE I-NAME
, O
M.D O
. O
 
OP63 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2089-03-28 I-DATE
RHINELAND I-LOCATION
EMERGENCY O
DEPT O
VISIT O
PIERRE O
, O
EDEN O
241-52-56-3 I-ID
VISIT O
DATE O
: O
03/28/89 I-DATE
The O
patient O
was O
interviewed O
and O
examined O
by O
myself O
with O
the O
resident O
on O
3/28/89 I-DATE
. O
 
Please O
see O
resident O
's O
note O
for O
full O
details O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
The O
patient O
is O
a O
female O
with O
history O
of O
coronary O
artery O
disease O
, O
AICD O
, O
and O
cardiomyopathy O
who O
comes O
in O
today O
with O
chest O
pain O
, O
onset O
iffy O
while O
she O
is O
walking O
, O
substernal O
right O
anterior O
chest O
. O
 
Went O
to O
sleep O
, O
had O
some O
shortness O
of O
breath O
, O
no O
diaphoresis O
, O
nausea O
or O
dizziness O
. O
 
Similar O
to O
this O
pain O
in O
the O
past O
was O
her O
myocardial O
infarction O
. O
 
She O
has O
chronic O
risk O
factors O
of O
hypercholesterolemia O
, O
apparent O
menopausal O
, O
echocardiogram O
on O
9/87 I-DATE
, O
10 O
to O
15 O
% O
global O
hypokinesis O
. O
 
Catheterization O
is O
left O
main O
disease O
, O
50 O
% O
ostial O
disease O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
As O
in O
history O
of O
present O
illness O
but O
no O
recent O
upper O
respiratory O
infection O
symptoms O
or O
orthopnea O
, O
or O
exercise O
intolerance O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
As O
above O
. O
 
Surgery O
procedure O
: O
ASAD O
placement O
. O
 
MEDICATIONS O
: O
See O
nurses O
notes O
for O
details O
. O
 
ALLERGIES O
: O
See O
nurses O
notes O
for O
details O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
No O
tobacco O
or O
ETOH O
. O
 
Lives O
with O
family O
, O
accompanied O
by O
a O
friend O
tonight O
. O
 
Family O
history O
: O
Diabetes O
. O
 
PHYSICAL O
EXAMINATION O
: O
Alert O
and O
awake O
, O
pleasant O
female O
in O
no O
apparent O
distress O
. O
 
Agree O
with O
resident O
's O
documentation O
including O
normal O
pulse O
, O
blood O
pressure O
120/86 O
, O
02 O
sat O
98 O
% O
. O
 
Clear O
lungs O
. O
 
Heart O
is O
regular O
rate O
and O
rhythm O
. O
 
Abdomen O
is O
soft O
. O
 
Neuro O
: O
Alert O
and O
oriented O
x3 O
. O
 
No O
obvious O
cranial O
, O
or O
motor O
or O
sensory O
deficit O
. O
 
LABORATORY O
EVALUATION O
: O
Given O
her O
history O
of O
coronary O
artery O
disease O
and O
her O
symptoms O
an O
electrocardiogram O
was O
unchanged O
. O
 
Hematocrit O
is O
37 O
. O
 
BUN O
and O
creatinine O
19 O
and O
1 O
. O
 
Liver O
function O
tests O
are O
within O
normal O
limits O
. O
 
CK O
127 O
, O
troponin O
.01 O
. O
 
Electrocardiogram O
, O
rhythm O
is O
paced O
, O
unchanged O
from O
priors O
. O
 
Chest O
x-ray O
is O
mild O
congestive O
heart O
failure O
compared O
to O
prior O
examinations O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
Aspirin O
was O
given O
and O
she O
is O
chest O
pain O
free O
currently O
. O
 
Case O
was O
discussed O
with O
Guzmans I-LOCATION
Hospital I-LOCATION
Cardiology O
. O
 
Will O
try O
for O
an O
exercise O
tolerance O
test O
later O
on O
in O
the O
afternoon O
. O
 
Care O
was O
discussed O
with O
Dr. O
Rhodes I-NAME
. O
 
FINAL O
DIAGNOSIS O
: O
Chest O
pain O
, O
rule O
out O
acute O
coronary O
syndrome O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Patient O
currently O
in O
stable O
condition O
. O
 
___________________________________ O
ZP289/32887 I-ID
FLORENCE I-NAME
F. I-NAME
CASEY I-NAME
, O
M.D O
. O
 
FC44 I-NAME
D:03/28/89 O
T:03/28/89 O
Dictated O
by O
: O
FLORENCE I-NAME
F. I-NAME
CASEY I-NAME
, O
M.D O
. O
 
FC44 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2090-07-15 I-DATE
EDVISIT^24152563^Pierre O
, O
Eden^07/15/90^MCCARTY O
, O
QUINTON I-NAME
Seen O
with O
Dr. O
Feliciano I-NAME
. O
 
The O
past O
medical O
history O
, O
social O
history O
, O
family O
history O
, O
review O
of O
systems O
, O
medications O
, O
and O
allergies O
were O
reviewed O
and O
confirmed O
. O
 
Please O
see O
resident's O
note O
for O
further O
details O
. O
 
I O
had O
interviewed O
and O
examined O
the O
patient O
myself O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Briefly O
, O
this O
is O
a O
75-year-old O
female O
with O
a O
known O
history O
of O
CAD O
, O
status O
post O
MI O
, O
EF O
of O
10 O
to O
15 O
% O
with O
an O
AICD O
placement O
. O
 
Also O
, O
history O
of O
CHF O
and O
hyperparathyroidism O
. O
 
She O
presents O
with O
complaints O
of O
shortness O
of O
breath O
for O
the O
past O
3 O
hours O
with O
some O
epigastric O
discomfort O
. O
 
She O
denies O
fever O
, O
chills O
, O
or O
cough O
. O
 
She O
has O
had O
some O
abdominal O
and O
chest O
discomfort O
. O
 
She O
may O
be O
from O
1 O
year O
ago O
showing O
no O
reversible O
ischemia O
but O
a O
previous O
catheterization O
showing O
no O
disease O
. O
 
SOCIAL O
HISTORY O
: O
She O
lives O
with O
her O
family O
. O
 
She O
is O
a O
former O
smoker O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Otherwise O
, O
negative O
. O
 
MEDICATIONS O
: O
She O
takes O
albuterol O
, O
Lipitor O
, O
captopril O
, O
digoxin O
, O
Levoxyl O
, O
Lasix O
, O
and O
Coumadin O
. O
 
ALLERGIES O
: O
Has O
allergies O
to O
morphine O
. O
 
PHYSICAL O
EXAMINATION O
: O
She O
is O
afebrile O
, O
heart O
rate111 O
, O
blood O
pressure O
105/7118 O
, O
and O
oxygen O
saturation O
100 O
% O
on O
4 O
liters O
. O
 
She O
is O
awake O
, O
alert O
, O
and O
in O
moderate O
distress O
. O
 
HEENT O
: O
Normocephalic O
, O
atraumatic O
. O
 
Pupils O
: O
Equal O
, O
round O
and O
reactive O
to O
light O
. O
 
Sclerae O
are O
anicteric O
. O
 
Neck O
is O
supple O
and O
nontender O
. O
 
Chest O
is O
with O
bibasilar O
crackles O
. O
 
Cardiovascular O
exam O
: O
Irregularly O
irregular O
with O
a O
2/6 O
systolic O
murmur O
at O
the O
left O
upper O
sternal O
border O
. O
 
Abdomen O
is O
soft O
and O
nontender O
. O
 
Skin O
is O
warm O
and O
dry O
. O
 
Extremities O
without O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
Neurological O
: O
Alert O
and O
oriented O
. O
 
Cranial O
nerves O
II O
through O
XII O
are O
intact O
. O
 
There O
are O
no O
motor O
or O
sensory O
deficits O
. O
 
Initial O
cardiogram O
showing O
numerous O
PVCs O
with O
occasional O
negative O
complex O
is O
consistent O
with O
her O
previous O
EKG O
with O
the O
appearance O
of O
likely O
atrial O
fibrillation O
. O
 
After O
some O
diuresis O
and O
a O
beta O
blockade O
, O
she O
has O
slowed O
down O
to O
the O
90s O
from O
the O
130s O
and O
appeared O
to O
have O
normal O
sinus O
rhythm O
with O
frequent O
PVCs O
. O
 
Her O
chest O
film O
shows O
some O
mild O
CHF O
, O
and O
she O
was O
started O
on O
heparin O
. O
 
LABORATORY O
DATA O
: O
Sodium O
134 O
, O
glucose O
178 O
. O
 
Normal O
extending O
chemistries O
. O
 
CK O
of O
115 O
with O
an O
MB O
of O
2 O
. O
 
Digoxin O
level O
is O
0.8 O
. O
 
TSH O
is O
8.8 O
. O
 
Troponin O
is O
less O
than O
assay O
. O
 
White O
count O
is O
7.5 O
, O
hematocrit O
42 O
, O
and O
platelets O
238,000 O
. O
 
INR O
2.1 O
. O
 
Heparin O
was O
not O
initiated O
as O
she O
was O
already O
anticoagulated O
, O
but O
she O
did O
receive O
diuresis O
. O
 
She O
is O
admitted O
in O
stable O
condition O
. O
 
CLINICAL O
IMPRESSION O
: O
Unstable O
angina O
with O
frequent O
PVCs O
. O
 
Her O
cardiology O
consultation O
is O
pending O
at O
this O
time O
. O
 
______________________________ O
MCCARTY O
, O
QUINTON I-NAME
M.D O
. O
 
D O
: O
07/16/90 I-DATE
T O
: O
07/16/90 I-DATE
Dictated O
By O
: O
MCCARTY O
, O
QUINTON I-NAME
eScription O
document:1-6926631 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2091-10-14 I-DATE
EDVISIT^24152563^Pierre O
, O
Eden^10/14/91^PITTMAN O
, O
THOMAS I-NAME
CHIEF O
COMPLAINT O
: O
Shortness O
of O
breath O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
67-year-old O
female O
with O
end-stage O
cardiac O
disease O
with O
ischemic O
cardiomyopathy O
, O
who O
I O
see O
together O
with O
the O
resident O
. O
 
The O
resident O
's O
history O
was O
reviewed O
. O
 
The O
patient O
was O
interviewed O
and O
examined O
by O
me O
. O
 
In O
brief O
, O
apparently O
the O
EMS O
was O
summoned O
to O
the O
scene O
inadvertently O
this O
morning O
. O
 
She O
is O
end-stage O
, O
she O
is O
on O
hospice O
and O
comfort O
measures O
only O
, O
and O
she O
apparently O
was O
quite O
poorly O
feeling O
this O
morning O
and O
was O
transported O
. O
 
Her O
son O
has O
called O
several O
times O
and O
wants O
to O
transport O
her O
back O
in O
a O
discussion O
with O
her O
. O
 
She O
is O
quite O
weak O
and O
understands O
her O
circumstances O
, O
wishes O
to O
be O
transported O
back O
as O
well O
. O
 
PAST O
MEDICAL O
HISTORY O
, O
REVIEW O
OF O
SYSTEMS O
, O
SOCIAL O
HISTORY O
, O
MEDICATIONS O
, O
AND O
ALLERGIES O
: O
All O
per O
the O
chart O
. O
 
PHYSICAL O
EXAMINATION O
: O
She O
is O
alert O
. O
 
She O
certainly O
appears O
end-stage O
. O
 
She O
has O
a O
JVP O
at O
14-16 O
cm O
. O
 
She O
has O
lungs O
with O
decreased O
breath O
sounds O
throughout O
her O
heart O
. O
 
There O
is O
a O
3/6 O
holosystolic O
murmur O
heard O
very O
weakly O
. O
 
Her O
abdomen O
is O
soft O
and O
nontender O
without O
organomegaly O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
She O
has O
electrocardiogram O
, O
which O
is O
remarkable O
for O
sinus O
rhythm O
with O
nonspecific O
intraventricular O
conduction O
delay O
and O
ugly O
appearing O
. O
 
Electrocardiogram O
is O
rather O
wide O
complexed O
. O
 
She O
has O
a O
first-degree O
AV O
block O
and O
a O
leftward O
axis O
. O
 
The O
case O
was O
discussed O
with O
her O
cardiologist O
, O
social O
worker O
, O
case O
manager O
, O
and O
family O
and O
she O
is O
discharged O
home O
. O
 
IMPRESSION O
: O
End-stage O
ischemic O
cardiomyopathy O
. O
 
DISPOSITION O
AND O
PLAN O
: O
She O
is O
discharged O
home O
to O
continue O
with O
hospice O
and O
expectant O
care O
. O
 
______________________________ O
PITTMAN O
, O
THOMAS I-NAME
M.D O
. O
 
D O
: O
10/14/91 I-DATE
T O
: O
10/14/91 I-DATE
Dictated O
By O
: O
PITTMAN O
, O
THOMAS I-NAME
eScription O
document:1-6434630 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2067-06-18 I-DATE
JELLICO I-LOCATION
EMERGENCY O
DEPT O
VISIT O
FOY O
, O
KEONTE O
H. I-NAME
732-35-79-0 I-ID
VISIT O
DATE O
: O
06/18/67 I-DATE
PRESENTING O
COMPLAINT O
and O
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
patient O
was O
evaluated O
in O
conjunction O
with O
a O
resident O
. O
 
Briefly O
, O
the O
history O
is O
as O
follows O
: O
This O
patient O
is O
a O
54-year-old O
black O
male O
with O
a O
history O
of O
insulin-dependent O
diabetes O
mellitus O
, O
who O
presents O
with O
acute O
, O
severe O
substernal O
chest O
pain O
. O
 
This O
pain O
began O
approximately O
five O
hours O
prior O
to O
presentation O
, O
but O
accelerated O
within O
the O
previous O
one O
to O
two O
hours O
. O
 
It O
is O
accompanied O
by O
diaphoresis O
, O
but O
not O
by O
shortness O
of O
breath O
or O
nausea O
. O
 
The O
patient O
does O
have O
a O
history O
of O
prior O
CVAs O
, O
but O
no O
history O
of O
previously O
documented O
cardiac O
disease O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
examination O
, O
the O
patient O
is O
in O
acute O
, O
severe O
distress O
. O
 
He O
is O
diaphoretic O
and O
somewhat O
pale O
. O
 
The O
vital O
signs O
are O
as O
recorded O
in O
the O
Nurses O
' O
Notes O
but O
are O
stable O
initially O
. O
 
The O
HEENT O
examination O
shows O
the O
sclerae O
to O
be O
anicteric O
. O
 
The O
oropharynx O
is O
somewhat O
dry O
. O
 
The O
neck O
is O
supple O
, O
without O
venous O
distention O
. O
 
The O
breath O
sounds O
are O
clear O
bilaterally O
. O
 
The O
heart O
shows O
a O
regular O
rate O
and O
rhythm O
with O
somewhat O
distant O
tones O
, O
without O
discrete O
murmur O
. O
 
The O
abdomen O
is O
slightly O
obese O
and O
soft O
throughout O
, O
without O
tenderness O
. O
 
The O
extremities O
show O
no O
discoloration O
or O
edema O
. O
 
LABORATORY O
EVALUATION O
: O
The O
electrocardiogram O
shows O
an O
acute O
anterior O
myocardial O
infarction O
. O
 
Other O
laboratory O
studies O
are O
pending O
at O
this O
time O
. O
 
A O
chest O
x-ray O
has O
been O
obtained O
, O
though O
it O
has O
not O
been O
processed O
at O
the O
time O
of O
this O
dictation O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
treated O
with O
aspirin O
and O
nitroglycerin O
en O
route O
. O
 
He O
was O
started O
on O
a O
nitroglycerin O
drip O
, O
which O
was O
incrementally O
increased O
to O
80 O
micrograms O
per O
minute O
. O
 
He O
was O
given O
morphine O
sulfate O
in O
2 O
mg O
increments O
to O
a O
total O
of O
10 O
mg O
. O
 
He O
was O
given O
5000 O
units O
of O
intravenous O
heparin O
. O
 
He O
was O
given O
2.5 O
mg O
of O
intravenous O
Lopressor O
. O
 
The O
Cardiology O
Service O
is O
here O
with O
the O
patient O
and O
he O
is O
being O
taken O
to O
the O
Cardiac O
Catheterization O
Laboratory O
for O
immediate O
angioplasty O
. O
 
FINAL O
DIAGNOSIS O
: O
Myocardial O
infarction O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
As O
above O
. O
 
Please O
see O
the O
handwritten O
record O
for O
further O
details O
. O
 
___________________________________ O
HA304/1577 I-ID
EDGAR I-NAME
BELTRAN I-NAME
, O
M.D O
. O
 
EB83 I-NAME
D:06/18/67 O
T:06/18/67 O
Dictated O
by O
: O
EDGAR I-NAME
BELTRAN I-NAME
, O
M.D O
. O
 
EB83 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2067-07-28 I-DATE
JELLICO I-LOCATION
EMERGENCY O
DEPT O
VISIT O
FOY O
, O
KEONTE O
H. I-NAME
732-35-79-0 I-ID
VISIT O
DATE O
: O
07/28/67 I-DATE
PRESENTING O
COMPLAINT O
: O
Chest O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
The O
patient O
was O
seen O
in O
the O
emergency O
department O
with O
Dr. O
Holden I-NAME
. O
 
History O
was O
reviewed O
with O
Dr. O
Holden I-NAME
and O
patient O
. O
 
Briefly O
, O
this O
is O
a O
59 I-AGE
year O
old O
gentleman O
with O
a O
past O
medical O
history O
positive O
for O
insulin O
dependent O
diabetes O
, O
CVA O
, O
peptic O
ulcer O
disease O
, O
who O
presented O
to O
the O
emergency O
department O
with O
acute O
substernal O
chest O
pain O
radiating O
to O
the O
left O
arm O
, O
positive O
diaphoresis O
and O
shortness O
of O
breath O
, O
three O
or O
four O
episodes O
in O
the O
last O
few O
hours O
, O
the O
last O
episode O
lasting O
20 O
minutes O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
As O
documented O
by O
Dr. O
Holden I-NAME
. O
 
PAST O
MEDICAL O
HISTORY O
: O
As O
documented O
by O
Dr. O
Holden I-NAME
. O
 
MEDICATIONS O
: O
As O
documented O
by O
Dr. O
Holden I-NAME
. O
 
ALLERGIES O
: O
As O
documented O
by O
Dr. O
Holden I-NAME
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
As O
documented O
by O
Dr. O
Holden I-NAME
. O
 
PHYSICAL O
EXAMINATION O
: O
No O
acute O
distress O
. O
 
Blood O
pressure O
is O
120/100 O
, O
pulse O
100 O
and O
regular O
, O
respirations O
16 O
, O
afebrile O
, O
O2 O
sat O
on O
room O
air O
97 O
% O
. O
 
Negative O
HEENT O
. O
 
Patent O
airway O
. O
 
Neck O
: O
Supple O
, O
no O
JVD O
, O
nodes O
or O
bruits O
. O
 
Lungs O
: O
Clear O
, O
equal O
breath O
sounds O
. O
 
Heart O
: O
Regular O
rate O
, O
no O
murmur O
. O
 
No O
chest O
wall O
tenderness O
. O
 
Abdomen O
: O
Soft O
, O
positive O
bowel O
sounds O
. O
 
Extremities O
: O
No O
deformities O
. O
 
Guaiac O
negative O
. O
 
Neurologic O
: O
Alert O
, O
nonfocal O
. O
 
The O
rest O
of O
the O
examination O
is O
unremarkable O
. O
 
LABORATORY O
EVALUATION O
: O
Electrolytes O
, O
BUN O
and O
creatinine O
were O
within O
normal O
limits O
. O
 
Glucose O
of O
26 O
. O
 
CBC O
negative O
. O
 
CK O
75 O
, O
troponin O
0 O
. O
 
EKG O
shows O
hyperacute O
T O
wave O
in O
V1 O
and O
V2 O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
In O
the O
emergency O
department O
, O
the O
patient O
was O
treated O
with O
IV O
Heparin O
, O
Nitroglycerin O
, O
aspirin O
. O
 
Symptoms O
improved O
markedly O
, O
and O
he O
was O
transferred O
to O
the O
Cardiac O
Service O
for O
further O
evaluation O
and O
treatment O
. O
 
FINAL O
DIAGNOSIS O
: O
Chest O
pain O
, O
rule O
out O
M.I O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Total O
time O
was O
2 O
hours O
. O
 
Condition O
on O
admission O
stable O
. O
 
___________________________________ O
MF916/9742 I-ID
TAYLOR I-NAME
E. I-NAME
INNIS I-NAME
, O
M.D O
. O
 
TI56 I-NAME
D:07/28/67 O
T:07/28/67 O
Dictated O
by O
: O
TAYLOR I-NAME
E. I-NAME
INNIS I-NAME
, O
M.D O
. O
 
TI56 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2068-12-22 I-DATE
Jellico I-LOCATION
EMERGENCY O
DEPT O
VISIT O
FOY O
, O
KEONTE O
H. I-NAME
732-35-79-0 I-ID
VISIT O
DATE O
: O
12/22/68 I-DATE
The O
patient O
was O
seen O
by O
me O
and O
examined O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Briefly O
, O
the O
history O
is O
as O
follows O
: O
the O
patient O
is O
a O
60-year-old O
black O
male O
with O
past O
medical O
history O
significant O
for O
insulin O
dependent O
diabetes O
mellitus O
, O
coronary O
artery O
disease O
, O
status O
post O
a O
myocardial O
infarction O
, O
status O
post O
cerebrovascular O
accident O
who O
now O
presents O
for O
evaluation O
of O
syncope O
. O
 
The O
patient O
states O
that O
this O
PM O
he O
had O
an O
episode O
where O
he O
experienced O
nausea O
, O
dizziness O
and O
weakness O
. O
 
He O
also O
states O
that O
he O
developed O
left O
sided O
substernal O
chest O
pressure O
which O
was O
non-radiating O
. O
 
He O
states O
that O
he O
took O
one O
sublingual O
nitroglycerin O
with O
relief O
of O
his O
discomfort O
. O
 
He O
states O
that O
after O
about O
10 O
minutes O
he O
had O
a O
brief O
syncopal O
episode O
lasting O
20-30 O
seconds O
. O
 
He O
states O
that O
it O
was O
witnessed O
by O
his O
wife O
and O
it O
was O
non-observed O
seizure O
activity O
, O
incontinence O
, O
or O
post O
ictal O
confusion O
. O
 
He O
states O
that O
the O
episode O
occurred O
while O
he O
was O
walking O
to O
the O
bathroom O
. O
 
He O
does O
remember O
falling O
to O
the O
floor O
, O
but O
denies O
any O
trauma O
. O
 
He O
specifically O
denies O
any O
headache O
, O
neck O
pain O
, O
chest O
pain O
, O
shortness O
of O
breath O
, O
abdominal O
pain O
, O
or O
focal O
numbness O
or O
weakness O
. O
 
The O
patient O
was O
found O
by O
paramedics O
awake O
, O
alert O
, O
oriented O
x O
3 O
. O
 
An O
Accu-Chek O
in O
the O
field O
revealed O
a O
blood O
sugar O
of O
30 O
and O
the O
patient O
was O
treated O
with O
1 O
amp O
of O
D50 O
. O
 
He O
was O
subsequently O
transferred O
to O
Jellico I-LOCATION
Community I-LOCATION
Hospital I-LOCATION
Emergency O
Department O
for O
further O
evaluation O
and O
management O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Review O
of O
systems O
is O
as O
noted O
above O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Past O
medical O
history O
is O
as O
noted O
above O
. O
 
MEDICATIONS O
: O
Current O
medications O
are O
significant O
for O
atenolol O
, O
Axid O
, O
nitroglycerin O
, O
Coumadin O
and O
insulin O
. O
 
ALLERGIES O
: O
He O
has O
a O
known O
drug O
allergy O
to O
zocor O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
Social O
history O
is O
significant O
for O
the O
patient O
stop O
smoking O
approximately O
one O
year O
ago O
. O
 
He O
denies O
alcohol O
use O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
EXAMINATION O
: O
Well-developed O
, O
well-nourished O
, O
well-appearing O
male O
in O
no O
acute O
distress O
. O
 
VITAL O
SIGNS O
: O
Temperature O
100.3 O
, O
blood O
pressure O
110/65 O
, O
pulse O
84 O
, O
respiratory O
rate O
18 O
and O
oxygen O
saturation O
is O
96 O
% O
on O
room O
air O
. O
 
HEAD O
, O
EYES O
, O
EARS O
, O
NOSE O
AND O
THROAT O
EXAMINATION O
: O
Normocephalic O
and O
atraumatic O
. O
 
Mucous O
membranes O
are O
moist O
without O
lesions O
. O
 
NECK O
EXAMINATION O
: O
The O
neck O
is O
supple O
, O
non-tender O
with O
full O
range O
of O
motion O
and O
no O
JVD O
. O
 
LUNGS O
: O
Lungs O
are O
clear O
to O
auscultation O
. O
 
CARDIOVASCULAR O
EXAMINATION O
: O
Heart O
has O
a O
regular O
rate O
and O
rhythm O
. O
 
ABDOMINAL O
EXAMINATION O
: O
Abdomen O
is O
soft O
, O
non-tender O
and O
non-distended O
. O
 
PELVIC O
EXAMINATION O
: O
Pelvis O
is O
stable O
. O
 
BACK O
EXAMINATION O
: O
Back O
has O
no O
costovertebral O
angle O
tenderness O
. O
 
No O
midline O
, O
thoracic O
, O
lumbar O
, O
and O
sacral O
spine O
tenderness O
. O
 
EXTREMITIES O
: O
Extremities O
are O
atraumatic O
, O
full O
range O
of O
motion O
with O
no O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
No O
calf O
tenderness O
and O
negative O
Homan O
's O
signs O
. O
 
NEUROLOGIC O
EXAMINATION O
: O
Awake O
, O
alert O
and O
oriented O
x O
3 O
. O
 
Speech O
is O
clear O
, O
fluent O
and O
articulate O
. O
 
Cranial O
nerves O
II-XII O
intact O
. O
 
Motor O
is O
5/5 O
. O
 
Reflexes O
are O
2+ O
with O
downgoing O
toes O
. O
 
Cerebella O
, O
finger O
to O
nose O
intact O
. O
 
Gait O
was O
not O
tested O
. O
 
LABORATORY O
EVALUATION O
: O
CBC O
, O
white O
blood O
cell O
count O
15 O
, O
hematocrit O
44 O
, O
and O
platelets O
346 O
. O
 
SMA O
7 O
notable O
for O
a O
blood O
sugar O
of O
264 O
, O
creatine O
phosphokinase O
42 O
, O
cardiac O
troponin O
I O
0.0 O
and O
INR O
of O
3.6 O
. O
 
ELECTROCARDIOGRAM O
: O
Electrocardiogram O
revealed O
a O
normal O
sinus O
rhythm O
at O
a O
rate O
of O
86 O
with O
right O
bundle O
branch O
block O
and O
nonspecific O
T O
wave O
changes O
. O
 
CHEST O
X-RAY O
: O
Chest O
x-ray O
is O
pending O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
will O
be O
admitted O
to O
the O
Medical O
Service O
for O
further O
evaluation O
and O
management O
. O
 
His O
primary O
care O
physician O
, O
Dr. O
Hooper I-NAME
was O
notified O
and O
agreed O
with O
the O
management O
and O
plan O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
His O
primary O
care O
physician O
, O
Dr. O
Hooper I-NAME
. O
 
FINAL O
DIAGNOSIS O
: O
1 O
. O
 
Syncope O
, O
rule O
out O
myocardial O
infarction O
. O
 
2 O
. O
 
Hypoglycemia O
, O
resolved O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
was O
admitted O
to O
the O
hospital O
in O
satisfactory O
condition O
. O
 
___________________________________ O
PD770/9096 I-ID
KYLE I-NAME
TEAGUE I-NAME
, O
M.D O
. O
 
KT24 I-NAME
D:12/23/68 O
T:12/23/68 O
Dictated O
by O
: O
KYLE I-NAME
TEAGUE I-NAME
, O
M.D O
. O
 
KT24 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2070-06-15 I-DATE
JELLICO I-LOCATION
COMMUNITY I-LOCATION
HOSPITAL I-LOCATION
Jellico I-LOCATION
Internal O
Medicine O
Associates O
44 I-LOCATION
Brigham I-LOCATION
St I-LOCATION
Elwood I-LOCATION
, O
OH I-LOCATION
49817 I-LOCATION
Foy O
, O
Keonte I-NAME
73235790 I-ID
06/15/70 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
pleasant O
62-year-old O
African O
American O
gentleman O
returns O
to O
my O
clinic O
today O
for O
follow-up O
of O
diabetes O
, O
status O
post O
MI O
, O
hyperlipidemia O
, O
and O
hypertension O
. O
 
1 O
. O
 
He O
brings O
in O
his O
blood O
sugar O
values O
with O
him O
today O
. O
 
These O
are O
improved O
since O
his O
last O
visit O
, O
and O
somewhat O
more O
believable O
ranging O
from O
128 O
to O
195 O
, O
predominantly O
higher O
in O
the O
evenings O
more O
than O
the O
mornings O
ranging O
from O
150 O
to O
190 O
. O
 
He O
is O
currently O
on O
a O
somewhat O
odd O
regime O
of O
6 O
units O
of O
insulin O
regular O
twice O
a O
day O
, O
with O
a O
large O
24 O
units O
of O
insulin O
at O
night O
, O
and O
14 O
units O
insulin O
in O
the O
morning O
. O
 
He O
has O
not O
had O
any O
further O
hypoglycemic O
attacks O
, O
is O
having O
no O
nocturnal O
awakening O
, O
and O
seems O
to O
be O
sticking O
more O
to O
the O
diet O
. O
 
He O
has O
however O
gained O
some O
weight O
, O
which O
is O
a O
little O
disconcerting O
. O
 
He O
does O
attend O
a O
podiatrist O
and O
is O
doing O
well O
from O
that O
perspective O
. O
 
He O
is O
to O
return O
to O
the O
ophthalmologist O
for O
further O
diabetic O
screening O
later O
on O
in O
the O
year O
. O
 
He O
missed O
his O
last O
nutrition O
appointment O
and O
is O
not O
interested O
in O
further O
follow-up O
with O
nutrition O
at O
this O
time O
. O
 
2 O
. O
 
Cardiovascular O
. O
 
He O
is O
on O
atorvastatin O
20 O
mg O
for O
hyperglyceridemia O
, O
atenolol O
25 O
mg O
, O
and O
aspirin O
. O
 
Further O
question O
regarding O
his O
stroke O
back O
in O
2061 I-DATE
shows O
that O
this O
presents O
with O
confusional O
episode O
with O
unsteadiness O
, O
resolving O
after O
approximately O
36 O
hours O
, O
and O
he O
was O
found O
to O
have O
a O
hole O
in O
his O
heart O
at O
that O
time O
. O
 
He O
was O
eventually O
stopped O
off O
Coumadin O
in O
2063 I-DATE
, O
but O
had O
a O
recurrent O
episode O
at O
that O
time O
and O
he O
was O
put O
on O
Coumadin O
for O
life O
at O
that O
point O
. O
 
He O
had O
an O
aborted O
myocardial O
infarction O
in O
2067 I-DATE
. O
 
He O
has O
had O
no O
chest O
pain O
in O
the O
interim O
, O
has O
good O
exercise O
tolerance O
with O
walking O
, O
although O
, O
he O
can O
only O
run O
about O
50 O
yards O
before O
getting O
very O
short O
of O
breath O
. O
 
He O
has O
no O
orthopnea O
or O
PND O
. O
 
He O
has O
no O
chest O
pain O
or O
use O
of O
sublingual O
nitro O
. O
 
3 O
. O
 
Health O
maintenance O
. O
 
We O
discussed O
screening O
colonoscopy O
versus O
flexible O
sigmoidoscopy O
and O
the O
relative O
benefit O
of O
each O
of O
those O
. O
 
He O
has O
agreed O
to O
proceed O
with O
colonoscopy O
, O
and O
I O
have O
instructed O
him O
stop O
his O
Coumadin O
and O
aspirin O
five O
days O
before O
the O
test O
and O
to O
have O
an O
INR O
checked O
on O
the O
day O
prior O
to O
the O
test O
. O
 
This O
will O
be O
scheduled O
by O
our O
secretary O
. O
 
He O
will O
restart O
the O
Coumadin O
after O
the O
colonoscopy O
at O
his O
standard O
dose O
and O
titrate O
up O
slowly O
. O
 
CURRENT O
MEDICATIONS O
: O
Include O
aspirin O
, O
atenolol O
, O
insulin O
, O
Coumadin O
, O
and O
Lipitor O
. O
 
Foy O
, O
Keonte I-NAME
73235790 I-ID
06/15/70 I-DATE
Page O
2 O
PHYSICAL O
EXAMINATION O
: O
His O
blood O
pressure O
is O
148/82 O
. O
 
He O
is O
tachycardic O
at O
98 O
beats O
per O
minute O
. O
 
Examination O
of O
his O
eyes O
shows O
persistent O
left- O
sided O
cataract O
. O
 
Examination O
of O
the O
heart O
and O
lungs O
was O
normal O
. O
 
The O
abdominal O
examination O
is O
also O
normal O
. O
 
His O
injection O
sites O
were O
clean O
and O
without O
erythema O
. O
 
There O
is O
no O
evidence O
of O
peripheral O
neuropathy O
and O
his O
feet O
appeared O
well O
. O
 
We O
spent O
some O
time O
today O
talking O
about O
diabetes O
education O
again O
, O
including O
appropriate O
foods O
, O
drinks O
, O
and O
what O
items O
to O
avoid O
. O
 
PLAN O
: O
1 O
. O
 
Supplied O
educational O
materials O
regarding O
diabetes O
management O
, O
including O
calorie O
counting O
, O
weight O
loss O
, O
information O
about O
hypoglycemia O
and O
hyperglycemia O
, O
and O
diabetic O
eye O
care O
. O
 
2 O
. O
 
I O
have O
increased O
insulin O
in O
the O
mornings O
from O
14 O
to O
16 O
units O
and O
left O
the O
other O
doses O
as O
is O
. O
 
3 O
. O
 
I O
have O
increased O
the O
atenolol O
from O
25 O
mg O
to O
50 O
mg O
for O
hypertension O
and O
cardioprotection O
with O
the O
tachycardia O
. O
 
4 O
. O
 
We O
will O
check O
cholesterol O
, O
hemoglobin O
A1c O
, O
CBC O
, O
and O
chem-7 O
. O
 
5 O
. O
 
I O
have O
scheduled O
an O
elective O
outpatient O
colonoscopy O
as O
detailed O
above O
for O
colorectal O
cancer O
screening O
. O
 
6 O
. O
 
Return O
to O
see O
in O
a O
week O
's O
time O
, O
understands O
. O
 
He O
can O
discuss O
any O
management O
issues O
regarding O
his O
insulin O
doses O
or O
others O
anytime O
. O
 
Yale I-NAME
Jordan I-NAME
, O
M.D O
. O
 
YJ I-NAME
: O
isenberg:74:585:40 O
; O
00-10142.doc O
; O
DD:06/15/70 O
; O
DT:06/16/70 O
; O
DV:06/15/70 O
========================== O
Preceptor O
's O
Note O
========================== O
62 I-AGE
year O
old O
man O
with O
dm O
and O
vascular O
disease O
. O
 
He O
is O
starting O
to O
improve O
his O
self-care O
of O
dm O
and O
last O
a1c O
was O
8.2 O
Blood O
sugars O
mostly O
less O
than O
250 O
. O
 
Increased O
am O
insulin O
and O
will O
increase O
atenolol O
from O
25 O
-- O
- O
> O
50 O
mg O
for O
a O
bp O
of O
150/88 O
. O
 
______________________________ O
Cochran O
, O
Patricia I-NAME
Hannah I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2066-07-26 I-DATE
CHIEF O
COMPLAINT O
: O
PER O
DR O
VARNEY I-NAME
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
s/p O
CABG O
2 O
weeks O
ago O
; O
doing O
well O
without O
Sx O
CP/SOB O
; O
was O
depressed O
last O
week O
but O
now O
feeling O
much O
better O
that O
she O
walking O
outside O
home O
and O
back O
on O
Wellbutrin O
( O
inadvertantly O
stopped O
) O
Here O
to O
have O
chest O
skin O
sutures O
removed O
PAST O
MEDICAL I-LOCATION
HISTORY O
: O
Entered O
By O
: O
frye I-NAME
On:03/13/2066 O
Endocrine O
disorders O
: O
type O
II O
, O
non-insulin O
dependent O
diabetes O
mellitus O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Const O
: O
no O
fever O
, O
chills O
, O
sweats O
, O
weight O
change O
, O
or O
malaise O
CV O
: O
no O
chest O
pain O
, O
dyspnea O
on O
exertion O
or O
palpitations O
Resp O
: O
no O
SOB O
, O
no O
cough O
, O
no O
wheezing O
GI O
: O
no O
abdominal O
pain O
, O
no O
diarrhea O
, O
no O
constipation O
Musc O
: O
no O
back O
, O
shoulder O
, O
limb O
pain O
, O
no O
myalgias O
Skin O
: O
no O
rashes O
or O
pruritis O
Psych O
: O
not O
depressed O
or O
anxious O
. O
 
EXAMINATION O
: O
well O
appearing O
, O
in O
good O
spirits O
lungs O
CTA O
; O
no O
JVD O
, O
incision O
C/D O
without O
erythema O
RRR O
nl O
S1S2 O
no O
murmur/rub O
no O
edema O
8 O
sutures O
removed O
without O
complication O
from O
along O
chest O
incision O
line O
IMPRESSION O
: O
Co O
n't O
current O
meds O
smok O
cessation O
reinforced O
D/C O
dig O
secondary O
to O
adverse O
effects O
f/u O
cardiac O
surg O
: O
Dr. O
Austin I-NAME
MEDICATIONS O
: O
ACETAMINOPHEN O
W/CODEINE O
30-300MG O
One O
PO O
q4 O
- O
PAIN O
: O
07/25/2066 I-DATE
- O
04/17/2067 I-DATE
ACT O
: O
emmons I-NAME
Script O
: O
Amt O
: O
12 O
Refill O
: O
0 O
Date O
: O
07/25/2066 I-DATE
: O
emmons I-NAME
LIPITOR O
10MG O
PO O
qd O
: O
05/10/2066 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
QS O
Refill O
: O
1 O
Date O
: O
11/20/2067 I-DATE
: O
rosenberg I-NAME
Glucophage O
500mg O
one O
PO O
bid O
: O
04/08/2065 I-DATE
- O
11/12/2067 I-DATE
ACT O
: O
stephens I-NAME
Script O
: O
Amt O
: O
60 O
Refill O
: O
3 O
Date O
: O
04/24/2067 I-DATE
: O
stephens I-NAME
ASPIRIN O
325MG O
PO O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
multivitamin O
1 O
po O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
LOPRESSOR O
50MG O
qd O
: O
03/02/2065 I-DATE
- O
11/12/2067 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
10/26/2066 I-DATE
: O
rosenberg I-NAME
IMMUNIZATIONS O
: O
Infl O
11/25/2065 I-DATE
Pneu O
11/25/2065 I-DATE
THIS O
IS O
A O
COPY O
PRODUCED O
FOR O
THE O
LMR O
. O
 
THE O
ORGINAL O
IS O
STORED O
ON O
THE O
BRIGHTPOINT I-LOCATION
SERVER O
AT O
COLUMBIA I-LOCATION
KINGWOOD I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
AND O
IN O
PRINT O
IN O
THE O
PATIENT O
'S O
CKMC I-LOCATION
PAPER O
RECORD O
. O
 
Record O
date O
: O
2067-08-07 I-DATE
CHIEF O
COMPLAINT O
: O
F/U O
DF O
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
f/u O
CABG/CAD/DM O
feeling O
very O
well O
without O
intercurrent O
problems O
, O
though O
discouraged O
about O
wt O
gain O
and O
not O
exercsiing O
regularly O
still O
not O
smoking O
after O
13 O
months O
! O
 
taking O
meds O
without O
difficulty O
or O
adverse O
effects O
checking O
feet O
daily O
; O
no O
CP O
, O
SOB O
orthop O
PND O
PAST O
MEDICAL I-LOCATION
HISTORY O
: O
Entered O
By O
: O
frye I-NAME
On:03/13/2066 O
Endocrine O
disorders O
: O
type O
II O
, O
non-insulin O
dependent O
diabetes O
mellitus O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Const O
: O
no O
fever O
, O
chills O
, O
sweats O
, O
weight O
change O
, O
or O
malaise O
CV O
: O
no O
chest O
pain O
, O
dyspnea O
on O
exertion O
or O
palpitations O
Resp O
: O
no O
SOB O
, O
no O
cough O
, O
no O
wheezing O
GI O
: O
no O
abdominal O
pain O
, O
no O
diarrhea O
, O
no O
constipation O
Musc O
: O
no O
back O
, O
shoulder O
, O
limb O
pain O
, O
no O
myalgias O
Skin O
: O
no O
rashes O
or O
pruritis O
Psych O
: O
not O
depressed O
or O
anxious O
. O
 
VITAL O
SIGNS O
: O
Date/Time O
: O
08/07/2067 I-DATE
04:17 O
PM O
- O
rosenberg I-NAME
Respiration O
: O
16 O
breaths/min O
Pulse O
1 O
: O
80 O
bpm O
Blood O
Pressure O
1 O
: O
130 O
/ O
80 O
mmHg O
Weight O
: O
202.00 O
lbs O
. O
 
EXAMINATION O
: O
[ O
Constitution O
] O
- O
well O
nourished O
and O
developed O
. O
 
[ O
Eyes O
] O
- O
conjunctivae O
clear O
, O
pupils O
equal O
, O
no O
discharge O
, O
[ O
ENMT O
] O
- O
Ears O
- O
, O
external O
ears O
normal O
. O
 
[ O
ENMT O
] O
- O
Nose O
no O
discharge O
. O
 
[ O
ENMT O
] O
- O
Throat O
- O
normal O
color O
and O
without O
tonsillar O
enlargement O
. O
 
[ O
Neck O
] O
- O
supple O
no O
lymphadenopathy O
or O
thyromegaly O
. O
 
[ O
CV O
] O
- O
regular O
rate O
no O
murmurs O
, O
rubs O
or O
gallops O
, O
no O
heave O
; O
carotid O
and O
pedal O
pulses O
normal O
, O
no O
extremities O
edema O
. O
 
No O
JVD O
. O
 
well O
healed O
stermotomy O
scar O
. O
 
[ O
Respiratory O
] O
- O
clear O
, O
breath O
sounds O
bilaterally O
, O
no O
accessory O
muscle O
use O
. O
 
[ O
GI O
] O
- O
abdomen O
soft O
, O
no O
hepatosplenomegaly O
, O
no O
abnormal O
masses O
or O
hernias O
. O
 
[ O
Skin O
] O
- O
no O
significant O
rashes O
or O
other O
lesions O
. O
 
[ O
Musc/Skel O
] O
- O
normal O
tone O
, O
no O
edema O
[ O
Neuro O
] O
- O
5/5 O
gross O
motor O
strength O
, O
grossly O
normal O
coordination O
and O
gait O
[ O
Psych O
] O
- O
alert O
and O
oriented O
for O
age O
, O
normal O
mood O
and O
affect O
IMPRESSION O
: O
BP O
well O
controlled O
, O
we O
discussed O
elevated O
HbA1c O
fro O
last O
visit O
of O
8.3 O
and O
need O
for O
exercise O
otherwise O
, O
Excellent O
secondary O
prevention O
regmen O
RTC O
3-4 O
mo O
ALLERGIES O
: O
No O
Known O
Drug O
Allergies O
04/17/2067 I-DATE
rosenberg I-NAME
MEDICATIONS O
: O
wellbutrin O
sr O
150mg O
2 O
tabs O
po O
qd O
: O
06/19/2067 I-DATE
- O
03/25/2068 I-DATE
ACT O
: O
um I-NAME
Script O
: O
Amt O
: O
60 O
Refill O
: O
3 O
Date O
: O
09/23/2067 I-DATE
: O
um I-NAME
HYDROCHLOROTHIAZIDE O
25MG O
One O
PO O
qd O
: O
09/06/2066 I-DATE
- O
03/25/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
11/20/2067 I-DATE
: O
rosenberg I-NAME
LIPITOR O
10MG O
PO O
qd O
: O
05/10/2066 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
QS O
Refill O
: O
1 O
Date O
: O
11/20/2067 I-DATE
: O
rosenberg I-NAME
Glucophage O
500mg O
one O
PO O
bid O
: O
04/08/2065 I-DATE
- O
11/12/2067 I-DATE
ACT O
: O
stephens I-NAME
Script O
: O
Amt O
: O
60 O
Refill O
: O
3 O
Date O
: O
04/24/2067 I-DATE
: O
stephens I-NAME
ASPIRIN O
325MG O
PO O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
multivitamin O
1 O
po O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
LOPRESSOR O
50MG O
qd O
: O
03/02/2065 I-DATE
- O
11/12/2067 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
10/26/2066 I-DATE
: O
rosenberg I-NAME
Glucophage O
850MG O
BID O
- O
01/29/2068 I-DATE
ACT O
: O
rosenberg I-NAME
IMMUNIZATIONS O
: O
Infl O
11/25/2065 I-DATE
Pneu O
11/25/2065 I-DATE
PROBLEMS O
- O
CARE O
PLANS O
: O
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
414.00 O
Coronary O
Artery O
Disease O
Careplan O
: O
RTC O
3 O
mo O
secondary O
prevention O
counseling O
reinforced O
including O
wt O
loss O
, O
exercise O
, O
co O
n't O
smoking O
cessation O
, O
medication O
adherence O
, O
diet O
, O
ASA O
, O
MVI O
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
250.00 O
Diabetes O
Mellitus O
, O
Uncomplicated O
Careplan O
: O
Diet O
: O
ADA O
Step O
II O
Medications O
: O
Glucophage O
- O
850MG O
- O
BID O
. O
 
will O
recheck O
HbA1c O
next O
visit O
Patient O
Education O
: O
1. O
diabetes O
teaching O
2. O
avoid O
concentrated O
sweets O
3. O
stress O
important O
of O
meticulous O
foot O
care O
and O
hygiene O
4. O
discuss O
importance O
of O
tight O
diabetes O
control O
, O
including O
potential O
complications O
of O
diabetes O
. O
 
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
272.4 O
Hyperlipidemia O
Careplan O
: O
Patient O
Education O
: O
1. O
reduce O
dietary O
saturated O
fats O
to O
less O
than O
10 O
% O
total O
calories O
2. O
reduce O
weight O
3. O
restrict O
total O
fat O
to O
< O
30 O
% O
of O
total O
calories O
4. O
limit O
cholesterol O
to O
< O
300 O
mg/d O
5. O
allow O
carbohydrates O
to O
account O
for O
50-60 O
% O
of O
calories O
. O
 
Substitute O
complex O
carbohydrates O
for O
saturated O
fats O
, O
increase O
intake O
of O
soluble O
fiber O
. O
 
THIS O
IS O
A O
COPY O
PRODUCED O
FOR O
THE O
LMR O
. O
 
THE O
ORGINAL O
IS O
STORED O
ON O
THE O
BRIGHTPOINT I-LOCATION
SERVER O
AT O
COLUMBIA I-LOCATION
KINGWOOD I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
AND O
IN O
PRINT O
IN O
THE O
PATIENT O
'S O
CKMC I-LOCATION
PAPER O
RECORD O
. O
 
Record O
date O
: O
2068-03-25 I-DATE
CHIEF O
COMPLAINT O
: O
F/U O
BH O
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
f/u O
CABG/CAD/DM/HTN O
feeling O
very O
well O
without O
intercurrent O
problems O
; O
encouaged O
about O
recent O
wt O
loss O
after O
joining O
wt O
watchers O
we O
increased O
glucophage O
9 O
mo O
ago O
due O
to O
HbA1c O
of O
8.3 O
; O
but O
repeat O
9.3 O
; O
thinks O
diet O
is O
much O
better O
now O
still O
not O
smoking O
after O
2 O
years O
! O
 
Has O
stpped O
Welbutrin O
and O
notes O
no O
problems O
with O
this O
; O
feeling O
well O
with O
Sx O
of O
depession O
taking O
meds O
without O
difficulty O
or O
adverse O
effects O
checking O
feet O
daily O
; O
no O
CP O
, O
SOB O
orthop O
PND O
PAST O
MEDICAL I-LOCATION
HISTORY O
: O
Entered O
By O
: O
frye I-NAME
On:03/13/2066 O
Endocrine O
disorders O
: O
type O
II O
, O
non-insulin O
dependent O
diabetes O
mellitus O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Const O
: O
no O
fever O
, O
chills O
, O
sweats O
, O
or O
malaise O
CV O
: O
no O
chest O
pain O
, O
dyspnea O
on O
exertion O
or O
palpitations O
Resp O
: O
no O
SOB O
, O
no O
cough O
, O
no O
wheezing O
GI O
: O
no O
abdominal O
pain O
, O
no O
diarrhea O
, O
no O
constipation O
Musc O
: O
no O
back O
, O
shoulder O
, O
limb O
pain O
, O
no O
myalgias O
Skin O
: O
no O
rashes O
or O
pruritis O
Psych O
: O
not O
depressed O
or O
anxious O
. O
 
VITAL O
SIGNS O
: O
Date/Time O
: O
03/25/2068 I-DATE
12:29 O
PM O
- O
rosenberg I-NAME
Respiration O
: O
16 O
breaths/min O
Pulse O
1 O
: O
84 O
bpm O
Blood O
Pressure O
1 O
: O
140 O
/ O
90 O
mmHg O
Weight O
: O
197.00 O
lbs O
. O
 
EXAMINATION O
: O
[ O
Constitution O
] O
- O
well O
nourished O
and O
developed O
. O
 
obese O
[ O
Eyes O
] O
- O
conjunctivae O
clear O
, O
pupils O
equal O
, O
no O
discharge O
, O
[ O
ENMT O
] O
- O
Ears O
- O
, O
external O
ears O
normal O
. O
 
[ O
ENMT O
] O
- O
Nose O
no O
discharge O
. O
 
[ O
ENMT O
] O
- O
Throat O
- O
normal O
color O
and O
without O
tonsillar O
enlargement O
. O
 
[ O
Neck O
] O
- O
supple O
no O
lymphadenopathy O
or O
thyromegaly O
. O
 
[ O
CV O
] O
- O
regular O
rate O
no O
murmurs O
, O
rubs O
or O
gallops O
, O
no O
heave O
; O
carotid O
and O
pedal O
pulses O
normal O
, O
no O
extremities O
edema O
. O
 
No O
JVD O
. O
 
well O
healed O
stermotomy O
scar O
. O
 
[ O
Respiratory O
] O
- O
clear O
, O
breath O
sounds O
bilaterally O
, O
no O
accessory O
muscle O
use O
. O
 
[ O
GI O
] O
- O
abdomen O
soft O
, O
no O
hepatosplenomegaly O
, O
no O
abnormal O
masses O
or O
hernias O
. O
 
[ O
Skin O
] O
- O
no O
significant O
rashes O
or O
other O
lesions O
. O
 
[ O
Musc/Skel O
] O
- O
normal O
tone O
, O
no O
edema O
[ O
Neuro O
] O
- O
5/5 O
gross O
motor O
strength O
, O
grossly O
normal O
coordination O
and O
gait O
[ O
Psych O
] O
- O
alert O
and O
oriented O
for O
age O
, O
normal O
mood O
and O
affect O
IMPRESSION O
: O
BP O
borderline O
, O
could O
use O
improvement O
we O
discussed O
elevated O
HbA1c O
fro O
last O
visit O
and O
need O
to O
improve O
glycemic O
control O
otherwise O
, O
Excellent O
secondary O
prevention O
regmen O
ALLERGIES O
: O
No O
Known O
Drug O
Allergies O
04/17/2067 I-DATE
rosenberg I-NAME
MEDICATIONS O
: O
glucovance O
5/500 O
bid O
for O
30 O
days O
: O
03/25/2068 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
# O
60 O
Refill O
: O
3 O
Date O
: O
03/25/2068 I-DATE
: O
rosenberg I-NAME
LESCOL O
XL O
80MG O
PO O
qd O
: O
03/25/2068 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
03/25/2068 I-DATE
: O
rosenberg I-NAME
ZESTRIL O
10MG O
PO O
qd O
: O
03/25/2068 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
01/13/2074 I-DATE
: O
rosenberg I-NAME
Glucophage O
850MG O
One O
PO O
bid O
: O
01/29/2068 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
emmons I-NAME
Script O
: O
Amt O
: O
60 O
Refill O
: O
5 O
Date O
: O
01/29/2068 I-DATE
: O
emmons I-NAME
toprol O
xl O
50MG O
one O
po O
qd O
: O
09/25/2067 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
um I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
03/11/2074 I-DATE
: O
um I-NAME
LIPITOR O
10MG O
PO O
qd O
: O
05/10/2066 I-DATE
- O
04/15/2068 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
QS O
Refill O
: O
1 O
Date O
: O
11/20/2067 I-DATE
: O
rosenberg I-NAME
ASPIRIN O
325MG O
PO O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
multivitamin O
1 O
po O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
IMMUNIZATIONS O
: O
Infl O
11/25/2065 I-DATE
Pneu O
11/25/2065 I-DATE
PROBLEMS O
- O
CARE O
PLANS O
: O
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
414.00 O
Coronary O
Artery O
Disease O
Careplan O
: O
RTC O
3 O
mo O
secondary O
prevention O
counseling O
reinforced O
including O
wt O
loss O
, O
exercise O
, O
co O
n't O
smoking O
cessation O
, O
medication O
adherence O
, O
diet O
, O
ASA O
, O
MVI O
As O
far O
as O
HTN O
goes O
, O
will O
change O
to O
ACE-i O
given O
benefits O
in O
prevention O
for O
both O
CAD O
and O
renal O
protection O
starting O
with O
lisinopril O
10 O
d O
and O
work O
up O
RTC O
1 O
mo O
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
250.00 O
Diabetes O
Mellitus O
, O
Uncomplicated O
Careplan O
: O
Diet O
: O
ADA O
Step O
II O
Medications O
: O
change O
to O
glucovane O
5/500 O
BID O
will O
recheck O
HbA1c O
today O
Patient O
Education O
: O
1. O
diabetes O
teaching O
2. O
avoid O
concentrated O
sweets O
3. O
stress O
important O
of O
meticulous O
foot O
care O
and O
hygiene O
4. O
discuss O
importance O
of O
tight O
diabetes O
control O
, O
including O
potential O
complications O
of O
diabetes O
. O
 
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
272.4 O
Hyperlipidemia O
Careplan O
: O
Patient O
Education O
: O
1. O
reduce O
dietary O
saturated O
fats O
to O
less O
than O
10 O
% O
total O
calories O
2. O
reduce O
weight O
3. O
restrict O
total O
fat O
to O
< O
30 O
% O
of O
total O
calories O
4. O
limit O
cholesterol O
to O
< O
300 O
mg/d O
5. O
allow O
carbohydrates O
to O
account O
for O
50-60 O
% O
of O
calories O
. O
 
Substitute O
complex O
carbohydrates O
for O
saturated O
fats O
, O
increase O
intake O
of O
soluble O
fiber O
. O
 
lipitor O
as O
prescribed O
; O
might O
change O
to O
lescol O
check O
LFTs O
and O
lipids O
today O
THIS O
IS O
A O
COPY O
PRODUCED O
FOR O
THE O
LMR O
. O
 
THE O
ORGINAL O
IS O
STORED O
ON O
THE O
BRIGHTPOINT I-LOCATION
SERVER O
AT O
COLUMBIA I-LOCATION
KINGWOOD I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
AND O
IN O
PRINT O
IN O
THE O
PATIENT O
'S O
CKMC I-LOCATION
PAPER O
RECORD O
. O
 
Record O
date O
: O
2069-01-13 I-DATE
CHIEF O
COMPLAINT O
: O
F/U O
BH O
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
feeling O
well O
except O
slight O
cold O
; O
getting O
daily O
exercise O
and O
still O
not O
smoking O
( O
2 O
years O
) O
f/u O
type O
2 O
DM O
and O
CAD O
we O
discussed O
the O
elevation O
in O
last O
HbA1c O
and O
need O
to O
improve O
control O
; O
possible O
need O
for O
insulin O
future O
not O
yet O
measuriong O
home O
glucose O
: O
given O
instructions O
a O
prescriptions O
today O
to O
do O
this O
No O
cp/SOB/DOE/Orthop O
we O
reviewed O
meds O
and O
above O
list O
is O
correct O
; O
adherent O
; O
no O
adverse O
effects O
doing O
dailt O
foot O
exams O
PAST O
MEDICAL I-LOCATION
HISTORY O
: O
Entered O
By O
: O
frye I-NAME
On:03/13/2066 O
Endocrine O
disorders O
: O
type O
II O
, O
non-insulin O
dependent O
diabetes O
mellitus O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Const O
: O
no O
fever O
, O
Const O
: O
no O
weight O
change O
, O
CV O
: O
no O
chest O
pain O
, O
CV O
: O
no O
palpitations O
, O
Resp O
: O
no O
shortness O
of O
breath O
, O
Resp O
: O
no O
cough O
, O
Resp O
: O
no O
wheezing O
, O
GI O
: O
no O
vomiting O
, O
GI O
: O
no O
constipation O
, O
GI O
: O
no O
diarrhea O
, O
GU O
: O
no O
frequent O
urination O
, O
Neuro O
: O
no O
headaches O
and O
Skin O
: O
no O
rash O
VITAL O
SIGNS O
: O
Date/Time O
: O
01/13/2069 I-DATE
10:03 O
AM O
- O
rosenberg I-NAME
Respiration O
: O
18 O
breaths/min O
Pulse O
1 O
: O
78 O
bpm O
Blood O
Pressure O
1 O
: O
110 O
/ O
70 O
mmHg O
Weight O
: O
196.00 O
lbs O
. O
 
EXAMINATION O
: O
[ O
Constitution O
] O
- O
well O
nourished O
and O
developed O
. O
 
[ O
Eyes O
] O
- O
conjunctivae O
clear O
, O
pupils O
equal O
, O
no O
discharge O
[ O
Neck O
] O
- O
supple O
no O
lymphadenopathy O
or O
thyromegaly O
. O
 
[ O
CV O
] O
- O
regular O
rate O
no O
murmurs O
, O
rubs O
or O
gallops O
, O
no O
heave O
; O
carotid O
pulses O
normal O
, O
no O
extremities O
edema O
. O
 
[ O
Respiratory O
] O
- O
clear O
, O
breath O
sounds O
bilaterally O
, O
no O
accessory O
muscle O
use O
. O
 
[ O
GI O
] O
- O
abdomen O
soft O
, O
no O
hepatosplenomegaly O
, O
no O
abnormal O
masses O
or O
hernias O
. O
 
[ O
Skin O
] O
- O
no O
significant O
rashes O
or O
other O
lesions O
. O
 
[ O
Musc/Skel O
] O
- O
normal O
tone O
, O
no O
edema O
; O
feet O
without O
lesions O
; O
decreased O
VS O
to O
ankles O
bilat O
[ O
Neuro O
] O
- O
5/5 O
gross O
motor O
strength O
, O
grossly O
normal O
coordination O
and O
gait O
[ O
Psych O
] O
- O
alert O
and O
oriented O
for O
age O
, O
normal O
mood O
and O
affect O
IMPRESSION O
: O
excellent O
regimen O
for O
DM O
and O
CAD O
but O
increased O
HBA1c O
a O
concern O
and O
we O
discussed O
diet/exercise O
for O
15 O
minutes O
will O
check O
HbA1c O
again O
today O
ALLERGIES O
: O
No O
Known O
Drug O
Allergies O
04/17/2067 I-DATE
rosenberg I-NAME
MEDICATIONS O
: O
lancets O
for O
gluc O
monitoring O
BID O
for O
3 O
mo O
: O
01/13/2069 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
QS O
Refill O
: O
3 O
Date O
: O
01/13/2069 I-DATE
: O
rosenberg I-NAME
one-touch O
basic O
glucose O
test O
strips O
BID O
for O
3 O
mo O
: O
01/13/2069 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
QS O
Refill O
: O
3 O
Date O
: O
01/13/2069 I-DATE
: O
rosenberg I-NAME
GLUCOPHAGE O
850MG O
One O
PO O
bid O
: O
06/17/2068 I-DATE
- O
09/22/2069 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
60 O
Refill O
: O
1 O
Date O
: O
06/10/2069 I-DATE
: O
rosenberg I-NAME
ZESTRIL O
10MG O
PO O
qd O
: O
03/25/2068 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
01/13/2074 I-DATE
: O
rosenberg I-NAME
toprol O
xl O
50MG O
one O
po O
qd O
: O
09/25/2067 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
um I-NAME
Script O
: O
Amt O
: O
30 O
Refill O
: O
3 O
Date O
: O
03/11/2074 I-DATE
: O
um I-NAME
LIPITOR O
10MG O
One O
PO O
qd O
: O
05/10/2066 I-DATE
- O
10/03/2073 I-DATE
ACT O
: O
emmons I-NAME
Script O
: O
Amt O
: O
90 O
Refill O
: O
1 O
Date O
: O
04/05/2073 I-DATE
: O
emmons I-NAME
ASPIRIN O
325MG O
PO O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
multivitamin O
1 O
po O
qd O
: O
03/02/2065 I-DATE
- O
03/30/2074 I-DATE
ACT O
: O
rosenberg I-NAME
IMMUNIZATIONS O
: O
INF2 O
11/24/2068 I-DATE
Infl O
11/25/2065 I-DATE
Pneu O
11/25/2065 I-DATE
PROBLEMS O
- O
CARE O
PLANS O
: O
Problem O
: O
a O
. O
 
Adult O
symptom O
( O
s O
) O
Code O
: O
250.00 O
Diabetes O
Mellitus O
, O
Uncomplicated O
Careplan O
: O
as O
above O
, O
RTC O
3 O
mo O
THIS O
IS O
A O
COPY O
PRODUCED O
FOR O
THE O
LMR O
. O
 
THE O
ORGINAL O
IS O
STORED O
ON O
THE O
BRIGHTPOINT I-LOCATION
SERVER O
AT O
COLUMBIA I-LOCATION
KINGWOOD I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
AND O
IN O
PRINT O
IN O
THE O
PATIENT O
'S O
CKMC I-LOCATION
PAPER O
RECORD O
. O
 
Record O
date O
: O
2096-02-15 I-DATE
ST I-LOCATION
VINCENT I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LAU O
, O
HELEN O
M. I-NAME
544-41-32-1 I-ID
VISIT O
DATE O
: O
02/15/96 I-DATE
PRESENTING O
COMPLAINT O
: O
Syncope O
. O
 
History O
and O
Physical O
reviewed O
. O
 
Patient O
examined O
with O
the O
Medicine O
Resident O
and O
medical O
student O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Briefly O
, O
this O
is O
a O
68 I-AGE
year O
old O
female O
with O
a O
history O
of O
coronary O
artery O
disease O
and O
syncope O
in O
the O
past O
who O
presents O
with O
two O
syncopal O
episodes O
today O
while O
in O
the O
Orthopedic O
Clinic O
. O
 
The O
patient O
was O
in O
the O
Orthopedic O
Clinic O
having O
her O
trigger O
finger O
evaluated O
and O
had O
a O
digital O
block O
done O
with O
Lidocaine O
. O
 
As O
she O
was O
walking O
out O
of O
the O
Clinic O
, O
she O
slumped O
to O
the O
chair O
, O
hit O
her O
head O
on O
the O
table O
and O
was O
out O
for O
a O
few O
minutes O
. O
 
Patient O
felt O
a O
pressure O
like O
sensation O
in O
the O
left O
chest O
with O
radiation O
to O
the O
neck O
, O
some O
shortness O
of O
breath O
and O
diaphoresis O
immediately O
preceding O
the O
event O
. O
 
When O
patient O
came O
to O
was O
slightly O
disoriented O
and O
approximately O
five O
minutes O
later O
felt O
the O
same O
light O
headedness O
and O
again O
lost O
consciousness O
while O
sitting O
in O
the O
chair O
. O
 
Patient O
had O
no O
fever O
, O
chills O
or O
recent O
illness O
. O
 
Past O
Medical O
History O
, O
Current O
Medications O
, O
Social O
History O
, O
Allergies O
all O
per O
Resident O
's O
note O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Per O
HPI O
, O
otherwise O
negative O
. O
 
PHYSICAL O
EXAMINATION O
: O
Patient O
's O
temperature O
was O
98.2 O
; O
Pulse O
62 O
; O
Blood O
Pressure O
163/89 O
; O
Respirations O
20 O
; O
Oxygen O
saturation O
97 O
% O
. O
 
General O
: O
Well O
developed O
elderly O
female O
in O
no O
apparent O
distress O
sitting O
on O
the O
gurney O
. O
 
HEENT O
: O
Is O
unremarkable O
. O
 
Neck O
: O
Supple O
. O
 
Chest O
: O
Is O
clear O
. O
 
Heart O
: O
Is O
regular O
rate O
and O
rhythm O
. O
 
Abdomen O
: O
Is O
soft O
, O
nontender O
. O
 
Extremities O
: O
No O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
Neurologic O
exam O
: O
Patient O
is O
alert O
and O
oriented O
x O
three O
, O
cranial O
nerves O
are O
intact O
, O
motor O
5/5 O
, O
sensation O
intact O
throughout O
. O
 
LABORATORY O
EVALUATION O
: O
EKG O
shows O
normal O
sinus O
rhythm O
with O
no O
acute O
changes O
. O
 
CPK O
was O
98 O
, O
troponin O
pending O
. O
 
Other O
labs O
were O
unremarkable O
. O
 
FINAL O
DIAGNOSIS O
: O
Syncopal O
episode O
with O
chest O
pressure O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Patient O
will O
be O
admitted O
to O
the O
Hospital O
for O
rule O
out O
MI O
, O
Short O
Stay O
Unit O
, O
for O
further O
work O
up O
and O
care O
. O
 
Condition O
on O
admission O
stable O
. O
 
___________________________________ O
XD305/7899 I-ID
IVAN I-NAME
UHER I-NAME
, O
M.D O
. O
 
IU67 I-NAME
D:02/15/96 O
T:02/15/96 O
Dictated O
by O
: O
IVAN I-NAME
UHER I-NAME
, O
M.D O
. O
 
IU67 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Approved O
but O
not O
reviewed O
by O
Attending O
Provider O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2096-07-19 I-DATE
ST I-LOCATION
VINCENT I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LAU O
, O
HELEN O
M. I-NAME
544-41-32-1 I-ID
VISIT O
DATE O
: O
07/19/96 I-DATE
The O
patient O
was O
seen O
by O
me O
and O
Dr. O
Foust I-NAME
07-19-96 I-DATE
at O
8:30 O
a.m. O
PRESENTING O
COMPLAINT O
and O
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
The O
patient O
is O
a O
67-year-old O
black O
female O
complaining O
of O
substernal O
chest O
pain O
times O
one O
hour O
while O
at O
the O
Pain O
Clinic O
this O
a.m O
. O
 
The O
complaints O
are O
presently O
resolved O
. O
 
The O
patient O
states O
she O
was O
being O
seen O
in O
the O
Pain O
Clinic O
for O
back O
pain O
, O
and O
developed O
the O
sudden O
onset O
of O
substernal O
chest O
pain O
associated O
with O
shortness O
of O
breath O
, O
nausea O
, O
vomiting O
, O
and O
diaphoresis O
, O
as O
well O
as O
syncope O
. O
 
The O
patient O
states O
the O
pain O
was O
a O
10/10 O
, O
worse O
than O
normal O
angina O
, O
and O
also O
reports O
one O
episodes O
of O
hematemesis O
this O
a.m. O
, O
with O
a O
small O
amount O
of O
red O
blood O
in O
the O
vomitus O
. O
 
The O
patient O
denies O
abdominal O
pain O
, O
weakness O
, O
or O
any O
other O
complaints O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Positive O
for O
angina O
. O
 
Positive O
catheterization O
approximately O
two O
years O
ago O
, O
with O
30-40 O
% O
lesions O
. O
 
Also O
, O
history O
of O
insulin-dependent O
diabetes O
mellitus O
and O
spinal O
stenosis O
. O
 
CARDIAC O
RISK O
FACTORS O
: O
Hypertension O
, O
increased O
cholesterol O
, O
diabetes O
mellitus O
. O
 
MEDICATIONS O
: O
Metoprolol O
, O
lovastatin O
, O
Macrodantin O
, O
Motrin O
, O
insulin O
70/30 O
, O
nitroglycerin O
, O
and O
aspirin O
. O
 
PHYSICAL O
EXAMINATION O
: O
This O
is O
a O
well-developed O
, O
well-nourished O
female O
lying O
on O
the O
stretcher O
, O
presently O
without O
complaints O
. O
 
The O
blood O
pressure O
is O
194/88 O
, O
the O
pulse O
90 O
, O
the O
respirations O
16 O
, O
and O
the O
O2 O
saturation O
97 O
% O
on O
2 O
liters O
per O
nasal O
cannula O
. O
 
The O
HEENT O
examination O
reveals O
a O
normocephalic O
, O
atraumatic O
head O
. O
 
The O
pupils O
are O
equal O
and O
reactive O
, O
and O
the O
extraocular O
movements O
are O
intact O
. O
 
The O
chest O
shows O
positive O
bibasilar O
rales O
and O
is O
otherwise O
clear O
. O
 
The O
abdomen O
is O
obese O
and O
soft O
, O
with O
positive O
bowel O
sounds O
. O
 
The O
heart O
has O
a O
regular O
rate O
and O
rhythm O
. O
 
The O
extremities O
are O
without O
cyanosis O
, O
clubbing O
, O
or O
edema O
. O
 
The O
rectal O
examination O
is O
guaiac-negative O
. O
 
On O
Neurologic O
Examination O
, O
the O
patient O
is O
alert O
and O
oriented O
times O
two O
( O
could O
not O
give O
the O
exact O
date O
) O
; O
otherwise O
, O
no O
focality O
. O
 
LABORATORY O
EVALUATION O
: O
The O
EKG O
shows O
a O
sinus O
rhythm O
unchanged O
from O
previous O
EKGs O
, O
with O
a O
normal O
interpretation O
and O
no O
signs O
of O
acute O
ischemia O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
is O
admitted O
to O
the O
hospital O
for O
rule O
out O
MI O
. O
 
Aspirin O
is O
given O
. O
 
Further O
work-up O
as O
per O
the O
inpatient O
Medicine O
team O
. O
 
The O
patient O
was O
admitted O
in O
stable O
condition O
at O
11:15 O
a.m O
. O
 
FINAL O
DIAGNOSIS O
: O
Rule O
out O
myocardial O
infarction O
( O
MI O
) O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
As O
above O
. O
 
The O
condition O
on O
admission O
is O
stable O
. O
 
___________________________________ O
OX540/6976 I-ID
MARY I-NAME
LUND I-NAME
, O
M.D O
. O
 
ML82 I-NAME
D:07/19/96 O
T:07/19/96 O
Dictated O
by O
: O
MARY I-NAME
LUND I-NAME
, O
M.D O
. O
 
ML82 I-NAME
 
Record O
date O
: O
2096-10-17 I-DATE
ST I-LOCATION
VINCENT I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LAU O
, O
HELEN O
M. I-NAME
544-41-32-1 I-ID
VISIT O
DATE O
: O
10/17/96 I-DATE
PRESENTING O
COMPLAINT O
and O
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
The O
patient O
is O
a O
68-year-old O
female O
status O
post O
CABG O
in O
September I-DATE
of O
this O
past O
year O
. O
 
She O
comes O
in O
with O
an O
acute O
headache O
this O
morning O
, O
followed O
by O
a O
syncopal O
event O
, O
which O
lasted O
approximately O
five O
seconds O
. O
 
Currently O
, O
she O
is O
complaining O
of O
intermittent O
chest O
pain O
and O
a O
continuing O
headache O
across O
her O
head O
and O
down O
to O
her O
eyes O
. O
 
PAST O
MEDICAL O
and O
SURGICAL O
HISTORY O
: O
The O
past O
history O
is O
notable O
for O
her O
CABG O
, O
as O
well O
as O
for O
a O
history O
of O
temporal O
arteritis O
. O
 
MEDICATIONS O
: O
She O
was O
on O
prednisone O
, O
which O
was O
recently O
stopped O
. O
 
The O
rest O
of O
the O
PAST O
MEDICAL O
HISTORY O
, O
MEDICATIONS O
, O
and O
ALLERGIES O
: O
As O
documented O
in O
the O
written O
chart O
by O
the O
resident O
physician O
, O
and O
as O
reviewed O
by O
me O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
examination O
, O
she O
is O
an O
elderly O
black O
female O
in O
no O
acute O
distress O
. O
 
She O
has O
a O
temperature O
of O
100 O
degrees O
F. O
, O
a O
pulse O
of O
90 O
, O
and O
a O
blood O
pressure O
of O
150/70 O
. O
 
The O
O2 O
saturation O
is O
97 O
% O
on O
room O
air O
. O
 
The O
examination O
is O
notable O
for O
a O
surgically O
altered O
pupil O
in O
the O
right O
eye O
, O
which O
is O
non-reactive O
. O
 
The O
extraocular O
movements O
are O
intact O
. O
 
She O
has O
no O
palpable O
temporal O
or O
skull O
tenderness O
. O
 
The O
lungs O
show O
rhonchorous O
breath O
sounds O
throughout O
. O
 
The O
cardiovascular O
examination O
shows O
a O
midline O
scar O
, O
with O
a O
regular O
rate O
and O
rhythm O
and O
no O
murmur O
. O
 
The O
abdomen O
is O
soft O
and O
non-tender O
. O
 
The O
extremities O
show O
1+ O
pitting O
edema O
bilaterally O
. O
 
The O
neurologic O
examination O
is O
grossly O
intact O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
This O
is O
an O
elderly O
female O
status O
post O
recent O
CABG O
, O
who O
had O
a O
syncopal O
episode O
this O
morning O
after O
complaining O
of O
a O
headache O
. O
 
The O
plan O
at O
this O
time O
is O
to O
obtain O
a O
head O
CT O
to O
rule O
out O
an O
intracerebral O
process O
. O
 
She O
has O
had O
an O
EKG O
, O
which O
does O
show O
some O
T-wave O
changes O
, O
different O
from O
when O
she O
was O
here O
for O
her O
CABG O
. O
 
She O
will O
also O
have O
cardiac O
enzymes O
sent O
and O
will O
be O
admitted O
to O
the O
hospital O
for O
further O
monitoring O
of O
her O
syncopal O
event O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
As O
above O
. O
 
The O
patient O
's O
condition O
on O
admission O
is O
stable O
. O
 
___________________________________ O
HA563/486 I-ID
FRANCES I-NAME
LOVELL I-NAME
, O
M.D O
. O
 
FL01 I-NAME
D:10/17/96 O
T:10/17/96 O
Dictated O
by O
: O
FRANCES I-NAME
LOVELL I-NAME
, O
M.D O
. O
 
FL01 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2097-01-30 I-DATE
ST I-LOCATION
VINCENT I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LAU O
, O
HELEN O
M. I-NAME
544-41-32-1 I-ID
VISIT O
DATE O
: O
01/30/97 I-DATE
PRESENTING O
COMPLAINT O
: O
Chest O
pain O
and O
shortness O
of I-DATE
breath O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
is O
a O
lady O
who O
has O
a O
history O
of I-DATE
a O
coronary O
artery O
bypass O
graft O
in O
September I-DATE
of I-DATE
2096 I-DATE
, O
who O
presents O
complaining O
of I-DATE
chest O
pain O
. O
 
The O
patient O
describes O
it O
as O
being O
sharp O
and O
stabbing O
. O
 
It O
was O
associated O
with O
some O
diaphoresis O
. O
 
She O
states O
that O
this O
pain O
is O
similar O
to O
her O
angina O
, O
however O
, O
it O
is O
more O
frequent O
and O
persistent O
. O
 
She O
has O
no O
fever O
, O
no O
chills O
, O
no O
cough O
, O
no O
vomiting O
, O
no O
diarrhea O
, O
no O
abdominal O
pain O
, O
and O
no O
urinary O
symptoms O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Past O
medical O
history O
is O
significant O
for O
hypertension O
, O
coronary O
artery O
disease O
, O
insulin O
dependent O
diabetes O
, O
chronic O
renal O
insufficiency O
, O
breast O
cancer O
, O
depression O
, O
mitral O
valve O
replacement O
, O
and O
hypothyroidism O
. O
 
MEDICATIONS O
: O
Medications O
are O
multiple O
and O
are O
on O
the O
chart O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
The O
patient O
never O
smoked O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
was O
afebrile O
and O
vital O
signs O
were O
stable O
. O
 
This O
is O
a O
well-developed O
, O
well-nourished O
female O
who O
was O
alert O
and O
oriented O
times O
three O
. O
 
Heent O
examination O
was O
normocephalic O
, O
atraumatic O
. O
 
Neck O
was O
soft O
and O
supple O
with O
no O
jugular O
venous O
distention O
. O
 
Mouth O
and O
throat O
normal O
with O
well O
hydrated O
, O
moist O
mucosa O
. O
 
Conjunctiva O
was O
clear O
. O
 
Sclera O
were O
anicteric O
. O
 
Heart O
had O
a O
regular O
rate O
and O
rhythm O
. O
 
Lungs O
were O
clear O
. O
 
Abdomen O
was O
non-tender O
and O
non-distended O
. O
 
The O
patient O
had O
no O
hepatosplenomegaly O
. O
 
Extremities O
showed O
no O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
Rectal O
was O
heme O
negative O
. O
 
LABORATORY O
EVALUATION O
: O
EKG O
showed O
first O
degree O
AV O
block O
, O
no O
acute O
ischemic O
changes O
. O
 
Chest O
x-ray O
showed O
mild O
pleural O
effusion O
. O
 
White O
count O
was O
9.7 O
. O
 
Hematocrit O
was O
28 O
. O
 
CPK O
and O
troponin O
were O
negative O
. O
 
Electrolytes O
were O
normal O
for O
her O
. O
 
BUN O
and O
creatinine O
were O
32 O
and O
1.2 O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
Nursing O
notes O
were O
reviewed O
. O
 
The O
patient O
was O
seen O
with O
the O
resident O
physician O
, O
Dr. O
Nix I-NAME
, O
and O
I O
agree O
with O
his O
note O
. O
 
Please O
see O
chart O
. O
 
FINAL O
DIAGNOSIS O
: O
Unstable O
angina O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
will O
be O
admitted O
. O
 
Condition O
at O
this O
time O
is O
satisfactory O
. O
 
___________________________________ O
MG040/1987 I-ID
VIRGIL I-NAME
HARRELL I-NAME
, O
M.D O
. O
 
VH79 I-NAME
D:02/12/97 O
T:02/13/97 O
Dictated O
by O
: O
VIRGIL I-NAME
HARRELL I-NAME
, O
M.D O
. O
 
VH79 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2089-02-20 I-DATE
Vi I-NAME
K. I-NAME
Xayarath I-NAME
, O
M.D. O
, O
Ph.D. O
Resident O
, O
Phoenix I-LOCATION
Neurology O
Neurology O
ED O
Consult O
Date O
: O
Thursday O
, O
February I-DATE
20 O
, O
2089 I-DATE
21:42 O
PCP O
: O
Rhonda I-NAME
Riddle I-NAME
; O
( O
called O
by O
Valerie I-NAME
Xian I-NAME
) O
Patient O
: O
Garrison I-NAME
Sexton I-NAME
HDH I-LOCATION
Record O
# O
4210443 I-ID
Chief O
Complaint O
: O
`` O
dizzy O
, O
slurred O
speech O
'' O
History O
of O
Present O
Illness O
: O
65 I-AGE
year O
old O
RH O
gentleman O
with O
Hx O
notable O
for O
HTN O
and O
CASHD O
, O
was O
working O
on O
taxes O
and O
making O
barbecued O
chicken O
this O
afternoon O
, O
when O
at O
1am O
he O
had O
the O
sudden O
onset O
of O
feeling O
`` O
dizzy O
, O
disoriented O
'' O
and O
having O
`` O
slurred O
speech O
'' O
. O
 
He O
reports O
that O
he O
`` O
could O
n't O
remember O
what O
I O
was O
trying O
to O
say O
'' O
, O
and O
that O
his O
words O
both O
sounded O
`` O
like O
[ O
I O
] O
was O
drunk O
'' O
. O
 
He O
also O
stated O
that O
at O
times O
, O
when O
he O
would O
try O
to O
talk O
, O
nothing O
would O
come O
out O
. O
 
He O
walked O
downstairs O
, O
with O
difficulty O
, O
and O
his O
wife O
noticed O
that O
in O
the O
hallway O
he O
was O
bumping O
into O
items O
on O
( O
falling O
to O
) O
his O
right O
. O
 
Denies O
weakness O
, O
paresthesias O
, O
pain O
. O
 
EMTs O
report O
that O
when O
asked O
the O
President O
's O
name O
, O
pt O
responded O
`` O
Chrysler O
Dodge O
'' O
. O
 
Brought O
initially O
to O
OSH O
, O
symptoms O
mostly O
resolved O
within O
20 O
minutes O
. O
 
I- O
CT O
at O
OSH O
negative O
. O
 
Pt O
transferred O
to O
HDH I-LOCATION
ED O
at O
suggestion O
of O
covering O
PCP O
. O
 
Past O
Medical O
Hx O
: O
HTN O
, O
Coronary O
artery O
disease O
( O
s/p O
angioplasty O
and O
atherectomy O
; O
s/p O
CABG O
x O
5 O
in O
2081 I-DATE
) O
, O
diabetes O
mellitus O
, O
prostate O
ca O
( O
s/p O
radical O
retropubic O
prostatectomy O
4/0 O
, O
negative O
nodes O
and O
margins O
) O
, O
obesity O
. O
 
Bladder O
suspension O
. O
 
Baseline O
bradycardia O
( O
40s O
average O
) O
. O
 
Allergies O
: O
Hydrochlorothiazide O
, O
furosemide O
, O
gemfibrozil O
, O
amoxicillin O
, O
hydrocodone O
, O
oxycodone O
Medicines O
: O
Isosorbide O
20 O
qid O
Cardizem O
HCM O
180 O
qD O
Atenolol O
25 O
qD O
ECASA O
325 O
qD O
Atorvastatin O
10 O
qD O
Glucophage O
500 O
bid O
Avapro O
150 O
qD O
Bumetanide O
1 O
qD O
Claritin O
1 O
qD O
Family O
History O
: O
Mom O
with O
stroke O
in O
her O
80s I-AGE
Social O
History O
: O
Married O
41 O
years O
. O
 
Pastor I-PROFESSION
( O
still O
practicing O
) O
. O
 
No O
cigarettes O
. O
 
EtOH O
< O
1 O
glass O
wine/month O
. O
 
Review O
of O
Systems O
: O
Mild O
frontal O
HA O
, O
no O
tinnitus O
, O
no O
CP/SOB/abdom O
pain O
. O
 
+ O
diplopia O
occasionally O
this O
AM O
( O
horizontal O
) O
, O
no O
dysuria O
. O
 
Examination O
: O
Gen O
: O
Pleasant O
65 I-AGE
yo O
RH O
gentleman O
, O
NAD O
148/67 O
P44-48 O
R16 O
RRR O
No O
carotid/occipital O
bruits O
. O
 
Neurologic O
exam O
MS O
: O
Alert O
, O
interactive O
, O
NAD O
. O
 
Fully O
oriented O
. O
 
Accurate O
describes O
stroke O
card O
scene O
. O
 
Speech O
: O
Articulate O
, O
appropriate O
. O
 
Reading O
and O
repetition O
intact O
. O
 
Naming O
all O
items O
on O
stroke O
card O
( O
`` O
couch O
'' O
; O
when O
asked O
for O
alternative O
, O
`` O
chair O
'' O
) O
. O
 
Several O
hesitancies O
of O
speech O
, O
occasional O
phonemic O
paraphasic O
error O
( O
recognized O
) O
. O
 
CN O
: O
PERRL O
4 O
2 O
bilaterally O
, O
EOMI O
, O
VFFtC O
, O
facial O
sensation O
intact O
, O
eyes O
shut O
tight O
, O
smile O
symmetric O
, O
hearing O
intact O
, O
palate O
elevates O
symmetrically O
, O
shoulder O
shrug O
strong O
, O
tongue O
midline O
. O
 
Motor O
: O
5/5 O
strength O
UE/LE O
bilaterally O
proximally O
and O
distally O
. O
 
Normal O
tone/bulk O
. O
 
No O
fasciculations O
noted O
. O
 
No O
drift O
. O
 
Rapid O
finger O
movements O
slightly O
slower O
on O
R O
( O
dominant O
side O
) O
than O
L. O
Sensory O
: O
Pinprick O
, O
temperature O
, O
light O
touch O
, O
vibration O
, O
proprioception O
intact O
. O
 
Reflexes O
: O
2+ O
B/T O
bilaterally O
. O
 
21+ O
patellar O
, O
1+ O
ankle O
reflexes O
. O
 
R O
toe O
up O
, O
L O
toe O
down O
( O
could O
not O
repeat O
1 O
hour O
later O
) O
. O
 
Coordination O
: O
F-N-F O
intact O
. O
 
Rapid O
alternating O
movements O
intact O
. O
 
Gait O
: O
Normal O
. O
 
Tandems O
well O
. O
 
Romberg O
negative O
. O
 
CXR O
: O
pending O
CT O
: O
from O
OSH O
, O
mild O
cortical O
atrophy O
with O
mild O
hydrocephalus O
ex O
vacuo O
. O
 
Basilar O
artery O
is O
prominent O
, O
though O
not O
severely O
hyperdense O
. O
 
Labs O
: O
NA O
142 O
K O
4.0 O
CL O
102 O
CO2 O
26.2 O
BUN O
34 O
CRE O
1.6 O
GLU O
106 O
CA O
8.7 O
PHOS O
3.3 O
MG O
1.6 O
WBC O
9.4 O
HCT O
37.1 O
( O
L O
) O
HGB O
13.3 O
( O
L O
) O
PLT O
152 O
MCV O
80 O
RDW O
13.0 O
% O
NEUT O
58 O
% O
LYMPH O
32 O
% O
MONO O
6 O
% O
EOS O
3 O
% O
BASO O
1 O
PT O
12.8 O
PTT O
25.8 O
Impression O
: O
65 I-AGE
year O
old O
gentleman O
with O
multiple O
stroke O
risk O
factors O
, O
onset O
of O
dysarthria O
, O
aphasia O
, O
dizziness O
, O
ataxia O
at O
13:00 O
today O
. O
 
Symptoms O
improving O
over O
first O
30-60 O
minutes O
, O
but O
residual O
RUE O
drift O
, O
dysarthria O
, O
and O
( O
initally O
) O
upgoing O
R O
toe O
. O
 
Suspicious O
for O
L O
MCA O
cortical O
event O
. O
 
L O
ICA O
stenosis O
and/or O
embolic O
event O
+/- O
fetal O
left O
PCA O
possible O
concerns O
( O
? O
cortical O
vs O
v-b O
etiology O
of O
dizziness O
) O
. O
 
Can O
not O
obtain O
CTA O
secondary O
to O
elevated O
creatinine O
. O
 
Plan O
: O
1 O
. O
 
Admit O
to O
RDA O
2 O
. O
 
MRI/MRA O
. O
 
MR O
Perfusion O
study O
if O
L O
ICA O
stenosis O
or O
suggestion O
of O
intracranial O
stenosis O
. O
 
3 O
. O
 
As O
event O
occurred O
on O
ASA O
, O
provide O
heparin O
PTT O
60-80 O
, O
continue O
ASA O
at O
decreased O
dose O
( O
81 O
qD O
) O
. O
 
Watch O
platelets O
, O
as O
pt O
starting O
with O
platelets O
= O
150 O
4 O
. O
 
Hold O
antihypertensive O
, O
but O
continue O
isosorbide O
for O
known O
cardiac O
ischemic O
history O
. O
 
5 O
. O
 
Echo O
, O
Holter O
( O
for O
known O
bradycardia O
; O
eval O
for O
events O
with O
HR O
< O
< O
40 O
. O
 
6 O
. O
 
PT/speech O
therapy O
. O
 
7 O
. O
 
Careful O
glycemic O
control O
( O
holding O
metformin O
) O
. O
 
Vi I-NAME
K. I-NAME
Xayarath I-NAME
, O
M.D. O
, O
Ph.D. O
Resident O
, O
Phoenix I-LOCATION
Neurology O
 
Record O
date O
: O
2092-03-17 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
HOLDEN I-LOCATION
DISTRICT I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
Three O
months O
of O
followup O
for O
multiple O
medical O
problems O
. O
 
History O
of O
present O
illness O
Since O
his O
last O
visit O
, O
he O
has O
started O
to O
resume O
exercising O
on O
his O
treadmill O
, O
but O
has O
not O
been O
watching O
his O
weight O
or O
diet O
. O
 
Major O
Problems O
Hyperlipidemia O
His O
most O
recent O
labs O
are O
within O
reasonable O
range O
with O
an O
LDL O
of O
76 O
and O
fasting O
triglycerides O
263 O
, O
which O
improved O
from O
his O
previous O
values O
. O
 
He O
has O
been O
intolerant O
to O
Lopid O
which O
resulted O
in O
pancreatitis O
. O
 
He O
has O
not O
lost O
any O
weight O
, O
but O
has O
begun O
to O
exercise O
. O
 
Allergic O
rhinitis O
He O
has O
chronic O
postnasal O
drip O
and O
nasal O
congestion O
for O
which O
he O
uses O
Nasonex O
on O
a O
regular O
basis O
with O
some O
improvement O
. O
 
He O
has O
had O
no O
sinus O
pains O
, O
headache O
, O
or O
recent O
sinusitis O
. O
 
Cerebrovascular O
accident O
The O
patient O
has O
had O
no O
recent O
neurological O
symptoms O
or O
changes O
. O
 
He O
had O
a O
mild O
aphasia O
which O
has O
totally O
resolved O
. O
 
He O
has O
had O
no O
headaches O
or O
any O
focal O
symptoms O
. O
 
Gastroesophageal O
reflux O
disease O
The O
patient O
continues O
on O
his O
ranitidine O
at O
night O
with O
improvement O
in O
his O
intermittent O
epigastric O
discomfort O
. O
 
Sleep O
apnea O
The O
patient O
had O
a O
sleep O
study O
in O
November I-DATE
2091 I-DATE
due O
to O
excessive O
fatigue O
and O
snoring O
. O
 
He O
was O
noted O
to O
have O
sleep O
apnea O
, O
and O
CPAP O
was O
prescribed O
. O
 
He O
has O
not O
been O
using O
the O
CPAP O
since O
he O
was O
recently O
on O
vacation O
, O
but O
he O
plans O
to O
start O
in O
the O
near O
future O
. O
 
During O
his O
sleep O
study O
, O
he O
was O
not O
uncomfortable O
wearing O
the O
mask O
and O
hopefully O
, O
this O
will O
help O
. O
 
Prostatic O
carcinoma O
The O
patient O
is O
followed O
regularly O
by O
the O
urologist O
and O
last O
had O
a O
visit O
in O
January I-DATE
2092 I-DATE
with O
PSA O
in O
a O
very O
good O
range O
at O
less O
than O
0.2 O
. O
 
He O
has O
no O
dysuria O
, O
urgency O
, O
frequency O
, O
or O
significant O
nocturia O
. O
 
Carpal O
tunnel O
syndrome O
Currently O
, O
he O
does O
not O
complain O
of O
any O
pain O
or O
paresthesias O
in O
his O
wrists O
. O
 
Coronary O
artery O
disease O
The O
patient O
has O
had O
no O
angina O
since O
his O
last O
visit O
. O
 
He O
exercises O
on O
a O
treadmill O
five O
times O
a O
week O
and O
can O
walk O
up O
to O
five O
miles O
in O
any O
given O
setting O
. O
 
He O
does O
not O
have O
any O
palpitations O
, O
chest O
pressure O
, O
pain O
, O
or O
significant O
dyspnea O
on O
exertion O
. O
 
Diabetes O
mellitus O
The O
patient O
checks O
his O
blood O
sugars O
at O
home O
, O
and O
they O
have O
been O
in O
the O
120 O
range O
, O
although O
he O
admits O
to O
not O
losing O
weight O
and O
on O
his O
recent O
trip O
was O
not O
exercising O
as O
regularly O
. O
 
He O
has O
had O
no O
symptoms O
with O
hypoglycemia O
. O
 
Hypertension O
The O
patient O
monitors O
his O
blood O
pressure O
closely O
at O
home O
and O
finds O
it O
to O
be O
at O
around O
120/70 O
. O
 
He O
has O
not O
had O
any O
headaches O
or O
any O
other O
focal O
symptoms O
. O
 
Atrial O
fibrillation O
- O
Inactivated O
Bronchitis O
- O
Inactivated O
Allergies O
Allergic O
drug O
reaction O
Acf O
inhibitor O
- O
cough O
. O
 
Procardia O
- O
leg O
edema O
. O
 
Lopid O
- O
pancreatitis O
. O
 
Cardura O
- O
ankle O
swelling O
. O
 
Dyazide O
- O
elevated O
bun/creat O
. O
 
Exedrin O
- O
rash O
. O
 
Amox O
- O
vomiting O
. O
 
Norvasc O
- O
leg O
edema O
. O
 
HCTZ O
- O
rash O
per O
derm O
. O
 
Estynil O
- O
rash O
. O
 
Drug O
allergy O
ACE O
inhibitor-cough O
procardia-leg O
edema O
lopid-pancreatitis O
cardura-ankle O
swelling O
dyazide-elevated O
bun/creat O
edecrine-rash O
amox-vomiting O
norvasc-leg O
edema O
hctz-rash O
per O
derm O
catapres-rash O
aggrenox O
- O
pancreatitis O
. O
 
Active O
Medications O
Lipitor O
20mg O
po O
qd O
Glucophage O
500 O
mg O
po O
BID O
; O
Dir O
: O
take O
1 O
tab O
am O
and O
2 O
tabs O
pm O
atenolol O
25mg O
po O
bid O
glyburide O
tablets O
1.25 O
po O
qd O
Isordil O
20 O
mg O
QID O
Cardizem O
cd O
180 O
mg O
PO O
QD O
Bumex O
1 O
mg O
2 O
tabs O
PO O
QD O
Avapro O
150 O
mg O
Nitro O
stat O
0.3mg O
SL O
PRN O
; O
Dir O
: O
chest O
pain O
, O
max O
3 O
pills O
& O
call O
pcp O
Coumadin O
5 O
mg O
po O
as O
directed O
folic O
acid O
1 O
mg O
PO O
4 O
QD O
Clarinex O
5mg O
po O
qd O
Zoloft O
100 O
mg O
po O
QHS O
aspirin O
81 O
mg O
ranitidine O
hcl O
300mg O
po O
qhs O
Nasonex O
50mcg/spray O
nasal O
qd O
; O
Dir O
: O
2 O
sprays/nostril O
; O
start O
2wks O
before O
expected O
allergy O
season O
free O
text O
medications O
lipitor O
10mg O
po O
qd O
; O
Dir O
: O
as O
directed O
Continuous O
positive O
airway O
pressure O
Accucheck O
advantage O
glucose O
test O
strips O
Change O
in O
therapies O
and O
Renewals O
Lipitor O
20mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
2/06/2087 I-DATE
atenolol O
25mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
3/25/2087 I-DATE
free O
text O
medications O
QTY O
: O
Refills O
: O
Start O
: O
03/17/2092 I-DATE
CPAP O
as O
directed O
Past O
medical O
history O
History O
of O
coronary O
artery O
bypass O
surgery O
in O
August I-DATE
2081 I-DATE
. O
 
History O
of O
carpal O
tunnel O
surgery O
bilaterally O
. O
 
History O
of O
prostatectomy O
in O
June I-DATE
2088 I-DATE
for O
prostate O
cancer O
. O
 
Procedures O
Colonoscopy O
in O
June I-DATE
2087 I-DATE
. O
 
Family O
history O
Mother O
with O
hypertension O
. O
 
Father O
with O
hypertension O
and O
Alzheimer O
's O
disease O
. O
 
Mother O
with O
a O
stroke O
and O
diabetes O
. O
 
Two O
brothers O
and O
a O
grandfather O
with O
colon O
polyps O
. O
 
A O
grandfather O
with O
colon O
cancer O
. O
 
A O
grandmother O
with O
breast O
cancer O
. O
 
Two O
brothers O
with O
hyperlipidemia O
. O
 
No O
history O
of O
prostate O
cancer O
. O
 
Social O
history O
The O
patient O
is O
a O
retired O
pastor I-PROFESSION
who O
lives O
with O
his O
wife O
. O
 
He O
is O
active O
, O
independent O
, O
and O
cares O
for O
his O
grandchildren O
on O
a O
regular O
basis O
. O
 
Habits O
Smoking O
status O
: O
never O
smoked O
Alcohol O
use O
status O
: O
occasional O
. O
 
Drug O
use O
status O
: O
none O
Activity O
level O
: O
active O
Review O
of O
systems O
Constitutional O
, O
some O
mild O
fatigue O
and O
snoring O
. O
 
A O
recent O
eye O
exam O
in O
January I-DATE
2092 I-DATE
by O
report O
, O
no O
retinopathy O
. O
 
Musculoskeletal O
, O
no O
recent O
joint O
problems O
or O
complaints O
. O
 
Dermatologic O
, O
he O
sees O
the O
podiatrist O
every O
six O
weeks O
for O
foot O
care O
. O
 
The O
remainder O
of O
his O
review O
of O
systems O
is O
negative O
in O
detail O
except O
for O
noted O
up O
in O
his O
problem O
list O
above O
. O
 
Physical O
examination O
Pulse O
56 O
and O
regular O
Blood O
pressure O
134/70 O
132-134/70 O
Weight O
186.5 O
pounds O
Skin O
No O
evidence O
of O
skin O
lesions O
Heent O
Full O
extraocular O
movements O
. O
 
No O
nystagmus O
. O
 
Nose O
, O
mild O
erythema O
. O
 
No O
discharge O
. O
 
Oropharynx O
, O
no O
lesions O
. O
 
Dentition O
in O
good O
repair O
Neck O
Thyroid O
, O
not O
enlarged O
. O
 
No O
fibroid O
nodules O
. O
 
Carotid O
upstrokes O
brisk O
. O
 
No O
bruits O
Chest O
Clear O
to O
auscultation O
and O
percussion O
Cor O
Normal O
S1 O
and O
S2 O
. O
 
Regular O
rhythm O
. O
 
No O
murmurs O
, O
gallops O
, O
or O
rubs O
Abdomen O
Obese O
and O
nontender O
Extrem O
No O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
Distal O
pulses O
, O
dorsalis O
pedis O
, O
and O
posterior O
tibial O
are O
full O
and O
symmetrical O
Foot O
exam O
No O
evidence O
of O
skin O
lesions O
Neuro O
Grossly O
nonfocal O
. O
 
Speech O
fluent O
without O
paraphasic O
errors O
. O
 
Memory O
, O
excellent O
and O
intact O
. O
 
Gait O
normal O
Assessment O
and O
plan O
The O
patient O
's O
multiple O
issues O
were O
reviewed O
in O
detail O
and O
his O
medications O
were O
updated O
. O
 
He O
remains O
overweight O
, O
and O
this O
was O
discussed O
with O
the O
patient O
in O
terms O
of O
portion O
control O
and O
continuing O
his O
vigorous O
exercise O
program O
. O
 
He O
will O
try O
to O
lose O
weight O
. O
 
Diabetes O
. O
 
His O
last O
hemoglobin O
A1c O
was O
not O
in O
adequate O
control O
. O
 
In O
the O
past O
, O
we O
have O
tried O
to O
increase O
his O
Glucophage O
. O
 
He O
did O
not O
tolerate O
it O
due O
to O
severe O
GI O
upset O
. O
 
If O
his O
sugars O
remain O
high O
, O
he O
will O
need O
his O
regimen O
adjusted O
. O
 
His O
eye O
exam O
and O
throat O
exam O
are O
up-to-date O
and O
urine O
for O
microalbumin O
was O
negative O
. O
 
Coronary O
artery O
disease O
. O
 
No O
recent O
angina O
. O
 
He O
will O
continue O
on O
his O
current O
regimen O
. O
 
Sleep O
apnea O
. O
 
It O
was O
highly O
recommended O
that O
he O
start O
his O
CPAP O
therapy O
for O
overall O
improvement O
in O
his O
health O
. O
 
Hypertension O
. O
 
Very O
well O
controlled O
, O
and O
no O
side O
effects O
to O
his O
current O
medications O
. O
 
Laboratory O
studies O
were O
sent O
, O
and O
he O
will O
return O
for O
followup O
in O
three O
months O
or O
sooner O
if O
needed O
. O
 
Addendum O
Allergies O
were O
reviewed O
. O
 
Note O
transcribed O
by O
outside O
service O
Transcription O
errors O
may O
be O
present O
. O
 
Signed O
electronically O
by O
Riddle O
, O
Rhonda I-NAME
on O
Mar I-DATE
31 O
, O
2092 I-DATE
 
Record O
date O
: O
2092-09-18 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
HOLDEN I-LOCATION
DISTRICT I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
Followup O
of O
multiple O
issues O
. O
 
History O
of O
present O
illness O
Since O
his O
last O
visit O
, O
the O
patient O
has O
had O
two O
episodes O
of O
pressure O
in O
his O
chest O
. O
 
This O
occurred O
approximately O
one O
week O
ago O
in O
the O
setting O
of O
walking O
up O
the O
stairs O
and O
carrying O
a O
heavy O
package O
. O
 
He O
notes O
that O
his O
pulse O
went O
up O
to O
101 O
and O
he O
had O
overall O
felt O
`` O
tired O
in O
his O
chest O
'' O
. O
 
He O
did O
not O
take O
any O
nitroglycerine O
, O
and O
his O
symptoms O
promptly O
resolved O
. O
 
He O
has O
continued O
to O
notice O
episodes O
of O
intermittent O
rapid O
pulses O
with O
pulses O
up O
to O
100 O
. O
 
He O
has O
had O
no O
syncope O
or O
near O
syncope O
. O
 
Generally O
, O
he O
has O
been O
walking O
on O
the O
treadmill O
up O
to O
four O
to O
six O
miles O
a O
day O
several O
times O
a O
week O
. O
 
Over O
the O
last O
few O
weeks O
, O
he O
has O
felt O
a O
little O
bit O
more O
fatigued O
and O
now O
can O
only O
walk O
approximately O
four O
miles O
. O
 
He O
has O
not O
had O
any O
sustained O
palpitation O
, O
syncope O
, O
or O
near O
syncope O
, O
but O
has O
noted O
a O
slight O
decrease O
in O
his O
exercise O
tolerance O
. O
 
Problem O
List O
( O
reviewed O
) O
Coronary O
artery O
disease O
MAJOR O
Hypertension O
MAJOR O
Diabetes O
mellitus O
MAJOR O
Carpal O
tunnel O
syndrome O
MAJOR O
Allergic O
rhinitis O
MAJOR O
Angina O
pectoris O
MAJOR O
STATUS O
POST O
Prostatic O
carcinoma O
MAJOR O
Cerebrovascular O
accident O
MAJOR O
Sleep O
apnea O
MAJOR O
Gastroesophageal O
reflux O
disease O
MAJOR O
Hyperlipidemia O
MAJOR O
Colonic O
polyp O
MAJOR O
Major O
Problems O
Coronary O
artery O
disease O
see O
HPI O
Hypertension O
The O
patient O
monitors O
his O
blood O
pressure O
closely O
at O
home O
and O
finds O
it O
to O
be O
at O
around O
120/70 O
. O
 
He O
has O
not O
had O
any O
headaches O
or O
any O
other O
focal O
symptoms O
. O
 
Diabetes O
mellitus O
The O
patient O
checks O
his O
blood O
sugars O
at O
home O
, O
and O
they O
have O
been O
in O
the O
120 O
range O
, O
he O
has O
been O
exercising O
more O
regularly O
. O
 
He O
has O
had O
no O
symptoms O
of O
hypoglycemia O
and O
generally O
has O
been O
doing O
well O
Carpal O
tunnel O
syndrome O
Currently O
, O
he O
does O
not O
complain O
of O
any O
pain O
or O
paresthesias O
in O
his O
wrists O
. O
 
Allergic O
rhinitis O
He O
has O
chronic O
postnasal O
drip O
and O
nasal O
congestion O
for O
which O
he O
uses O
clarinexon O
a O
regular O
basis O
with O
some O
improvement O
. O
 
He O
has O
had O
no O
sinus O
pains O
, O
headache O
, O
or O
recent O
sinusitis O
. O
 
Angina O
pectoris O
STATUS O
POST O
Unstable O
angina O
1/86 I-DATE
cath O
lad O
stenosis O
. O
 
ETT O
1/84 I-DATE
. O
 
ETT O
3/2091 I-DATE
mild O
ant./basal O
ischemia O
Prostatic O
carcinoma O
The O
patient O
is O
followed O
regularly O
by O
the O
urologist O
and O
last O
had O
a O
visit O
in O
July I-DATE
2092 I-DATE
with O
PSA O
in O
a O
very O
good O
range O
at O
less O
than O
0.2 O
. O
 
He O
has O
no O
dysuria O
, O
urgency O
, O
frequency O
, O
or O
significant O
nocturia O
Cerebrovascular O
accident O
The O
patient O
has O
had O
no O
recent O
neurological O
symptoms O
or O
changes O
. O
 
He O
had O
a O
mild O
aphasia O
which O
has O
totally O
resolved O
. O
 
He O
has O
had O
no O
headaches O
or O
any O
focal O
symptoms O
. O
 
Sleep O
apnea O
The O
patient O
had O
a O
sleep O
study O
in O
November I-DATE
2091 I-DATE
due O
to O
excessive O
fatigue O
and O
snoring O
. O
 
He O
was O
noted O
to O
have O
sleep O
apnea O
, O
and O
CPAP O
was O
prescribed O
. O
 
He O
has O
been O
using O
the O
CPAP O
.. O
Gastroesophageal O
reflux O
disease O
The O
patient O
continues O
on O
his O
ranitidine O
at O
night O
with O
improvement O
in O
his O
intermittent O
epigastric O
discomfort.No O
dysphagia O
, O
odynophagia O
Hyperlipidemia O
taking O
his O
medication O
, O
and O
watching O
his O
weight O
Colonic O
polyp O
7/11/92 I-DATE
2 O
polyps O
excised O
transverse O
colon O
Allergies O
Drug O
allergy O
ACE O
inhibitor-cough O
procardia-leg O
edema O
lopid-pancreatitis O
cardura-ankle O
swelling O
dyazide-elevated O
bun/creat O
edecrine-rash O
amox-vomiting O
norvasc-leg O
edema O
hctz-rash O
per O
derm O
catapres-rash O
aggrenox O
- O
pancreatitis O
. O
 
Active O
Medications O
Lipitor O
10mg O
po O
3 O
tabs O
qd O
dose O
has O
been O
increased O
to O
30mg O
Glucophage O
500 O
mg O
po O
BID O
take O
1 O
tab O
am O
and O
2 O
tabs O
pm O
atenolol O
25mg O
po O
bid O
glyburide O
tablets O
1.25 O
po O
qd O
Isordil O
20 O
mg O
QID O
Cardizem O
cd O
180 O
mg O
PO O
QD O
Bumex O
1 O
mg O
2 O
tabs O
PO O
QD O
Avapro O
150 O
mg O
Nitro O
stat O
0.3mg O
SL O
PRN O
chest O
pain O
, O
max O
3 O
pills O
& O
call O
pcp O
Coumadin O
5 O
mg O
po O
as O
directed O
folic O
acid O
1 O
mg O
PO O
4 O
QD O
Clarinex O
5mg O
po O
qd O
Zoloft O
100 O
mg O
1/2 O
tab O
po O
QHS O
aspirin O
81 O
mg O
ranitidine O
hcl O
300mg O
po O
qhs O
Nasonex O
50mcg/spray O
nasal O
qd O
2 O
sprays/nostril O
Advair O
100/50mcg O
spray O
inh O
bid O
free O
text O
medications O
lipitor O
10mg O
po O
qd O
as O
directed O
Continuous O
positive O
airway O
pressure O
use O
as O
directed O
Accucheck O
advantage O
glucose O
test O
strips O
use O
as O
directed O
qty:300 O
rfl:3 O
Past O
medical O
history O
History O
of O
coronary O
artery O
bypass O
surgery O
in O
August I-DATE
2081 I-DATE
. O
 
History O
of O
carpal O
tunnel O
surgery O
bilaterally O
. O
 
History O
of O
prostatectomy O
in O
June I-DATE
2088 I-DATE
for O
prostate O
cancer O
. O
 
Family O
history O
Mother O
with O
hypertension O
. O
 
Father O
with O
hypertension O
and O
Alzheimer O
's O
disease O
. O
 
Mother O
with O
a O
stroke O
and O
diabetes O
. O
 
Two O
brothers O
and O
a O
grandfather O
with O
colon O
polyps O
. O
 
A O
grandfather O
with O
colon O
cancer O
. O
 
A O
grandmother O
with O
breast O
cancer O
. O
 
Two O
brothers O
with O
hyperlipidemia O
. O
 
Brother O
with O
prostate O
cancer O
. O
 
Social O
history O
The O
patient O
is O
a O
retired O
pastor I-PROFESSION
who O
lives O
with O
his O
wife O
. O
 
He O
is O
active O
, O
independent O
, O
and O
cares O
for O
his O
grandchildren O
on O
a O
regular O
basis O
. O
 
Habits O
Activity O
level O
: O
active O
treadmill O
1-2 O
hours O
4-6X O
per O
week O
Smoking O
status O
: O
never O
smoked O
Alcohol O
use O
status O
: O
none/minimal O
occasional O
. O
 
Drug O
use O
status O
: O
none O
Procedures O
and O
Immunizations O
Influenza O
vaccine O
STATUS O
POST O
[ O
9/18/2092 I-DATE
] O
Fluzone O
Lot O
# O
S3124HR I-ID
Exp O
. O
 
26 I-DATE
Jun I-DATE
92 I-DATE
( O
l O
) O
Deltoid O
Left O
deltoid O
lot O
# O
STGLX647RM I-ID
Review O
of O
systems O
The O
patient O
has O
had O
no O
fevers O
, O
chills O
, O
or O
night O
sweats O
. O
 
He O
haschronic O
bilateral O
nasal O
congestion O
. O
 
He O
has O
no O
sputum O
production O
. O
 
No O
joint O
symptoms O
, O
GI O
, O
GU O
, O
or O
neurological O
complaints O
. O
 
No O
skin O
rashes O
. O
 
Physical O
examination O
Blood O
pressure O
120/70 O
Pulse O
72 O
, O
irregularly O
, O
irregular O
Weight O
182lbs O
General O
appearance O
Well O
developed O
, O
well O
nourished O
, O
no O
acute O
distress O
. O
 
Heent O
NC/AT O
, O
PERRL O
, O
EOMI O
, O
O/P O
clear O
without O
erythema O
or O
exudates O
. O
 
Neck O
JVP O
flat O
; O
carotids O
brisk O
, O
2+ O
bilaterally O
without O
bruits O
, O
no O
goiter O
. O
 
Chest O
Clear O
to O
auscultation O
bilaterally O
. O
 
Cor O
PMI O
at O
5th O
ICS O
, O
MCL O
. O
 
RRR O
nl O
s1 O
, O
s2 O
without O
m/r/g O
. O
 
Extrem O
No O
clubbing O
, O
cyanosis O
, O
edema O
. O
 
Full O
pedal O
pulses O
. O
 
Neuro O
Grossly O
nonfocal O
. O
 
Speech O
fluent O
without O
paraphasic O
errors O
. O
 
Memory O
, O
excellent O
and O
intact O
. O
 
Gait O
normal O
Foot O
exam O
Negative O
Preventive O
eye O
exam O
5/92 I-DATE
Selected O
recent O
labs O
ECG O
new O
atrial O
fibrillation O
at O
rate O
74 O
. O
 
Right O
bundle O
branch O
block O
, O
no O
ischemic O
changes O
Assessment O
and O
plan O
The O
patient O
's O
symptoms O
and O
exam O
as O
well O
as O
EKG O
are O
consistent O
with O
atrial O
fibrillation O
. O
 
Of O
note O
, O
the O
patient O
had O
a O
history O
of O
paroxysmal O
atrial O
fibrillation O
after O
his O
CABG O
. O
 
However O
, O
he O
has O
not O
had O
any O
significant O
symptoms O
since O
that O
time O
. O
 
He O
remains O
active O
without O
any O
evidence O
of O
congestive O
heart O
failure O
on O
exam O
. O
 
He O
continues O
to O
exercise O
on O
a O
regular O
basis O
. O
 
Given O
his O
slightly O
elevated O
pulse O
rate O
, O
his O
atenolol O
will O
be O
increased O
to O
25 O
mg O
PO O
BID O
from O
one O
per O
day O
which O
is O
what O
he O
is O
currently O
taking O
. O
 
His O
blood O
pressure O
is O
under O
good O
control O
. O
 
Given O
his O
recent O
episode O
of O
repeat O
stress O
test O
will O
be O
sent O
. O
 
If O
there O
is O
any O
prolonged O
episode O
of O
pain O
, O
he O
will O
come O
to O
the O
emergency O
room O
immediately O
. O
 
He O
is O
encouraged O
to O
use O
nitroglycerine O
sublingually O
if O
he O
has O
any O
evidence O
or O
any O
chest O
pressure O
. O
 
For O
his O
diabetes O
, O
his O
labs O
will O
be O
sent O
. O
 
He O
remains O
on O
Coumadin O
for O
anticoagulation O
, O
and O
his O
INR O
has O
been O
therapeutic O
. O
 
He O
will O
follow O
up O
in O
three O
months O
but O
sooner O
pending O
the O
above O
evaluation O
. O
 
If O
he O
has O
any O
increase O
in O
his O
symptoms O
, O
he O
will O
be O
admitted O
immediately O
. O
 
Note O
transcribed O
by O
outside O
service O
Transcription O
errors O
may O
be O
present O
. O
 
Signed O
electronically O
by O
Riddle O
, O
Rhonda I-NAME
on O
Sep I-DATE
25 O
, O
2092 I-DATE
 
Record O
date O
: O
2092-12-31 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
HOLDEN I-LOCATION
DISTRICT I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
Followup O
of O
recent O
MI O
and O
multiple O
medical O
problems O
. O
 
History O
of O
present O
illness O
Since O
the O
patient O
's O
last O
visit O
, O
he O
developed O
a O
maculopapular O
rash O
and O
his O
Plavix O
was O
discontinued O
. O
 
Since O
this O
is O
the O
only O
new O
medication O
, O
it O
was O
presumed O
that O
Plavix O
was O
the O
cause O
of O
the O
new O
skin O
rash O
. O
 
He O
also O
changed O
his O
beta O
blocker O
and O
started O
Toprol O
XL O
approximately O
one O
week O
ago O
. O
 
At O
home O
, O
he O
states O
his O
pulse O
has O
been O
under O
better O
control O
, O
and O
now O
, O
is O
in O
the O
60 O
range O
. O
 
He O
denies O
any O
palpitations O
, O
PND O
, O
orthopnea O
, O
or O
shortness O
of O
breath O
. O
 
He O
has O
had O
no O
recurrent O
angina O
and O
has O
tried O
this O
week O
to O
slowly O
start O
to O
walk O
for O
about O
15 O
minutes O
on O
his O
treadmill O
at O
a O
low O
pace O
. O
 
He O
has O
not O
had O
any O
angina O
or O
chest O
pain O
with O
this O
walking O
routine O
. O
 
He O
also O
knows O
that O
his O
sugars O
at O
home O
had O
been O
very O
low O
at O
55 O
and O
56 O
in O
the O
evening O
. O
 
He O
has O
had O
weight O
loss O
and O
slightly O
diminished O
appetite O
and O
this O
may O
account O
for O
his O
low O
blood O
sugars O
. O
 
He O
is O
here O
for O
a O
followup O
. O
 
Of O
note O
, O
his O
Bumex O
dose O
was O
decreased O
due O
to O
an O
elevated O
BUN O
and O
creatinine O
. O
 
His O
weight O
has O
been O
stabled O
, O
and O
he O
feels O
better O
on O
the O
lower O
dose O
of O
diuretics O
without O
symptoms O
of O
congestive O
heart O
failure O
. O
 
Major O
Problems O
Coronary O
artery O
disease O
see O
HPI O
Atrial O
fibrillation O
Rx O
with O
rate O
control O
, O
and O
coumadin O
. O
 
rate O
60 O
, O
s O
at O
home O
. O
 
No O
CHF O
, O
neuro O
Sx O
Hypertension O
The O
patient O
monitors O
his O
blood O
pressure O
closely O
at O
home O
and O
finds O
it O
to O
be O
at O
around O
110/70 O
. O
 
He O
has O
not O
had O
any O
headaches O
or O
any O
other O
focal O
symptoms O
. O
 
Diabetes O
mellitus O
See O
HPI O
Allergic O
rhinitis O
He O
has O
chronic O
postnasal O
drip O
and O
nasal O
congestion O
for O
which O
he O
uses O
clarinex O
on O
a O
regular O
basis O
with O
some O
improvement O
. O
 
He O
has O
had O
no O
sinus O
pains O
, O
headache O
, O
or O
recent O
sinusitis O
. O
 
Angina O
pectoris O
STATUS O
POST O
Unstable O
angina O
1/86 I-DATE
cath O
lad O
stenosis O
. O
 
ETT O
1/84 I-DATE
. O
 
ETT O
3/2091 I-DATE
mild O
ant./basal O
ischemia O
. O
 
S/P O
MI O
12/92 I-DATE
with O
cardiac O
cath O
, O
stent O
RCA O
. O
 
Cerebrovascular O
accident O
The O
patient O
has O
had O
no O
recent O
neurological O
symptoms O
or O
changes O
. O
 
He O
had O
a O
mild O
aphasia O
which O
has O
totally O
resolved O
. O
 
He O
has O
had O
no O
headaches O
or O
any O
focal O
symptoms O
. O
 
Sleep O
apnea O
The O
patient O
had O
a O
sleep O
study O
in O
November I-DATE
2091 I-DATE
due O
to O
excessive O
fatigue O
and O
snoring O
. O
 
He O
was O
noted O
to O
have O
sleep O
apnea O
, O
and O
CPAP O
was O
prescribed O
. O
 
He O
has O
been O
using O
the O
CPAP O
.. O
Gastroesophageal O
reflux O
disease O
The O
patient O
continues O
on O
his O
ranitidine O
at O
night O
with O
improvement O
in O
his O
intermittent O
epigastric O
discomfort.No O
dysphagia O
, O
odynophagia O
Hyperlipidemia O
taking O
his O
medication O
, O
and O
watching O
his O
weight O
Allergies O
Drug O
allergy O
ACE O
inhibitor-cough O
procardia-leg O
edema O
lopid-pancreatitis O
cardura-ankle O
swelling O
dyazide-elevated O
bun/creat O
edecrine-rash O
amox-vomiting O
norvasc-leg O
edema O
hctz-rash O
per O
derm O
catapres-rash O
aggrenox O
- O
pancreatitis.Plavix-rash O
Active O
Medications O
Accucheck O
Advantage O
glucose O
test O
strips O
Advair O
100/50mcg O
spray O
inh O
bid O
aspirin O
325 O
mg O
po O
qd O
Avapro O
150 O
mg O
Bumex O
1 O
mg O
2 O
tabs O
PO O
bid O
Cardizem O
cd O
180 O
mg O
PO O
QD O
Clarinex O
10mg O
po O
qd O
Continuous O
positive O
airway O
pressure O
Coumadin O
5 O
mg O
po O
as O
directed O
folic O
acid O
1 O
mg O
PO O
4 O
QD O
free O
text O
medications O
toprol O
xl O
100mg O
po O
qd O
Glucophage O
500 O
mg O
po O
BID O
glyburide O
tablets O
1.25 O
po O
qd O
Isordil O
20 O
mg O
QID O
Lipitor O
80mg O
po O
qd O
Nasonex O
50mcg/spray O
nasal O
qd O
2 O
sprays/nostril O
Nitro O
stat O
0.3mg O
SL O
PRN O
chest O
pain O
, O
max O
3 O
pills O
& O
amp O
; O
call O
pcp O
ranitidine O
hcl O
300mg O
po O
qhs O
Toprol O
XL O
50 O
mg O
po O
qd O
Zoloft O
100 O
mg O
1/2 O
tab O
po O
QHS O
Change O
in O
therapies O
and O
Renewals O
Lipitor O
80mg O
po O
qd O
Start O
: O
2/06/2087 I-DATE
atenolol O
25mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
3/25/2087 I-DATE
End O
: O
12/31/2092 I-DATE
- O
Inactivated O
Clarinex O
10mg O
po O
qd O
Start O
: O
1/24/2090 I-DATE
aspirin O
325 O
mg O
po O
qd O
Start O
: O
4/27/2090 I-DATE
Levaquin O
250 O
mg O
po O
qd O
x10d O
QTY:10 O
Refills:0 O
Start O
: O
12/11/2092 I-DATE
End O
: O
12/31/2092 I-DATE
- O
Inactivated O
free O
text O
medications O
toprol O
xl O
100mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
12/31/2092 I-DATE
Plavix O
75mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
12/15/2092 I-DATE
End O
: O
12/31/2092 I-DATE
- O
Inactivated O
Habits/Risk O
Screening O
Smoking O
status O
: O
never O
smoked O
Alcohol O
use O
status O
: O
none/minimal O
occasional O
. O
 
Review O
of O
systems O
The O
patient O
has O
had O
no O
fevers O
, O
chills O
, O
or O
night O
sweats O
. O
 
No O
cough O
. O
 
He O
has O
chronic O
nasal O
congestion O
. O
 
He O
has O
no O
sputum O
production O
. O
 
No O
joint O
symptoms O
, O
GI O
, O
GU O
, O
or O
neurological O
complaints O
. O
 
No O
skin O
rashes O
. O
 
Physical O
examination O
Blood O
pressure O
110/60 O
Pulse O
94 O
irregularly O
, O
irregular O
Weight O
172lbs O
height O
60in O
Office O
O2 O
saturation O
99 O
% O
General O
appearance O
Well O
developed O
, O
well O
nourished O
, O
no O
acute O
distress O
. O
 
Heent O
NC/AT O
, O
PERRL O
, O
EOMI O
, O
O/P O
clear O
without O
erythema O
or O
exudates O
. O
 
Neck O
JVP O
flat O
; O
carotids O
brisk O
, O
2+ O
bilaterally O
without O
bruits O
, O
no O
goiter O
. O
 
Chest O
Clear O
to O
auscultation O
bilaterally O
. O
 
Cor O
PMI O
at O
5th O
ICS O
, O
MCL O
. O
 
RRR O
nl O
s1 O
, O
s2 O
without O
m/r/g O
. O
 
Extrem O
No O
clubbing O
, O
cyanosis O
, O
edema O
. O
 
Full O
pedal O
pulses O
. O
 
Musc O
skel O
No O
bony O
deformities O
. O
 
Neuro O
Grossly O
nonfocal O
. O
 
Speech O
fluent O
without O
paraphasic O
errors O
. O
 
Memory O
, O
excellent O
and O
intact O
. O
 
Gait O
normal O
Preventive O
eye O
exam O
5/92 I-DATE
Assessment O
and O
plan O
The O
patient O
's O
multiple O
issues O
were O
reviewed O
with O
the O
patient O
in O
detail O
. O
 
His O
weight O
has O
remained O
fairly O
stable O
on O
the O
lower O
dose O
of O
diuretics O
, O
and O
a O
repeat O
BUN O
and O
creatinine O
were O
sent O
today O
. O
 
He O
was O
volume O
depleted O
at O
his O
last O
visit O
. O
 
Currently O
, O
he O
has O
no O
symptoms O
of O
unstable O
angina O
and O
no O
evidence O
of O
congestive O
heart O
failure O
on O
exam O
. O
 
His O
blood O
sugars O
have O
been O
low O
, O
and O
therefore O
, O
he O
will O
hold O
his O
glyburide O
for O
now O
. O
 
His O
pulse O
remained O
somewhat O
elevated O
, O
and O
he O
will O
follow O
up O
with O
his O
cardiologist O
relative O
to O
the O
need O
for O
cardioversion O
for O
an O
attempt O
to O
get O
him O
back O
into O
normal O
sinus O
rhythm O
. O
 
His O
weight O
control O
has O
been O
a O
problem O
. O
 
He O
will O
slowly O
increase O
his O
ambulation O
and O
will O
check O
his O
pulse O
and O
blood O
pressure O
at O
home O
. O
 
He O
will O
follow O
up O
here O
in O
two O
months O
or O
sooner O
if O
needed O
. O
 
Note O
transcribed O
by O
outside O
service O
Transcription O
errors O
may O
be O
present O
. O
 
Signed O
electronically O
by O
Riddle O
, O
Rhonda I-NAME
on O
Jan I-DATE
07 O
, O
2093 I-DATE
 
Record O
date O
: O
2112-07-28 I-DATE
OFFICE O
VISIT O
Dawson O
, O
Quinten I-NAME
MR O
# O
: O
4692758 I-ID
July I-DATE
28 O
, O
2112 I-DATE
Return O
visit O
. O
 
Reason O
for O
visit O
: O
A O
71-year-old O
male O
for O
comprehensive O
eval/management O
of O
multiple O
issues O
. O
 
Problems O
: O
1 O
. O
 
Diabetes O
: O
Continues O
on O
oral O
agents O
since O
2087 I-DATE
. O
 
A1C O
is O
below O
7.0 O
at O
goal O
. O
 
No O
hypoglycemia O
. O
 
Fasting O
sugars O
less O
than O
130 O
on O
balance O
. O
 
Has O
regular O
follow O
up O
. O
 
2 O
. O
 
Hypertension O
: O
Blood O
pressure O
well O
controlled O
on O
valsartan O
. O
 
Cardiac O
ultrasound O
2111 I-DATE
with O
normal O
ejection O
fraction O
, O
no O
LVH O
and O
normal O
mitral O
regurg O
. O
 
Continue O
current O
program O
. O
 
3 O
. O
 
Coronary O
artery O
disease O
: O
Patient O
had O
mildly O
abnormal O
stress O
test O
with O
moderate O
posterior O
ischemia O
in O
2112 I-DATE
. O
 
This O
was O
done O
due O
to O
exertional O
shortness O
of O
breath O
. O
 
Those O
symptoms O
have O
essentially O
resolved O
. O
 
He O
has O
never O
used O
nitroglycerin O
. O
 
He O
has O
gone O
through O
the O
cardiac O
rehab O
program O
. O
 
Now O
put O
on O
beta O
blocker O
due O
to O
patient O
's O
preference O
. O
 
No O
strong O
indication O
given O
. O
 
No O
MI O
or O
symptomatic O
angina O
. O
 
4 O
. O
 
Hyperlipidemia O
: O
Tight O
control O
of O
lipids O
achieved O
on O
Zocor O
. O
 
LDL O
less O
than O
100 O
. O
 
5 O
. O
 
Stroke O
: O
Status-post O
stroke O
2111 I-DATE
with O
slurred O
speech O
and O
left O
facial O
droop O
. O
 
Warfarin O
recommended O
for O
one O
year O
at O
that O
time O
for O
presumed O
cardiac O
embolus O
. O
 
Considered O
discontinuing O
this O
visit O
. O
 
6 O
. O
 
Anemia O
: O
Patient O
has O
had O
a O
mild O
hyperproliferative O
anemia O
. O
 
Has O
been O
seen O
by O
Dr. O
Barr I-NAME
. O
 
This O
has O
remained O
stable O
. O
 
Bone O
marrow O
biopsy O
nondiagnostic O
. O
 
7 O
. O
 
Hypogonadism O
: O
Patient O
has O
been O
evaluated O
by O
Dr. O
Dominique I-NAME
Stokes I-NAME
. O
 
Placed O
on O
AndroGel O
2111 I-DATE
. O
 
Testosterone O
levels O
have O
improved O
. O
 
Question O
if O
that O
has O
improved O
his O
fatigue O
and O
anemia O
. O
 
Review O
of O
systems O
: O
He O
does O
have O
sleep O
apnea O
on O
CPAP O
. O
 
Has O
bilateral O
hearing O
loss O
on O
audiogram O
. O
 
Has O
some O
peripheral O
edema O
on O
occasion O
. O
 
Have O
recommended O
support O
stockings O
. O
 
Urinalysis O
today O
showed O
greater O
than O
100 O
red O
blood O
cells O
and O
he O
said O
this O
was O
due O
to O
penile O
trauma O
from O
tight O
shorts O
. O
 
We O
will O
repeat O
this O
. O
 
He O
did O
see O
blood O
that O
day O
. O
 
He O
has O
never O
seen O
it O
since O
. O
 
He O
has O
multiple O
seborrheic O
keratoses O
including O
on O
his O
penis O
. O
 
He O
will O
see O
Field I-LOCATION
Crest I-LOCATION
Care I-LOCATION
Center I-LOCATION
. O
 
Otherwise O
ROS O
is O
negative O
. O
 
Family O
history O
: O
Mother O
died O
of O
cancer O
in O
her O
80 O
's O
of O
unknown O
primary O
. O
 
Father O
died O
of O
stroke O
in O
his O
80 O
's O
. O
 
Physical O
exam O
: O
Weight O
was O
197 O
. O
 
Baseline O
190 O
. O
 
Max O
210 O
. O
 
Goal O
185 O
. O
 
Blood O
pressure O
was O
140/78 O
. O
 
Pulse O
60 O
. O
 
Skin O
: O
normal O
. O
 
HEENT O
: O
pupils O
equal O
and O
reactive O
to O
light O
. O
 
EOMs O
full O
. O
 
Fundi O
normal O
. O
 
Mouth O
clear O
. O
 
Neck O
: O
JVP6 O
. O
 
Carotids O
2+ O
without O
bruit O
. O
 
Thyroid O
normal O
. O
 
Nodes O
: O
none O
. O
 
Chest O
: O
clear O
lungs O
. O
 
Cardiac O
: O
S1 O
and O
S2 O
normal O
. O
 
Grade O
II/VI O
Dawson O
, O
Quinten I-NAME
MR O
# O
: O
4692758 I-ID
July I-DATE
28 O
, O
2112 I-DATE
Page O
Two O
systolic O
murmur O
with O
mitral O
regurg O
. O
 
Abdomen O
: O
no O
mass O
or O
organomegaly O
. O
 
Extremities O
: O
trace O
edema O
. O
 
Pulses O
full O
. O
 
Rectal O
: O
mildly O
enlarged O
prostate O
without O
nodule O
. O
 
Stool O
guaiac O
negative O
. O
 
Assessment O
: O
Management O
of O
all O
medical O
problems O
as O
above O
. O
 
Lab O
work O
updated O
including O
PSA O
. O
 
Colorectal O
screening O
up O
to O
date O
with O
colonoscopy O
2108/Dr O
. O
 
Wilkinson I-NAME
. O
 
Disposition O
: O
Every O
four O
months O
, O
12/12 I-DATE
, O
comprehensive O
8/13 I-DATE
. O
 
Labs O
in O
advance O
. O
 
Gerald I-NAME
Everhart I-NAME
, O
M.D O
. O
 
Dictated/not O
read O
GE/tierney O
 
Record O
date O
: O
2114-01-10 I-DATE
OFFICE O
NOTE O
Quinten I-NAME
Dawson I-NAME
MR O
# O
4692758 I-ID
January I-DATE
10 O
, O
2114 I-DATE
Return O
visit O
. O
 
Reason O
for O
visit O
: O
73 I-AGE
year O
old O
male O
for O
evaluation/management O
multiple O
issues O
. O
 
Diabetes O
: O
he O
is O
on O
maximal O
dose O
of O
glipizide O
and O
Glucophage O
and O
A1C O
has O
been O
going O
up O
steadily O
now O
to O
8.0 O
. O
 
His O
sugars O
vary O
greatly O
in O
the O
morning O
from O
100 O
to O
174 O
. O
 
He O
hasn't O
been O
checking O
pre O
dinner O
. O
 
We O
discussed O
insulin O
and O
he O
really O
is O
quite O
against O
it O
. O
 
We O
will O
continue O
discussion O
open O
. O
 
Asked O
him O
to O
check O
pre O
dinner O
sugars O
. O
 
Coronary O
disease O
: O
patient O
had O
a O
mild O
posterior O
ischemia O
in O
2112 I-DATE
on O
a O
screening O
stress O
test O
. O
 
He O
is O
actually O
having O
some O
progressive O
dyspnea O
on O
exertion O
and O
a O
sense O
of O
chest O
tightness O
with O
one O
block O
. O
 
He O
is O
a O
bit O
of O
a O
denier O
. O
 
He O
has O
n't O
tried O
nitroglycerin O
, O
which O
I O
have O
given O
him O
. O
 
I O
suggested O
he O
do O
that O
. O
 
He O
will O
have O
a O
follow O
up O
stress O
test O
and O
we O
will O
arrange O
a O
cardiology O
consult O
. O
 
UTI O
: O
patient O
had O
an O
E O
coli O
UTI O
9/13 I-DATE
. O
 
He O
does O
n't O
really O
have O
much O
in O
terms O
of O
other O
prostate O
symptoms O
and O
no O
nocturia O
. O
 
He O
has O
however O
, O
developed O
urinary O
urgency O
again O
in O
the O
last O
week O
or O
two O
. O
 
Will O
check O
another O
culture O
. O
 
May O
need O
urology O
referral O
. O
 
Knee O
pain O
: O
patient O
with O
longstanding O
DJD O
of O
the O
knees O
. O
 
Will O
have O
a O
consult O
at O
Christiana I-LOCATION
Hospital I-LOCATION
considering O
replacement O
. O
 
Family O
history O
: O
unchanged O
. O
 
Review O
of O
systems O
: O
status O
post O
an O
embolic O
stroke O
in O
2111 I-DATE
and O
took O
warfarin O
for O
2 O
years O
and O
followed O
by O
Dr. O
Dillon I-NAME
. O
 
He O
is O
still O
on O
Celexa O
for O
depression O
. O
 
He O
is O
having O
hearing O
loss O
with O
equivocal O
audiograms O
. O
 
Suggested O
otology O
consult O
at O
Naples I-LOCATION
Community I-LOCATION
Hospital I-LOCATION
. O
 
He O
has O
a O
mild O
hypoproliferative O
anemia O
that O
is O
stable O
. O
 
Sleep O
apnea O
. O
 
All O
other O
systems O
negative O
. O
 
Physical O
exam O
: O
his O
weight O
is O
196 O
pounds O
. O
 
Most O
recent O
195 O
. O
 
BP O
was O
140/70 O
. O
 
Pulse O
60 O
. O
 
Skin O
normal O
. O
 
Nodes O
: O
none O
. O
 
Chest O
clear O
lungs O
. O
 
Cardiac O
: O
S1 O
, O
S2 O
normal O
. O
 
Grade O
II/VI O
systolic O
murmur O
of O
mitral O
regurgitation O
( O
confirmed O
by O
echo O
) O
. O
 
Abdomen O
no O
mass O
or O
organomegaly O
. O
 
Extremities O
: O
mild O
venous O
stasis O
. O
 
Trace O
edema O
. O
 
DP O
pulses O
are O
1+ O
. O
 
Assessment O
: O
management O
of O
multiple O
medical O
problems O
as O
above O
. O
 
Lab O
work O
up O
to O
date O
. O
 
Disposition O
: O
every O
4 O
months O
. O
 
Comprehensive O
5/14 I-DATE
. O
 
Gerald I-NAME
Everhart I-NAME
, O
M.D O
. O
 
Dictated/Not O
Read O
Quinten I-NAME
Dawson I-NAME
MR O
# O
4692758 I-ID
January I-DATE
10 O
, O
2114 I-DATE
Page O
2 O
/talbot O
cc O
. O
 
Cardiology O
consult O
 
Record O
date O
: O
2114-03-12 I-DATE
CARDIOLOGY O
SAN I-LOCATION
ANTONIO I-LOCATION
HOSPITAL I-LOCATION
Narrative O
Note O
: O
INITIAL O
CARDIAC O
CONSULT O
Name O
: O
Quinten I-NAME
Dawson I-NAME
Date O
: O
03/12/14 I-DATE
SAH I-LOCATION
# O
: O
469-27-58 I-ID
Age O
: O
73 I-AGE
Problem O
List O
: O
Diabetes O
. O
 
Hypertension O
. O
 
Hyperlipidemia O
. O
 
Sleep O
apnea O
. O
 
2/1/11 I-DATE
stroke O
4/4/12 I-DATE
exercise O
sestamibi-SAH O
: O
Small O
posterolateral O
scar O
and O
ischemia O
2/21/14 I-DATE
exercise O
sestamibi-SAH O
: O
Moderate-severe O
anterior O
apical O
and O
inferior O
ischemia O
. O
 
Medications O
: O
Glucophage O
850 O
mg O
t.i.d. O
, O
glipizide O
10 O
mg O
b.i.d. O
, O
Cozaar O
50 O
mg O
, O
Zocor O
20 O
mg O
, O
Detrol O
2 O
mg O
, O
Colace O
, O
aspirin O
81 O
, O
isosorbide O
40 O
mg O
q.a.m. O
, O
multivitamin O
, O
glucosamine O
and O
chondroitin O
b.i.d. O
, O
Naprosyn O
220-2 O
pills O
b.i.d. O
, O
Celexa O
20 O
mg. O
BiPAP O
Reactions O
to O
Medicines O
: O
None O
Chief O
Complaint O
: O
Shortness O
of O
breath O
which O
is O
, O
in O
fact O
, O
chest O
tightness O
History O
of O
Present O
Illness O
: O
This O
73 I-AGE
year-old O
hypertensive O
hyperlipidemic O
diabetic O
had O
a O
previous O
stroke O
on O
2/1/11 I-DATE
and O
a O
recent O
exercise O
test O
that O
showed O
extensive O
ischemia O
as O
noted O
above O
. O
 
He O
has O
noted O
shortness O
or O
breath O
for O
the O
last O
three O
months O
. O
 
In O
fact O
the O
shortness O
of O
breath O
is O
exertional O
chest O
tightness O
which O
comes O
on O
with O
exertion O
and O
is O
relieved O
by O
rest O
. O
 
He O
is O
sent O
by O
Dr. O
Everhart I-NAME
for O
consideration O
for O
coronary O
angiogram O
. O
 
On O
1/08/14 I-DATE
his O
cholesterol O
was O
165 O
, O
triglyceride O
109 O
, O
HDL O
54 O
and O
LDL O
89 O
. O
 
He O
does O
get O
some O
lightheadedness O
if O
he O
has O
a O
high O
sugar O
. O
 
He O
's O
had O
no O
rapid O
heart O
action O
or O
sudden O
dizzy O
spells O
. O
 
ROS O
: O
Const.-Negative O
Eyes O
-Negative O
ENMT O
: O
Bilateral O
hearing O
loss O
CV O
: O
See O
above O
Respiratory O
: O
Sleep O
apnea O
GI O
- O
. O
 
Recent O
constipation O
GU O
-Impotence O
. O
 
Urgency O
and O
incontinence O
MS O
- O
arthritis O
of O
both O
knees O
and O
hands O
. O
 
Considering O
knee O
replacement O
Skin O
- O
Negative O
Neuro O
-CVA O
in O
past O
. O
 
Mild O
residual O
left O
facial O
drooping O
and O
occasional O
trouble O
finding O
words O
. O
 
Psych O
- O
Depression O
well O
controlled O
on O
Celexa O
Endocrine O
- O
Diabetes O
Heme-No O
blood O
problems O
Allergies O
- O
No O
drug O
allergies O
and O
no O
allergies O
to O
dye O
Past O
History O
: O
T I-NAME
& O
A O
, O
laparoscopic O
cholecystectomy O
. O
 
He O
has O
no O
other O
major O
illnesses O
. O
 
He O
does O
not O
smoke O
and O
drinks O
about O
one O
glass O
of O
wine O
per O
day O
. O
 
Family O
History O
: O
His O
father O
died O
at O
83 I-AGE
of O
a O
stroke O
, O
cancer O
and O
diabetes O
. O
 
Mother O
died O
at O
73 I-AGE
of O
heart O
disease O
, O
diabetes O
and O
cancer O
. O
 
Two O
sisters O
are O
living O
without O
diabetes O
. O
 
Social O
History O
: O
He O
a O
mapping I-PROFESSION
technologist I-PROFESSION
and O
is O
actively O
working O
. O
 
He O
is O
divorced O
and O
has O
two O
children O
and O
one O
grandchild O
. O
 
His O
significant O
other O
works O
as O
an O
optician I-PROFESSION
. O
 
She O
is O
divorced O
and O
has O
three O
children O
and O
one O
grandchild O
. O
 
Complete O
Cardiovascular O
Exam O
: O
. O
 
BP O
100 O
50/65 O
. O
 
His O
jugular O
venous O
pressure O
is O
seven O
and O
he O
has O
no O
carotid O
bruits O
. O
 
He O
has O
no O
rales O
. O
 
He O
has O
a O
1/6 O
aortic O
ejection O
murmur O
, O
a O
2/6 O
MR O
murmur O
at O
the O
apex O
with O
a O
normal O
S2 O
and O
no O
S3 O
. O
 
He O
has O
no O
enlargement O
of O
the O
liver O
and O
no O
edema O
. O
 
EKG O
: O
NSR O
59 O
, O
LAE O
, O
NSTTWA O
Assessment O
: O
I O
agree O
he O
clearly O
needs O
a O
coronary O
angiogram O
as O
well O
as O
a O
left O
ventricular O
angiogram O
to O
assess O
MR O
. O
 
He O
should O
also O
have O
a O
left O
right O
heart O
catheter O
because O
of O
the O
aortic O
ejection O
murmur O
. O
 
In O
the O
meantime O
I O
will O
ask O
into O
double O
his O
isosorbide O
to O
40 O
mg O
in O
the O
morning O
and O
again O
at O
3 O
p.m. O
to O
give O
him O
better O
protection O
throughout O
the O
day O
. O
 
I O
will O
ask O
him O
to O
increase O
his O
aspirin O
to O
325 O
mg O
a O
day O
. O
 
I O
will O
also O
add O
fish O
oil O
1000 O
mg O
a O
day O
which O
is O
been O
shown O
to O
reduce O
the O
risk O
of O
sudden O
death O
. O
 
Finally O
we O
will O
double O
his O
Zocor O
to O
40 O
mg O
to O
try O
to O
reach O
the O
new O
goal O
of O
an O
LDL O
of O
less O
than O
70 O
. O
 
I O
explained O
the O
rationale O
for O
proceeding O
on O
with O
the O
catheterization O
and O
the O
probability O
that O
we O
will O
find O
multivessel O
disease O
that O
will O
not O
be O
suitable O
for O
PCI O
but O
rather O
for O
continued O
medicine O
or O
possible O
surgery O
. O
 
Of O
course O
the O
catheterization O
will O
determine O
that O
. O
 
He O
should O
not O
consider O
any O
total O
knee O
operation O
until O
the O
cardiac O
status O
is O
clarified O
. O
 
Quentin I-NAME
T. I-NAME
Edward I-NAME
, O
Jr. I-NAME
, O
M.D O
. O
 
CC O
: O
Mr. O
Quinten I-NAME
Dawson I-NAME
, O
653 I-LOCATION
Wildwood I-LOCATION
Lane I-LOCATION
, O
New I-LOCATION
Ashford I-LOCATION
, O
VA I-LOCATION
67999 I-LOCATION
Dr. O
Xavier I-NAME
Everhart I-NAME
, O
Internal O
Medicine O
, O
SAH I-LOCATION
Signed O
electronically O
by O
Quentin I-NAME
T I-NAME
Edward I-NAME
MD O
on O
Mar I-DATE
12 O
, O
2114 I-DATE
 
Record O
date O
: O
2114-04-07 I-DATE
07 I-DATE
April O
, O
2114 I-DATE
RENAL O
CONSULTATION O
NOTE O
Dawson O
, O
Quinten I-NAME
W I-NAME
SAH I-LOCATION
# O
469 I-ID
27 I-ID
58 I-ID
Intro O
: O
73 I-AGE
yo O
male O
s/p O
CABG O
with O
progressive O
acute O
renal O
failure O
. O
 
Present O
Illness O
and O
Past O
Med O
Hx O
: O
1 O
) O
Renal O
failure O
a O
) O
Baseline O
chronic O
renal O
failure O
i O
) O
Creat O
1.2 O
to O
1.4 O
range O
, O
1.5 O
on O
admission O
ii O
) O
History O
of O
DM O
iii O
) O
Preop O
urine O
negative O
for O
albumin O
and O
blood O
. O
 
b O
) O
Progressive O
renal O
failure O
i O
) O
Gradual O
rise O
in O
creatinine O
to O
2.7 O
ii O
) O
Non O
oliguric O
, O
making O
~ O
1 O
liter O
/day O
2 O
) O
CAD O
a O
) O
Cath O
i O
) O
Occluded O
RCA O
, O
subtotal O
circumflex O
and O
95 O
% O
LAD O
and O
90 O
% O
stenosis O
of O
first O
diagonal O
ii O
) O
EF O
preserved O
at O
55 O
% O
b O
) O
CABG O
i O
) O
Off O
pump O
ii O
) O
X O
4 O
vessels O
LIMA O
iii O
) O
Post O
op O
CPK O
to O
594 O
and O
troponin O
to O
0.53 O
. O
 
3 O
) O
DM O
type O
2 O
4 O
) O
Hyperlipidemia O
5 O
) O
Hypertension O
6 O
) O
S/p O
CVA O
7/2111 I-DATE
with O
residual O
word O
finding O
difficulty O
and O
mild O
facial O
droop O
. O
 
7 O
) O
Obstructive O
sleep O
apnea O
- O
uses O
home O
CPAP O
. O
 
8 O
) O
Diverticulosis O
9 O
) O
BPH O
- O
reports O
that O
he O
was O
in O
the O
process O
of O
getting O
this O
addressed O
when O
he O
developed O
symptoms O
of O
his O
CAD O
. O
 
10 O
) O
Peripheral O
neuropathy O
11 O
) O
Osteoarthritis O
12 O
) O
S/p O
cholecystectomy O
Meds O
: O
Albuterol O
ASA O
325 O
Celexa O
40 O
Plavix O
75 O
Nexium O
20 O
bid O
Furosemide O
40 O
bid O
Motrin O
500 O
tid O
Regular O
insulinSS O
q O
6 O
Metoprolol O
12.5 O
bid O
KCL O
20 O
qd O
Zocor O
40 O
qd O
Allergies O
: O
NKDA O
Soc O
Hx O
: O
Smoking O
: O
quit O
in O
2066 I-DATE
; O
EtOH O
: O
1 O
glass O
of O
wine O
a O
day O
; O
Divorced O
. O
 
Works O
in O
mapping I-PROFESSION
. O
 
Fam O
Hx O
: O
NC O
ROS O
: O
Chest O
pain O
and O
shortness O
of O
breath O
with O
walking O
to O
the O
bathroom O
relieved O
by O
percoset O
and O
rest O
. O
 
Denies O
cough O
, O
hemoptysis O
, O
chest O
pain O
, O
orthopnea O
, O
pnd O
, O
rhinitis O
, O
nausea O
, O
vomiting O
, O
hematemasis O
, O
melena O
, O
hematochezia O
, O
ocular O
problem O
, O
sinusitis O
, O
dyuria O
, O
urgency O
, O
hematuria O
, O
trouble O
voiding O
, O
skin O
rash O
, O
arthritis O
. O
 
Exam O
: O
Uncomfortable O
appearing O
BP O
: O
128/60 O
P O
: O
80 O
R O
: O
20 O
96 O
% O
on O
2 O
liters O
AFEBRILE O
SKIN O
: O
benign O
HEENT O
: O
anicteric O
, O
sclera O
clear O
NECK O
: O
Supple O
, O
no O
adenopathy O
, O
no O
thyromegaly O
CHEST O
: O
few O
rales O
COR O
: O
distant O
heart O
sounds O
. O
 
Without O
gallup O
or O
rub O
. O
 
ABD O
: O
positive O
bowel O
sounds O
, O
mildly O
distended O
, O
minimally O
tender O
. O
 
EXT O
: O
1+ O
edema O
Urine O
- O
PVR O
of O
~225 O
cc O
Labs O
: O
Na O
140 O
, O
K O
4.6 O
, O
Cl O
103 O
, O
HCO3 O
28.1 O
, O
BUN O
60 O
, O
Creat O
2.7 O
Amylase O
330 O
( O
32 O
) O
WBC O
7.1 O
, O
Hct O
26.1 O
, O
Plt O
91 O
UA O
dip O
with O
trace O
protein O
and O
negative O
blood O
Micro O
with O
many O
hyaline O
and O
few O
granular O
casts O
. O
 
EKG O
sinus O
at O
77 O
Non O
specific O
STTW O
changes O
, O
minimal O
change O
from O
other O
post O
op O
EKGs O
. O
 
Impression O
: O
1 O
) O
Renal O
failure O
a O
. O
 
Chronic O
component O
i. O
Suggestive O
of O
early O
DM O
nephrop O
ii O
. O
 
Baseline O
1.4 O
b O
. O
 
Acute O
component O
i. O
Prerenal O
component O
with O
pancreatitis O
ii O
. O
 
No O
major O
ATN O
iii. O
? O
 
obstructive O
component O
1. O
now O
with O
increased O
urine O
output O
after O
Foley O
catheter O
. O
 
2 O
) O
Pancreatitis O
a. O
Amylase O
up O
today O
3 O
) O
Chest O
pain O
a O
. O
 
With O
exertion O
- O
too O
bathroom O
. O
 
b O
. O
 
With O
shortness O
of O
breath O
c. O
Incisional O
with O
movement O
vs O
? O
 
ischemic O
Rec/Plan O
: O
1 O
) O
Foley O
catheter O
overnight O
2 O
) O
Urine O
for O
Na O
and O
creat O
. O
 
3 O
) O
Flomax O
for O
24 O
hours O
prior O
to O
removing O
Foley O
with O
voiding O
trial O
4 O
) O
Serial O
Amylase O
5 O
) O
Serial O
cardiac O
enzymes O
6 O
) O
Lasix O
prn O
. O
 
- O
now O
seems O
to O
be O
diuresing O
reasonably O
. O
 
7 O
) O
EKG O
with O
recurrent O
chest O
symptoms O
. O
 
Uriel I-NAME
Y. I-NAME
Springer I-NAME
 
Record O
date O
: O
2073-06-13 I-DATE
EDVISIT^98044905^WARE O
, O
VINCENT^06/13/73^ZORN O
, O
TYLER I-NAME
The O
patient O
is O
a O
65-year-old O
gentleman O
who O
presents O
complaining O
of O
shortness O
of O
breath O
, O
weakness O
, O
and O
fatigue O
. O
 
The O
patient O
was O
seen O
in O
conjunction O
with O
resident O
physician O
, O
Ostrowski I-NAME
. O
 
Please O
see O
her O
note O
for O
details O
of O
the O
visit O
. O
 
Resident O
's O
history O
was O
reviewed O
by O
me O
. O
 
The O
patient O
was O
interviewed O
and O
examined O
by O
me O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Significant O
for O
non-Hodgkin O
lymphoma O
, O
diabetes O
, O
and O
hypercholesterolemia O
. O
 
MEDICATIONS O
: O
Metformin O
, O
insulin O
, O
aspirin O
, O
and O
multivitamins O
. O
 
ALLERGIES O
: O
The O
patient O
has O
no O
allergies O
. O
 
FAMILY O
HISTORY O
: O
Negative O
for O
chronic O
diseases O
. O
 
SOCIAL O
HISTORY O
: O
No O
alcohol O
, O
tobacco O
, O
or O
illicit O
substances O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
followed O
by O
his O
hematology-oncologist O
for O
unexplainable O
anemia O
. O
 
The O
patient O
presents O
complaining O
of O
dyspnea O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Significant O
for O
dyspnea O
on O
exertion O
, O
weakness O
, O
fatigue O
, O
fever O
and O
shortness O
of O
breath O
, O
negative O
for O
headache O
, O
blurred O
vision O
, O
chest O
pain O
. O
 
Other O
systems O
were O
reviewed O
and O
found O
to O
be O
negative O
, O
unless O
noted O
positive O
on O
resident O
's O
note O
. O
 
PHYSICAL O
EXAMINATION O
: O
I O
concur O
with O
documented O
resident O
's O
note O
. O
 
Specifically O
, O
abdomen O
was O
soft O
and O
nontender O
. O
 
Rectal O
Exam O
: O
Guaiac O
negative O
, O
normal O
tone O
, O
and O
no O
masses O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
Laboratory O
studies O
remarkable O
for O
hematocrit O
of O
24 O
. O
 
EKG O
is O
unremarkable O
. O
 
Chest O
x-ray O
is O
negative O
. O
 
The O
patient O
's O
management O
was O
discussed O
with O
Dr. O
Walsh I-NAME
, O
oncology O
. O
 
The O
patient O
will O
be O
admitted O
to O
oncology O
hematology O
for O
workup O
. O
 
______________________________ O
ZORN O
, O
TYLER I-NAME
M.D O
. O
 
D O
: O
06/13/73 I-DATE
T O
: O
06/13/73 I-DATE
Dictated O
By O
: O
ZORN O
, O
TYLER I-NAME
eScription O
document:2-2004166 O
IFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2073-09-20 I-DATE
MANAMANA I-LOCATION
nfectious O
Disease O
Consultation O
Note O
Patient O
: O
Vincent I-NAME
Ware I-NAME
( O
71417347 I-ID
2Y I-ID
) O
Student O
: O
Casey I-NAME
Best I-NAME
, O
MS-4 O
ID O
Fellow O
: O
Tina I-NAME
Isaiah-Villagomez I-NAME
MD O
ID O
Attending O
: O
Alexander I-NAME
Y I-NAME
Xian I-NAME
MD O
Referring O
Physician O
: O
Webster I-NAME
MD O
Date O
of O
Consult O
: O
September I-DATE
20 O
, O
2073 I-DATE
Reason O
for O
consult O
: O
cough O
, O
nightsweats O
and I-PROFESSION
weightloss O
, O
two O
days O
prior O
to O
transplant O
HPI O
: O
66 I-AGE
yo O
M O
with O
h/o O
IDDM O
, O
large O
cell O
lymphoma O
in O
2066 I-DATE
, O
and I-PROFESSION
now O
with O
myelodysplastic O
syndrome O
. O
 
He O
was O
treated O
with O
CHOP O
in O
2066 I-DATE
followed O
by O
radiotherapy O
, O
completed O
in O
Nov I-DATE
2066 I-DATE
. O
 
He O
was O
free O
of O
disease O
since O
then O
until O
May I-DATE
2073 I-DATE
. O
 
He O
sought O
primary O
care O
for O
a O
URI O
and I-PROFESSION
was O
noted O
to O
be O
anemic O
( O
HCT O
31 O
) O
. O
 
His O
counts O
were O
followed O
and I-PROFESSION
when O
his O
HCT O
dropped O
as O
low O
as O
22 O
a O
Bone O
Marrow O
was O
done O
and I-PROFESSION
showed O
myelodysplastic O
syndrome O
. O
 
He O
was O
considered O
for O
a O
allogenic O
stem-cell O
transplant O
. O
 
His O
major O
complaint O
is O
a O
dry O
cough O
that O
he O
has O
had O
since O
May I-DATE
2073 I-DATE
. O
 
It O
is O
provoked O
by O
eating O
, O
drinking O
and I-PROFESSION
lying O
down O
. O
 
And O
only O
occasionally O
does O
he O
produce O
any O
sputum O
. O
 
He O
has O
been O
on O
numerous O
antibiotics O
in O
the O
past O
four O
months O
for O
the O
cough O
and I-PROFESSION
he O
also O
developed O
a O
periorbital O
cellulitis O
for O
which O
he O
was O
hospitalized O
at O
Educare-Fargo I-LOCATION
for O
which O
he O
received O
a O
3 O
week O
course O
of O
Ceftriaxone O
, O
Nafcillin O
and I-PROFESSION
flagyl O
( O
finished O
at O
the O
end O
of O
July I-DATE
) O
. O
 
In O
retrospect O
, O
he O
recognizes O
sinus O
pressure/congestion O
associated O
with O
periorbital O
cellulitis O
. O
 
In O
August I-DATE
2073 I-DATE
he O
had O
a O
questionable O
LLL O
PNA O
and I-PROFESSION
was O
treated O
with O
cipro O
. O
 
On O
pre-transplant O
work-up O
, O
CXR O
revealed O
increase O
conspicuity O
of O
ill-defined O
LL O
zone O
opacity O
. O
 
CT O
chest O
reviewed O
today O
revealed O
mutlifocal O
pneumonia O
with O
associated O
radiation-related O
changes O
. O
 
Throughout O
this O
time O
period O
he O
has O
only O
had O
a O
few O
days O
of O
fever O
for O
which O
he O
was O
at O
KCGH I-LOCATION
and I-PROFESSION
given O
abx O
and I-PROFESSION
defervesced O
. O
 
He O
recalls O
nightsweats O
as O
the O
fevers O
broke O
. O
 
He O
does O
admit O
to O
maybe O
a O
10 O
lb O
weight O
loss O
in O
the O
past O
4 O
months O
. O
 
He O
denies O
SOB O
( O
unless O
he O
s O
severely O
anemic O
) O
, O
orthopnea O
, O
sore O
throat O
, O
dysphagia O
, O
odynophagia O
, O
CP O
, O
palpitations O
, O
angina-like O
symptoms O
, O
acid-reflux O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
constipation O
, O
BRBPR O
, O
dysuria O
, O
frequency O
, O
nocturia O
, O
joint O
or O
muscle O
pain O
. O
 
He O
does O
have O
mild O
peripheral O
neuropathy O
in O
his O
feet O
bilaterally O
. O
 
PMH O
: O
MDS O
Peri-Orbital O
cellulitis O
, O
recent O
Insulin O
dependent O
diabetes O
mellitus O
Hypercholesterolemia O
Non-hodgkin O
s O
lymphoma O
( O
2066 I-DATE
; O
tx O
w/ O
CHOP O
and I-PROFESSION
radiation O
) O
Pt O
: O
RPR O
neg O
, O
CMV O
neg O
, O
HSV O
pos O
, O
TOXO O
pos O
, O
EBV O
pos O
, O
VZV O
pos O
, O
Hep O
Panel O
neg O
, O
HTLV O
neg O
and I-PROFESSION
HIV O
neg O
, O
PPD O
neg O
9/20/73 I-DATE
and I-PROFESSION
8/7/73 I-DATE
Donor O
: O
RPR O
neg O
, O
CMV O
neg O
, O
Hep O
Panel O
neg O
, O
HIV O
neg O
, O
HTLV O
neg O
, O
PPD O
neg O
( O
traveled O
to O
Saudi I-LOCATION
Arabia I-LOCATION
, O
Cartersville I-LOCATION
, O
Newport I-LOCATION
) O
Medications O
on O
admission O
: O
Cipro O
( O
last O
dose O
9/18/73 I-DATE
) O
Lantus O
and I-PROFESSION
novolog O
Procrit O
Zetia O
, O
ASA O
, O
VitB/MVI O
Inpatient O
medication O
: O
Antimicrobials/immune O
booster O
: O
Acyclovir O
Bactrim O
( O
to O
d/c O
day O
0 O
) O
Levaquin O
( O
to O
start O
day O
1 O
) O
GCSF O
( O
start O
d+1 O
) O
Immunosuppressants O
: O
Fludarabine O
, O
Vusulfan O
Tacrolimus O
( O
start O
day O
3 O
) O
Rapamycin O
( O
start O
day O
3 O
) O
Other O
: O
zoran O
, O
ativan/compazine O
, O
mvi/folate O
, O
ompeprazole O
, O
lantus O
, O
novolog O
, O
metformin O
, O
Demerol O
, O
oxycodone O
Allergies O
: O
NKDA O
Social O
History O
: O
He O
is O
a O
programmer I-PROFESSION
and I-PROFESSION
works O
as O
a O
Industrial I-PROFESSION
Engineering I-PROFESSION
and I-PROFESSION
Manufacturing I-PROFESSION
Technologist I-PROFESSION
at O
Activision I-LOCATION
Blizzard I-LOCATION
. O
 
NO O
occupational O
exposures O
. O
 
He O
is O
married O
with O
three O
children O
and I-PROFESSION
4 O
grandchildren O
. O
 
He O
does O
not O
smoke O
or O
drink O
. O
 
He O
has O
remote O
travel O
hx O
to O
the O
Rockefeller I-LOCATION
Centre I-LOCATION
, O
more O
recent O
global I-LOCATION
travel O
( O
Fernley I-LOCATION
, O
Cartersville I-LOCATION
, O
Iceland I-LOCATION
) O
, O
and I-PROFESSION
frequent O
travel O
to O
Muscat I-LOCATION
area O
. O
 
He O
recently O
gave O
his O
indoor O
cat O
away O
as O
he O
hypothesized O
that O
she O
had O
something O
to O
do O
with O
his O
cough/MDS O
. O
 
He O
does O
not O
recall O
tick O
bites O
and I-PROFESSION
has O
infrequently O
visited O
Storting I-LOCATION
and I-PROFESSION
Capitol I-LOCATION
. O
 
Family O
hx O
: O
Sister O
died O
of O
metastatic O
cancer O
likely O
lung O
. O
 
Father O
died O
of O
diabetes O
, O
Mother O
died O
at O
age O
90 I-AGE
. O
 
ROS O
: O
negative O
in O
detail O
except O
as O
outlined O
above O
in O
HPI O
Physical O
Exam O
: O
VS O
: O
T O
97.3 O
Tm O
98.6 O
HR O
88 O
BP O
120/70 O
R O
20 O
O2sat O
98 O
% O
RA O
Gen O
: O
WDWN O
male O
in O
NAD O
, O
AAOx3 O
doing O
extremely O
complex O
math O
at O
presentation O
HEENT O
: O
EOMI O
, O
conjunctiva O
pink O
, O
PERRLA O
, O
no O
oropharyngeal O
erythema O
, O
thrush O
or O
exudate O
CV O
: O
S1 O
S2 O
nl O
, O
RRR O
, O
no O
M/R/G O
Lungs O
: O
mild O
coarse O
crackles O
at O
L O
base O
; O
R O
clear O
Abd O
: O
soft O
, O
NT O
, O
ND O
, O
no O
organomegaly O
Ext O
: O
no O
C/C/E O
Lines O
: O
hickman O
, O
L O
subclavian O
, O
no O
erythema O
, O
warmth O
Relevant O
Labs O
: O
09/20/2073 I-DATE
CRE O
1.13 O
09/20/2073 I-DATE
LDH O
113 O
09/20/2073 I-DATE
ALT/SGPT O
15 O
, O
AST/SGOT O
13 O
, O
ALKP O
65 O
, O
TBILI O
0.5 O
, O
DBILI O
0.2 O
09/20/2073 I-DATE
1-3BGLUC O
PEND O
09/20/2073 I-DATE
WBC O
2.25 O
( O
* O
) O
, O
HGB O
8.5 O
( O
* O
) O
, O
HCT O
24.7 O
( O
* O
) O
, O
PLT O
118 O
( O
* O
) O
09/20/2073 I-DATE
% O
POLY-M O
70 O
, O
% O
BAND-M O
1 O
, O
% O
LYMPH-M O
18 O
, O
% O
ATYPS O
0 O
, O
% O
MONO-M O
10 O
( O
* O
) O
, O
% O
EOS-M O
0 O
, O
% O
BASO-M O
1 O
09/20/2073 I-DATE
GALACT-AG O
0.14 O
[ O
1 O
] O
Microbiology O
09/19/2073 I-DATE
Microbiology O
URINE O
: O
Total O
Colony O
Count O
100 O
: O
PROBABLE O
STAPHYLOCOCCI O
09/18/2073 I-DATE
NASAL O
( O
ASPERGILLUS O
SCREEN O
) O
: O
FUNGUS O
CULTURE O
: O
NO O
REPORT O
SO O
FAR O
Radiology O
09/19/2073 I-DATE
CT O
SCAN O
CHEST O
W/O O
CONTRAST O
REPORT O
NOT O
FINALIZED O
09/19/2073 I-DATE
Chest O
PA O
& O
Lateral O
IMPRESSION O
: O
Chest O
PA O
and I-PROFESSION
lateral O
views O
are O
compared O
to O
prior O
done O
on O
9/18/2073 I-DATE
. O
 
Paramediastinal O
opacification O
is O
changed O
. O
 
Cardiomediastinal O
silhoutte O
is O
stable O
. O
 
Nodular O
opacity O
in O
the O
left O
perihilar O
region O
appears O
less O
apparent O
. O
 
No O
new O
consolidations O
are O
seen O
. O
 
There O
is O
a O
new O
left-sided O
Hickman O
catheter O
with O
its O
tip O
in O
the O
SVC O
. O
 
No O
pneumothorax O
is O
seen O
. O
 
Impression O
: O
66 I-AGE
yo O
M O
with O
h/o O
IDDM O
, O
large O
cell O
lymphoma O
in O
2066 I-DATE
, O
and I-PROFESSION
now O
with O
myelodysplastic O
syndrome O
who O
presents O
with O
fourth O
months O
of O
cough O
of O
unclear O
etiology O
. O
 
The O
differential O
diagnosis O
is O
broad O
and I-PROFESSION
includes O
both O
infectious O
and I-PROFESSION
non-infectious O
diagnoses O
. O
 
Our O
leading O
diagnosis O
is O
either O
radiation O
fibrosis O
or O
a O
primary O
interstitial O
lung O
disease O
, O
such O
as O
COP O
. O
 
However O
, O
we O
also O
think O
that O
several O
infectious O
etiologies O
should O
be O
considered O
. O
 
Endemic O
mycoses O
( O
histo O
, O
blasto O
and I-PROFESSION
crypto O
) O
, O
cryptococcal O
pneumonia O
, O
nocardiasis O
, O
aspergillus O
, O
mucormycosis O
and I-PROFESSION
MAC O
are O
some O
diseases O
to O
consider O
in O
this O
patient O
. O
 
While O
the O
clinical O
picture O
of O
granulomas O
on O
chest O
CT O
and I-PROFESSION
cough O
is O
consistent O
with O
the O
diagnosis O
of O
mycobacterial O
disease O
, O
the O
patient O
is O
very O
low O
risk O
for O
this O
infection O
and I-PROFESSION
his O
lack O
of O
fevers O
, O
progressive O
weight O
loss O
and I-PROFESSION
systemic O
illness O
argues O
against O
this O
diagnosis O
. O
 
I O
( O
AYX I-NAME
) O
have O
interviewed O
and I-PROFESSION
examined O
Mr. O
Ware I-NAME
, O
and I-PROFESSION
confirmed O
all O
of O
the O
findings O
documented O
in O
this O
note O
. O
 
My O
highest O
suspicion O
is O
for O
an O
inflammatory O
process O
, O
such O
as O
radiation O
pneumonitis O
or O
BOOP/COP O
. O
 
An O
occult O
infection O
is O
quite O
possible O
, O
such O
as O
pulmonary O
MAC O
or O
a O
mold O
( O
the O
lesion O
in O
his O
left O
lower O
lobe O
is O
especially O
suspicious O
) O
. O
 
Clinically O
he O
is O
unchanged O
over O
many O
months O
, O
so O
empiric O
antibiotics O
would O
not O
be O
indicated O
. O
 
We O
recommend O
the O
following O
work-up O
: O
-Expectorated O
sputum O
for O
gram O
stain O
and I-PROFESSION
culture O
-Induced O
sputum O
for O
-PCP O
-Modified O
AFB O
smear O
( O
looking O
for O
Nocardia O
) O
-Fungal O
stain O
and I-PROFESSION
culture O
-Urine O
histo O
antigen O
-Serum O
cryptococcal O
antigen O
-Weekly O
monitoring O
of O
galactomannan O
and I-PROFESSION
D-glucan O
-Nasopharyngeal O
swab O
for O
respiratory O
viral O
panel O
( O
RSV O
, O
Adenovirus O
, O
Influenza O
A O
and I-PROFESSION
B O
, O
paraflu O
A O
and I-PROFESSION
B O
) O
and I-PROFESSION
viral O
culture O
If O
the O
above O
work-up O
is O
unrevealing O
, O
please O
consult O
pulmonology O
for O
a O
bronchoscopy O
-- O
sooner O
rather O
than O
later O
. O
 
It O
is O
reasonable O
to O
start O
is O
levaquin O
500 O
mg O
QD O
now O
to O
treat O
empirically O
for O
typical O
and I-PROFESSION
atypical O
pathogens O
( O
this O
medication O
is O
scheduled O
to O
begin O
in O
two O
days O
, O
per O
protocol O
) O
. O
 
Our O
recommendations O
were O
communicated O
to O
Dr. O
Dalton I-NAME
and I-PROFESSION
Dr. O
Robin I-NAME
Jeffery I-NAME
of O
the O
patient O
s O
primary O
team O
. O
 
Thank O
you O
for O
this O
consult O
. O
 
Our O
team O
will O
follow O
with O
you O
______________________________________ O
Tina I-NAME
Isaiah-Villagomez I-NAME
, O
MD O
; O
Fellow O
Alexander I-NAME
Y. I-NAME
Xian I-NAME
, O
MD O
; O
Attending O
-- O
Pager O
43486 I-CONTACT
Division O
of O
Infectious O
Diseases O
 
Record O
date O
: O
2074-12-21 I-DATE
EDVISIT^98044905^WARE O
, O
VINCENT^12/21/74^VILLA O
, O
SCOTT I-NAME
CHIEF O
COMPLAINT O
: O
Dyspnea O
on O
exertion O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Ware I-NAME
is O
a O
67-year-old O
man O
with O
a O
history O
of O
diabetes O
and O
myelodysplastic O
syndrome O
, O
status O
post O
stem O
cell O
transplant O
who O
presents O
to O
the O
Emergency O
Department O
with O
a O
2 O
to O
3 O
week O
history O
of O
increasing O
exertional O
dyspnea O
. O
 
The O
patient O
denies O
chest O
pain O
, O
palpitations O
, O
or O
syncope O
but O
does O
complain O
of O
bilateral O
lower O
extremity O
edema O
times O
several O
weeks O
. O
 
The O
patient O
has O
been O
worked O
up O
for O
the O
symptoms O
as O
an O
outpatient O
and O
placed O
on O
Lasix O
for O
the O
past O
2 O
weeks O
and O
had O
an O
echocardiogram O
today O
, O
which O
was O
remarkable O
for O
atrial O
fibrillation O
. O
 
The O
patient O
was O
sent O
to O
the O
Emergency O
Department O
for O
further O
evaluation O
. O
 
Please O
see O
the O
written O
record O
for O
further O
details O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Insulin-dependent O
diabetes O
, O
myelodysplastic O
syndrome O
, O
status O
post O
stem O
cell O
transplant O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Basal O
cell O
resection O
. O
 
SOCIAL O
HISTORY O
: O
The O
patient O
denies O
smoking O
, O
alcohol O
, O
or O
illicit O
drug O
use O
. O
 
MEDICATIONS O
: O
Lasix O
, O
vitamin O
D O
, O
Lantus O
, O
and O
acyclovir O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
I O
have O
examined O
the O
patient O
and O
agree O
with O
the O
physical O
as O
documented O
. O
 
Of O
note O
, O
the O
patient O
is O
awake O
and O
alert O
, O
in O
no O
acute O
distress O
. O
 
Vitals O
: O
Temperature O
is O
96.9 O
, O
pulse O
is O
100 O
to O
128 O
, O
respiratory O
rate O
of O
18 O
, O
blood O
pressure O
is O
118/70 O
, O
and O
oxygen O
saturation O
is O
96 O
% O
. O
 
Lungs O
: O
Clear O
bilaterally O
with O
no O
rales O
, O
rhonchi O
, O
or O
wheezing O
. O
 
Cardiovascular O
exam O
: O
Irregularly O
irregular O
rhythm O
. O
 
Normal O
S1 O
and O
S2 O
. O
 
No O
murmurs O
. O
 
Abdomen O
: O
Soft O
with O
no O
tenderness O
, O
guarding O
, O
or O
rebound O
. O
 
Extremity O
exam O
: O
The O
patient O
has O
bilateral O
lower O
extremity O
2+ O
pitting O
edema O
, O
left O
greater O
than O
right O
. O
 
No O
calf O
tenderness O
. O
 
MEDICAL O
DECISION O
MAKING O
AND O
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Mr. O
Ware I-NAME
is O
a O
67-year-old O
man O
with O
diabetes O
and O
a O
2-week O
history O
of O
increasing O
dyspnea O
on O
exertion O
. O
 
His O
chest O
x-ray O
did O
not O
demonstrate O
pulmonary O
edema O
, O
but O
was O
significant O
for O
bilateral O
pleural O
effusions O
. O
 
The O
patient O
's O
EKG O
demonstrated O
a O
flutter O
with O
a O
ventricular O
rate O
of O
121 O
with O
inferolateral O
T-wave O
inversions O
. O
 
The O
patient O
was O
given O
IV O
and O
p.o O
. O
 
Cardizem O
with O
control O
of O
the O
ventricular O
rate O
. O
 
At O
the O
time O
of O
this O
dictation O
, O
the O
patient's O
laboratory O
data O
are O
not O
available O
. O
 
The O
plan O
is O
to O
admit O
the O
patient O
to O
the O
hospital O
for O
further O
management O
. O
 
PRIMARY O
DIAGNOSIS O
: O
New O
onset O
AFib O
. O
 
DISPOSITION O
: O
Admission O
. O
 
CONDITION O
UPON O
ADMISSION O
: O
Good O
. O
 
______________________________ O
VILLA O
, O
SCOTT I-NAME
M.D O
. O
 
D O
: O
12/21/74 I-DATE
T O
: O
12/21/74 I-DATE
Dictated O
By O
: O
VILLA O
, O
SCOTT I-NAME
eScription O
document:7-5753770 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2075-03-03 I-DATE
ID O
CONSULT O
NOTE O
PATIENT O
NAME O
: O
Vincent I-NAME
Ware I-NAME
MRN O
: O
98044905 I-ID
DATE O
OF O
ADMISSION O
: O
3/02/75 I-DATE
DATE O
OF O
CONSULT O
: O
3/03/75 I-DATE
ID O
ATTENDING O
: O
Haney I-NAME
ID O
FELLOW O
: O
Riddle I-NAME
SERVICE O
ATTENDING O
: O
Vann I-NAME
REASON O
FOR O
CONSULT O
: O
Cough O
, O
dyspnea O
, O
fevers O
s/p O
HSCT O
off O
immune O
suppression O
HPI O
: O
Mr. O
Ware I-NAME
is O
a O
67-year-old O
man O
with O
a O
history O
non-Hodgkins O
's O
lymphoma O
( O
spinal O
mass O
, O
s/p O
CHOP O
, O
radiation O
, O
in O
long O
term O
remission O
) O
and I-PROFESSION
secondary O
MDS O
s/p O
reduced O
intensity O
allo-HSCT O
12/73 I-DATE
. O
 
His O
post-tx O
course O
was O
unremarkable O
. O
 
Peritransplant O
he O
devloped O
a O
multifocal O
PNA O
of I-DATE
unclear O
etiology O
. O
 
Pretransplant O
imaging O
showed O
peribronchial O
thickening O
, O
and I-PROFESSION
post O
transplant O
a O
tree O
& O
amp O
; O
bud O
appearance O
with O
more O
focal O
areas O
of I-DATE
consolidation O
. O
 
Per O
the O
patient O
, O
he O
had O
a O
dry O
hacking O
cough O
with O
occaisional O
fevers O
and I-PROFESSION
night O
sweats O
that O
lasted O
from O
April I-DATE
through O
November I-DATE
of I-DATE
73 I-DATE
and I-PROFESSION
resolved O
on O
their O
own O
. O
 
He O
had O
several O
courses O
of I-DATE
quinolones O
( O
and I-PROFESSION
other O
abx O
) O
during O
this O
period O
without O
significant O
relief O
, O
but O
ultimately O
his O
symptoms O
improved O
on O
their O
own O
. O
 
His O
immune O
suppression O
was O
d/c O
'd O
7/74 I-DATE
. O
 
He O
deveoloped O
iron O
overload O
( O
Ferritin O
1356 O
) O
and I-PROFESSION
started O
phlebotomy O
9/74 I-DATE
. O
 
Mr. O
Ware I-NAME
did O
well O
from O
a O
respiratory O
standpoint O
until O
11/74 I-DATE
when O
he O
noticed O
intermittent O
fevers O
approximately O
every O
2 O
weeks O
. O
 
At O
first O
they O
were O
in O
the O
99 O
range O
and I-PROFESSION
they O
would O
last O
1-2days O
and I-PROFESSION
be O
associated O
with O
malaise O
. O
 
He O
also O
again O
experienced O
symptoms O
of I-DATE
a O
dry O
hacking O
cough O
that O
occurs O
with O
change O
in O
positioning O
( O
not O
necessarily O
lying O
flat O
) O
. O
 
By O
the O
end O
of I-DATE
November I-DATE
, O
the O
fevers O
were O
a O
bit O
higher O
( O
100.5 O
) O
. O
 
He O
saw O
his O
PCP O
who O
thought O
he O
might O
have O
PNA O
. O
 
He O
obtained O
a O
CXR O
and I-PROFESSION
gave O
hime O
a O
course O
ofr O
azithromycin O
( O
5d O
) O
. O
 
His O
fevers O
improved O
. O
 
In O
early O
December I-DATE
, O
he O
began O
experienceing O
SOB O
with O
exertional O
dyspnea O
. O
 
He O
saw O
his O
PCP O
again O
who O
rx O
avelox O
. O
 
He O
got O
another O
CXR O
which O
showed O
some O
`` O
fluid O
'' O
and I-PROFESSION
was O
strated O
on O
lasix O
. O
 
He O
was O
also O
referred O
for O
echocardiogram O
, O
PFTs O
, O
and I-PROFESSION
chest O
CT. O
On O
arrival O
, O
he O
was O
found O
to O
be O
in O
AFB O
w/RVR O
. O
 
He O
was O
admitted O
from O
12/21-01/02 O
. O
 
He O
was O
rate O
controlled O
and I-PROFESSION
had O
minimal O
diuresis O
. O
 
Cardiac O
MRI O
suggested O
constrictive O
pericarditis O
and I-PROFESSION
possible O
areas O
of I-DATE
active O
pericarditis O
. O
 
Right O
& O
amp O
; O
left O
heart O
cath O
which O
showed O
no O
evidence O
of I-DATE
cosntriction O
hemodynamically O
. O
 
He O
had O
1 O
temperature O
to O
101.4 O
, O
and I-PROFESSION
given O
his O
history O
he O
was O
seen O
by O
our O
service O
. O
 
Blood O
cultures O
were O
negative O
. O
 
Induced O
sputum O
was O
negative O
for O
AFB O
x O
3 O
. O
 
He O
and I-PROFESSION
influenza/rsv/paraflu/adnevorus O
nasal O
swabs O
which O
were O
also O
negative O
. O
 
Sputum O
cultures O
grew O
oral O
flora O
. O
 
CMV O
VL O
, O
glucan O
, O
and I-PROFESSION
galactomannan O
were O
also O
negative O
. O
 
He O
improved O
w/regard O
to O
SOB O
but O
cough O
persisted O
. O
 
He O
was O
seen O
by O
Dr. O
Vann I-NAME
who O
was O
concerned O
for O
an O
immunologic O
process O
given O
his O
bilateral O
pleural O
effusions O
& O
amp O
; O
question O
of I-DATE
pericarditis O
. O
 
He O
had O
a O
URI O
syndrome O
in O
January I-DATE
that O
lasted O
3 O
weeks O
then O
resolved O
. O
 
On O
February I-DATE
19th I-DATE
, O
he O
noticed O
the O
onset O
of I-DATE
low-grade O
temps O
( O
100.0-100.5 O
) O
with O
malaise O
and I-PROFESSION
mild O
chills O
. O
 
These O
happened O
nightly O
through O
. O
 
He O
saw O
his O
PCP O
2/23 I-DATE
who O
rx O
moxifloxacin O
. O
 
He O
had O
no O
change O
in O
his O
symptoms O
. O
 
He O
had O
some O
mild O
rhinorrhea O
and I-PROFESSION
mildly O
increased O
SOB O
. O
 
He O
denies O
CP O
, O
abdominal O
pain O
, O
HA O
, O
N/V/D O
, O
joint O
pain O
, O
skin O
rashes O
, O
dysuria O
. O
 
His O
son O
had O
a O
`` O
head O
cold O
'' O
prior O
to O
the O
onset O
of I-DATE
his O
symptoms O
. O
 
No O
other O
sick O
contacts O
. O
 
He O
was O
admitted O
for O
further O
workup O
. O
 
He O
is O
up O
tp O
date O
received O
influenza O
& O
amp O
; O
pneumococcal O
vaccines O
. O
 
ROS O
: O
as O
above O
, O
otherwise O
negative O
PMH O
: O
1 O
. O
 
Lymphoma O
, O
non-Hodgkin O
's O
, O
large O
B-cell O
lymphoma O
status O
post O
CHOP O
in O
2066 I-DATE
and I-PROFESSION
radiation O
therapy O
for O
a O
T9 O
to O
T12 O
mass O
, O
in O
remission O
. O
 
2 O
. O
 
Secondary O
MDS O
, O
newly O
diagnosed O
06/73 I-DATE
s/p O
unrelated O
donor O
nonmyeloablative O
stem O
cell O
transplant O
12/73 I-DATE
Pt O
: O
RPR O
neg O
, O
CMV O
neg O
, O
HSV O
pos O
, O
TOXO O
pos O
, O
EBV O
pos O
, O
VZV O
pos O
, O
Hep O
Panel O
neg O
, O
HTLV O
neg O
and I-PROFESSION
HIV O
neg O
, O
PPD O
neg O
9/20/73 I-DATE
and I-PROFESSION
8/7/73 I-DATE
Donor O
: O
RPR O
neg O
, O
CMV O
neg O
, O
Hep O
Panel O
neg O
, O
HIV O
neg O
, O
HTLV O
neg O
, O
PPD O
neg O
( O
traveled O
to O
Saudi I-LOCATION
Arabia I-LOCATION
, O
Cartersville I-LOCATION
, O
Newport I-LOCATION
) O
3 O
. O
 
Diabetes O
mellitus O
type O
2 O
. O
 
He O
is O
on O
insulin O
at O
home O
and I-PROFESSION
his O
last O
hemoglobin O
A1C O
was O
around O
8 O
. O
 
4 O
. O
 
Hyperlipidemia O
on O
Zetia O
. O
 
5 O
. O
 
B12 O
deficiency O
. O
 
7 O
. O
 
History O
of I-DATE
basal O
cell O
cancer O
status O
post O
resection O
. O
 
8 O
. O
 
Tonsillectomy O
. O
 
9 O
. O
 
Orbital O
Cellulitis O
( O
7/73 I-DATE
tx O
with O
ceftriaxone/nafcillin/flagyl O
) O
Home O
Medications O
: O
Actigall O
( O
URSODIOL O
) O
300 O
MG O
( O
300MG O
CAPSULE O
Take O
1 O
) O
PO O
TID O
# O
90 I-AGE
Capsule O
( O
s O
) O
Aspirin O
( O
ACETYLSALICYLIC O
Acid O
) O
81 O
MG O
( O
81MG O
TABLET O
Take O
1 O
) O
PO O
QD O
Folic O
Acid O
1MG O
TABLET O
Take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
, O
please O
ship O
to O
patients O
home- O
they O
are O
out O
of I-DATE
medication O
# O
30 O
Tablet O
( O
s O
) O
Lantus O
( O
INSULIN O
Glargine O
) O
18 O
UNITS O
SC O
QHS O
Novolog O
( O
INSULIN O
Aspart O
) O
6-8 O
UNITS O
SC O
tid O
Vitamin O
D O
1000 O
U O
PO O
QD O
Acyclovir O
400mg O
PO O
TID O
Lasix O
20mg O
PO O
daily O
Current O
Medications O
: O
Acyclovir O
400mg O
po O
TID O
, O
ASA O
, O
Insulin O
, O
Pravaastatin O
, O
Sotalol O
, O
ASA O
, O
Vitamin O
D3 O
Allergies O
: O
NKDA O
FH O
: O
Mother O
lived O
to O
90 I-AGE
. O
 
Dad O
died O
of I-DATE
complications O
of I-DATE
diabetes/heart O
disease O
. O
 
One O
sister O
w/metastatic O
lung O
CA O
. O
 
Younger O
brother O
with O
skin O
CA O
. O
 
No O
rheumatologic O
disease O
that O
he O
is O
aware O
of I-DATE
. O
 
Social O
History O
: O
He O
is O
a O
programmer I-PROFESSION
and I-PROFESSION
works O
as O
a O
Industrial I-PROFESSION
Engineering I-PROFESSION
and I-PROFESSION
Manufacturing I-PROFESSION
Technologist I-PROFESSION
at O
Activision I-LOCATION
Blizzard I-LOCATION
. O
 
No O
occupational O
exposures O
. O
 
He O
is O
married O
with O
three O
children O
and I-PROFESSION
4 O
grandchildren O
. O
 
He O
does O
not O
smoke O
or O
drink O
. O
 
He O
has O
remote O
travel O
hx O
to O
the O
Rockefeller I-LOCATION
Centre I-LOCATION
, O
more O
recent O
global I-LOCATION
travel O
( O
Fernley I-LOCATION
, O
Cartersville I-LOCATION
, O
Iceland I-LOCATION
) O
, O
and I-PROFESSION
frequent O
travel O
to O
Muscat I-LOCATION
area O
. O
 
He O
recently O
gave O
away O
his O
indoor O
cat O
prior O
to O
transplant O
. O
 
He O
does O
not O
recall O
tick O
bites O
and I-PROFESSION
has O
infrequently O
visited O
Storting I-LOCATION
and I-PROFESSION
Acropolis I-LOCATION
. O
 
He O
works O
on O
model I-PROFESSION
planes I-PROFESSION
. O
 
He O
has O
no O
TB O
exposures O
. O
 
PHYSICAL O
EXAM O
: O
VITALS O
: O
tmax O
99.1 O
bp O
120/62 O
hr O
83 O
rr O
20 O
sat O
93 O
% O
RA O
GEN O
: O
NAD O
HEENT O
: O
NC/AT O
, O
PERRLA O
, O
OP O
clear O
without O
lesions O
or O
thrush O
NECK O
: O
supple O
CHEST O
: O
mildly O
decreased O
BS O
bilateral O
bases O
CV O
: O
RRR O
, O
NO O
M/G/R O
ABDOMEN O
: O
soft O
, O
NT/ND O
, O
normoactive O
BS O
, O
no O
HSM O
EXTREMITIES O
: O
no O
clubbing O
or O
cyanosis O
, O
trace O
to O
1+ O
bilateral O
LE O
edema O
LYMPH O
NODES O
: O
no O
cervical O
, O
submandibular O
, O
axillary O
, O
or O
inguinal O
adenopathy O
SKIN O
: O
no O
rashes O
LABORATORY O
: O
Na O
135 O
K O
5.1 O
CHL O
103 O
CO2 O
26 O
BUN O
16 O
Cr O
1.03 O
GLU O
259 O
AST O
35 O
ALT O
21 O
ALk O
Phos O
265 O
TB O
0.6 O
WBC O
9.71 O
HCT O
35.6 O
PLT O
366 O
67 I-AGE
% O
P O
, O
17 O
% O
L O
, O
6 O
% O
E O
ESR O
61 O
CMV O
2/9 I-DATE
negative O
MICROBIOLOGY O
: O
BLOOD O
3/02 I-DATE
, O
3/03 I-DATE
NGTD O
URINE O
3/02 I-DATE
1K O
probable O
enterococcus O
STOOL O
3/02 I-DATE
culture O
pending O
3/03 I-DATE
FlU/Paraflu/RSV O
pending O
RADIOLOGY O
: O
CXR O
3/02 I-DATE
: O
Increased O
moderate O
effusions O
since O
1/29/2075 I-DATE
. O
 
CHEST O
CT O
3/03 I-DATE
: O
Pericardial O
effusion O
has O
resolved O
without O
apparent O
change O
in O
bilateral O
pleural O
effusions O
since O
12/14/2074 I-DATE
. O
 
Prior O
granulomatous O
infection O
is O
evident O
. O
 
TTE O
: O
The O
left O
ventricle O
is O
normal O
in O
size O
. O
 
Overall O
left O
ventricular O
function O
is O
mildly O
to O
moderately O
reduced O
. O
 
The O
estimated O
ejection O
fraction O
is O
40-45 O
% O
. O
 
There O
is O
global I-LOCATION
hypokinesis O
with O
regional O
variation O
. O
 
There O
is O
septal O
? O
bounce O
? O
 
raising O
the O
possibility O
of I-DATE
constrictive O
physiology O
. O
 
IMPRESSION O
& O
amp O
; O
RECOMMENDATIONS O
: O
67yoM O
with O
h/o O
NHL O
in O
remission O
, O
secondary O
MDS O
s/p O
non O
myeloabaltive O
allo O
BMT O
now O
off O
all O
immune O
suppression O
since O
7/74 I-DATE
presenting O
with O
fevers O
, O
SOB O
, O
and I-PROFESSION
malaise O
. O
 
He O
has O
not O
yet O
had O
documented O
fevers O
in O
the O
hospital O
, O
but O
his O
rhinorrhea O
after O
sick O
contact O
during O
this O
season O
is O
suggestive O
of I-DATE
a O
viral O
syndrome O
. O
 
He O
has O
chronically O
mildly O
elevated O
LFTs O
which O
are O
stable O
. O
 
He O
has O
a O
new O
mild O
eospinophila O
of I-DATE
unclear O
etiology O
. O
 
-nasopharyngeal O
swab O
AND O
pertussis O
IgM/IgG O
for O
pertussis O
given O
persistent O
cough O
and I-PROFESSION
low O
grade O
temps O
-f/u O
respiratory O
viral O
panel O
-given O
mild O
eosinophilia O
, O
can O
check O
strongyloides O
antibody O
and I-PROFESSION
stool O
for O
ova O
and I-PROFESSION
parasites O
though O
no O
clear O
exposure O
history O
, O
would O
also O
check O
urinary O
histo O
Ag O
and I-PROFESSION
cocciodes O
IgM/IgG O
( O
given O
old O
granulomatous O
disease O
on O
chest O
CT O
) O
-would O
consider O
AM O
cortisol O
to O
r/o O
adrenal O
insufficiency O
-would O
repeat O
hepatitis O
serologies O
( O
HepB O
sAG O
, O
cAB O
, O
sAB O
, O
HepA O
AB O
, O
HepC O
Ab O
) O
given O
persistent O
mildly O
elevated O
LFTs O
-would O
check O
toxoplasma O
DNA O
given O
risk O
of I-DATE
dz O
post-transplant O
________________________________ O
Riley I-NAME
Riddle I-NAME
MD O
, O
MPH O
Infectious O
Disease O
Fellow O
pager O
65296 I-CONTACT
 
Record O
date O
: O
2082-11-22 I-DATE
ZHH I-LOCATION
EMERGENCY O
DEPT O
VISIT O
FINNEY O
, O
INDIANA O
432-94-73-9 I-ID
VISIT O
DATE O
: O
11/22/82 I-DATE
PRESENTING O
COMPLAINT O
: O
Chest O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Ms. O
Finney I-NAME
is O
a O
45 I-AGE
year-old O
woman O
with O
type O
II O
diabetes O
who O
presents O
with O
new O
onset O
of O
palpitations O
and O
chest O
tightness O
. O
 
The O
episodes O
last O
10-15 O
minutes O
and O
mainly O
occur O
with O
exertion O
, O
relieved O
by O
rest O
. O
 
These O
occurred O
at O
rest O
today O
and O
so O
she O
came O
to O
the O
hospital O
. O
 
She O
reports O
being O
ill O
lately O
with O
a O
cough O
, O
for O
a O
long O
time O
. O
 
She O
has O
no O
history O
of O
coronary O
artery O
disease O
. O
 
She O
has O
had O
no O
fever O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
She O
had O
recent O
dental O
work O
and O
she O
was O
told O
she O
has O
a O
heart O
murmur O
. O
 
MEDICATIONS O
: O
Oral O
hypoglycemics O
. O
 
ALLERGIES O
: O
No O
known O
allergies O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
She O
does O
not O
smoke O
. O
 
PHYSICAL O
EXAMINATION O
: O
VITAL O
SIGNS O
: O
Pulse O
111 O
, O
temperature O
100 O
, O
blood O
pressure O
157/69 O
. O
 
GENERAL O
: O
Alert O
, O
calm O
and O
oriented O
. O
 
In O
no O
distress O
. O
 
NECK O
: O
No O
adenopathy O
. O
 
Thyroid O
was O
not O
palpable O
. O
 
Oropharynx O
was O
normal O
. O
 
CHEST O
: O
Clear O
. O
 
CARDIOVASCULAR O
: O
Regular O
rate O
and O
rhythm O
. O
 
ABDOMEN O
: O
Soft O
and O
non-tender O
. O
 
EXTREMITIES O
: O
No O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
She O
had O
no O
rash O
. O
 
LABORATORY O
EVALUATION O
: O
Electrocardiogram O
showed O
mild O
ST O
segment O
change O
that O
was O
non-diagnostic O
and O
confirmed O
the O
tachycardia O
. O
 
Laboratory O
evaluation O
is O
pending O
at O
the O
time O
of O
dictation O
. O
 
Chest O
x-ray O
is O
pending O
and O
the O
results O
will O
be O
appended O
by O
my O
successor O
. O
 
FINAL O
DIAGNOSIS O
: O
Chest O
pain O
, O
exertional O
type O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Disposition O
will O
be O
appended O
by O
my O
successor O
. O
 
Patient O
is O
currently O
in O
stable O
condition O
. O
 
___________________________________ O
TJ371/9248 I-ID
YVES I-NAME
BLACKBURN I-NAME
, O
M.D O
. O
 
HB79 I-NAME
D:11/22/82 O
T:11/23/82 O
Dictated O
by O
: O
YVES I-NAME
BLACKBURN I-NAME
, O
M.D O
. O
 
HB79 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2086-06-29 I-DATE
EDVISIT^43294739^Finney O
, O
Indiana^06/29/86^GAY O
, O
G. I-NAME
VERNAL I-NAME
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
patient O
is O
a O
48-year-old O
female O
who O
presents O
to O
Zucker I-LOCATION
Hillside I-LOCATION
Hospital I-LOCATION
Department O
of O
Emergency O
Medicine O
with O
complaints O
of O
chest O
pain O
. O
 
She O
was O
admitted O
to O
ED O
Observation O
Unit O
, O
after O
having O
no O
acute O
findings O
on O
EKG O
and O
a O
normal O
set O
of O
cardiac O
enzymes O
. O
 
Awake O
, O
alert O
, O
and O
in O
no O
acute O
distress O
. O
 
Vital O
signs O
in O
the O
ED O
this O
a.m. O
were O
grossly O
within O
normal O
limits O
. O
 
No O
chest O
pain O
this O
a.m O
. O
 
PHYSICAL O
EXAMINATION O
: O
HEENT O
: O
Normocephalic O
, O
atraumatic O
. O
 
Pupils O
equal O
, O
round O
, O
and O
reactive O
. O
 
Fundi O
benign O
. O
 
Neck O
: O
Supple O
. O
 
Chest O
is O
clear O
to O
auscultation O
and O
percussion O
. O
 
No O
rales O
, O
wheezes O
, O
or O
rhonchi O
. O
 
Heart O
notes O
a O
normal O
S1 O
, O
S2 O
, O
no O
S3 O
, O
S4 O
, O
no O
murmur O
. O
 
Abdomen O
is O
benign O
, O
soft O
, O
nontender O
, O
no O
masses O
, O
guarding O
, O
rebound O
, O
or O
organomegaly O
. O
 
Extremities O
: O
Grossly O
within O
normal O
limits O
. O
 
Neurologic O
: O
Awake O
, O
alert O
, O
able O
to O
follow O
commands O
. O
 
Negative O
Babinski O
. O
 
She O
had O
a O
second O
set O
of O
cardiac O
enzymes O
done O
in O
the O
observation O
portion O
of O
the O
ED O
, O
which O
were O
negative O
. O
 
PLAN O
: O
Do O
ETT O
this O
a.m O
. O
 
If O
negative O
, O
to O
home O
to O
be O
followed O
by O
her O
PMD O
, O
to O
return O
to O
the O
Emergency O
Department O
at O
Zucker I-LOCATION
Hillside I-LOCATION
Hospital I-LOCATION
if O
her O
problems O
persist O
or O
worsen O
. O
 
______________________________ O
GAY O
, O
G. I-NAME
VERNAL I-NAME
M.D O
. O
 
D O
: O
06/30/86 I-DATE
T O
: O
06/30/86 I-DATE
Dictated O
By O
: O
GAY O
, O
G. I-NAME
VERNAL I-NAME
eScription O
document:3-9073761 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2087-08-15 I-DATE
EDVISIT^43294739^FINNEY O
, O
INDIANA^08/15/87^NARANJO O
, O
KENNETH I-NAME
The O
patient O
was O
seen O
and O
examined O
in O
the O
Emergency O
Department O
on O
08/15/2087 I-DATE
. O
 
The O
patient O
was O
seen O
by O
Dr. O
Kaminski I-NAME
. O
 
I O
have O
discussed O
the O
management O
with O
her O
. O
 
I O
have O
also O
seen O
the O
patient O
personally O
and O
reviewed O
the O
medical O
record O
. O
 
This O
is O
an O
addendum O
to O
the O
medical O
record O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
50-year-old O
female O
who O
is O
sent O
in O
by O
her O
primary O
doctor O
after O
having O
had O
EKG O
changes O
today O
. O
 
Her O
history O
, O
which O
I O
personally O
obtained O
and O
in O
review O
of O
the O
record O
, O
she O
has O
a O
history O
of O
sarcoidosis O
, O
recently O
has O
had O
increased O
cough O
and O
some O
shortness O
of O
breath O
, O
given O
albuterol O
with O
symptomatic O
improvement O
yesterday O
and O
returned O
today O
with O
some O
persistent O
pain O
, O
which O
she O
says O
is O
generally O
related O
to O
cough O
. O
 
She O
has O
had O
no O
fevers O
, O
chills O
, O
or O
shortness O
of O
breath O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
As O
indicated O
and O
otherwise O
negative O
. O
 
She O
is O
asymptomatic O
at O
this O
time O
. O
 
She O
has O
had O
no O
recent O
travel O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Diabetes O
. O
 
SOCIAL O
HISTORY O
: O
She O
is O
a O
nonsmoker O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
very O
well O
appearing O
, O
pleasant O
and O
in O
no O
acute O
distress O
. O
 
Her O
vital O
signs O
are O
stable O
. O
 
She O
is O
normocephalic O
, O
atraumatic O
. O
 
Pharynx O
and O
ENT O
is O
normal O
. O
 
Neck O
is O
supple O
and O
nontender O
. O
 
Chest O
is O
clear O
. O
 
Heart O
is O
regular O
with O
normal O
pulses O
. O
 
Abdomen O
is O
soft O
and O
nontender O
without O
masses O
that O
are O
appreciated O
. O
 
Skin O
is O
warm O
and O
dry O
. O
 
She O
has O
no O
CVA O
tenderness O
, O
no O
back O
tenderness O
. O
 
She O
is O
awake O
, O
alert O
, O
and O
oriented O
. O
 
Sensory O
and O
motor O
exam O
are O
normal O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
This O
is O
a O
woman O
who O
complains O
of O
having O
had O
some O
chest O
discomfort O
. O
 
She O
has O
a O
history O
of O
sarcoid O
and O
has O
EKG O
, O
which O
I O
reviewed O
, O
which O
shows O
lateral O
T-wave O
changes O
as O
suggested O
by O
her O
referring O
doctor O
. O
 
She O
is O
pain O
free O
. O
 
Initial O
lab O
results O
show O
hematocrit O
of O
40 O
, O
INR O
of O
1 O
, O
and O
a O
troponin O
which O
was O
negative O
. O
 
Plan O
at O
this O
time O
is O
for O
hospital O
admission O
to O
rule O
out O
MI O
given O
her O
EKG O
change O
. O
 
She O
looks O
clinically O
stable O
. O
 
______________________________ O
NARANJO O
, O
KENNETH I-NAME
M.D O
. O
 
D O
: O
08/15/87 I-DATE
T O
: O
08/15/87 I-DATE
Dictated O
By O
: O
NARANJO O
, O
KENNETH I-NAME
eScription O
document:3-7918390 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2089-11-05 I-DATE
EDOBS^43294739^FINNEY O
, O
INDIANA^11/04/89^YEAGER O
, O
HAROLD I-NAME
I O
saw O
this O
patient O
with O
Dr. O
Sawyer I-NAME
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
CHIEF O
COMPLAINT O
: O
Heart O
is O
racing O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
52-year-old O
female O
with O
history O
of O
diabetes O
mellitus O
type O
2 O
and O
sarcoid O
, O
who O
presents O
with O
onset O
one O
hour O
prior O
to O
admission O
of O
left O
arm O
pressure O
and O
heart O
racing O
. O
 
The O
patient O
denies O
shortness O
of O
breath O
. O
 
She O
has O
no O
nausea O
, O
vomiting O
, O
and O
no O
fevers O
or O
chills O
. O
 
She O
says O
that O
she O
has O
occasionally O
had O
these O
symptoms O
in O
the O
past O
, O
they O
have O
already O
stopped O
on O
their O
own O
. O
 
Tonight O
, O
they O
lasted O
for O
approximately O
30 O
minutes O
prior O
to O
calling O
EMS O
. O
 
En O
route O
EMS O
took O
12-lead O
ECG O
showing O
a O
rate O
of O
150 O
, O
suspected O
a O
flutter O
and O
was O
given O
20 O
mg O
diltiazem O
by O
EMS O
with O
no O
response O
. O
 
She O
describes O
feeling O
in O
her O
left O
arm O
as O
dull O
pain O
, O
it O
is O
3/10 O
, O
and O
it O
has O
not O
made O
better O
or O
worse O
by O
anything O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Please O
see O
paper O
chart O
. O
 
SOCIAL O
HISTORY O
: O
Please O
see O
paper O
chart O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Please O
see O
paper O
chart O
. O
 
MEDICATIONS O
: O
Please O
see O
paper O
chart O
. O
 
ALLERGIES O
: O
Please O
see O
paper O
chart O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
None O
. O
 
FAMILY O
HISTORY O
: O
Reviewed O
and O
noncontributory O
. O
 
PHYSICAL O
EXAMINATION O
: O
A O
middle-aged O
African-American O
woman O
, O
awake O
, O
alert O
, O
and O
in O
mild O
distress O
. O
 
Exam O
limited O
by O
obesity O
. O
 
Exam O
is O
significant O
for O
neck O
; O
normal O
to O
inspection O
, O
supple O
, O
nontender O
, O
and O
unable O
to O
appreciate O
JVP O
. O
 
Respiratory O
: O
No O
distress O
. O
 
Chest O
: O
Nontender O
and O
normal O
breath O
sounds O
. O
 
Cardiovascular O
: O
Tachycardic O
at O
115 O
and O
regular O
and O
2/6 O
systolic O
ejection O
murmur O
, O
no O
gallop O
, O
and O
no O
friction O
rub O
. O
 
Abdomen O
: O
Soft O
, O
nontender O
, O
no O
organomegaly O
, O
and O
no O
masses O
, O
otherwise O
, O
as O
documented O
on O
the O
paper O
chart O
. O
 
IMAGING O
STUDIES O
: O
ECG O
shows O
a O
flutter O
at O
150 O
beats O
per O
minute O
in O
ECG O
# O
1 O
. O
 
ECG O
final O
shows O
a O
sinus O
rhythm O
at O
approximately O
60 O
beats O
per O
minute O
with O
no O
signs O
of O
ischemia O
. O
 
IMPRESSION O
: O
The O
patient O
is O
a O
52-year-old O
female O
with O
a O
history O
of O
occasional O
brief O
palpitations O
now O
with O
one O
hour O
of O
continuous O
palpitations O
and O
ECG O
consistent O
with O
atrial O
flutter O
. O
 
She O
was O
given O
20 O
mg O
of O
diltiazem O
IV O
by O
EMS O
. O
 
In O
the O
Emergency O
Department O
, O
she O
was O
given O
20 O
mg O
without O
significant O
response O
, O
followed O
by O
40 O
mg O
ID O
and O
was O
achieved O
a O
good O
response O
. O
 
As O
the O
patient O
required O
a O
significant O
amount O
of O
diltiazem O
to O
slow O
her O
rate O
and O
convert O
her O
and O
she O
is O
also O
feeling O
somewhat O
nervous O
, O
we O
will O
keep O
her O
in O
the O
Observation O
Unit O
overnight O
. O
 
She O
should O
get O
an O
oral O
dose O
of O
diltiazem O
overnight O
. O
 
She O
should O
get O
cardiac O
monitoring O
in O
the O
morning O
. O
 
PLAN O
: O
To O
discuss O
with O
KEKELA I-LOCATION
Cardiology O
and O
obtain O
consultation O
as O
to O
possible O
discharge O
on O
beta-blockers O
versus O
calcium O
channel O
blockers O
. O
 
If O
the O
patient O
does O
not O
have O
a O
new O
symptoms O
she O
would O
be O
stable O
for O
discharge O
in O
the O
morning O
. O
 
PRIMARY O
DIAGNOSIS O
: O
Atrial O
flutter O
with O
rapid O
ventricular O
response O
. O
 
SECONDARY O
DIAGNOSIS O
: O
Left O
arm O
pain O
. O
 
CRITICAL O
CARE O
TIME O
: O
35 O
minutes O
. O
 
______________________________ O
YEAGER O
, O
HAROLD I-NAME
M.D O
. O
 
D O
: O
11/05/89 I-DATE
T O
: O
11/05/89 I-DATE
Dictated O
By O
: O
YEAGER O
, O
HAROLD I-NAME
eScription O
document:0-6602107 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2090-12-14 I-DATE
EDVISIT^43294739^FINNEY O
, O
INDIANA^12/15/90^MARTIN O
, O
CONSTANCE I-NAME
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
53-year-old O
female O
with O
a O
history O
of O
insulin-dependent O
diabetes O
, O
hypertension O
and O
atrial O
fibrillation O
who O
comes O
in O
to O
the O
ER O
complaining O
of O
sensation O
of O
a O
racing O
heart O
since O
5:10 O
p.m. O
in O
the O
evening O
. O
 
She O
said O
it O
was O
acute O
onset O
and O
felt O
like O
palpitations O
. O
 
She O
also O
said O
it O
felt O
like O
a O
burning O
. O
 
She O
had O
mild O
shortness O
of O
breath O
and O
left O
arm O
achiness O
. O
 
She O
had O
no O
nausea O
, O
no O
vomiting O
, O
no O
fevers O
or O
chills O
. O
 
She O
had O
no O
trauma O
, O
no O
lightheadedness O
, O
and O
no O
syncope O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
insulin-dependent O
diabetes O
, O
and O
atrial O
fibrillation O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Not O
related O
. O
 
SOCIAL O
HISTORY O
: O
No O
tobacco O
or O
occasional O
alcohol O
. O
 
FAMILY O
HISTORY O
: O
Reviewed O
and O
noncontributory O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Palpitations O
, O
otherwise O
negative O
. O
 
MEDICATIONS O
: O
Metoprolol O
, O
the O
patient O
missed O
two O
doses O
today O
, O
aspirin O
, O
simvastatin O
, O
glyburide O
and O
NovoLog O
. O
 
ALLERGIES O
: O
Erythromycin O
and O
IV O
dye O
. O
 
PHYSICAL O
EXAMINATION O
: O
Temperature O
97 O
, O
heart O
rate O
155 O
, O
respiratory O
rate O
18 O
, O
blood O
pressure O
136/52 O
, O
O2 O
100 O
% O
on O
2 O
liters O
. O
 
The O
patient O
is O
awake O
and O
alert O
, O
well O
developed O
, O
well O
nourished O
, O
talking O
in O
complete O
sentences O
, O
in O
no O
acute O
distress O
. O
 
ENT O
: O
Atraumatic O
, O
normal O
to O
inspection O
. O
 
Eyes O
are O
normal O
. O
 
Neck O
: O
Normal O
to O
inspection O
, O
supple O
, O
and O
nontender O
. O
 
Respiratory O
: O
Clear O
to O
auscultation O
bilaterally O
. O
 
Cardiovascular O
: O
Regular O
rate O
and O
rhythm O
. O
 
No O
murmurs O
, O
rubs O
, O
or O
gallops O
. O
 
GI O
: O
Abdomen O
is O
soft O
and O
nontender O
. O
 
Skin O
is O
intact O
, O
warm O
, O
and O
dry O
. O
 
Back O
is O
nontender O
. O
 
Musculoskeletal O
: O
No O
lower O
extremity O
swelling O
or O
edema O
. O
 
Neuropsychiatric O
: O
Oriented O
x3 O
. O
 
Mood O
and O
affect O
is O
normal O
. O
 
Cranial O
nerves O
II O
through O
XII O
tested O
and O
intact O
. O
 
No O
motor O
or O
sensory O
deficits O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Initial O
EKG O
showed O
a O
rate O
of O
about O
150 O
, O
unclear O
. O
 
It O
seemed O
that O
there O
was O
T O
waves O
in O
V3 O
. O
 
There O
is O
no O
evidence O
of O
ST O
elevation O
MI O
. O
 
We O
thought O
this O
could O
be O
an O
SVT O
. O
 
It O
was O
not O
really O
consistent O
with O
an O
atrial O
fibrillation O
. O
 
Our O
plan O
was O
to O
give O
adenosine O
, O
however O
, O
during O
the O
IV O
placement O
. O
 
Prior O
to O
giving O
adenosine O
, O
the O
patient O
converted O
to O
a O
normal O
sinus O
rhythm O
with O
mild O
tachycardia O
at O
around O
100 O
, O
but O
it O
was O
clear O
that O
there O
was O
T O
waves O
. O
 
At O
this O
point O
, O
we O
decided O
to O
give O
her O
baseline O
metoprolol O
dose O
and O
she O
missed O
two O
doses O
. O
 
LABORATORY O
DATA O
: O
Labs O
checked O
include O
sodium O
of O
139 O
, O
potassium O
3.7 O
, O
chloride O
104 O
, O
bicarbonate O
23 O
, O
BUN O
14 O
, O
creatinine O
0.81 O
, O
glucose O
268 O
. O
 
ALT O
19 O
, O
AST O
18 O
, O
CK O
350 O
, O
alkaline O
phosphatase O
128 O
, O
total O
bilirubin O
0.5 O
, O
CK-MB O
5.2 O
, O
troponin O
I O
less O
than O
0.04 O
, O
calcium O
9.1 O
, O
and O
mag O
1.9 O
. O
 
White O
blood O
cells O
10.29 O
, O
hematocrit O
42.7 O
, O
and O
platelets O
438 O
, O
000 O
. O
 
INR O
is O
1 O
. O
 
UA O
is O
negative O
for O
infection O
with O
trace O
blood O
present O
. O
 
PLAN O
: O
Our O
plan O
is O
to O
check O
two O
more O
enzymes O
because O
the O
patient O
had O
the O
left O
arm O
heaviness O
during O
the O
palpitations O
. O
 
If O
both O
of O
those O
enzymes O
are O
negative O
, O
we O
feel O
that O
she O
is O
safe O
to O
go O
home O
from O
the O
ED O
Observation O
Unit O
. O
 
It O
is O
unclear O
the O
etiology O
of O
her O
arrhythmia O
. O
 
It O
did O
seem O
to O
be O
likely O
SVT O
, O
which O
broke O
spontaneously O
. O
 
The O
patient O
is O
to O
follow O
up O
with O
her O
primary O
doctor O
. O
 
DISPOSITION O
: O
ED O
Observation O
Unit O
. O
 
CONDITION O
ON O
DISCHARGE O
: O
Satisfactory O
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident O
's O
documentation O
, O
the O
patient O
's O
chart O
, O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
______________________________ O
MARTIN O
, O
CONSTANCE I-NAME
M.D O
. O
 
D O
: O
12/15/90 I-DATE
T O
: O
12/15/90 I-DATE
Dictated O
By O
: O
MARTIN O
, O
CONSTANCE I-NAME
eScription O
document:8-4109370 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2062-10-30 I-DATE
54 I-AGE
yo O
male O
from O
Kazakhstan I-LOCATION
here O
for O
f/u O
of O
GI O
mucor O
. O
 
Briefly O
, O
he O
was O
admitted O
6/20/62 I-DATE
with O
DKA O
and O
MSSA O
bacteremia O
. O
 
He O
was O
found O
to O
have O
perirectal O
abscess O
s/p O
CT-guided O
drains O
as O
well O
as O
L O
hip O
infected O
prosthesis O
and O
abscess O
s/p O
removal O
and O
drainage O
in O
OR O
on O
7/07 I-DATE
and O
by O
IR O
7/22 I-DATE
, O
both O
sites O
positive O
for O
MSSA O
. O
 
Hospital O
course O
c/b O
GIB O
and O
was O
found O
to O
have O
free O
air O
with O
perforated O
duodenum O
s/p O
ex-lap O
6/22 I-DATE
, O
gastrectomy O
with O
partial O
large O
bowel O
resection O
, O
splenectomy O
and O
primary O
anastamosis O
, O
with O
path O
positive O
for O
mucormycosis O
without O
clean O
margins O
. O
 
He O
also O
had O
VRE/klebsiella O
LUQ O
abscess O
s/p O
IR O
drainage O
. O
 
He O
was O
initially O
treated O
with O
nafcillin O
and O
ambisome O
, O
but O
developed O
maculopapular O
rash O
on O
chest O
and O
arms O
thought O
to O
be O
secondary O
to O
nafcillin O
. O
 
So O
he O
was O
switched O
to O
vanco/ambisome/linezolid/meropenem/amikacin O
for O
LUQ O
abscess O
. O
 
After O
6 O
weeks O
of O
high-dose O
ambisome O
, O
he O
was O
taken O
back O
to O
OR O
on O
7/31 I-DATE
for O
re-exploration O
and O
was O
found O
to O
have O
some O
more O
necrosis O
around O
his O
esophageal-jejunostomy O
site O
that O
surgeons O
`` O
scooped O
out O
'' O
as O
much O
as O
they O
could O
, O
but O
were O
not O
able O
to O
get O
clean O
margins O
because O
of O
difficult O
anatomic O
restrictions O
. O
 
Given O
the O
inability O
to O
completely O
en-bloc O
resect O
Mr. O
Ethridge I-NAME
's O
GI O
mucor O
despite O
a O
long-trial O
of O
Ambisome O
, O
he O
was O
started O
on O
an O
investigational O
drug O
, O
posaconazole O
, O
provided O
by O
Emcor I-LOCATION
on O
a O
compassionate O
use O
basis O
. O
 
This O
has O
had O
50 O
% O
success O
of O
curing O
mucor O
as O
salvage O
therapy O
in O
small O
trials O
. O
 
He O
was O
started O
on O
this O
drug O
on O
8/28/62 I-DATE
and O
has O
tolerated O
it O
well O
despite O
some O
nausea O
, O
diarrhea O
. O
 
He O
has O
been O
at O
EDUCARE-FARGO I-LOCATION
reports O
increase O
in O
strength O
and O
improved O
ability O
to O
bear O
weight O
on O
his O
hip O
. O
 
He O
walks O
with O
a O
walker O
. O
 
He O
had O
repeat O
CT O
abd/pelvix O
10/26 I-DATE
which O
showed O
no O
intraabdominal O
collection O
and O
stable O
L O
hip O
collection O
. O
 
He O
had O
abd O
drains O
removed O
3 O
weeks O
ago O
but O
continues O
to O
have O
L O
hip O
drain O
, O
without O
much O
output O
. O
 
He O
was O
started O
on O
TPN O
1 O
week O
ago O
due O
to O
maltrition O
, O
despite O
po O
intake O
. O
 
He O
has O
been O
trying O
to O
eat O
, O
but O
reports O
some O
nausea O
and O
diarrhea O
, O
especially O
after O
he O
eats O
and O
since O
starting O
posaconazole O
. O
 
He O
reports O
good O
glycemic O
control O
. O
 
He O
denies O
fevers/abd O
pain/nightsweats/chills/visual O
changes/HA/melena/cough/SOB O
. O
 
PMHx O
: O
DM O
GI O
mucor O
s/p O
total O
gastrectomy O
, O
esophagojejunostomy O
, O
distal O
pancreatectomy O
, O
transverse O
colectomy O
6/62 I-DATE
s/p O
splenectomy O
s/p O
L O
THR O
3 O
years O
ago O
L O
hip O
MSSA O
abscess O
s/p O
resection O
of O
arthroplasty O
and O
drainage O
perirectal O
abscess O
VRE/klebsiella O
LUQ O
( O
subdiaphragmatic O
and O
esophageal O
hiatal O
) O
abscess O
CRI O
HTN O
anemia O
neg O
HIV O
7/62 I-DATE
Meds O
: O
posaconazole O
200 O
po O
QID O
( O
liquid O
) O
amlodipine O
5 O
qd O
metoprolol O
50 O
tid O
clonidine O
0.3 O
mg O
qweek O
niferex O
epogen O
30,000U O
SQ O
qweek O
insulin O
CZI O
All O
: O
nafcillin O
-- O
rash O
SH O
: O
immigrated O
to O
UKRAINE I-LOCATION
10 O
years O
ago O
, O
no O
relatives O
here O
, O
all O
in O
Kazakhstan I-LOCATION
, O
single O
, O
lived O
in O
Alva I-LOCATION
previously O
Habits O
: O
no O
EtOH/cig/IVDU O
FHx O
: O
NC O
PE O
: O
96.3 O
, O
60 O
, O
102/60 O
, O
16 O
HEENT O
: O
o/p O
clear O
, O
no O
cervical O
LAD O
, O
neck O
FROM O
, O
mild O
icterus O
in O
sclera O
Lungs O
: O
CTA O
CV O
: O
rr O
, O
s1 O
and O
s2 O
, O
no O
m/r/g O
Abd O
: O
soft O
, O
NT/ND O
, O
+BS O
, O
abd O
incisions O
well-healed O
Ext O
: O
L O
hip O
drain O
in O
place O
, O
limited O
ROM O
on O
L O
hip O
but O
improved O
Skin O
: O
no O
rash O
EKG O
: O
QT O
363 O
, O
no O
acute O
changes O
Imp O
: O
54 I-AGE
yo O
male O
with O
DM O
s/p O
long O
hospital O
course O
for O
DKA O
, O
multiple O
infections O
in O
hip O
and O
abd O
, O
and O
GI O
mucor O
s/p O
resection O
x2 O
, O
but O
with O
residual O
disease O
. O
 
Currently O
on O
posaconazole O
and O
tolerating O
well O
, O
but O
does O
have O
significant O
nausea O
, O
somewhat O
controlled O
with O
zofran O
. O
 
Diarrhea O
can O
be O
a O
component O
posaconazole O
side O
effect O
, O
or O
due O
to O
dumping O
syndrome O
. O
 
Plan O
: O
1 O
) O
continue O
posaconazole O
2 O
) O
need O
to O
have O
ortho O
f/u O
to O
evaluate O
L O
hip O
collection O
3 O
) O
RTC O
in O
1 O
month O
12/04/62 I-DATE
at O
10am O
to O
f/u O
for O
posaconazole O
. O
 
Will O
need O
EKG O
again O
at O
EDUCARE-FARGO I-LOCATION
before O
transfer O
here O
. O
 
Mr. O
Ethridge I-NAME
seen O
and O
examined O
with O
Dr. O
Roberts I-NAME
. O
 
He O
is O
very O
slowly O
improving O
in O
terms O
of O
strength O
, O
no O
doubt O
in O
part O
due O
to O
nocturnal O
TPN O
. O
 
Hard O
to O
tease O
out O
the O
cause O
of O
his O
nausea O
, O
although O
anatomic O
reasons O
are O
as O
likely O
as O
medication O
side O
effects O
. O
 
On O
balance O
, O
if O
his O
labs O
are O
ok O
, O
I O
'd O
favor O
continuing O
the O
posaconazole O
given O
most O
recent O
OR O
findings O
. O
 
ECG O
without O
QTc O
prolongation O
. O
 
Abdomen O
is O
bening O
. O
 
Left O
hip O
still O
sore O
, O
but O
more O
and O
more O
stable O
. O
 
Brandon I-NAME
Gaines I-NAME
, O
MD O
 
Record O
date O
: O
2064-01-08 I-DATE
Internal O
Medicine O
- O
Team O
3 O
Intern O
Admit O
Note O
Patient O
Name O
: O
Ethridge O
, O
Clayton I-NAME
Medical O
Record O
# O
: O
8381729 I-ID
Date O
of O
Admission O
: O
01/08/64 I-DATE
Attending O
: O
Dr. O
Burton I-NAME
CC/ID O
: O
clotted O
AV O
fistula O
/ O
renal O
failure O
HPI O
: O
The O
patient O
is O
a O
55 I-AGE
year O
old O
male O
with O
a O
past O
medical O
history O
significant O
for O
chronic O
renal O
failure O
( O
secondary O
to O
diabetes O
& O
hypertension O
) O
and O
gastrointestinal O
mucormycosis O
who O
underwent O
an O
arteriovenous O
graft O
placement O
ten O
days O
prior O
to O
admission O
. O
 
The O
patient O
was O
doing O
well O
until O
a O
few O
days O
prior O
to O
admission O
when O
he O
noticed O
a O
swelling O
in O
his O
new O
graft O
and O
a O
decrease O
in O
the O
degree O
of O
its O
pulse O
. O
 
Then O
on O
the O
morning O
of O
admission O
when O
he O
noticed O
his O
graft O
was O
without O
a O
palpable O
pulse O
or O
thrill O
. O
 
The O
patient O
then O
presented O
to O
the O
EDUCARE-PULLMAN I-LOCATION
ER O
for O
evaluation O
and O
treatment O
. O
 
In O
the O
ER O
, O
the O
patient O
was O
found O
to O
have O
an O
engorged O
AV O
graft O
without O
dopplerable O
pulse O
or O
bruit O
. O
 
The O
patient O
was O
seen O
by O
surgery O
and O
an O
ultrasound O
of O
the O
upper O
extremity O
revealed O
a O
clotted O
graft O
and O
so O
the O
patient O
was O
admitted O
to O
the O
medical O
service O
for O
further O
evaluation O
and O
treatment O
. O
 
Of O
note O
, O
the O
patient O
denies O
any O
pain O
/ O
numbness O
/ O
coolness O
in O
his O
hand O
. O
 
He O
further O
denies O
any O
shortness O
of O
breath O
, O
increased O
swelling O
in O
his O
legs O
, O
or O
changes O
in O
his O
weight O
. O
 
He O
does O
indicate O
that O
he O
has O
suffered O
from O
decreased O
oral O
intake O
lately O
secondary O
to O
feeling O
tired O
and O
having O
a O
decreased O
appetite O
. O
 
PMH O
: O
Diabetes O
mellitus O
Diabetic O
neuropathy O
Hypertension O
Chronic O
renal O
disease O
- O
secondary O
to O
diabetes O
& O
hypertension O
, O
baseline O
Cr O
4 O
Anemia O
- O
baseline O
hematocrit O
mid O
30s O
Gastrointestinal O
mucormycosis O
- O
s/p O
GI O
surgery O
( O
see O
below O
) O
PSH O
: O
Hip O
replacement O
Total O
gastrectomy O
, O
gastroesophagojejunostomy O
, O
distal O
pancreatectomy O
, O
transverse O
colectomy O
Splenectomy O
Left O
total O
hip O
replacement O
Allergies O
: O
Nafcillin O
- O
rash O
SH O
: O
Patient O
lives O
in O
Kemmerer I-LOCATION
at O
the O
Chestnut I-LOCATION
Lodge I-LOCATION
Sanitarium I-LOCATION
. O
 
He O
is O
from O
Kazakhstan I-LOCATION
originally O
, O
has O
no O
family O
nearby O
and O
works O
as O
a O
Glazier I-PROFESSION
. O
 
Tob O
: O
Denies O
EtOH O
: O
Denies O
Illicits O
: O
Denies O
FH O
: O
Non-contributory O
. O
 
Medications O
: O
procrit O
10,000 O
U O
qthursday O
catapres O
tts-3 O
qwednesday O
oscal O
po O
tid O
hydralazine O
50 O
mg O
po O
tid O
remeron O
15 O
mg O
po O
qhs O
colace O
100 O
mg O
po O
bid O
neurontin O
100 O
mg O
po O
qd O
folate O
1 O
mg O
po O
qd O
norvasc O
10 O
mg O
po O
qd O
trazadone O
50 O
mg O
po O
qhs O
nephrocaps O
daily O
bumetanide O
0.5 O
mg O
po O
qd O
niferex O
150 O
mg O
po O
qd O
calcitrol O
0.25 O
mg O
po O
qd O
enulose O
prn O
tramadol O
prn O
nitroglycerin O
ointment O
prn O
milk O
of O
magnesia O
prn O
maalox O
prn O
zofran O
prn O
lopermide O
prn O
tylenol O
prn O
Exam O
: O
VS O
: O
T=96.6 O
HR=62 O
BP=125/61 O
RR=18 O
SaO2=99 O
% O
on O
RA O
General O
: O
no O
acute O
distress O
, O
calm O
, O
resting O
comfortably O
. O
 
HEENT O
: O
pupils O
equal O
and O
reactive O
to O
light O
, O
anicteric O
sclera O
, O
extraocular O
movements O
intact O
. O
 
Skin O
: O
no O
rashes O
. O
 
Neck O
: O
supple O
. O
 
Chest O
: O
clear O
to O
auscultation O
bilaterally O
. O
 
CVS O
: O
regular O
rate O
& O
rhythm O
, O
III/VI O
holosystolic O
murmurs O
, O
no O
rubs O
. O
 
Abd O
: O
soft O
, O
non-distended O
, O
non-tender O
to O
palpation O
, O
normoactive O
bowel O
sounds O
. O
 
Extr O
: O
+1 O
edema O
, O
no O
papable O
thrill O
or O
auscultatable O
bruit O
in O
AV O
graft O
. O
 
MSK O
: O
no O
joint O
swelling O
, O
no O
erythema O
, O
full O
range O
of O
motion O
. O
 
Neuro O
: O
CN O
II O
through O
XII O
intact O
, O
motor O
strength O
5/5 O
UE O
and O
LE O
, O
sensory O
intact O
. O
 
DATA O
Test O
Description O
Result O
Ref O
. O
 
Range/Units O
Date/Time O
Last O
Abnormal O
Chemistry O
Lytes/Renal/Glucose O
Sodium O
136 O
135-145 O
mmol/L O
01/08/64 I-DATE
13:51 O
133 O
( O
L O
) O
08/28/62 I-DATE
Potassium O
4.9H O
3.4-4.8 O
mmol/L O
01/08/64 I-DATE
13:51 O
4.9 O
( O
H O
) O
01/08/64 I-DATE
Chloride O
111H O
100-108 O
mmol/L O
01/08/64 I-DATE
13:51 O
111 O
( O
H O
) O
01/08/64 I-DATE
Carbon O
Dioxide O
18.6L O
23.0-31.9 O
mmol/L O
01/08/64 I-DATE
13:51 O
18.6 O
( O
L O
) O
01/08/64 I-DATE
BUN O
82H O
8-25 O
mg/dl O
01/08/64 I-DATE
13:51 O
82 O
( O
H O
) O
01/08/64 I-DATE
Creatinine O
5.9H O
0.6-1.5 O
mg/dl O
01/08/64 I-DATE
13:51 O
5.9 O
( O
H O
) O
01/08/64 I-DATE
Glucose O
133H O
70-100 O
mg/dl O
01/08/64 I-DATE
17:54 O
133 O
( O
H O
) O
01/08/64 I-DATE
Hematology O
Complete O
Blood O
Count O
WBC O
5.1 O
4.5-11.0 O
th/cmm O
01/08/64 I-DATE
13:44 O
4.3 O
( O
L O
) O
04/29/63 I-DATE
RBC O
3.12L O
4.50-5.90 O
mil/cm O
01/08/64 I-DATE
13:44 O
3.12 O
( O
L O
) O
01/08/64 I-DATE
Hgb O
10.1L O
13.5-17.5 O
gm/dl O
01/08/64 I-DATE
13:44 O
10.1 O
( O
L O
) O
01/08/64 I-DATE
HCT O
31.1L O
41.0-53.0 O
% O
01/08/64 I-DATE
13:44 O
31.1 O
( O
L O
) O
01/08/64 I-DATE
MCV O
100 O
80-100 O
fl O
01/08/64 I-DATE
13:44 O
101 O
( O
H O
) O
12/22/63 I-DATE
MCH O
32.5 O
26.0-34.0 O
pg/rbc O
01/08/64 I-DATE
13:44 O
MCHC O
32.6 O
31.0-37.0 O
g/dl O
01/08/64 I-DATE
13:44 O
30.1 O
( O
L O
) O
07/09/62 I-DATE
PLT O
179 O
150-350 O
th/cumm O
01/08/64 I-DATE
13:44 O
370 O
( O
H O
) O
08/27/62 I-DATE
RDW O
15.0H O
11.5-14.5 O
% O
01/08/64 I-DATE
13:44 O
15.0 O
( O
H O
) O
01/08/64 I-DATE
Blood O
Differential O
% O
Neutrophils O
43 O
40-70 O
% O
01/08/64 I-DATE
13:44 O
77 O
( O
H O
) O
08/27/62 I-DATE
Lymphs O
46H O
22-44 O
% O
01/08/64 I-DATE
13:44 O
46 O
( O
H O
) O
01/08/64 I-DATE
Monos O
5 O
4-11 O
% O
01/08/64 I-DATE
13:44 O
2 O
( O
L O
) O
08/27/62 I-DATE
Eos O
5 O
0-8 O
% O
01/08/64 I-DATE
13:44 O
Basos O
1 O
0-3 O
% O
01/08/64 I-DATE
13:44 O
Urinalysis O
GLUC O
- O
UA O
Trace O
NEG O
01/08/64 I-DATE
15:20 O
Ketones O
NEGATIVE O
NEG O
01/08/64 I-DATE
15:20 O
Specific O
Gravity O
1.015 O
1.001-1.035 O
01/08/64 I-DATE
15:20 O
1.037 O
( O
H O
) O
07/16/59 I-DATE
Blood O
- O
UA O
NEGATIVE O
NEG O
01/08/64 I-DATE
15:20 O
pH O
5.0 O
5.0-9.0 O
01/08/64 I-DATE
15:20 O
Nitrites O
NEGATIVE O
NEG O
01/08/64 I-DATE
15:20 O
WBC O
Screen O
NEGATIVE O
NEG O
01/08/64 I-DATE
15:20 O
Hyaline O
Cast O
None O
0-5 O
/lpf O
01/08/64 I-DATE
16:19 O
RBC O
- O
UA O
3-5 O
0-2 O
/hpf O
01/08/64 I-DATE
16:19 O
WBC O
- O
UA O
0-2 O
0-2 O
/hpf O
01/08/64 I-DATE
16:19 O
Bacteria O
NEGATIVE O
NEG O
/hpf O
01/08/64 I-DATE
16:19 O
Squamous O
Cells O
NEGATIVE O
NEG O
/hpf O
01/08/64 I-DATE
16:19 O
Micro O
: O
Blood O
& O
urine O
cultures O
pending O
UpperExt O
U/S O
: O
Clotted O
right O
upper O
extremity O
arteriovenous O
graft O
. O
 
Impression O
: O
55 I-AGE
year O
old O
male O
with O
chronic O
renal O
failure O
, O
hypertension O
, O
diabetes O
and O
gastrointestinal O
mucormycosis O
who O
is O
s/p O
AV O
graft O
placement O
presents O
with O
clotted O
AV O
graft O
& O
renal O
failure O
. O
 
AV O
Graft O
Patient O
will O
undergo O
IR O
intervention O
on O
01/09 I-DATE
in O
an O
attempt O
to O
restore O
flow O
to O
the O
AV O
graft O
Will O
keep O
patient O
NPO O
after O
midnight O
Will O
avoid O
systemic O
anticoagulants O
Will O
obtain O
hypercoagulable O
labs O
Renal O
Failure O
Patient O
has O
chronic O
renal O
failure O
, O
secondary O
to O
diabetes O
and O
hypertension O
Will O
need O
dialysis O
soon O
Will O
continue O
nephrocaps O
, O
calcitrol O
, O
procrit O
Hypertension O
Will O
continue O
outpatient O
regimen O
Anemia O
Will O
continue O
iron O
supplementation O
/ O
procrit O
weekly O
injections O
Prophylaxis O
DVT O
prophylaxis O
: O
will O
encourage O
ambulation O
GI O
prophylaxis O
: O
will O
initiate O
nexium O
& O
colace O
Dispo O
Patient O
will O
likely O
return O
to O
Chestnut I-LOCATION
Lodge I-LOCATION
Sanitarium I-LOCATION
on O
discharge O
_________________________________ O
Uriel I-NAME
Q. I-NAME
Yarbrough I-NAME
, O
MD O
Pager O
# O
89356 I-CONTACT
 
Record O
date O
: O
2064-01-28 I-DATE
Patient O
Name O
: O
Ethridge O
, O
Clayton I-NAME
Medical O
Record O
# O
: O
8381729 I-ID
Attending O
: O
Dr. O
Burton I-NAME
CC/ID O
: O
fever O
post O
HD O
HPI O
: O
The O
patient O
is O
a O
55 I-AGE
year O
old O
male O
with O
a O
past O
medical O
history O
significant O
for O
chronic O
renal O
failure O
( O
secondary O
to O
diabetes O
& O
hypertension O
) O
and O
gastrointestinal O
mucormycosis O
who O
was O
recently O
admitted O
for O
a O
clotted O
AVF O
, O
s/p O
thrombectomy O
. O
 
Unfortunately O
, O
graft O
eventually O
reclotted O
and O
was O
deemed O
unsalvageable- O
the O
patient O
was O
then O
started O
on O
HD O
via O
a O
tunnelled O
catheter O
. O
 
Was O
tolerating O
this O
well O
, O
until O
day O
prior O
to O
admission O
noted O
a O
fever O
prior O
to O
going O
to O
HD O
. O
 
Blood O
cultures O
taken O
yesterday O
at O
HD O
, O
returned O
today O
with O
GPC O
in O
clusters O
, O
further O
speciation O
to O
follow O
. O
 
Admitted O
for O
fever O
workup O
. O
 
Pt O
. O
 
currently O
complains O
of O
some O
generalized O
fatigue O
, O
malaise O
, O
nausea O
. O
 
Has O
a O
hx O
of O
abdominal O
mucormycosis O
resulting O
in O
chronic O
abdominal O
discomfort O
, O
which O
today O
is O
at O
baseline O
. O
 
No O
CP O
, O
SOB O
. O
 
PMH O
: O
Diabetes O
mellitus O
Diabetic O
neuropathy O
Hypertension O
Chronic O
renal O
disease O
- O
secondary O
to O
diabetes O
& O
hypertension O
, O
baseline O
Cr O
4 O
Anemia O
- O
baseline O
hematocrit O
mid O
30s O
Gastrointestinal O
mucormycosis O
- O
s/p O
GI O
surgery O
( O
see O
below O
) O
PSH O
: O
Hip O
replacement O
Total O
gastrectomy O
, O
gastroesophagojejunostomy O
, O
distal O
pancreatectomy O
, O
transverse O
colectomy O
Splenectomy O
Left O
total O
hip O
replacement O
Allergies O
: O
Nafcillin O
- O
rash O
SH O
: O
Patient O
lives O
in O
Kemmerer I-LOCATION
at O
the O
Chestnut I-LOCATION
Lodge I-LOCATION
Sanitarium I-LOCATION
. O
 
He O
is O
from O
Kazakhstan I-LOCATION
originally O
, O
has O
no O
family O
nearby O
and O
works O
as O
a O
Glazier I-PROFESSION
. O
 
Tob O
: O
Denies O
EtOH O
: O
Denies O
Illicits O
: O
Denies O
FH O
: O
Non-contributory O
. O
 
Medications O
: O
1 O
) O
Tylenol O
PRN O
2 O
) O
Remeron O
15 O
mg O
at O
bedtime O
3 O
) O
Folic O
acid O
1 O
mg O
PO O
daily O
4 O
) O
Trazodone O
50 O
mg O
at O
bedtime O
5 O
) O
Nephrocaps O
1 O
PO O
daily O
6 O
) O
Calcium O
carbonate O
with O
vitamin O
D O
250 O
mg O
3 O
x O
day O
7 O
) O
Nexium O
20 O
mg O
PO O
daily O
8 O
) O
Hydralazine O
50 O
mg O
3 O
x O
day O
9 O
) O
Norvasc O
10 O
mg O
PO O
daily O
10 O
) O
Clonidine O
0.1 O
mg O
twice O
a O
day O
11 O
) O
Regular O
insulin O
sliding O
scale O
12 O
) O
Procrit O
10K O
U O
weekly O
Exam O
: O
VS O
: O
T=999.9 O
HR=69 O
BP=124/63 O
RR=18 O
SaO2=99 O
% O
on O
RA O
General O
: O
no O
acute O
distress O
, O
calm O
, O
resting O
comfortably O
. O
 
HEENT O
: O
pupils O
equal O
and O
reactive O
to O
light O
, O
anicteric O
sclera O
, O
extraocular O
movements O
intact O
. O
 
Skin O
: O
no O
rashes O
. O
 
Neck O
: O
supple O
. O
 
S O
subclavian O
HD O
catheter O
CDI O
Chest O
: O
clear O
to O
auscultation O
bilaterally O
. O
 
CVS O
: O
regular O
rate O
& O
rhythm O
, O
III/VI O
holosystolic O
murmurs O
, O
no O
rubs O
. O
 
Abd O
: O
soft O
, O
non-distended O
, O
non-tender O
to O
palpation O
, O
normoactive O
bowel O
sounds O
. O
 
Extr O
: O
+1 O
edema O
, O
no O
papable O
thrill O
or O
auscultatable O
bruit O
in O
AV O
graft O
. O
 
MSK O
: O
no O
joint O
swelling O
, O
no O
erythema O
, O
full O
range O
of O
motion O
. O
 
Neuro O
: O
CN O
II O
through O
XII O
intact O
, O
motor O
strength O
5/5 O
UE O
and O
LE O
, O
sensory O
intact O
. O
 
Results O
Date/Time O
NA O
K O
CL O
CO2 O
01/23/2064 I-DATE
135 O
3.9 O
101 O
26.2 O
Date/Time O
BUN O
CRE O
GLU O
01/23/2064 I-DATE
17 O
2.3 O
( O
H O
) O
01/23/2064 I-DATE
49 O
( O
H O
) O
5.1 O
( O
H O
) O
159 O
( O
H O
) O
Date/Time O
CA O
PHOS O
ALB O
01/23/2064 I-DATE
6.7 O
( O
L O
) O
4.1 O
3.0 O
( O
L O
) O
Date/Time O
CCOM O
01/25/2064 I-DATE
[ O
1 O
] O
01/23/2064 I-DATE
[ O
2 O
] O
Date/Time O
WBC O
RBC O
HGB O
HCT O
01/28/2064 I-DATE
5.3 O
2.50 O
( O
L O
) O
8.2 O
( O
L O
) O
25.6 O
( O
L O
) O
01/25/2064 I-DATE
7.0 O
2.45 O
( O
L O
) O
8.0 O
( O
L O
) O
25.4 O
( O
L O
) O
01/23/2064 I-DATE
4.6 O
2.37 O
( O
L O
) O
7.8 O
( O
L O
) O
24.2 O
( O
L O
) O
Date/Time O
MCV O
MCH O
MCHC O
PLT O
01/28/2064 I-DATE
103 O
( O
H O
) O
32.9 O
32.1 O
315 O
01/25/2064 I-DATE
104 O
( O
H O
) O
32.8 O
31.6 O
303 O
01/23/2064 I-DATE
102 O
( O
H O
) O
32.7 O
32.1 O
334 O
Date/Time O
RDW O
01/28/2064 I-DATE
14.1 O
01/25/2064 I-DATE
14.6 O
( O
H O
) O
01/23/2064 I-DATE
14.1 O
Date/Time O
DIFFR O
METHOD O
% O
NEUT O
% O
LYMPH O
01/28/2064 I-DATE
RECEIVED O
Auto O
46 O
45 O
( O
H O
) O
Date/Time O
% O
MONO O
% O
EOS O
% O
BASO O
01/28/2064 I-DATE
6 O
3 O
0 O
Date/Time O
ANEUT O
ALYMP O
AMONS O
AEOSN O
01/28/2064 I-DATE
2.48 O
2.34 O
0.31 O
0.14 O
Date/Time O
ABASOP O
01/28/2064 I-DATE
0.01 O
Date/Time O
ANISO O
HYPO O
MACRO O
MICRO O
01/28/2064 I-DATE
None O
1+ O
2+ O
None O
Date/Time O
PROTSF O
PROTCF O
PROTCA O
[ O
1 O
] O
RESULT O
COMMENT O
: O
PREDOMINANT O
GROWTH O
OF O
[ O
2 O
] O
RESULT O
COMMENT O
: O
Post O
dialysis O
Microbiology O
01/28/2064 I-DATE
21:47 O
EDUCARE-PULLMAN I-LOCATION
Microbiology O
Specimen O
Type O
BLOOD O
CULTURE O
Accession O
# O
5856E7910 I-ID
Specimen O
: O
5856E7910 I-ID
Collected O
28-Jan-64 I-DATE
21:47 O
Received O
28-Jan-64 I-DATE
21:47 O
Specimen O
Group O
: O
BLOOD/SERUM O
Specimen O
Type O
: O
BLOOD O
CULTURE O
Specimen O
Comment O
: O
PERIPHERAL O
IV O
SET O
2 O
Blood O
Culture O
- O
Pending O
01/28/2064 I-DATE
21:46 O
EDUCARE-PULLMAN I-LOCATION
Microbiology O
Specimen O
Type O
BLOOD O
CULTURE O
Accession O
# O
6934P2380 I-ID
Specimen O
: O
6934P2380 I-ID
Collected O
28-Jan-64 I-DATE
20:00 O
Received O
28-Jan-64 I-DATE
21:46 O
Specimen O
Group O
: O
BLOOD/SERUM O
Specimen O
Type O
: O
BLOOD O
CULTURE O
Specimen O
Comment O
: O
SET O
1 O
Blood O
Culture O
- O
Pending O
01/27/2064 I-DATE
15:01 O
EDUCARE-PULLMAN I-LOCATION
Microbiology O
Specimen O
Type O
BLOOD O
CULTURE O
Accession O
# O
6931L53151 I-ID
Specimen O
: O
6931L53151 I-ID
Collected O
27-Jan-64 I-DATE
12:30 O
Received O
27-Jan-64 I-DATE
15:01 O
Specimen O
Group O
: O
BLOOD/SERUM O
Specimen O
Type O
: O
BLOOD O
CULTURE O
Specimen O
Comment O
: O
SET O
2 O
DIALYSIS O
Blood O
Culture O
- O
Preliminary O
Reported O
: O
28-Jan-64 I-DATE
17:29 O
Aerobic O
bottle O
: O
GRAM O
POSITIVE O
COCCI O
IN O
CLUSTERS O
Susceptibilities O
pending O
RESULT O
CALLED O
TO O
CARE O
UNIT O
AND/OR O
MD O
ON O
1/28/64 I-DATE
01/27/2064 I-DATE
14:59 O
EDUCARE-PULLMAN I-LOCATION
Microbiology O
Specimen O
Type O
BLOOD O
CULTURE O
Accession O
# O
3194S62727 I-ID
Specimen O
: O
3194S62727 I-ID
Collected O
27-Jan-64 I-DATE
12:30 O
Received O
27-Jan-64 I-DATE
14:59 O
Specimen O
Group O
: O
BLOOD/SERUM O
Specimen O
Type O
: O
BLOOD O
CULTURE O
Specimen O
Comment O
: O
SET O
1 O
DIALYSIS O
Blood O
Culture O
- O
Preliminary O
Reported O
: O
28-Jan-64 I-DATE
07:24 O
NO O
GROWTH O
1 O
DAY O
Impression O
: O
55 I-AGE
year O
old O
male O
with O
chronic O
renal O
failure O
, O
hypertension O
, O
diabetes O
and O
gastrointestinal O
mucormycosis O
who O
is O
s/p O
recent O
tunnelled O
catheter O
placement O
, O
now O
presenting O
with O
fever O
post O
HD O
, O
GPC O
in O
blood O
. O
 
ID- O
Likely O
catheter O
related O
infection O
, O
will O
continue O
vanco O
for O
now O
, O
await O
speciation O
of O
GPC O
. O
 
Will O
recx O
if O
spikes O
above O
101.5 O
. O
 
FU O
urine O
cx O
. O
 
Vanco/Gent O
. O
 
Ultimately O
needs O
line O
out O
. O
 
ESRD-continue O
dialysis O
schedule O
, O
will O
continue O
nephrocaps O
, O
calcitrol O
, O
procrit O
Hypertension O
Will O
continue O
outpatient O
regime O
DM- O
Sliding O
scale O
insulin O
Heme O
Protein O
C O
and O
S O
levels O
decreased O
on O
repeat O
testing O
. O
 
I O
believe O
protein O
C O
can O
be O
influenced O
by O
ESRD O
, O
but O
not O
protein O
S. O
This O
needs O
to O
be O
followed O
up O
further O
. O
 
Prophylaxis O
DVT O
prophylaxis O
: O
Fragmin O
GI O
prophylaxis O
: O
nexium O
_____________________________________________ O
Herbert I-NAME
C. I-NAME
Guerrero I-NAME
, O
M. O
D O
. O
 
Record O
date O
: O
2064-07-28 I-DATE
Team O
2 O
Internal O
Medicine O
Intern O
Admission O
Note O
Name O
: O
Ethridge O
, O
Clayton I-NAME
MR O
# O
: O
8381729 I-ID
Admit O
Date O
: O
7/28/64 I-DATE
Attending O
: O
Dr. O
Tomlin I-NAME
Admitting O
intern I-PROFESSION
: O
Ursula I-NAME
Quiles I-NAME
, O
MD O
Code O
: O
Full O
Source O
: O
Medical O
record O
, O
Patient O
Chief O
Complaint O
: O
fistula O
clot O
History O
of I-DATE
Present O
Illness O
: O
Pt O
is O
a O
59 I-AGE
yo O
Khazakhstani I-LOCATION
male O
, O
with O
h/o O
HTN O
, O
DM O
, O
mucormycosis O
, O
and O
ESRD O
on O
HD O
presenting O
with O
a O
thrombosed O
AVF O
in O
his O
left O
arm O
, O
established O
in O
April I-DATE
of I-DATE
2064 I-DATE
by O
Dr. O
Jordon I-NAME
. O
 
The O
patient O
has O
a O
history O
of I-DATE
multiple O
problems O
with O
access O
( O
clots O
, O
stenoses O
) O
, O
requiring O
frequent O
thrombectomies O
and O
revisions O
. O
 
The O
patient O
first O
noticed O
a O
problem O
on O
July I-DATE
23 I-DATE
, O
and O
by O
the O
24th I-DATE
he O
said O
that O
`` O
the O
access O
had O
collapsed O
. O
'' O
 
On O
July I-DATE
25 I-DATE
, O
interventional O
radiology O
attempted O
to O
thrombectomize O
the O
clot O
, O
with O
no O
success O
, O
requiring O
placement O
of I-DATE
a O
new O
tunneled O
catheter O
in O
left O
IJ O
to O
allow O
dialysis O
. O
 
At O
present O
, O
patient O
is O
on O
the O
OR O
waiting O
list O
for O
tomorrow O
, O
for O
thrombectomy/revision O
. O
 
Of O
note O
, O
patient O
was O
admitted O
in O
April I-DATE
of I-DATE
2064 I-DATE
after O
a O
nurse O
at O
the O
McLaren I-LOCATION
Hospital I-LOCATION
detected O
a O
new O
cardiac O
murmur O
. O
 
Pt O
was O
found O
to O
have O
a O
RA O
thrombus O
by O
echo O
, O
presumed O
to O
be O
a O
complication O
from O
a O
prior O
catheter O
, O
started O
on O
a O
heparin O
gtt O
and O
transitioned O
to O
coumadin O
. O
 
ROS O
: O
No O
fever/chills O
, O
HA O
, O
SOB O
, O
CP O
, O
N/V/D O
( O
though O
states O
that O
stomach O
sometimes O
`` O
sensitive O
'' O
) O
. O
 
Past O
Medical O
History O
: O
DM O
- O
Type O
2 O
HTN O
ESRD O
on O
HD O
MWF O
, O
with O
h/o O
multiple O
problems O
with O
access O
, O
Cr O
baseline O
4 O
s/p O
extensive O
bowel O
resection O
for O
mucormycosis O
, O
June I-DATE
2062 I-DATE
( O
gastrectomy O
, O
esophagojejunostomy O
, O
splenectomy O
, O
distal O
pancreatectomy O
, O
segmental O
transverse O
colectomy O
) O
s/p O
L O
THR O
s/p O
resection O
arthroplasty O
of I-DATE
left O
femoral O
head O
and O
acetabulum O
for O
fungal O
infection O
( O
mucomycosis O
above O
, O
June I-DATE
2062 I-DATE
) O
R O
atrial O
thrombus O
by O
echo O
in O
4/63 I-DATE
Allergies O
: O
Nafcillin- O
rash O
Penicillin- O
rash O
Medications O
( O
upon O
admission O
) O
Remeron O
( O
MIRTAZAPINE O
) O
15 O
MG O
( O
15MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Nexium O
( O
ESOMEPRAZOLE O
) O
20 O
MG O
( O
20MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
QD O
TRAZODONE O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Colace O
( O
DOCUSATE O
Sodium O
) O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
TID O
Norvasc O
( O
AMLODIPINE O
) O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Diovan O
( O
VALSARTAN O
) O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
QD O
Insulin O
Regular O
Human O
SC O
NEPHROCAPS O
1 O
CAPSULE O
PO O
QD O
Renagel O
( O
SEVELAMER O
) O
806 O
MG O
( O
403MG O
CAPSULE O
take O
2 O
) O
PO O
TID O
Folate O
( O
FOLIC O
Acid O
) O
1 O
MG O
( O
1MG O
TABLET O
take O
1 O
) O
PO O
QD O
Calcium O
Carbonate O
( O
500 O
Mg O
Elemental O
Ca++ O
) O
1250 O
MG O
PO O
AC O
Warfarin O
Sodium O
2.5 O
MG O
( O
2.5MG O
TABLET O
take O
1 O
) O
PO O
QPM O
Social O
History O
: O
Patient O
is O
a O
native O
of I-DATE
Kazakhstan I-LOCATION
, O
who O
moved O
to O
the O
UKRAINE I-LOCATION
to O
study O
Electrical I-PROFESSION
Mechanics I-PROFESSION
at O
OpenMarket I-LOCATION
Inc I-LOCATION
. O
 
He O
is O
currently O
unable O
to O
pursue O
this O
field O
, O
due O
to O
his O
debilitated O
state O
, O
however O
he O
would O
like O
to O
try O
to O
intern I-PROFESSION
, O
when O
he O
feels O
up O
to O
it O
. O
 
He O
lives O
in O
the O
McLaren I-LOCATION
Hospital I-LOCATION
in O
Kemmerer I-LOCATION
( O
a O
facility O
for O
homeless O
individuals O
. O
) O
 
No O
tobacco O
, O
EtOH O
, O
illicits O
. O
 
Family O
History O
: O
Non-contributory O
. O
 
Exam O
: O
Vitals O
: O
BP O
121/62 O
HR O
78 O
RR O
16 O
T O
97.5 O
O2 O
sat O
100 O
% O
RA O
Gen O
: O
HEENT O
: O
PERL O
, O
OP O
without O
erythema O
, O
exudates O
; O
mucous O
membranes O
moist O
; O
no O
scleral O
icterus O
Pulm O
: O
CTA O
with O
good O
air O
movement O
bilat O
. O
 
; O
no O
c/w/r O
Cor/Cardiac O
: O
RRR O
nl O
. O
 
S1 O
, O
S2 O
; O
no O
m/g/r O
, O
neck O
veins O
flat O
Abdomen O
: O
S/NT/ND O
; O
+BS O
throughout O
; O
no O
HSM O
, O
palpable/pulsatile O
masses O
Extremity O
: O
no O
c/c/e O
; O
distal O
pulses O
2+ O
bilat O
; O
left O
LE O
shorter O
than O
right O
and O
internally O
rotated O
Neurological O
: O
CN O
II-XII O
grossly O
intact O
, O
strength O
5/5 O
all O
major O
muscle O
groups O
; O
DTR O
's O
2+ O
bilat O
. O
 
UE/LE O
, O
Laboratory O
Hematology O
EDUCARE-PULLMAN I-LOCATION
BLOOD O
27-Jul-2064 I-DATE
16:10 O
Accession O
# O
8911Z65654 I-ID
WBC O
8.0 O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
34.7 O
L O
( O
41.0-53.0 O
) O
% O
HGB O
11.0 O
L O
( O
13.5-17.5 O
) O
gm/dl O
RBC O
3.55 O
L O
( O
4.50-5.90 O
) O
mil/cmm O
PLT O
255 O
( O
150-350 O
) O
th/cumm O
MCV O
98 O
( O
80-100 O
) O
fl O
MCH O
31.1 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
31.8 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
15.3 O
H O
( O
11.5-14.5 O
) O
% O
Retic O
2.6 O
H O
( O
0.5-2.5 O
) O
% O
Chemistry O
EDUCARE-PULLMAN I-LOCATION
BLOOD O
27-Jul-2064 I-DATE
16:10 O
Accession O
# O
8911Z65654 I-ID
Plasma O
Sodium O
135 O
( O
135-145 O
) O
mmol/L O
Plasma O
Potassium O
5.0 O
H O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
100 O
( O
100-108 O
) O
mmol/L O
Plasma O
Carbon O
Dioxide O
19.4 O
L O
( O
23.0-31.9 O
) O
mmol/L O
Calcium O
7.7 O
L O
( O
8.5-10.5 O
) O
mg/dl O
Phosphorus O
5.3 O
H O
( O
2.6-4.5 O
) O
mg/dl O
Plasma O
Urea O
Nitrogen O
74 O
H O
( O
8-25 O
) O
mg/dl O
Plasma O
Creatinine O
7.7 O
H O
( O
0.6-1.5 O
) O
mg/dl O
Plasma O
Glucose O
113 O
H O
( O
70-110 O
) O
mg/dl O
Albumin O
3.7 O
( O
3.3-5.0 O
) O
g/dl O
Parathyroid O
Hormone O
187 O
H O
( O
10-60 O
) O
pg/ml O
EKG O
: O
NSR O
at O
75-80 O
, O
normal O
axis O
, O
normal O
intervals O
. O
 
No O
ST O
changes O
or O
TWIs O
compared O
to O
prior O
in O
April I-DATE
2064 I-DATE
( O
J O
point O
elevation O
in O
V1-V3 O
in O
both O
) O
. O
 
Cardiac O
Studies O
Echo O
: O
4/25/2064 I-DATE
EF O
65 O
% O
, O
LVH O
, O
mobile O
mass O
( O
27x22mm O
) O
in O
RA O
, O
small O
pericardial O
effusion O
. O
 
Radiology O
CXR O
July I-DATE
27 O
, O
2064 I-DATE
IMPRESSION O
: O
Dual O
lumen O
dialysis O
catheter O
from O
the O
left O
jugular O
region O
to O
the O
right O
atrium O
without O
pneumothorax O
, O
hematoma O
, O
or O
pleural O
effusion O
. O
 
No O
new O
or O
enlarging O
infiltrates O
or O
masses O
. O
 
Slight O
fullness O
in O
the O
region O
of I-DATE
the O
right O
thyroid O
gland O
. O
 
Assessment O
and O
Plan O
: O
59 I-AGE
yo O
Kazakhstani I-LOCATION
male O
, O
with O
HTN O
, O
DM O
, O
and O
ESRD O
on O
HD O
, O
and O
h/o O
access O
issues O
( O
multiple O
thromboses O
, O
stenoses O
requiring O
frequent O
revisions O
) O
and O
admitted O
with O
clotted O
left O
AVF O
for O
revision/thrombectomy O
in O
the O
OR O
. O
 
1 O
. O
 
Access O
: O
clotted O
L O
AVF O
, O
functional O
left O
IJ O
tunneled O
cath O
. O
 
a O
. O
 
On O
waiting O
list O
with O
Dr. O
Jordon I-NAME
for O
procedure O
tomorrow O
i. O
NPO O
p O
MN O
ii O
. O
 
Hold O
coumadin O
b. O
IV O
access O
for O
R O
arm O
. O
 
2 O
. O
 
ESRD O
on O
HD O
a O
. O
 
Patient O
for O
dialysis O
on O
Monday O
, O
if O
still O
inpatient O
. O
 
b. O
Contine O
nephrocaps O
, O
renagel O
, O
CaCarbonate O
, O
3 O
. O
 
DM O
: O
Pt O
reports O
well-controlled O
, O
rarely O
c O
FS O
> O
200 O
a. O
FS O
qam O
, O
qpm O
before O
breakfast O
and O
dinner O
; O
reg O
ins O
sliding O
scale O
b. O
Diabetic O
diet O
4 O
. O
 
HTN O
a O
. O
 
Continue O
outpatient O
regimen O
of I-DATE
norvasc O
and O
diovan O
b O
. O
 
Note O
: O
these O
meds O
are O
held O
on O
dialysis O
days O
( O
MWF O
) O
5. O
h/o O
R O
atrial O
clot O
a. O
INR O
goal O
1.8-2.5 O
b O
. O
 
Consider O
repeat O
echo O
, O
to O
evaluate O
clot O
stabilization O
and O
to O
better O
plan O
anticoagulation O
regimen O
c. O
Follow O
coags O
6 O
. O
 
Elevated O
K O
to O
5.8 O
5.0 O
on O
7/27 I-DATE
. O
 
a O
. O
 
Check O
pm O
labs O
, O
assess O
need O
for O
kayexalate O
. O
 
7 O
. O
 
Low O
Hct O
( O
lowest O
since O
1/64 I-DATE
) O
a O
. O
 
Anemia O
panel O
8 O
. O
 
Prophylaxis O
a. O
Nexium O
, O
on O
coumadin O
tx O
( O
though O
held O
tonight O
) O
9 O
. O
 
Code O
status O
: O
full O
code O
Ursula I-NAME
Quiles I-NAME
, O
MD O
Team O
2 O
intern I-PROFESSION
# O
50684 I-CONTACT
 
Record O
date O
: O
2059-06-19 I-DATE
PROMPTCARE I-LOCATION
INTERNAL O
MEDICINE O
ASSOCIATES O
Rutledge O
, O
Eva I-NAME
29195561 I-ID
6-19-59 I-DATE
HPI O
: O
This O
is O
a O
regularly O
scheduled O
visit O
for O
this O
Eva I-NAME
Ruledge I-NAME
a O
44-year O
old O
woman O
with O
a O
history O
of O
hypertension O
and O
borderline O
obesity O
. O
 
She O
was O
last O
here O
in O
February I-DATE
with O
no O
complaints O
, O
but O
did O
have O
an O
elevated O
creatinine O
for O
which O
she O
was O
referred O
to O
the O
Internal O
Medicine O
for O
further O
evaluation O
. O
 
The O
patient O
did O
not O
, O
however O
, O
present O
to O
the O
Internal O
Medicine O
as O
planned O
. O
 
She O
states O
that O
she O
has O
been O
`` O
too O
busy O
. O
'' O
 
Her O
only O
complaint O
today O
is O
of O
some O
right O
leg O
pain O
, O
which O
she O
says O
is O
chronic O
and O
which O
is O
relieved O
to O
some O
extent O
by O
acetaminophen O
. O
 
Eva I-NAME
continues O
to O
take O
Procardia O
XL O
30 O
mg. O
PO O
q.day O
. O
 
A O
noted O
in O
her O
ambulatory O
record O
, O
the O
Procardia O
is O
prescribed O
as O
a O
b.i.d O
. O
 
drug O
, O
however O
, O
Eva I-NAME
believes O
it O
gives O
her O
headaches O
and O
refuses O
to O
take O
it O
other O
than O
on O
an O
almost O
p.r.n O
. O
 
basis O
. O
 
Review O
of O
systems O
is O
essentially O
normal O
. O
 
Specifically O
, O
she O
denies O
any O
headaches O
, O
any O
chest O
pain O
, O
any O
shortness O
of O
breath O
. O
 
She O
also O
denies O
any O
symptoms O
or O
signs O
referable O
to O
her O
urinary O
tract O
. O
 
She O
has O
no O
history O
of O
dysuria O
, O
of O
frequent O
urinary O
tract O
infection O
, O
or O
of O
hematuria O
. O
 
Physical O
Examination O
: O
She O
is O
robust O
appearing O
. O
 
Vital O
signs O
are O
significant O
for O
a O
blood O
pressure O
of O
140/100 O
. O
 
HEENT O
exam O
is O
unremarkable O
. O
 
Lungs O
are O
clear O
. O
 
Cardiac O
exam O
reveals O
a O
regular O
rate O
and O
rhythm O
, O
a O
normal O
S1 O
, O
S2 O
. O
 
No O
S3 O
is O
appreciated O
. O
 
There O
are O
no O
murmurs O
or O
rubs O
. O
 
Abdomen O
is O
slightly O
obese O
, O
nontender O
, O
and O
with O
normal O
bowel O
sounds O
. O
 
No O
masses O
are O
appreciated O
. O
 
Lower O
extremities O
are O
without O
edema O
and O
joint O
exam O
does O
not O
suggest O
effusion O
or O
limitation O
of O
her O
range O
of O
motion O
. O
 
Indeed O
, O
exam O
of O
her O
legs O
is O
entirely O
unremarkable O
. O
 
Laboratory O
: O
Will O
include O
a O
repeat O
creatinine O
, O
a O
urinalysis O
and O
urine O
sediment O
and O
a O
urine O
creatinine O
. O
 
Assessment O
and O
Plan O
: O
1 O
. O
 
Hypertension O
: O
Eva I-NAME
has O
had O
persistently O
elevated O
blood O
pressure O
on O
her O
Procardia O
. O
 
I O
have O
asked O
her O
to O
stop O
taking O
Procardia O
, O
which O
she O
blames O
for O
headaches O
and O
to O
begin O
taking O
taking O
atenolol O
, O
beginning O
at O
50 O
mg. O
PO O
q.day O
. O
 
I O
will O
see O
her O
in O
a O
few O
days O
in O
order O
to O
make O
sure O
that O
she O
is O
not O
having O
any O
difficulties O
with O
this O
drug O
and O
also O
to O
check O
her O
blood O
pressure O
once O
again O
. O
 
2 O
. O
 
Right O
leg O
pain O
: O
This O
would O
appear O
to O
be O
chronic O
and O
may O
well O
be O
related O
to O
her O
work O
, O
which O
requires O
her O
to O
scuttle O
throughout O
the O
hospital O
at O
fairly O
high O
speed O
( O
She O
is O
a O
Pulping I-PROFESSION
Control I-PROFESSION
Operator I-PROFESSION
. O
) O
 
I O
have O
asked O
her O
to O
continue O
taking O
Tylenol O
and O
we O
will O
re-evaluate O
her O
need O
for O
more O
powerful O
agents O
, O
such O
as O
nonsteroidals O
if O
the O
need O
arises O
. O
 
PROMPTCARE I-LOCATION
INTERNAL O
MEDICINE O
ASSOCIATES O
Rutledge O
, O
Eva I-NAME
Page O
2 O
29195561 I-ID
6-19-59 I-DATE
3 O
. O
 
Elevated O
creatinine O
: O
Unfortunately O
, O
Eva I-NAME
has O
not O
kept O
her O
Renal O
appointment O
. O
 
In O
order O
to O
prevent O
this O
from O
recurring O
a O
third O
time O
, O
I O
have O
called O
and O
made O
an O
appointment O
for O
her O
with O
Dr. O
Eileen I-NAME
Xayavong I-NAME
. O
 
She O
is O
to O
see O
him O
on O
the O
29th I-DATE
of O
this O
month O
at O
1:00 O
p.m. O
and O
I O
have O
also O
left O
a O
message O
on O
his O
E O
mail O
mentioning O
Eva I-NAME
to O
him O
. O
 
Hopefully O
, O
he O
can O
help O
ultrasound O
identify O
the O
etiology O
of O
this O
elevated O
creatinine O
before O
there O
is O
further O
loss O
of O
her O
kidney O
function O
. O
 
4 O
. O
 
Health O
Maintenance O
: O
The O
patient O
was O
scheduled O
to O
have O
a O
Pap O
smear O
today O
, O
but O
again O
was O
`` O
too O
busy O
to O
stay O
that O
long O
. O
'' O
 
She O
is O
to O
see O
me O
again O
shortly O
, O
and O
a O
Pap O
smear O
will O
be O
done O
at O
that O
time O
. O
 
Her O
February I-DATE
mammogram O
was O
essentially O
not O
suggestive O
of O
malignancy O
and O
will O
not O
be O
repeated O
until O
next O
year O
. O
 
_________________________ O
Ulysses I-NAME
Quijano I-NAME
, O
M.D O
. O
 
TD O
: O
PX:4740 O
DD:6-20-59 O
DT:6-19-59 O
DV:6-19-59 O
* O
* O
* O
* O
* O
* O
* O
* O
Approved O
but O
not O
reviewed O
by O
Attending O
Provider O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2066-10-08 I-DATE
Patient O
Name O
: O
RUTLEDGE O
, O
EVA O
[ O
MRN O
: O
37947241ZGJ I-ID
] O
Date O
of O
Visit O
: O
10/08/2066 I-DATE
PROMPTCAREIMA O
Clinic O
Note O
Mrs. O
Rutledge I-NAME
is O
a O
former O
patient O
of O
Dr. O
Xia I-NAME
's O
who O
comes O
in O
today O
to O
establish O
a O
new O
PCP O
and I-PROFESSION
for O
follow-up O
of O
her O
hypertension O
, O
diabetes O
, O
chronic O
renal O
insufficiency O
( O
baseline O
creatinine O
2.2 O
) O
, O
and I-PROFESSION
GERD O
. O
 
She O
is O
currently O
on O
procardia O
xl O
, O
losartan O
, O
and I-PROFESSION
atenolol O
for O
her O
hypertension O
. O
 
She O
takes O
a O
baby O
aspirin O
qd O
for O
cardiac O
protection O
. O
 
Her O
diabetes O
is O
controlled O
by O
diet O
alone O
, O
and I-PROFESSION
her O
GERD O
by O
zantac O
150 O
qd O
or O
bid O
prn O
. O
 
Her O
last O
HbA1C O
was O
6.9 O
, O
with O
a O
malb/cr O
ratio O
of O
222.2 O
and I-PROFESSION
trace O
protein O
on O
U/A O
. O
 
She O
has O
had O
a O
prior O
cardiac O
work-up O
for O
atypical O
chest O
pain O
with O
a O
negative O
ETT/SPECT O
in O
2062 I-DATE
and I-PROFESSION
a O
negative O
ETT O
in O
2064 I-DATE
. O
 
An O
echo O
in O
2062 I-DATE
showed O
an O
EF O
of O
65 O
% O
with O
no O
valvular O
abnormalities O
. O
 
She O
is O
currently O
well O
with O
no O
complaints O
. O
 
She O
is O
being O
followed O
in O
opthalmology O
for O
possible O
glaucoma O
. O
 
She O
does O
not O
check O
her O
blood O
sugars O
at O
home O
, O
although O
she O
has O
a O
glucometer O
. O
 
When O
asked O
if O
her O
sugars O
are O
ever O
low O
, O
she O
states O
that O
she O
has O
the O
same O
symptoms O
with O
hypoglycemia O
that O
she O
does O
with O
hyperglycemia O
: O
dizziness O
and I-PROFESSION
hot O
flashes O
. O
 
She O
's O
not O
had O
this O
recently O
. O
 
She O
also O
does O
not O
check O
her O
BP O
at O
home O
. O
 
She O
denies O
any O
numbness O
or O
tingling O
in O
her O
fingers O
, O
or O
any O
chest O
pain O
. O
 
She O
did O
pull O
a O
muscle O
in O
her O
shoulder O
last O
night O
and I-PROFESSION
still O
feels O
tender O
in O
that O
area O
. O
 
She O
follows O
a O
diabetic O
diet O
( O
avoids O
sweets O
) O
, O
gets O
no O
regular O
exercise O
, O
but O
works O
in O
Electrical I-PROFESSION
and I-PROFESSION
Avionics I-PROFESSION
Mechanics I-PROFESSION
so O
does O
have O
physical O
activity O
during O
the O
day O
. O
 
PSHx O
: O
none O
PGynHx O
: O
G7 O
P4 O
SAB1 O
TAB2 O
, O
still O
menstruating O
q O
month O
, O
no O
hot O
flashes O
, O
heavy O
periods O
but O
no O
clots O
; O
LMP O
10/01/66 I-DATE
Allergies O
: O
NKAD O
Habits O
: O
never O
smoked O
, O
very O
rare O
EtOH O
, O
no O
illicit O
drugs O
Medications O
: O
ASA O
81MG O
PO O
QD O
ATENOLOL O
100MG O
PO O
QD O
( O
she O
has O
run O
out O
of O
this O
and I-PROFESSION
did O
not O
take O
it O
today O
) O
PROCARDIA O
XL O
30MG O
PO O
QD O
RANITIDINE O
HCL O
150MG O
PO O
QD O
LOSARTAN O
50MG O
PO O
2 O
qd O
Physical O
Exam O
================ O
Vital O
signs O
================ O
Blood O
Pressure O
: O
-- O
136/76 O
Pulse O
: O
-- O
76 O
Weight O
: O
-- O
139 O
[ O
Pounds O
] O
General O
: O
no O
acute O
distress O
HEENT O
: O
PERLA O
, O
anicteric O
, O
O/P O
clear O
Neck O
: O
no O
thyromegaly O
or O
LAN O
; O
no O
carotid O
bruits O
Chest O
: O
lungs O
are O
clear O
to O
auscultation O
bilaterally O
with O
no O
crackles O
Heart O
: O
regular O
rate O
and I-PROFESSION
rhythm O
, O
S1 O
and I-PROFESSION
S2 O
normal O
, O
no O
m/g/r O
Abd O
: O
soft O
, O
NT/ND O
. O
 
+BS O
. O
 
No O
HSM O
or O
masses O
Pelvic O
: O
Pap O
done O
, O
with O
normal O
vaginal O
mucosa O
and I-PROFESSION
cervix O
Ext O
: O
no O
edema O
, O
peripheral O
pulses O
present O
and I-PROFESSION
feet O
without O
lesions O
. O
 
Assessment O
: O
51 I-AGE
yo O
woman O
with O
diabetes O
, O
hypertension O
, O
CRI O
from O
hypertension/diabetic O
nephropathy O
likely O
. O
 
Current O
Plan O
: O
1 O
. O
 
Diabetes O
. O
 
Checking O
A1C O
off O
medication O
. O
 
Would O
like O
to O
have O
patient O
check O
FS O
when O
she O
's O
feeling O
ill O
or O
if O
A1C O
is O
elevated O
. O
 
Will O
refer O
to O
NP O
for O
review O
glucometer O
use O
, O
diabetic O
diet O
. O
 
She O
has O
been O
tried O
on O
glucotrol O
XL O
in O
the O
past O
and I-PROFESSION
was O
hypoglycemia O
. O
 
This O
is O
also O
probably O
not O
a O
good O
choice O
due O
to O
her O
renal O
insufficiency O
. O
 
May O
try O
glyburide O
if O
A1C O
elevated O
. O
 
Being O
followed O
by O
opthalmology O
with O
upcoming O
appt O
. O
 
Podiatry O
referral O
deferred O
. O
 
Consider O
repeat O
referral O
to O
nutrition O
. O
 
Lipids O
very O
good O
( O
LDL O
82 O
) O
last O
check O
off O
medication O
. O
 
2 O
. O
 
Hypertension O
. O
 
BP O
borderline O
elevated O
today O
, O
but O
off O
atenolol O
. O
 
HR O
also O
up O
. O
 
Refilled O
all O
meds O
; O
will O
ask O
NP O
to O
check O
her O
pressure O
at O
next O
visit O
. O
 
Will O
continue O
qd O
ASA O
for O
CAD/stroke O
prevention O
. O
 
3 O
. O
 
GERD O
. O
 
Continue O
zantac O
bid O
as O
needed O
. O
 
Also O
recommended O
that O
patient O
start O
using O
Tums O
for O
calcium O
supplementation O
and I-PROFESSION
relief O
of O
intermittent O
dyspepsia O
. O
 
She O
will O
try O
this O
and I-PROFESSION
get O
back O
to O
me O
about O
the O
effect O
. O
 
4 O
. O
 
Chronic O
renal O
insufficiency O
. O
 
Will O
get O
24-hour O
urine O
to O
assess O
creatinine O
clearance O
and I-PROFESSION
urine O
protein O
. O
 
Checking O
chem O
7 O
today O
for O
K O
and I-PROFESSION
Creatinine O
. O
 
5 O
. O
 
Health O
maintenance O
. O
 
Patient O
due O
to O
dT O
shot O
, O
requested O
today O
. O
 
Normal O
mammogram O
in O
5/66 I-DATE
. O
 
Stool O
guaiac O
and I-PROFESSION
flex O
sig O
can O
be O
done O
at O
next O
appt O
; O
will O
follow-up O
Pap O
. O
 
______________________________ O
Xena I-NAME
Danielle I-NAME
Elmore I-NAME
, O
M.D O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
51 I-AGE
yo O
Puerto I-LOCATION
Rican I-LOCATION
woman O
with O
dm O
, O
htn O
, O
cri O
. O
 
Cre O
last O
checked O
2.2 O
. O
 
On O
procadia O
, O
losartan O
, O
atenolol O
. O
 
Ran O
out O
of O
atenolol O
. O
 
Does O
not O
check O
blood O
sugars O
. O
 
No O
neuropathy O
. O
 
She O
is O
active O
through O
her O
job O
( O
Electrical I-PROFESSION
and I-PROFESSION
Avionics I-PROFESSION
Mechanics I-PROFESSION
Technician I-PROFESSION
) O
. O
 
ETT O
was O
negative O
10/64 I-DATE
. O
 
136/76 O
pulse O
76 O
Plan O
: O
currently O
, O
on O
diet O
control O
. O
 
Last O
A1c O
6.9 O
% O
. O
 
Refilled O
Meds O
. O
 
Pap O
done O
. O
 
______________________________ O
Xen I-NAME
Chris I-NAME
Emmons I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2069-11-18 I-DATE
HPI O
54 I-AGE
yo O
F O
with O
h/o O
CRI O
, O
DM O
on O
insulin O
, O
HTN O
, O
obesity O
, O
GERD O
, O
glaucoma O
, O
anemia O
, O
p/f O
for O
f/u O
. O
 
She O
is O
generally O
doing O
well O
and O
has O
no O
complaints O
. O
 
She O
lost O
her O
glucometer O
and O
hasnt O
check O
her O
BS O
for O
2 O
weeks O
. O
 
Last O
A1C O
after O
starting O
insulin O
down O
to O
7.5 O
, O
only O
on O
5 O
glyburide O
bc O
of O
BS O
lows O
. O
 
For O
her O
CRI O
, O
which O
is O
multifactorial O
( O
DM O
, O
HTN O
and O
L O
renal O
artery O
stenosis O
) O
she O
sees O
Dr O
Uriarte I-NAME
in O
Internal O
Medicine O
, O
saw O
him O
yesterday O
, O
Cr O
stable O
and O
PTH O
up O
a O
bit O
to O
226 O
. O
 
================ O
Problems O
================ O
ESSENTIAL O
HYPERTENSION O
MODERATE O
OBESITY O
Diabetes O
mellitus O
Chronic O
renal O
dysfunction O
cre O
cl O
estimate O
23 O
in O
12/67 I-DATE
Glaucoma O
Lactose O
intolerance O
Atypical O
chest O
pain O
negative O
ETT O
4/8/67 I-DATE
, O
negative O
ETT O
2064 I-DATE
, O
ETT O
w/ O
SPECT O
2062 I-DATE
Iron-deficiency O
anemia O
Gastritis O
EGD O
9/67 I-DATE
, O
also O
GERD O
symptoms O
================ O
Medications O
================ O
Asa O
81 O
MG O
PO O
QD O
Procardia O
XL O
60 O
MG O
( O
60MG O
TABLET O
take O
1 O
) O
PO O
QD O
, O
may O
use O
adalat O
instead O
Ranitidine O
HCL O
150 O
MG O
PO O
QD O
Losartan O
100 O
MG O
PO O
QD O
Glyburide O
5MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Ferrous O
GLUCONATE O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
, O
Take O
one O
tablet O
with O
every O
meal O
for O
iron O
deficiency O
Hydrochlorothiazide O
25MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
, O
Take O
every O
day O
for O
blood O
pressure O
Toprol O
XL O
( O
METOPROLOL O
SUCCINATE O
EXTENDED O
... O
50MG O
TABLET O
CR O
24HR O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Calcitriol O
0.25MCG O
CAPSULE O
take O
1 O
Capsule O
( O
s O
) O
PO O
QD O
Zocor O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Lantus O
( O
INSULIN O
GLARGINE O
) O
16 O
UNITS O
SC O
QHS O
, O
dose O
increase O
Timolol O
XE O
0.25 O
% O
1 O
DROP O
OU O
QD O
, O
must O
keep O
appt O
Xalatan O
( O
LATANOPROST O
) O
1 O
DROP O
OU O
QPM O
, O
must O
keep O
scheduled O
appt O
ALLERGIES O
NKDA O
PHYSICAL O
EXAM O
VS O
: O
BP O
110/60 O
Cor O
: O
RRR O
, O
nl O
S1S2 O
, O
1/6 O
sys O
M O
, O
no O
rubs O
, O
gallops O
Lungs O
: O
CTA O
b/l O
, O
no O
rales O
, O
rhonchi O
or O
wheezes O
Abd O
: O
Soft O
, O
NTND O
. O
 
Normal O
active O
bowel O
sounds O
. O
 
No O
c/c/e O
A/P O
54 I-AGE
yo O
F O
with O
h/o O
CRI O
, O
DM O
, O
HTN O
, O
obesity O
, O
GERD O
, O
glaucoma O
, O
anemia O
for O
f/u O
. O
 
1 O
. O
 
DM O
: O
Last O
A1C O
7.5 O
from O
9.3 O
after O
starting O
insulin O
, O
still O
on O
Lantus O
16 O
and O
now O
Glyburide O
5 O
qam O
. O
 
She O
sees O
Optho O
2x/yr O
as O
she O
has O
glaucoma O
, O
saw O
them O
2mos O
ago O
. O
 
-- O
Prescribed O
glucometer O
-- O
Cont O
current O
regimen O
-- O
check O
A1C O
( O
pt O
left O
without O
getting O
labs O
, O
will O
get O
at O
next O
visit O
) O
-- O
2/69 I-DATE
urine O
mcalb/cr O
200 O
-- O
on O
statin O
2 O
. O
 
CRI O
: O
Multifactorial O
, O
followed O
by O
Dr O
Uriarte I-NAME
. O
 
Last O
Cr O
2.8 O
on O
5/69 I-DATE
. O
 
She O
has O
2ndary O
hyperparathyroidism O
as O
well O
, O
PTH O
yest O
226 O
. O
 
On O
Calcitriol O
. O
 
-- O
Cont O
ARB O
. O
 
-- O
F/u O
with O
Dr O
Uriarte I-NAME
. O
 
3 O
. O
 
Anemia O
, O
h/o O
, O
Fe O
deficiency O
, O
on O
Fe O
supp O
. O
 
Last O
Hct O
36 O
. O
 
4 O
. O
 
H/o O
bowel O
ischemia O
but O
most O
recent O
CT O
wnl O
so O
more O
likely O
it O
was O
an O
infectious O
etiology O
. O
 
5 O
. O
 
HTN O
: O
Cont O
on O
ARB O
, O
Toprol O
, O
Procardia O
, O
HCTZ O
. O
 
Today O
somewhat O
high O
, O
increased O
Procardia O
to O
60 O
qd O
. O
 
On O
ASA O
for O
1ry O
prevention O
of O
CAD O
. O
 
Statin O
. O
 
6.GERD O
: O
Cont O
Zantac O
, O
well O
controlled O
sx O
. O
 
7 O
. O
 
Galucoma O
: O
followed O
by O
Optho O
, O
cont O
eye O
drops O
8 O
. O
 
HM O
: O
-- O
lipids O
8/69much O
improved O
with O
addition O
of O
statin O
TC O
121 O
, O
TG O
309 O
, O
HDL O
28 O
, O
LDL O
31 O
. O
 
Lfts O
ok. O
Will O
check O
again O
in O
Feb I-DATE
-- O
BMD O
10/68 I-DATE
wnl O
-- O
colonoscopy O
2/68 I-DATE
wnl O
-- O
Mammo O
will O
be O
scheduled O
for O
12/69 I-DATE
-- O
PAP O
overdue O
, O
will O
reschedule O
a O
PAP O
appt O
______________________________ O
Quiana I-NAME
Gagnon I-NAME
, O
M.D O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
I O
have O
discussed O
the O
evaluation O
and O
care O
of O
this O
patient O
with O
Dr. O
Gagnon I-NAME
. O
 
______________________________ O
David I-NAME
R. I-NAME
Quintin I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2072-03-13 I-DATE
Patient O
Name O
: O
RUTLEDGE O
, O
EMMA O
[ O
MRN O
: O
37947241ZGJ I-ID
] O
Date O
of O
Visit:3/13/2072 O
HPI O
DM O
, O
CRI O
, O
HTN- O
, O
with O
L5-S1 O
disc O
protrusion O
on O
MRI O
, O
with O
normal O
Ct O
scan O
hip/leg O
56 I-AGE
yo O
F O
with O
h/o O
CRI O
, O
DM O
on O
insulin O
, O
HTN O
, O
obesity O
, O
GERD O
, O
glaucoma O
, O
anemia O
, O
p/f O
for O
f/u O
. O
 
For O
her O
CRI O
, O
which O
is O
multifactorial O
( O
DM O
, O
HTN O
and O
L O
renal O
artery O
stenosis O
) O
she O
sees O
Dr O
Uriarte I-NAME
in O
Internal O
Medicine O
, O
w/ O
an O
appt O
on O
next O
week O
and O
unchanged O
Cr O
4.5 O
She O
had O
an O
AV O
fistula O
placed O
in O
anticipation O
for O
future O
dialysis O
. O
 
In O
March I-DATE
2070 I-DATE
, O
she O
was O
admitted O
for O
for O
ischemia O
colitis O
and O
had O
a O
colonoscopy O
revealing O
this O
. O
 
Underwent O
surgery O
for O
ischemia O
colitis O
in O
April I-DATE
2070 I-DATE
with O
a O
right O
colectomy O
. O
 
She O
had O
a O
mammo O
in O
2/13/2071 I-DATE
wnl O
. O
 
Pap O
9/27/2070 I-DATE
wnl O
. O
 
separated O
from O
husband O
. O
 
Has O
children O
and O
granchildren O
. O
 
Needs O
refills O
of O
losartan O
, O
procardia O
, O
and O
toprol O
XL O
. O
 
Main O
issues O
for O
her O
are O
her O
leg O
pain O
( O
due O
to O
L5-S1 O
disc O
protrusion O
) O
, O
and O
HTN O
which O
is O
elevated O
171/94 O
( O
sec O
to O
leg O
pain O
) O
Denies O
trauma O
, O
fall O
. O
 
Had O
PT O
at O
home O
briefly O
but O
not O
at O
PROMPTCARE I-LOCATION
. O
 
She O
was O
supposed O
to O
have O
had O
an O
appt O
with O
ortho O
spine O
clinic O
per O
discharge O
summary O
, O
but O
she O
said O
they O
did O
not O
call O
her O
. O
 
================ O
Problems O
================ O
ESSENTIAL O
HYPERTENSION O
MODERATE O
OBESITY O
Diabetes O
mellitus O
Chronic O
renal O
dysfunction O
cre O
cl O
estimate O
23 O
in O
12/68 I-DATE
Glaucoma O
Lactose O
intolerance O
Atypical O
chest O
pain O
negative O
ETT O
4/8/67 I-DATE
, O
negative O
ETT O
2064 I-DATE
, O
ETT O
w/ O
SPECT O
2062 I-DATE
Iron-deficiency O
anemia O
Gastritis O
EGD O
9/67 I-DATE
, O
also O
GERD O
symptoms O
================ O
Medications O
================ O
Asa O
81 O
MG O
PO O
QD O
Procardia O
XL O
60 O
MG O
( O
60MG O
TABLET O
take O
1 O
) O
PO O
QD O
, O
may O
use O
adalat O
instead O
Ranitidine O
HCL O
150 O
MG O
PO O
QD O
Losartan O
100 O
MG O
PO O
QD O
Glyburide O
5MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Ferrous O
GLUCONATE O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
, O
Take O
one O
tablet O
with O
every O
meal O
for O
iron O
deficiency O
Hydrochlorothiazide O
25MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
, O
Take O
every O
day O
for O
blood O
pressure O
Toprol O
XL O
( O
METOPROLOL O
SUCCINATE O
EXTENDED O
... O
50MG O
TABLET O
CR O
24HR O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Calcitriol O
0.25MCG O
CAPSULE O
take O
1 O
Capsule O
( O
s O
) O
PO O
QD O
Zocor O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Lantus O
( O
INSULIN O
GLARGINE O
) O
16 O
UNITS O
SC O
QHS O
, O
dose O
increase O
Timolol O
XE O
0.25 O
% O
1 O
DROP O
OU O
QD O
, O
must O
keep O
appt O
Xalatan O
( O
LATANOPROST O
) O
1 O
DROP O
OU O
QPM O
, O
must O
keep O
scheduled O
appt O
ALLERGIES O
NKDA O
PHYSICAL O
EXAM O
Vital O
Signs O
BP O
171/94 O
, O
P O
90 O
, O
Wt O
125 O
lb O
FS O
: O
84 O
postprandial O
HEENT O
: O
op O
clear O
, O
supple O
neck O
, O
no O
thyromegaly O
HEART O
RR O
, O
S1S2 O
LUNGS O
CTA O
no O
r/r/w O
ABD O
: O
+Bs O
, O
soft O
, O
nt O
, O
nd O
LABS O
HGA1C O
A/P O
56 I-AGE
yo O
F O
with O
h/o O
CRI O
, O
DM O
, O
HTN O
, O
obesity O
, O
GERD O
, O
glaucoma O
, O
anemia O
for O
f/u O
s/p O
right O
colectomy O
for O
ischemia O
colitis O
, O
sciatica O
with O
L5-S1 O
disc O
protrusion O
on O
MRI O
3 O
weeks O
ago O
. O
 
1 O
. O
 
DM O
: O
Last O
A1C O
7.5 O
down O
from O
9.3 O
previously O
after O
starting O
insulinTaking O
novulin O
12 O
units O
QAM O
and O
novulog O
4 O
units O
q O
OM O
. O
 
She O
sees O
Optho O
2x/yr O
as O
she O
has O
glaucoma O
w/ O
an O
appt O
3/28/2071 I-DATE
. O
 
missed O
podiatry O
again O
. O
 
-check O
HGA1C O
; O
Cr O
increased O
to O
4.5 O
per O
renal O
and O
has O
app O
with O
renal O
next O
week O
2 O
. O
 
CRI O
: O
Multifactorial O
, O
followed O
by O
Dr O
Uriarte I-NAME
. O
 
Last O
Cr O
2.5 O
on O
4/2070 I-DATE
. O
 
She O
has O
2ndary O
hyperparathyroidism O
as O
well O
, O
On O
Calcitriol O
. O
 
-- O
Cont O
ARB O
. O
 
-- O
F/u O
with O
Dr O
Uriarte I-NAME
. O
 
- O
Cr O
4.5 O
3 O
. O
 
Anemia O
, O
h/o O
, O
Fe O
deficiency O
, O
on O
Fe O
supp O
. O
 
Last O
Hct O
33 O
in O
4/2070 I-DATE
. O
 
4 O
. O
 
H/o O
bowel O
ischemia O
s/p O
colectomy O
f/u O
with O
surgery O
. O
 
5 O
. O
 
HTN O
: O
Cont O
on O
ARB O
, O
Toprol O
, O
Procardia O
. O
 
Increase O
toprol O
XL O
to O
100 O
mg O
poq O
d. O
Cont O
losartan O
100 O
mg O
qd O
, O
procardia O
60 O
mg O
poq O
d. O
Has O
been O
off O
HCTZ O
. O
 
Pulse O
90 O
and O
should O
tolerate O
inc O
toprol O
to O
100 O
6.GERD O
: O
Cont O
Zantac O
, O
well O
controlled O
sx O
. O
 
7 O
. O
 
Glaucoma O
: O
followed O
by O
Optho O
, O
cont O
eye O
drops O
8 O
. O
 
HM O
: O
-- O
lipids O
recheck O
today O
-- O
BMD O
10/68 I-DATE
wnl O
-- O
colonoscopy O
3/2070 I-DATE
c/w O
ischemia O
colitis O
o/w O
unremarkable O
( O
s/p O
surgery O
4/8/2070 I-DATE
) O
-- O
Mammo O
wnl O
2/2071 I-DATE
. O
 
recsched O
next O
visit O
, O
because O
she O
is O
most O
concerned O
with O
her O
leg/hip O
pain O
from O
sciatica O
-- O
PAP O
utd O
Breast O
exam O
done O
. O
 
SBE O
counseled O
. O
 
RTC O
1 O
month O
for O
BP O
check O
; O
f/u O
HGA1C O
______________________________ O
Betty I-NAME
Doris I-NAME
Hanna I-NAME
, O
MD O
 
Record O
date O
: O
2092-09-21 I-DATE
MEDIQUIK I-LOCATION
Cardiovascular O
Division O
CVD O
TR1 O
23 I-LOCATION
Tamworth I-LOCATION
Place I-LOCATION
TRENT O
, O
SHIRLEY I-NAME
Galena I-LOCATION
, O
MN I-LOCATION
64864 I-LOCATION
99210914 I-ID
( O
176 O
) O
232-6146 I-CONTACT
09/21/92 I-DATE
Robert I-NAME
J. I-NAME
Trujillo I-NAME
, O
M.D O
. O
 
Department O
of O
Vascular O
Surgery O
Lenox I-LOCATION
Care I-LOCATION
Center I-LOCATION
21 I-LOCATION
Tamworth I-LOCATION
Place I-LOCATION
Galena I-LOCATION
, O
MN I-LOCATION
64864 I-LOCATION
Dear O
Dr. O
Trujillo I-NAME
: O
Thank O
you O
for O
referring O
Mrs. O
Shirley I-NAME
Trent I-NAME
, O
a O
68-year-old O
lady O
with O
peripheral O
artery O
disease O
, O
on O
whom O
you O
plan O
to O
do O
revascularization O
of O
the O
right O
leg O
. O
 
Her O
history O
is O
well O
known O
to O
you O
but O
I O
will O
repeat O
it O
for O
our O
records O
. O
 
She O
has O
a O
long O
history O
of O
cigarette O
smoking O
with O
a O
3-packet-per-day O
history O
for O
30 O
years O
, O
stopping O
15 O
years O
ago O
. O
 
She O
has O
developed O
claudication O
, O
particularly O
in O
the O
right O
leg O
, O
over O
the O
last O
year O
since O
her O
husband O
died O
, O
which O
has O
all O
the O
typical O
symptoms O
and O
is O
relieved O
by O
rest O
. O
 
This O
seems O
predominantly O
in O
the O
right O
calf O
but O
is O
also O
in O
the O
right O
thigh O
as O
well O
. O
 
She O
had O
segmental O
leg O
pressures O
done O
which O
shows O
some O
mild O
diminution O
in O
the O
left O
leg O
but O
an O
ankle-brachial O
index O
of O
0.65 O
in O
the O
right O
leg O
. O
 
An O
MR O
angiogram O
showed O
stenosis O
, O
although O
I O
do O
not O
have O
the O
full O
report O
on O
this O
as O
yet O
. O
 
She O
has O
intercurrent O
problems O
with O
insulin-dependent O
diabetes O
mellitus O
, O
which O
she O
has O
had O
for O
10 O
years O
. O
 
Her O
other O
cardiac O
risk O
factors O
apart O
from O
cigarette O
smoking O
include O
a O
family O
history O
of O
myocardial O
infarction O
in O
her O
father O
, O
and O
it O
is O
uncertain O
what O
her O
cholesterol O
level O
is O
. O
 
She O
has O
no O
history O
of O
hypertension O
, O
although O
I O
am O
uncertain O
whether O
this O
has O
been O
checked O
in O
the O
past O
. O
 
She O
has O
a O
past O
history O
of O
partial O
gastrectomy O
in O
2059 I-DATE
for O
a O
bleeding O
peptic O
ulcer O
and O
this O
has O
led O
to O
some O
difficulty O
in O
swallowing O
tablets O
and O
keeping O
them O
down O
. O
 
She O
also O
has O
a O
past O
history O
of O
a O
right O
middle O
lobectomy O
in O
2079 I-DATE
for O
adenocarcinoma O
that O
had O
clear O
margins O
and O
did O
not O
require O
further O
adjunctive O
therapy O
. O
 
She O
also O
had O
a O
cholecystectomy O
in O
2079 I-DATE
, O
which O
was O
uneventful O
. O
 
Systems O
review O
reveal O
no O
chest O
discomfort O
, O
dyspnea O
, O
ankle O
edema O
, O
palpitations O
, O
syncope O
, O
cough O
, O
sputum O
, O
hemoptysis O
, O
GI O
bleeding O
, O
weakness O
down O
the O
arms O
, O
face O
, O
or O
legs O
, O
seizures O
or O
visual O
disturbances O
, O
and O
all O
other O
systems O
are O
negative O
. O
 
She O
lives O
alone O
, O
and O
her O
current O
medications O
include O
insulin O
only O
. O
 
She O
has O
no O
allergies O
. O
 
On O
physical O
examination O
, O
she O
is O
alert O
and O
orientated O
without O
any O
signs O
of O
jaundice O
, O
clubbing O
, O
or O
cyanosis O
. O
 
Her O
heart O
rate O
was O
85 O
beats O
per O
minute O
with O
a O
blood O
pressure O
of O
160/85 O
in O
both O
arms O
. O
 
The O
jugular O
venous O
pressure O
was O
not O
elevated O
, O
and O
her O
carotid O
upstrokes O
were O
reduced O
, O
but O
she O
had O
no O
bruits O
audible O
. O
 
Her O
apex O
beat O
was O
not O
palpable O
, O
and O
she O
had O
a O
normal O
first O
and O
second O
heart O
sound O
without O
added O
sounds O
, O
murmurs O
, O
or O
gallops O
. O
 
Her O
chest O
was O
clear O
to O
percussion O
and O
auscultation O
. O
 
She O
had O
no O
hepatosplenomegaly O
and O
no O
abdominal O
masses O
or O
pulsations O
. O
 
She O
had O
the O
scars O
from O
previous O
operations O
present O
. O
 
Her O
femoral O
pulses O
were O
absent O
on O
the O
right O
side O
and O
reduced O
on O
the O
left O
side O
without O
bruits O
. O
 
She O
had O
reduced O
but O
palpable O
dorsalis O
pedis O
and O
posterior O
tibial O
pulses O
on O
the O
left O
leg O
but O
no O
pedal O
pulses O
on O
the O
right O
leg O
. O
 
There O
were O
no O
trophic O
changes O
in O
her O
legs O
. O
 
She O
had O
reduced O
sensation O
to O
pinprick O
in O
both O
feet O
to O
the O
mid O
calf O
level O
in O
a O
stocking O
distribution O
. O
 
Her O
ECG O
showed O
sinus O
rhythm O
without O
abnormalities O
. O
 
Assessment O
: O
This O
lady O
obviously O
has O
severe O
claudication O
and O
requires O
revascularization O
, O
but O
is O
uncertain O
whether O
she O
has O
any O
myocardial O
ischemia O
. O
 
I O
therefore O
think O
a O
stress O
test O
is O
required O
. O
 
She O
also O
has O
difficulty O
in O
swallowing O
medications O
and O
this O
will O
prove O
a O
problem O
for O
the O
long-term O
management O
of O
her O
atherosclerosis O
, O
which O
I O
would O
like O
to O
further O
evaluate O
. O
 
Plan O
: O
I O
therefore O
organized O
a O
dobutamine O
stress O
test O
to O
assess O
for O
myocardial O
ischemia O
and O
cardiovascular O
risk O
. O
 
I O
have O
also O
asked O
her O
to O
start O
on O
a O
small O
dose O
of O
a O
beta-blocker O
for O
reducing O
her O
perioperative O
risk O
as O
well O
as O
treating O
her O
blood O
pressure O
, O
which O
is O
elevated O
. O
 
I O
have O
also O
asked O
her O
to O
have O
a O
fasting O
blood O
lipid O
test O
today O
so O
we O
can O
assess O
her O
cholesterol O
level O
, O
as O
it O
is O
likely O
that O
she O
would O
benefit O
from O
lipid-lowering O
therapy O
. O
 
I O
plan O
to O
evaluate O
all O
these O
in O
approximately O
a O
month O
or O
so O
after O
her O
operation O
so O
that O
we O
can O
manage O
her O
in O
the O
long O
term O
. O
 
I O
will O
let O
you O
know O
the O
results O
of O
her O
stress O
test O
when O
they O
become O
available O
. O
 
Thank O
you O
for O
allowing O
me O
to O
take O
part O
in O
this O
lady O
's O
care O
. O
 
Yours O
sincerely O
, O
Dictated O
By O
: O
James I-NAME
Patel I-NAME
______________________________ O
James I-NAME
Patel I-NAME
, O
MBBS O
, O
PHD O
eScription O
document:8-6022994 O
TFFocus O
CC O
: O
Rose I-NAME
Samuel I-NAME
Isaac-Ly I-NAME
M.D O
. O
 
Internal O
Medicine O
20 I-LOCATION
Tamworth I-LOCATION
Place I-LOCATION
Galena I-LOCATION
, O
MN I-LOCATION
64864 I-LOCATION
DD O
: O
09/21/92 I-DATE
DT O
: O
09/21/92 I-DATE
DV O
: O
09/21/92 I-DATE
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2093-06-12 I-DATE
Dutch I-LOCATION
19 I-LOCATION
Tamworth I-LOCATION
Place I-LOCATION
TRENT O
, O
SHIRLEY I-NAME
Galena I-LOCATION
, O
MN I-LOCATION
64864 I-LOCATION
99210914 I-ID
( O
676 O
) O
312-7662 I-CONTACT
06/12/93 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Trent I-NAME
is O
69 I-AGE
, O
a O
pleasant O
lady O
who O
is O
now O
a O
widow O
well O
known O
to O
me O
for O
her O
insulin-dependent O
diabetes O
and O
her O
poor O
compliance O
with O
treatment O
. O
 
In O
the O
past O
, O
she O
also O
has O
experienced O
upper O
GI O
bleeding O
due O
to O
a O
peptic O
ulcer O
and O
has O
undergone O
cholecystectomy O
as O
well O
as O
lobectomy O
for O
carcinoma O
of O
the O
lung O
. O
 
CURRENT O
MEDICATIONS O
: O
Humulin O
N O
25 O
units O
in O
the O
morning O
. O
 
She O
is O
supposed O
to O
be O
using O
28 O
units O
in O
the O
morning O
and O
8 O
units O
in O
the O
evening O
depending O
on O
blood O
sugars O
. O
 
She O
also O
has O
been O
prescribed O
an O
ACE O
inhibitor O
and O
a O
beta O
blocker O
, O
which O
she O
has O
neglected O
to O
take O
. O
 
Her O
last O
visit O
to O
the O
practice O
was O
in O
September I-DATE
of O
last O
year O
. O
 
At O
the O
time O
of O
her O
last O
visit O
, O
I O
referred O
to O
vascular O
surgery O
because O
of O
claudication O
of O
the O
right O
leg O
. O
 
She O
underwent O
a O
femoral O
public O
TL O
bypass O
in O
December I-DATE
and O
did O
well O
postoperatively O
. O
 
She O
was O
discharged O
on O
simvastatin O
, O
Plavix O
, O
as O
well O
as O
atenolol O
and O
lisinopril O
. O
 
She O
abandoned O
all O
tablets O
on O
her O
own O
and O
did O
not O
come O
for O
her O
followup O
appointment O
with O
us O
. O
 
Today O
, O
she O
tells O
me O
that O
claudication O
in O
the O
right O
leg O
has O
disappeared O
completely O
but O
during O
the O
past O
two O
months O
, O
she O
has O
begun O
noticing O
pain O
in O
the O
left O
leg O
after O
10-15 O
minutes O
of O
walking O
which O
forces O
her O
to O
stop O
. O
 
An O
arteriogram O
carried O
out O
in O
September I-DATE
of O
last O
year O
showed O
mild O
diffuse O
disease O
involving O
the O
left O
common O
iliac O
, O
external O
iliac O
, O
and O
common O
femoral O
arteries O
. O
 
She O
did O
not O
have O
symptoms O
on O
the O
left O
side O
at O
the O
time O
. O
 
The O
patient O
denies O
chest O
pain O
, O
palpitation O
, O
shortness O
of O
breath O
, O
orthopnea O
, O
and O
ankle O
edema O
. O
 
Prior O
to O
her O
bypass O
surgery O
on O
the O
right O
leg O
, O
she O
underwent O
a O
Persantine O
MIBI O
which O
showed O
only O
1 O
mm O
ST O
depressions O
and O
was O
considered O
not O
diagnostic O
. O
 
Ms. O
Trent I-NAME
has O
experienced O
some O
polyuria O
and O
mild O
polydipsia O
and O
has O
two O
times O
nocturia O
. O
 
She O
denies O
dysuria O
. O
 
The O
last O
hemoglobin O
A1c O
was O
8.4 O
in O
September I-DATE
of O
last O
year O
. O
 
At O
that O
time O
, O
her O
serum O
cholesterol O
was O
238 O
, O
HDL O
was O
59 O
, O
and O
triglycerides O
were O
263 O
. O
 
PHYSICAL O
EXAMINATION O
: O
Today O
, O
she O
is O
pleasant O
and O
talkative O
. O
 
Her O
weight O
is O
127-1/2 O
pounds O
, O
blood O
pressure O
180/76 O
, O
and O
heart O
rate O
is O
96 O
. O
 
Oxygen O
saturation O
100 O
% O
on O
room O
air O
. O
 
Random O
fingerstick O
glucose O
is O
202 O
. O
 
Extraocular O
movements O
are O
full O
. O
 
The O
thyroid O
is O
not O
enlarged O
. O
 
The O
neck O
veins O
are O
flat O
. O
 
The O
chest O
is O
clear O
to O
auscultation O
. O
 
The O
breasts O
are O
free O
of O
masses O
. O
 
There O
is O
no O
axillary O
lymphadenopathy O
. O
 
The O
heart O
sounds O
are O
regular O
. O
 
There O
are O
no O
rubs O
or O
gallops O
. O
 
There O
is O
a O
midline O
abdominal O
scar O
which O
corresponds O
to O
an O
old O
operation O
for O
peptic O
ulcer O
. O
 
There O
is O
also O
a O
right O
upper O
quadrant O
cholecystectomy O
scar O
which O
is O
surrounded O
by O
a O
mass O
, O
which O
has O
been O
present O
in O
the O
past O
that O
probably O
represents O
fibrosis O
under O
the O
scar O
. O
 
No O
other O
masses O
are O
palpable O
. O
 
The O
lower O
extremities O
are O
free O
of O
edema O
. O
 
I O
do O
not O
palpate O
the O
pulse O
except O
in O
the O
dorsalis O
pedis O
area O
of O
the O
right O
side O
, O
but O
there O
are O
no O
trophic O
changes O
and O
the O
skin O
is O
warm O
and O
pink O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
A O
69-year-old O
widow O
lady O
with O
moderately O
controlled O
insulin-dependent O
diabetes O
and O
hyperlipidemia O
. O
 
She O
has O
not O
been O
compliant O
with O
her O
medications O
. O
 
She O
has O
suffered O
from O
peripheral O
vascular O
disease O
and O
claudication O
in O
the O
past O
underwent O
a O
bypass O
surgery O
on O
the O
right O
lower O
extremity O
in O
October I-DATE
of O
last O
year O
. O
 
She O
now O
has O
mild O
symptoms O
of O
claudication O
on O
the O
left O
. O
 
She O
continues O
to O
consume O
three O
or O
four O
beers O
a O
day O
. O
 
The O
relationship O
to O
her O
vascular O
atherosclerosis O
is O
not O
clear O
. O
 
Liver O
function O
in O
the O
past O
has O
been O
normal O
and O
she O
does O
not O
have O
significant O
proteinuria O
. O
 
Today O
, O
I O
have O
repeated O
her O
hemoglobin O
A1c O
, O
comprehensive O
panel O
, O
CBC O
, O
and O
urine O
analysis O
. O
 
I O
have O
spent O
20 O
minutes O
speaking O
to O
her O
and O
to O
her O
daughter O
concerning O
the O
importance O
of O
compliance O
and O
explaining O
the O
rationale O
for O
the O
lisinopril O
. O
 
I O
have O
prescribed O
Lipitor O
10 O
mg O
p.o O
. O
 
q.d. O
, O
lisinopril O
10 O
mg O
p.o O
. O
 
q.d. O
, O
and O
enteric-coated O
aspirin O
81 O
mg O
p.o O
. O
 
q.d O
. O
 
She O
is O
also O
to O
take O
a O
multivitamin O
q.d O
. O
 
I O
will O
see O
her O
again O
after O
the O
above O
test O
results O
to O
decide O
whether O
we O
need O
to O
adjust O
her O
medications O
. O
 
I O
have O
increased O
her O
insulin O
to O
28 O
units O
every O
morning O
. O
 
She O
will O
come O
to O
see O
the O
nurse O
practitioner O
in O
three O
days O
' O
time O
to O
learn O
how O
to O
use O
a O
glucometer O
and O
to O
review O
diabetes O
care O
. O
 
An O
electrocardiogram O
will O
be O
obtained O
and O
a O
consultation O
will O
be O
arranged O
with O
vascular O
surgery O
concerning O
the O
claudication O
now O
on O
the O
left O
leg O
. O
 
______________________________ O
Rose I-NAME
Irvin-Ly I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Rose I-NAME
Irvin-Ly I-NAME
eScription O
document:0-2524422 O
EMSSten O
Tel O
DD O
: O
06/12/93 I-DATE
DT O
: O
06/13/93 I-DATE
DV O
: O
06/12/93 I-DATE
 
Record O
date O
: O
2093-11-24 I-DATE
History O
of O
Present O
Illness O
Asked O
by O
Dr. O
Trujillo I-NAME
to O
comment O
on O
diabetes O
management O
for O
this O
patient O
. O
 
Hx O
from O
chart O
as O
pt O
is O
dutch I-LOCATION
speaking O
only O
. O
 
Mrs. O
Trent I-NAME
is O
a O
pleasant O
69 I-AGE
y/o O
woman O
with O
type O
2 O
DM O
insulin O
treated O
. O
 
She O
has O
acknowledged O
difficulty O
following O
her O
regimen O
, O
per O
notes O
should O
be O
taking O
insulin O
BID O
but O
only O
takes O
it O
in O
am O
- O
prescribed O
dose O
NPH O
30 O
in O
am O
and O
8 O
at O
HS O
. O
 
Reports O
BG O
at O
home O
near O
150 O
. O
 
She O
is O
s/p O
L O
SFA O
and O
doing O
well O
from O
that O
standopoint O
, O
however O
developed O
N O
& O
V O
today O
and O
required O
NG O
tube O
placement O
, O
now O
better O
but O
remaoins O
NPO O
. O
 
She O
has O
been O
on O
NPH O
30 O
in O
am O
and O
BG O
's O
have O
been O
126- O
low O
200 O
's O
. O
 
Past O
Medical O
History O
Hypertension O
Hyperlipidemia O
PVD O
- O
s/p O
R O
fem O
pop O
PUD O
/ O
GERD O
kidney O
stones O
lung O
cancer O
- O
lobectomy O
Medications O
Text O
Significant O
meds O
: O
zocor O
; O
lisinopril O
; O
pspcid O
; O
lopresor O
; O
hydralazine O
; O
pavix O
; O
reglan O
currently O
on O
D5 O
1/2NS O
at O
100 O
ml/hr O
Family O
History O
NC O
Social O
History O
Smoking O
none O
EtOH O
1-2 O
beers O
daily O
Other O
widowed O
recently O
Review O
of O
Systems O
NA O
Physical O
Exam O
VS O
98.4 O
; O
126/58 O
; O
94 O
% O
sat O
on O
RA O
; O
72 O
General O
Appearance O
Well/ O
post O
op O
HEENT O
MM O
moist O
, O
sclera O
anicteric O
Neck O
no O
thyromgally O
, O
trachea O
midline O
Chest O
Resp O
unlabored O
Cor/Cardiac O
RRR O
Edema O
: O
none O
Abdomen O
Soft O
Extremity O
Skin O
intact O
, O
no O
deformity O
Musc O
Skel O
Nl O
build O
, O
no O
joint O
deformity O
Neurological O
A/O O
Sensory O
exam O
: O
diminished O
to O
touch O
Skin O
Intact O
No O
acanthosis O
nigracans O
Laboratory O
Data O
A1c O
: O
pend O
Creat O
: O
0.7 O
Assessment O
Type O
2 O
DM O
- O
uncontrolled O
in O
the O
post O
operative O
period O
requring O
IV O
insulin O
for O
control O
. O
 
Complicated O
by O
PVD O
, O
neuropathy O
, O
retinopathy O
and O
nephropathy O
. O
 
Glycemic O
control O
in O
the O
post O
operative O
period O
is O
essential O
to O
good O
wound O
healing O
and O
minimizing O
risk O
of O
infections O
. O
 
Our O
target O
is O
to O
maintain O
BG O
under O
150 O
. O
 
Recommendation O
- O
While O
NPO O
please O
use O
1/2 O
day O
time O
NPH O
but O
her O
usual O
prescribed O
bed O
time O
dose O
- O
for O
now O
15 O
nph O
in O
am O
and O
8 O
at O
hs O
- O
Once O
eating O
can O
resume O
usual O
doses O
, O
may O
need O
addition O
of O
rapid O
action O
insulin O
with O
meals O
as O
well O
Thank O
you O
, O
please O
page O
Internal O
Medicine O
# O
42721 I-CONTACT
with O
any O
questions O
. O
 
Wendy I-NAME
Kiefer I-NAME
MD O
 
Record O
date O
: O
2094-12-08 I-DATE
Neurology O
Resident O
ED O
Consult O
Note O
Patient O
Name O
: O
Trent O
, O
Shirley I-NAME
MRN O
: O
99210914 I-ID
Date O
: O
12/08/94 I-DATE
PCP O
: O
Dr. O
Rose I-NAME
Irvin-Ly I-NAME
CC O
: O
right O
sided O
weakness O
HPI O
: O
The O
patient O
is O
a O
70 I-AGE
year-old O
right-handed O
Dutch-speaking O
female O
with O
history O
of O
DM O
, O
PVD O
presenting O
to O
ED O
with O
right-sided O
weakness O
which O
started O
yesterday O
morning O
. O
 
The O
patient O
's O
grand-nephew O
is O
translating O
, O
initially O
, O
then O
joined O
by O
Dutch I-LOCATION
interpreter O
; O
history O
is O
challenging O
to O
obtain O
. O
 
The O
patient O
reports O
that O
since O
she O
awoke O
in O
the O
AM O
on O
12/07/94 I-DATE
, O
she O
noticed O
that O
her O
RUE O
and O
RLE O
was O
weak O
and O
numb O
. O
 
She O
apparently O
had O
come O
to O
the O
ED O
about O
2 O
days O
ago O
for O
RLE O
numbness O
and O
pain O
which O
has O
been O
worsening O
over O
the O
past O
1-2 O
months O
, O
but O
reportedly O
had O
good O
strength O
on O
neurological O
exam O
, O
and O
she O
was O
not O
admitted O
. O
 
She O
was O
given O
a O
2-day O
course O
of O
Levaquin O
for O
UTI O
. O
 
She O
states O
that O
despite O
the O
pain O
in O
the O
RLE O
2 O
days O
ago O
, O
she O
was O
able O
to O
move O
her O
RLE O
whereas O
since O
yesterday O
she O
has O
not O
been O
able O
to O
move O
it O
as O
easily O
or O
bear O
weight O
. O
 
She O
also O
noted O
that O
her O
RUE O
was O
weak O
, O
and O
she O
was O
unable O
to O
raise O
it O
very O
far O
off O
the O
bed O
. O
 
She O
was O
unable O
to O
walk O
independently O
since O
yesterday O
, O
and O
required O
full O
assistance O
of O
her O
son O
to O
walk O
to O
the O
bathroom O
. O
 
She O
has O
had O
no O
facial O
weakness O
. O
 
She O
has O
never O
had O
weakness O
of O
this O
kind O
in O
her O
right O
arm O
or O
leg O
, O
but O
had O
similar O
weakness O
in O
the O
left O
arm O
and O
leg O
in O
2089 I-DATE
which O
completely O
resolved O
. O
 
She O
states O
that O
she O
has O
had O
a O
mild O
right-sided O
headache O
since O
yesterday O
AM O
. O
 
Since O
this O
morning O
, O
she O
has O
had O
nausea O
and O
vomiting O
as O
well O
( O
did O
not O
have O
this O
yesterday O
) O
, O
and O
has O
not O
had O
any O
fevers O
or O
chest O
pain O
. O
 
She O
has O
had O
SOB O
today O
. O
 
She O
reports O
having O
frequent O
BLE O
spasms O
, O
usually O
at O
night O
, O
and O
her O
legs O
become O
quite O
restless O
. O
 
ROS O
: O
Gen O
: O
No O
fevers/chills/sweats O
, O
CP O
, O
palpitations O
, O
N/V O
, O
URI O
, O
cough O
, O
abd O
pain O
, O
dysuria O
, O
melena O
, O
BRBPR O
, O
rash O
, O
travel O
Neurological O
: O
Recent O
RLE O
pain O
as O
above O
. O
 
No O
recent O
new O
changes O
in O
memory O
, O
vision O
, O
hearing O
. O
 
No O
vertigo/dizziness O
, O
no O
bowel/bladder O
incontinence O
. O
 
No O
swallowing O
or O
speech O
problems O
. O
 
No O
h/o O
seizures O
. O
 
Possible O
TIA O
in O
2089 I-DATE
with O
transient O
left-sided O
weakness O
, O
CT O
head O
normal O
per O
PCP O
note O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Diabetes O
type O
1 O
Right O
middle O
lobectomy O
on O
Jun I-DATE
07 O
, O
2079 I-DATE
for O
T1N0M0 O
papillary O
adenocarcinoma O
. O
 
Peptic O
ulcer O
with O
bleeding O
Hyperlipidemia O
Peripheral O
vascular O
disease O
R O
LE O
bypass O
surgery O
about O
2 O
years O
ago O
LLE O
bypass O
surgery O
about O
1 O
year O
ago O
. O
 
Left O
LE O
claudication O
Recent O
pain/numbness O
in O
RLE O
with O
shooting O
pain O
from O
buttocks O
to O
calf' O
? O
 
TIA O
in O
2089 I-DATE
MEDICATIONS O
Insulin O
Lispro O
Insulin O
NPH O
( O
or O
Humulin O
N O
? O
) O
 
Atorvastatin O
10 O
PO O
QD O
Lisinopril O
20 O
PO O
QD O
EC O
Aspirin O
81 O
PO O
QD O
ALLERGIES O
: O
NKDA O
SOCIAL O
HISTORY O
: O
From O
Suriname I-LOCATION
, O
recently O
spent O
time O
there O
until O
5/94 I-DATE
. O
 
Widowed O
, O
lives O
with O
son O
. O
 
Per O
LMR O
, O
no O
smoking O
, O
1-2 O
beers/day O
. O
 
EXAM O
VS O
: O
T O
97.5 O
HR O
106 O
BP O
186/72 O
RR O
18 O
Sat O
90 O
% O
on O
RA O
PE O
: O
General O
Uncomfortable O
, O
vomiting O
HEENT O
AT/NC O
, O
MMM O
no O
lesions O
Neck O
Supple O
, O
no O
bruits O
Chest O
CTA O
B O
CVS O
Tachycardic O
, O
regular O
ABD O
soft O
, O
NTND O
, O
+ O
BS O
EXT O
no O
C/C/E O
NEUROLOGICAL O
MS O
: O
General O
: O
alert O
, O
feeling O
ill/nauseous O
Orientation O
: O
states O
January I-DATE
2082 I-DATE
Attention O
: O
fair-months O
of O
year O
forward O
only O
, O
skipping O
one O
Speech/Lang O
: O
fluent O
w/o O
paraphasic O
errors O
; O
simple O
and O
complex O
command-following O
w/o O
L/R O
confusion O
. O
 
Repetition O
, O
naming O
intact O
( O
via O
Suriname I-LOCATION
interpreter O
) O
Praxis O
: O
Mimics O
brushing O
hair O
with O
both O
hands O
. O
 
CN O
: O
II O
, O
III O
: O
VF O
difficult O
to O
test O
due O
to O
pt O
cooperation O
, O
appears O
to O
blink O
to O
threat O
on O
both O
sides. O
, O
pupils O
3 O
2 O
mm O
bilaterally O
to O
light O
, O
could O
not O
visualize O
optic O
disc O
due O
to O
pt O
cooperation O
. O
 
III O
, O
IV O
, O
V O
: O
EOM O
appear O
intact O
, O
does O
not O
maintain O
upward O
gaze O
, O
no O
nystagmus O
noted O
, O
no O
gaze O
preference O
V O
: O
sensation O
intact O
to O
LT/temp O
VII O
: O
Facial O
strength O
intact O
VIII O
: O
hears O
finger O
rub O
bilaterally O
IX O
, O
X O
: O
voice O
normal O
, O
palate O
elevates O
symmetrically O
XI O
: O
SCM/trapezeii O
5/5 O
bilaterally O
XII O
: O
tongue O
protrudes O
midline O
without O
atrophy O
or O
fasciculation O
Motor O
: O
Normal O
bulk O
and O
tone O
; O
no O
tremor O
, O
rigidity O
, O
or O
bradykinesia O
. O
 
Unable O
to O
cooperate O
to O
test O
drift O
, O
but O
appears O
to O
have O
some O
difficulty O
raising O
right O
arm O
. O
 
When O
right O
arm O
was O
passively O
raised O
by O
examiner O
, O
pt O
was O
able O
to O
maintain O
posture O
for O
several O
seconds O
without O
drift O
or O
tremor O
. O
 
Moves O
LUE O
with O
ease O
for O
overhead O
movements O
; O
difficult O
to O
test O
against O
resistance O
due O
to O
pt O
cooperation/understanding O
of O
task O
. O
 
Unable O
to O
elevate O
RLE O
off O
bed O
; O
elevates O
LLE O
only O
slightly O
off O
bed O
. O
 
Reflex O
: O
Pt O
holding O
extremities O
tensely O
, O
unable O
to O
relax O
; O
appears O
to O
have O
1+ O
for O
BUEs O
, O
unable O
to O
elicit O
patellar O
or O
ankle O
jerks O
. O
 
Toe O
appears O
to O
be O
upgoing O
bilaterally O
but O
difficult O
exam O
. O
 
Sensation O
: O
Inconsistent O
responses O
for O
BUE O
and O
BLE O
. O
 
Subjectively O
decreased O
to O
LT O
on O
the O
RLE O
. O
 
Coordination O
: O
manipulating O
objects O
without O
dysmetria O
LUE O
, O
less O
movement O
of O
the O
RUE O
. O
 
Gait O
: O
unable O
to O
test O
at O
this O
time O
due O
to O
pt O
feeling O
ill O
. O
 
LAB O
: O
12/08/94 I-DATE
12:06 O
NA O
136 O
K O
3.5 O
( O
# O
) O
CL O
99 O
CO2 O
25 O
BUN O
15 O
CRE O
1.0 O
EGFR O
58 O
( O
T O
) O
GLU O
313 O
( O
* O
) O
ANION O
12 O
CA O
9.2 O
TP O
8.0 O
ALB O
4.4 O
GLOB O
3.6 O
ALT/SGPT O
16 O
AST/SGOT O
19 O
ALKP O
106 O
TBILI O
0.6 O
CK O
PEND O
CK-MB O
3.1 O
TROP-I O
< O
0.1 O
WBC O
12.55 O
( O
* O
) O
HGB O
10.4 O
( O
* O
) O
HCT O
35.2 O
( O
* O
) O
MCV O
69.3 O
( O
* O
# O
T O
) O
PLT O
458 O
( O
* O
) O
RDW O
16.6 O
( O
* O
# O
) O
PT O
13.1 O
PT-INR O
1.0 O
PTT O
25.3 O
( O
# O
) O
IMAGING O
: O
CT O
head O
without O
contrast O
12/08/94 I-DATE
: O
Prelim O
: O
Mulitple O
regions O
of O
hypodensity O
in O
the O
subcortical O
white O
matter O
bilaterally O
, O
and O
in O
bilateral O
capsulothalamic O
regions O
as O
well O
as O
the O
left O
caudate/periventricular O
region O
. O
 
MRI/MRA O
head O
and O
neck O
: O
Not O
yet O
completed O
. O
 
Recent O
MRI O
of O
L-spine O
11/24/94 I-DATE
: O
The O
vertebral O
bodies O
, O
posterior O
elements O
, O
and O
alignment O
are O
intact O
. O
 
Very O
prominent O
facet O
degeneration O
is O
seen O
on O
the O
right O
at O
L5-S1 O
, O
and O
less O
prominently O
elsewhere O
. O
 
There O
is O
straightening O
of O
the O
lumbar O
spine O
. O
 
T12-L1 O
, O
L1-L2 O
, O
L2-L3 O
, O
L3-L4 O
: O
Normal O
caliber O
canal O
and O
foramina O
. O
 
L4-L5 O
: O
Mild O
broadbased O
bulge O
and O
facet O
hypertrophy O
is O
not O
associated O
with O
significant O
stenosis O
. O
 
L5-S1 O
: O
Prominent O
facet O
hypertrophy O
as O
described O
with O
ligamentum O
hypertrophy O
and O
broadbased O
disk O
protrusion O
mildly O
narrows O
the O
central O
canal O
and O
mildly O
narrows O
each O
foramen O
. O
 
There O
is O
narrowing O
of O
the O
lateral O
recesses O
on O
each O
side O
, O
and O
may O
be O
impingement O
of O
the O
traversing O
S1 O
nerve O
roots O
, O
more O
prominent O
on O
the O
right O
, O
as O
seen O
in O
images O
17 O
and O
18 O
of O
the O
axial O
sequence O
. O
 
Old O
CT O
brain O
6/16/89 I-DATE
: O
Mildly O
prominent O
ventricles O
and O
subarachnoid O
spaces O
are O
not O
uncommon O
for O
a O
patient O
of O
this O
age O
. O
 
There O
are O
no O
regions O
of O
hypoattenuation O
within O
the O
brain O
to O
suggest O
a O
prior O
infarction O
. O
 
Basal O
ganglia O
and O
basis O
pontis O
appear O
normal O
without O
evidence O
of O
lacunar O
infarction O
. O
 
No O
significant O
periventricular O
white O
matter O
changes O
are O
evident O
. O
 
_______________________________________________________________ O
IMPRESSION O
: O
70 I-AGE
year-old O
right-handed O
female O
with O
h/o O
DM O
, O
PVD O
presenting O
to O
ED O
for O
RUE O
and O
RLE O
numbness O
and O
weakness O
, O
onset O
12/07/94 I-DATE
AM O
. O
 
She O
has O
had O
numbness/tingling O
and O
shooting O
pain O
in O
the O
RLE O
for O
the O
past O
1-2 O
months O
likely O
due O
to O
disease O
in O
the O
lumbar O
spine O
seen O
on O
MRI O
( O
L5-S1 O
) O
. O
 
She O
states O
that O
the O
current O
weakness O
in O
the O
RLE O
is O
new O
, O
as O
is O
the O
weakness O
in O
the O
RUE O
. O
 
Additionally O
, O
she O
has O
new O
nausea/vomiting O
and O
SOB O
since O
this O
AM O
. O
 
While O
in O
the O
ED O
, O
following O
her O
CT O
scans O
, O
she O
was O
tachycardic O
to O
the O
150s O
and O
hypertensive O
to O
the O
230s O
systolic O
. O
 
She O
had O
persistent O
nausea O
and O
vomiting O
. O
 
Her O
neurological O
exam O
was O
difficult O
with O
inconsistent O
findings O
. O
 
She O
appears O
to O
have O
decreased O
spontaneous O
movement O
of O
the O
RUE O
, O
but O
when O
passively O
moved O
into O
shoulder O
flexion O
she O
was O
able O
to O
hold O
the O
position O
against O
gravity O
for O
several O
seconds O
. O
 
Her O
RLE O
symptoms O
are O
likely O
confounded O
by O
her O
lumbar O
spine O
disease O
at O
L5/S1 O
as O
noted O
above O
. O
 
She O
is O
hyperglycemic O
( O
serum O
glucose O
313 O
) O
, O
has O
a O
mild O
leukocytosis O
, O
is O
iron O
deficient O
, O
and O
has O
new O
onset O
today O
of O
fairly O
severe O
nausea/vomiting O
and O
SOB O
of O
unclear O
etiology O
. O
 
She O
appears O
to O
have O
vasculopathic O
changes/lacunes O
in O
the O
brain O
seen O
as O
hypodensities O
on O
the O
CT O
today O
, O
all O
appearing O
old O
. O
 
She O
does O
not O
have O
any O
right O
facial O
weakness O
, O
no O
dysarthria O
, O
no O
aphasia O
, O
no O
flaccidity/spasticity O
, O
no O
gaze O
preference O
. O
 
While O
stroke O
can O
not O
be O
ruled O
out O
, O
her O
exam O
does O
not O
clearly O
suggest O
a O
typical O
stroke O
syndrome O
. O
 
Ddx O
includes O
seizure O
, O
infection O
or O
metabolic O
abnormality O
causing O
unmasking O
of O
stroke-like O
symptoms O
, O
migraine O
phenomena O
superimposed O
on O
current O
medical/metabolic O
abnormalities O
. O
 
RECOMMENDATIONS O
: O
1 O
. O
 
MRI/MRA O
of O
the O
head O
and O
neck O
( O
stroke O
protocol O
) O
, O
as O
well O
as O
MRI O
of O
C-spine O
given O
UE O
symptoms O
2 O
. O
 
We O
currently O
recommend O
admission O
to O
medicine O
given O
multiple O
medical O
issues O
( O
severe O
HTN O
, O
SOB O
as O
yet O
unexplained O
, O
N/V O
, O
hyperglycemia O
) O
. O
 
3 O
. O
 
BP O
control O
: O
Labetolol O
to O
maintain O
BP O
less O
than O
200 O
systolic O
; O
avoid O
large/rapid O
shifts O
to O
maintain O
cerebral O
perfusion O
pressure O
. O
 
Would O
allow O
some O
degree O
of O
hypertension O
( O
max O
200 O
SBP O
) O
until O
stroke O
protocol O
MRI/MRA O
obtained O
. O
 
4 O
. O
 
Glycemic O
control-need O
to O
clarify O
home O
insulin O
regimen O
5 O
. O
 
Resend O
cardiac O
markers O
in O
setting O
of O
tachycardia O
to O
150s O
6 O
. O
 
F/u O
PE O
protocol O
CT O
( O
done O
in O
ED O
) O
. O
 
7 O
. O
 
Patient O
will O
be O
followed O
by O
the O
Neurology O
consult O
service O
. O
 
This O
case O
was O
discussed O
with O
Dr. O
James I-NAME
Rosado I-NAME
MD O
, O
senior O
Neurology O
resident O
. O
 
________________________________ O
Alex I-NAME
Waters I-NAME
, O
MD O
Resident O
in O
Neurology O
Pager O
# O
45445 I-CONTACT
 
Record O
date O
: O
2096-02-22 I-DATE
RE O
: O
TRENT O
, O
SHIRLEY I-NAME
LCC I-LOCATION
# O
99210914 I-ID
02/22/2096 I-DATE
Xitlalic I-NAME
Pearson I-NAME
, O
M.D O
. O
 
Martha I-LOCATION
Washington I-LOCATION
Hospital I-LOCATION
617 I-LOCATION
Comanche I-LOCATION
Street I-LOCATION
Milbank I-LOCATION
, O
MN I-LOCATION
49757 I-LOCATION
Dear O
Dr. O
Pearson I-NAME
: O
I O
had O
the O
pleasure O
of O
seeing O
Mrs. O
Shirley I-NAME
Trent I-NAME
in O
follow O
up O
this O
morning O
. O
 
Mrs. O
Trent I-NAME
is O
a O
71 I-AGE
year-old O
right-handed O
woman O
with O
a O
history O
of O
a O
left O
corona O
radiata O
stroke O
in O
December I-DATE
2094 I-DATE
complicated O
by O
a O
dense O
right O
hemiparesis O
. O
 
She O
presented O
today O
with O
her O
granddaughter O
, O
Ms. O
Carey I-NAME
Trent I-NAME
. O
 
Ms. O
Trent I-NAME
translated O
and O
provided O
supplemental O
interval O
history O
. O
 
Interval O
History O
Mrs. O
Trent I-NAME
moved O
to O
the O
Eddie I-LOCATION
Bauer I-LOCATION
Nursing O
home O
approximately O
one O
month O
ago O
. O
 
She O
has O
continued O
to O
have O
a O
dense O
paresis O
of O
the O
right O
arm O
and O
leg O
, O
which O
has O
confined O
her O
to O
a O
wheelchair O
. O
 
She O
has O
had O
spasticity O
, O
in O
particular O
of O
the O
right O
leg O
, O
that O
has O
been O
painful O
at O
times O
and O
has O
contributed O
to O
sleeping O
difficulties O
. O
 
Baclofen O
was O
initiated O
and O
titrated O
to O
20 O
mg O
TID O
, O
with O
some O
efficacy O
. O
 
According O
to O
Carey I-NAME
, O
another O
medication O
may O
have O
been O
used O
around O
the O
turn O
of O
the O
year O
. O
 
Gabapentin O
was O
initiated O
at O
a O
dose O
of O
100 O
mg O
HS O
on O
2/10/96 I-DATE
. O
 
Mrs. O
Trent I-NAME
related O
that O
she O
has O
had O
a O
depressed O
mood O
in O
recent O
months O
. O
 
A O
son O
with O
whom O
she O
was O
close O
died O
in O
August I-DATE
of O
last O
year O
from O
complications O
following O
an O
admission O
to O
the O
hospital O
with O
asthma O
. O
 
This O
was O
extremely O
difficult O
for O
Mrs. O
Trent I-NAME
. O
 
She O
has O
felt O
`` O
alone O
, O
'' O
but O
has O
enjoyed O
visits O
to O
the O
nursing O
home O
from O
Carey I-NAME
and O
from O
Carey I-NAME
's O
aunt O
, O
one O
of O
Mrs. O
Trent I-NAME
's O
daughters O
. O
 
Her O
other O
children O
have O
not O
maintained O
close O
contact O
. O
 
Mrs. O
Trent I-NAME
had O
increased O
weakness O
and O
slurring O
of O
her O
speech O
in O
early O
February I-DATE
, O
which O
may O
have O
been O
related O
to O
a O
urinary O
tract O
infection O
or O
sedating O
medication O
used O
at O
that O
time O
. O
 
Aside O
from O
that O
episode O
, O
Mrs. O
Trent I-NAME
reported O
no O
episodes O
of O
weakness O
, O
numbness O
, O
clumsiness O
, O
visual O
changes O
, O
slurred O
speech O
, O
dizziness O
, O
language O
difficulties O
, O
or O
other O
neurological O
symptoms O
concerning O
for O
stroke O
since O
her O
stroke O
in O
December I-DATE
2094 I-DATE
. O
 
Past O
Medical O
History O
type O
2 O
diabetes O
mellitus O
requiring O
insulin O
h/o O
peptic O
ulcer O
disease O
with O
GI O
bleeding O
hyperlipidemia O
peripheral O
arterial O
disease O
, O
bypass O
surgery O
on O
the O
right O
leg O
, O
mild O
symptoms O
of O
claudication O
on O
the O
left O
left O
internal O
carotid O
artery O
stenosis O
Medications O
( O
confirmed O
) O
Baclofen O
20 O
MG O
( O
10MG O
TABLET O
take O
2 O
) O
PO O
TID O
Clopidogrel O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Gabapentin O
100 O
MG O
( O
100MG O
CAPSULE O
take O
1 O
) O
PO O
QHS O
Metoclopramide O
HCL O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
AC O
Mirtazapine O
30 O
MG O
( O
30MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Multivitamin O
WITH O
FOLIC O
ACID O
( O
MULTIVITAMINS O
) O
1 O
TAB O
PO O
QD O
x O
60 O
days O
Novolog O
( O
INSULIN O
ASPART O
) O
SC O
QAM O
, O
QPM O
and O
SS O
Omeprazole O
20 O
MG O
( O
20MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
QD O
Toprol O
XL O
( O
METOPROLOL O
SUCCINATE O
EXTENDED O
RELEASE O
) O
100 O
MG O
( O
100MG O
TAB.SR O
24H O
take O
1 O
) O
PO O
QD O
Allergies O
NKA O
Social O
History O
Mrs. O
Trent I-NAME
is O
originally O
from O
Suriname I-LOCATION
. O
 
She O
is O
widowed O
, O
with O
six O
living O
children O
. O
 
A O
son O
died O
at O
age O
42 I-AGE
in O
August I-DATE
, O
2095 I-DATE
. O
 
Mrs. O
Trent I-NAME
has O
a O
remote O
history O
of O
smoking O
. O
 
She O
does O
not O
consume O
alcohol O
. O
 
She O
has O
recently O
spent O
much O
of O
her O
time O
watching O
television O
( O
like O
soap O
operas O
in O
Dutch I-LOCATION
) O
and O
participating O
in O
group O
activities O
( O
such O
as O
Bingo O
) O
at O
the O
home O
. O
 
Review O
of O
Systems O
Negative O
for O
chest O
pain O
, O
shortness O
of O
breath O
, O
visual O
changes O
, O
weakness O
, O
numbness O
, O
burning O
pain O
, O
paresthesias O
, O
difficulties O
speaking O
or O
understanding O
others O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
pain O
or O
burning O
on O
urination O
. O
 
Positive O
for O
frequent O
nighttime O
awakening O
. O
 
Appetite O
has O
been O
`` O
o.k O
. O
'' O
 
Exam O
Blood O
Pressure O
128/58 O
Heart O
Rate O
76 O
Neck O
: O
no O
carotid O
bruits O
Lungs O
: O
CTA O
bilaterally O
Heart O
: O
regular O
rate O
and O
rhythm O
, O
II/VI O
systolic O
ejection O
murmur O
ABD O
: O
soft O
, O
nontender O
, O
nondistended O
, O
bowel O
sounds O
present O
EXT O
: O
no O
edema O
MS O
: O
alert O
, O
pleasant O
, O
cooperative O
, O
good O
eye O
contact O
. O
 
Fatigued O
, O
mildly O
depressed O
looking O
affect O
. O
 
Oriented O
to O
`` O
LCC I-LOCATION
'' O
in O
`` O
Galena I-LOCATION
, O
'' O
`` O
March I-DATE
2095 I-DATE
. O
'' O
 
Speech O
fluent O
in O
Dutch I-LOCATION
. O
 
Followed O
2-step O
verbal O
commands O
with O
left O
hand O
. O
 
Recalled O
recent O
events O
from O
soap O
opera O
episodes O
in O
detail O
. O
 
CN O
: O
pupils O
4mm O
, O
round O
, O
LR O
to O
2mm O
. O
 
EOMI O
. O
 
Mild O
right O
UMN O
facial O
weakness O
. O
 
Palate O
elevation O
symmetrical O
and O
tongue O
protrusion O
midline O
. O
 
MOTOR O
: O
increased O
tone O
with O
clasp O
knife O
phenomenon O
right O
arm O
and O
leg O
. O
 
Minimal O
movement O
of O
right O
arm O
( O
elbow O
flexion O
, O
index O
finger O
extension O
, O
finger O
flexion O
) O
and O
right O
foot O
( O
knee O
flexion O
, O
ankle O
flexion O
, O
toe O
extension O
) O
. O
 
5/5 O
strength O
in O
proximal O
and O
distal O
muscles O
of O
the O
left O
arm O
and O
leg O
. O
 
SENSORY O
: O
reduced O
sensation O
to O
temperature O
and O
vibration O
right O
arm O
and O
leg O
relative O
to O
the O
left O
. O
 
DTRs O
: O
3 O
in O
the O
right O
biceps O
, O
BR O
, O
triceps O
, O
2 O
on O
the O
left O
. O
 
Trace O
patellar O
and O
ankle O
reflexes O
bilaterally O
. O
 
Right O
plantar O
response O
extensor O
, O
left O
flexor O
. O
 
CEREB O
: O
no O
dysmetria O
left O
finger O
nose O
finger O
. O
 
MRI O
brain O
12/10/94 I-DATE
: O
small-to-medium O
sized O
stroke O
in O
the O
left O
corona O
radiata O
CTA O
head O
and O
neck O
12/11/94 I-DATE
: O
dense O
calcification O
at O
the O
carotid O
bifurcation O
, O
precluding O
a O
legitimate O
interpretation O
. O
 
CNIS O
12/14/94 I-DATE
: O
demonstrated O
25 O
to O
49 O
% O
stenosis O
in O
the O
proximal O
left O
ICA O
; O
velocity O
of O
143 O
in O
the O
proximal O
ICA O
versus O
50 O
in O
the O
distal O
CCA O
suggests O
a O
possible O
moderate O
( O
50-70 O
% O
) O
stenosis O
of O
the O
vessel O
Echocardiogram O
( O
transthoracic O
) O
12/14/94 I-DATE
: O
estimated O
EF O
of O
55 O
to O
60 O
% O
, O
no O
regional O
wall O
motion O
abnormalities O
, O
mild O
left O
atrial O
enlargement O
, O
and O
no O
other O
significant O
abnormalities O
. O
 
Impression O
Mrs. O
Shirley I-NAME
Trent I-NAME
is O
a O
71 I-AGE
year-old O
right-handed O
woman O
who O
had O
a O
stroke O
in O
the O
left O
corona O
radiata O
in O
December I-DATE
2094 I-DATE
. O
 
Her O
stroke O
risk O
factors O
include O
history O
of O
diabetes O
mellitus O
, O
dyslipidemia O
, O
peripheral O
arterial O
disease O
, O
and O
left O
carotid O
stenosis O
with O
a O
calcified O
plaque O
. O
 
She O
has O
not O
had O
any O
clinical O
events O
suggestive O
of O
stroke O
in O
the O
interim O
between O
11/94 I-DATE
and O
now O
. O
 
Mrs. O
Trent I-NAME
's O
current O
neurological O
and O
psychiatric O
problems O
include O
spasticity O
of O
the O
right O
arm O
and O
leg O
and O
depression O
. O
 
Plan O
1 O
. O
 
We O
will O
obtain O
repeat O
carotid O
studies O
to O
assess O
for O
interval O
progression O
of O
the O
left O
carotid O
stenosis O
. O
 
2 O
. O
 
We O
recommend O
continued O
management O
of O
vascular O
risk O
factors O
, O
with O
( O
1 O
) O
target O
BP O
120/80 O
or O
less O
, O
( O
2 O
) O
target O
LDL O
< O
100 O
, O
( O
3 O
) O
continued O
glycemic O
control O
. O
 
Continue O
clopidogrel O
as O
an O
antiplatelet O
agent O
. O
 
3 O
. O
 
Regarding O
the O
spasticity O
, O
it O
is O
reasonable O
to O
utilize O
a O
higher O
evening O
dose O
of O
gabapentin O
and O
assess O
the O
efficacy O
. O
 
Other O
potential O
agents O
to O
consider O
for O
future O
use O
include O
cyclobenzaprine O
, O
tizanidine O
, O
and O
trihexyphenidyl O
. O
 
I O
will O
continue O
to O
follow O
and O
would O
be O
happy O
to O
discuss O
this O
management O
with O
you O
at O
any O
time O
. O
 
4 O
. O
 
I O
agree O
with O
mirtazapine O
for O
antidepressant O
therapy O
given O
Mrs. O
Trent I-NAME
's O
poor O
appetite O
and O
impaired O
sleep O
. O
 
After O
her O
gabapentin O
has O
been O
appropriately O
titrated O
, O
one O
may O
consider O
increasing O
mirtazapine O
to O
45 I-LOCATION
mg O
HS O
. O
 
5 O
. O
 
Mrs. O
Trent I-NAME
will O
be O
scheduled O
for O
follow O
up O
in O
approximately O
6 O
months O
. O
 
It O
is O
a O
pleasure O
to O
participate O
in O
the O
care O
of O
Mrs. O
Trent I-NAME
with O
you O
. O
 
Greater O
than O
50 O
% O
of O
this O
60 O
minute O
follow O
up O
visit O
was O
spent O
counseling O
regarding O
the O
above O
issues O
. O
 
Please O
do O
not O
hesitate O
to O
contact O
me O
with O
questions O
. O
 
Sincerely O
, O
______________________________ O
James I-NAME
Rosado I-NAME
, O
M.D O
. O
 
Neurology O
Lenox I-LOCATION
Care I-LOCATION
Center I-LOCATION
cc O
: O
Ms. O
Carey I-NAME
Trent I-NAME
45 I-LOCATION
Hoyts I-LOCATION
Lane I-LOCATION
, O
Qpt O
. O
 
0 O
Galena I-LOCATION
, O
MN I-LOCATION
64864 I-LOCATION
 
Record O
date O
: O
2121-03-31 I-DATE
Kern I-LOCATION
Medical I-LOCATION
Center I-LOCATION
Preadmission O
Testing O
Area O
Department O
of O
Internal O
Medicine O
Preanesthetic O
Assessment O
Tina I-NAME
L. I-NAME
Purcell I-NAME
, O
M.D O
. O
 
Associate O
Medical I-LOCATION
Director O
March I-DATE
31 O
, O
2121 I-DATE
Medical I-LOCATION
Record O
Number O
: O
4698877 I-ID
Isabella I-NAME
T. I-NAME
Valle I-NAME
Procedure O
: O
The O
patient O
is O
a O
53 I-AGE
year O
old O
female O
scheduled O
for O
parathyroidectomy O
. O
 
Surgery O
is O
scheduled O
on O
4/03/21 I-DATE
. O
 
Chief O
Complaint O
& O
Present O
Illness O
: O
hyperparathyroidism-parathormone O
level O
> O
900-resulting O
in O
spontaneous O
fractures O
. O
 
Patient O
had O
previous O
semi O
total O
parathyroidectomy O
in O
2112 I-DATE
. O
 
Past O
Surgical O
History O
: O
Prior O
surgery O
includes O
: O
' O
09 I-DATE
TAH-BSO O
; O
' O
10 I-DATE
parathyroidectomy O
; O
' O
13 I-DATE
renal O
transplant O
recipient O
; O
'18 O
left O
nephrectomy-easy O
mask O
and O
intubation O
; O
ventral O
hernia O
repair O
; O
AV O
fistulas O
x2-general O
anesthesia O
without O
any O
known O
problems O
Family O
History O
: O
There O
is O
no O
family O
history O
of O
adverse O
reactions O
to O
general O
anesthesia O
. O
 
Medications O
: O
Neoral O
, O
Lasix O
40 O
mg O
, O
Norvasc O
5 O
mg O
b.i.d. O
, O
Lipitor O
20 O
mg O
b.i.d. O
, O
Cellcept O
50 O
mg O
q.i.d. O
, O
Bactrim O
, O
Estrotab O
, O
prednisone O
10 I-DATE
mg O
, O
Epogen O
, O
iron O
, O
insulin O
NPH O
45 O
units O
plus O
regular O
10 I-DATE
units O
in O
a.m O
. O
 
Allergies O
: O
none O
Social O
History O
: O
Smoking O
: O
none O
Alcohol O
use O
: O
rare O
Substance O
Abuse O
: O
none O
Allergen O
Exposure O
within O
3 O
Months O
( O
blood O
products/pregnancy O
) O
: O
none O
Review O
of O
Systems O
: O
HEENT O
: O
negative O
Cardiovascular O
: O
hypertension O
; O
patient O
usually O
walks O
one O
mile O
per O
day O
and O
climbs O
one O
flight O
of O
stairs O
without O
any O
angina O
or O
shortness O
of O
breath O
Respiratory O
: O
negative O
Renal O
: O
polycystic O
renal O
disease O
diagnosed O
15 O
years O
ago O
resulting O
in O
renal O
transplant O
2/13 I-DATE
and O
now O
renal O
failure O
with O
elevated O
creatinine O
5.3-no O
dialysis O
at O
present O
Hepatobiliary O
: O
negative O
Neurological O
: O
negative O
Gastrointestinal O
: O
no O
reflux O
Hematological O
: O
bruises O
easily O
, O
anemia-last O
hematocrit O
31 O
percent O
but O
has O
been O
as O
low O
as O
19 O
within O
the O
last O
year O
Endocrine/metabolic O
: O
diabetes O
treated O
with O
insulin-blood O
sugar O
190 O
Musculoskeletal/Skin O
: O
recent O
infection O
in O
left O
foot O
fourth O
toe O
; O
left O
hip O
deterioration O
causing O
pain O
Psychiatric O
: O
negative O
Obstetrical O
: O
negative O
Vital O
Signs O
: O
BP O
: O
152/87 O
mm O
Hg O
P O
: O
88 O
bpm O
Resp O
: O
20 O
rpm O
SaO2 O
: O
97 O
% O
Temp O
: O
97.7 O
degrees O
F O
Ht O
: O
66 O
inches O
Wt O
: O
158.8 O
pounds O
Exam O
: O
HEEN O
& O
T O
: O
good O
range O
of O
motion O
, O
no O
bruits O
Airway O
: O
Mallampatti O
Class O
II O
Teeth O
: O
dentures O
Lungs O
: O
clear O
to O
auscultation O
bilaterally O
Heart O
: O
regular O
rhythm O
, O
no O
murmurs O
Assessment O
: O
ASA O
Physical O
Status O
III-53 O
year O
old O
female O
with O
history O
of O
polycystic O
disease O
in O
renal O
failure O
status O
post O
renal O
transplant O
. O
 
Patient O
has O
elevated O
parathormone O
level O
with O
resultant O
spontaneous O
fractures O
. O
 
EKG O
today O
shows O
normal O
sinus O
rhythm O
with O
biphasic O
T-wave O
in O
V4 O
and O
inverted O
T-wave O
in O
V5 O
, O
V6 O
. O
 
Discussed O
patient O
with O
Dr. O
Uren-T-wave O
changes O
are O
new O
since O
1/21 I-DATE
. O
 
He O
will O
order O
a O
preoperative O
stress O
test O
. O
 
Plan O
: O
Proposed O
Anesthetic O
: O
general O
endotracheal O
anesthesia O
Monitors O
: O
standard O
Pain O
Management O
: O
PCA O
Autologous O
blood O
: O
none O
Premedication O
: O
STRESS O
steroids O
Usual O
Medications O
: O
in O
a.m. O
of O
surgery O
Medications O
to O
be O
held O
on O
day O
of O
surgery O
: O
Lipitor O
D/C O
'd O
today O
Diabetic O
medications O
: O
NPH O
24 O
units O
in O
a.m.-no O
regular O
insulin O
NSAIDS O
: O
D/C'd O
Aspirin O
: O
none O
NPO O
: O
after O
midnight O
Ancillary O
Studies O
: O
EKG-normal O
sinus O
rhythm O
, O
possible O
lateral O
ischemia-official O
reading O
pending O
________________________________________ O
Tina I-NAME
Purcell I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2122-04-23 I-DATE
Patient O
Name O
: O
VALLE O
, O
ISABELLA O
[ O
MRN O
: O
4698877KMC O
] O
Date O
of O
Visit O
: O
4/23/2122 I-DATE
, O
10:45 O
p O
Neurosurgery O
H O
& O
P O
: O
CC/HPI O
: O
54 I-AGE
yo O
F O
w/ O
h/o O
PCKD O
and O
HTN O
presents O
w/ O
worst O
H/A O
of O
her O
life O
. O
 
The O
patient O
over-slept O
this O
morning O
because O
of O
a O
severe O
H/A O
and O
`` O
groginess O
. O
'' O
 
She O
awoke O
at O
10 I-DATE
am O
by O
her O
Husband O
who O
was O
calling O
to O
check O
on O
her O
( O
given O
she O
usually O
awakens O
by O
6 O
am O
) O
. O
 
She O
called O
911 O
and O
was O
transferred O
to O
us O
for O
further O
care O
. O
 
We O
were O
consulted O
at O
10:40 O
pm O
for O
Head O
CT O
showing O
SAH O
. O
 
She O
now O
only O
c/o O
mild O
H/A O
w/o O
any O
vertigo O
, O
tinnitus O
, O
weakness O
, O
nor O
numbness O
. O
 
PMH O
: O
Polycystic O
kidney O
disease O
: O
- O
renal O
failure O
- O
s/p O
renal O
transplant O
in O
'13 O
- O
s/p O
nephrectomy O
in O
'18 O
- O
now O
on O
peritoneal O
dialysis O
Secondary O
Hyperparathyroidism O
- O
has O
had O
spont O
fractures O
- O
s/p O
semi O
total O
parathyroidectomy O
in O
2112 I-DATE
HTN O
Hypercholesteremia O
IDDM O
PSH O
: O
' O
09 I-DATE
TAH-BSO O
' O
10 I-DATE
parathyroidectomy O
' O
18 I-DATE
left O
nephrectomy O
AV O
fistulas O
x2 O
Meds O
: O
Lasix O
40 O
mg O
Norvasc O
10 I-DATE
mg O
po O
qd O
Lipitor O
40 O
mg O
po O
qd O
, O
prednisone O
10 I-DATE
mg O
, O
Epogen O
10kU O
4x/week O
Insulin O
NPH O
38 O
units O
plus O
regular O
8 O
units O
in O
a.m. O
NKDA O
SH O
: O
non-contributory O
. O
 
FH O
: O
Mother O
died O
of O
an O
aneurysm O
at O
KMC I-LOCATION
PE O
: O
Afebrile O
, O
BP O
160/80 O
, O
P O
80 O
, O
R O
16 O
Neuro O
: O
AA O
& O
Ox3 O
, O
speech O
clear O
PRL O
( O
L6 O
to O
5 O
, O
R O
5 O
to O
4 O
) O
, O
FOV O
full O
grossly O
, O
EOMI O
, O
FS O
, O
TML O
, O
SCM/TPZ O
5/5 O
B O
MAE O
@ O
5/5 O
, O
mild O
RUE O
drift O
No O
gross O
sensory O
deficit O
DTR O
: O
1+ O
B O
Bicep/BR/Patella O
NEG O
Babinski's O
No O
cerebellar O
signs O
Head O
CTA O
: O
Fischer O
grade O
1 O
SAH O
in O
B O
sylvian O
fissures O
. O
 
Small O
amount O
of O
paramesencephalic O
SAH O
in O
the O
Right O
. O
 
A O
6 O
mm O
L O
MCA O
bifurcation O
aneurysm O
pointing O
latero-superiorly O
is O
seen O
. O
 
LABS O
: O
Normal O
CBC O
, O
lytes O
, O
and O
coags O
except O
WBC O
= O
12.6 O
, O
K O
= O
5.3 O
, O
BUN/CR O
= O
48 O
/ O
9.6 O
, O
Trop O
= O
0.25 O
A/P O
: O
54 I-AGE
yo O
F O
w/ O
PCDK O
& O
HTN O
p/w O
Hunt O
Hess O
grade O
2 O
, O
Fischer O
grade O
1 O
SAH O
from O
L O
MCA O
aneurysm O
. O
 
D/W O
Drs O
. O
 
Ashley I-NAME
& O
Dang I-NAME
: O
- O
D/W O
Dr. O
Uren I-NAME
and O
Dr. O
Quenton I-NAME
Vanburen I-NAME
who O
related O
that O
CTA O
and O
Angio O
could O
both O
be O
done O
for O
this O
patient O
safely O
. O
 
A O
dialysis O
RN O
will O
be O
by O
soon O
to O
dialyse O
the O
patient O
. O
 
CTA O
done O
. O
 
- O
Booked O
for O
OR O
Waitlist O
in O
AM O
- O
Pre-op O
labs O
done O
- O
EKG O
shows O
no O
ischemia O
w/ O
LVH O
- O
Vanc/Gent O
for O
open O
Peritoneal O
catheter O
noted O
on O
exam O
______________________________ O
Michael I-NAME
Tomlinson I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2122-07-21 I-DATE
Valle O
, O
Isabella I-NAME
KMC I-LOCATION
Neuro O
EW O
Consult O
Date O
7/21/22 I-DATE
MRN O
4698877 I-ID
DOB O
: O
7/30/67 I-DATE
CC O
: O
Unresponsive O
this O
AM O
, O
with O
R O
sided O
deficit O
HPI O
: O
54 I-AGE
yo O
? O
handedness O
WF O
with O
sig O
h/o O
PCKD O
on O
peritoneal O
dialysis O
, O
HTN O
, O
hypercholesterolemia O
, O
IDDM O
, O
s/p O
L O
MCA O
aneurysmal O
rupture O
and O
repair O
4/22 I-DATE
, O
who O
presents O
this O
AM O
found O
unresponsive O
by O
husband O
( O
All O
report O
given O
by O
EMS O
< O
can O
not O
contact O
husband O
and O
he O
is O
not O
currently O
present O
. O
) O
 
Pt O
reportedly O
was O
last O
seen O
in O
USOH O
last O
night O
about O
9pm O
when O
peritoneal O
dialysis O
was O
started O
. O
 
She O
was O
found O
this O
AM O
with O
her O
dialysate O
fluid O
half O
run O
through O
and O
it O
was O
on O
the O
floor O
, O
she O
was O
unresponsive O
. O
 
Pt O
intermittenly O
responds O
to O
commands O
and O
is O
not O
speaking O
, O
so O
ROS O
is O
unabl O
to O
obtain O
at O
this O
point O
. O
 
ALL O
: O
unknown O
if O
any O
allergies O
Meds O
: O
Lipitor O
, O
Prednisone O
, O
Zestril O
, O
Norvasc O
, O
Calcitol O
, O
Phenytoin O
, O
Mesnest O
, O
Nephrocaps O
, O
Phoslo O
, O
Insulin O
NPH O
37 O
and O
Reg O
7 O
Med O
Hx O
: O
as O
above O
, O
HTN O
, O
hypercholesterolemia O
, O
PCKD O
, O
IDDM O
, O
s/p O
L O
MCA O
aneurysm O
4/22 I-DATE
Soc O
Hx O
: O
unknown O
at O
this O
time O
PE O
: O
T O
96.6 O
P O
101 O
R O
20 O
BP O
167/62 O
O2=100 O
RA O
Gen O
: O
WF O
, O
appears O
older O
than O
stated O
age O
, O
withdrawing O
R O
side O
, O
looking O
to O
left O
HEENT O
: O
normocephalic O
, O
atraumatic O
Neck O
: O
supple O
, O
no O
bruits O
Lungs O
: O
CTAB O
no O
w/r/c O
Heart O
: O
RRR O
S1 O
, O
S2 O
, O
no O
m/r/g O
Abd O
: O
soft O
, O
+BSs O
, O
slightly O
firm O
, O
peritoneal O
dialysate O
access O
in O
abdomen O
, O
abd O
bandaged O
, O
fluid O
exuding O
from O
abdomen O
Ext O
: O
no O
c/c/e O
Neuro O
: O
alert O
, O
can O
not O
assess O
if O
pt O
is O
oriented O
to O
person O
, O
place O
, O
time O
, O
pt O
completely O
aphasic O
, O
follows O
verbal O
commands O
, O
can O
not O
perform O
rest O
of O
MMSE O
at O
this O
time O
CN O
: O
PERRLA O
, O
EOMI O
, O
eyes O
deviated O
to O
L O
, O
not O
roving O
, O
able O
to O
track O
and O
cross O
midline O
, O
no O
blink O
to O
threat O
on O
the O
L O
, O
visual O
acuity O
unable O
to O
assess O
, O
sensation O
face O
equal O
bilaterally O
, O
R O
sided O
NLF O
flattening O
, O
Motor O
: O
no O
PND O
on O
L O
, O
can O
not O
lift O
R O
arm O
off O
bed O
to O
command O
, O
normal O
bulk O
on O
R O
, O
increased O
tone O
on O
R O
, O
atrophy O
of O
leg O
and O
arm O
on O
L O
, O
no O
tremors O
or O
fasiculations O
noted O
Strength O
unable O
to O
assess O
officially O
, O
moving O
L O
arm O
and O
leg O
spontaneously O
, O
no O
movement O
of O
R O
upper O
and O
lower O
extremities O
, O
only O
demonstrates O
flexor O
withraw O
to O
painful O
stimuli O
on O
R O
side O
Sensation O
: O
unable O
to O
assess O
, O
pt O
does O
not O
respond O
to O
questions O
re O
: O
extinction O
or O
sensation O
but O
does O
respond O
to O
painful O
stimuli O
Cerebellum O
: O
unable O
to O
assess O
Gait O
: O
unable O
to O
assess O
Reflexes O
: O
biceps O
, O
triceps O
, O
BR O
R O
3+ O
, O
L O
2+ O
Patellar O
, O
Achilles O
3+ O
R O
, O
2+ O
L O
, O
toes O
upgoing O
on O
R O
, O
downgoing O
on O
L O
Labs O
: O
WBC O
sig O
for O
17.5 O
w/ O
90 O
% O
N O
, O
chem O
7 O
pending O
Imaging O
: O
Pending O
CXR O
A/P O
: O
54 I-AGE
yo O
WF O
with O
sig O
medical O
problems O
, O
including O
L O
MCA O
stroke O
in O
4/22 I-DATE
, O
now O
with O
new O
R O
sided O
deficits O
? O
stroke O
vs. O
sz O
-CT O
no O
angio O
for O
now O
givenperitoneal O
dialysis O
-likely O
for O
MRI/A O
of O
head O
and O
neck O
with O
diffusion O
as O
per O
acute O
stroke O
protocol O
-likely O
CMF O
admission/ O
stroke O
team O
unless O
suspicion O
for O
sz O
, O
infectious O
cause O
Thelma I-NAME
Delarosa I-NAME
MD O
, O
PhD O
Neurology O
Resident O
Pager O
04272 I-CONTACT
 
Record O
date O
: O
2123-03-02 I-DATE
TEAM O
2 O
INTERN O
ADMISSION O
NOTE O
Name O
: O
Isabella I-NAME
Valle I-NAME
4698877 I-ID
Date O
of O
Admission O
: O
3/01/2123 I-DATE
Attending O
: O
Dr. O
L. I-NAME
Uren I-NAME
HPI O
: O
55 I-AGE
y/o O
female O
with O
multiple O
medical O
problems O
presents O
to O
ED O
after O
husban O
called O
EMS O
for O
seizure O
that O
lasted O
approximately O
5 O
minutes O
. O
 
She O
has O
a O
known O
seizure O
disorder O
secondary O
to O
hemmorragic O
CVA O
in O
past O
. O
 
Pt O
. O
 
had O
recent O
reduction O
in O
Dilantin O
dose O
and O
has O
documented O
subtherapuetic O
levels O
since O
this O
change O
. O
 
Pt O
. O
 
denies O
any O
other O
complaints O
prior O
to O
or O
after O
seizure O
. O
 
In O
the O
ED O
waiting O
area-pt O
. O
 
Suffered O
another O
seizure O
and O
was O
transferred O
to O
the O
trauma O
section O
of O
the O
ER O
. O
 
Patient O
was O
given O
2mg O
of O
Ativan O
with O
resolution O
of O
seizure O
and O
then O
was O
in O
an O
obvious O
post-ictal O
state O
. O
 
Foley O
was O
placed O
with O
drainage O
of O
pus O
and O
patient O
given O
80mg O
IV O
gentamycin O
and O
1 O
gram O
of O
Vancomycin O
. O
 
Head O
CT O
negative O
for O
any O
acute O
process O
and O
abd/pelvic O
CT O
performed-results O
pending O
. O
 
Past O
Med O
: O
# O
1 O
. O
 
Subarachnoid O
hemorrhage O
, O
status O
post O
left O
MCA O
aneurysm O
clipped O
in O
04/22 I-DATE
. O
 
# O
2 O
. O
 
Left O
MCA O
stroke O
in O
07/22 I-DATE
. O
 
# O
3 O
. O
 
End O
stage O
renal O
disease O
from O
polycystic O
kidney O
disease O
status O
post O
left O
nephrectomy O
, O
status O
post O
renal O
transplant O
and O
hemodialysis O
. O
 
# O
4 O
. O
 
Steroid O
induced O
diabetes O
mellitus O
. O
 
# O
5 O
. O
 
Hypertension O
. O
 
# O
6 O
. O
 
Status O
post O
parathyroidectomy O
. O
 
# O
7 O
. O
 
Status O
post O
thyroid O
adenoma O
resection O
. O
 
# O
8 O
. O
 
History O
of O
fungal O
peritonitis O
in O
07/22 I-DATE
. O
 
# O
9 O
. O
 
Hyperlipidemia O
. O
 
# O
10 O
. O
 
Recent O
line O
sepsis O
with O
Enterococci O
10/22 I-DATE
. O
 
# O
11 O
. O
 
Status O
post O
TAH/BSO O
for O
menorrhagia O
, O
and O
status O
post O
ventral O
hernia O
repair O
. O
 
# O
12 O
HD O
catheter O
infection O
Meds O
: O
Lopressor O
25 O
Bid O
, O
Lactobacillus O
1 O
packt O
PO O
bid O
, O
Ranitidine O
50 O
IV O
qd O
, O
Colace O
100 O
mg O
PO O
bid O
, O
Aggrenox O
1 O
cap O
PO O
BID O
, O
Dulcolax O
prn O
, O
Celexa O
40 O
po O
qd O
, O
CaCO3 O
1250 O
po O
tid O
, O
prednisone O
5 O
mg O
po O
qam O
, O
Lipitor O
20 O
po O
qd O
Allergies O
: O
NKDA O
Social O
History O
: O
no O
tobacco O
, O
or O
etoh O
, O
lives O
with O
husband O
who O
helps O
her O
with O
ADLs O
as O
she O
is O
hemiparetic O
Family O
History O
: O
not O
obtained O
Physical O
Exam O
: O
T= O
98.1 O
, O
RR=20 O
, O
P=63 O
, O
BP=124/66 O
, O
97 O
% O
2L O
GEN O
: O
NAD O
HEENT O
: O
PERRL O
, O
no O
oral O
lesions O
visible O
LUNGS O
: O
clear O
posteriorly O
crackles O
HEART O
: O
S1 O
, O
S2 O
, O
+systolic O
murmer O
heard O
throughout O
ABD O
: O
BS+ O
, O
soft O
, O
NT O
EXT O
: O
No O
edema O
except O
for O
RUE O
NEURO O
: O
can O
not O
move O
right O
side O
of O
body O
, O
upgoing O
toes O
on O
right O
Labs O
: O
WBC O
12.8 O
H O
4.5-11.0 O
th/cmm O
HCT O
37.2 O
36.0-46.0 O
% O
HGB O
11.4 O
L O
12.0-16.0 O
gm/dl O
RBC O
3.52 O
L O
4.00-5.20 O
mil/cmm O
PLT O
988 O
H O
150-350 O
th/cumm O
MCV O
106 O
H O
80-100 O
fl O
MCH O
32.3 O
26.0-34.0 O
pg/rbc O
MCHC O
30.6 O
L O
31.0-37.0 O
g/dl O
RDW O
18.7 O
H O
11.5-14.5 O
% O
PT O
13.0 O
11.1-13.1 O
sec O
PT-INR O
1.1 O
Result O
Text O
: O
PT-INR O
values O
are O
valid O
only O
for O
WARFARIN O
ANTI-COAG O
THERAPY O
. O
 
APTT O
23.8 O
22.1-35.1 O
sec O
DIFFERENTIAL O
REQUEST O
RECEIVED O
Diff O
Method O
Auto O
Poly O
63 O
40-70 O
% O
Lymphs O
31 O
22-44 O
% O
Monos O
4 O
4-11 O
% O
EOS O
1 O
0-8 O
% O
Basos O
1 O
0-3 O
% O
Absolute O
Neuts O
8.11 O
H O
1.8-7.7 O
th/cmm O
Absolute O
Lymphs O
3.92 O
1.0-4.8 O
th/cmm O
Absolute O
Monos O
0.54 O
H O
0.2-0.4 O
th/cmm O
Absolute O
EOS O
0.18 O
0.1-0.3 O
th/cmm O
Absolute O
Basos O
0.08 O
0.0-0.3 O
th/cmm O
Aniso O
2+ O
NORMAL O
Hypo O
3+ O
NORMAL O
Macrocytes O
3+ O
Microcytes O
None O
Sodium O
( O
Stat O
Lab O
) O
136 O
135-145 O
mmol/L O
Potassium O
( O
Stat O
Lab O
) O
5.9 O
H O
3.4-4.8 O
mmol/L O
Result O
Text O
: O
SPECIMEN O
NOT O
HEMOLYZED O
Chloride O
( O
Stat O
Lab O
) O
97 O
L O
100-108 O
mmol/L O
CO2 O
( O
Stat O
Lab O
) O
34.2 O
H O
24.0-30.0 O
mmol/L O
BUN O
( O
Stat O
Lab O
) O
36 O
H O
8-25 O
mg/dl O
Creatinine O
( O
Stat O
Lab O
) O
4.4 O
H O
0.6-1.5 O
mg/dl O
Glucose O
( O
Stat O
Lab O
) O
100 O
70-110 O
mg/dl O
Calcium O
7.6 O
L O
8.5-10.5 O
mg/dl O
Phosphorus O
2.0 O
L O
2.6-4.5 O
mg/dl O
Magnesium O
1.7 O
1.4-2.0 O
meq/L O
Dilantin O
, O
Chem O
2.0 O
L O
5.0-20.0 O
mcg/ml O
UA-SED-RBC O
50-100 O
0-2 O
/hpf O
UA-SED-WBC O
PACKED O
0-2 O
/hpf O
UA-SED-Bacteria O
Few O
NEG O
/hpf O
Hyaline O
Cast O
3-5 O
0-5 O
/lpf O
Squamous O
Cells O
Few O
NEG O
/hpf O
Microscopic O
Sediment O
Completed O
EKG O
: O
NSR O
, O
prolonged O
QT-no O
change O
from O
prior-non O
specific O
ST/T O
wave O
abnormalities O
CT O
Head-1 O
. O
 
No O
intracranial O
hemorrhage O
or O
CT O
evidence O
of O
acute O
stroke O
though O
MRI O
diffusion O
weighted O
imaging O
would O
be O
more O
sensitive O
. O
 
2 O
. O
 
Stable O
encephalomalacia O
and O
Wallerian O
degeneration O
from O
left O
MCA O
stroke O
. O
 
3 O
. O
 
Prior O
left O
pterional O
craniotomy O
and O
left O
MCA O
aneurysm O
clipping O
. O
 
Assessment/Plan O
: O
1 O
. O
 
Seizures-likely O
in O
setting O
of O
subtherapuetic O
Dilantin O
dose-will O
finish O
one O
gram O
load O
and O
start O
PO O
dilantin O
in O
am O
at O
300 O
tid O
per O
neurology O
recommendations O
and O
check O
levels O
and O
await O
levels O
10-15 O
. O
 
Head O
CT O
negative O
for O
new O
process O
and O
no O
evidence O
of O
other O
reason O
for O
seizure O
. O
 
Patient O
on O
Keppra O
in O
past-needed O
now O
? O
 
Will O
ask O
neurology O
2 O
. O
 
Pyuria-uncertian O
if O
significant O
due O
to O
the O
patient O
's O
likely O
minimal O
urine O
output-sent O
for O
culture-will O
await O
results-continue O
broad O
specrtrum O
coverage O
of O
potential O
pathogens O
with O
Vancomycin O
( O
1 O
gram O
given O
in O
ED O
) O
and O
ceftriaxone O
. O
 
3 O
. O
 
High O
WBC-Abd O
CT O
reportedly O
negative O
as O
was O
CXR-will O
check O
final O
results O
and O
patient O
without O
symptoms-blood O
cultures O
pending-follow O
temp O
curve O
and O
WBC O
and O
continue O
abx O
until O
cultures O
negative O
4 O
. O
 
Electrolyte O
abnormalities-patient O
on O
hemodialysis-will O
schedule O
for O
am-if O
not O
possible O
will O
have O
to O
treat O
for O
hyperkalemia O
. O
 
5 O
. O
 
Renal O
transplant-continue O
Prednisone O
6 O
. O
 
CVA-Will O
continue O
Aggrenox O
for O
now O
7 O
. O
 
Other-continue O
home O
meds O
for O
now O
except O
lactobacillus O
as O
certain O
of O
purpose O
? O
 
Bradley I-NAME
Burch I-NAME
69264 I-CONTACT
Team O
2 O
Intern O
 
Record O
date O
: O
2120-01-18 I-DATE
January I-DATE
18 O
, O
2120 I-DATE
Freeman I-NAME
Faust I-NAME
, O
M.D O
. O
 
Evergreen I-LOCATION
Court I-LOCATION
Hospital I-LOCATION
97 I-LOCATION
Factory I-LOCATION
Street I-LOCATION
Haleyville I-LOCATION
, O
MN I-LOCATION
78826 I-LOCATION
RE O
: O
Jacob I-NAME
Rodriquez I-NAME
, O
M.D O
. O
 
MR O
# O
863-35-65-5 I-ID
Dear O
Dr. O
Faust I-NAME
: O
Thank O
you O
for O
kindly O
referring O
your O
patient O
, O
Jacob I-NAME
Rodriquez I-NAME
, O
to O
the O
Internal O
Medicine O
for O
evaluation O
of I-DATE
pulmonary O
hypertension O
. O
 
Although O
I O
'm O
sure O
you O
are O
familiar O
with O
his O
history O
, O
I O
will O
review O
it O
now O
for O
our O
records O
. O
 
Dr. O
Rodriquez I-NAME
is O
a O
77-year-old O
retired O
Electrician I-PROFESSION
at O
Wells I-LOCATION
Fargo I-LOCATION
who O
by O
his O
report O
has O
enjoyed O
excellent O
health O
until O
the O
past O
year O
. O
 
He O
denies O
any O
prior O
history O
of I-DATE
hypertension O
, O
coronary O
artery O
disease O
, O
chest O
pains O
, O
significant O
childhood O
illnesses O
or O
malignancy O
. O
 
He O
describes O
his O
usual O
baseline O
health O
as O
excellent O
. O
 
He O
is O
a O
religious O
walker O
, O
walking O
multiple O
times O
each O
week O
as O
well O
as O
a O
woodwind O
and I-LOCATION
singing O
enthusiast O
. O
 
Dr. O
Rodriquez I-NAME
states O
that O
in O
approximately O
April I-DATE
or O
Mayof O
the O
past O
year O
he O
was O
first O
diagnosed O
with O
hyperglycemia O
. O
 
This O
was O
treated O
with O
Metformin O
. O
 
Subsequently O
Hydrochlorothiazide O
and I-LOCATION
Zestril O
were O
added O
apparently O
for O
hypertension O
( O
although O
the O
patient O
does O
not O
believe O
he O
has O
been O
diagnosed O
with O
hypertension O
) O
. O
 
He O
subsequently O
developed O
diarrhea O
which O
he O
felt O
was O
related O
to O
Glucophage O
which O
was O
subsequently O
reduced O
in O
dose O
. O
 
In O
June I-DATE
of I-DATE
the O
past O
year O
the O
patient O
was O
noted O
to O
be O
anemic O
which O
was O
felt O
to O
be O
related O
to O
sulfa O
in O
his O
Hydrochlorothiazide O
. O
 
At O
that O
time O
he O
also O
was O
found O
to O
have O
lower O
extremity O
edema O
which O
worsened O
with O
the O
discontinuation O
of I-DATE
the O
Hydrochlorothiazide O
. O
 
The O
patient O
states O
in O
September I-DATE
of I-DATE
2119 I-DATE
he O
traveled O
to O
trinidad I-LOCATION
and I-LOCATION
tobago I-LOCATION
. O
 
While O
in O
trinidad I-LOCATION
and I-LOCATION
tobago I-LOCATION
he O
had O
a O
marked O
increase O
in O
his O
lower O
extremity O
edema O
to O
the O
point O
that O
he O
found O
it O
difficult O
to O
ambulate O
. O
 
He O
denied O
any O
difficulty O
with O
chest O
pains O
or O
shortness O
of I-DATE
breath O
. O
 
He O
had O
no O
hemoptysis O
and I-LOCATION
no O
focal O
unilateral O
leg O
swelling O
despite O
the O
long O
period O
of I-DATE
immobility O
during O
the O
trip O
. O
 
He O
was O
seen O
by O
a O
Trinidad I-LOCATION
physician O
who O
prescribed O
an O
ethacrynic O
acid O
which O
reduced O
his O
lower O
extremity O
edema O
significantly O
. O
 
However O
, O
he O
subsequently O
developed O
diarrhea O
to O
this O
medication O
and I-LOCATION
it O
was O
stopped O
. O
 
Subsequently O
his O
lower O
extremity O
has O
once O
again O
worsened O
and I-LOCATION
has O
been O
treated O
with O
increasing O
doses O
of I-DATE
Lasix O
and I-LOCATION
with O
the O
recent O
addition O
of I-DATE
Zaroxolyn O
. O
 
At O
the O
present O
time O
Dr. O
Rodriquez I-NAME
states O
that O
he O
has O
no O
overt O
shortness O
of I-DATE
breath O
. O
 
He O
still O
able O
to O
sing O
vigorously O
and I-LOCATION
to O
play O
woodwinds O
without O
any O
Page O
2 O
Freeman I-NAME
Faust I-NAME
, O
M.D O
. O
 
RE O
: O
Jacob I-NAME
Rodriquez I-NAME
, O
M.D O
. O
 
January I-DATE
18 O
, O
2120 I-DATE
limitation O
. O
 
He O
does O
find O
ambulating O
difficult O
due O
to O
the O
swelling O
in O
his O
lower O
extremities O
. O
 
He O
has O
no O
chest O
pain O
, O
has O
no O
cough O
, O
no O
sputum O
production O
, O
no O
hemoptysis O
. O
 
He O
has O
no O
fevers O
or O
chills O
. O
 
He O
believes O
his O
weight O
is O
increased O
by O
35 O
pounds O
in O
the O
past O
several O
months O
. O
 
He O
believes O
this O
is O
entirely O
due O
to O
edema O
accumulation O
. O
 
He O
denies O
any O
difficulties O
with O
disrupted O
sleep O
although O
he O
does O
note O
that O
he O
's O
becoming O
increasingly O
fatigued O
during O
the O
day O
and I-LOCATION
is O
often O
napping O
in O
the O
reclining O
chair O
which O
is O
new O
for O
him O
. O
 
He O
denies O
any O
history O
of I-DATE
snoring O
. O
 
He O
has O
noted O
no O
new O
joint O
complaints O
although O
he O
has O
had O
a O
pruritic O
eruption O
on O
the O
anterior O
surface O
of I-DATE
his O
right O
lower O
extremity O
as O
well O
as O
on O
his O
left O
arm O
. O
 
This O
has O
been O
present O
for O
approximately O
two O
or O
three O
months O
. O
 
Other O
than O
that O
he O
believes O
his O
bowel O
and I-LOCATION
bladder O
function O
is O
normal O
. O
 
Review O
of I-DATE
systems O
is O
otherwise O
unremarkable O
. O
 
His O
past O
medical O
history O
is O
significant O
for O
: O
1 O
. O
 
Type O
II O
diabetes O
as O
above O
. O
 
2 O
. O
 
An O
apparent O
diagnosis O
of I-DATE
labile O
hypertension O
noted O
in O
his O
chart O
. O
 
3 O
. O
 
Anemia O
thought O
secondary O
to O
Hydrochlorothiazide O
. O
 
4 O
. O
 
Past O
history O
of I-DATE
right O
bundle O
branch O
block O
. O
 
He O
has O
no O
history O
of I-DATE
rheumatic O
fever O
. O
 
Current O
medications O
include O
Atenolol O
25mg O
daily O
, O
folic O
acid O
, O
Glucophage O
850mg O
bid O
, O
Lasix O
120mg O
daily O
, O
Lisinopril O
15mg O
daily O
, O
compression O
stockings O
, O
Metolazone O
2.5mg O
daily O
was O
added O
recently O
. O
 
Drug O
allergies O
include O
possible O
hemolytic O
anemia O
due O
to O
Hydrochlorothiazide O
. O
 
Family O
history O
is O
significant O
for O
diabetes O
mellitus O
. O
 
Social O
history O
is O
assuming O
for O
the O
fact O
that O
the O
patient O
is O
an O
immigrant O
from O
trinidad I-LOCATION
and I-LOCATION
tobago I-LOCATION
. O
 
He O
has O
been O
living O
in O
Haleyville I-LOCATION
since O
the O
early O
2059 I-DATE
's O
. O
 
He O
is O
a O
Electrician I-PROFESSION
at O
Wells I-LOCATION
Fargo I-LOCATION
. O
 
He O
has O
minimal O
exposure O
to O
chemicals O
in O
his O
research O
towards O
his O
bachelor O
's O
degree O
but O
none O
since O
then O
. O
 
He O
is O
a O
non O
tobacco O
user O
. O
 
He O
uses O
alcohol O
minimally O
. O
 
He O
's O
never O
had O
any O
blood O
transfusions O
. O
 
He O
lives O
with O
his O
wife O
. O
 
They O
have O
no O
pets O
. O
 
He O
does O
not O
enjoy O
any O
unusual O
hobbies O
not O
noted O
above O
. O
 
He O
has O
been O
exposed O
to O
tuberculosis O
in O
the O
past O
and I-LOCATION
has O
a O
history O
of I-DATE
a O
positive O
PPD O
. O
 
On O
physical O
examination O
today O
Dr. O
Rodriquez I-NAME
weighs O
193 O
pounds O
. O
 
Blood O
pressure O
is O
136/90 O
. O
 
Pulse O
83 O
and I-LOCATION
regular O
. O
 
Respiratory O
rate O
is O
20 O
. O
 
Temperature O
is O
96.8 O
. O
 
Resting O
oxygen O
saturation O
is O
98-99 O
% O
with O
ambulation O
in O
the O
hallway O
. O
 
This O
fell O
to O
a O
minimum O
of I-DATE
97 I-LOCATION
% O
with O
an O
increase O
in O
his O
heart O
rate O
to O
100 O
. O
 
HEENT O
exam O
is O
significant O
for O
a O
clear O
oropharynx O
. O
 
Sclera O
are O
white O
. O
 
Conjunctiva O
are O
minimally O
pale O
. O
 
Page O
3 O
Freeman I-NAME
Faust I-NAME
, O
M.D O
. O
 
RE O
: O
Jacob I-NAME
Rodriquez I-NAME
, O
M.D O
. O
 
January I-DATE
18 O
, O
2120 I-DATE
The O
thyroid O
gland O
is O
normal O
. O
 
Jugular O
venous O
distention O
to O
approximately O
10 O
cm O
. O
 
was O
noted O
. O
 
Neck O
was O
supple O
. O
 
Examination O
of I-DATE
the O
chest O
revealed O
diminished O
breath O
sounds O
bilaterally O
with O
dullness O
at O
both O
bases O
. O
 
There O
was O
no O
egophony O
and I-LOCATION
no O
wheezes O
. O
 
Otherwise O
the O
lungs O
were O
clear O
. O
 
Cardiac O
exam O
with O
a O
regular O
rate O
in O
rhythm O
, O
normal O
S1 O
and I-LOCATION
S2 O
, O
an O
intermittent O
S4 O
was O
appreciated O
. O
 
No O
RV O
heave O
or O
lift O
was O
appreciated O
. O
 
No O
pulmonary O
artery O
tap O
was O
appreciated O
. O
 
The O
pontic O
component O
of I-DATE
S2 O
was O
moderately O
enhanced O
. O
 
No O
appreciable O
murmurs O
were O
detected O
. O
 
The O
point O
of I-DATE
maximum O
impulse O
was O
in O
the O
anterior O
axillary O
line O
. O
 
Examination O
of I-DATE
the O
abdomen O
revealed O
a O
nontender O
abdomen O
with O
a O
palpable O
liver O
edge O
, O
three O
fingerbreadths O
below O
the O
right O
costal O
margin O
. O
 
This O
was O
nontender O
and I-LOCATION
smooth O
. O
 
Minimal O
splenomegaly O
was O
also O
appreciated O
as O
well O
. O
 
Normal O
bowel O
sounds O
were O
present O
. O
 
Examination O
of I-DATE
the O
extremities O
reveal O
three O
plus O
symmetric O
edema O
to O
the O
top O
of I-DATE
the O
thigh O
in O
the O
lower O
extremities O
, O
one O
plus O
edema O
was O
also O
present O
in O
both O
upper O
extremities O
. O
 
No O
clubbing O
was O
noted O
. O
 
There O
were O
no O
skin O
changes O
consistent O
with O
collagen O
vascular O
disease O
. O
 
Multiple O
follicular O
lesions O
were O
noted O
on O
the O
anterior O
aspect O
of I-DATE
the O
right O
thigh O
as O
well O
as O
on O
the O
left O
arm O
. O
 
Neurological O
exam O
was O
grossly O
nonfocal O
. O
 
Objective O
data O
include O
a O
CBC O
which O
most O
recently O
demonstrated O
a O
white O
count O
of I-DATE
11.8 O
, O
hematocrit O
of I-DATE
32.1 O
, O
platelet O
count O
of I-DATE
250 O
. O
 
Differential O
was O
not O
remarkable O
. O
 
LVH O
is O
elevated O
at O
599 O
, O
AST O
is O
most O
recently O
22 O
. O
 
A O
urinalysis O
on O
12/07/19 I-DATE
was O
negative O
for O
protein O
. O
 
No O
reportive O
cast O
was O
made O
. O
 
A O
CEA O
was O
notable O
for O
a O
level O
of I-DATE
2.4 O
on O
1/05/20 I-DATE
. O
 
An O
echocardiogram O
obtained O
on O
12/22/19 I-DATE
demonstrated O
normal O
LV O
size O
with O
mild O
concentric O
LVH O
and I-LOCATION
preserved O
LV O
function O
. O
 
The O
right O
ventricle O
was O
mildly O
dilated O
and I-LOCATION
hypertrophied O
with O
mild O
reduction O
in O
RV O
function O
. O
 
There O
was O
trace O
MR O
with O
moderate O
TR O
. O
 
A O
peak O
systolic O
artery O
pressure O
of I-DATE
64 O
plus O
right O
atrial O
pressure O
was O
noted O
. O
 
In O
summary O
Dr. O
Rodriquez I-NAME
is O
a O
77-year-old O
gentleman O
with O
a O
clear O
cut O
pulmonary O
hypertension O
. O
 
The O
etiology O
of I-DATE
this O
is O
not O
clear O
at O
the O
moment O
. O
 
Differential O
diagnosis O
could O
include O
chronic O
thromboembolic O
disease O
, O
occult O
underlying O
pulmonary O
disease O
( O
doubt O
) O
, O
obstructive O
sleep O
apnea O
, O
and I-LOCATION
collagen O
vascular O
disease O
. O
 
In O
addition O
some O
patients O
develop O
a O
marked O
pulmonary O
artery O
hypertension O
in O
the O
setting O
of I-DATE
stiff O
left O
ventricle O
even O
with O
preserved O
left O
ventricular O
function O
although O
this O
I O
think O
would O
be O
a O
diagnosis O
of I-DATE
exclusion O
. O
 
The O
degree O
of I-DATE
his O
edema O
is O
quite O
striking O
and I-LOCATION
I O
agree O
with O
increasing O
his O
diuretic O
regimen O
. O
 
I O
'm O
embarking O
on O
a O
course O
of I-DATE
evaluation O
to O
exclude O
the O
most O
likely O
causes O
. O
 
In O
specific O
he O
will O
be O
having O
a O
CT O
with O
IV O
contrast O
to O
rule O
out O
chronic O
thromboembolic O
disease O
this O
afternoon O
. O
 
This O
has O
already O
been O
arranged O
by O
Dr. O
Faust I-NAME
. O
 
In O
addition O
I O
'm O
sending O
serology O
including O
an O
ANA O
, O
an O
antidouble O
stranded O
DNA O
and I-LOCATION
an O
anti O
SCL70 O
. O
 
I O
've O
also O
asked O
Dr. O
Rodriquez I-NAME
Page O
4 O
Freeman I-NAME
Faust I-NAME
, O
M.D O
. O
 
RE O
: O
Jacob I-NAME
Rodriquez I-NAME
, O
M.D O
. O
 
January I-DATE
18 O
, O
2120 I-DATE
to O
undergo O
polysonography O
to O
exclude O
obstructive O
sleep O
apnea O
. O
 
He O
will O
be O
following O
up O
with O
our O
pulmonary O
function O
lab O
to O
have O
formal O
pulmonary O
function O
testing O
performed O
in O
addition O
to O
having O
an O
arterial O
blood O
gas O
drawn O
. O
 
If O
this O
evaluation O
should O
be O
unrevealing O
, O
he O
may O
require O
more O
invasive O
diagnostics O
. O
 
I O
've O
already O
consulted O
formally O
with O
Dr. O
Eddie I-NAME
Roy I-NAME
, O
the O
physician O
with O
most O
experience O
in O
pulmonary O
hypertension O
at O
this O
hospital O
and I-LOCATION
he O
would O
be O
able O
to O
assist O
us O
in O
the O
further O
evaluation O
of I-DATE
Dr. O
Rodriquez I-NAME
if O
our O
workup O
is O
nondiagnostic O
. O
 
Dr. O
Faust I-NAME
, O
thank O
you O
again O
for O
referring O
Dr. O
Rodriquez I-NAME
for O
evaluation O
. O
 
I O
'll O
plan O
on O
seeing O
him O
in O
approximately O
three O
to O
four O
weeks O
after O
his O
diagnostic O
tests O
have O
been O
performed O
. O
 
Please O
do O
not O
hesitate O
to O
call O
me O
with O
any O
further O
questions O
or O
concerns O
. O
 
Sincerely O
, O
Jose I-NAME
Church I-NAME
, O
M.D O
. O
 
/ray O
DD O
: O
01/18/20 I-DATE
DT O
: O
01/19/:0 I-DATE
DV O
: O
01/18/20 I-DATE
 
Record O
date O
: O
2120-09-08 I-DATE
MARY I-LOCATION
EMERGENCY O
DEPT O
VISIT O
RODRIQUEZ O
, O
JACOB O
863-35-65-5 I-ID
VISIT O
DATE O
: O
09/08/20 I-DATE
I O
saw O
and O
examined O
the O
patient O
personally O
. O
 
I O
also O
reviewed O
and O
confirm O
the O
resident O
's O
detailed O
note O
. O
 
Please O
refer O
to O
it O
. O
 
PRESENTING O
COMPLAINT O
: O
Foot O
ulcer O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
is O
a O
78-year-old O
gentleman O
who O
is O
a O
diabetic O
developed O
left O
foot O
ulcer O
six O
weeks O
ago O
after O
he O
had O
shaving O
of O
some O
calluses O
by O
a O
podiatrist O
. O
 
The O
wound O
has O
not O
healed O
and O
then O
got O
infected O
. O
 
He O
was O
started O
on O
Keflex O
, O
then O
when O
the O
initial O
cultures O
came O
back O
showing O
resistance O
to O
Keflex O
so O
he O
was O
switched O
to O
Cipro O
, O
however O
, O
his O
final O
cultures O
showed O
MRSA O
. O
 
He O
comes O
in O
with O
increasing O
redness O
and O
pain O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
diabetes O
, O
peripheral O
vascular O
disease O
, O
mitral O
regurgitation O
, O
anemia O
, O
sleep O
apnea O
and O
pulmonary O
hypertension O
. O
 
MEDICATIONS O
: O
Documented O
on O
the O
chart O
. O
 
ALLERGIES O
: O
Documented O
on O
the O
chart O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
He O
is O
a O
Electrician I-PROFESSION
. O
 
He O
drinks O
alcohol O
occasionally O
, O
he O
does O
not O
smoke O
. O
 
Family O
history O
of O
kidney O
stones O
. O
 
PHYSICAL O
EXAMINATION O
: O
VITAL O
SIGNS O
: O
He O
is O
afebrile O
, O
vital O
signs O
are O
stable O
. O
 
GENERAL O
: O
The O
patient O
was O
awake O
, O
alert O
in O
no O
distress O
. O
 
He O
does O
not O
look O
toxic O
. O
 
HEART O
: O
He O
had O
a O
small O
heart O
murmur O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
. O
 
ABDOMEN O
: O
Soft O
and O
nontender O
. O
 
EXTREMITIES O
: O
He O
had O
multiple O
ulcers O
on O
his O
left O
foot O
, O
stage O
two O
or O
three O
, O
an O
ulcer O
on O
his O
heel O
as O
well O
as O
the O
distal O
third O
and O
fourth O
toes O
. O
 
There O
was O
some O
mild O
surrounding O
cellulitis O
. O
 
He O
had O
3+ O
pedal O
edema O
. O
 
The O
casts O
were O
symmetric O
and O
nontender O
. O
 
There O
is O
no O
adenopathy O
. O
 
LABORATORY O
EVALUATION O
: O
The O
patient O
had O
a O
white O
count O
of O
about O
16 O
, O
mildly O
elevated O
but O
no O
bandemia O
. O
 
His O
BUN O
and O
creatinine O
were O
50 O
and O
1.8 O
. O
 
Blood O
cultures O
were O
sent O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
He O
was O
given O
a O
dose O
of O
Vancomycin O
. O
 
Surgery O
was O
consulted O
. O
 
The O
primary O
came O
and O
saw O
the O
patient O
as O
well O
and O
he O
was O
admitted O
to O
the O
hospital O
. O
 
FINAL O
DIAGNOSIS O
: O
Diabetic O
foot O
ulceration O
with O
cellulitis O
, O
rule O
out O
osteomyelitis O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Condition O
is O
stable O
. O
 
___________________________________ O
TT554/9917 I-ID
CHRISTOPHER I-NAME
QUIGLEY I-NAME
, O
M.D O
. O
 
CQ03 I-NAME
D:09/09/20 O
T:09/09/20 O
Dictated O
by O
: O
CHRISTOPHER I-NAME
QUIGLEY I-NAME
, O
M.D O
. O
 
CQ03 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2120-12-15 I-DATE
Chief O
Complaint O
This O
is O
a O
visit O
for O
this O
patient O
with O
a O
chief O
complaint O
1.diabetes O
management O
, O
difficulty O
getting O
in O
control.Also O
to O
monitor O
for O
potential O
complications O
of O
treatment O
and O
complications O
of O
the O
disease O
. O
 
2. O
followup O
of O
ulcers O
on O
feet O
3. O
edema O
4. O
hypertension O
5. O
pulmonary O
hypertension O
Problems O
Venous O
insufficiency O
Edema O
Mitral O
regurgitation O
Anemia O
Hypertension O
Bundle O
branch O
block O
Pulmonary O
hypertension O
Diabetes O
mellitus O
Sleep O
apnea O
Lower O
extremity O
ulcer O
History O
of O
Present O
Illness O
Diabetes= O
on O
oral O
agents- O
just O
glyburide O
one O
2.5 O
mg O
qd O
Trying O
to O
keep O
diet O
- O
reviewed O
weight O
: O
stable O
Keeps O
track O
of O
sugars- O
Does O
not O
Bring O
in O
book O
to O
review O
- O
but O
says O
that O
sugars O
are O
running O
about O
200 O
past O
two O
weeks O
No O
hypoglycemic O
episodes O
no O
polyuria O
, O
polydipsia O
, O
no O
fevers O
, O
no O
weight O
loss O
2. O
followup O
of O
ulcers O
on O
feet- O
ws O
to O
have O
started O
on O
antibiotics O
wednesday O
, O
but O
the O
prescription O
was O
not O
delivered O
. O
 
Three/of O
four O
ulcers O
have O
healed O
. O
 
Seeing O
nurse O
daily O
for O
dressing O
changes O
. O
 
Has O
heel O
pad O
to O
remove O
pressure O
3. O
edema O
taking O
zaroxylyn O
and O
lasix O
better O
controlled O
when O
on O
both O
4. O
hypertension O
on O
lisinopril O
, O
lasix O
. O
 
not O
on O
atenolol O
? O
 
why O
5. O
pulmonary O
hypertension O
not O
using O
his O
CPAP O
- O
did O
not O
like O
it O
this O
summer O
-- O
found O
it O
hot O
. O
 
Discussed O
- O
advised O
to O
try O
again O
. O
 
Past O
Medical O
History O
Past O
Medical O
History O
- O
pulm O
hypertension O
sleep O
apnea O
diabetes O
mitral O
regurg O
anemia O
, O
felt O
secondary O
to O
HCTZ O
RBBB O
+PPD O
in O
college O
Allergies O
METFORMIN O
Diarrhea O
EDECRIN O
( O
ETHACRYNATE O
SODIUM O
) O
GI O
upset O
HCTZ O
( O
HYDROCHLOROTHIAZIDE O
) O
Hemolytic O
anemia O
Preventive O
Health O
History O
says O
he O
is O
up O
to O
date O
. O
 
has O
not O
had O
colonoscopy- O
we O
are O
waiting O
for O
ulcers O
to O
heal O
, O
etc O
. O
 
Habits O
smoking-no O
drink O
alcohol-social O
only O
drug O
use O
no O
illicit O
drugs O
seat O
belts O
yes O
Review O
of O
Systems O
Constitutional O
: O
no O
weight O
loss O
, O
fevers O
, O
fatigue O
, O
aches O
Skin O
: O
Persistent O
rash O
on O
back O
, O
responsive O
to O
steroid O
cream O
; O
No O
change O
moles O
HEENT O
: O
saw O
eye O
doctor O
- O
has O
hemorrhage O
- O
to O
get O
laser O
treatment O
Respir O
: O
no O
cough O
, O
sputum O
; O
no O
wheezing O
Cor O
: O
no O
chest O
pain O
, O
SOB O
, O
PND O
. O
 
+edema O
GI O
: O
no O
heartburn O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
constip O
GU O
: O
no O
dysuria O
, O
frequency O
, O
urgency O
, O
hematuria O
Endo O
: O
no O
sweating O
, O
heat O
intolerance O
Heme O
: O
no O
bruising O
, O
bleeding O
Vital O
Signs O
Blood O
Pressure O
: O
164/86 O
Weight O
: O
185 O
Pounds O
Physical O
Exam O
WdWN O
male O
164/86 O
185 O
pounds O
82 O
eczema O
on O
back O
with O
some O
round O
1+ O
palpable O
femoral O
pulses O
bilaterally O
, O
nonpalp O
popliteal O
arteries O
. O
 
Neuropathic O
ulcers O
on O
heel O
, O
left O
foot O
: O
ulcer O
on O
heel O
still O
open O
, O
with O
some O
drainage O
. O
 
clean O
margins O
edema O
1+ O
Neck O
: O
supple O
no O
nodes O
; O
thyroid O
not O
enlarged O
, O
no O
nodules O
. O
 
no O
bruits O
CHEST O
: O
some O
crackles O
at O
bases O
, O
R O
> O
L O
; O
no O
wheezes O
, O
rhonchi O
COR O
: O
reg O
rhythm O
, O
murm O
, O
soft O
, O
systolic O
blowing O
m O
; O
, O
No O
thrill O
, O
gallop O
, O
rub O
ABD O
: O
soft O
, O
BS O
nl O
. O
 
no O
masses O
No O
liver/spleen O
enlarg O
; O
no O
tendrnes O
Impression O
Diabetes O
. O
 
on O
glyburide O
+ O
evidence O
of O
visual O
changes O
( O
hemorrhage O
) O
- O
followed O
by O
ophthal O
No O
evid O
of O
hypoglycemic O
episodes O
by O
hx O
. O
 
Not O
adequately O
controlled O
on O
current O
regimen O
. O
 
2. O
followup O
of O
ulcers O
on O
feet- O
three O
healed O
, O
one O
still O
open O
3. O
edema O
pretty O
good O
control O
4. O
hypertension O
still O
not O
adequately O
controlled O
5. O
pulmonary O
hypertension O
Plan O
Total O
face-to-face O
visit O
time O
: O
45 O
minutes O
Time O
spent O
counselling O
: O
38 O
min O
Diagnosis O
explained O
reviewed O
potential O
complications O
of O
diabetes O
reviewed O
diet O
reviewed O
meds O
- O
increase O
glyburide O
Ophthalmology O
return O
in O
one O
month O
2. O
followup O
of O
ulcers O
on O
feet O
3. O
edema O
4. O
hypertension O
5. O
pulmonary O
hypertension O
Return O
: O
 
Record O
date O
: O
2121-03-28 I-DATE
Chief O
Complaint O
This O
is O
a O
visit O
for O
this O
patient O
with O
a O
chief O
complaint O
1.diabetes O
managementAlso O
to O
monitor O
for O
potential O
complications O
of O
treatment O
and O
complications O
of O
the O
disease O
. O
 
2. O
followup O
of O
ulcers O
on O
feet O
3. O
edema O
4. O
hypertension O
5. O
pulmonary O
hypertension O
Problems O
Venous O
insufficiency O
Edema O
Mitral O
regurgitation O
Anemia O
Hypertension O
Bundle O
branch O
block O
Pulmonary O
hypertension O
Diabetes O
mellitus O
Sleep O
apnea O
Lower O
extremity O
ulcer O
History O
of O
Present O
Illness O
Diabetes= O
on O
oral O
agents- O
just O
glyburide O
5mg O
tab O
bid O
Trying O
to O
keep O
diet O
- O
reviewed O
Says O
sugars O
in O
range O
- O
tho O
again O
no O
diary.Tells O
me O
that O
sugars O
usually O
in O
acceptable O
range O
, O
tho O
once O
was O
55 O
. O
 
No O
other O
hypoglycemic O
episodes O
no O
polyuria O
, O
polydipsia O
, O
no O
fevers O
, O
no O
weight O
loss O
We O
talked O
again O
about O
bringing O
in O
his O
log- O
I O
suspect O
he O
is O
very O
out O
of O
range O
but O
dont O
know O
, O
and O
his O
report O
of O
sugars O
of O
55 O
make O
me O
concerned O
about O
increasing O
meds O
. O
 
Still O
having O
problems O
with O
ulcers O
- O
seeing O
Dr O
Ulbrich I-NAME
regularly O
seeing O
nurse O
daily O
for O
dressing O
changes O
. O
 
Has O
heel O
pad O
to O
remove O
pressure O
. O
 
Has O
had O
shoes O
checked O
. O
 
Is O
to O
see O
Dr O
Ulbrich I-NAME
's O
nurse O
today O
for O
debridement O
. O
 
Is O
off O
antibiotics O
now O
; O
was O
on O
? O
 
a O
few O
weeks O
ago O
? O
? O
 
3. O
edema- O
good O
control O
recently O
taking O
zaroxylyn O
and O
lasix O
better O
controlled O
when O
on O
both O
4. O
hypertension O
on O
lisinopril O
, O
lasix O
. O
 
not O
on O
atenolol O
- O
he O
stopped O
it O
because O
he O
did O
not O
like O
it O
, O
made O
him O
feel O
sleepy O
. O
 
Need O
to O
consider O
increasing O
bp O
meds- O
will O
await O
Creatinine O
tpday O
5. O
pulmonary O
hypertension O
not O
using O
his O
CPAP O
- O
did O
not O
like O
it O
Discussed O
- O
advised O
to O
try O
again.we O
reviewed O
the O
whole O
issue O
of O
pulm O
hypertension/ O
leg O
swelling O
etc O
Past O
Medical O
History O
Past O
Medical O
History O
- O
pulm O
hypertension O
sleep O
apnea O
diabetes O
mitral O
regurg O
anemia O
, O
felt O
secondary O
to O
HCTZ O
RBBB O
+PPD O
in O
college O
Allergies O
METFORMIN O
Diarrhea O
EDECRIN O
( O
ETHACRYNATE O
SODIUM O
) O
GI O
upset O
HCTZ O
( O
HYDROCHLOROTHIAZIDE O
) O
Hemolytic O
anemia O
Preventive O
Health O
History O
says O
he O
is O
up O
to O
date O
. O
 
has O
not O
had O
colonoscopy- O
we O
are O
waiting O
for O
ulcers O
to O
heal O
, O
etc O
. O
 
Habits O
smoking-no O
drink O
alcohol-social O
only O
drug O
use O
no O
illicit O
drugs O
seat O
belts O
yes O
Review O
of O
Systems O
Constitutional O
: O
no O
weight O
loss O
, O
fevers O
, O
++fatigue O
, O
NOaches O
Skin O
: O
rash O
better O
( O
shingles O
) O
HEENT O
: O
Got O
laser O
treatment- O
stable O
Respir O
: O
no O
cough O
, O
sputum O
; O
no O
wheezing O
Cor O
: O
no O
chest O
pain O
, O
SOB O
, O
PND O
. O
 
+edema O
, O
. O
 
better O
than O
before O
GI O
: O
no O
heartburn O
, O
nausea O
, O
vomiting O
, O
constip O
. O
 
GU O
: O
no O
dysuria O
, O
frequency O
, O
urgency O
, O
hematuria O
Endo O
: O
no O
sweating O
, O
heat O
intolerance O
Heme O
: O
no O
bruising O
, O
bleeding O
Vital O
Signs O
Blood O
Pressure O
: O
140/80 O
Left O
Arm O
Weight O
182 O
today O
Physical O
Exam O
WdWN O
male O
eczema O
on O
back O
1+ O
palpable O
femoral O
pulses O
bilaterally O
, O
nonpalp O
popliteal O
arteries O
. O
 
Feet O
: O
dressings O
not O
changed O
as O
he O
is O
sseeing O
Dr O
Ulbrich I-NAME
shortly O
after O
this O
apt O
today O
1+ O
femoral O
pulses O
bilaterallyNothing O
palp O
below O
Neck O
: O
supple O
no O
nodes O
; O
thyroid O
not O
enlarged O
, O
no O
nodules O
. O
 
no O
bruits O
CHEST O
: O
some O
crackles O
at O
bases O
, O
R O
> O
L O
; O
no O
wheezes O
, O
rhonchi O
Extrem O
: O
1+ O
edema O
Impression O
Diabetes O
. O
 
on O
glyburide O
+ O
evidence O
of O
visual O
changes O
( O
hemorrhage O
) O
- O
followed O
by O
ophthal O
? O
 
hypoglycemic O
episodes O
by O
hx O
. O
 
? O
? O
 
adequately O
controlled O
on O
current O
regimen O
. O
 
Last O
A1C O
very O
high O
. O
 
If O
still O
high O
, O
I O
think O
he O
needs O
much O
more O
help O
getting O
in O
control O
. O
 
Since O
he O
sees O
nurse O
daily O
, O
will O
have O
to O
ask O
for O
her O
to O
check O
sugars O
, O
adjust O
meds O
after O
. O
 
2. O
ulcers O
3. O
edema O
4. O
hypertension O
not O
adequately O
controlled O
5. O
pulmonary O
hypertension O
6 O
. O
 
Renal O
insuff- O
need O
to O
better O
control O
his O
sugars O
and O
bp O
7 O
anemia O
8 O
. O
 
Really O
overall O
not O
doing O
well O
. O
 
Plan O
1 O
. O
 
Diabetes O
: O
will O
check O
A1C O
and O
sugar O
. O
 
Will O
contact O
VNA O
to O
begin O
sugars O
by O
VNA O
so O
we O
can O
try O
and O
control O
better O
. O
 
reviewed O
meds O
- O
reviewed O
vascular O
complications O
reviewed O
checking O
sugars O
and O
bringing O
in O
book O
2. O
followup O
of O
ulcers O
on O
feet O
to O
see O
Dr O
Ulbrich I-NAME
. O
 
3. O
edema O
continue O
current O
combination O
of O
lasix O
and O
zaroxy O
. O
 
Check O
K O
, O
creat O
4. O
hypertension O
check O
renal O
function O
- O
? O
 
restart O
atenolol O
or O
add O
increase O
lisinopril O
5. O
pulmonary O
hypertension O
encourage O
cpap O
6. O
anemia- O
check O
if O
elig O
for O
epo O
Could O
start O
at O
40000u/week O
Return O
: O
one O
month O
Call O
pt O
when O
i O
have O
results O
Note O
: O
reviewed O
old O
heme O
values O
. O
 
Tends O
to O
run O
high O
WBC O
, O
low O
lymphs O
, O
high O
ESR O
. O
 
? O
? O
? O
 
why O
. O
 
May O
need O
heme O
consult O
. O
 
Record O
date O
: O
2078-05-01 I-DATE
HENDRICKS O
, O
HANNAH I-NAME
75322175 I-ID
05/01/2078 I-DATE
Hunter I-NAME
N. I-NAME
Ishikawa I-NAME
, O
M.D O
. O
 
Surgery O
03 I-LOCATION
Greenwood I-LOCATION
Drive I-LOCATION
Dyersville I-LOCATION
, O
WI I-LOCATION
69617 I-LOCATION
Dear O
Hicks I-NAME
, O
I O
had O
the O
pleasure O
of I-PROFESSION
seeing O
Hannah I-NAME
Hendricks I-NAME
in O
Internal O
Medicine O
today O
. O
 
She O
was O
seen O
alongside O
my O
attending O
, O
Dr. O
Heidi I-NAME
Erik-Roy I-NAME
. O
 
As O
you O
know O
, O
she O
is O
a O
lovely O
52-year-old O
female O
in O
whom O
you O
have O
found O
a O
left O
lower O
extremity O
bypass O
surgery O
. O
 
She O
comes O
in O
today O
for O
perioperative O
risk O
assessment O
. O
 
Ms. O
Hendricks I-NAME
tells O
me O
that O
she O
has O
longstanding O
type O
1 O
diabetes O
, O
hypertension O
, O
hyperlipidemia O
, O
and O
peripheral O
arterial O
disease O
. O
 
She O
in O
fact O
has O
undergone O
lower O
extremity O
bypass O
grafting O
in O
both O
her O
left O
and O
right O
lower O
extremities O
. O
 
Specifically O
, O
she O
is O
status O
post O
a O
right O
fem-pop O
bypass O
in O
2066 I-DATE
and O
a O
left O
fem-DP O
bypass O
also O
in O
2066 I-DATE
. O
 
It O
appears O
that O
her O
right O
graft O
has O
been O
functioning O
well O
, O
but O
her O
left O
graft O
was O
noted O
to O
be O
occluded O
many O
years O
ago O
. O
 
She O
comes O
in O
now O
with O
a O
nonhealing O
ulcer O
and O
gangrene O
in O
her O
left O
toe O
. O
 
You O
have O
planned O
a O
redo O
bypass O
for O
this O
upcoming O
Saturday I-DATE
. O
 
Ms. O
Hendricks I-NAME
tells O
me O
that O
she O
has O
never O
had O
any O
history O
of I-PROFESSION
coronary O
artery O
disease O
. O
 
She O
has O
never O
had O
any O
chest O
discomfort O
, O
shortness O
of I-PROFESSION
breath O
, O
orthopnea O
, O
PND O
, O
lower O
extremity O
edema O
, O
palpitations O
, O
lightheadedness O
, O
or O
syncope O
. O
 
She O
does O
have O
a O
strong O
family O
history O
of I-PROFESSION
coronary O
artery O
disease O
with O
a O
brother O
who O
had O
several O
myocardial O
infarctions O
and O
died O
at O
the O
age O
of I-PROFESSION
48 I-AGE
of I-PROFESSION
an O
MI O
. O
 
She O
has O
a O
report O
of I-PROFESSION
a O
prior O
EKG O
with O
suggestion O
of I-PROFESSION
an O
old O
anteroseptal O
MI O
. O
 
She O
has O
never O
had O
any O
evaluation O
for O
underlying O
coronary O
artery O
disease O
nor O
has O
she O
had O
any O
symptoms O
referable O
to O
CAD O
. O
 
In O
terms O
of I-PROFESSION
her O
functional O
capacity O
, O
she O
tells O
me O
that O
up O
until O
a O
year O
ago O
, O
she O
was O
doing O
spinning O
classes O
without O
any O
chest O
discomfort O
or O
shortness O
of I-PROFESSION
breath O
whatsoever O
. O
 
Because O
of I-PROFESSION
increasing O
discomfort O
in O
her O
left O
lower O
extremity O
, O
she O
had O
to O
reduce O
her O
exercise O
and O
of I-PROFESSION
late O
has O
only O
been O
able O
to O
do O
weightlifting O
without O
aerobic O
exercise O
. O
 
She O
is O
however O
able O
to O
climb O
stairs O
in O
her O
home O
without O
any O
discomfort O
in O
her O
chest O
or O
any O
shortness O
of I-PROFESSION
breath O
. O
 
She O
is O
unfortunately O
limited O
significantly O
by O
foot O
pain O
. O
 
Her O
past O
medical O
history O
is O
as O
noted O
above O
including O
type O
1 O
diabetes O
for O
which O
she O
uses O
an O
insulin O
pump O
, O
peripheral O
arterial O
disease O
, O
status O
post O
bilateral O
lower O
extremity O
bypass O
, O
hypertension O
, O
and O
hyperlipidemia O
. O
 
Her O
current O
medications O
include O
aspirin O
325 O
mg O
, O
which O
she O
started O
a O
few O
days O
ago O
, O
Lipitor O
10 O
mg O
once O
daily O
, O
Diovan O
160 O
mg O
twice O
daily O
, O
vitamin O
C O
, O
vitamin O
B O
and O
folic O
acid O
supplementation O
. O
 
She O
has O
no O
clear O
drug O
allergies O
, O
but O
does O
get O
nauseous O
and O
vomiting O
with O
Percocet O
. O
 
She O
is O
a O
past O
smoker O
and O
had O
smoked O
for O
approximately O
three O
years O
, O
one O
pack O
per O
day O
in O
her O
early O
20s O
. O
 
She O
works O
as O
a O
Senior I-PROFESSION
Manager I-PROFESSION
of I-PROFESSION
Broadcasting I-PROFESSION
at O
giant I-LOCATION
food I-LOCATION
in O
Albemarle I-LOCATION
. O
 
As O
I O
mentioned O
previously O
, O
her O
family O
history O
is O
notable O
for O
a O
brother O
who O
died O
of I-PROFESSION
an O
MI O
in O
his O
late O
40s O
. O
 
On O
physical O
examination O
, O
her O
blood O
pressure O
is O
135/79 O
, O
heart O
rate O
is O
97 O
and O
her O
weight O
is O
137 O
pounds O
. O
 
In O
general O
, O
she O
is O
very O
well O
appearing O
and O
in O
no O
apparent O
distress O
at O
rest O
. O
 
She O
has O
a O
jugular O
venous O
pressure O
of I-PROFESSION
approximately O
5 O
cm O
of I-PROFESSION
water O
. O
 
She O
has O
2+ O
carotids O
with O
no O
audible O
bruits O
. O
 
Her O
upper O
extremities O
demonstrate O
2+ O
brachial O
and O
radial O
pulses O
bilaterally O
. O
 
Her O
chest O
is O
clear O
to O
auscultation O
bilaterally O
. O
 
Her O
cardiac O
exam O
reveals O
a O
regular O
rate O
and O
rhythm O
, O
normal O
S1 O
and O
S2 O
, O
and O
a O
soft O
2/6 O
systolic O
ejection O
murmur O
best O
heard O
at O
the O
left O
sternal O
border O
. O
 
Her O
abdomen O
is O
benign O
. O
 
She O
has O
no O
abdominal O
bruits O
and O
no O
significantly O
palpable O
aorta O
. O
 
Her O
lower O
extremity O
exam O
is O
notable O
for O
a O
hyperemic O
left O
foot O
with O
a O
bandage O
, O
which O
is O
covering O
what O
is O
reportedly O
a O
gangrenous O
toe O
. O
 
Her O
left O
lower O
extremity O
pulses O
are O
1+ O
in O
the O
femoral O
, O
absent O
popliteal O
and O
absent O
distal O
pulses O
. O
 
In O
her O
right O
lower O
extremity O
, O
she O
has O
1+ O
femoral O
, O
with O
no O
bruit O
, O
2+ O
popliteal O
, O
2+ O
DP O
and O
1+ O
PT O
. O
 
An O
EKG O
done O
in O
our O
clinic O
today O
demonstrates O
a O
normal O
sinus O
rhythm O
at O
a O
rate O
of I-PROFESSION
97 O
beats O
per O
minute O
with O
a O
left O
axis O
deviation O
. O
 
There O
is O
left O
atrial O
enlargement O
and O
Q-waves O
in O
V1 O
through O
V3 O
suggestive O
of I-PROFESSION
an O
old O
anteroseptal O
MI O
. O
 
There O
are O
also O
Q-waves O
in O
lead O
III O
and O
aVF O
, O
which O
raises O
suspicion O
of I-PROFESSION
an O
old O
inferior O
MI O
. O
 
In O
summary O
, O
Ms. O
Hendricks I-NAME
is O
a O
lovely O
52-year-old O
female O
with O
longstanding O
diabetes O
, O
hypertension O
, O
hyperlipidemia O
, O
and O
peripheral O
arterial O
disease O
who O
comes O
in O
today O
for O
perioperative O
risk O
assessment O
in O
light O
of I-PROFESSION
an O
anticipated O
redo O
left O
lower O
extremity O
bypass O
graft O
. O
 
She O
appears O
to O
have O
an O
excellent O
functional O
capacity O
up O
until O
several O
months O
ago O
. O
 
However O
, O
I O
am O
concerned O
by O
her O
electrocardiogram O
, O
which O
raises O
the O
suspicion O
of I-PROFESSION
underlying O
coronary O
artery O
disease O
given O
the O
findings O
of I-PROFESSION
a O
probable O
inferior O
and O
old O
anteroseptal O
myocardial O
infarction O
. O
 
As O
such O
, O
I O
think O
that O
it O
would O
be O
wise O
to O
better O
delineate O
her O
burden O
of I-PROFESSION
coronary O
artery O
disease O
by O
way O
of I-PROFESSION
a O
stress O
test O
prior O
to O
her O
surgery O
. O
 
Given O
that O
her O
functional O
status O
has O
been O
so O
good O
up O
until O
recently O
, O
I O
do O
not O
think O
that O
we O
need O
to O
delay O
her O
surgery O
. O
 
However O
, O
I O
would O
start O
her O
on O
a O
beta-blocker O
and O
as O
such O
, O
I O
have O
given O
her O
a O
prescription O
for O
atenolol O
25 O
mg O
once O
daily O
, O
which O
she O
will O
start O
today O
and O
continue O
up O
to O
and O
beyond O
the O
perioperative O
period O
. O
 
During O
the O
perioperative O
period O
, O
we O
would O
recommend O
that O
she O
has O
tight O
control O
of I-PROFESSION
her O
blood O
pressure O
and O
heart O
rate O
with O
a O
goal O
blood O
pressure O
less O
than O
120/80 O
and O
a O
goal O
heart O
rate O
less O
than O
60 O
. O
 
I O
would O
also O
make O
sure O
to O
obtain O
a O
postoperative O
EKG O
to O
ensure O
there O
has O
not O
been O
any O
changes O
. O
 
We O
will O
try O
to O
arrange O
for O
an O
exercise O
test O
with O
arm O
ergometry O
and O
MIBI O
imaging O
for O
tomorrow O
morning O
. O
 
If O
we O
are O
unable O
to O
do O
arm O
exercise O
, O
we O
will O
obtain O
an O
adenosine O
MIBI O
. O
 
I O
will O
follow O
up O
with O
the O
results O
tomorrow O
after O
the O
study O
is O
performed O
. O
 
As O
I O
mentioned O
because O
her O
functional O
capacity O
is O
good O
, O
I O
do O
not O
anticipate O
that O
we O
will O
need O
to O
make O
any O
changes O
in O
the O
surgical O
scheduling O
based O
on O
the O
test O
results O
. O
 
This O
is O
more O
in O
order O
to O
give O
us O
a O
sense O
of I-PROFESSION
the O
underlying O
burden O
of I-PROFESSION
coronary O
artery O
disease O
. O
 
It O
was O
a O
pleasure O
seeing O
Ms. O
Hendricks I-NAME
in O
clinic O
today O
. O
 
We O
are O
certainly O
available O
during O
the O
perioperative O
period O
if O
any O
cardiovascular O
issues O
are O
to O
arise O
. O
 
Please O
feel O
free O
to O
contact O
me O
with O
any O
questions O
. O
 
Sincerely O
, O
______________________________ O
Fatima I-NAME
K I-NAME
Baird I-NAME
, O
M.D O
. O
 
eScription O
document:0-1465457 O
IFFocus O
CC O
: O
Trevon I-NAME
Schmidt I-NAME
M.D O
. O
 
54 I-LOCATION
Clinton I-LOCATION
Street I-LOCATION
Decatur I-LOCATION
, O
WI I-LOCATION
96857 I-LOCATION
DD O
: O
05/01/78 I-DATE
DT O
: O
05/02/78 I-DATE
DV O
: O
05/01/78 I-DATE
 
Record O
date O
: O
2078-05-08 I-DATE
ED O
Surgery O
Consult O
Date/Time O
: O
5/8/78 I-DATE
4:56PM O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
Name O
: O
Hendricks I-NAME
, O
Hannah I-NAME
MRN O
# O
75322175 I-ID
Resident O
: O
Xavier I-NAME
G. I-NAME
England I-NAME
, O
MD O
, O
EdM O
Attending O
: O
Dr. O
Hunter I-NAME
Ishikawa I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
CC O
: O
Bleeding O
from O
groin O
wound O
HPI O
: O
Ms. O
Hendricks I-NAME
is O
a O
52yoF O
with O
a O
history O
of O
PVD O
and O
non-healing O
wounds O
of O
the O
LLE O
s/p O
redo O
left O
femoral-tibial O
bypass O
with O
arm O
vein O
on O
5/3/78 I-DATE
who O
was O
discharged O
to O
home O
yesterday O
and O
now O
returns O
after O
she O
noted O
a O
gush O
of O
blood O
from O
her O
left O
groin O
wound O
while O
coughing O
earlier O
today O
. O
 
She O
was O
doing O
well O
until O
this O
morning O
when O
she O
coughed O
and O
immediately O
noted O
that O
her O
left O
pant O
leg O
was O
soaked O
with O
blood O
from O
the O
left O
groin O
down O
the O
left O
leg O
. O
 
When O
she O
took O
off O
her O
pants O
there O
was O
no O
active O
bleeding O
from O
the O
wound O
and O
she O
denies O
any O
light-headedness O
or O
dizziness O
. O
 
There O
has O
been O
no O
further O
bleeding O
from O
the O
wound O
and O
she O
is O
otherwise O
without O
complaints O
. O
 
PMHx O
: O
PVD O
, O
HTN O
, O
Hypercholesterolemia O
PSHx O
: O
Right O
fem-pop O
bypass O
2066 I-DATE
, O
Left O
fem-dp O
bypass O
2066 I-DATE
, O
redo O
left O
fem-pt O
bypass O
5/3/78 I-DATE
. O
 
Meds O
: O
Tylenol O
, O
ASA O
, O
Vitamin O
C O
, O
Atenolol O
, O
Lipitor O
, O
Colace O
, O
Folic O
Acid O
, O
Lactulose O
, O
Milk O
of O
Magnesia O
, O
Oxycodone O
, O
Valsartan O
All O
: O
Percocet- O
& O
gt O
; O
nausea O
SHx O
: O
Denies O
any O
recent O
etoh/ivda/tob O
PE O
: O
98.7 O
78 O
134/72 O
12 O
100 O
% O
on O
RA O
General O
: O
No O
distress O
HEENT O
: O
NCAT O
Chest O
: O
CTAB O
Heart O
: O
RRR O
, O
no O
mrg O
Abdomen O
: O
soft O
, O
NT/NE O
Extremities O
: O
RUE O
wound O
healing O
well O
without O
erythema/warmth/tenderness O
. O
 
Left O
groin O
wound O
with O
small O
mobile O
collection O
at O
cephalad O
portion O
of O
wound O
. O
 
No O
obvious O
bleeding O
. O
 
Pulses O
: O
Biphasic O
dp/pt O
on O
LLE O
Labs O
: O
CBC O
: O
Pending O
Imaging O
: O
LLE O
U/S O
at O
bedside O
: O
3x2 O
cm O
simple O
fluid O
collection O
at O
cephalad O
portion O
of O
groin O
wound O
. O
 
Assessment/Plan O
: O
- O
52yoF O
s/p O
recent O
redo O
left O
fem-tib O
bypass O
with O
right O
arm O
vein O
with O
single O
episode O
of O
bleeding O
from O
left O
groin O
wound O
. O
 
This O
likely O
represents O
extrusion O
of O
a O
postoperative O
hematoma O
. O
 
There O
is O
currently O
no O
evidence O
of O
active O
bleeding O
from O
the O
wound O
. O
 
A O
CBC O
should O
be O
obtained O
in O
the O
ED O
to O
ensure O
that O
her O
hct O
is O
stable O
and O
she O
can O
then O
d/c O
home O
. O
 
She O
will O
follow O
up O
with O
Dr. O
Ishikawa I-NAME
at O
her O
scheduled O
postop O
visit O
. O
 
Should O
the O
bleeding O
persist O
or O
return O
she O
should O
return O
to O
the O
ER O
or O
the O
clinic O
for O
a O
vascular O
U/S O
to O
assess O
for O
a O
pseudoaneurysm O
or O
AV O
fistula O
. O
 
D/W O
Dr. O
Casey I-NAME
Iacono I-NAME
( O
Surgery O
Fellow O
) O
, O
who O
agrees O
with O
assessment O
and O
plan O
. O
 
Thanks O
, O
Xavier I-NAME
G. I-NAME
England I-NAME
, O
MD O
, O
EdM O
# O
15725 I-CONTACT
 
Record O
date O
: O
2078-09-17 I-DATE
HENDRICKS O
, O
HANNAH I-NAME
75322175 I-ID
09/17/2078 I-DATE
Trevon I-NAME
Schmidt I-NAME
, O
M.D O
. O
 
47 I-LOCATION
Clinton I-LOCATION
Street I-LOCATION
, O
Guite O
299 O
Decatur I-LOCATION
, O
WI I-LOCATION
33955 I-LOCATION
Dear O
Dr. O
Schmidt I-NAME
: O
Your O
patient O
, O
Hannah I-NAME
Hendricks I-NAME
, O
was O
in O
the O
Surgery O
Clinic O
today O
. O
 
As O
you O
know O
, O
she O
is O
a O
52-year-old O
woman O
with O
a O
history O
of O
peripheral O
vascular O
disease O
. O
 
She O
underwent O
a O
redo O
left O
femoral O
to O
anterior O
tibial O
bypass O
graft O
using O
basilic O
and O
cephalic O
vein O
from O
her O
right O
arm O
on O
May I-DATE
3 O
, O
2078 I-DATE
. O
 
She O
has O
done O
well O
since O
the O
procedure O
. O
 
She O
is O
now O
comes O
here O
complaining O
of O
left O
foot O
pain O
. O
 
She O
had O
an O
ultrasound O
in O
the O
vascular O
lab O
to O
rule O
out O
a O
DVT O
, O
which O
it O
did O
. O
 
She O
explains O
the O
discomfort O
as O
pain O
and O
burning O
in O
the O
bottom O
of O
her O
foot O
as O
well O
as O
her O
arch O
and O
over O
the O
dorsum O
of O
the O
foot O
. O
 
On O
exam O
, O
she O
is O
a O
well O
appearing O
female O
in O
no O
acute O
distress O
. O
 
She O
is O
alert O
and O
oriented O
x3 O
. O
 
She O
appears O
grossly O
neurologically O
intact O
. O
 
Her O
lower O
extremity O
exam O
reveals O
easily O
palpable O
bypass O
graft O
pulse O
in O
her O
left O
leg O
. O
 
Her O
left O
foot O
is O
warm O
and O
well O
perfused O
and O
she O
has O
a O
very O
small O
pinhole O
ulcer O
over O
the O
plantar O
aspect O
of O
her O
left O
great O
toe O
. O
 
This O
does O
not O
appear O
infected O
and O
I O
can O
not O
probe O
to O
bone O
. O
 
It O
remains O
superficial O
. O
 
She O
has O
no O
other O
ischemic O
skin O
changes O
noted O
. O
 
I O
have O
discussed O
with O
Hannah I-NAME
that O
her O
discomfort O
most O
likely O
is O
due O
to O
peripheral O
neuropathy O
due O
to O
her O
diabetes O
. O
 
She O
also O
experienced O
this O
discomfort O
prior O
to O
her O
surgery O
. O
 
She O
is O
enquiring O
about O
starting O
Neurontin O
. O
 
I O
have O
said O
she O
would O
be O
able O
to O
try O
either O
Neurontin O
or O
Lyrica O
to O
help O
with O
the O
peripheral O
neuropathy O
. O
 
She O
will O
return O
next O
week O
for O
her O
postoperative O
graft O
scan O
to O
assess O
her O
circulation O
. O
 
She O
knows O
to O
contact O
us O
sooner O
if O
thing O
worsen O
. O
 
If O
I O
can O
be O
of O
further O
assistance O
in O
her O
care O
, O
do O
not O
hesitate O
to O
contact O
me O
. O
 
Sincerely O
, O
Hunter I-NAME
Shea I-NAME
, O
MD O
Dictated O
by O
: O
Quanisha I-NAME
Logan I-NAME
, O
PA-C O
 
Record O
date O
: O
2078-09-26 I-DATE
Date O
09/26/2078 I-DATE
Surgery O
ADMISSION O
NOTE O
PATIENT O
: O
Hendricks O
, O
Hannah I-NAME
MRN O
: O
75322175 I-ID
Attending O
: O
Shea I-NAME
CC O
: O
L O
foot O
pain O
HPI O
: O
52 I-AGE
y/o O
F O
with O
Hx O
of I-PROFESSION
HTN O
, O
hyperlipidemia O
, O
PVD O
, O
s/p O
R O
fem-pop O
bypass O
and O
L O
fem-DP O
bypass O
, O
both O
in O
2066 I-DATE
. O
 
She O
was O
doing O
well O
until O
April I-DATE
2078 I-DATE
, O
when O
she O
presented O
with O
a O
non-healing O
ulcer O
and O
gangrene O
in O
her O
L O
third O
toe O
and O
subsequently O
underwent O
a O
redo O
L O
fem-anterior O
tibial O
bypass O
using O
R O
basilic O
and O
cephalic O
veins O
on O
5/3/78 I-DATE
. O
 
On O
6/11/78 I-DATE
she O
had O
graft O
scanning O
, O
which O
indicated O
a O
widely O
patent O
left O
leg O
graft O
and O
ankle-brachial O
indices O
at O
that O
time O
were O
normal O
bilaterally O
. O
 
However O
, O
she O
presented O
on O
9/17/78 I-DATE
c/o O
L O
foot O
pain O
. O
 
On O
physical O
exam O
, O
she O
was O
noted O
to O
have O
a O
very O
small O
pinhole O
ulcer O
over O
the O
plantar O
aspect O
of I-PROFESSION
her O
left O
great O
toe O
. O
 
She O
now O
presents O
with O
increasing O
pain O
, O
& O
# O
8220 O
; O
32 O
& O
# O
8221 O
; O
on O
scale O
0-10 O
that O
is O
constant O
in O
nature O
, O
with O
occasional O
sharp O
spikes O
in O
intensity O
. O
 
She O
also O
confirms O
loss O
of I-PROFESSION
sensation O
and O
motor O
strength O
in O
the O
L O
foot O
, O
but O
there O
is O
no O
paresthesia O
. O
 
She O
denies O
CP O
, O
SOB O
, O
N/V O
, O
flank O
pain O
, O
or O
any O
urinary O
Sx O
and O
has O
no O
history O
of I-PROFESSION
cardiac O
disease O
. O
 
PMH O
: O
- O
diabetes O
type O
1 O
since O
age O
10 I-AGE
- O
PVD O
- O
HTN O
- O
hyperlipidemia O
PSH O
: O
- O
L O
fem-anterior O
tibial O
bypass O
- O
5/3/78 I-DATE
- O
Right O
fem-pop O
bypass O
- O
2066 I-DATE
- O
Left O
fem-DP O
bypass O
& O
# O
8211 O
; O
2066 I-DATE
MEDS O
: O
- O
Atenolol O
25mg O
PO O
QD O
- O
Valsartan O
160mg O
PO O
BID O
- O
ASA O
325mg O
PO O
QD O
- O
Oxycodone O
5-10mg O
PO O
Q3H O
PRN O
pain O
- O
Vitamin O
C O
500mg O
PO O
BID O
- O
Folic O
Acid O
1mg O
PO O
BID O
- O
Colace O
100mg O
PO O
BID O
- O
Neurontin O
300mg O
PO O
TID O
ALL O
: O
Percocet O
- O
nausea O
FH O
: O
Brother O
died O
of I-PROFESSION
heart O
attack O
at O
48 I-AGE
, O
father O
had O
MI O
x3 O
; O
no O
one O
else O
in O
the O
family O
has O
had O
either O
DM O
type O
I O
or O
PVD O
SH O
: O
Lives O
in O
Morehead I-LOCATION
, O
WI I-LOCATION
with O
her O
partner O
. O
 
Smoked O
for O
3 O
years O
in O
her O
early O
20 I-AGE
's O
, O
but O
there O
is O
no O
recent O
EtOH/TOB/IVDU O
. O
 
Works O
as O
a O
Senior I-PROFESSION
Manager I-PROFESSION
of I-PROFESSION
Broadcasting I-PROFESSION
. O
 
PHYSICAL O
EXAMINATION O
: O
VITALS O
97.8 O
74 O
136/48 O
18 O
95 O
% O
RA O
FSglucose O
74 O
General O
& O
# O
8211 O
; O
NAD O
, O
well O
appearing O
Pulmonary O
& O
# O
8211 O
; O
clear O
to O
auscultation O
bilaterally O
, O
with O
no O
crackles O
or O
wheezes O
appreciated O
Cardiac O
& O
# O
8211 O
; O
regular O
rate O
and O
rhythm O
; O
S1 O
and O
S2 O
normal O
; O
no O
murmurs O
, O
rubs O
or O
gallops O
; O
Abdomen O
& O
# O
8211 O
; O
soft O
, O
non-distended O
; O
non-tender O
without O
rebound O
and O
guarding O
Extremity O
& O
# O
8211 O
; O
Warm O
bilaterally O
; O
well-healed O
bypass O
incisions O
bilaterally O
; O
L O
foot O
erythematous O
, O
mildly O
edematous O
; O
no O
clubbing O
, O
cyanosis O
; O
ulcer O
on O
the O
L O
big O
toe O
and O
a O
small O
dermal O
hematoma O
on O
the O
L O
5th O
toe O
; O
tissue O
loss O
of I-PROFESSION
tip O
of I-PROFESSION
2nd O
and O
3rd O
toes O
, O
tip O
of I-PROFESSION
3rd O
toe O
with O
blackened O
, O
necrotic O
tissue O
, O
no O
drainage O
Pulses O
: O
Fem O
Pop O
DP O
PT O
R O
2+ O
2+ O
2+ O
2+ O
L O
2+ O
2+ O
non-dopplerable O
non- O
dopplerable O
Neurology O
& O
# O
8211 O
; O
CN O
II-XII O
grossly O
intact O
, O
5/5 O
motor O
strength O
and O
normal O
sensation O
bilaterally O
including O
L O
foot O
Mental O
status O
& O
# O
8211 O
; O
alert O
and O
oriented O
x O
3 O
-- O
LABORATORIES O
: O
Chem O
7 O
, O
CBC O
, O
coags O
, O
clot O
ordered O
UA O
negative O
-- O
EKG O
: O
Sinus O
; O
rate O
~75 O
; O
normal O
intervals O
; O
normal O
R O
wave O
progression O
; O
T O
wave O
inversion O
in O
V1 O
; O
no O
ST O
segment O
changes O
; O
overall O
comparable O
to O
previous O
EKG O
-- O
RADIOLOGICAL O
STUDIES O
: O
CXR O
09/26/2078 I-DATE
: O
( O
Prelim O
) O
Lung O
fields O
clear O
, O
no O
effusions O
09/26/78 I-DATE
Type O
: O
Arterial O
Ultrasound O
Tests O
The O
following O
are O
the O
velocities O
in O
cm/s O
, O
proximal O
to O
distal O
: O
COMMON O
FEMORAL O
200 O
PROXIMAL O
ANASTOMOSIS O
307 O
PROXIMAL O
GRAFT O
84 O
PROXIMAL O
GRAFT O
211 O
PROXIMAL O
GRAFT O
318 O
PROXIMAL-MID O
94 O
MID O
THIGH O
26 O
DISTAL O
THIGH O
13 O
PROX O
TO O
DISTAL O
ANASTOMOSIS O
5 O
DISTAL O
ANASTOMOSIS O
40 O
Brachial O
pressure=152 O
/ O
Right O
ankle=141 O
abi=0.92 O
/ O
Left O
ankle=30 O
( O
anterior O
tibial O
) O
abi=0.19 O
Date O
: O
09/17/78 I-DATE
Type O
: O
Venous O
Ultrasound O
Tests O
There O
is O
no O
evidence O
of I-PROFESSION
thrombosis O
in O
either O
the O
right O
or O
left O
common O
femoral O
, O
superficial O
femoral O
and O
popliteal O
veins O
. O
 
There O
is O
no O
gross O
evidence O
of I-PROFESSION
deep O
vein O
thrombosis O
in O
the O
left O
calf O
. O
 
Date O
: O
06/11/78 I-DATE
Type O
: O
Arterial O
Ultrasound O
Tests O
right O
brachial O
pressure O
168 O
mmHg O
left O
brachial O
pressure O
169 O
mmhg O
right O
dp O
154 O
mmhg O
left O
dp O
143 O
mmHg O
right O
pt O
156 O
mmHg O
left O
pt O
151 O
mmHg O
Patent O
arterial O
bypass O
graft O
with O
no O
evidence O
of I-PROFESSION
hemodynamically O
significant O
stenosis O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
52 I-AGE
y/o O
F O
with O
Hx O
of I-PROFESSION
diabetes O
type O
I O
and O
PVD O
, O
s/p O
several O
bypasses O
, O
presenting O
with O
worsening O
L O
foot O
pain O
of I-PROFESSION
two O
weeks O
duration O
. O
 
On O
physical O
exam O
, O
L O
foot O
is O
exquisitely O
tender O
and O
while O
it O
is O
warm O
to O
touch O
, O
it O
is O
erythematous O
and O
there O
is O
an O
ulcer O
on O
the O
plantar O
surface O
of I-PROFESSION
the O
big O
toe O
. O
 
In O
addition O
, O
ABIs O
from O
today O
show O
L O
ankle O
ABI O
of I-PROFESSION
0.19 O
. O
 
The O
etiology O
of I-PROFESSION
her O
pain O
is O
an O
occlusion O
of I-PROFESSION
the O
L O
fem-anterior O
tibial O
bypass O
vs. O
diabetic O
neuropathy O
, O
however O
, O
she O
has O
been O
taking O
neurontin O
without O
relief O
and O
the O
diabetic O
neuropathy O
is O
less O
likely O
. O
 
- O
oxycodone O
for O
pain O
control O
, O
continue O
neurontin O
- O
continue O
home O
atenolol O
, O
ASA O
, O
Valsartan O
- O
NPO O
from O
midnight O
, O
pepcid O
- O
check O
chem7 O
, O
CBC O
, O
coags O
- O
has O
an O
insulin O
pump O
- O
angiography O
vs. O
angioplasty O
tomorrow O
_____________ O
Hayden I-NAME
Shepherd I-NAME
MANAMANA I-LOCATION
IV O
01722 I-CONTACT
Patient O
seen O
and O
examined O
. O
 
Agree O
with O
medical O
student O
note O
above O
. O
 
Briefly O
, O
52yF O
with O
DM O
I O
, O
HTN O
, O
hyperlipidemia O
s/p O
bilateral O
revascularization O
procedures O
for O
PVD O
presents O
with O
complaints O
of I-PROFESSION
left O
foot O
pain O
limiting O
walking O
to O
several O
feet O
as O
well O
as O
with O
small O
ulcers O
on O
her O
toes O
. O
 
ABIs O
are O
very O
diminished O
on O
the O
left O
and O
graft O
scan O
shows O
elevated O
velocities O
at O
proximal O
anastomosis O
. O
 
She O
is O
admitted O
in O
anticipation O
of I-PROFESSION
angiography O
in O
am O
. O
 
N O
: O
Cont O
oxycodone O
, O
neurontin O
CV O
: O
Cont O
home O
meds O
Resp O
: O
F/u O
final O
CXR O
read O
GI O
: O
Diabetic O
diet O
; O
NPO O
after O
MN O
GU O
: O
D5 O
& O
# O
189 O
; O
NS O
@ O
100 O
after O
MN O
; O
foley O
to O
be O
placed O
at O
6AM O
Heme O
: O
SQH O
ID O
: O
No O
issues O
Endo O
: O
Patient O
has O
insulin O
pump O
and O
knows O
to O
adjust O
this O
when O
she O
is O
NPO O
Other O
: O
Consent O
for O
angiogram O
in O
chart O
Discussed O
with O
Dr. O
Weller I-NAME
, O
vascular O
chief O
resident O
, O
who O
agrees O
with O
assessment O
and O
plan O
. O
 
______________ O
Kathryn I-NAME
Brewer I-NAME
, O
MD O
PGY O
2 O
Pg O
68283 I-CONTACT
 
Record O
date O
: O
2079-08-04 I-DATE
EDVISIT^75322175^HENDRICKS O
, O
HANNAH^08/04/79^FAULKNER O
, O
GABRIAL I-NAME
CHIEF O
COMPLAINT O
: O
Lower O
extremity O
cellulitis O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
53-year-old O
diabetic O
vasculopathic O
with O
a O
history O
of I-PROFESSION
multiple O
lower O
extremity O
arterial O
bypass O
who O
comes O
in O
today O
with O
bilateral O
lower O
extremity O
cellulitis O
, O
has O
diagnosed O
by O
her O
PCP O
. O
 
She O
was O
recently O
treated O
at O
an O
outside O
hospital O
for O
bilateral O
lower O
extremity O
cellulitis O
, O
had O
a O
2-day O
hospital O
stay O
, O
and O
was O
discharged O
home O
on O
Keflex O
. O
 
She O
felt O
that O
she O
did O
have O
some O
improvement O
but O
over O
the O
past O
48 O
hours O
has O
had O
worsening O
erythema O
in O
lower O
extremities O
. O
 
She O
has O
also O
been O
having O
some O
emesis O
, O
myalgias O
and O
fatigue O
, O
but O
has O
not O
had O
any O
hematemesis O
, O
abdominal O
pain O
, O
constipation O
, O
diarrhea O
, O
or O
other O
symptomatology O
. O
 
She O
has O
also O
not O
noticed O
any O
urinary O
symptoms O
of I-PROFESSION
frequency O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Peripheral O
vascular O
disease O
, O
hypertension O
, O
hyperlipidemia O
, O
and O
diabetes O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Amputation O
to O
the O
left O
second O
, O
third O
and O
fifth O
toes O
, O
bilateral O
fem-pop O
bypasses O
right O
in O
2061 I-DATE
, O
left O
in O
2066 I-DATE
and O
anterior O
tibial O
bypass O
graft O
in O
05/2078 I-DATE
. O
 
SOCIAL O
HISTORY O
: O
The O
patient O
works O
as O
a O
Senior I-PROFESSION
Manager I-PROFESSION
of I-PROFESSION
Broadcasting I-PROFESSION
and O
denies O
tobacco O
, O
alcohol O
, O
or O
drugs O
. O
 
PHYSICAL O
EXAMINATION O
: O
Blood O
pressure O
146/66 O
, O
pulse O
98 O
, O
respiratory O
rate O
20 O
, O
temperature O
101.2 O
, O
and O
O2 O
saturation O
99 O
% O
on O
room O
air O
. O
 
General O
: O
This O
is O
a O
well-appearing O
woman O
in O
no O
apparent O
distress O
. O
 
Respiratory O
: O
Clear O
to O
auscultation O
bilaterally O
, O
no O
rales O
, O
rhonchi O
, O
or O
wheezes O
. O
 
Cardiovascular O
: O
Regular O
rate O
and O
rhythm O
, O
no O
murmurs O
, O
rubs O
, O
or O
gallops O
. O
 
GI O
: O
The O
abdomen O
is O
soft O
. O
 
The O
patient O
does O
have O
insulin O
pump O
in O
place O
, O
but O
has O
no O
erythema O
or O
fluctuance O
over O
the O
pump O
. O
 
Skin O
is O
warm O
, O
dry O
, O
and O
intact O
with O
the O
exception O
of I-PROFESSION
the O
left O
lower O
extremity O
, O
which O
is O
erythematous O
, O
warm O
and O
slightly O
swollen O
compared O
to O
the O
right O
lower O
extremity O
. O
 
This O
erythema O
stops O
at O
the O
ankle O
and O
does O
not O
extend O
up O
above O
the O
knee O
. O
 
The O
patient O
also O
has O
an O
open O
chronic O
nonhealing O
wound O
on O
the O
plantar O
surface O
of I-PROFESSION
her O
left O
foot O
as O
well O
. O
 
There O
is O
no O
erythema O
surrounding O
this O
wound O
Neurologic O
: O
Awake O
, O
alert O
, O
and O
oriented O
x3 O
except O
for O
some O
decreased O
sensation O
in O
her O
left O
foot O
, O
which O
is O
chronic O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
was O
seen O
and O
evaluated O
by O
me O
and O
the O
resident O
. O
 
I O
confirm O
that O
I O
have O
seen O
and O
evaluated O
the O
patient O
, O
reviewed O
the O
resident O
's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of I-PROFESSION
care O
, O
and O
disposition O
with O
the O
patient O
as O
well O
as O
the O
resident O
. O
 
The O
patient O
had O
a O
CBC O
and O
metabolic O
panel O
. O
 
CBC O
showed O
white O
count O
of I-PROFESSION
14 O
with O
shift O
. O
 
LFTs O
were O
within O
normal O
limits O
. O
 
X-ray O
of I-PROFESSION
her O
left O
foot O
showed O
no O
osteomyelitis O
seen O
on O
x-ray O
and O
x-ray O
of I-PROFESSION
her O
tib-fib O
continued O
to O
show O
no O
osteomyelitis O
. O
 
Given O
the O
erythema O
and O
swelling O
, O
I O
was O
concerned O
about O
a O
cellulitis O
in O
this O
vasculopathic O
who O
was O
also O
diabetic O
and O
so O
we O
gave O
her O
a O
1 O
g O
of I-PROFESSION
vancomycin O
( O
especially O
given O
the O
fact O
that O
she O
has O
failed O
outpatient O
therapy O
with O
oral O
antibiotics O
) O
and O
we O
are O
admitting O
her O
to O
the O
Medicine O
Service O
for O
cellulitis O
. O
 
The O
patient's O
erythema O
and O
swelling O
does O
not O
extend O
to O
her O
foot O
and O
would O
be O
extremely O
atypical O
for O
a O
DVT O
. O
 
We O
also O
notified O
the O
Internal O
Medicine O
resident O
of I-PROFESSION
the O
patient O
's O
admission O
to O
Medicine O
as O
she O
is O
followed O
closely O
by O
Surgery O
and O
this O
notification O
was O
made O
at O
8:30 O
p.m O
. O
 
Given O
the O
fact O
that O
she O
does O
not O
have O
osteomyelitis O
at O
this O
point O
we O
have O
not O
discussed O
the O
PICC O
line O
and O
given O
the O
fact O
that O
she O
does O
not O
have O
any O
____ O
abnormalities O
, O
I O
did O
not O
believe O
that O
she O
needs O
pressors O
or O
aggressive O
hydration O
and O
we O
are O
starting O
her O
on O
maintenance O
fluids O
, O
antibiotics O
, O
and O
admitting O
her O
to O
the O
hospital O
. O
 
DIAGNOSIS O
: O
Left O
lower O
extremity O
cellulitis O
. O
 
CONDITION O
: O
Stable O
. O
 
DISPOSITION O
: O
Admit O
to O
hospital O
. O
 
______________________________ O
FAULKNER O
, O
GABRIAL I-NAME
MD O
D O
: O
08/05/79 I-DATE
T O
: O
08/05/79 I-DATE
Dictated O
By O
: O
FAULKNER O
, O
GABRIAL I-NAME
eScription O
document:7-11192535 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2095-03-16 I-DATE
Trinity I-LOCATION
Regional I-LOCATION
Medical I-LOCATION
Center I-LOCATION
8699 I-LOCATION
Mill I-LOCATION
Street I-LOCATION
MARSH O
, O
CARL I-NAME
Albertville I-LOCATION
, O
RI I-LOCATION
87193 I-LOCATION
39955317 I-ID
( O
906 O
) O
517-8625 I-CONTACT
03/16/2095 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Marsh I-NAME
is O
a O
73-year-old O
male O
who O
comes O
for O
first O
visit O
to O
TRMC I-LOCATION
to O
initiate O
longitudinal O
care O
and O
follow O
up O
of O
multiple O
medical O
problems O
. O
 
PROBLEMS O
: O
1 O
. O
 
Chronic O
renal O
failure O
. O
 
He O
has O
been O
on O
dialysis O
for O
the O
past O
four O
years O
. O
 
He O
is O
currently O
dialyzed O
two O
times O
per O
week O
. O
 
He O
apparently O
had O
been O
three O
times O
per O
week O
in O
the O
past O
. O
 
2 O
. O
 
Hyperlipidemia O
. O
 
Fasting O
lipid O
analysis O
one O
year O
ago O
showed O
total O
cholesterol O
225 O
, O
triglycerides O
265 O
, O
LDL O
161 O
, O
and O
HDL O
40 O
. O
 
He O
has O
not O
been O
treated O
. O
 
3 O
. O
 
Hyperparathyroidism O
. O
 
PTH O
level O
one O
year O
ago O
was O
143 O
. O
 
He O
is O
on O
calcium O
replacement O
. O
 
4 O
. O
 
IgG O
monoclonal O
gammopathy O
. O
 
This O
was O
noted O
on O
immunoelectrophoresis O
. O
 
It O
was O
at O
very O
low O
levels O
. O
 
MEDICATIONS O
: O
Aspirin O
81 O
mg O
q.d. O
, O
Nephrocaps O
one O
q.d. O
, O
and O
PhosLo O
2001 O
mg O
t.i.d O
. O
 
by O
his O
report O
. O
 
REVIEW O
OF O
SYMPTOMS O
: O
He O
states O
he O
was O
told O
he O
was O
hypertensive O
at O
last O
dialysis O
. O
 
No O
significant O
weight O
change O
, O
febrile O
signs O
or O
symptoms O
, O
headache O
, O
blurred O
vision O
, O
tinnitus O
, O
chest O
pain O
, O
cough O
, O
shortness O
of O
breath O
, O
nausea O
, O
abdominal O
pain O
, O
nightsweats O
, O
diarrhea O
, O
skin O
rash O
, O
bruising O
, O
joint O
pain O
, O
or O
focal O
weakness O
. O
 
ALLERGIES O
: O
No O
known O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
appears O
well O
. O
 
Blood O
pressure O
on O
multiple O
measurements O
range O
from O
150-160/78-82 O
, O
weight O
144 O
pounds O
, O
and O
heart O
rate O
72 O
and O
regular O
. O
 
Chest O
: O
Clear O
to O
percussion O
and O
auscultation O
. O
 
Cardiovascular O
exam O
: O
No O
extra O
sounds O
or O
murmurs O
. O
 
Abdominal O
exam O
: O
No O
masses O
, O
tenderness O
, O
or O
organomegaly O
. O
 
Extremities O
: O
No O
edema O
. O
 
Skin O
: O
No O
rash O
. O
 
Musculoskeletal O
exam O
: O
Grossly O
intact O
. O
 
ASSESSMENT/PLAN O
: O
1 O
. O
 
Chronic O
renal O
failure O
. O
 
The O
patient O
will O
continue O
on O
dialysis O
. O
 
I O
have O
requested O
screening O
blood O
tests O
. O
 
2 O
. O
 
Hyperlipidemia O
. O
 
This O
needs O
to O
be O
treated O
. O
 
I O
have O
asked O
him O
to O
return O
for O
reestablishment O
of O
baseline O
. O
 
3 O
. O
 
Hyperparathyroidism O
. O
 
Secondary O
to O
chronic O
renal O
failure O
. O
 
He O
is O
on O
calcium O
replacement O
. O
 
4 O
. O
 
Low-grade O
IgG O
monoclonal O
gammopathy O
. O
 
Will O
recheck O
values O
and O
follow O
. O
 
5 O
. O
 
Hypertension O
. O
 
A O
degrees O
systolic O
hypertension O
warrants O
therapy O
. O
 
He O
is O
due O
for O
dialysis O
tomorrow O
, O
however O
. O
 
I O
gave O
him O
a O
prescription O
for O
atenolol O
25 O
mg O
p.o O
. O
 
q.d O
. O
 
6 O
. O
 
Adult O
health O
maintenance O
. O
 
I O
gave O
him O
a O
prescription O
for O
aspirin O
, O
which O
he O
should O
be O
taking O
and O
asked O
him O
to O
return O
in O
two O
weeks O
for O
a O
full O
annual O
review O
. O
 
I O
instructed O
him O
to O
show O
renal O
staff O
the O
prescriptions O
tomorrow O
at O
dialysis O
. O
 
______________________________ O
Xavier I-NAME
T I-NAME
Mccoy I-NAME
, O
M.D O
. O
 
eScription O
document:4-4113812 O
EMS O
DD O
: O
03/16/95 I-DATE
DT O
: O
03/16/95 I-DATE
DV O
: O
03/16/95 I-DATE
 
Record O
date O
: O
2095-09-19 I-DATE
KEKELA I-LOCATION
INPATIENT O
DIALYSIS O
ADMIT O
NOTE O
NAME O
: O
Marsh O
, O
Carl I-NAME
MRN O
: O
99579205 I-ID
Primary O
Care O
MD O
: O
Xavier I-NAME
T. I-NAME
Mccoy I-NAME
Outpatient O
Nephrologist O
: O
Keith I-NAME
Tierney I-NAME
Outpatient O
Dialysis O
Unit O
: O
Sanford I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
, O
S I-DATE
and O
T I-DATE
Estimated O
dry O
weight O
: O
61 O
kg O
Dialysis O
access O
: O
left O
AVF O
Reason O
for O
admission O
: O
body O
jerking O
since O
last O
night O
HPI O
: O
74 I-AGE
year O
old O
Turkmenistan I-LOCATION
male O
with O
a O
past O
medical O
history O
of I-DATE
ESRD O
presumably O
secondary O
to O
HTN O
presents O
to O
the O
KEKELA I-LOCATION
ED O
with O
complaints O
of I-DATE
body O
jerking O
since O
last O
night O
. O
 
The O
patient O
was O
in O
his O
otherwise O
good O
state O
of I-DATE
health O
when O
he O
went O
to O
his O
normal O
dialysis O
session O
yesterday O
. O
 
The O
session O
was O
uneventful O
, O
and O
he O
finished O
dialysis O
around O
7:30 O
pm O
. O
 
Around O
9 O
pm O
, O
he O
started O
noting O
un-controlable O
jerky O
movements O
of I-DATE
his O
jaw O
, O
arms O
, O
and O
legs O
. O
 
He O
was O
unable O
to O
stand O
by O
himself O
, O
and O
had O
difficulty O
with O
any O
motor O
activity O
. O
 
It O
was O
so O
bad O
that O
he O
was O
unable O
to O
feed O
himself O
, O
and O
needed O
help O
from O
his O
wife O
to O
do O
so O
. O
 
The O
jerking O
continued O
throughout O
the O
night O
without O
getting O
better O
, O
and O
his O
daughter O
called O
his O
PCP O
's O
office O
today O
, O
at O
which O
time O
he O
was O
instructed O
to O
proceed O
to O
the O
KEKELA I-LOCATION
ED O
. O
 
He O
has O
had O
a O
similar O
episode O
like O
this O
before O
in O
January I-DATE
of I-DATE
2092 I-DATE
, O
when O
he O
developed O
the O
exact O
same O
jerking O
movements O
after O
a O
long O
three O
day O
weekend O
when O
he O
went O
without O
dialysis O
( O
see O
note O
in O
LMR O
by O
neurology O
consultant O
) O
. O
 
It O
was O
deemed O
at O
that O
time O
that O
his O
myoclonus O
was O
due O
to O
electrolyte O
disarray O
, O
and O
he O
was O
admitted O
to O
EDUCARE-FARGO I-LOCATION
and O
received O
dialysis O
the O
same O
day O
with O
complete O
resolution O
of I-DATE
symptoms O
. O
 
He O
has O
been O
symptom-free O
since O
that O
time O
. O
 
He O
reports O
no O
other O
new O
events O
. O
 
He O
denies O
any O
new O
medications O
. O
 
Past O
Medical O
History O
: O
1 O
. O
) O
 
ESRD O
secondary O
to O
hypertension O
n O
on O
HD O
since O
November I-DATE
2090 I-DATE
n O
current O
access O
is O
left O
radiocephalic O
fistula O
placed O
in O
April I-DATE
of I-DATE
2091 I-DATE
n O
currently O
followed O
by O
Dr. O
Tierney I-NAME
at O
the O
Sanford I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
2 O
. O
) O
 
HTN O
3 O
. O
) O
 
IgG O
monoclonal O
gammopathy O
4 O
. O
) O
 
Hyperlipidemia O
Allergies O
: O
NKDA O
Medications O
: O
Vitamin O
D O
Atenolol O
25 O
mg O
po O
qd O
ASA O
( O
he O
stopped O
on O
his O
own O
) O
Nephrocaps O
1 O
tab O
po O
qd O
Phos-Lo O
2001 O
mg O
po O
tid O
Social O
History O
: O
The O
patient O
immigrated O
from O
Tonga I-LOCATION
to O
Uganda I-LOCATION
in O
2061 I-DATE
. O
 
He O
lives O
with O
his O
wife O
in O
Mount I-LOCATION
Airy I-LOCATION
. O
 
He O
lives O
with O
his O
wife O
in O
Mount I-LOCATION
Airy I-LOCATION
. O
 
He O
has O
five O
adult O
children O
. O
 
Review O
of I-DATE
Systems O
: O
Constitutional O
: O
( O
- O
) O
fevers O
, O
chills O
, O
night O
sweats O
. O
 
Pulmonary O
: O
( O
- O
) O
shortness O
of I-DATE
breath O
. O
 
Cardiovascular O
: O
( O
- O
) O
chest O
pain O
, O
palpitations O
. O
 
Gastrointestinal O
: O
( O
- O
) O
N/V O
, O
diarrhea O
, O
constipation O
Skin O
: O
denies O
easy O
bruising O
Rheumatologic O
: O
No O
arthritis O
or O
gout O
Neurologic O
: O
( O
+ O
) O
jerking O
movements O
PHYSICAL O
EXAM O
Temp O
: O
98.2 O
BP O
: O
102/61 O
HR O
: O
63 O
RR:20 O
Sats O
: O
96 O
% O
on O
RA O
Gen O
: O
pleasant O
older O
gentleman O
, O
lying O
in O
gurney O
with O
obvious O
myoclonus O
affecting O
his O
speech O
HEENT O
: O
sclerae O
non-icteric O
, O
mucous O
membranes O
moist O
, O
normal O
sized O
tongue O
Neck O
: O
supple O
, O
JVP O
8 O
, O
2+ O
carotids O
Lungs O
: O
slightly O
diminished O
breath O
sound O
on O
the O
left O
, O
otherwise O
unremarkable O
Cor O
: O
S1 O
, O
S2 O
, O
regular O
with O
PVC O
's O
, O
soft O
systolic O
murmur O
at O
base O
Abd O
: O
soft O
, O
NTND O
, O
no O
HSM O
, O
no O
bruits O
Ext O
: O
no O
edema O
in O
LE O
b/l O
, O
1+ O
pulses O
distally O
Skin O
: O
+ O
fat O
pads O
in O
supraclavicular O
region O
Access O
: O
left O
AVF O
with O
good O
thrill O
Neuro O
: O
CN O
3-12 O
intact O
myoclonic O
jerking O
evident O
in O
jaw O
, O
arms O
, O
and O
legs O
, O
worse O
with O
intentional O
movements O
strength O
normal O
throughout O
sensation O
preserved O
to O
light O
touch O
reflexes O
1+ O
in O
upper O
extremities O
, O
difficult O
in O
LE O
due O
to O
myoclonic O
jerking O
cerebellar O
exam O
normal O
LABS O
: O
GLUCOSE O
73 O
( O
54-118 O
) O
mg/dL O
UREA O
N O
41 O
* O
( O
9-25 O
) O
mg/dL O
CREATININE O
9.2 O
* O
( O
0.7-1.3 O
) O
mg/dL O
SODIUM O
141 O
( O
136-142 O
) O
mmol/L O
POTASSIUM O
5.5 O
* O
( O
3.5-5.0 O
) O
mmol/L O
CHLORIDE O
91 O
* O
( O
98-108 O
) O
mmol/L O
TOTAL O
CO2 O
37 O
* O
( O
23-32 O
) O
mmol/L O
ANION O
GAP O
13 O
( O
3-15 O
) O
mmol/L O
ALT/GPT O
19 O
( O
7-52 O
) O
U/L O
AST/GOT O
24 O
( O
9-30 O
) O
U/L O
ALK O
PHOS O
59 O
( O
36-118 O
) O
U/L O
AMYLASE O
176 O
* O
( O
20-70 O
) O
U/L O
TOT O
BILI O
0.4 O
( O
0.2-1.2 O
) O
mg/dL O
LIPASE O
50 O
( O
3-60 O
) O
U/L O
TOT O
PROT O
8.5 O
* O
( O
6.0-8.0 O
) O
g/dL O
ALBUMIN O
4.6 O
( O
3.7-5.4 O
) O
g/dL O
GLOBULIN O
3.9 O
( O
2.0-4.0 O
) O
g/dL O
CALCIUM O
9.7 O
( O
8.8-10.5 O
) O
mg/dL O
PHOSPHATE O
6.1 O
* O
# O
( O
2.4-5.0 O
) O
mg/dL O
MAGNESIUM O
2.4 O
( O
1.8-2.5 O
) O
mg/dL O
WBC O
7.64 O
( O
4-10 O
) O
K/uL O
RBC O
4.68 O
( O
4.5-6.4 O
) O
M/uL O
HGB O
14.5 O
( O
13.5-18.0 O
) O
g/dL O
HCT O
41.8 O
( O
40-54 O
) O
% O
MCV O
89.3 O
( O
80-95 O
) O
um3 O
MCH O
30.9 O
( O
27-32 O
) O
uug O
MCHC O
34.6 O
( O
32-36 O
) O
g/dL O
RDW O
14.8 O
* O
( O
10-14.5 O
) O
PLT O
232 O
( O
150-450 O
) O
K/uL O
LYMP O
% O
25.7 O
( O
18-41 O
) O
MONO O
% O
9.2 O
* O
( O
2.5-8.5 O
) O
NEUT O
% O
61.0 O
( O
48-76 O
) O
EOS O
% O
3.9 O
( O
0-5 O
) O
BASO O
% O
0.3 O
( O
0-1.5 O
) O
PT O
14.1 O
( O
11.8-14.6 O
) O
sec O
PTT O
27.5 O
( O
23.8-36.6 O
) O
sec O
PT O
( O
INR O
) O
1.1 O
( O
0.9-1.1 O
) O
ASSESSMENT O
: O
74 I-AGE
year O
old O
male O
who O
presents O
with O
: O
1 O
. O
) O
 
Myoclonus O
unclear O
etiology O
without O
obvious O
precipitants O
; O
the O
last O
time O
this O
happened O
, O
it O
was O
in O
the O
setting O
of I-DATE
not O
getting O
dialyzed O
after O
three O
days O
. O
 
While O
he O
did O
get O
dialysis O
yesterday O
per O
his O
normal O
schedule O
, O
it O
is O
odd O
that O
his O
potassium O
today O
is O
5.5 O
, O
suggesting O
perhaps O
either O
dietary O
indiscretion O
( O
which O
he O
denies O
) O
or O
, O
perhaps O
, O
inadequate O
dialysis O
. O
 
In O
addition O
, O
he O
says O
that O
his O
dialysis O
center O
has O
been O
taking O
him O
off O
early O
a O
few O
times O
in O
the O
past O
week O
, O
though O
he O
notes O
that O
he O
got O
a O
full O
run O
yesterday O
( O
3 O
hours O
) O
2 O
. O
) O
 
chronic O
HD O
3 O
. O
) O
 
h/o O
MGUS O
shoulder O
fat O
pads O
PLAN O
: O
1 O
. O
) O
 
Admit O
to O
Renal O
Medicine O
service O
, O
Dr. O
Tierney I-NAME
attending O
2 O
. O
) O
 
Will O
plan O
on O
dialysis O
tomorrow O
for O
two O
reasons O
: O
( O
1 O
) O
high O
potassium O
, O
( O
2 O
) O
see O
if O
this O
helps O
with O
myoclonus O
3 O
. O
) O
 
Will O
contact O
dialysis O
center O
tomorrow O
to O
see O
if O
any O
problems O
with O
his O
runs O
, O
and O
what O
his O
most O
recent O
URR O
or O
Kt/V O
was O
4 O
. O
) O
 
continue O
Phos-Lo O
2001 O
tid O
with O
meals O
5 O
. O
) O
 
Kayexalate O
30 O
po O
tonight O
for O
elevated O
potassium O
Discussed O
with O
Dr. O
Tierney I-NAME
______________________ O
Uriah I-NAME
T. I-NAME
Quin I-NAME
, O
M.D O
. O
 
Renal O
Fellow O
# O
80467 I-CONTACT
 
Record O
date O
: O
2096-12-13 I-DATE
Trinity I-LOCATION
Regional I-LOCATION
Medical I-LOCATION
Center I-LOCATION
1190 I-LOCATION
Mill I-LOCATION
Street I-LOCATION
MARSH O
, O
CARL I-NAME
Albertville I-LOCATION
, O
RI I-LOCATION
87193 I-LOCATION
39955317 I-ID
( O
906 O
) O
517-8625 I-CONTACT
12/13/2096 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Marsh I-NAME
is O
a O
75-year-old O
male O
who O
comes O
for O
comprehensive O
exam O
and O
follow O
up O
medical O
problems O
. O
 
1 O
. O
 
Chronic O
renal O
failure O
. O
 
He O
is O
on O
chronic O
dialysis O
twice O
a O
week O
. O
 
2 O
. O
 
Hyperlipidemia O
. O
 
Fasting O
lipid O
analysis O
18 O
months O
ago O
showed O
total O
cholesterol O
221 O
, O
triglycerides O
192 O
, O
LDL O
136 O
, O
and O
HDL O
47 O
. O
 
3 O
. O
 
Cataracts O
. O
 
He O
is O
about O
to O
undergo O
cataract O
removal O
. O
 
Comes O
as O
well O
today O
for O
clearance O
. O
 
MEDICATIONS O
: O
Nephrocaps O
1 O
p.o O
. O
 
daily O
, O
Phoslo O
670 O
mg O
tablets O
3 O
p.o O
. O
 
t.i.d. O
, O
and O
senna O
two O
tablets O
b.i.d O
. O
 
p.r.n O
. O
 
ALLERGIES O
: O
No O
known O
allergies O
to O
any O
medications O
. O
 
HABITS O
: O
He O
smokes O
one O
pack O
per O
week O
. O
 
Denies O
alcohol O
or O
drug O
use O
. O
 
FAMILY O
HISTORY O
: O
Unchanged O
. O
 
SOCIAL O
HISTORY O
: O
He O
lives O
with O
wife O
and O
daughter O
. O
 
He O
is O
retired O
. O
 
REVIEW O
OF O
SYMPTOMS O
: O
No O
significant O
weight O
change O
, O
febrile O
signs O
or O
symptoms O
, O
headache O
, O
blurred O
vision O
, O
tinnitus O
, O
chest O
pain O
, O
cough O
, O
shortness O
of O
breath O
, O
nausea O
, O
abdominal O
pain O
, O
nightsweats O
, O
diarrhea O
, O
dysuria O
, O
polyuria O
, O
skin O
rash O
, O
bruising O
, O
joint O
pain O
, O
or O
focal O
weakness O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
125/82 O
, O
weight O
138 O
pounds O
, O
and O
temperature O
97.3 O
. O
 
BMI O
19.8 O
. O
 
Skin O
exam O
: O
No O
rash O
. O
 
Head O
and O
neck O
exam O
: O
Patient O
has O
bilateral O
arcus O
senilis O
. O
 
He O
is O
edentulous O
. O
 
Chest O
: O
Clear O
to O
percussion O
and O
auscultation O
. O
 
Cardiovascular O
exam O
: O
No O
extra O
sounds O
or O
murmurs O
. O
 
Pedal O
pulses O
are O
trace O
posterior O
tibial O
bilaterally O
. O
 
Abdominal O
exam O
: O
No O
masses O
, O
tenderness O
, O
or O
organomegaly O
. O
 
Stool O
guaiac O
negative O
. O
 
GU O
exam O
: O
Both O
testes O
descended O
. O
 
Testes O
were O
soft O
. O
 
Prostate O
2+ O
enlarged O
without O
masses O
or O
tenderness O
. O
 
Lymph O
exam O
: O
No O
axillary O
or O
cervical O
lymphadenopathy O
. O
 
Musculoskeletal O
exam O
: O
Grossly O
intact O
. O
 
Neuro O
exam O
: O
Grossly O
intact O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Chronic O
renal O
failure O
. O
 
Appears O
to O
be O
stable O
on O
routine O
dialysis O
. O
 
Will O
check O
screening O
blood O
work O
. O
 
2 O
. O
 
Hyperlipidemia O
. O
 
His O
LDL O
goal O
is O
less O
than O
130 O
. O
 
He O
is O
slightly O
above O
that O
. O
 
Encouraged O
careful O
attention O
to O
nutrition O
. O
 
3 O
. O
 
Cataract O
. O
 
EKG O
and O
other O
preop O
testing O
were O
requested O
. O
 
4 O
. O
 
Adult O
health O
maintenance O
. O
 
Tetanus O
and O
Pneumovax O
given O
last O
year O
. O
 
He O
reports O
influenza O
vaccine O
was O
given O
elsewhere O
. O
 
A O
colonoscopy O
has O
not O
been O
done O
according O
to O
our O
records O
. O
 
Colonoscopy O
requested O
today O
. O
 
Home O
guaiac O
cards O
given O
as O
well O
. O
 
______________________________ O
Xavier I-NAME
T I-NAME
Mccoy I-NAME
, O
M.D. O
, O
M.Sc O
. O
 
eScription O
document:6-2359741 O
EMSSten O
Tel O
DD O
: O
12/14/96 I-DATE
DT O
: O
12/15/96 I-DATE
DV O
: O
12/13/96 I-DATE
 
Record O
date O
: O
2098-02-04 I-DATE
Trinity I-LOCATION
Regional I-LOCATION
Medical I-LOCATION
Center I-LOCATION
1949 I-LOCATION
Mill I-LOCATION
Street I-LOCATION
MARSH O
, O
CARL I-NAME
Albertville I-LOCATION
, O
RI I-LOCATION
87193 I-LOCATION
39955317 I-ID
( O
906 O
) O
517-8625 I-CONTACT
02/04/2098 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
76-year-old O
man O
male O
who O
comes O
in O
for O
follow O
up O
of O
chronic O
kidney O
disease O
and O
other O
medical O
problems O
. O
 
PROBLEMS O
: O
1 O
. O
 
Chronic O
renal O
disease O
. O
 
He O
has O
dialysis O
twice O
per O
week O
. O
 
He O
tells O
me O
he O
is O
on O
the O
transplant O
list O
. O
 
The O
transplant O
team O
would O
like O
a O
positive O
CVS O
treated O
with O
levofloxacin O
2 O
. O
 
Hyperlipidemia O
. O
 
Fasting O
lipid O
analysis O
2 O
weeks O
ago O
showed O
total O
cholesterol O
255 O
, O
triglycerides O
203 O
, O
HDL O
39 O
, O
and O
LDL O
175 O
. O
 
He O
had O
been O
taking O
Crestor O
but O
says O
the O
bottle O
emptied O
and O
he O
did O
not O
know O
to O
refill O
it O
. O
 
3 O
. O
 
Secondary O
hyperparathyroidism O
. O
 
Recent O
PTH O
829 O
, O
calcium O
10.1 O
, O
and O
phosphorus O
6.7 O
. O
 
4 O
. O
 
Superficial O
back O
pain O
. O
 
He O
had O
an O
abscess O
drained O
overlying O
the O
right O
scapula O
several O
months O
ago O
. O
 
Since O
then O
, O
he O
has O
had O
some O
mild O
pain O
. O
 
MEDICATIONS O
: O
He O
did O
not O
bring O
any O
tonight O
. O
 
As O
listed O
: O
1 O
. O
 
Aspirin O
325 O
mg O
daily O
. O
 
2 O
. O
 
Nephrocaps O
1 O
daily O
. O
 
3 O
. O
 
Phoslo O
2001 O
mg O
t.i.d O
. O
 
REVIEW O
OF O
SYMPTOMS O
: O
No O
significant O
weight O
change O
, O
febrile O
signs O
or O
symptoms O
, O
headache O
, O
blurred O
vision O
, O
tinnitus O
, O
chest O
pain O
, O
cough O
, O
shortness O
of O
breath O
, O
nausea O
, O
abdominal O
pain O
, O
nightsweats O
, O
diarrhea O
, O
dysuria O
, O
polyuria O
, O
bruising O
, O
joint O
pain O
, O
or O
focal O
weakness O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
in O
no O
acute O
distress O
. O
 
Chest O
: O
Clear O
to O
percussion O
and O
auscultation O
. O
 
Skin O
exam O
: O
There O
are O
two O
small O
cavities O
overlying O
the O
right O
scapula O
filled O
with O
dirt O
and O
slight O
surrounding O
erythema O
.. O
Abdominal O
exam O
: O
No O
masses O
, O
tenderness O
or O
organomegaly O
. O
 
Extremities O
: O
No O
edema O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Chronic O
kidney O
disease O
. O
 
On O
dialysis O
. O
 
2 O
. O
 
Hyperlipidemia O
. O
 
I O
prescribed O
Zocor O
. O
 
3 O
. O
 
Secondary O
hyperparathyroidism O
. O
 
I O
am O
concerned O
about O
bone O
status O
. O
 
Bone O
mineral O
density O
exam O
requested O
. O
 
4 O
. O
 
Skin O
changes O
after O
abscess O
drainage O
. O
 
Area O
was O
cleaned O
and O
covered O
. O
 
The O
patient O
has O
history O
of O
elevated O
total O
protein O
and O
amylase O
. O
 
Will O
need O
follow O
up O
. O
 
______________________________ O
Xavier I-NAME
T I-NAME
Mccoy I-NAME
, O
M.D. O
, O
M.Sc O
. O
 
eScription O
document:6-6685590 O
MEeScription O
DD O
: O
02/04/98 I-DATE
DT O
: O
02/04/98 I-DATE
DV O
: O
02/04/98 I-DATE
 
Record O
date O
: O
2085-08-21 I-DATE
MIMA O
5Z O
36 I-LOCATION
Santa I-LOCATION
Fe I-LOCATION
Road I-LOCATION
, O
Suite O
Z O
WILKERSON O
, O
EDWARD I-NAME
Louisa I-LOCATION
, O
MS I-LOCATION
59817 I-LOCATION
37199514 I-ID
( O
238 O
) O
757-3898 I-CONTACT
08/21/85 I-DATE
CHIEF O
COMPLAINT O
: O
The O
patient O
is O
a O
61 I-AGE
year O
old O
gentleman O
here O
for O
his O
first O
visit O
to O
me O
as O
his O
PCP O
, O
referred O
by O
Dr. O
Xavier I-NAME
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS/PAST O
MEDICAL O
HISTORY O
BY O
PROBLEMS O
: O
The O
patient O
has O
no O
acute O
complaints O
today O
. O
 
His O
medical O
history O
includes O
: O
1 O
. O
 
Hypertension O
. O
 
He O
is O
currently O
on O
hydrochlorothiazide O
25 O
mg O
q.d O
. O
 
and O
aspirin O
q.d O
. O
 
2 O
. O
 
Hypercholesterolemia O
. O
 
The O
patient O
is O
on O
30 O
mg O
q.h.s O
. O
 
of O
simvastatin O
. O
 
His O
last O
lipid O
panel O
in O
April I-DATE
of O
this O
year O
showed O
total O
cholesterol O
of O
196 O
, O
triglycerides O
169 O
, O
HDL O
52 O
, O
and O
LDL O
of O
110 O
. O
 
He O
has O
no O
LFTs O
on O
file O
. O
 
3 O
. O
 
Psychiatry O
. O
 
According O
to O
the O
patient O
, O
he O
carried O
a O
diagnosis O
of O
major O
depression O
with O
paranoid O
features O
. O
 
He O
is O
being O
followed O
by O
Dr. O
Uhler I-NAME
, O
psychiatrist O
at O
Marshfield I-LOCATION
Clinic I-LOCATION
as O
well O
as O
Betty I-NAME
Villasenor I-NAME
, O
a O
therapist O
at O
Marshfield I-LOCATION
Clinic I-LOCATION
. O
 
He O
is O
currently O
on O
Depakote O
, O
Tegretol O
, O
Risperdal O
, O
and O
Paxil O
although O
he O
does O
not O
know O
the O
doses O
of O
his O
medications O
. O
 
He O
still O
feels O
depressed O
but O
his O
paranoid O
symptoms O
have O
subsided O
. O
 
He O
has O
no O
manic O
or O
hypermanic O
episodes O
. O
 
MEDICATIONS O
: O
Aspirin O
325 O
mg O
q.d. O
, O
Paxil O
, O
Risperdal O
, O
Tegretol O
, O
Depakote O
doses O
unknown O
, O
simvastatin O
30 O
mg O
q.h.s. O
, O
HCTZ O
20 O
mg O
q.d O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
: O
No O
tobacco O
, O
alcohol O
, O
or O
recreational O
drugs O
. O
 
He O
quit O
drinking O
alcohol O
16 O
years O
ago O
. O
 
He O
has O
not O
been O
sexually O
active O
for O
16 O
years O
and O
is O
currently O
not O
interested O
. O
 
He O
lives O
by O
himself O
in O
Denver I-LOCATION
Drive I-LOCATION
, O
walks O
about O
20 O
minutes O
per O
day O
, O
and O
is O
from O
Louisa I-LOCATION
originally O
. O
 
FAMILY O
HISTORY O
: O
Mother O
and O
father O
died O
of O
MIs O
in O
their O
70s O
. O
 
There O
is O
no O
history O
of O
sudden O
cardiac O
death O
. O
 
No O
cancer O
, O
liver O
, O
kidney O
, O
or O
thyroid O
disease O
in O
the O
family O
. O
 
PHYSICAL O
EXAMINATION O
: O
Blood O
pressure O
132/84 O
, O
heart O
rate O
84 O
, O
and O
weight O
202 O
pounds O
. O
 
The O
remainder O
of O
the O
exam O
is O
deferred O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Hypertension O
. O
 
The O
patient O
is O
well O
controlled O
on O
his O
current O
regimen O
. O
 
I O
will O
therefore O
not O
change O
anything O
today O
. O
 
2 O
. O
 
Hypercholesterolemia O
. O
 
The O
patient O
is O
at O
his O
goal O
LDL O
level O
. O
 
I O
will O
continue O
to O
follow O
his O
lipid O
panel O
yearly O
. O
 
I O
will O
also O
check O
LFTs O
today O
, O
given O
that O
he O
had O
a O
statin O
. O
 
3 O
. O
 
Psychiatry O
. O
 
The O
patient O
will O
follow O
up O
with O
his O
psychiatrist O
and O
therapist O
. O
 
He O
will O
let O
me O
know O
his O
actual O
medication O
and O
medication O
doses O
at O
his O
earliest O
convenience O
. O
 
Also O
, O
I O
will O
recheck O
an O
LFT O
as O
stated O
above O
, O
given O
that O
he O
is O
on O
possibly O
hepatotoxic O
psychoactive O
medications O
. O
 
4 O
. O
 
Healthcare O
maintenance O
. O
 
I O
have O
emphasized O
to O
the O
patient O
the O
benefits O
of O
weight O
reduction O
as O
well O
as O
increasing O
his O
exercise O
. O
 
He O
is O
not O
interested O
in O
any O
exercise O
as O
in O
walking O
and O
I O
have O
therefore O
counseled O
him O
to O
walk O
longer O
and O
faster O
. O
 
He O
had O
a O
negative O
flexible O
sigmoidoscopy O
in O
November I-DATE
2083 I-DATE
and O
I O
will O
give O
him O
stool O
cards O
today O
. O
 
His O
last O
tetanus O
was O
10 O
years O
ago O
and O
he O
is O
not O
interested O
in O
the O
booster O
today O
. O
 
His O
immunizations O
are O
otherwise O
up O
to O
date O
according O
to O
him O
and O
he O
will O
need O
the O
remainder O
of O
the O
history O
and O
a O
full O
physical O
exam O
at O
the O
next O
visit O
in O
3 O
months O
' O
time O
. O
 
______________________________ O
Wyatt I-NAME
Yeo I-NAME
, O
M.D O
. O
 
eScription O
document:0-726841 O
CFFocus O
DD O
: O
08/21/85 I-DATE
DT O
: O
08/22/85 I-DATE
DV O
: O
08/21/85 I-DATE
========================== O
Preceptor O
's O
Note O
========================== O
August I-DATE
21st I-DATE
Dr O
Yeo I-NAME
Mr O
Wilkerson I-NAME
61 I-AGE
year O
old O
man O
Hx O
hypertension.Hx O
elev O
cholesterol O
, O
on O
zocor O
. O
 
Recently O
underwent O
a O
stress O
test O
for O
chest O
pain O
, O
with O
completely O
negative O
dopamine O
MIBI O
. O
 
PMH O
also O
+ O
depression O
and O
paranoia O
, O
on O
rx O
. O
 
BP O
132/84 O
, O
p O
84 O
. O
 
\Health O
maintenance O
: O
will O
be O
given O
stool O
cards O
, O
is O
up O
to O
date O
with O
others O
. O
 
Declines O
tetanus O
. O
 
Dr. O
Yeo I-NAME
and O
I O
jointly O
interviewed O
and O
examined O
this O
61year O
old O
patient O
who O
presents O
with O
for O
f/u O
hypercholesterolemia O
, O
hypertension O
, O
recent O
stress O
test O
. O
 
See O
resident O
's O
note O
for O
details O
. O
 
PMH/FH/SH O
significant O
for O
depression/paranoia O
. O
 
ROS O
remarkable O
for O
+ O
depression O
at O
this O
time O
. O
 
On O
exam O
, O
we O
found O
bp O
132/80 O
pulse O
80 O
. O
 
Rest O
of O
exam O
deferred O
. O
 
See O
Resident O
's O
note O
for O
further O
detail O
. O
 
Impression O
and O
Plan O
reviewed O
and O
I O
agree O
with O
the O
resident O
's O
assessment O
of O
and O
diagnosis O
of O
dperession O
, O
hypertension O
. O
 
We O
agree O
on O
the O
plan O
to O
review O
test O
results O
with O
patient O
, O
stool O
cards O
given O
, O
tetanus O
offered O
and O
declined O
. O
 
______________________________ O
Connie I-NAME
Angelina I-NAME
Wills I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2087-03-11 I-DATE
Telephone O
call O
from O
pt O
Complaining O
of O
brief O
episodes O
of O
feeling O
faint O
, O
sweaty O
on O
the O
back O
of O
his O
neck O
yesterday O
and O
today O
. O
 
Sxs O
resolve O
when O
he O
sits O
down O
and O
rests O
a O
few O
minutes O
. O
 
No O
associated O
sxs O
headaches O
, O
ataxia O
, O
vertigo O
, O
nausea O
, O
palps O
, O
CP O
, O
SOB O
, O
URI O
sxs O
, O
fever O
, O
trauma O
. O
 
Checked O
fingerstick O
when O
sxs O
developed O
today O
, O
125 O
. O
 
Drank O
orange O
juice O
, O
but O
sxs O
persisted O
, O
resolved O
after O
approx O
1hr O
. O
 
Problems O
Elevated O
cholesterol O
PSYCH O
DISORDER O
: O
ANXIETY O
, O
PARANOIA O
, O
DEPRESSION O
PERSONALITY O
DISORDER O
H/O O
hematuria O
H/O O
breast O
mass O
Hypertension O
Borderline O
diabetes O
mellitus O
Overweight O
Erectile O
dysfunction O
Medications O
Risperdal O
( O
RISPERIDONE O
) O
3 O
MG O
PO O
QD O
Tegretol O
( O
CARBAMAZEPINE O
) O
400 O
MG O
PO O
QD O
Paxil O
( O
PAROXETINE O
) O
40MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Depakote O
( O
DIVALPROEX O
Sodium O
) O
500MG O
, O
2 O
Tablet O
( O
s O
) O
PO O
QD O
Thorazine O
( O
CHLORPROMAZINE O
Hcl O
) O
25MG O
, O
1/2 O
Tablet O
( O
s O
) O
PO O
QD O
ASA O
81 O
MG O
PO O
QD O
Hctz O
( O
HYDROCHLOROTHIAZIDE O
) O
25MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
10MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Folate O
( O
FOLIC O
Acid O
) O
1MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
METFORMIN O
500MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
He O
declines O
appt O
today O
for O
eval O
. O
 
Urged O
to O
come O
to O
ED O
today O
for O
eval O
if O
sxs O
worsen O
. O
 
Otherwise O
, O
agrees O
to O
urgent O
care O
appt O
tomorrow O
at O
2:50pm O
. O
 
_____________________________________________ O
Patricia I-NAME
Y I-NAME
Whittaker I-NAME
, O
N.P. O
, O
M.S O
. O
 
Record O
date O
: O
2088-03-03 I-DATE
Patient O
Name O
: O
WILKERSON O
, O
EDWARD O
[ O
MRN O
: O
37199514MEDIQUIK O
] O
Date O
of O
Visit O
: O
3/3/2088 I-DATE
MIMA O
PCP O
VISIT O
Health O
problems O
discussed O
: O
1 O
. O
 
DM O
type O
2 O
. O
 
Fingerstick O
in O
the O
office O
today O
130 O
. O
 
At O
home O
, O
these O
have O
been O
mostly O
in O
the O
84 O
-130s O
, O
but O
rarely O
up O
to O
the O
180-190s O
. O
 
Last O
HbA1c O
was O
5.8 O
. O
 
-- O
given O
outlier O
hyperglycemia O
and O
no O
hypoglycemia O
, O
increase O
metformin O
to O
1000 O
bid O
from O
1000 O
qAM/500 O
qPM O
-- O
recheck O
A1c O
today O
-- O
increase O
lisinopril O
to O
20 O
daily O
given O
BP O
142/66 O
today O
2 O
. O
 
Lipids O
. O
 
Last O
dLDL O
108 O
. O
 
Denies O
any O
muscle O
cramps O
or O
weakness O
. O
 
-- O
increase O
atorvastatin O
to O
40 O
daily O
, O
check O
transaminases O
3 O
. O
 
Weight O
. O
 
Has O
lost O
11 O
pounds O
intentionally O
since O
September I-DATE
by O
doing O
more O
walking O
, O
eating O
fewer O
potatoes O
, O
red O
meat O
, O
rice O
. O
 
BMI O
now O
26 O
. O
 
Patient O
congratulated O
, O
encouraged O
to O
continue O
with O
his O
current O
diet O
and O
increase O
exercise O
as O
tolerated O
. O
 
Cautioned O
on O
caffeine O
given O
h/o O
SVT O
. O
 
4 O
. O
 
SVT O
. O
 
To O
see O
Dr O
. O
 
Pate I-NAME
from O
cardiology O
in O
2 O
days O
to O
f/u O
his O
SVT O
. O
 
No O
known O
further O
episodes O
since O
starting O
verapamil O
. O
 
5 O
. O
 
Health O
maintenance O
. O
 
-- O
due O
for O
colonoscopy O
: O
referred O
, O
given O
Rx O
for O
Golytely O
PE O
: O
Blood O
Pressure O
: O
142/66 O
[ O
Left O
Arm O
, O
Sitting O
] O
Pulse O
: O
74 O
[ O
Regular O
, O
Brachial O
] O
Weight O
: O
191 O
[ O
Pounds O
] O
NAD O
, O
does O
not O
appear O
to O
be O
responding O
to O
internal O
stimuli O
JVP O
7 O
CTA O
bilat O
RRR O
no O
mrg O
, O
no O
heave O
Abd O
soft O
, O
nt/nd O
, O
nabs O
, O
no O
mass O
No O
foot O
lesions O
Trace O
bilat O
ankle O
pitting O
2+ O
DP O
and O
PTs O
bilat O
______________________________ O
Floyd I-NAME
Bobby I-NAME
Ventura I-NAME
, O
M.D O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
Pt O
discussed O
with O
Dr. O
Ventura I-NAME
; O
I O
agree O
with O
his O
evaluation O
and O
plan O
. O
 
______________________________ O
Nancy I-NAME
Elizabeth I-NAME
Roman I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2093-01-17 I-DATE
EDVISIT^37199514^WILKERSON O
, O
EDWARD^01/17/93^HODGES O
, O
CHAD I-NAME
Please O
see O
the O
written O
documentation O
undertaken O
by O
Dr. O
Caldwell I-NAME
, O
the O
resident O
who O
saw O
the O
patient O
primarily O
. O
 
I O
have O
seen O
and O
examined O
the O
patient O
personally O
, O
reviewed O
the O
written O
documentation O
and O
agree O
with O
the O
assessment O
and O
plan O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Mr. O
Wilkerson I-NAME
is O
a O
68-year-old O
gentleman O
without O
significant O
past O
medical O
history O
, O
who O
is O
actually O
being O
seen O
here O
by O
his O
primary O
care O
physician O
who O
happens O
to O
be O
a O
resident O
rotating O
____ O
normally O
sees O
him O
in O
MIMAIMA O
Clinic O
. O
 
According O
to O
Dr. O
Caldwell I-NAME
, O
his O
PCP O
, O
he O
generally O
does O
not O
have O
very O
much O
past O
medical O
history O
, O
but O
when O
he O
gets O
infected O
, O
he O
gets O
confused O
. O
 
He O
presents O
today O
with O
confusion O
. O
 
His O
visiting O
nurse O
today O
noticed O
that O
he O
has O
been O
having O
weakness O
and O
fatigue O
over O
the O
last O
few O
days O
, O
but O
today O
, O
he O
was O
confused O
as O
he O
has O
been O
when O
he O
has O
been O
ill O
in O
the O
past O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Dementia O
, O
SVT O
, O
hypertension O
, O
and O
diabetes O
type O
2 O
. O
 
SOCIAL O
HISTORY O
: O
He O
is O
a O
former O
smoker O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Otherwise O
, O
negative O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Otherwise O
negative O
except O
as O
previously O
dictated O
. O
 
MEDICATIONS O
: O
Lisinopril O
, O
hydrochlorothiazide O
, O
omeprazole O
, O
Risperdal O
, O
Tegretol O
, O
verapamil O
, O
and O
Tylenol O
# O
3 O
. O
 
ALLERGIES O
: O
He O
has O
no O
known O
drug O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
He O
is O
a O
healthy O
, O
well-appearing O
Caucasian O
gentleman O
who O
nevertheless O
is O
disoriented O
to O
time O
. O
 
He O
knows O
place O
and O
name O
. O
 
His O
heart O
rate O
is O
101 O
, O
respiratory O
rate O
is O
20 O
, O
blood O
pressure O
is O
121/92 O
, O
and O
oxygen O
saturation O
is O
96 O
% O
on O
room O
air O
, O
and O
his O
temperature O
is O
101.5 O
. O
 
He O
had O
left O
lower O
lobe O
crackles O
in O
his O
lung O
exam O
. O
 
The O
remainder O
of O
his O
physical O
exam O
was O
otherwise O
normal O
. O
 
Mucus O
membranes O
were O
moist O
. O
 
Abdomen O
was O
soft O
. O
 
Extremities O
had O
no O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
LABORATORY O
DATA O
: O
The O
patient O
had O
a O
normal O
chest O
x-ray O
, O
negative O
urinalysis O
. O
 
White O
blood O
cell O
count O
was O
7.12 O
. O
 
He O
had O
a O
creatinine O
of O
1.24 O
, O
up O
from O
his O
baseline O
and O
a O
lactate O
of O
3.8 O
. O
 
His O
chest O
x-ray O
showed O
no O
acute O
process O
. O
 
IMPRESSION O
: O
My O
impression O
is O
that O
the O
patient O
has O
severe O
sepsis O
by O
virtue O
of O
evidence O
of O
change O
in O
his O
mental O
status O
and O
his O
creatinine O
, O
he O
was O
given O
a O
liter O
of O
normal O
saline O
in O
the O
Emergency O
Department O
as O
a O
bolus O
. O
 
Given O
that O
pneumonia O
and O
urinary O
tract O
infection O
were O
highest O
on O
the O
list O
, O
we O
decided O
to O
treat O
him O
with O
Rocephin O
and O
azithromycin O
. O
 
He O
will O
be O
admitted O
to O
the O
Medical O
Service O
. O
 
______________________________ O
HODGES O
, O
CHAD I-NAME
M.D O
. O
 
D O
: O
01/17/93 I-DATE
T O
: O
01/17/93 I-DATE
Dictated O
By O
: O
HODGES O
, O
CHAD I-NAME
eScription O
document:0-50096032 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2093-04-11 I-DATE
MEDIQUIK I-LOCATION
Neurology O
Consultation O
Edward I-NAME
Wilkerson I-NAME
MRN O
: O
37199514 I-ID
Please O
refer O
to O
Student O
Doctor O
Nicky I-NAME
Li I-NAME
for O
HPI O
, O
ROS O
and O
past O
medical O
history O
. O
 
Briefly O
, O
68 I-AGE
yr O
old O
male O
w O
a O
h/o O
HTN O
, O
HL O
, O
DMII O
, O
peripheral O
neuropathy O
, O
schizoaffective O
disorder O
, O
Borderline O
Personality O
Disorder O
s/p O
SVT O
ablation O
on O
4/10 I-DATE
who O
post-operatively O
has O
been O
confused O
with O
gait O
disturbance O
. O
 
Neurology O
was O
consulted O
for O
an O
evaluation O
of O
gait O
disturbance O
and O
encephalopathy O
. O
 
On O
exam O
patient O
is O
normotensive O
and O
afebrile O
with O
cognition O
remarkable O
for O
inattention O
, O
disorientation O
, O
perseveration O
and O
preservation O
of O
speech O
and O
visual O
spatial O
processing O
. O
 
His O
physical O
exam O
is O
further O
remarkable O
for O
asterixis O
and O
bilateral O
upper O
extremity O
tremulousness O
. O
 
His O
cranial O
nerves O
are O
intact O
. O
 
His O
has O
four O
limb O
give O
way O
weakness O
without O
focality O
. O
 
Reflexes O
are O
3+ O
and O
symmetric O
in O
the O
upper O
extremities O
and O
2+ O
and O
symmetric O
in O
the O
lower O
extremities O
. O
 
Toes O
are O
down O
. O
 
Finger O
to O
nose O
is O
preserved O
. O
 
He O
is O
unable O
to O
stand O
without O
assistance O
. O
 
Differential O
includes O
toxic O
metabolic O
disturbance O
( O
i.e O
. O
 
hyper O
ammonia O
in O
the O
setting O
of O
depakote O
use O
vs. O
drugs O
of O
abuse O
, O
vs. O
alcohol O
withdrawal O
vs. O
additional O
superimposed O
toxic O
metabolic O
disturbance O
) O
Recommendations O
: O
-please O
check O
Liver O
function O
panel O
-check O
ammonia O
-Check O
B12 O
, O
folate O
, O
RPR O
, O
TSH O
-please O
start O
multivitamin O
and O
thiamine O
100mg O
daily O
-please O
check O
carbamazepine O
and O
valproic O
acid O
levels O
; O
please O
verify O
carbamazepine O
dosing O
as O
prior O
records O
suggest O
400mg O
QD O
and O
patient O
is O
on O
BID O
dosing O
-serum O
and O
urine O
toxicology O
screen O
-obtain O
collateral O
history O
regarding O
possible O
alcohol O
abuse O
and O
monitor O
for O
alcohol O
withdrawal O
-would O
hold O
amitriptyline O
given O
anticholinergic O
properties O
-if O
above O
workup O
negative O
and O
unrevealing O
would O
consider O
NCHCT O
but O
defer O
imaging O
at O
this O
time O
Please O
page O
73703 I-CONTACT
with O
questions O
Charles I-NAME
Wallace I-NAME
MDp73703 O
 
Record O
date O
: O
2072-12-16 I-DATE
MRN O
: O
56817864 I-ID
CAROLYN I-LOCATION
HUNTINGTON I-LOCATION
BAILEY I-LOCATION
HEALTH I-LOCATION
CENTER I-LOCATION
468 I-LOCATION
Kristina I-LOCATION
Street I-LOCATION
Xia I-NAME
, O
Jean I-NAME
North I-LOCATION
East I-LOCATION
, O
AL I-LOCATION
81699 I-LOCATION
CHB9278143 O
( O
687 O
) O
396-2722 I-CONTACT
12-15-72 I-DATE
CHIEF O
COMPLAINT O
: O
Ms. O
Xia I-NAME
is O
a O
53 I-AGE
year O
old O
woman O
who O
comes O
in O
in O
follow O
up O
. O
 
She O
notes O
that O
she O
is O
still O
having O
occasional O
sweats O
at O
night O
. O
 
She O
is O
using O
the O
clonidine O
but O
she O
ca O
n't O
take O
it O
two O
times O
a O
day O
, O
it O
makes O
her O
too O
sleepy O
, O
so O
she O
takes O
it O
about O
3:30 O
towards O
the O
end O
of O
her O
workday O
and O
then O
again O
before O
she O
goes O
to O
bed O
. O
 
She O
is O
having O
some O
right O
lower O
back O
pain O
and O
otherwise O
is O
feeling O
well O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Negative O
except O
as O
noted O
. O
 
She O
is O
also O
taking O
the O
Cozaar O
which O
she O
had O
been O
taking O
before O
. O
 
She O
was O
called O
back O
in O
today O
as O
a O
result O
of O
labs O
which O
were O
done O
recently O
which O
showed O
hemoglobin O
A1C O
of O
8.7 O
, O
an O
elevated O
urine O
microalbuminuria O
and O
hypertension O
which O
needed O
follow O
up O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
exam O
today O
, O
she O
is O
well O
developed O
and O
well O
nourished O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
158/116 O
, O
pulse O
80 O
, O
weight O
166 O
. O
 
Pupils O
are O
equal O
and O
equally O
reactive O
to O
light O
. O
 
Lids O
and O
conjunctiva O
normal O
. O
 
Retinal O
fields O
normal O
. O
 
Disks O
sharp O
. O
 
Mouth O
and O
pharynx O
without O
erythema O
or O
exudate O
. O
 
No O
adenopathy O
or O
tenderness O
in O
the O
submandibular O
, O
cervical O
, O
posterior O
cervical O
, O
supraclavicular O
areas O
. O
 
Heart O
sounds O
: O
S1 O
, O
S2 O
, O
with O
a O
II/VI O
systolic O
murmur O
heard O
best O
at O
the O
right O
sternal O
border O
. O
 
No O
rub O
or O
gallop O
. O
 
Her O
chest O
was O
clear O
to O
auscultation O
anteriorly O
and O
posteriorly O
with O
no O
rales O
, O
wheezes O
or O
rhonchi O
. O
 
She O
was O
clear O
to O
percussion O
. O
 
She O
has O
normal O
bowel O
sounds O
. O
 
Her O
abdomen O
was O
soft O
and O
nontender O
, O
no O
mass O
, O
organomegaly O
, O
and O
no O
guarding O
, O
no O
rebound O
. O
 
Her O
extremities O
are O
without O
edema O
, O
cyanosis O
or O
clubbing O
. O
 
She O
has O
no O
spine O
or O
flank O
tenderness O
. O
 
Her O
neck O
is O
supple O
, O
no O
bruits O
. O
 
Her O
skin O
is O
essentially O
quite O
dry O
and O
itchy O
. O
 
She O
has O
multiple O
dark O
, O
hyperpigmented O
, O
post-inflammatory O
scarring O
on O
her O
lower O
extremities O
. O
 
Her O
mouth O
and O
pharynx O
are O
without O
erythema O
or O
exudate O
. O
 
IMPRESSION/PLAN O
: O
1 O
. O
 
Hypertension O
. O
 
Her O
blood O
pressure O
is O
really O
not O
well O
controlled O
. O
 
I O
will O
add O
atenolol O
to O
her O
regimen O
50mg O
PO O
q.d O
. O
 
She O
drinks O
one O
cup O
of O
coffee O
a O
day O
and O
rarely O
has O
alcohol O
although O
she O
notes O
that O
she O
will O
occasionally O
have O
one O
, O
a O
scotch O
, O
on O
Friday I-DATE
or O
Saturday I-DATE
. O
 
She O
does O
not O
do O
drugs O
. O
 
She O
will O
return O
in O
three O
week O
for O
follow O
up O
of O
her O
blood O
pressure O
and O
at O
that O
time O
for O
a O
physical O
exam O
for O
which O
she O
will O
be O
due O
. O
 
2 O
. O
 
Diabetes O
. O
 
The O
patient O
had O
been O
told O
in O
the O
past O
that O
she O
had O
diabetes O
but O
she O
was O
told O
she O
did O
not O
need O
any O
sort O
of O
treatment O
for O
it O
. O
 
Her O
creatinine O
was O
0.8 O
last O
month O
and O
I O
explained O
to O
her O
that O
with O
her O
elevated O
hemoglobin O
at O
8.7 O
she O
needs O
treatment O
. O
 
We O
will O
start O
her O
on O
Glucophage O
500mg O
PO O
b.i.d O
. O
 
I O
expect O
we O
will O
need O
to O
increase O
this O
and O
if O
she O
tolerates O
this O
she O
should O
increase O
it O
to O
1000mg O
over O
the O
next O
week O
. O
 
I O
also O
explained O
to O
her O
that O
if O
she O
does O
not O
eat O
or O
she O
is O
unable O
to O
eat O
or O
if O
she O
is O
NPO O
she O
needs O
to O
stop O
taking O
this O
medication O
. O
 
I O
suggested O
she O
actually O
take O
it O
with O
food O
to O
insure O
that O
she O
only O
takes O
when O
she O
is O
eating O
. O
 
I O
gave O
her O
a O
referral O
to O
Ophthalmology O
and O
to O
Podiatry O
. O
 
She O
also O
requested O
a O
glucometer O
machine O
and O
this O
was O
ordered O
for O
her O
along O
with O
CAROLYN I-LOCATION
HUNTINGTON I-LOCATION
BAILEY I-LOCATION
HEALTH I-LOCATION
CENTER I-LOCATION
592 I-LOCATION
Kristina I-LOCATION
Street I-LOCATION
Xia I-NAME
, O
Jean I-NAME
North I-LOCATION
East I-LOCATION
, O
AL I-LOCATION
81699 I-LOCATION
CHB9278143 O
( O
687 O
) O
396-2722 I-CONTACT
12-16-72 I-DATE
Page O
2 O
lancets O
, O
alcohol O
wipes O
and O
test O
strips O
and O
again O
she O
will O
return O
in O
two O
weeks O
for O
follow O
up O
. O
 
______________________________ O
Yolanda I-NAME
Osburn I-NAME
, O
M.D O
. O
 
CP I-NAME
: O
FO:3549 O
; O
DD:12-16-72 O
; O
DT:12-16-72 O
; O
DV:12-16-72 O
 
Record O
date O
: O
2076-04-23 I-DATE
Carolyn I-LOCATION
Huntington I-LOCATION
Bailey I-LOCATION
Health I-LOCATION
Center I-LOCATION
592 I-LOCATION
Kristina I-LOCATION
Street I-LOCATION
XIA O
, O
JEAN I-NAME
North I-LOCATION
East I-LOCATION
, O
AL I-LOCATION
81699 I-LOCATION
58269151 I-ID
( O
375 O
) O
512-0897 I-CONTACT
04/23/76 I-DATE
SUBJECTIVE O
: O
The O
patient O
comes O
in O
today O
for O
followup O
of O
various O
problems O
. O
 
She O
has O
hypertension O
. O
 
She O
reports O
she O
ran O
out O
of O
medication O
she O
received O
yesterday O
for O
refills O
but O
has O
not O
gotten O
them O
yet O
. O
 
She O
brings O
in O
her O
medication O
bottles O
. O
 
Apparently O
, O
for O
her O
blood O
pressure O
, O
she O
is O
taking O
Norvasc O
and O
Cozaar O
, O
for O
her O
diabetes O
she O
is O
taking O
Glucotrol O
and O
Glucophage O
. O
 
Regarding O
her O
diabetes O
, O
she O
says O
her O
fasting O
sugar O
are O
somewhere O
around O
90 O
. O
 
Her O
last O
hemoglobin O
A1c O
was O
in O
11/2075 I-DATE
and O
was O
6.4 O
% O
. O
 
Her O
hypertension O
, O
she O
has O
been O
out O
of O
medication O
for O
three O
or O
four O
day O
, O
but O
she O
generally O
reports O
is O
well O
controlled O
. O
 
She O
does O
not O
know O
why O
she O
was O
on O
atenolol O
, O
but O
has O
been O
taking O
it O
. O
 
She O
has O
no O
complaints O
. O
 
She O
does O
complain O
of O
lower O
back O
pain O
. O
 
She O
says O
she O
has O
had O
this O
for O
many O
many O
years O
. O
 
She O
underwent O
physical O
therapy O
last O
year O
which O
was O
at O
Schroder I-LOCATION
Hospital I-LOCATION
. O
 
She O
says O
she O
has O
no O
trauma O
. O
 
She O
has O
pain O
across O
the O
lower O
back O
. O
 
She O
rates O
it O
8/10 O
. O
 
She O
has O
it O
everyday O
and O
radiates O
down O
to O
her O
right O
leg O
. O
 
It O
has O
been O
worse O
recently O
. O
 
She O
takes O
Aleve O
with O
minimal O
relief O
. O
 
She O
says O
that O
she O
wants O
a O
speciality O
referral O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
She O
has O
no O
chest O
pain O
or O
pressure O
, O
palpitations O
, O
pedal O
edema O
. O
 
She O
has O
no O
shortness O
of O
breath O
, O
cough O
, O
or O
wheezing O
. O
 
She O
has O
no O
urinary O
frequency O
or O
urgency O
. O
 
She O
has O
no O
nausea O
or O
vomiting O
, O
no O
diarrhea O
, O
heartburn O
or O
abdominal O
pain O
. O
 
Medications O
Cozaar O
( O
LOSARTAN O
) O
100 O
MG O
PO O
QD O
, O
NEEDS O
TO O
MAKE O
AN O
APPOINTMENT O
Glucophage O
( O
METFORMIN O
) O
1000 O
MG O
take O
bid O
bid O
PO O
BID O
Norvasc O
( O
AMLODIPINE O
) O
10 O
MG O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Glucotrol O
XL O
( O
GLIPIZIDE O
XL O
) O
5 O
MG O
take O
qd O
Tablet O
( O
s O
) O
PO O
QD O
Ultram O
( O
TRAMADOL O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
Q6H O
PRN O
pain O
Skelaxin O
( O
METAXALONE O
) O
800 O
MG O
( O
800MG O
TABLET O
take O
1 O
) O
PO O
TID O
PRN O
muscle O
pain O
Problems O
Diabetes O
HX O
kidney O
stones O
Perimenopausal O
sx O
Hypertension O
Allergies O
Clonidine O
Hcl O
- O
Sleepiness O
, O
Codeine O
- O
Rash O
, O
Vital O
signs O
BP O
174/100 O
, O
P O
72 O
, O
Wt O
163 O
lb O
Gen O
: O
Well O
appearing O
in O
NAD O
ENT-Sclera O
were O
white O
, O
conjuctiva O
clear O
. O
 
The O
oropharynx O
was O
pink O
without O
exudate O
. O
 
The O
neck O
was O
supple O
with O
out O
adenopathy O
. O
 
LUNG- O
clear O
bilaterally O
, O
without O
rhonci O
, O
wheeze O
or O
rales O
, O
Normal O
excursion O
was O
noted O
. O
 
Cor- O
heart O
rate O
was O
normal O
, O
rhythm O
was O
regular O
. O
 
No O
murmurs O
, O
gallops O
or O
rubs O
were O
detected O
ABD- O
soft O
, O
nontender O
, O
with O
bowel O
sounds O
present O
. O
 
No O
organomegaly O
was O
detected O
. O
 
Extremities O
: O
no O
clubbing O
cyanosis O
or O
edema O
. O
 
No O
swelling O
or O
erythema O
was O
noted O
on O
joint O
examOn O
examination O
, O
there O
is O
pain O
on O
palpation O
of O
the O
lower O
lumbar O
region O
including O
over O
the O
sacroiliac O
area O
. O
 
She O
has O
positive O
straight O
leg O
raise O
on O
the O
right O
. O
 
Skin- O
no O
abnormal O
lesions O
noted O
. O
 
MMP O
ASSESSMENT O
: O
1 O
. O
 
Hypertension O
, O
poorly O
controlled O
at O
this O
time O
. O
 
We O
will O
have O
her O
start O
the O
Norvasc O
and O
Cozaar O
, O
have O
her O
return O
in O
two O
weeks O
for O
followup O
of O
blood O
pressure O
. O
 
2 O
. O
 
Diabetes O
. O
 
I O
will O
check O
a O
hemoglobin O
A1c O
. O
 
It O
is O
due O
, O
it O
has O
been O
six O
months O
. O
 
I O
will O
have O
her O
continue O
Glucophage O
at O
this O
point O
. O
 
3 O
. O
 
Lower O
back O
pain O
. O
 
I O
will O
obtain O
x-ray O
of O
the O
lower O
back O
. O
 
We O
will O
have O
her O
see O
Orthopedics O
for O
evaluation O
of O
her O
back O
pain O
. O
 
______________________________ O
Charles I-NAME
Moran I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Charles I-NAME
Moran I-NAME
eScription O
document:0-0545950 O
SFFocus O
DD O
: O
04/23/76 I-DATE
DT O
: O
04/24/76 I-DATE
DV O
: O
04/23/76 I-DATE
 
Record O
date O
: O
2077-01-22 I-DATE
Carolyn I-LOCATION
Huntington I-LOCATION
Bailey I-LOCATION
Health I-LOCATION
Center I-LOCATION
592 I-LOCATION
Kristina I-LOCATION
Street I-LOCATION
XIA O
, O
JEAN I-NAME
North I-LOCATION
East I-LOCATION
, O
AL I-LOCATION
81699 I-LOCATION
58269151 I-ID
( O
375 O
) O
512-0897 I-CONTACT
01/22/77 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Xia I-NAME
is O
a O
57-year-old O
woman O
who O
comes O
in O
for O
evaluation O
of O
treatment O
of O
diabetes O
and O
hypertension O
, O
reporting O
that O
for O
the O
last O
3 O
days O
she O
has O
had O
trouble O
with O
her O
vision O
, O
her O
blood O
pressure O
has O
been O
high O
. O
 
She O
has O
been O
having O
a O
lot O
of O
headaches O
. O
 
She O
has O
had O
pain O
in O
her O
right O
thumb O
that O
goes O
to O
her O
right O
lateral O
side O
area O
. O
 
She O
has O
been O
having O
hot O
flashes O
but O
no O
fevers O
, O
sweats O
or O
chills O
. O
 
Her O
sugars O
have O
been O
okay O
in O
the O
99-120 O
range O
, O
the O
highest O
was O
about O
135-140 O
. O
 
She O
does O
not O
really O
understand O
why O
she O
is O
feeling O
so O
bad O
with O
these O
headaches O
and O
other O
problems O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Conducted O
in O
detail O
and O
was O
otherwise O
negative O
. O
 
MEDICATIONS O
: O
She O
has O
not O
taken O
any O
medications O
for O
the O
last O
two O
days O
. O
 
She O
does O
have O
her O
diabetes O
medications O
but O
no O
blood O
pressure O
medication O
. O
 
She O
usually O
takes O
Cozaar O
100 O
daily O
, O
Glucophage O
1000 O
b.i.d. O
, O
Glucotrol O
XL O
5 O
daily O
, O
Lipitor O
20 O
daily O
, O
Norvasc O
10 O
daily O
. O
 
She O
has O
not O
been O
needing O
Nexium O
of O
late O
. O
 
ALLERGIES O
: O
Clonidine O
caused O
sleepiness O
and O
codeine O
rash O
. O
 
SOCIAL O
HISTORY O
: O
She O
does O
not O
smoke O
or O
use O
street O
drugs O
. O
 
She O
does O
have O
a O
little O
bit O
of O
white O
wine O
when O
she O
has O
guests O
on O
occasion O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
exam O
, O
well O
developed O
, O
well O
nourished O
, O
no O
acute O
distress O
. O
 
Blood O
pressure O
152/120 O
, O
pulse O
76 O
, O
temperature O
97.2 O
, O
weight O
166 O
. O
 
Pleasant O
, O
articulate O
in O
English O
, O
she O
appears O
comfortable O
. O
 
Pupils O
equal O
, O
equally O
reactive O
to O
light O
. O
 
Retinal O
fields O
have O
sharp O
disks O
. O
 
Mouth O
and O
pharynx O
without O
erythema O
or O
exudate O
, O
no O
adenopathy O
or O
tenderness O
in O
the O
submandibular O
, O
cervical O
, O
posterior O
cervical O
, O
supraclavicular O
areas O
. O
 
Thyroid O
nontender O
, O
non-nodular O
. O
 
Neck O
supple O
, O
no O
spine O
or O
flank O
tenderness O
. O
 
No O
bruits O
, O
no O
stridor O
. O
 
Heart O
sounds O
S1 O
, O
S2 O
, O
regular O
rate O
and O
rhythm O
, O
no O
murmur O
, O
rub O
or O
gallop O
. O
 
Chest O
is O
clear O
to O
auscultation O
anteriorly O
and O
posteriorly O
with O
no O
rales O
, O
wheezes O
or O
rhonchi O
. O
 
She O
is O
clear O
to O
percussion O
. O
 
Normal O
bowel O
sounds O
. O
 
Abdomen O
soft O
, O
nontender O
, O
no O
mass O
, O
organomegaly O
, O
no O
guarding O
, O
no O
rebound O
. O
 
Extremities O
are O
without O
edema O
, O
cyanosis O
or O
clubbing O
, O
no O
calf O
tenderness O
. O
 
Sensation O
is O
intact O
to O
microfilament O
testing O
bilaterally O
on O
her O
feet O
. O
 
Pedal O
pulses O
are O
present O
. O
 
Feet O
are O
warm O
. O
 
There O
is O
no O
rash O
, O
maceration O
, O
or O
lesion O
on O
her O
feet O
. O
 
LABORATORY O
DATA O
: O
Hemoglobin O
A1c O
from O
October I-DATE
was O
7.2 O
. O
 
LDL O
from O
last O
May I-DATE
was O
164 O
. O
 
IMPRESSION O
AND O
PLAN O
: O
1 O
. O
 
Diabetes O
. O
 
Her O
diabetes O
has O
been O
near O
goal O
. O
 
We O
will O
recheck O
glucose O
, O
hemoglobin O
A1c O
, O
UA O
, O
and O
microalbuminuria O
and O
see O
how O
she O
is O
doing O
today O
. O
 
2 O
. O
 
Elevated O
cholesterol O
. O
 
Her O
cholesterol O
was O
nowhere O
near O
our O
target O
of O
100 O
. O
 
She O
is O
on O
an O
increased O
Lipitor O
. O
 
We O
will O
check O
cholesterol O
, O
see O
how O
she O
is O
doing O
at O
this O
point O
, O
and O
an O
OT O
, O
PT O
to O
make O
sure O
she O
is O
tolerating O
the O
medication O
. O
 
3 O
. O
 
Hypertension O
. O
 
All O
of O
her O
symptoms O
today O
are O
most O
likely O
due O
to O
her O
hypertension O
. O
 
I O
explained O
at O
great O
length O
that O
the O
reason O
for O
all O
of O
her O
symptoms O
is O
the O
fact O
she O
stopped O
taking O
her O
medication O
. O
 
She O
seemed O
surprised O
that O
it O
would O
have O
such O
an O
immediate O
and O
strong O
effect O
and O
I O
explained O
to O
her O
that O
it O
does O
. O
 
She O
has O
to O
take O
her O
medication O
every O
day O
. O
 
I O
told O
her O
she O
had O
to O
leave O
the O
Carolyn I-LOCATION
Huntington I-LOCATION
right O
now O
, O
go O
immediately O
to O
the O
drugstore O
to O
pick O
up O
the O
medication O
and O
she O
said O
she O
would O
do O
that O
. O
 
I O
also O
asked O
her O
to O
return O
next O
week O
so O
we O
can O
recheck O
her O
blood O
pressure O
and O
make O
sure O
it O
is O
controlled O
. O
 
4 O
. O
 
Health I-LOCATION
maintenance O
. O
 
I O
will O
schedule O
her O
for O
a O
mammogram O
. O
 
5 O
. O
 
Colonic O
adenoma O
from O
11/2076 I-DATE
. O
 
She O
will O
need O
follow-up O
colonoscopy O
every O
three O
years O
per O
GI O
. O
 
hga1c O
6.9 O
, O
ldl O
86 O
, O
letter O
to O
pt O
______________________________ O
Yolanda I-NAME
Osburn I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Yolanda I-NAME
Osburn I-NAME
eScription O
document:9-2062651 O
EMSSten O
Tel O
DD O
: O
01/23/77 I-DATE
DT O
: O
01/24/77 I-DATE
DV O
: O
01/22/77 I-DATE
 
Record O
date O
: O
2078-06-22 I-DATE
Patient O
Name O
: O
XIA O
, O
JEAN O
[ O
58269151 I-ID
( O
PROMPTCARE I-LOCATION
) O
] O
Date O
of O
Visit O
: O
06/22/2078 I-DATE
Reason O
for O
Visit O
pt O
was O
cleaning O
ear O
, O
now O
has O
pain O
mainly O
in O
left O
. O
 
worse O
over O
past O
three O
days O
. O
 
reports O
now O
taking O
atenolol O
( O
50 O
mg O
which O
she O
just O
took O
half O
an O
hour O
ago O
) O
and O
losartan O
, O
Reports O
stopped O
amilodipine O
and O
hctz O
. O
 
she O
had O
leg O
cramps O
, O
but O
is O
not O
clear O
which O
of O
these O
caused O
that O
. O
 
reports O
feels O
bp O
is O
high O
because O
she O
forgot O
to O
take O
med O
. O
 
Review O
of O
Systems O
Constitutional O
: O
No O
fever O
, O
chills O
, O
fatigue O
, O
nightsweats O
, O
insomnia O
, O
change O
in O
weight O
ENT/Mouth O
: O
No O
rhinitis O
, O
epistaxis O
, O
sinus O
pain O
, O
change O
in O
hearing O
, O
tinnitus O
, O
discharge O
from O
ears O
, O
oral O
lesions O
, O
problems O
chewing O
, O
dental O
pain O
, O
sore O
throat O
Cardiovascular O
: O
no O
chest O
pain O
, O
pressure O
, O
palpitation O
, O
PND O
, O
orthopnea O
, O
dyspnea O
on O
exertion O
, O
pedal O
edema O
, O
nocturia O
, O
claudication O
, O
Respiratory O
: O
no O
cough O
, O
sputum O
, O
dyspnea O
, O
pleuritic O
pain O
, O
wheeze O
, O
loud O
snoring O
, O
hemoptysis O
Allergies O
CLONIDINE O
- O
Sleepiness O
, O
Codeine O
- O
Rash O
, O
LISINOPRIL O
- O
cough O
, O
Ibuprofen O
- O
cramps O
, O
AMLODIPINE O
- O
cramps O
, O
Problems O
Diabetes O
HX O
kidney O
stones O
Perimenopausal O
sx O
Hypertension O
Colonic O
adenoma O
11/11/76 I-DATE
Medications O
Lipitor O
( O
ATORVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
, O
please O
cancel O
previous O
script O
for O
10 O
mg O
of O
lipitor O
thanks O
you O
, O
dr O
osburn I-NAME
Glucotrol O
Xl O
( O
GLIPIZIDE O
Xl O
) O
5 O
MG O
take O
qd O
Tablet O
( O
s O
) O
PO O
QD O
PIROXICAM O
20 O
MG O
( O
20MG O
CAPSULE O
take O
1 O
) O
PO O
QD O
Glucophage O
( O
METFORMIN O
) O
1000 O
MG O
take O
bid O
bid O
PO O
BID O
Cozaar O
( O
LOSARTAN O
) O
100 O
MG O
PO O
QD O
ATENOLOL O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
QD O
Cortisporin O
Otic O
Suspension O
4 O
DROP O
AS O
QID O
Vital O
Signs O
BLOOD O
PRESSURE O
210/118 O
PULSE O
80 O
TEMPERATURE O
97.3 O
F O
WEIGHT O
160 O
lb O
Physical O
Exam O
Gen O
: O
Well O
appearing O
in O
NAD O
, O
WD O
, O
WN O
ENT-Sclera O
were O
white O
, O
fundi O
disc O
sharp O
, O
conjunctiva O
clear O
, O
tympanic O
membranes O
normal O
, O
ear O
canal O
AS O
somewhat O
red O
. O
 
The O
oropharynx O
was O
pink O
without O
exudate O
. O
 
The O
neck O
was O
supple O
with O
out O
adenopathy O
. O
 
LUNG- O
clear O
bilaterally O
, O
without O
rhonci O
, O
wheeze O
or O
rales O
, O
Normal O
excursion O
was O
noted O
. O
 
Cor- O
heart O
rate O
was O
normal O
, O
rhythm O
was O
regular O
. O
 
No O
murmurs O
, O
gallops O
or O
rubs O
were O
detected O
Extremities O
: O
no O
clubbing O
cyanosis O
or O
edema O
. O
 
Skin- O
no O
abnormal O
lesions O
noted O
. O
 
Impression O
Ear- O
benign O
exam O
but O
symptomatic O
- O
try O
cortisporun O
otic O
HTN- O
very O
high O
, O
no O
sign O
of O
end O
organ O
injury O
at O
this O
moment- O
will O
increase O
atenolol O
to O
100 O
, O
and O
have O
her O
rtc O
for O
recheck O
. O
 
It O
would O
be O
helpful O
to O
know O
whether O
cramps O
came O
from O
hctz O
or O
amilodipine O
. O
 
______________________________ O
Charles I-NAME
Craig I-NAME
Max I-NAME
Zavaleta I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2092-05-06 I-DATE
Patient O
Name O
: O
WILHELM O
, O
GOLDY I-NAME
; O
MRN O
: O
9543443 I-ID
Dictated O
at O
: O
05/06/2092 I-DATE
by O
EDWARD I-NAME
XAYASANE I-NAME
, O
M.D O
. O
 
CHIEF O
COMPLAINT O
: O
Right O
leg O
pain O
and O
difficulty O
walking O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Wilhelm I-NAME
is O
a O
68-year-old O
right-handed O
female O
who O
has O
had O
a O
three-week O
history O
of O
having O
right O
leg O
pain O
and O
difficulty O
walking O
. O
 
She O
states O
that O
her O
pain O
started O
about O
three O
weeks O
ago O
when O
she O
was O
bending O
and O
picking O
up O
a O
pot O
. O
 
She O
states O
she O
had O
a O
pain O
in O
her O
back O
that O
radiated O
around O
her O
right O
side O
down O
her O
groin O
into O
her O
medial O
leg O
, O
not O
past O
the O
knee O
. O
 
She O
states O
that O
it O
went O
away O
at O
that O
time O
. O
 
The I-LOCATION
next O
day O
she O
felt O
worsened O
and O
had O
difficulty O
working O
and O
saw O
her O
physician O
. O
 
An O
MRI O
was O
ordered O
. O
 
Since O
then O
, O
she O
feels O
about O
60-75 O
percent O
better O
. O
 
She O
states O
that O
her O
pain O
is O
constant O
and O
describes O
it O
as O
a O
sharp O
pain O
. O
 
She O
does O
state O
she O
feels O
weak O
and O
her O
knee O
would O
buckle O
. O
 
She O
does O
not O
have O
any O
numbness O
or O
tingling O
. O
 
She O
states O
she O
uses O
a O
walker O
to O
get O
to O
her O
bathroom O
, O
however O
, O
otherwise O
stays O
in O
the O
recliner O
. O
 
Her O
symptoms O
are O
increased O
with O
lying O
down O
and O
standing O
and O
decreased O
with O
sitting O
. O
 
Therapeutically O
, O
she O
has O
not O
received O
any O
physical O
therapy O
or O
occupational O
therapy O
. O
 
She O
is O
currently O
taking O
Darvocet O
, O
however O
, O
less O
frequently O
, O
and O
Celebrex O
for O
arthritis O
. O
 
Diagnostically O
, O
she O
has O
had O
an O
MRI O
scan O
in O
April I-DATE
2092 I-DATE
that O
showed O
multi-level O
spinal O
stenosis O
, O
most O
prominent O
at O
L3/L4 O
, O
especially O
on O
the O
right O
side O
, O
secondary O
to O
facet O
arthropathy O
and O
ligamentum O
flavum O
infolding O
, O
as O
well O
as O
possibly O
a O
mild O
disk O
bulge O
. O
 
Her O
mammogram O
was O
done O
in O
2091 I-DATE
which O
was O
okay O
. O
 
She O
has O
not O
had O
a O
bone O
mineral O
density O
at O
this O
time O
. O
 
MEDICATIONS O
: O
Currently O
, O
the O
medication O
she O
is O
on O
is O
Celebrex O
, O
Hyzaar O
for O
her O
blood O
pressure O
, O
and O
Darvocet O
for O
her O
pain O
. O
 
ALLERGIES O
: O
She O
states O
that O
taking O
Tylenol O
With O
Codeine O
gives O
her O
toes O
a O
burning O
sensation O
, O
and O
ibuprofen O
causes O
tinnitus O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
She O
has O
got O
high O
blood O
pressure O
and O
shoulder O
arthritis O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
She O
had O
a O
left O
breast O
biopsy O
which O
she O
states O
was O
not O
cancerous O
. O
 
SOCIAL/FUNCTIONAL O
HISTORY O
: O
She O
is O
functionally O
currently O
not O
working O
. O
 
She O
is O
taking O
sick O
time O
. O
 
She O
has O
not O
worked O
for O
the O
past O
three O
weeks O
. O
 
She O
is O
a O
Head I-PROFESSION
Nurse I-PROFESSION
and O
worked O
at O
The I-LOCATION
Library I-LOCATION
Corporation I-LOCATION
for O
the O
last O
35 O
years O
. O
 
She O
states O
her O
job O
is O
medium O
as O
far O
as O
intensity O
of O
work O
. O
 
Functionally O
, O
her O
activities O
of O
daily O
living O
are O
limited O
, O
and O
she O
uses O
an O
assistive O
device O
. O
 
SOCIAL O
HISTORY O
: O
She O
is O
widowed O
and O
she O
has O
four O
healthy O
children O
, O
ages O
51 I-AGE
, O
50 I-AGE
, O
48 I-AGE
, O
and O
46 I-AGE
. O
 
She O
does O
not O
smoke O
or O
drink O
. O
 
FAMILY O
HISTORY O
: O
She O
has O
aunts O
with O
diabetes O
and O
brother O
that O
had O
an O
myocardial O
infarction O
at O
59. O
REVIEW O
OF O
SYSTEMS O
: O
On O
review O
of O
systems O
, O
no O
fevers O
, O
chills O
, O
recent O
infections O
, O
bladder O
, O
thyroid O
problems O
, O
rash O
, O
shortness O
of O
breath O
, O
palpations O
, O
chest O
pain O
, O
nausea O
, O
abdominal O
pain O
, O
diarrhea O
, O
or O
bowel O
or O
bladder O
or O
sexual O
problems O
or O
urination O
difficulty O
. O
 
She O
does O
have O
some O
joint O
pain O
and O
swelling O
in O
her O
shoulders O
and O
her O
feet O
occasionally O
. O
 
She O
does O
not O
have O
any O
numbness O
or O
tingling O
. O
 
She O
does O
have O
some O
trouble O
walking O
secondary O
to O
the O
pain O
. O
 
She O
does O
not O
feel O
fatigued O
and O
her O
appetite O
is O
okay O
and O
she O
does O
not O
feel O
anxious O
or O
stressed O
. O
 
She O
does O
have O
some O
mild O
trouble O
with O
sleeping O
, O
however O
, O
this O
has O
improved O
over O
the O
last O
few O
days O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
examination O
, O
well-developed O
, O
well-nourished O
, O
well-groomed O
, O
normal O
mood O
and O
affect O
, O
but O
slightly O
anxious O
with O
movement O
, O
female O
in O
no O
acute O
distress O
at O
this O
time O
. O
 
On O
musculoskeletal O
examination O
of O
lumbar O
spine O
, O
flexion O
was O
within O
normal O
limits O
. O
 
Extension O
she O
had O
her O
type O
of O
pain O
at O
about O
10-20 O
degrees O
. O
 
Side-bending O
was O
unremarkable O
. O
 
On O
hip O
examination O
she O
had O
some O
decreased O
internal O
rotation O
on O
the O
right O
when O
compared O
to O
the O
left O
. O
 
Straight O
leg O
raise O
bilaterally O
was O
negative O
, O
however O
, O
supine O
, O
slight O
guarding O
on O
the O
right O
. O
 
Femoral O
stretch O
was O
positive O
on O
the O
right O
but O
not O
on O
the O
left O
. O
 
On O
neurological O
examination O
, O
as O
far O
as O
motor O
examination O
, O
there O
is O
some O
slight O
decrease O
, O
half O
a O
grade O
, O
quadriceps O
and O
hip O
flexors O
; O
however O
, O
this O
was O
functional O
; O
otherwise O
unremarkable O
on O
the O
right O
or O
the O
left O
. O
 
Her O
reflexes O
were O
2 O
plus O
in O
the O
achilles O
. O
 
Babinskis O
were O
downgoing O
, O
1 O
plus O
at O
the O
patella O
on O
the O
right O
, O
and O
2 O
plus O
on O
the O
left O
. O
 
Sensory O
examination O
slightly O
decreased O
at O
L3 O
on O
the O
right O
; O
however O
, O
normal O
throughout O
; O
otherwise O
, O
gait O
was O
antalgic O
on O
the O
right O
and O
she O
did O
not O
want O
to O
bear O
weight O
. O
 
IMPRESSION O
: O
1 O
. O
 
Right O
L3 O
acute O
radiculopathy O
secondary O
to O
herniated O
disk O
and O
facet O
arthropathy O
. O
 
2 O
. O
 
Functional O
limitations O
secondary O
to O
pain O
, O
causing O
her O
functional O
weakness O
. O
 
RECOMMENDATIONS O
: O
1 O
. O
 
Transforaminal O
epidural O
steroid O
injection O
at O
L3 O
and O
L4 O
on O
the O
right O
. O
 
2 O
. O
 
Physical O
therapy O
after O
her O
injection O
. O
 
3 O
. O
 
Continue O
her O
medications O
of O
Darvocet O
and O
Celebrex O
. O
 
4 O
. O
 
Keep O
her O
out O
of O
work O
until O
she O
is O
able O
to O
receive O
the O
injection O
, O
as O
well O
as O
continue O
with O
her O
physical O
therapy O
to O
improve O
her O
strength O
, O
given O
her O
acute O
radiculopathy O
. O
 
The I-LOCATION
patient O
was O
seen O
and O
examined O
with O
Dr. O
Xayasane I-NAME
, O
who O
agrees O
with O
the O
plan O
above O
. O
 
_______________________________ O
Edward I-NAME
Xayasane I-NAME
, O
M.D O
. O
 
cc O
: O
David I-NAME
Utterback I-NAME
, O
M.D O
. O
 
DD:05/06/2092 O
DT:05/09/2092 O
TL:95468 O
:423 O
 
Record O
date O
: O
2097-06-03 I-DATE
Time O
of O
visit O
: O
6/03/2097 I-DATE
, O
1330 O
hours O
Time O
of O
note O
: O
1630 O
hours O
Patient O
seen O
and O
examined O
with O
the O
team O
. O
 
Note O
of O
Dr. O
Ellis I-NAME
reviewed O
, O
findings O
confirmed O
. O
 
Available O
electronic O
notes O
reviewed O
, O
X-rays O
reviewed O
, O
labs O
reviewed O
. O
 
73 I-AGE
y. O
o. O
woman O
who O
has O
worked O
as O
a O
nurse I-PROFESSION
at O
TLC I-LOCATION
for O
40 O
years O
. O
 
Nonsmoker O
. O
 
History O
of O
hypertension O
treated O
with O
Hyzaar O
. O
 
Current O
illness O
began O
5-6 O
months O
ago O
with O
fatigue O
, O
dyspnea O
on O
exertion O
that O
has O
progressed O
to O
the O
point O
that O
she O
has O
to O
stop O
to O
catch O
her O
breath O
after O
walking O
up O
only O
4-5 O
steps O
in O
a O
stairwell O
. O
 
She O
finds O
it O
difficult O
to O
get O
started O
on O
her O
work O
because O
of O
fatigue O
. O
 
She O
has O
had O
a O
cough O
that O
initially O
produced O
yellowish O
, O
`` O
slimy O
'' O
sputum O
, O
but O
more O
recently O
has O
been O
dry O
. O
 
She O
notes O
occasional O
wheezing O
. O
 
She O
also O
noted O
muscle O
and O
joint O
pain O
involving O
the O
shoulders O
and O
lower O
extremities O
over O
the O
past O
5-6 O
months O
that O
she O
attributed O
to O
`` O
arthritis O
'' O
. O
 
No O
polyuria O
, O
but O
has O
noted O
nocturia O
X2 O
for O
the O
past O
5-6 O
months O
. O
 
During O
the O
same O
period O
of O
time O
, O
has O
noted O
very O
dry O
mouth O
. O
 
No O
abdominal O
pain O
, O
but O
some O
difficulty O
with O
constipation O
for O
the O
past O
two O
weeks O
. O
 
Appetite O
diminished O
and O
she O
lost O
about O
30 O
pounds O
. O
 
She O
noted O
a O
nodule O
on O
the O
extensor O
surface O
of O
the O
left O
elbow O
that O
her O
PCP O
`` O
cut O
into O
'' O
recently O
. O
 
She O
has O
also O
noted O
a O
nodule O
on O
the O
dorsal O
surface O
of O
the O
right O
foot O
that O
seems O
to O
`` O
get O
larger O
'' O
. O
 
She O
experienced O
substernal O
chest O
pain O
with O
radiation O
to O
the O
back O
that O
lasted O
several O
hours O
, O
prompting O
her O
to O
come O
to O
the O
ER O
. O
 
No O
associated O
diaphoresis O
, O
nausea O
. O
 
Pain O
somewhat O
better O
with O
sitting O
up O
. O
 
Of O
note O
, O
she O
has O
known O
of O
having O
a O
cardiac O
murmur O
for O
many O
years O
. O
 
Exam O
: O
Pleasant O
black O
woman O
in O
no O
distress O
. O
 
BP O
158/79 O
, O
Pulse O
80 O
, O
regular O
; O
O2 O
sat O
98 O
% O
on O
room O
air O
. O
 
Afebrile O
. O
 
Skin O
darkly O
pigmented O
nodule O
left O
elbow O
extensor O
surface O
, O
similar O
nodule O
right O
dorsal O
foot O
just O
proximal O
to O
4th/5th O
toe O
. O
 
No O
other O
rashes O
. O
 
HEENT O
: O
pale O
conjunctivae O
, O
anicteric O
. O
 
No O
nasal O
findings O
, O
no O
facial O
skin O
findings O
( O
specifically O
, O
no O
lupus O
pernio O
) O
. O
 
Dry O
mucous O
membranes O
. O
 
Neck O
: O
small O
, O
soft O
, O
mobile O
0.5 O
cm O
node O
left O
anterior O
cervical O
chain O
. O
 
Chest O
: O
inspiratory O
crackles O
at O
both O
bases O
. O
 
Cardiac O
: O
No O
JVD O
. O
 
Regular O
rhythm O
. O
 
III/VI O
( O
I O
do O
not O
feel O
a O
thrill O
) O
harsh O
nearly O
holosystolic O
murmur O
heard O
throughout O
the O
precordium O
, O
but O
especially O
prominent O
at O
the O
RUSB O
with O
radiation O
to O
the O
clavicles O
, O
neck O
. O
 
Also O
heard O
at O
the O
apex O
and O
radiates O
to O
the O
left O
mid-back O
( O
? O
same O
murmur O
) O
. O
 
The O
murmur O
intensifies O
when O
she O
stands O
. O
 
No O
gallops O
. O
 
No O
rub O
. O
 
Abdomen O
soft O
and O
nontender O
. O
 
No O
spleen O
tip O
. O
 
Liver O
edge O
not O
palpable O
. O
 
Lymph O
nodes O
: O
fullness O
below O
the O
left O
axilla O
, O
although O
not O
confident O
of O
discrete O
nodes O
. O
 
Data O
: O
There O
is O
considerable O
testing O
available O
to O
us O
from O
her O
recent O
visits O
to O
the O
Walk-In O
Clinic O
and O
to O
Dr. O
Utter I-NAME
. O
 
A O
CXR O
from O
5/2097 I-DATE
shows O
bilateral O
hilar O
adenopathy O
, O
mediastinal O
adenopathy O
, O
and O
interstitial O
infiltrates O
. O
 
Creatinine O
1.7 O
Date/Time O
CA O
ALB O
06/03/2097 I-DATE
12.3 O
( O
H O
) O
3.4 O
06/02/2097 I-DATE
12.8 O
( O
H O
) O
3.5 O
05/28/2097 I-DATE
11.8 O
( O
H O
) O
3.5 O
Date/Time O
ALT/SGPT O
AST/SGOT O
ALKP O
TBILI O
06/03/2097 I-DATE
41 O
( O
H O
) O
41 O
( O
H O
) O
67 O
0.7 O
Date/Time O
NT-BNP O
CK O
CK-MB O
CKMBRI O
06/03/2097 I-DATE
135 O
9.6 O
( O
H O
) O
06/03/2097 I-DATE
126 O
8.6 O
( O
H O
) O
6.8 O
( O
H O
) O
E O
06/02/2097 I-DATE
4285 O
( O
H O
) O
[ O
1 O
] O
06/02/2097 I-DATE
NEGATIVE O
Date/Time O
TROP-I O
TROP-T O
06/03/2097 I-DATE
0.12 O
( O
H O
) O
06/03/2097 I-DATE
0.12 O
( O
H O
) O
06/02/2097 I-DATE
NEGATIVE O
06/02/2097 I-DATE
NEGATIVE O
Date/Time O
FE O
TIBC O
FER O
05/28/2097 I-DATE
33 O
237 O
130 O
Date/Time O
WBC O
RBC O
HGB O
HCT O
06/03/2097 I-DATE
6.4 O
3.98 O
( O
L O
) O
10.2 O
( O
L O
) O
30.4 O
( O
L O
) O
Date/Time O
MCV O
MCH O
MCHC O
PLT O
06/03/2097 I-DATE
76 O
( O
L O
) O
25.5 O
( O
L O
) O
33.5 O
198 O
Date/Time O
DIFFR O
METHOD O
% O
NEUT O
% O
LYMPH O
06/03/2097 I-DATE
RECEIVED O
Auto O
71 O
( O
H O
) O
20 O
( O
L O
) O
Date/Time O
% O
MONO O
% O
EOS O
% O
BASO O
06/03/2097 I-DATE
6 O
3 O
0 O
Date/Time O
RETIC O
06/03/2097 I-DATE
1.7 O
Serum O
angiotensin O
converting O
enzyme O
68 O
( O
7-46 O
U/L O
) O
LDH O
354 O
EKG O
: O
ST O
elevations O
V1-3 O
. O
 
Problems O
: O
1 O
. O
 
Dyspnea O
on O
exertion O
, O
progressive O
. O
 
2 O
. O
 
Interstitial O
lung O
disease O
. O
 
3 O
. O
 
Bilateral O
hilar O
adenopathy O
4 O
. O
 
Weight O
loss O
5 O
. O
 
Symptomatic O
hypercalcemia O
Nocturia O
Arthralgias O
Constipation O
Fatigue O
6 O
. O
 
Prominent O
systolic O
murmur O
( O
s O
? O
) O
. O
 
Changes O
with O
maneuvers O
suggest O
this O
may O
be O
secondary O
to O
hypertrophic O
obstructive O
cardiomyopathy O
. O
 
There O
was O
evidence O
to O
suggest O
this O
on O
an O
echo O
from O
2085 I-DATE
, O
but O
obviously O
, O
need O
more O
recent O
data O
. O
 
7 O
. O
 
Minimally O
elevated O
troponins O
. O
 
Uncertain O
significance O
. O
 
8 O
. O
 
Anemia O
, O
mildly O
microcytic O
. O
 
9 O
. O
 
Elevated O
LDH O
. O
 
10 O
. O
 
Renal O
insufficiency O
, O
likely O
secondary O
to O
uncontrolled O
hypercalcemia O
. O
 
11 O
. O
 
History O
of O
hypertension O
. O
 
Discussion O
: O
Sarcoidosis O
, O
until O
proven O
otherwise O
. O
 
She O
is O
obviously O
older O
than O
typical O
presentation O
of O
sarcoidosis O
, O
but O
she O
had O
previous O
lymphadenopathy O
that O
may O
have O
been O
a O
first O
presentation O
of O
the O
illness O
with O
spontaneous O
remission O
. O
 
The O
lung O
findings O
, O
systemic O
symptoms O
, O
hypercalcemia O
, O
anemia O
, O
abnormal O
serum O
ACE O
level O
are O
all O
suggestive O
of O
this O
diagnosis O
. O
 
Her O
hypercalcemia O
is O
symptomatic O
and O
should O
be O
treated O
with O
volume O
repletion O
. O
 
She O
should O
not O
receive O
diuretics O
at O
present O
. O
 
Long O
term O
treatment O
will O
be O
dependent O
on O
the O
underlying O
diagnosis O
and O
its O
treatment O
. O
 
I O
think O
she O
will O
need O
corticosteroids O
for O
her O
sarcoidosis O
and O
I O
expect O
this O
will O
improve O
the O
hypercalcemia O
, O
but O
we O
need O
definitive O
diagnosis O
first O
. O
 
The O
cardiac O
murmur O
is O
impressive O
, O
but O
likely O
unrelated O
to O
the O
pulmonary O
disease O
. O
 
We O
need O
echocardiogram O
to O
better O
define O
valvular O
function O
. O
 
The O
minimally O
elevated O
troponins O
are O
not O
felt O
to O
be O
of O
clinical O
significance O
at O
this O
point O
. O
 
Appreciate O
Cardiology O
input O
on O
this O
finding O
. O
 
Suggest O
: O
1 O
. O
 
Stop O
HCTZ O
, O
avoid O
diuretics O
until O
fully O
volume O
repleted O
. O
 
2 O
. O
 
IV O
normal O
saline O
. O
 
May O
need O
rates O
in O
the O
150-200 O
range O
to O
control O
her O
hypercalcemia O
acutely O
, O
but O
she O
has O
had O
this O
for O
some O
time O
, O
so O
can O
be O
conservative O
with O
fluids O
approach O
. O
 
3 O
. O
 
Agree O
with O
check O
PTH O
, O
vitamin O
D O
levels O
. O
 
4 O
. O
 
Follow O
lytes O
, O
creatinine O
, O
calcium O
, O
Hct O
. O
 
5 O
. O
 
Agree O
with O
check O
echocardiogram O
. O
 
6 O
. O
 
We O
should O
ask O
the O
Pulmonary O
Service O
to O
see O
her O
in O
consultation O
. O
 
Bronchoscopy O
with O
biopsy O
may O
be O
the O
best O
way O
to O
obtain O
confirmatory O
tissue O
for O
diagnosis O
of O
sarcoidosis O
. O
 
_____________________________________________ O
Edmond I-NAME
I. I-NAME
Utterback I-NAME
, O
M.D O
. O
 
Pager O
# O
57863 I-CONTACT
Internal O
Medicine O
B O
Attending O
 
Record O
date O
: O
2097-06-29 I-DATE
Internal O
Medicine O
B O
Intern O
Admission O
Note O
PATIENT O
: O
GOLDY I-NAME
WILHELM I-NAME
MRN O
: O
9543443 I-ID
ADMIT O
DATE O
: O
June I-DATE
29 O
, O
2097 I-DATE
ATTENDING O
: O
Dr. O
William I-NAME
Xian I-NAME
PCP O
: O
Dr. O
Casey I-NAME
Frey I-NAME
( O
new O
) O
CONTACT O
: O
Leo I-NAME
Wilhelm I-NAME
, O
son O
705-690-8475 I-CONTACT
CODE O
: O
Full O
Source O
: O
Patient O
, O
family O
, O
chart O
ID/CC O
: O
no O
appetite O
, O
acute O
renal O
failure O
HPI O
: O
73 I-AGE
yo O
black O
woman O
with O
h/o O
HTN O
and O
recurrent O
non-malignant O
axillary O
lymphadenopathy O
, O
newly O
diagnosed O
with O
HOCM O
in O
the O
setting O
of O
fatigue O
, O
weight O
loss O
and O
hypercalcemia O
concerning O
for O
sarcoidosis O
during O
a O
work-up O
at O
her O
last O
admission O
to O
MEDIQUIK I-LOCATION
on O
6/2-6/20/97 O
. O
 
At O
that O
time O
, O
the O
patient O
noted O
that O
3-4 O
mo O
PTA O
she O
had O
experienced O
worsening O
fatigue O
and O
dry O
mouth O
, O
as O
well O
as O
poor O
oral O
intake O
with O
associated O
30 O
lb O
weight O
loss O
. O
 
In O
early O
May I-DATE
, O
she O
presented O
to O
the O
walk-in O
clinic O
with O
these O
complaints O
and O
a O
CXR O
showed O
increased O
interstitial O
markings O
and O
mediastinal O
lymphadenopathy O
subsequently O
confirmed O
by O
CT. O
A O
PET O
CT O
showed O
FDG O
avidity O
in O
multiple O
enlarged O
thoracic O
and O
axillary O
nodes O
. O
 
The O
patient O
was O
seen O
at O
the O
lymphoma O
center O
by O
Dr. O
Utter I-NAME
, O
and O
concern O
was O
raised O
for O
multiple O
processes O
including O
sarcoid O
, O
lupus-like O
syndromes O
, O
Castleman O
's O
, O
and O
indolent O
lymphoma O
. O
 
Labs O
drawn O
at O
different O
times O
in O
recent O
past O
were O
notable O
for O
a O
Ca O
of O
11.8 O
with O
Alb O
of O
3.5 O
, O
a O
mild O
tranaminitis O
in O
the O
40s O
, O
LDH O
of O
354 O
, O
ACE O
of O
68 O
, O
normal O
TSH O
, O
HCT O
of O
30.2 O
, O
ESR O
of O
85 O
, O
SPEP O
with O
diffuse O
gamma O
globulin O
increase O
, O
positive O
ANA O
at O
1:2560 O
with O
nuclear O
pore O
staining O
( O
highly O
specific O
for O
biliary O
cirrhosis O
) O
, O
elevated O
B2MG O
at O
17.5 O
, O
and O
elevated O
kappa O
and O
lambda O
free O
light O
chains O
at O
66 O
and O
83.5 O
, O
respectively O
and O
negative O
HIV O
. O
 
The O
patient O
s O
hypercalcemia O
was O
treated O
with O
IVF O
, O
lasix O
at O
times O
, O
and O
a O
dose O
of O
bisphosphonate O
, O
which O
led O
to O
a O
decrease O
in O
Ca O
to O
10.1 O
. O
 
Axillary O
lymph O
node O
biopsy O
6/08/97 I-DATE
revealed O
non-specific O
follicular O
hyperplasia O
, O
though O
to O
be O
consistent O
with O
a O
reactive O
process O
. O
 
Oncology O
was O
consulted O
, O
and O
a O
lymphoma O
work-up O
was O
pursued O
; O
flow O
cytometry O
revealed O
polyclonal O
CD19+ O
B O
cells O
, O
CD4+ O
and O
CD8+ O
T O
cells O
, O
with O
no O
evidence O
for O
a O
monoclonal O
B O
or O
unusual O
T O
cell O
population O
. O
 
Repeat O
CT O
examination O
of O
the O
chest O
revealed O
no O
change O
in O
the O
bilateral O
axillary O
, O
mediastinal O
, O
and O
hilar O
lymphadenopathy O
and O
offered O
no O
further O
clues O
to O
diagnostic O
possibilities O
. O
 
The O
patient O
underwent O
pulmonary O
function O
testing O
, O
which O
showed O
a O
reduction O
in O
the O
FEV1 O
, O
FVC O
, O
and O
FEV1/FVC O
ratio O
; O
total O
lung O
capacity O
and O
subdivisions O
were O
normal O
, O
resistance O
and O
specific O
conductance O
were O
normal O
, O
and O
single O
breath O
diffusion O
capacity O
was O
reduced O
. O
 
On O
7/19/97 I-DATE
, O
a O
bronchoscopy O
was O
attempted O
, O
but O
the O
patient O
was O
unable O
to O
tolerate O
the O
procedure O
, O
and O
it O
was O
not O
performed O
. O
 
Thoracic O
surgery O
was O
consulted O
and O
recommended O
that O
the O
patient O
be O
evaluated O
in O
the O
outpatient O
setting O
for O
biopsy O
under O
general O
anesthesia O
. O
 
Fungal O
antibodies O
were O
sent O
, O
and O
a O
trial O
of O
steroids O
was O
not O
attempted O
during O
hospitalization O
. O
 
Since O
discharge O
, O
the O
pt O
reports O
that O
she O
continues O
to O
feel O
very O
fatigued O
, O
and O
has O
not O
felt O
like O
eating O
. O
 
She O
reports O
significant O
acid O
reflux O
, O
saying O
only O
water O
goes O
down O
and O
a O
lack O
of O
appetite O
with O
very O
dry O
mouth O
. O
 
She O
notes O
continued O
weight O
loss O
of O
15lbs O
since O
leaving O
the O
hospital O
, O
tolerating O
little O
more O
than O
1-2 O
cans O
of O
Ensure/day O
per O
her O
family O
. O
 
She O
further O
denies O
N/V O
, O
diarrhea O
, O
fever/chills/dizziness O
or O
recent O
infection O
. O
 
Of O
note O
, O
she O
has O
been O
drinking O
little O
, O
but O
urinating O
9-10 O
times O
a O
day O
, O
clear O
urine O
with O
large O
volumes O
. O
 
She O
has O
not O
had O
a O
bowel O
movement O
for O
several O
days O
. O
 
She O
has O
continued O
her O
medications O
as O
instructed O
at O
the O
time O
of O
discharge O
. O
 
In O
addition O
, O
her O
family O
notes O
a O
dramatic O
change O
in O
her O
mood O
and O
activity O
level O
since O
prior O
to O
hospitalization O
. O
 
She O
used O
to O
be O
very O
active O
, O
working O
nearly O
every O
day O
and O
keeping O
up O
her O
household O
. O
 
She O
now O
spends O
most O
of O
her O
day O
in O
bed O
sleeping O
, O
relying O
on O
her O
children O
for O
help O
and O
awakening O
early O
in O
the O
AM O
unintentionally O
. O
 
She O
has O
felt O
too O
tired O
to O
pursue O
her O
usual O
nightly O
bingo O
game O
. O
 
She O
denies O
suicidal O
ideation O
, O
saying O
she O
has O
her O
four O
grandchildren O
to O
liver O
for O
. O
 
ED O
COURSE O
: O
At O
the O
ED O
, O
the O
patient O
was O
afebrile O
, O
HR O
59 O
, O
BP O
136/61 O
, O
RR O
16 O
, O
O2 O
Sat O
95 O
% O
. O
 
She O
was O
given O
IVF O
and O
labs O
were O
drawn O
. O
 
PMH/PSH O
: O
HOCM O
LAD O
HTN O
Uterine O
prolapse O
Urge O
incontinence O
Rectocele O
Bladder O
prolapse O
MEDICATIONS O
ON O
ADMISSION O
: O
Multivitamins O
( O
Mvi O
) O
1 O
TAB O
PO O
QD O
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
325 O
MG O
PO O
QD O
Atorvastatin O
( O
Lipitor O
) O
40 O
MG O
PO O
QD O
Sennosides O
( O
Senna O
Tablets O
) O
2 O
TAB O
PO O
BID O
prn O
[ O
constipation O
] O
Docusate O
Sodium O
( O
Colace O
) O
100 O
MG O
PO O
TID O
prn O
[ O
constipation O
] O
Metoprolol O
Tartrate O
( O
Lopressor O
) O
100 O
MG O
PO O
Q6H O
Omeprazole O
( O
Prilosec O
) O
40 O
MG O
PO O
QD O
Verapamil O
Hcl O
60 O
MG O
PO O
Q8H O
Nifedipine O
( O
Sustained O
Release O
) O
30 O
MG O
PO O
QD O
ALLERGIES O
: O
NKDA O
SH O
: O
No O
EtOH O
, O
tob O
, O
drugs O
. O
 
Originally O
from O
Tajikistan I-LOCATION
. O
 
4 O
children O
, O
4 O
grandchildren O
, O
all O
in O
the O
area O
. O
 
Widowed O
for O
42 O
years O
, O
has O
worked O
at O
MEDIQUIK I-LOCATION
for O
40 O
years O
as O
a O
nurse I-PROFESSION
. O
 
FH O
: O
DM O
in O
children O
. O
 
Exam O
: O
VS O
: O
T=98.3 O
HR=73-84 O
reg O
BP= O
127-160/63-74 O
RR=18-20 O
SaO2= O
96 O
% O
RA O
General O
: O
thin O
black O
woman O
lying O
in O
bed O
HEENT O
: O
PERRL O
, O
prominent O
arcus O
senilus O
w/ O
? O
band O
keratopathy O
, O
dry O
muc O
membranes O
, O
geographic O
tongue O
Skin O
: O
atrophic O
, O
hypopigmented O
scars O
over O
knees O
bilaterally O
Neck O
: O
Soft O
and O
supple O
, O
no O
appreciable O
cervical O
LAD O
, O
flat O
JVP O
Chest O
: O
dry O
crackles O
diffusely O
at O
bases O
, O
otherwise O
clear O
Cardiac O
: O
regular O
, O
IV/VI O
harsh O
SEM O
at O
RSB O
, O
louder O
with O
valsalva O
Abd O
: O
soft O
, O
nontender O
Extr O
: O
without O
edema O
Neuro O
: O
A O
& O
O O
x3 O
, O
CN O
II-XII O
intact O
, O
motor O
strength O
grossly O
intact O
throughout O
, O
patient O
able O
to O
stand O
and O
walk O
unassisted O
DTRs O
within O
nlm O
range O
DATA O
: O
06/30/97 I-DATE
06/29/97 I-DATE
06/20/97 I-DATE
05:05 O
03:51 O
00:06 O
NA O
136 O
132 O
( O
L O
) O
136 O
K O
3.5 O
3.5 O
3.4 O
CL O
104 O
104 O
99 O
( O
L O
) O
CO2 O
25.3 O
25.2 O
23.8 O
BUN O
19 O
30 O
( O
H O
) O
17 O
CRE O
1.8 O
( O
H O
) O
2.2 O
( O
H O
) O
1.6 O
( O
H O
) O
GLU O
93 O
113 O
( O
H O
) O
TBILI O
0.5 O
DBILI O
0.2 O
TP O
8.0 O
ALB O
3.4 O
GLOB O
4.6 O
( O
H O
) O
AMY O
90 O
LIPS O
4.1 O
ALT/SGPT O
55 O
( O
H O
) O
AST/SGOT O
56 O
( O
H O
) O
ALKP O
113 O
( O
H O
) O
TBILI O
0.5 O
DBILI O
0.2 O
CK O
61 O
CK-MB O
5.4 O
WBC O
5.8 O
6.7 O
5.8 O
RBC O
3.84 O
( O
L O
) O
3.64 O
( O
L O
) O
3.73 O
( O
L O
) O
HGB O
10.4 O
( O
L O
) O
9.7 O
( O
L O
) O
10.0 O
( O
L O
) O
HCT O
29.9 O
( O
L O
) O
28.0 O
( O
L O
) O
28.5 O
( O
L O
) O
MCV O
78 O
( O
L O
) O
77 O
( O
L O
) O
76 O
( O
L O
) O
MCH O
27.0 O
26.7 O
26.9 O
MCHC O
34.8 O
34.8 O
35.2 O
PLT O
235 O
247 O
247 O
RDW O
16.5 O
( O
H O
) O
16.4 O
( O
H O
) O
16.0 O
( O
H O
) O
DIFFR O
Received O
Received O
METHOD O
see O
detail O
see O
detail O
% O
NEUT O
63 O
70 O
% O
LYMPH O
24 O
20 O
( O
L O
) O
% O
MONO O
8 O
6 O
% O
EOS O
4 O
3 O
% O
BASO O
1 O
1 O
ANEUT O
4.30 O
4.10 O
ALYMP O
1.60 O
1.16 O
AMONS O
0.51 O
( O
H O
) O
0.37 O
AEOSN O
0.25 O
0.15 O
ABASOP O
0.04 O
0.03 O
ANISO O
1+ O
( O
H O
) O
None O
HYPO O
None O
None O
MACRO O
None O
None O
MICRO O
2+ O
( O
H O
) O
2+ O
( O
H O
) O
P-COM O
see O
detail O
see O
detail O
PT O
12.4 O
( O
T O
) O
PT-INR O
1.1 O
( O
T O
) O
UA-COLOR O
Yellow O
Yellow O
UA-APP O
Clear O
Clear O
UA-GLUC O
Negative O
1+ O
UA-BILI O
Negative O
Negative O
UA-KET O
Negative O
Negative O
UA-SPGR O
1.010 O
1.010 O
( O
T O
) O
UA-BLD O
1+ O
1+ O
UA-PH O
5.5 O
6.0 O
UA-PROT O
1+ O
1+ O
UA-UROBI O
Trace O
Negative O
UA-NIT O
Negative O
Negative O
UA-WBC O
Negative O
Negative O
HCAST O
0-2 O
3-5 O
UAS-RBC O
0-2 O
0-2 O
UAS-WBC O
3-5 O
3-5 O
UAS-BACT O
Negative O
Negative O
UAS-SQHI O
Negative O
Few O
ECG O
: O
NSR O
@ O
82bpm O
, O
LVH O
unchanged O
from O
prior O
study O
Impression O
: O
73F O
h/o O
newly O
dx O
HOCM O
, O
chronic O
systemic O
LAD O
, O
fatigue O
, O
and O
weight O
loss O
concerning O
for O
sarcoid O
vs. O
PBC O
vs. O
neoplasm O
, O
presenting O
with O
acute O
renal O
failure O
in O
setting O
of O
little O
PO O
intake O
and O
likely O
hypercalcemia O
. O
 
Hypercalcemia O
( O
as O
in O
vitamin O
D O
excess O
secondary O
to O
sarcoid O
) O
can O
cause O
polyuria O
via O
osmotic O
diuresis O
, O
with O
dehydration O
, O
anorexia O
, O
constipation O
, O
and O
PUD O
, O
fatigue O
and O
depression O
. O
 
This O
would O
thus O
represent O
a O
unifying O
diagnosis O
for O
this O
pt O
s O
anorexia O
and O
acute O
renal O
failure O
, O
which O
is O
most O
likely O
prerenal O
. O
 
Plan O
: O
ARF O
: O
- O
f/u O
Ca O
+ O
Phos O
. O
 
Expect O
Ca O
to O
be O
high O
, O
Phos O
to O
be O
low O
. O
 
Cont O
IVF O
- O
Cre O
2.2 O
1.8 O
( O
bl O
1.2-15 O
) O
s/p O
IVF O
500cc O
x1 O
, O
on O
D5 O
NS O
@ O
100cc/hr O
, O
re-evaluate O
and O
re-bolus O
in O
AM O
- O
Maintain O
good O
UO O
, O
no O
Foley O
b/c O
recording O
stricts O
I O
s O
+ O
O O
s O
, O
700cc O
out O
of O
clear O
urine O
O/N O
Fatigue/Weight O
Loss/LAD/lack O
of O
appetite O
: O
-prior O
labs O
somewhat O
concerning O
for O
PBC O
, O
esp O
with O
elev O
AlkP O
-f/u O
anti-mitochondrial O
Ab O
, O
TSH O
, O
f/u O
pending O
labs O
from O
prior O
w/u O
-consider O
re-attempting O
transbronchial O
biopsy O
, O
revisit O
w/ O
thoracics O
Anemia O
: O
-Hct O
stable O
, O
slightly O
microcytic O
. O
 
MVI O
___________________________________________ O
Casey I-NAME
Frey I-NAME
, O
M.D O
. O
 
Pager O
46311 I-CONTACT
 
Record O
date O
: O
2097-12-15 I-DATE
SECTIONS O
OF O
THIS O
NOTE O
WERE O
CREATED O
WITH O
A O
'COPY O
AND O
PASTE O
' O
ACTION O
. O
 
THESE O
SECTIONS O
MAY O
NOT O
HAVE O
COPIED O
COMPLETELY O
. O
 
PLEASE O
USE O
CAUTION O
WHEN O
RENDERING O
CLINICAL O
JUDGMENT O
BASED O
ON O
THE O
INFORMATION O
IN O
THIS O
NOTE O
. O
 
Internal O
Medicine O
B O
Admission O
Note O
PATIENT O
: O
Goldy I-NAME
Wilhelm I-NAME
MRN O
: O
9543443 I-ID
ADMIT O
DATE O
: O
12/15/97 I-DATE
ATTENDING O
: O
Gregory I-NAME
Thomson I-NAME
PCP O
: O
Casey I-NAME
Frey I-NAME
CONTACT O
: O
Gracen I-NAME
Logan I-NAME
( O
HCP O
, O
daughter O
) O
625-248-3647 I-CONTACT
; O
Flowers I-NAME
( O
son O
) O
705-690-8475 I-CONTACT
Code O
status O
: O
Full O
Source O
: O
patient O
, O
son O
, O
records O
CC O
: O
N/V O
, O
poor O
PO O
intake O
HPI O
: O
Ms. O
Wilhelm I-NAME
is O
a O
74 I-AGE
year-old O
woman O
with O
a O
history O
of O
HOCM O
, O
HTN O
, O
DM O
, O
and O
sarcoidosis O
who O
underwent O
a O
Hartmann O
& O
# O
8217 O
; O
s O
procedure O
with O
small O
bowel O
resection O
on O
10/18 I-DATE
after O
which O
she O
was O
discharged O
to O
Harton I-LOCATION
Center I-LOCATION
on O
11/07 I-DATE
and O
then O
re-admitted O
to O
MEDIQUIK I-LOCATION
on O
11/17 I-DATE
with O
left-sided O
pleuritic O
chest O
pain O
and O
a O
saddle O
pulmonary O
embolus O
as O
well O
as O
large O
right O
lower O
extremity O
DVT O
. O
 
She O
had O
an O
IVC O
filter O
placed O
and O
was O
started O
on O
anticoagulation O
and O
discharged O
again O
to O
Harton I-LOCATION
Center I-LOCATION
on O
12/1 I-DATE
and O
now O
presents O
with O
nausea O
, O
vomiting O
, O
and O
several O
days O
of O
poor O
PO O
intake O
. O
 
This O
is O
actually O
her O
fifth O
admission O
to O
MEDIQUIK I-LOCATION
this O
year O
& O
# O
8211 O
; O
first O
in O
June I-DATE
when O
she O
was O
diagnosed O
with O
HOCM O
and O
then O
in O
July I-DATE
when O
she O
was O
started O
on O
empiric O
steroids O
for O
sarcoidosis O
. O
 
She O
says O
her O
appetite O
has O
never O
returned O
to O
normal O
since O
her O
surgery O
( O
although O
her O
July I-DATE
admission O
note O
also O
documented O
malaise O
and O
poor O
appetite O
) O
and O
that O
she O
has O
had O
some O
mild O
nausea O
on O
a O
daily O
basis O
since O
her O
surgery O
. O
 
The O
nausea O
and O
her O
fatigue O
became O
worse O
four O
or O
five O
days O
prior O
to O
admission O
and O
since O
then O
she O
has O
been O
vomiting O
many O
times O
a O
day O
. O
 
The O
nausea O
is O
not O
related O
to O
meals O
and O
she O
has O
not O
noted O
any O
blood O
in O
the O
emesis O
. O
 
She O
has O
had O
poor O
intake O
as O
a O
result O
of O
the O
nausea O
and O
has O
only O
had O
broth O
over O
the O
last O
few O
days O
. O
 
She O
denies O
fevers O
, O
chills O
, O
headaches O
, O
cough O
, O
abdominal O
pain O
, O
or O
change O
in O
the O
character O
of O
her O
colostomy O
output O
. O
 
ED O
COURSE O
: O
On O
arrival O
to O
the O
ED O
, O
vitals O
were O
as O
follows O
: O
98 O
, O
164/84 O
, O
84 O
, O
24 O
, O
98 O
% O
/RA O
. O
 
Her O
abdomen O
was O
non-tender O
and O
minimally O
distended O
. O
 
CT O
of O
the O
abdomen O
was O
concerning O
for O
a O
distal O
small O
bowel O
obstruction O
although O
no O
focal O
transition O
point O
was O
identified O
. O
 
She O
was O
seen O
by O
surgery O
and O
an O
NGT O
was O
placed O
. O
 
She O
was O
given O
2L O
of O
IVF O
and O
morphine O
2mg O
IV O
x2 O
. O
 
ROS O
As O
above O
, O
otherwise O
reports O
baseline O
blurry O
vision O
( O
has O
been O
told O
of O
cataracts O
in O
the O
past O
) O
. O
 
Denies O
SOB O
, O
cough O
, O
CP O
, O
chest O
pressure O
, O
orthopnea O
, O
palpitations O
. O
 
Foley O
catheter O
in O
place O
but O
denies O
suprapubic O
tenderness O
. O
 
MEDICAL O
HISTORY O
- O
PE O
: O
saddle O
embolus O
11/17 I-DATE
, O
s/p O
IVC O
filter O
, O
on O
coumadin O
- O
lupus O
anticoagulant O
positive O
- O
HTN O
- O
HOCM O
: O
diagnosed O
6/97 I-DATE
- O
Sarcoidosis O
: O
empirically O
started O
on O
prednisone O
7/97 I-DATE
in O
the O
setting O
of O
hypercalcemia O
- O
PBC O
: O
+AMA O
, O
not O
confirmed O
on O
biopsy O
- O
Urge O
incontinence O
, O
rectocele O
, O
bladder O
prolapse O
- O
H/o O
PAF O
- O
DM O
SURGICAL O
HISTORY O
- O
10/18/97 I-DATE
: O
Perforated O
diverticulitis O
, O
s/p O
ex O
lap O
, O
hartmanns O
procedure O
, O
small O
bowel O
resection O
and O
mobilization O
of O
left O
colon O
- O
Multiple O
LN O
biopsies O
FAMILY O
HISTORY O
Three O
children O
with O
DM O
. O
 
SOCIAL O
HISTORY O
Originally O
from O
. O
 
Widowed O
42 O
years O
, O
4 O
children O
, O
4 O
grandchildren O
. O
 
Works O
in O
TLC I-LOCATION
as O
a O
nurse I-PROFESSION
. O
 
No O
tobacco/alcohol/drugs O
. O
 
ALLERGIES O
: O
NKDA O
MEDICATIONS O
ON O
ADMISSION O
: O
1 O
. O
 
Acetaminophen O
( O
Tylenol O
) O
650 O
MG O
PO O
Q4H O
prn O
2 O
. O
 
Albuterol O
Inhaler O
( O
Albuterol O
Mdi O
) O
4 O
PUFF O
INH O
Q2H O
prn O
bronchospasm O
3 O
. O
 
Albuterol O
Nebulizer O
2.5 O
MG O
QID O
4 O
. O
 
Aluminum/Magnesium O
Hydroxide O
+ O
Simethicone O
( O
Maalox O
Susp O
) O
15-30 O
ML O
PO O
Q6H O
prn O
GI O
Upset/Heartburn O
5 O
. O
 
Amiodarone O
200 O
MG O
QD O
6 O
. O
 
Ascorbic O
Acid O
500 O
MG O
BID O
7 O
. O
 
Bisacodyl O
( O
Dulcolax O
) O
10 O
MG O
PO O
QD O
prn O
constipation O
8 O
. O
 
Clopidogrel O
( O
Plavix O
) O
75 O
MG O
QD O
9 O
. O
 
Docusate O
Sodium O
( O
Colace O
) O
100 O
MG O
BID O
10 O
. O
 
Ferrous O
Sulfate O
325 O
MG O
QD O
11 O
. O
 
Furosemide O
( O
Lasix O
) O
20 O
MG O
QOD O
12 O
. O
 
Insulin O
Regular O
Inj O
Sliding O
scale O
SC O
If O
BS O
& O
lt O
; O
= O
200 O
give O
0 O
Units O
For O
BS O
from O
201 O
to O
250 O
give O
4 O
Units O
For O
BS O
from O
251 O
to O
300 O
give O
6 O
Units O
For O
BS O
from O
301 O
to O
350 O
give O
8 O
Units O
For O
BS O
from O
351 O
to O
400 O
give O
10 O
Units O
13 O
. O
 
Ipratropium O
Inhaler O
4 O
PUFF O
INH O
Q2H O
prn O
bronchospasm O
14 O
. O
 
Magnesium O
Oxide O
400 O
MG O
BID O
15 O
. O
 
Metoprolol O
Tartrate O
( O
Lopressor O
) O
100 O
MG O
Q8H O
16 O
. O
 
Mirtazapine O
7.5 O
MG O
QHS O
17 O
. O
 
Omeprazole O
20 O
MG O
BID O
18 O
. O
 
Ondansetron O
Odt O
( O
Chemo O
N/V O
) O
( O
Zofran O
Odt O
( O
Chemo O
N/V O
) O
) O
4 O
MG O
PO O
Q8H O
prn O
nausea O
19 O
. O
 
Oxycodone O
5-10 O
MG O
PO O
Q6H O
prn O
pain O
20 O
. O
 
Pentoxifylline O
( O
Trental O
) O
400 O
MG O
TID O
21 O
. O
 
Prednisone O
5 O
MG O
QD O
22 O
. O
 
Quetiapine O
( O
Seroquel O
) O
25 O
MG O
PO O
BID O
prn O
agitation O
23 O
. O
 
Sennosides O
( O
Senna O
Tablets O
) O
2 O
TAB O
PO O
QHS O
prn O
constipation O
24 O
. O
 
Simethicone O
160 O
MG O
TID O
25 O
. O
 
Spironolactone O
( O
Aldactone O
) O
25 O
MG O
QD O
26 O
. O
 
Verapamil O
Hcl O
60 O
MG O
TID O
27 O
. O
 
Warfarin O
Sodium O
( O
Coumadin O
) O
5 O
MG O
QPM O
PHYSICAL O
EXAM O
VITALS O
: O
99.1 O
, O
95 O
, O
132/86 O
, O
97 O
% O
/RA O
GEN O
& O
# O
8217 O
; O
L O
pleasant O
African-American O
woman O
, O
tired O
but O
NAD O
, O
HEENT O
dry O
mucous O
membranes O
, O
NGT O
in O
place O
, O
OP O
clear O
, O
+conjunctival O
pallor O
NECK O
supple O
, O
no O
LAD O
, O
JVP O
& O
lt O
; O
5 O
cm O
, O
no O
carotid O
bruits O
HEART O
RRR O
, O
normal O
S1 O
, O
S2 O
, O
3/6 O
SEM O
louder O
at O
base O
and O
increases O
in O
harshness O
with O
valsalva O
LUNG O
CTAB O
, O
no O
rhonchi O
, O
rales O
ABD O
+BS O
, O
soft O
, O
non-tender O
, O
non-distended O
, O
midline O
incisional O
wound O
with O
dry O
, O
sterile O
dressing O
, O
colostomy O
bag O
in O
LLQ O
with O
brown O
stool O
EXT O
R O
LE O
with O
dry O
sterile O
dressing O
over O
shin O
, O
2+ O
DP O
pulse O
, O
wwp O
; O
L O
LE O
with O
dry O
sterile O
dressing O
from O
foot O
to O
knee O
, O
toes O
warm O
, O
no O
edema O
NEURO O
: O
AO O
x O
3 O
; O
alert O
; O
CN O
II-XII O
grossly O
intact O
; O
Motor O
: O
4/5 O
B O
UE/LE O
; O
sensation O
grossly O
intact O
to O
light O
touch O
LABS O
: O
& O
# O
183 O
; O
Hematology O
: O
12/15/97 I-DATE
12/14/97 I-DATE
WBC O
6.0 O
7.4 O
HGB O
7.6 O
( O
L O
) O
8.6 O
( O
L O
) O
HCT O
22.7 O
( O
L O
) O
25.6 O
( O
L O
) O
MCV O
87 O
87 O
PLT O
372 O
( O
H O
) O
416 O
( O
H O
) O
RDW O
15.2 O
( O
H O
) O
15.3 O
( O
H O
) O
% O
NEUT O
68 O
( O
H O
) O
79 O
( O
H O
) O
% O
LYMPH O
24 O
16 O
( O
L O
) O
% O
MONO O
7 O
5 O
% O
EOS O
1 O
0 O
% O
BASO O
0 O
0 O
& O
# O
183 O
; O
Chemistries O
: O
12/15/97 I-DATE
12/14/97 I-DATE
NA O
134 O
( O
L O
) O
133 O
( O
L O
) O
K O
4.5 O
5.7 O
( O
HT O
) O
CL O
100 O
100 O
CO2 O
22.7 O
( O
L O
) O
22.5 O
( O
L O
) O
BUN O
31 O
( O
H O
) O
32 O
( O
H O
) O
CRE O
1.8 O
( O
H O
) O
2.1 O
( O
H O
) O
GLU O
82 O
139 O
( O
H O
) O
ALB O
2.7 O
( O
L O
) O
LACT O
0.6 O
& O
# O
183 O
; O
LFTs O
: O
ALT/SGPT O
23 O
AST/SGOT O
18 O
ALKP O
123 O
( O
H O
) O
TBILI O
0.5 O
DBILI O
0.1 O
& O
# O
183 O
; O
Coags O
: O
12/15/97 I-DATE
12/14/97 I-DATE
PT O
38.7 O
( O
H O
) O
35.7 O
( O
HT O
) O
PT-INR O
4.3 O
3.9 O
( O
T O
) O
PTT O
48.1 O
( O
HT O
) O
RADIOLOGY/STUDIES O
: O
CXR O
( O
12/14 I-DATE
) O
: O
Lines/tubes O
: O
Interval O
placement O
of O
left-sided O
PICC O
line O
the O
tip O
of O
the O
PICC O
line O
does O
not O
cross O
midline O
there O
is O
a O
nasogastric O
tube O
with O
the O
tip O
below O
the O
diaphragm O
Lungs O
: O
There O
is O
a O
persistent O
opacity O
in O
the O
left O
mid O
hemithorax O
Pleura O
: O
There O
is O
no O
pleural O
effusion O
or O
pneumothorax O
. O
 
Heart O
and O
mediastinum O
: O
The O
heart O
and O
the O
mediastinum O
are O
normal O
. O
 
CT O
Abd O
( O
12/14 I-DATE
) O
: O
LOWER O
THORAX O
: O
There O
been O
interval O
resolution O
of O
the O
previously O
identified O
bilateral O
pleural O
effusions O
. O
 
There O
is O
linear O
atelectasis O
of O
the O
lung O
bases O
. O
 
HEPATOBILIARY O
: O
No O
focal O
hepatic O
lesions O
. O
 
No O
biliary O
ductal O
dilatation O
. O
 
There O
are O
stable O
findings O
of O
porcelain O
gallbladder O
. O
 
SPLEEN O
: O
No O
splenomegaly O
. O
 
PANCREAS O
: O
No O
focal O
masses O
or O
ductal O
dilatation O
. O
 
ADRENALS O
: O
No O
adrenal O
nodules O
. O
 
KIDNEYS/URETERS O
: O
No O
hydronephrosis O
, O
stones O
, O
or O
solid O
mass O
lesions O
. O
 
Two O
left O
renal O
exophytic O
lesions O
are O
identified O
, O
stable O
in O
size O
compared O
with O
the O
prior O
examination O
and O
consistent O
with O
renal O
cysts O
. O
 
PELVIC O
ORGANS/BLADDER O
: O
There O
is O
a O
Foley O
catheter O
in O
place O
. O
 
There O
is O
a O
fibroid O
uterus O
. O
 
PERITONEUM O
/ O
RETROPERITONEUM O
: O
No O
free O
air O
is O
seen O
. O
 
There O
is O
trace O
free O
fluid O
. O
 
LYMPH O
NODES O
: O
No O
lymphadenopathy O
. O
 
VESSELS O
: O
There O
are O
scattered O
vascular O
calcifications O
. O
 
An O
IVC O
filter O
is O
in O
place O
. O
 
GI O
TRACT O
: O
There O
is O
diffuse O
dilation O
of O
the O
proximal O
and O
mid O
small O
bowel O
with O
multiple O
air O
fluid O
levels O
. O
 
There O
are O
loops O
of O
nondilated O
distal O
small O
bowel O
and O
the O
colon O
is O
not O
dilated O
. O
 
There O
has O
been O
a O
prior O
a O
prior O
colostomy O
. O
 
There O
is O
diverticulosis O
. O
 
BONES O
AND O
SOFT O
TISSUES O
: O
Unremarkable O
. O
 
IMPRESSION O
: O
Findings O
concerning O
for O
distal O
small O
bowel O
obstruction O
though O
no O
discrete O
transition O
point O
is O
identified O
. O
 
Alternately O
, O
this O
could O
reflect O
ileus O
. O
 
Close O
clinical O
follow O
up O
advised O
. O
 
EKG O
: O
NSR O
at O
94bpm O
, O
leftward O
axis O
, O
biatrial O
enlargement O
, O
normal O
PR O
interval O
, O
narrow O
QRS O
, O
LVH O
, O
TWIs O
in O
I O
, O
aVL O
ASSESSMENT O
& O
amp O
; O
PLAN O
Ms. O
Wilhelm I-NAME
is O
a O
74 I-AGE
year-old O
woman O
with O
a O
history O
of O
HOCM O
, O
hypertension O
, O
sarcoidosis O
, O
diabetes O
, O
who O
underwent O
a O
Hartmann O
& O
# O
8217 O
; O
s O
procedure O
with O
small O
bowel O
resection O
on O
10/18 I-DATE
and O
was O
re-admitted O
on O
11/17 I-DATE
with O
a O
saddle O
PE O
and O
large O
RLE O
DVT O
for O
which O
she O
was O
managed O
with O
IVC O
filter O
and O
anticoagulation O
who O
now O
presents O
with O
several O
days O
of O
nausea O
and O
vomiting O
and O
concern O
for O
small O
bowel O
obstruction O
on O
CT. O
SBO O
: O
Her O
clinical O
presentation O
and O
CT O
findings O
are O
concerning O
for O
small O
bowel O
obstruction O
( O
although O
ileus O
remains O
a O
possibility O
. O
 
Lactate O
was O
within O
normal O
limits O
so O
small O
bowel O
ischemia O
unlikely O
. O
 
Also O
abdominal O
exam O
remains O
benign O
at O
this O
time O
. O
 
Appreciate O
surgery O
input O
NGT O
to O
low O
wall O
suction O
NPO O
except O
meds O
for O
bowel O
rest O
Serial O
abdominal O
exams O
Check O
colostomy O
output O
guaiac O
Acute O
renal O
failure O
: O
Her O
creatinine O
was O
up O
from O
a O
baseline O
of O
1.0 O
to O
2.1 O
on O
admission O
. O
 
With O
IVF O
hydration O
in O
the O
ED O
it O
has O
already O
started O
to O
come O
down O
to O
1.8 O
so O
it O
was O
likely O
pre-renal O
in O
the O
setting O
of O
poor O
intake O
and O
vomiting O
. O
 
Continue O
IVF O
while O
NPO O
Will O
trend O
Cr O
and O
pursue O
further O
ARF O
work-up O
if O
not O
down O
on O
AM O
labs O
Anemia O
: O
Baseline O
hematocrit O
in O
low O
30s O
, O
last O
32.6 O
prior O
to O
discharge O
on O
11/30 I-DATE
. O
 
She O
does O
not O
appear O
to O
have O
an O
active O
source O
of O
bleeding O
and O
her O
bilirubin O
is O
within O
normal O
limits O
so O
she O
is O
unlikely O
to O
be O
hemolyzing O
. O
 
She O
likely O
either O
has O
iron-deficiency O
anemia O
( O
although O
she O
has O
been O
taking O
iron O
supplements O
) O
or O
anemia O
of O
chronic O
disease O
& O
# O
8211 O
; O
or O
a O
combination O
thereof O
. O
 
Her O
RDW O
is O
only O
mildly O
elevated O
which O
likely O
indicates O
inappropriately O
low O
hematopoiesis O
. O
 
Transfuse O
1U O
PRBCs O
Check O
colostomy O
guaiac O
Check O
iron O
studies O
, O
reticulocyte O
count O
Elevated O
INR/hypercoagulability O
: O
She O
is O
baseline O
hypercoagulable O
with O
lupus O
anticoagulant O
and O
has O
had O
the O
recent O
large O
DVT/PE O
s/p O
IVC O
filter O
placement O
. O
 
She O
comes O
in O
with O
an O
elevated O
INR O
and O
is O
likely O
supratherapeutic O
on O
her O
coumadin O
. O
 
She O
does O
not O
need O
to O
be O
reversed O
as O
she O
does O
not O
seem O
to O
be O
actively O
bleeding O
. O
 
Hold O
Coumadin O
for O
now O
Follow O
up O
INR O
, O
goal O
2-3 O
HOCM/HTN O
: O
Continue O
lopressor O
, O
verapamil O
Sarcoid O
: O
Continue O
Prednisone O
at O
5mg O
daily O
PAF O
Continue O
Amiodarone O
& O
# O
8211 O
; O
follow-up O
with O
PCP O
regarding O
indication O
for O
Amio O
F/E/N O
: O
NPO O
PPX O
: O
coumadin O
, O
PPI O
, O
bowel O
regimen O
CODE O
: O
Full O
__________________________________ O
Antoinette I-NAME
S I-NAME
Delaney I-NAME
, O
MD O
, O
Pager O
# O
63784 I-CONTACT
 
Record O
date O
: O
2098-08-03 I-DATE
Internal O
Medicine O
G O
Intern O
Admission O
Note O
PATIENT O
: O
Wilhelm O
, O
Goldy I-NAME
MRN O
: O
9543443 I-ID
ADMIT O
DATE O
: O
8/2/98 I-DATE
PCP O
: O
Dr. O
Casey I-NAME
Frey I-NAME
HPI O
: O
74F O
with O
sarcoidosis O
, O
HTN O
, O
CHF O
, O
HOCM O
, O
PE O
s/p O
IVC O
filter O
now O
on O
coumadin O
, O
PVD O
s/p O
L O
BKA O
, O
and O
DM O
who O
presents O
from O
her O
rehab O
facility O
with O
failure O
to O
thrive O
and O
increasing O
lethargy O
for O
several O
weeks O
. O
 
Of O
note O
, O
pt O
had O
recent O
admission O
to O
MEDIQUIK I-LOCATION
( O
6/29-7/05 O
) O
at O
which O
time O
she O
presented O
with O
similar O
complaints O
of O
fatigue/lethargy O
and O
routine O
CBC O
demonstrated O
an O
elevated O
WBC O
( O
15 O
) O
and O
low O
Hct O
( O
23 O
) O
. O
 
She O
was O
ultimately O
found O
to O
have O
an O
Enterococcus O
bacteremia O
and O
intra-abdominal O
abscess O
that O
grew O
out O
E. O
coli O
. O
 
She O
underwent O
IR O
drainage O
of O
the O
abdominal O
collection O
and O
completed O
a O
course O
of O
Vanc/CTX O
. O
 
Outpatient O
f/u O
abd O
CT O
( O
7/18 I-DATE
) O
showed O
near O
complete O
resolution O
of O
the O
intra-abdominal O
collection O
. O
 
Since O
that O
time O
, O
however O
, O
pt O
& O
# O
8217 O
; O
s O
sons O
report O
increasing O
lethargy O
at O
her O
nursing O
facility O
. O
 
Patient O
has O
no O
complaints O
. O
 
Specifically O
, O
she O
denies O
fatigue O
, O
chest O
pain O
, O
shortness O
of O
breath O
, O
dizziness O
, O
motor O
weakness O
and O
fevers O
and O
chills O
. O
 
However O
, O
given O
concern O
on O
the O
part O
of O
her O
sons O
, O
pt O
was O
taken O
to O
the O
MEDIQUIK I-LOCATION
ED O
. O
 
In O
the O
MEDIQUIK I-LOCATION
ED O
, O
she O
was O
afebrile O
with O
HR O
70 O
, O
BP O
150/74 O
, O
RR O
24 O
, O
and O
Sa02 O
100 O
% O
RA O
. O
 
PMH O
: O
Hypertension O
History O
of O
Congestive O
heart O
failure O
, O
HOCM O
( O
EF O
=77 O
% O
) O
Pulmonary O
embolism O
( O
11/97 I-DATE
) O
s/p O
IVC O
filter O
now O
on O
coumadin O
Peripheral O
vascular O
disease O
s/p O
left O
BKA O
4/29/98 I-DATE
due O
to O
ischemic O
gangrene O
of O
left O
foot O
. O
 
Diabetes O
mellitus O
( O
HbA1C O
= O
6.3mg/dL O
- O
1/98 I-DATE
) O
Sarcoidosis O
Breast O
mass O
w/ O
axillary O
lymphadenopathy O
Perforated O
small O
bowel O
diverticulitis O
s/p O
sigmoid O
resection O
w/Hartmann O
procedure O
with O
diverting O
colostomy O
by O
Dr. O
Joshi I-NAME
in O
10/97 I-DATE
( O
removed O
9 O
'' O
of O
jejunum O
) O
Heterozygous O
hemoglobin O
S O
- O
on O
6/20/2085 I-DATE
Hb O
electropheresis O
Meds O
: O
1 O
. O
 
Artificial O
Tears O
1 O
DROP O
OD O
QID O
2 O
. O
 
Bisacodyl O
( O
Dulcolax O
) O
5 O
MG O
PO O
QD O
prn O
constipation O
3 O
. O
 
Calcium O
Carbonate/Vitd O
( O
250mg O
Ca++/125u O
Vitd O
) O
2 O
TAB O
PO O
BID O
4 O
. O
 
Citalopram O
( O
Celexa O
) O
40 O
MG O
PO O
QD O
5 O
. O
 
Clonidine O
0.1 O
MG O
PO O
BID O
6 O
. O
 
Docusate O
Sodium O
( O
Colace O
) O
100 O
MG O
PO O
BID O
7 O
. O
 
Hydralazine O
Hcl O
100 O
MG O
PO O
QID O
8 O
. O
 
Insulin O
Glargine O
( O
Lantus O
) O
25 O
UNITS O
SC O
QAM O
9 O
. O
 
Megestrol O
Acetate O
Suspension O
( O
Megace O
) O
400 O
MG O
PO O
QD O
10 O
. O
 
Melatonin O
3 O
MG O
PO O
QHS O
11 O
. O
 
Metoclopramide O
Hcl O
( O
Reglan O
) O
10 O
MG O
PO O
Q6H O
12 O
. O
 
Multivitamins O
( O
Mvi O
) O
1 O
TAB O
PO O
QD O
13 O
. O
 
Niferex O
150 O
150 O
MG O
PO O
BID O
14 O
. O
 
Omeprazole O
( O
Prilosec O
) O
20 O
MG O
PO O
QD O
15 O
. O
 
Ondansetron O
Odt O
( O
Zofran O
Odt O
) O
4 O
MG O
PO O
Q8H O
prn O
nausea/vomiting O
16 O
. O
 
Pentoxifylline O
400 O
MG O
PO O
TID O
17 O
. O
 
Polyethylene O
Glycol O
( O
Miralax O
) O
17 O
GM O
PO O
QD O
18 O
. O
 
Prednisone O
10 O
MG O
PO O
QD O
19 O
. O
 
Propoxyphene O
Nap/Acetaminophen O
100/650 O
( O
Darvocet-N O
100 O
) O
1 O
TAB O
PO O
Q4H O
prn O
20 O
. O
 
Propranolol O
Hcl O
( O
Inderal O
) O
60 O
MG O
PO O
QID O
21 O
. O
 
Verapamil O
Hcl O
120 O
MG O
PO O
TID O
22 O
. O
 
Warfarin O
Sodium O
( O
Coumadin O
) O
4 O
MG O
PO O
QPM O
Allergies O
: O
Propranolol O
- O
SOB O
Family O
history O
: O
Noncontributory O
Social O
History O
: O
Pt O
lives O
at O
Ingham I-LOCATION
Hospital I-LOCATION
. O
 
She O
denies O
EtOH O
, O
tobacco O
, O
and O
illicit O
drugs O
. O
 
ROS O
: O
As O
per O
HPI O
PE O
: O
Vitals O
: O
T O
97.2 O
HR O
85 O
BP O
192/80 O
RR O
18 O
Sa02 O
98 O
% O
RA O
Gen O
: O
Quiet O
woman O
, O
whispering O
, O
appears O
somnolent O
but O
NAD O
HEENT O
: O
PERRL O
, O
MMM O
, O
o/p O
clear O
Neck O
: O
No O
bruits O
, O
JVP O
flat O
Chest O
: O
CTAB O
Card O
: O
RRR O
, O
nl O
s1/s2 O
, O
II/VI O
crescendo/decrescendo O
murmur O
at O
USBs O
, O
harsh O
SEM O
at O
apex O
Abd O
: O
+ O
BS O
, O
NTND O
, O
no O
HSM O
, O
rectal O
exam O
is O
guaiac O
negative O
Ext O
: O
L O
BKA O
, O
R O
pulses O
acquired O
via O
doppler O
Neuro O
: O
A O
& O
amp O
; O
Ox3 O
, O
CNs O
II-XII O
intact O
Labs O
: O
140 O
106 O
46 O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
( O
145 O
5.7 O
( O
H O
) O
23 O
1.58 O
Baseline O
Cr O
1.2 O
Ca O
9.2 O
PO4 O
3.9 O
Mg O
2 O
15.5 O
& O
gt O
; O
25.1 O
& O
lt O
; O
252 O
( O
Baseline O
Hct O
30 O
) O
PT O
40 O
PTT O
30.8 O
INR O
4.6 O
U/A O
: O
0-2 O
RBCs O
, O
20-50 O
WBCs O
, O
moderate O
squams O
EKG O
: O
84bpm O
, O
sinus O
, O
normal O
axis O
, O
ST O
elevations O
in O
V2-V3 O
( O
old O
) O
Imaging O
: O
CXR O
( O
8/2/98 I-DATE
) O
: O
1 O
. O
 
Increased O
interstitial O
markings O
may O
represent O
worsened O
mild O
pulmonary O
edema O
or O
interstitial O
infection O
. O
 
Abd O
CT O
( O
7/18/98 I-DATE
) O
: O
Near O
complete O
resolution O
of O
previously O
seen O
left O
lower O
quadrant O
fluid O
collection O
. O
 
Stable O
small O
cystic O
lesions O
in O
pancreas O
which O
likely O
represent O
side O
branch O
IPMN O
. O
 
Abd O
CT O
( O
6/30/98 I-DATE
) O
: O
New O
4.8 O
x O
4.0 O
cm O
thick O
walled O
fluid O
collection O
in O
the O
LLQ O
which O
contains O
a O
small O
amount O
of O
gas O
. O
 
This O
would O
be O
amenable O
to O
percutaneous O
drainage O
. O
 
Small O
bilateral O
pleural O
effusions O
, O
decreased O
in O
size O
. O
 
Bilateral O
benign O
renal O
cysts O
. O
 
Gallbladder O
wall O
calcifications O
. O
 
A/P O
: O
74F O
with O
sarcoidosis O
, O
HTN O
, O
CHF O
, O
HOCM O
, O
PE O
s/p O
IVC O
filter O
now O
on O
coumadin O
, O
PVD O
s/p O
L O
BKA O
, O
and O
DM O
who O
presents O
from O
her O
rehab O
facility O
with O
failure O
to O
thrive O
and O
increasing O
lethargy O
for O
several O
weeks O
. O
 
1 O
. O
 
Failure O
to O
thrive O
/ O
lethargy O
: O
The O
etiology O
of O
this O
pt O
& O
# O
8217 O
; O
s O
lethargy O
is O
unclear O
. O
 
It O
is O
notable O
, O
however O
, O
that O
her O
presentation O
on O
this O
admission O
is O
very O
similar O
to O
her O
presentation O
in O
July I-DATE
at O
which O
time O
she O
was O
found O
to O
be O
bacteremic O
with O
an O
additional O
intra-abdominal O
bacterial O
collection O
. O
 
At O
present O
, O
there O
is O
no O
clear O
source O
of O
infection O
, O
although O
her O
urinalysis O
is O
suspicious O
for O
a O
UTI O
. O
 
Elevated O
WBC O
in O
someone O
on O
chronic O
steroids O
is O
concerning O
for O
infection O
, O
but O
pt O
is O
hemodynamically O
stable O
and O
afebrile O
. O
 
In O
addition O
to O
bacteremia O
, O
UTI O
and O
re-accumulation O
of O
an O
intra-abdominal O
collection O
, O
other O
possible O
causes O
of O
her O
lethargy O
include O
toxic/metabolic O
causes O
( O
such O
as O
uremia O
) O
, O
anemia O
, O
or O
depression O
. O
 
- O
F/u O
blood O
, O
urine O
, O
and O
respiratory O
cultures O
- O
Will O
hold O
off O
on O
empirically O
starting O
abx O
based O
on O
urinalysis O
( O
If O
we O
were O
to O
start O
abx O
, O
would O
recommend O
vanc/cefepime O
given O
micro O
history O
) O
- O
Culture O
if O
spikes O
- O
Consider O
repeat O
abd O
imaging O
if O
pt O
continues O
to O
have O
a O
leukocytosis O
and O
doesn O
& O
# O
8217 O
; O
t O
clinically O
improve O
2 O
. O
 
Anemia O
& O
# O
8211 O
; O
Source O
of O
anemia O
has O
been O
unclear O
in O
the O
past O
. O
 
During O
last O
admission O
, O
pt O
was O
found O
to O
be O
guaiac O
positive O
on O
rectal O
exam O
but O
guaiac O
negative O
out O
of O
colostomy O
. O
 
GI O
at O
that O
time O
had O
deferred O
colonoscopy O
. O
 
It O
is O
possible O
that O
her O
anemia O
may O
be O
responsible O
for O
her O
failure O
to O
thrive O
. O
 
- O
Type O
and O
screen O
- O
Will O
transfuse O
1 O
unit O
of O
pRBCs O
and O
monitor O
for O
clinical O
improvement O
- O
Check O
post-transfusion O
Hct O
3 O
. O
 
HTN O
& O
# O
8211 O
; O
pt O
has O
long-standing O
refractory O
hypertension O
despite O
numerous O
anti-hypertensive O
agents O
- O
Per O
pharmacy O
recommendations O
, O
holding O
propranolol O
given O
h/o O
SOB O
- O
Continue O
clonidine O
, O
verapimil O
and O
hydral O
( O
titrate O
as O
needed O
) O
4 O
. O
 
Elevated O
INR O
& O
# O
8211 O
; O
pt O
has O
a O
supratherapeutic O
INR O
. O
 
Given O
that O
pt O
is O
near O
discharge O
Hct O
from O
previous O
admission O
, O
do O
not O
feel O
that O
she O
is O
actively O
bleeding O
. O
 
As O
such O
, O
do O
not O
feel O
the O
need O
to O
actively O
reverse O
her O
. O
 
- O
Monitor O
daily O
INRs O
- O
Hold O
warfarin O
overnight O
5 O
. O
 
Renal O
insufficiency O
& O
# O
8211 O
; O
Cr O
1.58 O
today O
( O
baseline O
1.2 O
) O
. O
 
Likely O
secondary O
to O
prerenal O
- O
Fluid O
resuscitation O
- O
Recheck O
lytes O
in O
AM O
6 O
. O
 
Diabetes O
- O
FSG O
QAC O
+ O
HS O
- O
Lantus O
+ O
RISS O
7 O
. O
 
FEN O
- O
Diabetic O
diet O
8 O
. O
 
PPx O
& O
# O
8211 O
; O
Pboots O
, O
teds O
on O
R O
leg O
Gerardo I-NAME
Valadez I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
, O
PGY-1 O
Pager O
47234 I-CONTACT
 
Record O
date O
: O
2093-01-13 I-DATE
EDVISIT^32612454^Barr O
, O
Nicky^01/13/93^IP O
, O
CARRIE I-NAME
I O
saw O
this O
patient O
in O
conjunction O
with O
Dr. O
Xue I-NAME
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident O
's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
CHIEF O
COMPLAINT O
: O
A O
57-year-old O
with O
back O
pain O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
young O
woman O
with O
a O
complicated O
past O
medical O
history O
, O
presents O
with O
a O
chronic O
history O
of O
low O
back O
pain O
, O
worse O
over O
the O
last O
week O
. O
 
She O
states O
that O
3 O
years O
ago O
, O
she O
had O
a O
motor O
vehicle O
accident O
. O
 
Since O
that O
time O
, O
has O
had O
chronic O
low O
back O
pain O
. O
 
She O
has O
been O
able O
to O
ambulate O
at O
home O
. O
 
Denies O
any O
fevers O
, O
rashes O
, O
history O
of O
urinary O
incontinence O
, O
weakness O
, O
or O
numbness O
. O
 
She O
went O
to O
EDUCARE-FARGO I-LOCATION
earlier O
this O
week O
and O
was O
prescribed O
Percocet O
, O
comes O
here O
now O
because O
the O
patient O
's O
family O
and O
the O
patient O
would O
like O
to O
change O
her O
care O
to O
Lansing I-LOCATION
Dover I-LOCATION
Clinic I-LOCATION
. O
 
Denies O
any O
numbness O
or O
weakness O
. O
 
States O
that O
she O
is O
no O
longer O
taking O
her O
pills O
at O
home O
. O
 
Denies O
any O
suicidal O
or O
homicidal O
ideation O
, O
has O
a O
flat O
affect O
. O
 
Denies O
any O
depression O
. O
 
Her O
son O
, O
however O
, O
with O
whom O
she O
lives O
disagrees O
and O
is O
very O
concerned O
that O
she O
may O
be O
depressed O
. O
 
He O
is O
also O
very O
concerned O
that O
she O
is O
not O
taking O
her O
medicines O
and O
that O
she O
is O
not O
caring O
for O
herself O
well O
at O
home O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Remarkable O
for O
hypertension O
, O
diabetes O
, O
and O
a O
prior O
stroke O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
She O
has O
also O
had O
knee O
surgery O
. O
 
SOCIAL O
HISTORY O
, O
FAMILY O
HISTORY O
, O
AND O
REVIEW O
OF O
SYSTEMS O
: O
As O
per O
the O
written O
note O
. O
 
The O
patient O
was O
counseled O
regarding O
smoking O
cessation O
. O
 
MEDICATIONS O
: O
Hydrochlorothiazide O
and O
Coumadin O
. O
 
ALLERGIES O
: O
None O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
awake O
and O
alert O
in O
no O
acute O
distress O
. O
 
Vital O
signs O
are O
within O
normal O
limits O
as O
documented O
. O
 
For O
full O
physical O
exam O
findings O
, O
please O
see O
the O
resident's O
written O
note O
. O
 
Specifically O
, O
HEENT O
, O
neck O
, O
respiratory O
, O
cardiac O
, O
rectal O
, O
and O
abdominal O
exam O
are O
within O
normal O
limits O
as O
documented O
. O
 
Skin O
exam O
is O
remarkable O
for O
erythematous O
changes O
in O
the O
groin O
where O
the O
patient O
has O
significant O
skin O
fold O
due O
to O
obesity O
. O
 
Musculoskeletal O
exam O
is O
otherwise O
unremarkable O
. O
 
Range O
of O
motion O
is O
full O
. O
 
Strength O
and O
tone O
is O
normal O
. O
 
The O
patient O
does O
have O
a O
positive O
straight O
leg O
raise O
on O
the O
left O
, O
reproducing O
her O
back O
pain O
. O
 
Neurologically O
, O
the O
patient O
has O
a O
flat O
affect O
but O
is O
oriented O
with O
intact O
cranial O
nerves O
and O
no O
focal O
neurologic O
deficit O
in O
either O
motor O
or O
sensory O
distribution O
. O
 
She O
does O
, O
however O
, O
walk O
with O
a O
limp O
, O
which O
is O
chronic O
for O
her O
. O
 
LABORATORY O
DATA O
: O
White O
blood O
count O
is O
slightly O
elevated O
at O
11.3 O
. O
 
BUN O
and O
creatinine O
is O
also O
significantly O
elevated O
at O
26 O
and O
1.1 O
, O
respectively O
. O
 
Potassium O
is O
also O
quite O
low O
at O
2.9 O
. O
 
Urinalysis O
is O
positive O
with O
35-40 O
white O
blood O
cells O
, O
15-20 O
red O
blood O
cells O
, O
and O
2+ O
bacteria O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
My O
chief O
concern O
for O
this O
patient O
is O
her O
inability O
to O
care O
for O
self O
at O
home O
. O
 
It O
is O
apparent O
that O
her O
son O
is O
interested O
in O
helping O
her O
and O
do O
so O
, O
but O
the O
patient O
on O
physical O
exam O
has O
some O
obvious O
lack O
of O
hygiene O
and O
I O
am O
concerned O
that O
potentially O
the O
patient O
has O
either O
an O
underlying O
neurologic O
or O
psychiatric O
issue O
that O
is O
preventing O
her O
from O
thriving O
at O
home O
. O
 
Psychiatry O
initially O
was O
consulted O
. O
 
Their O
impression O
was O
that O
the O
patient O
may O
have O
neuro O
behavior O
problem O
that O
needs O
further O
outpatient O
workup O
, O
and O
she O
was O
referred O
to O
a O
specific O
providers O
within O
the O
next O
2 O
weeks O
. O
 
The O
patient O
was O
treated O
with O
potassium O
chloride O
for O
her O
hypokalemia O
. O
 
Care O
coordinator O
and O
social O
services O
were O
consulted O
. O
 
The O
patient O
will O
have O
a O
home O
safety O
evaluation O
and O
will O
be O
referred O
for O
primary O
care O
services O
, O
was O
discharged O
with O
a O
cane O
for O
ambulation O
, O
and O
will O
likely O
also O
receive O
VNA O
Services O
to O
help O
her O
with O
medication O
compliance O
and O
other O
ADLs O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
DIAGNOSES O
: O
1 O
. O
 
Chronic O
low O
back O
pain O
. O
 
2 O
. O
 
Hypokalemia O
. O
 
3 O
. O
 
Urinary O
tract O
infection O
. O
 
4 O
. O
 
Failure O
to O
thrive O
. O
 
DISPOSITION O
: O
Discharged O
. O
 
CONDITION O
ON O
DISCHARGE O
: O
Satisfactory O
. O
 
______________________________ O
IP O
, O
CARRIE I-NAME
MD O
D O
: O
01/13/93 I-DATE
T O
: O
01/13/93 I-DATE
Dictated O
By O
: O
IP O
, O
CARRIE I-NAME
eScription O
document:1-1843613 O
BFFocus O
 
Record O
date O
: O
2093-02-28 I-DATE
Personal O
Data O
and O
Overall O
Health O
Mrs. O
Barr I-NAME
is O
a O
57 I-AGE
years O
old O
lady O
with O
multiple O
significant O
medical O
problems O
new O
to O
KEKELA I-LOCATION
. O
 
Chief I-PROFESSION
Complaint O
She O
is O
here O
today O
for O
a O
Physical O
Exam O
History O
of O
Present O
Illness O
Patient O
has O
HO O
HTN O
for O
years O
and O
CVA O
. O
 
She O
has O
had O
4 O
CVAs O
in O
the O
past O
. O
 
First O
one O
in O
2087 I-DATE
, O
2088 I-DATE
, O
2089 I-DATE
and O
2090 I-DATE
. O
 
She O
was O
not O
taking O
her O
BP O
meds O
those O
times O
and O
she O
has O
been O
smoking O
1 O
PPD O
since O
then O
despite O
being O
told O
she O
had O
to O
quit O
smoking O
. O
 
She O
was O
seen O
at O
the O
LDC I-LOCATION
ED O
twice O
in O
Jan I-DATE
13 I-DATE
and O
21/05 I-DATE
. O
 
First O
visit O
she O
was O
taken O
by O
her O
son O
after O
he O
could O
n't O
take O
care O
of O
her O
anymore O
. O
 
Not O
doing O
anything O
at O
home O
, O
not O
caring O
about O
anything O
. O
 
Was O
seen O
by O
psych O
and O
arranged O
to O
have O
a O
PCP O
, O
spoke O
about O
therapy O
as O
well O
. O
 
Then O
1/21/93 I-DATE
seen O
for O
chest O
pain O
. O
 
EKG O
negative O
and O
was O
D/C O
home O
. O
 
Had O
a O
MIBI O
done O
1/23/93 I-DATE
1 O
. O
 
Clinical O
Response O
: O
Non-ischemic O
. O
 
2 O
. O
 
ECG O
Response O
: O
No O
ECG O
changes O
during O
infusion O
. O
 
3 O
. O
 
Myocardial O
Perfusion O
: O
Normal O
. O
 
4 O
. O
 
Global O
LV O
Function O
: O
Normal O
. O
 
She O
states O
she O
is O
supposed O
to O
be O
on O
Coumadin O
for O
the O
strokes O
and O
she O
self O
D/C O
it O
last O
year O
. O
 
Previous O
PCP O
at O
EDUCARE-FARGO I-LOCATION
Dr. O
Nancy I-NAME
Odell I-NAME
. O
 
Changing O
to O
KEKELA I-LOCATION
because O
her O
son O
thinks O
she O
can O
get O
better O
help O
here O
. O
 
She O
looks O
depressed O
and O
I O
mentioned O
that O
to O
her O
. O
 
She O
states O
`` O
I O
always O
have O
looked O
the O
same O
'' O
. O
 
After O
speaking O
for O
her O
for O
20 O
minutes O
she O
tells O
me O
that O
at O
age O
28 I-AGE
she O
had O
a O
miscarriage O
of O
her O
twins O
. O
 
She O
was O
jumping O
rope O
and O
after O
coming O
back O
home O
her O
husband O
told O
her O
if O
she O
was O
trying O
to O
kill O
the O
twins O
. O
 
That O
night O
she O
had O
a O
miscarriage O
and O
one O
baby O
was O
born O
in O
the O
toilet O
and O
the O
otherone O
was O
taken O
by O
the O
EMTs O
. O
 
She O
was O
4 O
months O
pregnant O
. O
 
She O
had O
therapy O
then O
and O
meds O
and O
felt O
a O
little O
better O
. O
 
Her O
husband O
died O
6 O
years O
ago O
and O
before O
he O
died O
he O
reminded O
her O
that O
she O
had O
killed O
his O
twins O
. O
 
She O
felt O
bad O
and O
has O
felt O
bad O
since O
. O
 
She O
cries O
during O
interview O
. O
 
She O
worked O
for O
many O
years O
for O
mcilhenny I-LOCATION
company I-LOCATION
, O
Fire I-PROFESSION
Chief I-PROFESSION
and O
retird O
last O
year O
. O
 
She O
denies O
being O
depressed O
, O
denies O
suicidal O
ideation O
or O
plan O
. O
 
States O
has O
trouble O
sleeping O
and O
wants O
AMbien O
she O
has O
taken O
in O
the O
past O
. O
 
Also O
has O
taken O
Zoloft O
in O
the O
past O
. O
 
Not O
interested O
on O
meds O
now O
. O
 
Past O
Medical O
History O
Hypertension O
Obesity O
Cerebrovascular O
accident O
2087,2088,2089,2090 O
Past O
Surgical O
History O
Cesarean O
section O
x O
1 O
Left O
leg O
ORIF O
Allergies O
NKA O
Medications O
HYDROCHLOROTHIAZIDE O
25 O
MG O
PO O
QD O
Metoprolol O
Tartrate O
50MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Family O
History O
Negative O
for O
breast O
cancer O
, O
colon O
cancer O
, O
prostate O
cancer O
, O
skin O
cancer O
, O
leukemias O
, O
CAD O
, O
Myocardial O
infarction O
, O
Hypertension O
, O
Diabetes O
Mellitus O
, O
Hypercholesterolemia O
, O
Asthma O
. O
 
Social O
History O
Lives O
at O
home O
with O
her O
son O
and O
his O
wife O
Smoking O
1 O
PPD O
cigarretes O
ETOH O
occasional O
. O
 
Denies O
IVDA O
. O
 
Denies O
other O
recreational O
drugs O
Sexually O
active O
with O
the O
same O
partner O
for O
the O
past O
1 O
year O
. O
 
Does O
n't O
use O
condoms O
. O
 
No O
history O
of O
blood O
transfussions O
Retired O
MC I-LOCATION
employee O
- O
Fire I-PROFESSION
Chief I-PROFESSION
Routine O
screening O
questions O
for O
abuse O
asked O
. O
 
Patient O
stated O
that O
abuse O
is O
not O
an O
issue O
at O
the O
present O
time O
. O
 
Habits O
Exercises O
rarely O
Uses O
seat O
belt O
most O
of O
the O
time O
Preventive O
Health O
History O
Last O
Physical O
exam O
1/92 I-DATE
Last O
mammogram O
1/92 I-DATE
at O
EDUCARE-FARGO I-LOCATION
by O
her O
report O
Last O
Pap O
smear O
1/92 I-DATE
normal O
at O
EDUCARE-FARGO I-LOCATION
by O
her O
report O
COlonoscopy O
- O
never O
Bone O
density O
test O
- O
never O
Review O
of O
Systems O
Cardiopulmonary O
: O
Occasional O
chest O
pain O
, O
Denies O
shortness O
of O
breath O
, O
PND O
, O
orthopnea O
, O
leg O
edema O
, O
Palpitations O
HEENT O
: O
does O
n't O
wear O
glasses O
, O
normal O
hearing O
Genitourinary O
: O
denies O
dysuria O
, O
polyuria O
, O
vaginal O
discharge O
. O
 
Occasional O
back O
pain O
LMP O
: O
4/92 I-DATE
General O
: O
Denies O
weight O
changes O
, O
fever O
, O
chills O
, O
night O
sweats O
. O
 
Does O
n't O
follow O
a O
diet O
, O
eats O
fast O
foods O
, O
regular O
sodas O
Endocrino O
: O
Denies O
dizzyness O
, O
diaphoresis O
Gastrointestinal O
: O
Denies O
diarrhea O
, O
constipation O
, O
abdominal O
pain O
, O
heartburn O
, O
nausea O
, O
vomiting O
, O
no O
rectal O
bleeding O
Skin O
: O
no O
lesions O
, O
no O
hair O
loss O
Neurological O
: O
no O
weakness O
, O
numbness O
, O
tingling O
after O
the O
strokes O
. O
 
Recovered O
completely O
Musculoskeletal O
: O
left O
leg O
pain O
every O
day O
and O
low O
back O
pain O
. O
 
Wants O
Celebrex O
. O
 
Psychiatric O
: O
no O
anxiety O
, O
Denies O
depression O
or O
suicidal O
thoughts O
but O
cries O
many O
times O
when O
confronted O
about O
depression O
All O
other O
systems O
are O
negative O
Vital O
Signs O
BLOOD O
PRESSURE O
150/90 O
PULSE O
76 O
RESPIRATORY O
RATE O
14 O
TEMPERATURE O
97 O
F O
HEIGHT O
64 O
in O
WEIGHT O
234 O
lb O
BMI O
40.2 O
Physical O
Exam O
Alert O
, O
obese O
, O
unkempt O
, O
in O
no O
respiratory O
distress O
, O
tolerates O
decubitus O
Normocephalic O
, O
no O
scalp O
lesions O
, O
wearing O
a O
wig O
. O
 
PEERL O
, O
EOMI O
, O
no O
jaundice O
in O
sclerae O
, O
no O
conjunctival O
hyperhemia O
. O
 
Bilateral O
fundoscopy O
: O
sharp O
disks O
, O
no O
papilledema O
, O
no O
AV O
nicking O
Bilateral O
otoscopy O
: O
normal O
, O
no O
exudates O
, O
normal O
timpanic O
membranes O
. O
 
No O
sinus O
tenderness O
on O
palpation O
on O
percussion O
. O
 
Bilateral O
rhinoscopy O
: O
normal O
Oral O
mucosa O
moist O
, O
no O
oral O
thrush O
, O
no O
lesions O
, O
no O
masses O
Throat O
: O
normal O
, O
no O
exudates O
or O
plaques O
, O
normal O
tonsils O
. O
 
Neck O
: O
supple O
, O
no O
masses O
or O
adenopathies O
, O
normal O
thyroid O
palpation O
, O
no O
JVD O
, O
normal O
carotid O
pulses O
, O
no O
carotid O
bruit O
. O
 
Lungs O
: O
N O
use O
of O
accesory O
muscles O
, O
no O
intercostal O
retractions O
, O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
, O
normal O
percussion O
, O
no O
egophony O
. O
 
Heart O
: O
regular O
, O
rhythmic O
, O
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
. O
 
Breast O
examination O
: O
Large O
sized O
breasts O
, O
no O
masses O
, O
no O
skin O
lesions O
, O
no O
tenderness O
, O
no O
nipple O
discharges O
or O
axillary O
adenopathies O
. O
 
Abdomen O
: O
lower O
midline O
surgical O
scar O
, O
no O
aortic O
bruit O
, O
soft O
, O
diffuse O
tenderness O
, O
no O
masses O
or O
organomegalies O
, O
BS O
( O
+ O
) O
, O
no O
rebound O
. O
 
No O
inguinal O
adenopathies O
or O
hernias O
, O
good O
femoral O
pulses O
. O
 
Pelvic O
exam O
: O
athrophic O
external O
genitalia O
, O
no O
masses O
or O
lesions O
, O
normal O
hair O
distribution O
, O
no O
cystocele O
or O
rectocele O
. O
 
No O
masses O
, O
scaring O
or O
tenderness O
on O
urethra O
examination O
. O
 
Stool O
seen O
on O
the O
rectal O
area O
Speculum O
exam O
: O
Normal O
looking O
cervix O
, O
closed O
oz O
, O
no O
vaginal O
discharge O
or O
lesions O
. O
 
Pap O
smear O
taken O
, O
GC O
and O
Chlamydia O
taken O
. O
 
Bimanual O
exam O
: O
no O
cervical O
motion O
tenderness O
, O
no O
masses O
, O
no O
adnexal O
tenderness O
or O
masses O
, O
unable O
to O
feel O
uterine O
size O
due O
to O
obesity O
Rectal O
exam O
: O
no O
external O
hemmorrhoids O
Digital O
exam O
: O
no O
lesions O
, O
normal O
sphincter O
tone O
, O
Guaiac O
stool O
Negative O
Ext O
: O
1++ O
edema O
left O
leg O
, O
ORIF O
midline O
large O
surgical O
scar O
seen O
, O
good O
pulses O
, O
normal O
skin O
, O
no O
varicosities O
Skin O
: O
no O
lesions O
Neurological O
: O
Alert O
, O
oriented O
x O
3 O
, O
Speech O
normal O
. O
 
Cranial O
nerves O
Normal O
, O
Strenght O
5/5/ O
bilateral O
symmetrical O
in O
upper O
and O
lower O
extremities O
. O
 
DTR O
2++ O
symmetrical O
, O
sensory O
intact O
, O
no O
pathological O
reflexes O
Assessment O
Physical O
exam O
remarkable O
for O
: O
1 O
. O
 
HYPERTENSION O
Explained O
the O
pathophysiology O
of O
Hypertension O
and O
the O
importance O
of O
goog O
blood O
pressure O
control O
Explained O
the O
increased O
risk O
of O
CVA O
, O
CAD O
, O
eye O
and O
renal O
problems O
Spoke O
about O
the O
need O
to O
quit O
smoking O
, O
loose O
weight O
, O
follow O
a O
low O
fat O
low O
carb O
diet O
. O
 
Patient O
undesrtood O
Recommended O
to O
follow O
a O
low O
salt O
diet O
and O
exercise O
regulalry O
Will O
check O
a O
SMA-7 O
, O
CBCm O
TSH O
and O
U/A O
to O
evaluate O
renal O
function O
Continue O
taking O
HCTZ O
QD O
# O
30 O
and O
6 O
refills O
and O
follow O
up O
in O
6 O
weeks O
for O
BP O
check O
. O
 
Increase O
Metroprolol O
to O
50 O
mg O
BID O
# O
60 O
and O
6 O
refills O
Increased O
risk O
for O
CAD O
and O
needs O
to O
modify O
life O
style O
. O
 
2 O
. O
 
HO O
CEREBROVASCULAR O
ACCIDENT O
She O
reports O
4 O
strokes O
and O
no O
residual O
neurological O
deficit O
. O
 
Declines O
Coumadin O
. O
 
Is O
on O
ASA O
sometimes O
Start O
Plavix O
75mg O
QD O
# O
30 O
and O
6 O
refills O
to O
decrease O
risk O
of O
CVA O
Again O
needs O
to O
quit O
smoking O
ASAP O
3 O
. O
 
OBESITY O
Calculated O
BMI O
40 O
Obesity O
Type O
2 O
Spoke O
about O
diet O
and O
exercise O
as O
the O
main O
steps O
to O
loose O
weigth O
. O
 
Explained O
that O
Obesity O
predisposes O
patients O
to O
develop O
Diabetes O
Mellitus O
, O
Hypertension O
, O
CAD O
, O
CVA O
, O
Strokes O
, O
Osteoarthritis O
specially O
of O
the O
knees O
, O
Colon O
cancer O
and O
breast O
cancer O
and O
endometrial O
cancer O
in O
woman O
Encouraged O
the O
patient O
to O
increase O
the O
exercise O
to O
5-7 O
times O
per O
week O
and O
35-45 O
minutes O
of O
cardiovascular O
. O
 
Change O
to O
diet O
sodas O
, O
and O
avoid O
fast O
foods O
completely O
Increase O
the O
amount O
of O
vegetables O
and O
avoid O
carbohydrates O
, O
sugar O
products O
and O
follow O
a O
low O
fat O
diet O
Check O
TSH O
, O
Lipid O
profile O
and O
Glucose O
4 O
. O
 
SMOKER O
Recommendations O
to O
quit O
smoking O
Spoke O
about O
increased O
risk O
for O
lung O
cancer O
, O
bladder O
cancer O
, O
cervical O
cancer O
, O
CAD O
, O
CVA O
on O
smokers O
Spoke O
about O
Nicotine O
patch O
, O
Nicotine O
gum O
, O
Zyban O
etc O
Recommended O
the O
patient O
to O
use O
Nicorette O
gum O
. O
 
Referal O
to O
see O
Georgia I-NAME
Upshaw I-NAME
- O
smoking O
cessation O
counselour O
. O
 
She O
is O
not O
iterested O
on O
quitting O
5 O
. O
 
DEPRESSION O
Spent O
25 O
minutes O
with O
her O
talking O
about O
depression O
. O
 
She O
was O
very O
quit O
at O
the O
beggining O
of O
the O
visit O
and O
denied O
depression O
even O
after O
finishing O
her O
visit O
. O
 
But O
she O
cried O
a O
lot O
when O
telling O
me O
about O
her O
twins O
. O
 
Explained O
that O
is O
never O
late O
to O
get O
therapy O
and O
feel O
happier O
on O
meds O
and O
therapy O
. O
 
She O
has O
had O
4 O
CVA O
and O
still O
smokes O
and O
does O
n't O
care O
of O
herself O
, O
which O
is O
remarkable O
and O
seems O
to O
me O
she O
is O
passively O
suicidal O
by O
following O
those O
behaviours O
. O
 
Spoke O
about O
depression O
and O
different O
modalities O
of O
therapy O
Spoke O
about O
mental O
therapy O
and O
pharmacological O
therapy O
for O
depression O
. O
 
Recommended O
her O
to O
start O
medications O
, O
she O
declines O
I O
agree O
to O
Rx O
Ambien O
5 O
mg O
QHS O
PRN O
# O
30 O
and O
6 O
refills O
She O
will O
call O
the O
Psychiatric O
department O
at O
KEKELA I-LOCATION
to O
start O
therapy O
5 O
. O
 
MENOPAUSE O
Start O
Calcium O
500 O
mg O
2 O
tb O
QD O
# O
60 O
and O
6 O
refills O
MVI O
# O
30 O
and O
6 O
refills O
Schedule O
BDT O
and O
tehrapy O
if O
indicated O
6 O
. O
 
LEFT O
LEG O
PAIN O
after O
ORIF O
Tylenol O
XS O
TID O
for O
now O
No O
Celebre O
on O
a O
patient O
with O
high O
risk O
of O
CVA O
and O
CAD O
Plan O
Will O
send O
the O
Pap O
smear O
results O
in O
2 O
weeks O
Will O
call O
if O
GC O
or O
Chlamydia O
positive O
in O
48 O
hours O
Will O
check O
a O
lipid O
profile O
Schedule O
BDT O
Schedule O
mammogram O
Schedule O
colonoscopy O
Three O
stool O
cards O
given O
to O
bring O
soon O
Counseling O
Recommendations O
to O
exercise O
2-3 O
times O
per O
week O
Follow O
a O
low O
fat O
diet O
 
Record O
date O
: O
2093-12-26 I-DATE
Patient O
Name O
: O
BARR O
, O
NICKY O
[ O
MRN O
: O
32612454LDC O
] O
Date O
of O
Visit O
: O
12/26/93 I-DATE
Chief O
Complaint O
Mrs O
Barr I-NAME
is O
here O
to O
follow O
up O
on O
Hypertension O
, O
diabetes O
History O
of O
Present O
Illness O
Mrs O
Barr I-NAME
has O
been O
doing O
well O
. O
 
Has O
a O
8 O
weeks O
grandaughter O
and O
is O
very O
happy O
with O
her O
. O
 
Interesetd O
on O
quiting O
smoking O
. O
 
Can O
not O
hold O
the O
baby O
as O
long O
as O
she O
smokes O
and O
she O
has O
decided O
to O
quit O
to O
be O
able O
to O
care O
or O
the O
baby O
. O
 
She O
is O
taking O
all O
her O
meds O
as O
directed O
. O
 
HbA1C O
in O
5/93 I-DATE
7.2 O
and O
LDL O
99 O
on O
Lipitor O
20 O
mg. O
She O
still O
smokes O
1/2 O
PPD O
but O
better O
than O
before O
Declines O
the O
FLu O
shot O
and O
Pneumovax O
Not O
exercising O
. O
 
Walks O
daily O
1-2 O
blocks O
for O
chores O
. O
 
Review O
of O
Systems O
C/P O
: O
Denies O
chest O
pain O
, O
SOB O
Skin O
( O
- O
) O
MSK O
( O
- O
) O
HEENT O
: O
Denies O
cold O
sx O
GU O
( O
- O
) O
General O
: O
Denies O
fever O
, O
chills O
, O
weigth O
loss O
GI O
: O
Denies O
nausea O
, O
vomiting O
, O
diarrhea O
Neuro O
: O
denies O
headaches O
All O
other O
systems O
negative O
Problems O
Cerebrovascular O
accident O
: O
x O
4 O
Obesity O
: O
BMI O
40 O
- O
Type O
3 O
Hypertension O
Diabetes O
mellitus O
type O
2 O
Osteopenia O
: O
T O
score O
-1.8 O
L1-4 O
Allergies O
NKA O
Medications O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Hydrochlorothiazide O
25 O
MG O
PO O
QD O
Metoprolol O
TARTRATE O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
QD O
Multivitamins O
1 O
CAPSULE O
PO O
QD O
Ambien O
( O
ZOLPIDEM O
TARTRATE O
) O
5 O
MG O
PO O
QHS O
Fosamax O
( O
ALENDRONATE O
) O
35MG O
TABLET O
PO O
QSunday O
AM O
, O
Take O
it O
with O
8 O
Oz O
of O
water O
Lisinopril O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QD O
Oscal O
500 O
+ O
D O
( O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
500MG O
ELEM O
CA O
) O
/ O
VIT O
D O
200 O
IU O
) O
) O
2 O
TAB O
PO O
qd O
Ibuprofen O
800 O
MG O
( O
800MG O
TABLET O
take O
1 O
) O
PO O
TID O
PRN O
leg O
pain O
Lipitor O
( O
ATORVASTATIN O
) O
20MG O
TABLET O
PO O
QHS O
Vital O
Signs O
BP O
136/90 O
, O
P O
68 O
, O
RR O
14 O
, O
Wt O
242 O
lb O
Physical O
Exam O
Alert O
, O
in O
no O
distress O
, O
obese O
, O
happy O
looking O
, O
smiling O
HEENT O
: O
PEERL O
, O
EOMI O
, O
oral O
mucosa O
moist O
, O
no O
lesions O
Neck O
: O
supple O
, O
no O
masses O
or O
nodes O
, O
no O
JVD O
. O
 
Lungs O
: O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
Heart O
: O
regular O
, O
. O
 
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
Abdomen O
: O
soft O
, O
no O
tenderness O
BS O
( O
+ O
) O
, O
no O
rebound O
Ext O
: O
no O
edema O
, O
normal O
skin O
Feet O
exam O
: O
normal O
ksin O
, O
. O
 
good O
DP O
, O
good O
capillary O
filling O
Assessment O
1 O
. O
 
HYPERTENSION O
Poorly O
controlled O
today O
Continue O
Lisinopril O
5 O
mg O
QD O
# O
30 O
and O
3 O
refills O
Increase O
Metroprolol O
to O
50 O
mg O
BID O
from O
QD O
and O
HCTZ O
25 O
mg O
QD O
See O
me O
in O
8 O
weeks O
to O
recheck O
BP O
Check O
SMA-7 O
2 O
. O
 
CEREBROVASCULAR O
ACCIDENT O
Uncontrolled O
HTN O
Smoking O
- O
active O
Elevated O
LDL O
Obese O
Sedentary O
On O
statins O
. O
 
Goal O
LDL O
< O
100 O
Check O
Lipid O
profile O
and O
LFTs O
Goal O
LDL O
< O
70 O
Quit O
smoking O
- O
try O
Nicorette O
Gum O
. O
 
Referal O
to O
see O
Georgia I-NAME
Upshaw- O
smoking O
cessation O
counselour O
Plavix O
75 O
mg O
QD O
3 O
. O
 
DIABETES O
MELLITUS O
HbA1C O
7.2 O
in O
5/93 I-DATE
Goal O
below O
7 O
Repeat O
HbA1C O
and O
microalbuminuria O
Due O
for O
eye O
exam O
. O
 
Declines O
Flu O
shot O
4 O
. O
 
OSTEOPENIA O
Continue O
Fosamax O
35 O
mg O
Q O
week O
, O
calcium O
and O
MVI O
Plan O
Follow O
up O
in O
8 O
weeks O
_____________________________________________ O
Victoria I-NAME
Amy-Armstrong I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2094-09-07 I-DATE
Patient O
Name O
: O
BARR O
, O
NICKY O
[ O
32612454 I-ID
( O
LDC I-LOCATION
) O
] O
Date O
of O
Visit O
: O
09/07/2094 I-DATE
Chief O
Complaint O
Mrs O
Barr I-NAME
is O
here O
to O
follow O
up O
on O
Hypertension O
, O
diabetes O
, O
cholesterol O
History O
of O
Present O
Illness O
Mrs O
Barr I-NAME
has O
been O
doing O
well O
. O
 
Did O
n't O
take O
her O
blood O
pressure O
meds O
today O
, O
forgot O
Seen O
yesterday O
by O
RN O
and O
got O
glucemeter O
. O
 
Still O
can O
not O
make O
it O
work O
Has O
been O
on O
Metformin O
850 O
mg O
TID O
and O
Avandia O
4 O
mg O
QD O
Not O
checking O
her O
glucose O
yet O
Last O
HbA1C O
9.6 O
on O
6/28 I-DATE
down O
from O
5/11/94 I-DATE
- O
10.6 O
She O
is O
taking O
Lipitor O
80 O
mg O
for O
few O
weeks O
. O
 
Last O
LDL O
134 O
on O
6/28 I-DATE
On O
Lisinopril O
to O
40 O
mg O
QD O
and O
Metoprolol O
100 O
mg O
BID O
She O
still O
smokes O
1/2 O
PPD O
Review O
of O
Systems O
C/P O
: O
Occasional O
chest O
pain O
on O
and O
off O
, O
No O
SOB O
or O
leg O
edema O
Skin O
( O
- O
) O
MSK O
( O
- O
) O
HEENT O
: O
Denies O
cold O
sx O
General O
: O
Denies O
fever O
, O
chills O
, O
weigth O
loss O
GI O
: O
Denies O
nausea O
, O
vomiting O
, O
diarrhea O
Neuro O
: O
denies O
headaches O
Psych O
: O
depressed O
. O
 
All O
other O
systems O
negative O
Problems O
Cerebrovascular O
accident O
: O
x O
4 O
Obesity O
: O
BMI O
40 O
- O
Type O
3 O
Hypertension O
Diabetes O
mellitus O
type O
2 O
Osteopenia O
: O
T O
score O
-1.8 O
L1-4 O
Allergies O
NKA O
Medications O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Hydrochlorothiazide O
25 O
MG O
PO O
QD O
Multivitamins O
1 O
CAPSULE O
PO O
QD O
Fosamax O
( O
ALENDRONATE O
) O
35MG O
TABLET O
PO O
QSundayAM O
, O
Take O
it O
with O
8 O
Oz O
of O
water O
Oscal O
500 O
+ O
D O
( O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
500MG O
ELEM O
CA O
) O
/ O
VIT O
D O
200 O
IU O
) O
) O
2 O
TAB O
PO O
qd O
Ambien O
( O
ZOLPIDEM O
TARTRATE O
) O
5 O
MG O
PO O
QHS O
Ibuprofen O
800 O
MG O
( O
800MG O
TABLET O
take O
1 O
) O
PO O
TID O
PRN O
leg O
pain O
Lisinopril O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
, O
dose O
increased O
from O
10 O
to O
20 O
mg O
QD O
on O
5/11/94 I-DATE
and O
from O
20 O
to O
40 O
mg O
today O
6/1/94 I-DATE
Metoprolol O
TARTRATE O
150 O
MG O
( O
100MG O
TABLET O
take O
1.5 O
) O
PO O
BID O
, O
Change O
of O
dose O
from O
100 O
mg O
BID O
to O
150 O
mg O
BID O
Avandia O
( O
ROSIGLITAZONE O
) O
4 O
MG O
( O
4MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
80MG O
TABLET O
PO O
QHS O
, O
dose O
increased O
from O
40 O
to O
80 O
mg O
today O
Metformin O
850MG O
TABLET O
PO O
TID O
, O
dose O
increased O
today O
from O
500 O
mg O
TID O
to O
850 O
mg O
TID O
. O
 
Thanks O
Vital O
Signs O
BP O
160/110 O
, O
P O
78 O
, O
RR O
14 O
, O
Temp O
97 O
F O
, O
Wt O
249 O
lb O
Physical O
Exam O
Alert O
, O
in O
no O
distress O
, O
obese O
, O
flat O
affect O
HEENT O
: O
oral O
mucosa O
moist O
, O
no O
lesions O
. O
 
Throat O
clear O
Neck O
: O
supple O
, O
no O
masses O
or O
nodes O
, O
no O
JVD O
. O
 
Lungs O
: O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
Heart O
: O
regular O
, O
. O
 
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
Abdomen O
: O
soft O
, O
no O
tenderness O
BS O
( O
+ O
) O
, O
no O
rebound O
Ext O
: O
no O
edema O
, O
normal O
skin O
Feet O
exam O
: O
normal O
skin O
, O
. O
 
good O
DP O
, O
good O
capillary O
filling O
Assessment O
1 O
. O
 
HYPERTENSION O
Poorly O
controlled O
today O
has O
n't O
taken O
her O
meds O
yet O
Explained O
the O
importance O
of O
taking O
BP O
meds O
eraly O
AM O
Keep O
same O
meds O
and O
see O
me O
in O
6 O
weeks O
Continue O
Metroprolol O
to O
150 O
mg O
BID O
Continue O
HCTZ O
25 O
mg O
QD O
Continue O
Lisinopril O
to O
40 O
mg O
QD O
See O
me O
in O
2 O
weeks O
to O
recheck O
BP O
2 O
. O
 
CEREBROVASCULAR O
ACCIDENT O
Uncontrolled O
HTN O
Smoking O
- O
active O
Elevated O
LDL O
Obese O
Sedentary O
On O
statins O
. O
 
Goal O
LDL O
< O
100 O
Goal O
LDL O
< O
70 O
Plavix O
75 O
mg O
QD O
3 O
. O
 
DIABETES O
MELLITUS O
Start O
checking O
glucose O
QD O
Continue O
Avandia O
4 O
mg O
QD O
and O
Metformin O
850 O
mg O
TID O
Goal O
below O
7 O
Repeat O
HbA1C O
now O
and O
glucose O
Nutritionist O
referal O
Due O
for O
eye O
exam O
. O
 
LDL O
134 O
on O
Lipitor O
40 O
Repeat O
cholesterol O
and O
lipir O
profile O
today O
4 O
. O
 
OSTEOPENIA O
Continue O
Fosamax O
35 O
mg O
Q O
week O
, O
calcium O
and O
MVI O
Plan O
Follow O
up O
in O
2 O
weeks O
_____________________________________________ O
Victoria I-NAME
Amy-Armstrong I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2094-10-26 I-DATE
Saint I-LOCATION
John I-LOCATION
Valley I-LOCATION
Health I-LOCATION
Center I-LOCATION
157 I-LOCATION
Peterborough I-LOCATION
Place I-LOCATION
KIM I-NAME
JR O
, O
DOUGLAS I-NAME
Sulphur I-LOCATION
, O
AR I-LOCATION
26822 I-LOCATION
20163512 I-ID
( O
426 O
) O
819-5183 I-CONTACT
10/26/94 I-DATE
CHIEF O
COMPLAINT O
: O
Followup O
of O
atrial O
fibrillation O
and O
recent O
lab O
results O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
A O
54 I-AGE
year O
old O
male O
with O
history O
of O
paroxysmal O
atrial O
fibrillation O
, O
borderline O
diabetes O
, O
and O
borderline O
hypertension O
who O
presents O
back O
to O
clinic O
for O
followup O
. O
 
He O
reports O
that O
he O
has O
been O
feeling O
generally O
well O
. O
 
He O
reports O
that O
he O
feels O
like O
he O
is O
in O
sinus O
today O
. O
 
He O
denies O
any O
chest O
pain O
, O
shortness O
of O
breath O
, O
palpitations O
, O
or O
edema O
. O
 
I O
reviewed O
with O
him O
his O
lab O
results O
from O
10/14/2094 I-DATE
, O
which O
were O
remarkable O
for O
a O
total O
cholesterol O
of O
242 O
, O
HDL O
of O
33 O
, O
triglyceride O
level O
of O
549 O
, O
hemoglobin O
A1c O
of O
9.8 O
, O
and O
INR O
of O
1.0 O
. O
 
The O
patient O
denies O
any O
symptoms O
of O
hyperglycemia O
or O
hypoglycemia O
. O
 
MEDICATIONS O
: O
None O
. O
 
ALLERGIES O
: O
Penicillin O
. O
 
SOCIAL O
HISTORY O
: O
The O
patient O
is O
smoking O
2 O
packs O
per O
day O
. O
 
PHYSICAL O
EXAMINATION O
: O
Vital O
signs O
: O
Weight O
193 O
pounds O
, O
blood O
pressure O
140/98 O
, O
pulse O
92 O
and O
regular O
. O
 
Well-developed O
, O
well-nourished O
male O
in O
no O
acute O
distress O
. O
 
HEENT O
: O
Anicteric O
sclerae O
, O
oropharynx O
clear O
. O
 
Neck O
: O
Supple O
, O
no O
JVD O
. O
 
Lungs O
: O
Clear O
to O
auscultation O
bilaterally O
. O
 
Cardiovascular O
exam O
: O
Regular O
rate O
and O
rhythm O
, O
S1 O
, O
S2 O
normal O
, O
no O
murmur O
. O
 
Abdomen O
: O
Soft O
, O
nontender O
, O
nondistended O
, O
normal O
bowel O
sounds O
. O
 
Extremities O
: O
No O
cyanosis O
, O
clubbing O
, O
or O
edema O
. O
 
ASSESSMENT O
AND O
PLAN O
1 O
. O
 
Paroxysmal O
atrial O
fibrillation O
. O
 
EKG O
done O
today O
showing O
normal O
sinus O
rhythm O
at O
96 O
beats O
per O
minute O
with O
normal O
intervals O
, O
flat O
T-waves O
in O
leads O
III O
, O
aVF O
, O
V5 O
, O
and O
V6 O
. O
 
No O
ST O
changes O
. O
 
Will O
refer O
to O
cardiology O
regarding O
whether O
to O
anticoagulate O
him O
. O
 
Will O
treat O
today O
with O
Ecotrin O
325 O
mg O
p.o O
. O
 
q.d O
. O
 
2 O
. O
 
History O
of O
borderline O
diabetes O
. O
 
Last O
hemoglobin O
A1c O
was O
9.8 O
. O
 
Will O
treat O
with O
Glucophage O
500 O
mg O
p.o O
. O
 
q.a.m O
. O
 
Dietary O
recommendations O
given O
. O
 
We O
will O
schedule O
for O
a O
nursing O
educator O
and O
nutritionist O
appointment O
. O
 
Home O
fingerstick O
monitoring O
as O
directed O
. O
 
3 O
. O
 
Hypertension O
. O
 
Elevated O
diastolic O
blood O
pressure O
. O
 
Will O
treat O
with O
lisinopril O
10 O
mg O
p.o O
. O
 
day O
, O
# O
30 O
tablets O
dispensed O
with O
2 O
refills O
. O
 
Will O
follow O
. O
 
4 O
. O
 
Smoking O
cessation O
counseling O
given O
. O
 
Will O
follow O
. O
 
______________________________ O
QUEST I-NAME
J. I-NAME
QUEENAN I-NAME
, O
M.D O
. O
 
eScription O
document:2-320209 O
 
Record O
date O
: O
2095-04-03 I-DATE
LEPROSARIUM I-LOCATION
EMERGENCY O
DEPT O
VISIT O
KIM O
, O
DOUGLAS O
JR I-NAME
201-63-51-2 I-ID
VISIT O
DATE O
: O
04/03/95 I-DATE
The O
patient O
was O
seen O
primarily O
by O
me O
. O
 
PRESENTING O
COMPLAINT O
: O
Fall O
, O
right O
knee O
injury O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Mr. O
Killian I-NAME
is O
a O
very O
pleasant O
54-year-old O
gentleman O
, O
with O
a O
history O
of O
diabetes O
, O
who O
had O
a O
fall O
on O
December I-DATE
18 O
, O
2094 I-DATE
. O
 
At O
the O
time O
, O
he O
sustained O
an O
injury O
to O
his O
right O
knee O
which O
healed O
and O
then O
began O
to O
break O
down O
, O
and O
he O
developed O
a O
large O
wound O
which O
began O
draining O
and O
had O
foul O
odor O
. O
 
The O
patient O
had O
continued O
difficulty O
ambulating O
and O
presented O
to O
the O
emergency O
department O
for O
evaluation O
. O
 
The O
patient O
denies O
having O
any O
hardware O
in O
his O
knee O
. O
 
No O
history O
of O
osteomyelitis O
. O
 
No O
hardware O
. O
 
No O
history O
of O
peripheral O
neuropathy O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Patient O
denies O
any O
fevers O
or O
chills O
. O
 
No O
nausea O
or O
vomiting O
. O
 
No O
abdominal O
pain O
. O
 
No O
chest O
pain O
or O
shortness O
of O
breath O
. O
 
Patient O
is O
only O
complaining O
of O
difficulty O
ambulating O
secondary O
to O
the O
pain O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Two O
patellar O
tendon O
repairs O
at O
EDUCARE-PULLMAN I-LOCATION
in O
2083 I-DATE
, O
repair O
of O
a O
patellar O
fracture O
. O
 
Recent O
diagnosis O
of O
diabetes O
, O
atrial O
fibrillation O
. O
 
Hypertension O
, O
high O
cholesterol O
, O
and O
positive O
PPD O
. O
 
MEDICATIONS O
: O
Please O
see O
nurses O
note O
for O
list O
of O
medications O
. O
 
ALLERGIES O
: O
PENICILLIN O
( O
rash O
) O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
The O
patient O
is O
a O
smoker O
. O
 
He O
does O
not O
drink O
alcohol O
. O
 
He O
works O
in O
engineering I-PROFESSION
, O
and O
lives O
alone O
. O
 
Family O
history O
is O
noncontributory O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
Patient O
is O
awake O
, O
alert O
, O
talking O
in O
full O
sentences O
, O
in O
mild O
distress O
secondary O
to O
pain O
. O
 
VITAL O
SIGNS O
: O
Afebrile O
, O
temperature O
99.3 O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
161/96 O
, O
pulse O
95 O
. O
 
HEAD O
: O
Atraumatic O
. O
 
NECK O
: O
Supple O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
. O
 
No O
wheezes O
, O
rales O
or O
rhonchi O
. O
 
HEART O
: O
Regular O
rate O
. O
 
No O
murmurs O
, O
gallops O
or O
rubs O
. O
 
ABDOMEN O
: O
Soft O
, O
nontender O
. O
 
SKIN O
: O
A O
large O
ulcer O
to O
the O
right O
knee O
, O
right O
over O
the O
patella O
, O
with O
significant O
amount O
of O
break-down O
necrotic O
tissue O
and O
purulent O
discharge O
with O
a O
foul O
odor O
. O
 
The O
depth O
of O
the O
wound O
is O
difficult O
to O
assess O
. O
 
Intact O
motor O
function O
and O
sensation O
. O
 
Full O
flexion O
and O
extension O
of O
the O
knee O
, O
and O
evidence O
of O
well-healed O
midline O
scar O
above O
the O
ulcer O
. O
 
NEURO O
: O
Intact O
with O
good O
pulses O
palpable O
throughout O
. O
 
LABORATORY O
EVALUATION O
: O
Plain O
film O
of O
the O
right O
knee O
, O
CT O
of O
the O
right O
knee O
, O
and O
laboratory O
values O
done O
. O
 
Laboratory O
values O
demonstrated O
a O
white O
count O
of O
14 O
, O
ESR O
of O
13 O
, O
ESRP O
of O
2.1 O
. O
 
Rest O
of O
the O
labs O
were O
normal O
except O
for O
an O
elevated O
glucose O
to O
226 O
. O
 
Film O
of O
the O
knee O
shows O
patellofemoral O
arthritis O
with O
no O
evidence O
of O
osteomyelitis O
, O
no O
hardware O
seen O
. O
 
CT O
of O
the O
knee O
showed O
a O
superficial O
ulcer O
to O
the O
depth O
of O
the O
patellar O
tendon O
but O
the O
patellar O
tendon O
itself O
was O
intact O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
initially O
seen O
by O
orthopedic O
who O
felt O
that O
the O
ulcer O
was O
over O
the O
patellar O
tendon O
, O
at O
the O
site O
of O
prior O
surgeries O
, O
with O
no O
effusion O
or O
joint O
pain O
, O
and O
normal O
range O
of O
motion O
with O
joint O
involvement O
unlikely O
. O
 
We O
are O
all O
very O
hesitant O
to O
tap O
this O
knee O
and O
it O
will O
not O
be O
done O
at O
this O
time O
for O
fear O
of O
introducing O
infection O
into O
the O
joint O
. O
 
The O
patient O
is O
awaiting O
consultation O
by O
general O
surgery O
for O
probable O
admission O
and O
debridement O
in O
the O
operating O
room O
. O
 
The O
plan O
at O
this O
time O
was O
to O
hold O
off O
on O
antibiotics O
. O
 
Blood O
cultures O
were O
sent O
. O
 
The O
patient O
is O
receiving O
IV O
fluids O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
Orthopedics O
, O
general O
surgery O
. O
 
FINAL O
DIAGNOSIS O
: O
Knee O
ulcer O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
was O
admitted O
and O
transitioned O
to O
ED O
Obs O
, O
awaiting O
evaluation O
by O
the O
surgical O
service O
for O
probable O
admission O
. O
 
The O
patient O
is O
currently O
in O
stable O
and O
satisfactory O
condition O
, O
in O
Obs O
awaiting O
surgery O
evaluation O
. O
 
___________________________________ O
VN983/2356 O
SHERRY I-NAME
PERKINS I-NAME
, O
M.D O
. O
 
SP79 I-NAME
D:04/03/95 O
T:04/04/95 O
Dictated O
by O
: O
SHERRY I-NAME
PERKINS I-NAME
, O
M.D O
. O
 
SP79 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2096-02-13 I-DATE
Saint I-LOCATION
John I-LOCATION
Valley I-LOCATION
Health I-LOCATION
Center I-LOCATION
707 I-LOCATION
Newburgh I-LOCATION
Street I-LOCATION
Sulphur I-LOCATION
, O
AR I-LOCATION
. O
 
26822 I-LOCATION
859-168-0145 I-CONTACT
CC O
: O
f/up O
of O
RLE O
ulcerations O
HPI O
: O
55 I-AGE
yo O
male O
with O
f/up O
for O
RLE O
ulcerations O
reporting O
a O
temp O
this O
past O
Wednesday I-DATE
AM O
to O
101.2 O
. O
 
Started O
Keflex O
at O
home O
because O
he O
had O
some O
and O
took O
for O
2 O
days O
. O
 
Also O
, O
reports O
FS O
's O
have O
been O
above O
200 O
. O
 
Changing O
dressings O
as O
directed O
. O
 
================ O
Problems O
================ O
Smoking O
S/P O
R O
knee O
surgery O
x O
3 O
S/P O
tonsillectomy O
Hypertension O
H/O O
+PPD O
in O
'70 O
's O
, O
treated O
for O
1 O
yr O
diabetes O
mellitus O
type O
2 O
Hypertriglyceridemia O
H/O O
paroxysmal O
afib O
VNA O
171-311-7974 I-CONTACT
================ O
Medications O
================ O
ATENOLOL O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
QAM O
COUMADIN O
( O
WARFARIN O
SODIUM O
) O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
QPM O
ECASA O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
81MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
GLUCOPHAGE O
( O
METFORMIN O
) O
850MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
GLYBURIDE O
1.25MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
20MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
PERCOCET O
( O
OXYCODONE+APAP O
) O
325-5MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
pain O
SERAX O
( O
OXAZEPAM O
) O
15MG O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PRN O
insomnia O
================ O
Allergies O
================ O
Penicillins O
Unknown O
PEx O
: O
VS O
: O
Wt O
196 O
, O
BP O
130/86 O
, O
T O
99.2 O
, O
P O
76 O
regular O
WDWN O
male O
in O
NAD O
. O
 
HEENT O
: O
anicteric O
sclerae O
. O
 
Neck O
: O
supple O
, O
no O
JVD O
. O
 
Lungs O
: O
CTA O
. O
 
CV O
: O
Irregularly O
irregular O
Abd O
: O
soft O
, O
NT/ND O
, O
nl O
BS O
. O
 
Ext O
: O
slow O
healing O
ulcers O
on O
RLE O
with O
ongoing O
mild O
surrounding O
erythema O
A/P O
: O
1 O
. O
 
RLE O
ulcerations O
, O
slow O
to O
heal O
, O
ongoing O
dressing O
changes O
as O
directed O
. O
 
Will O
continue O
Keflex O
500 O
mg O
QID O
x O
1 O
more O
week O
. O
 
Percocet O
5/325 O
1 O
tab O
po O
qhs-BID O
PRN O
pain O
2 O
. O
 
DM O
, O
increase O
Glyburide O
to O
2.5 O
mg O
po O
qd O
as O
directed O
. O
 
Follow O
home O
FS O
as O
directed O
. O
 
Quijada I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2098-10-14 I-DATE
Saint I-LOCATION
John I-LOCATION
Valley I-LOCATION
Health I-LOCATION
Center I-LOCATION
739 I-LOCATION
Newburgh I-LOCATION
Street I-LOCATION
Sulphur I-LOCATION
, O
AR I-LOCATION
. O
 
26822 I-LOCATION
CC O
: O
s/p O
foreign O
body O
removal O
and O
HTN/AFIB O
management O
HPI O
: O
58 I-AGE
yo O
male O
who O
presents O
back O
to O
clinic O
having O
undergone O
paraesophageal O
hernia O
repair O
and O
PEG O
placement O
on O
8/13/98 I-DATE
. O
 
9/25 I-DATE
had O
foreign O
body O
removed O
by O
dilatation O
by O
Dr. O
Doty I-NAME
secondary O
to O
esophageal O
stricture O
and O
placed O
on O
mech O
soft O
diet O
. O
 
Doing O
well O
. O
 
Denies O
any O
CP O
, O
SOB O
, O
or O
abd O
pain O
. O
 
No O
fever O
. O
 
10/13 I-DATE
INR O
2.4 O
. O
 
================ O
Problems O
================ O
Smoking O
S/P O
R O
knee O
surgery O
x O
3 O
S/P O
tonsillectomy O
Hypertension O
H/O O
+PPD O
in O
'70 O
's O
, O
treated O
for O
1 O
yr O
diabetes O
mellitus O
type O
2 O
Elevated O
cholesterol O
H/O O
paroxysmal O
atrial O
fibrillation O
427.31 O
VNA O
171-311-7974 I-CONTACT
H/O O
drug O
abuse O
- O
patient O
prefers O
not O
to O
use O
any O
narcotics O
Sleep O
disorder O
09/23/97 I-DATE
colonoscopy O
normal O
Fatty O
liver O
Cataracts O
s/p O
paraesophageal O
hernia O
repair O
with O
PEG O
8/13/98 I-DATE
================ O
Medications O
================ O
ATENOLOL O
100MG O
TABLET O
PO O
QD O
COLACE O
( O
DOCUSATE O
SODIUM O
) O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
QD O
COUMADIN O
( O
WARFARIN O
SODIUM O
) O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QPM O
, O
none O
except O
Wednesdays I-DATE
ECASA O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
81MG O
TABLET O
EC O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
GLUCOPHAGE O
( O
METFORMIN O
) O
1000MG O
TABLET O
take O
1 O
PO O
BID O
HYDROCHLOROTHIAZIDE O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
IRON O
SULFATE O
( O
FERROUS O
SULFATE O
) O
325 O
MG O
( O
325 O
( O
65 O
) O
MG O
TABLET O
take O
1 O
) O
PO O
QD O
LISINOPRIL O
40MG O
TABLET O
take O
1 O
PO O
QD O
PRILOSEC O
OTC O
( O
OMEPRAZOLE O
OTC O
) O
20 O
MG O
( O
20MG O
TABLET O
DR O
take O
1 O
) O
PO O
QD O
SIMETHICONE O
80 O
MG O
( O
80MG O
TAB O
CHEW O
take O
1 O
) O
PO O
BID O
PRN O
TRAZODONE O
300 O
MG O
( O
100MG O
TABLET O
take O
3 O
) O
PO O
HS O
ZOCOR O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
================ O
Allergies O
================ O
Penicillins O
: O
Rash O
PEx O
: O
VS O
: O
Wt O
175 O
, O
BP O
122/82 O
, O
P O
80 O
regular O
, O
T O
97.9 O
WDWN O
older O
male O
in O
NAD O
. O
 
HEENT O
: O
anicteric O
sclerae O
Neck O
: O
supple O
, O
no O
JVD O
, O
no O
LAD O
. O
 
Lungs O
: O
CTA O
. O
 
CV O
: O
RRR O
Abd O
: O
soft O
, O
NT/ND O
. O
 
Ext O
: O
no O
c/c/edema O
. O
 
A/P O
: O
1. O
s/p O
hernia O
repair O
and O
PEG O
placement O
with O
recent O
foreign O
body O
removal O
9/25 I-DATE
due O
to O
esophageal O
stricture O
, O
doing O
well O
. O
 
Mech O
soft O
diet O
as O
per O
surgery O
. O
 
f/up O
with O
Dr. O
Langley I-NAME
as O
scheduled O
. O
 
RTC O
if O
new O
or O
worsening O
symptoms O
. O
 
2 O
. O
 
HTN O
, O
stable O
, O
no O
change O
in O
regimen O
. O
 
3. O
paroxysmal O
AFIB O
, O
coumadin O
therapeutic O
without O
changes O
. O
 
10/13 I-DATE
INR O
2.4 O
. O
 
Quijada I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2099-07-17 I-DATE
KEKELA I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LEON O
, O
MAURICE O
436-34-21-1 I-ID
VISIT O
DATE O
: O
07/17/99 I-DATE
Patient O
seen O
on O
7/17/99 I-DATE
by O
myself O
and O
the O
medical O
resident O
at O
4:30 O
p.m. O
PRESENTING O
COMPLAINT O
: O
Chest O
wall O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
The O
patient O
is O
a O
44 I-AGE
year O
old O
male O
complaining O
of O
chest O
wall O
pain O
, O
constant O
, O
times O
24 O
hours O
. O
 
The O
patient O
states O
the O
pain O
is O
worse O
with O
respirations O
and O
movement O
. O
 
The O
patient O
claims O
similar O
episode O
in O
past O
, O
and O
was O
told O
had O
a O
'' O
pulled O
muscle O
'' O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Patient O
denies O
trauma O
, O
denies O
nausea O
and O
vomiting O
, O
diaphoresis O
and O
shortness O
of O
breath O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Positive O
for O
hypertension O
and O
asthma O
. O
 
MEDICATIONS O
: O
Procardia O
, O
Albuterol O
, O
Accolate O
. O
 
ALLERGIES O
: O
None O
. O
 
PHYSICAL O
EXAMINATION O
: O
A O
well O
developed O
, O
well O
nourished O
male O
lying O
on O
stretcher O
, O
communicative O
and O
in O
no O
apparent O
distress O
. O
 
Temp O
98.3 O
, O
heart O
rate O
112 O
, O
blood O
pressure O
133/86 O
, O
pulse O
ox O
95 O
% O
on O
room O
air O
. O
 
HEENT O
- O
normocephalic O
, O
atraumatic O
. O
 
Heart O
- O
regular O
rate O
and O
rhythm O
without O
murmurs O
, O
rubs O
or O
gallops O
. O
 
Lungs O
clear O
without O
wheezing O
. O
 
Abdomen O
soft O
, O
non-tender O
, O
positive O
bowel O
sounds O
. O
 
Extremities O
without O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
Chest O
wall O
- O
positive O
reproducible O
pain O
on O
palpation O
which O
improved O
when O
palpation O
stopped O
. O
 
FINAL O
DIAGNOSIS O
: O
Chest O
wall O
pain O
, O
probable O
costochondritis O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Plan O
- O
discharge O
with O
nonsteroidal O
anti-inflammatories O
which O
patient O
has O
taken O
and O
tolerated O
in O
the O
past O
. O
 
Discharged O
in O
stable O
condition O
. O
 
___________________________________ O
HP506/6486 I-ID
WINIFRED I-NAME
MANNING I-NAME
, O
M.D O
. O
 
WM26 I-NAME
D:07/17/99 O
T:07/17/99 O
Dictated O
by O
: O
WINIFRED I-NAME
MANNING I-NAME
, O
M.D O
. O
 
WM26 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2099-02-01 I-DATE
KEKELA I-LOCATION
EMERGENCY O
DEPT O
VISIT O
LEON O
, O
MAURICE O
436-34-21-1 I-ID
VISIT O
DATE O
: O
02/01/99 I-DATE
Resident O
history O
reviewed O
, O
patient O
seen O
and O
examined O
by O
me O
. O
 
PRESENTING O
COMPLAINT O
: O
Chest O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
patient O
is O
a O
45-year-old O
black O
male O
who O
now O
presents O
for O
evaluation O
of O
chest O
pain O
. O
 
The O
patient O
states O
he O
has O
had O
intermittent O
left-sided O
chest O
pain O
for O
the O
past O
several O
weeks O
. O
 
He O
states O
he O
had O
a O
more O
prolonged O
episode O
of O
substernal O
chest O
pressure O
today O
while O
driving O
. O
 
He O
states O
the O
pain O
radiated O
down O
his O
left O
arm O
and O
he O
did O
experience O
a O
mild O
amount O
of O
associated O
shortness O
of O
breath O
and O
diaphoresis O
. O
 
He O
denies O
any O
nausea O
, O
vomiting O
, O
palpitations O
, O
light-headedness O
or O
syncope O
. O
 
On O
arrival O
he O
states O
the O
pain O
is O
approximately O
7/10 O
in O
intensity O
. O
 
He O
denies O
any O
prior O
history O
of O
coronary O
artery O
disease O
, O
pulmonary O
embolus O
or O
deep O
venous O
thrombosis O
. O
 
His O
cardiac O
risk O
factors O
include O
history O
of O
hypertension O
and O
hypercholesterolemia O
. O
 
He O
also O
denies O
any O
chest O
wall O
trauma O
or O
any O
recent O
upper O
respiratory O
infection O
symptoms O
, O
cough O
, O
fever O
or O
chills O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Negative O
except O
per O
HPI O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Significant O
for O
hypertension O
, O
asthma O
and O
hypercholesterolemia O
. O
 
MEDICATIONS O
: O
Tenovate O
, O
albuterol O
MDI O
, O
Azmacort O
MDI O
, O
adalat O
. O
 
ALLERGIES O
: O
Bupropron O
which O
causes O
pruritus O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
He O
is O
adopted O
and O
does O
not O
know O
his O
family O
history O
. O
 
The O
patient O
is O
a O
former O
smoker O
who O
quit O
approximately O
one O
year O
ago O
. O
 
The O
patient O
is O
a O
former O
smoker O
with O
an O
approximately O
15-pack-year O
history O
. O
 
He O
states O
he O
quit O
one O
year O
ago O
. O
 
He O
does O
admit O
to O
heavy O
drinking O
, O
approximately O
3-4 O
drinks O
per O
day O
. O
 
He O
has O
no O
prior O
history O
of O
illicit O
drug O
use O
and O
currently O
lives O
with O
his O
family O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
This O
is O
a O
well-developed O
, O
well-nourished O
, O
slightly O
anxious O
appearing O
male O
who O
appears O
in O
otherwise O
no O
acute O
distress O
. O
 
VITAL O
SIGNS O
: O
Temperature O
is O
96.2 O
, O
blood O
pressure O
142/96 O
, O
pulse O
108 O
, O
respiratory O
rate O
20 O
, O
oxygen O
saturation O
96 O
% O
on O
room O
air O
. O
 
HEENT O
: O
Mucous O
membranes O
are O
moist O
without O
lesions O
. O
 
NECK O
: O
Supple O
without O
jugular O
venous O
distention O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
. O
 
HEART O
: O
Tachycardic O
, O
regular O
rate O
and O
rhythm O
without O
gallops O
, O
murmurs O
or O
rubs O
. O
 
ABDOMEN O
: O
Soft O
, O
nontender O
, O
nondistended O
. O
 
EXTREMITIES O
: O
No O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
No O
calf O
tenderness O
. O
 
Negative O
Homan O
's O
sign O
. O
 
NEURO O
: O
Awake O
, O
alert O
, O
oriented O
x O
3 O
. O
 
Nonfocal O
. O
 
LABORATORY O
EVALUATION O
: O
CBC O
, O
white O
count O
6.2 O
, O
hematocrit O
45 I-AGE
, O
platelets O
210 O
. O
 
SMA-7 O
notable O
for O
a O
bicarb O
of O
19 O
. O
 
D-dimer O
is O
pending O
. O
 
CPK O
134 O
, O
cardiac O
troponin O
I O
0.00 O
, O
coagulation O
profile O
is O
normal O
. O
 
Electrocardiogram O
shows O
normal O
sinus O
rhythm O
at O
a O
rate O
of O
93 O
with O
nonspecific O
T O
wave O
changes O
. O
 
No O
significant O
change O
compared O
with O
prior O
tracing O
dated O
May I-DATE
01 O
, O
2099 I-DATE
. O
 
Chest O
x-ray O
reveals O
no O
acute O
disease O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
treated O
with O
aspirin O
, O
nitroglycerin O
and O
morphine O
with O
relief O
of O
his O
pain O
and O
remained O
hemodynamically O
stable O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
The O
patient O
's O
primary O
care O
physician O
, O
Dr. O
Greene I-NAME
was O
notified O
and O
agrees O
with O
the O
management O
plan O
. O
 
FINAL O
DIAGNOSIS O
: O
Atypical O
chest O
pain O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
was O
admitted O
to O
emergency O
department O
observation O
under O
low O
risk O
for O
cardiac O
ischemia O
protocol O
and O
is O
currently O
awaiting O
evaluation O
with O
an O
exercise O
stress O
test O
as O
well O
as O
results O
of O
D-dimer O
to O
evaluate O
for O
the O
remote O
possibility O
of O
pulmonary O
embolism O
. O
 
The O
patient O
is O
currently O
in O
stable O
condition O
. O
 
___________________________________ O
CL893/2080 I-ID
MAX I-NAME
RHODES I-NAME
, O
M.D O
. O
 
MR75 I-NAME
D:02/01/99 O
T:02/01/99 O
Dictated O
by O
: O
MAX I-NAME
RHODES I-NAME
, O
M.D O
. O
 
MR75 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2099-09-27 I-DATE
EDVISIT^43634211^LEON O
, O
MAURICE^9/27/2099^HALEY O
, O
BEVERLY I-NAME
ADDENDUM O
: O
The O
patient O
had O
dizzy O
spells O
since O
12/2099 I-DATE
, O
which O
resolved O
after O
resection O
of O
his O
cervical O
medullary O
tumor O
. O
 
He O
had O
recurrence O
3 O
times O
this O
morning O
of O
similar O
episodes O
. O
 
He O
feels O
presyncopal O
and O
has O
headache O
. O
 
He O
denies O
any O
nausea O
, O
vomiting O
, O
fevers O
, O
chills O
or O
upper O
respiratory O
symptoms O
. O
 
He O
has O
had O
some O
epigastric O
pain O
. O
 
During O
all O
of O
these O
episodes O
, O
he O
never O
lost O
consciousness O
, O
but O
he O
does O
a O
fall O
and O
slump O
. O
 
He O
feels O
lightheaded O
prior O
to O
the O
episode O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Remarkable O
for O
rheumatoid O
arthritis O
, O
psoriasis O
, O
hypertension O
, O
cholesterol O
, O
and O
asthma O
. O
 
Social O
history O
, O
family O
history O
, O
and O
review O
of O
systems O
are O
as O
per O
the O
written O
note O
. O
 
The O
patient O
was O
counseled O
regarding O
smoking O
cessation O
. O
 
MEDICATIONS O
: O
Aspirin O
, O
Lipitor O
, O
nifedipine O
, O
and O
Neurontin O
. O
 
ALLERGIES O
: O
None O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
is O
awake O
, O
alert O
, O
in O
no O
acute O
distress O
. O
 
Vital O
signs O
are O
remarkable O
for O
temperature O
of O
97.3 O
, O
pulse O
58 O
, O
respiratory O
rate O
16 O
, O
blood O
pressure O
134/79 O
, O
and O
oxygen O
saturation O
is O
96 O
% O
on O
room O
air O
. O
 
For O
full O
physical O
exam O
findings O
, O
please O
see O
the O
resident O
's O
written O
notes O
. O
 
Specifically O
, O
HEENT O
exam O
is O
atraumatic O
and O
normal O
to O
inspection O
. O
 
There O
is O
minimal O
right O
ptosis O
on O
my O
exam O
. O
 
Neck O
is O
normal O
, O
supple O
, O
with O
posterior O
well-healed O
cervical O
scar O
. O
 
There O
is O
no O
lymphadenopathy O
on O
my O
exam O
. O
 
Respiratory O
, O
cardiac O
, O
abdominal O
, O
skin O
, O
and O
musculoskeletal O
exam O
are O
within O
normal O
limits O
as O
documented O
. O
 
Neurologically O
, O
the O
patient O
is O
oriented O
with O
normal O
pleasant O
mood O
and O
affect O
. O
 
Speech O
is O
fluent O
. O
 
Cranial O
nerves O
are O
remarkable O
only O
for O
intermittent O
right-sided O
ptosis O
. O
 
Extraocular O
movements O
are O
otherwise O
intact O
, O
and O
the O
patient O
is O
moving O
all O
4 O
extremities O
without O
any O
motor O
or O
sensory O
deficit O
. O
 
LABORATORY O
DATA O
: O
CBC O
and O
electrolytes O
are O
remarkable O
for O
BUN O
and O
creatinine O
ratio O
of O
22-0.9 O
respectively O
. O
 
CK O
and O
troponin O
are O
flat O
. O
 
INR O
is O
1 O
. O
 
EKG O
demonstrates O
sinus O
rhythm O
without O
any O
significant O
ST-T O
wave O
changes O
when O
compared O
to O
prior O
studies O
. O
 
IMAGING O
STUDIES O
: O
Head O
CT O
is O
unremarkable O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
with O
possible O
presyncope O
without O
EKG O
changes O
, O
nor O
any O
evidence O
for O
new O
disease O
on O
his O
head O
CT O
, O
will O
undergo O
consultation O
by O
Neurology O
and O
Neurosurgery O
, O
and O
will O
be O
admitted O
to O
the O
ED O
Observation O
area O
for O
likely O
MR O
imaging O
prior O
to O
admission O
. O
 
The O
patient O
if O
not O
admitted O
to O
either O
of O
the O
Neurosurgery O
or O
Neurology O
Services O
will O
require O
admission O
to O
the O
Medicine O
Service O
for O
syncope O
workup O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
DISPOSITION O
: O
Admitted O
to O
ED O
Observation O
Unit O
. O
 
PRIMARY O
DIAGNOSIS O
: O
Near O
syncope O
. O
 
SECONDARY O
DIAGNOSIS O
: O
Status O
post O
cervical O
medullary O
tumor O
resection O
. O
 
______________________________ O
HALEY O
, O
BEVERLY I-NAME
MD O
D O
: O
09/27/99 I-DATE
T O
: O
09/27/99 I-DATE
Dictated O
By O
: O
HALEY O
, O
BEVERLY I-NAME
eScription O
document:7-2933615 O
BFFocus O
 
Record O
date O
: O
2099-03-29 I-DATE
Neurology O
resident O
consult O
note O
Patient O
Name O
: O
Leon I-NAME
MRN O
: O
43634211 I-ID
Date O
: O
0021 I-DATE
Consult O
reason O
: O
? O
abnormal O
gait O
HPI O
: O
53RHM O
who O
going O
to O
bed O
Wednesday I-DATE
was O
in O
usoh O
, O
but O
Thursday I-DATE
2:30AM O
awoke O
w/ O
terrible O
HA O
, O
so O
came O
to O
ED O
; O
got O
CT O
head O
and O
LP O
, O
both O
negative O
for O
blood O
. O
 
However O
, O
BP O
was O
reportedly O
as O
high O
as O
190/106 O
( O
and O
wife O
says O
she O
& O
# O
8217 O
; O
s O
measured O
it O
this O
high O
at O
home O
at O
least O
once O
in O
past O
2 O
weeks O
) O
, O
and O
blood O
glucose O
400s O
. O
 
I O
see O
no O
LMR O
note O
about O
the O
visit O
, O
but O
am O
told O
that O
he O
was O
given O
some O
medication O
for O
his O
BP O
, O
given O
some O
insulin O
and O
a O
Rx O
for O
insulin O
, O
and O
instructed O
to O
see O
his O
PCP O
the O
next O
day O
, O
and O
discharged O
. O
 
Friday I-DATE
he O
did O
see O
his O
PCP O
, O
who O
told O
him O
not O
to O
take O
insulin O
but O
to O
take O
oral O
DM O
meds O
instead O
, O
and O
told O
him O
to O
return O
to O
the O
ED O
b/c O
he O
still O
had O
a O
terrible O
HA O
, O
so O
he O
came O
back O
to O
the O
EDUCARE-PULLMAN I-LOCATION
ED O
tonight O
. O
 
He O
was O
given O
caffeine O
, O
ibuprofen O
, O
Tylenol O
, O
and O
compazine O
, O
reported O
that O
his O
HA O
was O
gone O
. O
 
However O
, O
a O
staff O
physician O
in O
the O
ED O
on O
exam O
noted O
a O
wide O
based O
gait O
. O
 
An O
MRI O
was O
originally O
ordered O
, O
but O
canceled O
when O
it O
came O
to O
notice O
that O
he O
has O
an O
implanted O
device O
to O
prevent O
syncope O
that O
precludes O
MRI O
. O
 
Neurology O
is O
now O
consulted.to O
comment O
on O
his O
gait O
and O
other O
sx O
. O
 
Patient O
and O
his O
wife O
tell O
me O
that O
his O
gait O
is O
baseline O
, O
and O
has O
been O
as O
it O
is O
for O
years O
; O
they O
have O
noticed O
no O
change O
and O
have O
no O
complaints O
. O
 
He O
is O
very O
unpleasant O
and O
un-forthcoming O
about O
his O
history O
, O
slow O
to O
cooperate O
w/ O
exam O
; O
says O
he O
wants O
to O
go O
home O
, O
resents O
being O
in O
the O
ED O
still O
now O
that O
his O
HA O
is O
gone O
. O
 
VS O
in O
ED O
tonight O
: O
BP O
172/95 O
max O
, O
but O
mostly O
150-160s O
; O
temp O
98 O
, O
hr O
89 O
, O
100 O
% O
RA O
Blood O
glucose O
not O
measured O
tonight O
. O
 
ROS O
: O
Negative O
for O
: O
changes O
in O
vision O
or O
hearing O
, O
neck O
pain O
, O
tinnitus O
, O
vertigo O
, O
weakness O
, O
numbness O
, O
difficulty O
with O
comprehension O
, O
speaking O
, O
language O
, O
swallowing O
, O
eating O
, O
balance O
or O
gait O
. O
 
General O
review O
of O
systems O
negative O
for O
: O
fevers O
, O
chills O
, O
rashes O
, O
change O
in O
weight O
, O
energy O
level O
or O
appetite O
, O
chest O
pain O
, O
palpitations O
, O
shortness O
of O
breath O
, O
cough O
, O
abdominal O
pain O
, O
nausea O
, O
vomiting O
, O
and O
change O
in O
bowel O
or O
bladder O
habits O
( O
i.e O
incontinence O
) O
. O
 
MEDS O
: O
metoprolol O
, O
omeprazole O
, O
simvastatin O
( O
he O
is O
unsure O
whether O
this O
is O
all O
) O
ALL O
: O
nkda O
PMH O
: O
-HTN O
; O
he O
denies O
prior O
dx O
of O
DM O
before O
yesterday O
night O
-recurrent O
cardiogenic O
syncope O
, O
for O
which O
he O
has O
had O
& O
# O
8220 O
; O
Reveal O
& O
# O
8221 O
; O
device O
implanted O
, O
then O
explanted O
b/c O
of O
pain O
, O
then O
recurrent O
sycope O
and O
reimplantation O
of O
device O
, O
after O
which O
syncope O
stopped O
( O
see O
notes O
in O
LMR O
from O
Dr. O
Susan I-NAME
Root I-NAME
) O
SH O
: O
denies O
t/e/d O
, O
works O
as O
& O
# O
8220 O
; O
Pipefitter I-PROFESSION
& O
# O
8221 O
; O
FH O
: O
HTN O
, O
DM O
Neurologic O
Examination O
: O
MS O
: O
unpleasant O
, O
uncooperative O
w/ O
history O
, O
angry O
about O
being O
in O
the O
ED O
still O
AOx3 O
, O
appropriately O
interactive O
and O
conversational O
. O
 
Normal O
affect O
. O
 
Speech O
is O
fluent O
with O
intact O
comprehension O
and O
repetition O
, O
no O
paraphasic O
errors O
. O
 
Concentration O
and O
attention O
intact O
. O
 
CN O
: O
Visual O
fields O
full O
to O
confrontation O
; O
pupils O
equal O
and O
reactive O
3 O
& O
gt O
; O
2 O
direct O
and O
concensual O
; O
no O
ptosis O
; O
Extraocular O
movements O
full O
without O
nystagmus O
; O
facial O
sensation O
to O
LT O
normal O
. O
 
Hearing O
intact O
to O
finger O
rub O
bilaterally O
; O
face O
, O
tongue O
and O
palate O
are O
symmetric O
; O
SCM O
and O
traps O
5/5 O
. O
 
Motor O
: O
Normal O
bulk O
and O
tone O
; O
no O
tremor O
, O
rigidity O
, O
or O
bradykinesia O
. O
 
No O
pronator O
drift O
. O
 
Finger O
tapping O
normal O
. O
 
Delt O
Bi O
Tri O
FE O
IP O
Quad O
Hamst O
TibAnt O
EHL O
Gastro O
C5 O
C6 O
C7 O
C8/T1 O
L2 O
L3 O
L4-S1 O
L4 O
L5 O
S1 O
R O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
L O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
Sensory O
: O
Intact/symmetric O
LT/PP/T/JPS O
throughout O
. O
 
Reflexes O
: O
absent O
throughout O
. O
 
Cerebellar O
: O
Finger-nose-finger O
, O
rapid O
alternating O
movements O
, O
heel-knee-shin O
normal O
and O
symmetric O
b/l O
. O
 
Gait O
: O
Slightly O
wide O
based O
. O
 
Normal O
arm O
swing O
, O
normal O
speed O
. O
 
Able O
to O
walk O
on O
toes O
and O
heels O
. O
 
Some O
difficulty O
w/ O
tandem O
walk O
. O
 
Negative O
Romberg O
. O
 
A/P O
: O
53RHM O
w/ O
HTN O
urgency O
yesterday O
, O
newly O
diagnosed O
DM O
w/ O
FS O
in O
300-400s O
yesterday O
, O
who O
yesterday O
presented O
w/ O
new O
HA O
and O
negative O
w/u O
for O
SAH O
, O
now O
back O
again O
for O
same O
HA O
, O
which O
has O
finally O
resolved O
in O
apparently O
in O
concert O
w/ O
some O
improvement O
in O
BP O
( O
current O
BP O
150s O
) O
and O
w/ O
medications O
. O
 
Neurology O
was O
specifically O
consulted O
for O
his O
gait O
, O
which O
does O
appear O
a O
bit O
wide-based O
, O
but O
he O
and O
wife O
confirm O
that O
this O
is O
chronic O
, O
and O
I O
strongly O
doubt O
any O
relation O
to O
his O
current O
HA O
problems O
. O
 
Most O
obvious O
medical O
issues O
to O
focus O
on O
here O
are O
his O
poorly O
controlled O
HTN O
, O
which O
I O
suspect O
is O
the O
primary O
cause O
of O
his O
HA O
, O
and O
his O
uncontrolled O
DM O
, O
of O
which O
he O
obviously O
does O
not O
yet O
understand O
the O
import O
and O
does O
not O
seem O
likely O
to O
comply O
with O
insulin O
treatment O
without O
further O
education O
. O
 
In O
any O
case O
, O
I O
find O
no O
acute O
neurological O
issues O
. O
 
Recs O
: O
-BP O
management O
-DM O
management O
. O
 
Thanks O
for O
this O
interesting O
consult O
. O
 
Case/plan O
discussed O
w/ O
KEKELA I-LOCATION
neurology O
attending O
by O
phone O
, O
Dr. O
Ivan I-NAME
Guy I-NAME
. O
 
Call O
w/ O
questions O
86383 I-CONTACT
. O
 
Keith I-NAME
Gilbert I-NAME
, O
MD O
, O
PhD O
, O
Neurology O
resident O
PGY3 O
Addendum O
: O
He O
did O
not O
mention O
this O
when O
I O
questioned O
him O
and O
wife O
about O
PMH O
, O
but O
digging O
through O
prior O
LMR O
notes O
I O
find O
this O
addition O
to O
his O
PMH O
: O
A O
note O
from O
Dr. O
Robert I-NAME
Irish I-NAME
, O
neurosurgery O
, O
from O
3/2099 I-DATE
notes O
that O
he O
is O
s/p O
& O
# O
8220 O
; O
cervical O
laminectomy O
and O
foramen O
magnum O
resection O
followed O
by O
removal O
of O
an O
intramedullary O
tumor O
near O
his O
foramen O
magnum O
. O
 
He O
is O
doing O
much O
better O
today O
. O
 
He O
states O
that O
his O
headaches O
are O
considerably O
better O
, O
and O
the O
left O
hemibody O
dysesthesias O
are O
much O
better O
tolerated O
since O
the O
initiation O
of O
Neurontin. O
& O
# O
8221 O
; O
 
Record O
date O
: O
2072-11-25 I-DATE
RGH I-LOCATION
EMERGENCY O
DEPT O
VISIT O
MULLINS O
, O
DOLORES O
U I-NAME
728-41-92-0 I-ID
VISIT O
DATE O
: O
01/24/73 I-DATE
This O
patient O
was O
seen O
, O
interviewed O
and O
examined O
by O
myself O
as O
well O
as O
Dr. O
Hawkins I-NAME
whose O
note O
I O
reviewed O
and O
with O
which O
I O
agree O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
is O
a O
70-year-old O
female O
who O
presents O
with O
inability O
to O
control O
her O
left O
arm O
and O
left O
leg O
. O
 
The O
patient O
had O
onset O
of O
her O
symptoms O
approximately O
two O
hours O
prior O
to O
arrival O
. O
 
The O
patient O
denies O
any O
change O
in O
sensation O
but O
she O
definitely O
did O
notice O
weakness O
with O
decreased O
ability O
to O
control O
her O
left O
side O
extremities O
. O
 
The O
patient O
states O
that O
her O
left O
arm O
control O
was O
regained O
after O
approximately O
one O
or O
two O
hours O
. O
 
Her O
left O
leg O
control O
is O
better O
but O
still O
is O
not O
back O
to O
baseline O
. O
 
Review O
of O
systems O
, O
family O
history O
and O
social O
history O
as O
per O
the O
resident O
's O
note O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Insulin-dependent O
diabetes O
mellitus O
, O
hypertension O
. O
 
MEDICATIONS O
: O
Insulin O
, O
Diltiazem O
, O
labetalol O
. O
 
ALLERGIES O
: O
TETANUS O
. O
 
PHYSICAL O
EXAMINATION O
: O
This O
is O
a O
well-developed O
, O
well-nourished O
female O
, O
in O
mild O
distress O
, O
appears O
concerned O
. O
 
Temperature O
is O
96.9 O
degrees O
, O
pulse O
65 O
, O
respiratory O
rate O
of O
18 O
, O
blood O
pressure O
is O
163/104 O
. O
 
Repeat O
blood O
pressure O
is O
174/80 O
. O
 
Oxygen O
saturation O
is O
97 O
% O
on O
room O
air O
. O
 
HEENT O
: O
Normocephalic O
, O
atraumatic O
. O
 
Pupils O
are O
equally O
round O
and O
reactive O
to O
light O
and O
accommodation O
. O
 
Extraocular O
motions O
are O
intact O
. O
 
No O
nystagmus O
. O
 
NECK O
: O
Supple O
with O
full O
range O
of O
motion O
. O
 
2+ O
carotids O
, O
no O
bruits O
. O
 
CARDIAC O
: O
Regular O
rate O
and O
rhythm O
. O
 
EXTREMITIES O
: O
No O
clubbing O
, O
cyanosis O
or O
edema O
. O
 
Extremities O
are O
nontender O
to O
palpation O
throughout O
. O
 
NEURO O
: O
Alert O
, O
oriented O
x O
3 O
. O
 
Follows O
commands O
, O
appropriate O
. O
 
Cranial O
nerves O
II-XII O
are O
intact O
. O
 
There O
is O
5/5 O
motor O
strength O
in O
individual O
motor O
group O
testing O
of O
the O
upper O
extremities O
and O
lower O
extremities O
bilaterally O
. O
 
The O
patient O
is O
unable O
to O
stand O
without O
assistance O
. O
 
Comprehension O
is O
within O
normal O
limits O
. O
 
Further O
details O
of O
the O
physical O
examination O
are O
as O
per O
the O
resident O
's O
note O
. O
 
LABORATORY O
EVALUATION O
: O
Labs O
are O
significant O
for O
a O
glucose O
of O
162 O
, O
BUN O
of O
20 O
, O
creatinine O
1.3 O
, O
sodium O
145 O
, O
potassium O
4.2 O
, O
chloride O
108 O
, O
bicarb O
26 O
, O
calcium O
9.4 O
. O
 
White O
count O
is O
8.1 O
, O
hematocrit O
39.0 O
, O
platelets O
341 O
. O
 
A O
UA O
shows O
no O
blood O
, O
no O
leucocyte O
esterase O
, O
no O
ketones O
. O
 
Head O
CT O
shows O
no O
acute O
intracranial O
abnormality O
and O
mild O
involutional O
changes O
. O
 
EKG O
shows O
a O
sinus O
rhythm O
at O
57 O
beats O
per O
minute O
with O
non-specific O
T O
wave O
changes O
. O
 
This O
is O
compared O
to O
an O
EKG O
from O
2068 I-DATE
and O
was O
found O
to O
be O
without O
significant O
change O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
seen O
and O
evaluated O
in O
the O
Emergency O
Department O
with O
labs O
and O
studies O
obtained O
as O
documented O
above O
. O
 
The O
initial O
concerns O
were O
for O
a O
focal O
seizure O
versus O
a O
TIA O
. O
 
The O
patient O
was O
hypertensive O
on O
her O
arrival O
and O
, O
therefore O
, O
received O
labetalol O
for O
improved O
blood O
pressure O
control O
and O
the O
Neurology O
Service O
was O
consulted O
early O
in O
the O
patient O
's O
care O
. O
 
The O
patient O
does O
not O
have O
any O
evidence O
of O
focal O
motor O
group O
weakness O
at O
this O
time O
, O
nor O
sensation O
changes O
. O
 
The O
patient O
will O
require O
admission O
to O
the O
Neurology O
Service O
for O
further O
workup O
of O
her O
seizure O
versus O
TIA O
. O
 
FINAL O
DIAGNOSIS O
: O
TIA O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
is O
admitted O
to O
the O
hospital O
in O
satisfactory O
condition O
. O
 
___________________________________ O
OH527/2519 I-ID
YULIANNA I-NAME
ELKINS I-NAME
, O
M.D O
. O
 
YE96 I-NAME
D:01/24/73 O
T:01/24/73 O
Dictated O
by O
: O
YULIANNA I-NAME
ELKINS I-NAME
, O
M.D O
. O
 
YE96 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2079-09-01 I-DATE
Rheumatology O
Consult O
Note O
Name O
: O
Mullins O
, O
Dolores I-NAME
U I-NAME
MRN O
: O
72841920 I-ID
DOB O
: O
06/06/02 I-DATE
Location O
: O
78Q-47-4 O
Consult O
date O
: O
09/01/79 I-DATE
Referring O
Physician O
: O
Gay I-NAME
Langley I-NAME
Source O
of O
history O
: O
patient O
interview O
, O
medical O
records O
Code O
status O
: O
Full O
Reason O
for O
Consult O
: O
bilateral O
LE O
pain O
up O
to O
knees O
HPI O
: O
77 I-AGE
yo O
F O
w/h/o O
type O
I O
DM O
and O
HTN O
. O
 
At O
the O
beginning O
of O
this O
year O
, O
she O
began O
to O
have O
intermittent O
burning O
pain O
of O
her O
feet O
and O
sometimes O
her O
lower O
legs/feet O
. O
 
This O
pain O
typically O
occurred O
on O
one O
leg O
more O
than O
the O
other O
, O
without O
an O
overall O
predominance O
of O
one O
side O
. O
 
In O
the O
past O
month O
, O
she O
has O
had O
continuous O
, O
bilateral O
burning O
pain O
that O
began O
in O
both O
feet O
. O
 
Several O
weeks O
ago O
, O
her O
pain O
worsened O
considerably O
such O
that O
she O
was O
having O
difficulty O
shopping O
. O
 
Around O
this O
time O
, O
the O
pain O
spread O
up O
her O
legs O
to O
above O
her O
knees O
. O
 
She O
also O
noted O
having O
difficulty O
putting O
on O
shoes O
and O
was O
told O
by O
a O
friend O
that O
her O
feet O
were O
swollen O
( O
she O
is O
unable O
to O
see O
her O
feet O
due O
to O
blindness O
) O
. O
 
Her O
pain O
continued O
to O
worsen O
until O
the O
night O
prior O
to O
admission O
, O
when O
she O
was O
in O
her O
bathroom O
and O
found O
herself O
in O
such O
pain O
that O
she O
was O
unable O
to O
get O
up O
to O
leave O
the O
bathroom O
. O
 
A O
friend O
found O
her O
after O
8 O
hours O
and O
EMS O
was O
called O
. O
 
In O
the O
ED O
, O
she O
was O
found O
to O
have O
BP O
elevated O
to O
190 O
, O
Cr O
elevated O
to O
2.8 O
, O
FSG O
down O
to O
51 O
, O
and O
R-sided O
hydronephrosis O
. O
 
Labetolol/diltiazem O
were O
given O
for O
HTN O
with O
good O
response O
, O
IV O
hydration O
was O
given O
with O
subsequent O
decline O
in O
Cr O
, O
and O
Foley O
was O
placed O
with O
resolution O
of O
hydronephrosis O
on O
subsequent O
MRI O
. O
 
She O
has O
never O
had O
burning O
pain O
of O
the O
kind O
that O
she O
presented O
with O
prior O
to O
this O
year O
. O
 
Of O
note O
, O
she O
has O
had O
years O
of O
tingling O
without O
numbness O
in O
her O
lower O
extremities O
bilaterally O
extending O
to O
above O
her O
knees O
. O
 
She O
also O
notes O
numbness O
of O
the O
tips O
of O
her O
R O
2nd-4th O
digits O
. O
 
ROS O
positive O
for O
subjective O
decline O
in O
urine O
output O
and O
constipation O
( O
1 O
BM/2days O
) O
. O
 
She O
denies O
fever/chills/sweats O
, O
recent O
weight O
loss O
, O
fatigue O
, O
hypoglycemic O
episodes O
, O
cough/rhinorrhea/sore O
throat O
, O
SOB O
, O
orthpnea O
, O
CP O
, O
palpitations O
, O
abdominal O
pain O
, O
diarrhea O
, O
dysuria O
, O
polyuria/polydipsia O
. O
 
PMH O
: O
1 O
) O
DM O
type O
1 O
, O
since O
2060 I-DATE
, O
c/b O
retinopathy O
, O
nephropathy O
2 O
) O
HTN O
3 O
) O
Hypercholesterolemia O
4 O
) O
L O
internal O
capsule O
CVA O
11/72 I-DATE
5 O
) O
L O
eye O
legally O
blind O
2/2 O
open O
angle O
glaucoma O
6 O
) O
thyroid O
nodule O
7/78 I-DATE
benign O
per O
patient O
7 O
) O
CRI O
per O
HHMR I-LOCATION
, O
Cr O
1.4 O
( O
4/78 I-DATE
, O
1/79 I-DATE
) O
and O
1.84 O
on O
6/29/79 I-DATE
PSH O
: O
1 O
) O
bilateral O
cataracts O
2 O
) O
L O
eye O
glaucoma O
surgery O
3 O
) O
L O
eye O
pressure O
shunt O
4 O
) O
TAH O
at O
age O
25 I-AGE
Admission O
Meds O
: O
1 O
) O
Labetalol O
200 O
mg O
bid O
2 O
) O
HCTZ O
25 I-AGE
mg O
qd O
3 O
) O
Lovastatin O
20 O
mg O
qd O
4 O
) O
Enalapril O
20 O
mg O
qd O
5 O
) O
Diltiazem O
120 O
mg O
bid O
6 O
) O
ASA O
81 O
mg O
qd O
7 O
) O
Novolin O
10 O
U I-NAME
qam O
8 O
) O
NPH O
70 O
U I-NAME
qam O
, O
40 O
U I-NAME
qpm O
Inpatient O
Meds O
: O
1 O
) O
Ferrous O
sulphate O
325 O
po O
tid O
2 O
) O
Enoxaparin O
30 O
sc O
qd O
3 O
) O
Simvastatin O
40 O
po O
qhs O
4 O
) O
Diltiazem O
SR O
120 O
po O
bid O
5 O
) O
Labetolol O
200 O
mg O
bid O
6 O
) O
Novolog O
SS O
ac O
, O
RISS O
qhs O
7 O
) O
NPH O
70 O
U I-NAME
qam O
, O
30 O
U I-NAME
qpm O
8 O
) O
Regular O
Insulin O
10 O
U I-NAME
qam O
9 O
) O
Colchicine O
0.6 O
mg O
qd O
( O
2 O
doses O
given O
) O
10 O
) O
Lumigan O
ou O
1 O
drop O
qd O
11 O
) O
Prednisolone O
1 O
% O
1 O
drop O
au O
bid O
12 O
) O
Colace O
100 O
mg O
po O
bid O
13 O
) O
ASA O
81 O
mg O
po O
qd O
14 O
) O
Oxycodone O
10 O
mg O
po O
q6h O
prn O
Gabapentin O
100 O
mg O
tid O
5 O
doses O
given O
before O
being O
discontinued O
Allergies O
: O
NKDA O
SH O
: O
Never O
smoked O
, O
does O
not O
currently O
drink O
ETOH O
, O
no O
h/o O
substance O
abuse O
, O
lives O
on O
the O
2nd O
floor O
of O
an O
apartment O
( O
15 O
steps O
) O
and O
has O
neighbors O
who O
check O
in O
on O
her O
. O
 
She O
is O
widowed O
with O
closest O
family O
being O
a O
cousin O
in O
Alaska I-LOCATION
. O
 
She O
has O
been O
able O
to O
meet O
her O
needs O
of O
daily O
living O
independently O
. O
 
FH O
: O
Mother O
with O
fatal O
MI O
at O
65 I-AGE
, O
no O
family O
h/o O
rheumatic O
disease O
or O
cancer O
. O
 
PE O
: O
Tm O
99.5 O
, O
Tc O
97.3 O
, O
HR O
51 O
( O
46-72 O
) O
, O
BP O
126/50 O
( O
120-154/50-70 O
) O
, O
RR O
18 O
( O
16-18 O
) O
, O
O2 O
sat O
96 O
% O
( O
94-98 O
) O
RA O
Gen O
NAD O
when O
immobile O
, O
but O
great O
pain O
with O
minimal O
movement O
or O
contact O
with O
lower O
extremities O
HEENT O
2 O
mm O
pupils O
, O
EOM O
intact O
, O
no O
scleral O
icterus O
, O
oropharnyx O
nl O
, O
no O
gouty O
tophi O
on O
pinna O
Neck O
Supple O
, O
no O
lymphadenopathy O
, O
no O
JVD O
CV O
RRR O
, O
nl O
S1 O
S2 O
, O
2/6 O
SEM O
best O
heard O
in O
RUSB O
Chest O
Late O
inspiratory O
crackles O
at O
bases O
bilaterally O
Abd O
+BS O
, O
soft O
, O
NT O
, O
ND O
, O
liver O
edge O
above O
chostochondral O
margin O
, O
no O
palpable O
splenomegaly O
, O
no O
masses O
Back O
R O
CVA O
and O
flank O
tenderness O
MSK O
Heberdin O
and O
Bouchard O
s O
nodes O
of O
PIPs/DIPs O
bilaterally O
, O
varus O
deformity O
of O
R O
2nd-4th O
DIPs O
, O
no O
joint O
tenderness O
or O
reduced O
ROM O
of O
upper O
extremities O
; O
visible O
knee O
effusions O
bilaterally O
without O
erythema O
or O
warmth O
; O
exquisite O
tenderness O
to O
minimal O
motion O
or O
palpation O
of O
knees O
, O
tibio-talars O
, O
tarsals O
, O
and O
MTPs O
; O
no O
effusions O
palpable O
or O
visible O
in O
tibio-talars O
, O
tarsals O
, O
and O
MTPs O
Ext O
WWP O
, O
1+ O
pedal O
edema O
bilaterally O
Pulses O
2+ O
DP O
bilaterally O
Skin O
no O
rashes O
, O
dry O
skin O
covering O
LEs O
greatest O
on O
medial O
aspect O
Neuro O
no O
focal O
upper O
extremity O
motor O
deficits O
, O
5/5 O
finger O
grip O
Labs O
: O
Na O
139 O
, O
K O
4.2 O
, O
Cl O
106 O
, O
CO2 O
23 O
, O
BUN O
61 O
, O
Cr O
1.79 O
( O
1.69 O
yesterday O
) O
, O
Glu O
141 O
, O
Ca O
8.9 O
, O
P O
3.8 O
, O
Mg O
2.1 O
TP O
6.9 O
, O
Alb O
3.0 O
, O
Glob O
3.9 O
ALT O
14 O
, O
AST O
12 O
, O
ALKP O
76 O
, O
TBILI O
0.4 O
FE O
12 O
, O
TIBC O
205 O
, O
B12 O
303 O
, O
Folate O
12.7 O
HGBA1C O
6.1 O
Uric O
acid O
11.5 O
ESR O
101 O
, O
CRP O
141.6 O
WBC O
12.51 O
( O
N76 O
L14 O
M8 O
E2 O
) O
, O
Hct O
28.8 O
, O
Plt O
398 O
Beta-hydroxybutyrate O
0.41 O
UA O
sg O
1.018 O
, O
pH O
5.0 O
, O
protein O
2+ O
, O
6 O
WBCs/hpf O
, O
2+ O
bacteria O
, O
1+ O
squames O
, O
no O
urine O
crystals O
Studies O
: O
TTE O
( O
8/31/79 I-DATE
, O
no O
prior O
studies O
) O
Mild O
concentric O
LVH O
, O
LVEF O
77 I-AGE
% O
, O
impaired O
relaxation O
c/w O
diastolic O
dysfunction O
, O
mild O
left O
atrial O
enlargement O
, O
nl O
right O
atrium O
and O
ventricle O
, O
mild O
aortic O
stenosis O
, O
mild O
mitral O
regurgitation O
, O
estimated O
PASP O
48.6 O
, O
nl O
aortic O
root O
, O
no O
pericardial O
effusions O
LE O
Doppler O
( O
8/31/79 I-DATE
) O
No O
evidence O
of O
proximal O
DVTs O
or O
calf O
DVTs O
bilaterally O
Abdominal O
MRI O
( O
8/31/79 I-DATE
) O
Tiny O
cortical O
right O
renal O
hemorrhagic O
cysts O
, O
small O
hiatal O
hernia O
, O
right O
extrarenal O
pelvis O
without O
hydronephrosis O
or O
obstructing O
mass O
lesion O
Renal O
U/S O
( O
8/30/79 I-DATE
) O
Mild O
right O
hydronephrosis O
with O
prominent O
extrarenal O
pelvis O
and O
multiple O
renal O
cysts O
, O
nl O
left O
kidney O
CXR O
( O
8/29/79 I-DATE
) O
No O
evidence O
of O
pulmonary O
edema O
, O
PNX O
, O
or O
pleural O
effusion O
; O
aorta O
tortuous O
and O
partially O
calcified O
; O
degenerative O
changes O
of O
thoracic O
spine O
and O
left O
shoulder O
, O
cardiac O
silhouette O
prominent O
but O
wnl O
Microbiology O
: O
Blood O
cultures O
x2 O
Negative O
at O
2 O
days O
Urine O
cultures O
x2 O
5000 O
colonies O
mixed O
, O
500 O
colonies O
probable O
lactobacilli O
A/P O
: O
77 I-AGE
yo O
F O
w/h/o O
DM O
and O
HTN O
who O
presented O
with O
several O
weeks O
of O
worsening O
bilateral O
LE O
burning O
pain O
exacerbated O
by O
movement O
and O
pressure O
. O
 
She O
was O
found O
to O
have O
exquisitely O
tender O
joints O
up O
to O
and O
including O
her O
knees O
with O
visible O
synovial O
effusions O
of O
her O
knees O
bilaterally O
. O
 
Aspiration O
of O
one O
of O
her O
knees O
revealed O
needle-shaped O
negatively O
birefringent O
crystals O
, O
diagnostic O
of O
gout O
. O
 
This O
is O
consistent O
with O
her O
elevated O
uric O
acid O
and O
her O
elevated O
markers O
of O
inflammation O
( O
ESR/CRP O
) O
. O
 
Given O
that O
she O
has O
a O
long O
history O
of O
symptoms O
of O
LE O
diabetic O
neuropathy O
and O
that O
she O
has O
some O
diffuse O
soft O
tissue O
tenderness O
, O
she O
may O
also O
have O
some O
pain O
from O
diabetic O
neuropathy O
that O
may O
declare O
itself O
after O
her O
gout O
is O
treated O
. O
 
However O
, O
her O
current O
inability O
to O
walk O
can O
be O
clearly O
attributed O
to O
gout O
. O
 
Recs O
: O
- O
Solumedrol O
40 O
mg O
bid O
IV O
, O
prednisone O
40 O
mg O
qd O
starting O
tomorrow O
with O
12-day O
outpatient O
taper O
( O
40 O
mg O
x O
3 O
days O
, O
30 O
mg O
x O
3 O
days O
, O
20 O
mg O
x O
3 O
days O
, O
10 O
mg O
x O
3 O
days O
) O
- O
Colchicine O
po O
0.6 O
mg O
qd O
for O
2 O
weeks O
, O
then O
0.6 O
mg O
qod O
for O
2 O
weeks O
- O
Continue O
to O
hold O
HCTZ O
discuss O
with O
PCP O
need O
to O
restart O
as O
outpatient O
as O
it O
is O
a O
risk O
factor O
for O
hyperuricemia O
- O
F/u O
with O
rheumatology O
in O
4 O
weeks O
for O
initiation O
of O
allopurinol O
( O
please O
arrange O
appointment O
w/ O
Dr. O
Yau I-NAME
) O
Procedure O
: O
R O
knee O
aspiration O
Patient O
was O
informed O
of O
the O
risks O
of O
bleeding O
and O
infection O
and O
gave O
consent O
. O
 
The O
medial O
aspect O
of O
the O
right O
knee O
was O
sterilized O
using O
iodine O
swabs O
x3 O
, O
sterile O
gloves O
used O
in O
a O
one-handed O
sterile O
lateral O
approach O
. O
 
1.5cc O
of O
1 O
% O
lidocaine O
was O
injected O
to O
raise O
a O
wheal O
inferior O
to O
the O
R O
patella O
. O
 
A O
18G O
needle O
was O
inserted O
into O
the O
knee O
and O
approximately O
20cc O
of O
opaque O
, O
yellow O
fluid O
was O
withdrawn O
. O
 
A O
slide O
was O
prepared O
and O
examined O
under O
the O
microscope O
by O
myself O
, O
Dr. O
Yau I-NAME
, O
and O
Dr. O
Woodard I-NAME
. O
 
Abundant O
intracellular O
and O
extracellular O
needle-shapped O
negatively O
birefringent O
crystals O
were O
observed O
. O
 
Synovial O
fluid O
sample O
was O
also O
submitted O
for O
culture O
, O
Gram O
stain O
, O
cell O
count O
, O
and O
crystal O
analysis O
. O
 
__________________________________ O
Isaac I-NAME
Ito I-NAME
, O
MS4 O
x79975 O
Addendum O
: O
Patient O
seen O
, O
records O
reviewed O
, O
case O
reviewed O
with O
medical O
student O
. O
 
Agree O
with O
excellent O
note O
above O
. O
 
Patient O
seen O
with O
Dr. O
Woodard I-NAME
. O
 
______________________ O
Unknown I-NAME
Yau I-NAME
, O
MD O
Rheumatology O
fellow O
 
Record O
date O
: O
2080-06-04 I-DATE
EDVISIT^72841920^MULLINS O
, O
DOLORES^06/04/80^KROLL O
, O
OLIVIA I-NAME
The O
patient O
was O
seen O
in O
conjunction O
with O
the O
PA O
. O
 
This O
is O
a O
shared O
visit O
. O
 
I O
confirm O
I O
have O
interviewed O
and O
examined O
the O
patient O
. O
 
CHIEF O
COMPLAINT O
: O
Rule O
out O
CVA O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Briefly O
, O
this O
is O
a O
70-year-old O
female O
with O
hypertension O
, O
hypercholesteremia O
, O
and O
diabetes O
who O
was O
found O
by O
a O
neighbor O
at O
approximately O
9:30 O
this O
morning O
, O
nonverbal O
with O
right-sided O
facial O
droop O
. O
 
The O
patient O
was O
seated O
in O
the O
chair O
upon O
EMS O
arrival O
. O
 
Per O
the O
neighbor O
who O
had O
returned O
from O
vacation O
, O
went O
up O
to O
check O
on O
her O
and O
found O
her O
this O
way O
, O
nonverbal O
, O
seated O
in O
a O
chair O
, O
but O
consciousness O
. O
 
Per O
EMS O
, O
the O
patient O
was O
responding O
to O
commands O
, O
able O
to O
stand O
, O
had O
symmetric O
handgrips O
, O
unknown O
when O
she O
was O
last O
seen O
normal O
. O
 
Per O
the O
neighbor O
, O
the O
patient O
's O
baseline O
is O
alert O
and O
oriented O
. O
 
Fingerstick O
in O
the O
field O
was O
179 O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
As O
stated O
per O
HPI O
and O
written O
chart O
. O
 
SOCIAL O
HISTORY O
: O
Unknown O
. O
 
FAMILY O
HISTORY O
: O
Unknown O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Limited O
secondary O
to O
the O
patient O
's O
medical O
condition O
and O
severity O
. O
 
MEDICATIONS O
: O
Per O
medication O
list O
. O
 
ALLERGIES O
: O
Tetanus O
per O
old O
medical O
records O
. O
 
PHYSICAL O
EXAMINATION O
: O
Blood O
pressure O
216/76 O
, O
pulse O
is O
68 O
, O
and O
O2 O
saturation O
99 O
% O
. O
 
HEENT O
: O
Atraumatic O
with O
left O
pupil O
defect O
. O
 
Lungs O
: O
Equal O
and O
bilateral O
. O
 
Cardiovascular O
: O
S1 O
and O
S2 O
. O
 
Abdomen O
: O
Soft O
and O
nontender O
. O
 
Skin O
: O
Intact O
, O
warm O
, O
and O
dry O
. O
 
Neurologic O
: O
Right-sided O
facial O
droop O
, O
bilateral O
hand O
grip O
. O
 
Normal O
plantar O
flexion O
able O
to O
sit O
up O
, O
and O
following O
commands O
. O
 
IMAGING O
STUDIED O
: O
EKG O
normal O
sinus O
, O
no O
acute O
ST O
segment O
elevation O
. O
 
LABORATORY O
DATA O
: O
Chemistries O
are O
remarkable O
for O
creatinine O
of O
2.8 O
, O
sodium O
and O
chloride O
pending O
. O
 
Bicarbonate O
of O
22 O
. O
 
CK O
256 O
with O
a O
MB O
of O
4 O
, O
troponin O
negative O
. O
 
No O
white O
count O
, O
hematocrit O
of O
34 O
, O
and O
platelets O
of O
410,000 O
. O
 
INR O
1.1 O
. O
 
UA O
showed O
3+ O
protein O
, O
no O
leukocyte O
esterase O
, O
nitrites O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Upon O
the O
patient O
's O
arrival O
in O
Emergency O
Department O
, O
Stroke O
team O
was O
paged O
, O
underwent O
a O
stat O
head O
CT O
, O
which O
showed O
no O
bleed O
, O
but O
a O
question O
of O
a O
hypodensity O
. O
 
The O
patient O
sent O
her O
for O
an O
urgent O
MRI/MRA O
and O
will O
be O
admitted O
to O
the O
Neurology O
Service O
. O
 
PRIMARY O
DIAGNOSIS O
: O
CVA O
. O
 
SECONDARY O
DIAGNOSES O
: O
Diabetes O
and O
hypertension O
. O
 
DISPOSITION O
: O
Plan O
for O
admission O
to O
Neurology O
Service O
. O
 
Please O
see O
written O
chart O
and O
nurse O
's O
note O
. O
 
Old O
HHMR I-LOCATION
records O
reviewed O
. O
 
______________________________ O
KROLL O
, O
OLIVIA I-NAME
M.D O
. O
 
D O
: O
06/04/80 I-DATE
T O
: O
06/04/80 I-DATE
Dictated O
By O
: O
KROLL O
, O
OLIVIA I-NAME
eScription O
document:7-1892564 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2080-07-19 I-DATE
EDVISIT^72841920^MULLINS O
, O
DOLORES^07/19/80^TAVARES O
, O
IDRIS I-NAME
I O
saw O
this O
patient O
with O
Dr. O
Xavier I-NAME
Palacios I-NAME
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
Please O
see O
the O
resident O
's O
note O
for O
further O
details O
. O
 
CHIEF O
COMPLAINT O
: O
Fast O
heart O
rate O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
78-year-old O
female O
with O
history O
of O
a O
left O
MCA O
stroke O
, O
atrial O
fibrillation O
, O
hypertension O
, O
diabetes O
, O
and O
renal O
insufficiency O
who O
was O
transferred O
from O
Southwest I-LOCATION
Montana I-LOCATION
Radiology I-LOCATION
for O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
The O
patient O
has O
been O
in O
Southwest I-LOCATION
Montana I-LOCATION
for O
the O
last O
several O
weeks O
. O
 
During O
her O
rehabilitation O
stay O
, O
the O
patient O
was O
noted O
to O
have O
sinus O
bradycardia O
and O
sinus O
pauses O
. O
 
The O
patient O
's O
metoprolol O
was O
stopped O
. O
 
The O
patient O
was O
previously O
on O
metoprolol O
6.25 O
mg O
every O
6 O
hours O
. O
 
The O
patient O
was O
noted O
to O
have O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
on O
exam O
this O
morning O
. O
 
The O
patient O
is O
followed O
by O
Dr. O
Octavia I-NAME
Xue I-NAME
of O
Heritage I-LOCATION
Hospital I-LOCATION
Cardiology O
. O
 
Given O
the O
difficulty O
that O
Southwest I-LOCATION
Montana I-LOCATION
has O
had O
____ O
the O
patient O
's O
atrial O
fibrillation O
, O
the O
patient O
was O
transferred O
here O
to O
Riverton I-LOCATION
General I-LOCATION
Hospital I-LOCATION
for O
further O
management O
and O
further O
placement O
. O
 
The O
patient O
is O
asymptomatic O
. O
 
The O
patient O
denies O
any O
chest O
pain O
or O
shortness O
of O
breath O
. O
 
The O
patient O
denies O
any O
lightheadedness O
. O
 
The O
patient O
has O
no O
other O
complaints O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
's O
vital O
signs O
revealed O
the O
following O
: O
Temperature O
is O
96.4 O
, O
heart O
rate O
of O
79 O
, O
respiratory O
rate O
of O
18 O
, O
blood O
pressure O
is O
112/63 O
, O
and O
oxygen O
saturations O
at O
100 O
% O
on O
room O
air O
. O
 
The O
patient O
's O
oxygen O
saturation O
was O
interpreted O
as O
normal O
. O
 
General I-LOCATION
: O
No O
acute O
distress O
, O
pleasant O
, O
and O
multiple O
family O
members O
at O
bedside O
. O
 
HEENT O
: O
The O
patient's O
head O
was O
normocephalic O
. O
 
Mucous O
membranes O
were O
dry O
. O
 
Posterior O
oropharynx O
was O
clear O
. O
 
Neck O
: O
Supple O
. O
 
No O
carotid O
bruits O
. O
 
No O
JVD O
. O
 
Respiratory O
: O
Clear O
to O
auscultation O
bilaterally O
. O
 
No O
focal O
rhonchi O
, O
rales O
, O
or O
wheezes O
. O
 
Cardiovascular O
: O
Irregularly O
irregular O
, O
tachycardic O
. O
 
No O
gross O
murmurs O
, O
rubs O
, O
or O
gallops O
were O
appreciated O
. O
 
GI O
: O
Abdomen O
: O
Soft O
. O
 
No O
rebound O
or O
guarding O
. O
 
Minimal O
suprapubic O
tenderness O
to O
palpation O
. O
 
G-tube O
in O
place O
. O
 
Rectal O
exam O
: O
Deferred O
. O
 
GU O
exam O
: O
Deferred O
. O
 
Skin O
: O
Warm O
and O
dry O
. O
 
No O
rash O
or O
lesions O
were O
noted O
. O
 
Back O
: O
No O
costovertebral O
angle O
tenderness O
. O
 
Extremities O
: O
Warm O
and O
well O
perfused O
. O
 
Lower O
extremity O
pitting O
edema O
rising O
up O
to O
the O
knees O
. O
 
No O
palpable O
cords O
. O
 
Neurologic O
: O
The O
patient O
was O
alert O
and O
oriented O
. O
 
The O
patient O
moved O
all O
4 O
extremities O
with O
fair O
strength O
. O
 
The O
patient O
did O
have O
a O
right O
facial O
droop O
. O
 
I O
did O
not O
ambulate O
the O
patient O
. O
 
INITIAL O
IMPRESSION O
AND O
PLAN O
: O
The O
patient O
is O
a O
78-year-old O
female O
with O
history O
of O
atrial O
fibrillation O
, O
and O
recent O
left O
MCA O
stroke O
who O
was O
transferred O
from O
Southwest I-LOCATION
Montana I-LOCATION
for O
management O
of O
her O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
The O
patient O
is O
hemodynamically O
stable O
at O
this O
time O
. O
 
The O
patient O
is O
asymptomatic O
. O
 
The O
patient O
will O
need O
rate O
control O
and O
will O
need O
to O
be O
admitted O
to O
Heritage I-LOCATION
Hospital I-LOCATION
Cardiology O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Upon O
arrival O
to O
the O
Emergency O
Department O
, O
the O
patient O
had O
history O
and O
physical O
exam O
performed O
. O
 
The O
patient O
then O
had O
12-lead O
EKG O
performed O
. O
 
The O
patient's O
12-lead O
EKG O
was O
notable O
for O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
The O
patient O
did O
have O
some O
nonspecific O
ST-T O
changes O
when O
compared O
to O
her O
prior O
EKG O
. O
 
The O
patient O
's O
laboratory O
studies O
so O
far O
has O
been O
largely O
unremarkable O
. O
 
The O
patient's O
first O
set O
of O
cardiac O
markers O
were O
negative O
. O
 
The O
patient's O
complete O
blood O
count O
was O
notable O
for O
an O
elevated O
white O
blood O
cell O
count O
of O
10.8 O
. O
 
The O
patient O
's O
hematocrit O
of O
33.2 O
. O
 
The O
patient's O
platelets O
were O
somewhat O
elevated O
at O
560,000 O
. O
 
The O
patient's O
portable O
chest O
x-ray O
has O
been O
ordered O
and O
results O
of O
the O
patient O
's O
portable O
chest O
x-ray O
are O
still O
pending O
at O
this O
time O
. O
 
The O
case O
was O
then O
discussed O
with O
the O
Heritage I-LOCATION
Hospital I-LOCATION
cardiologist O
on O
call O
. O
 
The O
patient O
____ O
will O
be O
admitted O
to O
Heritage I-LOCATION
Hospital I-LOCATION
Cardiology O
and O
to O
a O
monitor O
bed O
. O
 
I O
did O
try O
to O
page O
Dr. O
Octavia I-NAME
Xue I-NAME
to O
let O
her O
know O
about O
the O
patient's O
admission O
to O
Heritage I-LOCATION
Hospital I-LOCATION
Cardiology O
. O
 
The O
patient O
and O
patient O
's O
family O
were O
in O
agreement O
with O
the O
plan O
. O
 
The O
patient O
was O
started O
on O
metoprolol O
down O
her O
G-tube O
. O
 
The O
patient O
had O
a O
good O
response O
to O
the O
metoprolol O
. O
 
The O
patient O
was O
given O
metoprolol O
6.25 O
mg. O
PRIMARY O
DIAGNOSES O
: O
1 O
. O
 
Atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
2 O
. O
 
History O
of O
a O
left O
MCA O
stroke O
. O
 
DISPOSITION O
: O
The O
patient O
was O
admitted O
to O
Heritage I-LOCATION
Hospital I-LOCATION
Cardiology O
. O
 
CONDITION O
AT O
TIME O
OF O
DISPOSITION O
: O
Stable O
and O
satisfactory O
. O
 
______________________________ O
TAVARES O
, O
IDRIS I-NAME
M.D O
. O
 
D O
: O
07/19/80 I-DATE
T O
: O
07/19/80 I-DATE
Dictated O
By O
: O
TAVARES O
, O
IDRIS I-NAME
eScription O
document:4-5337537 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2085-11-28 I-DATE
CC O
: O
Pt O
presents O
to O
walk-in O
clinic O
, O
wants O
to O
establish O
care O
w/ O
me O
. O
 
HPI O
: O
73 I-AGE
y.o O
. O
 
man O
, O
here O
w/ O
his O
son O
, O
wants O
to O
establish O
care O
w/ O
me O
. O
 
He O
needs O
medication O
refills O
today O
. O
 
Prior O
MD O
was O
Dr. O
Valerio I-NAME
on O
the O
Weedsport I-LOCATION
. O
 
He O
has O
DM O
, O
HTN O
, O
glaucoma O
, O
is O
legally O
blind O
. O
 
He O
feels O
well O
today O
, O
has O
no O
complaints O
presently O
. O
 
Problems O
Diabetes O
mellitus O
Hypertension O
Glaucoma O
Visual O
impairment O
: O
pt O
legally O
blind O
Medications O
DIPYRIDAMOLE O
75MG O
, O
2 O
Tablet O
( O
s O
) O
PO O
TID O
Enalapril O
Maleate O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Metoprolol O
Tartrate O
50MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
TRAZODONE O
50MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PRN O
insomnia O
Insulin O
70/30 O
Human O
30 O
UNITS O
SC O
BID O
: O
30U O
qAM O
, O
30U O
qPM O
Allergies O
NKDA O
PE O
: O
156/80 O
72 O
Gen O
: O
overweight O
, O
elderly O
man O
, O
NAD O
HEENT O
: O
PERRL O
, O
EOM O
intact O
; O
oral O
mucosa O
moist O
, O
no O
lesions O
Neck O
: O
supple O
, O
no O
LAN O
Lungs O
: O
clear O
to O
auscultation O
bilaterally O
CV O
: O
RRR O
, O
nl O
S1 O
, O
S2 O
, O
no O
M/R/G O
Extrem O
: O
no O
clubbing O
, O
cyanosis O
or O
edema O
A/P O
: O
73 I-AGE
y.o O
. O
 
man O
w/ O
DM O
, O
HTN O
, O
claucoma O
, O
legally O
blind O
, O
here O
to O
establish O
care O
. O
 
Will O
refill O
pt O
's O
meds O
; O
he O
should O
make O
appt O
w/ O
me O
in O
one O
month O
for O
CPE O
; O
he O
will O
obtain O
his O
medical O
records O
prior O
to O
next O
visit O
. O
 
Record O
date O
: O
2086-01-17 I-DATE
Xavier I-NAME
Oshea I-NAME
MGH O
# O
581 I-ID
77 I-ID
50 I-ID
1/17/86 I-DATE
Referred O
for O
urologic O
consultation O
by O
: O
Veronica I-NAME
Frey I-NAME
, O
MD O
Reason O
for O
consultation O
: O
Voiding O
dysfunction O
Chief O
Complaint O
of O
: O
Problem O
urinatingHistory O
of O
Present O
Illness O
Pt O
iss/p O
TURP O
in O
2082 I-DATE
in O
NY I-LOCATION
. O
 
for O
BPH O
. O
 
He O
was O
on O
Flomax O
but O
stopped O
because O
he O
felt O
it O
was O
not O
helping O
his O
nocturia O
3-4x O
. O
 
He O
says O
he O
had O
2 O
prostate O
bx O
's O
in O
NY I-LOCATION
that O
were O
negative O
. O
 
His O
PSA O
in O
past O
has O
been O
in O
range O
of O
5.2-6.5 O
. O
 
He O
has O
sent O
some O
Urology O
notes O
from O
previous O
providers O
but O
these O
are O
not O
here O
today.No O
frequency O
, O
hesitancy O
or O
urgency O
or O
gross O
hematuria O
. O
 
Past O
Medical O
History O
: O
Diabetes O
mellitus O
Hypertension O
Glaucoma O
Visual O
impairment O
: O
pt O
legally O
blind O
Past O
Surgical O
History O
: O
Medications O
: O
DIPYRIDAMOLE O
75MG O
, O
2 O
Tablet O
( O
s O
) O
PO O
TID O
Enalapril O
Maleate O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Metoprolol O
Tartrate O
50MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
TRAZODONE O
50MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PRN O
insomnia O
Insulin O
70/30 O
Human O
30 O
UNITS O
SC O
BID O
: O
30U O
qAM O
, O
30U O
qPM O
Insulin O
Nph O
Human O
30 O
UNITS O
SC O
BID O
BEFORE O
BREAKFAST O
AND O
BEFORE O
SUPPER O
Allergies O
: O
NKDA O
Family O
History O
mother O
died O
age O
37 I-AGE
of O
? O
PE O
; O
father O
died O
age O
52 I-AGE
complication O
of O
EtOHism O
; O
otherwise O
non-contributory O
. O
 
Social O
History O
language O
: O
English O
living O
: O
w/ O
son O
and O
his O
wife O
; O
moved O
here O
from O
NY I-LOCATION
in O
12/2084 I-DATE
work O
: O
retired O
tobacco O
: O
2 O
ppd O
x O
24 O
yrs O
; O
quit O
age O
39 I-AGE
EtOH O
: O
remote O
hx O
heavy O
use O
; O
quit O
age O
39 I-AGE
drug O
: O
none O
sexual O
: O
not O
active O
No O
family O
history O
of O
GU O
diseases O
or O
malignancies O
Married/Single O
Sexually O
Active O
Smoke O
Alcohol O
use O
Review O
of O
Systems O
: O
ROS O
: O
pt O
denies O
fever O
, O
chills O
, O
wt O
change O
; O
denies O
eye O
problems O
, O
visual O
change O
, O
hearing O
problems O
, O
sinus O
symptoms O
, O
throat O
soreness O
; O
denies O
chest O
pain O
, O
palpitations O
; O
denies O
sob O
, O
wheezing O
, O
cough O
; O
denies O
nausea O
, O
vomiting O
, O
diarrhea O
, O
constipation O
, O
abdominal O
pain O
, O
BRBPR O
; O
denies O
hesitancy O
, O
weak O
stream O
, O
denies O
cold O
or O
heat O
intolerance O
, O
tremor O
, O
hair O
loss O
; O
denies O
polyuria O
, O
polydipsia O
, O
polyphagia O
; O
denies O
rashes O
; O
All O
other O
systems O
reviewed O
and O
are O
unremarkable O
. O
 
Genitourinary O
Review O
of O
Systems O
No O
Kidney O
stones O
No O
Urinary O
tract O
infections O
No O
Strictures O
No O
Sexually O
transmitted O
diseases O
Physical O
Examination O
: O
Vital O
Signs O
: O
Well O
nourished O
, O
well-developed O
Respirations O
: O
14 O
Pulse O
Regular O
Complete O
Genitourinary O
Examination O
: O
Flank O
: O
Non O
tender O
to O
palpation O
or O
masses O
Bladder O
: O
Non O
tender O
Non O
distended O
Scrotum O
: O
No O
lesions O
Intrascrotal O
: O
No O
hydrocele O
, O
varicocele O
or O
spermatocele O
Hernia O
: O
Non O
palpable O
Epididymus O
: O
No O
masses O
, O
cyst O
Testes O
: O
Descended O
bilaterally O
No O
masses O
or O
tenderness O
Urethral O
Meatus O
: O
Normal O
size O
and O
location O
Penis O
: O
Foreskin O
without O
lesions O
Prostate O
: O
No O
Nodules O
, O
non O
tender O
or O
boggy O
BPH O
1+ O
Seminal O
Vesicles O
: O
Symmetric O
Sphincter O
Tone O
: O
Normal O
Hemorrhoids O
: O
Absent O
Rectal O
Masses O
: O
Absent O
Laboratory O
Values O
: O
X-Ray O
studies O
: O
N/A O
Post-void O
residual O
by O
bladder O
scan O
is O
cc's O
An O
independent O
review O
of O
a O
urinalysis O
shows O
: O
No O
WBC's O
No O
RBC's O
No O
Glucose O
No O
Protein O
No O
Bilirubin O
Nitrite O
Negative O
: O
Impression O
: O
S/P O
TURP O
for O
BPH O
with O
persistent O
LUTS O
Plan O
: O
Repeat O
PSA O
and O
Free O
% O
Recommended O
to O
restart O
Flomax O
0.4mgqhs O
( O
Pt O
will O
think O
about O
this O
) O
Follow O
Up O
: O
prn O
Signed O
, O
Taj I-NAME
E. I-NAME
Landers I-NAME
, O
MD O
Urology- O
Martinsville I-LOCATION
General I-LOCATION
Hospital I-LOCATION
Norfolk I-LOCATION
University I-LOCATION
131-631-4189 I-CONTACT
cc O
: O
Dr. O
Veronica I-NAME
Frey I-NAME
 
Record O
date O
: O
2088-02-18 I-DATE
Reason O
for O
Visit O
Mr. O
Oshea I-NAME
is O
here O
for O
f/u O
of I-PROFESSION
diabetes O
, O
other O
issues O
. O
 
We O
increased O
his O
70/30 O
insulin O
from O
30 O
to O
35U O
BID O
last O
month O
. O
 
He O
has O
been O
keeping O
track O
of I-PROFESSION
sugars O
at O
least O
BID O
since O
then O
. O
 
He O
still O
has O
the O
majority O
of I-PROFESSION
sugars O
in O
the O
low O
200 O
range O
, O
some O
in O
the O
300 O
's O
, O
a O
few O
in O
the O
100 O
's O
. O
 
Interestingly O
, O
his O
fasting O
sugars O
are O
for O
the O
most O
part O
higher O
than O
his O
daytime O
sugars O
. O
 
He O
has O
not O
been O
adhering O
to O
a O
good O
diabetes O
diet O
- O
he O
enjoys O
a O
blueberry O
muffin O
from O
RR I-LOCATION
Donnelley I-LOCATION
daily O
. O
 
His O
daughter-in-law O
who O
is O
also O
my O
patient O
has O
told O
me O
that O
he O
eats O
anything O
he O
wants O
and O
all O
the O
wrong O
things O
. O
 
I O
addressed O
this O
issue O
w/ O
Mr. O
Oshea I-NAME
. O
 
He O
says O
he O
tries O
, O
but O
he O
enjoys O
these O
things O
and O
feels O
he O
does O
n't O
have O
much O
else O
in O
life O
to O
enjoy O
. O
 
He O
is O
worried O
about O
his O
remaining O
vision O
. O
 
He O
was O
told O
by O
Dr. O
Villagomez I-NAME
that O
the O
pressure O
in O
his O
L O
eye O
was O
unusually O
high O
. O
 
She O
wants O
to O
see O
him O
back O
again O
this O
month O
for O
another O
exam O
and O
wants O
him O
to O
bring O
his O
eye O
drops O
. O
 
He O
also O
is O
having O
trouble O
sleeping O
. O
 
He O
never O
had O
a O
great O
sleep O
pattern O
since O
he O
worked O
as O
a O
Senior I-PROFESSION
Manager I-PROFESSION
of I-PROFESSION
Broadcasting I-PROFESSION
and O
was O
up O
at O
all O
hours O
. O
 
He O
has O
no O
trouble O
falling O
asleep O
, O
but O
wakes O
up O
about O
2 O
a.m. O
every O
morning O
and O
ca O
n't O
fall O
back O
asleep O
. O
 
He O
does O
take O
naps O
in O
the O
afternoon O
at O
times O
. O
 
Problems O
H/O O
Cerebrovascular O
accident O
: O
unclear O
when O
; O
pt O
describes O
as O
mild O
stroke O
; O
was O
started O
on O
dipyrimadole O
at O
that O
time O
by O
neurologist O
. O
 
Diabetes O
mellitus O
Hypertension O
Glaucoma O
Visual O
impairment O
: O
pt O
legally O
blind O
Retinopathy O
: O
s/p O
multiple O
laser O
surg O
; O
legally O
blind O
Benign O
prostatic O
hypertrophy O
: O
followed O
by O
Dr. O
Landers I-NAME
Medications O
Artificial O
Tears O
2 O
DROP O
OS O
TID O
TRAZODONE O
50MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PRN O
insomnia O
Timolol O
Maleate O
0.5 O
% O
2 O
DROP O
OU O
BID O
Insulin O
70/30 O
Human O
35 O
UNITS O
SC O
BID O
DIPYRIDAMOLE O
75MG O
TABLET O
take O
2 O
Tablet O
( O
s O
) O
PO O
TID O
Enalapril O
Maleate O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
days O
Metoprolol O
Tartrate O
50MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
90 O
days O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Ambien O
( O
ZOLPIDEM O
Tartrate O
) O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QHS O
PRN O
insomnia O
Proscar O
( O
FINASTERIDE O
) O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QD O
Flomax O
( O
TAMSULOSIN O
) O
0.4 O
MG O
( O
0.4MG O
CAP.SR O
24H O
take O
1 O
) O
PO O
QD O
Allergies O
NKA O
Social O
History O
language O
: O
English O
living O
: O
w/ O
son O
and O
his O
wife O
; O
pt O
's O
wife O
passed O
away O
; O
moved O
here O
from O
NY I-LOCATION
in O
12/2084 I-DATE
work O
: O
retired O
Senior I-PROFESSION
Manager I-PROFESSION
of I-PROFESSION
Broadcasting I-PROFESSION
tobacco O
: O
2 O
ppd O
x O
24 O
yrs O
; O
quit O
age O
39 I-AGE
EtOH O
: O
remote O
hx O
heavy O
use O
; O
quit O
age O
39 I-AGE
drug O
: O
none O
sexual O
: O
not O
active O
domestic O
violence O
: O
neg O
Review O
of I-PROFESSION
Systems O
Denies O
headache O
, O
visual O
change O
, O
confusion O
, O
focal O
weakness O
or O
paresthesias O
; O
denies O
chest O
pain O
, O
sob O
, O
change O
in O
exercise O
tolerance O
, O
pedal O
edema O
, O
orthopnea O
; O
denies O
symptoms O
of I-PROFESSION
hypoglycemia O
; O
does O
have O
frequent O
urination O
, O
some O
urinary O
incontinence O
despite O
meds O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
124/60 O
PULSE O
72 O
WEIGHT O
238 O
lb O
Physical O
Exam O
Gen O
: O
obese O
man O
, O
NAD O
, O
appears O
tired O
today O
HEENT O
: O
PERRL O
, O
EOM O
intact O
, O
oral O
mucosa O
moist O
, O
no O
lesions O
Neck O
: O
supple O
, O
no O
LAN O
, O
no O
masses O
Lungs O
: O
clear O
bilat O
CV O
: O
RRR O
, O
nl O
S1 O
, O
S2 O
, O
no O
M/R/G O
Extrem O
: O
no O
edema O
; O
radial O
and O
p.t O
. O
 
pulses O
2+ O
bilat O
Assessment O
and O
Plan O
75 I-AGE
y.o O
. O
 
man O
w/ O
DM O
type O
2 O
, O
HTN O
, O
hyperlipidemia O
, O
BPH O
, O
legally O
blind O
, O
still O
w/ O
elevated O
blood O
sugars O
. O
 
1 O
) O
DM O
: O
emphasized O
to O
pt O
the O
importance O
of I-PROFESSION
diet O
in O
controlling O
blood O
sugar O
; O
he O
says O
he O
will O
make O
an O
honest O
attempt O
to O
do O
better O
; O
will O
recheck O
HbA1c O
in O
April I-DATE
; O
he O
will O
continue O
to O
monitor O
blood O
sugars O
at O
home O
; O
has O
appt O
w/ O
Dr. O
Villagomez I-NAME
of I-PROFESSION
MEDIQUIK I-LOCATION
this O
month O
, O
is O
up O
to O
date O
w/ O
podiatry O
. O
 
2 O
) O
hyperlipidemia O
: O
will O
recheck O
fasting O
lipids O
in O
April I-DATE
; O
continue O
lipitor O
. O
 
3 O
) O
HTN O
: O
good O
control O
today O
; O
continue O
enalapril O
, O
metoprolol O
. O
 
4 O
) O
BPH O
: O
followed O
by O
Dr. O
Landers I-NAME
; O
has O
f/u O
w/ O
him O
later O
this O
year O
. O
 
5 O
) O
insomnia O
: O
early O
morning O
waking O
difficult O
to O
treat O
w/ O
a O
pill O
; O
despite O
my O
discussion O
w/ O
pt O
regarding O
this O
, O
he O
would O
like O
to O
try O
Ambien O
. O
 
Will O
give O
some O
for O
short O
term O
use O
. O
 
RTC O
in O
3 O
mos O
for O
f/u O
, O
sooner O
prn O
. O
 
Record O
date O
: O
2088-03-02 I-DATE
Mediquik I-LOCATION
B O
- O
Intern O
Admission O
Note O
Oshea I-NAME
, O
Xavier I-NAME
MR O
# O
581-77-50 I-ID
Date O
of O
Presented O
to O
EW O
: O
2/27/88 I-DATE
Date O
Admitted O
to O
Internal O
Medicine O
: O
3/01/88 I-DATE
Contact O
: O
Daughter-In-Law O
( O
Petty I-NAME
) O
: O
138-378-3051 I-CONTACT
Attendings O
: O
Dr. O
Queen I-NAME
& O
Dr. O
Pineda I-NAME
Source O
: O
Patient O
, O
pass-off O
, O
daughter-in-law O
CC O
: O
falls O
HPI O
: O
Mr. O
Oshea I-NAME
is O
a O
pleasant O
76-year-old O
male O
with O
a O
past O
medical O
history O
significant O
for O
DM O
, O
HTN O
, O
h/of O
CVA O
, O
and O
glaucoma O
who O
presents O
after O
increasing O
number O
of O
falls O
at O
home O
. O
 
Pt O
lives O
with O
daughter-in-law O
and O
grandchildren O
, O
who O
were O
both O
recently O
sick O
and O
recovering O
from O
influenza O
. O
 
The O
pt O
began O
to O
have O
a O
non-productive O
cough O
associated O
with O
a O
fever O
( O
101o-102o O
) O
, O
watery O
eyes O
, O
diaphoresis O
, O
and O
chills O
early O
this O
week O
after O
his O
family O
was O
sick O
. O
 
His O
daughter-in-law O
states O
that O
he O
has O
also O
been O
increasingly O
confused O
during O
this O
time O
period O
. O
 
He O
has O
been O
confusing O
the O
time O
of O
day O
( O
confusing O
night O
for O
daytime O
and O
vice O
versa O
) O
, O
increasingly O
forgetful O
, O
and O
falling O
more O
than O
usual O
. O
 
He O
has O
been O
falling O
with O
increasing O
frequency O
over O
the O
last O
3 O
months O
. O
 
On O
average O
, O
he O
would O
fall O
about O
once O
a O
week O
. O
 
On O
the O
day O
prior O
to O
admission O
, O
the O
pt O
walked O
to O
Procter I-LOCATION
Gamble I-LOCATION
( O
2 O
blocks O
from O
house O
) O
and O
fell O
twice O
. O
 
He O
was O
helped O
back O
up O
by O
by-standers O
. O
 
He O
describes O
the O
fall O
as O
his O
legs O
giving O
out O
from O
under O
him O
, O
and O
has O
been O
shuffling O
his O
gait O
more O
than O
usual O
recently O
. O
 
During O
each O
fall O
he O
denies O
LOC O
, O
denies O
CP O
, O
denies O
, O
SOB O
, O
denies O
incontinence O
, O
and O
denies O
head O
trauma O
. O
 
On O
the O
day O
of O
presentation O
, O
the O
daughter-in-law O
reports O
that O
the O
pt O
fell O
13 O
times O
and O
when O
she O
could O
no O
longer O
help O
him O
rise O
called O
EMS O
. O
 
EW O
Vital O
signs O
: O
T:98.6o O
, O
P:99 O
, O
BP:174/65 O
, O
RR:20 O
, O
SaO2 O
: O
91 O
% O
on O
RA O
EW O
: O
After O
the O
pt O
presented O
to O
the O
EW O
, O
he O
tested O
positive O
for O
influenza O
A O
and O
was O
treated O
supportively O
. O
 
He O
was O
also O
noted O
to O
have O
a O
UTI O
and O
given O
a O
dose O
of O
antibiotics O
( O
levofloxacin O
and O
vancomycin O
) O
. O
 
ROS O
: O
as O
noted O
above O
PMH O
: O
1 O
. O
 
H/O O
Cerebrovascular O
accident O
: O
unclear O
when O
; O
pt O
describes O
as O
mild O
stroke O
; O
was O
started O
on O
dipyrimadole O
at O
that O
time O
by O
neurologist O
. O
 
2 O
. O
 
Diabetes O
mellitus O
c/b O
diabetic O
retinopathy O
3 O
. O
 
Hypertension O
4 O
. O
 
Glaucoma O
5 O
. O
 
Retinopathy O
: O
s/p O
multiple O
laser O
surg O
; O
legally O
blind O
6 O
. O
 
BPH O
: O
followed O
by O
Dr. O
Landers I-NAME
MEDICATIONS O
( O
From O
PCP O
note O
, O
reviewed O
with O
patient O
) O
: O
1 O
. O
 
Artificial O
Tears O
2 O
DROP O
OS O
TI O
2 O
. O
 
Trazadone O
50MG O
PO O
QHS O
PRN O
insomnia O
3 O
. O
 
Timolol O
Maleate O
0.5 O
% O
2 O
DROP O
OU O
BID O
4 O
. O
 
Insulin O
70/30 O
Human O
35 O
UNITS O
SC O
BID O
5 O
. O
 
DIPYRIDAMOLE O
75MG O
PO O
TID O
6 O
. O
 
Enalapril O
Maleate O
20MG O
PO O
BID O
7 O
. O
 
Metoprolol O
Tartrate O
50MG O
PO O
BID O
8 O
. O
 
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
PO O
QD O
9 O
. O
 
Ambien O
( O
ZOLPIDEM O
Tartrate O
) O
5 O
MG O
PO O
QHS O
PRN O
insomnia O
10 O
. O
 
Proscar O
( O
FINASTERIDE O
) O
5 O
MG O
PO O
QD O
11 O
. O
 
Flomax O
( O
TAMSULOSIN O
) O
0.4 O
MG O
PO O
QD O
Allergies O
: O
NKDA O
SH O
: O
Pt O
has O
complicated O
living O
situation O
. O
 
He O
has O
been O
living O
with O
his O
daughter-in-law O
( O
Petty I-NAME
) O
for O
the O
past O
year O
. O
 
His O
daughter-in-law O
seems O
to O
be O
estranged O
from O
his O
son O
. O
 
She O
cares O
for O
him O
greatly O
, O
but O
is O
unable O
to O
care O
for O
him O
any O
longer O
. O
 
The O
pt O
's O
daughter O
in O
New I-LOCATION
York I-LOCATION
has O
agreed O
to O
take O
care O
of O
him O
. O
 
Tob O
: O
quit O
@ O
age O
39 I-AGE
, O
48 O
pack O
year O
history O
( O
2ppd O
x O
24 O
years O
) O
EtOH O
: O
quit O
@ O
age O
39 I-AGE
, O
EtOH O
abuse O
previously O
Ivdu O
: O
denied O
FH O
: O
Father O
: O
Died O
@ O
52 I-AGE
from O
EtOH O
abuse O
( O
unclear O
exact O
etiology O
) O
Mother O
: O
Died O
@ O
36 I-AGE
from O
blood O
clot O
in O
heart O
Brother O
: O
Died O
of O
suicide O
at O
50 I-AGE
Sisters O
: O
Healthy O
Exam O
: O
VS O
( O
Floor O
) O
: O
T=96 O
, O
HR=84 O
, O
BP=154/78 O
, O
RR=24 O
, O
SaO2= O
93 O
% O
on O
RA O
General O
: O
NAD O
Heent O
: O
oral O
mucosa O
dry O
Neck O
: O
supple O
, O
JVP O
not O
elevated O
Chest O
: O
diffuse O
rhonchi O
, O
soft O
expiratory O
wheeze O
CV O
: O
RRR O
, O
nl O
S1 O
, O
S2 O
Abd O
: O
+BS O
, O
soft O
, O
NTND O
Extr O
: O
trace O
edema O
, O
superficial O
abrasions O
over O
knees O
bilaterally O
Neuro O
: O
alert O
, O
slightly O
confused O
, O
nonfocal O
MMSE O
: O
24/30 O
, O
pt O
lost O
3 O
points O
on O
orientation O
( O
not O
oriented O
to O
year/season/day O
) O
, O
lost O
1 O
point O
for O
recall O
, O
lost O
2 O
points O
for O
language O
Gait O
: O
pt O
uneasy O
on O
feet O
, O
negative O
romberg O
sign O
DATA O
: O
02/28/88 I-DATE
02/28/88 I-DATE
02/27/88 I-DATE
01/17/88 I-DATE
20:24 O
13:13 O
22:21 O
17:58 O
NA O
131 O
( O
L O
) O
129 O
( O
L O
) O
140 O
K O
3.5 O
3.3 O
( O
L O
) O
3.8 O
CL O
99 O
( O
L O
) O
97 O
( O
L O
) O
99 O
( O
L O
) O
CO2 O
30.6 O
27.4 O
32.3 O
( O
H O
) O
BUN O
11 O
10 O
12 O
CRE O
1.0 O
1.0 O
1.1 O
GLU O
246 O
( O
H O
) O
194 O
( O
H O
) O
210 O
( O
H O
) O
148 O
( O
H O
) O
02/28/88 I-DATE
02/27/88 I-DATE
01/17/88 I-DATE
00:25 O
23:07 O
17:58 O
CA O
8.7 O
9.5 O
PHOS O
3.0 O
MG O
1.8 O
OSM O
278 O
( O
L O
) O
02/27/88 I-DATE
22:17 O
CK-MB O
Negative O
TROP-I O
Negative O
02/28/88 I-DATE
00:22 O
UNA O
63 O
UCREAT O
0.93 O
UOSM O
440 O
02/27/88 I-DATE
22:51 O
WBC O
5.4 O
RBC O
4.74 O
HGB O
15.2 O
HCT O
42.0 O
MCV O
89 O
MCH O
32.0 O
MCHC O
36.1 O
PLT O
242 O
RDW O
13.8 O
DIFFR O
Received O
METHOD O
Auto O
% O
NEUT O
79 O
( O
H O
) O
% O
LYMPH O
14 O
( O
L O
) O
% O
MONO O
7 O
% O
EOS O
0 O
% O
BASO O
0 O
02/27/88 I-DATE
22:51 O
PT O
13.7 O
( O
HT O
) O
PTT O
30.0 O
( O
T O
) O
U/A O
( O
2/28/88 I-DATE
) O
: O
yellow O
, O
cloudy O
, O
gluc O
1+ O
, O
prot O
: O
1+ O
, O
Urine O
Nitrite O
: O
Positive O
, O
UA-BLD O
: O
2+ O
, O
UA-WBC O
: O
2+ O
, O
UAS-WBC O
: O
10-20 O
, O
UAS-Bact O
: O
Moderate O
, O
UASquamous O
: O
Negative O
Micro O
: O
UC O
: O
Abundant O
( O
> O
=100,000 O
CFU/ml O
) O
STAPHYLOCOCCUS O
SPECIES O
Nasal O
Swab O
: O
POSITIVE O
for O
INFLUENZA O
VIRUS O
TYPE O
A O
ANTIGEN O
EKG O
( O
3/01/88 I-DATE
) O
: O
NSR O
at O
84 O
bpm O
w/ O
RBBB O
, O
LAHB O
, O
q O
waves O
in O
V3-4 O
, O
no O
ST O
segment O
changes O
Radiology O
: O
CXR O
( O
2/27/88 I-DATE
) O
: O
No O
evidence O
of O
acute O
cardiopulmonary O
process O
. O
 
CT O
Brain O
( O
2/27/88 I-DATE
) O
: O
1 O
. O
 
Atherosclerotic O
disease O
, O
extensive O
microangiopathic O
changes O
and O
chronic O
appearing O
lacunar O
infarcts O
, O
as O
described O
. O
 
No O
specific O
evidence O
of O
acute O
infarction O
, O
although O
DW-MRI O
is O
more O
sensitive O
for O
acute O
ischemia O
. O
 
2 O
. O
 
No O
intracranial O
hemorrhage O
. O
 
Assessment O
: O
76yo O
M O
w/ O
history O
of O
DM O
, O
HTN O
, O
and O
h/o O
of O
CVA O
presents O
with O
AMS O
and O
increasing O
falls O
in O
setting O
of O
influenza O
. O
 
PLAN O
: O
1 O
. O
 
Delirium O
: O
Pt O
's O
waxing O
and O
waning O
mental O
status O
likely O
secondary O
from O
his O
underlying O
infectious O
processes O
- O
influenza O
and O
UTI O
. O
 
a O
. O
 
Correct O
hyponatremia O
b O
. O
 
Monitor O
mental O
status O
as O
infection O
is O
treated O
2 O
. O
 
Falls O
: O
Pt O
's O
recent O
falls O
likely O
have O
a O
multifactorial O
etiology O
. O
 
Pt O
has O
many O
risk O
factors O
for O
falls O
including O
visual O
impairment O
, O
mild O
cognitive O
impairment O
( O
on O
MMSE O
) O
, O
possible O
diabetic O
neuropathy O
, O
and O
a O
. O
 
Check O
orthostatic O
vital O
signs O
b O
. O
 
Check O
RPR/B12 O
c. O
Pt O
needs O
PT O
evaluation O
, O
may O
require O
walker O
or O
other O
equipment O
to O
help O
him O
ambulate O
3 O
. O
 
Hypovolemic O
Hyponatremia O
: O
Pt O
clinically O
appears O
hypovolemic O
. O
 
A O
FeNa O
of O
0.5 O
% O
also O
suggests O
a O
hypovolemic O
picture O
. O
 
a O
. O
 
Will O
check O
Na O
now O
, O
and O
if O
sodium O
continues O
to O
improve O
will O
continue O
IVFs O
4 O
. O
 
UTI O
: O
Pt O
has O
positive O
U/A O
and O
UC O
for O
stap O
( O
awaiting O
speciation O
and O
sensitivity O
) O
. O
 
Staph O
is O
an O
unusual O
cause O
of O
a O
UTI O
. O
 
A O
further O
investigation O
of O
the O
cause O
of O
source O
of O
the O
staph O
is O
warranted O
. O
 
Empiric O
coverage O
with O
vancomycin O
is O
also O
necessary O
given O
the O
pt O
's O
history O
of O
methicillin O
and O
levofloxacin O
resistant O
CNS O
. O
 
a. O
F/u O
UC O
b. O
Empiric O
treatment O
with O
Vancomycin O
1g O
q12h O
for O
7 O
days O
( O
CrCl O
> O
60 O
) O
, O
await O
c O
& O
s O
for O
possible O
alternative O
agents O
5 O
. O
 
Influenza O
A O
a O
. O
 
Continuous O
oxygen O
monitoring O
b O
. O
 
Supportive O
care O
6 O
. O
 
Code O
Status O
: O
Discussed O
with O
patient O
, O
who O
expressed O
to O
me O
he O
would O
like O
to O
be O
DNR/DNI O
7 O
. O
 
PPx O
a. O
Nexium O
b. O
Fragmin O
_________________________________ O
David I-NAME
Phillips I-NAME
, O
MD O
Pager O
# O
93278 I-CONTACT
 
Record O
date O
: O
2095-08-21 I-DATE
Bailey I-LOCATION
EMERGENCY O
DEPT O
VISIT O
DARLING O
, O
BETTY O
785-67-87-3 I-ID
Resident O
history O
reviewed O
, O
the O
patient O
seen O
, O
interviewed O
, O
and O
examined O
by O
me O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
Briefly O
, O
the O
history O
is O
as O
follows O
: O
The O
patient O
is O
a O
75-year-old O
white O
female O
with O
past O
medical O
history O
significant O
for O
throat O
cancer O
, O
status O
post O
radiation O
therapy O
; O
breast O
cancer O
, O
status O
post O
multiple O
lumpectomies O
; O
non-insulin O
dependent O
diabetes O
mellitus O
, O
hypothyroidism O
, O
hypertension O
, O
and O
peripheral O
vascular O
disease O
with O
bilateral O
carotid O
stenosis O
- O
status O
post O
right O
carotid O
endarterectomy O
, O
who O
was O
seen O
earlier O
today O
at O
Faith I-LOCATION
Hospital I-LOCATION
after O
an O
episode O
of O
word O
finding O
difficulty O
associated O
with O
acute O
vision O
loss O
in O
her O
left O
eye O
while O
riding O
as O
a O
passenger O
in O
a O
car O
. O
 
The O
event O
was O
witnessed O
and O
reportedly O
there O
was O
severe O
word O
finding O
difficulty O
. O
 
The O
patient O
was O
transferred O
to O
the O
Bailey I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
Emergency O
Department O
for O
further O
evaluation O
and O
management O
. O
 
On O
arrival O
, O
she O
states O
her O
symptoms O
have O
largely O
resolved O
. O
 
Evaluation O
at O
the O
outside O
facility O
included O
a O
head O
CT O
which O
reportedly O
revealed O
no O
events O
of O
acute O
hemorrhage O
. O
 
Prior O
to O
transfer O
, O
she O
was O
treated O
with O
aspirin O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
All O
systems O
reviewed O
are O
negative O
except O
per O
HPI O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
As O
noted O
above O
. O
 
MEDICATIONS O
: O
Klonopin O
, O
Glyburide O
, O
Coumadin O
, O
meclozine O
, O
Timoptic O
ophthalmic O
drops O
, O
Zestril O
, O
Celebrex O
, O
and O
Synthroid O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
The O
patient O
denies O
tobacco O
, O
alcohol O
, O
or O
any O
history O
of O
illicit O
drug O
use O
. O
 
She O
presently O
lives O
alone O
. O
 
Family O
history O
is O
only O
notable O
for O
a O
sister O
with O
breast O
cancer O
. O
 
PHYSICAL O
EXAMINATION O
: O
Well-developed O
, O
well-nourished O
, O
well-appearing O
female O
who O
appears O
in O
no O
acute O
distress O
. O
 
VITAL O
SIGNS O
: O
Temperature O
96 O
, O
blood O
pressure O
167/84 O
, O
pulse O
92 O
, O
respiratory O
rate O
18 O
, O
O2 O
saturations O
100 O
% O
on O
room O
air O
. O
 
HEENT O
: O
Normocephalic O
, O
atraumatic O
. O
 
Pupils O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O
 
Extraocular O
muscles O
intact O
. O
 
Funduscopic O
exam O
reveals O
sharp O
disks O
bilaterally O
. O
 
NECK O
: O
Supple O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
. O
 
HEART O
: O
Regular O
rate O
and O
rhythm O
with O
a O
2/6 O
systolic O
murmur O
at O
the O
left O
sternal O
border O
. O
 
ABDOMEN O
: O
Soft O
, O
nontender O
, O
nondistended O
. O
 
NEURO O
: O
Awake O
, O
alert O
, O
and O
oriented O
x O
3 O
. O
 
Speech O
clear O
and O
fluent O
and O
well O
articulated O
. O
 
Motor O
5/5 O
and O
symmetric O
throughout O
. O
 
Reflexes O
2+ O
with O
downgoing O
toes O
. O
 
Cerebellar O
: O
Finger-to-nose O
intact O
. O
 
Gait O
not O
tested O
. O
 
LABORATORY O
EVALUATION O
: O
SMA-7 O
notable O
for O
glucose O
of O
124 O
. O
 
CBC O
: O
White O
count O
8.2 O
, O
hematocrit O
36.3 O
, O
platelets O
379 O
. O
 
Coagulation O
profile O
notable O
for O
an O
INR O
of O
2.0 O
. O
 
Urinalysis O
benign O
. O
 
EKG O
: O
Normal O
sinus O
rhythm O
at O
a O
rate O
of O
70 O
with O
nonspecific O
T-wave O
changes O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
She O
is O
currently O
awaiting O
evaluation O
with O
an O
MRI O
and O
MR O
angiogram O
of O
the O
head O
and O
neck O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
The O
patient O
was O
seen O
in O
consultation O
by O
Neurology O
. O
 
FINAL O
DIAGNOSIS O
: O
Transient O
ischemic O
attack O
vs. O
cerebrovascular O
accident O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
will O
be O
admitted O
to O
the O
Neurology O
Service O
for O
further O
evaluation O
and O
management O
. O
 
The O
patient O
is O
currently O
in O
stable O
condition O
. O
 
___________________________________ O
YA226/51903 I-ID
OMAR I-NAME
IM I-NAME
, O
M.D O
. O
 
OI23 I-NAME
D:08/21/95 O
T:08/21/95 O
Dictated O
by O
: O
OMAR I-NAME
IM I-NAME
, O
M.D O
. O
 
OI23 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2095-12-09 I-DATE
Cookson I-LOCATION
Memorial I-LOCATION
Home I-LOCATION
Internal O
Medicine O
Room O
960 O
87 I-LOCATION
Wellesley I-LOCATION
Rd I-LOCATION
Darling O
, O
Betty I-NAME
Seattle I-LOCATION
, O
SC I-LOCATION
84126 I-LOCATION
78567873 I-ID
( O
121 O
) O
537-3484 I-CONTACT
12/09/95 I-DATE
CHIEF O
COMPLAINT O
: O
Multiple O
acute O
and O
chronic O
medical O
issues O
, O
including O
subacute O
weight O
loss O
. O
 
IDENTIFICATION O
: O
This O
is O
my O
first O
medical O
visit O
with O
this O
75-year-old O
woman O
with O
multiple O
recent O
hospitalizations O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
She O
has O
a O
long O
history O
of O
severe O
cerebrovascular O
disease O
, O
with O
multiple O
strokes O
. O
 
She O
has O
stenosis O
in O
both O
anterior O
and O
posterior O
circulation O
. O
 
Past O
right O
carotid O
endarterectomy O
. O
 
In O
August I-DATE
2095 I-DATE
, O
she O
was O
admitted O
to O
BMH I-LOCATION
with O
a O
right O
cerebellar O
stroke O
, O
complicated O
by O
a O
brief O
intubation O
and O
pneumonia O
. O
 
She O
underwent O
stenting O
of O
her O
right O
vertebral O
artery O
and O
left O
common O
carotid O
artery O
. O
 
She O
had O
subsequent O
episodes O
of O
worsening O
speech O
, O
and O
was O
started O
on O
Coumadin O
, O
with O
an O
INR O
goal O
of O
2.5 O
to O
3.0 O
. O
 
She O
is O
followed O
closely O
by O
Neurology O
and O
may O
, O
at O
some O
point O
, O
undergo O
further O
interventional O
radiology O
procedures O
, O
to O
be O
determined O
. O
 
During O
her O
most O
recent O
hospitalization O
she O
had O
some O
confusion O
which O
was O
attributed O
to O
low O
sodium O
. O
 
This O
was O
felt O
to O
be O
the O
result O
of O
osmotic O
diuresis O
, O
and O
possible O
SIADH O
. O
 
This O
is O
being O
treated O
with O
salt O
tablets O
, O
saline O
boluses O
in O
her O
G-tube O
, O
water O
restriction O
, O
and O
low-dose O
Lasix O
. O
 
No O
evidence O
of O
adrenal O
insufficiency O
. O
 
Since O
leaving O
the O
hospital O
, O
she O
has O
had O
ongoing O
weight O
loss O
. O
 
Baseline O
weight O
170 O
pounds O
. O
 
Weight O
in O
early O
September I-DATE
, O
167 O
pounds O
. O
 
Weight O
October I-DATE
20th I-DATE
, O
160 O
pounds O
. O
 
Weight O
November I-DATE
28th I-DATE
, O
141 O
pounds O
. O
 
Weight O
today O
in O
clinic O
146 O
pounds O
on O
our O
scale O
. O
 
She O
had O
a O
swallowing O
study O
on O
October I-DATE
26 O
, O
2095 I-DATE
, O
which O
revealed O
no O
aspiration O
, O
but O
very O
poor O
bolus O
formation O
. O
 
The O
G-tube O
was O
placed O
in O
August I-DATE
, O
and O
has O
healed O
well O
, O
but O
has O
never O
been O
used O
for O
daily O
tube O
feeds O
on O
an O
outpatient O
basis O
. O
 
Over O
the O
past O
couple O
of O
weeks O
, O
she O
has O
worsening O
trouble O
with O
coughing O
, O
choking O
and O
sputtering O
, O
as O
she O
attempts O
to O
swallow O
. O
 
Her O
caloric O
p.o O
. O
 
intake O
sounds O
as O
if O
it O
has O
been O
quite O
minimal O
, O
with O
a O
couple O
of O
ounces O
of O
potatoes O
or O
pureed O
foods O
here O
and O
there O
. O
 
She O
is O
drinking O
two O
or O
three O
can O
of O
booster O
Ensure O
daily O
, O
but O
clearly O
not O
meeting O
her O
caloric O
needs O
. O
 
Today O
's O
visit O
was O
with O
the O
patient O
, O
and O
her O
daughter O
( O
phone O
number O
507.741.8042 I-CONTACT
) O
. O
 
Most O
recent O
laboratory O
studies O
, O
done O
12/7/2095 I-DATE
: O
Sodium O
137 O
, O
potassium O
4.8 O
, O
chloride O
95 O
, O
Bicarb O
32 O
, O
BUN O
22 O
, O
creatinine O
1.0 O
, O
calcium O
9.9 O
, O
glucose O
162 O
. O
 
The O
patient O
has O
felt O
increasingly O
weak O
and O
debilitated O
, O
as O
her O
weight O
has O
decreased O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Also O
remarkable O
for O
slight O
bright O
red O
blood O
per O
rectum O
within O
the O
last O
week O
. O
 
The O
patient's O
daughter O
describes O
that O
she O
had O
a O
normal O
colonoscopy O
in O
early O
2095 I-DATE
, O
at O
the O
Richwood I-LOCATION
Area I-LOCATION
Community I-LOCATION
Hospital I-LOCATION
. O
 
The O
patient O
's O
daughter O
will O
bring O
me O
these O
records O
at O
the O
next O
visit O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
1 O
. O
 
Cerebrovascular O
disease O
, O
as O
noted O
above O
. O
 
2 O
. O
 
Throat O
cancer O
in O
early O
2060s I-DATE
. O
 
Status O
post O
XRT O
to O
the O
neck O
( O
may O
have O
predisposed O
her O
to O
the O
severe O
carotid O
and O
vertebral O
disease O
) O
. O
 
3 O
. O
 
Breast O
cancer O
. O
 
Details O
unknown O
. O
 
Will O
review O
at O
next O
visit O
. O
 
4 O
. O
 
Diabetes O
, O
type O
II O
. O
 
On O
glyburide O
. O
 
Further O
details O
unknown O
. O
 
5 O
. O
 
SIADH O
. O
 
Will O
review O
hospital O
chart O
in O
detail O
. O
 
6 O
. O
 
Hypertension O
. O
 
Per O
Neurology O
, O
goal O
blood O
pressure O
140 O
to O
170 O
. O
 
7 O
. O
 
Hypothyroidism O
. O
 
Details O
unknown O
. O
 
Recent O
TSH O
normal O
. O
 
8 O
. O
 
Glaucoma O
. O
 
9 O
. O
 
Anxiety O
. O
 
Being O
followed O
by O
Psychiatry O
on O
an O
active O
basis O
. O
 
This O
was O
apparently O
a O
large O
factor O
during O
her O
recent O
hospitalizations O
. O
 
10 O
. O
 
Possible O
recent O
anemia O
. O
 
Has O
not O
been O
evaluated O
thus O
far O
. O
 
MEDICATIONS O
: O
1 O
. O
 
Lisinopril O
40 O
mg O
p.o O
. O
 
q.d O
. O
 
2 O
. O
 
Synthroid O
100 O
mcg O
p.o O
. O
 
q.d O
. O
 
3 O
. O
 
Lasix O
10 O
mg O
p.o O
. O
 
Qa O
m O
and O
Qpm O
4 O
. O
 
Glyburide O
5 O
mg O
p.o O
. O
 
b.i.d O
. O
 
5 O
. O
 
Colace O
100 O
mg O
p.o O
. O
 
b.i.d O
. O
 
to O
t.i.d O
. O
 
6 O
. O
 
Enteric-coated O
baby O
aspirin O
81 O
mg O
p.o O
. O
 
q.d O
. O
 
7 O
. O
 
Sodium O
chloride O
1 O
g O
p.o O
. O
 
Qa O
m O
via O
G-tube O
8 O
. O
 
Timolol O
0.5 O
% O
, O
one O
drop O
to O
the O
right O
eye O
q.d O
. O
 
9 O
. O
 
Prevacid O
30 O
mg O
p.o O
. O
 
q.d O
. O
 
10 O
. O
 
Normal O
saline O
300 O
cc O
via O
G-tube O
after O
breakfast O
, O
lunch O
, O
and O
dinner O
11 O
. O
 
Multivitamin O
p.o O
. O
 
q.d O
. O
 
12 O
. O
 
Coumadin O
, O
with O
goal O
INR O
2.5 O
to O
3.0 O
( O
followed O
by O
Internal O
Medicine O
) O
13 O
. O
 
Xalatan O
0.005 O
% O
, O
one O
drop O
each O
eye O
q.h.s O
. O
 
14 O
. O
 
Dulcolax O
5 O
mg O
p.o O
. O
 
q.d O
. O
 
PRN O
, O
constipation O
15 O
. O
 
Risperdal O
0.125 O
mg O
to O
0.25 O
mg O
p.o O
. O
 
q.h.s O
. O
 
PRN O
16 O
. O
 
Ambien O
5 O
mg O
to O
10 O
mg O
p.o O
. O
 
q.h.s O
. O
 
PRN O
17 O
. O
 
Saliva O
substitute O
PRN O
18 O
. O
 
Nystatin O
, O
swish-and-swallow O
PRN O
19 O
. O
 
Fleet O
Enema O
PRN O
20 O
. O
 
Tylenol O
650 O
mg O
p.o O
. O
 
PRN O
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
: O
The O
patient O
has O
four O
children O
. O
 
Her O
daughter O
Fitzpatrick I-NAME
is O
a O
Food I-PROFESSION
Service I-PROFESSION
Supervisor I-PROFESSION
. O
 
Another O
daughter O
is O
staying O
with O
the O
patient O
full-time O
. O
 
Visiting O
nurse O
is O
involved O
. O
 
Previous O
to O
the O
last O
few O
months O
, O
the O
patient O
was O
fairly O
independent O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
Cachectic O
, O
anxious O
woman O
, O
who O
is O
slightly O
unsteady O
on O
her O
feet O
, O
but O
safe O
with O
ambulation O
if O
she O
moves O
slowly O
and O
carefully O
. O
 
Has O
a O
cane O
, O
but O
does O
not O
always O
use O
it O
. O
 
VITAL O
SIGNS O
: O
BP O
214/108 O
, O
initially O
( O
patient O
very O
anxious O
) O
, O
and O
171/74 O
on O
repeat O
. O
 
Pulse O
80 O
. O
 
Weight O
146.5 O
pounds O
, O
fully O
clothed O
. O
 
ABDOMEN O
: O
With O
good O
bowel O
sounds O
. O
 
Soft O
, O
nontender O
and O
nondistended O
. O
 
No O
hepatosplenomegaly O
. O
 
No O
masses O
. O
 
G-tube O
is O
flushed O
with O
water O
, O
and O
flushes O
easily O
. O
 
G-tube O
site O
itself O
is O
well-healed O
and O
nontender O
, O
with O
no O
pussy O
discharge O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
. O
 
HEART O
: O
Regular O
rate O
and O
rhythm O
. O
 
No O
murmurs O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Weight O
loss O
. O
 
Probably O
due O
to O
poor O
caloric O
intake O
. O
 
This O
is O
a O
significant O
health O
concern O
for O
her O
, O
as O
she O
has O
become O
progressively O
cachectic O
and O
weak O
. O
 
This O
is O
probably O
attributed O
to O
, O
by O
some O
extent O
, O
her O
progressive O
dysphagia O
. O
 
She O
is O
referred O
urgently O
to O
Nutrition O
, O
and O
will O
see O
them O
on O
Tuesday I-DATE
. O
 
I O
suggested O
to O
the O
daughter O
and O
to O
the O
nutritionist O
that O
we O
transition O
her O
to O
tube O
feeds O
for O
at O
least O
a O
couple O
of O
weeks O
, O
to O
get O
her O
muscle O
mass O
up O
, O
and O
then O
reevaluate O
. O
 
She O
should O
continue O
to O
take O
p.o O
. O
 
foods O
as O
tolerated O
, O
but O
she O
needs O
to O
attempt O
to O
meet O
her O
caloric O
intake O
via O
the O
G-tube O
, O
since O
she O
is O
clearly O
not O
meeting O
it O
p.o O
. O
 
Will O
try O
Glucerna O
because O
of O
her O
diabetes O
history O
. O
 
The O
patient O
's O
daughter O
and O
the O
nutritionist O
are O
aware O
of O
her O
issues O
with O
vitamin O
K O
and O
Coumadin O
, O
and O
they O
will O
discuss O
this O
further O
when O
she O
sees O
Nutrition O
Clinic O
in O
two O
days O
. O
 
2 O
. O
 
Cerebrovascular O
disease O
. O
 
Followed O
closely O
by O
Neurology O
. O
 
No O
acute O
change O
in O
neuro O
status O
today O
. O
 
Will O
continue O
Coumadin O
. O
 
Being O
followed O
closely O
by O
Internal O
Medicine O
for O
this O
. O
 
Recent O
INR O
1.4 O
. O
 
Will O
adjust O
Coumadin O
as O
advised O
by O
IM O
nurse O
. O
 
3 O
. O
 
SIADH O
. O
 
I O
need O
to O
review O
these O
records O
more O
closely O
, O
and O
try O
to O
make O
sure O
there O
is O
no O
other O
underlying O
disorder O
. O
 
In O
the O
meantime O
, O
her O
sodiums O
have O
been O
quite O
good O
recently O
. O
 
4 O
. O
 
Diabetes O
. O
 
Recent O
hyperglycemia O
, O
with O
sugars O
in O
the O
300 O
to O
350 O
range O
. O
 
Most O
recently O
, O
with O
sugars O
in O
the O
100 O
to O
200 O
range O
over O
the O
past O
few O
days O
. O
 
Continue O
glyburide O
5 O
mg O
p.o O
. O
 
b.i.d O
. O
 
Finger-sticks O
three O
to O
four O
times O
daily O
. O
 
Further O
adjustments O
PRN O
. O
 
Our O
current O
goal O
is O
simply O
to O
maintain O
her O
sugars O
between O
120 O
and O
approximately O
220 O
to O
250 O
. O
 
Once O
her O
dietary O
issues O
are O
stabilized O
, O
we O
can O
aim O
for O
slightly O
tighter O
control O
. O
 
Wish O
to O
avoid O
hypoglycemia O
, O
given O
her O
troubles O
with O
p.o O
. O
 
intake O
. O
 
5 O
. O
 
Recent O
history O
of O
bright O
red O
blood O
per O
rectum O
. O
 
Daughter O
will O
bring O
me O
her O
recent O
colonoscopy O
report O
, O
and O
we O
will O
take O
it O
from O
there O
. O
 
6 O
. O
 
Constipation O
. O
 
Continue O
Colace O
. O
 
Add O
Dulcolax O
PRN O
. O
 
Continue O
Fleet O
Enema O
PRN O
by O
visiting O
nurse O
. O
 
If O
she O
does O
have O
chronic O
constipation O
, O
this O
may O
impact O
her O
appetite O
and O
her O
ability O
to O
eat O
successfully O
. O
 
7 O
. O
 
Hypertension O
. O
 
Currently O
in O
reasonable O
control O
. O
 
Goal O
BP O
140 O
to O
170 O
, O
systolic O
. O
 
Initial O
severe O
hypertension O
this O
visit O
, O
attributed O
to O
anxiety O
, O
which O
clearly O
is O
a O
major O
issue O
for O
her O
. O
 
Follow-up O
at O
next O
visit O
. O
 
8 O
. O
 
Anxiety O
. O
 
Followed O
by O
Psychiatry O
. O
 
Extensive O
reassurance O
given O
today O
to O
the O
patient O
. O
 
She O
is O
very O
concerned O
about O
her O
weight O
loss O
, O
as O
am O
I. O
I O
tried O
to O
reassure O
her O
that O
we O
would O
take O
this O
seriously O
and O
address O
it O
in O
a O
very O
rapid O
fashion O
. O
 
Addendum O
- O
spoke O
with O
psych O
- O
they O
will O
start O
paxil O
5 O
mg O
qd O
watch O
for O
worsening O
SIADH O
and/or O
anthicholinergic O
side O
effects O
. O
 
9 O
. O
 
Multiple O
other O
issues O
. O
 
To O
be O
addressed O
at O
further O
visits O
. O
 
Given O
her O
weight O
loss O
and O
complexity O
, O
I O
will O
see O
her O
on O
a O
weekly O
basis O
for O
the O
next O
few O
weeks O
, O
or O
sooner O
PRN O
. O
 
Daughter O
has O
my O
pager O
number O
, O
and O
knows O
how O
to O
reach O
me O
. O
 
______________________________ O
Julia I-NAME
Yale I-NAME
, O
M.D O
. O
 
CC O
: O
eScription O
document:0-136282 O
ST O
eScription O
DD O
: O
12/09/95 I-DATE
DT O
: O
12/09/95 I-DATE
DV O
: O
12/09/95 I-DATE
 
Record O
date O
: O
2097-11-30 I-DATE
Cookson I-LOCATION
Memorial I-LOCATION
Home I-LOCATION
Internal O
Medicine O
Room O
960 O
50 I-LOCATION
Wellesley I-LOCATION
Rd I-LOCATION
DARLING O
, O
BETTY I-NAME
Seattle I-LOCATION
, O
SC I-LOCATION
84126 I-LOCATION
78567873 I-ID
( O
121 O
) O
537-3484 I-CONTACT
11/30/97 I-DATE
CHIEF O
COMPLAINT O
: O
Hypertension O
, O
proteinuria O
, O
status O
post O
fall O
, O
reevaluate O
Coumadin O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Urgent O
care O
visit O
for O
this O
77-year-old O
woman O
with O
the O
history O
of O
diabetes O
, O
multiple O
strokes O
, O
hypertension O
, O
hyperlipidemia O
, O
and O
multiple O
other O
issues O
. O
 
Last O
week O
she O
was O
at O
Saint I-LOCATION
Joseph I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
for O
an O
eye O
evaluation O
. O
 
It O
was O
a O
very O
very O
windy O
day O
. O
 
Afterwards O
she O
was O
outside O
and O
a O
huge O
gust O
of O
wind O
knocked O
her O
over O
. O
 
Her O
daughter O
Fitzpatrick I-NAME
was O
with O
her O
and O
Fitzpatrick I-NAME
herself O
actually O
had O
to O
hold O
on O
to O
something O
when O
the O
wind O
blew O
. O
 
There O
is O
no O
chest O
pain O
or O
presyncope O
, O
and O
no O
loss O
of O
consciousness O
either O
before O
, O
during O
, O
or O
after O
the O
episode O
. O
 
She O
struck O
her O
left O
trochanteric O
area O
, O
left O
deltoid O
area O
, O
and O
left O
eyebrow O
. O
 
She O
was O
taken O
to O
EFH I-LOCATION
where O
she O
had O
a O
normal O
head O
CT. O
A O
single O
stitch O
was O
placed O
in O
the O
laceration O
along O
the O
lateral O
edge O
of O
her O
left O
eyebrow O
. O
 
She O
had O
films O
of O
her O
wrist O
and O
hips O
both O
of O
which O
were O
fine O
. O
 
She O
has O
bruising O
in O
these O
areas O
. O
 
Other O
than O
some O
pain O
where O
the O
bruising O
is O
she O
feels O
entirely O
back O
to O
normal O
. O
 
She O
had O
marked O
hypertension O
up O
to O
250 O
. O
 
She O
was O
treated O
with O
hydralazine O
in O
the O
ER O
, O
and O
was O
noted O
to O
have O
proteinuria O
with O
some O
hematuria O
. O
 
Her O
blood O
pressure O
at O
home O
since O
then O
has O
been O
180 O
and O
210 O
systolic O
on O
her O
usual O
40 O
mg O
daily O
of O
lisinopril O
. O
 
She O
is O
not O
on O
a O
beta-blocker O
currently O
. O
 
She O
has O
not O
had O
any O
episodes O
of O
chest O
pain O
. O
 
She O
does O
feel O
slightly O
more O
woozy O
than O
usual O
. O
 
MEDICATIONS O
: O
Metformin O
500 O
mg O
p.o O
. O
 
b.i.d. O
, O
Prevacid O
30 O
mg O
p.o O
. O
 
q.d. O
, O
atorvastatin O
10 O
mg O
q.d. O
, O
sertraline O
50 I-LOCATION
mg O
q.d. O
, O
warfarin O
, O
lisinopril O
40 O
mg O
q.d. O
, O
Ambien O
10 O
mg O
q.h.s O
. O
 
p.r.n. O
, O
levothyroxine O
100 O
mg O
p.o O
. O
 
q.d. O
, O
aspirin O
, O
eyedrops O
, O
Colace O
, O
and O
Dulcolax O
. O
 
SOCIAL O
HISTORY O
: O
She O
is O
looking O
forward O
to O
a O
good O
Christmas I-DATE
. O
 
She O
is O
here O
today O
with O
her O
daughter O
Fitzpatrick I-NAME
. O
 
PHYSICAL O
EXAMINATION O
: O
Temperature O
97.2 O
, O
pulse O
74 O
, O
BP O
208/66 O
, O
weight O
148 O
pounds O
. O
 
GENERAL O
: O
Well O
appearing O
woman O
. O
 
HEENT O
: O
PERRL O
. O
 
Single O
stitch O
along O
the O
lateral O
aspect O
of O
her O
left O
eyebrow O
is O
easily O
removed O
. O
 
No O
evidence O
of O
any O
infection O
. O
 
Her O
left O
deltoid O
area O
is O
fine O
and O
she O
has O
good O
range O
of O
motion O
in O
the O
shoulder O
. O
 
Her O
left O
ribcage O
is O
slightly O
tender O
but O
without O
any O
bony O
step-offs O
. O
 
She O
walks O
well O
with O
no O
pain O
in O
her O
left O
hip O
. O
 
There O
is O
a O
hand O
sized O
deep O
purple O
bruise O
over O
the O
trochanteric O
bursa O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
Mechanical O
fall O
with O
laceration O
and O
bruising O
but O
no O
more O
serious O
complications O
. O
 
Fortunately O
she O
did O
not O
have O
intracranial O
bleeding O
. O
 
I O
am O
not O
sure O
why O
her O
blood O
pressure O
is O
up O
, O
whether O
this O
is O
related O
to O
the O
stress O
of O
the O
falls O
verses O
independent O
causes O
. O
 
Given O
that O
the O
high O
blood O
pressure O
has O
persisted O
, O
I O
will O
add O
atenolol O
12.5 O
mg O
p.o O
. O
 
q.d. O
, O
and O
discuss O
via O
phone O
or O
E-mail O
with O
her O
daughter O
next O
week O
to O
see O
how O
well O
this O
is O
working O
. O
 
Goal O
BP O
140-160 O
systolic O
. O
 
Her O
urine O
was O
checked O
today O
. O
 
Hematuria O
has O
resolved O
. O
 
She O
has O
2+ O
proteinuria O
. O
 
I O
will O
recheck O
this O
in O
a O
week O
or O
two O
after O
we O
treat O
her O
hypertension O
. O
 
We O
spent O
over O
half O
of O
today O
's O
45-minute O
visit O
discussing O
risks O
and O
benefits O
of O
Coumadin O
therapy O
. O
 
Although O
she O
is O
at O
risk O
for O
falls O
, O
she O
feels O
quite O
clearly O
that O
she O
prefers O
to O
be O
on O
the O
Coumadin O
due O
to O
her O
fear O
of O
having O
a O
repeated O
thrombotic O
stroke O
. O
 
She O
feels O
that O
she O
has O
not O
had O
any O
bleeding O
complications O
, O
and O
that O
she O
really O
would O
not O
like O
to O
suffer O
through O
another O
stroke O
. O
 
I O
explained O
that O
there O
was O
some O
risk O
with O
falls O
of O
intracranial O
hemorrhage O
and O
its O
consequences O
. O
 
I O
spoke O
with O
Dr. O
Dewitt I-NAME
last O
month O
about O
her O
Coumadin O
, O
and O
we O
both O
feel O
that O
it O
seems O
to O
be O
working O
well O
in O
terms O
of O
stroke O
prevention O
, O
but O
that O
she O
is O
at O
increased O
risk O
for O
falls O
. O
 
It O
seems O
to O
me O
that O
she O
is O
in O
a O
gray O
area O
with O
no O
clear O
right O
answer O
in O
terms O
of O
risk O
benefit O
analysis O
for O
Coumadin O
for O
her O
. O
 
She O
feels O
very O
strongly O
that O
she O
wishes O
to O
continue O
. O
 
This O
was O
discussed O
in O
detail O
with O
her O
and O
her O
daughter O
, O
and O
this O
probably O
is O
a O
reasonable O
decision O
. O
 
I O
encouraged O
her O
to O
restart O
physical O
therapy O
to O
work O
on O
her O
strength O
and O
hopefully O
diminish O
her O
risk O
of O
a O
subsequent O
fall O
. O
 
More O
than O
half O
of O
today O
's O
45-minute O
visit O
spent O
in O
patient O
counseling O
and O
education O
. O
 
______________________________ O
Julia I-NAME
Yale I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Julia I-NAME
Yale I-NAME
eScription O
document:3-5285833 O
EMSSten O
Tel O
DD O
: O
11/30/97 I-DATE
DT O
: O
11/30/97 I-DATE
DV O
: O
11/30/97 I-DATE
 
Record O
date O
: O
2098-06-13 I-DATE
Betty I-NAME
has O
been O
doing O
`` O
okay O
'' O
since O
our O
last O
visit O
; O
she O
continues O
to O
report O
a O
slow O
decline O
in O
swallowing O
ability O
. O
 
She O
had O
a O
video O
swallow O
at O
SJMH I-LOCATION
; O
she O
and O
Fitzpatrick I-NAME
were O
told O
that O
the O
underlying O
problem O
was O
local O
changes O
due O
to O
her O
radiation O
. O
 
Her O
gait O
has O
been O
unchanged O
, O
but O
she O
still O
feels O
it O
has O
deteriorated O
a O
little O
over O
the O
last O
year O
. O
 
She O
is O
gardening O
, O
and O
trying O
to O
stay O
active O
; O
she O
has O
had O
no O
falls O
and O
uses O
a O
cane O
. O
 
She O
recently O
added O
amlodipine O
for O
her O
hypertension O
. O
 
Echocardiogram O
: O
Date O
: O
9/02/95 I-DATE
: O
borderline O
LVH O
, O
preserved O
EF O
. O
 
Posterobasal O
HK O
. O
 
Not O
done O
for O
PFO O
. O
 
Brain O
& O
Vessel O
Studies O
: O
MRI/A O
: O
CTA O
: O
3/20/98 I-DATE
: O
`` O
severe O
proximal O
LICA O
stenosis O
'' O
, O
just O
distal O
to O
bifurcation O
... O
no O
comment O
on O
comparison O
. O
 
9/29/95 I-DATE
: O
> O
90 O
% O
RCCA O
, O
unchanged O
from O
the O
exam O
of O
9/04/95 I-DATE
. O
 
> O
90 O
% O
LCCA O
proximal O
to O
the O
stent O
with O
elevated O
flow O
velocities O
within O
the O
stent O
. O
 
70-75 O
% O
LICA O
. O
 
The O
estimation O
of O
stenosis O
in O
the O
left O
internal O
carotid O
artery O
may O
be O
low O
because O
of O
tandem O
stenoses O
in O
the O
left O
carotid O
artery O
. O
 
Compared O
to O
the O
study O
of O
9/04/95 I-DATE
, O
the O
LICA O
lesion O
is O
modestly O
worse O
. O
 
> O
50 O
% O
in O
B O
ECAs O
. O
 
9/26/95 I-DATE
: O
Lbif O
stenosis O
> O
= O
50 O
% O
. O
 
Rbif O
without O
significant O
stenosis O
. O
 
RVA O
dominant O
. O
 
Ultrasound O
: O
8/24/95 I-DATE
: O
Low O
RCCA O
50-75 O
% O
, O
Mid O
LCCA O
75-90 O
% O
, O
calcified O
LICA O
possibly O
> O
50 O
% O
Angiography O
: O
8/27/95 I-DATE
: O
proximal O
RCCA O
stenosis O
> O
80 O
% O
, O
ACA O
cross-filling O
from O
L O
-- O
> O
R O
. O
 
Right O
vertebral O
irregular/stenotic O
. O
 
LCCA O
, O
bifurcation O
, O
LICA O
with O
significant O
tandem O
stenoses O
; O
at O
the O
proximal O
mid-LCCA O
, O
> O
80 O
% O
. O
 
Functional O
Cerebrovascular O
Studies O
: O
Diamox O
SPECT O
7/14/97 I-DATE
: O
interpreted O
as O
normal O
. O
 
Vascular O
Procedures O
: O
Right O
CEA O
( O
years O
ago O
) O
8/31/95 I-DATE
: O
( O
1 O
) O
right O
vertebral O
origin O
balloon O
angioplasty O
, O
successful O
. O
 
( O
2 O
) O
LCCA O
stent O
followed O
by O
balloon O
angioplasty O
. O
 
( O
3 O
) O
although O
wanted O
to O
stent O
LICA O
, O
exceeded O
fluoro O
time O
. O
 
Lipids O
: O
Date O
: O
11/96 I-DATE
: O
TC O
183 O
TG O
91 O
LDL O
72 O
HDL O
82 O
, O
Lipoprotein O
( O
a O
) O
: O
, O
Homocysteine O
: O
8.7 O
Hypercoagulable O
studies O
: O
Date O
: O
ESR O
: O
Anticardiolipin O
IgG O
/ O
IgM O
: O
negative O
9/05 I-DATE
Blood O
Pressure O
: O
12/15/97-3/5/98 O
: O
141-194/58-76 O
( O
with O
pulse O
between O
56 O
and O
70 O
) O
Diabetes O
: O
2/97 I-DATE
: O
HbA1C O
8.6 O
Smoking O
: O
none O
Other O
: O
s/p O
XRT O
for O
throat O
cancer O
~30 O
years O
ago O
Medications O
COUMADIN O
( O
directed O
by O
Internal O
Medicine O
) O
ASPIRIN O
81 O
LISINOPRIL O
40 O
ATENOLOL O
12.5 O
( O
started O
11/97 I-DATE
) O
ATORVASTATIN O
10 O
METFORMIN O
500 O
AM O
/ O
1000 O
PM O
FUROSEMIDE O
10 O
( O
started O
12/97 I-DATE
) O
MULTIVITAMIN O
QD O
XALATAN O
1 O
DROP O
OU O
QPM O
LEVOTHYROXINE O
100MCG O
QD O
AMBIEN O
prn O
sleep O
SERTRALINE O
50 O
QD O
PREVACID O
Blood O
pressure O
in O
the O
left O
arm O
is O
174/60 O
. O
 
She O
appears O
well O
overall O
, O
but O
slightly O
anxious O
. O
 
Cognitively O
, O
she O
appears O
unchanged O
; O
her O
speech O
is O
fluent O
, O
with O
intact O
repetition O
and O
comprehension O
, O
and O
her O
recall O
of O
recent O
events O
( O
corroborated O
by O
her O
daughter O
) O
is O
good O
. O
 
Pupils O
are O
equal O
and O
reactive O
, O
EOMI O
, O
VFFTC O
. O
 
Face O
, O
tongue O
and O
palate O
are O
symmetric O
, O
but O
she O
is O
dysarthric O
; O
glottal O
sounds O
worst O
. O
 
This O
sounds O
slightly O
worse O
than O
our O
previous O
visit O
. O
 
Strength O
is O
full O
in O
all O
extremities O
; O
her O
mild O
dysmetria O
is O
unchanged O
. O
 
Her O
walk O
, O
always O
wide-based O
and O
slightly O
unsteady O
, O
appears O
mildly O
worse O
than O
our O
previous O
visit O
, O
but O
she O
is O
not O
using O
a O
cane O
, O
and O
is O
able O
to O
catch O
herself O
after O
mild O
stumbles O
. O
 
She O
is O
unable O
to O
tandem O
gait O
. O
 
Impression O
: O
Betty I-NAME
is O
a O
78 I-AGE
year O
old O
woman O
with O
progressive O
cerebrovascular O
disease O
due O
to O
local O
radiation O
, O
plus O
diabetes O
, O
hypertension O
, O
hyperlipidemia O
. O
 
She O
is O
s/p O
left O
ICA O
stents O
and O
right O
VA O
angioplasty O
. O
 
Her O
most O
significant O
vascular O
lesion O
is O
stenosis O
proximal O
to O
the O
ICA O
stent O
, O
but O
there O
is O
no O
hint O
now O
of O
transient O
or O
orthostatic O
symptoms O
. O
 
My O
continued O
feeling O
is O
that O
we O
ought O
to O
focus O
on O
her O
controllable O
risk O
factors O
, O
such O
as O
diabetes O
, O
hypertension O
, O
hyperlipidemia O
, O
as O
you O
are O
doing O
. O
 
I O
understand O
you O
have O
recently O
been O
adjusting O
her O
antihypertensive O
regimen O
. O
 
I O
would O
recommend O
a O
goal O
systolic O
blood O
pressure O
no O
lower O
than O
120 O
mmHg O
. O
 
I O
think O
a O
reasonable O
way O
to O
approach O
this O
is O
to O
use O
( O
1 O
) O
her O
clinical O
status O
, O
and O
( O
2 O
) O
'functional O
' O
imaging O
, O
such O
as O
Diamox O
SPECT O
, O
to O
follow O
her O
cerebrovascular O
disease O
. O
 
I O
think O
intervention O
would O
be O
warranted O
if O
there O
were O
a O
deterioration O
in O
one O
of O
these O
parameters O
. O
 
I O
have O
not O
yet O
heard O
from O
Howard I-NAME
Yelverton I-NAME
about O
his O
thoughts O
regarding O
the O
recent O
scan O
, O
but O
I O
did O
review O
the O
CT O
scans O
with O
neuroradiology O
. O
 
Our O
impression O
is O
that O
, O
while O
the O
wording O
of O
the O
reports O
seems O
to O
suggest O
significant O
progression O
of O
the O
LICA O
stenosis O
, O
it O
's O
not O
significant O
enough O
to O
prompt O
us O
to O
act O
, O
in O
the O
absence O
of O
symptomatic O
or O
functional O
changes O
. O
 
I O
am O
ordering O
a O
Diamox O
SPECT O
scan O
, O
since O
the O
previous O
one O
was O
in O
July I-DATE
of O
last O
year O
. O
 
This O
is O
my O
last O
general O
neurology O
clinic O
at O
BMH I-LOCATION
; O
I O
will O
be O
a O
neuromuscular O
fellow O
here O
next O
year O
. O
 
While O
I O
can O
be O
available O
for O
questions O
or O
concerns O
, O
I O
will O
be O
referring O
Betty I-NAME
's O
care O
to O
one O
of O
the O
more O
junior O
residents O
. O
 
________________________ O
Elvin I-NAME
Cox I-NAME
MD O
, O
MBA O
BMH I-LOCATION
Neurology O
 
Record O
date O
: O
2067-12-06 I-DATE
Chief O
Complaint O
1. O
cough O
is O
better O
. O
 
She O
uses O
the O
inhalers O
regularly O
. O
 
2 O
. O
 
Funny O
taste O
in O
the O
mouth O
after O
she O
does O
the O
inhalers O
in O
the O
morning O
. O
 
No O
sore O
throat O
. O
 
She O
does O
rinse O
her O
mouth O
after O
the O
pulmicort O
. O
 
3 O
. O
 
No O
recurrence O
of O
the O
hand O
numbness O
. O
 
Problems O
Hypertension O
Insomnia O
H/O O
cerebrovascular O
accident O
borderline O
aodm O
Basal O
cell O
carcinoma O
Medications O
Vioxx O
( O
ROFECOXIB O
) O
25MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Lotrisone O
Cream O
( O
BETAMETHASONE O
And O
Clotri O
... O
 
APPLY O
CREAM O
TOP O
BID O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Allegra O
( O
FEXOFENADINE O
Hcl O
) O
60MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
. O
 
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ATENOLOL O
100MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
: O
take O
1/2 O
in O
morning O
and O
1 O
in O
evening O
Flonase O
( O
FLUTICASONE O
Nasal O
Spray O
) O
1-2 O
SPRAY O
NAS O
QD O
Celexa O
( O
CITALOPRAM O
) O
20MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Prilosec O
( O
OMEPRAZOLE O
) O
20MG O
, O
1 O
Capsule O
( O
s O
) O
PO O
QHS O
Dyazide O
( O
TRIAMTERENE O
37.5 O
Mg/hctz O
25 O
Mg O
) O
1 O
CAPSULE O
PO O
QD O
LISINOPRIL O
10MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Albuterol O
Inhaler O
2 O
PUFF O
INH O
Q4-6H O
PRN O
.cough O
: O
use O
with O
chamber O
Singulair O
( O
MONTELUKAST O
) O
10MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Pulmicort O
( O
BUDESONIDE O
Oral O
Inhaler O
) O
2 O
PUFF O
INH O
BID O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
Allergies O
Sulfa O
- O
Unknown O
Penicillins O
- O
Unknown O
Social O
History O
Married O
. O
 
Her O
husband O
has O
Alzheimer O
's O
. O
 
His O
moods O
are O
variable O
. O
 
She O
has O
been O
going O
to O
FitSport I-LOCATION
and O
exercising O
better O
. O
 
non-smoker O
. O
 
Six O
children O
and O
six O
grandchildren O
. O
 
No O
alcohol O
in O
30 O
years O
. O
 
Prior O
alcohol O
dependence O
. O
 
Her O
daughter O
, O
son-in-law O
and O
18 I-AGE
month I-AGE
old O
twins O
are O
living O
in O
her O
house O
. O
 
Her O
Daughter O
, O
Uber I-NAME
, O
in O
Vietnam I-LOCATION
may O
come O
back O
for O
the O
holidays O
. O
 
Her O
Daughter O
, O
Ingalls I-NAME
, O
lives O
in O
BOURNE-she O
is O
a O
variable O
cause O
of O
stress O
. O
 
She O
is O
going O
to O
FitSport I-LOCATION
almost O
every O
day O
. O
 
Review O
of O
Systems O
ROS-Sleep O
has O
been O
OK O
, O
occ O
wakening O
in O
the O
middle O
of O
the O
night-she O
uses O
amytriptiline O
at O
night O
. O
 
energy O
is O
better O
since O
she O
is O
exercising O
more O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
140/80 O
Exam O
HEENT-NC/AT O
, O
EOMI O
, O
PERRL O
TM-Clear O
Pharynx-Clear O
Chest-clear O
to O
P O
and O
A O
Cor-S1S2 O
normal O
no O
murmers O
, O
rubs O
or O
gallops O
Abd-soft O
, O
nontender O
, O
no O
hepatosplenomegaly O
Ext-no O
edema O
Disposition O
and O
Plans O
1 O
. O
 
Cough-we O
discussed O
that O
she O
will O
need O
to O
stay O
on O
the O
albuterol O
and O
the O
pulmicort O
in O
order O
to O
prevent O
the O
cough O
from O
coming O
back O
. O
 
2 O
. O
 
Insomnia O
which O
had O
been O
such O
a O
problem O
seems O
better O
now O
. O
 
Continue O
the O
celexa O
20mg O
and O
she O
is O
also O
on O
amytriptiline O
( O
per O
Dr. O
Dill I-NAME
) O
. O
 
She O
will O
double O
check O
the O
dose O
through O
him O
. O
 
3 O
. O
 
Hyperlipidemia-On O
lipitor O
. O
 
Check O
LFTs O
and O
CPK O
along O
with O
chol/HDL O
today O
. O
 
4 O
. O
 
HTN-good O
control O
on O
the O
lisinopril O
, O
atenolol O
and O
dyazide O
. O
 
Check O
electrolytes O
today O
. O
 
5 O
. O
 
Borderline O
AODM O
. O
 
Check O
glucose O
today O
. O
 
______________________________ O
Othel I-NAME
Vidal I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2068-06-01 I-DATE
Chief O
Complaint O
1 O
. O
 
She O
increased O
the O
lisinopril O
to O
20mg O
. O
 
she O
is O
tolerating O
it O
well O
. O
 
No O
dizziness O
, O
no O
side O
effects O
. O
 
BP O
at O
home O
is O
excellent O
. O
 
2 I-AGE
. O
 
She O
is O
interested O
in O
starting O
an O
antioxidant O
, O
her O
friend O
used O
it O
and O
felt O
better O
. O
 
3 O
. O
 
Skin O
lesions O
: O
left O
side O
of O
the O
face O
, O
left O
forearm O
. O
 
Problems O
Hypertension O
Insomnia O
H/O O
cerebrovascular O
accident O
borderline O
aodm O
Basal O
cell O
carcinoma O
Medications O
Vioxx O
( O
ROFECOXIB O
) O
25MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Lotrisone O
Cream O
( O
BETAMETHASONE O
And O
Clotri O
... O
 
APPLY O
CREAM O
TOP O
BID O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Allegra O
( O
FEXOFENADINE O
Hcl O
) O
60MG O
CAPSULE O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ATENOLOL O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
take O
1/2 O
in O
morning O
and O
1 O
in O
evening O
Flonase O
( O
FLUTICASONE O
Nasal O
Spray O
) O
1-2 O
SPRAY O
NAS O
QD O
Prilosec O
( O
OMEPRAZOLE O
) O
20MG O
CAPSULE O
CR O
take O
1 O
Capsule O
( O
s O
) O
PO O
QHS O
Dyazide O
( O
TRIAMTERENE O
37.5 O
Mg/hctz O
25 O
Mg O
) O
1 O
CAPSULE O
PO O
QD O
Albuterol O
Inhaler O
2 I-AGE
PUFF O
INH O
Q4-6H O
PRN O
.cough O
, O
use O
with O
chamber O
Singulair O
( O
MONTELUKAST O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
Pulmicort O
( O
BUDESONIDE O
Oral O
Inhaler O
) O
4 O
PUFF O
INH O
BID O
Robitussin O
Ac O
( O
GUAIFENESIN O
Ac O
) O
5 O
ML O
TO O
10 O
ML O
PO O
Q4H O
PRN O
.cough O
, O
UL5104263 I-ID
Celexa O
( O
CITALOPRAM O
) O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
20MG O
TABLET O
take O
1 O
PO O
QD O
Allergies O
Sulfa O
- O
Unknown O
Penicillins O
- O
Unknown O
Social O
History O
Married O
. O
 
Her O
husband O
has O
Alzheimer O
's O
. O
 
He O
has O
gotten O
a O
little O
more O
'mellow' O
non-smoker O
. O
 
Six O
children O
and O
six O
grandchildren O
. O
 
Her O
daughter O
with O
her O
2 I-AGE
year O
old O
twins O
, O
and O
other O
daughter O
, O
Judd I-NAME
, O
are O
living O
with O
her O
. O
 
No O
alcohol O
in O
30 O
years O
. O
 
Prior O
alcohol O
dependence O
. O
 
Review O
of O
Systems O
ROS-no O
chest O
pain O
, O
shortness O
of O
breath O
, O
no O
cough O
. O
 
Mood O
is O
good O
. O
 
Sleep O
is O
good O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
114/64 O
Exam O
Chest-clear O
to O
P O
and O
A O
Cor-S1S2 O
normal O
no O
murmers O
, O
rubs O
or O
gallops O
Abd-soft O
, O
nontender O
, O
no O
hepatosplenomegaly O
Ext-no O
edema O
Skin-raised O
, O
erythematous O
lesion O
near O
left O
angle O
of O
the O
jaw O
, O
raised O
verrucous O
lestion O
on O
left O
calf O
. O
 
Disposition O
and O
Plans O
1 O
. O
 
BP O
is O
under O
excellent O
control O
. O
 
Continue O
atenolol O
, O
dyzide O
, O
lisinopril O
. O
 
f/u O
with O
me O
in O
3 O
months O
, O
sooner O
for O
any O
problems O
. O
 
2 I-AGE
. O
 
Asthma-under O
good O
control O
. O
 
3 O
. O
 
Skin O
lesions O
: O
she O
will O
f/u O
with O
Dr. O
Kim I-NAME
. O
 
______________________________ O
Othel I-NAME
Vidal I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2068-09-26 I-DATE
Reason O
for O
Visit O
Patient O
presents O
for O
pre-op O
physical O
exam O
. O
 
Having O
left O
eye O
cataract O
surgery O
Dr. O
Janes I-NAME
on O
10/04/68 I-DATE
. O
 
Feels O
well O
. O
 
Problems O
Hypertension O
Insomnia O
H/O O
cerebrovascular O
accident O
borderline O
aodm O
Basal O
cell O
carcinoma O
Asthma O
Hyperlipidemia O
Procedures O
Tonsillectomy O
Medications O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Allegra O
( O
FEXOFENADINE O
Hcl O
) O
60MG O
CAPSULE O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
ATENOLOL O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
take O
1/2 O
in O
morning O
and O
1 O
in O
evening O
Flonase O
( O
FLUTICASONE O
Nasal O
Spray O
) O
1-2 O
SPRAY O
NAS O
QD O
Prilosec O
( O
OMEPRAZOLE O
) O
20MG O
CAPSULE O
CR O
take O
1 O
Capsule O
( O
s O
) O
PO O
QHS O
Dyazide O
( O
TRIAMTERENE O
37.5 O
Mg/hctz O
25 O
Mg O
) O
1 O
CAPSULE O
PO O
QD O
Albuterol O
Inhaler O
2 O
PUFF O
INH O
Q4-6H O
PRN O
.cough O
, O
use O
with O
chamber O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
Pulmicort O
( O
BUDESONIDE O
Oral O
Inhaler O
) O
4 O
PUFF O
INH O
BID O
Celexa O
( O
CITALOPRAM O
) O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
20MG O
TABLET O
take O
1 O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Singulair O
( O
MONTELUKAST O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Allergies O
Sulfa O
- O
Unknown O
Penicillins O
- O
Unknown O
Assessment O
and O
Plan O
1 O
. O
 
Pre-op O
Physical O
Exam O
-EKG O
-Labs O
: O
CBC O
, O
PT O
, O
PTT O
-Completed O
form O
, O
see O
chart O
-will O
fax O
form O
once O
have O
lab O
results O
_____________________________________________ O
Inez I-NAME
Yelverton I-NAME
, O
NP O
 
Record O
date O
: O
2070-04-02 I-DATE
Chief O
Complaint O
1 O
. O
 
Feels O
pretty O
well O
. O
 
She O
had O
the O
MOHS O
surgery O
on O
the O
left O
side O
of O
her O
face O
, O
it O
has O
gotten O
infected O
. O
 
2 O
. O
 
Her O
husband O
, O
Xin I-NAME
, O
has O
progressive O
dementia O
and O
that O
is O
difficult O
. O
 
Problems O
Hypertension O
on O
atenolol O
and O
lisinopril O
Insomnia O
much O
better O
recently O
H/O O
cerebrovascular O
accident O
on O
aspirin O
and O
plavix O
Basal O
cell O
carcinoma O
s/p O
MOHS O
surgery O
in O
3/2070 I-DATE
Asthma O
well O
controlled O
with O
flovent O
and O
singulair O
. O
 
She O
uses O
PRN O
albuterol O
Hyperlipidemia O
on O
Lipitor O
Diabetes O
mellitus O
type O
2 O
: O
Started O
metformin O
2069 I-DATE
checking O
blood O
sugars O
at O
home O
. O
 
Medications O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Flonase O
( O
FLUTICASONE O
Nasal O
Spray O
) O
1-2 O
SPRAY O
NAS O
QD O
Prilosec O
( O
OMEPRAZOLE O
) O
20MG O
CAPSULE O
CR O
take O
1 O
Capsule O
( O
s O
) O
PO O
QHS O
Albuterol O
Inhaler O
2 O
PUFF O
INH O
Q4-6H O
PRN O
.cough O
, O
use O
with O
chamber O
Flovent O
( O
FLUTICASONE O
Propionate O
) O
44MCG O
AEROSOL O
take O
2 O
Puff O
( O
s O
) O
INH O
BID O
Dyazide O
( O
TRIAMTERENE O
37.5 O
Mg/hctz O
25 O
Mg O
) O
1 O
CAPSULE O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Glucophage O
( O
METFORMIN O
) O
500MG O
TABLET O
PO O
BID O
ATENOLOL O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
take O
1/2 O
in O
morning O
and O
1 O
in O
evening O
Celexa O
( O
CITALOPRAM O
) O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
20MG O
TABLET O
take O
1 O
PO O
QD O
Singulair O
( O
MONTELUKAST O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Allegra O
( O
FEXOFENADINE O
Hcl O
) O
60MG O
CAPSULE O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
Allergies O
Sulfa O
- O
Unknown O
Penicillins O
- O
Unknown O
Social O
History O
Marital O
status O
: O
married O
EtOH O
: O
none O
for O
many O
years O
Occupation O
: O
cashier I-PROFESSION
, O
active O
in O
the O
community O
Exercise O
: O
active O
liefstyle O
Review O
of O
Systems O
ROS-no O
fever O
, O
chills O
, O
shortness O
of O
breath O
. O
 
She O
has O
ongoing O
cough O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
120/78 O
Exam O
Chest-clear O
to O
P O
and O
A O
Cor-S1S2 O
normal O
no O
murmers O
, O
rubs O
or O
gallops O
Abd-soft O
, O
nontender O
, O
no O
hepatosplenomegaly O
Ext-no O
edema O
Disposition O
and O
Plans O
1 O
. O
 
Routine O
health-scheduled O
mammogram O
, O
colonoscopy O
. O
 
2 O
. O
 
Type O
2 O
DM-she O
will O
see O
Carolyn I-NAME
Delong I-NAME
, O
nutrition O
. O
 
She O
will O
start O
doing O
home O
glucose O
monitoring O
. O
 
Continue O
the O
metformin O
BID O
. O
 
Check O
HbA1C O
today O
, O
she O
will O
schedule O
ophtho O
and O
podiatry O
apt O
for O
yearly O
check O
. O
 
3 O
. O
 
HTN O
is O
under O
excellent O
control O
. O
 
4 O
. O
 
Depression O
is O
controlled O
with O
celexa-she O
is O
sleeping O
better O
. O
 
5 O
. O
 
Asthma-controlled O
with O
singulair O
, O
flovent O
and O
albuterol O
. O
 
6 O
. O
 
Hyperlipidemia-check O
labs O
every O
6 O
months O
. O
 
______________________________ O
Othel I-NAME
Vidal I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2071-11-17 I-DATE
Chief O
Complaint O
Urso I-NAME
comes O
in O
with O
several O
days O
of O
: O
nausea O
, O
diarrhea O
( O
5-6 O
times O
) O
with O
'everything O
going O
through O
her O
' O
. O
 
She O
has O
no O
vomiting O
. O
 
+ O
abd O
cramping O
pain O
. O
 
No O
blood O
in O
the O
stool O
. O
 
She O
had O
low O
grade O
fever O
. O
 
In O
addition O
, O
she O
feels O
increased O
chest O
congestion O
, O
cough O
, O
productive O
of O
white O
sputum O
. O
 
Her O
finger O
sticks O
at O
home O
are O
running O
at O
280 O
. O
 
No O
one O
at O
home O
has O
been O
sick O
. O
 
She O
had O
dental O
work O
done O
and O
received O
antibiotics O
about O
a O
month O
ago O
. O
 
Problems O
Hypertension O
: O
Well O
controlled O
on O
dyazide O
, O
lisinopril O
and O
atenolol O
Insomnia O
H/O O
cerebrovascular O
accident O
Basal O
cell O
carcinoma O
Asthma O
: O
on O
Flovent O
and O
Singulair O
. O
 
Good O
control O
Hyperlipidemia O
: O
On O
lipitor O
Diabetes O
mellitus O
type O
2 O
: O
On O
Glucovance O
2.5/500 O
BID O
Medications O
Albuterol O
Inhaler O
2 O
PUFF O
INH O
Q4-6H O
PRN O
.cough O
, O
use O
with O
chamber O
ATENOLOL O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
take O
1/2 O
in O
morning O
and O
1 O
in O
evening O
Carmol O
40 O
Cream O
( O
UREA O
40 O
% O
) O
1 O
APPLICATION O
TOP O
QD O
, O
apply O
to O
thick O
skin O
on O
feet O
once O
a O
day O
Celexa O
( O
CITALOPRAM O
) O
20MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Dyazide O
( O
TRIAMTERENE O
37.5 O
Mg/hctz O
25 O
Mg O
) O
1 O
CAPSULE O
PO O
QD O
Flonase O
( O
FLUTICASONE O
Nasal O
Spray O
) O
1-2 O
SPRAY O
NAS O
QD O
Flovent O
( O
FLUTICASONE O
Propionate O
) O
44MCG O
AEROSOL O
take O
2 O
Puff O
( O
s O
) O
INH O
BID O
Glucovance O
( O
GLYBURIDE/METFORMIN O
) O
2.5/500 O
MG O
PO O
BID O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
20MG O
TABLET O
take O
1 O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
PREDNISONE O
10MG O
TABLET O
take O
4 O
po O
qd O
x O
3 O
days O
, O
2 O
po O
qd O
x O
3 O
days O
, O
1 O
po O
qd O
x O
3 O
days O
Tablet O
( O
s O
) O
PO O
QAM O
PRN O
bronchitis O
Serevent O
Diskus O
( O
SALMETEROL O
Diskus O
) O
1 O
PUFF O
INH O
BID O
Singulair O
( O
MONTELUKAST O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Triamcinolone O
Ointment O
0.1 O
% O
OINTMENT O
TOP O
bid O
PRN O
, O
apply O
to O
rash O
two O
to O
three O
times O
per O
day O
; O
avoid O
face O
, O
groin O
, O
and O
underarms O
Allergies O
Sulfa O
- O
Unknown O
Penicillins O
- O
Unknown O
Social O
History O
Married O
, O
her O
husband O
has O
Alzheimers O
. O
 
He O
has O
been O
moved O
to O
Portland I-LOCATION
Sanatorium I-LOCATION
. O
 
Her O
daughter O
and O
3 O
grandchildren O
are O
living O
with O
her O
. O
 
Her O
other O
daughter O
has O
breast O
cancer O
and O
is O
going O
through O
RT O
treatments O
. O
 
She O
had O
7 O
children O
, O
one O
died O
. O
 
She O
has O
6 O
adult O
children O
. O
 
EtOH-none O
Smoking-none O
Review O
of O
Systems O
ROS-No O
chest O
pain O
, O
no O
headache O
, O
no O
photophobia O
. O
 
Vital O
Signs O
BLOOD O
PRESSURE O
110/68 O
PULSE O
83 O
TEMPERATURE O
98.1 O
F O
O2 O
SAT O
96 O
Exam O
HEENT-NC/AT O
, O
EOMI O
, O
PERRL O
TM-Clear O
Pharynx-Clear O
Chest-clear O
to O
P O
and O
A-no O
wheezing O
on O
exam O
today O
. O
 
Cor-S1S2 O
normal O
no O
murmers O
, O
rubs O
or O
gallops O
Abd-soft O
, O
nontender O
, O
no O
hepatosplenomegaly O
Disposition O
and O
Plans O
1 O
. O
 
Type O
2 O
DM O
. O
 
She O
has O
elevated O
blood O
sugar O
at O
home O
. O
 
Will O
increase O
glyburide/metformin O
to O
5/500 O
. O
 
Check O
HbA1c O
today O
. O
 
2 O
. O
 
Diarrhea-will O
check O
C.diff O
and O
stool O
C O
and O
S. O
Use O
imodium O
PRN O
. O
 
3 O
. O
 
Cough O
and O
congestion O
. O
 
Will O
check O
CXR O
today O
. O
 
Will O
write O
for O
zithromax O
, O
hold O
on O
starting O
and O
call O
tomorrow O
with O
how O
she O
is O
doing O
. O
 
4 O
. O
 
Chronic O
cough O
and O
mucus O
production O
. O
 
Will O
f/u O
again O
in O
10 O
days O
, O
bring O
in O
medication O
that O
she O
is O
using O
and O
discuss O
further O
management O
. O
 
______________________________ O
Othel I-NAME
Vidal I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2143-04-03 I-DATE
PL I-LOCATION
Neurology O
PROMPTCARE/Leprosarium O
Neurology O
0446 I-LOCATION
Sky I-LOCATION
Meadow I-LOCATION
Drive I-LOCATION
, O
Suite O
20 O
LIU O
, O
OLGA I-NAME
Tunis I-LOCATION
, O
IA I-LOCATION
49952 I-LOCATION
94318406 I-ID
077-765-3083 I-CONTACT
04/03/2143 I-DATE
DATE O
OF O
BIRTH O
: O
09/12/81 I-DATE
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
61-year-old O
ambidextrous O
female O
is O
referred O
by O
Dr. O
Orellana I-NAME
for O
followup O
of O
possible O
stroke O
or O
TIA O
. O
 
The O
patient O
is O
interviewed O
and O
available O
records O
are O
reviewed O
. O
 
In O
February I-DATE
, O
she O
developed O
left O
leg O
weakness O
on O
arising O
one O
morning O
. O
 
There O
was O
also O
some O
possible O
ataxia O
of O
the O
left O
upper O
extremity O
with O
decreased O
control O
of O
both O
the O
arm O
and O
the O
leg O
. O
 
This O
seemed O
to O
occur O
for O
two O
days O
in O
a O
row O
and O
on O
one O
occasion O
, O
she O
fell O
getting O
out O
of O
bed O
. O
 
The O
symptoms O
resolved O
before O
she O
could O
be O
evaluated O
. O
 
She O
attributed O
the O
symptoms O
to O
not O
enough O
air O
pressure O
in O
her O
air O
mattress O
and O
once O
this O
was O
corrected O
, O
she O
feels O
that O
the O
event O
has O
not O
re-occured O
. O
 
The O
second O
event O
was O
apparently O
associated O
with O
some O
left O
facial O
weakness O
as O
well O
. O
 
She O
was O
seen O
by O
Neurology O
on O
02/10/43 I-DATE
after O
she O
was O
admitted O
. O
 
The O
history O
includes O
also O
lightheadedness O
and O
foggy O
vision O
per O
that O
report O
. O
 
Initially O
MRI O
of O
the O
head O
showed O
no O
acute O
events O
but O
did O
show O
a O
change O
in O
the O
right O
posterior O
cerebral O
artery O
and O
a O
lesion O
in O
the O
left O
temporal O
lobe O
. O
 
Also O
, O
in O
the O
record O
is O
noted O
that O
at O
the O
time O
of O
the O
second O
event O
, O
her O
glucose O
was O
very O
low O
at O
around O
32 O
and O
symptoms O
resolved O
after O
treatment O
with O
D50 O
. O
 
There O
was O
also O
further O
history O
that O
the O
patient O
had O
been O
seeing O
a O
chiropractor O
for O
treatment O
of O
neck O
pain O
in O
the O
several O
months O
leading O
up O
to O
the O
event O
. O
 
On O
examination O
at O
the O
time O
of O
admission O
, O
there O
were O
no O
clear O
findings O
. O
 
MRI O
was O
said O
to O
show O
periventricular O
white O
matter O
changes O
. O
 
The O
area O
of O
abnormality O
adjacent O
to O
the O
left O
lateral O
ventricle O
was O
thought O
to O
perhaps O
represent O
an O
old O
prior O
small O
hemorrhage O
. O
 
MRA O
of O
the O
brain O
showed O
absence O
of O
visualization O
of O
the O
right O
PCA O
about O
1 O
cm O
beyond O
its O
origin O
but O
MRA O
of O
the O
neck O
showed O
no O
significant O
changes O
. O
 
Subsequent O
echocardiogram O
showed O
mild O
LVH O
with O
no O
evidence O
of O
a O
shunt O
. O
 
Currently O
, O
the O
patient O
is O
asymptomatic O
and O
presents O
for O
routine O
followup O
. O
 
It O
has O
been O
unclear O
what O
the O
cause O
of O
her O
symptoms O
was O
. O
 
Some O
have O
attributed O
the O
symptoms O
to O
hypoglycemia O
and O
another O
formulation O
was O
that O
of O
a O
thalamic O
TIA O
given O
the O
changes O
in O
the O
right O
PCA O
on O
MRA O
. O
 
Another O
consideration O
was O
dissection O
from O
manipulation O
by O
the O
chiropractor O
. O
 
There O
is O
no O
clinical O
history O
to O
go O
with O
the O
possible O
old O
small O
hemorrhage O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Notable O
for O
multifocal O
muscle O
aches O
and O
a O
chronic O
cough O
. O
 
The O
patient O
also O
has O
some O
shortness O
of O
breath O
but O
there O
is O
no O
report O
of O
chest O
pain O
or O
fever O
or O
chills O
. O
 
There O
are O
no O
medication O
allergies O
reported O
. O
 
PAST O
FAMILY/SOCIAL O
HISTORY O
: O
Past O
medical O
history O
is O
notable O
for O
hypertension O
, O
hypercholesterolemia O
, O
spinal O
stenosis O
, O
diabetes O
, O
depression O
, O
neuropathy O
, O
anxiety O
, O
COPD O
, O
arthritis O
, O
and O
sinus O
symptoms O
. O
 
MEDICATIONS O
: O
Lisinopril O
, O
Lopressor O
, O
glyburide O
, O
Naprosyn O
, O
Neurontin O
, O
Paxil O
, O
Lescol O
, O
Advair O
, O
trazodone O
, O
Glucophage O
, O
and O
? O
___ O
? O
. O
 
Not O
withstanding O
the O
above O
, O
the O
patient O
continues O
to O
smoke O
. O
 
She O
uses O
alcohol O
occasionally O
. O
 
She O
has O
a O
12th O
grade O
education O
. O
 
She O
lives O
alone O
and O
is O
a O
widow O
. O
 
PHYSICAL O
EXAMINATION O
: O
Blood O
pressure O
is O
148/86 O
, O
pulse O
83 O
and O
regular O
, O
respirations O
20 O
. O
 
The O
patient O
is O
overweight O
. O
 
Height O
is O
5 O
foot O
3 O
inches O
. O
 
Weight O
is O
217 O
pounds O
. O
 
Range O
of O
motion O
of O
the O
neck O
is O
reduced O
in O
all O
quadrants O
, O
though O
without O
clear O
spasm O
. O
 
Poor O
neck O
posture O
is O
noted O
. O
 
Funduscopic O
examination O
is O
normal O
with O
regard O
to O
disks O
and O
vessels O
. O
 
Cardiovascular O
testing O
, O
carotids O
are O
2+ O
without O
bruits O
. O
 
Temporal O
arteries O
are O
normal O
. O
 
Musculoskeletal O
testing O
, O
gait O
and O
station O
show O
a O
slight O
slowing O
of O
gait O
that O
has O
been O
present O
for O
years O
. O
 
Romberg O
is O
negative O
. O
 
Tandem O
gait O
is O
normal O
. O
 
The O
patient O
does O
move O
slowly O
in O
general O
, O
this O
is O
probably O
not O
reflective O
of O
true O
bradykinesia O
. O
 
There O
is O
some O
asymmetry O
of O
the O
shoulders O
with O
elevation O
on O
the O
right O
compared O
with O
the O
left O
. O
 
This O
affects O
movements O
of O
the O
arms O
and O
range O
of O
motion O
of O
the O
arms O
but O
it O
appears O
to O
be O
orthopedic O
in O
nature O
and O
not O
neurologic O
. O
 
There O
is O
no O
focal O
muscle O
weakness O
or O
atrophy O
noted O
. O
 
NEUROLOGICAL O
TESTING O
: O
Mental O
status O
is O
essentially O
normal O
to O
orientation O
, O
memory O
, O
attention O
, O
language O
and O
fund O
of O
information O
. O
 
Cranial O
nerve O
testing O
, O
pupils O
are O
3 O
mm O
and O
briskly O
reactive O
. O
 
Extraocular O
movements O
are O
full O
. O
 
Visual O
fields O
are O
intact O
. O
 
There O
is O
no O
facial O
sensory O
loss O
, O
but O
there O
is O
a O
mild O
facial O
asymmetry O
that O
did O
not O
look O
pathological O
. O
 
Visual O
fields O
are O
intact O
. O
 
Hearing O
is O
intact O
. O
 
Oropharynx O
is O
normal O
. O
 
Palate O
elevates O
well O
. O
 
Tongue O
is O
midline O
. O
 
Sensory O
testing O
shows O
absent O
vibration O
sensation O
in O
the O
feet O
bilaterally O
but O
sensory O
testing O
is O
otherwise O
intact O
. O
 
Reflexes O
are O
absent O
in O
the O
lower O
extremities O
and O
1+ O
in O
the O
upper O
extremities O
. O
 
There O
is O
possible O
withdrawal O
at O
the O
left O
toe O
but O
the O
right O
toe O
seems O
downgoing O
. O
 
Coordination O
testing O
today O
seemed O
intact O
. O
 
Prior O
neurologic O
evaluation O
from O
02/10/43 I-DATE
is O
reviewed O
. O
 
Homocystine O
level O
was O
elevated O
at O
14 O
, O
normal O
zero O
to O
ten O
. O
 
Recommended O
treatment O
included O
folate O
, O
pyridoxine O
, O
and O
B12 O
. O
 
IMPRESSION O
: O
Transient O
neurologic O
symptoms O
, O
question O
etiology O
. O
 
Comment O
. O
 
I O
would O
agree O
with O
prior O
examiners O
that O
the O
symptoms O
probably O
do O
not O
relate O
to O
the O
position O
of O
the O
bed O
or O
air O
in O
the O
air O
mattress O
. O
 
I O
do O
not O
think O
the O
symptoms O
are O
approximate O
enough O
to O
the O
chiropractic O
manipulation O
to O
be O
relevant O
. O
 
Symptoms O
could O
have O
related O
to O
hypoglycemia O
or O
could O
have O
been O
vascular O
in O
nature O
. O
 
In O
this O
regard O
, O
the O
PCA O
stenosis O
or O
occlusion O
may O
be O
relevant O
. O
 
It O
is O
not O
immediately O
clear O
how O
to O
fit O
in O
the O
old O
hemorrhage O
. O
 
PLAN O
: O
Although O
, O
she O
should O
be O
on O
some O
type O
of O
antiplatelet O
agent O
. O
 
She O
was O
on O
aspirin O
at O
the O
time O
of O
the O
event O
and O
therefore O
would O
be O
considered O
an O
aspirin O
failure O
. O
 
We O
therefore O
suggested O
Plavix O
75 O
mg O
daily O
. O
 
We O
were O
subsequently O
called O
by O
the O
pharmacy O
and O
informed O
that O
she O
is O
already O
on O
Aggrenox O
. O
 
It O
probably O
does O
not O
matter O
which O
medication O
she O
chooses O
; O
however O
, O
she O
should O
be O
on O
one O
or O
the O
other O
and O
not O
both O
. O
 
For O
treatment O
of O
the O
homocysteine O
level O
elevation O
, O
we O
have O
added O
simply O
multivitamins O
two O
daily O
. O
 
I O
am O
not O
sure O
how O
significant O
this O
finding O
is O
in O
relation O
to O
the O
above O
symptoms O
. O
 
She O
is O
advised O
to O
watch O
her O
glucose O
level O
and O
adjust O
medicines O
accordingly O
. O
 
We O
have O
suggested O
a O
followup O
in O
Neurology O
in O
six O
months O
. O
 
______________________________ O
Robert I-NAME
F I-NAME
Titus I-NAME
, O
MD O
eScription O
document:0-9416184 O
IL I-NAME
DD O
: O
04/11/43 I-DATE
DT O
: O
04/11/43 I-DATE
DV O
: O
04/03/43 I-DATE
 
Record O
date O
: O
2145-07-25 I-DATE
Olga I-NAME
comes O
in O
for O
4 O
mo O
f/u O
. O
 
She O
c/o O
worsening O
L O
knee O
pain O
with O
swelling O
. O
 
She O
is O
due O
to O
see O
Dr. O
Walter I-NAME
in O
11/45 I-DATE
. O
 
She O
had O
RTKR O
done O
last O
year O
. O
 
Breathing O
has O
been O
stable O
. O
 
Increased O
stress O
taking O
care O
of O
elderly O
mother O
who O
does O
not O
live O
with O
her O
. O
 
Problems O
Hypertension O
Diabetes O
mellitus O
type O
2 O
Hyperlipidemia O
Chronic O
obstructive O
pulmonary O
disease O
Smoking O
Polycythemia O
Depression O
Degenerative O
joint O
disease O
Total O
hip O
replacement O
Diverticulosis O
Obesity O
Transient O
ischemic O
attack O
Allergies O
NKA O
Medications O
Advair O
Diskus O
500/50 O
( O
FLUTICASONE O
Propionate/salmeterol O
500/50 O
) O
1 O
PUFF O
INH O
BID O
ALPRAZOLAM O
0.25 O
MG O
( O
0.25MG O
TABLET O
take O
1 O
) O
PO O
QD O
HYDROCHLOROTHIAZIDE O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lescol O
( O
FLUVASTATIN O
) O
40 O
MG O
( O
40MG O
CAPSULE O
take O
1 O
) O
PO O
QHS O
LISINOPRIL O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
BID O
METFORMIN O
1000 O
MG O
( O
1000MG O
TABLET O
take O
1 O
) O
PO O
BID O
NAPROXEN O
500 O
MG O
( O
500MG O
TABLET O
take O
1 O
) O
PO O
BID O
PAROXETINE O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
TRAZODONE O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Verapamil O
Sustained O
Release O
120 O
MG O
( O
120MG O
TABLET O
SA O
take O
1 O
) O
PO O
QD O
Social O
hx O
- O
continues O
to O
smoke O
. O
 
Married O
with O
children O
. O
 
PE O
: O
Flowsheets O
BLOOD O
PRESSURE O
140/100 O
Rpt O
by O
me O
140/94 O
TEMPERATURE O
97.0 O
F O
PULSE O
70 O
RESPIRATORY O
RATE O
18 O
WEIGHT O
213 O
lb O
( O
stable O
) O
Pt O
appears O
well O
, O
in O
NAD O
NEck O
- O
no O
bruits O
or O
nodes O
Chest O
- O
clear O
Cor O
- O
RRR O
, O
nlS1S2 O
Ext O
- O
no O
C/C/Ed O
L O
knee O
positive O
swelling O
A/P O
: O
1 O
. O
 
COPD O
- O
stable O
2 O
. O
 
HTN O
- O
mildly O
elevated O
. O
 
3 O
. O
 
DM O
- O
check O
HgA1C O
4 O
. O
 
Hyperlipidemia O
- O
check O
lipids O
today O
. O
 
5 O
. O
 
RTC O
4 O
months O
CPE/PAP O
. O
 
3 O
stool O
cards O
and O
tetanus O
today O
. O
 
6 O
. O
 
L O
knee O
DJD O
- O
suggested O
seeing O
Dr. O
Walter I-NAME
sooner O
. O
 
Janet I-NAME
Orellana I-NAME
MD O
 
Record O
date O
: O
2145-12-19 I-DATE
Olga I-NAME
comes O
in O
accomapnied O
by O
her O
daughter O
after O
undergoing O
L O
TKR O
by O
Dr. O
Walter I-NAME
on O
10/15/45 I-DATE
. O
 
She O
was O
transferred O
to O
Leprosarium I-LOCATION
rehab O
when O
after O
5 O
days O
, O
her O
INR O
increased O
to O
16 O
prompting O
readmission O
to O
MEDIQUIK I-LOCATION
. O
 
While O
there O
, O
R O
leg O
weakness O
was O
noted O
. O
 
MRI O
LS O
spine O
showed O
DJD O
and O
some O
spinal O
stenosis O
. O
 
She O
was O
transferred O
to O
Parsons I-LOCATION
Hospital I-LOCATION
on O
11/05 I-DATE
where O
she O
stayed O
till O
12/10/45 I-DATE
. O
 
She O
has O
been O
staying O
with O
her O
daughter O
since O
then O
. O
 
She O
is O
receiving O
VNA O
, O
PT O
. O
 
She O
continues O
to O
have O
R O
quadriceps O
weakness O
, O
can O
not O
lift O
leg O
. O
 
It O
is O
in O
a O
brace O
with O
knee O
immobilized O
. O
 
She O
is O
unable O
to O
walk O
independently O
. O
 
SHe O
notes O
her O
L O
lower O
leg O
is O
swollen O
. O
 
SHe O
is O
taking O
percoset O
for O
pain O
in O
leg O
. O
 
Also O
has O
pain O
in O
low O
back O
. O
 
Her O
breathing O
has O
been O
stable O
. O
 
She O
has O
lost O
more O
weight O
. O
 
She O
was O
on O
a O
strict O
ADA O
diet O
while O
at O
rehab O
. O
 
Problems O
Hypertension O
Diabetes O
mellitus O
type O
2 O
Hyperlipidemia O
Chronic O
obstructive O
pulmonary O
disease O
Polycythemia O
Depression O
Degenerative O
joint O
disease O
: O
s/p O
R O
TKR O
11/44 I-DATE
Total O
hip O
replacement O
Diverticulosis O
Obesity O
Transient O
ischemic O
attack O
Smoking O
Insomnia O
Allergies O
NKA O
Medications O
Advair O
Diskus O
500/50 O
( O
FLUTICASONE O
Propionate/salmeterol O
500/50 O
) O
1 O
PUFF O
INH O
BID O
ALPRAZOLAM O
0.25 O
MG O
( O
0.25MG O
TABLET O
take O
1 O
) O
PO O
QD O
HYDROCHLOROTHIAZIDE O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
LISINOPRIL O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
BID O
x O
30 O
days O
METFORMIN O
1000 O
MG O
( O
1000MG O
TABLET O
take O
1 O
) O
PO O
BID O
NAPROXEN O
500 O
MG O
( O
500MG O
TABLET O
take O
1 O
) O
PO O
BID O
x O
30 O
days O
OMEPRAZOLE O
20 O
MG O
( O
20MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
SIMVASTATIN O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
TRAZODONE O
125 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Verapamil O
Sustained O
Release O
120 O
MG O
( O
120MG O
TABLET O
SA O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
PE O
: O
Vital O
Signs O
WEIGHT O
196 O
lb O
( O
-15lbs/2.5mos O
) O
134/70 O
P60 O
T97 O
Walker O
in O
room O
, O
unable O
to O
get O
on O
table O
Pt O
alert O
and O
oriented O
, O
thinner O
NEck O
- O
no O
nodes O
or O
bruits O
Chest O
- O
clear O
Cor O
-RRR O
, O
nlS1S2 O
Abd O
- O
soft O
, O
NT O
Ext O
- O
L O
knee O
scar O
well O
healed O
; O
LLL O
bigger O
than O
right O
with O
trace O
pitting O
edema O
, O
no O
tenderness O
over O
calf O
, O
no O
redness O
or O
warmth O
Neuro O
- O
R O
leg O
in O
brace O
; O
3/5 O
strenght O
, O
CN O
's O
grossly O
intact O
A/P O
: O
1 O
. O
 
R O
leg O
weakness O
- O
Obtain O
MRI O
brain O
. O
 
Refer O
neurology O
. O
 
EMG O
was O
discussed O
, O
per O
PT O
recommendation O
. O
 
2 O
. O
 
Requests O
back O
brace O
- O
PT O
to O
order O
. O
 
3 O
. O
 
Pain O
back O
- O
Vicodin O
5/500mg O
prn O
. O
 
4 O
. O
 
Resume O
Neurontin O
. O
 
5 O
. O
 
HTN O
- O
stable O
. O
 
6 O
. O
 
DM O
- O
check O
HGA1C O
. O
 
7 O
. O
 
Weight O
loss O
- O
follow O
. O
 
8/ O
f/u O
3 O
months O
. O
 
Janet I-NAME
Orellana I-NAME
MD O
 
Record O
date O
: O
2146-02-20 I-DATE
Olga I-NAME
comes O
in O
for O
f/u O
, O
accomapanied O
by O
her O
daughter O
. O
 
She O
was O
admitted O
to O
MEDIQUIK I-LOCATION
in O
12/45 I-DATE
for O
inability O
to O
walk O
secondary O
to O
R O
leg O
weakness O
; O
transferred O
to O
Parsons I-LOCATION
Hospital I-LOCATION
in O
Vernal I-LOCATION
on O
1/7 I-DATE
till1/29 O
. O
 
She O
loved O
it O
there O
. O
 
She O
had O
EMG O
while O
there O
which O
revealed O
R O
femoral O
neuropaty O
, O
with O
6 O
mo O
rpt O
test O
recommended O
. O
 
She O
wears O
a O
brace O
most O
of O
the O
time O
, O
and O
walks O
with O
aid O
of O
walker O
. O
 
She O
was O
with O
her O
daughter O
initially O
upon O
d/c O
, O
and O
now O
at O
her O
own O
home O
alone O
for O
past O
10 O
days O
. O
 
MAnaging O
okay O
. O
 
Received O
PT O
few O
times O
a O
week O
. O
 
VNA O
d/c O
'd O
. O
 
Wants O
to O
be O
able O
to O
drive O
again O
. O
 
Has O
some O
mobility O
in O
R O
leg O
, O
but O
not O
much O
. O
 
Notes O
swelling O
L O
dorsum O
foot O
. O
 
Meds O
were O
reviewed O
today O
. O
 
She O
ran O
out O
of O
lisinopril O
and O
cozaar O
( O
started O
in O
rehab O
) O
couple O
wks O
ago O
. O
 
She O
does O
not O
take O
HCTZ O
daily O
secondary O
to O
urinary O
frequency O
. O
 
Her O
metformin O
was O
d/c O
'd O
, O
secondary O
to O
low O
fsbs O
reads O
in O
am O
in O
30 O
's O
. O
 
Her O
zocor O
was O
stopped O
in O
hospital O
. O
 
She O
needs O
refills O
today O
. O
 
She O
has O
remained O
off O
cigarettes O
! O
! O
 
Problems O
Hypertension O
Diabetes O
mellitus O
type O
2 O
Hyperlipidemia O
Chronic O
obstructive O
pulmonary O
disease O
Depression O
Degenerative O
joint O
disease O
: O
s/p O
R O
TKR O
11/44 I-DATE
Transient O
ischemic O
attack O
Insomnia O
Allergies O
NKA O
Medications O
Advair O
Diskus O
500/50 O
( O
FLUTICASONE O
Propionate/salmeterol O
500/50 O
) O
1 O
PUFF O
INH O
BID O
ALPRAZOLAM O
0.25 O
MG O
( O
0.25MG O
TABLET O
take O
1 O
) O
PO O
QD O
GABAPENTIN O
600 O
MG O
( O
600MG O
TABLET O
take O
1 O
) O
PO O
BID O
LISINOPRIL O
60 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
BID O
x O
30 O
days O
PAROXETINE O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
TRAZODONE O
150 O
MG O
( O
150MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Verapamil O
Sustained O
Release O
120 O
MG O
( O
120MG O
TABLET O
SA O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
HCTZ O
25mg O
qd O
PE O
: O
Vital O
Signs O
BLOOD O
PRESSURE O
130/80 O
PULSE O
68 O
RESPIRATORY O
RATE O
17 O
TEMPERATURE O
97.0 O
F O
Pt O
in O
NAD O
, O
appears O
well O
Neck O
- O
no O
bruits O
Chest O
- O
clear O
without O
wheezes O
Cor O
-RRR O
, O
nlS1S2 O
Ext O
- O
trace O
edema O
LL's O
A/P O
: O
1 O
. O
 
HTN O
- O
stable O
on O
metoprolol O
and O
verapamil O
alone O
. O
 
d/c O
HCTZ O
. O
 
d/c O
cozaar O
. O
 
2 O
. O
 
DM O
- O
check O
HgA1c O
; O
off O
meds O
. O
 
3 O
. O
 
Elev O
CHol O
- O
check O
lipids O
today O
. O
 
Resume O
zocor O
. O
 
4 O
. O
 
Leg O
edema O
- O
use O
lasix O
20mg O
prn O
. O
 
5 O
. O
 
R O
femoral O
neuropathy O
- O
cont O
PT O
. O
 
6 O
. O
 
COPD O
- O
stable O
. O
 
6. O
f/u O
2 O
months O
. O
 
J. I-NAME
Orellana I-NAME
MD O
 
Record O
date O
: O
2063-09-04 I-DATE
124-23-22-9 I-ID
She O
returns O
for O
follow-up O
visit O
. O
 
She O
has O
essential O
hypertension O
and O
diabetes O
and O
is O
s/p O
a O
small O
CVA O
. O
 
Medications O
currently O
include O
vasotec O
20 O
b.i.d. O
, O
chlorpropamide O
250 O
b.i.d O
. O
 
I O
once O
again O
encouraged O
her O
to O
take O
aspirin O
which O
she O
said O
gives O
her O
a O
funny O
feeling O
in O
her O
stomach O
, O
but O
she O
is O
now O
agreeable O
to O
taking O
80 O
mg O
q.d O
. O
 
Hydrochlorothiazide O
was O
stopped O
secondary O
to O
an O
episode O
of O
hyponatremia O
. O
 
She O
said O
she O
has O
felt O
the O
best O
over O
the O
last O
three O
months O
and O
reports O
no O
cardiovascular O
or O
neurological O
symptoms O
. O
 
Blood O
pressure O
130/70 O
. O
 
No O
JVD O
. O
 
Carotid O
impulses O
normal O
. O
 
No O
bruits O
. O
 
Lungs O
clear O
. O
 
Cardiac O
exam O
normal O
. O
 
Unremarkable O
abdomen O
. O
 
Full O
pulses O
throughout O
with O
no O
edema O
. O
 
ECG O
is O
within O
normal O
limits O
. O
 
I O
have O
made O
no O
changes O
to O
her O
medical O
regimen O
and O
she O
will O
return O
to O
see O
Dr. O
Isaiah I-NAME
Viola I-NAME
in O
six O
months O
. O
 
Otha I-NAME
V. I-NAME
Espinal I-NAME
, O
M.D O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Approved O
but O
not O
reviewed O
by O
Attending O
Provider O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2070-03-22 I-DATE
PROMPTCARE I-LOCATION
EMERGENCY O
DEPT O
VISIT O
UMALI O
, O
DANA O
YURI I-NAME
124-23-22-9 I-ID
The O
patient O
was O
seen O
by O
me O
along O
with O
Dr. O
Frank I-NAME
Griffin I-NAME
on O
03/22/70 I-DATE
. O
 
The O
history O
is O
documented O
by O
Dr. O
Griffin I-NAME
. O
 
It O
was O
reviewed O
by O
me O
with O
the O
patient O
found O
to O
be O
accurate O
and O
complete O
. O
 
The O
physical O
examination O
was O
confirmed O
by O
my O
examination O
. O
 
Evaluation O
and O
management O
was O
also O
concurred O
with O
. O
 
PRESENTING O
COMPLAINT O
: O
Right O
face O
and O
arm O
numbness O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
is O
a O
66-year-old O
woman O
with O
a O
new O
onset O
at O
11 O
p.m. O
with O
right O
face O
and O
right O
arm O
numbness O
, O
now O
improving O
. O
 
No O
speech O
or O
motor O
deficits O
. O
 
No O
recent O
illness O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
No O
fever O
, O
chills O
, O
nausea O
or O
vomiting O
. O
 
No O
headache O
, O
no O
neck O
stiffness O
. O
 
All O
negative O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
History O
of O
hypertension O
, O
diabetes O
and O
has O
a O
history O
of O
hypercholesterolemia O
. O
 
She O
had O
a O
cerebrovascular O
accident O
with O
left O
sided O
weakness O
which O
has O
resolved O
in O
the O
past O
. O
 
MEDICATIONS O
: O
Hydrochlorothiazide O
, O
Zocor O
, O
Glyburide O
, O
Captopril O
and O
enalapril O
. O
 
The O
patient O
also O
takes O
metformin O
. O
 
ALLERGIES O
: O
None O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
She O
does O
not O
smoke O
or O
drink O
. O
 
She O
lives O
with O
her O
family O
and O
her O
husband O
. O
 
The O
patient O
speaks O
Taiwanese I-LOCATION
and O
daughter O
and O
son O
are O
interpreting O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
Awake O
, O
alert O
and O
oriented O
woman O
in O
no O
apparent O
distress O
. O
 
She O
is O
a O
very O
pleasant O
lady O
, O
smiling O
at O
times O
and O
makes O
eye O
contact O
. O
 
VITAL O
SIGNS O
: O
Temperature O
97.8 O
, O
pulse O
84 O
, O
respirations O
20 O
, O
blood O
pressure O
166/66 O
. O
 
HEENT O
: O
Normal O
. O
 
NECK O
: O
Normal O
. O
 
LUNGS O
: O
Clear O
of O
rales O
, O
wheezes O
or O
rhonchi O
. O
 
CARDIOVASCULAR O
: O
Regular O
, O
rate O
and O
rhythm O
. O
 
ABDOMEN O
: O
Nondistended O
. O
 
Bowel O
sounds O
are O
normoactive O
and O
nontender O
. O
 
SKIN O
: O
Intact O
, O
warm O
and O
dry O
with O
no O
lesions O
or O
rashes O
. O
 
EXTREMITIES O
: O
No O
cyanosis O
. O
 
Normal O
extremities O
with O
no O
deformities O
, O
joint O
effusions O
or O
crepitance O
noted O
over O
her O
joints O
. O
 
She O
has O
a O
subjective O
decreased O
sensation O
over O
her O
right O
lower O
forearm O
. O
 
NEUROLOGICAL O
: O
Cranial O
nerves O
II O
through O
XII O
are O
intact O
. O
 
She O
is O
oriented O
x3 O
. O
 
She O
has O
5/5 O
motor O
in O
upper O
and O
lower O
extremities O
. O
 
She O
has O
not O
walked O
, O
therefore O
gait O
can O
not O
be O
assessed O
. O
 
She O
has O
no O
dysarthria O
, O
no O
dysmetria O
and O
no O
signs O
of O
any O
focal O
weakness O
. O
 
LABORATORY O
EVALUATION O
: O
Electrocardiogram O
revealed O
a O
sinus O
rhythm O
. O
 
CT O
of O
the O
head O
was O
negative O
on O
initial O
evaluation O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
As O
such O
, O
neurology O
was O
called O
and O
they O
elected O
to O
admit O
her O
. O
 
She O
was O
admitted O
on O
03/22/70 I-DATE
by O
Dr. O
Yang I-NAME
in O
stable O
condition O
. O
 
___________________________________ O
JT365/31932 I-ID
NORRIS I-NAME
ELDER I-NAME
, O
M.D O
. O
 
NE00 I-NAME
D:03/22/70 O
T:03/23/70 O
Dictated O
by O
: O
NORRIS I-NAME
ELDER I-NAME
, O
M.D O
. O
 
NE00 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2077-09-20 I-DATE
UMALI O
, O
DANA I-NAME
12423229 I-ID
09/20/2077 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Umali I-NAME
returns O
for O
followup O
after O
her O
angioplasty O
of O
a O
superficial O
femoral O
artery O
occlusive O
disease O
, O
with O
a O
more O
proximal O
left O
iliac O
stent O
placement O
of O
the O
common O
iliac O
. O
 
She O
has O
a O
nonhealing O
left O
great O
toe O
ulceration O
. O
 
She O
is O
followed O
by O
Dr. O
Holden I-NAME
, O
and O
I O
performed O
an O
endovascular O
recanalization O
. O
 
PHYSICAL O
EXAMINATION O
: O
Today O
, O
she O
is O
doing O
well O
, O
after O
her O
procedure O
on O
09/14/77 I-DATE
. O
 
IMAGING O
: O
Noninvasive O
vascular O
lab O
studies O
were O
performed O
today O
, O
showing O
an O
ABI O
on O
the O
left O
of O
0.67 O
on O
the O
right O
of O
0.42 O
. O
 
This O
is O
a O
great O
improvement O
from O
the O
0.24 O
ABI O
on O
the O
left O
before O
the O
endovascular O
procedure O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
Dr. O
Holden I-NAME
explained O
to O
the O
patient O
and O
family O
about O
toe O
amputation O
recommendations O
at O
this O
time O
. O
 
Otherwise O
, O
from O
a O
circulatory O
standpoint O
, O
we O
counseled O
them O
that O
this O
was O
the O
optimal O
time O
to O
perform O
toe O
amputation O
to O
allow O
for O
primary O
healing O
. O
 
They O
will O
follow O
up O
with O
Dr. O
Holden I-NAME
in O
2 O
weeks O
, O
once O
they O
decide O
. O
 
Vernon I-NAME
Ramses I-NAME
Cruz I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2077-12-04 I-DATE
EDVISIT^12423229^UMALI O
, O
DANA^12/04/77^DUFFY O
, O
FELICIA I-NAME
CHIEF O
COMPLAINT O
: O
Foot O
pain O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Umali I-NAME
is O
a O
73-year-old O
woman O
with O
a O
history O
of O
diabetes O
, O
peripheral O
vascular O
disease O
who O
presents O
to O
the O
Emergency O
Department O
complaining O
of O
several O
days O
of O
increasing O
right O
great O
toe O
pain O
. O
 
The O
patient O
denies O
fever O
, O
chills O
, O
or O
drainage O
from O
the O
foot O
. O
 
Please O
see O
the O
written O
record O
for O
further O
details O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
diabetes O
, O
CVA O
, O
peripheral O
vascular O
disease O
, O
and O
hyperlipidemia O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Left O
great O
toe O
amputation O
and O
left O
lower O
extremity O
arterial O
revascularization O
. O
 
MEDICATIONS O
: O
Please O
see O
the O
LMR O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
PHYSICAL O
EXAMINATION O
: O
I O
have O
examined O
the O
patient O
and O
agree O
with O
the O
physical O
as O
documented O
. O
 
Of O
note O
, O
the O
patient O
is O
awake O
, O
alert O
, O
and O
in O
no O
distress O
. O
 
Vitals O
: O
Heart O
rate O
88 O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
135/63 O
, O
temperature O
97 O
, O
and O
oxygen O
saturation O
98 O
% O
on O
room O
air O
. O
 
Lungs O
: O
Clear O
bilaterally O
with O
no O
rales O
, O
rhonchi O
, O
or O
wheezing O
. O
 
Cardiovascular O
exam O
: O
Regular O
rate O
and O
rhythm O
. O
 
Normal O
S1 O
and O
S2 O
. O
 
Abdomen O
: O
Soft O
. O
 
No O
tenderness O
, O
guarding O
, O
or O
rebound O
. O
 
Extremity O
exam O
: O
The O
patient O
's O
right O
lower O
extremity O
is O
warm O
with O
less O
than O
2 O
second O
capillary O
refills O
. O
 
The O
patient O
has O
no O
palpable O
or O
Doppler O
to O
dorsalis O
pedis O
or O
posterior O
tibial O
pulses O
. O
 
The O
patient O
's O
right O
great O
toe O
is O
tender O
, O
erythematous O
, O
and O
mildly O
swollen O
. O
 
MEDICAL O
DECISION O
MAKING O
AND O
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Ms. O
Umali I-NAME
is O
a O
73-year-old O
woman O
with O
diabetes O
, O
peripheral O
vascular O
disease O
who O
presents O
to O
the O
Emergency O
Department O
with O
right O
foot O
cellulitis O
. O
 
The O
patient O
's O
labs O
are O
available O
on O
the O
LMR O
. O
 
Of O
note O
, O
the O
patient O
's O
white O
count O
is O
11.7 O
. O
 
The O
patient O
was O
evaluated O
by O
the O
Vascular O
Surgery O
Service O
. O
 
The O
plan O
is O
to O
obtain O
an O
x-ray O
of O
the O
foot O
and O
admit O
the O
patient O
to O
the O
Vascular O
Surgery O
Service O
for O
further O
management O
. O
 
PRIMARY O
DIAGNOSIS O
: O
Right O
foot O
cellulitis O
. O
 
SECONDARY O
DIAGNOSIS O
: O
Diabetes O
with O
poor O
control O
. O
 
THIRD O
DIAGNOSIS O
: O
Peripheral O
vascular O
disease O
. O
 
DISPOSITION O
: O
Admission O
. O
 
CONDITION O
UPON O
ADMISSION O
: O
Good O
. O
 
______________________________ O
DUFFY O
, O
FELICIA I-NAME
M.D O
. O
 
D O
: O
12/04/77 I-DATE
T O
: O
12/04/77 I-DATE
Dictated O
By O
: O
DUFFY O
, O
FELICIA I-NAME
eScription O
document:6-60827686 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2074-11-11 I-DATE
LEPROSARIUM I-LOCATION
EMERGENCY O
DEPT O
VISIT O
OLIVIER O
, O
OZELL O
337-67-25-9 I-ID
VISIT O
DATE O
: O
11/11/74 I-DATE
Resident O
history O
reviewed O
, O
patient O
interviewed O
and O
examined O
by O
me O
. O
 
PRESENTING O
COMPLAINT O
: O
Cough O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
is O
a O
67-year-old O
woman O
from O
South I-LOCATION
Korea I-LOCATION
who O
has O
been O
in O
Canada I-LOCATION
for O
one O
year O
, O
translated O
by O
her O
son O
. O
 
She O
has O
had O
a O
cough O
for O
three O
days O
, O
which O
is O
white O
, O
and O
then O
turned O
to O
yellow O
productive O
sputum O
. O
 
She O
has O
mild O
shortness O
of O
breath O
, O
chronic O
dyspnea O
on O
exertion O
, O
and O
chest O
pain O
only O
with O
coughing O
. O
 
The O
patient O
has O
no O
fever O
, O
no O
chills O
, O
no O
nausea O
, O
no O
vomiting O
. O
 
Positive O
coryza O
, O
cough O
, O
and O
sore O
throat O
. O
 
She O
has O
been O
self-treating O
with O
amoxicillin O
for O
two O
days O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
See O
HPI O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
hypothyroidism O
, O
obstructive O
sleep O
apnea O
. O
 
Surgical O
history O
is O
positive O
for O
cholecystectomy O
. O
 
MEDICATIONS O
: O
Synthroid O
, O
Amoxil O
, O
hydrochlorothiazide O
. O
 
ALLERGIES O
: O
Penicillin O
; O
she O
had O
urticaria O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
Social O
history O
is O
negative O
for O
tobacco O
, O
ETOH O
, O
intravenous O
drug O
abuse O
. O
 
She O
lives O
with O
family O
. O
 
Family O
history O
is O
cancer O
. O
 
PHYSICAL O
EXAMINATION O
: O
Vital O
signs O
are O
stable O
at O
98 O
, O
83 O
, O
17 O
, O
162/67 O
, O
and O
94 O
% O
. O
 
GENERAL O
: O
This O
patient O
is O
awake O
, O
alert O
, O
and O
oriented O
, O
well-nourished O
, O
well-developed O
, O
in O
no O
distress O
. O
 
HEENT O
: O
Pupils O
are O
equal O
, O
round O
, O
reactive O
to O
light O
and O
accommodation O
. O
 
Extraocular O
muscles O
are O
intact O
. O
 
Oropharynx O
has O
no O
enlarged O
tonsils O
and O
no O
exudate O
. O
 
NECK O
: O
Supple O
. O
 
RESPIRATORY O
: O
No O
respiratory O
distress O
. O
 
She O
has O
bi-basilar O
crackles O
. O
 
CARDIOVASCULAR O
: O
Regular O
rate O
and O
rhythm O
. O
 
S1 O
, O
S2 O
. O
 
ABDOMEN O
: O
Soft O
, O
non-tender O
. O
 
EXTREMITIES O
: O
No O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
NEUROPSYCHIATRIC O
: O
Alert O
and O
oriented O
x O
3 O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
will O
be O
discharged O
on O
a O
Z-pak O
and O
is O
to O
follow O
up O
with O
the O
Lakeview I-LOCATION
Clinic I-LOCATION
. O
 
FINAL O
DIAGNOSIS O
: O
Bronchitis O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
was O
discharged O
home O
in O
satisfactory O
condition O
. O
 
___________________________________ O
OK878/13176 I-ID
ROXANNE I-NAME
SPEARS I-NAME
, O
M.D O
. O
 
RS40 I-NAME
D:11/11/74 O
T:11/12/74 O
Dictated O
by O
: O
ROXANNE I-NAME
SPEARS I-NAME
, O
M.D O
. O
 
RS40 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2076-03-23 I-DATE
Lakeview I-LOCATION
Clinic I-LOCATION
Note O
Patient O
comes O
in O
today O
for O
follow-up O
of O
recent O
hospitalization O
for O
L1 O
fracture O
following O
a O
fall O
. O
 
She O
was O
in O
her O
usual O
state O
of O
health O
until O
2 O
months O
ago O
when O
she O
suffered O
a O
mechanical O
fall O
while O
visiting O
family O
in O
South I-LOCATION
Korea I-LOCATION
. O
 
She O
sustained O
an O
L1 O
fracture O
without O
surgical O
intervention O
, O
and O
returned O
to O
canada I-LOCATION
where O
she O
presented O
to O
the O
ED O
on O
3/9/76 I-DATE
wiht O
back O
pain O
, O
L1 O
planar O
fracture O
with O
evidence O
of O
minimal O
cord O
compressionl O
She O
was O
admitted O
and O
seen O
by O
neurosurgery O
who O
felt O
that O
there O
was O
no O
acute O
indication O
for O
surgery O
. O
 
Since O
then O
, O
she O
has O
had O
continued O
pain O
in O
her O
back O
with O
occasional O
burning O
in O
her O
feet O
but O
no O
numbness O
or O
tingling O
. O
 
She O
would O
like O
to O
undergo O
surgery O
at O
this O
point O
because O
her O
pain O
is O
intolerable O
. O
 
She O
is O
in O
contact O
with O
a O
neurosurgeon O
at O
this O
time O
regarding O
when O
to O
proceed O
with O
surgery O
. O
 
She O
is O
otherwise O
doing O
well O
. O
 
ROS O
positive O
for O
chest O
tightness O
with O
walking O
one O
block O
with O
some O
feeling O
of O
being O
`` O
winded O
. O
'' O
 
She O
does O
not O
have O
this O
feeling O
at O
rest O
, O
and O
states O
it O
has O
been O
ongoing O
for O
the O
past O
year O
. O
 
She O
describes O
some O
peripheral O
edema O
, O
as O
well O
as O
PND O
. O
 
Also O
c/o O
left O
eye O
tearing O
and O
R O
ear O
itching O
. O
 
no O
eye O
pain O
or O
change O
in O
her O
vision O
. O
 
Problems O
Hypertension O
Elevated O
cholesterol O
Cervical O
polyp O
endometrial O
polyp O
osteoarthritis O
Sleep O
apnea O
Current O
Medications O
: O
DIOVAN O
80 O
mg O
PO O
QD O
Nexium O
( O
ESOMEPRAZOLE O
) O
20 O
MG O
PO O
QD O
x O
30 O
day O
( O
s O
) O
HYDROCHLOROTHIAZIDE O
25MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Celebrex O
( O
CELECOXIB O
) O
100MG O
, O
1 O
Capsule O
( O
s O
) O
PO O
bid O
Levothyroxine O
Sodium O
125MCG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QD O
x O
30 O
day O
( O
s O
) O
Caltrate O
And O
D O
2 O
TABS O
PO O
qd O
x O
30 O
day O
( O
s O
) O
Percocet O
( O
OXYCODONE+APAP O
) O
325-5 O
, O
1 O
Tablet O
( O
s O
) O
PO O
Q6H O
x O
20 O
day O
( O
s O
) O
Lopid O
( O
GEMFIBROZIL O
) O
600MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
QPM O
x O
30 O
day O
( O
s O
) O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
12.5MG O
, O
1 O
Tablet O
( O
s O
) O
PO O
BID O
x O
30 O
day O
( O
s O
) O
fosomax O
70 O
PO O
qwk O
x O
30 O
day O
( O
s O
) O
Physical O
Exam O
VSS O
: O
BP144/76 O
, O
wt O
209 O
lbs O
HEENT O
: O
no O
mouth O
lesions O
Thyroid O
: O
no O
thyromegaly O
Chest O
: O
scant O
crackles O
at O
bilateral O
bases O
Heart O
: O
regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
normal O
, O
no O
gallops O
, O
no O
murmurs O
Abd O
: O
soft O
, O
NT/ND O
Extr O
: O
1-2+ O
ankle O
edema O
, O
brisk O
capillary O
refill O
Recent O
Relevant O
Data O
: O
random O
glucose O
148 O
Hemoglobin O
A1c O
: O
6.8 O
CBC O
, O
chem O
7 O
, O
tash O
, O
cholesterol O
all O
WNL O
in O
march I-DATE
2076. O
iPTH O
41 O
, O
alk O
phos O
hi O
at O
129 O
, O
nl O
LFTs O
, O
ESR O
34 O
SPEP O
negative O
, O
bone O
scan O
with O
osteopenia O
, O
mammogram O
negative O
CXR O
with O
? O
 
of O
confluence O
of O
shadows O
vs O
nodule O
at O
2nd O
rib O
space O
, O
favor O
shadows O
, O
ecg O
with O
T O
wave O
abnormalities O
and O
low O
qrs O
voltages O
ETT O
2074 I-DATE
10 O
min O
82 O
% O
predicted O
negative O
for O
ischmia O
Echo O
2074 I-DATE
EF O
60 O
% O
Assessment O
and O
Current O
Plan O
: O
67 I-AGE
yo O
F O
with O
recent O
L1 O
planar O
fracture O
and O
multiple O
medical O
problems O
including O
HTN O
and O
new O
DM O
1 O
. O
 
Neurosurg O
for O
possible O
surgery O
later O
this O
month O
, O
percocet O
for O
pain O
control O
- O
will O
need O
PFTs O
pre-op O
given O
some O
c/o O
DOE O
2 O
. O
 
CV O
: O
will O
also O
need O
nuclear O
study O
of O
heart O
given O
anginal O
sx O
's O
and O
new O
T O
wave O
abnormalities O
on O
ECG O
. O
 
Can O
not O
do O
ETT O
given O
resting O
ECG O
abnormalities O
, O
and O
will O
need O
pharmocologic O
stress O
given O
she O
can O
not O
walk O
from O
back O
pain O
. O
 
- O
will O
start O
her O
on O
lasix O
both O
for O
BP O
and O
for O
diuresis O
as O
she O
appears O
volume O
overloaded O
. O
 
- O
will O
rpt O
echo O
if O
dobutamine O
MIBI O
not O
informative O
3.optho O
referral O
per O
pt O
request O
for O
eye O
tearing O
4.elevated O
gluc O
and O
A1c O
concerning O
for O
new O
DM O
. O
 
However O
, O
given O
only O
1 O
high O
b.s O
documented O
and O
A1C O
borderline O
elevated O
, O
I O
have O
advised O
her O
that O
we O
can O
probably O
control O
this O
with O
diet O
, O
exercise O
, O
and O
wt O
loss.She O
will O
see O
nutrition O
to O
help O
her O
avoid O
high O
carb O
foods O
and O
to O
lose O
wt O
. O
 
If O
this O
fails O
to O
control O
her O
DM O
we O
will O
start O
her O
on O
Metformin O
. O
 
She O
will O
need O
optho O
eval O
for O
this O
reason O
as O
well O
. O
 
5 O
. O
 
Pt O
with O
strong O
fhx O
of O
uterine O
ca O
, O
wishes O
to O
see O
GYN O
regarding O
screening O
for O
this O
. O
 
She O
denies O
sx O
's O
of O
vaginal O
bleeding O
at O
this O
pt O
. O
 
6.consider O
rpt O
CXR O
given O
? O
of O
shadow O
vs O
nodule O
. O
 
7. O
will O
review O
HM O
at O
next O
visit O
Patient O
will O
return O
for O
a O
follow-up O
visit O
in O
clinic O
in O
1 O
wk O
for O
chem O
7 O
and O
1 O
month O
to O
see O
me O
re O
bp O
and O
volume O
status O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
67 I-AGE
yr O
old O
woman O
with O
recent O
L1 O
fracture O
, O
with O
minimal O
cord O
compression O
, O
has O
had O
persistent O
pain O
and O
is O
in O
contact O
with O
a O
neurosurgeon O
for O
consideration O
of O
surgery O
. O
 
Also O
has O
had O
some O
exertional O
chest O
pain O
in O
last O
yr O
, O
and O
has O
baseline O
EKG O
T O
wave O
changes O
, O
and O
is O
unable O
to O
do O
treadmill O
due O
to O
back O
pain O
. O
 
Will O
get O
dobutamine O
MIBI O
study O
. O
 
Repeat O
CXR O
as O
above O
in O
resident O
's O
note O
. O
 
Record O
date O
: O
2079-06-18 I-DATE
Pt O
is O
a O
pleasant O
obese O
70yo O
South I-LOCATION
Korean I-LOCATION
woman O
presenting O
for O
f/u O
DM O
, O
HTN O
. O
 
She O
is O
a O
poor O
historian O
, O
accompanied O
by O
family O
members O
who O
interpret O
, O
both O
in O
Korean I-LOCATION
and O
English I-LOCATION
. O
 
Also O
spoke O
w/ O
daughter O
by O
phone O
during O
the O
visit O
to O
help O
clarify O
med O
regimen O
. O
 
Problems O
Hypertension O
Elevated O
cholesterol O
Cervical O
polyp O
endometrial O
polyp O
osteoarthritis O
Sleep O
apnea O
diastolic O
heart O
failure O
Restrictive O
pulmonary O
disease O
Diabetes O
mellitus O
type O
2 O
FH O
Uncoded O
Information O
: O
Comments O
: O
Denies O
family O
h/o O
ovarian O
, O
endometrial O
, O
breast O
or O
GI O
cancer O
. O
 
Reports O
mother O
and O
older O
sister O
with O
endometrial O
ca O
. O
 
Medications O
Colace O
( O
DOCUSATE O
SODIUM O
) O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
Caltrate O
and O
D O
2 O
TABS O
PO O
qd O
, O
keep O
md O
appt O
for O
11/15/77 I-DATE
Lopressor O
( O
METOPROLOL O
TARTRATE O
) O
12.5MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Zantac O
( O
RANITIDINE O
HCL O
) O
150MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Estrace O
( O
ESTRADIOL O
) O
1 O
GM O
PV O
BIW O
, O
keep O
md O
appt O
for O
11/15/77 I-DATE
Neurontin O
( O
GABAPENTIN O
) O
300 O
MG O
( O
300MG O
CAPSULE O
take O
1 O
) O
PO O
TID O
Loratadine O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Diazepam O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QHS O
x O
30 O
days O
Nexium O
( O
ESOMEPRAZOLE O
) O
40 O
MG O
( O
40MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
Hydrochlorothiazide O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
Levothyroxine O
SODIUM O
100MCG O
TABLET O
PO O
QD O
Fosamax O
( O
ALENDRONATE O
) O
70 I-AGE
MG O
( O
70MG O
TABLET O
take O
1 O
) O
PO O
QWEEK O
Diovan O
( O
VALSARTAN O
) O
160 O
MG O
( O
160MG O
TABLET O
take O
1 O
) O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Metformin O
500 O
MG O
( O
500MG O
TABLET O
take O
1 O
) O
PO O
BID O
Percocet O
( O
OXYCODONE+APAP O
) O
325-5 O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
x O
30 O
days O
Zocor O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
, O
to O
replace O
lipitor O
Last O
seen O
by O
PCP O
approx O
3 O
wks O
ago O
. O
 
Pt O
was O
having O
sxs O
dyastolic O
dysfunction O
, O
asked O
to O
take O
Lasix O
20mg O
qd O
. O
 
Bp O
meds O
include O
Diovan O
160mg O
, O
HCTZ O
25mg O
and O
Bisoprolol O
5mg O
qd O
, O
which O
replaced O
Lopressor O
at O
some O
point O
. O
 
Unclear O
from O
pt/family O
when O
this O
was O
changed O
. O
 
Patient O
denies O
CP O
, O
increased O
SOB O
or O
edema O
. O
 
Sleeps O
on O
2 O
pillows O
. O
 
Adds O
salt O
to O
food O
and O
is O
sedentary O
. O
 
Has O
gained O
an O
additional O
# O
2 O
since O
last O
visit O
. O
 
According O
to O
her O
daughter O
, O
she O
eats O
sweets O
every O
day O
and O
complains O
of O
feeling O
dizzy O
if O
she O
does O
not O
eat O
sweets O
. O
 
Also O
eats O
mod O
amts O
starches O
. O
 
Takes O
Metformin O
500mg O
bid O
w/ O
recent O
A1c O
6.7 O
. O
 
She O
uses O
a O
glucometer O
to O
test O
fingersticks O
, O
though O
inconsistently O
. O
 
Family O
reports O
typical O
fasting O
results O
110-130 O
, O
randoms O
150-170 O
's O
; O
no O
200 O
's O
. O
 
She O
is O
a O
former O
smoker O
. O
 
No O
alcohol O
or O
OTC O
meds O
. O
 
Followed O
by O
multiple O
disciplines O
including O
cards O
, O
neuro O
, O
ortho O
and O
pain O
mgmt O
. O
 
Also O
has O
upcoming O
appt O
w/ O
nutrition O
. O
 
Exam O
: O
pleasant O
obese O
70yo O
woman O
NAD O
Bp O
144/64 O
in O
triage O
, O
140/70 O
rechecked O
by O
me O
HR O
64reg O
Wt O
# O
220 O
Random O
fingerstick O
137 O
Neck O
: O
obese O
, O
supple O
; O
no O
JVD O
Lungs O
: O
clear O
; O
no O
rales O
, O
ronchi O
, O
wheezes O
Cor O
: O
RRR O
; O
no O
r/m/g O
Extrems O
: O
( O
+ O
) O
1 O
ptiting O
edema O
bilat O
1/3 O
up O
legs O
; O
pulses O
intact O
, O
no O
lesions O
A/P O
: O
70yo O
woman O
w/ O
multiple O
medical O
problems O
, O
overall O
poor O
understanding O
of O
meds O
and O
problems O
. O
 
Pt O
counselled O
regarding O
importance O
of O
no O
sweets O
or O
added O
salt O
in O
her O
diet O
. O
 
She O
needs O
to O
lose O
wt O
for O
both O
her O
medical O
and O
subjectvie O
well O
being O
. O
 
Encouraged O
to O
walk O
as O
tolerated O
, O
elevate O
feet O
when O
seated O
. O
 
Asked O
to O
bring O
all O
meds O
plus O
glucometer O
to O
next O
PCP O
appt O
in O
2 O
wks O
for O
full O
clarification O
. O
 
Cont O
current O
regimen O
for O
now O
until O
completely O
sure O
of O
her O
regimen O
. O
 
Asked O
to O
check O
fingersticks O
when O
feeling O
dizzy O
. O
 
If O
< O
80 O
, O
treat O
w/ O
4oz O
orange O
juice O
and O
healthy O
snack O
. O
 
Sent O
to O
lab O
to O
check O
basic O
panel O
on O
Lasix O
, O
also O
for O
urine O
malb/creat O
for O
hx O
DM O
, O
f/u O
as O
needed O
. O
 
RTC O
to O
PCP O
, O
other O
appts O
as O
scheduled O
, O
prn O
. O
 
_____________________________________________ O
Virginia I-NAME
M I-NAME
Townsend I-NAME
, O
N.P. O
, O
M.S O
. O
 
Record O
date O
: O
2079-10-02 I-DATE
71F O
w/ O
multiple O
medical O
problems O
, O
including O
dCHF O
, O
restrictive O
lung O
disease O
, O
severe O
polyarthritis O
returns O
to O
clinic O
doing O
significantly O
better O
for O
the O
most O
part O
. O
 
Regarding O
her O
shortness O
of O
breath O
, O
she O
undewent O
a O
stress O
test O
which O
was O
completely O
wnl O
. O
 
She O
has O
also O
lost O
some O
weight O
( O
intentional O
) O
and O
states O
that O
, O
although O
she O
still O
gets O
short O
of O
breath O
with O
exertion O
, O
it O
is O
noticeably O
better O
. O
 
She O
is O
being O
followed O
by O
the O
pulmonary O
department O
and O
is O
under O
consideration O
for O
a O
cardiopulmonary O
exercise O
test O
. O
 
For O
her O
cough O
, O
the O
nexium O
has O
helped O
a O
lot O
and O
she O
likely O
has O
sig O
reflux O
despite O
the O
negative O
esophagram O
. O
 
The O
weight O
loss O
is O
probably O
helping O
with O
the O
gerd O
as O
well O
. O
 
Regarding O
her O
arthritis O
, O
he O
L O
shoulder O
pain O
is O
much O
improved O
with O
PT O
. O
 
Her O
biggest O
complaint O
at O
the O
moment O
, O
though O
, O
is O
her O
low O
back O
pain O
. O
 
She O
was O
seen O
in O
pain O
clinic O
for O
two O
injections O
. O
 
She O
states O
that O
the O
injections O
may O
have O
helped O
for O
1-2 O
days O
but O
then O
the O
pain O
returned O
. O
 
She O
says O
this O
is O
her O
most O
limiting O
symptom O
. O
 
She O
is O
begging O
for O
narcotics O
. O
 
Lastly O
, O
she O
has O
clear O
stress O
urinary O
incontinence O
, O
was O
cleared O
for O
a O
TOT O
sling O
but O
has O
now O
decided O
to O
push O
this O
procedure O
off O
until O
next O
spring I-DATE
. O
 
Problems O
Hypertension O
Elevated O
cholesterol O
Cervical O
polyp O
endometrial O
polyp O
osteoarthritis O
Sleep O
apnea O
diastolic O
heart O
failure O
Restrictive O
pulmonary O
disease O
Diabetes O
mellitus O
type O
2 O
Medications O
Caltrate O
and O
D O
2 O
TABS O
PO O
qd O
, O
keep O
md O
appt O
for O
11/15/77 I-DATE
Zantac O
( O
RANITIDINE O
HCL O
) O
150MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
keep O
md O
appt O
for O
oct I-DATE
12 I-DATE
Percocet O
( O
OXYCODONE+APAP O
) O
325-5 O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
x O
30 O
days O
Ativan O
( O
LORAZEPAM O
) O
1 O
MG O
( O
1MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Naproxen O
375 O
MG O
( O
375MG O
TABLET O
take O
1 O
) O
PO O
BID O
x O
30 O
days O
Miralax O
( O
POLYETHYLENE O
GLYCOL O
) O
17 O
GM O
PO O
QD O
x O
7 O
days O
, O
Each O
17 O
GM O
dose O
to O
be O
dissolved O
in O
8 O
oz O
of O
water O
Estrace O
( O
ESTRADIOL O
) O
1 O
GM O
( O
0.01 O
% O
CREAM/APPL O
) O
PV O
BIW O
Nexium O
( O
ESOMEPRAZOLE O
) O
40 O
MG O
( O
40MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
bid O
x O
30 O
days O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
x O
30 O
days O
Hydrochlorothiazide O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
Levothyroxine O
SODIUM O
100MCG O
TABLET O
PO O
QD O
Colace O
( O
DOCUSATE O
SODIUM O
) O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
x O
30 O
days O
, O
keep O
md O
appt O
oct I-DATE
12 I-DATE
2077 I-DATE
for O
more O
refills O
Loratadine O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Neurontin O
( O
GABAPENTIN O
) O
300 O
MG O
( O
300MG O
CAPSULE O
take O
1 O
) O
PO O
TID O
x O
30 O
days O
, O
generic O
ok O
; O
keep O
md O
appt O
for O
11/15/77 I-DATE
Fosamax O
( O
ALENDRONATE O
) O
70 O
MG O
( O
70MG O
TABLET O
take O
1 O
) O
PO O
QWEEK O
Diovan O
( O
VALSARTAN O
) O
160 O
MG O
( O
160MG O
TABLET O
take O
1 O
) O
PO O
QD O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Metformin O
Variable O
( O
500MG/5ML O
SOLUTION O
take O
1 O
ML O
) O
PO O
Calcium O
+ O
D O
( O
500 O
ELEM O
. O
 
CA O
) O
( O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
500MG O
ELEM O
CA O
) O
/ O
VIT O
D O
200 O
IU O
) O
) O
2 O
TAB O
( O
500MG-200 O
TABLET O
) O
PO O
Q12H O
x O
30 O
days O
Senna O
TABLETS O
( O
SENNOSIDES O
) O
2 O
TAB O
( O
187MG O
TABLET O
) O
PO O
BID O
x O
30 O
days O
Lipitor O
( O
ATORVASTATIN O
) O
10 O
MG O
PO O
QD O
Carvedilol O
6.25 O
MG O
( O
6.25MG O
TABLET O
take O
1 O
) O
PO O
BID O
Oxycodone O
5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
q12h O
PRN O
pain O
Allergies O
Penicillins O
- O
rash O
, O
Gadolinium O
Chelates O
- O
Itching O
, O
Hives O
, O
Bronchospasm O
or O
Wheezing O
: O
8/03/76 I-DATE
Patient O
developed O
a O
moderate O
( O
grade O
II O
) O
reaction O
to O
Gadolinuim O
. O
 
Based O
on O
this O
even O
, O
recommendations O
for O
future O
studies O
include O
pre-treatment O
with O
corticosteroids O
followed O
by O
Gadolinium O
chealtes O
. O
 
PE O
: O
BP O
138/76 O
, O
P O
67 O
, O
Wt O
199 O
lb O
( O
from O
214 O
) O
FINGER O
BLOOD O
GLUCOSE O
104 O
JVP O
flat O
, O
lungs O
clear O
w/ O
scant O
crackles O
rrr O
s1 O
s2 O
abd O
obese O
, O
nt/nd/ O
+BS O
No O
edema O
A/P O
: O
71F O
w/ O
MMPs O
including O
CAD O
w/ O
recent O
normal O
MIBI O
, O
diastolic O
CHF O
, O
restrictive O
lung O
disease O
, O
osteoarthritis O
returns O
to O
clinic O
doing O
somewhat O
better O
than O
before O
. O
 
1 O
) O
CV O
: O
Pt O
has O
diastolic O
CHF O
, O
w/ O
vol O
status O
cont O
to O
be O
improved O
on O
exam O
w/ O
almost O
no O
le O
edema O
on O
lasix O
( O
minimal O
hjr O
) O
. O
 
She O
still O
c/o O
doe O
but O
even O
this O
is O
much O
improved O
. O
 
Etiology O
is O
likely O
multifactorial O
( O
restrictive O
lung O
, O
diastolic O
chf O
, O
obesity/OSA/deconditioning O
) O
. O
 
Recent O
echo O
w/ O
EF O
65 O
% O
and O
DD O
. O
 
Recent O
MIBI O
wnl O
-- O
no O
ischemia O
. O
 
BP O
well O
controlled O
and O
HR O
60s O
. O
 
Cont O
to O
eat O
salt O
. O
 
-cont O
diovan O
160 O
, O
hctz O
25 O
, O
lasix O
20 O
, O
carvedilol O
, O
plavix O
( O
per O
family O
doc O
) O
, O
lipitor O
. O
 
-Close O
monitoring O
of O
electrolytes O
. O
 
Re-check O
today O
. O
 
-low O
fat O
, O
low O
Na O
diet O
-Check O
lytes O
, O
LFTs O
today O
. O
 
-F/U O
with O
cardiology O
in O
clinic O
2 O
) O
Pulm O
: O
Shortness O
of O
breath O
likely O
multifactorial O
. O
 
Recent O
PFTs O
reveal O
presence O
of O
restrictive O
lung O
disease O
with O
impaired O
diffusion O
. O
 
However O
, O
effort O
was O
sub-optimal O
and O
patient O
volume O
overloaded O
. O
 
Also O
w/ O
significant O
obesity O
. O
 
Pt O
had O
recent O
sleep O
study O
confirming O
OSA O
. O
 
CT O
chest O
w/ O
non-specific O
findings O
and O
an O
`` O
indeterminate O
'' O
nodule O
. O
 
-Am O
not O
opposed O
to O
cardiopulmonary O
testing O
per O
pulmonary O
, O
though O
sxs O
are O
slowly O
improving O
. O
 
-Pt O
would O
like O
to O
discuss O
w/ O
pulm O
re O
: O
CPAP O
for O
her O
OSA O
. O
 
Will O
hold O
off O
setting O
up O
cpap O
titration O
until O
then O
. O
 
-Repeat O
CT O
chest O
regarding O
pulm O
nodule O
-- O
likely O
benign O
-F/u O
in O
pulm O
dept O
3 O
) O
Endocrine O
: O
Pt O
w/ O
recently O
diagnosed O
diabetes O
w/ O
hba1c O
about O
6.8 O
. O
 
FS O
log O
reveals O
good O
AM O
glycemic O
control O
. O
 
Also O
w/ O
a O
hx O
of O
hypothyroidism O
. O
 
Feeling O
cold O
recently O
, O
needs O
more O
test O
strips O
. O
 
-Cont O
metfromin O
to O
1000/500 O
. O
 
-Check O
Hba1c O
at O
next O
visit O
. O
 
-Cont O
Home O
glucometer O
. O
 
Refills O
given O
. O
 
-Re-check O
TSH O
today O
. O
 
-Re-emphasized O
need O
for O
continued O
weight O
loss O
and O
congratulated O
patient O
on O
recent O
efforts O
. O
 
4 O
) O
OB/GYN O
: O
Hx O
of O
thickened O
endometrial O
stripe O
, O
but O
normal O
endometrial O
bipsy O
. O
 
Also O
hx O
of O
atrophic O
vaginitis O
prescribed O
topical O
estrogen O
cream O
. O
 
Not O
currently O
sexually O
active O
. O
 
Also O
w/ O
urinary O
incontinence O
, O
needs O
a O
TOT O
sling O
but O
pushing O
this O
off O
for O
now O
. O
 
-cont O
topical O
estradiol O
-f/u O
in O
ob/gyn O
regarding O
sling O
in O
future O
. O
 
5 O
) O
GI O
: O
Patient O
c/o O
sensation O
of O
fullness O
in O
throat O
, O
occasional O
dysphagia O
w/ O
regurgitation O
now O
improved O
on O
increased O
dose O
of O
nexium O
. O
 
Barium O
swallow O
wnl O
. O
 
Has O
abd O
scar O
w/ O
mild O
drainage O
tract O
. O
 
Per O
surgery O
, O
correction O
only O
needed O
for O
cosmetic O
purposes O
. O
 
+gallstones O
on O
CT. O
-Cont O
nexium O
BID O
-weight O
loss O
6 O
) O
MSK O
: O
Has O
degenerative O
disk O
disease O
, O
arthritis O
s/p O
lumbar O
fusion O
. O
 
Also O
w/ O
R O
and O
L O
glenohumeral O
OA O
, O
b/l O
knee O
OA O
s/p O
knee O
replacements O
. O
 
Recently O
dxd O
carpal O
tunnel O
b/l O
s/p O
tunnel O
release O
. O
 
Recent O
lumbar O
injection O
w/ O
only O
transient O
pain O
relief O
. O
 
Requesting O
oxycodone O
. O
 
-Cont O
ibuprofen O
for O
pain O
. O
 
-Will O
prescribe O
oxycodone O
5mg O
BID O
prn O
pain O
. O
 
Pt O
informed O
that O
I O
am O
still O
hoping O
that O
this O
be O
temporary O
. O
 
However O
, O
may O
need O
chronic O
narcotics O
if O
cant O
get O
relief O
from O
pain O
clinic O
. O
 
-f/u O
in O
pain O
clinic O
for O
repeat O
injection/eval O
. O
 
-F/u O
with O
Dr O
Ferrara I-NAME
in O
ortho O
clinic O
7 O
) O
Health O
: O
- O
mammogram O
on O
7/16/79 I-DATE
wnl O
. O
 
-Will O
need O
repeat O
colonoscopy O
in O
2.5 O
years O
2/2 O
polyp/small O
adenoma O
at O
old O
colonoscopy O
. O
 
-Desperately O
needs O
to O
cont O
to O
lose O
weight O
. O
 
Nutrition O
f/u O
. O
 
-RTC O
to O
see O
me O
in O
two O
months O
. O
 
_____________________________________________ O
Erik I-NAME
D. I-NAME
Raines I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2080-05-27 I-DATE
71F O
w/ O
MMPs O
returns O
to O
clinic O
for O
a O
routine O
f/u O
visit O
. O
 
Since O
I O
last O
saw O
her O
, O
she O
has O
made O
some O
nice O
strides O
. O
 
Her O
breathing O
and O
ability O
to O
exert O
herself O
is O
significantly O
better O
w/ O
BP O
control O
, O
diuretics O
, O
control O
of O
gerd O
, O
and O
mild O
weight O
loss O
. O
 
She O
had O
a O
sling O
placed O
for O
incontinence O
which O
has O
helped O
. O
 
She O
also O
has O
some O
improved O
back O
pain O
w/ O
lidoderm O
patches O
and O
prn O
oxycodone O
. O
 
She O
had O
a O
sleep O
study O
recently O
confirming O
the O
presence O
of O
sleep O
apnea O
. O
 
Problems O
Hypertension O
Elevated O
cholesterol O
Cervical O
polyp O
endometrial O
polyp O
osteoarthritis O
Sleep O
apnea O
diastolic O
heart O
failure O
Restrictive O
pulmonary O
disease O
Diabetes O
mellitus O
type O
2 O
Medications O
Calcium O
+ O
D I-NAME
( O
500 O
ELEM O
. O
 
CA O
) O
( O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
500MG O
ELEM O
CA O
) O
/ O
VIT O
D I-NAME
200 O
IU O
) O
) O
2 O
TAB O
( O
500MG-200 O
TABLET O
) O
PO O
Q12H O
Carvedilol O
6.25 O
MG O
( O
6.25MG O
TABLET O
take O
1 O
) O
PO O
BID O
Celebrex O
( O
CELECOXIB O
) O
100 O
MG O
( O
100MG O
CAPSULE O
take O
1 O
) O
PO O
BID O
Diovan O
( O
VALSARTAN O
) O
160 O
MG O
( O
160MG O
TABLET O
take O
1 O
) O
PO O
QD O
Fosamax O
( O
ALENDRONATE O
) O
70 O
MG O
( O
70MG O
TABLET O
take O
1 O
) O
PO O
QWEEK O
Hydrochlorothiazide O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
QD O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
Levothyroxine O
SODIUM O
100MCG O
TABLET O
PO O
QD O
Lidoderm O
5 O
% O
PATCH O
( O
LIDOCAINE O
5 O
% O
PATCH O
) O
1 O
PATCH O
( O
5 O
% O
ADH O
. O
 
PATCH O
) O
TRANSDERMAL O
QD O
, O
Patch O
should O
be O
applied O
to O
intact O
skin O
only O
, O
covering O
the O
most O
painful O
area O
( O
s O
) O
. O
 
Remove O
release O
liner O
and O
apply O
up O
to O
3 O
patches O
at O
one O
time O
, O
for O
up O
to O
12 I-DATE
hours O
within O
a O
24-hour O
period O
. O
 
Patches O
may O
be O
cut O
into O
smaller O
sizes O
with O
scissors O
prior O
to O
removal O
of O
the O
release O
liner O
. O
 
Loratadine O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
Metformin O
Variable O
( O
500MG/5ML O
SOLUTION O
take O
1 O
ML O
) O
PO O
Neurontin O
( O
GABAPENTIN O
) O
300 O
MG O
( O
300MG O
CAPSULE O
take O
1 O
) O
PO O
TID O
x O
30 O
days O
Percocet O
( O
OXYCODONE+APAP O
) O
325-5 O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
TID O
x O
30 O
days O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
take O
1 O
) O
PO O
QD O
Prilosec O
( O
OMEPRAZOLE O
) O
20 O
MG O
( O
20MG O
CAPSULE O
DR O
take O
1 O
) O
PO O
QD O
Senna O
TABLETS O
( O
SENNOSIDES O
) O
2 O
TAB O
( O
187MG O
TABLET O
) O
PO O
BID O
Zantac O
( O
RANITIDINE O
HCL O
) O
150MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
, O
keep O
md O
appt O
for O
oct I-DATE
12 I-DATE
Zocor O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
, O
to O
replace O
lipitor O
Allergies O
Penicillins O
- O
rash O
, O
Gadolinium O
Chelates O
- O
Itching O
, O
Hives O
, O
Bronchospasm O
or O
Wheezing O
: O
8/03/76 I-DATE
Patient O
developed O
a O
moderate O
( O
grade O
II O
) O
reaction O
to O
Gadolinuim O
. O
 
Based O
on O
this O
even O
, O
recommendations O
for O
future O
studies O
include O
pre-treatment O
with O
corticosteroids O
followed O
by O
Gadolinium O
chealtes O
. O
 
PE O
: O
PULSE O
67 O
BLOOD O
PRESSURE O
124/62 O
WEIGHT O
202 O
lb O
FINGER O
BLOOD O
GLUCOSE O
103 O
well O
appearing O
, O
nad O
, O
JVP O
7 O
lungs O
clear O
, O
rrr O
s1 O
s2 O
soft O
sys O
murmur O
abd O
soft O
nt/nd O
+bs O
legs O
w/ O
essentially O
no O
edema O
A/P O
: O
71F O
w/ O
MMPs O
including O
CAD O
w/ O
recent O
normal O
MIBI O
, O
diastolic O
CHF O
, O
restrictive O
lung O
disease O
, O
osteoarthritis O
returns O
to O
clinic O
doing O
better O
than O
before O
. O
 
1 O
) O
CV O
: O
Pt O
has O
diastolic O
CHF O
, O
w/ O
vol O
status O
cont O
to O
be O
improved O
on O
exam O
w/ O
almost O
no O
le O
edema O
on O
lasix O
( O
minimal O
hjr O
) O
. O
 
She O
still O
c/o O
doe O
but O
even O
this O
is O
much O
improved O
. O
 
Etiology O
is O
likely O
multifactorial O
( O
restrictive O
lung O
, O
diastolic O
chf O
, O
obesity/OSA/deconditioning O
) O
. O
 
Recent O
echo O
w/ O
EF O
65 O
% O
and O
DD O
. O
 
Recent O
MIBI O
wnl O
-- O
no O
ischemia O
. O
 
BP O
well O
controlled O
and O
HR O
60s O
. O
 
Cont O
to O
eat O
salt O
. O
 
-cont O
diovan O
160 O
, O
hctz O
25 O
, O
lasix O
20 O
, O
carvedilol O
, O
plavix O
( O
per O
family O
doc O
) O
, O
lipitor O
. O
 
-Close O
monitoring O
of O
electrolytes O
. O
 
Re-check O
today O
. O
 
-low O
fat O
, O
low O
Na O
diet O
-Check O
lytes O
, O
LFTs O
today O
. O
 
-F/U O
with O
cardiology O
in O
clinic O
2 O
) O
Pulm O
: O
Shortness O
of O
breath O
likely O
multifactorial O
. O
 
Recent O
PFTs O
reveal O
presence O
of O
restrictive O
lung O
disease O
with O
impaired O
diffusion O
. O
 
However O
, O
effort O
was O
sub-optimal O
and O
patient O
volume O
overloaded O
. O
 
Also O
w/ O
significant O
obesity O
. O
 
Pt O
had O
recent O
sleep O
study O
confirming O
OSA O
. O
 
CT O
chest O
w/ O
non-specific O
findings O
and O
an O
`` O
indeterminate O
'' O
nodule O
. O
 
-Am O
not O
opposed O
to O
cardiopulmonary O
testing O
per O
pulmonary O
, O
though O
sxs O
are O
slowly O
improving O
. O
 
-Had O
+ O
sleep O
study O
and O
have O
provided O
Rx O
for O
cpap O
to O
begin O
next O
month O
. O
 
-Repeat O
CT O
chest O
regarding O
pulm O
nodule O
-- O
likely O
benign O
-F/u O
in O
pulm O
dept O
3 O
) O
Endocrine O
: O
Pt O
w/ O
recently O
diagnosed O
diabetes O
w/ O
hba1c O
about O
6.8 O
. O
 
FS O
log O
reveals O
good O
AM O
glycemic O
control O
. O
 
Also O
w/ O
a O
hx O
of O
hypothyroidism O
. O
 
Feeling O
cold O
recently O
, O
needs O
more O
test O
strips O
. O
 
-Cont O
metfromin O
500 O
BID O
. O
 
-Check O
Hba1c O
. O
 
-Cont O
Home O
glucometer O
. O
 
Refills O
given O
. O
 
-Re-check O
TSH O
today O
for O
complaints O
of O
feeling O
cold O
. O
 
-Re-emphasized O
need O
for O
continued O
weight O
loss O
and O
congratulated O
patient O
on O
recent O
efforts O
. O
 
4 O
) O
OB/GYN O
: O
Hx O
of O
thickened O
endometrial O
stripe O
, O
but O
normal O
endometrial O
bipsy O
. O
 
Also O
hx O
of O
atrophic O
vaginitis O
prescribed O
topical O
estrogen O
cream O
. O
 
Not O
currently O
sexually O
active O
. O
 
Also O
w/ O
urinary O
incontinence O
s/p O
sling O
w/ O
improvement O
. O
 
-cont O
topical O
estradiol O
-f/u O
in O
ob/gyn O
clinic O
5 O
) O
GI O
: O
Patient O
c/o O
sensation O
of O
fullness O
in O
throat O
, O
occasional O
dysphagia O
w/ O
regurgitation O
now O
improved O
on O
increased O
dose O
of O
nexium O
. O
 
Barium O
swallow O
wnl O
. O
 
Has O
abd O
scar O
w/ O
mild O
drainage O
tract O
. O
 
Per O
surgery O
, O
correction O
only O
needed O
for O
cosmetic O
purposes O
. O
 
+gallstones O
on O
CT. O
-Cont O
nexium O
BID O
-weight O
loss O
6 O
) O
MSK O
: O
Has O
degenerative O
disk O
disease O
, O
arthritis O
s/p O
lumbar O
fusion O
. O
 
Also O
w/ O
R O
and O
L O
glenohumeral O
OA O
, O
b/l O
knee O
OA O
s/p O
knee O
replacements O
. O
 
Recently O
dxd O
carpal O
tunnel O
b/l O
s/p O
tunnel O
release O
. O
 
Recent O
lumbar O
injection O
w/ O
only O
transient O
pain O
relief O
. O
 
Requesting O
oxycodone O
. O
 
-Cont O
ibuprofen O
for O
pain O
and O
represcribe O
lidoderm O
patch O
which O
seems O
to O
help O
. O
 
-Will O
cont O
oxycodone O
5mg O
BID O
prn O
pain O
. O
 
Pt O
informed O
that O
I O
am O
still O
hoping O
that O
this O
be O
temporary O
. O
 
However O
, O
may O
need O
chronic O
narcotics O
if O
cant O
get O
relief O
from O
pain O
clinic O
. O
 
-f/u O
in O
pain O
clinic O
for O
repeat O
injection/eval O
. O
 
-F/u O
with O
Dr O
Ferrara I-NAME
in O
ortho O
clinic O
7 O
) O
Health O
: O
- O
mammogram O
on O
7/16/79 I-DATE
wnl O
. O
 
-Will O
need O
repeat O
colonoscopy O
in O
2.5 O
years O
2/2 O
polyp/small O
adenoma O
at O
old O
colonoscopy O
. O
 
-Desperately O
needs O
to O
cont O
to O
lose O
weight O
. O
 
Nutrition O
f/u O
. O
 
-RTC O
to O
see O
me O
in O
three O
months O
. O
 
_____________________________________________ O
Erik I-NAME
D I-NAME
Raines I-NAME
, O
MD O
========================== O
Preceptor O
's O
Note O
========================== O
Discussed O
with O
Dr. O
Raines I-NAME
. O
 
71 I-AGE
yo O
woman O
with O
multiple O
medical O
problems O
including O
DM O
, O
HTN O
, O
OSA O
, O
obesity O
. O
 
We O
will O
arrange O
for O
CPAP O
. O
 
_____________________________________________ O
Tannon I-NAME
Jose I-NAME
Olivares I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2120-10-23 I-DATE
Patient O
Name O
: O
FLAHERTY O
, O
XAVIER I-NAME
; O
MRN O
: O
1935081 I-ID
Dictated O
on O
: O
10/23/2120 I-DATE
by O
ROSITA I-NAME
KO I-NAME
, O
M.D O
. O
 
The O
patient O
is O
a O
72-year-old O
male O
, O
paraplegic O
, O
referred O
for O
evaluation O
of O
recurrent O
bladder O
infections O
. O
 
The O
patient O
has O
persistent O
presence O
of O
bacteria O
in O
his O
urine O
and O
there O
is O
a O
concern O
that O
he O
might O
have O
a O
persistent O
source O
of O
infection O
. O
 
The O
patient O
denies O
fevers O
, O
chills O
, O
sweats O
, O
decrease O
in O
energy O
, O
loss O
of O
appetite O
, O
pain O
in O
the O
lower O
abdomen O
or O
penile O
discharge O
. O
 
He O
reports O
there O
is O
some O
soreness O
around O
the O
meatus O
, O
which O
he O
attributes O
to O
self-catheterizing O
he O
is O
required O
to O
do O
3 O
times O
a O
day O
. O
 
He O
is O
well O
educated O
in O
terms O
of O
cleaning O
around O
the O
side O
and O
the O
appropriate O
way O
to O
do O
self-catheterization O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Diabetes O
, O
hypertension O
, O
paraplegia O
secondary O
to O
unclear O
disk O
problems O
in O
2107 I-DATE
, O
right O
hip O
ulcer O
with O
trochanteric O
osteomyelitis O
in O
December I-DATE
2118 I-DATE
, O
treated O
with O
Unasyn O
x6 O
weeks O
and O
debridement O
and O
surgical O
flap O
, O
sacral O
decubiti O
in O
2119 I-DATE
treated O
with O
Unasyn O
x6 O
weeks O
, O
local O
debridement O
healing O
by O
secondary O
intention O
. O
 
No O
history O
of O
kidney O
stones O
. O
 
SOCIAL O
: O
Ex-tobacco O
use O
2-3 O
packs O
per O
day O
, O
quit O
25 O
years O
. O
 
Alcohol O
prior O
heavy O
use O
, O
quit O
25 O
years O
. O
 
Lives O
alone O
. O
 
Prior O
work O
included O
Heavy-Duty I-PROFESSION
Equipment I-PROFESSION
Mechanic I-PROFESSION
, O
Ironworker I-PROFESSION
, O
as O
well O
as O
Electric I-PROFESSION
Appliance I-PROFESSION
Servicer I-PROFESSION
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
MEDICATIONS O
: O
Blood O
pressure O
medication O
, O
name O
unknown O
. O
 
Metformin O
. O
 
Note O
, O
patient O
had O
been O
on O
Bactrim O
prophylaxis O
over O
the O
spring I-DATE
. O
 
PHYSICAL O
EXAMINATION O
: O
Blood O
pressure O
150/100 O
, O
heart O
rate O
100 O
, O
temperature O
97.9 O
. O
 
In O
general O
, O
vigorous O
, O
well-appearing O
man O
in O
wheelchair O
. O
 
Awake O
and O
alert O
. O
 
HEENT O
, O
sclerae O
anicteric O
. O
 
Conjunctivae O
noninjected O
. O
 
Neck O
supple O
. O
 
No O
significant O
lymphadenopathy O
. O
 
Chest O
, O
clear O
to O
auscultation O
bilaterally O
. O
 
Cardiac O
, O
regular O
rate O
and O
rhythm O
. O
 
No O
murmurs O
. O
 
Abdomen O
benign O
. O
 
Extremities O
, O
warm O
and O
well O
perfused O
. O
 
No O
edema O
. O
 
IMPRESSION O
: O
Presence O
of O
bacteria O
in O
static O
urine O
within O
the O
bladder O
is O
not O
necessarily O
diagnostic O
as O
infection O
given O
patient O
's O
lack O
of O
symptoms O
and O
likely O
reflects O
colonization O
. O
 
PLAN O
: O
Would O
not O
treat O
patient O
with O
antibiotics O
unless O
he O
develops O
signs O
or O
symptoms O
of O
infection O
such O
as O
fevers O
, O
chills O
, O
sweats O
, O
elevated O
white O
blood O
cell O
count O
, O
pain O
in O
the O
suprapubic O
area O
or O
decreased O
energy O
. O
 
_________________________ O
Rosita I-NAME
Ko I-NAME
, O
M.D O
. O
 
DD:10/23/2120 O
DT:10/24/2120 O
AO:29724 I-ID
:0269 I-ID
 
Record O
date O
: O
2121-05-19 I-DATE
Internal O
Medicine O
HOLY I-LOCATION
CROSS I-LOCATION
HOSPITAL I-LOCATION
History O
of O
present O
illness O
The O
patient O
is O
a O
72 I-AGE
year O
old O
male O
, O
with O
a O
past O
medical O
history O
of O
paraplegia O
( O
due O
to O
spinal O
ischemia O
) O
, O
DMII O
, O
HTN O
, O
and O
recurrent O
UTI O
's O
, O
who O
came O
in O
for O
a O
follow O
up O
visit O
. O
 
The O
patient O
says O
that O
he O
has O
been O
feeling O
well O
. O
 
He O
continues O
to O
exercise O
frequently O
. O
 
No O
chest O
pain O
, O
abdominal O
pain O
, O
SOB O
, O
or O
fevers O
. O
 
Allergies O
No O
known O
drug O
allergy O
Change O
in O
therapies O
and O
Renewals O
Zestril O
30mg O
PO O
QD O
QTY:90 O
Refills:3 O
Start O
: O
11/22/2118 I-DATE
iron O
supplement O
325mg O
po O
qd O
QTY:30 O
Refills:1 O
year O
Start O
: O
6/15/2119 I-DATE
aspirin O
81 O
mg O
po O
qd O
QTY:30 O
Refills:1 O
yr O
Start O
: O
6/15/2119 I-DATE
Xanax O
0.25mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
6/15/2119 I-DATE
free O
text O
medications O
regranex O
45 O
gram O
QTY:1 O
Refills:1 O
yr O
Start O
: O
6/19/2119 I-DATE
Glucophage O
850 O
mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
7/18/2120 I-DATE
take O
with O
meals O
Lipitor O
20mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
4/07/2121 I-DATE
Neurontin O
300 O
mg O
po O
tid O
QTY:270 O
Refills:3 O
Start O
: O
4/07/2121 I-DATE
multivitamins O
1 O
tab O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
5/19/2121 I-DATE
atenolol O
25mg O
po O
qd O
Start O
: O
5/19/2121 I-DATE
Past O
medical O
history O
Paraplegia- O
On O
10/06 I-DATE
the O
patient O
had O
a O
lumbar O
laminectomy O
for O
sciatica O
. O
 
His O
sciatical O
pain O
improved O
until O
5/07 I-DATE
when O
he O
developed O
proximal O
leg O
weakness O
. O
 
By O
7/07 I-DATE
the O
patient O
was O
bound O
to O
a O
wheelchair O
. O
 
Orginally O
an O
extensive O
workup O
suggested O
that O
the O
patient O
had O
an O
extramedullary O
tumor O
from O
T8-T12 O
. O
 
However O
all O
biopsies O
were O
inconclusive O
. O
 
The O
patient O
subsequently O
received O
a O
T10 O
laminectomy O
on O
9/09 I-DATE
that O
revealed O
Spinal O
Vascular O
Malformation O
but O
no O
tumor O
. O
 
The O
patient O
received O
serial O
MRI O
's O
until O
12/14 I-DATE
that O
were O
able O
to O
demonstrate O
no O
`` O
recurrent O
'' O
tumors O
. O
 
DMII-first O
diagnosed O
in O
2113 I-DATE
HTN O
Recurrent O
UTI O
's O
PSA O
of O
6.6 O
Flap O
3 O
Closure O
Surgery-patient O
says O
that O
he O
received O
this O
surgery O
to O
correct O
damage O
to O
his O
skin O
caused O
by O
his O
multiple O
back O
surgeries O
2690 O
's O
received O
surgery O
for O
shrapnel O
removal O
Sacral O
decubitus O
ulcers O
Family O
history O
Father O
- O
was O
an O
alcoholic O
who O
died O
in O
an O
accident O
Mom- O
died O
at O
the O
age O
of O
76 I-AGE
with O
peripheral O
vascular O
disease O
Brother- O
died O
in O
50 O
's O
of O
CAD O
, O
was O
an O
alcoholic O
Social O
history O
The O
patient O
lives O
alone O
. O
 
He O
never O
married O
and O
has O
no O
children O
. O
 
He O
is O
a O
retired O
Heavy-Duty I-PROFESSION
Equipment I-PROFESSION
Mechanic I-PROFESSION
( O
15yrs O
) O
and O
Concrete I-PROFESSION
Finisher I-PROFESSION
( O
25yrs O
) O
. O
 
He O
is O
a O
veteran I-PROFESSION
. O
 
The O
patient O
quit O
smoking O
20 O
years O
ago O
but O
had O
smoked O
1.5ppd O
* O
20yrs O
( O
30 O
pack O
year O
) O
. O
 
Very O
rarely O
drinks O
. O
 
Physical O
examination O
Pulse O
92 O
Blood O
pressure O
150/80 O
Respiratory O
rate O
16 O
General O
appearance O
NAD O
Heent O
PERRLA O
, O
EOMI O
, O
no O
oral O
erythema O
or O
lesions O
Chest O
b/l O
clear O
to O
ascultation O
Cor O
S1/S2+ O
, O
RRR O
, O
no O
murmurs O
Abdomen O
Nt/nd/ O
+bs O
Extrem O
no O
edema O
Assessment O
and O
plan O
The O
patient O
is O
a O
72 I-AGE
year O
old O
male O
, O
with O
a O
past O
medical O
history O
of O
paraplegia O
( O
due O
to O
spinal O
ischemia O
) O
, O
DMII O
, O
HTN O
, O
and O
recurrent O
UTI O
's O
, O
who O
came O
in O
for O
a O
follow O
up O
visit O
. O
 
1 O
. O
 
Diabetes O
-HemA1C O
10/20- O
> O
7.5 O
. O
 
Will O
recheck O
-cont O
metformin O
to O
850mg O
bid O
- O
Ordered O
repeat O
chem O
7 O
( O
creatinine O
) O
and O
LFTs O
-patient O
sees O
an O
opthamologist O
yearly O
-referred O
patient O
again O
to O
podiatrist O
-NEXT O
visit O
patient O
will O
bring O
cath O
supplies O
and O
WILL O
check O
for O
microalbuniuria O
- O
-increased O
lipitor O
to O
20 O
( O
patient O
's O
Chol O
179 O
and O
LDL O
111 O
) O
- O
> O
goal O
LDL O
70 O
-patient O
refused O
nutrition O
consult O
-patient O
is O
taking O
ASA O
-patient O
is O
on O
a O
MVI O
2 O
. O
 
HTN O
-started O
atenolol O
25 O
qd O
-current O
regiment O
is O
atenolol O
25qd O
and O
Zestril O
to O
30mg O
qd O
3 O
. O
 
? O
CAD O
-EKG O
4/21 I-DATE
showed O
evidence O
of O
old O
( O
`` O
silent O
'' O
) O
inferior O
MI O
-ordered O
TTE O
-WILL O
consider O
ETT O
-will O
check O
homocysteine O
level O
3 O
. O
 
Paraplegia O
-on O
neurontin O
for O
neuropathic O
pain O
control O
4.Recurent O
UTI O
-appreciate O
ID O
consult O
will O
give O
prophylaxis O
for O
recurrent O
UTI O
's O
. O
 
Also O
, O
will O
not O
treat O
patient O
unless O
he O
has O
systemic O
symptoms O
of O
fevers O
or O
there O
is O
a O
great O
increase O
in O
the O
amount O
of O
burning O
he O
has O
on O
urination O
5 O
. O
 
Elevated O
PSA O
-appreciate O
urology O
consult O
-they O
felt O
that O
in O
light O
of O
stability O
of O
PSA O
and O
patient O
's O
desire O
not O
be O
biopsied O
that O
no O
intervention O
should O
occur O
at O
this O
time O
. O
 
-urology O
wants O
to O
see O
the O
patient O
annually O
( O
next O
visit O
12/21 I-DATE
) O
6 O
. O
 
Anxiety O
-well O
controlled O
, O
will O
continue O
the O
Zanax O
7 O
. O
 
Health O
Maintenance O
-patient O
has O
received O
pneumovac O
-last O
colonoscopy O
was O
on O
12/18 I-DATE
-NEEDS O
flu O
vaccine O
in O
spring I-DATE
Return O
to O
clinic O
in O
1 O
month O
Addendum O
I O
was O
present O
during O
key O
portions O
of O
the O
evaluation O
of O
the O
patient O
and O
agree O
with O
John I-NAME
Ross I-NAME
's O
findings O
and O
plan O
as O
written.Diabetes O
followup O
good O
. O
 
Appropriately O
managed O
. O
 
Rebecca I-NAME
Downs I-NAME
Signed O
electronically O
by O
John I-NAME
Ross I-NAME
MD O
on O
May I-DATE
25 O
, O
2121 I-DATE
Rebecca I-NAME
Downs I-NAME
MD O
on O
May I-DATE
29 O
, O
2121 I-DATE
 
Record O
date O
: O
2122-09-14 I-DATE
Internal O
Medicine O
HOLY I-LOCATION
CROSS I-LOCATION
HOSPITAL I-LOCATION
History O
of O
present O
illness O
Mr. O
Flaherty I-NAME
is O
a O
74 I-AGE
year O
old O
male O
with O
a O
PMH O
paraplegia O
( O
secondary O
to O
spinal O
ischemia O
) O
, O
DM O
, O
HTN O
, O
sacral O
decibutus O
ulcer O
, O
and O
recurrent O
UTI O
's O
who O
came O
in O
for O
a O
follow O
up O
visit O
. O
 
The O
patient O
says O
that O
he O
feels O
well O
. O
 
He O
says O
that O
his O
fingersticks O
have O
averaged O
about O
`` O
124 O
'' O
and O
have O
ranged O
80-150 O
. O
 
He O
's O
says O
that O
he O
's O
improved O
his O
diet O
. O
 
He O
says O
that O
his O
BP O
has O
been O
checked O
several O
times O
by O
visiting O
nurses O
and O
each O
time O
was O
SBP O
of O
120 O
. O
 
He O
says O
that O
his O
abcess O
under O
his O
left O
axilla O
has O
healed O
well O
and O
is O
no O
longer O
bothering O
him O
. O
 
He O
says O
that O
his O
sacral O
decibutus O
ulcer O
has O
resolved O
. O
 
On O
review O
of O
systems O
, O
no O
chest O
pain O
, O
SOB O
, O
abdominal O
pain O
, O
nausea/vomiting O
, O
fevers O
, O
dysuria O
, O
or O
lightheadnesses O
. O
 
Allergies O
No O
known O
drug O
allergy O
Change O
in O
therapies O
and O
Renewals O
Zestril O
20mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
11/22/2118 I-DATE
iron O
supplement O
325mg O
po O
qd O
QTY:30 O
Refills:1 O
year O
Start O
: O
6/15/2119 I-DATE
aspirin O
81 O
mg O
po O
qd O
QTY:30 O
Refills:1 O
yr O
Start O
: O
6/15/2119 I-DATE
Xanax O
0.25mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
6/15/2119 I-DATE
Glucophage O
1000 O
mg O
po O
bid O
QTY:180 O
Refills:3 O
Start O
: O
7/18/2120 I-DATE
take O
with O
meals O
Lipitor O
20mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
4/07/2121 I-DATE
Neurontin O
300 O
mg O
po O
tid O
QTY:270 O
Refills:3 O
Start O
: O
4/07/2121 I-DATE
multivitamins O
1 O
tab O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
5/19/2121 I-DATE
atenolol O
25mg O
po O
qd O
QTY:90 O
Refills:6 O
Start O
: O
5/19/2121 I-DATE
Past O
medical O
history O
1 O
. O
 
Paraplegia- O
On O
10/06 I-DATE
the O
patient O
had O
a O
lumbar O
laminectomy O
for O
sciatica O
. O
 
His O
sciatical O
pain O
improved O
until O
5/07 I-DATE
when O
he O
developed O
proximal O
leg O
weakness O
. O
 
By O
7/07 I-DATE
the O
patient O
was O
bound O
to O
a O
wheelchair O
. O
 
Orginally O
an O
extensive O
workup O
suggested O
that O
the O
patient O
had O
an O
extramedullary O
tumor O
from O
T8-T12 O
. O
 
However O
all O
biopsies O
were O
inconclusive O
. O
 
The O
patient O
subsequently O
received O
a O
T10 O
laminectomy O
on O
9/09 I-DATE
that O
revealed O
Spinal O
Vascular O
Malformation O
but O
no O
tumor O
. O
 
The O
patient O
received O
serial O
MRI O
's O
until O
12/14 I-DATE
that O
were O
able O
to O
demonstrate O
no O
`` O
recurrent O
'' O
tumors O
. O
 
2 O
. O
 
DMII-first O
diagnosed O
in O
2113 I-DATE
3 O
. O
 
HTN O
4 O
. O
 
Recurrent O
UTI's O
5 O
. O
 
PSA O
of O
6.6 O
6 O
. O
 
Flap O
3 O
Closure O
Surgery-patient O
says O
that O
he O
received O
this O
surgery O
to O
correct O
damage O
to O
his O
skin O
caused O
by O
his O
multiple O
back O
surgeries O
2070 O
's O
received O
surgery O
for O
shrapnel O
removal O
7 O
. O
 
Sacral O
decubitus O
ulcers O
Family O
history O
Father O
- O
was O
an O
alcoholic O
who O
died O
in O
an O
accident O
Mom- O
died O
at O
the O
age O
of O
76 I-AGE
with O
peripheral O
vascular O
disease O
Brother- O
died O
in O
50 O
's O
of O
CAD O
, O
was O
an O
alcoholic O
Social O
history O
The O
patient O
lives O
alone O
. O
 
He O
never O
married O
and O
has O
no O
children O
. O
 
He O
is O
a O
retired O
Heavy-Duty I-PROFESSION
Equipment I-PROFESSION
Mechanic I-PROFESSION
( O
15yrs O
) O
and O
Concrete I-PROFESSION
Finisher I-PROFESSION
( O
25yrs O
) O
. O
 
He O
is O
a O
veteran I-PROFESSION
. O
 
The O
patient O
quit O
smoking O
20 O
years O
ago O
but O
had O
smoked O
1.5ppd O
* O
20yrs O
( O
30 O
pack O
year O
) O
. O
 
Very O
rarely O
drinks O
. O
 
Physical O
examination O
Blood O
pressure O
135/70 O
Pulse O
82 O
Respiratory O
rate O
12 O
General O
appearance O
NAD O
, O
pleasant O
. O
 
In O
a O
wheelchair O
Skin O
Abcess O
under O
left O
axilla O
has O
healed O
well O
. O
 
No O
erythema O
or O
exudate O
. O
 
Heent O
PERRLA O
, O
EOMI O
, O
no O
oral O
erythema O
or O
lesions O
Chest O
b/l O
clear O
to O
ascultation O
Cor O
S1/S2+ O
, O
RRR O
, O
no O
murmurs O
Abdomen O
Nt/nd/ O
+bs O
Rectal O
exam O
refused O
Genitalia O
refused O
Extrem O
no O
edema O
Neuro O
CNII-XII O
intact O
, O
5/5 O
strength O
in O
upper O
2 O
extermities O
, O
no O
numbness O
or O
tingling O
, O
0/5 O
strength O
b/l O
lower O
extremities O
Assessment O
and O
plan O
The O
patient O
is O
a O
74 I-AGE
year O
old O
male O
, O
with O
a O
past O
medical O
history O
of O
paraplegia O
( O
due O
to O
spinal O
ischemia O
) O
, O
DMII O
, O
HTN O
, O
and O
recurrent O
UTI O
's O
, O
who O
came O
in O
for O
a O
follow O
up O
visit O
. O
 
1 O
. O
 
Diabetes O
-spoke O
with O
the O
patient O
about O
his O
diabetes O
control O
. O
 
He O
understands O
that O
his O
hemoglobin O
A1C O
is O
8.4 O
. O
 
However O
, O
he O
doesnt O
want O
to O
start O
insulin O
( O
inconvenient O
) O
and O
actos O
( O
the O
expense O
) O
. O
 
Our O
plan O
is O
to O
check O
another O
hemoglobin O
A1C O
since O
his O
diet O
has O
improved O
. O
 
Will O
consider O
starting O
low O
dose O
glypizide O
if O
hem O
A1C O
still O
grossly O
elevated O
-current O
regiment O
is O
metformin O
1000mg O
bid O
-HemA1C O
2/22 I-DATE
was O
8.5 O
-patient O
sees O
an O
opthamologist O
yearly O
-patient O
saw O
a O
podiatrist O
in O
1/22 I-DATE
-patient O
on O
lipitor O
20 O
- O
> O
9/21 I-DATE
lipid O
panel O
Cholesterol O
147 O
, O
LDL O
67 O
, O
HDL O
42 O
-patient O
is O
taking O
ASA O
-patient O
is O
on O
a O
MVI O
2 O
. O
 
HTN O
-spoke O
with O
the O
patient O
about O
the O
fact O
that O
his O
SBP O
is O
130-135 O
. O
 
He O
said O
that O
he O
would O
like O
to O
hold O
off O
on O
advancing O
treatment O
for O
now O
-for O
now O
will O
continue O
Zestril O
20mg O
qd O
and O
atenolol O
25mg O
po O
qd O
-current O
regiment O
is O
atenolol O
25qd O
and O
Zestril O
10mg O
qd O
3 O
. O
 
Sacral O
decibutus O
ulcer O
-patient O
says O
that O
the O
wound O
has O
healed O
4 O
. O
 
Paraplegia O
-on O
neurontin O
for O
neuropathic O
pain O
control O
-WILL O
CONSIDER O
increase O
the O
dosage O
5.Recurent O
UTI O
-Will O
not O
give O
prophylaxis O
for O
recurrent O
UTI O
's O
. O
 
Also O
, O
will O
not O
treat O
patient O
unless O
he O
has O
systemic O
symptoms O
of O
fevers O
or O
there O
is O
a O
great O
increase O
in O
the O
amount O
of O
burning O
he O
has O
on O
urination O
6 O
. O
 
Elevated O
PSA O
-urology O
felt O
that O
in O
light O
of O
stability O
of O
PSA O
and O
patient O
's O
desire O
not O
be O
biopsied O
that O
no O
intervention O
should O
occur O
at O
this O
time O
. O
 
-urology O
wants O
to O
see O
the O
patient O
annually O
. O
 
Spoke O
with O
the O
patient O
again O
about O
this O
today O
. O
 
He O
doesnt O
want O
to O
see O
urology O
again O
and O
doesnt O
want O
a O
rectal O
exam O
. O
 
7 O
. O
 
Anxiety O
-well O
controlled O
, O
will O
continue O
the O
Zanax O
8 O
. O
 
Health O
Maintenance O
-patient O
has O
received O
pneumovac O
-last O
colonoscopy O
was O
on O
12/18 I-DATE
-gave O
the O
patient O
a O
flu O
vaccine O
( O
9/22 I-DATE
) O
( O
Lot O
BDIKB454QH I-ID
and O
expiration O
7/3/23 I-DATE
) O
Return O
to O
clinic O
in O
2 O
months O
( O
spoke O
to O
patient O
about O
him O
coming O
more O
frequently O
but O
he O
says O
that O
it O
is O
very O
difficult O
to O
come O
in O
so O
he O
'll O
do O
the O
best O
he O
can O
) O
Addendum O
I O
was O
present O
during O
key O
portions O
of O
the O
evaluation O
of O
the O
patient O
and O
agree O
with O
John I-NAME
Ross I-NAME
's O
findings O
and O
plan O
as O
written O
. O
 
Pt O
. O
 
is O
thin O
, O
has O
gotten O
maximum O
benefit O
from O
metformin O
so O
options O
include O
sulfonyurea O
or O
insulin O
. O
 
Francis I-NAME
Lawrence I-NAME
Signed O
electronically O
by O
Ross I-NAME
, O
John I-NAME
on O
Sep I-DATE
21 O
, O
2122 I-DATE
Lawrence I-NAME
, O
Francis I-NAME
X I-NAME
on O
Sep I-DATE
22 O
, O
2122 I-DATE
 
Record O
date O
: O
2126-09-04 I-DATE
Manamana I-LOCATION
5 O
Admission O
Note O
PATIENT O
: O
Flaherty I-NAME
, O
Xavier I-NAME
MRN O
: O
1935081 I-ID
ADMIT O
DATE O
: O
9/04/26 I-DATE
PCP O
: O
Michael I-NAME
Ring I-NAME
MD O
ATTENDING O
PHYSICIAN O
: O
Manamana I-LOCATION
5 O
WARD O
Source O
: O
patient O
, O
chart O
( O
please O
note O
that O
patient O
is O
a O
poor O
historian O
) O
CHIEF O
COMPLAINT- O
s/p O
2 O
falls O
at O
home O
fever O
in O
the O
emergency O
ward O
HISTORY O
OF O
THE O
PRESENT O
ILLNESS O
Mr. O
Flaherty I-NAME
is O
a O
78 I-AGE
yo O
gentleman O
with O
a O
PMH O
notable O
for O
diabetes O
mellitus O
, O
HTN O
, O
paraplegia O
2/2 O
spinal O
vascular O
malformations O
now O
wheelchair O
bound O
with O
a O
suprapubic O
catheter O
, O
and O
multiple O
ulcers O
who O
presents O
after O
2 O
falls O
at O
home O
, O
found O
by O
EMS O
to O
be O
living O
in O
squalor O
and O
found O
to O
have O
a O
Tmax O
of O
104 O
degrees O
F O
in O
the O
emergency O
ward O
. O
 
Patient O
states O
that O
he O
was O
in O
his O
usual O
state O
of O
health O
, O
which O
includes O
wheeling O
himself O
around O
his O
apartment O
and O
preparing O
simple O
meals O
such O
as O
oatmeal O
, O
until O
the O
week O
prior O
to O
admission O
. O
 
Mr O
Flaherty I-NAME
noted O
that O
he O
felt O
& O
# O
8220 O
; O
lousy O
& O
# O
8221 O
; O
throughout O
the O
week O
. O
 
He O
is O
unable O
to O
characterize O
this O
feeling O
, O
stating O
simply O
, O
& O
# O
8220 O
; O
something O
wasn O
& O
# O
8217 O
; O
t O
right. O
& O
# O
8221 O
; O
Patient O
states O
he O
& O
# O
8220 O
; O
may O
have O
felt O
nauseous O
& O
# O
8221 O
; O
and O
& O
# O
8220 O
; O
I O
might O
have O
had O
a O
fever. O
& O
# O
8221 O
; O
However O
, O
patient O
denies O
vomiting O
, O
sick O
contacts O
, O
abdominal O
pain O
, O
change O
in O
appetite O
, O
recent O
antibiotic O
use O
, O
SOB O
, O
DOE O
, O
chest O
pain/pressure/tightness O
, O
suprapubic O
pain O
, O
change O
in O
stool O
caliber/color/frequency O
, O
sore O
throat O
, O
change O
in O
his O
chronic O
cough O
, O
sputum O
production O
, O
drainage O
around O
his O
SPC O
site O
, O
hematemesis O
, O
pain O
at O
his O
ulcer O
sites O
, O
and O
increased O
pus/output O
from O
ulcer O
sites O
. O
 
Of O
note O
, O
patient O
states O
, O
& O
# O
8220 O
; O
If O
it O
wasn O
& O
# O
8217 O
; O
t O
for O
the O
fireman O
, O
I O
wouldn O
& O
# O
8217 O
; O
t O
be O
here O
. O
 
Of O
note O
, O
patient O
states O
, O
& O
# O
8220 O
; O
My O
house O
is O
fine. O
& O
# O
8221 O
; O
He O
denies O
feeling O
unsafe O
at O
home O
, O
denies O
difficulty O
with O
bills O
, O
denies O
rodent/vermin/cockroach O
infestation O
, O
denies O
leaving O
his O
stove O
on O
. O
 
EMS- O
& O
gt O
; O
ED O
course O
: O
Upon O
EMS O
arrival O
, O
they O
found O
his O
apartment O
in O
disarray O
and O
placed O
a O
section O
12 O
order O
. O
 
VS O
: O
BP O
: O
140/90 O
, O
HR O
117 O
, O
RR20 O
, O
T97.1 O
, O
95 O
% O
RA O
, O
after O
blood O
cultures O
were O
drawn O
, O
the O
patient O
was O
started O
on O
unasyn O
, O
given O
a O
500 O
cc O
bolus O
, O
and O
sent O
to O
the O
floor O
. O
 
REVIEW O
OF O
SYSTEMS O
General O
no O
weight O
loss O
, O
gain O
; O
no O
chills O
, O
night O
sweats O
HEENT O
+rhinorrhea O
Pulmonary O
no O
wheezing O
, O
no O
hemoptysis O
Cardiac O
no O
palpitations O
Endocrine O
no O
polydipsia O
, O
polyuria O
, O
or O
polyphagia O
Extremity O
& O
# O
8211 O
; O
no O
lower O
extremity O
edema O
Neurology O
& O
# O
8211 O
; O
no O
headache O
, O
no O
photophobia O
, O
no O
changes O
in O
strength O
or O
sensation O
PAST O
MEDICAL O
HISTORY/PSH O
1 O
. O
 
Paraplegia- O
2/2 O
spinal O
ischemia O
from O
surgical O
complication O
2 O
. O
 
DMII O
- O
first O
diagnosed O
in O
2113 I-DATE
, O
last O
A1C O
8.4 O
( O
8/1/26 I-DATE
) O
3 O
. O
 
HTN O
4 O
. O
 
Recurrent O
UTI O
's O
( O
requires O
catheterization O
to O
urinate O
) O
5 O
. O
 
PSA O
of O
6.6 O
6 O
. O
 
2070 O
's O
received O
surgery O
for O
shrapnel O
removal O
7 O
. O
 
Sacral O
decubitus O
ulcers O
MEDICATIONS O
ON O
ADMISSION O
- O
iron O
supplement O
325mg O
po O
bid O
- O
from O
325mg O
po O
daily O
- O
Rx O
( O
Qty:180 O
Rf:3 O
) O
- O
aspirin O
81 O
mg O
po O
daily- O
atenolol O
50mg O
po O
daily O
( O
called O
to O
pharm O
) O
- O
Colace O
100mg O
1 O
po O
daily O
take O
one O
tab O
tid- O
Glucophage O
1000 O
mg O
po O
bid O
take O
with O
meals- O
Lantus O
SoloStar O
Pen O
10 O
units O
sc O
at O
bedtime- O
Lipitor O
20mg O
po O
daily- O
multivitamins O
1 O
tab O
po O
daily- O
Neurontin O
600 O
mg O
po O
tid- O
Xanax O
0.25mg O
po O
bid O
prn- O
Zestril O
40mg O
po O
daily O
ALLERGIES/ADVERSE O
REACTIONS O
nkda O
FAMILY O
HISTORY O
Father O
- O
was O
an O
alcoholic O
who O
died O
in O
an O
accident O
Mom- O
died O
at O
the O
age O
of O
76 I-AGE
with O
peripheral O
vascular O
disease O
Brother- O
died O
in O
50 O
's O
of O
CAD O
, O
was O
an O
alcoholic O
SOCIAL O
HISTORY O
General O
& O
# O
8211 O
; O
Pt O
lives O
alone O
in O
a O
2 O
bdr O
apt O
. O
 
Needs O
help O
with O
shopping O
, O
which O
he O
gets O
from O
his O
good O
friend O
. O
 
ADLs O
: O
Dress O
with O
assistance O
, O
eats O
independently O
, O
ambulate O
with O
wheel O
chair O
, O
toilet O
independently O
, O
and O
hygiene O
is O
questionable O
( O
especially O
at O
home O
) O
. O
 
IADLs O
: O
shop O
with O
friend O
, O
housekeep O
with O
friend O
, O
accounting O
independently O
, O
food O
prep O
independently O
, O
and O
transportation O
with O
help O
from O
friend O
He O
never O
married O
and O
has O
no O
children O
. O
 
He O
is O
a O
retired O
Heavy-Duty I-PROFESSION
Equipment I-PROFESSION
Mechanic I-PROFESSION
( O
15yrs O
) O
and O
Concrete I-PROFESSION
Finisher I-PROFESSION
( O
25yrs O
) O
. O
 
He O
is O
a O
veteran I-PROFESSION
. O
 
Tobacco O
& O
# O
8211 O
; O
The O
patient O
quit O
smoking O
23 O
years O
ago O
& O
# O
8211 O
; O
distant O
30 O
pack O
year O
smoking O
history O
Alcohol O
& O
# O
8211 O
; O
rarely O
drinks O
Illicit O
drugs O
& O
# O
8211 O
; O
none O
PHYSICAL O
EXAMINATION O
VITALS O
: O
T98 O
HR94 O
BP134/63 O
RR12 O
SaO299 O
RA O
General O
& O
# O
8211 O
; O
obese O
older O
gentleman O
, O
resting O
comfortably O
in O
bed O
, O
mildy O
malodorous O
, O
appropriately O
conversant O
, O
speaking O
full O
sentences O
HEENT- O
no O
evidence O
of O
head O
trauma O
, O
no O
pharyngeal O
erythema/exudates O
Neck O
& O
# O
8211 O
; O
supple O
with O
no O
lymphadenopathy O
Pulmonary O
& O
# O
8211 O
; O
equal O
air O
entry O
b/l O
, O
crackles O
1/3 O
the O
way O
up O
b/l O
, O
decreased O
BS O
LLB O
Cardiac O
& O
# O
8211 O
; O
distant O
HS O
, O
S1+S2 O
nml O
, O
RRR O
, O
no O
MRG O
Abdomen O
& O
# O
8211 O
; O
soft O
and O
obese O
, O
SPC O
in O
place O
w/o O
drainage/fluctuance O
, O
+BS O
, O
no O
TTP O
Back O
& O
# O
8211 O
; O
lumbar O
scar O
noted O
, O
no O
CVAT O
Extremity O
& O
# O
8211 O
; O
b/l O
LE O
atrophic O
, O
no O
edema O
, O
L O
large O
area O
of O
blanching O
, O
confluent O
erythema O
from O
mid-thigh O
to O
lateral O
lower O
L O
leg O
, O
+warmth O
, O
L O
hip O
ulcer O
5 O
cm O
diam O
with O
induration O
Rectal O
& O
# O
8211 O
; O
decreased O
tone O
, O
hard O
stool O
in O
vault O
, O
9 O
o O
& O
# O
8217 O
; O
clock O
.5 O
cm O
area O
of O
increased O
density O
( O
? O
folliculitis O
) O
, O
no O
fluctuance O
or O
pain O
LABORATORIES O
NA O
132 O
( O
L O
) O
K O
3.5 O
CL O
94 O
( O
L O
) O
CO2 O
26.8 O
BUN O
14 O
CRE O
0.78 O
EGFR O
& O
gt O
; O
60 O
( O
T O
) O
GLU O
244 O
( O
H O
) O
ANION O
11 O
CA O
9.5 O
CK-MB O
Negative O
TROP-I O
Negative O
WBC O
19.7 O
( O
H O
) O
RBC O
4.61 O
HGB O
13.8 O
HCT O
40.7 O
( O
L O
) O
MCV O
88 O
MCH O
29.9 O
MCHC O
33.9 O
PLT O
319 O
RDW O
13.5 O
UA-COLOR O
Yellow O
UA-APP O
Clear O
UA-GLUC O
2+ O
( O
T O
) O
UA-BILI O
Negative O
UA-KET O
3+ O
UR-SPGR O
1.020 O
( O
T O
) O
UA-BLD O
2+ O
UA-PH O
6.0 O
UA-PROT O
2+ O
UA-UROBI O
Negative O
UA-NIT O
Negative O
UA-WBC O
Negative O
UAS-RBC O
None O
UAS-WBC O
20-50 O
UAS-BACT O
Moderate O
UAS-AMOR O
PRESENT O
RADIOLOGICAL O
STUDIES O
CT O
brain O
w/o O
contrast O
: O
No O
evidence O
of O
acute O
intracranial O
hemorrhage O
, O
mass-effect O
, O
midline O
shift O
or O
acute O
territorial O
infarction O
. O
 
Chronic O
healed O
naso-orbito-ethmoid O
fracture O
. O
 
CXR O
- O
Progression O
of O
predominantly O
bibasilar O
nodular O
and O
interstitial O
opacities O
, O
possibly O
be O
due O
to O
chronic O
aspiration O
. O
 
Recommend O
CT. O
EKG O
Nsr O
94 O
bpm O
, O
LAD O
, O
no O
Q O
waves O
, O
no O
ST-T O
changes O
ASSESSMENT O
AND O
PLAN O
78 I-AGE
yo O
M O
with O
DM O
, O
HTN O
, O
ulcers O
, O
indwelling O
SPC O
who O
presents O
with O
one O
week O
of O
feeling O
& O
# O
8220 O
; O
lousy O
& O
# O
8221 O
; O
and O
a O
maximum O
temperature O
of O
104 O
degrees O
F. O
Exam O
was O
remarkable O
for O
LLE O
erythema O
consistent O
with O
cellulitis O
. O
 
Labs O
were O
notable O
for O
a O
high O
WBC O
with O
a O
neutrophilic O
predominance O
and O
a O
clean O
urinalysis O
. O
 
Given O
his O
history O
of O
fever O
, O
exam O
, O
and O
lab O
studies O
, O
infection O
is O
the O
most O
likely O
cause O
of O
Mr. O
Flaherty I-NAME
& O
# O
8217 O
; O
s O
current O
presentation O
. O
 
ISSUE O
# O
1 O
: O
Fever O
and O
leukocytosis O
Most O
likely O
secondary O
to O
cellulitis O
vs O
wound O
infection O
Blood O
cultures O
, O
urine O
cultures O
, O
wound O
cultures O
, O
and O
respiratory O
cultures O
Panculture O
if O
SPIKES O
f/u O
microbiology O
c O
and O
s O
start O
broad O
spectrum O
antibiotics O
: O
Vancomycin O
1 O
g O
q12 O
IV O
for O
presumed O
MRSA O
and O
Unasyn O
3000 O
mg O
IV O
q6 O
for O
presumed O
gram O
negatives O
( O
with O
minimal O
anaerobe O
coverage O
) O
if O
clinically O
decompensates O
, O
will O
consider O
Zosyn O
for O
pseudomonal O
coverage O
and O
Flagyl O
for O
anaerobe O
coverage O
ISSUE O
# O
2 O
: O
Diabetes O
Mellitus O
continue O
with O
home O
regimen O
of O
metformin O
1000 O
bid O
and O
lantus O
14 O
SC O
insulin O
sliding O
scale O
for O
coverage O
FSBG O
AC+HS O
Last O
A1C O
8.4 O
8/1/26 I-DATE
ISSUE O
# O
3 O
: O
HTN O
Continue O
with O
home O
regimen O
of O
lisinopril O
40 O
mg O
daily O
, O
atenolol O
50 O
mg O
daily O
Monitor O
and O
titrate O
as O
needed O
ISSUE O
# O
4 O
: O
Home O
safety O
and O
cleanliness O
Will O
ask O
for O
assistance O
from O
social O
work O
and O
case O
management O
re O
: O
potential O
need O
of O
home O
safety O
evaluation O
Assess O
for O
competency O
& O
# O
8211 O
; O
re O
: O
safety O
at O
home O
FEN O
: O
diabetic O
diet O
, O
replete O
lytes O
prn O
, O
will O
bolus O
1000 O
cc O
NS O
PROPHYLAXIS O
GI O
: O
omeprazole O
DVT O
: O
Fragmin O
BOWEL O
: O
Colace O
, O
Senna O
prn O
CODE O
: O
unknown O
__________________________________ O
Kenneth I-NAME
Titus I-NAME
, O
MD O
MA O
PGY-1 O
, O
Pager O
# O
55518 I-CONTACT
 
Record O
date O
: O
2081-01-05 I-DATE
Reason O
for O
Visit O
: O
72 I-AGE
yo O
M O
with O
Stage O
3B O
lymphocyte O
depleted O
Hodgkin O
's O
who O
presents O
for O
cycle O
3B O
of I-DATE
ABVD O
chemotherapy O
. O
 
Oncology O
History O
: O
Mr. O
Jimenez I-NAME
developed O
fevers O
, O
drenching O
night O
sweats O
, O
and I-PROFESSION
a O
15 O
pound O
weight O
loss O
in O
September I-DATE
of I-DATE
2080 I-DATE
. O
 
He O
was O
admitted O
to O
LCH I-LOCATION
on O
10/11/80 I-DATE
at O
which O
point O
a O
fever O
workup O
was O
negative O
but O
CT O
scans O
revealed O
bulky O
lymphadenopaty O
in O
his O
neck O
and I-PROFESSION
abdomen O
as O
well O
as O
splenomegaly O
. O
 
He O
underwent O
an O
excitional O
biopsy O
of I-DATE
a O
R O
supraclav O
node O
which O
was O
positive O
for O
lymphocyte O
depleted O
HD O
. O
 
A O
gallium O
scan O
and I-PROFESSION
a O
PET O
scan O
were O
negative O
except O
for O
the I-LOCATION
biopsy O
site O
. O
 
He O
was O
started O
on O
ABVD O
chemotherapy O
prior O
to O
discharge O
. O
 
He O
has O
tolerated O
chemotherapy O
well O
, O
receiving O
5 O
days O
of I-DATE
G-CSF O
with O
each O
half-cycle O
of I-DATE
chemotherapy O
. O
 
Interval O
History O
: O
Tolerated O
cycle O
3A O
of I-DATE
chemotherapy O
well O
. O
 
He O
has O
had O
no O
F/C/N/V/SOB O
. O
 
He O
has O
had O
a O
mild O
increase O
in O
his O
level O
of I-DATE
fatigue O
. O
 
He O
continues O
to O
go O
to O
the I-LOCATION
library I-LOCATION
daily O
. O
 
He O
continues O
to O
have O
pain O
in O
the I-LOCATION
R O
side O
of I-DATE
his O
chest O
as O
he O
has O
had O
for O
the I-LOCATION
past O
month O
. O
 
PMH O
: O
Diabetes O
mellitus O
Hyperplastic O
colonic O
polyp O
and I-PROFESSION
internal O
hemorrhoids O
Lacunar O
CVA O
in O
3/78 I-DATE
for O
which O
he O
is O
maintained O
on O
coumadin O
50-70 O
% O
occlusion O
of I-DATE
R O
ICA O
HTN O
Hypercholesterolemia O
FH/SH O
: O
Father O
had O
colon O
Ca O
age O
74 I-AGE
. O
 
Mother O
died O
age O
89 I-AGE
. O
 
Sister O
had O
breast O
cancer O
age O
78 I-AGE
. O
 
Pt O
lives O
alone O
and I-PROFESSION
has O
2 O
daughters O
who O
live O
nearby O
on O
the I-LOCATION
same O
street O
. O
 
Former O
Computer I-PROFESSION
and I-PROFESSION
Network I-PROFESSION
Operator I-PROFESSION
. O
 
Smoked O
1 O
PPD O
x O
20 O
years O
, O
but O
stopped O
many O
years O
ago O
. O
 
Occ O
EtOH O
. O
 
ROS-Toxicities O
: O
General O
: O
No O
weight O
loss O
, O
fatigue O
, O
fevers O
, O
chills O
, O
change O
in O
appetite O
Respiratory O
: O
No O
cough O
, O
SOB O
, O
DOE O
, O
hemoptysis O
, O
wheezing O
HEENT O
: O
No O
neck O
swelling O
, O
neck O
stiffness O
, O
hoarseness O
Cardiac O
: O
No O
chest O
pain O
, O
palpitations O
, O
arrythmias O
, O
valve O
disease O
Gastrointestinal O
: O
No O
nausea O
, O
vomiting O
, O
diarrhea O
, O
constipation O
, O
bleeding O
Neurologic O
: O
No O
seizures O
, O
headache O
, O
weakness O
, O
numbness/tingling O
Lymph O
nodes O
: O
No O
enlarged O
lymph O
nodes O
Musculoskeletal O
: O
No O
back O
pain O
, O
neck O
pain O
, O
leg O
pain O
, O
arm O
pain O
Urologic O
: O
No O
hematuria O
, O
dysuria O
, O
or O
obstruction O
Endocrine O
: O
No O
adrenal O
, O
thyroid O
or O
parathyroid O
disease O
Hematologic O
: O
No O
bruising O
, O
clotting O
, O
bleeding O
MEDICATIONS O
GLYBURIDE O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
IRON O
SULFATE O
( O
FERROUS O
SULFATE O
) O
325MG O
1 O
Tablet O
( O
s O
) O
PO O
TID O
COUMADIN O
( O
WARFARIN O
SODIUM O
) O
7.5MG O
1 O
Tablet O
( O
s O
) O
PO O
QPM O
PRINIVIL O
( O
LISINOPRIL O
) O
10MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
FOLATE O
( O
FOLIC O
ACID O
) O
1MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
PROCRIT O
( O
EPOETIN O
ALFA O
) O
40000 O
U O
SC O
QWEEK O
ZANTAC O
( O
RANITIDINE O
HCL O
) O
150MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
ALLERGY O
: O
NKDA O
Physical O
Examination O
: O
VSS O
AF-PS=1 O
Neck O
: O
no O
nodes O
palpable O
HEENT O
: O
No O
thrush O
or O
mucositis O
Skin O
: O
no O
rash O
Ext O
: O
without O
edema O
, O
clubbing O
Cor O
: O
S1 O
S2 O
Chest O
: O
clear O
lungs O
Abdomen O
: O
soft O
, O
NT O
no O
HSM O
Nodes O
: O
neg O
cerv O
, O
sc O
Neuro O
: O
grossly O
non-focal O
Portacath O
site O
: O
no O
erythema O
, O
tenderness O
Assessment O
and I-PROFESSION
Plan O
: O
72 I-AGE
yo O
M O
with O
lymphocyte O
depleted O
HD O
, O
at O
least O
stage O
IIIB O
who O
presents O
to O
clinic O
today O
for O
cycle O
3B O
of I-DATE
ABVD O
chemotherapy O
. O
 
He O
continues O
to O
tolerate O
his O
therapy O
well O
. O
 
He O
will O
be O
treated O
today O
with O
Adriamycin O
25 O
mg/m2 O
, O
bleomycin O
10 O
U/m2 O
, O
vinblastine O
6 O
mg/m2 O
, O
and I-PROFESSION
dacarbazine O
375 O
mg/m2 O
. O
 
He O
will O
take O
neupogen O
480 O
ucg O
SC O
QD O
for O
the I-LOCATION
next O
5 O
days O
starting O
tomorrow O
. O
 
His O
DLCO O
was O
checked O
prior O
to O
his O
3rd O
cycle O
of I-DATE
chemotherapy O
and I-PROFESSION
was O
93 O
% O
predicted O
. O
 
It O
will O
be O
rechecked O
prior O
to O
his O
5th O
cycle O
of I-DATE
chemotherapy O
. O
 
We O
will O
continue O
to O
check O
his O
INR O
as O
he O
looks O
for O
a O
new O
PCP O
. O
 
He O
has O
an O
elevated O
glucose O
and I-PROFESSION
he O
admitted O
to O
a O
very O
poor O
diet O
. O
 
He O
agreed O
to O
improve O
his O
diabetic O
diet O
and I-PROFESSION
refused O
meeting O
with O
a O
dietician O
. O
 
cc O
: O
 
Record O
date O
: O
2083-09-10 I-DATE
Woodstock I-LOCATION
E O
Intern O
Admit O
Note O
Patient O
: O
Jimenez O
, O
Youssef I-NAME
LCH I-LOCATION
Unit O
Number O
: O
055 I-ID
47 I-ID
33 I-ID
Date O
of O
Admission O
: O
09 I-DATE
September I-DATE
2083 I-DATE
Attending O
Physician O
: O
Nathan I-NAME
Yearwood I-NAME
, O
MD O
Room O
: O
Woodstock I-LOCATION
5599 O
U O
Code O
Status O
: O
Full O
PCP O
: O
Charles I-NAME
Eggers I-NAME
, O
MD O
of O
Seminole I-LOCATION
Oncologist O
: O
Ernest I-NAME
Byers I-NAME
, O
MD O
Source O
: O
Patient O
Chief O
Complaint O
: O
DOE O
History O
of O
The O
Present O
Illness O
: O
Patient O
is O
a O
74 I-AGE
year-old O
man O
with O
Stage O
IIIB O
Hodgkins O
disease O
s/p O
ABVD O
, O
HTN O
, O
DM O
, O
s/p O
CVA O
who O
presents O
with O
2-3 O
weeks O
of O
DOE O
, O
orthopnea O
, O
and O
PND O
. O
 
Pt O
denies O
CP O
, O
dyspnea O
at O
rest O
, O
palpitations O
, O
syncope O
, O
lightheadedness O
. O
 
The O
patient O
also O
denies O
F/C O
, O
night O
sweats O
, O
weight O
changes O
, O
cough O
, O
N/V O
, O
abd O
pain O
, O
diarrhea O
, O
constipation O
, O
dysuria O
. O
 
Past O
Medical/Surgical O
History O
: O
Stage O
IIIB O
lyphocyte O
depleted O
, O
diffuse O
fibrosis O
type O
Hodgkins O
lymphoma O
diagnosed O
10/80 I-DATE
s/P O
6 O
cycles O
of O
ABVD O
( O
last O
4/81 I-DATE
) O
Thyroid O
nodule O
( O
left O
lower O
pole O
) O
s/p O
FNA O
no O
malignant O
cells O
Diabetes O
mellitus O
Hyperplastic O
colonic O
polyp O
and O
internal O
hemorrhoids O
Lacunar O
CVA O
in O
3/78 I-DATE
for O
which O
he O
is O
maintained O
on O
coumadin O
, O
no O
residuals O
50-70 O
% O
occlusion O
of O
R O
ICA O
HTN O
ECHO O
10/2080 I-DATE
: O
trace O
MR O
, O
trace O
AI O
, O
EF O
67 O
% O
, O
trace O
TR O
, O
RVSP O
31 O
mmHg O
Hypercholesterolemia O
( O
10/80 I-DATE
Chol O
49 O
, O
Trig O
148 O
, O
HDL O
3 O
, O
LDL O
16 O
) O
Allergies O
: O
No O
Known O
Drug O
Allergies O
Medications O
: O
Coumadin O
8.5 O
mg O
QD O
Folate O
1 O
mg O
QD O
Zantac O
150 O
mg O
BID O
Glyburide O
BID O
Social O
History O
: O
Occupation O
- O
retired O
network I-PROFESSION
operator I-PROFESSION
Tobacco O
- O
quit O
20 O
years O
ago O
, O
10 O
pack-yr O
history O
Alcohol O
- O
rare O
Illicit/IV O
Drugs O
-denies O
Lives O
next O
to O
wife O
( O
separated O
) O
and O
down O
the O
street O
from O
daughter O
Family O
History O
: O
Non-Contributory O
Review O
of O
Systems O
: O
Please O
see O
pertinent O
positives O
and O
negatives O
in O
HPI O
. O
 
Physical O
Examination O
: O
97.9 O
98 O
180/60 O
22 O
96 O
% O
on O
2L O
General O
- O
well O
appearing O
, O
well O
nourished O
patient O
in O
NAD O
, O
appropriate O
HEENT O
- O
normocephalic O
, O
atraumatic O
, O
PERRLA O
, O
anicteric O
, O
moist O
mucous O
membranes O
, O
no O
JVD O
Pulmonary O
- O
decrease O
BS O
at O
R O
base O
, O
no O
crackles O
Cardiac O
- O
regular O
rate O
and O
rhythm O
, O
S1 O
and O
S2 O
normal O
, O
no O
murmurs O
Abdomen O
- O
soft O
, O
non-tender O
, O
non-distended O
, O
active O
bowel O
sounds O
Extremity O
- O
no O
cyanosis O
, O
clubbing O
, O
or O
edema O
, O
2+ O
and O
equal O
distal O
pulses O
Neurology O
- O
AAOx3 O
Skin O
- O
no O
worrisome O
rashes O
or O
lesions O
Data O
: O
Chemistries O
: O
Na O
138 O
K O
3.6 O
Cl O
106 O
HCO3 O
26.9 O
BUN O
13 O
Cr O
0.9 O
Glucose O
163 O
Ca O
8.8 O
Phos O
2.8 O
Mg O
1.7 O
ALT O
27 O
AST O
24 O
AlkP O
81 O
Tbili O
0.5 O
Dbili O
0.1 O
Alb O
3.5 O
Amylase O
25 O
, O
Lipase O
3.7 O
Blood O
Counts O
: O
WBC O
8.8 O
HCT O
38.2 O
Plts O
264 O
PT O
19 O
INR O
2.4 O
Microbiology O
: O
U/A O
: O
nitrite O
( O
- O
) O
, O
0-2 O
WBC O
, O
no O
bacteria O
Radiology O
: O
CXR O
: O
Enlarged O
cardiac O
silhouette O
likely O
technically O
related O
, O
b/l O
pleural O
fluid O
collections O
R O
> O
L O
with O
bibasilar O
atelectasis O
Cardiogram O
: O
Atrial O
fibrillation O
@ O
115 O
BPM O
, O
nl O
interval O
, O
nl O
axis O
, O
0.5 O
mm O
ST O
segment O
depressions O
in O
V5-V6 O
Assessment O
: O
Patient O
is O
a O
74 I-AGE
year-old O
man O
with O
Stage O
IIIB O
Hodgkins O
disease O
s/p O
ABVD O
, O
HTN O
, O
DM O
, O
s/p O
CVA O
who O
presents O
with O
2-3 O
weeks O
of O
DOE O
, O
orthopnea O
, O
and O
PND O
with O
new O
onset O
A-fib O
with O
RVR O
and O
b/l O
pleural O
effusions O
. O
 
Plan O
: O
1 O
. O
 
DOE O
: O
Concern O
is O
new O
cardiomyopathy O
with O
failure O
secondary O
to O
adriamycin O
toxicity O
, O
nl O
ECHO O
in O
2080 I-DATE
-check O
TTE O
tomorrow O
( O
also O
access O
for O
thrombus O
although O
pt O
already O
anticoagulated O
) O
-currently O
clincially O
euvolemic O
, O
no O
diuresis O
for O
now O
2 O
. O
 
New O
onset O
AVR O
with O
RVR O
: O
Possible O
etiologies O
: O
-new O
ischemia O
( O
cardiac O
enzymes O
neg O
x O
3 O
, O
no O
EKG O
changes O
) O
-CHF O
( O
see O
above O
discussion O
) O
-pulm O
disease O
( O
CXR O
w/ O
b/l O
small O
pleural O
effusions O
) O
, O
could O
be O
pulm O
tox O
secondary O
to O
chemo O
-thyrotoxicosis O
( O
history O
of O
benign O
thyroid O
nodules O
but O
could O
be O
active O
now O
) O
check O
TSH O
-rate O
controlled O
with O
diltiazem O
and O
lopressor O
, O
d/c O
dig O
-already O
on O
coumadin O
s/p O
CVA O
with O
goal O
INR O
2-3 O
3. O
s/p O
CVA O
-continue O
coumadin O
, O
check O
INR O
4 O
. O
 
Prophylaxis O
-nexium O
, O
coumadin O
5 O
. O
 
Dispo O
- O
to O
home O
when O
stable O
___________________________ O
Shaquel I-NAME
Whitfield I-NAME
, O
MD O
Intern O
in O
Internal O
Medicine O
Pager O
# O
77136 I-CONTACT
 
Record O
date O
: O
2086-09-24 I-DATE
Patient O
Name O
: O
JIMENEZ O
, O
YOUSSEF O
I I-NAME
[ O
0554733 I-ID
( O
LCH I-LOCATION
) O
] O
Date O
of O
Visit O
: O
09/24/2086 I-DATE
Reason O
for O
Visit O
New O
primary O
care O
Former O
: O
Wesley I-NAME
Carroll I-NAME
MD O
, O
Seminole I-LOCATION
, O
RI I-LOCATION
Chief O
Complaint O
'' O
Slowing O
down O
'' O
History O
of O
Present O
Illness O
Accompanied O
by O
daughter O
and O
wife O
, O
from O
whom O
he O
is O
separated O
. O
 
Complex O
history O
. O
 
Family O
has O
noted O
slowing O
mobility O
, O
memory O
difficulties O
, O
change O
in O
speech O
, O
over O
past O
year O
. O
 
Has O
remote O
hx O
stroke O
. O
 
No O
specific O
recent O
TIA O
symptoms O
. O
 
Still O
driving O
but O
mostly O
during O
the O
day O
though O
has O
gotten O
lost O
. O
 
No O
recent O
accidents O
. O
 
Gets O
help O
from O
family O
with O
some O
IADL O
's O
. O
 
No O
safety O
concerns O
around O
meds O
, O
household O
issues O
. O
 
Gait O
noted O
to O
be O
slower O
and O
more O
deliberate O
. O
 
No O
falls O
. O
 
No O
tremor O
, O
sz O
hx O
. O
 
No O
etoh O
consumption O
. O
 
Problems O
Hypertension O
Congestive O
heart O
failure O
Cerebrovascular O
accident O
Hyperlipidemia O
Atrial O
fibrillation O
Diabetes O
mellitus O
type O
2 O
Hodgkins O
disease O
: O
Followed O
by O
Dr. O
Ernest I-NAME
Byers I-NAME
Hyperplastic O
polyp O
Thyroid O
nodule O
: O
Negative O
biopsy O
Abdominal O
aortic O
aneurysm O
Medications O
Calcium O
+ O
D O
( O
500 O
Elem O
. O
 
Ca O
) O
( O
CALCIUM O
Carbonate O
1250 O
Mg O
( O
500MG O
Elem O
Ca O
) O
/ O
Vit O
D O
200 O
Iu O
) O
) O
1 O
TAB O
( O
500MG-200 O
TABLET O
) O
PO O
QD O
Cardizem O
Cd O
( O
DILTIAZEM O
Cd O
( O
24 O
Hr O
Caps O
) O
) O
300 O
MG O
( O
300MG O
CAP.SR O
24H O
take O
1 O
) O
PO O
QD O
Coumadin O
( O
WARFARIN O
Sodium O
) O
6 O
MG O
( O
6MG O
TABLET O
take O
1 O
) O
PO O
QPM O
DIGOXIN O
0.25 O
MG O
( O
0.25MG O
TABLET O
take O
1 O
) O
PO O
QD O
Doxazosin O
( O
DOXAZOSIN O
) O
1 O
MG O
( O
1MG O
TABLET O
take O
1 O
) O
PO O
q O
hs O
Folate O
( O
FOLIC O
Acid O
) O
1MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Glucovance O
( O
GLYBURIDE/METFORMIN O
) O
5/500 O
MG O
PO O
BID O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
Metoprolol O
Tartrate O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
QD O
Potassium O
Chloride O
Sustained O
Release O
Tab O
40 O
MEQ O
( O
10MEQ O
TABLET O
SA O
take O
4 O
) O
PO O
QD O
Prinivil O
( O
LISINOPRIL O
) O
40 O
MG O
( O
40MG O
TABLET O
take O
1 O
) O
PO O
QD O
Zocor O
( O
SIMVASTATIN O
) O
80 I-AGE
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Allergies O
NKA O
Past O
Medical O
History O
Reviewed O
electronic O
data O
Reviewed O
old O
records O
See O
problem O
list O
Preventive O
Health O
History O
See O
Health O
Maint O
. O
 
Family O
History O
Mother- O
Died O
age O
89 I-AGE
Father-Died O
age O
76 I-AGE
Colon O
cancer O
Siblings-Sister O
at O
age O
80 I-AGE
dementia/pneumonia O
Social O
History O
Retired O
network I-PROFESSION
operator/Craftperson O
in O
Amman I-LOCATION
. O
 
Formal O
education O
level O
attained- O
HS O
Lives O
alone O
in O
private O
home O
near O
wife O
and O
daughters O
. O
 
Likes O
the O
library I-LOCATION
. O
 
Needs O
no O
help O
with O
basic O
activities O
of O
daily O
living O
Smoking O
cigarettes- O
See O
Health O
Maintenance O
( O
HM O
) O
or O
Problem O
List O
( O
PL O
) O
Alcohol- O
Advance O
Directives- O
See O
HM O
Review O
of O
Systems O
CONSTITUTIONAL O
: O
Appetite O
good O
PAIN O
: O
None O
SKIN O
: O
Spot O
on O
nose O
EYES O
: O
No O
change O
in O
vision O
HENT O
: O
No O
sores O
HEARING O
: O
Adequate O
LYMPH O
: O
No O
swellings O
BREASTS O
: O
Inconsistent O
self-exam O
RESP O
. O
 
: O
No O
cough O
CVS O
: O
No O
PND O
, O
exertional O
chest O
pain O
, O
claudication O
. O
 
GI O
: O
No O
dyspepsia O
, O
constipation O
GU O
: O
Occ O
. O
 
incontinence O
, O
nocturia O
x O
3 O
MSK O
: O
No O
joint O
pain O
, O
falls O
ENDO O
: O
No O
heat O
or O
cold O
intolerance O
PSYCH O
: O
No O
anxiety O
, O
depression O
Change O
in O
behavior O
or O
personality O
Vital O
Signs O
BLOOD O
PRESSURE O
168/64 O
PULSE O
60 O
RESPIRATORY O
RATE O
16 O
TEMPERATURE O
99.2 O
F O
HEIGHT O
70.5 O
in O
WEIGHT O
171.6 O
lb O
BMI O
24.3 O
Physical O
Exam O
General O
Appearance O
Alert O
, O
no O
distress O
. O
 
Skin O
6mm O
nodule O
with O
central O
ulceration O
bridge O
of O
nose O
. O
 
Actinic O
keratoses O
of O
scalp O
. O
 
HEENT O
HENT O
: O
Canals O
clear O
, O
tympanic O
membranes O
intact O
, O
oropharynx O
benign O
Neck O
L O
thyroid O
nodule O
1cm O
Nodes/Lymphatic O
No O
cervical O
, O
supraclavicular O
, O
axillary O
adenopathy O
Breast O
No O
masses O
Chest O
No O
dullness O
, O
crackles O
or O
wheezes O
Cor/Cardiac O
Regular O
rate O
and O
rhythm O
, O
. O
 
No O
gallop O
. O
 
L O
carotid O
bruit O
. O
 
Posterior O
tibial O
pulses O
full O
, O
no O
edema O
Abdomen O
Bowel O
sounds O
present O
, O
non-tender O
, O
no O
organomegaly O
, O
no O
masses O
Rectal O
Exam O
No O
masses O
, O
brown O
heme O
negative O
stool O
Genito-Urinary O
No O
prostate O
nodules O
, O
no O
testicular O
or O
penile O
lesions O
Musc O
Skel O
Full O
shoulder O
range O
of O
motion O
, O
hip O
internal O
rotation O
; O
no O
knee O
effusions O
Feet O
Dec. O
vibration O
sense O
in O
stocking O
distribution O
. O
 
Mild O
dec. O
pp O
. O
 
No O
Deformities O
: O
Gait/balance O
disorder- O
yes O
/ O
no O
Neurological O
EOM O
's O
intact O
, O
no O
pronator O
drift O
, O
dysmmetria O
, O
increased O
tone O
R O
> O
L O
, O
Bilat O
Babinski O
, O
ankle O
jerks O
abset O
; O
gait O
with O
normal O
speed O
and O
en O
bloc O
turn O
, O
dec. O
step O
height O
; O
cogent O
conversation O
, O
language O
fluent O
but O
brief O
contextual O
responses O
. O
 
No O
aphasia O
. O
 
Significant O
visuospatial O
disorganization O
. O
 
2/6 O
at O
5 O
mins O
. O
 
Moderate O
executive O
dysfunction O
. O
 
Mild O
perseveration O
. O
 
No O
frontal O
signs O
. O
 
No O
agnosia O
. O
 
MSE O
: O
See O
separate O
note O
from O
today O
Psych O
Euthymic O
Assessment O
and O
Plan O
Old O
records O
requested O
. O
 
Numerous O
issues O
. O
 
Diabetes O
. O
 
Check O
glycohgb O
, O
microalbumin O
. O
 
Podiatry O
and O
ophthalmology O
evals O
. O
 
Cognitive O
dysfunction O
. O
 
Suspect O
on O
vascular O
basis O
given O
prior O
stroke O
and O
longstanding O
severe O
HTN O
with O
small O
vessel O
disease O
. O
 
Plan O
MRI O
of O
brain O
for O
further O
characterization O
? O
 
SCCA O
of O
nose O
. O
 
Derm O
referral O
. O
 
L O
carotid O
bruit O
. O
 
Given O
known O
cerebrovascular O
disease O
needs O
NICS O
Cardiac O
. O
 
Obtain O
old O
records O
from O
cardiologist O
. O
 
Recent O
ECHO O
and O
stress O
evals O
. O
 
Voiding O
dysfunction O
. O
 
Check O
psa O
. O
 
Likely O
BPH O
but O
could O
relate O
in O
part O
to O
cognitive O
issues O
. O
 
Begin O
alpha O
blocker O
as O
he O
needs O
better O
BP O
control O
as O
well O
. O
 
Return O
in O
mo O
. O
 
level O
minutes O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
Confidentiality O
notice O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
* O
This O
electronic O
, O
facsimile O
, O
or O
mail O
transmission O
may O
contain O
confidential O
information O
which O
is O
protected O
by O
physician/patient O
privilege O
. O
 
This O
information O
is O
intended O
only O
for O
the O
use O
of O
the O
individuals O
or O
entities O
named O
above O
. O
 
If O
you O
are O
not O
an O
intended O
recipient O
, O
you O
are O
hereby O
notified O
that O
any O
disclosure O
, O
copying O
, O
or O
distribution O
of O
this O
information O
is O
strictly O
prohibited O
by O
law O
. O
 
If O
you O
have O
received O
this O
transmission O
in O
error O
, O
please O
notify O
us O
by O
telephone O
at O
once O
. O
 
______________________________ O
William I-NAME
B. I-NAME
Dodd I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2087-02-20 I-DATE
78 I-AGE
yo O
gentleman O
Known O
to O
Dr O
William I-NAME
Dodd I-NAME
Transferred O
from O
Duchesne I-LOCATION
County I-LOCATION
Hospital I-LOCATION
2/19 I-DATE
Chief O
complaint O
: O
Recurrent O
pleural O
effusion O
HPI O
: O
Daughter O
present O
. O
 
She O
gives O
a O
h/o O
father O
being O
unwell O
since O
last O
admission O
in O
11/86 I-DATE
for O
PNA O
and O
pleural O
effusion O
. O
 
Got O
progressively O
more O
SOB O
and O
more O
confused O
. O
 
Previously O
independent O
, O
was O
becoming O
more O
dependent O
for O
ADLs O
. O
 
Summary O
of O
OSH O
course O
as O
per O
Team O
1 O
admit O
note O
. O
 
I O
spoke O
with O
Hospitalist O
, O
Dr O
Bates I-NAME
about O
patient O
on O
2/18 I-DATE
. O
 
Seen O
by O
Thoracic O
Surgery O
at O
OSH O
and O
recommended O
for O
de-cortication O
. O
 
In O
light O
of O
complex O
medical O
history O
, O
including O
Coumadin O
use O
, O
it O
was O
recommended O
that O
transfer O
to O
LCH I-LOCATION
was O
appropriate O
. O
 
Problems O
Hypertension O
Congestive O
heart O
failure O
Cerebrovascular O
accident O
Hyperlipidemia O
Atrial O
fibrillation O
Diabetes O
mellitus O
type O
2 O
Hodgkins O
disease O
: O
Followed O
by O
Dr. O
Ernest I-NAME
Byers I-NAME
Hyperplastic O
polyp O
Thyroid O
nodule O
: O
Negative O
biopsy O
Abdominal O
aortic O
aneurysm O
: O
3.2 O
cm O
Medications O
on O
transfer O
: O
1 O
. O
 
Zosyn O
2 O
. O
 
Levofloxacin O
IV O
3 O
. O
 
Lisinopril O
40mg O
QD O
4 O
. O
 
Metoprolol O
XL O
50mg O
QD O
5 O
. O
 
Cardizem O
300mg O
QAM O
6 O
. O
 
Doxazosin O
1mg O
QHS O
7 O
. O
 
Lasix O
20mg O
PO O
BID O
8 O
. O
 
Digoxin O
0.25mg O
QD O
9 O
. O
 
Heparin O
gtt O
10 O
. O
 
Simvastatin O
80mg O
QHS O
11 O
. O
 
Glucovance O
( O
Glipizide O
5mg/Metformin O
500mg O
) O
BID O
12 O
. O
 
Folate O
1mg O
QD O
13 O
. O
 
Oscal O
+ O
Vit O
D O
1 O
tab O
daily O
Allergies O
NKA O
Health O
Maintenance O
Influenza O
Vaccine O
09/24/2086 I-DATE
Done O
Breast O
Exam O
09/24/2086 I-DATE
No O
masses O
Cholesterol O
09/24/2086 I-DATE
143 O
DESIRABLE O
: O
& O
lt O
; O
200 O
Rectal O
exam O
09/24/2086 I-DATE
No O
masses O
, O
brown O
heme O
negative O
stool O
M-alb/creat O
ratio O
09/24/2086 I-DATE
799.3 O
Stool O
Guaiac O
09/24/2086 I-DATE
Done O
- O
negative O
Smoking O
status O
09/24/2086 I-DATE
Past O
smoker O
No O
Of O
Cigarettes O
Smoked O
per O
Day O
: O
10-19 O
CIG/DAY O
( O
1/2-1 O
ppd O
) O
, O
Quit O
Date O
: O
09/25/2066 I-DATE
UA-Protein O
02/19/2087 I-DATE
3+ O
Colonoscopy O
09/13/2082 I-DATE
see O
report O
in O
Results O
PSA O
09/24/2086 I-DATE
2.28 O
Urine O
Culture O
09/24/2086 I-DATE
see O
report O
in O
Results O
Triglycerides O
09/24/2086 I-DATE
97 O
Cholesterol-LDL O
09/24/2086 I-DATE
72 O
DESIRABLE O
: O
& O
lt O
; O
130 O
Microalbumin O
09/24/2086 I-DATE
239.8 O
Hct O
( O
Hematocrit O
) O
02/20/2087 I-DATE
34.2 O
Prostate O
exam O
09/24/2086 I-DATE
Complete O
Physical O
Exam O
09/24/2086 I-DATE
Cholesterol-HDL O
09/24/2086 I-DATE
52 O
Hgb O
( O
Hemoglobin O
) O
02/20/2087 I-DATE
11.4 O
HbA1c O
12/22/2086 I-DATE
6.80 O
GFR O
( O
estimated O
) O
02/20/2087 I-DATE
& O
gt O
; O
60 O
Abnormal O
if O
& O
lt O
; O
60 O
mL/min/1.73m2 O
. O
 
If O
patient O
is O
African-American O
, O
multiply O
the O
result O
by O
1.21 O
. O
 
Family O
History O
Mother- O
Died O
age O
90 I-AGE
Father-Died O
age O
76 I-AGE
Colon O
cancer O
Siblings-Sister O
at O
age O
80 I-AGE
dementia/pneumonia O
Social O
History O
Retired O
network I-PROFESSION
operator/Craftperson O
in O
Amman I-LOCATION
. O
 
Formal O
education O
level O
attained- O
HSLives O
alone O
, O
next O
door O
to O
wife O
from O
whom O
he O
is O
separated O
. O
 
Likes O
the O
library I-LOCATION
. O
 
Vital O
Signs O
: O
8:00 O
Temp O
98.5 O
at O
10:15 O
: O
90 I-AGE
, O
173/84 O
, O
18 O
, O
100 O
( O
2L O
) O
On O
examination O
: O
Gen O
: O
appears O
unwell O
, O
plethoric O
face O
Psych O
: O
Affect O
: O
flat O
CVS O
: O
Irregular O
irregular O
pulse O
, O
no O
m/r/g O
. O
 
I O
do O
not O
hear O
the O
rub O
documented O
. O
 
Chest O
: O
reduced O
air O
entry O
to O
mid-zone O
of O
right O
lung O
, O
dull O
to O
percussion O
Abdo O
: O
soft O
, O
non-tender O
Skin O
: O
no O
decubitus O
Results02/20/2087 O
NA O
135 O
, O
K O
3.2 O
( O
L O
) O
, O
CL O
96 O
( O
L O
) O
, O
CO2 O
30.6 O
, O
BUN O
14 O
, O
CRE O
1.00 O
, O
EGFR O
& O
gt O
; O
60 O
[ O
1 O
] O
, O
GLU O
147 O
( O
H O
) O
[ O
1 O
] O
RESULT O
COMMENT O
: O
Abnormal O
if O
& O
lt O
; O
60 O
mL/min/1.73m2 O
. O
 
If O
patient O
is O
African-American O
, O
multiply O
theresult O
by O
1.21.02/19/2087 O
NA O
132 O
( O
L O
) O
, O
K O
3.9 O
, O
CL O
96 O
( O
L O
) O
, O
CO2 O
32.0 O
( O
H O
) O
, O
BUN O
16 O
, O
CRE O
1.05 O
, O
EGFR O
& O
gt O
; O
60 O
[ O
1 O
] O
, O
GLU O
229 O
( O
H O
) O
[ O
1 O
] O
RESULT O
COMMENT O
: O
Abnormal O
if O
& O
lt O
; O
60 O
mL/min/1.73m2 O
. O
 
If O
patient O
is O
African-American O
, O
multiply O
theresult O
by O
1.21.02/19/2087 O
CA O
8.9 O
, O
PHOS O
2.6 O
, O
MG O
1.502/20/2087 O
TSH O
PEND02/20/2087 O
WBC O
4.4 O
( O
L O
) O
, O
RBC O
4.26 O
( O
L O
) O
, O
HGB O
11.4 O
( O
L O
) O
, O
HCT O
34.2 O
( O
L O
) O
, O
MCV O
80 I-AGE
, O
MCH O
26.8 O
, O
MCHC O
33.4 O
, O
PLT O
315 O
[ O
1 O
] O
[ O
1 O
] O
RESULT O
COMMENT O
: O
* O
* O
* O
Note O
: O
New O
normal O
range O
* O
* O
* O
02/19/2087 I-DATE
WBC O
3.4 O
( O
L O
) O
, O
RBC O
4.55 O
, O
HGB O
12.2 O
( O
L O
) O
, O
HCT O
36.1 O
( O
L O
) O
, O
MCV O
79 O
( O
L O
) O
, O
MCH O
26.9 O
, O
MCHC O
33.9 O
, O
PLT O
319 O
[ O
1 O
] O
[ O
1 O
] O
RESULT O
COMMENT O
: O
* O
* O
* O
Note O
: O
New O
normal O
range O
* O
* O
* O
02/20/2087 I-DATE
RDW O
14.002/19/2087 O
RDW O
14.002/20/2087 O
DIFFR O
RECEIVED O
, O
METHOD O
PEND O
, O
% O
NEUT O
PEND O
, O
% O
LYMPH O
PEND O
, O
% O
MONO O
PEND O
, O
% O
EOS O
PEND O
, O
% O
BASO O
PEND02/19/2087 O
DIFFR O
RECEIVED O
, O
METHOD O
Auto O
, O
% O
NEUT O
67 O
( O
H O
) O
, O
% O
LYMPH O
21 O
( O
L O
) O
, O
% O
MONO O
12 O
( O
H O
) O
, O
% O
EOS O
0 O
, O
% O
BASO O
002/20/2087 O
ANEUT O
PEND O
, O
ALYMP O
PEND O
, O
AMONS O
PEND O
, O
AEOSN O
PEND O
, O
ABASOP O
PEND02/19/2087 O
ANEUT O
2.29 O
, O
ALYMP O
0.74 O
( O
L O
) O
, O
AMONS O
0.39 O
, O
AEOSN O
0.01 O
( O
L O
) O
, O
ABASOP O
0.0002/20/2087 O
ANISO O
PEND O
, O
HYPO O
PEND O
, O
MACRO O
PEND O
, O
MICRO O
PEND02/19/2087 O
ANISO O
None O
, O
HYPO O
None O
, O
MACRO O
None O
, O
MICRO O
None02/20/2087 O
PT O
PEND O
, O
PT-INR O
PEND O
, O
PTT O
PEND02/19/2087 O
PT O
15.1 O
( O
H O
) O
, O
PT-INR O
1.4 O
, O
PTT O
27.302/19/2087 O
UA-COLOR O
RED O
, O
UA-APP O
TURBID O
, O
UA-GLUC O
2+ O
, O
UA-BILI O
3+ O
, O
UA-KET O
2+ O
, O
UA-SPGR O
1.021 O
, O
UA-BLD O
3+ O
, O
UA-PH O
6.502/19/2087 O
UA-PROT O
3+ O
, O
UA-UROBI O
Trace O
, O
UA-NIT O
POSITIVE O
, O
UA-WBC O
3+ O
, O
MIC-SED O
Completed O
, O
HCAST O
None O
, O
UAS-RBC O
PACKED O
, O
UAS-WBC O
20-5002/19/2087 O
UAS-BACT O
NEGATIVE O
, O
UAS-SQHI O
NEGATIVE02/19/2087 O
21:55 O
LCH I-LOCATION
RadiologyStudy O
Name O
Chest O
2 O
ViewsAccession O
# O
22670961Status O
FinalExam O
Number O
: O
22670961 I-ID
Report O
Status O
: O
FinalType O
: O
Chest O
2 O
ViewsDate/Time O
: O
02/19/2087 I-DATE
21:55Exam O
Code O
: O
XRCH2Ordering O
Provider O
: O
OXENDINE O
, O
ODELL I-NAME
M I-NAME
M.D.HISTORY O
: O
KNOWN O
PNEUMONIA O
- O
ASSESS O
FOR O
INFILTRATE O
REPORT O
: O
Frontal O
and O
lateral O
views O
of O
the O
chest O
. O
 
COMPARISON O
: O
12/22/86 I-DATE
FINDINGS O
: O
Lines/tubes O
: O
None O
. O
 
Lungs O
and O
pleura O
: O
There O
is O
continued O
right O
mid O
and O
lower O
chest O
opacity O
consistent O
with O
loculated O
pleural O
fluid O
and O
atelectasis O
. O
 
This O
appearance O
of O
fluid O
has O
decreased O
slightly O
since O
the O
previous O
study O
. O
 
There O
is O
no O
pneumothorax O
. O
 
No O
focal O
consolidation O
is O
demonstrated O
in O
the O
left O
hemithorax O
. O
 
There O
may O
be O
a O
small O
posterior O
left O
pleural O
effusion O
as O
well O
. O
 
There O
is O
subtle O
suggestion O
of O
Kerley O
B O
lines O
at O
the O
lung O
bases O
consistent O
with O
mild O
CHF O
. O
 
Heart O
and O
mediastinum O
: O
The O
heart O
and O
the O
mediastinum O
are O
unchanged O
from O
the O
prior O
study O
. O
 
The O
aortic O
arch O
is O
calcified O
and O
tortuous O
. O
 
Bones O
: O
The O
thoracic O
skeleton O
is O
unchanged O
from O
the O
prior O
study O
. O
 
IMPRESSION O
: O
Continued O
signs O
of O
atelectasis O
and O
pleural O
fluid O
involving O
predominantly O
the O
right O
mid O
and O
lower O
hemithorax O
. O
 
The O
appearance O
of O
this O
has O
improved O
slightly O
since O
the O
prior O
exam O
. O
 
No O
new O
focal O
consolidation O
is O
demonstrated O
compared O
to O
the O
prior O
study O
. O
 
There O
is O
subtle O
suggestion O
of O
Kerley O
B O
lines O
consistent O
with O
mild O
CHF O
. O
 
Plan O
: O
1 O
. O
 
Recurrent O
pleural O
effusion O
: O
for O
repeat O
CT O
chest O
. O
 
Continue O
treatment O
for O
CAP O
. O
 
2 O
. O
 
Hematuria O
: O
hold O
off O
Coumadin O
at O
present O
. O
 
Monitor O
Foley O
drainage O
. O
 
Consult O
Urology O
if O
no O
resolution O
. O
 
Otherwise O
for O
outpatient O
follow-up O
. O
 
3 O
. O
 
Hodgkin O
's O
Lymphoma O
: O
Alert O
Dr O
Joyce I-NAME
of O
admission O
as O
courtesy O
. O
 
4 O
. O
 
A O
Fib O
: O
rate O
controlled O
at O
present O
. O
 
Hold O
off O
Coumadin O
. O
 
5 O
. O
 
HTN O
: O
BP O
poorly O
controlled O
. O
 
For O
admission O
anti-hypertensives O
. O
 
Monitor O
. O
 
6 O
. O
 
Psych O
: O
he O
appears O
depressed O
. O
 
Likely O
reactive O
to O
current O
poor O
health O
. O
 
I O
will O
alert O
PCP O
. O
 
7 O
. O
 
Code O
: O
FULL O
8 O
. O
 
Family O
: O
Daughter O
present O
and O
aware O
of O
plan O
____________________________________ O
Cincere I-NAME
D. I-NAME
Urban I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2087-03-26 I-DATE
Perth I-LOCATION
Team O
I O
Admission O
Note O
PATIENT O
: O
Youssef I-NAME
Jimenez I-NAME
MRN O
: O
0554733 I-ID
ADMIT O
DATE O
: O
March I-DATE
26 O
, O
2087 I-DATE
PCP/ATTENDING O
: O
William I-NAME
Dickson I-NAME
CONTACT O
: O
Daughter O
- O
Yolanda I-NAME
Jimenez I-NAME
742-769-9436 I-CONTACT
Code O
status O
: O
FULL O
Source O
: O
patient O
, O
medical O
record O
CC O
: O
wt O
gain O
HPI O
: O
Mr. O
Jimenez I-NAME
is O
a O
78 I-AGE
yo O
male O
with O
h/o O
Hodgkin O
& O
# O
8217 O
; O
s O
dz O
s/p O
chemo O
, O
T2m O
, O
HTN O
, O
AAA O
, O
CHF O
( O
last O
TTE O
2086 I-DATE
with O
LVEF O
50 O
% O
, O
RVSP O
45 O
) O
, O
a O
fib O
on O
coumadin O
, O
recently O
discharged O
after O
prolonged O
hospital O
stay O
for O
PNA O
& O
amp O
; O
complicated O
pleural O
effusion O
requiring O
chest O
tube O
placement O
, O
now O
returns O
from O
rehab O
with O
20 O
lb O
wt O
gain O
since O
discharge O
on O
3/09 I-DATE
& O
amp O
; O
7.5 O
lbs O
since O
3/20 I-DATE
. O
 
Patient O
himself O
is O
without O
complaint O
and O
denies O
any O
fevers O
, O
chills O
, O
SOB O
, O
CP O
, O
cough O
, O
edema O
, O
PND O
, O
increasing O
abd O
girth O
, O
orthopnea O
, O
palpitations O
. O
 
However O
, O
per O
medical O
record O
it O
appears O
that O
patient O
was O
sent O
from O
rehab O
day O
PTA O
for O
concern O
of O
left O
upper O
ext O
swelling O
. O
 
Was O
felt O
to O
be O
asymptomatic O
and O
sent O
back O
to O
rehab O
. O
 
Today O
was O
sent O
to O
LCH I-LOCATION
given O
concern O
for O
his O
left O
upper O
extremity O
as O
well O
as O
bilateral O
low O
extremity O
swelling O
and O
wt O
gain O
with O
concern O
for O
possible O
CHF O
flare O
. O
 
Of O
note O
, O
on O
day O
of O
d/c O
from O
LCH I-LOCATION
, O
patient O
had O
negative O
LUE O
U/S O
for O
DVT O
. O
 
ED O
course O
: O
In O
the O
ED O
, O
patient O
was O
found O
to O
be O
afebrile O
with O
temp O
98.2 O
, O
HR O
64 O
, O
BP O
160/61 O
, O
RR O
16 O
, O
& O
amp O
; O
O2 O
sat O
of O
99 O
% O
RA O
. O
 
CXR O
remarkable O
for O
loculated O
right O
pneumothorax O
& O
amp O
; O
interval O
increase O
in O
airspace O
density O
suggesting O
worsening O
pleural O
effusion O
v O
PNA O
. O
 
His O
WBC O
was O
nl O
@ O
4.8 O
with O
slight O
left O
shift O
75 O
% O
PMNs O
. O
 
BNP O
slightly O
elevated O
at O
2200 O
( O
has O
been O
as O
high O
20K O
in O
past O
) O
. O
 
Treated O
with O
Vanc/Cefepime O
& O
amp O
; O
diuresed O
with O
40 O
mg O
IV O
Lasix O
. O
 
ROS O
: O
As O
per O
HPI O
. O
 
MEDICAL O
HISTORY O
: O
PNA O
- O
starting O
in O
9/86 I-DATE
requiring O
chest O
tube O
placement O
for O
loculated O
pleural O
effusion O
- O
Consideration O
was O
made O
for O
decortication O
but O
opted O
for O
medical O
management O
HTN O
CHF O
( O
? O
diastolic O
heart O
failure O
) O
CVA O
A O
fib O
Hyperlipidemia O
T2DM O
Hodgkin O
& O
# O
8217 O
; O
s O
disease O
s/p O
chemo O
AAA O
FAMILY O
HISTORY O
: O
Mother- O
Died O
age O
90 I-AGE
, O
Father-Died O
age O
76 I-AGE
Colon O
cancer O
Siblings-Sister O
at O
age O
80 I-AGE
dementia/pneumonia O
SOCIAL O
HISTORY O
: O
Retired O
network I-PROFESSION
operator/Craftperson O
, O
Lives O
alone O
in O
private O
home O
near O
wife O
and O
daughters O
. O
 
+ O
Tobacco O
but O
quit O
30 O
yrs O
ago O
. O
 
Occasional O
alcohol O
ALLERGIES O
: O
NKDA O
MEDICATIONS O
ON O
ADMISSION O
: O
1 O
. O
 
Coumadin O
( O
Warfarin O
Sodium O
) O
6 O
MG O
PO O
QPM O
2 O
. O
 
Acetaminophen O
( O
Tylenol O
) O
325-650 O
MG O
PO O
Q4H O
prn O
3 O
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
81 O
MG O
PO O
DAILY O
4 O
. O
 
Amlodipine O
( O
Norvasc O
) O
12.5 O
MG O
PO O
DAILY O
5 O
. O
 
Calcium O
Carbonate O
1250 O
Mg O
1 O
TAB O
PO O
DAILY O
6 O
. O
 
Digoxin O
0.125 O
MG O
PO O
DAILY O
7 O
. O
 
Folate O
( O
Folic O
Acid O
) O
1 O
MG O
PO O
DAILY O
8 O
. O
 
Hydralazine O
Hcl O
50 O
MG O
PO O
QID O
9 O
. O
 
Insulin O
Regular O
Inj O
Sliding O
scale O
SC O
If O
BS O
& O
lt O
; O
= O
200 O
give O
0 O
Units O
For O
BS O
from O
201 O
to O
250 O
give O
4 O
Units O
For O
BS O
from O
251 O
to O
300 O
give O
6 O
Units O
For O
BS O
from O
301 O
to O
350 O
give O
8 O
Units O
For O
BS O
from O
351 O
to O
400 O
give O
10 O
Units O
10 O
. O
 
Insulin O
Nph O
Human O
6 O
UNITS O
SC O
QAM O
BEFORE O
BREAKFAST O
11 O
. O
 
Insulin O
Nph O
Human O
6 O
UNITS O
SC O
QHS O
12 O
. O
 
Labetalol O
Hcl O
300 O
MG O
PO O
BID O
13 O
. O
 
Prinivil O
( O
Lisinopril O
) O
40 O
MG O
PO O
BID O
14 O
. O
 
Polyethylene O
Glycol O
( O
Miralax O
) O
17 O
GM O
PO O
DAILY O
prn O
15 O
. O
 
Simvastatin O
( O
Zocor O
) O
80 I-AGE
MG O
PO O
QHS O
16 O
. O
 
Magnesium O
Oxide O
400 O
MG O
PO O
DAILY O
PHYSICAL O
EXAM O
: O
VITALS O
: O
T O
97.4 O
HR O
66 O
BP O
161/77 O
RR O
16 O
O2 O
sat O
98 O
% O
RA O
GEN O
& O
# O
8217 O
; O
L O
Elderly O
white O
male O
. O
 
NAD O
; O
Non-toxic O
appearing O
. O
 
HEENT O
MMM O
; O
No O
scleral O
icterus O
; O
No O
pale O
conjunctiva O
NECK O
Supple O
; O
No O
thyromegaly O
; O
No O
LAD O
. O
 
JVP~7 O
cm O
; O
No O
carotid O
bruits O
CV O
: O
RRR O
with O
occasional O
ectopy O
; O
normal O
S1 O
, O
S2 O
no O
c/r/m/g O
LUNG O
: O
Crackles O
right O
base O
ABD O
: O
Soft O
, O
non-tender O
, O
non-distended O
; O
Hyperactive O
BS O
. O
 
No O
HSM O
. O
 
No O
masses O
, O
rebound O
. O
 
No O
CVA O
tenderness O
. O
 
EXT O
: O
2+ O
edema O
bilateral O
low O
ext O
to O
shin O
; O
1+ O
left O
upper O
ext O
; O
Warm O
well-perfused O
with O
cap O
refill O
& O
lt O
; O
2 O
sec O
; O
No O
clubbing/cyanosis O
NEURO O
: O
AO O
x O
3 O
; O
CN O
II-XII O
grossly O
intact O
including O
PERRL O
, O
EOM O
, O
& O
amp O
; O
visual O
fields O
; O
Motor O
: O
5/5 O
B O
UE/LE O
; O
sensation O
grossly O
intact O
to O
light O
touch O
; O
DTRs O
( O
/brachioradialis/patellar/Achilles O
) O
2+ O
& O
amp O
; O
symmetric O
bilaterally O
; O
Good O
coordination O
on O
Finger-to-nose O
; O
no O
pronator O
drift O
SKIN O
Slight O
erythematous O
macules O
on O
right O
low O
ext O
anterior O
shin O
; O
no O
warmth O
, O
tenderness O
& O
# O
183 O
; O
Hematology O
: O
WBC O
4.8 O
RBC O
3.70 O
( O
L O
) O
HGB O
10.2 O
( O
L O
) O
HCT O
30.0 O
( O
L O
) O
MCV O
81 O
MCH O
27.5 O
MCHC O
33.9 O
PLT O
236 O
RDW O
15.6 O
( O
H O
) O
DIFFR O
Received O
METHOD O
see O
detail O
% O
NEUT O
75 O
( O
H O
) O
% O
LYMPH O
14 O
( O
L O
) O
% O
MONO O
8 O
% O
EOS O
3 O
% O
BASO O
0 O
ANEUT O
3.64 O
ALYMP O
0.64 O
( O
L O
) O
AMONS O
0.38 O
AEOSN O
0.16 O
ABASOP O
0.02 O
ANISO O
None O
HYPO O
None O
MACRO O
None O
MICRO O
None O
& O
# O
183 O
; O
Chemistries O
: O
NA O
134 O
( O
L O
) O
K O
4.6 O
( O
T O
) O
CL O
99 O
( O
L O
) O
CO2 O
26.0 O
BUN O
16 O
CRE O
0.82 O
EGFR O
see O
detail O
GLU O
182 O
( O
H O
) O
ANION O
9 O
CA O
8.8 O
PHOS O
3.4 O
MG O
1.7 O
TP O
7.5 O
ALB O
3.2 O
( O
L O
) O
GLOB O
4.3 O
( O
H O
) O
ALT/SGPT O
26 O
AST/SGOT O
39 O
ALKP O
210 O
( O
H O
) O
TBILI O
0.4 O
DBILI O
see O
detail O
& O
# O
183 O
; O
Cardiac O
Enzymes O
: O
NT-BNP O
2221 O
( O
HT O
) O
CK-MB O
Negative O
TROP-I O
Negative O
& O
# O
183 O
; O
Coags O
: O
PT O
34.9 O
( O
HT O
) O
PT-INR O
3.8 O
( O
T O
) O
PTT O
32.4 O
( O
T O
) O
& O
# O
183 O
; O
Toxicology O
: O
DIG O
Refuse O
& O
# O
183 O
; O
Radiology O
: O
CXR O
: O
LOCULATED O
RIGHT O
LOWER O
LOBE O
PNEUMOTHORAX O
MORE O
APPARENT O
ON O
THE O
CURRENT O
STUDY O
COMPARED O
TO O
THE O
RADIOGRAPH O
OF O
3/07/87 I-DATE
. O
 
INTERVAL O
INCREASE O
IN O
PATCHY O
AIRSPACE O
DENSITY O
INVOLVING O
THE O
RIGHT O
LOWER O
LOBE O
COULD O
SUGGEST O
WORSENING O
NO O
PLEURAL O
EFFUSION O
AND O
OR O
PNEUMONIA O
. O
 
& O
# O
183 O
; O
EKG O
: O
A O
fib O
with O
rate O
with O
? O
 
escape O
jxnal O
rhythm O
at O
times O
. O
 
Normal O
axis O
. O
 
No O
QRS-widening O
. O
 
No O
ST-elevations O
. O
 
Scooped O
ST O
depressions O
V5-V6 O
likely O
2/2 O
digoxin O
. O
 
No O
Q-waves O
or O
TWI O
. O
 
QTc O
436 O
ASSESSMENT O
& O
amp O
; O
PLAN O
Mr. O
Jimenez I-NAME
is O
a O
78 I-AGE
yo O
male O
with O
h/o O
Hodgkin O
& O
# O
8217 O
; O
s O
dz O
s/p O
chemo O
, O
T2m O
, O
HTN O
, O
AAA O
, O
CHF O
( O
last O
TTE O
2086 I-DATE
with O
LVEF O
50 O
% O
, O
RVSP O
45 O
) O
, O
a O
fib O
on O
coumadin O
, O
recently O
discharged O
after O
prolonged O
hospital O
stay O
for O
PNA O
& O
amp O
; O
complicated O
pleural O
effusion O
requiring O
chest O
tube O
placement O
, O
now O
returns O
from O
rehab O
with O
20 O
lb O
wt O
gain O
since O
discharge O
on O
3/09 I-DATE
& O
amp O
; O
7.5 O
lbs O
since O
3/20 I-DATE
& O
amp O
; O
increasing O
pleural O
effusion O
. O
 
Increasing O
wt O
gain O
could O
be O
secondary O
to O
low O
ext O
edema O
. O
 
? O
right O
heart O
failure O
2/2 O
to O
pulm O
htn O
or O
perhaps O
diastolic O
dysfunction O
; O
however O
BNP O
not O
very O
elevated O
. O
 
Patient O
& O
# O
8217 O
; O
s O
albumin O
is O
only O
slightly O
below O
3.4 O
as O
well O
. O
 
Low O
suspicion O
for O
DVTs O
given O
exam O
with O
bilateral O
low O
ext O
swelling O
& O
amp O
; O
recent O
negative O
LUE O
noninvasive O
. O
 
1 O
. O
 
Low O
ext O
edema/wt O
gain O
: O
Patient O
responding O
well O
to O
IV O
lasix O
from O
ED O
. O
 
a O
. O
 
Trial O
of O
daily O
PO O
lasix O
b O
. O
 
Strict O
I/O/s O
, O
daily O
wt O
c. O
Consider O
a O
repeat O
TTE O
, O
but O
recently O
performed O
5 O
months O
ago O
so O
expect O
little O
change O
. O
 
2 O
. O
 
Loculated O
pleural O
effusion O
: O
With O
effusion O
enlarging O
, O
question O
if O
patient O
would O
be O
candidate O
for O
decortication/pleurodesis O
. O
 
a O
. O
 
Consider O
thoracic O
surgery O
consult O
3 O
. O
 
ID O
: O
Will O
hold O
on O
further O
antibiotics O
at O
this O
time O
. O
 
Afebrile O
without O
elev O
WBC O
. O
 
Suspect O
CXR O
showing O
increasing O
pleural O
effusion O
. O
 
Low O
suspicion O
for O
PNA O
. O
 
4 O
. O
 
CV O
: O
a O
. O
 
Rhythm O
: O
Rate O
control O
with O
digoxin O
, O
labetalol O
. O
 
Hold O
coumadin O
for O
elevated O
INR O
. O
 
Restart O
when O
& O
lt O
; O
3.3. O
b. O
HTN O
: O
Cont O
Norvasc O
, O
labetalol O
, O
hydralazin O
, O
lisinopril O
c. O
PVD O
: O
Cont O
statin O
, O
ASA O
5 O
. O
 
T2DM O
: O
Cont O
NPH O
6 O
units O
BID O
+ O
RISS O
F/E/N O
: O
No O
conc O
sweets O
. O
 
PROPHYLAXIS O
: O
GI O
: O
Not O
indicated O
. O
 
DVT O
: O
Coumadin O
BOWEL O
: O
OBR O
CODE O
: O
FULL O
__________________________________ O
Alois I-NAME
B. I-NAME
Benton I-NAME
, O
MDMedicine O
Resident O
( O
PGY1 O
) O
Pager O
# O
46876 I-CONTACT
 
Record O
date O
: O
2127-05-18 I-DATE
May I-DATE
18 O
, O
2127 I-DATE
Robert I-NAME
Xenakis I-NAME
, O
M.D O
. O
 
Internal O
Medicine O
Assoc O
. O
 
Internal O
Medicine O
56th O
Floor O
Houston I-LOCATION
Medical I-LOCATION
Center I-LOCATION
Hayti I-LOCATION
, O
DE I-LOCATION
69436 I-LOCATION
RE O
: O
MCKEE O
, O
Norma I-NAME
MR O
# O
: O
6987776 I-ID
DOB O
: O
7/7/75 I-DATE
Dear O
Robert I-NAME
, O
Thank O
you O
for O
allowing O
me O
to O
share O
in O
the O
medical O
care O
of O
Ms. O
Norma I-NAME
Mckee I-NAME
, O
a O
51-year-old O
female O
patient O
with O
the O
history O
of O
seizure O
disorder O
, O
hypertension O
, O
borderline O
diabetes O
, O
gastroesophageal O
reflux O
disease O
and O
panic O
related O
symptoms O
, O
and O
depressive O
disorder O
, O
who O
complains O
of O
excessive O
daytime O
sleepiness O
with O
recent O
polysomnographic O
abnormalities O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
As O
you O
already O
know O
, O
Ms. O
Mckee I-NAME
describes O
a O
longstanding O
history O
of O
snoring O
symptomatology O
and O
suspected O
nocturnal O
respiratory O
pauses O
, O
and O
describes O
a O
`` O
restless O
sleep O
'' O
, O
but O
only O
relatively O
recently O
( O
over O
the O
last O
five O
months O
, O
particularly O
after O
12/26 I-DATE
of O
last O
year O
) O
. O
 
She O
has O
described O
marked O
increased O
daytime O
sleepiness O
. O
 
She O
essentially O
describes O
a O
nocturnal O
sleep O
pattern O
which O
involves O
`` O
sleeping O
around O
the O
clock O
'' O
during O
which O
time O
she O
may O
initiate O
sleep O
between O
12:30 O
and O
1:00 O
a.m. O
, O
and O
after O
a O
couple O
awakenings O
, O
will O
wake O
up O
at O
10:00 O
a.m. O
, O
only O
to O
demonstrate O
frequent O
and O
often O
prolonged O
daytime O
naps O
of O
four O
hours O
duration O
. O
 
The O
patient O
states O
she O
will O
waken O
for O
a O
couple O
of O
hours O
and O
then O
reinitiate O
sleep O
for O
an O
additional O
four O
hours O
. O
 
She O
states O
that O
she O
is O
so O
tired O
that O
she O
can O
`` O
fall O
asleep O
right O
after O
breakfast O
'' O
. O
 
She O
then O
would O
get O
up O
for O
lunch O
and O
then O
go O
right O
back O
to O
sleep O
and O
sustain O
sleep O
until O
3:00 O
p.m. O
in O
the O
afternoon O
. O
 
Ms. O
Mckee I-NAME
also O
demonstrates O
a O
history O
of O
seizures O
initiated O
at O
3 I-AGE
to O
4 I-AGE
years O
of O
age O
, O
and O
was O
initially O
started O
on O
phenobarbital O
therapy O
. O
 
She O
later O
switched O
to O
Dilantin O
therapy O
, O
but O
more O
recently O
and O
particularly O
since O
the O
mid O
10 O
's O
, O
she O
has O
been O
on O
Tegretol O
antiepileptic O
monotherapy O
200 O
mg O
tablets O
, O
four O
tablets O
po O
q.a.m O
. O
 
and O
three O
tablets O
po O
q.h.s O
. O
 
While O
Ms. O
Mckee I-NAME
also O
demonstrates O
both O
daytime O
and O
nocturnal O
seizures O
, O
there O
has O
been O
increased O
predilections O
for O
nocturnal O
seizures O
over O
the O
last O
year O
, O
and O
an O
increased O
amount O
of O
`` O
diffuse O
'' O
spike O
wave O
discharges O
are O
evident O
during O
light O
sleep O
, O
as O
detailed O
during O
a O
recent O
polysomnographic O
evaluation O
( O
please O
see O
below O
) O
. O
 
CURRENT O
MEDICATIONS O
: O
Remeron O
, O
Celexa O
, O
Zestril O
, O
Prilosec O
, O
carbamazepine O
( O
200 O
mg O
tablets O
, O
four O
tablets O
in O
the O
morning O
and O
three O
tablets O
at O
night O
) O
, O
clonazepam O
, O
hydrochlorothiazide O
, O
Premarin O
, O
tetracycline O
and O
klor-con O
. O
 
ALLERGIES O
: O
No O
adverse O
drug O
allergies O
reported O
. O
 
SLEEP O
HISTORY O
: O
Sleep O
onset O
intended O
for O
11:00 O
p.m. O
but O
the O
patient O
does O
not O
often O
sleep O
until O
12:30 O
to O
1:00 O
a.m. O
She O
describes O
one O
to O
two O
early O
morning O
awakenings O
, O
with O
relative O
ease O
with O
regards O
to O
subsequent O
reinitiation O
and O
maintenance O
. O
 
Sleep O
offset O
initially O
occurs O
at O
8:30 O
to O
9:00 O
a.m. O
and O
sometimes O
as O
late O
as O
10:00 O
a.m O
. O
 
The O
patient O
will O
then O
get O
up O
and O
right O
after O
breakfast O
fall O
asleep O
for O
several O
hours O
in O
duration O
( O
up O
to O
four O
hours O
) O
. O
 
The O
patient O
then O
will O
reawaken O
and O
have O
lunch O
and O
then O
after O
a O
couple O
of O
hours O
of O
sustained O
wakefulness O
, O
will O
reinitiate O
sleep O
for O
an O
additional O
four O
hours O
of O
sleep O
. O
 
Patient O
may O
sleep O
until O
3:00 O
p.m. O
on O
certain O
given O
afternoons O
. O
 
The O
patient O
describes O
a O
history O
of O
prominent O
snoring O
symptomatology O
and O
suspected O
nocturnal O
respiratory O
pauses O
as O
well O
as O
`` O
restless O
'' O
sleep O
. O
 
She O
denies O
a O
history O
of O
restless O
lower O
limb O
sensory O
complaints O
of O
nocturnal O
lower O
limb O
movements O
suggestive O
of O
periodic O
limb O
movement O
disorder O
. O
 
She O
denies O
the O
history O
of O
abnormal O
arousal O
behaviors O
or O
associated O
narcoleptic O
symptoms O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
1 O
. O
 
Seizure O
disorder O
. O
 
2 O
. O
 
Hypertension O
. O
 
3 I-AGE
. O
 
Borderline O
diabetes O
. O
 
4 I-AGE
. O
 
Gastroesophageal O
reflux O
disease O
. O
 
5 O
. O
 
Depressive O
disorder O
. O
 
6 O
. O
 
Panic O
related O
symptoms O
. O
 
SOCIAL O
HISTORY O
: O
Patient O
denies O
active O
tobacco O
use O
. O
 
She O
has O
discontinued O
all O
alcoholic O
beverage O
intake O
due O
to O
her O
reflux O
disease O
. O
 
She O
averages O
two O
cups O
of O
tea O
per O
day O
. O
 
While O
describing O
an O
overweight O
status O
, O
she O
has O
increased O
her O
weight O
by O
10-20 O
pounds O
over O
the O
past O
four O
years O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
examination O
, O
the O
patient O
demonstrates O
a O
mildly O
hypersomnolent O
facies O
. O
 
Speech O
is O
clear O
and O
fluent O
. O
 
Receptive O
language O
functioning O
essentially O
intact O
. O
 
No O
obvious O
cranial O
nerve O
deficits O
are O
appreciated O
. O
 
No O
focal O
sensory O
motor O
neurologic O
deficits O
are O
noted O
. O
 
No O
significant O
appendicular O
dystaxias O
or O
dysmetrias O
are O
currently O
in O
evidence O
. O
 
The O
routine O
gait O
appears O
to O
be O
normal O
based O
, O
without O
evidence O
of O
significant O
gait O
dystaxias O
. O
 
No O
current O
clinical O
ictal O
manifestations O
are O
present O
. O
 
No O
acute O
evidence O
of O
`` O
microsleeps O
'' O
are O
noted O
. O
 
On O
HEENT O
examination O
, O
there O
is O
evidence O
of O
a O
small O
posterior O
oropharyngeal O
apeture O
, O
with O
increased O
redundant O
tissue O
evident O
posteriorly O
and O
a O
mildly O
elongated O
uvula O
, O
as O
well O
as O
a O
high O
riding O
base O
of O
the O
tongue O
and O
mildly O
increased O
tonsillar O
size O
. O
 
Vital O
signs O
include O
a O
blood O
pressure O
of O
144/88 O
( O
seated O
, O
left O
arm O
) O
and O
a O
heart O
rate O
of O
88 O
, O
with O
a O
respiratory O
rate O
of O
14 O
. O
 
IMPRESSION O
: O
1 O
. O
 
Hypersomnia O
( O
780.54 O
) O
: O
Likely O
to O
be O
a O
result O
of O
frequent O
sleep O
disordered O
breathing O
events O
and O
their O
associated O
arousals O
. O
 
Other O
diagnostic O
possibilities O
include O
the O
presence O
of O
gastroesophageal O
reflux O
associated O
arousals O
as O
well O
as O
nocturnal O
sleep O
disruptions O
due O
to O
sleep O
related O
epilepsy O
( O
although O
seizures O
appear O
to O
be O
under O
relatively O
good O
control O
on O
Tegretol O
anticonvulsant O
monotherapy O
) O
. O
 
2 O
. O
 
Obstructive O
sleep O
disordered O
breathing O
( O
780.53 O
) O
: O
Patient O
describes O
a O
history O
of O
prominent O
snoring O
symptomatology O
and O
nocturnal O
respiratory O
pauses O
as O
well O
as O
extremely O
frequent O
intermittent O
obstructive O
apneas O
and O
a O
respiratory O
disturbance O
index O
of O
26 O
per O
hour O
as O
noted O
during O
a O
recent O
3/26/27 I-DATE
sleep O
study O
with O
associated O
O2 O
desaturations O
down O
to O
76 O
percent O
. O
 
Good O
clinical O
response O
to O
nocturnal O
CPAP O
therapy O
noted O
. O
 
3 I-AGE
. O
 
Seizure O
disorder O
: O
Recent O
literature O
suggests O
that O
there O
is O
a O
possible O
association O
between O
treatment O
of O
obstructive O
sleep O
disorder O
and O
increased O
seizure O
frequency O
in O
patients O
who O
are O
susceptible O
; O
i.e. O
, O
thereby O
giving O
a O
further O
impetus O
for O
regular O
ongoing O
home O
CPAP O
therapy O
. O
 
PLAN O
: O
1 O
. O
 
Suggest O
regular O
home O
CPAP O
administration O
( O
CPAP O
Mallinckrodt O
; O
Respironics O
`` O
contour O
classic O
'' O
mask O
; O
ramp O
time O
of O
20 O
minutes O
; O
warm O
air O
humidification O
; O
at O
12 O
cm O
of O
water O
pressure O
) O
. O
 
2 O
. O
 
Pending O
clinical O
response O
, O
will O
reassess O
the O
patient O
's O
level O
of O
alertness O
, O
decrease O
amount O
of O
early O
morning O
awakenings O
, O
and O
possibly O
decrease O
seizure O
frequency O
at O
the O
next O
sleep O
study O
evaluation O
in O
12-14 O
weeks O
times O
. O
 
3 I-AGE
. O
 
In O
addition O
, O
patient O
is O
advised O
to O
continue O
efforts O
at O
weight O
reduction O
, O
use O
of O
an O
oro-dental O
, O
and/or O
potential O
ENT O
surgical O
approaches O
may O
also O
help O
to O
improve O
upper O
airway O
signs O
and O
symptoms O
. O
 
4 I-AGE
. O
 
Patient O
to O
continue O
on O
Tegretol O
anticonvulsant O
monotherapy O
200 O
mg O
tablets O
, O
four O
tablets O
po O
q.a.m O
. O
 
and O
three O
tablets O
po O
q.h.s O
. O
 
until O
an O
assessment O
of O
seizure O
frequency O
with O
nocturnal O
CPAP O
therapy O
has O
been O
made O
. O
 
5 O
. O
 
Follow O
up O
neurologic O
reevaluation O
in O
our O
sleep O
study O
department O
is O
tentatively O
scheduled O
in O
12-14 O
weeks O
time O
. O
 
Once O
again O
, O
thank O
you O
for O
allowing O
me O
to O
share O
in O
the O
medical O
care O
of O
Ms. O
Norma I-NAME
Mckee I-NAME
. O
 
I O
hope O
this O
letter O
finds O
you O
in O
the O
best O
of O
health O
. O
 
Sincerely O
, O
Salvador I-NAME
B. I-NAME
Irvin I-NAME
, O
M.D O
. O
 
Department O
of O
Sleep O
Studies O
Houston I-LOCATION
Medical I-LOCATION
Center I-LOCATION
ADDENDUM O
: O
Sleep O
study O
results O
( O
3/26/27 I-DATE
) O
: O
1 O
. O
 
Extremely O
frequent O
intermittent O
obstructive O
( O
82 O
) O
and O
partially O
obstructive O
apneas O
( O
63 O
) O
during O
supine O
sleep O
, O
as O
well O
as O
intermittent O
hypopneas O
( O
19 O
) O
and O
nocturnal O
hypoventilations O
, O
intermittent O
snore O
arousals O
( O
4 I-AGE
) O
and O
episodes O
of O
moderate O
snoring O
( O
respiratory O
disturbance O
index O
= O
26 O
per O
hour O
) O
with O
associated O
arousals O
and O
O2 O
desaturations O
down O
to O
76 O
% O
. O
 
Insofar O
as O
stage O
REM O
sleep O
was O
not O
achieved O
, O
the O
actual O
degree O
of O
respiratory O
compromise O
may O
be O
under O
represented O
. O
 
2 O
. O
 
CPAP O
administration O
( O
CPAP O
Mallinckrodt O
; O
Respironics O
`` O
contour O
classic O
'' O
mask O
; O
ramp O
time O
of O
20 O
minutes O
; O
warm O
air O
humidification O
; O
at O
12 O
cm O
of O
water O
pressure O
) O
served O
to O
considerably O
reduce O
the O
frequency O
of O
these O
nocturnal O
respiratory O
disturbances O
, O
help O
consolidate O
sleep O
, O
as O
well O
as O
improve O
O2 O
saturations O
( O
i.e. O
, O
to O
96 O
% O
and O
above O
, O
even O
during O
REM O
supine O
sleep O
) O
and O
overall O
sleep O
stage O
architecture O
. O
 
3 I-AGE
. O
 
Slightly O
increased O
periodic O
limb O
movements O
of O
sleep O
, O
activated O
during O
both O
`` O
light O
'' O
non-REM O
, O
as O
well O
as O
stage O
REM O
sleep O
( O
index O
= O
8 O
per O
hour O
) O
with O
infrequent O
limb O
associated O
arousals O
( O
index O
= O
1 O
per O
hour O
) O
both O
of O
which O
may O
serve O
to O
interfere O
with O
the O
continuity O
of O
sleep O
( O
the O
presence O
of O
REM O
related O
nocturnal O
lower O
limb O
movements O
may O
suggest O
some O
degree O
of O
REM O
motor O
disinhibition O
) O
. O
 
4 I-AGE
. O
 
Cardiac O
rates O
typically O
ranged O
between O
72-87 O
beats O
per O
minute O
; O
average O
80 O
beats O
per O
minute O
. O
 
5 O
. O
 
EEG O
evidence O
of O
frequent O
bursts O
and O
brief O
runs O
of O
`` O
diffuse O
'' O
spike-wave O
discharges O
were O
evident O
during O
light O
sleep O
, O
without O
associated O
clinical O
accompaniment O
. O
 
6 O
. O
 
Inability O
to O
achieve O
stage O
REM O
sleep O
under O
pre-CPAP O
conditions O
, O
but O
with O
prominent O
`` O
slow O
wave O
and O
REM O
rebounds O
'' O
subsequently O
noted O
with O
CPAP O
administration O
; O
i.e. O
, O
accounting O
for O
more O
than O
41 O
% O
and O
more O
than O
31 O
% O
of O
the O
CPAP O
sleep O
times O
, O
respectively O
. O
 
7 O
. O
 
Total O
recording O
period O
: O
405 O
minutes O
; O
total O
sleep O
time O
: O
377 O
minutes O
. O
 
DD:05/18/2127 O
DT:05/20/2127 O
RS:91294 I-ID
:1305 I-ID
 
Record O
date O
: O
2130-02-16 I-DATE
INTERNAL O
MEDICINE O
ASSOCIATES O
HOUSTON I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
Personal O
data O
and O
overall O
health O
This O
is O
a O
54-year-old O
woman O
with O
hypertension O
, O
hyperlipidemia O
, O
glucose O
intolerance O
, O
depression O
, O
and O
agoraphobia O
. O
 
Reason O
for O
visit O
Extended O
interval O
visit O
. O
 
Major O
Problems O
Depression O
/chronic O
mood O
disorder O
with O
elements O
of O
paranoia/ O
( O
? O
) O
 
psychosis/agoraphobia O
. O
 
Medicines O
reviewed O
. O
 
She O
will O
follow O
up O
with O
Dr. O
Thurston I-NAME
. O
 
She O
is O
largely O
homebound O
, O
fearful O
of O
her O
phone O
, O
fearful O
of O
going O
out O
, O
overeating O
, O
under O
exercising O
but O
not O
despondent O
or O
self-destructive O
. O
 
She O
does O
have O
support O
from O
sister O
and O
brother O
who O
live O
at O
home O
with O
her O
. O
 
P O
: O
Per O
Dr. O
Thurston I-NAME
. O
 
Discussed O
the O
potential O
of O
transitional O
therapist O
if O
she O
relocates O
. O
 
Family O
history O
risk O
factors O
/ O
cad O
; O
diabetes O
. O
 
An O
episode O
of O
chest O
discomfort O
occurred O
at O
rest O
watching O
TV O
. O
 
He O
had O
to O
get O
up O
and O
go O
to O
bed O
. O
 
They O
were O
no O
episymptoms O
of O
sweat O
, O
nausea O
, O
vomiting O
, O
and O
dyspnea O
, O
but O
she O
did O
have O
both O
chest O
and O
left O
arm O
discomfort O
, O
the O
duration O
was O
an O
hour O
, O
this O
occurred O
a O
month O
ago O
. O
 
She O
has O
been O
active O
since O
then O
around O
the O
house O
without O
pain O
and O
had O
no O
pain O
walking O
in O
today O
. O
 
A O
: O
Episode O
of O
chest O
discomfort O
with O
family O
history O
of O
CAD O
and O
multiple O
risk O
factors O
. O
 
P O
: O
Check O
EKG O
. O
 
She O
will O
call O
for O
recurrent O
symptoms O
. O
 
Glucose O
intolerance O
/family O
history O
of O
diabetes O
. O
 
Lots O
of O
sugars O
and O
carbohydrates O
. O
 
Weight O
is O
up O
. O
 
P O
: O
Update O
hemoglobin O
A1c O
next O
month O
when O
she O
returns O
for O
fasting O
blood O
; O
urine O
microalbumin O
today O
; O
long O
overdue O
for O
an O
eye O
exam O
and O
she O
and O
her O
sister O
promised O
to O
schedule O
this O
. O
 
Diet O
reviewed O
and O
weight O
program O
urged O
. O
 
Hiatal O
hernia O
Only O
occasional O
reflux O
and O
heartburn O
but O
one O
episode O
at O
the O
holiday O
rather O
vigorous O
reflux O
with O
a O
vomiting O
episode O
without O
chest O
pain O
. O
 
There O
was O
vigorous O
vomiting O
and O
she O
actually O
experienced O
some O
blood O
. O
 
She O
states O
`` O
one-half O
cup O
. O
'' O
 
Stools O
were O
dark O
for O
several O
days O
thereafter O
, O
then O
cleared O
, O
now O
normal O
and O
she O
has O
had O
no O
satiety O
, O
dysphagia O
, O
or O
recurrent O
symptoms O
. O
 
She O
has O
a O
well O
documented O
GERD O
and O
reflux O
, O
and O
HH O
on O
barium O
swallow O
in O
2123 I-DATE
. O
 
She O
has O
not O
been O
having O
major O
breakthrough O
reflux O
on O
Prilosec O
20 O
mg. O
A O
: O
Episode O
of O
reflux O
, O
vomiting O
possible O
esophageal O
tear O
with O
symptoms O
now O
abated O
and O
color O
looks O
good O
. O
 
She O
does O
not O
appear O
markedly O
anemic O
. O
 
There O
are O
no O
symptoms O
to O
suggest O
Barrett O
, O
but O
obviously O
this O
is O
a O
consideration O
. O
 
P O
: O
Check O
CBC O
, O
stool O
guaiac O
for O
starters O
and O
iron O
level O
. O
 
If O
she O
significantly O
anemic O
and O
these O
symptoms O
persist O
an O
EGD O
would O
be O
appropriate O
though O
he O
may O
have O
to O
negotiate O
this O
, O
given O
her O
agoraphobia O
. O
 
Minimally O
, O
she O
will O
stay O
on O
Prilosec O
one O
or O
two O
a O
day O
in O
the O
meantime O
and O
call O
me O
if O
there O
is O
anymore O
vomiting O
, O
bleeding O
, O
or O
black O
stools O
. O
 
Hypertension O
Blood O
pressure O
is O
okay.P O
: O
Continue O
current O
treatment O
. O
 
02/16/2130 I-DATE
: O
Menstrual O
disorder O
/ O
status O
post O
hysterectomy O
, O
BSO O
for O
endometriomas O
, O
fibroids O
. O
 
Ran O
out O
of O
Premarin O
three O
days O
ago O
, O
not O
terribly O
troubled O
by O
hot O
flashes O
. O
 
P O
: O
Discontinue O
Premarin O
. O
 
If O
hot O
flashes O
reoccur O
badly O
, O
we O
can O
go O
to O
0.3 O
and O
then O
wean O
more O
slowly O
. O
 
She O
will O
let O
me O
know O
. O
 
Overweight O
P O
: O
Encouraged O
weight O
loss O
. O
 
02/16/2130 I-DATE
: O
Sciatica O
No O
recurrence O
. O
 
02/16/2130 I-DATE
: O
Seizure O
disorder O
We O
will O
check O
Tegretol O
level O
, O
CBC O
, O
and O
LFTs O
. O
 
She O
is O
overdue O
and O
had O
episode O
at O
the O
holidays O
of O
fainting O
like O
feeling O
without O
seizure O
prodrome O
or O
seizure O
activity O
. O
 
P O
: O
Check O
levels O
. O
 
Call O
for O
any O
further O
episodes O
. O
 
Described O
episode O
was O
not O
clearly O
arrhythmic O
by O
her O
symptoms O
and O
she O
had O
no O
post O
ictal O
. O
 
She O
will O
let O
me O
know O
if O
this O
occurs O
again O
and O
seek O
attention O
at O
that O
time O
. O
 
Sleep O
apnea O
Sister O
states O
she O
needs O
a O
new O
sleep O
device O
and O
we O
will O
take O
care O
of O
a O
referral O
on O
contact O
from O
her O
supplier O
. O
 
Gallstones O
/ O
status O
post O
cholecystectomy O
at O
time O
of O
hysterectomy O
. O
 
The O
episode O
of O
abdominal O
discomfort O
and O
vomiting O
was O
not O
clearly O
colic O
and O
she O
is O
post O
hysterectomy O
, O
but O
might O
have O
a O
recurrent O
stone O
. O
 
No O
obvious O
icterus O
today O
. O
 
P O
: O
LFT O
profile O
. O
 
Call O
for O
further O
difficulties O
. O
 
Chest O
pain O
CT O
as O
above O
. O
 
P O
: O
Check O
EKG O
. O
 
Active O
Medications O
Tegretol O
200mg O
po O
7 O
TABLETS O
PER O
DAY O
potassium O
chloride O
20meq O
po O
QD O
hydrochlorothiazide O
12.5 O
mg O
po O
qd O
tetracycline O
500mg O
po O
QD O
lisinopril O
30 O
mg O
po O
qd O
Prilosec O
20mg O
po O
QD O
Celexa O
20 O
mg O
2 O
po O
qd O
Klonopin O
0.5mg O
po O
1/2 O
qd O
Remeron O
15 O
mg O
po O
2tabs O
qd O
Seroquel O
25 O
mg O
po O
2tabs O
bid O
and O
4 O
ab O
qhs O
Flexeril O
10 O
mg O
po O
tid O
PRN O
muscle O
spasm O
Lipitor O
10mg O
po O
qd O
Change O
in O
therapies O
and O
Renewals O
Tegretol O
200mg O
po O
7 O
TABLETS O
PER O
DAY O
QTY:350 O
Refills O
: O
nr O
Start O
: O
4/12/20 I-DATE
potassium O
chloride O
20meq O
po O
QD O
QTY:90 O
Refills:3 O
Start O
: O
8/2/20 I-DATE
hydrochlorothiazide O
12.5 O
mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
10/16/23 I-DATE
tetracycline O
500mg O
po O
QD O
QTY:90 O
Refills:3 O
Start O
: O
9/11/21 I-DATE
lisinopril O
30 O
mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
5/22/23 I-DATE
Prilosec O
20mg O
po O
QD O
QTY:90 O
Refills:3 O
Start O
: O
9/18/23 I-DATE
Celexa O
20 O
mg O
2 O
po O
qd O
Start O
: O
11/2/24 I-DATE
Klonopin O
0.5mg O
po O
1/2 O
qd O
Start O
: O
10/18/2125 I-DATE
Premarin O
0.625mg O
po O
QD O
QTY:90 O
Refills:3 O
Start O
: O
10/18/2125 I-DATE
End O
: O
2/16/2130 I-DATE
- O
Inactivated O
Seroquel O
25 O
mg O
po O
2tabs O
bid O
and O
4 O
ab O
qhs O
Start O
: O
8/13/2127 I-DATE
Lipitor O
10mg O
po O
qd O
QTY:90 O
Refills:3 O
Start O
: O
11/30/2129 I-DATE
Procedures O
Influenza O
vaccine O
STATUS O
POST O
left O
arm O
, O
lot O
# O
N2453KM I-ID
, O
Aventis O
. O
 
Family O
history O
Negative O
in O
the O
interval O
. O
 
Social O
history O
See O
detail O
above O
. O
 
No O
smoking O
. O
 
No O
alcohol O
. O
 
No O
risk O
exposures O
. O
 
Review O
of O
systems O
Episode O
of O
chest O
pain O
; O
vomiting O
episode O
; O
faint O
spell O
as O
described O
above O
. O
 
She O
denies O
blood O
or O
melena O
now O
. O
 
No O
dysuria O
. O
 
Not O
much O
activity O
. O
 
All O
other O
issues O
negative O
except O
as O
above O
- O
eye O
exam O
overdue O
and O
she O
promises O
to O
do O
it O
. O
 
She O
does O
not O
have O
any O
self-breast O
exams O
in O
these O
two O
years O
from O
last O
mammogram O
. O
 
Physical O
examination O
Pulse O
70 O
and O
regular O
Blood O
pressure O
130/88 O
on O
arrival O
, O
repeat O
120/78 O
with O
large O
cuff O
Weight O
284 O
pounds O
Height O
5 O
feet O
4-1/2 O
inches O
General O
appearance O
Flat O
affect O
but O
spirits O
are O
no O
worse O
than O
previously O
and O
she O
does O
not O
appear O
unusually O
pale O
Skin O
Chronic O
skin O
changes O
as O
before O
Heent O
Negative O
icterus O
not O
particularly O
pale O
and O
conjunctiva O
. O
 
Pharynx O
benign O
. O
 
No O
obvious O
bleeding O
source O
Neck O
Negative O
. O
 
No O
jugular O
venous O
distension O
, O
bruits O
or O
change O
in O
thyroid O
Nodes O
Negative O
Breasts O
Benign O
Chest O
Clear O
Cor O
Regular O
rhythm O
. O
 
S4 O
, O
no O
murmur O
Abdomen O
Obese O
and O
nontender O
Rectal O
exam O
Declines O
Genitalia O
Genitalia O
, O
deferred O
Extrem O
Trace O
edema O
. O
 
Reasonable O
pulses O
Musc O
skel O
Negative O
Neuro O
Normal O
sensation O
in O
feet O
, O
touch O
and O
vibration O
Disposition O
Flu O
shot O
given O
. O
 
EKG O
to O
be O
checked O
. O
 
Urine O
microalbumin O
to O
be O
done O
. O
 
Sister O
will O
schedule O
eye O
exam O
and O
confirm O
a O
mammogram O
. O
 
Fasting O
labs O
on O
03/09/2130 I-DATE
when O
she O
sees O
Dr. O
Thurston I-NAME
with O
hemoglobin O
A1c O
. O
 
Prompt O
call O
for O
any O
further O
vomiting O
of O
blood O
with O
EGD O
as O
next O
step O
. O
 
Return O
visit O
here O
in O
six O
months O
for O
an O
interval O
visit O
unless O
new O
issues O
develop O
in O
the O
meantime O
. O
 
CC O
: O
Queen I-NAME
Thurston I-NAME
, O
MD O
Note O
transcribed O
by O
outside O
service O
Transcription O
errors O
may O
be O
present O
. O
 
Signed O
electronically O
by O
Xenakis O
, O
Robert I-NAME
on O
Mar I-DATE
3 O
, O
2130 I-DATE
 
Record O
date O
: O
2133-01-22 I-DATE
Wise I-NAME
, O
Willa I-NAME
Internal O
Medicine O
Associates O
, O
Suite O
7 O
Bayne-Jones I-LOCATION
Army I-LOCATION
Community I-LOCATION
Hospital I-LOCATION
, O
0th O
Floor O
, O
Noom O
038 O
Hayti I-LOCATION
, O
DE I-LOCATION
, O
36349-2179 I-LOCATION
RE O
: O
NORMA I-NAME
MCKEE I-NAME
01/22/2133 I-DATE
Admission O
Note O
IMA O
COnsult O
note O
Covering O
for O
Dr O
Robert I-NAME
Xenakis I-NAME
CC O
57yo O
with O
multiple O
medical O
, O
psychiatric O
problems O
admitted O
with O
recurrent O
SBO O
and O
acute O
renal O
failure O
HPI O
Pt O
has O
Hx O
TAB/BSO O
, O
appendectomy O
and O
cholecystectomy O
7/2125 I-DATE
. O
 
She O
was O
admitted O
8/2130 I-DATE
with O
SBO O
, O
treated O
conservatively O
with O
NG O
suction O
. O
 
She O
has O
chronic O
constipation O
. O
 
5 O
days O
ago O
she O
awoke O
with O
nausea O
, O
developed O
vomiting O
, O
and O
has O
been O
unable O
to O
keep O
liquids O
down O
. O
 
She O
has O
severe O
depression O
, O
agorophobia O
, O
and O
did O
not O
want O
to O
come O
in O
to O
the O
hospital O
She O
states O
she O
had O
small O
bowel O
movement O
2-3 O
days O
ago O
. O
 
She O
has O
had O
difficulty O
passing O
urine O
, O
with O
a O
very O
small O
amount O
urine O
output O
yesterdat O
. O
 
She O
had O
a O
few O
episodes O
of O
near O
syncope O
when O
changing O
from O
sitting O
to O
standing O
, O
but O
no O
syncope/ O
LOC/ O
falls O
. O
 
PMHx- O
surgery O
as O
above O
Problems O
: O
Chest O
pain O
Depression O
followed O
by O
Dr O
Kopp I-NAME
psychiatry O
Glucose O
intolerance O
Headache O
Hematochezia O
Hiatal O
hernia O
Hyperlipidemia O
Hypertension O
Seizure O
disorder O
Small O
bowel O
obstruction O
Hx O
Umbilical O
hernia O
Easy O
bruisability O
Sciatica O
Sleep O
apnea O
Family O
history O
risk O
factors O
Diabetes O
mellitus O
Iron O
deficiency O
anemia O
Obesity O
Acne O
Medications O
: O
vitamin O
d O
400 O
units O
po O
daily O
tetracycline O
500mg O
po O
daily O
Nizoral O
cream O
2 O
% O
top O
daily-bid O
rub O
gently O
into O
affected O
area O
once O
to O
twice O
daily O
lisinopril O
30 O
mg O
po O
daily O
Prilosec O
20mg O
po O
daily O
potassium O
chloride O
20meq O
po O
daily O
hydrochlorothiazide O
12.5 O
mg O
po O
daily O
free O
text O
medications O
HEAD O
GEAR O
model O
# O
rsp1007930 O
MiraLax O
1 O
pkt O
daily O
or O
prn O
simvastatin O
20mg O
po O
qpm O
Klonopin O
0.5mg O
po O
bid O
Celexa O
40mg O
po O
daily O
mirtazapine O
30mg O
po O
at O
bedtime O
Seroquel O
po O
1600 O
mg O
daily O
Tegretol O
200mg O
po O
7 O
TABLETS O
PER O
DAY O
CPAP O
mask O
Respironics O
Comfort O
Select O
- O
medium O
Family O
history O
: O
Father O
with O
CAD O
, O
diabetes O
, O
and O
hypertension O
. O
 
Sister O
with O
hypertension O
, O
diabetes O
, O
and O
hyperlipidemia O
. O
 
Brother O
with O
hypertension O
and O
obesity O
. O
 
Social O
history O
: O
No O
tobacco O
. O
 
No O
alcohol O
. O
 
See O
depression O
issues O
above O
. O
 
Largely O
homebound O
. O
 
Physical O
Exam O
: O
Blood O
pressure O
: O
100/60 O
Pulse O
: O
110 O
Respiratory O
rate O
: O
14 O
Temperature O
: O
97.7 O
O2 O
sat O
95 O
% O
2 O
liters O
General O
appearance O
: O
Ill O
appearing O
Skin O
: O
facial O
acne O
HEENT O
: O
NG O
tube O
in O
place O
. O
 
mucous O
membranes O
dry O
Neck O
: O
no O
adenopathy O
Chest O
: O
Clear O
Cor O
: O
S4 O
, O
no O
murmur O
Abdomen O
: O
Obese.Distended O
Extrem O
: O
There O
is O
1+ O
edema O
. O
 
Selected O
Recent O
Labs O
: O
01/22/33 I-DATE
Plasma O
Sodium O
135 O
, O
01/22/33 I-DATE
Plasma O
Potassium O
3.7 O
, O
01/22/33 I-DATE
Plasma O
Chloride O
78 O
L O
, O
01/22/33 I-DATE
Plasma O
Carbon O
Dioxide O
44.0 O
H O
, O
01/22/33 I-DATE
Transaminase-SGPT O
30 O
, O
01/22/33 I-DATE
Transaminase-SGOT O
30 O
, O
01/22/33 I-DATE
Alkaline O
Phosphatase O
104 O
H O
, O
01/22/33 I-DATE
Total O
Bilirubin O
0.7 O
, O
01/22/33 I-DATE
Direct O
Bilirubin O
0.3 O
, O
12/14/14 I-DATE
5'-Nucleotidase O
8 O
, O
01/22/33 I-DATE
Total O
Protein O
7.5 O
, O
01/22/33 I-DATE
Albumin O
3.8 O
, O
01/22/33 I-DATE
Globulin O
3.7 O
, O
03/07/31 I-DATE
Creatine O
Kinase O
104 O
, O
01/21/33 I-DATE
Creatine O
Kinase O
Isoenzymes O
NEGATIVE O
, O
01/21/33 I-DATE
Troponin-I O
NEGATIVE O
, O
01/22/33 I-DATE
Plasma O
Urea O
Nitrogen O
67 O
H O
, O
01/22/33 I-DATE
Calcium O
9.7 O
, O
01/22/33 I-DATE
Plasma O
Creatinine O
5.8 O
H O
, O
01/22/33 I-DATE
Plasma O
Glucose O
200 O
H O
, O
01/22/33 I-DATE
Lipase O
11 O
L O
, O
01/22/33 I-DATE
Phosphorus O
6.7 O
H O
, O
01/22/33 I-DATE
WBC O
5.5 O
, O
01/22/33 I-DATE
HCT O
36.4 O
, O
01/22/33 I-DATE
PLT O
342 O
, O
01/21/33 I-DATE
UA-Turbidity O
Clear O
, O
01/21/33 I-DATE
UA-Glucose O
NEGATIVE O
, O
01/21/33 I-DATE
Bili O
2+ O
, O
01/21/33 I-DATE
UA-Ketones O
Trace O
, O
01/21/33 I-DATE
UA-Specific O
Gravity O
& O
gt O
; O
1.030 O
, O
01/21/33 I-DATE
UA-Occult O
Blood O
NEGATIVE O
, O
01/21/33 I-DATE
UA-pH O
5.0 O
, O
01/21/33 I-DATE
UA-Albumin O
2+ O
, O
01/21/33 I-DATE
Urobilinogen O
NEGATIVE O
, O
01/21/33 I-DATE
UA-Nitrite O
NEGATIVE O
, O
01/21/33 I-DATE
UA-WBC O
Screen O
NEGATIVE O
, O
01/21/33 I-DATE
Hyaline O
Cast O
None O
, O
01/21/33 I-DATE
Granular O
Cast O
0-2 O
, O
01/21/33 I-DATE
UA-SED-RBC O
3-5 O
, O
01/21/33 I-DATE
UA-SED-WBC O
0-2 O
, O
01/21/33 I-DATE
UA-SED-Bacteria O
Many O
, O
01/21/33 I-DATE
Squamous O
Cells O
Moderate O
, O
01/21/33 I-DATE
Tubular O
Cells O
Few O
Abdominal O
CT O
Renal O
no O
hydronephrosis/renal O
masses O
. O
 
Dilated O
loops O
of O
bowel/ O
no O
masses/ O
consistent O
with O
SBO O
Assessment O
and O
plan O
: O
Patient O
with O
recurrent O
SBO O
. O
 
Unfortunately O
she O
has O
had O
vomiting O
X O
4-5 O
days O
, O
and O
now O
has O
acute O
renal O
failure O
, O
most O
likely O
due O
to O
hypotension O
, O
dehydration O
and O
ATN O
Her O
psychiatric O
problem O
is O
significant O
. O
 
Hold O
HCTZ/ O
ACE O
IV O
hydration O
. O
 
Renal O
consult O
. O
 
NG O
suction O
for O
SBO O
. O
 
Dr O
Xenakis I-NAME
back O
tomorrow O
. O
 
Willa I-NAME
Wise I-NAME
, O
MD O
pager O
# O
58824 I-CONTACT
Signed O
electronically O
by O
Willa I-NAME
Wise I-NAME
, O
MD O
Document O
Status O
: O
Final O
 
Record O
date O
: O
2134-01-05 I-DATE
698-77-76 I-ID
Mckee I-NAME
, O
Norma I-NAME
January I-DATE
5 O
, O
2134 I-DATE
Endocrine/Diabetes O
Present O
Illness O
: O
Ms. O
Mckee I-NAME
thinks O
that O
she O
will O
be O
discharged O
today O
. O
 
If O
so O
, O
we O
must O
be O
confident O
that O
she O
is O
able O
to O
draw O
up O
and O
inject O
insulin O
reliably O
. O
 
She O
will O
also O
needs O
prescriptions O
for O
metformin O
, O
insulin O
syringes O
( O
give O
her O
1 O
cc O
syringes O
) O
, O
NPH O
and O
Regular O
insulins O
. O
 
She O
apparently O
has O
glucose O
testing O
material O
at O
home O
. O
 
Will O
start O
with O
the O
following O
regimen O
, O
in O
addition O
to O
metformin O
500 O
mg O
bid O
. O
 
She O
will O
follow O
up O
with O
her O
PCP O
, O
Dr. O
Robert I-NAME
Xenakis I-NAME
. O
 
Before O
Breakfast O
: O
NPH O
30 O
Units O
Regular O
8 O
Units O
Blood O
Sugar O
under O
101 O
10 O
Units O
101-150 O
12 O
Units O
151-200 O
14 O
Units O
201-250 O
16 O
Units O
251-300 O
18 O
Units O
301-350 O
20 O
Units O
351-400 O
22 O
Units O
Over O
400 O
Before O
Supper O
: O
Regular O
8 O
Units O
Blood O
Sugar O
under O
101 O
10 O
Units O
101-150 O
12 O
Units O
151-200 O
14 O
Units O
201-250 O
16 O
Units O
251-300 O
18 O
Units O
301-350 O
20 O
Units O
351-400 O
& O
# O
183 O
; O
This O
is O
only O
an O
initial O
set O
of O
guidelines O
. O
 
The O
doses O
will O
have O
to O
be O
adjusted O
based O
on O
experience O
, O
diet O
, O
exercise O
, O
and O
illness O
. O
 
& O
# O
183 O
; O
Goal O
is O
to O
have O
blood O
sugars O
before O
meals O
in O
the O
90-130 O
range O
and O
blood O
sugars O
at O
bedtime O
in O
the O
110-140 O
range O
. O
 
& O
# O
183 O
; O
Check O
blood O
sugars O
initially O
before O
meals O
and O
at O
bedtime O
each O
day O
. O
 
Record O
the O
times O
, O
blood O
sugars O
, O
insulin O
doses O
and O
all O
food O
on O
the O
sheets O
provided O
and O
bring O
these O
sheets O
to O
your O
medical O
appointments O
. O
 
& O
# O
183 O
; O
Call O
Dr. O
Xenakis I-NAME
& O
# O
8217 O
; O
s O
office O
for O
any O
blood O
sugars O
under O
70 O
, O
or O
any O
symptoms O
of O
hypoglycemia O
( O
low O
blood O
sugars O
) O
. O
 
& O
# O
183 O
; O
Also O
call O
if O
blood O
sugars O
are O
often O
over O
180 O
. O
 
Elliot I-NAME
N. I-NAME
Xi I-NAME
, O
M.D. O
, O
Ph.D O
. O
 
Record O
date O
: O
2135-08-03 I-DATE
WSA I-LOCATION
TEAM O
4 O
Surgery O
Admission O
Note O
Patient O
: O
Mckee O
, O
Norma I-NAME
MRN O
: O
6987776 I-ID
Date O
: O
8/3/2135 I-DATE
PCP O
: O
Dr. O
Robert I-NAME
Xenakis I-NAME
Attending O
: O
Dr. O
Kirk I-NAME
Senior O
: O
Dr. O
Huerta I-NAME
Intern O
: O
Dr. O
Dukes I-NAME
CC O
: O
abdominal O
pain/n/v O
HPI O
: O
60F O
obese O
s/p O
exlap/TAH/BSO/appy/chole O
( O
Meyers/Hayes O
-7/25 O
) O
c/b O
ventral O
hernia O
and O
recurrent O
SBO O
s/p O
exlap/ventral O
hernia O
repair O
with O
alloderm O
( O
Steves I-NAME
- O
12/33 I-DATE
) O
, O
and O
partial O
SBO O
managed O
nonoperatively O
12/34 I-DATE
, O
and O
most O
recently O
5/23-49 I-DATE
. O
 
Pt O
reports O
that O
she O
had O
dinner O
last O
night O
about O
6pm O
and O
had O
her O
last O
BM O
at O
10pm O
( O
also O
last O
flatus O
) O
. O
 
She O
began O
to O
experience O
N/V O
at O
about O
11pm O
and O
had O
several O
episodes O
of O
NBNB O
emesis O
. O
 
Pt O
reports O
the O
pain O
is O
constant O
, O
and O
located O
adjacent O
to O
her O
midline O
incision O
. O
 
Pt O
felt O
that O
her O
ventral O
hernia O
was O
protruding O
more O
. O
 
She O
denies O
any O
diarrhea O
, O
blood O
in O
her O
stools O
, O
no O
dysuria O
. O
 
She O
has O
not O
experienced O
any O
fevers O
. O
 
chills O
, O
CP O
, O
SOB O
. O
 
PMH O
: O
Epilepsy O
Schizophrenia O
Diabetes O
mellitus O
type O
2 O
Hypertensive O
disorder O
Obesity O
Sleep O
apnea O
Hyperlipidemia O
recurrent O
UTI O
s/p O
exlap/TAH/BSO/appy/chole O
( O
Meyers/Hayes O
) O
( O
7/01 I-DATE
) O
c/b O
ventral O
hernia O
and O
recurrent O
SBO O
s/p O
exlap/ventral O
hernia O
repair O
with O
alloderm O
( O
Steves I-NAME
) O
( O
12/33 I-DATE
) O
, O
most O
recently O
w/pSBO O
managed O
nonoperatively O
12/34 I-DATE
duodenal O
ulcer O
s/p O
EGD/clipping O
( O
11/34 I-DATE
) O
Medications O
: O
citalopram O
90mg O
tegretol O
800mg O
qam O
600mg O
qpm O
colace O
100mg O
tid O
hctz O
25mg O
lisinopril O
45mg O
mvi O
perphenazine O
16mg O
bid O
remeron O
30 O
bid O
simvastatin O
20mg O
qpm O
clonazepam O
1mg O
qam O
, O
0.5mg O
qafternoon O
and O
qhs O
seroquel O
400mg O
qam O
and O
qafternoon O
, O
800mg O
qhs O
metoprolol O
25mg O
bid O
omeprazole O
20mg O
bid O
vitamin O
D O
400mg O
asa O
81mg O
caltrate O
600mg O
bid O
metformin O
500mg O
bid O
potassium O
20meq O
insulin O
NPH O
18units O
qam O
insulin O
regular O
SS O
qam/qsupper O
Allergies O
: O
ARIPIPRAZOLE O
- O
Caused O
anger O
, O
agitation O
, O
tearfulness O
Exam O
: O
VS O
: O
99.4 O
116 O
171/79 O
18 O
95 O
% O
RA O
Gen O
: O
NAD O
CV O
: O
RRR O
Pulm O
: O
CTAB O
Abd O
: O
soft O
, O
obese O
with O
additionally O
protruding O
ventral O
hernia O
; O
well-healed O
lower O
midline O
incision O
, O
moderately O
distended O
, O
minimally O
tender O
over O
inferior O
incision O
& O
amp O
; O
to O
the O
right O
of O
it O
, O
no O
skin O
changes O
; O
hypoactive O
BS O
; O
hernia O
is O
reducible O
on O
exam O
with O
palpable O
large O
& O
gt O
; O
5cm O
fascial O
defect O
Rectal O
: O
no O
stool O
palpated O
in O
vault O
, O
guaiac O
negative O
, O
no O
masses/tenderness O
Labs O
: O
WBC O
19.7 O
H O
( O
4.5-11.0 O
) O
th/cmmHCT O
43.7 O
( O
36.0-46.0 O
) O
% O
HGB O
14.9 O
( O
12.0-16.0 O
) O
gm/dlRBC O
5.14 O
( O
4.00-5.20 O
) O
mil/cmmPLT O
464 O
H O
( O
150-400 O
) O
th/cummMCV O
85 O
( O
80-100 O
) O
flMCH O
29.1 O
( O
26.0-34.0 O
) O
pg/rbcMCHC O
34.2 O
( O
31.0-37.0 O
) O
g/dlRDW O
14.5 O
( O
11.5-14.5 O
) O
% O
Diff O
Method O
ManualPoly O
63 O
( O
40-70 O
) O
% O
Bands O
28 O
H O
( O
0-10 O
) O
% O
Lymphs O
2 O
L O
( O
22-44 O
) O
% O
Atyps O
1 O
H O
( O
0 O
) O
% O
Monos O
4 O
( O
4-11 O
) O
% O
EOS O
0 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
Metas O
2 O
H O
( O
0 O
) O
% O
Absolute O
Neuts O
12.41 O
H O
( O
1.8-7.7 O
) O
th/cmmAbsolute O
Bands O
5.52 O
th/cmmAbsolute O
Lymphs O
0.39 O
L O
( O
1.0-4.8 O
) O
th/cmmAbsolute O
Monos O
0.79 O
( O
0.2-1.2 O
) O
th/mm3Absolute O
EOS O
0.00 O
L O
( O
0.1-0.3 O
) O
th/cmmAbsolute O
Basos O
0.00 O
( O
0.0-0.3 O
) O
th/cmmToxic O
Granulation O
PRESENTAniso O
None O
( O
None O
) O
Hypo O
None O
( O
None O
) O
Macrocytes O
None O
( O
None O
) O
Microcytes O
None O
( O
None O
) O
PLT O
Comments O
Large O
Forms O
Plasma O
Sodium O
131 O
L O
( O
135-145 O
) O
mmol/LPlasma O
Potassium O
4.2 O
( O
3.4-4.8 O
) O
mmol/LPlasma O
Chloride O
88 O
L O
( O
100-108 O
) O
mmol/LPlasma O
Carbon O
Dioxide O
24.2 O
( O
23.0-31.9 O
) O
mmol/LPlasma O
Anion O
GAP O
19 O
H O
( O
3-15 O
) O
mmol/LCalcium O
10.8 O
H O
( O
8.5-10.5 O
) O
mg/dlPhosphorus O
3.7 O
( O
2.6-4.5 O
) O
mg/dlMagnesium O
1.7 O
( O
1.4-2.0 O
) O
meq/LPlasma O
Urea O
Nitrogen O
14 O
( O
8-25 O
) O
mg/dlPlasma O
Creatinine O
1.23 O
( O
0.60-1.50 O
) O
mg/dlPlasma O
Glucose O
245 O
H O
( O
70-110 O
) O
mg/dlTotal O
Protein O
8.6 O
H O
( O
6.0-8.3 O
) O
g/dlAlbumin O
5.2 O
H O
( O
3.3-5.0 O
) O
g/dlGlobulin O
3.4 O
( O
2.3-4.1 O
) O
g/dlDirect O
Bilirubin O
0.3 O
( O
0-0.4 O
) O
mg/dlTotal O
Bilirubin O
0.6 O
( O
0.0-1.0 O
) O
mg/dlAlkaline O
Phosphatase O
248 O
H O
( O
30-100 O
) O
U/LTransaminase-SGPT O
165 O
H O
( O
7-30 O
) O
U/LAmylase O
149 O
H O
( O
3-100 O
) O
units/LTransaminase-SGOT O
239 O
H O
( O
9-32 O
) O
U/LLipase O
22 O
( O
13-60 O
) O
U/L O
Studies O
: O
Abd/Pelv O
CT O
: O
Mechanical O
small O
bowel O
obstruction O
with O
transition O
point O
within O
a O
large O
ventral O
hernia O
containing O
mostly O
ileum O
. O
 
There O
is O
a O
significant O
amount O
of O
retained O
stool O
within O
the O
colon O
which O
may O
indicate O
partial O
or O
early O
obstruction O
. O
 
Impression/Plan O
: O
59F O
p/w O
low-grade O
SBO O
due O
to O
adhesions O
v O
intermittently O
incarcerated O
ventral O
incisional O
hernia O
. O
 
Pt O
is O
minimally O
tender O
on O
exam O
, O
elevated O
WBC O
; O
CT O
showing O
mechanical O
SBO O
with O
transition O
point O
at O
ventral O
hernia O
. O
 
- O
NPO/NGT O
- O
IVF O
, O
foley O
, O
strict O
ins/outs O
, O
serial O
electrolytes O
. O
 
- O
Admit O
to O
WSA I-LOCATION
Team O
4 O
, O
Attending O
Dr. O
Kirk I-NAME
. O
 
- O
RISS O
and O
hold O
metformin/lisinopril O
while O
NPO O
. O
 
- O
Repeat O
CBC O
w/diff O
and O
U/A O
- O
Cont O
Cipro O
for O
UTI O
Case O
was O
seen O
and O
discussed O
with O
Dr. O
Patrizia I-NAME
Scott I-NAME
, O
senior O
surgical O
resident O
. O
 
Cheryl I-NAME
H. I-NAME
Holland I-NAME
, O
MD O
, O
DMD O
pager O
# O
67268 I-CONTACT
PGY-2 O
General O
Surgery O
 
Record O
date O
: O
2154-11-14 I-DATE
Department O
of O
Orthopedic O
Surgery O
42 I-LOCATION
Wood I-LOCATION
St I-LOCATION
OLIVE O
, O
XAVIER I-NAME
Sydney I-LOCATION
, O
WV I-LOCATION
65157 I-LOCATION
26690002 I-ID
-- O
-- O
-- O
-- O
-- O
-- O
-- O
11/14/54 I-DATE
Michael I-NAME
Ulrey I-NAME
, O
M.D O
. O
 
45 I-LOCATION
Wood I-LOCATION
St I-LOCATION
Sydney I-LOCATION
, O
WV I-LOCATION
65157 I-LOCATION
RE O
: O
Xavier I-NAME
Olive I-NAME
Dear O
Michael I-NAME
, O
Mr. O
Xavier I-NAME
Olive I-NAME
presents O
for O
evaluation O
, O
thanks O
for O
your O
referral O
. O
 
As O
you O
recall O
he O
is O
a O
71-year-old O
gentleman O
who O
is O
status O
post O
angioplasty O
on O
the O
left O
for O
high-grade O
stenotic O
lesions O
of O
the O
distal O
superficial O
femoral O
artery O
and O
the O
popliteal O
artery O
on O
the O
left O
. O
 
The O
patient O
presents O
now O
for O
further O
evaluation O
of O
his O
`` O
claudication O
symptoms O
'' O
. O
 
The O
patient O
states O
he O
has O
bilateral O
lower O
extremity O
symptoms O
, O
there O
are O
about O
equivalent O
in O
nature O
. O
 
He O
has O
very O
minimal O
low O
back O
pain O
. O
 
He O
states O
it O
seems O
to O
be O
getting O
worse O
and O
seems O
to O
be O
associated O
with O
some O
abnormal O
gait O
. O
 
He O
states O
on O
a O
bad O
day O
its O
about O
a O
9/10 O
and O
even O
on O
a O
good O
day O
sometimes O
it O
can O
be O
as O
high O
as O
8-9/10 O
. O
 
The O
episodes O
are O
almost O
daily O
and O
are O
brought O
on O
by O
things O
like O
walking O
. O
 
He O
can O
walk O
less O
than O
one O
block O
at O
which O
point O
he O
has O
lateral O
calf O
burning O
and O
at O
times O
notes O
some O
slow O
shuffling O
and O
occasionally O
falling O
. O
 
When O
he O
is O
having O
severe O
symptoms O
he O
notes O
his O
legs O
to O
be O
weak O
. O
 
He O
denies O
any O
bowel O
or O
bladder O
abnormalities O
of O
late O
, O
but O
has O
a O
historic O
of O
a O
chronic O
UTI O
secondary O
to O
his O
benign O
prostatic O
hypertrophy O
. O
 
He O
has O
very O
little O
back O
pain O
associated O
with O
his O
symptomatology O
. O
 
He O
has O
had O
no O
physical O
therapy O
to O
date O
and O
no O
spinal O
injections O
. O
 
He O
describes O
his O
general O
health O
as O
poor O
, O
but O
when O
specially O
asked O
he O
states O
it O
is O
because O
he O
his O
71 I-AGE
and O
has O
a O
history O
of O
hypertension O
. O
 
Years O
ago O
he O
stated O
he O
was O
in O
excellent O
health O
. O
 
His O
weight O
is O
steady O
at O
200 O
with O
no O
significant O
weight O
gain O
or O
loss O
. O
 
He O
does O
n't O
smoke O
and O
drinks O
socially O
. O
 
Quit O
smoking O
33 O
years O
ago O
. O
 
He O
does O
not O
think O
he O
will O
ever O
be O
pain O
free O
. O
 
Review O
of O
Systems O
: O
Reveals O
that O
he O
is O
a O
diet O
controlled O
diabetic O
and O
he O
has O
been O
for O
the O
past O
couple O
of O
years O
. O
 
He O
has O
difficulty O
with O
sleep O
. O
 
He O
has O
a O
balance O
problem O
and O
also O
has O
benign O
prostatic O
hypertrophy O
leading O
to O
chronic O
urinary O
tract O
infection O
, O
for O
this O
he O
takes O
Cardura O
. O
 
He O
has O
a O
history O
of O
high O
blood O
pressure O
. O
 
Denies O
any O
other O
cardiovascular O
abnormality O
. O
 
No O
respiratory O
malfunction O
. O
 
He O
has O
had O
surgery O
for O
something O
`` O
in O
his O
colon O
'' O
he O
has O
also O
had O
a O
bypass O
surgery O
. O
 
He O
is O
on O
Plavix O
and O
aspirin O
. O
 
Physical O
Examination O
: O
Shows O
that O
he O
is O
solid O
built O
, O
healthy O
appearing O
male O
. O
 
He O
is O
able O
to O
toe O
and O
heel O
walk O
but O
on O
the O
left O
side O
his O
T O
band O
seems O
to O
be O
slightly O
weak O
. O
 
Single O
toe O
raises O
show O
that O
the O
right O
leg O
is O
stronger O
than O
the O
left O
leg O
. O
 
He O
has O
no O
tenderness O
to O
his O
PSIS O
and O
he O
has O
no O
Waddell O
signs O
. O
 
He O
has O
negative O
Trendelenburg O
bilaterally O
. O
 
Forward O
flexion O
allows O
him O
to O
get O
to O
the O
patella O
. O
 
Extension O
is O
pain O
free O
and O
passive O
hyperextension O
does O
not O
reproduce O
the O
symptoms O
. O
 
Motor O
testing O
is O
normal O
in O
his O
lower O
extremities O
. O
 
Sensory O
is O
symmetric O
. O
 
He O
has O
negative O
straight O
leg O
raises O
. O
 
He O
has O
no O
palpable O
pulses O
. O
 
He O
is O
hairless O
in O
his O
lower O
extremities O
. O
 
He O
had O
no O
clonus O
or O
Babinski O
and O
a O
negative O
Hoffman O
's O
suggesting O
that O
he O
is O
not O
myelopathic O
despite O
his O
`` O
balance O
abnormality O
'' O
. O
 
He O
is O
on O
multiple O
meds O
for O
his O
hypertension O
, O
for O
his O
diabetes O
, O
and O
for O
his O
gastroesophageal O
reflux O
. O
 
Personal O
review O
of O
his O
plain O
films O
and O
a O
CAT O
scan O
indicating O
with O
, O
show O
decent O
residual O
lumbar O
lordosis O
with O
a O
stent O
noted O
in O
his O
iliac O
artery O
on O
the O
right O
. O
 
CT O
scan O
shows O
lumbosacral O
facet O
hypertrophy O
. O
 
At O
this O
point O
, O
impression O
is O
of O
spinal O
stenosis O
and O
degenerative O
disk O
disease O
. O
 
I O
have O
asked O
him O
to O
obtain O
an O
MRI O
and O
return O
to O
see O
me O
after O
that O
. O
 
Thanks O
for O
the O
referral O
. O
 
______________________________ O
Stephen I-NAME
Nichols I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Stephen I-NAME
Nichols I-NAME
eScription O
document:6-0190274 O
EFFocus O
DD O
: O
11/14/54 I-DATE
DT O
: O
11/14/54 I-DATE
DV O
: O
11/14/54 I-DATE
 
Record O
date O
: O
2155-07-11 I-DATE
July I-DATE
11 O
, O
2155 I-DATE
Name O
: O
Olive I-NAME
, O
Xavier I-NAME
MRN O
: O
26690002 I-ID
Mr. O
Olive I-NAME
was O
seen O
with O
Dr. O
Innis I-NAME
in O
general O
neurology O
clinic O
on O
07/11/55 I-DATE
. O
 
Dr. O
Innis I-NAME
was O
present O
for O
or O
performed O
all O
salient O
aspects O
of O
the O
history O
and O
physical O
exam O
and O
together O
we O
discussed O
with O
the O
patient O
the O
work-up O
and O
treatment O
plan O
. O
 
Return O
visit O
. O
 
Mr. O
Olive I-NAME
is O
a O
71y O
old O
RHM O
, O
with O
Idiopathic O
Parkinson O
's O
disease O
. O
 
He O
was O
started O
on O
Sinemet O
25/100mg O
tid O
with O
significant O
improvement O
in O
his O
balance O
& O
gait O
& O
rest O
tremor O
. O
 
However O
there O
were O
still O
periods O
of O
shuffling O
& O
stumbling O
especially O
going O
down O
slope O
. O
 
He O
also O
complained O
of O
persistant O
fatigue O
in O
his O
legs O
. O
 
We O
started O
him O
on O
Amantadine O
100mg O
tid O
during O
his O
last O
visit O
. O
 
He O
did O
not O
tolerate O
it O
well O
& O
complained O
of O
dizziness O
especially O
when O
he O
goes O
out O
, O
even O
with O
reduced O
dose O
of O
100mg O
bid O
. O
 
He O
has O
discontinued O
it O
since O
then O
. O
 
He O
is O
tolerating O
Sinemet O
well O
, O
no O
hallucinations O
, O
on-off O
phenomenon O
. O
 
He O
does O
not O
notice O
any O
wearing O
off O
of O
the O
effect O
prior O
to O
next O
dose O
. O
 
No O
dyskinesias O
. O
 
No O
new O
Neurological O
symptoms O
. O
 
He O
still O
has O
poor O
balance O
but O
his O
posture O
is O
much O
improved O
. O
 
PMHx O
: O
HTN O
Hyperlipidemia O
DM O
type-2 O
PVD O
BPH O
H/O O
colon O
cancer O
, O
s/p O
partial O
colectomy O
H/O O
throat O
surgery O
in O
past O
, O
does O
not O
know O
the O
details O
Medications O
at O
Home O
: O
Sinemet O
25/100mg O
bid O
. O
 
Simvastatin O
10mg O
QHS O
Ranitidine O
150mg O
QHS O
Metformin O
850mg O
tid O
Lisinopril O
2.5mg O
QD O
Gabapentin O
100mg O
bid O
Folic O
acid O
1mg O
QD O
Atenolol O
25mg O
QD O
Glyburide O
2.5mg O
QD O
Bupropion O
150mg O
QD O
Ferrous O
gluconate O
325mg O
TID O
Terazosin O
4mg O
QHS O
Pyridoxine O
50mg O
QD O
Plavix O
75mg O
QD O
Allergies O
: O
NKDA O
Limited O
physical O
Exam O
: O
Neuro O
: O
MS O
: O
Alert O
, O
oriented O
, O
appropriately O
interactive O
. O
 
Follows O
all O
commands O
. O
 
Speech O
is O
fluent O
without O
paraphasic O
errors O
. O
 
Voice O
is O
hypophonic O
. O
 
Facial O
expression O
is O
flat O
. O
 
CN O
II-XII O
: O
Visual O
fields O
full O
to O
confrontation O
; O
PERRLA O
3.5 O
= O
> O
3.0 O
; O
no O
ptosis O
; O
no O
nystagmus O
, O
no O
hypometric O
saccades O
, O
full O
EOMI O
, O
no O
restriction O
of O
upgaze O
; O
sensation O
on O
face O
normal O
bilaterally O
, O
no O
facial O
asymmetry O
; O
reduced O
spontaneous O
blinking O
of O
eyes O
; O
good O
smile O
; O
good O
cheek O
puff O
; O
tongue O
and O
palate O
midline O
; O
grossly O
normal O
hearing O
; O
good O
shoulder O
shrug O
and O
head O
turn O
. O
 
Motor O
: O
normal O
bulk O
, O
axial O
rigidity O
present O
. O
 
Mild O
cogwheel O
rigidity O
, O
R O
> O
L O
at O
rest O
. O
 
No O
rest O
tremor O
. O
 
No O
drift O
. O
 
Strength O
5/5 O
throughout O
including O
: O
biceps O
, O
triceps O
, O
brachioradialis O
, O
finger O
flexor O
and O
extension O
, O
hip O
, O
knee O
and O
ankle O
flex O
and O
extensions O
. O
 
No O
bradykinesia O
. O
 
Sensation O
: O
Decreased O
to O
touch O
, O
temperature O
and O
pin O
prick O
bilaterally O
in O
feet O
. O
 
Vibration O
reduced O
in O
toes O
. O
 
JP O
sense O
normal O
bilaterally O
. O
 
Cerebellar O
: O
Good O
FNF O
, O
rapid O
alternating O
movements O
Gait/Stance O
: O
Gait O
is O
wide O
based O
with O
mild O
stooped O
posture O
, O
slightly O
unsteady O
but O
no O
festination O
noted O
today O
. O
 
Decreased O
arm O
swing O
noted O
while O
walking O
. O
 
Not O
able O
to O
tandem O
. O
 
Rhomberg O
negative O
. O
 
Able O
to O
rise O
and O
sit O
without O
assistance O
. O
 
Assessment O
and O
Plan O
: O
71y O
old O
RHM O
, O
with O
early O
idiopathic O
Parkinson O
's O
disease O
. O
 
No O
evidence O
of O
restricted O
up O
gaze O
( O
PSP O
) O
, O
or O
parkinson-plus O
syndrome O
at O
this O
time O
. O
 
He O
had O
a O
good O
response O
to O
Sinemet O
but O
still O
has O
persistent O
fatigue O
& O
periods O
of O
festination O
. O
 
Recommend O
increasing O
Sinemet O
to O
37.5/150mg O
tid O
7am O
, O
12noon O
, O
& O
5pm O
. O
 
Wife O
will O
give O
me O
a O
call O
in O
2wks O
to O
let O
me O
know O
his O
progress O
. O
 
Follow O
up O
in O
Neurology O
clinic O
in O
3mths O
. O
 
Patient O
& O
family O
can O
contact O
me O
in O
interim O
with O
any O
concerns O
. O
 
Thank O
you O
very O
much O
for O
allowing O
me O
to O
participate O
in O
the O
care O
of O
this O
patient O
. O
 
Sincerely O
, O
___________________________________ O
Isabella I-NAME
Edmond I-NAME
, O
M.D O
. O
 
Resident O
in O
Neurology O
Pager O
# O
: O
98768 I-CONTACT
CC O
: O
Michael I-NAME
Ulrey I-NAME
MD O
24 I-LOCATION
WOOD I-LOCATION
ST I-LOCATION
SYDNEY I-LOCATION
, O
WV I-LOCATION
65157 I-LOCATION
Ximena I-NAME
Keane I-NAME
46 I-LOCATION
Marshall I-LOCATION
Street I-LOCATION
Conneaut I-LOCATION
Lake I-LOCATION
, O
WV I-LOCATION
: O
85486 I-LOCATION
 
Record O
date O
: O
2157-05-17 I-DATE
CARDIOLOGY O
TRUMBULL I-LOCATION
MEMORIAL I-LOCATION
HOSPITAL I-LOCATION
Reason O
for O
visit O
: O
Second O
opinion O
regarding O
painful O
legs O
with O
walking O
at O
less O
than O
50 O
yards O
and O
also O
balance O
disorder O
. O
 
Interval O
History O
: O
Mr. O
Xavier I-NAME
Olive I-NAME
is O
a O
73-year-old O
gentleman O
who O
comes O
into O
Trumbull I-LOCATION
Memorial I-LOCATION
Vascular O
Center I-LOCATION
for O
a O
second O
opinion O
regarding O
his O
lower O
extremity O
discomfort O
and O
also O
his O
progressive O
difficulty O
walking O
and O
maintaining O
balance O
. O
 
His O
referring O
physician O
is O
Dr. O
Ximena I-NAME
Keane I-NAME
, O
practicing O
out O
of O
Alexandria I-LOCATION
Clinic I-LOCATION
. O
 
Mr. O
Olive I-NAME
also O
heard O
about O
the O
TMH I-LOCATION
VC O
through O
TV O
advertisements O
. O
 
He O
is O
73 I-AGE
years O
old O
, O
has O
history O
of O
diabetes O
starting O
in O
2135 I-DATE
, O
known O
history O
of O
peripheral O
artery O
disease O
with O
claudication O
and O
calf O
discomfort O
, O
for O
which O
he O
has O
previously O
seen O
Dr. O
Cain I-NAME
at O
Alexandria I-LOCATION
Clinic I-LOCATION
, O
and O
also O
has O
been O
evaluated O
and O
treated O
at O
the O
Corcoran I-LOCATION
District I-LOCATION
Hospital I-LOCATION
. O
 
Specifically O
, O
he O
describes O
having O
been O
evaluated O
by O
Dr. O
Cain I-NAME
and O
others O
some O
three O
or O
four O
years O
ago O
, O
and O
undergoing O
at O
least O
two O
procedures O
, O
all O
related O
to O
his O
legs O
cramping O
up O
. O
 
He O
received O
prior O
stenting O
to O
his O
right O
common O
iliac O
artery O
and O
his O
left O
superficial O
femoral O
artery O
, O
so O
far O
as O
I O
can O
tell O
. O
 
The O
stents O
were O
placed O
at O
Pomeroy I-LOCATION
Care I-LOCATION
Center I-LOCATION
( O
Big I-LOCATION
Rapids I-LOCATION
, O
AC I-LOCATION
) O
and O
also O
he O
had O
evaluation O
at O
the O
Corcoran I-LOCATION
District I-LOCATION
Hospital I-LOCATION
, O
and O
may O
have O
had O
a O
stenting O
procedure O
or O
revascularization O
procedure O
there O
. O
 
The O
patient O
and O
his O
wife O
are O
somewhat O
unclear O
about O
the O
dates O
and O
locations O
and O
times O
, O
but O
he O
does O
state O
that O
the O
treatments O
apparently O
did O
not O
help O
him O
at O
all O
. O
 
Currently O
, O
he O
has O
discomfort O
in O
both O
calves O
when O
he O
walks O
too O
far O
or O
too O
fast O
, O
and O
this O
stops O
him O
at O
about O
50 O
yards O
. O
 
The O
issue O
was O
complicated O
by O
the O
fact O
that O
he O
has O
had O
progressive O
parkinsonian-type O
symptoms O
, O
walking O
in O
a O
shuffle O
, O
tipping O
forward O
, O
and O
occasionally O
even O
falling O
forward O
and O
losing O
his O
balance O
completely O
. O
 
His O
legs O
are O
rubbery O
, O
and O
he O
does O
even O
realize O
that O
he O
is O
falling O
forward O
when O
it O
happens O
. O
 
It O
is O
worse O
when O
he O
is O
carrying O
things O
that O
weigh O
anything O
. O
 
At O
the O
same O
time O
, O
his O
calves O
do O
cramp O
up O
in O
a O
typical O
fashion O
consistent O
with O
claudication O
, O
and O
he O
has O
known O
peripheral O
artery O
disease O
. O
 
Also O
feels O
though O
his O
hips O
sometimes O
are O
cramping O
up O
. O
 
The O
patient O
feels O
quite O
disabled O
by O
his O
symptoms O
, O
especially O
as O
a O
gentleman O
who O
was O
active O
and O
never O
had O
physical O
problems O
of O
this O
nature O
. O
 
Again O
, O
there O
is O
some O
degree O
of O
blurring O
between O
the O
parkinsonian O
symptoms O
and O
his O
claudication O
, O
as O
to O
which O
is O
truly O
causing O
his O
disability O
. O
 
Past O
medical O
history O
: O
Diabetes O
, O
onset O
in O
2135 I-DATE
. O
 
Parkinsonian-type O
movement O
disorder O
, O
followed O
by O
Dr. O
Jeffers I-NAME
and O
Innis I-NAME
, O
and O
for O
which O
he O
was O
placed O
on O
Sinemet O
, O
presuming O
it O
was O
due O
to O
Parkinson O
's O
. O
 
The O
patient O
has O
not O
improved O
despite O
trying O
the O
medications O
. O
 
MRI O
at O
AC I-LOCATION
starting O
in O
2153 I-DATE
has O
shown O
apparent O
central O
and O
peripheral O
atrophy O
, O
unchanged O
. O
 
Status O
post O
vertebrobasilar O
TIA O
by O
report O
. O
 
Neuropathy O
, O
documented O
by O
EMG O
in O
2151 I-DATE
with O
no O
spinal O
stenosis O
by O
MRI O
. O
 
Cervical O
spondylosis O
. O
 
Tracheal O
tumor O
resection O
in O
2128 I-DATE
performed O
via O
a O
suprasternal O
incision O
. O
 
Hypertension O
. O
 
Mild O
renal O
artery O
stenosis O
documented O
by O
arteriography O
in O
2153 I-DATE
during O
one O
of O
his O
peripheral O
angiograms O
. O
 
Current O
Medications O
: O
lisinopril O
2.5 O
mg O
QD O
glyburide O
2.5 O
mg O
QD O
cilostazol O
100 O
mg O
BID O
terazosin O
4 O
mg O
QD O
Sinemet O
25/100 O
mg O
2 O
tabs O
TID O
aspirin O
325 O
mg O
QD O
pyridoxine O
50 O
mg O
QD O
atenolol O
25 O
mg O
QD O
folic O
acid O
1 O
mg O
QD O
gabapentin O
100 O
mg O
BID O
metformin O
hydrochloride O
850 O
mg O
TID O
ranitidine O
HCl O
150 O
mg O
QHS O
Zocor O
10 O
mg O
QHS O
Plavix O
; O
Dir O
: O
Stopped O
because O
of O
ecchymosis O
and O
epistaxis O
-stop O
Allergies O
: O
No O
known O
allergies O
Family O
history O
: O
Noncontributory O
. O
 
No O
coronary O
artery O
disease O
or O
MI O
. O
 
Social O
history O
: O
He O
is O
retried O
Motor I-PROFESSION
Vehicle I-PROFESSION
Body I-PROFESSION
Repairer I-PROFESSION
. O
 
He O
used O
to O
work O
at O
GM I-LOCATION
. O
 
He O
lives O
with O
his O
wife O
, O
who O
comes O
in O
today O
with O
him O
. O
 
He O
has O
three O
children O
. O
 
Nondrinker O
. O
 
He O
smoked O
until O
30 O
years O
ago O
. O
 
Review O
of O
systems O
: O
Detailed O
review O
of O
systems O
was O
carried O
out O
. O
 
It O
was O
also O
reviewed O
on O
the O
patient O
questionnaire O
sheet O
that O
the O
patient O
brought O
with O
him O
. O
 
He O
does O
claim O
to O
have O
some O
dyspnea O
with O
exertion O
as O
well O
as O
intermittent O
indigestion O
consistent O
with O
GERD O
. O
 
He O
has O
nocturia O
. O
 
He O
wears O
dentures O
. O
 
No O
significant O
weight O
loss O
or O
anorexia O
. O
 
No O
visual O
changes O
or O
other O
neurologic O
symptoms O
other O
than O
the O
gait O
disturbance O
and O
neuropathy O
. O
 
He O
denies O
chest O
discomfort O
or O
anything O
to O
suggest O
cardiac O
ischemia O
. O
 
Otherwise O
, O
review O
of O
systems O
is O
negative O
in O
detail O
. O
 
Physical O
examination O
: O
-Pulse O
: O
68 O
and O
regular O
. O
 
Afebrile O
-BP O
: O
105/55 O
, O
obtained O
by O
myself O
. O
 
Equal O
bilaterally O
-General O
: O
Well-developed O
male O
in O
no O
distress O
, O
appears O
his O
stated O
age O
. O
 
Slightly O
stooped O
over O
, O
and O
has O
a O
parkinsonian-type O
affect O
and O
appearance O
-Skin O
: O
Without O
rashes O
-Heent O
: O
Normal O
facies O
, O
or O
slightly O
masked O
, O
with O
normal O
extraocular O
motions O
and O
reactive O
pupils O
-Neck O
: O
Carotid O
upstrokes O
are O
normal O
, O
no O
bruits O
. O
 
No O
JVD O
-Chest O
: O
Clear O
-Cardiac O
: O
Discloses O
normal O
S1 O
and O
S2 O
, O
no O
S3 O
or O
S4 O
, O
and O
no O
murmurs O
-Abdomen O
: O
Moderately O
obese O
, O
protuberant O
, O
soft O
, O
and O
nontender O
. O
 
Good O
bowel O
sounds O
, O
no O
organomegaly O
, O
no O
enlargement O
of O
the O
aorta O
. O
 
May O
be O
a O
soft O
bruit O
in O
the O
midline O
to O
deep O
auscultation O
-Extremities O
: O
Femoral O
pulses O
are O
2+ O
bilaterally O
, O
with O
soft O
bruits O
on O
both O
sides O
. O
 
Below O
this O
, O
no O
cyanosis O
or O
edema O
( O
perhaps O
trace O
to O
1+ O
edema O
) O
, O
and O
posterior O
tibial O
pulses O
are O
1 O
to O
2+ O
. O
 
Dorsalis O
pedis O
pulses O
are O
not O
easily O
palpable O
. O
 
Good O
capillary O
refill O
-Neuro O
: O
Gait O
is O
disturbed O
, O
with O
slight O
shuffling O
and O
slightly O
stooped O
. O
 
His O
strength O
is O
normal O
, O
and O
sensory O
findings O
are O
slightly O
abnormal O
with O
diminished O
sensation O
in O
a O
stocking-glove O
distribution O
. O
 
He O
does O
not O
have O
any O
cogwheeling O
to O
my O
examination O
. O
 
Otherwise O
, O
no O
focal O
deficits O
Procedures O
: O
Free O
text O
procedures O
Exercise O
ABIs-resting O
ABI O
is O
normal O
on O
the O
right O
and O
left O
at O
0 O
. O
 
92 O
and O
1.03 O
, O
respectively O
. O
 
The O
toe O
brachial O
index O
drops O
to O
0.29 O
on O
the O
right O
side O
and O
0.91 O
at O
1 O
minute O
after O
exercise O
. O
 
I O
am O
not O
sure O
what O
to O
make O
of O
these O
ABIs O
since O
it O
appears O
that O
the O
actual O
ankle-brachial O
indices O
were O
not O
measured O
following O
exercise O
. O
 
EKG O
: O
demonstrates O
normal O
sinus O
rhythm O
or O
sinus O
bradycardia O
at O
heart O
rate O
of O
55 O
. O
 
There O
is O
normal O
axis O
and O
intervals O
, O
with O
no O
evidence O
of O
prior O
infraction O
, O
and O
perhaps O
a O
slight O
right O
ventricular O
conduction O
delay O
. O
 
Other O
Data O
: O
DOB O
: O
11/25/2083 I-DATE
. O
 
Assessment O
and O
plan O
: O
Lower O
extremity O
arterial O
disease O
( O
PAD O
) O
-the O
patient O
clearly O
has O
history O
of O
PAD O
with O
prior O
interventions O
on O
both O
sides O
. O
 
Currently O
, O
complains O
of O
symptoms O
that O
sound O
like O
claudication O
, O
predominantly O
involving O
the O
calves O
on O
both O
sides O
, O
right O
slightly O
ahead O
of O
the O
left O
, O
and O
I O
would O
not O
be O
surprised O
if O
he O
has O
significant O
focal O
obstructive O
disease O
along O
the O
length O
of O
his O
iliac O
of O
SFA O
. O
 
Since O
his O
ABIs O
are O
well O
preserved O
at O
rest O
, O
I O
suspect O
he O
does O
not O
have O
pre-occlusion O
of O
the O
SFA O
, O
for O
example O
. O
 
On O
the O
other O
hand O
, O
he O
does O
have O
diabetes O
and O
his O
ABIs O
may O
be O
falsely O
elevated O
. O
 
His O
major O
limitation O
is O
due O
to O
a O
combination O
of O
the O
claudication O
that O
occurs O
less O
than O
50 O
yards O
and O
stops O
him O
at O
that O
point O
, O
and O
the O
gait O
disturbance O
that O
he O
has O
related O
to O
his O
movement O
disorder O
, O
possible O
Parkinson O
's O
disease O
. O
 
I O
am O
not O
sure O
that O
this O
latter O
entity O
has O
been O
well O
enough O
defined O
, O
and O
I O
would O
suggest O
that O
we O
have O
him O
see O
a O
neurologist O
here O
to O
better O
ascertain O
the O
nature O
of O
that O
disease O
, O
and O
as O
to O
whether O
there O
is O
anything O
better O
available O
in O
the O
way O
of O
treatment O
. O
 
1 O
. O
 
As O
far O
his O
peripheral O
artery O
disease O
, O
it O
would O
be O
extremely O
helpful O
to O
obtain O
films O
from O
AC I-LOCATION
and/or O
the O
CDH I-LOCATION
, O
to O
better O
define O
what O
procedures O
were O
actually O
performed O
and O
where O
stents O
were O
placed O
. O
 
Given O
that O
it O
has O
been O
a O
year O
or O
more O
since O
his O
last O
intervention O
, O
it O
is O
likely O
he O
will O
need O
another O
angiographic O
study O
( O
or O
MRA/CTA O
) O
in O
order O
to O
ascertain O
the O
nature O
of O
his O
disease O
. O
 
2 O
. O
 
Neurologic O
disorder-we O
will O
refer O
to O
a O
neurologist O
. O
 
PLAN O
: O
1 O
. O
 
Formal O
exercise O
ABIs O
. O
 
2 O
. O
 
Obtain O
angiographic O
studies O
from O
AC I-LOCATION
. O
 
3 O
. O
 
Followup O
visit O
in O
one O
month O
. O
 
4 O
. O
 
Appointment O
with O
Dr. O
Ruiz I-NAME
. O
 
Changes O
to O
Medications O
this O
visit O
lisinopril O
2.5 O
mg O
QD O
glyburide O
2.5 O
mg O
QD O
cilostazol O
100 O
mg O
BID O
terazosin O
4 O
mg O
QD O
Sinemet O
25/100 O
mg O
2 O
tabs O
TID O
aspirin O
325 O
mg O
QD O
pyridoxine O
50 O
mg O
QD O
atenolol O
25 O
mg O
QD O
folic O
acid O
1 O
mg O
QD O
gabapentin O
100 O
mg O
BID O
metformin O
hydrochloride O
850 O
mg O
TID O
ranitidine O
HCl O
150 O
mg O
QHS O
Zocor O
10 O
mg O
QHS O
Plavix O
Stopped O
because O
of O
ecchymosis O
and O
epistaxis O
- O
InactivatedCC O
: O
Outpatient O
V O
Chart O
; O
Brittany I-NAME
Naylor I-NAME
; O
Ximena I-NAME
Keane I-NAME
M.D O
. O
 
Signed O
electronically O
by O
Jared I-NAME
Xayasane I-NAME
MD O
on O
Sep I-DATE
17 O
, O
2157 I-DATE
 
Record O
date O
: O
2158-06-08 I-DATE
-- O
-- O
-- O
-- O
-- O
-- O
- O
Parkinson O
's O
Clinic O
Trumbull I-LOCATION
Memorial I-LOCATION
Hospital I-LOCATION
- O
Corcoran I-LOCATION
District I-LOCATION
Hospital I-LOCATION
( O
315 O
) O
433-0039 I-CONTACT
Office O
Visit O
Chief O
Complaint O
: O
Increased O
falling O
History O
of O
Present O
Illness O
: O
C/O O
increased O
falling O
. O
 
His O
legs O
buckling O
underneath O
him O
. O
 
He O
has O
occasional O
dizzyness O
. O
 
Denies O
angino O
, O
or O
sob O
. O
 
He O
does O
not O
use O
a O
walker O
. O
 
He O
arrived O
today O
in O
a O
wheel O
chair O
. O
 
They O
both O
state O
he O
leans O
forward O
and O
the O
he O
falls O
. O
 
Medications O
: O
atenolol O
25 O
mg O
: O
1 O
tab O
po O
qd O
; O
pyridoxine O
100 O
mg O
: O
1 O
tab O
po O
qd O
; O
Sinemet O
25/100 O
: O
2 O
tab O
po O
qid O
, O
7:30A O
, O
12 O
, O
5 O
, O
9P O
; O
Sinemet O
25/100 O
: O
1.5 O
tab O
po O
qid O
; O
glyburide O
2.5 O
mg O
: O
1 O
tab O
po O
qd O
; O
Zocor O
10 O
mg O
: O
0.5 O
tab O
po O
qhs O
; O
gabapentin O
100 O
mg O
: O
1 O
tab O
po O
bid O
; O
folic O
acid O
1 O
mg O
: O
1 O
tab O
po O
qd O
; O
Pletal O
100 O
mg O
: O
1 O
tab O
po O
bid O
; O
pyridoxine O
50 O
mg O
: O
1 O
tab O
po O
qd O
; O
metformin O
850 O
mg O
: O
1 O
tab O
po O
tid O
; O
ASA O
81 O
mg O
: O
1 O
tab O
po O
qd O
; O
prazosin O
4 O
mg O
: O
1 O
tab O
po O
qd O
; O
Lisinopril O
2.5 O
mg O
: O
1 O
tab O
po O
qd O
; O
Zantac O
150 O
mg O
: O
1 O
tab O
po O
qhs O
. O
 
Allergies O
: O
NKDA O
. O
 
Review O
of O
Systems O
: O
The O
following O
systems O
reviews O
were O
contributory O
: O
endocrine O
[ O
pertinent O
positives O
: O
diabetes O
mellitus O
] O
; O
cardiovascular O
[ O
pertinent O
positives O
: O
hypertension O
, O
occasional O
light O
headed O
ness O
; O
pertinent O
negatives O
: O
chest O
pain O
with O
exertion O
, O
chest O
pain O
at O
rest O
, O
dyspnea O
on O
exertion O
, O
peripheral O
edema O
] O
; O
gastrointestinal O
[ O
pertinent O
positives O
: O
diarrhea O
] O
and O
urinary O
tract O
[ O
pertinent O
positives O
: O
nocturia O
, O
urgency O
] O
. O
 
The O
following O
systems O
reviews O
were O
noncontributory O
: O
general O
; O
psychological O
and O
musculoskeletal O
. O
 
General O
Examination O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
-- O
- O
6/08/2158 I-DATE
1:31 O
pm O
: O
In O
his O
right O
arm O
, O
his O
blood O
pressure O
was O
100/42 O
and O
his O
pulse O
was O
60 O
per O
minute O
when O
lying O
; O
his O
blood O
pressure O
was O
80/40 O
and O
his O
pulse O
was O
64 O
rrr O
per O
minute O
when O
sitting O
. O
 
The O
orthostatic O
change O
was O
symptomatic O
. O
 
He O
appeared O
well-nourished O
and O
well-groomed O
. O
 
6/08/2158 I-DATE
1:36 O
pm O
: O
In O
his O
right O
arm O
, O
his O
blood O
pressure O
was O
90/40 O
when O
sitting O
. O
 
Rating O
Scales O
: O
UPDRS O
Subscale O
III O
( O
Motor O
Examination O
) O
: O
Subscale O
total O
score O
was O
22 O
out O
of O
108 O
. O
 
This O
subscale O
was O
completed O
while O
the O
patient O
was O
ON O
. O
 
Tremor O
at O
rest O
was O
rated O
on O
a O
0 O
to O
4 O
scale O
( O
with O
0 O
being O
absent O
) O
: O
0 O
in O
the O
face O
, O
0 O
in O
the O
right O
upper O
extremity O
, O
0 O
in O
the O
left O
upper O
extremity O
, O
0 O
in O
the O
right O
lower O
extremity O
, O
0 O
in O
the O
left O
lower O
extremity O
, O
. O
 
Action O
or O
postural O
tremor O
of O
the O
hands O
was O
rated O
on O
a O
0 O
to O
4 O
scale O
( O
with O
0 O
being O
absent O
) O
: O
0 O
in O
the O
right O
upper O
extremity O
, O
0 O
in O
the O
left O
upper O
extremity O
, O
. O
 
Rigidity O
was O
rated O
on O
a O
0 O
to O
4 O
scale O
( O
with O
0 O
being O
absent O
) O
: O
1 O
in O
the O
right O
upper O
extremity O
, O
1 O
in O
the O
left O
upper O
extremity O
, O
1 O
in O
the O
right O
lower O
extremity O
, O
1 O
in O
the O
left O
lower O
extremity O
, O
. O
 
The O
following O
movements O
were O
rated O
on O
a O
0 O
to O
4 O
scale O
( O
with O
0 O
being O
normal O
) O
: O
Finger O
Taps O
: O
1 O
in O
the O
right O
upper O
extremity O
, O
1 O
in O
the O
left O
upper O
extremity O
; O
Hand O
movements O
: O
1 O
in O
the O
right O
upper O
extremity O
, O
1 O
in O
the O
left O
upper O
extremity O
; O
Rapid O
alternating O
hand O
movements O
: O
1 O
in O
the O
right O
upper O
extremity O
, O
1 O
in O
the O
left O
upper O
extremity O
; O
Leg O
agility O
: O
1 O
in O
the O
right O
lower O
extremity O
, O
2 O
in O
the O
left O
lower O
extremity O
. O
 
Each O
of O
the O
following O
was O
rated O
on O
a O
0-4 O
scale O
( O
with O
0 O
being O
normal O
) O
: O
Speech O
: O
1 O
( O
slight O
loss O
of O
expression O
, O
diction O
and/or O
volume O
) O
; O
Facial O
expression O
: O
1 O
( O
minimal O
hypomimia O
; O
could O
be O
normal O
'pokerface O
' O
) O
; O
Arising O
from O
a O
chair O
: O
1 O
( O
slow O
or O
may O
need O
more O
than O
one O
attempt O
) O
; O
Posture O
: O
1 O
( O
not O
quite O
erect O
, O
slightly O
stooped O
posture O
; O
could O
be O
normal O
for O
older O
person O
) O
; O
Gait O
: O
2 O
( O
walks O
with O
difficulty O
but O
requires O
little O
or O
no O
assistance O
; O
may O
have O
some O
festination O
, O
short O
steps O
, O
or O
propulsion O
) O
; O
Postural O
stability O
: O
1 O
( O
retropulsion O
, O
but O
recovers O
unaided O
) O
; O
Body O
bradykinesia O
and O
hypokinesia O
: O
2 O
( O
mild O
degree O
of O
slowness O
& O
poverty O
of O
movement O
that O
is O
definitely O
abnormal O
; O
alternatively O
, O
some O
reduced O
amplitude O
) O
. O
 
Assessment O
: O
1 O
. O
 
Parkinson O
's O
Disease O
: O
Parkinson O
with O
decline O
in O
strength O
and O
endurance O
. O
 
It O
is O
possible O
that O
the O
added O
Sinemet O
is O
causing O
a O
decrease O
in O
his O
blood O
pressure O
. O
 
I O
made O
a O
referral O
to O
Mary I-NAME
Darnell I-NAME
PT O
here O
at O
TMH I-LOCATION
. O
 
In O
addition O
Dr O
Edward I-NAME
Nguyen I-NAME
felt O
a O
slight O
reduction O
of O
the O
Sinemet O
to O
1.5 O
tab O
QID O
may O
help O
his O
blood O
pressure O
with O
out O
changing O
his O
motor O
ability O
. O
 
RTC O
1 O
month O
Dr O
Edward I-NAME
Nguyen I-NAME
and O
2 O
months O
Genevieve I-NAME
Noland I-NAME
, O
NP O
Recommendations O
: O
Medication O
given O
: O
Sinemet O
25/100 O
: O
2 O
tab O
po O
qid O
. O
 
Medication O
changes O
included O
: O
Stopped O
: O
pyridoxine O
50 O
mg O
: O
1 O
tab O
po O
qd O
; O
Sinemet O
25/100 O
: O
1.5 O
tab O
po O
qid O
. O
 
Started O
: O
6/08/2158 I-DATE
Sinemet O
25/100 O
: O
1.5 O
tab O
po O
qid O
. O
 
This O
patient O
's O
history O
, O
physical O
examination O
, O
assessment O
and O
recommendations O
were O
completed O
by O
Genevieve I-NAME
Noland I-NAME
, O
NP O
. O
 
Record O
date O
: O
2071-08-08 I-DATE
Reason O
for O
Visit O
Mr. O
Whitehead I-NAME
is O
here O
for O
follow-up O
of O
multiple O
issues O
. O
 
Problems O
LOW O
BACK O
PAIN O
he O
had O
prolonged O
discogenic O
back O
pain O
in O
1/2070 I-DATE
and O
could O
not O
get O
appt O
with O
NAMG I-LOCATION
orthopedic/back O
surgeon O
and O
went O
to O
Montreal I-LOCATION
Medical I-LOCATION
Center I-LOCATION
. O
 
He O
underwent O
L4/5 O
lamenictomy O
in O
2/2070 I-DATE
. O
 
He O
has O
persistent O
right-lower O
back O
pain O
and O
has O
seen O
Dr. O
Conley I-NAME
. O
 
A O
myleogram O
done O
on O
8/5/71 I-DATE
showed O
degenerative O
disc O
disease O
with O
moderate O
spinal O
stenosis O
at O
L4/5 O
. O
 
He O
will O
be O
seeing O
Dr. O
Sheehan I-NAME
. O
 
Mr. O
Whitehead I-NAME
is O
contemplating O
surgery O
as O
he O
can O
not O
walk O
without O
pain O
. O
 
Elevated O
blood O
sugar O
BS O
was O
191 O
in O
11/1/69 I-DATE
and O
was O
in O
similar O
range O
during O
his O
hospitalization O
in O
Montreal I-LOCATION
Medical I-LOCATION
. O
 
He O
has O
been O
on O
meds O
for O
NIDDM O
. O
 
He O
could O
not O
tolerate O
high O
dose O
of O
glucophage O
and O
is O
now O
seeing O
endocrine O
. O
 
His O
HBA1c O
was O
7.5 O
in O
6/71 I-DATE
on O
glyburide O
5 O
mg O
bid O
and O
glucophage O
500 O
mg O
qd O
. O
 
He O
has O
regular O
optho O
exam O
and O
is O
on O
zestoretic O
. O
 
Little O
rationale O
to O
check O
for O
microalbuminuria O
as O
he O
is O
already O
on O
ace-inh O
. O
 
His O
lipids O
are O
controlled O
with O
diet O
and O
lipitor O
. O
 
To O
see O
endocrine O
in O
9/71 I-DATE
. O
 
hyperlipidemia O
now O
on O
lipitor O
40 O
mg O
qhs O
. O
 
He O
has O
NIDDM O
and O
HTN O
. O
 
His O
lipid O
profile O
from O
4/71 I-DATE
showed O
a O
LDL O
of O
103 O
. O
 
LFT O
were O
normal O
. O
 
COntinue O
med O
. O
 
HYPERTENSION O
Now O
on O
zestoretic O
20/25 O
qd O
+ O
atenolol O
50 O
mg O
qd O
. O
 
He O
has O
significant O
white O
coat O
component O
. O
 
It O
is O
again O
high O
at O
170/80 O
in O
left O
arm O
. O
 
His O
BP O
reading O
in O
hospital O
for O
myelogram O
this O
week O
was O
130/80 O
. O
 
No O
change O
. O
 
h/o O
PROSTATITIS O
had O
recurring O
prostatitis O
sx O
's O
and O
saw O
Dr. O
Dotson I-NAME
. O
 
Cystoscopy O
in O
1/2070 I-DATE
was O
normal O
. O
 
He O
is O
on O
flomax O
0.4 O
mg O
qd O
and O
doing O
better O
. O
 
His O
PSA O
was O
2.9 O
in O
8/69 I-DATE
and O
3.2 O
in O
8/70 I-DATE
. O
 
To O
see O
Dr. O
Dotson I-NAME
soon O
. O
 
Neurological O
symptoms O
he O
reports O
having O
intolerance O
to O
bright O
lights O
, O
tingling O
in O
his O
mid O
anterior O
abdomen O
and O
chest O
as O
well O
as O
numbness O
in O
his O
left O
middle O
three O
digits O
with O
some O
neck O
discomfort O
. O
 
His O
MRI O
of O
his O
LS O
spine O
done O
at O
Montreal I-LOCATION
Medical I-LOCATION
in O
early O
2070 I-DATE
evidently O
showed O
( O
by O
his O
report O
) O
no O
cord O
abnormalities O
. O
 
His O
sx O
's O
sound O
like O
left-sided O
cervical O
radiculopathy O
but O
his O
visual O
and O
abdominal O
sx O
's O
makes O
me O
concerned O
about O
systemic O
demyelinating O
conditions O
. O
 
Will O
check O
TSH O
, O
B12 O
and O
have O
him O
see O
Dr. O
Conley I-NAME
. O
 
[ O
08/28/70 I-DATE
] O
TSH O
and O
B12 O
levels O
were O
normal O
. O
 
His O
sx O
's O
in O
his O
eyes O
and O
abdomen O
have O
essentially O
resolved O
. O
 
He O
still O
has O
some O
cervical O
radiculopathy O
syptoms O
. O
 
He O
will O
see O
Dr. O
Conley I-NAME
( O
yet O
to O
do O
so O
) O
. O
 
[ O
01/21/71 I-DATE
] O
still O
did O
not O
see O
Dr. O
Conley I-NAME
. O
 
He O
now O
has O
right O
neck O
pain O
. O
 
His O
left O
sided O
numbness O
has O
resolved O
. O
 
Again O
referred O
him O
to O
Dr. O
Conley I-NAME
. O
 
He O
likely O
has O
cervical O
radiculopathy O
. O
 
[ O
04/09/71 I-DATE
] O
c-spine O
MRI O
ordered O
by O
Dr. O
Conley I-NAME
showed O
mutliple O
levels O
of O
spondylothis O
. O
 
Vital O
Signs O
Blood O
Pressure O
: O
170/70 O
Weight O
: O
187 O
Pounds O
Physical O
Exam O
Chest O
clear O
Cor/Cardiac O
s1s2 O
s4 O
with O
s4 O
Neurological O
He O
has O
normal O
motor O
strength O
in O
his O
limbs O
. O
 
Normal O
straight O
leg O
raise O
bilaterally O
. O
 
Medications O
MICRONASE O
( O
GLYBURIDE O
) O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Start O
Date O
: O
8/8/71 I-DATE
ATENOLOL O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
ZESTORETIC O
20-25 O
( O
LISINOPRIL/HYDROCLOROTH O
... O
20/25 O
PO O
QD O
Prilosec O
SA O
20MG O
PO O
BIw O
LIPITOR O
( O
ATORVASTATIN O
) O
40MG O
PO O
QHS O
GLUCOPHAGE O
( O
METFORMIN O
) O
500MG O
PO O
QD O
Start O
Date O
: O
2/19/71 I-DATE
FLOMAX O
( O
TAMSULOSIN O
) O
0.4MG O
PO O
QD O
ASPIRIN O
( O
ACETYLSALICYLIC O
ACID O
) O
81MG O
PO O
QD O
MVI O
( O
MULTIVITAMINS O
) O
1CAPSULE O
PO O
QD O
Disposition O
and O
Plans O
Follow-up O
in O
12/71 I-DATE
. O
 
cc O
: O
Dr. O
Conley I-NAME
 
Record O
date O
: O
2072-04-24 I-DATE
Reason O
for O
Visit O
Mr. O
Whitehead I-NAME
is O
here O
for O
FU O
of O
his O
many O
issues O
. O
 
Problems O
benign O
prostatic O
hypertrophy O
PSA O
was O
2.9 O
in O
8/69 I-DATE
and O
3.2 O
in O
8/70 I-DATE
and O
3.0 O
in O
2/72 I-DATE
. O
 
He O
has O
done O
well O
on O
flomax O
and O
now O
sees O
Dr. O
Pena I-NAME
. O
 
hyperlipidemia O
now O
on O
lipitor O
40 O
mg O
qhs O
. O
 
He O
has O
NIDDM O
and O
HTN O
. O
 
His O
lipid O
profile O
from O
4/71 I-DATE
showed O
a O
LDL O
of O
103 O
. O
 
LFT O
were O
normal O
. O
 
Will O
check O
lab O
work O
and O
continue O
med O
. O
 
Elevated O
blood O
sugar O
BS O
was O
191 O
in O
11/1/69 I-DATE
and O
was O
in O
similar O
range O
during O
his O
hospitalization O
in O
Montreal I-LOCATION
Medical I-LOCATION
. O
 
He O
has O
been O
on O
meds O
for O
NIDDM O
. O
 
He O
could O
not O
tolerate O
high O
dose O
of O
glucophage O
and O
has O
seen O
Dr. O
Lozano I-NAME
in O
diabetic O
unit O
. O
 
His O
HBA1c O
was O
7.5 O
in O
6/71 I-DATE
and O
7.6 O
in O
9/71 I-DATE
on O
glyburide O
5 O
mg O
bid O
and O
glucophage O
XR O
500 O
mg O
qd O
. O
 
He O
is O
on O
zestoretic O
. O
 
Little O
rationale O
to O
check O
for O
microalbuminuria O
as O
he O
is O
already O
on O
ace-inh O
. O
 
His O
lipids O
are O
controlled O
with O
diet O
and O
lipitor O
. O
 
He O
has O
no O
neuropathic O
sx O
's O
and O
sees O
ophtho O
regularly O
. O
 
HYPERTENSION O
Now O
on O
zestoretic O
20/25 O
bid O
+ O
atenolol O
50 O
mg O
qd O
. O
 
He O
has O
significant O
white O
coat O
component O
. O
 
BP O
is O
again O
145/80 O
and O
is O
lower O
at O
home O
. O
 
Pulse O
is O
70 O
but O
it O
again O
sped O
up O
when O
he O
was O
being O
examined O
. O
 
LOW O
BACK O
PAIN O
he O
had O
prolonged O
discogenic O
back O
pain O
in O
1/2070 I-DATE
and O
could O
not O
get O
appt O
with O
NAMG I-LOCATION
orthopedic/back O
surgeon O
and O
went O
to O
Montreal I-LOCATION
Medical I-LOCATION
Center I-LOCATION
. O
 
He O
underwent O
L4/5 O
lamenictomy O
in O
2/2070 I-DATE
. O
 
He O
has O
persistent O
right-lower O
back O
pain O
and O
has O
seen O
Drs O
. O
 
Conley I-NAME
and O
Sheehan I-NAME
. O
 
A O
myleogram O
done O
on O
8/5/71 I-DATE
showed O
degenerative O
disc O
disease O
with O
moderate O
spinal O
stenosis O
at O
L4/5 O
. O
 
He O
continues O
to O
have O
chronic O
low O
back O
pain O
in O
the O
right O
hip O
and O
right O
anterior O
thigh O
. O
 
He O
exercises O
regularly O
and O
has O
not O
benefitted O
from O
prior O
epidural O
injection O
. O
 
Dr. O
Sheehan I-NAME
felt O
that O
pain O
may O
be O
from O
some O
instability O
vs O
scar O
tissue O
from O
prior O
surgery O
. O
 
Fusion O
surgery O
was O
discussed O
but O
Mr. O
Whitehead I-NAME
is O
not O
too O
keen O
on O
it O
. O
 
[ O
12/25/71 I-DATE
] O
still O
has O
back O
pain O
but O
not O
ready O
for O
fusion O
surgery O
yet O
. O
 
Review O
of O
Systems O
Otherwise O
negative O
. O
 
Vital O
Signs O
Pulse O
: O
70 O
Regular O
Weight O
: O
189 O
Pounds O
Blood O
Pressure O
: O
145/80 O
Left O
Arm O
Physical O
Exam O
Chest O
clear O
Cor/Cardiac O
s1s2 O
s4 O
Abdomen O
soft O
and O
nontender O
, O
no O
masses O
or O
organomegaly O
, O
normal O
bowel O
sounds O
Extremity O
no O
edema O
noted O
, O
pulses O
are O
1+ O
Medications O
MVI O
( O
MULTIVITAMINS O
) O
1CAPSULE O
PO O
QD O
ASPIRIN O
( O
ACETYLSALICYLIC O
ACID O
) O
81MG O
PO O
QD O
FLOMAX O
( O
TAMSULOSIN O
) O
0.4MG O
PO O
QD O
LIPITOR O
( O
ATORVASTATIN O
) O
40MG O
PO O
QHS O
ZESTORETIC O
20-25 O
( O
LISINOPRIL/HYDROCLOROTH O
... O
20/25 O
PO O
QD O
GLUCOPHAGE O
XR O
( O
METFORMIN O
XR O
) O
500MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Prilosec O
SA O
20MG O
PO O
QD O
ATENOLOL O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
MICRONASE O
( O
GLYBURIDE O
) O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Disposition O
and O
Plans O
Follow-up O
in O
9/72 I-DATE
. O
 
Will O
contact O
him O
with O
results O
of O
lab O
work O
. O
 
Record O
date O
: O
2074-03-25 I-DATE
Reason O
for O
Visit O
FU O
of O
several O
issues O
Problems O
DVT O
dx O
with O
left O
calf O
DVT O
on O
3/20/74 I-DATE
in O
setting O
of O
being O
sedentary O
from O
low O
back O
pain O
. O
 
Had O
face O
joint O
block O
on O
3/09/74 I-DATE
. O
 
D-dimer O
was O
high O
and O
cxr O
was O
clear O
. O
 
No O
respiratory O
sx O
's O
to O
suggest O
pulmonary O
embolism O
. O
 
HE O
is O
on O
fragmin O
bid O
for O
3 O
more O
days O
. O
 
INR O
was O
2.5 O
on O
3/23/74 I-DATE
and O
he O
is O
on O
2.5 O
mg O
qd O
. O
 
He O
will O
be O
seeing O
Internal O
Medicine O
on O
3/28/74 I-DATE
. O
 
Will O
treat O
him O
with O
coumadin O
for O
six O
months O
. O
 
He O
has O
moderate O
post-phlebitic O
pain O
and O
is O
on O
prn O
percocets O
. O
 
Elevated O
blood O
sugar O
BS O
was O
191 O
in O
11/1/69 I-DATE
and O
was O
in O
similar O
range O
during O
his O
hospitalization O
in O
Montreal I-LOCATION
Medical I-LOCATION
. O
 
He O
has O
been O
on O
meds O
for O
NIDDM O
. O
 
His O
glucophage O
was O
stopped O
as O
his O
cr O
was O
in O
the O
1.5-1.7 O
range O
. O
 
He O
is O
now O
on O
glyburide O
10 O
mg O
bid O
and O
his O
sugars O
are O
still O
high O
with O
fasting O
levels O
in O
the O
180-250 O
range O
. O
 
His O
HBA1c O
was O
7 O
in O
11/73 I-DATE
. O
 
Will O
transition O
him O
to O
insuline O
with O
25 O
units O
NPH O
sc O
qhs O
and O
he O
will O
monitor O
sugars O
bid O
and O
report O
back O
to O
me O
. O
 
FU O
in O
one O
month O
to O
recheck O
HBA1c O
. O
 
benign O
prostatic O
hypertrophy O
PSA O
was O
2.9 O
in O
8/69 I-DATE
and O
3.2 O
in O
8/70 I-DATE
and O
3.0 O
in O
2/72 I-DATE
. O
 
PSA O
was O
checked O
while O
in O
hospital O
by O
resident O
in O
3/74 I-DATE
and O
it O
was O
12.9 O
. O
 
Discussed O
ramification O
of O
this O
test O
. O
 
Will O
favor O
rechecking O
his O
PSA O
in O
one O
month O
. O
 
Due O
to O
recent O
DVT O
and O
his O
being O
on O
coumadin O
, O
he O
would O
not O
be O
amenable O
to O
undergo O
prostate O
biopsy O
in O
the O
next O
few O
weeks O
. O
 
If O
PSA O
remains O
high O
, O
will O
have O
him O
see O
urology O
. O
 
Vital O
Signs O
Weight O
: O
183 O
Pounds O
Blood O
Pressure O
: O
130/70 O
Left O
Arm O
Physical O
Exam O
Extremity O
minimal O
swelling O
in O
left O
calf O
without O
cords O
Medications O
ASPIRIN O
( O
ACETYLSALICYLIC O
ACID O
) O
81MG O
PO O
QD O
ATENOLOL O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
FLOMAX O
( O
TAMSULOSIN O
) O
0.4MG O
PO O
QD O
INSULIN O
NPH O
HUMAN O
25UNITS O
SC O
QHS O
LIPITOR O
( O
ATORVASTATIN O
) O
40MG O
PO O
QD O
MVI O
( O
MULTIVITAMINS O
) O
1CAPSULE O
PO O
QD O
ZESTORETIC O
20-25 O
( O
LISINOPRIL/HYDROCLOROTH O
... O
20/25 O
PO O
BID O
Disposition O
and O
Plans O
FU O
in O
one O
month O
. O
 
Total O
visit O
time O
was O
40 O
minutes O
. O
 
Record O
date O
: O
2078-03-18 I-DATE
Freeman I-LOCATION
Internal O
Medicine O
Intern O
Admission O
Note O
PATIENT O
: O
Whitehead O
, O
Aidan I-NAME
D I-NAME
MRN O
: O
9855218 I-ID
ADMIT O
DATE O
: O
3/17/78 I-DATE
ATTENDING O
: O
Bell O
, O
Charley I-NAME
Source O
: O
Patient O
and O
chart O
CC O
: O
Diarrhea O
HPI O
: O
1M O
with O
DM O
, O
HTN O
, O
HL O
, O
and O
Parkinson O
's O
disease O
. O
 
In O
7/77 I-DATE
, O
he O
had O
been O
treated O
at O
NAMG I-LOCATION
for O
a O
left O
lower O
lobe O
PNA O
with O
levofloxacin O
, O
and O
developed O
diarrhea O
while O
in O
the O
hospital O
. O
 
After O
discharge O
, O
he O
continued O
to O
have O
profuse O
diarrhea O
, O
and O
was O
treated O
with O
IV O
hydration O
and O
metronidazole O
C. O
diff O
infection O
, O
first O
found O
to O
be O
positive O
on O
7/31/77 I-DATE
. O
 
Since O
then O
he O
has O
had O
multiple O
episodes O
of O
recurrent O
C. O
diff O
. O
 
Most O
recently O
, O
he O
was O
admitted O
to O
NAMG I-LOCATION
for O
treatment O
of O
recurrent O
C. O
diff O
in O
1/77 I-DATE
, O
with O
improvement O
after O
receiving O
inpatient O
vancomycin O
and O
flagyl O
, O
and O
discharged O
to O
NAMG I-LOCATION
, O
where O
he O
was O
for O
3 O
weeks O
. O
 
He O
received O
21 O
days O
of O
flagyl O
. O
 
After O
about O
two O
weeks O
, O
he O
noticed O
a O
gradual O
increase O
in O
his O
stool O
frequency O
. O
 
Three O
weeks O
prior O
to O
admission O
, O
he O
began O
taking O
500 O
mg O
PO O
Flagyl O
q8h O
, O
which O
he O
had O
at O
home O
. O
 
He O
felt O
that O
his O
symptoms O
were O
improved O
somewhat O
on O
the O
flagyl O
. O
 
One O
week O
ago O
, O
he O
saw O
his O
PCP O
, O
where O
a O
C. O
diff O
stool O
toxin O
was O
negative O
. O
 
At O
that O
point O
, O
he O
stopped O
the O
PO O
flagyl O
, O
and O
shortly O
afterward O
his O
diarrhea O
again O
progressively O
worsened O
. O
 
Currently O
he O
is O
having O
10 O
BM O
per O
day O
, O
and O
he O
states O
that O
they O
are O
similar O
to O
odor O
, O
color O
, O
and O
frequency O
to O
his O
prior O
C. O
diff O
episodes O
. O
 
He O
has O
also O
had O
a O
few O
days O
of O
lower O
abdominal O
pain O
, O
2-3/10 O
, O
with O
no O
clear O
pattern O
, O
and O
noticed O
a O
few O
flecks O
of O
blood O
in O
his O
stool O
2 O
days O
ago O
on O
one O
occasion O
. O
 
He O
denies O
other O
symptoms O
including O
fever/chills O
, O
n/v O
, O
cp O
, O
sob O
, O
and O
dizziness O
. O
 
He O
reports O
that O
when O
he O
had O
taken O
PO O
vancomycin O
in O
the O
past O
, O
it O
cost O
$ O
40 O
per O
tablet O
. O
 
ED O
: O
Afebrile O
, O
HR O
70s O
. O
 
Hypertensive O
to O
189/82 O
. O
 
He O
was O
given O
1000 O
cc O
NS O
, O
5 O
mg O
PO O
amlodipine O
, O
20 O
mg O
PO O
lisinopril O
, O
500 O
mg O
IV O
flagyl O
. O
 
ROS O
: O
Otherwise O
negative O
in O
detail O
. O
 
PMHx O
: O
Lower O
back O
pain O
Hypertension O
Hyperlipidemia O
Elevated O
blood O
sugar O
Parkinson O
& O
# O
8217 O
; O
s O
disease O
C. O
difficile O
colitis O
ALLERGIES O
: O
NKDA O
MEDICATIONS O
: O
1 I-AGE
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
81 I-AGE
MG O
PO O
QD O
2 O
. O
 
Amlodipine O
( O
Norvasc O
) O
5 O
MG O
PO O
QD O
3 O
. O
 
Atenolol O
100 O
MG O
PO O
QD O
4 O
. O
 
Atorvastatin O
( O
Lipitor O
) O
20 O
MG O
PO O
QD O
5 O
. O
 
Carbidopa/Levodopa O
25/100 O
( O
Sinemet O
25/100 O
) O
1.5 O
TAB O
PO O
TID O
6 O
. O
 
Citalopram O
( O
Celexa O
) O
20 O
MG O
PO O
QD O
7 O
. O
 
Insulin O
Nph O
Human O
10 O
UNITS O
SC O
QPM O
BEFORE O
SUPPER O
8 O
. O
 
Insulin O
Nph O
Human O
5 O
UNITS O
SC O
QAM O
BEFORE O
BREAKFAST O
9 O
. O
 
Lactobacillus O
PO O
BID O
unit O
strength O
: O
form O
: O
CAPSULE O
10 O
. O
 
Lisinopril O
20 O
MG O
PO O
QD O
11 O
. O
 
Lorazepam O
( O
Ativan O
) O
1 I-AGE
MG O
PO O
as O
directed O
one O
to O
two O
tablets O
1-2 O
hours O
under O
tongue O
prior O
to O
MRI O
and/or O
injection O
12 O
. O
 
Omeprazole O
20 O
MG O
PO O
QD O
GENERIC O
OK O
13 O
. O
 
Tamsulosin O
( O
Flomax O
) O
0.4 O
MG O
PO O
QHS O
FAMILY O
HISTORY O
: O
Noncontributory O
SOCIAL O
HISTORY O
: O
Lives O
with O
his O
wife O
. O
 
Has O
2 O
adult O
stepchildren O
, O
1 I-AGE
a O
Web I-PROFESSION
Technician I-PROFESSION
in O
the O
area O
. O
 
Tob O
: O
Denies O
EtOH O
: O
Denies O
Drug O
use O
: O
Denies O
PHYSICAL O
EXAM O
VITALS O
: O
T O
97.9 O
HR O
77 O
BP O
164/70 O
RR O
SpO2 O
100 O
GEN O
& O
# O
8217 O
; O
L O
: O
Alert O
, O
well O
appearing O
, O
NAD O
. O
 
HEENT O
: O
AT O
/ O
NC O
. O
 
EOMI O
, O
no O
nystagmus O
. O
 
PERRL O
6mm O
- O
& O
gt O
; O
4mm O
bilaterally O
. O
 
MMM O
. O
 
2+ O
carotids O
without O
bruits O
. O
 
No O
lympadenopathy O
. O
 
Heart O
: O
RRR O
, O
no O
MRG O
LUNG O
: O
CTAB O
ABD O
: O
Soft O
, O
NT/ND O
, O
NABS O
. O
 
No O
organomegaly O
. O
 
EXT O
: O
WWP O
. O
 
2+ O
L O
lower O
extremity O
edema O
. O
 
2+ O
DP O
PT O
pulses O
. O
 
NEURO O
: O
A+Ox3 O
. O
 
CN O
II-XII O
, O
speech O
, O
language O
, O
strength O
, O
and O
sensation O
intact O
. O
 
CHEMISTRIES O
Chemistry O
Detail O
for O
WHITEHEAD O
, O
AIDAN I-NAME
D I-NAME
Plasma O
Sodium O
140 O
( O
135-145 O
) O
mmol/L O
Plasma O
Potassium O
3.1 O
L O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
102 O
( O
100-108 O
) O
mmol/L O
Plasma O
Carbon O
Dioxide O
30.5 O
( O
23.0-31.9 O
) O
mmol/L O
Plasma O
Anion O
GAP O
8 O
( O
3-15 O
) O
mmol/L O
Calcium O
8.8 O
( O
8.5-10.5 O
) O
mg/dl O
Phosphorus O
2.4 O
L O
( O
2.6-4.5 O
) O
mg/dl O
Magnesium O
1.6 O
( O
1.4-2.0 O
) O
meq/L O
Plasma O
Urea O
Nitrogen O
16 O
( O
8-25 O
) O
mg/dl O
Plasma O
Creatinine O
1.11 O
( O
0.60-1.50 O
) O
mg/dl O
eGFR O
& O
gt O
; O
60 O
mL/min/1.73m2 O
Abnormal O
if O
& O
lt O
; O
60 O
mL/min/1.73m2 O
. O
 
If O
patient O
is O
African-American O
, O
multiply O
the O
result O
by O
1.21 O
. O
 
Plasma O
Glucose O
135 O
H O
( O
70-110 O
) O
mg/dl O
Total O
Protein O
7.1 O
( O
6.0-8.3 O
) O
g/dl O
Albumin O
3.8 O
( O
3.3-5.0 O
) O
g/dl O
Globulin O
3.3 O
( O
2.6-4.1 O
) O
g/dl O
Direct O
Bilirubin O
0.1 O
( O
0-0.4 O
) O
mg/dl O
Total O
Bilirubin O
0.5 O
( O
0.0-1.0 O
) O
mg/dl O
Alkaline O
Phosphatase O
94 O
( O
45-115 O
) O
U/L O
Transaminase-SGPT O
19 O
( O
10-55 O
) O
U/L O
Amylase O
32 O
( O
3-100 O
) O
units/L O
Transaminase-SGOT O
12 O
( O
10-40 O
) O
U/L O
Lipase O
12 O
L O
( O
13-60 O
) O
U/L O
WBC O
10.8 O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
36.9 O
L O
( O
41.0-53.0 O
) O
% O
HGB O
12.9 O
L O
( O
13.5-17.5 O
) O
gm/dl O
RBC O
3.96 O
L O
( O
4.50-5.90 O
) O
mil/cmm O
PLT O
244 O
( O
150-400 O
) O
th/cumm O
MCV O
93 O
( O
80-100 O
) O
fl O
MCH O
32.6 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
35.0 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
14.4 O
( O
11.5-14.5 O
) O
% O
DIFFERENTIAL O
REQUEST O
RECEIVED O
Diff O
Method O
Auto O
Poly O
79 O
H O
( O
40-70 O
) O
% O
Lymphs O
14 O
L O
( O
22-44 O
) O
% O
Monos O
5 O
( O
4-11 O
) O
% O
EOS O
2 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
Absolute O
Neuts O
8.50 O
H O
( O
1.8-7.7 O
) O
th/cmm O
Absolute O
Lymphs O
1.48 O
( O
1.0-4.8 O
) O
th/cmm O
Absolute O
Monos O
0.54 O
H O
( O
0.2-0.4 O
) O
th/cmm O
Absolute O
EOS O
0.26 O
( O
0.1-0.3 O
) O
th/cmm O
Absolute O
Basos O
0.03 O
( O
0.0-0.3 O
) O
th/cmm O
Aniso O
None O
( O
None O
) O
Hypo O
None O
( O
None O
) O
Macrocytes O
None O
( O
None O
) O
Microcytes O
None O
( O
None O
) O
RADIOLOGY O
: O
3/17 I-DATE
KUB O
. O
 
Study O
done O
, O
radiology O
read O
pending O
. O
 
ECG O
: O
Normal O
sinus O
rhythm O
, O
rate O
84 O
. O
 
Normal O
axis O
. O
 
Normal O
intervals O
. O
 
No O
ST O
segment O
deviation O
or O
T O
wave O
inversion O
. O
 
ASSESSMENT O
& O
amp O
; O
PLAN O
: O
81M O
with O
recurrent O
C. O
diff O
infections O
presenting O
with O
diarrhea O
. O
 
Likely O
he O
has O
a O
recurrent O
episode O
of O
C. O
diff O
infection O
. O
 
1 I-AGE
. O
 
Diarrhea O
. O
 
- O
IV O
flagyl O
500 O
mg O
Q8H O
and O
PO O
vancomycin O
250 O
mg O
Q6H O
- O
stool O
c. O
diff O
toxin O
- O
ID O
consult O
re O
: O
appropriate O
management O
of O
multiply O
recurrent O
C. O
diff O
infection O
- O
consider O
social O
services O
consult O
if O
ID O
feels O
PO O
vancomycin O
is O
the O
only O
viable O
option O
at O
this O
point O
. O
 
2 O
. O
 
HTN O
- O
HTN O
improved O
s/p O
receiving O
his O
home O
regimen O
in O
the O
ED O
. O
 
- O
will O
replace O
atenolol O
with O
metoprolol O
while O
in-patient O
, O
up-titrate O
as O
needed O
, O
starting O
37.5mg O
Q8h O
3 O
. O
 
L O
lower O
extremity O
edema O
. O
 
Patient O
states O
he O
was O
evaluated O
at O
OSH O
recently O
and O
felt O
to O
not O
have O
a O
DVT O
. O
 
Will O
disuss O
whether O
any O
further O
workup O
is O
neeed O
with O
pt O
& O
# O
8217 O
; O
s O
PCP O
in O
AM O
. O
 
3 O
. O
 
FEN O
. O
 
PO O
diet O
as O
tolerated O
. O
 
RISS O
/ O
NPH O
. O
 
4 O
. O
 
PPX O
. O
 
Lovenox O
. O
 
Alexander I-NAME
X. I-NAME
Jenks I-NAME
, O
MD O
, O
PhD O
Pager O
84261 I-CONTACT
 
Record O
date O
: O
2064-07-26 I-DATE
July I-DATE
26 O
, O
2064 I-DATE
Harry I-NAME
R. I-NAME
Lynn I-NAME
, O
M.D O
. O
 
Doraville I-LOCATION
County I-LOCATION
Health I-LOCATION
Center I-LOCATION
897 I-LOCATION
Cider I-LOCATION
Street I-LOCATION
Platteville I-LOCATION
, O
HI I-LOCATION
79812 I-LOCATION
RE O
: O
Isabelle I-NAME
Y O
. O
 
Quick I-NAME
ATCH I-LOCATION
: O
655-75-45 I-ID
Dear O
Harry I-NAME
and O
Yair I-NAME
: O
My O
thanks O
for O
your O
kind O
referral O
of I-DATE
the O
above O
noted O
patient O
with O
respect O
to O
her O
disabling O
claudication O
and O
of I-DATE
course O
she O
is O
not O
in O
a O
very O
happy O
circumstance O
. O
 
As O
you O
know O
, O
she O
is O
just O
52 I-AGE
years O
of I-DATE
age O
. O
 
Her O
cardiovascular O
risk O
factors O
include O
type O
2 O
diabetes O
treated O
with O
metformin O
and O
Glyburide O
, O
hypertension O
, O
hyperlipidemia O
and O
she O
is O
a O
former O
cigarette O
smoker O
but O
she O
has O
not O
smoked O
in O
a O
year O
. O
 
She O
spends O
a O
lot O
of I-DATE
time O
caring O
for O
her O
partially O
disabled O
husband O
. O
 
She O
has O
known O
and O
impressive O
history O
of I-DATE
peripheral O
vascular O
disease O
. O
 
She O
has O
undergone O
bilateral O
leg O
revascularizations O
. O
 
On O
the O
left O
side O
initially O
an O
iliac O
stent O
was O
tried O
but O
in O
January I-DATE
of I-DATE
2063 I-DATE
she O
had O
a O
left O
iliofemoral O
endarterectomy O
with O
angioplasty O
and O
in O
situ O
above O
knee O
left O
fem-pop O
bypass O
graft O
. O
 
This O
reconstruction O
is O
functioning O
well O
, O
as O
evidenced O
by O
pulse O
examination O
and O
she O
certainly O
does O
not O
have O
any O
major O
symptoms O
in O
the O
left O
side O
. O
 
In O
April I-DATE
of I-DATE
2063 I-DATE
she O
had O
a O
right O
common O
femoral O
and O
external O
iliac O
endarterectomy O
with O
a O
right O
fem-pop O
bypass O
graft O
to O
the O
above-knee O
popliteal O
artery O
using O
transposed O
greater O
saphenous O
veins O
. O
 
There O
had O
previously O
been O
a O
right O
iliac O
PTA O
and O
stent O
. O
 
She O
states O
that O
the O
procedure O
in O
the O
right O
leg O
was O
only O
transiently O
of I-DATE
benefit O
. O
 
By O
last O
spring I-DATE
, O
i.e O
. O
 
a O
year O
ago O
she O
again O
had O
rather O
limiting O
claudication O
. O
 
She O
says O
this O
is O
now O
worse O
over O
the O
past O
several O
months O
and O
she O
quantifies O
this O
as O
severe O
calf O
pain O
after O
just O
a O
couple O
of I-DATE
blocks O
. O
 
Importantly O
she O
does O
not O
have O
ischemic O
rest O
pain O
and O
she O
has O
never O
had O
tissue O
loss O
. O
 
Recently O
resting O
ABIs O
were O
recorded O
at O
0.46 O
on O
the O
right O
and O
0.8 O
on O
the O
left O
. O
 
Her O
continued O
complaints O
led O
to O
a O
repeat O
arteriogram O
last O
October I-DATE
documenting O
a O
superficial O
femoral O
artery O
occlusion O
( O
? O
? O
? O
 
length O
thereof O
- O
she O
did O
not O
bring O
the O
films O
themselves O
) O
and O
a O
patent O
albeit O
small O
reconstituted O
above-knee O
popliteal O
artery O
with O
decent O
runoff O
. O
 
Understandably O
Dr. O
Adcock I-NAME
was O
reluctant O
about O
recommending O
further O
revascularizations O
. O
 
She O
has O
sought O
an O
opinion O
here O
in O
this O
regard O
. O
 
She O
has O
no O
known O
coronary O
artery O
disease O
and O
her O
general O
system O
review O
is O
notable O
for O
a O
prior O
hospitalization O
in O
2061 I-DATE
for O
severe O
pancreatitis O
requiring O
laparotomy O
. O
 
On O
physical O
examination O
blood O
pressure O
was O
140/80 O
. O
 
Pulse O
was O
70 O
and O
regular O
. O
 
Carotid O
upstroke O
was O
normal O
and O
there O
were O
no O
major O
carotid O
bruits O
. O
 
She O
has O
femoral O
pulses O
on O
both O
sides O
and O
the O
left O
fem-pop O
bypass O
graft O
in O
situ O
is O
palpable O
, O
as O
is O
the O
left O
popliteal O
pulse O
. O
 
There O
is O
no O
right O
popliteal O
nor O
right O
foot O
pulse O
. O
 
She O
does O
have O
dependent O
rubor O
on O
that O
right O
side O
although O
there O
is O
no O
tissue O
breakdown O
. O
 
This O
is O
of I-DATE
course O
a O
very O
unhappy O
situation O
. O
 
Further O
attempts O
at O
surgical O
revascularization O
in O
the O
setting O
of I-DATE
having O
both O
greater O
saphenous O
veins O
harvested O
and O
so O
forth O
is O
really O
not O
justified O
for O
claudication O
alone O
since O
the O
result O
can O
be O
anticipated O
to O
be O
not O
very O
good O
. O
 
However O
I O
am O
not O
absolutely O
ruling O
this O
out O
. O
 
I O
would O
suggest O
the O
following O
. O
 
Her O
risk O
factor O
control O
is O
decent O
and O
she O
should O
certainly O
stay O
on O
the O
Lipitor O
, O
aspirin O
and O
Plavix O
. O
 
Since O
her O
problem O
is O
claudication O
I O
would O
like O
Yair I-NAME
to O
institute O
Pletal O
at O
full O
dosages O
and O
give O
this O
at O
least O
a O
couple O
of I-DATE
months O
before O
we O
can O
say O
that O
she O
has O
had O
an O
adequate O
trial O
with O
question O
benefit O
. O
 
She O
will O
get O
the O
actual O
arteriogram O
from O
the O
October I-DATE
study O
to O
me O
. O
 
If O
it O
seems O
reasonable O
and O
the O
right O
superficial O
femoral O
artery O
block O
is O
not O
too O
long O
an O
attempt O
at O
percutaneous O
recanalization O
could O
be O
considered O
. O
 
I O
will O
get O
back O
to O
you O
after O
review O
of I-DATE
the O
films O
themselves O
. O
 
My O
thanks O
once O
again O
. O
 
With O
every O
best O
wish O
. O
 
Sincerely O
, O
Daniel I-NAME
W. I-NAME
Iniguez I-NAME
, O
M.D O
. O
 
cc O
: O
Yair I-NAME
K. I-NAME
Bennett I-NAME
, O
M.D. O
, O
208 I-LOCATION
Pheasant I-LOCATION
Lane I-LOCATION
, O
Platteville I-LOCATION
, O
HI I-LOCATION
79812 I-LOCATION
DWI/yim O
 
Record O
date O
: O
2064-09-10 I-DATE
Date O
: O
9/10/64 I-DATE
, O
0857 O
am O
Medical O
Record O
Number O
: O
6557545 I-ID
, O
Quick O
, O
Isabelle I-NAME
. O
 
Procedure O
: O
The O
patient O
is O
a O
52 I-AGE
year O
old O
female O
scheduled O
for O
a O
right O
femoral O
popliteal O
BPG O
. O
 
Surgery O
is O
to O
be O
performed O
on O
9/17/64 I-DATE
, O
by O
Dr. O
Iyer I-NAME
. O
 
Chief O
Complaint O
& O
Present O
Illness O
: O
Patient O
has O
history O
of I-DATE
claudication O
within O
past O
year O
. O
 
She O
underwent O
a O
left O
ileofemoral O
endarterectomy O
1/63 I-DATE
, O
and O
a O
right O
right O
common O
femoral O
and O
external O
iliac O
endarterectomy O
with O
right O
fem-pop O
4/63 I-DATE
. O
 
She O
denies O
any O
relief O
with O
any O
previous O
procedures O
. O
 
She O
states O
she O
has O
to O
stop O
before O
walking O
1 O
block O
due O
to O
pain O
in O
both O
legs O
R O
> O
L O
. O
 
Pain O
resolves O
with O
rest O
. O
 
Past O
Medical O
History O
: O
1. O
type O
2 O
diabetes O
treated O
with O
metformin O
and O
Glyburide O
2. O
hypertension O
3. O
hyperlipidemia O
4 O
. O
 
PVD O
5 O
. O
 
Chronic O
pancreatitis O
Past O
Surgical O
History O
: O
1 O
. O
 
January I-DATE
of I-DATE
2063 I-DATE
she O
had O
a O
left O
iliofemoral O
endarterectomy O
with O
angioplasty O
and O
in O
situ O
above O
knee O
left O
fem-pop O
bypass O
graft O
. O
 
2 O
. O
 
April I-DATE
of I-DATE
2063 I-DATE
she O
had O
a O
right O
common O
femoral O
and O
external O
iliac O
endarterectomy O
with O
a O
right O
fem-pop O
bypass O
graft O
to O
the O
above-knee O
popliteal O
artery O
using O
transposed O
greater O
saphenous O
veins O
3 O
. O
 
10/09/63 I-DATE
, O
aortogram O
bilateral O
lower O
extremity O
runoff O
with O
a O
right O
common O
runoff O
4 O
. O
 
Whipple O
procedure O
for O
chronic O
pancreatitis O
2061 I-DATE
Denies O
problems O
with O
general O
anesthesia O
Family O
History O
: O
There O
is O
no O
family O
history O
if O
adverse O
reactions O
to O
general O
anesthesia O
. O
 
Medications O
: O
Pre-admission O
Medication O
List O
for O
QUICK O
, O
ISABELLE O
Y I-NAME
6557545 I-ID
( O
ATCH I-LOCATION
) O
52 I-AGE
F O
Last O
signed O
by O
: O
RICO O
, O
HELEN O
U. O
, O
RNC O
on O
09/10/2064 I-DATE
at O
09:21 O
1 O
. O
 
Pioglitazone O
( O
Actos O
) O
15 O
MG O
PO O
QAM O
2 O
. O
 
Glyburide O
1.25 O
MG O
PO O
QAM O
3 O
. O
 
Metformin O
500 O
MG O
PO O
BID O
4 O
. O
 
Clopidogrel O
( O
Plavix O
) O
75 O
MG O
PO O
QAM O
dose O
last O
taken O
09/10/2064 I-DATE
5 O
. O
 
Atorvastatin O
( O
Lipitor O
) O
20 O
MG O
PO O
QHS O
6 O
. O
 
Atenolol O
50 O
MG O
PO O
QAM O
7 O
. O
 
Pantoprazole O
( O
Protonix O
) O
40 O
MG O
PO O
QAM O
8 O
. O
 
Cyproheptadine O
Hcl O
4 O
MG O
PO O
BID O
9 O
. O
 
Amitriptyline O
Hcl O
50 O
MG O
PO O
QHS O
10 O
. O
 
Therapeutic O
Multivitamins O
( O
Multivitamin O
Therapeutic O
) O
1 O
TAB O
PO O
QHS O
11 O
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
81 O
MG O
PO O
QAM O
Allergies O
: O
NKDA O
Social O
History O
: O
Smoking O
: O
1ppd/27 O
years O
, O
quit O
2 O
years O
ago O
Alcohol O
use O
: O
none O
Substance O
abuse O
: O
none O
Allergen O
Exposure O
: O
( O
transfusion/pregnancy O
) O
: O
none O
in O
last O
3 O
months O
. O
 
Exercise O
: O
walks O
20 O
minutes- O
1/2 O
hour O
daily O
Occupation O
: O
none O
Marital O
Status O
: O
married O
Review O
of I-DATE
Systems O
: O
General O
: O
Independent O
with O
ADL O
, O
well O
developed O
, O
well O
nourished O
. O
 
HEENT O
: O
History O
of I-DATE
sinus O
infections O
in O
past O
. O
 
No O
history O
of I-DATE
head O
injury O
, O
glaucoma O
, O
cataracts O
, O
eye O
redness O
, O
eye/nose/throat O
pain O
, O
earaches O
, O
ear O
infections O
, O
nose O
bleeds O
, O
excessive O
tearing O
, O
eye/ear O
discharge O
, O
vision O
changes O
( O
including O
double O
vision O
, O
spot O
, O
specks O
, O
or O
flashing O
lights O
) O
, O
tinnitus O
, O
vertigo O
, O
motion O
sickness O
, O
or O
hearing O
loss O
. O
 
Respiratory O
: O
Denies O
cough O
sputum O
, O
hemoptysis O
, O
wheezing O
, O
asthma O
, O
bronchitis O
, O
emphysema O
, O
pneumonia O
, O
tuberculosis O
, O
COPD O
, O
sleep O
apnea O
, O
or O
pleurisy O
. O
 
Cardiovascular O
: O
History O
of I-DATE
HTN O
, O
hypercholesterolemia O
. O
 
Stress O
test O
9/8/64 I-DATE
, O
shows O
no O
evidence O
for O
myocardial O
ischemia O
, O
EF O
70 O
% O
. O
 
No O
history O
of I-DATE
rheumatic O
fever O
, O
MI O
, O
angina O
, O
syncope O
, O
palpitations O
, O
edema O
, O
dyspnea O
, O
chest O
pain O
, O
orthopnea O
, O
or O
paroxysmal O
nocturnal O
dyspnea O
. O
 
GI O
: O
No O
history O
of I-DATE
GERD O
, O
PUD O
, O
bleeding O
, O
changes O
in O
bowel O
habits O
, O
difficulty O
swallowing O
, O
appetite O
changes O
, O
nausea O
, O
vomiting O
, O
constipation O
, O
diarrhea O
, O
abdominal O
pain O
, O
food O
intolerance O
, O
excessive O
belching O
or O
gas O
. O
 
Hepatobiliary O
: O
History O
of I-DATE
chronic O
pancreatitis O
s/p O
Whipple O
. O
 
Has O
taken O
protonix O
since O
surgery O
. O
 
No O
history O
of I-DATE
jaundice O
, O
hepatitis O
, O
or O
colic O
. O
 
GU O
: O
No O
history O
of I-DATE
CRF O
, O
hematuria O
, O
obstruction O
, O
colic O
, O
stones O
, O
UTI O
, O
polyuria O
, O
nocturia O
, O
decreased O
caliber O
or O
force O
of I-DATE
urinary O
stream O
, O
hesitancy O
, O
incontinence O
, O
or O
frequency O
of I-DATE
urination O
. O
 
Musculoskeletal O
: O
No O
history O
of I-DATE
arthritis O
, O
muscle O
pain O
, O
joint O
pain O
, O
stiffness O
, O
gout O
, O
or O
limitations O
with O
ROM O
. O
 
Neuro O
: O
History O
of I-DATE
right O
inner O
leg O
numbness O
. O
 
No O
history O
of I-DATE
seizures O
, O
stroke O
, O
TIAs O
, O
migraine O
, O
fainting O
, O
weakness O
, O
paralysis O
, O
tingling O
, O
tremors O
, O
or O
other O
involuntary O
movements O
. O
 
Peripheral O
Vascular O
: O
History O
of I-DATE
bilateral O
claudication O
R O
> O
L O
. O
 
No O
history O
of I-DATE
DVT O
, O
varicosities O
, O
cramps O
, O
or O
ulcers O
. O
 
Endocrine O
: O
History O
of I-DATE
type O
II O
diabetes O
( O
non O
insulin O
dependent O
) O
diagnosed O
2 O
years O
ago O
. O
 
Checks O
BS O
regularly O
usually O
150 O
-160 O
in O
am O
. O
 
No O
history O
of I-DATE
thyroid O
problems O
, O
heat O
or O
cold O
intolerance O
, O
excessive O
sweating O
, O
excessive O
thirst O
Heme/Onc O
: O
History O
of I-DATE
easy O
bruising O
. O
 
No O
history O
of I-DATE
bleeding O
, O
anemia O
, O
lymphadenopathy O
, O
chemotherapy O
or O
radiation O
. O
 
Psychiatric O
: O
No O
history O
of I-DATE
anxiety O
, O
panic O
attacks O
, O
depression O
, O
or O
psychosis O
. O
 
Skin O
: O
No O
history O
of I-DATE
rash O
, O
abnormal O
pigmentation O
, O
pruritis O
, O
lumps O
, O
or O
sores O
. O
 
Physical O
Exam O
: O
SaO2 O
: O
100 O
Resp O
: O
16 O
Temp:96.4 O
Ht O
: O
65in O
Wt O
: O
132.6 O
BP O
: O
140/82 O
AP O
: O
80 O
General O
: O
Well O
developed O
, O
thin O
HEENT O
: O
Normocephalic O
, O
cranium O
intact O
without O
depressions O
. O
 
no O
icterus O
, O
thyroid O
non-palpable O
, O
neck O
veins O
flat O
, O
carotids O
palpable O
without O
bruits O
, O
no O
swelling O
, O
lumps O
, O
masses O
, O
tenderness O
, O
or O
visible O
pulsations O
. O
 
Movement O
symmetrical O
with O
full O
range O
of I-DATE
motion O
. O
 
Frontal O
and O
maxillary O
sinuses O
non-tender O
. O
 
Airway O
: O
Mallampatti O
Class O
I O
Teeth O
: O
missing O
lower O
molars O
Chest O
: O
Breath O
sounds O
clear O
. O
 
No O
abnormal O
retraction O
or O
impairment O
of I-DATE
lower O
interspaces O
during O
inspiration O
. O
 
Symmetrical O
, O
even O
respiratory O
movement O
. O
 
Heart O
: O
Regular O
rhythm O
, O
normal O
rate O
, O
no O
murmurs O
, O
rubs O
or O
gallops O
, O
S1=S2 O
. O
 
Abdomen O
: O
Soft O
, O
non-tender O
, O
with O
scars O
, O
no O
distention O
, O
normal O
bowel O
sounds O
, O
no O
organomegaly O
or O
palpable O
masses O
. O
 
Contour O
round O
, O
symmetrical O
, O
without O
lesions O
, O
striae O
, O
or O
dilated O
veins O
. O
 
No O
visible O
peristalsis O
or O
pulsations O
. O
 
GU/Rectal O
: O
No O
CVA O
tenderness O
or O
hernias O
. O
 
LMP O
- O
10 O
years O
ago O
, O
postmenopausal O
Lymphatics O
: O
No O
lymphadenopathy O
Peripheral O
Vascular O
: O
No O
edema O
, O
varicosities O
. O
 
Spider O
veins O
Carotids- O
2+ O
Radials- O
2+ O
Femorals- O
2+ O
Anterior O
tibial- O
not O
palpable O
Dorsalis O
pedis- O
not O
palpable O
Neuro O
: O
CNII O
: O
Visual O
Acuity O
: O
Able O
to O
read O
newspaper O
and O
see O
distances O
with O
glasses O
. O
 
Visual O
fields O
full O
to O
confrontation O
. O
 
CN O
III O
, O
IV O
, O
and O
VI O
, O
: O
EOMs O
intact O
, O
parallel O
, O
no O
ptosis O
. O
 
PERRLA O
& O
A O
. O
 
CN O
V O
& O
VII O
: O
Intact O
. O
 
Temporal O
and O
masseter O
muscle O
contractions O
equal O
in O
symmetry O
and O
strength O
. O
 
Equal O
sensation O
to O
sharp O
stimulus O
to O
forehead O
, O
cheek O
, O
and O
jaws O
. O
 
CNVIII O
: O
Intact O
. O
 
No O
loss O
of I-DATE
hearing O
to O
either O
ear O
via O
whisper O
test O
. O
 
CN O
IX O
, O
X O
: O
Intact O
. O
 
Voice O
without O
hoarseness O
or O
nasal O
quality O
. O
 
Uvula O
midline O
. O
 
CN O
XI O
: O
Intact O
. O
 
Equal O
strength O
and O
contraction O
to O
trapezii O
and O
sternomastoid O
muscle O
. O
 
CN O
XII O
: O
Intact O
. O
 
Tongue O
movement O
symmetrical O
without O
deviations O
or O
protrusions O
. O
 
No O
atrophy O
or O
fasciculations O
as O
tongue O
lies O
on O
floor O
of I-DATE
mouth O
. O
 
Mental O
Status O
: O
Oriented O
x O
3 O
. O
 
Appearance O
neat O
and O
clean O
. O
 
Pt O
pleasant O
and O
cooperative O
for O
exam O
. O
 
Able O
to O
answer O
questions O
appropriately O
and O
clearly O
. O
 
Able O
to O
articulate O
own O
thoughts O
and O
questions O
logically O
and O
coherently O
. O
 
Coordination O
: O
Gait O
- O
slow O
, O
steady O
Strength O
and O
Tone O
: O
Tone O
and O
strength O
intact O
to O
upper O
and O
lower O
extremities O
. O
 
Sensory O
: O
Intact O
. O
 
Reflexes O
: O
not O
tested O
Extremities O
: O
No O
clubbing O
or O
cyanosis O
. O
 
Musculoskeletal O
: O
Normal O
range O
of I-DATE
motion O
. O
 
Skin O
: O
Warm O
and O
dry O
to O
touch O
. O
 
Turgor O
intact O
. O
 
Color O
consistent O
. O
 
No O
lesions O
, O
rashes O
, O
or O
edema O
. O
 
Assessment O
: O
ASA O
physical O
status O
: O
III O
. O
 
Patient O
is O
a O
52 I-AGE
year O
old O
female O
scheduled O
for O
a O
right O
femoral O
popliteal O
BPG O
. O
 
Patient O
has O
history O
of I-DATE
PVD O
, O
HTN O
type O
II O
diabetes O
, O
hyperlipidemia O
, O
chronic O
pancreatitis O
s/p O
Whipple O
, O
and O
no O
problems O
with O
general O
anesthesia O
. O
 
Have O
enclosed O
stress O
test O
from O
Hospital I-LOCATION
Lafayette I-LOCATION
, O
Platteville I-LOCATION
, O
Hi I-LOCATION
. O
 
Anesthesia O
consent O
form O
and O
tentative O
plans O
reviewed O
and O
explained O
. O
 
Patient O
will O
sign O
anesthesia O
consent O
form O
day O
of I-DATE
surgery O
. O
 
Plan O
: O
Proposed O
anesthetic O
: O
general O
, O
epidural O
Monitors O
: O
standard O
, O
arterial O
line O
Pain O
Management O
: O
IVPCA/epidural O
Autologous O
Blood O
: O
none O
Premedication O
: O
none O
Usual O
Medications O
: O
Pre-admission O
Medication O
List O
for O
QUICK O
, O
ISABELLE O
Y I-NAME
6557545 I-ID
( O
ATCH I-LOCATION
) O
52 I-AGE
F O
Last O
signed O
by O
: O
RICO O
, O
HELEN O
U. O
, O
RNC O
on O
09/10/2064 I-DATE
at O
09:21 O
1 O
. O
 
Pioglitazone O
( O
Actos O
) O
15 O
MG O
PO O
QAM O
2 O
. O
 
Glyburide O
1.25 O
MG O
PO O
QAM O
3 O
. O
 
Metformin O
500 O
MG O
PO O
BID O
4 O
. O
 
Clopidogrel O
( O
Plavix O
) O
75 O
MG O
PO O
QAM O
dose O
last O
taken O
09/10/2064 I-DATE
5 O
. O
 
Atorvastatin O
( O
Lipitor O
) O
20 O
MG O
PO O
QHS O
6 O
. O
 
Atenolol O
50 O
MG O
PO O
QAM O
7 O
. O
 
Pantoprazole O
( O
Protonix O
) O
40 O
MG O
PO O
QAM O
8 O
. O
 
Cyproheptadine O
Hcl O
4 O
MG O
PO O
BID O
9 O
. O
 
Amitriptyline O
Hcl O
50 O
MG O
PO O
QHS O
10 O
. O
 
Therapeutic O
Multivitamins O
( O
Multivitamin O
Therapeutic O
) O
1 O
TAB O
PO O
QHS O
11 O
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
81 O
MG O
PO O
QAM O
Medications O
to O
be O
held O
on O
day O
of I-DATE
surgery O
: O
< O
> O
Diabetic O
Medications O
: O
< O
> O
NSAIDS O
: O
Avoid O
for O
three O
days O
prior O
to O
surgery O
Aspirin O
: O
Avoid O
for O
one O
week O
prior O
to O
surgery O
. O
 
NPO O
: O
< O
> O
Ancillary O
Studies O
: O
< O
> O
__________________________________________________________________ O
Helen I-NAME
Rico I-NAME
, O
MSN O
, O
APRN-BC O
, O
FNP O
___________________________________________________________________ O
 
Record O
date O
: O
2065-08-02 I-DATE
Vascular O
Surgery O
Admission O
Note O
Patient O
Name O
: O
Quick O
, O
Isabelle I-NAME
MRN O
: O
6557545 I-ID
Date O
and O
Time O
: O
8/02/65 I-DATE
2:40PM O
Attending O
: O
Dr. O
Iyer I-NAME
Fellow O
: O
Dr. O
Wade I-NAME
Junior O
Resident O
: O
Dr. O
Joyce I-NAME
cc O
: O
thrombosed O
R O
fem-pop O
BPG O
; O
increasing O
rest O
pain O
in O
R O
leg O
HPI O
: O
The O
patient O
is O
a O
53 I-AGE
year O
old O
woman O
with O
a O
past O
medical O
history O
of O
diabetes O
, O
HTN O
, O
and O
PVD O
s/p O
L O
fem-pop O
BPG O
with O
in-situ O
vein O
2063 I-DATE
, O
R O
fem O
to O
AK O
pop O
BPG O
with O
GSV O
2063 I-DATE
, O
R O
fem-BK O
pop O
BPG O
with O
propatent O
graft O
9/17/64 I-DATE
, O
and O
multiple O
attempts O
at O
angiographic O
intervention O
who O
presents O
with O
worsening O
rest O
pain O
in O
the O
R O
leg O
X O
1 O
month O
. O
 
Immediately O
following O
her O
2nd O
R O
fem-pop O
BPG O
in O
9/2064 I-DATE
, O
she O
felt O
well O
and O
without O
significant O
LE O
pain O
. O
 
Over O
the O
past O
month O
, O
however O
, O
the O
patient O
reports O
that O
she O
has O
had O
progressive O
pain O
in O
her O
R O
foot O
and O
leg O
, O
which O
wakes O
her O
up O
from O
sleep O
almost O
every O
night O
. O
 
She O
can O
walk O
less O
than O
one O
block O
without O
disabling O
claudication O
which O
improves O
with O
rest O
. O
 
She O
also O
has O
noticed O
discoloration O
of O
her O
R O
foot O
, O
along O
with O
numbness O
and O
paresthesias O
, O
which O
have O
been O
progressive O
over O
the O
same O
time O
period O
. O
 
She O
denies O
all O
symptoms O
other O
than O
RLE O
pain O
and O
claudication O
as O
described O
. O
 
Specifically O
, O
she O
denies O
chest O
pain O
, O
shortness O
of O
breath O
, O
dizziness O
, O
headache O
, O
and O
fevers/chills O
. O
 
She O
reports O
that O
her O
left O
leg O
is O
occasionally O
painful O
, O
although O
it O
has O
been O
tolerable O
in O
comparison O
to O
her O
R O
leg O
. O
 
She O
has O
been O
taking O
aspirin O
and O
plavix O
regularly O
, O
but O
has O
not O
taken O
coumadin O
for O
2 O
days O
( O
last O
dose O
7/31/65 I-DATE
) O
. O
 
She O
last O
underwent O
arterial O
LENIs O
on O
7/17/65 I-DATE
, O
which O
demonstrated O
critical O
ischemia O
in O
her O
R O
leg O
and O
a O
thrombosed O
R O
fem-pop O
BPG O
( O
see O
below O
for O
official O
report O
) O
. O
 
She O
is O
admitted O
for O
elective O
revascularization O
of O
her O
R O
leg O
. O
 
PMH O
: O
DM O
II O
HTN O
PVD O
Hyperlipidemia O
Chronic O
Pancreatitis O
PSH O
: O
9/20/64 I-DATE
: O
angio/PTA O
L O
proximal O
fem-pop O
bpg O
and O
L O
SFA O
9/17/64 I-DATE
: O
R O
CFA O
endarterectomy O
; O
R O
fem-BK O
pop O
BPG O
w/ O
propatent O
graft O
10/2063 I-DATE
, O
angio O
w/ O
BLE O
runoff O
4/2063 I-DATE
: O
R O
CFA O
and O
EIA O
endarterectomy O
; O
R O
fem-pop O
BPG O
to O
AK O
pop O
using O
transposed O
greater O
saphenous O
veins O
1/2063 I-DATE
: O
L O
iliofemoral O
endarterectomy O
with O
PTA O
& O
amp O
; O
in O
situ O
vein O
AK O
L O
fem-pop O
bpg O
2061 I-DATE
: O
Whipple O
procedure O
for O
chronic O
pancreatitis O
Meds O
: O
1 O
. O
 
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
325 O
MG O
PO O
2 O
. O
 
Atenolol O
50 O
MG O
PO O
QD O
3 O
. O
 
Clopidogrel O
( O
Plavix O
) O
75 O
MG O
PO O
QD O
4 O
. O
 
Cyproheptadine O
Hcl O
4 O
MG O
PO O
BID O
5 O
. O
 
Glipizide O
2.5 O
MG O
PO O
QD O
6 O
. O
 
Metformin O
500 O
MG O
PO O
TID O
7 O
. O
 
Multivitamins O
1 O
TAB O
PO O
QD O
8 O
. O
 
Pantoprazole O
( O
Protonix O
) O
40 O
MG O
PO O
QD O
9 O
. O
 
Pioglitazone O
( O
Actos O
) O
30 O
MG O
PO O
QD O
10 O
. O
 
Simvastatin O
20 O
MG O
PO O
QD O
11 O
. O
 
Warfarin O
Sodium O
( O
Coumadin O
) O
5 O
MG O
PO O
QD O
ALL O
: O
NKDA O
Social O
: O
Previous O
smoker O
, O
quit O
approximately O
3 O
years O
ago O
Denies O
EtOH O
ROS O
: O
as O
above O
; O
otherwise O
negative O
with O
exception O
of O
presenting O
complaints O
PE O
: O
VS O
: O
T O
98.2 O
HR O
80 O
BP O
129/65 O
RR O
18 O
96 O
% O
RA O
NAD O
, O
comfortable-appearing O
middle-aged O
woman O
, O
NAD O
Neck O
: O
no O
bruits O
appreciated O
CV O
: O
RRR O
, O
no O
m/r/g O
Pulm O
: O
CTA O
bilaterally O
, O
no O
wheezes O
or O
crackles O
Abd O
: O
soft O
, O
non O
tender O
, O
non O
distended O
; O
R O
vertical O
paramedian O
scar O
, O
well-healed O
Ext O
: O
LLE O
warm O
, O
with O
well O
healed O
femoral O
and O
L O
knee O
incisions O
, O
normal O
color O
and O
sensation O
R O
foot O
cool O
, O
with O
small O
amount O
of O
discoloration O
present O
distal O
to O
mid-metatarsals O
; O
sensation O
grossly O
intact O
although O
subjectively O
less O
than O
L O
foot O
Pulses O
: O
Rad O
Fem O
Pop O
DP O
PT O
R O
2+ O
1+ O
NP O
weak O
Doppler O
signal O
no O
doppler O
signal O
L O
2+ O
2+ O
NP O
strong O
Doppler O
signal O
+ O
Doppler O
signal O
PVRs O
demonstrate O
pulsatile O
signals O
in O
LLE O
; O
waveforms O
are O
flat O
in O
RLE O
EKG O
: O
normal O
sinus O
rhythm O
, O
no O
ischemic O
changes O
Labs O
: O
Plasma O
Sodium O
139 O
( O
135-145 O
) O
mmol/L O
Plasma O
Potassium O
4.9 O
H O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
101 O
( O
100-108 O
) O
mmol/L O
Plasma O
Carbon O
Dioxide O
28.7 O
( O
23.0-31.9 O
) O
mmol/L O
Plasma O
Anion O
GAP O
9 O
( O
3-15 O
) O
mmol/L O
Phosphorus O
3.7 O
( O
2.6-4.5 O
) O
mg/dl O
Magnesium O
1.6 O
( O
1.4-2.0 O
) O
meq/L O
Plasma O
Urea O
Nitrogen O
9 O
( O
8-25 O
) O
mg/dl O
Plasma O
Creatinine O
0.94 O
( O
0.60-1.50 O
) O
mg/dl O
eGFR O
& O
gt O
; O
60 O
mL/min/1.73m2 O
Plasma O
Glucose O
289 O
H O
( O
70-110 O
) O
mg/dl O
WBC O
8.1 O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
39.3 O
( O
36.0-46.0 O
) O
% O
HGB O
13.8 O
( O
12.0-16.0 O
) O
gm/dl O
RBC O
4.31 O
( O
4.00-5.20 O
) O
mil/cmm O
PLT O
281 O
( O
150-400 O
) O
th/cumm O
MCV O
91 O
( O
80-100 O
) O
fl O
MCH O
31.9 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
35.0 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
15.6 O
H O
( O
11.5-14.5 O
) O
% O
PT O
15.8 O
H O
( O
10.3-13.2 O
) O
sec O
PT-INR O
1.4 O
APTT O
28.3 O
( O
22.1-34.0 O
) O
sec O
UA-Color O
Yellow O
( O
YELLOW O
) O
UA-Turbidity O
Clear O
( O
CLEAR O
) O
UA-Glucose O
2+ O
( O
NEG O
) O
UA-Bili O
NEGATIVE O
( O
NEG O
) O
UA-Ketones O
NEGATIVE O
( O
NEG O
) O
UA-Specific O
Gravity O
1.005 O
( O
1.001-1.035 O
) O
UA-Occult O
Blood O
NEGATIVE O
( O
NEG O
) O
UA-pH O
5.0 O
( O
5.0-9.0 O
) O
UA-Albumin O
NEGATIVE O
( O
NEG O
) O
UA-Urobilinogen O
NEGATIVE O
( O
NEG O
) O
UA-Nitrite O
NEGATIVE O
( O
NEG O
) O
UA-WBC O
Screen O
NEGATIVE O
( O
NEG O
) O
Imaging O
: O
CXR O
8/02 I-DATE
: O
clear O
lungs O
Arterial O
LENI O
( O
7/17/65 I-DATE
) O
: O
1 O
. O
 
Critical O
peripheral O
arterial O
disease O
in O
the O
right O
leg O
at O
rest O
. O
 
2 O
. O
 
Disease O
is O
located O
in O
the O
aorto-iliac O
, O
femoral O
and O
popliteal O
segments O
on O
the O
right O
side O
. O
 
3 O
. O
 
Mild O
peripheral O
arterial O
disease O
in O
the O
left O
leg O
at O
rest O
. O
 
4 O
. O
 
Disease O
is O
located O
in O
the O
aorto-iliac O
and O
tibial/peroneal O
segments O
on O
the O
left O
side O
. O
 
5 O
. O
 
There O
has O
been O
a O
significant O
drop O
in O
the O
ankle/brachial O
index O
in O
the O
right O
leg O
since O
the O
last O
exam O
, O
from O
0.77 O
to O
0.26 O
. O
 
6 O
. O
 
Occlusion O
of O
the O
right O
femoral O
to O
popliteal O
PTFE O
bypass O
graft O
. O
 
Assessment O
: O
The O
patient O
is O
a O
53 I-AGE
year O
old O
woman O
with O
a O
past O
medical O
history O
of O
diabetes O
, O
HTN O
, O
and O
PVD O
s/p O
L O
fem-pop O
BPG O
with O
in-situ O
vein O
2063 I-DATE
, O
R O
fem O
to O
AK O
pop O
BPG O
with O
GSV O
2063 I-DATE
, O
R O
fem-BK O
pop O
BPG O
with O
propatent O
graft O
9/17/64 I-DATE
, O
and O
multiple O
attempts O
at O
angiographic O
intervention O
who O
presents O
with O
worsening O
rest O
pain O
in O
the O
R O
leg O
X O
1 O
month O
. O
 
Given O
her O
progressive O
pain O
, O
worsening O
PVRs O
, O
and O
thrombosed O
BPG O
, O
she O
will O
go O
to O
the O
OR O
8/03 I-DATE
for O
fem-pop O
thrombectomy O
, O
possible O
fem-fem O
bypass O
graft O
, O
and O
angiogram O
with O
possible O
angioplasty/stent O
. O
 
Plan O
: O
-Admit O
to O
Vascular O
Surgery O
, O
attending O
Dr. O
Iyer I-NAME
-Labs O
, O
EKG O
, O
CXR O
-Hold O
Coumadin O
, O
continue O
aspirin/plavix O
, O
begin O
heparin O
drip O
at O
500 O
Units/hr O
, O
with O
sliding O
scale O
and O
target O
PTT O
40-60 O
-Hold O
heparin O
drip O
on O
call O
to O
OR O
-NPO O
p O
midnight O
, O
IV O
fluids O
-Consent O
obtained O
and O
placed O
in O
chart O
Case O
discussed O
with O
Dr. O
David I-NAME
Wade I-NAME
, O
Vascular O
Fellow O
Francis I-NAME
D. I-NAME
Link I-NAME
ATCH I-LOCATION
Surgery O
Pager O
40232 I-CONTACT
 
Record O
date O
: O
2062-09-18 I-DATE
Tammy I-NAME
Umphrey I-NAME
PDI I-LOCATION
Unit O
No O
: O
094-22-07 I-ID
CLEVELAND I-LOCATION
PUBLIC I-LOCATION
INSTITUTE I-LOCATION
Internal O
Medicine O
Date O
: O
September I-DATE
18 O
, O
2062 I-DATE
MEDICATIONS O
: O
Glynase O
3 O
mg O
q.a.m. O
, O
Glucophage O
500 O
mg O
q.p.m. O
, O
Ultram O
50 O
mg O
b.i.d. O
, O
Synthroid O
? O
 
dose O
q.d. O
, O
Premarin O
0.625 O
mg O
q.d. O
, O
Monopril O
40 O
mg O
q.d. O
, O
Dyazide O
1 O
q.d. O
, O
Neurontin O
300 O
mg O
q.i.d. O
, O
glucosamine O
chondroitin O
, O
vitamin O
E O
400 O
IU O
q.d. O
, O
Citracal O
2 O
q.d. O
, O
Centrum O
Silver O
1 O
q.d O
. O
 
( O
1 O
) O
Diabetes O
mellitus O
: O
Went O
on O
cruise O
. O
 
Ate O
frequently O
but O
watched O
portions O
. O
 
Apparently O
patient O
checks O
blood O
sugars O
between O
3:00 O
and O
3:00 O
and O
when O
she O
has O
shakiness O
. O
 
She O
was O
under O
the O
impression O
that O
after O
lunch O
she O
had O
to O
fast O
for O
three O
hours O
prior O
to O
checking O
sugar O
, O
at O
which O
point O
notes O
low O
blood O
sugars O
in O
the O
50 O
's O
to O
70 O
's O
with O
shakiness O
, O
for O
which O
she O
takes O
a O
handful O
of O
raisins O
. O
 
Generally O
eats O
breakfast O
at O
8:30 O
, O
lunch O
12:00 O
or O
12:30 O
, O
supper O
at O
5:30 O
. O
 
Snacks O
in O
the O
evening O
, O
always O
apple O
and O
yogurt O
. O
 
Most O
recently O
, O
additionally O
popcorn O
and O
saltine O
crackers O
, O
occasional O
pretzels O
. O
 
After O
takes O
raisins O
, O
shakiness O
of O
hypoglycemic O
symptoms O
resolve O
. O
 
While O
on O
cruise O
, O
patient O
found O
that O
she O
could O
actually O
walk O
more O
than O
she O
thought O
she O
could O
. O
 
Since O
she O
has O
been O
home O
, O
has O
not O
been O
walking O
routinely O
. O
 
( O
2 O
) O
HTN O
: O
No O
chest O
pain O
, O
shortness O
of O
breath O
or O
palpitations O
. O
 
( O
3 O
) O
Back O
pain/lower O
extremity O
pain O
. O
 
States O
taking O
glucosamine O
chondroitin O
. O
 
Over O
the O
last O
two O
or O
three O
months O
, O
feels O
that O
it O
is O
helping O
with O
decreased O
pain O
. O
 
Also O
has O
been O
seen O
at O
physical O
therapy O
again O
. O
 
Feels O
that O
this O
is O
helping O
. O
 
PE O
: O
Weight O
down O
2 O
pounds O
! O
. O
 
Blood O
pressure O
, O
right O
arm O
: O
126/68 O
. O
 
Chest O
is O
clear O
. O
 
Cardiac O
: O
Regular O
rhythm O
at O
66 O
, O
no O
murmur O
or O
gallop O
. O
 
A/P O
: O
( O
1 O
) O
Diabetes O
mellitus O
: O
Somewhat O
better O
control O
with O
mildly O
elevated O
morning O
sugars O
. O
 
Have O
asked O
patient O
to O
decrease O
popcorn O
and/or O
crackers O
at O
h.s O
. O
 
Have O
advised O
patient O
to O
take O
small O
handful O
of O
raisins O
prior O
to O
onset O
of O
hypoglycemic O
symptoms O
advised O
around O
2:00 O
to O
2:30 O
p.m. O
Have O
encouraged O
patient O
to O
continue O
to O
walk O
daily O
. O
 
Continue O
current O
treatment O
. O
 
( O
2 O
) O
Back O
pain/lower O
extremity O
pain O
: O
Some O
improvement O
with O
PT O
and O
increased O
med O
. O
 
Continue O
for O
now O
. O
 
( O
3 O
) O
HTN O
: O
At O
goal O
. O
 
Return O
to O
clinic O
at O
the O
beginning O
of O
November I-DATE
to O
Dr. O
Ullom I-NAME
to O
resume O
care O
. O
 
Kathleen I-NAME
L I-NAME
Kuhn I-NAME
, O
RNC O
, O
ANP O
KL/utz/orton O
 
Record O
date O
: O
2063-12-13 I-DATE
NAME O
: O
Umphrey O
, O
Tammy I-NAME
MRN O
: O
0942207 I-ID
The O
patient O
is O
here O
as O
a O
walk-in O
. O
 
Her O
spouse O
is O
present O
. O
 
Patient O
says O
she O
is O
status O
post O
a O
fall O
this O
past O
Monday I-DATE
at O
home O
. O
 
Says O
that O
she O
seems O
to O
have O
lost O
her O
balance O
while O
opening O
a O
door O
at O
home O
. O
 
Denies O
prodromal O
symptoms O
including O
shortness O
of O
breath O
, O
dizziness O
, O
or O
palpitations O
. O
 
There O
was O
no O
loss O
of O
consciousness O
. O
 
Patient O
was O
seen O
in O
the O
emergency O
room O
that O
day O
for O
trauma O
to O
the O
head O
. O
 
Had O
a O
negative O
CT O
of O
her O
head O
and O
had O
an O
x-ray O
of O
her O
pelvis O
, O
as O
she O
complained O
of O
some O
hip O
pain O
. O
 
Both O
studies O
were O
negative O
. O
 
Patient O
was O
then O
sent O
home O
with O
Roxicet O
. O
 
Patient O
was O
seen O
in O
the O
walk-in O
clinic O
at O
CPI I-LOCATION
yesterday O
, O
after O
noticing O
a O
swollen O
tongue O
and O
some O
difficulty O
swallowing O
. O
 
Patient O
was O
immediately O
told O
to O
stop O
both O
her O
Roxicet O
and O
Monopril O
and O
was O
treated O
for O
angioedema O
with O
Zantac O
and O
Claritin O
. O
 
Today O
patient O
has O
no O
further O
throat O
tightness O
or O
tongue O
swelling O
. O
 
She O
is O
, O
however O
, O
uncomfortable O
continuing O
the O
Effexor O
for O
unclear O
reasons O
and O
wants O
to O
stop O
it O
. O
 
Patient O
is O
also O
complaining O
of O
severe O
low O
back O
pain O
, O
which O
she O
says O
has O
persisted O
since O
her O
fall O
on O
Monday I-DATE
. O
 
Did O
not O
have O
an O
x-ray O
of O
the O
area O
. O
 
Says O
it O
is O
very O
painful O
to O
sit O
. O
 
Roxicet O
was O
not O
helping O
. O
 
She O
is O
off O
her O
Ultram O
as O
well O
. O
 
PHYSICAL O
EXAM O
: O
WD/overweight O
female O
in O
NAD O
. O
 
Vital O
signs O
as O
per O
LMR O
, O
WNL O
. O
 
Weight O
213 O
pounds O
. O
 
Lungs O
- O
clear O
bilateral O
breath O
sounds O
. O
 
Cor O
- O
RRR O
, O
S1 O
, O
S2 O
, O
without O
murmur O
or O
S3 O
noted O
. O
 
Back O
- O
slightly O
bent O
gait O
. O
 
Tenderness O
over O
lower O
sacrum O
. O
 
No O
asymmetry O
or O
obvious O
deformity O
. O
 
X-ray O
of O
sacrum O
12/13/63 I-DATE
- O
could O
not O
see O
fracture O
as O
per O
my O
reading O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
( O
1 O
) O
Angioedema O
. O
 
Agree O
that O
most O
likely O
culprits O
are O
Roxicet O
since O
it O
was O
started O
only O
two O
days O
ago O
, O
and O
ACE O
inhibitors O
which O
have O
been O
associated O
with O
angioedema O
. O
 
Currently O
on O
Lopressor O
and O
Dyazide O
, O
patient O
's O
blood O
pressure O
is O
WNL O
. O
 
So O
will O
follow O
for O
now O
. O
 
( O
2 O
) O
Low O
back O
pain O
. O
 
Reviewed O
the O
possibility O
of O
a O
coccygeal O
fracture O
for O
which O
treatment O
would O
not O
be O
any O
different O
than O
pain O
management O
and O
a O
donut O
pillow O
. O
 
Patient O
was O
given O
a O
prescription O
for O
the O
pillow O
. O
 
She O
was O
told O
to O
look O
out O
for O
signs O
of O
nerve O
compression O
and O
to O
go O
to O
the O
ER O
if O
she O
experienced O
any O
perianal O
numbness O
or O
incontinence O
. O
 
Will O
notify O
patient O
by O
phone O
if O
x-ray O
shows O
a O
fracture O
. O
 
( O
3 O
) O
Depression O
. O
 
Did O
not O
feel O
I O
was O
able O
to O
speak O
freely O
in O
front O
of O
the O
patient's O
spouse O
. O
 
Had O
been O
put O
on O
the O
Effexor O
by O
Dr. O
Zeman I-NAME
. O
 
Advised O
patient O
to O
let O
her O
psychiatrist O
know O
that O
we O
are O
tapering O
her O
off O
of O
the O
Effexor O
. O
 
Will O
take O
25 O
mg O
q.o.d O
. O
 
for O
the O
next O
week O
. O
 
( O
4 O
) O
Pain O
control O
. O
 
Will O
switch O
from O
Vicodin O
to O
Vicodin O
ES O
1 O
q O
. O
 
6 O
as O
needed O
. O
 
Knows O
to O
go O
to O
ER O
if O
experiences O
any O
symptoms O
consistent O
with O
angioedema O
. O
 
Return O
to O
clinic O
in O
approximately O
one O
month O
. O
 
Susan I-NAME
Ullom I-NAME
, O
M.D O
. O
 
SU/utz/rankin O
 
Record O
date O
: O
2064-08-28 I-DATE
Patient O
Name O
: O
UMPHREY O
, O
FRANKIE I-NAME
; O
MRN O
: O
0942207 I-ID
Dictated O
on O
: O
08/28/2064 I-DATE
by O
WHITNEY I-NAME
EASTERLING I-NAME
, O
M.D O
. O
 
CHIEF O
COMPLAINT O
: O
Falling O
and O
low O
back O
pain O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
66 I-AGE
year O
old O
, O
right-handed O
female O
whose O
past O
medical O
history O
is O
significant O
for O
status O
post O
laminectomy O
at O
L3 O
to O
L5 O
in O
January I-DATE
of I-DATE
2061 I-DATE
. O
 
The O
patient O
was O
in O
her O
usual O
state O
of I-DATE
health O
with O
some O
residual O
weakness O
from O
the O
stenosis O
and O
occasional O
buckling O
of I-DATE
her O
knees O
without O
loss O
of I-DATE
consciousness O
until O
12/01 I-DATE
when O
she O
fell O
backwards O
. O
 
There O
was O
no O
obvious O
leg O
buckling O
. O
 
She O
said O
she O
just O
came O
off O
balance O
without O
loss O
of I-DATE
consciousness O
or O
dizziness O
or O
preceding O
lightheadedness O
. O
 
Since O
then O
she O
has O
had O
several O
falls O
always O
when O
she O
is O
moving O
. O
 
MEDICATIONS O
: O
Her O
medications O
have O
included O
in O
the O
past O
Motrin O
800 O
t.i.d O
. O
 
without O
significant O
effect O
on O
her O
low O
back O
pain O
. O
 
Ultram O
q.i.d O
. O
 
was O
beneficial O
. O
 
Neurontin O
300 O
q.i.d O
. O
 
which O
was O
also O
beneficial O
without O
side O
effect O
and O
chondroitin O
sulfate O
which O
she O
feels O
has O
been O
very O
helpful O
without O
side O
effect O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
She O
has O
bilateral O
dysesthesias O
, O
left O
sciatica O
to O
her O
ankle O
. O
 
She O
has O
had O
weight O
loss O
without O
fevers O
, O
chills O
or O
night O
sweat O
. O
 
She O
has O
had O
no O
retinopathy O
and O
she O
has O
a O
history O
of I-DATE
reflux O
and O
otherwise O
her O
cardiovascular O
, O
pulmonary O
, O
GI/GU O
and O
musculoskeletal O
review O
of I-DATE
systems O
are O
unremarkable O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Spinal O
stenosis O
with O
a O
laminectomy O
at O
L3 O
, O
4 O
and O
5 O
in O
January I-DATE
of I-DATE
2061 I-DATE
. O
 
She O
has O
had O
left O
knee O
arthroscopy O
. O
 
She O
had O
mild O
spinal O
stenosis O
at O
T12 O
to O
L1 O
, O
severe O
at O
L3/4 O
and O
4/5 O
with O
bilateral O
foraminal O
disease O
. O
 
She O
has O
had O
a O
ten O
year O
history O
of I-DATE
diabetes O
. O
 
She O
has O
hypertension O
and O
hypothyroidism O
. O
 
MEDICATIONS O
: O
Synthroid O
, O
Premarin O
, O
glynase O
, O
glucophage O
, O
metoprolol O
and O
Effexor O
. O
 
ALLERGIES O
: O
No O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
: O
She O
is O
married O
. O
 
No O
history O
of I-DATE
tobacco O
or O
alcohol O
. O
 
FAMILY O
HISTORY O
: O
Positive O
for O
coronary O
artery O
disease O
, O
breast O
cancer O
and O
diabetes O
. O
 
PHYSICAL O
EXAMINATION O
: O
She O
is O
a O
well-appearing O
, O
well-nourished O
, O
66 I-AGE
year O
old O
female O
. O
 
Her O
mental O
state O
examination O
is O
normal O
. O
 
Cranial O
nerves O
II O
through O
XII O
are O
intact O
. O
 
Motor O
strength O
is O
significant O
for O
full O
strength O
in O
the O
upper O
extremities O
as O
well O
as O
the O
lower O
extremities O
. O
 
Sensation O
is O
intact O
to O
all O
modalities O
with O
bilateral O
lower O
extremity O
dysesthesia O
reported O
subjectively O
. O
 
DTR O
's O
are O
symmetric O
with O
downgoing O
toes O
bilaterally O
. O
 
Coordination O
is O
intact O
with O
no O
axial O
or O
appendicular O
ataxia O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
This O
is O
a O
66 I-AGE
year O
old O
right-handed O
female O
with O
history O
of I-DATE
spinal O
stenosis O
status O
post O
decompression O
who O
has O
a O
history O
of I-DATE
falls O
. O
 
We O
will O
obtain O
an O
MRI O
of I-DATE
her O
lumbosacral O
to O
evaluate O
that O
area O
for O
any O
recurrent O
pathology O
or O
new O
changes O
. O
 
For O
her O
radicular O
pain O
will O
increase O
her O
Neurontin O
400 O
q.i.d O
. O
 
We O
would O
like O
to O
obtain O
EMG O
with O
nerve O
conduction O
studies O
of I-DATE
the O
lower O
extremities O
to O
evaluate O
possible O
need O
for O
reoperation O
. O
 
The O
patient O
will O
return O
to O
clinic O
after O
these O
studies O
. O
 
The O
patient O
was O
seen O
and O
evaluated O
and O
management O
was O
discussed O
with O
the O
attending O
. O
 
_______________________________ O
Whitney I-NAME
Easterling I-NAME
, O
M.D O
. O
 
DD:08/28/2064 O
DT:08/29/2064 O
DT:2617 I-ID
:6415 I-ID
 
Record O
date O
: O
2066-08-27 I-DATE
Team O
A O
Intern O
Admit O
Note O
Patient O
Name O
: O
Tammy I-NAME
Umphrey I-NAME
MR O
# O
0942207 I-ID
Date O
of O
Admission O
: O
8/26/66 I-DATE
Attending O
: O
Yoel I-NAME
Pollard I-NAME
PCP O
: O
Susan I-NAME
Ullom I-NAME
CC/ID O
: O
70 I-AGE
yo O
woman O
with O
significant O
disability O
following O
cerebral O
aneurysm O
rupture O
1/ I-DATE
66 I-DATE
, O
admitted O
with O
likely O
UTI O
and O
question O
of O
altered O
mental O
status O
HPI O
: O
( O
As O
summarized O
from O
ED O
admit O
note O
and O
computer O
notes O
, O
pt O
is O
not O
able O
to O
give O
history O
and O
family O
is O
not O
present O
. O
) O
 
Ms. O
Umphrey I-NAME
is O
somewhat O
cognitively O
and O
expressively O
impaired O
following O
rupture O
of O
a O
cerebral O
aneurysm O
1/ I-DATE
66 I-DATE
; O
she O
was O
required O
sub-occipital O
craniotomy O
, O
clot O
evacuation O
, O
and O
placement O
for O
a O
VP O
shunt O
. O
 
She O
was O
transferred O
to O
Kingsley I-LOCATION
County I-LOCATION
Clinic I-LOCATION
2/66 I-DATE
, O
and O
was O
d/c O
'd O
5/31/66 I-DATE
. O
 
Discharge O
summary O
indicates O
that O
her O
baseline O
at O
that O
time O
included O
being O
able O
to O
follow O
1 O
step O
commands O
part O
of O
the O
time O
and O
some O
attempts O
at O
communication O
. O
 
She O
gets O
nutrition O
and O
medication O
through O
a O
G-tube O
at O
this O
point O
, O
and O
has O
had O
an O
indwelling O
foley O
catheter O
. O
 
Computer O
notes O
suggest O
that O
prior O
to O
August I-DATE
5 I-DATE
, O
the O
indwelling O
foley O
catheter O
had O
been O
removed O
. O
 
However O
, O
the O
patient O
's O
constant O
incontinence O
and O
difficulty O
keeping O
a O
decubitus O
ulcer O
dry O
, O
the O
notes O
suggest O
that O
the O
foley O
was O
replaced O
8/5/66 I-DATE
. O
 
8/09/66 I-DATE
Ms. O
Umphrey I-NAME
was O
taken O
to O
the O
emergency O
room O
; O
the O
symptoms O
she O
was O
having O
at O
that O
time O
are O
not O
clear O
. O
 
U/A O
was O
suggestive O
of O
a O
UTI O
, O
and O
she O
was O
treated O
with O
a O
3-day O
course O
of O
levofloxacin O
. O
 
There O
is O
no O
record O
of O
her O
foley O
catheter O
being O
changed O
at O
that O
time O
, O
and O
urine O
cultures O
were O
not O
sent O
. O
 
Telephone O
notes O
from O
8/23 I-DATE
suggest O
that O
Ms. O
Umphrey I-NAME
had O
yeast O
infection O
and O
foley O
blockage O
; O
8/25 I-DATE
the O
VNA O
checked O
a O
U/A O
at O
home O
; O
results O
were O
consistent O
with O
a O
UTI O
. O
 
Her O
husband O
reports O
that O
she O
has O
also O
been O
more O
somnolent O
and O
less O
herself O
over O
the O
last O
few O
days O
. O
 
She O
was O
sent O
to O
the O
PDI I-LOCATION
ED O
for O
further O
evaluation O
. O
 
In O
the O
ED O
, O
repeat O
U/A O
was O
consistent O
with O
UTI O
; O
urine O
culture O
grew O
abundant O
staph O
aureus O
. O
 
She O
was O
given O
a O
dose O
of O
levofloxacin O
500mg O
and O
transferred O
to O
the O
floor O
. O
 
PMH O
: O
( O
Per O
chart- O
pt O
unable O
to O
provide O
history O
) O
1 O
. O
 
S/P O
aneurysm O
rupture O
, O
suboccipital O
craniotomy O
for O
microsurgical O
trapping O
and O
clipping O
of O
distal O
PICA O
aneurysm O
, O
and O
evacuation O
of O
4th O
ventricular O
clot O
. O
 
2 O
. O
 
S/P O
right O
VP O
shunt O
placement O
. O
 
3 O
. O
 
? O
decubitus O
ulcer O
3 O
. O
 
History O
of O
hypothyroidism O
. O
 
4 O
. O
 
Type O
II O
diabetes O
mellitus O
. O
 
5 I-DATE
. O
 
HTN O
6 O
. O
 
Gastritis O
7 O
. O
 
OA O
in O
hips O
bilaterally O
Medications O
: O
Glyburide O
2.5 O
mg O
qd O
Prozac O
30mg O
qd O
Prevacid O
30mg O
qd O
Synthroid O
137 O
mg O
qd O
Cozaar O
25mg O
qd O
Ritalin O
20mg O
8am O
and O
1pm O
Lipitor O
10mg O
qhs O
MVI O
ASA O
81mg O
qd O
Colace O
100mg O
tid O
Allergies O
: O
finosopril O
, O
percocet O
, O
erythromycin O
SH O
: O
Lives O
with O
husband O
, O
who O
sounds O
like O
he O
is O
primary O
caregiver O
. O
 
Has O
VNA O
come O
into O
home O
to O
help O
with O
care O
. O
 
Tob O
: O
unknown O
EtOH O
: O
unknown O
Illicits O
: O
unknown O
FH O
: O
unknown O
Exam O
: O
VS O
: O
T= O
98.6 O
HR= O
80 O
BP= O
129/75 O
RR= O
20 O
SaO2= O
94 O
% O
on O
room O
air O
General O
: O
No O
acute O
distress O
. O
 
Sleepy O
, O
but O
easily O
arousable O
. O
 
HEENT O
: O
PER O
3 O
to O
2 O
bilaterally O
. O
 
Slight O
crusting O
over O
eyelids O
bilaterally O
. O
 
Anicteric O
sclera O
, O
no O
conjunctival O
injection O
. O
 
EOMI O
. O
 
Continuous O
purposeful O
tongue O
movements O
. O
 
Dry O
mucous O
membranes O
, O
but O
pt O
breathes O
solely O
through O
mouth O
. O
 
Skin O
: O
Telangiectasias O
over O
face O
and O
chin O
. O
 
Neck O
: O
Supple O
. O
 
Neck O
plethoric O
; O
difficult O
to O
assess O
JVD O
. O
 
Carotids O
2+ O
bilaterally O
, O
no O
bruits O
. O
 
No O
thyromegaly O
, O
no O
cervical O
adenopathy O
. O
 
Chest O
: O
upper O
airway O
sounds O
, O
otherwise O
CTA O
bilat O
anteriorly O
. O
 
CVS O
: O
Difficult O
to O
distinguish O
over O
upper O
airway O
sounds O
. O
 
Abd O
: O
Obese O
. O
 
Soft O
, O
non-distended O
. O
 
Does O
not O
appear O
to O
be O
tender O
. O
 
Extr O
: O
no O
clubbing O
or O
edema O
bilaterally O
. O
 
Neuro O
: O
Sleeping O
but O
arousable O
, O
follows O
simple O
commands O
, O
but O
not O
able O
to O
answer O
questions O
. O
 
Good O
hand O
squeeze O
bilaterally O
. O
 
DTRs O
difficult O
to O
elicit O
in O
arms O
, O
2+ O
in O
patellae O
bilaterally O
. O
 
DATA O
Chemistry O
: O
Plasma O
Sodium O
126 O
L O
( O
135-145 O
) O
mmol/L O
Plasma O
Potassium O
4.0 O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
89 O
L O
( O
100-108 O
) O
mmol/L O
Plasma O
Carbon O
Dioxide O
27.1 O
( O
23.0-31.9 O
) O
mmol/L O
Calcium O
10.1 O
( O
8.5-10.5 O
) O
mg/dl O
Plasma O
Urea O
Nitrogen O
14 O
( O
8-25 O
) O
mg/dl O
Plasma O
Creatinine O
0.6 O
( O
0.6-1.5 O
) O
mg/dl O
Plasma O
Glucose O
101 O
( O
70-110 O
) O
mg/dl O
Heme O
: O
WBC O
11.5 O
H O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
38.2 O
( O
36.0-46.0 O
) O
% O
HGB O
13.5 O
( O
12.0-16.0 O
) O
gm/dl O
RBC O
4.53 O
( O
4.00-5.20 O
) O
mil/cmm O
PLT O
474 O
H O
( O
150-350 O
) O
th/cumm O
MCV O
84 O
( O
80-100 O
) O
fl O
MCH O
29.9 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
35.4 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
15.8 O
H O
( O
11.5-14.5 O
) O
% O
DIFFERENTIAL O
REQUEST O
RECEIVED O
Diff O
Method O
Automated O
with O
manual O
review O
Poly O
81 O
H O
( O
40-70 O
) O
% O
Lymphs O
11 O
L O
( O
22-44 O
) O
% O
Monos O
5 I-DATE
( O
4-11 O
) O
% O
EOS O
3 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
Urinalysis O
: O
UA-Color O
Yellow O
( O
YELLOW O
) O
UA-Turbidity O
SLIGHT O
( O
CLEAR O
) O
UA-Specific O
Gravity O
1.010 O
( O
1.005-1.035 O
) O
UA-pH O
7.5 O
( O
5.0-8.5 O
) O
UA-WBC O
Screen O
3+ O
( O
NEG O
) O
UA-Nitrite O
POSITIVE O
( O
NEG O
) O
UA-Albumin O
Trace O
( O
NEG O
) O
UA-Glucose O
NEGATIVE O
( O
NEG O
) O
UA-Ketones O
NEGATIVE O
( O
NEG O
) O
UA-Urobilinogen O
NEGATIVE O
( O
NEG O
) O
UA-Bili O
NEGATIVE O
( O
NEG O
) O
UA-Occult O
Blood O
Trace O
( O
NEG O
) O
UA-SED-WBC O
20-50 O
/hpf O
UA-SED-RBC O
0-2 O
/hpf O
UA-SED-Bacteria O
Many O
/hpf O
UA-SED-Bladder O
Cells O
Few O
/hpf O
UA-SED-Amorphous O
Crystals O
Many O
/hpf O
Microbiology O
: O
CXR O
: O
The O
findings O
are O
consistent O
with O
pulmonary O
venous O
hypertension O
with O
possible O
early O
interstitial O
edema O
. O
 
Head O
CT O
: O
1 O
. O
 
No O
significant O
change O
compared O
to O
prior O
CT O
Brain-04/18/2066 O
. O
 
No O
change O
in O
ventricle O
size O
. O
 
No O
acute O
infarct O
; O
although O
, O
this O
is O
better O
assessed O
with O
MR O
with O
diffusion O
. O
 
2 O
. O
 
Patchy O
low O
attenuation O
areas O
in O
the O
centrum O
semiovale O
bilaterally O
which O
are O
more O
prominent O
now O
and O
most O
likely O
are O
due O
to O
chronic O
microangiopathic O
changes O
in O
this O
agroup O
. O
 
EKG O
: O
Normal O
sinus O
rhythm O
, O
normal O
axis O
, O
normal O
intervals O
. O
 
Flattened O
T-waves O
, O
but O
not O
changed O
from O
prior O
exam O
. O
 
No O
evidence O
of O
acute O
ischemia O
. O
 
Impression O
: O
70 I-AGE
yo O
woman O
with O
compromised O
baseline O
neurologic O
function O
, O
admitted O
with O
complicated O
UTI O
and O
possible O
change O
in O
mental O
status O
. O
 
Mental O
status O
changes O
: O
given O
likely O
undertreated O
UTI O
8/09/66 I-DATE
, O
pt O
likely O
has O
recurrent O
complicated O
UTI O
and O
may O
have O
some O
mental O
status O
alterations O
from O
this O
source O
. O
 
Important O
to O
rule O
out O
VP-shunt O
complication O
as O
cause O
of O
mental O
status O
chage O
, O
but O
CT O
appears O
unchanged O
from O
4/66 I-DATE
. O
 
Hyponatremia O
may O
also O
be O
contributing O
somewhat O
to O
mental O
status O
changes O
. O
 
-will O
treat O
UTI O
and O
pursue O
possibility O
of O
urosepsis O
with O
blood O
cultures O
-will O
check O
TSH O
and O
am O
cortisol O
which O
could O
also O
contribute O
to O
mental O
status O
changes O
, O
particularly O
given O
pts O
history O
of O
hypothyroidism O
UTI O
-likely O
UTI- O
tx O
-will O
send O
blood O
cultures O
to O
assess O
for O
sepsis O
from O
urinary O
source O
-unclear O
if O
staph O
aureus O
is O
true O
urinary O
pathogen O
, O
but O
will O
treat O
with O
vancomycin O
until O
sensitivities O
come O
back O
, O
then O
treat O
with O
appropriate O
antibiotic O
-treat O
with O
levoquin O
for O
complicated O
UTI O
while O
awaiting O
final O
microbiology O
data O
-change O
foley O
now O
-resend O
u/a O
and O
culture O
after O
1-2 O
days O
of O
antibiotics O
Hyponatremia- O
may O
be O
contributing O
to O
any O
change O
in O
mental O
status O
-volume O
status O
very O
difficult O
to O
assess- O
if O
hypovolemic O
, O
likely O
hypovolemic O
hyponatremia O
. O
 
If O
euvolemic O
, O
likely O
SIADH O
, O
which O
could O
be O
caused O
by O
neurologic O
process O
, O
pain O
, O
or O
infection O
-given O
difficulty O
assessing O
volume O
status O
, O
will O
send O
urine O
for O
sodium O
and O
osm O
. O
 
If O
low O
sodium O
high O
osm O
, O
likely O
hypovolemic O
. O
 
If O
higher O
sodium O
, O
more O
likely O
SIADH O
. O
 
DM O
-will O
switch O
patient O
to O
ISS O
for O
now O
to O
assess O
in-hospital O
insulin O
requirements O
Hypothyroidism- O
continue O
levothyroxine O
at O
home O
dose O
, O
checking O
TSH O
GI/FEN- O
ranitidine O
BID O
, O
glucerna O
tube O
feeds O
per O
KCC I-LOCATION
discharge O
summary O
HTN-continue O
home O
medications O
wound O
care O
consult O
requested O
for O
report O
of O
decubitus O
ulcer O
_________________________________ O
Wendy I-NAME
Randolph I-NAME
MD O
# O
61504 I-CONTACT
 
Record O
date O
: O
2067-02-12 I-DATE
teaM O
B O
Intern O
Admit O
Note O
Pt O
: O
Umphrey O
, O
Tammy O
MR O
# O
: O
0942207 I-ID
Date O
of O
Admission O
: O
2/11/67 I-DATE
Attending O
: O
PCP O
Dr. O
Baird I-NAME
( O
Cleveland I-LOCATION
Public I-LOCATION
Institute I-LOCATION
) O
Source O
: O
Chart O
and O
Pt O
. O
 
's O
husband O
- O
Pt O
is O
non-verbal O
HPI O
: O
70yo O
F O
PMH O
of O
DM O
, O
CHF O
, O
bullous O
pemphigoid O
and O
HTN O
, O
s/p O
intracranial O
aneurysm O
rupture O
1/66 I-DATE
, O
s/p O
VP O
shunt O
placement O
. O
 
Pt O
. O
 
is O
minimally O
responsive O
at O
baseline O
, O
cared O
for O
at O
home O
by O
her O
husband O
with O
the O
assistence O
of O
VNA O
. O
 
She O
is O
s/p O
suprapubic O
catheter O
placement O
by O
IR O
on O
2/4/2067 I-DATE
. O
 
She O
was O
discharged O
from O
PDI I-LOCATION
on O
2/09/2067 I-DATE
after O
an O
admission O
for O
occlusion O
of O
her O
superpublic O
catheter O
. O
 
She O
represents O
to O
the O
ED O
today O
after O
her O
husband O
, O
who O
is O
the O
primary O
care O
giver O
noted O
on O
the O
morning O
of O
admit O
that O
the O
catheter O
was O
not O
draining O
, O
but O
the O
pt O
. O
 
was O
incont O
. O
 
Of O
urine O
. O
 
He O
attempted O
to O
flush O
the O
catheter O
and O
was O
unable O
to O
. O
 
VNA O
was O
called O
and O
also O
attempted O
to O
flush O
the O
catheter O
. O
 
The O
VNA O
nurse O
noted O
that O
it O
was O
possible O
to O
instill O
water O
, O
but O
not O
possible O
to O
draw O
any O
back O
. O
 
VNA O
contacted O
the O
pts O
. O
 
PCP O
and O
IR O
, O
who O
placed O
the O
catheter O
on O
her O
previous O
admit O
, O
and O
the O
pt O
. O
 
was O
brought O
to O
the O
ED O
. O
 
PMH O
: O
1. O
s/p O
IC O
aneurysm O
rupture O
1/66 I-DATE
2 O
. O
 
Bullous O
pemphigoid O
-biopsy O
proven O
2/67 I-DATE
3 O
. O
 
DM2 O
4 O
. O
 
HTN O
5. O
gastritis O
6 O
. O
 
UTI O
7. O
s/p O
G O
tube O
placement O
8 O
. O
 
SIADH O
9 O
. O
 
Aspiration O
PNA O
- O
To O
complete O
course O
of O
Cefpodoxime/Ceftriaxonew O
2/16 I-DATE
Meds O
: O
Asa O
( O
CHILDRENS O
) O
81MG O
PO O
QD O
Mvi O
ELIXIR O
( O
MULTIVITAMIN O
SOLUTION O
) O
5 O
ML O
PO O
QD O
Colace O
( O
DOCUSATE O
SODIUM O
) O
100 O
MG O
( O
100MG O
TABLET O
take O
1 O
) O
PO O
TID O
Synthroid O
( O
LEVOTHYROXINE O
SODIUM O
) O
137MCG O
TABLET O
PO O
QD O
Fluoxetine O
HCL O
20MG O
CAPSULE O
take O
1 O
Capsule O
( O
s O
) O
PO O
QD O
Prevacid O
( O
LANSOPRAZOLE O
) O
30MG O
SUSPDR O
REC O
JTUBE O
QD O
Cozaar O
( O
LOSARTAN O
) O
25 O
MG O
( O
25MG O
TABLET O
take O
1 O
) O
PO O
BID O
Ritalin O
( O
METHYLPHENIDATE O
HCL O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
BID O
Lipitor O
( O
ATORVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
Ascorbic O
ACID O
1000 O
MG O
( O
500MG/5ML O
SYRUP O
take O
10 O
ML O
) O
PO O
BID O
Glyburide O
2.5 O
MG O
( O
5MG O
TABLET O
take O
1 O
) O
PO O
QD O
Cefpodoxime O
200 O
mg O
bid O
x O
4 O
more O
days O
Allergies O
: O
Fosinopril O
Sodium O
- O
Angiodema O
, O
tongue O
swelling O
, O
PERCOCET O
- O
Angiodema O
, O
Erythromycins O
- O
SOB O
levaquin O
- O
Rash O
SH O
: O
Pt O
. O
 
cared O
for O
at O
home O
by O
husband O
with O
VNA O
. O
 
Minimally O
responsive O
at O
baseline O
. O
 
ROS O
: O
Bullous O
lesion O
, O
worst O
along O
left O
flank O
. O
 
Exam O
: O
VS O
: O
BP O
118/74 O
P O
80 O
T O
97.0 O
RR O
18 O
98 O
% O
RA O
GEN O
: O
awake O
, O
responds O
to O
voice O
. O
 
HEENT O
: O
PERRLA O
, O
supple O
, O
no O
LAD O
Lungs O
: O
CTAB O
- O
anterior O
Cor O
: O
RRR O
, O
no O
mumurs O
, O
rubs O
, O
gallops O
Abd O
: O
Soft O
non-tender O
. O
 
BS O
+ O
Extr O
: O
Scattered O
bullae O
on O
b/l O
lower O
extremities O
. O
 
NO O
decbus O
. O
 
PPP O
. O
 
Neuro O
: O
. O
 
Opens O
eyes O
to O
voice O
, O
some O
rigidity O
upper O
and O
lower O
extremities O
. O
 
GU O
: O
Superpubic O
tube O
in O
place O
, O
site O
clean O
with O
min O
. O
 
erythema O
, O
no O
discharge O
, O
Scant O
drainage O
in O
bag O
. O
 
Foley O
in O
place O
draining O
clear O
urine O
. O
 
Labs O
: O
Hematology O
Detail O
for O
UMPHREY O
, O
TAMMY I-NAME
U I-NAME
PDI I-LOCATION
RANDOM O
12-Feb-2067 I-DATE
00:27 O
Accession O
# O
8859J84563 I-ID
Test O
Description O
Result O
Flags O
Ref O
. O
 
Range O
Units O
UA-Color O
Yellow O
( O
YELLOW O
) O
UA-Turbidity O
Clear O
( O
CLEAR O
) O
UA-Glucose O
NEGATIVE O
( O
NEG O
) O
UA-Bili O
NEGATIVE O
( O
NEG O
) O
UA-Ketones O
NEGATIVE O
( O
NEG O
) O
UA-Specific O
Gravity O
1.020 O
( O
1.001-1.035 O
) O
UA-Occult O
Blood O
NEGATIVE O
( O
NEG O
) O
UA-pH O
5.5 O
( O
5.0-9.0 O
) O
UA-Albumin O
NEGATIVE O
( O
NEG O
) O
UA-Urobilinogen O
NEGATIVE O
( O
NEG O
) O
UA-Nitrite O
NEGATIVE O
( O
NEG O
) O
UA-WBC O
Screen O
2+ O
( O
NEG O
) O
UA-SED-RBC O
0-2 O
( O
0-2 O
) O
/hpf O
UA-SED-WBC O
20-50 O
( O
0-2 O
) O
/hpf O
UA-SED-Bacteria O
Few O
( O
NEG O
) O
/hpf O
Hyaline O
Cast O
5-10 O
( O
0-5 O
) O
/lpf O
Squamous O
Cells O
Few O
( O
NEG O
) O
/hpf O
_____________________________________________________________________________________ O
A/P O
: O
70 I-AGE
year O
old O
woman O
s/p O
IC O
aneurysm O
rupture O
, O
now O
with O
minimally O
responsive O
state O
, O
presents O
with O
occluded O
superpublic O
cathere O
. O
 
1 O
) O
GU O
- O
Foley O
placed O
in O
ED O
. O
 
Will O
send O
UA/Culture O
. O
 
Contact O
IR O
for O
revision O
of O
tube O
given O
2nd O
admission O
this O
month O
for O
occlusion O
. O
 
2 O
) O
ID O
- O
completing O
course O
of O
cefpodoxime O
for O
aspiration O
pna O
3 O
) O
F/E/N O
- O
Nocturnal O
tube O
feeds O
, O
as O
per O
home O
program O
4 O
) O
HTN O
Cozaar O
, O
as O
per O
home O
regimen O
5 O
) O
ENDO O
- O
RISS O
, O
cont O
. O
 
glyburide O
. O
 
6 O
) O
Prophy O
- O
Nexium O
, O
fragmin O
_______________________________ O
G. I-NAME
George I-NAME
Vetter I-NAME
, O
MD O
Pager O
# O
05967 I-CONTACT
 
Record O
date O
: O
2091-12-28 I-DATE
December I-DATE
28 O
, O
2091 I-DATE
Nikkolas I-NAME
Nancy-Jasmine I-NAME
693-31-18-1 I-ID
I O
saw O
Nikkolas I-NAME
Nancy-Jasmine I-NAME
today O
for O
evaluation O
concerning O
his O
stroke O
in O
August I-DATE
2091 I-DATE
. O
 
The O
information O
available O
today O
is O
limited O
to O
his O
knowledge O
of O
the O
events O
. O
 
He O
is O
an O
67-year-old O
Honduran I-LOCATION
man O
with O
a O
history O
of O
diabetes O
mellitus O
and O
HTN O
. O
 
In O
August I-DATE
he O
suffered O
a O
stroke O
. O
 
He O
reports O
that O
his O
speech O
was O
affected O
and O
that O
he O
developed O
severe O
right O
arm O
and O
leg O
weakness O
without O
sensory O
loss O
. O
 
He O
recalls O
no O
problem O
with O
his O
vision O
. O
 
He O
was O
hospitalized O
at O
Dubuque I-LOCATION
Obstetrics I-LOCATION
Gynocology I-LOCATION
Center I-LOCATION
. O
 
He O
does O
no O
know O
the O
extent O
of O
the O
evaluation O
. O
 
He O
was O
discharged O
on O
aspirin O
to O
Mitchell I-LOCATION
County I-LOCATION
Hospital I-LOCATION
. O
 
He O
is O
now O
living O
at O
home O
with O
his O
wife O
and O
son O
with O
visiting O
nurse O
assistance O
. O
 
His O
primary O
care O
physician O
is O
at O
Flagler I-LOCATION
Hospital I-LOCATION
. O
 
He O
has O
severe O
residual O
weakness O
of O
the O
right O
arm O
and O
leg O
. O
 
He O
also O
complains O
of O
dizziness O
and O
an O
abnormal O
numbness O
in O
his O
mouth O
. O
 
The O
dizziness O
is O
worst O
in O
the O
morning O
. O
 
He O
also O
notices O
a O
noise O
in O
his O
head O
when O
he O
sleeps O
. O
 
He O
has O
DM O
and O
HTN O
. O
 
He O
is O
a O
nonsmoker O
. O
 
I O
do O
n't O
have O
cholesterol O
information O
. O
 
There O
is O
no O
history O
of O
cardiac O
disease O
. O
 
There O
is O
no O
history O
of O
alcohol O
abuse O
. O
 
He O
is O
currently O
taking O
aspirin O
, O
insulin O
, O
antihypertensive O
medication O
of O
some O
type O
and O
possibly O
a O
cholesterol O
lowering O
agent O
, O
although O
he O
is O
no O
sure O
of O
this O
. O
 
He O
has O
no O
known O
allergies O
. O
 
He O
is O
aware O
of O
no O
significant O
family O
history O
. O
 
He O
is O
married O
. O
 
He O
lives O
with O
his O
wife O
and O
22-year-old O
son O
. O
 
He O
came O
to O
america I-LOCATION
from O
Honduras I-LOCATION
in O
2073 I-DATE
. O
 
He O
worked O
nights O
in O
construction I-PROFESSION
until O
his O
stroke O
. O
 
Pulse O
66 O
, O
regular O
. O
 
BP O
186/110 O
. O
 
There O
are O
no O
cranial O
bruits O
. O
 
The O
carotid O
pulses O
are O
full O
with O
no O
bruits O
. O
 
The O
lungs O
are O
clear O
. O
 
The O
heart O
is O
regular O
with O
no O
murmur O
. O
 
The O
abdomen O
is O
benign O
. O
 
The O
mental O
state O
is O
normal O
; O
he O
speaks O
Spanish I-LOCATION
and O
broken O
English O
. O
 
He O
is O
able O
to O
name O
, O
repeat O
, O
and O
comprehend O
well O
. O
 
His O
fluency O
in O
his O
native O
language O
is O
probably O
normal O
. O
 
Cranial O
nerves O
are O
intact O
. O
 
There O
is O
severe O
weakness O
of O
the O
right O
arm O
and O
leg O
: O
right O
interossei O
and O
finger O
flexors O
1/5 O
, O
finger O
extensors O
0/5 O
, O
biceps O
1/5 O
, O
triceps O
0-1/5 O
, O
deltoid O
0-1/5 O
. O
 
( O
He O
tries O
to O
raise O
his O
arm O
proximally O
by O
elevating O
the O
shoulder O
. O
) O
 
Right O
iliopsoas O
2/5 O
, O
quadriceps O
2/5 O
, O
hamstrings O
1/5 O
, O
distally O
0/5 O
. O
 
The O
tone O
is O
only O
mildly O
increased O
. O
 
Sensation O
is O
intact O
. O
 
Reflexes O
are O
slghtly O
brisker O
in O
the O
right O
upper O
extremity O
( O
RUE O
2+/4 O
, O
LUE O
2/4 O
, O
knees O
2+/4 O
, O
ankles O
2/4 O
) O
. O
 
The O
right O
plantar O
response O
is O
mute O
; O
he O
withdraws O
the O
left O
. O
 
Coordination O
is O
intact O
; O
weakness O
inhibits O
adequate O
testing O
on O
the O
right O
. O
 
He O
wears O
a O
right O
AFO O
. O
 
He O
can O
stand O
up O
from O
his O
wheelchair O
and O
bear O
weight O
maneuvering O
himself O
to O
the O
examining O
table O
, O
but O
he O
can O
not O
walk O
unsupported O
. O
 
His O
examination O
is O
most O
consistent O
with O
a O
right O
equal O
arm O
and O
leg O
pure O
motor O
hemiparesis O
, O
sparing O
the O
face O
. O
 
This O
was O
likely O
due O
to O
a O
lacunar O
infarction O
in O
the O
left O
basis O
pontis O
from O
small O
vessel O
occlusion O
. O
 
He O
has O
major O
stroke O
risk O
factors O
, O
including O
DM O
, O
HTN O
, O
and O
probably O
hypercholesterolemia O
. O
 
Currently O
his O
major O
needs O
are O
to O
establish O
good O
control O
of O
his O
blood O
pressure O
and O
to O
control O
other O
risk O
factors O
, O
including O
optimtal O
glucose O
control O
and O
likely O
medication O
for O
hyperlipidemia O
, O
and O
to O
continue O
physical O
and O
occupational O
therapy O
to O
maximize O
his O
functional O
status O
. O
 
To O
review O
the O
studies O
that O
were O
done O
to O
investigate O
his O
stroke O
in O
August I-DATE
, O
I O
will O
request O
the O
record O
of O
that O
hospitalization O
from O
DOGC I-LOCATION
. O
 
I O
will O
also O
request O
his O
records O
from O
his O
physician O
at O
the O
Flagler I-LOCATION
Hospital I-LOCATION
. O
 
He O
will O
certainly O
need O
an O
adjustment O
of O
his O
antihypertensive O
regimen O
. O
 
He O
tells O
me O
that O
he O
is O
planning O
to O
see O
his O
PCP O
for O
this O
purpose O
. O
 
I O
asked O
him O
to O
return O
here O
in O
a O
month O
to O
review O
this O
. O
 
Sincerely O
, O
Patrick I-NAME
Winn I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2092-05-24 I-DATE
BAYONNE I-LOCATION
MEDICAL I-LOCATION
CENTER I-LOCATION
Internal O
Medicine O
15 I-LOCATION
Hassell I-LOCATION
Brook I-LOCATION
Road I-LOCATION
Daytona I-LOCATION
Highridge I-LOCATION
Estates I-LOCATION
, O
AZ I-LOCATION
39757 I-LOCATION
Nancy-Jasmine O
, O
Nikkolas I-NAME
69331181 I-ID
05/24/92 I-DATE
The O
patient O
is O
a O
67-year-old O
man O
with O
hypertension O
, O
diabetes O
, O
and O
history O
of O
recent O
stroke O
who O
comes O
in O
for O
follow O
up O
and O
for O
evaluation O
of O
positive O
PPD O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
He O
was O
being O
evaluated O
for O
day O
program O
and O
in O
the O
course O
of O
this O
had O
a O
PPD O
placed O
which O
was O
positive O
. O
 
He O
has O
no O
history O
of O
prior O
TB O
testing O
. O
 
He O
has O
had O
no O
chest O
pain O
, O
shortness O
of O
breath O
, O
cough O
, O
fever O
, O
chills O
, O
weight O
loss O
or O
night O
sweats O
. O
 
He O
has O
had O
no O
known O
exposure O
to O
TB O
. O
 
He O
is O
being O
treated O
for O
hypertension O
which O
has O
been O
difficult O
to O
control O
but O
seems O
recently O
to O
be O
doing O
quite O
well O
on O
a O
combination O
of O
HCTZ O
12.5mg O
, O
metoprolol O
50mg O
b.i.d. O
, O
Norvasc O
10mg O
PO O
q.d. O
, O
Zestril O
20mg O
PO O
q.d O
. O
 
Today O
's O
blood O
pressure O
was O
terrific O
at O
128/70 O
. O
 
He O
has O
diabetes O
and O
his O
hemoglobin O
A1C O
came O
down O
from O
10.4 O
in O
February I-DATE
to O
7.9 O
in O
May I-DATE
. O
 
He O
had O
been O
started O
in O
February I-DATE
on O
Glucophage O
500mg O
PO O
b.i.d O
. O
 
and O
seems O
to O
e O
tolerating O
it O
quite O
well O
. O
 
He O
did O
have O
a O
stroke O
in O
August I-DATE
2091 I-DATE
with O
right-sided O
hemiparesis O
. O
 
He O
is O
able O
to O
walk O
to O
the O
bathroom O
with O
a O
cane O
but O
otherwise O
uses O
a O
wheelchair O
. O
 
He O
had O
a O
form O
for O
me O
to O
complete O
for O
a O
day O
program O
listing O
his O
typical O
functioning O
. O
 
PHYSICAL O
EXAMINATION O
: O
He O
is O
a O
well-developed O
, O
well-nourished O
, O
pleasant O
man O
. O
 
Weight O
was O
not O
done O
. O
 
Blood O
pressure O
128/70 O
. O
 
HEENT O
: O
throat O
clear O
. O
 
Neck O
supple O
, O
no O
adenopathy O
or O
thyromegaly O
. O
 
No O
carotid O
bruits O
. O
 
No O
JVD O
. O
 
Heart O
: O
no O
murmurs O
. O
 
Lungs O
are O
clear O
. O
 
Extremities O
: O
no O
edema O
. O
 
Neuro O
: O
he O
has O
weakness O
in O
the O
right O
leg O
and O
arm O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
1 O
. O
 
Positive O
PPD O
. O
 
At O
the O
time O
of O
this O
dictation O
, O
his O
chest O
x-ray O
came O
back O
and O
is O
completely O
normal O
. O
 
Given O
his O
age O
and O
unknown O
duration O
of O
his O
positive O
PPD O
, O
will O
not O
treat O
. O
 
2 O
. O
 
Hypertension O
. O
 
Doing O
well O
on O
current O
combination O
of O
medications O
. O
 
3 O
. O
 
Diabetes O
, O
doing O
much O
better O
since O
he O
started O
Glucophage O
. O
 
At O
his O
next O
visit O
, O
I O
will O
need O
to O
confirm O
when O
his O
last O
eye O
appointment O
was O
. O
 
4 O
. O
 
Status O
post O
CVA O
. O
 
He O
seems O
to O
be O
functioning O
well O
. O
 
Nena I-NAME
Quiambao I-NAME
, O
M.D O
. O
 
NQ I-NAME
: O
jaeger I-NAME
; O
80-55488880.doc O
; O
DD O
: O
5/27/92 I-DATE
; O
DT O
: O
5/28/92 I-DATE
; O
DV O
: O
5/24/92 I-DATE
 
Record O
date O
: O
2093-04-28 I-DATE
BMC I-LOCATION
EMERGENCY O
DEPT O
VISIT O
NANCY-JASMINE O
, O
NIKKOLAS O
693-31-18-1 I-ID
VISIT O
DATE O
: O
04/28/93 I-DATE
The O
patient O
was O
seen O
, O
interviewed O
and O
examined O
by O
myself O
as O
well O
as O
Dr. O
Judd I-NAME
whose O
note O
I O
have O
reviewed O
, O
and O
whose O
findings O
I O
have O
confirmed O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
This O
patient O
is O
a O
68 I-AGE
year-old O
male O
who O
presents O
with O
slurred O
speech O
. O
 
The O
patient O
has O
a O
history O
of O
a O
prior O
cerebrovascular O
accident O
with O
residual O
right O
sided O
deficit O
. O
 
One O
day O
prior O
to O
arrival O
, O
the O
patient O
was O
found O
to O
have O
increasing O
slurring O
of O
speech O
and O
he O
was O
found O
to O
increasing O
weakness O
over O
his O
baseline O
on O
the O
right O
side O
. O
 
The O
patient O
arrives O
without O
acute O
complaints O
except O
for O
difficulty O
speaking O
. O
 
He O
denies O
any O
headache O
. O
 
He O
also O
does O
complain O
of O
some O
throat O
pain O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Review O
of O
systems O
is O
as O
per O
the O
written O
note O
. O
 
The O
patient O
denies O
fevers O
, O
chills O
, O
chest O
pain O
, O
shortness O
of O
breath O
or O
dysphagia O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
The O
patient O
's O
past O
medical O
history O
is O
significant O
for O
hypertension O
, O
diabetes O
mellitus O
, O
cerebrovascular O
accident O
and O
otherwise O
as O
per O
the O
written O
note O
. O
 
MEDICATIONS O
: O
The O
patient O
's O
medications O
include O
Tylenol O
, O
aspirin O
, O
Avenida O
, O
Glucophage O
, O
Zoloft O
, O
hydrochlorothiazide O
, O
metoprolol O
and O
otherwise O
as O
per O
the O
written O
note O
. O
 
ALLERGIES O
: O
The O
patient O
has O
no O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
The O
patient O
's O
social O
history O
and O
family O
history O
are O
as O
per O
the O
written O
note O
and O
are O
significant O
for O
past O
tobacco O
use O
and O
no O
alcohol O
use O
. O
 
He O
lives O
with O
family O
and O
goes O
to O
a O
day O
care O
facility O
. O
 
PHYSICAL O
EXAMINATION O
: O
GENERAL O
: O
The O
patient O
is O
a O
well O
nourished O
male O
in O
no O
acute O
distress O
. O
 
VITAL O
SIGNS O
: O
Temperature O
97 O
, O
pulse O
62 O
, O
respiratory O
rate O
16 O
, O
blood O
pressure O
163/96 O
, O
oxygen O
saturation O
100 O
% O
on O
room O
air O
. O
 
NECK O
: O
Supple O
with O
full O
range O
of O
motion O
. O
 
No O
nuchal O
rigidity O
. O
 
LUNGS O
: O
Clear O
to O
auscultation O
bilaterally O
with O
good O
air O
movement O
. O
 
CARDIAC O
: O
Regular O
with O
ectopy O
. O
 
No O
murmur O
is O
auscultated O
. O
 
NEUROLOGIC O
: O
Alert O
, O
oriented O
x O
3 O
, O
dysarthric O
. O
 
Finger O
to O
nose O
is O
within O
normal O
limits O
bilaterally O
. O
 
There O
is O
5/5 O
motor O
strength O
throughout O
the O
left O
upper O
extremity O
and O
left O
lower O
extremity O
. O
 
The O
right O
upper O
extremity O
and O
right O
lower O
extremity O
there O
is O
3/5 O
motor O
strength O
throughout O
all O
motor O
groups O
tested O
. O
 
The O
patient O
is O
able O
to O
follow O
all O
commands O
. O
 
His O
ability O
to O
understand O
appears O
to O
be O
completely O
intact O
. O
 
Further O
details O
of O
the O
patient O
's O
physical O
examination O
are O
as O
per O
the O
written O
note O
. O
 
LABORATORY O
EVALUATION O
: O
Laboratory O
studies O
are O
significant O
for O
a O
glucose O
of O
195 O
, O
BUN O
of O
14 O
, O
creatinine O
of O
1.2 O
, O
bicarbonate O
of O
26 O
, O
CK O
of O
68 I-AGE
, O
toxicology O
screen O
which O
is O
negative O
, O
troponin O
of O
0.04 O
, O
white O
count O
of O
7.4 O
, O
hematocrit O
of O
42.0 O
, O
platelets O
of O
327 O
and O
a O
urinalysis O
that O
is O
pending O
. O
 
A O
head O
CT O
is O
also O
pending O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
The O
patient O
was O
interviewed O
and O
examined O
in O
the O
emergency O
department O
. O
 
His O
past O
medical O
records O
were O
reviewed O
. O
 
The O
patient O
has O
new O
neurologic O
findings O
on O
top O
of O
an O
old O
cerebrovascular O
accident O
. O
 
CONSULTATIONS O
( O
including O
PCP O
) O
: O
The O
neurology O
service O
was O
therefore O
consulted O
and O
a O
head O
CT O
was O
ordered O
. O
 
The O
patient O
will O
be O
admitted O
to O
the O
neurology O
service O
for O
further O
work O
up O
and O
he O
will O
likely O
also O
undergo O
an O
MRI/MRA O
. O
 
FINAL O
DIAGNOSIS O
: O
Cerebrovascular O
accident O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
The O
patient O
is O
admitted O
to O
the O
neurology O
service O
in O
satisfactory O
condition O
. O
 
___________________________________ O
KM855/90247 I-ID
ALISHA I-NAME
VIOLA I-NAME
, O
M.D O
. O
 
AV51 I-NAME
D:04/28/93 O
T:04/28/93 O
Dictated O
by O
: O
ALISHA I-NAME
VIOLA I-NAME
, O
M.D O
. O
 
AV51 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2093-07-03 I-DATE
Nathan I-NAME
D. I-NAME
Akins I-NAME
, O
MD O
, O
MPH O
BMC I-LOCATION
Internal O
Medicine O
Associates O
96 I-LOCATION
Hassell I-LOCATION
Brook I-LOCATION
Road I-LOCATION
Daytona I-LOCATION
Highridge I-LOCATION
Estates I-LOCATION
, O
AZ I-LOCATION
39757 I-LOCATION
( O
742 O
) O
270-8900 I-CONTACT
CC O
: O
Follow-up O
from O
Stroke O
69 I-AGE
yo O
man O
with O
HTN O
, O
DM O
, O
CVA O
in O
5/93 I-DATE
underwent O
rehab O
and O
is O
now O
living O
at O
home O
comes O
in O
for O
follow-up O
care O
. O
 
He O
is O
under O
the O
care O
of O
Park I-LOCATION
Nicollet I-LOCATION
Clinic I-LOCATION
. O
 
I O
have O
recently O
refilled O
all O
of O
his O
medication O
. O
 
He O
has O
no O
complaints O
today O
. O
 
He O
denies O
F O
, O
C O
, O
N O
, O
V O
, O
CP O
, O
SOB O
, O
abd O
pain O
, O
B/B O
changes O
, O
HA O
and O
feels O
he O
is O
getting O
along O
well O
at O
home O
. O
 
His O
family O
helps O
him O
greatly O
. O
 
He O
underwent O
PT O
and O
OT O
. O
 
His O
home O
care O
nurse O
wants O
a O
modified O
barrium O
swallow O
to O
see O
if O
he O
can O
be O
advanced O
off O
of O
thick O
liquids O
to O
solids O
. O
 
He O
only O
recently O
began O
taking O
TID O
metoprolol O
. O
 
He O
reports O
no O
problems O
with O
his O
medication O
. O
 
MEDICATIONS O
AVANDIA O
( O
ROSIGLITAZONE O
) O
4 O
MG O
PO O
QD O
ZOLOFT O
( O
SERTRALINE O
) O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
EC O
ASA O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
325MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
GLUCOPHAGE O
( O
METFORMIN O
) O
850MG O
1 O
Tablet O
( O
s O
) O
PO O
qam O
NORVASC O
( O
AMLODIPINE O
) O
10MG O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
ZESTRIL O
( O
LISINOPRIL O
) O
5MG O
1 O
Tablet O
( O
s O
) O
PO O
QD O
GLUCOPHAGE O
( O
METFORMIN O
) O
500MG O
1 O
Tablet O
( O
s O
) O
PO O
qpm O
COLACE O
( O
DOCUSATE O
SODIUM O
) O
100MG O
1 O
Capsule O
( O
s O
) O
PO O
BID O
ZOCOR O
( O
SIMVASTATIN O
) O
20MG O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
PLAVIX O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
SENNA O
TABLETS O
2 O
TAB O
PO O
QHS O
LOPRESSOR O
( O
METOPROLOL O
TARTRATE O
) O
50MG O
1 O
Tablet O
( O
s O
) O
PO O
TID O
PE O
: O
Gen O
: O
WDWN O
in O
NAD O
in O
wheelchair O
. O
 
VS O
: O
BP O
140/85 O
P70 O
HEENT O
: O
EOMI O
, O
PEERL O
, O
OP O
nl O
, O
conjunctiva O
pink O
, O
sclera O
anicteric O
. O
 
Neck O
: O
Supple O
, O
no O
lymphadenopathy O
Lungs O
: O
CTA O
B O
CV O
: O
RRR O
no O
M O
, O
r O
, O
g. O
Abd O
: O
Soft O
. O
 
NABS O
, O
NTND O
, O
no O
HSM O
Ext O
: O
No O
c/c/e O
Neuro O
: O
Right O
hemiparesis O
. O
 
A/P O
: O
1. O
s/p O
CVA O
: O
although O
he O
has O
a O
dense O
residual O
deficit O
. O
 
He O
is O
getting O
along O
relatively O
well O
at O
home O
. O
 
ASA O
, O
plavix O
. O
 
Consider O
additional O
PT/OT O
if O
not O
receiving O
at O
home O
. O
 
Ordered O
modified O
barrium O
swallow O
in O
hopes O
of O
advancing O
to O
solids O
. O
 
2 O
. O
 
HTN O
: O
elevated O
pressure O
today O
, O
especially O
given O
DM O
. O
 
If O
remains O
elevated O
at O
next O
visit O
would O
intensify O
regimen O
. O
 
Metoprolol O
50 O
tid O
, O
zestril O
5 O
qd O
, O
norvasc O
10 O
qhs O
. O
 
3 O
. O
 
DM O
: O
Sugars O
have O
been O
in O
100-200 O
range O
. O
 
Again O
, O
will O
intensify O
at O
next O
visit O
if O
remain O
elevated O
now O
that O
he O
is O
on O
a O
stable O
regimen O
. O
 
Metformin O
500 O
qpm O
, O
rosiglitazone O
4 O
qd O
. O
 
Needs O
A1C O
at O
next O
visit O
. O
 
4 O
. O
 
Chol O
: O
on O
zocor O
20 O
qhs O
. O
 
Will O
need O
to O
re-check O
fasting O
cholesterol O
at O
next O
visit O
. O
 
5 O
. O
 
Depression O
: O
Zoloft O
50 O
qd O
. O
 
6 O
. O
 
HCM O
: O
Deferred O
- O
f/u O
with O
me O
in O
1 O
month O
. O
 
Record O
date O
: O
2094-02-04 I-DATE
BMC I-LOCATION
NEUROLOGY O
ED O
NOTE O
Date O
: O
2/04/2094 I-DATE
Name O
: O
Nancy-Jasmine O
, O
Nikkolas I-NAME
MR O
# O
: O
69331181 I-ID
CC O
: O
1 O
week O
of O
improving O
dysarthria O
, O
dysphagia O
, O
and O
vertigo O
, O
and O
persistent O
difficulty O
walking O
, O
comes O
in O
today O
for O
medication O
refill O
and O
gait O
instability O
HPI O
: O
68yo O
RHM O
with O
HTN O
, O
NIDDM O
, O
2 O
prior O
strokes O
( O
8/91 I-DATE
5/93 I-DATE
) O
who O
after O
running O
out O
of O
his O
medications O
in O
Honduras I-LOCATION
woke O
up O
7 O
days O
ago O
with O
dysarthria O
, O
dysphagia O
, O
and O
rotatory O
vertigo O
. O
 
He O
had O
a O
L O
thalamocapsular O
infarct O
in O
8/2091 I-DATE
with O
R O
residual O
hemiparesis O
, O
and O
a O
R O
thalamocapsular O
infarct O
5/93 I-DATE
with O
subsequent O
residual O
dysarthria O
. O
 
During O
his O
May I-DATE
hospitalization O
he O
had O
dysphagia O
for O
which O
he O
briefly O
received O
tube O
feeds O
before O
graduating O
to O
POs O
. O
 
He O
went O
to O
Honduras I-LOCATION
approximately O
3 O
months O
ago O
, O
and O
ran O
out O
of O
many O
of O
his O
medications O
in O
the O
last O
2 O
weeks O
, O
including O
plavix O
, O
lopressor O
, O
and O
metformin O
. O
 
He O
self-d/c O
'd O
zestril O
for O
new O
nausea O
that O
he O
felt O
was O
related O
. O
 
Since O
symptom O
onset O
7 O
days O
ago O
, O
patient O
has O
noted O
slow O
improvement O
in O
both O
dysarthria O
and O
dysphagia O
. O
 
He O
continues O
to O
note O
vertigo O
present O
sitting O
, O
worse O
standing O
, O
and O
absent O
supine O
. O
 
He O
has O
had O
difficulty O
ambulating O
as O
well O
, O
despite O
the O
use O
of O
his O
tripod O
cane O
, O
and O
his O
children O
have O
helped O
him O
at O
home O
. O
 
He O
returned O
from O
Honduras I-LOCATION
3 O
days O
ago O
to O
refill O
his O
medications O
and O
get O
his O
symptoms O
evaluated O
. O
 
ROS O
notable O
for O
poor O
vision O
bilaterally O
, O
worse O
on O
the O
L O
per O
patient O
. O
 
Pt O
denied O
diplopia O
, O
trouble O
chewing O
, O
numbness O
of O
face O
, O
tinnitus O
. O
 
No O
HA O
, O
F/C O
, O
V O
, O
CP/pressure O
, O
SOB O
, O
heartburn O
, O
constipation O
, O
diarrhea O
, O
dysuria O
. O
 
Of O
note O
, O
admission O
FSBG O
was O
353 O
. O
 
PMH O
: O
HTN O
NIDDM O
Strokes O
as O
above O
. O
 
MRA O
5/93 I-DATE
showed O
multifocal O
stenoses O
of O
Circle O
of O
Willis O
with O
vertebrobasilar O
insufficiency O
Positive O
PPD O
MEDS O
: O
ASA O
325mg O
QD O
, O
plavix O
75 O
qd O
( O
out O
) O
, O
lopressor O
75 O
bid O
( O
out O
) O
, O
zestril O
30 O
qd O
( O
self-d/c O
'd O
) O
, O
norvasc O
10 O
, O
metformin O
850 O
qd O
( O
out O
) O
, O
Avandia O
4 O
qd O
, O
Zoloft O
25 O
qd O
, O
Zocor O
20 O
qd O
( O
unclear O
if O
taking O
) O
, O
Zantac O
150 O
bid O
ALL O
: O
NKDA O
SH O
: O
Tob O
: O
no O
EtOH O
: O
no O
Street O
drugs O
: O
no O
Honduran I-LOCATION
immigrant O
. O
 
9 O
children O
, O
8 O
live O
with O
pt O
in O
America I-LOCATION
. O
 
FH O
: O
CAD O
and O
HTN O
VS O
: O
T O
: O
98.8 O
BP O
: O
218/112 O
P O
: O
68 I-AGE
RR O
: O
18 O
O2 O
sat O
: O
96 O
% O
General O
: O
WNWD O
, O
NAD O
, O
somewhat O
unkempt O
HEENT O
: O
Anicteric O
, O
MMM O
without O
lesions O
, O
OP O
clear O
Neck O
: O
Supple O
, O
No O
LAD O
, O
no O
carotid O
bruits O
, O
no O
thyromegaly O
CV O
: O
RRR O
s1s2 O
no O
m/r/g O
Resp O
: O
CTAB O
no O
r/w/r O
Abd O
: O
+BS O
Soft/NT/ND O
no O
HSM/masses O
Ext O
: O
No O
C/C/E O
, O
Distal O
pulses O
intact O
Skin O
: O
No O
rashes O
, O
petechiae O
MS O
: O
A O
& O
O O
x O
3 O
, O
following O
commands O
Speech O
fluent O
w/o O
paraphasic O
errors O
No O
evidence O
of O
neglect O
with O
visual O
or O
tactile O
stimulation O
CN O
: O
I O
not O
tested O
, O
II O
, O
III O
PERRL O
, O
VFF O
by O
confrontation O
; O
III O
, O
IV O
, O
VI O
EOMI O
, O
no O
nystagmus O
( O
supine O
, O
sitting O
, O
standing O
) O
, O
no O
ptosis O
; O
V- O
sensation O
intact O
to O
LT/PP O
, O
masseters O
strong O
symmetrically O
; O
VII O
L O
NLF O
flattening O
; O
VIII O
hears O
finger O
snap O
; O
IX O
, O
X O
voice O
with O
mild O
lingual O
dysarthria O
, O
palate O
elevates O
symmetrically O
, O
gag O
& O
swallow O
intact O
; O
XI O
SCM/Trapezii O
5/5 O
B O
; O
XII O
tongue O
protrudes O
midline O
, O
no O
atrophy O
or O
fasciculations O
. O
 
Vertigo O
not O
precipitated O
on O
standing O
. O
 
Motor O
: O
nl O
bulk O
and O
tone O
, O
no O
tremor O
, O
rigidity O
or O
bradykinesia O
. O
 
No O
pronator O
drift O
. O
 
D O
Bi O
Tri O
WF O
WE O
DI O
Grip O
Hip O
flex O
knee/ext O
flex O
dors O
plant O
L O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
5 O
R O
2 O
3 O
2 O
3 O
2 O
1 O
3 O
4 O
4 O
4 O
0 O
0 O
DTRs O
: O
Bi O
Tri O
BR O
Pat O
Ach O
Plantar O
L O
2 O
2 O
2 O
2 O
2 O
up O
R O
3 O
3 O
3 O
2 O
2 O
down O
Sensory O
: O
LT O
, O
vibration O
, O
temperature O
, O
pinprick O
intact O
. O
 
Stereognosis O
& O
double O
sim O
stim O
is O
normal O
. O
 
Coord O
: O
finger O
tap O
rapid O
on O
L O
, O
can O
not O
do O
on O
R O
, O
FNF O
intact O
on O
L. O
HKS O
intact O
, O
foot O
tap O
rapid O
on O
L O
, O
impaired O
on O
R. O
Gait O
: O
Unable O
to O
stand O
with O
legs O
together O
and O
eyes O
open O
, O
retropulsing O
. O
 
Gait O
unstable O
, O
falling O
back O
. O
 
Labs O
: O
Lytes/Renal/Glucose O
Sodium O
142 O
136-142 O
mmol/L O
02/04/94 I-DATE
15:15 O
144 O
( O
* O
) O
05/05/93 I-DATE
06:20 O
Potassium O
4.5 O
3.5-5.0 O
mmol/L O
02/04/94 I-DATE
15:15 O
5.4 O
( O
* O
) O
04/28/93 I-DATE
11:05 O
Chloride O
107 O
98-108 O
mmol/L O
02/04/94 I-DATE
15:15 O
110 O
( O
* O
) O
05/05/93 I-DATE
06:20 O
Carbon O
Dioxide O
26 O
23-32 O
mmol/L O
02/04/94 I-DATE
15:15 O
21 O
( O
* O
) O
05/04/93 I-DATE
08:38 O
Blood O
Urea O
Nitro O
9 O
9-25 O
mg/dL O
02/04/94 I-DATE
15:15 O
Creatinine O
1.1 O
0.7-1.3 O
mg/dL O
02/04/94 I-DATE
15:15 O
Glucose O
195 O
* O
# O
54-118 O
mg/dL O
02/04/94 I-DATE
15:15 O
195 O
( O
* O
# O
) O
02/04/94 I-DATE
15:15 O
Anion O
Gap O
9 O
3-15 O
mmol/L O
02/04/94 I-DATE
15:15 O
General O
Chemistries O
Calcium O
10.3 O
8.8-10.5 O
mg/dL O
02/04/94 I-DATE
15:15 O
10.7 O
( O
* O
) O
01/25/92 I-DATE
14:30 O
Phosphorus O
3.3 O
2.4-5.0 O
mg/dL O
04/28/93 I-DATE
11:05 O
Magnesium O
2.0 O
1.8-2.5 O
mg/dL O
05/05/93 I-DATE
06:20 O
1.5 O
( O
* O
) O
04/28/93 I-DATE
11:05 O
Total O
Bilirubin O
0.3 O
# O
0.2-1.2 O
mg/dL O
07/08/93 I-DATE
14:58 O
0.1 O
( O
* O
# O
) O
04/28/93 I-DATE
11:05 O
Total O
Protein O
6.7 O
6.0-8.0 O
g/dL O
07/08/93 I-DATE
14:58 O
Albumin O
3.9 O
3.7-5.4 O
g/dL O
07/08/93 I-DATE
14:58 O
Globulin O
2.8 O
2.0-4.0 O
g/dL O
07/08/93 I-DATE
14:58 O
Amylase O
32 O
20-70 O
U/L O
02/04/94 I-DATE
15:15 O
Lipase O
51 O
3-60 O
U/L O
07/08/93 I-DATE
14:58 O
Liver O
Function O
Tests O
ALT O
( O
SGPT O
) O
10 O
7-52 O
U/L O
07/08/93 I-DATE
14:58 O
6 O
( O
* O
) O
01/25/92 I-DATE
14:30 O
AST O
( O
SGOT O
) O
14 O
9-30 O
U/L O
07/08/93 I-DATE
14:58 O
Alkaline O
Phospha O
39 O
36-118 O
U/L O
07/08/93 I-DATE
14:58 O
Total O
Bilirubin O
0.3 O
# O
0.2-1.2 O
mg/dL O
07/08/93 I-DATE
14:58 O
0.1 O
( O
* O
# O
) O
04/28/93 I-DATE
11:05 O
Hematology O
Complete O
Blood O
Count O
WBC O
8.05 O
4-10 O
K/uL O
02/04/94 I-DATE
15:15 O
HCT O
45.5 O
# O
40-54 O
% O
02/04/94 I-DATE
15:15 O
38.8 O
( O
* O
) O
07/08/93 I-DATE
14:58 O
HGB O
14.9 O
# O
13.5-18.0 O
g/dL O
02/04/94 I-DATE
15:15 O
13.1 O
( O
* O
) O
07/08/93 I-DATE
14:58 O
RBC O
5.40 O
# O
4.5-6.4 O
M/uL O
02/04/94 I-DATE
15:15 O
PLT O
390 O
# O
150-450 O
K/uL O
02/04/94 I-DATE
15:15 O
MCV O
84.2 O
80-95 O
um3 O
02/04/94 I-DATE
15:15 O
MCH O
27.6 O
27-32 O
uug O
02/04/94 I-DATE
15:15 O
MCHC O
32.8 O
32-36 O
g/dL O
02/04/94 I-DATE
15:15 O
RDW O
14.1 O
10-14.5 O
02/04/94 I-DATE
15:15 O
15.2 O
( O
* O
) O
07/08/93 I-DATE
14:58 O
Blood O
Differential O
% O
Neutrophils O
- O
Au O
57.6 O
48-76 O
02/04/94 I-DATE
15:15 O
Lymphocytes O
- O
Au O
34.9 O
18-41 O
02/04/94 I-DATE
15:15 O
Monocytes O
- O
Auto O
5.3 O
2.5-8.5 O
02/04/94 I-DATE
15:15 O
Eosinophils O
- O
Au O
1.9 O
0-5 O
02/04/94 I-DATE
15:15 O
Basophils O
- O
Auto O
0.3 O
0-1.5 O
02/04/94 I-DATE
15:15 O
Blood O
Diff O
- O
Absolute O
Abs O
Neuts O
Auto O
4.63 O
1.9-7.6 O
02/04/94 I-DATE
15:15 O
Abs O
Lymphs O
Auto O
2.81 O
0.8-4.1 O
02/04/94 I-DATE
15:15 O
Abs O
Monos O
Auto O
0.43 O
.10-0.8 O
02/04/94 I-DATE
15:15 O
Abs O
EOS O
Auto O
0.15 O
0-0.5 O
02/04/94 I-DATE
15:15 O
Abs O
Basos O
Auto O
0.02 O
0.00-0.15 O
02/04/94 I-DATE
15:15 O
Hematology O
Miscellaneous O
HGB O
A1C O
8.3 O
* O
4.4-6.3 O
% O
07/08/93 I-DATE
14:58 O
8.3 O
( O
* O
) O
07/08/93 I-DATE
14:58 O
Coagulation O
Routine O
Coagulation O
PT O
13.1 O
11.4-14.1 O
sec O
02/04/94 I-DATE
15:15 O
PT-INR O
1.0 O
0.9-1.1 O
02/04/94 I-DATE
15:15 O
PTT O
26.3 O
23.8-36.6 O
sec O
02/04/94 I-DATE
15:15 O
Prior O
: O
Lipid O
Tests O
Cholesterol O
236 O
140-240 O
mg/dL O
05/01/93 I-DATE
12:12 O
Triglycerides O
187 O
* O
35-150 O
mg/dL O
05/01/93 I-DATE
12:12 O
187 O
( O
* O
) O
05/01/93 I-DATE
12:12 O
HDL O
38 O
* O
40-60 O
mg/dL O
05/01/93 I-DATE
12:12 O
38 O
( O
* O
) O
05/01/93 I-DATE
12:12 O
Calculated O
LDL O
161 O
* O
50-160 O
mg/dL O
05/01/93 I-DATE
12:12 O
161 O
( O
* O
) O
05/01/93 I-DATE
12:12 O
VLDL O
37 O
mg/dL O
05/01/93 I-DATE
12:12 O
Chemistry O
Miscellaneous O
HOMOCYSTEINE O
12.5 O
* O
4.5-12.4 O
umol/L O
04/30/93 I-DATE
06:47 O
12.5 O
( O
* O
) O
04/30/93 I-DATE
06:47 O
LIPOa O
67 O
* O
0-30 O
mg/dL O
04/30/93 I-DATE
06:47 O
67 O
( O
* O
) O
04/30/93 I-DATE
06:47 O
Urinalysis O
Urinalysis O
Color O
YELLOW O
02/04/94 I-DATE
13:53 O
Glucose O
- O
UA O
3+ O
0-0 O
02/04/94 I-DATE
13:53 O
Bilirubin O
NEG O
02/04/94 I-DATE
13:53 O
Ketones O
NEG O
02/04/94 I-DATE
13:53 O
Specific O
Gravity O
1.023 O
1.003-1.035 O
02/04/94 I-DATE
13:53 O
Occult O
Blood O
NEG O
02/04/94 I-DATE
13:53 O
pH O
5.5 O
4.5-8.0 O
02/04/94 I-DATE
13:53 O
Protein O
TR O
02/04/94 I-DATE
13:53 O
Urobilinogen O
NEG O
02/04/94 I-DATE
13:53 O
Nitrites O
NEG O
02/04/94 I-DATE
13:53 O
WBC O
Screen O
NEG O
02/04/94 I-DATE
13:53 O
Casts O
NEG O
02/04/94 I-DATE
13:53 O
RBC O
- O
Urine O
Sed O
NEG O
0-2 O
02/04/94 I-DATE
13:53 O
WBC O
- O
Urine O
Sed O
NEG O
0-4 O
02/04/94 I-DATE
13:53 O
Bacteria O
NEG O
02/04/94 I-DATE
13:53 O
Mucous O
NEG O
02/04/94 I-DATE
13:53 O
Squamous O
Cells O
NEG O
02/04/94 I-DATE
13:53 O
Crystals O
NEG O
02/04/94 I-DATE
13:53 O
Amorph O
Crystals O
NEG O
02/04/94 I-DATE
13:53 O
Other/Comments O
NEG O
02/04/94 I-DATE
13:53 O
CXR O
: O
clear O
CT O
head O
: O
bilateral O
thalamocapsular O
infarcts O
CTA O
: O
pending O
MRI/MRA O
: O
pending O
Assessment O
: O
68yo O
RHM O
with O
history O
of O
bilateral O
thalamocapsular O
infarcts O
and O
multifocal O
stenoses O
of O
vessels O
of O
Circle O
of O
Willis O
, O
with O
prior O
symptoms O
of O
dysarthria O
, O
dysphagia O
, O
and O
gait O
instability O
, O
here O
in O
the O
setting O
of O
medication O
noncompliance O
, O
hypertensive O
and O
hyperglycemic O
, O
with O
1 O
week O
of O
recurrent O
symptoms O
. O
 
Exam O
notable O
for O
absence O
of O
vertigo O
or O
nystagmus O
, O
as O
well O
as O
retropulsing O
stance O
and O
gait O
. O
 
Hyperglycemia O
and O
hypertension O
may O
well O
be O
exacerbating O
patient O
's O
prior O
deficits O
. O
 
However O
, O
can O
not O
rule O
out O
possibility O
of O
a O
subacute O
infarct O
in O
the O
setting O
of O
plavix O
and O
antihypertensive O
discontinuation O
. O
 
Plan O
: O
- O
Check O
CTA O
to O
assess O
Circle O
of O
Willis O
Check O
MRI O
brain O
stroke O
protocol O
Control O
HTN O
, O
goal O
SBP O
~160-180 O
Control O
hyperglycemia O
If O
stroke O
present O
, O
admit O
to O
Neurology O
. O
 
R/O O
MI O
Discussed O
with O
Dr. O
Costello I-NAME
. O
 
Thank O
you O
for O
this O
interesting O
consult O
. O
 
_____________________________ O
Peter I-NAME
Quale I-NAME
, O
IJ6 I-NAME
pgr O
20951 I-CONTACT
 
Record O
date O
: O
2067-08-15 I-DATE
Neuro O
30 I-LOCATION
Caitlyn I-LOCATION
Circle I-LOCATION
HEATH O
, O
HANNAH I-NAME
Prestonsburg I-LOCATION
, O
MS I-LOCATION
54151 I-LOCATION
91156456 I-ID
535-022-8716 I-CONTACT
08/15/67 I-DATE
CHIEF O
COMPLAINT O
: O
Stroke O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
72-year-old O
right-handed O
woman O
with O
a O
history O
of O
hypertension O
, O
diabetes O
, O
and O
hypercholesterolemia O
who O
was O
admitted O
to O
the O
Neurology O
Service O
on O
06/18/2067 I-DATE
with O
right-arm O
weakness O
and O
difficulty O
speaking O
. O
 
She O
presented O
to O
the O
Emergency O
Room O
5.5 O
hours O
after O
last O
seeming O
normal O
. O
 
Her O
initial O
NI O
stroke O
scale O
was O
11 O
. O
 
She O
was O
admitted O
to O
the O
Neurology O
Service O
for O
a O
stroke O
workup O
. O
 
Her O
imaging O
studies O
showed O
a O
left O
MCA O
infarct O
involving O
the O
left O
corona O
radiata O
, O
head O
of O
the O
caudate O
basal O
ganglia O
, O
and O
an O
MI O
cutoff O
on O
the O
CTA O
and O
MRA O
in O
addition O
to O
a O
left O
ICA O
occlusion O
. O
 
She O
was O
taken O
to O
angiogram O
for O
interventional O
neuroradiology O
. O
 
She O
had O
an O
angiogram O
. O
 
Radiology O
felt O
they O
were O
unable O
to O
access O
the O
cause O
and O
no O
intervention O
was O
attempted O
and O
the O
patient O
was O
admitted O
to O
the O
Neuro O
ICU O
for O
blood O
pressure O
monitoring O
and O
hypertensive O
therapy O
. O
 
She O
remained O
stable O
anti-coagulated O
on O
heparin O
. O
 
During O
the O
hospital O
stay O
, O
she O
spontaneously O
converted O
to O
rapid O
ventricular O
rate O
atrial O
fibrillation O
, O
which O
was O
felt O
to O
be O
the O
likely O
source O
of O
her O
stroke O
and O
as O
such O
was O
planned O
to O
remain O
anti-coagulated O
. O
 
She O
was O
discharged O
to O
rehab O
and O
subsequently O
went O
home O
from O
rehab O
on O
08/04/2067 I-DATE
. O
 
At O
home O
, O
she O
had O
been O
noted O
to O
have O
elevations O
in O
blood O
pressure O
but O
has O
been O
feeling O
O.K O
. O
 
VNA O
sees O
her O
once O
a O
week O
. O
 
At O
rehab O
, O
for O
unclear O
reasons O
, O
her O
warfarin O
was O
discontinued O
and O
in O
speaking O
to O
the O
discharging O
physician O
from O
the O
Tracy I-LOCATION
Medical I-LOCATION
Clinic I-LOCATION
, O
this O
was O
done O
for O
a O
question O
of O
vaginal O
bleeding O
although O
the O
patient O
is O
unaware O
of O
any O
such O
problems O
. O
 
She O
continues O
to O
get O
PT O
and O
occupational O
therapy O
twice O
per O
week O
and O
complains O
that O
her O
memory O
remains O
poor O
. O
 
According O
to O
the O
family O
member O
and O
her O
daughter O
who O
are O
here O
interpreting O
for O
her O
at O
Clinic I-LOCATION
today O
, O
she O
continues O
to O
have O
right-sided O
weakness O
, O
although O
significantly O
improved O
and O
decreased O
verbal O
output O
although O
her O
daughter O
seemed O
to O
be O
able O
to O
communicate O
well O
with O
her O
. O
 
Since O
her O
discharge O
, O
she O
has O
not O
had O
any O
new O
episodes O
of O
numbness O
, O
weakness O
, O
headaches O
, O
or O
visual O
changes O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
She O
denies O
any O
fevers O
, O
chills O
, O
weight O
loss O
, O
chest O
pain O
, O
shortness O
of O
breath O
, O
palpitations O
, O
leg O
cramps O
, O
claudication O
, O
dyspnea O
on O
exertion O
, O
cough O
, O
wheezing O
, O
hemoptysis O
, O
heartburn O
, O
abdominal O
pain O
, O
hematemesis O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
melena O
, O
dysuria O
, O
changes O
in O
bowel O
or O
bladder O
habits O
, O
rashes O
, O
arthralgias O
, O
myalgias O
, O
polyuria O
, O
polydypsia O
, O
breathing O
, O
or O
bleeding O
problems O
. O
 
Review O
of O
neurological O
systems O
as O
above O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
diabetes O
, O
and O
elevated O
cholesterol O
. O
 
MEDICATIONS O
: O
Metoprolol O
, O
Zoloft O
, O
Zocor O
, O
and O
Captopril O
. O
 
ALLERGIES O
: O
She O
has O
no O
known O
drug O
allergies O
. O
 
SOCIAL O
HISTORY O
: O
The O
patient O
lives O
in O
Castle I-LOCATION
Rock I-LOCATION
with O
her O
son O
. O
 
No O
history O
of O
tobacco O
or O
alcohol O
. O
 
FAMILY O
HISTORY O
: O
A O
sister O
had O
a O
stroke O
. O
 
PHYSICAL O
EXAMINATION O
: O
Her O
blood O
pressure O
was O
150/80 O
, O
her O
heart O
rate O
was O
70 O
, O
respiratory O
rate O
of O
12 O
. O
 
General O
: O
Pleasant O
woman O
in O
no O
acute O
distress O
. O
 
HEENT O
: O
Atraumatic O
, O
normocephalic O
, O
sclera O
anicteric O
, O
and O
oropharynx O
is O
clear O
. O
 
There O
is O
no O
thyromegaly O
. O
 
Neck O
: O
Supple O
, O
no O
bruits O
, O
with O
2+ O
carotids O
. O
 
Heart O
: O
Regular O
rate O
and O
rhythm O
. O
 
Lungs O
: O
Clear O
to O
auscultation O
. O
 
Abdomen O
: O
Has O
good O
bowel O
sounds O
, O
soft O
, O
nontender O
, O
no O
hepatosplenomegaly O
. O
 
Extremities O
: O
No O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
Skin O
: O
No O
rashes O
or O
ulcers O
. O
 
Neurological O
exam O
( O
conducted O
via O
her O
daughter O
and O
the O
interpreter O
) O
: O
She O
is O
alert O
and O
oriented O
. O
 
She O
is O
attentive O
. O
 
She O
is O
non-fluent O
with O
really O
minimal O
verbal O
output O
. O
 
She O
has O
decreased O
naming O
and O
decreased O
comprehension O
. O
 
She O
does O
not O
have O
any O
neglect O
or O
apraxia O
. O
 
Registration O
is O
3/4 O
. O
 
Short-term O
memory O
is O
0/4 O
in O
5 O
minutes O
. O
 
Pupils O
are O
3 O
and O
reactive O
to O
2 O
millimeters O
. O
 
Fundi O
are O
normal O
. O
 
Extraocular O
movements O
are O
intact O
with O
nystagmus O
. O
 
Visual O
fields O
are O
full O
to O
confrontation O
. O
 
She O
has O
a O
right O
facial O
droop O
. O
 
Facial O
sensation O
is O
intact O
. O
 
Hearing O
is O
normal O
. O
 
Motor O
exam O
: O
There O
is O
increased O
muscle O
tone O
on O
the O
right O
arm O
and O
leg O
. O
 
She O
has O
strength O
on O
the O
left O
is O
normal O
. O
 
On O
the O
right O
, O
her O
strength O
is O
at O
least O
4/5 O
in O
all O
muscle O
groups O
on O
the O
left O
on O
the O
neck O
, O
except O
for O
about O
3/5 O
in O
the O
distal O
arm O
. O
 
She O
reports O
decreased O
pinprick O
and O
temperature O
on O
the O
right O
arm O
. O
 
There O
is O
no O
ataxia O
on O
the O
left O
. O
 
Gait O
is O
slow O
, O
walks O
with O
a O
cane O
, O
and O
so O
conducts O
the O
right O
leg O
. O
 
Her O
reflexes O
are O
brisker O
on O
the O
right O
at O
about O
3 O
and O
she O
has O
a O
right O
plantar O
extensor O
response O
. O
 
IMAGING O
DATA O
: O
Initial O
head O
CT O
on O
06/18/2067 I-DATE
did O
not O
show O
any O
acute O
stroke O
or O
hemorrhage O
. O
 
On O
the O
CT O
, O
there O
was O
a O
question O
of O
a O
left O
MI O
cutoff O
. O
 
CT O
angiogram O
also O
showed O
a O
distal O
left O
ICA O
stenosis O
with O
minimal O
distal O
interflow O
. O
 
MRI O
of O
the O
brain O
showed O
a O
left O
MCA O
infarction O
involving O
the O
left O
corona O
radiata O
, O
head O
of O
the O
caudate O
basal O
ganglia O
. O
 
She O
has O
had O
mild O
to O
moderate O
chronic O
small O
vessel O
ischemic O
changes O
on O
her O
MRI O
. O
 
Echo O
showed O
a O
normal O
EF O
of O
55 O
% O
without O
any O
clot O
, O
no O
PFO O
. O
 
IMPRESSION O
: O
This O
is O
a O
73-year-old O
woman O
with O
significant O
vascular O
risk O
factors O
, O
including O
paroxysmal O
atrial O
fibrillation O
with O
a O
left O
ICA O
MCA O
clot O
resulting O
in O
a O
left O
MCA O
territory O
infarct O
. O
 
On O
exam O
, O
she O
has O
residual O
aphasia O
involving O
both O
comprehension O
and O
fluency O
; O
and O
a O
moderate O
right O
hemiparesis O
. O
 
It O
is O
unclear O
to O
me O
why O
the O
warfarin O
was O
discontinued O
but O
given O
her O
stroke O
and O
the O
documentation O
of O
paroxysmal O
atrial O
fibrillation O
during O
her O
hospital O
stay O
, O
I O
think O
that O
she O
would O
benefit O
from O
anti-coagulation O
therapy O
. O
 
I O
have O
asked O
her O
to O
get O
a O
follow O
up O
PCP O
evaluation O
at O
the O
OCH I-LOCATION
to O
determine O
if O
indeed O
there O
are O
any O
contraindications O
to O
anti-coagulation O
. O
 
If O
there O
are O
no O
such O
contraindications O
, O
she O
should O
restart O
on O
warfarin O
. O
 
In O
addition O
, O
her O
blood O
pressure O
is O
still O
not O
well O
controlled O
and O
I O
would O
ask O
her O
to O
increase O
her O
Captopril O
to O
12.5 O
mg O
t.i.d O
. O
 
and O
to O
maintain O
a O
blood O
pressure O
diary O
. O
 
RECOMMENDATIONS O
: O
1 O
. O
 
Continue O
anti-hypertensive O
and O
increase O
Captopril O
to O
12.5 O
mg O
t.i.d O
. O
 
2 O
. O
 
Blood O
pressure O
diary O
for O
next O
clinic O
appointment O
. O
 
3 O
. O
 
Continue O
risk O
factor O
modification O
with O
the O
management O
of O
blood O
pressure O
, O
diabetes O
, O
and O
hypercholesterol O
as O
she O
is O
doing O
. O
 
4 O
. O
 
PCP O
evaluation O
for O
question O
of O
bleeding O
problem O
during O
rehab O
stay O
and O
resumption O
of O
warfarin O
if O
there O
are O
no O
contraindications O
per O
the O
PCP O
. O
 
5 O
. O
 
Continue O
physical O
therapy O
and O
occupation O
therapy O
for O
gait O
training O
and O
language O
rehab O
. O
 
6 O
. O
 
Return O
to O
clinic O
in O
6 O
months O
or O
sooner O
if O
there O
are O
any O
new O
problems O
. O
 
More O
than O
50 O
% O
of O
this O
clinic O
visit O
was O
spent O
on O
patient O
education O
and O
counseling O
. O
 
______________________________ O
Jordan I-NAME
Namari I-NAME
Akers I-NAME
, O
MD O
, O
PHD O
Dictated O
By O
: O
Jordan I-NAME
Namari I-NAME
Akers I-NAME
eScription O
document:7-1410500 O
VSSten O
Tel O
DD O
: O
09/16/67 I-DATE
DT O
: O
09/16/67 I-DATE
DV O
: O
09/16/67 I-DATE
 
Record O
date O
: O
2069-05-27 I-DATE
May I-DATE
27 O
, O
2069 I-DATE
Chad I-NAME
Norwood I-NAME
, O
MD O
Re O
: O
Hannah I-NAME
Heath I-NAME
OCH I-LOCATION
# O
: O
91156456 I-ID
Dear O
Dr. O
Norwood I-NAME
, O
I O
had O
the O
pleasure O
of O
seeing O
your O
patient O
, O
Hannah I-NAME
Heath I-NAME
, O
for O
consultation O
in O
the O
Vascular O
dept O
at O
the O
OCH I-LOCATION
. O
 
As O
you O
know O
she O
is O
a O
72 I-AGE
year-old O
woman O
with O
prior O
stroke O
. O
 
I O
will O
review O
his O
medical O
history O
for O
our O
records O
. O
 
HPI O
: O
This O
is O
a O
72-year-old O
right-handed O
woman O
with O
a O
history O
of O
hypertension O
, O
diabetes O
, O
and O
hypercholesterolemia O
and O
PAF O
with O
a O
prior O
stroke O
( O
2067 I-DATE
) O
who O
subsequently O
was O
admitted O
to O
the O
OCH I-LOCATION
again O
for O
SDH O
with O
supratherapeutic O
INR O
in O
2068 I-DATE
. O
 
She O
has O
a O
prolonged O
hospital O
course O
as O
well O
as O
rehab O
stay O
and O
now O
returns O
having O
made O
significant O
recovery O
. O
 
She O
is O
here O
with O
her O
family O
who O
is O
translating O
. O
 
She O
ambulates O
with O
walker O
, O
but O
does O
well O
over O
short O
distances O
without O
it O
. O
 
She O
communicates O
well O
with O
eth O
family O
and O
is O
able O
to O
feed O
and O
dress O
herself O
. O
 
She O
has O
an O
aid O
for O
bathing O
three O
ties O
per O
week O
. O
 
She O
has O
not O
needed O
the O
PEG O
tube O
in O
the O
past O
6 O
months O
and O
is O
eager O
to O
have O
it O
removed O
. O
 
She O
has O
not O
had O
any O
new O
episodes O
of O
weakness O
, O
numbness O
, O
visual O
or O
language O
changes O
. O
 
ROS O
: O
Denies O
fevers O
, O
chills O
, O
chest O
pain O
, O
SOB O
, O
palpitations O
, O
leg O
cramps O
, O
claudication O
, O
DOE O
, O
cough O
, O
wheezing O
, O
hemoptysis O
, O
heartburn O
, O
abdominal O
pain O
, O
hematemesis O
, O
nausea O
, O
vomiting O
, O
diarrhea O
, O
melena O
, O
dysuria O
, O
changes O
in O
bowl O
or O
bladder O
habits O
, O
rashes O
, O
arthralgia O
or O
myalgias O
, O
polyuria O
, O
polydipsia O
, O
bruising O
or O
bleeding O
problems O
. O
 
Review O
of O
neurological O
system O
as O
above O
. O
 
PMH O
: O
Hypertension O
Diabetes O
Elevated O
cholesterol O
. O
 
Stroke O
SDH O
MEDS O
: O
Lipitor O
10mg O
qd O
Protonix O
40mg O
qd O
Diltiazem O
60mg O
qd O
Metoprolol O
50mg O
qd O
ALL O
: O
NKDA O
SHX O
: O
Married O
and O
lives O
with O
her O
husband O
. O
 
She O
has O
a O
very O
supportive O
family O
. O
 
FHX O
: O
Sister O
with O
seizures O
. O
 
PHYSICAL O
EXAM O
: O
BP O
: O
120/60 O
HR:70 O
RR O
: O
14 O
GEN O
: O
Pleasant O
woman O
in O
NAD O
. O
 
HEENT O
. O
 
AT/NC O
. O
 
Sclera O
anicteric O
. O
 
OP O
is O
clear O
. O
 
There O
is O
no O
thyromegaly O
. O
 
NECK O
: O
Supple O
. O
 
No O
LAD O
. O
 
Carotids O
are O
2+ O
without O
bruits O
. O
 
HEART O
: O
RRR O
, O
no O
m/r/g O
LUNGS O
: O
CTA O
ABD O
: O
+BS O
. O
 
Soft O
. O
 
PEG O
site O
inspected O
. O
 
Slightly O
red O
margin O
. O
 
No O
significant O
drainage O
at O
this O
time O
. O
 
No O
odor O
. O
 
EXT O
: O
No O
c/c/e O
SKIN O
: O
No O
rashes O
or O
ulcers O
. O
 
NEURO O
: O
Cognitive O
testing O
limited O
secondary O
to O
language O
barrier O
. O
 
Alert O
and O
oriented O
. O
 
Interacting O
well O
in O
Spanish O
with O
her O
family O
members O
. O
 
No O
neglect O
or O
apraxias O
. O
 
Pupils O
3- O
> O
2mm O
. O
 
Fundi O
are O
normal O
. O
 
EOMI O
without O
nystagmus O
. O
 
Right O
field O
cut O
. O
 
Right O
facial O
. O
 
Tongue O
and O
palate O
are O
midline O
. O
 
Facial O
sensation O
is O
intact O
. O
 
Hearing O
is O
normal O
. O
 
On O
motor O
exam O
there O
is O
normal O
muscle O
bulk O
, O
but O
increased O
tone O
right O
more O
than O
left O
. O
 
She O
has O
a O
mild O
right O
HP O
. O
 
There O
is O
a O
RPD O
. O
 
On O
sensory O
exam O
, O
pp/temp/vib O
are O
symmetric O
. O
 
There O
is O
distal O
gradient O
loss O
of O
sensation O
. O
 
There O
is O
no O
loss O
of O
cortical O
sensation O
. O
 
There O
is O
mild O
ataxia O
with O
FNF O
and O
HTS O
and O
RAM O
on O
the O
right O
. O
 
Gait O
is O
normal O
based O
and O
uses O
a O
walker O
. O
 
Reflexes O
are O
symmetric O
. O
 
Plantar O
responses O
are O
extensor O
. O
 
DATA O
: O
MRI O
2068 I-DATE
: O
old O
right O
MCA O
stroke O
CT O
2068 I-DATE
: O
SDH O
ASSESSMENT/ O
RECOMMENDATIONS O
: O
72 I-AGE
year-old O
woman O
with O
vascular O
risk O
factors O
including O
atrial O
fibrillation O
and O
prior O
stroke O
with O
a O
subsequent O
SDH O
with O
super O
elevated O
INR O
who O
now O
returns O
for O
follow-up O
. O
 
She O
has O
had O
a O
significant O
recovery O
. O
 
Our O
goal O
should O
now O
be O
secondary O
stroke O
prevention O
and O
risk O
factor O
modification O
. O
 
Given O
that O
her O
bleed O
was O
a O
SDH O
and O
in O
the O
setting O
of O
elevated O
INR O
, O
it O
is O
worth O
considering O
restarting O
warfarin O
, O
until O
then O
, O
she O
should O
at O
least O
be O
on O
ASA O
and O
I O
have O
communicated O
this O
with O
them O
. O
 
She O
should O
continue O
with O
her O
BP O
and O
cholesterol O
treatment O
as O
well O
. O
 
She O
is O
eager O
to O
remove O
the O
PEG O
and O
I O
will O
refer O
her O
to O
Dr O
Queen I-NAME
for O
this O
. O
 
RTC O
as O
needed O
. O
 
Call O
with O
questions O
. O
 
More O
than O
50 O
% O
of O
this O
visit O
was O
spent O
on O
patient O
education O
and O
counseling O
. O
 
Thank O
you O
for O
allowing O
me O
to O
participate O
in O
the O
care O
of O
your O
patient O
. O
 
I O
will O
continue O
to O
follow O
along O
with O
you O
. O
 
Sincerely O
, O
Jordan I-NAME
N. I-NAME
Akers I-NAME
, O
M.D. O
, O
Ph.D. O
Department O
of O
Neurology O
Stroke O
Division O
Orange I-LOCATION
City I-LOCATION
Hospital I-LOCATION
Prestonsburg I-LOCATION
, O
MS I-LOCATION
54151 I-LOCATION
 
Record O
date O
: O
2070-08-28 I-DATE
CC O
: O
follow-up O
HPI O
: O
75-year-old O
woman O
with O
a O
history O
of O
hypertension O
, O
diabetes O
, O
and O
hypercholesterolemia O
and O
PAF O
with O
a O
prior O
stroke O
( O
2067 I-DATE
) O
who O
subsequently O
was O
admitted O
to O
the O
OCH I-LOCATION
again O
for O
SDH O
with O
supratherapeutic O
INR O
in O
2068 I-DATE
. O
 
She O
has O
a O
prolonged O
hospital O
course O
as O
well O
as O
rehab O
stay O
and O
now O
returns O
having O
made O
significant O
recovery O
. O
 
Her O
PEG O
was O
pulled-out O
in O
06/69 I-DATE
. O
 
She O
is O
here O
with O
her O
husband O
who O
is O
translating O
from O
columbian I-LOCATION
. O
 
I O
saw O
her O
about O
1 O
month O
a O
go O
with O
hiperpigmentation O
of O
the O
skin O
, O
which O
I O
felt O
was O
melasma O
, O
and O
treated O
her O
with O
hydroquinone O
TP O
, O
sun O
blocking O
cream O
and O
avoidance O
of O
sun O
exposure O
. O
 
Both O
she O
and O
her O
husband O
say O
tha O
her O
hiperpigmentation O
has O
decreased O
significantly O
. O
 
At O
present O
she O
has O
no O
symptoms O
and O
says O
she O
feels O
well O
. O
 
She O
ambulates O
with O
a O
cane O
, O
and O
she O
is O
planning O
a O
6-month O
trip O
to O
Columbia I-LOCATION
next O
October I-DATE
with O
her O
husband O
. O
 
She O
denies O
any O
other O
symptoms O
: O
constipation O
, O
polydypsia O
, O
polyuria O
, O
excessive O
fatigue O
, O
weakness O
Denies O
fevers O
, O
chills O
, O
CP O
, O
SOB O
, O
n/v O
. O
 
GI/GU O
complaints O
. O
 
PMH O
: O
Hypertension O
Diabetes O
Elevated O
cholesterol O
. O
 
Stroke O
SDH O
MEDS O
Medications O
( O
updated O
8/28/70 I-DATE
) O
LISINOPRIL O
10 O
MG O
( O
30MG O
TABLET O
take O
1 O
) O
PO O
QD O
ATORVASTATIN O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
DILTIAZEM O
60 O
MG O
( O
60MG O
TABLET O
take O
1 O
) O
PO O
QID O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
BID O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
ALL O
: O
NKDA O
SHX O
: O
Originally O
from O
Columbia I-LOCATION
. O
 
Married O
and O
lives O
with O
her O
husband O
. O
 
She O
has O
a O
very O
supportive O
family O
. O
 
FHX O
: O
Sister O
with O
seizures O
. O
 
PHYSICAL O
EXAM O
: O
BP O
: O
155/75 O
HR:75 O
GEN O
: O
Pleasant O
woman O
in O
NAD O
. O
 
Amiling O
, O
in O
a O
wheelchair O
. O
 
Interactve O
, O
appropriate O
reponses O
. O
 
HEENT O
. O
 
AT/NC O
. O
 
Sclera O
anicteric O
. O
 
OP O
is O
clear O
. O
 
There O
is O
no O
thyromegaly O
. O
 
NECK O
: O
Supple O
. O
 
No O
LAD O
. O
 
Carotids O
are O
2+ O
without O
bruits O
. O
 
HEART O
: O
RRR O
, O
no O
m/r/g O
LUNGS O
: O
CTA O
SKIN O
: O
Hyperpigmented O
skin O
in O
face O
, O
symmetric O
distribution O
, O
affecting O
more O
densely O
more O
cephalad O
areas O
of O
her O
face O
. O
 
The O
only O
area O
which O
is O
spaired O
is O
the O
nasolabial O
region O
. O
 
ASSESSMENT/ O
RECOMMENDATIONS O
: O
No O
evidence O
of O
acute O
illness O
. O
 
Other O
problems O
: O
1 O
) O
HTN O
: O
on O
lisinopril O
10 O
mg O
po O
qd O
, O
and O
diltiazem O
. O
 
Her O
BP O
today O
is O
slihtly O
elevated O
at O
150/75 O
. O
 
I O
will O
increase O
her O
lisinorpil O
dose O
. O
 
to O
30 O
mg O
po O
qd O
. O
 
Her O
las O
BMP O
was O
unremarkable O
. O
 
2 O
) O
DM O
: O
last O
A1C O
was O
7.1 O
in O
07/70 I-DATE
. O
 
She O
controlls O
her O
DM O
with O
diet O
. O
 
Urine O
microabuminuria O
, O
UA O
are O
pending O
. O
 
3 O
) O
Lipids O
: O
will O
re-check O
. O
 
On O
lipitor O
10 O
mg O
po O
qd O
. O
 
5 O
) O
F/u O
with O
me O
after O
they O
return O
from O
Columbia I-LOCATION
_____________________________________________ O
David I-NAME
Timothy I-NAME
Howard I-NAME
Baldwin I-NAME
, O
M.D O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
Discussed O
with O
Dr. O
Timothy I-NAME
Howard I-NAME
Baldwin I-NAME
. O
 
Agree O
with O
assessment O
and O
plan O
as O
above O
. O
 
_____________________________________________ O
Caleb I-NAME
N. I-NAME
Womack I-NAME
, O
M.D. O
, O
M.P.H O
. O
 
CC O
: O
follow-up O
HPI O
: O
75-year-old O
woman O
with O
a O
history O
of O
hypertension O
, O
diabetes O
, O
and O
hypercholesterolemia O
and O
PAF O
with O
a O
prior O
stroke O
( O
2067 I-DATE
) O
who O
subsequently O
was O
admitted O
to O
the O
OCH I-LOCATION
again O
for O
SDH O
with O
supratherapeutic O
INR O
in O
2068 I-DATE
. O
 
She O
has O
a O
prolonged O
hospital O
course O
as O
well O
as O
rehab O
stay O
and O
now O
returns O
having O
made O
significant O
recovery O
. O
 
Her O
PEG O
was O
pulled-out O
in O
06/69 I-DATE
. O
 
She O
is O
here O
with O
her O
husband O
who O
is O
translating O
from O
Columbian I-LOCATION
. O
 
I O
saw O
her O
about O
1 O
month O
a O
go O
with O
hiperpigmentation O
of O
the O
skin O
, O
which O
I O
felt O
was O
melasma O
, O
and O
treated O
her O
with O
hydroquinone O
TP O
, O
sun O
blocking O
cream O
and O
avoidance O
of O
sun O
exposure O
. O
 
Both O
she O
and O
her O
husband O
say O
tha O
her O
hiperpigmentation O
has O
decreased O
significantly O
. O
 
At O
present O
she O
has O
no O
symptoms O
and O
says O
she O
feels O
well O
. O
 
She O
ambulates O
with O
a O
cane O
, O
and O
she O
is O
planning O
a O
6-month O
trip O
to O
Columbia I-LOCATION
next O
October I-DATE
with O
her O
husband O
. O
 
She O
denies O
any O
other O
symptoms O
: O
constipation O
, O
polydypsia O
, O
polyuria O
, O
excessive O
fatigue O
, O
weakness O
Denies O
fevers O
, O
chills O
, O
CP O
, O
SOB O
, O
n/v O
. O
 
GI/GU O
complaints O
. O
 
PMH O
: O
Hypertension O
Diabetes O
Elevated O
cholesterol O
. O
 
Stroke O
SDH O
MEDS O
Medications O
( O
updated O
8/28/70 I-DATE
) O
LISINOPRIL O
10 O
MG O
( O
30MG O
TABLET O
take O
1 O
) O
PO O
QD O
ATORVASTATIN O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
QD O
DILTIAZEM O
60 O
MG O
( O
60MG O
TABLET O
take O
1 O
) O
PO O
QID O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
50 O
MG O
( O
50MG O
TABLET O
take O
1 O
) O
PO O
BID O
Lasix O
( O
FUROSEMIDE O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QD O
ALL O
: O
NKDA O
SHX O
: O
Originally O
from O
Columbia I-LOCATION
. O
 
Married O
and O
lives O
with O
her O
husband O
. O
 
She O
has O
a O
very O
supportive O
family O
. O
 
FHX O
: O
Sister O
with O
seizures O
. O
 
PHYSICAL O
EXAM O
: O
BP O
: O
155/75 O
HR:75 O
GEN O
: O
Pleasant O
woman O
in O
NAD O
. O
 
Amiling O
, O
in O
a O
wheelchair O
. O
 
Interactve O
, O
appropriate O
reponses O
. O
 
HEENT O
. O
 
AT/NC O
. O
 
Sclera O
anicteric O
. O
 
OP O
is O
clear O
. O
 
There O
is O
no O
thyromegaly O
. O
 
NECK O
: O
Supple O
. O
 
No O
LAD O
. O
 
Carotids O
are O
2+ O
without O
bruits O
. O
 
HEART O
: O
RRR O
, O
no O
m/r/g O
LUNGS O
: O
CTA O
SKIN O
: O
Hyperpigmented O
skin O
in O
face O
, O
symmetric O
distribution O
, O
affecting O
more O
densely O
more O
cephalad O
areas O
of O
her O
face O
. O
 
The O
only O
area O
which O
is O
spaired O
is O
the O
nasolabial O
region O
. O
 
ASSESSMENT/ O
RECOMMENDATIONS O
: O
No O
evidence O
of O
acute O
illness O
. O
 
Other O
problems O
: O
1 O
) O
HTN O
: O
on O
lisinopril O
10 O
mg O
po O
qd O
, O
and O
diltiazem O
. O
 
Her O
BP O
today O
is O
slihtly O
elevated O
at O
150/75 O
. O
 
I O
will O
increase O
her O
lisinorpil O
dose O
. O
 
to O
30 O
mg O
po O
qd O
. O
 
Her O
las O
BMP O
was O
unremarkable O
. O
 
2 O
) O
DM O
: O
last O
A1C O
was O
7.1 O
in O
07/70 I-DATE
. O
 
She O
controlls O
her O
DM O
with O
diet O
. O
 
Urine O
microabuminuria O
, O
UA O
are O
pending O
. O
 
3 O
) O
Lipids O
: O
will O
re-check O
. O
 
On O
lipitor O
10 O
mg O
po O
qd O
. O
 
5 O
) O
F/u O
with O
me O
after O
they O
return O
from O
Columbian I-LOCATION
_____________________________________________ O
David I-NAME
Timothy I-NAME
Howard I-NAME
Baldwin I-NAME
, O
M.D O
. O
 
========================== O
Preceptor O
's O
Note O
========================== O
Discussed O
with O
Dr. O
Timothy I-NAME
Howard I-NAME
Baldwin I-NAME
. O
 
Agree O
with O
assessment O
and O
plan O
as O
above O
. O
 
_____________________________________________ O
Caleb I-NAME
N. I-NAME
Womack I-NAME
, O
M.D. O
, O
M.P.H O
. O
 
Record O
date O
: O
2072-03-01 I-DATE
EDVISIT^91156456^HEATH O
, O
HANNAH^03/01/72^YEAGER O
, O
CHRISTOPHER I-NAME
I O
saw O
this O
patient O
with O
Dr. O
Rosalia I-NAME
West I-NAME
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
Please O
see O
the O
resident O
's O
note O
for O
further O
details O
. O
 
CHIEF O
COMPLAINT O
: O
Altered O
mental O
status O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
76-year-old O
female O
with O
history O
of O
prior O
strokes O
, O
hypertension O
, O
diabetes O
, O
and O
paroxysmal O
atrial O
fibrillation O
, O
who O
presents O
with O
altered O
mental O
status O
. O
 
As O
per O
report O
, O
the O
patient O
has O
not O
been O
acting O
like O
herself O
and O
not O
communicating O
or O
speaking O
like O
herself O
. O
 
The O
patient O
was O
in O
her O
usual O
state O
of O
health O
until O
a O
few O
days O
ago O
where O
she O
started O
to O
develop O
a O
cough O
as O
well O
as O
some O
chills O
. O
 
The O
patient O
's O
family O
members O
state O
that O
the O
patient O
has O
not O
been O
out O
of O
bed O
and O
has O
been O
unwilling O
to O
eat O
. O
 
The O
patient O
's O
family O
members O
state O
that O
the O
patient O
is O
not O
acting O
like O
her O
usual O
self O
. O
 
The O
patient O
's O
family O
members O
deny O
noting O
the O
patient O
complaining O
of O
any O
nausea O
, O
vomiting O
, O
chest O
pain O
or O
shortness O
of O
breath O
. O
 
The O
patient O
was O
actually O
taken O
to O
clinic O
yesterday O
because O
the O
patient O
was O
starting O
to O
speak O
less O
. O
 
The O
patient O
was O
seen O
clinic O
and O
was O
thought O
to O
be O
depressed O
. O
 
The O
patient O
has O
a O
known O
history O
of O
a O
facial O
droop O
. O
 
The O
patient O
was O
incontinent O
of O
urine O
today O
. O
 
PHYSICAL O
EXAMINATION O
: O
The O
patient O
's O
vital O
signs O
reveal O
the O
following O
: O
Temperature O
was O
102.8 O
, O
heart O
rate O
110-160 O
beats O
per O
minute O
, O
respiratory O
rate O
20 O
, O
blood O
pressure O
is O
144/110 O
, O
and O
oxygen O
saturation O
was O
95 O
% O
on O
room O
air O
. O
 
The O
patient O
's O
oxygen O
saturation O
was O
interpreted O
as O
borderline O
low O
. O
 
General O
: O
No O
acute O
distress O
, O
multiple O
family O
members O
at O
bedside O
. O
 
HEENT O
: O
The O
patient O
's O
head O
was O
normocephalic O
and O
atraumatic O
, O
no O
scalp O
hematomas O
. O
 
Pupils O
were O
equal O
, O
round O
, O
and O
reactive O
to O
light O
. O
 
Mucous O
membranes O
were O
somewhat O
dry O
, O
right O
facial O
droop O
noted O
, O
no O
drooling O
. O
 
Neck O
: O
Supple O
, O
no O
JVD O
, O
no O
carotid O
bruits O
appreciated O
. O
 
There O
was O
no O
meningismus O
. O
 
Respiratory O
: O
Poor O
cooperation O
with O
exam O
. O
 
Fair O
aeration O
, O
no O
focal O
rhonchi O
, O
rales O
, O
or O
wheezes O
, O
no O
increased O
work O
of O
breathing O
or O
use O
of O
accessory O
muscles O
was O
noted O
. O
 
Cardiovascular O
: O
Irregularly O
irregular O
, O
tachycardic O
, O
unable O
to O
appreciate O
any O
gross O
murmurs O
, O
rubs O
, O
or O
gallops O
. O
 
GI O
: O
Abdomen O
: O
Soft O
, O
no O
rebound O
or O
guarding O
, O
prior O
well-healed O
prior O
G-tube O
scar O
noted O
. O
 
Rectal O
exam O
deferred O
. O
 
GU O
exam O
: O
The O
patient O
was O
incontinent O
of O
urine O
. O
 
Skin O
: O
Warm O
and O
dry O
. O
 
No O
rash O
or O
lesions O
were O
noted O
. O
 
Back O
: O
The O
patient O
did O
not O
have O
any O
costovertebral O
angle O
tenderness O
. O
 
There O
is O
no O
midline O
thoracic O
, O
lumbar O
, O
or O
sacral O
spine O
tenderness O
to O
palpation O
. O
 
Extremities O
: O
Warm O
and O
well O
perfused O
, O
no O
clubbing O
, O
cyanosis O
or O
asymmetrical O
lower O
extremity O
edema O
was O
noted O
. O
 
There O
were O
no O
palpable O
cords O
. O
 
Neuro O
: O
The O
patient O
was O
alert O
, O
the O
patient O
was O
a O
verbal O
. O
 
The O
patient O
grossly O
moved O
all O
4 O
extremities O
with O
fair O
strength O
. O
 
The O
patient O
responded O
to O
touch O
appropriately O
. O
 
The O
patient O
was O
unable O
to O
cooperate O
with O
cranial O
nerve O
examination O
. O
 
INITIAL O
IMPRESSION O
AND O
PLAN O
: O
The O
patient O
is O
a O
76-year-old O
female O
with O
history O
of O
prior O
stroke O
, O
hypertension O
, O
diabetes O
, O
and O
paroxysmal O
atrial O
fibrillation O
, O
who O
presents O
with O
altered O
mental O
status O
and O
urinary O
incontinence O
. O
 
Differential O
diagnosis O
at O
this O
time O
includes O
infectious O
versus O
a O
metabolic O
abnormality O
. O
 
The O
patient O
has O
no O
new O
deficits O
on O
neuro O
exam O
as O
per O
the O
family O
and O
as O
per O
review O
of O
prior O
notes O
. O
 
Repeat O
stroke O
is O
certainly O
on O
the O
differential O
, O
however O
, O
I O
have O
a O
lower O
suspicion O
then O
for O
a O
metabolic O
or O
infectious O
etiology O
. O
 
The O
patient O
will O
need O
to O
have O
a O
large O
workup O
including O
laboratory O
studies O
, O
urine O
studies O
, O
Foley O
catheter O
, O
portable O
chest O
x-ray O
, O
and O
repeat O
noncontrast O
head O
CT O
scan O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
Upon O
arrival O
to O
the O
Emergency O
Department O
, O
the O
patient O
had O
history O
and O
physical O
exam O
performed O
. O
 
The O
patient O
was O
noted O
to O
be O
in O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
The O
patient O
's O
12-lead O
EKG O
revealed O
a O
rate O
of O
166 O
beats O
per O
minute O
, O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
, O
stable O
T-wave O
inversions O
noted O
over O
the O
lateral O
leads O
as O
well O
as O
over O
the O
precordial O
leads O
. O
 
No O
definite O
ST O
segment O
abnormalities O
were O
noted O
. O
 
The O
patient O
then O
had O
a O
portable O
chest O
x-ray O
and O
as O
per O
report O
, O
the O
patient O
's O
portable O
chest O
x-ray O
did O
not O
reveal O
any O
acute O
cardiopulmonary O
process O
or O
findings O
. O
 
The O
patient O
did O
have O
a O
noncontrast O
head O
CT O
scan O
and O
the O
patient O
's O
noncontrast O
head O
CT O
scan O
was O
notable O
for O
some O
right-sided O
edema O
. O
 
The O
patient O
will O
have O
this O
followed O
up O
with O
an O
MRI O
of O
the O
brain O
. O
 
The O
patient O
's O
laboratory O
studies O
were O
notable O
for O
sodium O
of O
131 O
and O
potassium O
of O
5.2 O
. O
 
The O
patient's O
lactic O
acid O
was O
1.7 O
. O
 
The O
patient O
's O
white O
blood O
cell O
count O
was O
not O
elevated O
. O
 
The O
patient O
was O
not O
anemic O
. O
 
The O
patient's O
urinalysis O
was O
consistent O
with O
infection O
. O
 
The O
patient O
's O
first O
set O
of O
cardiac O
markers O
were O
negative O
. O
 
The O
patient O
's O
coagulation O
studies O
were O
normal O
. O
 
The O
patient O
was O
treated O
with O
ceftriaxone O
for O
her O
urinary O
tract O
infection O
. O
 
The O
patient O
could O
possibly O
have O
urosepsis O
given O
her O
fever O
and O
tachycardia O
. O
 
Urine O
sepsis O
is O
my O
leading O
diagnosis O
at O
this O
time O
. O
 
The O
patient O
's O
right-sided O
edema O
is O
certainly O
concerning O
, O
however O
, O
I O
do O
not O
feel O
that O
the O
patient O
will O
need O
to O
be O
admitted O
to O
Neurology O
at O
this O
time O
. O
 
The O
patient O
will O
be O
admitted O
to O
medicine O
for O
presumed O
urosepsis O
. O
 
The O
patient O
will O
need O
to O
be O
admitted O
to O
a O
monitor O
bed O
. O
 
The O
patient O
's O
blood O
pressure O
is O
normal O
, O
and O
as O
such O
, O
I O
do O
not O
feel O
that O
the O
patient O
needs O
an O
intensive O
care O
unit O
bed O
. O
 
In O
terms O
the O
patient O
's O
atrial O
fibrillation O
with O
rapid O
ventricular O
response O
, O
the O
patient O
was O
given O
metoprolol O
IV O
. O
 
The O
patient O
was O
not O
given O
any O
oral O
medications O
secondary O
to O
her O
possible O
stroke O
. O
 
The O
patient O
was O
given O
rectal O
Tylenol O
as O
well O
as O
rectal O
Kayexalate O
for O
her O
elevated O
potassium O
at O
5.2 O
. O
 
PRIMARY O
DIAGNOSES O
: O
1 O
. O
 
Urosepsis O
. O
 
2 O
. O
 
Atrial O
fibrillation O
with O
rapid O
ventricular O
response O
. O
 
3 O
. O
 
Hyponatremia O
. O
 
4 O
. O
 
Hyperkalemia O
. O
 
DISPOSITION O
: O
The O
patient O
was O
admitted O
to O
the O
Medicine O
and O
to O
a O
monitor O
bed O
. O
 
CONDITION O
AT O
THE O
TIME O
OF O
DISPOSITION O
: O
Stable O
, O
but O
guarded O
. O
 
______________________________ O
YEAGER O
, O
CHRISTOPHER I-NAME
M.D O
. O
 
D O
: O
03/01/72 I-DATE
T O
: O
03/01/72 I-DATE
Dictated O
By O
: O
YEAGER O
, O
CHRISTOPHER I-NAME
eScription O
document:4-2135677 O
IFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2092-08-16 I-DATE
EDVISIT^06129040^MACK O
, O
ROSE^08/16/92^GRAHAM O
, O
ANGELA I-NAME
This O
patient O
's O
visit O
was O
shared O
with O
PA O
, O
Quiring I-NAME
. O
 
I O
also O
personally O
interviewed O
and O
examined O
this O
patient O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
50-year-old O
female O
with O
past O
medical O
history O
of O
type O
1 O
diabetes O
, O
peripheral O
vascular O
disease O
, O
and O
hypothyroidism O
who O
presents O
for O
evaluation O
of O
an O
infected O
left O
heel O
ulcer O
. O
 
The O
patient O
is O
status O
post O
bypass O
grafting O
in O
her O
lower O
extremities O
and O
skin O
grafting O
of O
a O
nonhealing O
ulcer O
on O
her O
right O
heel O
. O
 
Since O
that O
time O
, O
she O
has O
developed O
a O
chronic O
nonhealing O
ulcer O
on O
the O
left O
heel O
, O
which O
has O
been O
followed O
closely O
by O
VNA O
. O
 
Today O
, O
she O
was O
seen O
by O
her O
VNA O
who O
was O
very O
concerned O
about O
redness O
and O
swelling O
of O
her O
left O
foot O
with O
redness O
that O
extended O
underneath O
the O
plantar O
surface O
of O
the O
foot O
and O
over O
the O
dorsal O
surface O
and O
concern O
for O
infection O
of O
this O
ulcer O
. O
 
The O
patient O
has O
minimal O
sensation O
in O
the O
left O
foot O
. O
 
She O
states O
sometimes O
she O
can O
feel O
a O
pressure O
sensation O
. O
 
She O
does O
have O
some O
pain O
when O
she O
tries O
to O
weightbear O
, O
has O
not O
noted O
any O
fevers O
, O
has O
noted O
some O
chills O
and O
states O
that O
her O
fingerstick O
earlier O
today O
was O
elevated O
. O
 
She O
denies O
any O
abdominal O
pain O
, O
nausea O
, O
or O
vomiting O
. O
 
She O
does O
note O
that O
her O
foot O
does O
appear O
to O
be O
somewhat O
slightly O
more O
swollen O
but O
has O
not O
noticed O
redness O
up O
until O
today O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Positive O
for O
hypothyroidism O
, O
type O
1 O
diabetes O
, O
and O
peripheral O
vascular O
disease O
with O
a O
nonhealing O
diabetic O
foot O
ulcers O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
She O
is O
status O
post O
femoral O
bypass O
grafting O
, O
thyroidectomy O
, O
skin O
grafting O
for O
nonhealing O
wounds O
, O
and O
right O
foot O
debridement O
in O
the O
past O
. O
 
SOCIAL O
HISTORY O
: O
She O
smoked O
in O
the O
past O
, O
does O
not O
drink O
. O
 
She O
lives O
with O
family O
, O
is O
followed O
by O
a O
VNA O
, O
and O
is O
not O
working O
. O
 
FAMILY O
HISTORY O
: O
Reviewed O
and O
is O
also O
positive O
for O
diabetes O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
All O
other O
systems O
reviewed O
and O
otherwise O
negative O
except O
per O
the O
HPI O
. O
 
MEDICATIONS O
: O
Insulin O
. O
 
ALLERGIES O
: O
She O
has O
an O
allergy O
to O
codeine O
, O
aspirin O
, O
erythromycin O
, O
oxycodone O
, O
and O
sulfa O
. O
 
PHYSICAL O
EXAMINATION O
: O
Her O
temperature O
is O
98.6 O
, O
her O
pulse O
105 O
, O
respirations O
16 O
, O
blood O
pressure O
117/70 O
, O
and O
O2 O
saturations O
are O
100 O
% O
on O
room O
air O
. O
 
The O
patient O
is O
awake O
, O
alert O
, O
frail O
, O
and O
thin O
female O
. O
 
She O
is O
in O
no O
respiratory O
distress O
. O
 
Her O
head O
examination O
is O
normocephalic O
and O
atraumatic O
. O
 
Her O
conjunctivae O
are O
slightly O
pale O
. O
 
She O
has O
moist O
mucous O
membranes O
. O
 
The O
airway O
is O
patent O
. O
 
Her O
neck O
is O
supple O
with O
full O
range O
of O
motion O
without O
any O
pain O
. O
 
The O
trachea O
is O
midline O
. O
 
Her O
lungs O
are O
clear O
to O
auscultation O
bilaterally O
with O
equal O
breath O
sounds O
. O
 
No O
respiratory O
distress O
, O
no O
accessory O
muscle O
use O
, O
and O
no O
chest O
wall O
tenderness O
. O
 
Her O
cardiac O
examination O
is O
tachycardic O
and O
regular O
at O
about O
100 O
with O
a O
3/6 O
systolic O
murmur O
. O
 
Her O
abdomen O
is O
nondistended O
, O
soft O
, O
and O
nontender O
. O
 
No O
guarding O
and O
no O
peritoneal O
signs O
. O
 
Her O
skin O
is O
remarkable O
for O
healing O
superficial O
ulcers O
on O
the O
right O
heel O
. O
 
On O
the O
left O
heel O
, O
she O
has O
a O
superficial O
ulcer O
with O
a O
dark O
eschar O
, O
which O
is O
approximately O
4 O
x O
4 O
cm O
in O
diameter O
. O
 
There O
is O
no O
purulent O
discharge O
around O
the O
area O
; O
however O
, O
the O
skin O
of O
the O
left O
foot O
is O
fairly O
violaceous O
and O
warm O
on O
the O
plantar O
surface O
of O
the O
foot O
surrounding O
the O
ulcer O
extending O
up O
the O
lateral O
aspect O
of O
the O
foot O
to O
the O
anterior O
aspect O
of O
the O
left O
ankle O
was O
demarcated O
in O
the O
Emergency O
Department O
. O
 
There O
is O
no O
other O
break O
in O
the O
skin O
visualized O
. O
 
Her O
back O
is O
nontender O
with O
full O
range O
of O
motion O
. O
 
Extremities O
are O
remarkable O
for O
lower O
extremity O
atrophy O
. O
 
She O
does O
have O
1+ O
edema O
of O
both O
feet O
. O
 
She O
has O
minimal O
sensation O
on O
palpation O
of O
her O
feet O
with O
no O
obvious O
tenderness O
on O
palpation O
over O
her O
left O
foot O
. O
 
Her O
pulses O
are O
trace O
. O
 
She O
is O
alert O
and O
oriented O
x3 O
, O
has O
a O
depressed O
affect O
. O
 
See O
the O
PA O
note O
for O
remainder O
of O
the O
details O
of O
the O
physical O
examination O
. O
 
EMERGENCY O
DEPARTMENT O
COURSE O
: O
The O
patient O
had O
IV O
access O
initiated O
. O
 
Laboratory O
studies O
were O
sent O
including O
blood O
cultures O
. O
 
She O
was O
started O
on O
IV O
antibiotics O
, O
vancomycin O
, O
and O
gentamicin O
and O
was O
consulted O
to O
Vascular O
Surgery O
. O
 
Her O
feet O
remained O
elevated O
. O
 
She O
had O
a O
plain O
x-ray O
performed O
of O
her O
foot O
, O
which O
showed O
no O
obvious O
evidence O
of O
osteomyelitis O
and O
no O
subcutaneous O
gas O
. O
 
Her O
laboratory O
studies O
are O
remarkable O
for O
hyperglycemia O
and O
she O
was O
started O
on O
IV O
fluids O
. O
 
DISPOSITION O
: O
She O
is O
admitted O
to O
Surgery O
. O
 
DIAGNOSIS O
: O
Left O
foot O
, O
nonhealing O
ulcer O
with O
left O
foot O
cellulitis O
, O
and O
peripheral O
vascular O
disease O
. O
 
See O
the O
note O
for O
details O
. O
 
______________________________ O
GRAHAM O
, O
ANGELA I-NAME
M.D O
. O
 
D O
: O
08/16/92 I-DATE
T O
: O
08/16/92 I-DATE
Dictated O
By O
: O
GRAHAM O
, O
ANGELA I-NAME
eScription O
document:3-3296461 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2092-10-26 I-DATE
SECTIONS O
OF O
THIS O
NOTE O
WERE O
CREATED O
WITH O
A O
'COPY O
AND O
PASTE O
' O
ACTION O
. O
 
THESE O
SECTIONS O
MAY O
NOT O
HAVE O
COPIED O
COMPLETELY O
. O
 
PLEASE O
USE O
CAUTION O
WHEN O
RENDERING O
CLINICAL O
JUDGMENT O
BASED O
ON O
THE O
INFORMATION O
IN O
THIS O
NOTE.GCC O
Team O
A O
Infectious O
Disease O
Consultation O
Patient O
: O
Mack O
, O
Rose I-NAME
C I-NAME
( O
06129040 I-ID
, O
63I O
) O
ID O
Fellow O
: O
Amanda I-NAME
Qualls I-NAME
ID O
Attending O
: O
Craig I-NAME
Faulkner I-NAME
Referring O
Physician O
: O
Dr. O
Kevin I-NAME
Katz I-NAME
Date O
of O
Consult O
: O
10/26/2092 I-DATE
Reason O
for O
Consult O
: O
DM O
, O
chronic O
R O
and O
L. O
foot O
ulcerations O
; O
L. O
foot O
ulceration O
with O
surrounding O
erythema O
, O
pain O
HPI O
: O
50F O
w/longstanding O
type O
I O
DM O
with O
retinopathy O
, O
nephropathy O
, O
autonomic O
and O
peripheral O
neuropathy O
, O
recent O
development O
of O
L. O
heel O
and O
forefoot O
ulcers O
, O
here O
with O
a O
few O
days O
of O
pain O
, O
erythema O
, O
and O
swelling O
around O
her O
L. O
forefoot O
ulcer O
. O
 
She O
has O
an O
extremely O
complicated O
history O
of O
R O
and O
now O
L. O
foot O
infections O
and O
ulcerations O
, O
in O
setting O
of O
here O
severe O
neuropathy O
and O
DM O
. O
 
She O
originally O
sustained O
a O
R. O
5th O
metatarsal O
fracture O
in O
2083 I-DATE
, O
with O
poor O
union O
, O
and O
subsequent O
fracture O
of O
her O
2nd O
& O
# O
8211 O
; O
4th O
metatarsals O
. O
 
She O
developed O
a O
chronic O
ulcerated O
callus O
over O
her O
R. O
lateral O
metatarsal O
heads O
, O
with O
underlying O
osteomyelitis O
& O
# O
8212 O
; O
this O
did O
not O
improve O
despite O
multiple O
courses O
of O
antibiotics O
. O
 
She O
underwent O
I+D O
of O
her O
R. O
foot O
ulceration O
in O
12/89 I-DATE
, O
OR O
cultures O
grew O
P. O
aeruginosa O
. O
 
In O
3/90 I-DATE
, O
she O
underwent O
debridement O
of O
her O
chronic O
R. O
lateral O
plantar O
ulceration O
and O
skin O
grafting O
. O
 
In O
6/90 I-DATE
, O
she O
underwent O
deep O
debridement O
of O
her O
ongoing O
5th O
metatarsal O
osteomyelitis O
, O
along O
with O
excision O
of O
her O
5th O
metatarsal O
& O
# O
8212 O
; O
bone O
cultures O
grew O
MSSA O
. O
 
She O
did O
well O
until O
2/92 I-DATE
, O
when O
she O
underwent O
R. O
ankle O
revision O
for O
an O
equinovarus O
deformity O
of O
her O
R. O
hindfoot O
( O
calcaneal O
osteotomy O
, O
lateral O
translation O
, O
dorsiflexion O
first O
metatarsal O
osteotomy O
, O
and O
Achilles O
lengthening O
) O
. O
 
She O
subsequently O
developed O
a O
R. O
heel O
ulceration O
, O
and O
in O
4/92 I-DATE
, O
underwent O
debridement O
of O
this O
ulceration O
, O
removal O
of O
a O
screw O
, O
and O
placement O
of O
a O
vacuum O
sponge O
. O
 
Her O
wound O
continued O
to O
heal O
poorly O
, O
and O
she O
underwent O
R. O
SFA O
to O
posterior O
tibial O
bypass O
grafting O
. O
 
In O
7/92 I-DATE
, O
she O
underwent O
debridement O
of O
her O
R. O
heel O
wound O
and O
placement O
of O
a O
full O
thickness O
skin O
graft O
, O
which O
has O
taken O
well O
; O
she O
feels O
that O
her O
R. O
heel O
has O
been O
healing O
nicely O
. O
 
During O
her O
long O
hospitalization O
in O
4/92 I-DATE
, O
she O
started O
developing O
L. O
heel O
and O
L. O
forefoot O
ulcerations O
. O
 
She O
attributes O
the O
heel O
ulcerations O
to O
chronic O
pressure O
from O
her O
position O
in O
bed O
, O
and O
the O
forefoot O
ulcerations O
to O
the O
boots O
that O
were O
used O
to O
relieve O
her O
heel O
pressure O
, O
which O
apparently O
abraded O
her O
forefoot O
chronically O
. O
 
These O
ulcerations O
continued O
to O
worsen O
over O
the O
next O
few O
months O
, O
and O
she O
presented O
with O
cellulitis O
of O
this O
area O
in O
8/92 I-DATE
. O
 
She O
received O
vancomycin O
, O
levofloxacin O
, O
flagyl O
initially O
, O
then O
augmentin O
, O
with O
persistent O
poor O
healing O
of O
her O
wounds O
. O
 
On O
9/10 I-DATE
, O
she O
underwent O
operative O
debridement O
of O
her O
L. O
plantar O
heel O
ulcer O
& O
# O
8212 O
; O
she O
was O
found O
to O
have O
extensive O
necrotic O
yellow-brown O
tissue O
underlying O
her O
L. O
heel O
eschar O
, O
which O
was O
extensively O
debrided O
; O
she O
received O
a O
course O
of O
linezolid O
postoperatively O
. O
 
She O
had O
an O
angiogram O
on O
9/12 I-DATE
, O
which O
showed O
no O
significant O
flow O
limiting O
lesions O
in O
her O
LLE O
, O
and O
good O
flow O
through O
her O
prior O
R. O
SFA O
to O
posterior O
tibial O
bypas O
graft O
. O
 
She O
feels O
that O
her O
wounds O
have O
been O
healing O
fairly O
well O
recently O
; O
she O
feels O
that O
her O
R. O
heel O
is O
almost O
completely O
healed O
, O
and O
that O
her O
L. O
heel O
ulcer O
is O
smaller O
than O
it O
was O
previously O
. O
 
Her O
L. O
forefoot O
ulcer O
is O
also O
more O
shallow O
than O
it O
was O
in O
the O
past O
. O
 
Over O
the O
past O
2-3 O
days O
, O
she O
developed O
fairly O
acute O
swelling O
, O
erythema O
, O
and O
pain O
around O
her O
forefoot O
ulcer O
, O
with O
erythema O
spreading O
to O
the O
dorsal O
surface O
of O
her O
foot O
. O
 
She O
was O
seen O
in O
vascular O
surgery O
clinic O
, O
and O
was O
admitted O
for O
antibiotics O
and O
further O
debridement O
. O
 
She O
has O
a O
chronic O
& O
# O
8216 O
; O
fast O
heartbeat O
, O
& O
# O
8217 O
; O
denies O
any O
systemic O
symptoms O
( O
no O
fevers O
, O
chills O
, O
sweats O
, O
notable O
weight O
changes O
) O
, O
headaches O
, O
sinus O
symptoms O
, O
sore O
throat O
, O
cough O
, O
shortness O
of O
breath O
, O
chest O
pain O
, O
nausea O
, O
vomiting O
, O
abdominal O
pain O
, O
diarrhea O
, O
blood O
in O
her O
bowel O
movements O
, O
dysuria O
, O
frequency O
, O
LE O
edema O
, O
rashes O
, O
myalgias O
, O
or O
new O
arthralgias O
. O
 
She O
feels O
that O
her O
foot O
erythema O
has O
improved O
significantly O
overnight O
with O
vancomycin O
. O
 
PMH O
: O
poorly O
controlled O
type O
I O
DM O
since O
age O
12 I-AGE
& O
# O
8212 O
; O
complicated O
by O
diabetic O
retinopathy O
s/p O
bilateral O
vitrectomies O
for O
retinal O
hemorrhage O
, O
nephropathy O
, O
peripheral O
neuropathy O
, O
autonomic O
nephropathy O
( O
gastroparesis O
) O
& O
# O
8212 O
; O
on O
an O
insulin O
pump O
chronic O
foot O
ulcerations O
, O
initially O
R O
, O
now O
L O
, O
requiring O
numerous O
antibiotic O
courses O
and O
operative O
interventions O
: O
2083 I-DATE
: O
R. O
5th O
metatarsal O
fracture O
in O
2083 I-DATE
, O
poor O
union O
, O
subsequent O
fracture O
of O
the O
remainder O
of O
her O
R. O
metarsals O
chronic O
ulcerated O
callus O
over O
R. O
lateral O
metatarsal O
heads O
, O
with O
underlying O
osteomyelitis O
, O
no O
improvement O
despite O
multiple O
courses O
of O
antibiotics O
12/89 I-DATE
: O
I+D O
of O
R. O
foot O
ulceration O
& O
# O
8212 O
; O
cultures O
grew O
P. O
aeruginosa O
3/90 I-DATE
: O
debridement O
of O
chronic O
R. O
lateral O
plantar O
ulceration O
and O
skin O
grafting O
6/90 I-DATE
: O
deep O
debridement O
of O
her O
5th O
metatarsal O
osteomyelitis O
, O
excision O
of O
her O
5th O
metatarsal O
& O
# O
8212 O
; O
cultures O
grew O
MSSA O
2/92 I-DATE
: O
calcaneal O
osteotomy O
, O
lateral O
translation O
, O
dorsiflexion O
first O
metatarsal O
osteotomy O
, O
and O
Achilles O
lengthening O
for O
equinovarus O
deformity O
of O
her O
R. O
hindfoot O
4/92 I-DATE
: O
subsequent O
development O
of O
R. O
heel O
ulceration O
, O
s/p O
debridement O
of O
her O
ulceration O
, O
removal O
of O
a O
screw O
, O
vacuum O
sponge O
placement O
4/92 I-DATE
: O
R. O
SFA O
to O
posterior O
tibial O
bypass O
grafting O
7/92 I-DATE
: O
debridement O
of O
her O
R. O
heel O
wound O
and O
full O
thickness O
skin O
graft O
( O
12 I-AGE
x O
5cm O
) O
9/92 I-DATE
: O
development O
of O
L. O
heel O
and O
forefoot O
ulcerations O
at O
rehabilitation O
, O
with O
debridement O
of O
her O
L. O
plantar O
heel O
ulcer O
on O
9/10 I-DATE
& O
# O
8212 O
; O
found O
to O
have O
extensive O
necrotic O
yellow-brown O
tissue O
underlying O
her O
eschar O
PICC-associated O
RUE O
DVT O
7/92 I-DATE
, O
on O
coumadin O
s/p O
L. O
ankle O
fracture O
in O
2083 I-DATE
R. O
foot O
RSD O
s/p O
multiple O
R. O
lumbar O
sympathetic O
blocks O
s/p O
R. O
carpal O
tunnel O
surgery O
hypothyroidism O
iron O
deficiency O
anemia O
depression O
& O
# O
8212 O
; O
inpatient O
admission O
2090 I-DATE
with O
suicidal O
ideations O
s/p O
subtotal O
thyroidectomy O
2073 I-DATE
s/p O
breast O
lumpectomy O
2078 I-DATE
& O
# O
8212 O
; O
has O
missed O
her O
follow-up O
mammogram O
appointments O
due O
to O
her O
foot O
issues O
2088 I-DATE
colonoscopy O
with O
& O
# O
8216 O
; O
precancerous O
polyp O
& O
# O
8217 O
; O
& O
# O
8212 O
; O
needs O
repeat O
evaluation O
Home O
Medications O
: O
insulin O
pump O
Acetaminophen650 O
MG O
PO O
Q6H O
prn O
Pain O
, O
Headache O
Calcium O
Carbonate O
1250 O
Mg O
( O
500 O
Mg O
Elem O
Ca O
) O
1 O
TAB O
PO O
TID O
Clonazepam0.5 O
MG O
PO O
BID O
Clonazepam0.25 O
MG O
PO O
QD O
prn O
Insomnia O
, O
Anxiety O
Clotrimazole O
1 O
% O
Cream O
TOPICAL O
TP O
BID O
prn O
Itching O
Desipramine O
Hcl175 O
MG O
PO O
HS O
Docusate O
Sodium O
( O
Colace O
) O
100 O
MG O
PO O
BID O
Folic O
Acid1 O
MG O
PO O
QD O
Haloperidol O
1 O
MG O
PO O
QHS O
Hydromorphone O
Hcl O
( O
Dilaudid O
) O
4 O
MG O
PO O
Q4H O
prn O
Levothyroxine O
Sodium250 O
MCG O
PO O
QD O
Omeprazole40 O
MG O
PO O
QD O
Sennosides O
Liquid2 O
TSP O
PO O
QHS O
Therapeutic O
Multivitamins O
( O
Multivitamin O
Therapeutic O
) O
1 O
TAB O
PO O
QD O
Trazodone200 O
MG O
PO O
QHS O
Warfarin O
Sodium5 O
MG O
PO O
QPM O
Inpatient O
Medications O
: O
Antibiotics O
: O
-vancomycin O
1g O
IV O
bid O
( O
10/25- O
) O
Immunosuppressants O
: O
none O
Others O
: O
home O
medications O
, O
SC O
heparin O
, O
novolog O
sliding O
scale O
q6hrs O
Allergies O
: O
& O
# O
183 O
; O
ASA O
& O
# O
224 O
; O
asthma O
& O
# O
183 O
; O
erythromycin O
& O
# O
224 O
; O
severe O
nausea O
, O
syncope O
& O
# O
183 O
; O
sulfa O
& O
# O
224 O
; O
rash O
, O
nausea O
& O
# O
183 O
; O
IV O
contrast O
& O
# O
224 O
; O
nausea O
, O
has O
tolerated O
LE O
angiogram O
recently O
without O
problems O
SocHx O
: O
-was O
walking O
with O
a O
cane O
; O
more O
recently O
, O
has O
been O
using O
a O
wheelchair O
; O
still O
non-weight O
bearing O
on O
her O
L. O
foot O
, O
but O
has O
been O
working O
with O
physical O
therapy O
-lives O
in O
Girard I-LOCATION
with O
her O
parents O
, O
sister O
-Tob O
: O
smoked O
30 O
years O
, O
rolled O
her O
own O
cigarettes O
; O
quit O
8 O
years O
ago O
-EtOH O
: O
none O
recently O
-IVDU O
: O
no O
IVDU O
; O
used O
marijuana O
in O
the O
past O
FamHx O
: O
sister O
& O
# O
8212 O
; O
gestational O
DM O
ROS O
: O
negative O
in O
detail O
except O
as O
described O
above O
in O
HPI O
. O
 
Exam O
: O
Tm O
99.2Tc O
97.4 O
HR O
96-122BP O
120-136/50-72RR O
16O2 O
sat O
99-100 O
% O
RA O
Gen O
: O
thin O
, O
pale O
, O
chronically O
ill O
appearing O
woman O
in O
NAD O
HEENT O
: O
clear O
oropharynx O
without O
thrush O
, O
ulcerations O
; O
few O
cracked O
teeth O
, O
no O
significant O
cervical/supraclavicular O
lymphadenopathy O
, O
few O
L. O
axillary O
nodes O
Pulm O
: O
lungs O
clear O
CV O
: O
tachycardic O
, O
regular O
, O
II/VI O
SEM O
Abd O
: O
soft O
, O
NT O
, O
+normal O
BS O
, O
no O
HSM O
Extr O
: O
warm O
, O
no O
edema O
, O
1+ O
PT O
pulses O
bilaterally O
; O
R. O
heel O
ulcer/skin O
graft O
site O
healing O
well O
, O
minimal O
drainage O
; O
L. O
heel O
ulcer O
fairly O
shallow O
, O
2cm O
in O
diameter O
, O
3cm O
L. O
forefoot O
ulcer O
with O
necrotic O
material O
at O
base O
, O
some O
drainage O
, O
minimal O
surrounding O
erythema O
Skin O
: O
no O
rashes O
, O
no O
nail O
changes O
Labs O
: O
( O
10/26 I-DATE
) O
WBC O
4.35 O
( O
4-10 O
) O
K/uL O
LYMP O
% O
16.2 O
* O
( O
18-41 O
) O
% O
MONO O
% O
5.8 O
( O
2.5-8.5 O
) O
% O
NEUT O
% O
77.8 O
* O
( O
48-76 O
) O
% O
EOS O
% O
0 O
( O
0-5 O
) O
% O
BASO O
% O
0.2 O
( O
0-1.5 O
) O
% O
HCT O
32.3 O
* O
( O
36-48 O
) O
% O
PLT O
452 O
* O
( O
150-450 O
) O
K/uL O
PTT O
54.3 O
* O
( O
23.8-36.6 O
) O
sec O
PT O
( O
INR O
) O
2.1 O
* O
( O
0.9-1.1 O
) O
GLUCOSE O
265 O
* O
# O
( O
54-118 O
) O
mg/dL O
UREA O
N O
20 O
( O
9-25 O
) O
mg/dL O
CREATININE O
1.36 O
* O
( O
0.7-1.3 O
) O
mg/dL O
ALT/GPT O
11 O
( O
7-52 O
) O
U/L O
AST/GOT O
9 O
( O
9-30 O
) O
U/L O
ALK O
PHOS O
113 O
( O
36-118 O
) O
U/L O
TOT O
BILI O
0.3 O
( O
0.2-1.2 O
) O
mg/dL O
ALBUMIN O
3.6 O
* O
# O
( O
3.7-5.4 O
) O
g/dL O
UA O
( O
10/25 I-DATE
) O
: O
sg O
1.013 O
, O
1+ O
glucose O
, O
( O
- O
) O
LE O
, O
( O
- O
) O
nitr O
Microbiology O
: O
& O
# O
183 O
; O
9/10 I-DATE
: O
L. O
foot O
debridement O
cx O
: O
4+ O
CoNS O
( O
ox/PCN/lev-R O
) O
, O
4+ O
Corynebacterium O
spp O
& O
# O
183 O
; O
8/14 I-DATE
: O
R. O
groin O
wound O
cx O
: O
many O
MRSA O
& O
# O
183 O
; O
7/92 I-DATE
: O
R. O
foot O
skin O
graft O
cx O
: O
3+ O
CoNS O
, O
3+ O
diphtheroids O
& O
# O
183 O
; O
4/92 I-DATE
: O
R. O
heel O
biopsy O
cx O
: O
few O
S. O
simulans O
( O
ox/PCN-R O
, O
vanc/tet/rif/bactr-S O
) O
. O
 
few O
S. O
epidermidis O
( O
PCN/lev-R O
, O
ox-S O
) O
, O
few O
diphtheroids O
& O
# O
183 O
; O
6/90 I-DATE
: O
rare O
MSSA O
( O
PCN-R O
, O
erythro-I O
, O
otherwise O
sensitive O
) O
& O
# O
183 O
; O
12/89 I-DATE
: O
R. O
foot O
debridement O
cx O
: O
many O
P. O
aeruginosa O
( O
S O
to O
all O
tested O
agents O
) O
& O
# O
183 O
; O
12/89 I-DATE
: O
R. O
foot O
wound O
culture O
: O
rare O
MSSA O
, O
rare O
alpha-hemolytic O
streptococci O
, O
many O
bacteroides O
gracilis O
, O
many O
peptostreptococcus O
prevotii O
, O
few O
fusobacterium O
nucleatum O
, O
moderate O
anaerobic O
GNRs O
Radiology O
: O
& O
# O
183 O
; O
10/25 I-DATE
: O
PA/lateral O
CXR O
: O
no O
acute O
cardiopulmonary O
process O
& O
# O
183 O
; O
9/12 I-DATE
: O
BLE O
angiogram O
: O
distal O
aorta O
and O
iliac O
vessels O
without O
stenosis O
, O
R O
CFA O
and O
PFA O
widely O
patent O
, O
proximal O
1-2cm O
SFA O
with O
mild-moderate O
stenosis O
, O
without O
flow O
limitation O
; O
remainder O
of O
SFA O
above O
bypass O
without O
obvious O
stenosis O
, O
R O
mid-SFA O
to O
mid-PT O
bypass O
widely O
patent O
, O
PT O
outflow O
vessel O
good O
quality O
, O
other O
tibial O
vessels O
quite O
atretic O
; O
LLE O
: O
L. O
CFA O
and O
PFA O
widely O
patent O
, O
L. O
SFA O
with O
mild O
eccentric O
proximal O
stenosis O
, O
L. O
popliteal O
with O
mild-moderate O
non-flow O
limiting O
stenosis O
, O
two O
vessel O
PT O
and O
peroneal O
runoff O
good O
quality O
& O
# O
183 O
; O
8/16/92 I-DATE
: O
L. O
foot O
films O
: O
diffuse O
bone O
demineralization O
, O
no O
fracture O
or O
dislocation O
; O
dorsal O
talar O
osteophyte O
, O
nonspecific O
punctate O
calcification O
in O
plantar O
aspect O
of O
calcaneus O
, O
no O
evidence O
of O
osteomyelitis O
, O
soft O
tissue O
swelling O
in O
plantar O
aspect O
of O
foot O
Impression/Recommendations O
: O
50F O
w/longstanding O
type O
I O
DM O
with O
severe O
peripheral O
neuropathy O
, O
recent O
development O
of O
L. O
heel O
and O
forefoot O
ulcers O
, O
here O
with O
cellulitis O
surrounding O
her O
L. O
forefoot O
ulcer O
, O
improving O
on O
vancomycin O
. O
 
Awaiting O
debridement O
today O
, O
need O
to O
determine O
depth O
of O
her O
infection O
and O
whether O
it O
extends O
to O
bone O
: O
& O
# O
183 O
; O
Continue O
vancomycin O
1g O
IV O
bid O
for O
now O
. O
 
Her O
renal O
function O
is O
impaired O
from O
her O
DM O
& O
# O
8212 O
; O
would O
check O
a O
vancomycin O
trough O
prior O
to O
her O
next O
dose O
. O
 
& O
# O
183 O
; O
Please O
send O
biopsy O
of O
bone O
underlying O
her O
L. O
forefoot O
ulcer O
for O
gram O
stain O
, O
aerobic O
culture O
, O
and O
anaerobic O
culture O
from O
OR O
today O
. O
 
& O
# O
183 O
; O
Needs O
to O
be O
on O
MRSA O
contact O
precautions O
& O
# O
8212 O
; O
grew O
abundant O
MRSA O
from O
her O
R. O
groin O
wound O
last O
month O
. O
 
& O
# O
183 O
; O
Has O
missed O
her O
follow-up O
mammogram O
appointments O
and O
colonoscopy O
appointments O
for O
follow-up O
of O
an O
abnormal O
lumpectomy O
finding O
and O
a O
& O
# O
8216 O
; O
precancerous O
polyp O
& O
# O
8217 O
; O
because O
of O
her O
recent O
foot O
issues O
. O
 
Unable O
to O
stand O
for O
mammography O
because O
of O
her O
foot O
issues O
& O
# O
8212 O
; O
will O
discuss O
optimal O
imaging O
of O
her O
L. O
breast O
with O
breast O
radiology O
, O
will O
hopefully O
be O
able O
to O
obtain O
this O
study O
during O
this O
hospitalization O
. O
 
Discussed O
with O
Dr. O
Craig I-NAME
Faulkner I-NAME
, O
ID O
Attending O
. O
 
Recommendations O
discussed O
with O
Dr. O
Zane I-NAME
Querry I-NAME
of O
primary O
team O
. O
 
Thank O
you O
for O
this O
interesting O
consult O
& O
# O
8212 O
; O
we O
will O
continue O
to O
follow O
with O
you O
. O
 
____________________________________ O
Amanda I-NAME
Qualls I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2092-12-26 I-DATE
Diabetes O
CONSULT O
REPORT O
CC O
Asked O
by O
Dr. O
Katz I-NAME
to O
see O
the O
patient O
for O
assistance O
with O
management O
of O
hyperglycemia O
. O
 
HPI O
This O
is O
a O
50 I-AGE
year O
old O
male O
patient O
with O
a O
history O
of O
type O
1 O
diabetes O
diagnosed O
40 O
years O
ago O
at O
an O
age O
of O
10 I-AGE
. O
 
Pt O
was O
initially O
treated O
with O
insulin O
and O
has O
been O
requiring O
insulin O
since O
diagnosis O
. O
 
Pt O
was O
started O
on O
an O
insulin O
pump O
in O
2079 I-DATE
. O
 
Current O
basal O
rates O
are O
0.6 O
units O
from O
12am-6am O
, O
0.7 O
units O
from O
6am O
to O
6:30pm O
and O
then O
0.6 O
units O
at O
6:30pm O
again O
. O
 
Pt O
uses O
a O
carb O
ratio O
of O
10:1 O
. O
 
Pt O
can O
not O
recall O
her O
correction O
factor O
as O
it O
is O
programmed O
into O
her O
pump O
. O
 
Monitors O
her O
blood O
glucoses O
at O
least O
4 O
times O
per O
day O
and O
reports O
variable O
glucoses O
for O
70- O
& O
gt O
; O
200 O
. O
 
Reports O
hypoglycemic O
episodes O
1-2 O
times O
per O
week O
and O
she O
is O
usually O
symptomatic O
with O
glucoses O
of O
70 O
. O
 
Reports O
that O
she O
was O
admitted O
to O
the O
hospital O
about O
one O
month O
ago O
with O
DKA O
. O
 
States O
that O
she O
had O
flu-like O
symptoms O
and O
severe O
vomiting O
and O
was O
admitted O
ot O
Ames I-LOCATION
Pathology I-LOCATION
Center I-LOCATION
for O
treatment O
. O
 
Had O
never O
had O
DKA O
before O
. O
 
Pt O
reports O
complications O
associated O
with O
diabetes O
. O
 
Reports O
retinopathy O
and O
has O
had O
several O
laster O
surgeries O
. O
 
Reports O
nephropathy O
as O
well O
as O
an O
episode O
of O
renal O
failure O
related O
to O
a O
hospitalization O
this O
summer O
. O
 
Reports O
peripheral O
neuropathy O
as O
well O
as O
peripheral O
vascular O
disease O
, O
including O
non-healing O
ulcers O
that O
have O
lead O
to O
right O
TMA O
. O
 
Patient O
is O
admitted O
for O
stenosis O
of O
right O
bypass O
graft O
stenosis O
and O
is O
going O
to O
the O
cath O
lab O
for O
angiogram O
shortly O
. O
 
Currently O
receiving O
D5W O
with O
150 O
meq O
of O
Bicarb O
at O
125 O
ccs/hr O
for O
renal O
protection O
. O
 
BG O
today O
( O
with O
IV O
fluid O
infusing O
) O
: O
230 O
( O
4am O
) O
, O
271 O
( O
9am O
) O
, O
and O
195 O
( O
11am O
- O
prior O
to O
leaving O
for O
cath O
) O
BG O
12/25 I-DATE
: O
152 O
( O
1pm O
) O
, O
196 O
( O
6pm O
) O
, O
172 O
( O
8pm O
) O
Pt O
is O
using O
her O
insulin O
pump O
. O
 
Allergies O
Erythromycins O
- O
rash O
Sulfa O
- O
rash O
Aspirin O
- O
rash O
Medications O
Diabetes O
medications O
at O
home O
included O
: O
Insulin O
pump O
, O
see O
HPI O
Diabetes O
medications O
now O
include O
: O
Insulin O
pump O
Problems O
Anemia O
Anxiety O
Deep O
venous O
thrombosis O
Depression O
Hypothyroidism O
Palpitations O
Right O
TMA O
Let O
ankle O
fracture O
FHX O
No O
history O
of O
hormonal O
disorders O
in O
any O
family O
members O
SHX O
and O
Habits O
Non-smoker O
ROS O
Patient O
is O
post-operative O
. O
 
Physical O
Examination O
General O
: O
Patient O
is O
in O
no O
apparent O
distress O
. O
 
Vitals O
: O
BP O
110/60 O
, O
HR O
99 O
, O
Temp O
HENT O
: O
Inspection O
reveals O
no O
abnormalities O
. O
 
Eyes O
: O
Conjunctivae O
, O
sclera O
and O
lids O
are O
normal O
. O
 
No O
icterus O
. O
 
Respiratory O
: O
Assessment O
of O
respiratory O
effort O
reveals O
even O
respirations O
without O
use O
of O
accessory O
muscles O
Skin O
: O
No O
skin O
rash O
, O
warm O
and O
dry O
skin O
. O
 
No O
acanthosis O
nigricans O
. O
 
Neurological O
Examination O
: O
Alert O
and O
oriented O
to O
person O
, O
place O
, O
time O
, O
and O
situation O
. O
 
Grossly O
nonfocal O
exam O
. O
 
Psychiatric O
: O
Mood O
and O
affect O
appropriate O
to O
situation O
. O
 
Extremity O
exam O
: O
No O
pedal O
edema O
, O
right O
foot O
with O
bandage O
. O
 
Lab O
Results O
12/25/2092 I-DATE
NA O
136 O
, O
K O
4.5 O
, O
CL O
107 O
, O
CO2 O
22 O
( O
* O
) O
, O
BUN O
52 O
( O
* O
) O
, O
CRE O
2.11 O
( O
* O
) O
, O
EGFR O
25 O
, O
GLU O
212 O
( O
* O
) O
12/02/2092 I-DATE
HGBA1C O
9.0 O
( O
H O
) O
12/25/2092 I-DATE
WBC O
6.55 O
, O
RBC O
4.34 O
( O
# O
) O
, O
HGB O
10.5 O
( O
* O
# O
) O
, O
HCT O
33.5 O
( O
* O
# O
) O
, O
MCV O
77.2 O
( O
* O
# O
) O
, O
MCH O
24.2 O
( O
* O
) O
, O
MCHC O
31.4 O
( O
* O
) O
, O
PLT O
302 O
( O
# O
) O
Assessment O
T1DM O
- O
Uncontrolled O
. O
 
Pt O
appears O
alert O
, O
oriented O
and O
confident O
to O
use O
her O
insulin O
pump O
in O
the O
hospital O
. O
 
Pt O
is O
able O
to O
verbalize O
her O
insulin O
doses O
and O
states O
that O
she O
would O
prefer O
to O
continue O
with O
pump O
use O
. O
 
Suspect O
that O
IV O
fluids O
are O
contributing O
to O
hyperglycemia O
, O
therefore O
reluctant O
to O
change O
insulin O
doses O
since O
IV O
fluids O
will O
likely O
stop O
later O
today O
. O
 
While O
in O
procedure O
, O
will O
need O
to O
monitor O
blood O
glucoses O
more O
closely O
, O
but O
anticipate O
that O
pump O
can O
continue O
as O
programmed O
. O
 
Recommendations O
1 O
. O
 
Continue O
with O
insulin O
pump O
. O
 
Instructed O
pt O
that O
she O
must O
: O
a. O
report O
all O
pre-meal O
bolus O
doses O
to O
the O
RN O
so O
that O
it O
can O
be O
documented O
on O
the O
flow O
sheet O
. O
 
b. O
have O
blood O
glucoses O
checked O
as O
ordered O
using O
the O
hospital O
approved O
glucose O
meter O
. O
 
c. O
alert O
RN O
if O
she O
feel O
uncomfortable O
using O
insulin O
pump O
. O
 
RN O
should O
page O
HO O
and/or O
diabetes O
dept O
immediately O
for O
orders O
for O
SC O
insulin O
. O
 
d. O
agree O
to O
discontinue O
insulin O
pump O
and O
start O
SC O
insulin O
if O
deemed O
necessary O
by O
house O
staff O
. O
 
Pt O
agrees O
to O
all O
of O
the O
above O
. O
 
2 O
. O
 
Monitor O
blood O
glucoses O
at O
least O
before O
all O
meals O
and O
at O
bedtime O
. O
 
Please O
also O
check O
blood O
glucoses O
with O
any O
symptoms O
of O
hypoglycemia O
or O
at O
pt O
's O
request O
. O
 
Be O
sure O
to O
record O
these O
values O
on O
the O
daily O
flow O
sheet O
. O
 
3 O
. O
 
For O
procedure O
today O
, O
I O
spoke O
with O
Kathryn I-NAME
Kincaid I-NAME
and O
asked O
that O
blood O
glucoses O
be O
monitored O
hourly O
while O
in O
cath O
lab O
unless O
BG O
is O
less O
than O
140 O
. O
 
If O
BG O
less O
than O
140 O
, O
monitor O
blood O
glucoses O
every O
30 O
minutes O
. O
 
Treat O
BG O
less O
than O
80 O
with O
1/2 O
amp O
D50 O
and O
continue O
to O
monitor O
as O
described O
above O
. O
 
Do O
not O
remove O
insulin O
pump O
. O
 
Page O
5-8112 I-CONTACT
with O
any O
concerns O
during O
the O
procedure O
. O
 
Diabetes O
dept O
will O
continue O
to O
monitor O
. O
 
Please O
page O
5-8112 I-CONTACT
with O
any O
questions O
or O
concerns O
. O
 
Thank O
you O
. O
 
________________________ O
Faye I-NAME
Easley I-NAME
, O
NP O
 
Record O
date O
: O
2094-03-19 I-DATE
Infectious O
Disease O
Consult O
Note O
Pt O
: O
Rose I-NAME
Mack I-NAME
MR O
# O
: O
06129040 I-ID
Consult O
Date O
: O
3/19/94 I-DATE
CC/RFC O
: O
Pt O
is O
a O
52 I-AGE
year O
old O
w/ O
chronic O
R O
heel O
wound O
, O
now O
w/ O
wound O
infection O
. O
 
Consultation O
was O
requested O
by O
Dr. O
Katz I-NAME
for O
recommendations O
regarding O
antibiotic O
management O
. O
 
HPI O
: O
Pt O
has O
longstanding O
DM O
and O
PVD O
complicated O
by O
severe O
R O
foot O
ulceration O
. O
 
She O
underwent O
R O
femoral O
to O
posterior O
tibial O
bypass O
graft O
in O
5/92 I-DATE
and O
skin O
grafting O
in O
7/92 I-DATE
. O
 
R O
heel O
wound O
subsequently O
improved O
but O
pt O
developed O
L O
plantar O
ulceration O
requiring O
debridement O
10/92 I-DATE
. O
 
Cultures O
grew O
MSSA O
. O
 
Pt O
was O
subsequently O
treated O
w/ O
extended O
course O
of O
doxycycline O
, O
rifampin O
through O
2/93 I-DATE
. O
 
She O
subsequently O
did O
well O
until O
developing O
R O
heel O
ulcer O
while O
undergoing O
psychiatric O
hospitalization O
in O
mid O
2/94 I-DATE
. O
 
She O
was O
initially O
hospitalized O
at O
Altadena I-LOCATION
Hospital I-LOCATION
, O
where O
she O
underwent O
debridement O
of O
wound O
and O
treatment O
w/ O
extended O
course O
of O
penicillin O
VK O
and O
probenicid O
. O
 
Wound O
failed O
to O
improve O
. O
 
Pt O
was O
rehospitalized O
on O
3/18 I-DATE
at O
GCCfor O
further O
management O
. O
 
She O
underwent O
incision O
and O
debridement O
on O
3/18 I-DATE
. O
 
Intraoperative O
evaluation O
revealed O
ulcer O
wound O
tracking O
to O
bone O
. O
 
Intraoperative O
gram O
stain O
revealed O
GPCs O
in O
pairs O
. O
 
Intraoperative O
cultures O
are O
pending O
. O
 
Pt O
was O
subsequently O
treated O
w/ O
vancomycin O
, O
levofloxacin O
and O
metronidazole O
. O
 
On O
interview O
, O
pt O
reports O
feeling O
generally O
well O
. O
 
No O
F/C/NS O
. O
 
Appetite O
normal O
. O
 
Had O
previously O
noted O
creeping O
erythema O
up O
R O
leg O
, O
now O
resolved O
. O
 
PMH O
( O
from O
EMR O
) O
DM O
type O
1 O
: O
c/b O
PVD O
, O
neuropathy O
, O
nephropathy O
PVD O
: O
s/p O
right O
mid O
superficial O
femoral O
artery O
to O
mid O
posterior O
tibial O
bypass O
graft O
with O
reversed O
ipsilateral O
greater O
saphenous O
vein O
CKD O
Hx O
femoral O
neck O
fracture O
: O
in O
situ O
screw O
fixation O
Anemia O
Anxiety/Depression O
Deep O
venous O
thrombosis O
Hypothyroidism O
: O
s/p O
subtotal O
thyroidectomy O
74 I-DATE
S/p O
R O
carpal O
tunnel O
surgery O
Meds O
on O
Consultation O
Plavix O
Lopressor O
Simvastatin O
Lantus O
Levoxyl O
Abilify O
Cogentin O
Nortriptyline O
Trazadone O
Probenecid O
Neurontin O
All O
Erythromycins O
cause O
rash O
Sulfa O
causes O
rash O
Aspirin O
causes O
rash O
SHx O
Pt O
lives O
at O
home O
w/ O
her O
parents O
FHx O
NC O
ROS O
Ten O
point O
review O
of O
systems O
negative O
except O
as O
noted O
in O
HPI O
. O
 
Exam O
Pt O
is O
a O
tired O
appearing O
middle O
aged O
woman O
, O
lying O
comfortably O
in O
bed O
VS O
: O
T- O
96.4 O
, O
HR- O
84 O
, O
BP- O
153/72 O
, O
RR- O
18 O
, O
Sat- O
100 O
% O
on O
2L O
HEENT O
: O
MMM O
, O
w/o O
exudates O
Chest O
: O
CTAB O
; O
no O
crackles O
, O
no O
wheezes O
CV O
: O
RRR O
; O
normal O
S1S2 O
, O
no O
m/r/g O
appreciated O
Abd O
: O
NABS O
; O
soft O
, O
non-tender O
, O
non-distended O
; O
no O
organomegaly O
Extr O
: O
R O
heel O
w/ O
2 O
x O
2cm O
wound O
vac O
dressing O
in O
place O
, O
no O
surrounding O
erythema O
; O
L O
foot O
without O
erythem O
or O
ulceration O
Neuro O
: O
MS O
nl O
, O
motor O
and O
sensory O
normal O
Skin O
: O
scattered O
patchy O
erythematous O
rash O
across O
trunk O
and O
upper O
extremities O
Labs O
Chemistry O
: O
BUN O
: O
19 O
Cr O
: O
1.3 O
Tbili O
: O
0.2 O
ALT O
: O
20 O
AST O
: O
22 O
AP O
: O
290 O
Heme O
: O
WBC O
: O
4.7 O
HCT O
: O
33.2 O
Plt O
: O
290 O
Impression O
52F O
w/ O
DM O
, O
PVD O
and O
hx O
of O
R O
heel O
ulceration O
s/p O
skin O
grafting O
in O
5/92 I-DATE
and O
L O
midfoot O
MSSA O
infection O
in O
9/92 I-DATE
, O
now O
w/ O
relapse O
of O
R O
heel O
ulceration O
. O
 
Intraoperative O
cultures O
show O
involvement O
of O
bone O
. O
 
Clinical O
picture O
is O
concerning O
for O
osteomyelitis O
. O
 
Possible O
culprit O
organisms O
include O
drug O
resistant O
Staphylococcus O
aureus O
, O
which O
should O
be O
treated O
empirically O
while O
awaiting O
cultures O
. O
 
Pt O
will O
likely O
require O
an O
extended O
course O
of O
IV O
therapy O
for O
treatment O
of O
osteomyelitis O
. O
 
Recommendations O
Follow O
up O
intraoperative O
cultures O
Continue O
vancomycin O
1g O
IV O
Q24H O
; O
check O
trough O
prior O
to O
fourth O
dose O
. O
 
Discontinue O
levofloxacin O
, O
metronidazole O
. O
 
_______________________________ O
Victor I-NAME
Reid I-NAME
, O
M.D O
. O
 
( O
pager O
# O
81625 I-CONTACT
) O
Case O
discussed O
with O
infectious O
disease O
attending O
, O
Dr. O
Amber I-NAME
Akins I-NAME
. O
 
Record O
date O
: O
2082-01-28 I-DATE
Critical O
care O
PULMONARY O
FELLOW O
ADMIT O
NOTE O
Reason O
for O
Admission O
: O
focal O
neurologic O
deficits O
HPI O
: O
48 I-AGE
yo O
man O
with O
CF O
, O
HTN O
, O
GERD O
, O
spinal O
stenosis O
, O
DM O
, O
CF O
arthropathy O
, O
h/o O
crypto O
meningitis O
and O
h/o O
left O
UE O
paresthesias O
who O
presented O
to O
Sheffield I-LOCATION
Care I-LOCATION
Center I-LOCATION
1/26 I-DATE
with O
complaints O
of O
sudden-onset O
right O
hand O
paresthesias O
, O
followed O
by O
left O
sided O
weakness O
and O
left O
sided O
visual O
deficits O
. O
 
Also O
with O
frontal-occipital O
headache O
during O
this O
time O
. O
 
He O
presented O
to O
the O
Sheffield I-LOCATION
Center I-LOCATION
ED O
, O
and O
shortly O
after O
he O
was O
seen O
his O
left O
sided O
weakness O
resolved O
, O
although O
his O
visual O
field O
deficits O
and O
right O
hand O
paresthesia O
as O
well O
as O
his O
headache O
had O
remained O
. O
 
He O
denies O
F/C/N/V O
. O
 
No O
neck O
stiffness O
. O
 
He O
had O
a O
noncontrast O
head O
CT O
which O
was O
negative O
for O
any O
acute O
process O
per O
radiology O
read O
. O
 
He O
had O
an O
LP O
with O
2 O
WBC O
, O
2 O
RBC O
, O
glucose O
98 O
, O
protein O
84 O
, O
appeared O
clear O
. O
 
Gram O
stain O
with O
no O
orgs O
, O
rare O
polys O
. O
 
ESR O
44 O
, O
crypto O
ag O
pending O
. O
 
He O
was O
transferred O
to O
HSH I-LOCATION
because O
Sheffield I-LOCATION
Center I-LOCATION
does O
not O
have O
an O
MRI O
machine O
. O
 
He O
says O
that O
his O
pulmonary O
status O
has O
been O
stable O
, O
and O
produces O
a O
moderate O
amount O
of O
yellow O
sputum O
. O
 
He O
does O
not O
do O
chest O
PT O
at O
home O
. O
 
He O
has O
a O
h/o O
mild O
sinusitis O
, O
but O
he O
says O
that O
it O
has O
n't O
been O
bothering O
him O
lately O
. O
 
He O
has O
been O
having O
normal O
bowel O
movements O
with O
no O
difficulties O
with O
constipation O
. O
 
PMH O
: O
CF O
HTN O
GERD O
Gout O
Spinal O
stenosis O
( O
2062 I-DATE
) O
CF O
induced O
DM O
CF O
arthropathy O
Crypto O
meningitis O
2062 I-DATE
Nephrotic O
syndrome O
Bilateral O
cataracts O
Current O
Meds O
: O
Lasix O
20 O
bid O
Advair O
250/50 O
bid O
ASA O
81 O
qd O
Albuterol O
prn O
Pancreacarb O
8 O
tabs O
with O
meals O
, O
3-5 O
w/snacks O
Colchicine O
0.5mg O
qd O
Cozaar O
50qd O
Zestril O
40mg O
qd O
Accolate O
20mg O
bid O
Prandin O
2-4 O
mg O
tid O
qac O
Vit O
E O
and O
D O
Celebrex O
100mg O
qd O
Vit O
K O
5mg O
3x/wk O
Protoniz O
40mg O
qd O
Azithro O
500 O
3x/wk O
Probenecid O
250mg O
bid O
Allergies O
: O
NKDA O
Family O
History O
: O
mother O
died O
of O
Hodgkins O
dz O
at O
33 I-AGE
. O
 
Father O
with O
CVA O
, O
HTN O
, O
sister O
with O
CF O
Social O
History O
: O
Occupation/exposures O
: O
shoe I-PROFESSION
repairer I-PROFESSION
Smoking O
: O
no O
tobacco O
, O
+occasional O
marijuana O
. O
 
Occasional O
alcohol O
. O
 
Physical O
Exam O
: O
Vitals O
: O
T O
97.9 O
, O
HR O
78 O
, O
BP O
118/68 O
, O
RR O
20 O
, O
99 O
% O
RA O
Gen O
: O
comfortable O
in O
NAD O
HEENT/neck O
: O
OP O
clear O
, O
PERRL O
, O
EOMI O
, O
no O
nuchal O
rigidity O
Lungs/chest O
: O
diminished O
breath O
sounds O
bilaterally O
, O
no O
crackles O
or O
wheezes O
Heart O
: O
RRR O
no O
murmurs O
Abd O
: O
soft O
nt/nd O
+BS O
Extr O
: O
no O
edema O
Neuro O
: O
+left O
unilateral O
left-sided O
hemianopsia O
. O
 
OTW O
CN O
II-XII O
intact O
. O
 
5/5 O
strength O
throughout O
, O
normal O
sensation O
, O
normal O
cerebellar O
exam O
, O
normal O
gait O
. O
 
+paresthesias O
in O
right O
hand O
in O
a O
glove O
distribution O
. O
 
Lab O
: O
pending O
Imaging O
: O
pending O
Impression O
: O
48 I-AGE
yo O
man O
with O
CF O
, O
CF-induced O
DM O
, O
and O
HTN O
, O
who O
presented O
to O
an O
outside O
hospital O
with O
focal O
neuro O
changes O
of O
unclear O
etiology O
, O
but O
concerning O
for O
a O
CVA O
. O
 
Recommendations O
: O
1 O
. O
 
Neuro O
: O
Would O
get O
a O
brain O
MRI/MRA O
to O
further O
evaluate O
. O
 
After O
the O
MRI O
is O
done O
, O
would O
get O
a O
neurology O
consult O
in O
the O
morning O
. O
 
Continue O
ASA O
, O
BP O
control O
in O
the O
meantime O
. O
 
Patient O
may O
need O
a O
repeat O
LP O
depending O
on O
neuro O
consult O
recs O
. O
 
2 O
. O
 
Pulm O
: O
CF O
appears O
stable O
. O
 
Would O
continue O
his O
outpatient O
Advair O
, O
albuterol O
, O
azithro O
. O
 
3 O
. O
 
GI O
: O
continue O
enzymes O
, O
vitamins O
. O
 
High O
calorie O
, O
high O
protein O
CF O
diet O
. O
 
4 O
. O
 
Endo O
: O
monitor O
blood O
glucose O
. O
 
______________________ O
Quiana I-NAME
Titus I-NAME
, O
M.D O
. O
 
Critical O
care O
Fellow O
Pager O
: O
33911 I-CONTACT
Lung O
Transplant O
Attending O
Note O
: O
I O
have O
seen O
and O
examined O
the O
patient O
with O
Dr. O
Titus I-NAME
and O
I O
agree O
with O
her O
evaluation O
and O
plan O
as O
outlined O
above O
. O
 
Mr. O
Aguilar I-NAME
is O
a O
48 I-AGE
yo O
man O
with O
h/o O
CF O
with O
mild O
pulmonary O
disease O
, O
who O
presented O
to O
an O
OSH O
on O
1/26 I-DATE
with O
sudden O
onset O
of O
right O
upper O
ext O
paresthesias O
, O
followed O
by O
a O
loss O
of O
left O
visual O
field O
, O
diplopia O
, O
and O
left O
sided O
weakness O
. O
 
The O
patient O
denies O
incontinence O
but O
had O
some O
gait O
instability O
related O
to O
weakness O
. O
 
The O
patient O
was O
evaluated O
at O
the O
OSH O
with O
non-contrast O
head O
CT O
and O
L/P O
which O
were O
significant O
only O
for O
elevated O
CSF O
protein O
. O
 
Currently O
symptoms O
have O
resolved O
other O
than O
persistent O
occipital O
headache O
which O
began O
with O
the O
onset O
of O
the O
other O
symptoms O
, O
as O
well O
as O
unilateral O
hemianopsia O
in O
the O
left O
eye O
evident O
on O
exam O
. O
 
Exam O
also O
notable O
for O
disdiadochokinesis O
, O
otherwise O
neurologic O
exam O
non-focal O
. O
 
Lung O
exam O
notable O
for O
diminished O
BS O
but O
no O
wheezes O
or O
crackles O
. O
 
DDX O
for O
above O
includes O
ischemic O
process O
, O
though O
symptoms O
appear O
to O
be O
multi-focal O
, O
vs. O
mononeuritis O
multiplex O
related O
to O
inflammatory O
process O
. O
 
Less O
likely O
is O
mass O
lesion O
leading O
to O
above O
symptoms O
, O
or O
meningeal O
process O
. O
 
We O
plan O
to O
obtain O
CNS O
MRI O
, O
neuro O
consult O
. O
 
Will O
await O
MRI O
findings O
prior O
to O
pursuing O
further O
serologic O
work-up O
. O
 
Continue O
maintenance O
medications O
for O
CF O
. O
 
_______________________ O
Debra I-NAME
F. I-NAME
Mullen I-NAME
, O
MD O
 
Record O
date O
: O
2082-09-29 I-DATE
I O
have O
personally O
reviewed O
the O
history O
, O
examined O
the O
patient O
, O
and O
reviewed O
and O
edited O
the O
note O
and O
I O
agree O
with O
the O
assessment O
and O
plan O
developed O
under O
my O
personal O
supervision O
as O
documented O
by O
previosu O
PA O
note O
from O
Ursula I-NAME
Bowers I-NAME
, O
PA-C O
. O
 
Please O
see O
additional O
comments O
below O
. O
 
Vicente I-NAME
Aguilar I-NAME
is O
a O
49 I-AGE
y/o O
male O
with O
cystic O
fibrosis O
, O
moderate O
to O
severe O
lung O
disease O
, O
colonized O
with O
mucoid-type O
Pseudomonas O
aeruginosa O
pancreatic O
insufficiency O
, O
CF O
related O
DM O
, O
HTN O
, O
renal O
insufficiency O
with O
proteinuria O
, O
recent O
h/o O
CVA O
, O
gout O
, O
cataracts O
who O
is O
currently O
experiencing O
a O
subacute O
exacerbation O
of O
his O
pulmonary O
disease O
requiring O
hospitalization O
to O
initiate O
IV O
antibiotics O
. O
 
His O
symptoms O
include O
long-standing O
fatigue O
, O
increased O
cough O
and O
sputum O
production O
, O
some O
SOB O
with O
mild O
chest O
tightness O
and O
wheezing O
. O
 
His O
FEV1 O
significantly O
decreased O
during O
recent O
clicni O
visit O
. O
 
He O
also O
reports O
some O
sinus O
headaches O
, O
but O
denies O
sinus O
pain O
or O
tenderness O
. O
 
He O
denies O
hemoptysis O
, O
fever/chills O
, O
nausea O
, O
vomiting O
, O
diarrhea O
or O
constipation O
. O
 
Please O
see O
details O
regarding O
recent O
MRI/MRA O
results O
on O
PA O
note O
above O
, O
as O
well O
as O
medications O
, O
and O
other O
pertinent O
historical O
data O
reviewed O
independently O
. O
 
VSS O
: O
afebrile O
, O
oxygen O
saturation O
Gen O
: O
alert O
, O
NAD O
HEENT O
: O
sclera O
clear O
, O
persistent O
visual O
defects O
right O
upper O
quadrant O
visual O
field O
, O
neck O
supple O
CV O
: O
regular O
Lungs O
: O
essentially O
clear O
with O
good O
aeration O
, O
no O
wheezes O
wuth O
few O
scattered O
ronchi O
. O
 
Abdomen O
: O
soft O
, O
NT O
, O
ND O
, O
no O
masses O
Ext O
: O
warm O
, O
clubbing O
Neuro O
: O
normal O
gait O
, O
oriented O
x O
3 O
. O
 
Assessment/Plan O
: O
Vicente I-NAME
Aguilar I-NAME
is O
a O
49 I-AGE
y/o O
male O
with O
cystic O
fibrosism O
noderate O
to O
severe O
lung O
disease O
with O
past O
medical O
history O
as O
noted O
above O
who O
is O
currently O
experiencing O
a O
subacute O
exacerbation O
of O
his O
pulmonary O
disease O
requiring O
hospitalization O
to O
initiate O
IV O
antibiotics O
1 O
. O
 
PULM/ID O
: O
We O
will O
start O
treatment O
with O
tobramycin O
700 O
mg O
IV O
q O
am O
, O
as O
well O
as O
Ceftazidime O
2 O
g O
IV O
q O
8 O
hours O
based O
on O
culture O
results O
. O
 
We O
will O
continue O
maintenance O
pulmonary O
medications O
including O
bronchodilators O
, O
mucolytics O
and O
steroids O
. O
 
We O
will O
discuss O
hypertonic O
saline O
therapy O
and O
trial O
its O
use O
if O
agreeable O
. O
 
We O
will O
send O
a O
new O
sputum O
sample O
for O
culture O
. O
 
Chest O
x-ray O
after O
PICC O
placement O
. O
 
Will O
review O
routine O
admission O
labs O
. O
 
2 O
. O
 
CVS O
: O
monitor O
blood O
pressure O
assess O
need O
for O
other O
protective O
medications O
. O
 
Will O
continue O
antihypertensives O
, O
ACEi O
and O
ARB O
if O
creatinine O
stable O
. O
 
We O
will O
review O
findings O
from O
recent O
MRI/MRA O
. O
 
Check O
lipid O
profile O
if O
not O
done O
, O
on O
Zocor O
. O
 
3 O
. O
 
FEN/GI O
: O
High O
calorie O
, O
high O
protein O
CF O
diet O
. O
 
4 O
. O
 
Renal O
: O
check O
electrolytes O
, O
as O
well O
as O
UA O
with O
random O
protein O
and O
creatinine O
. O
 
His O
creatinine O
was O
elevated O
to O
1.6 O
, O
now O
1.5 O
and O
was O
1.1-1.4 O
at O
baseline O
. O
 
He O
described O
an O
incident O
last O
week O
with O
nausea O
and O
vomiting O
that O
likely O
led O
to O
above O
result O
while O
taking O
colchicine O
, O
celebrex O
, O
and O
other O
meds O
. O
 
This O
is O
probabyl O
on O
its O
way O
to O
improvement O
. O
 
We O
did O
not O
hold O
ACEi O
and O
ARB O
at O
this O
time O
, O
but O
will O
repeat O
Cr O
tonight O
. O
 
He O
will O
drink O
fluids O
during O
the O
day O
priro O
to O
PICC O
by O
IR O
. O
 
He O
does O
not O
have O
a O
nephrologist O
adn O
will O
need O
to O
find O
him O
one O
. O
 
He O
did O
have O
a O
renal O
biopsy O
in O
teh O
late O
60s I-DATE
adn O
thus O
will O
look O
for O
results O
, O
but O
renal O
disease O
likely O
multigfactorial O
. O
 
We O
will O
tobra O
levels O
bvery O
close O
adn O
started O
at O
low O
dose O
for O
his O
size O
. O
 
Will O
likely O
check O
renal O
US O
while O
here O
. O
 
5 O
. O
 
Endo O
: O
continue O
insulin O
regimen O
. O
 
He O
will O
check O
blood O
sugars O
more O
frequently O
and O
folow O
HgA1c O
. O
 
He O
did O
state O
that O
he O
occasionally O
gets O
blood O
sugars O
in O
the O
40s O
when O
he O
wakes O
up O
, O
but O
usually O
nto O
when O
he O
is O
sedentary O
, O
ie O
. O
 
admitted O
to O
hospital O
. O
 
IF O
BS O
normal O
here O
, O
he O
will O
check O
them O
very O
closely O
at O
home O
as O
well O
and O
make O
adjustments O
as O
necesary O
. O
 
We O
will O
also O
need O
toset O
him O
up O
with O
Endocrinologist O
. O
 
6 O
. O
 
Access O
: O
PICC O
line O
to O
be O
placed O
in O
IR O
7 O
. O
 
Dispo O
: O
14 O
day O
of O
inpatient O
IV O
antibiotics O
8 O
. O
 
Neuro O
: O
He O
was O
last O
seen O
by O
Neurologist O
on O
8/30 I-DATE
and O
was O
discharged O
from O
routine O
follow-up O
. O
 
He O
will O
continue O
anti-hypertensive O
meds O
and O
ASA O
. O
 
He O
contineu O
sot O
have O
visual O
deficit O
in O
R O
upper O
quadrant O
. O
 
_____________________________________________ O
Quinton I-NAME
Israel I-NAME
, O
D.O O
. O
 
Record O
date O
: O
2084-12-07 I-DATE
Pulmonary O
Service O
Admission O
Note O
Vicente I-NAME
Aguilar I-NAME
# O
98179909 I-ID
December I-DATE
7 O
, O
2084 I-DATE
HPI O
51 I-AGE
y/o O
male O
with O
cystic O
fibrosis O
, O
pancreatic O
insufficency O
and O
CRI O
who O
was O
last O
admitted O
for O
cleanout O
in O
1/2084 I-DATE
now O
presenting O
after O
being O
seen O
by O
Dr O
Mann I-NAME
as O
outpatient O
on O
long I-LOCATION
island I-LOCATION
with O
newly O
increased O
creatinine O
above O
baseline O
and O
to O
initiate O
cleanout O
. O
 
He O
notes O
he O
has O
been O
doing O
fairly O
well O
this O
last O
year O
. O
 
He O
was O
seen O
for O
a O
physical O
by O
his O
primary O
care O
physician O
Dr O
Haas I-NAME
on O
November I-DATE
13th I-DATE
at O
which O
time O
he O
reports O
she O
told O
him O
he O
was O
doing O
well O
. O
 
Dr O
Mann I-NAME
followed O
up O
with O
her O
on O
his O
lab O
studies O
and O
results O
and O
called O
Mr O
Aguilar I-NAME
on O
friday I-DATE
alerting O
him O
to O
the O
change O
in O
his O
renal O
function O
. O
 
It O
was O
decided O
that O
he O
be O
admitted O
for O
renal O
work-up O
as O
well O
as O
initiating O
cleanout O
as O
he O
does O
his O
cleanouts O
yearly O
. O
 
He O
notes O
he O
has O
felt O
generally O
well O
with O
no O
increased O
cough O
or O
sputum O
, O
chest O
pain O
or O
tightness O
. O
 
He O
notes O
he O
has O
'danced O
around O
' O
some O
cold O
symptoms O
earlier O
in O
the O
summer I-DATE
but O
has O
had O
none O
since O
. O
 
He O
denies O
any O
fevers O
or O
chills O
and O
notes O
he O
only O
gets O
sweats O
if O
he O
has O
a O
low O
blood O
sugar O
. O
 
He O
denies O
any O
N/V O
, O
diarrhea O
or O
constipation O
and O
has O
stable O
appetite O
. O
 
He O
notes O
stable O
weight O
of O
185-186 O
lbs O
. O
 
He O
notes O
he O
has O
had O
erratic O
control O
of O
his O
blood O
sugar O
as O
he O
does O
at O
times O
'forget O
' O
to O
give O
himself O
insulin O
. O
 
He O
does O
monitoe O
his O
BS O
four O
times O
per O
day O
. O
 
He O
denies O
any O
dysuria O
, O
hematuria O
or O
urgency O
. O
 
he O
does O
note O
frequency O
has O
increased O
over O
the O
year O
, O
he O
now O
urinates O
every O
few O
hours O
. O
 
He O
denies O
any O
sore O
throat O
or O
sinus O
pain O
, O
does O
have O
occasional O
mild O
congestion O
. O
 
Reviwe O
of O
systems O
: O
he O
has O
a O
flu O
shot O
, O
denies O
sick O
contacts O
. O
 
notes O
his O
prostate O
exam O
at O
his O
PCP O
office O
was O
reported O
to O
be O
normal O
. O
 
denies O
reflux O
symptoms O
, O
does O
have O
feeling O
of O
pills O
`` O
sticking O
' O
when O
he O
swallows O
them O
occasionally O
. O
 
PMH O
: O
Cystic O
Fibrosis O
Pancreatic O
insufficiency O
CF O
related O
Diabetes O
Mellitus O
Hypertension O
Nephrotic O
syndrome O
( O
baseline O
creatinine O
1.1 O
) O
, O
chart O
dx O
at O
CHB O
of O
GN O
, O
unclear O
source O
of O
dx O
Gout O
Cataracts O
Allergies O
: O
NKDA O
Medications O
: O
Aspirin O
81 O
mg O
po O
daily O
Colchicine O
0.6 O
mg O
po O
daily O
Probenecid O
250 O
mg O
po O
bid O
Azithromycin O
500 O
mg O
po O
q O
thu/sat/Monday O
simvastatin O
20 O
mg O
po O
qhs O
Cozaar O
50 O
mg O
po O
BID O
Accolate O
20 O
mg O
po O
bid O
Albuterol O
inh O
prn O
Plaretase O
8000 O
6 O
tabs O
po O
qac/ O
snacks O
( O
what O
his O
pharmacy O
switched O
him O
to O
as O
pancrecarb O
not O
available O
) O
Protonix O
40 O
mg O
po O
daily O
Lantus O
12 O
u O
qhs O
Humalog O
scale O
ac O
FH/SH O
: O
lives O
on O
long I-LOCATION
island I-LOCATION
with O
partner O
of O
4 O
years O
, O
she O
is O
a O
Notary I-PROFESSION
. O
 
Works O
in O
shoe I-PROFESSION
repair I-PROFESSION
. O
 
Denies O
tobacco O
, O
usually O
drinks O
daily O
galss O
of O
grand O
marnier O
. O
 
notes O
prior O
daily O
marajuana O
smoking O
, O
now O
3-4 O
times O
per O
month O
recently O
. O
 
PHYSICAL O
EXAM O
( O
in O
CDIC O
) O
: O
Vitals O
: O
see O
nursing O
flowsheet O
GEN O
: O
NAD O
. O
 
Pleaseant O
male O
. O
 
Nad O
. O
 
HEENT O
: O
PERRL O
, O
op O
moist O
, O
with O
no O
exudates O
, O
no O
sinus O
pain O
or O
tendernes O
, O
no O
LAN O
LUNGS O
: O
clear O
to O
auscultation O
bilaterally O
, O
no O
wheezes O
or O
rhonchi O
HEART O
: O
S1S2 O
reg O
, O
no O
m/g/r O
, O
rrr O
ABDOMEN O
: O
soft O
. O
 
NT/ND O
, O
active O
BS O
, O
no O
HSM O
EXT O
: O
trace O
digital O
clubbing O
b/l O
, O
trace O
b/l O
ankle O
edema O
NEURO O
: O
alert O
and O
oriented O
x O
3 O
, O
no O
focal O
deficits O
DATA O
( O
from O
CHB O
) O
: O
-reported O
BUN/Cre O
from O
PCP O
office- O
68/2.1 O
-no O
other O
updated O
data O
Assessment/Plan O
: O
Mr O
Aguilar I-NAME
is O
a O
51 I-AGE
M O
with O
cystic O
fibrosis O
and O
hx O
of O
CRI O
who O
presents O
now O
with O
significant O
worsening O
of O
his O
renal O
function O
seen O
on O
outpatient O
labs O
as O
well O
as O
it O
having O
been O
nearly O
one O
year O
since O
prior O
cleanout O
. O
 
He O
is O
being O
admitted O
for O
initiation O
of O
cleanout O
and O
evaluation O
of O
renal O
dysfunction O
. O
 
He O
will O
be O
admitted O
to O
pulmonary O
PA O
service O
. O
 
1 O
) O
Pulm/ID O
: O
Based O
on O
his O
past O
sputum O
culture O
studies O
from O
CHB O
and O
his O
renal O
function O
we O
will O
start O
him O
on O
Ceftaz O
at O
renal O
dose O
of O
2g O
q24h O
and O
cipro O
250 O
q12h O
. O
 
Have O
used O
aminoglycosides O
in O
the O
past O
but O
given O
his O
renal O
function O
will O
avoid O
these O
at O
this O
time O
. O
 
Will O
get O
a O
f/u O
CXR O
to O
compare O
to O
his O
study O
done O
last O
year O
to O
assess O
for O
any O
change O
. O
 
Will O
consult O
RT O
for O
Chest O
PT O
TID O
and O
discuss O
restarting O
hypertonic O
saline/pulmozyme O
. O
 
Will O
continue O
other O
pulmonary O
inhalers O
. O
 
2 O
) O
FEN/GI O
: O
Will O
maintain O
on O
high O
calorie O
, O
high O
protein O
CF O
diet O
and O
continue O
current O
regimen O
of O
vitamins O
and O
enzymes O
. O
 
Will O
get O
Nutrition O
consult O
as O
patient O
has O
not O
been O
seen O
in O
quite O
some O
time O
. O
 
Will O
monitor O
bowels O
, O
currently O
stable O
. O
 
3 O
) O
CV O
: O
history O
of O
HTN O
, O
will O
continue O
home O
cozaar O
and O
lisinopril O
for O
now O
but O
may O
consider O
alternative O
choices O
given O
renal O
dysfunction O
if O
needed O
. O
 
Will O
monitor O
vital O
signs O
. O
 
4 O
) O
ENDO O
: O
CF O
related O
DM O
: O
will O
continue O
lantus O
and O
SSI O
and O
check O
FSBS O
AC/HS O
. O
 
Will O
send O
HgA1c O
given O
his O
report O
of O
erratic O
control O
at O
home O
. O
 
5 O
) O
Rheum O
: O
Gouty O
arthritis O
has O
been O
stable O
, O
will O
contiue O
probenecid O
and O
celebrex O
6 O
) O
Renal O
: O
Recent O
BUN/creatinine O
as O
reported O
from O
his O
PCP O
is O
significantly O
elevated O
from O
his O
prior O
levels O
earlier O
this O
year O
. O
 
Patient O
has O
not O
been O
followed O
regularly O
by O
nephrology O
in O
the O
past O
. O
 
Unclear O
the O
exact O
nature O
of O
his O
renal O
dysfunction O
and O
the O
etiology O
of O
its O
worsening O
of O
late O
. O
 
Will O
send O
for O
renal O
ultrasound O
and O
send O
urine O
lytes O
, O
protein O
, O
creatinine O
and O
eosinophils O
to O
begin O
work-up O
and O
will O
consider O
renal O
consult O
. O
 
Will O
start O
gentle O
IVF O
hydration O
overnight O
. O
 
7 O
) O
Access O
: O
PICC O
line O
in O
IR O
today O
8 O
) O
PPX O
: O
sc O
heparin O
, O
PPI O
9 O
) O
Dispo O
: O
TBD O
______________________________________ O
Francine I-NAME
Morales I-NAME
, O
PA-C O
68626 I-CONTACT
 
Record O
date O
: O
2085-08-29 I-DATE
Pulmonary O
Service O
Admission O
Note O
HPI O
: O
52 I-AGE
yo O
male O
with O
Cystic O
Fibrosis O
, O
CKD O
, O
CF O
related O
Arthritis O
presents O
with O
c/o O
increased O
cough O
, O
sputum O
production O
, O
SOB O
and O
fatigue O
for O
several O
weeks O
. O
 
He O
also O
has O
had O
a O
15 O
lb O
weight O
loss O
over O
the O
past O
2 O
months O
. O
 
His O
po O
intake O
has O
been O
decreased O
. O
 
He O
denies O
fever O
, O
chills O
, O
night O
sweats O
, O
chest O
tightness O
, O
hemoptysis O
or O
blood O
streaking O
. O
 
PMH O
: O
Cystic O
Fibrosis O
Pancreatic O
insufficiency O
CKD O
CF O
related O
Diabetes O
Mellitus O
Hypertension O
Nephrotic O
syndrome O
( O
baseline O
creatinine O
1.1 O
) O
, O
chart O
dx O
at O
CHB O
of O
GN O
, O
unclear O
source O
of O
dx O
Gout O
Cataracts O
Allergies O
: O
NKDA O
Medications O
: O
Accolate O
20 O
MG O
PO O
BID O
Allopurinol O
300 O
MG O
daily O
Aspirin O
81 O
MG O
PO O
QD O
Azithromycin O
500 O
MG O
po O
Q O
Thursday/Saturday/Monday O
Colchicine O
0.6 O
MG O
PO O
Q O
thu/sat/monday O
HCTZ O
25 O
mg O
daily O
Humalog O
SS O
q O
AC O
( O
approx O
20 O
units O
) O
Lantus O
15 O
UNITS O
SC O
QHS O
Lopressor O
50 O
MG O
PO O
BID O
Pancrecarb O
MS O
8 O
( O
PANCRELIPASE O
8,000 O
UNITS O
( O
PANCRECARB O
MS O
8 O
) O
) O
8 O
TABS O
PO O
QAC O
and O
snacks O
Probenecid O
250 O
MG O
PO O
QD O
Prednisone O
15 O
MG O
daily O
Protonix O
40 O
mg O
PO O
QD O
Simvastatin O
20 O
MG O
po O
q O
hs O
Symbicort O
80/4.5 O
2 O
PUFF O
INH O
BID O
Pulmozyme O
2.5 O
mg O
nebulized O
bid O
Hypertonic O
Saline O
4mL O
inhaled O
bid O
FH/SH O
: O
lives O
on O
long I-LOCATION
island I-LOCATION
with O
partner O
of O
5 O
years O
, O
she O
is O
a O
Notary I-PROFESSION
. O
 
Works O
in O
shoe I-PROFESSION
repair I-PROFESSION
. O
 
Denies O
tobacco O
, O
usually O
drinks O
daily O
glass O
of O
grand O
marnier O
. O
 
notes O
prior O
daily O
marajuana O
smoking O
, O
now O
3-4 O
times O
per O
month O
recently O
. O
 
Review O
of O
systems O
: O
Denies O
sick O
contacts O
. O
 
denies O
reflux O
symptoms O
. O
 
states O
urine O
output O
regular O
, O
but O
had O
several O
day O
period O
of O
constipation O
and O
abdominal O
that O
he O
was O
able O
to O
resolve O
with O
prune O
juice O
and O
Activia O
yogurt O
. O
 
PHYSICAL O
EXAM O
( O
in O
CDIC O
) O
: O
Vitals O
: O
see O
nursing O
flowsheet O
GEN O
: O
NAD O
. O
 
Pleaseant O
male O
. O
 
Nad O
. O
 
HEENT O
: O
PERRL O
, O
op O
moist O
, O
with O
no O
exudates O
, O
no O
sinus O
pain O
or O
tendernes O
, O
no O
LAN O
LUNGS O
: O
clear O
to O
auscultation O
bilaterally O
, O
no O
wheezes O
or O
rhonchi O
HEART O
: O
S1S2 O
reg O
, O
no O
m/g/r O
, O
rrr O
ABDOMEN O
: O
soft O
. O
 
NT/ND O
, O
active O
BS O
, O
no O
HSM O
EXT O
: O
trace O
digital O
clubbing O
b/l O
, O
trace O
b/l O
ankle O
edema O
NEURO O
: O
alert O
and O
oriented O
x O
3 O
, O
no O
focal O
deficits O
DATA O
( O
from O
CHB O
) O
: O
PFT O
& O
# O
8217 O
; O
s O
2/01/85 I-DATE
: O
65/43/14 O
12/12/84 I-DATE
: O
78/46/14 O
2/4/2084 I-DATE
: O
90/56/18 O
1/26/84 I-DATE
: O
85/53/14 O
10/6/82 I-DATE
: O
45/50/20 O
8/13/82 I-DATE
: O
48/33/14 O
Sputum O
cultures O
: O
2/01/85 I-DATE
: O
PsA O
( O
pan O
sensitive O
) O
, O
PsA O
( O
pan O
sensitive O
) O
, O
PsA O
( O
pan O
sensitive O
) O
12/8/84 I-DATE
: O
MRSA O
( O
S O
: O
linezolid O
, O
synercid O
, O
tetra O
, O
tigecycline O
, O
vanco O
) O
, O
PsA O
# O
1pan O
sensitive O
, O
PsA O
# O
2 O
( O
S O
: O
cipro O
, O
zosyn O
, O
tobra O
) O
, O
PsA O
# O
3 O
( O
S O
: O
amik O
, O
azt O
, O
ceft O
, O
cipro O
, O
gent O
, O
zosyn O
, O
tobra O
) O
1/26/84 I-DATE
PsA O
: O
( O
S O
: O
ceftaz O
, O
cipro O
, O
zosyn O
, O
tobra O
) O
PsA O
: O
( O
pan O
sensitive O
) O
PsA O
: O
( O
pan O
sensitive O
) O
Assessment/Plan O
: O
Mr O
Aguilar I-NAME
is O
a O
51 I-AGE
M O
with O
cystic O
fibrosis O
and O
CKD O
presenting O
with O
subacute O
CF O
exacerbation O
for O
IV O
antiobiotic O
cleanout O
. O
 
He O
will O
be O
admitted O
to O
pulmonary O
PA O
service O
. O
 
1 O
) O
Pulm/ID O
: O
Start O
Ceftaz O
2 O
g O
IV O
q O
12 O
, O
Cipro O
500 O
mg O
po O
q O
12 O
, O
Vanco O
1 O
g O
IV O
q O
24 O
Sputum O
cx O
to O
CHB O
, O
Chest O
xray O
, O
PT O
c/s O
for O
treadmill O
, O
Chest O
PT O
BID O
, O
hypertonic O
saline O
, O
pulmozyme O
2 O
) O
FEN/GI O
: O
Will O
maintain O
on O
high O
calorie O
, O
high O
protein O
CF O
diet O
and O
continue O
current O
regimen O
of O
vitamins O
and O
enzymes O
. O
 
Will O
get O
Nutrition O
consult O
as O
inpatient O
has O
not O
been O
seen O
in O
quite O
some O
time O
. O
 
Will O
monitor O
bowels O
, O
currently O
stable O
. O
 
3 O
) O
CV O
: O
History O
of O
HTN O
, O
will O
continue O
home O
cozaar O
and O
lisinopril O
for O
now O
but O
may O
consider O
alternative O
choices O
given O
renal O
dysfunction O
if O
needed O
. O
 
Will O
monitor O
vital O
signs O
. O
 
4 O
) O
ENDO O
: O
CF O
related O
DM O
: O
will O
continue O
lantus O
and O
SSI O
and O
check O
FSBS O
AC/HS O
. O
 
Will O
send O
HgA1c O
given O
his O
report O
of O
erratic O
control O
at O
home O
. O
 
5 O
) O
Rheum O
: O
Gouty O
arthritis O
has O
been O
stable O
, O
will O
contiue O
probenecid O
. O
 
Obtain O
uric O
acid O
level.Wean O
prednisone O
. O
 
6 O
) O
Renal O
: O
Followed O
by O
Dr O
Esparza I-NAME
-no O
current O
issues O
, O
last O
bun/cr O
: O
82/1.77 O
, O
BP O
maintained O
on O
hctz/lopressor O
. O
 
7 O
) O
Access O
: O
PICC O
line O
in O
IR O
today O
8 O
) O
PPX O
: O
sc O
heparin O
, O
PPI O
9 O
) O
Dispo O
: O
TBD O
______________________________________ O
Ursula I-NAME
Bowers I-NAME
, O
PA-C O
34680 I-CONTACT
Pulmonary O
Attending O
I O
have O
seen O
and O
examined O
Mr. O
Aguilar I-NAME
with O
PA O
Bowers I-NAME
with O
whose O
note O
I O
agree O
. O
 
Admission O
for O
`` O
clean-out O
'' O
for O
CF O
. O
 
Increased O
dyspnea O
and O
sputum O
and O
decrease O
in O
spirometry O
. O
 
No O
hemoptysis O
. O
 
Plan O
as O
reviewed O
with O
team O
is O
to O
start O
Ceftazidime O
2 O
g O
IV O
q O
12 O
, O
Cipro O
500 O
mg O
po O
q O
12 O
, O
Vancomycin O
1 O
g O
IV O
q O
24 O
. O
 
Sputum O
cx O
will O
be O
sent O
to O
CHB O
. O
 
We O
will O
initiate O
chest O
PT O
BID O
, O
hypertonic O
saline O
, O
pulmozyme O
. O
 
Encourage O
ambulation O
. O
 
He O
is O
on O
prednisone O
at O
15 O
mg O
given O
hx O
of O
arthritis O
. O
 
No O
alterations O
in O
dose O
at O
present O
for O
pulmonary O
status O
. O
 
IR O
picc O
pending O
. O
 
Laboratory O
studies O
and O
chest O
x O
ray O
pending O
and O
will O
be O
reviewed O
personally O
once O
available O
. O
 
Disposition O
pending O
. O
 
Full O
code O
. O
 
Rachel I-NAME
G. I-NAME
Richardson I-NAME
, O
MD O
 
Record O
date O
: O
2112-01-27 I-DATE
NAME O
: O
Werner O
, O
Brian I-NAME
MRN O
: O
4097229 I-ID
This O
patient O
reports O
approximately O
3-4 O
years O
ago O
he O
had O
episodes O
of O
right O
sided O
visual O
loss O
. O
 
He O
thought O
it O
was O
only O
related O
to O
his O
right O
eye O
. O
 
What O
he O
describes O
is O
a O
right O
peripheral O
hemispheric O
visual O
loss O
. O
 
He O
reports O
having O
a O
history O
of O
headaches O
in O
the O
past O
. O
 
It O
is O
nothing O
that O
is O
significantly O
worse O
than O
usual O
. O
 
On O
Thursday I-DATE
he O
reports O
having O
a O
mild O
bitemporal O
headache O
and O
then O
later O
that O
day O
ensuing O
right O
peripheral O
loss O
that O
has O
lasted O
for O
the O
past O
3-4 O
days O
. O
 
In O
the O
past O
his O
visual O
loss O
only O
lasted O
for O
about O
one O
day O
. O
 
He O
denies O
any O
other O
focal O
neurological O
complaints O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
. O
 
He O
is O
on O
a O
baby O
aspirin O
a O
day O
. O
 
He O
denies O
any O
further O
headaches O
. O
 
He O
denies O
any O
numbness O
, O
tingling O
or O
weakness O
on O
one O
side O
of O
his O
body O
or O
other O
. O
 
He O
has O
chronic O
left O
knee O
problems O
from O
an O
old O
injury O
. O
 
He O
is O
unable O
to O
bend O
the O
leg O
. O
 
He O
has O
no O
new O
problems O
with O
his O
gait O
. O
 
He O
denies O
any O
symptoms O
of O
jaw O
claudication O
. O
 
PHYSICAL O
EXAM O
: O
His O
exam O
reveals O
no O
temporal O
artery O
tenderness O
to O
palpation O
. O
 
His O
funduscopic O
exam O
appears O
normal O
on O
undilated O
exam O
. O
 
His O
visual O
fields O
reveals O
what O
appears O
to O
be O
consistent O
with O
right O
bilateral O
hemianopsia O
. O
 
PERRLA O
. O
 
EOMI O
. O
 
Cranial O
nerves O
II-XII O
are O
otherwise O
intact O
. O
 
His O
motor O
strength O
is O
5/5 O
. O
 
He O
has O
no O
pronator O
drift O
. O
 
His O
cerebellar O
exam O
is O
intact O
. O
 
His O
blood O
pressure O
is O
150/100 O
. O
 
Carotid O
- O
no O
bruit O
. O
 
Cor O
- O
RRR O
no O
MGR O
Lungs O
- O
CTA O
ASSESSMENT O
AND O
PLAN O
: O
Question O
bilateral O
hemianopsia O
. O
 
The O
patient O
will O
get O
scheduled O
for O
an O
MRI/MRA O
as O
soon O
as O
possible O
. O
 
He O
was O
sent O
to O
the O
NDMG I-LOCATION
Ophthalmology O
Clinic O
to O
confirm O
bilateral O
vs. O
unilateral O
hemianopsia O
( O
central O
vs. O
peripheral O
etiology O
) O
today O
for O
further O
evaluation O
plus/minus O
ESR O
and O
CBC O
at O
that O
point O
in O
time O
. O
 
Ernestine I-NAME
Phan I-NAME
, O
M.D O
. O
 
EP/gillis/cook O
 
Record O
date O
: O
2114-09-25 I-DATE
NAME O
: O
Werner O
, O
Brian I-NAME
MRN O
: O
4097229 I-ID
Last O
week O
he O
had O
a O
right O
carotid O
endarterectomy O
. O
 
Initially O
, O
he O
had O
some O
hoarseness O
. O
 
It O
went O
away O
but O
now O
it O
has O
returned O
. O
 
He O
did O
have O
a O
period O
of O
100.4 O
while O
at O
home O
and O
has O
felt O
a O
little O
chilled O
. O
 
He O
is O
still O
hoarse O
today O
. O
 
He O
feels O
a O
little O
achy O
in O
the O
joints O
. O
 
Medications O
Albuterol O
INHALER O
1-2 O
PUFF O
INH O
QID O
PRN O
, O
Take O
as O
directed O
Zestril O
( O
LISINOPRIL O
) O
30MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Hctz O
( O
HYDROCHLOROTHIAZIDE O
) O
12.5MG O
CAPSULE O
take O
1 O
Capsule O
( O
s O
) O
PO O
QD O
, O
THIS O
WAS O
FAXED O
TO O
YOU O
ON O
5/8/14 I-DATE
Coumadin O
( O
WARFARIN O
SODIUM O
) O
5MG O
TABLET O
take O
1.5 O
Tablet O
( O
s O
) O
PO O
QPM O
Salsalate O
750MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
PRN O
Flonase O
NASAL O
SPRAY O
( O
FLUTICASONE O
NASAL O
SPRAY O
) O
1-2 O
SPRAY O
( O
50MCG O
SPRAY O
) O
NAS O
BID O
Problems O
Hypertension O
Osteoathritis O
Gastroesophageal O
reflux O
disease O
Diverticulitis O
Cerebrovascular O
accident O
: O
L O
cerebellar O
2112 I-DATE
, O
s/p O
L O
CEA O
Lung O
nodule O
: O
Repeat O
chest O
CT O
10/14 I-DATE
. O
 
Allergies O
Penicillins O
- O
Rash O
, O
Penicillins O
- O
Rash O
Vital O
Signs O
BP O
140/78 O
, O
P O
76 O
, O
Temp O
98.1 O
F O
On O
exam O
, O
he O
is O
hoarse O
. O
 
Temperature O
is O
98.1 O
, O
however O
. O
 
Throat O
is O
clear O
. O
 
His O
right O
CEA O
is O
clean O
. O
 
Heart O
: O
Regular O
rate O
and O
rhythm O
, O
no O
murmurs O
, O
gallops O
or O
rubs O
. O
 
Lungs O
clear O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
( O
1 O
) O
Bronchitis/laryngitis O
. O
 
Chest O
x-ray O
today O
is O
clear O
. O
 
I O
elected O
to O
go O
ahead O
and O
treat O
him O
with O
doxycycline O
100 O
mg O
b.i.d O
. O
 
for O
the O
next O
10 O
days O
. O
 
He O
does O
have O
follow-up O
with O
his O
neurosurgeon O
in O
the O
next O
10 O
days O
or O
so O
. O
 
( O
2 O
) O
Health O
maintenance O
. O
 
Double O
check O
on O
LFTs O
and O
A1c O
since O
his O
LFTs O
and O
blood O
sugars O
were O
up O
in O
the O
hospital O
. O
 
Also O
check O
a O
CBC O
. O
 
Thomas I-NAME
D. I-NAME
Kinney I-NAME
, O
M.D O
. O
 
TDK/gillis/dougherty O
 
Record O
date O
: O
2119-12-22 I-DATE
Radiology O
H O
& O
amp O
; O
P O
Pt O
: O
WERNER O
, O
Brian I-NAME
U I-NAME
MRN O
: O
4097229 I-ID
Date O
: O
12/22/2119 I-DATE
10:56h O
CC O
: O
elective O
left O
carotid O
artery O
stent O
placement O
HPI O
: O
73yo O
RHM O
with O
h/o O
left O
PCA O
stroke O
( O
residual O
right O
partial O
visual O
field O
cut O
) O
and O
h/o O
bilateral O
carotid O
endarterectomies O
having O
recurrent O
stenosis O
of O
left O
ICA O
here O
for O
elective O
left O
ICA O
stent O
placement O
. O
 
He O
is O
noted O
on O
CTA O
head/neck O
on O
11/14/19 I-DATE
to O
have O
a O
'bovine O
' O
variant O
left O
common O
carotid O
artery O
takeoff O
( O
origin O
of O
the O
left O
CCA O
from O
the O
proximal O
innominate O
artery O
- O
anatomic O
variant O
) O
for O
access O
considerations O
. O
 
ROS O
: O
very O
mild O
chronic O
cough O
, O
denies O
f/c/n/v O
, O
denies O
CP O
or O
palpitations O
, O
denies O
SOB O
or O
abd O
pain O
, O
no O
recent O
loss O
of O
weight O
or O
appetite O
problems O
. O
 
PMH/PSH O
: O
- O
s/p O
left O
CEA O
2112 I-DATE
, O
s/p O
right O
CEA O
2114 I-DATE
- O
h/o O
left O
PCA O
stroke O
2112 I-DATE
- O
h/o O
vertigo O
- O
HTN O
/ O
HL O
- O
s/p O
LLE O
surgery O
for O
fracture O
related O
to O
motorcycle O
accident O
in O
2068 I-DATE
( O
can O
not O
bend O
left O
knee O
) O
- O
GERD O
- O
osteoarthritis O
- O
h/o O
elevated O
transaminases O
- O
s/p O
biopsy O
on O
8mm O
macule O
of O
left O
midcalf O
( O
lentigo O
vs O
early O
junctional O
nevus O
) O
in O
2116 I-DATE
- O
s/p O
left O
inguinal O
hernia O
repair O
2111 I-DATE
- O
s/p O
surgical O
trigger O
finger O
release O
of O
left O
hand O
Dupuytren O
's O
contracture O
of O
middle O
finger O
- O
question O
of O
COPD O
on O
inhalers O
prn O
, O
with O
smoking O
history O
( O
quit O
smoking O
in O
2100s I-DATE
) O
MEDICATIONS O
: O
ASA O
325mg O
daily O
( O
took O
dose O
this O
AM O
) O
Plavix O
75mg O
daily O
( O
started O
& O
gt O
; O
10days O
ago O
, O
took O
dose O
this O
AM O
) O
Albuterol O
2puffs O
QID O
prn O
SOB/wheeze O
Flovent O
110mcg O
inh O
bid O
prn O
SOB/wheeze O
Nifedipine O
ER O
60mg O
daily O
Niacin O
ER O
500mg O
qhs O
Ranitidine O
150mg O
BID O
MVI O
1tab O
daily O
ALLERGIES/ADR O
: O
Penicillin O
( O
rash O
) O
Lisinopril O
( O
cough O
) O
Atorvastatin O
( O
elevated O
transaminases O
, O
myalgias O
) O
FMH/SH O
: O
father O
with O
lung O
cancer O
, O
mother O
with O
stroke O
, O
brother O
with O
strokes O
in O
age O
50s I-AGE
; O
~1ppd O
since O
teens O
, O
quit O
smoking O
in O
2100 O
's O
; O
rare O
EtOH O
; O
retired O
mailman I-PROFESSION
; O
lives O
with O
wife O
Javonna I-NAME
Werner I-NAME
026-003-5757 I-CONTACT
or O
631-133-0409 I-CONTACT
in O
Sayre I-LOCATION
( O
KY I-LOCATION
) O
. O
 
EXAM O
: O
AVSS O
per O
report O
Awake/alert O
, O
fully O
oriented O
x3 O
, O
appropriately O
conversant O
PERRL O
/ O
EOMI O
, O
right O
visual O
field O
cut O
in O
far O
lateral O
right O
visual O
field O
past O
approximately O
60-degrees O
( O
right O
homonymous O
hemianopsia O
) O
Face O
sensation O
to O
LT O
in O
b/l O
V123 O
, O
masseters O
strong O
b/l O
, O
face O
strength O
full O
b/l O
, O
hearing O
to O
finger O
rub O
b/l O
Voice O
clear O
with O
UML/TML O
, O
SCM O
& O
amp O
; O
shoulder O
shrugs O
full O
strength O
b/l O
No O
pronator O
drift O
, O
full O
strength O
in O
BUE/BLE O
to O
resistance O
testing O
except O
minimal O
bending O
ROM O
of O
left O
knee O
joint O
related O
to O
old O
LLE O
injury O
from O
motorcycle O
accident O
s/p O
surgery O
2068 I-DATE
, O
gait O
with O
LLE O
limp O
related O
to O
minimal O
left O
knee O
bending O
Sensation O
to O
LT O
in O
distal O
BUE/BLE O
Cardiac O
: O
S1S2 O
, O
no O
murmurs O
noted O
Lungs O
: O
clear O
to O
auscultation O
bilaterally O
Abdomen O
: O
soft O
, O
NT/ND O
A/P O
: O
73yo O
RHM O
with O
h/o O
left O
PCA O
stroke O
( O
residual O
right O
partial O
visual O
field O
cut O
) O
and O
h/o O
bilateral O
carotid O
endarterectomies O
having O
recurrent O
stenosis O
of O
left O
ICA O
here O
for O
elective O
left O
ICA O
stent O
placement O
. O
 
He O
is O
noted O
on O
CTA O
head/neck O
on O
11/14/19 I-DATE
to O
have O
a O
'bovine O
' O
variant O
left O
common O
carotid O
artery O
takeoff O
( O
origin O
of O
the O
left O
CCA O
from O
the O
proximal O
innominate O
artery O
- O
anatomic O
variant O
) O
for O
access O
considerations O
. O
 
- O
Consent O
with O
discussion O
of O
potential O
benefits/risks O
& O
amp O
; O
alternatives O
discussed O
with O
opportunity O
for O
questions O
provided O
. O
 
_____________________________________ O
Victor I-NAME
Donovan I-NAME
, O
MD O
( O
Radiology O
Fellow O
) O
Discussed O
with O
Dr O
Landen I-NAME
Mccarthy I-NAME
 
Record O
date O
: O
2120-01-20 I-DATE
Visit O
Note O
Patient O
Name O
: O
WERNER O
, O
BRIAN I-NAME
U I-NAME
MRN O
: O
4097229 I-ID
Dictated O
Date O
: O
01/20/2120 I-DATE
Dictated O
by O
: O
Taniya I-NAME
Xing I-NAME
, O
M.D O
. O
 
Date O
of O
Visit O
: O
01/20/2120 I-DATE
Bryan I-NAME
returns O
for O
followup O
of O
cerebrovascular O
disease O
. O
 
A O
lot O
has O
happened O
since O
I O
last O
saw O
him O
in O
10/2119 I-DATE
. O
 
A O
CTA O
revealed O
severe O
stenosis O
of O
his O
left O
ICA O
. O
 
He O
is O
status O
post O
bilateral O
carotid O
endarterectomies O
and O
also O
has O
known O
vertebral O
disease O
with O
a O
history O
of O
a O
left O
occipital O
stroke O
. O
 
He O
subsequently O
was O
referred O
to O
Dr. O
Mccarthy I-NAME
and O
was O
scheduled O
to O
undergo O
left O
ICA O
stent O
placement O
in O
December I-DATE
. O
 
In O
November I-DATE
1 O
morning O
after O
going O
to O
the O
bathroom O
he O
developed O
sudden O
onset O
of O
vertigo O
. O
 
His O
wife O
called O
911 O
. O
 
He O
continued O
to O
have O
positional O
vertigo O
in O
the O
emergency O
room O
such O
that O
if O
he O
sat O
up O
he O
would O
become O
very O
vertiginous O
and O
off O
balance O
but O
if O
he O
laid O
with O
his O
eyes O
closed O
. O
 
He O
felt O
better O
. O
 
He O
was O
found O
to O
be O
orthostatic O
and O
his O
symptoms O
improved O
according O
to O
the O
chart O
by O
the O
next O
day O
though O
according O
to O
the O
patient O
, O
it O
took O
a O
couple O
of O
days O
for O
his O
symptoms O
to O
improve O
significantly O
. O
 
An O
MRI O
of O
the O
brain O
was O
unrevealing O
for O
ischemia O
. O
 
Although O
he O
significantly O
improved O
he O
still O
feels O
& O
# O
34 O
; O
a O
little O
off O
balance O
& O
# O
34 O
; O
. O
 
He O
is O
fine O
when O
he O
is O
sitting O
but O
he O
notes O
when O
he O
stands O
up O
he O
just O
& O
# O
34 O
; O
feels O
off O
& O
# O
34 O
; O
. O
 
He O
does O
not O
feel O
acutely O
vertiginous O
and O
does O
not O
have O
any O
sense O
of O
movement O
but O
does O
not O
feel O
as O
steady O
as O
he O
used O
to O
on O
his O
feet O
. O
 
He O
has O
seen O
Guy I-NAME
in O
physical O
therapy O
and O
is O
working O
on O
balance O
therapy O
. O
 
He O
subsequently O
did O
undergo O
left O
ICA O
stent O
placement O
on O
12/22/2119 I-DATE
without O
any O
complication O
. O
 
There O
was O
no O
worsening O
of O
his O
sense O
of O
imbalance O
or O
no O
new O
neurologic O
symptoms O
. O
 
Also O
of O
note O
, O
I O
neglected O
to O
mention O
above O
, O
that O
when O
he O
became O
acutely O
vertiginous O
in O
November I-DATE
there O
were O
no O
other O
accompanying O
symptoms O
. O
 
He O
was O
discharged O
after O
his O
left O
carotid O
endarterectomy O
on O
Plavix O
as O
well O
as O
aspirin O
that O
he O
had O
been O
on O
prior O
to O
his O
admission O
. O
 
He O
also O
was O
switched O
while O
in O
the O
hospital O
from O
hydrochlorothiazide O
to O
Inderal O
for O
blood O
pressure O
control O
although O
he O
was O
orthostatic O
sitting O
up O
. O
 
Lying O
down O
he O
was O
hypertensive O
. O
 
He O
has O
had O
no O
new O
neurologic O
symptoms O
since O
his O
discharge O
from O
NDMG I-LOCATION
after O
his O
carotid O
endarterectomy O
on O
12/22/2119 I-DATE
. O
 
CURRENT O
MEDICATIONS O
: O
Aspirin O
, O
gemfibrozil O
, O
nifedipine O
, O
Plavix O
, O
propranolol O
, O
ranitidine O
. O
 
PHYSICAL O
EXAMINATION O
: O
Pleasant O
, O
healthy-appearing O
74-year-old O
male O
. O
 
Blood O
pressure O
160/90 O
sitting O
, O
standing O
155/90 O
. O
 
Cranial O
nerve O
examination O
notable O
for O
right O
homonymous O
hemianopsia O
. O
 
Auscultation O
of O
the O
neck O
: O
Unremarkable O
. O
 
No O
bruits O
. O
 
There O
are O
bilateral O
CEA O
scars O
. O
 
Motor O
examination O
: O
No O
drift O
. O
 
Power O
5/5 O
throughout O
. O
 
Fine O
finger O
movements O
intact O
. O
 
In O
the O
lower O
extremities O
. O
 
Power O
5/5 O
on O
the O
right O
. O
 
The O
left O
he O
is O
status O
post O
left O
knee O
fusion O
. O
 
The O
left O
iliopsoas O
and O
dorsiflexion O
are O
full O
strength O
. O
 
His O
gait O
shows O
left O
limp O
due O
to O
knee O
fusion O
, O
but O
he O
appears O
steady O
. O
 
DTRs O
1+ O
throughout O
. O
 
DATA O
: O
MRI O
of O
the O
brain O
in O
11/2119 I-DATE
shows O
chronic O
left O
occipital O
lobe O
infarct O
otherwise O
unremarkable O
. O
 
CTA O
of O
the O
head O
and O
neck O
11/14/2119 I-DATE
showed O
stable O
left O
PCA O
territory O
chronic O
infarct O
with O
encephalomalacia O
and O
nonspecific O
periventricular O
white O
matter O
hypoattenuation O
as O
previously O
described O
. O
 
CTA O
of O
the O
head O
showed O
stable O
moderate O
stenosis O
of O
the O
left O
supraclinoid O
ICA O
. O
 
Stable O
occlusion O
or O
near O
occlusion O
of O
the O
left O
vertebral O
artery O
at O
the O
dural O
penetration O
to O
the O
take O
off O
of O
the O
PICA O
. O
 
There O
is O
reconstruction O
of O
contrast O
in O
the O
distal O
aspect O
. O
 
There O
is O
moderate O
stenosis O
of O
the O
distal O
left O
interdural O
vertebral O
artery O
with O
severe O
stenosis O
at O
the O
left O
vertebrobasilar O
junction O
and O
also O
unchanged O
. O
 
Stable O
moderate O
to O
severe O
stenosis O
within O
the O
right O
intradural O
vertebral O
artery O
. O
 
Mild O
areas O
of O
stenosis O
within O
the O
basilar O
artery O
and O
left O
T1 O
and O
T2 O
segments O
also O
unchanged O
. O
 
A O
CTA O
of O
the O
neck O
shows O
a O
short O
segment O
of O
severe O
stenosis O
of O
the O
proximal O
left O
ICA O
, O
which O
is O
stable O
since O
the O
most O
recent O
study O
. O
 
The O
right O
carotid O
artery O
demonstrates O
no O
significant O
stenosis O
. O
 
Dominant O
right O
vertebral O
artery O
with O
hypoplastic O
left O
vertebral O
artery O
demonstrates O
moderate O
stenosis O
at O
its O
origin O
and O
diffuse O
areas O
of O
moderate O
stenosis O
of O
the O
throughout O
unchanged O
. O
 
Mild O
to O
moderate O
right O
subclavian O
artery O
stenosis O
just O
proximal O
to O
the O
vertebral O
artery O
take O
off O
unchanged O
. O
 
Multiple O
thyroid O
nodules O
as O
described O
since O
most O
recent O
study O
. O
 
New O
ground O
glass O
nodule O
in O
the O
lower O
lobe O
the O
right O
lung O
, O
which O
is O
likely O
inflammatory O
in O
nature O
. O
 
Followup O
chest O
x-ray O
11/14/2119 I-DATE
was O
unremarkable O
. O
 
Cardiac O
ultrasound O
shows O
evidence O
of O
a O
PFO O
, O
which O
is O
now O
noted O
following O
performance O
of O
Valsalva O
maneuver O
not O
previously O
noted O
. O
 
In O
09/2113 I-DATE
Holter O
monitor O
was O
unremarkable O
. O
 
IMPRESSION O
: O
A O
74-year-old O
male O
with O
long-standing O
cerebrovascular O
disease O
and O
history O
notable O
for O
left O
occipital O
lobe O
infarct O
with O
vertebrobasilar O
disease O
as O
described O
above O
, O
status O
post O
bilateral O
carotid O
endarterectomies O
with O
recent O
restenosis O
on O
the O
left O
treated O
with O
stenting O
in O
12/2119 I-DATE
. O
 
He O
has O
been O
doing O
well O
considering O
. O
 
The O
cause O
of O
his O
episode O
of O
vertigo O
and O
imbalance O
is O
unclear O
. O
 
It O
is O
difficulty O
to O
tease O
out O
whether O
or O
not O
this O
was O
a O
posterior O
circulation O
TIA O
versus O
small O
stroke O
not O
detected O
on O
MRI O
versus O
vasovagal O
etiology O
. O
 
He O
checks O
out O
well O
today O
and O
I O
do O
not O
find O
any O
new O
findings O
on O
examination O
and O
his O
walking O
is O
steady O
though O
subjectively O
he O
feels O
he O
is O
not O
quite O
back O
to O
baseline O
. O
 
Agree O
with O
Plavix O
added O
to O
his O
aspirin O
dose O
after O
his O
carotid O
stent O
placement O
. O
 
His O
blood O
pressure O
is O
a O
little O
high O
today O
. O
 
He O
will O
be O
following O
up O
with O
Dr. O
Kinney I-NAME
in O
2 O
weeks O
. O
 
Recommended O
that O
he O
continue O
to O
work O
with O
Guy I-NAME
on O
vestibular O
therapy O
. O
 
Followup O
with O
me O
in O
3 O
months O
. O
 
___________________________ O
Taniya I-NAME
Xing I-NAME
, O
M.D O
. O
 
cc O
: O
DD O
: O
01/20/2120 I-DATE
11:05:58 O
TD O
: O
01/21/2120 I-DATE
07:49:40 O
TR O
: O
7038300 I-ID
BackJob O
ID O
: O
6183328 I-ID
VoiceJob O
ID O
: O
62867896 I-ID
 
Record O
date O
: O
2121-06-06 I-DATE
Reason O
for O
Visit O
Here O
for O
CPE O
and O
f/u O
on O
chronic O
cough/HTN O
( O
not O
using O
flovent O
) O
. O
 
GERD O
controlled O
well O
with O
ranitidine O
. O
 
Feeling O
more O
fatigued O
recently O
. O
 
No O
specific O
symptoms.Review O
of O
Systems O
Denies O
CP O
, O
abd O
pain O
, O
joint O
pains O
, O
SOB/cough O
, O
bowel/bladder O
problems O
. O
 
& O
# O
160 O
; O
Remainder O
of O
review O
of O
systems O
is O
negative O
in O
detail.Allergies O
Penicillins O
- O
RashLISINOPRIL O
- O
coughATORVASTATIN O
- O
Elevated O
LFTs/myalgiasMedications O
Albuterol O
Inhaler O
1-2 O
PUFF O
INH O
QID O
PRN O
, O
Take O
as O
directed O
# O
1 O
Can O
( O
s O
) O
Asa O
( O
ACETYLSALICYLIC O
Acid O
) O
325 O
MG O
( O
325MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
Tablet O
( O
s O
) O
Diclofenac O
1 O
% O
Gel O
1 O
% O
GEL O
( O
GM O
) O
Take O
1 O
TOP O
QID O
PRN O
, O
Dosing O
cards O
supplied O
in O
the O
drug O
product O
carton O
. O
 
# O
1 O
Month O
( O
s O
) O
SupplyFlovent O
Inhaler O
( O
FLUTICASONE O
Propionate O
) O
2 O
PUFF O
( O
110MCG O
AER O
W/ADAP O
) O
INH O
BID O
# O
3 O
Inhaler O
( O
s O
) O
Gemfibrozil O
600 O
MG O
TABLET O
Take O
0.5 O
PO O
QD O
# O
30 O
Tablet O
( O
s O
) O
Mvi O
( O
MULTIVITAMINS O
) O
1 O
CAPSULE O
PO O
QDNiacin O
Extended O
Release O
( O
NICOTINIC O
Acid O
Extended O
Release O
) O
500 O
MG O
( O
500MG O
TABLET O
SA O
Take O
1 O
) O
PO O
QHS O
# O
30 O
Tablet O
( O
s O
) O
Nifedipine O
( O
EXTENDED O
Release O
) O
60 O
MG O
( O
60MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
30 O
Tablet O
( O
s O
) O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
( O
75MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Propranolol O
Hcl O
20 O
MG O
( O
20 O
MG O
TABLET O
Take O
1 O
) O
PO O
BID O
# O
60 O
Tablet O
( O
s O
) O
Ranitidine O
Hcl O
150 O
MG O
( O
150MG O
TABLET O
Take O
1 O
) O
PO O
BID O
PRN O
# O
Tablet O
( O
s O
) O
Problems O
Hypertension O
Osteoathritis O
Gastroesophageal O
reflux O
disease O
Diverticulitis O
Cerebrovascular O
accident O
: O
L O
cerebellar O
2112 I-DATE
, O
s/p O
L O
CEALung O
nodule O
: O
No O
further O
f/u O
needed O
per O
CT O
4/16.Endarterectomy O
: O
R O
, O
2114 I-DATE
. O
 
L O
stent O
12/19Goiter O
: O
multinodular O
, O
USG O
2115Adenomatous O
polyp O
: O
Repeat O
colonoscope O
2123Hyperlipidemia O
Dupuytren O
's O
contracture O
: O
B O
, O
L O
repairedSocial O
History O
Work O
: O
RetiredMarital O
status O
: O
marriedChildren O
: O
yesHabits O
: O
Quit O
cigs O
, O
no O
drugs O
. O
 
Social O
Etoh.Sexually O
activeFamily O
History O
NC.Vital O
Signs O
BLOOD O
PRESSURE O
122/62PULSE O
72WEIGHT O
175 O
lbPhysical O
Exam O
NADSkin O
: O
ClearHEENT O
: O
PERRLA O
, O
EOMI O
, O
TM O
's O
and O
Throat O
clearNeck O
: O
Supple O
, O
no O
palpable O
thyroid O
or O
LN'sAxillae O
: O
No O
palpable O
LNsLungs O
: O
Clear O
to O
P O
and O
ACor O
: O
RRRAbd O
: O
Soft O
, O
NABS O
, O
no O
bruits O
, O
NT O
, O
no O
masses O
or O
HSMExt O
: O
No O
edema O
, O
can O
not O
flex O
L O
knee O
, O
chronic O
. O
 
+ O
R O
Dupuytrens.Neuro O
: O
Fully O
intactAssessment O
and O
Plan O
1 O
. O
 
Cough O
- O
use O
flovent O
2 O
bid O
- O
has O
helped O
a O
great O
deal O
in O
past O
2 O
. O
 
Hyperlipidemia O
- O
Taking O
gemfibrozil O
c O
good O
effect O
- O
check O
lipids3 O
. O
 
HTN/old O
CVA/DM O
- O
Good O
control O
, O
cont O
ASA/plavix O
. O
 
4 O
. O
 
Multinodular O
goiter O
- O
Stable O
5 O
. O
 
ED O
-okay O
with O
levitra6 O
. O
 
GERD O
- O
ranitidine O
150 O
mg O
p.r.n O
. O
 
helps.7 O
. O
 
OA O
- O
Stable8 O
. O
 
R O
Dupuytrens O
- O
Discussed O
, O
follow9 O
. O
 
Fatigue O
- O
Check O
chems O
, O
CBC O
, O
TSH O
. O
 
DC O
propranolol O
and O
f/u O
3-4 O
wks O
for O
BP O
check10 O
. O
 
Hlth O
maint O
- O
colonoscopy O
utd O
Greater O
than O
25 O
minutes O
was O
spent O
in O
direct O
patient O
care O
. O
 
Greater O
than O
50 O
% O
of O
this O
time O
was O
spent O
with O
counseling O
and O
coordination O
of O
care O
. O
 
Specifically O
I O
counseled O
the O
patient O
in O
regards O
to O
the O
pathophysiology O
of O
his/her O
diagnosis O
and O
appropriate O
treatment O
options O
. O
 
F/u O
1 O
mnth O
. O
 
_________________Thomas O
D I-NAME
Kinney I-NAME
, O
MD O
 
Record O
date O
: O
2082-06-29 I-DATE
CKMC I-LOCATION
EMERGENCY O
DEPT O
VISIT O
UHRICH O
, O
KARSON O
456-30-26-8 I-ID
VISIT O
DATE O
: O
06/29/82 I-DATE
The O
patient O
was O
seen O
and O
evaluated O
with O
the O
medical O
intern O
, O
I O
agree O
with O
the O
medical O
intern O
's O
note O
. O
 
PRESENTING O
COMPLAINT O
: O
The O
patient O
is O
a O
65-year-old O
female O
with O
a O
history O
of O
hypertension O
, O
hypercholesterolemia O
, O
depression O
, O
H O
pylori O
, O
gastric O
reflux O
with O
increasing O
back O
pain O
and O
epigastric O
pain O
. O
 
HISTORY O
OF O
PRESENTING O
COMPLAINT O
: O
She O
says O
over O
the O
last O
couple O
of O
days O
it O
is O
unrelieved O
with O
food O
but O
not O
exacerbated O
by O
food O
. O
 
She O
occasionally O
has O
a O
pressure O
in O
her O
epigastrium O
, O
no O
radiation O
to O
her O
neck O
, O
chest O
, O
no O
shortness O
of O
breath O
, O
no O
palpitations O
, O
no O
diaphoresis O
, O
no O
vomiting O
, O
no O
hematochezia O
, O
or O
melena O
but O
she O
has O
had O
increased O
frequency O
of O
her O
BM O
to O
three O
or O
four O
a O
day O
. O
 
No O
dysuria O
or O
urgency O
. O
 
She O
describes O
the O
pain O
as O
constant O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Hypertension O
, O
hypercholesterolemia O
, O
GERD O
. O
 
MEDICATIONS O
: O
Tetracycline O
, O
Prilosec O
, O
Ativan O
, O
atenolol O
, O
Zestril O
. O
 
ALLERGIES O
: O
Aspirin O
which O
causes O
upset O
stomach O
. O
 
SOCIAL O
HISTORY O
AND O
FAMILY O
HISTORY O
: O
Nonsmoker O
. O
 
PHYSICAL O
EXAMINATION O
: O
Temperature O
98.1 O
, O
pulse O
92 O
, O
respiratory O
rate O
16 O
, O
blood O
pressure O
196/84 O
. O
 
Skin O
: O
Warm O
and O
dry O
. O
 
She O
is O
well-developed O
, O
well-nourished O
female O
in O
no O
distress O
. O
 
Pupils O
are O
equal O
, O
round O
, O
reactive O
light O
. O
 
Extraocular O
movements O
are O
full O
. O
 
Sinuses O
nontender O
. O
 
Oropharynx O
clear O
. O
 
Nasopharynx O
clear O
. O
 
Neck O
: O
Supple O
, O
full O
range O
of O
motion O
. O
 
There O
is O
no O
JVD O
. O
 
Heart O
: O
Regular O
rate O
and O
rhythm O
without O
murmur O
. O
 
Abdomen O
is O
soft O
. O
 
Lungs O
are O
clear O
. O
 
Extremities O
: O
There O
is O
no O
clubbing O
, O
cyanosis O
, O
or O
edema O
. O
 
Rectal O
exam O
is O
nontender O
with O
brown O
, O
trace O
guaiac O
positive O
stool O
. O
 
Neurologic O
exam O
is O
nonfocal O
. O
 
LABORATORY O
EVALUATION O
: O
Patient O
had O
a O
white O
count O
of O
7.5 O
, O
hemoglobin O
of O
14 O
, O
platelet O
count O
of O
259 O
. O
 
Electrolytes O
are O
normal O
. O
 
Amylase O
and O
lipase O
are O
71 O
and O
204 O
respectively O
. O
 
H O
pylori O
IgA O
is O
positive O
from O
previous O
studies O
. O
 
CK O
is O
72 O
, O
troponin O
is O
0 O
. O
 
Chest O
x-ray O
is O
reviewed O
with O
Radiologist O
and O
is O
normal O
. O
 
EKG O
shows O
normal O
sinus O
rhythm O
with O
some O
T O
wave O
flattening O
in O
the O
inferior O
lateral O
leads O
. O
 
THERAPY O
RENDERED/COURSE O
IN O
ED O
: O
Patient O
was O
seen O
, O
given O
aspirin O
, O
Lopressor O
, O
and O
nitroglycerin O
. O
 
If O
her O
pain O
does O
n't O
resolve O
with O
and O
a O
GI O
cocktail O
she O
will O
be O
admitted O
to O
the O
Observation O
Unit O
. O
 
Because O
of O
the O
concern O
that O
her O
pain O
goes O
to O
her O
back O
, O
she O
has O
a O
CT O
scan O
to O
rule O
out O
aortic O
dissection O
which O
is O
reviewed O
with O
the O
Radiologist O
and O
is O
negative O
. O
 
FINAL O
DIAGNOSIS O
: O
Atypical O
chest O
pain O
, O
perhaps O
consistent O
with O
angina O
. O
 
DISPOSITION O
( O
including O
condition O
upon O
discharge O
) O
: O
Condition O
at O
this O
time O
is O
stable O
. O
 
___________________________________ O
DM972/9882 I-ID
URIEL I-NAME
NIX I-NAME
, O
M.D O
. O
 
UN49 I-NAME
D:06/29/82 O
T:06/29/82 O
Dictated O
by O
: O
URIEL I-NAME
NIX I-NAME
, O
M.D O
. O
 
UN49 I-NAME
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2088-10-12 I-DATE
EDVISIT^45630268^UHRICH O
, O
KARSON^10/12/88^ABREU O
, O
OLIVIA I-NAME
The O
patient O
was O
seen O
primarily O
by O
myself O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
This O
is O
a O
71-year-old O
female O
with O
a O
history O
of O
diabetes O
, O
high O
blood O
pressure O
, O
and O
hypercholesterolemia O
presents O
to O
the O
emergency O
room O
with O
some O
right O
thumb O
pain O
and O
swelling O
after O
poking O
with O
a O
turkey O
bone O
2 O
days O
ago O
. O
 
Denies O
any O
fevers O
or O
chills O
. O
 
Does O
report O
some O
increased O
redness O
and O
swelling O
at O
the O
right O
side O
. O
 
Also O
reports O
some O
left O
dental O
pain O
that O
started O
this O
morning O
. O
 
She O
has O
had O
history O
of O
dental O
pain O
in O
the O
past O
, O
however O
, O
much O
worse O
today O
. O
 
No O
fevers O
and O
no O
chills O
. O
 
Tolerating O
secretions O
. O
 
No O
pain O
on O
swallowing O
. O
 
No O
recent O
dental O
work O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
As O
noted O
above O
, O
hypercholesterolemia O
, O
diabetes O
, O
and O
hypertension O
. O
 
ALLERGIES O
: O
Aspirin O
. O
 
MEDICATIONS O
: O
Atenolol O
, O
Protonix O
, O
amitriptyline O
, O
and O
Lipitor O
. O
 
SOCIAL O
HISTORY O
: O
Denies O
any O
tobacco O
, O
alcohol O
, O
or O
IV O
drug O
use O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
No O
past O
surgery O
or O
procedure O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Right O
thumb O
pain O
and O
left O
tooth O
pain O
. O
 
PHYSICAL O
EXAMINATION O
: O
Mild O
tachycardic O
at O
108 O
and O
low-grade O
temperature O
99.2 O
. O
 
Rectal O
same O
. O
 
She O
is O
an O
elderly O
female O
in O
mild O
to O
moderate O
distress O
complaining O
significant O
dental O
pain O
. O
 
Head O
and O
neck O
exam O
, O
post O
dental O
exam O
, O
the O
patient O
has O
pain O
over O
tooth O
# O
16 O
which O
is O
intact O
. O
 
No O
surrounding O
fluctuance O
, O
pus O
discharge O
, O
or O
bleeding O
. O
 
Tooth O
is O
intact O
in O
the O
socket O
. O
 
Does O
appear O
to O
have O
caries O
. O
 
Posterior O
pharynx O
is O
clear O
. O
 
Neck O
is O
supple O
with O
full O
range O
of O
motion O
. O
 
Lungs O
are O
clear O
to O
auscultation O
bilaterally O
. O
 
Cardiac O
exam O
reveals O
S1 O
and O
S2 O
. O
 
Regular O
rate O
. O
 
No O
gallops O
, O
rubs O
, O
or O
murmurs O
. O
 
Abdomen O
is O
soft O
and O
nontender O
. O
 
On O
extremity O
exam O
, O
right O
thumb O
, O
the O
patient O
has O
an O
indurated O
right O
thumb O
with O
some O
streaking O
up O
into O
her O
mid O
forearm O
on O
the O
lateral O
aspect O
. O
 
There O
is O
some O
induration O
and O
warmth O
to O
touch O
. O
 
There O
is O
no O
foreign O
body O
visualized O
. O
 
There O
is O
no O
area O
of O
pus O
discharge O
or O
bleeding O
. O
 
2+ O
radial O
pulses O
. O
 
LABORATORY O
DATA O
: O
Normal O
CBC O
. O
 
X-ray O
of O
the O
right O
hand O
shows O
no O
evidence O
of O
foreign O
body O
. O
 
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
IMPRESSION O
AND O
PLAN O
: O
This O
is O
a O
71-year-old O
female O
with O
diabetes O
presenting O
with O
cellulitis O
and O
some O
streaking O
. O
 
She O
had O
received O
IV O
Ancef O
in O
the O
emergency O
room O
. O
 
She O
will O
be O
admitted O
for O
continued O
IV O
antibiotics O
and O
observation O
. O
 
______________________________ O
ABREU O
, O
OLIVIA I-NAME
M.D O
. O
 
D O
: O
10/12/88 I-DATE
T O
: O
10/12/88 I-DATE
Dictated O
By O
: O
ABREU O
, O
OLIVIA I-NAME
eScription O
document:1-4087689 O
BFFocus O
 
Record O
date O
: O
2090-09-28 I-DATE
UHRICH O
, O
KARSON I-NAME
45630268 I-ID
09/28/2090 I-DATE
DATE O
OF O
ADMISSION O
: O
09/27/2090 I-DATE
PRIMARY O
CARE O
PHYSICIAN O
: O
Roger I-NAME
L. I-NAME
Albright I-NAME
, O
M.D O
. O
 
Columbia I-LOCATION
Kingwood I-LOCATION
Medical I-LOCATION
Center I-LOCATION
57 I-LOCATION
Wood I-LOCATION
St I-LOCATION
, O
Q6-24 O
North I-LOCATION
Andover I-LOCATION
, O
KY I-LOCATION
41454 I-LOCATION
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Uhrich I-NAME
is O
a O
73-year-old O
woman O
with O
past O
medical O
history O
notable O
for O
hypertension O
and O
dyslipidemia O
, O
but O
no O
coronary O
artery O
disease O
who O
presents O
with O
a O
three-day O
history O
of O
progressive O
weakness O
and O
lightheadedness O
. O
 
The O
history O
is O
obtained O
in O
Spanish O
from O
the O
patient O
and O
through O
her O
daughter O
who O
assisted O
with O
translation O
. O
 
In O
general O
, O
she O
has O
apparently O
been O
doing O
well O
with O
no O
episodes O
of O
chest O
discomfort O
or O
exertional O
dyspnea O
until O
roughly O
three O
days O
ago O
when O
she O
has O
began O
to O
notice O
episodic O
problems O
with O
walking O
even O
short O
distances O
before O
she O
feels O
as O
though O
she O
might O
pass O
out O
. O
 
The O
episodes O
have O
occurred O
multiple O
times O
per O
day O
and O
after O
a O
particularly O
severe O
episode O
this O
morning O
, O
she O
brought O
her O
mother O
to O
the O
emergency O
department O
for O
evaluation O
. O
 
There O
have O
been O
no O
syncopal O
episodes O
and O
no O
complaints O
of O
palpitations O
, O
orthopnea O
, O
PND O
, O
or O
lower O
extremity O
edema O
. O
 
The O
patient O
has O
not O
had O
symptoms O
like O
this O
before O
and O
has O
been O
chronically O
treated O
with O
atenolol O
for O
hypertension O
for O
many O
years O
. O
 
Her O
only O
cardiovascular O
evaluation O
has O
been O
with O
adenosine O
MIBI O
in O
2085 I-DATE
, O
which O
revealed O
normal O
systolic O
function O
and O
no O
evidence O
for O
ischemia O
. O
 
PAST O
MEDICAL O
HISTORY O
: O
Notable O
for O
hypertension O
, O
hypercholesterolemia O
, O
gastritis O
, O
and O
osteoarthritis O
. O
 
She O
also O
carries O
the O
diagnosis O
of O
diabetes O
mellitus O
but O
is O
not O
currently O
treated O
for O
this O
. O
 
MEDICATIONS O
ON O
ADMISSION O
: O
Included O
amitriptyline O
25 O
mg O
at O
bedtime O
, O
aspirin O
81 O
mg O
daily O
, O
atenolol O
25 O
mg O
daily O
, O
Lipitor O
10 O
mg O
at O
bedtime O
, O
hydrochlorothiazide/lisinopril O
25/20 O
one O
tablet O
daily O
, O
loratadine O
10 O
mg O
daily O
, O
and O
Protonix O
40 O
mg O
daily O
. O
 
She O
developed O
gastrointestinal O
irritation O
with O
higher O
doses O
of O
aspirin O
. O
 
SOCIAL O
AND O
FAMILY O
HISTORY O
: O
As O
noted O
in O
the O
housestaff O
notes O
. O
 
PHYSICAL O
EXAMINATION O
: O
In O
the O
Emergency O
Department O
, O
her O
heart O
rate O
is O
38 O
beats O
per O
minute O
and O
her O
blood O
pressure O
is O
110/70 O
mmHg O
. O
 
Her O
venous O
pressures O
are O
low O
and O
there O
are O
BLANK O
waves O
present O
every O
other O
beat O
. O
 
The O
chest O
is O
clear O
to O
auscultation O
and O
percussion O
bilaterally O
. O
 
Cardiovascular O
exam O
reveals O
bradycardia O
with O
normal O
S1 O
, O
wide O
physiologically O
split O
S2 O
, O
and O
an O
audible O
S4 O
. O
 
There O
is O
no O
murmur O
. O
 
The O
abdomen O
is O
soft O
and O
nontender O
. O
 
The O
liver O
is O
not O
palpably O
enlarged O
. O
 
The O
extremities O
are O
warm O
without O
edema O
. O
 
Electrocardiogram O
reveals O
sinus O
rhythm O
with O
2:1 O
AV O
block O
and O
right O
bundle-branch O
block O
. O
 
There O
is O
left O
axis O
deviation O
consistent O
with O
left O
anterior O
fascicular O
block O
. O
 
There O
is O
no O
response O
of O
her O
heart O
rate O
to O
mild O
calisthenics O
in O
the O
bed O
. O
 
Laboratories O
are O
notable O
for O
normal O
BUN O
to O
creatinine O
ratio O
of O
23/1.2 O
with O
a O
potassium O
of O
4.1 O
and O
a O
hematocrit O
of O
35 I-LOCATION
% O
. O
 
Initial O
cardiac O
biomarkers O
were O
negative O
. O
 
In O
summary O
, O
Karson I-NAME
Uhrich I-NAME
is O
a O
73-year-old O
woman O
with O
hypertension O
and O
dyslipidemia O
who O
presents O
with O
a O
three-day O
history O
of O
presyncope O
and O
weakness O
in O
the O
context O
of O
a O
new O
diagnosis O
of O
2:1 O
AV O
block O
. O
 
Review O
of O
previous O
electrocardiograms O
reveals O
no O
right O
bundle-branch O
block O
and O
left O
anterior O
fascicular O
block O
and O
of O
late O
this O
represents O
progression O
of O
her O
underlying O
conduction O
system O
disease O
. O
 
We O
will O
proceed O
to O
permanent O
temporary O
pacemaker O
implantation O
for O
backup O
support O
and O
will O
arrange O
electrophysiologic O
consultation O
for O
permanent O
pacemaker O
implantation O
. O
 
There O
is O
no O
history O
to O
suggest O
an O
ischemic O
syndrome O
, O
so O
I O
did O
not O
think O
additional O
pharmacologic O
stress O
test O
is O
necessary O
. O
 
Her O
beta-blocker O
will O
be O
held O
overnight O
in O
addition O
to O
her O
amitriptyline O
to O
see O
if O
this O
facilitates O
recovery O
of O
her O
AV O
nodal O
function O
. O
 
Overall O
, O
I O
think O
this O
likely O
represents O
infra-hisian O
block O
and O
a O
pacemaker O
should O
be O
curative O
therapy O
. O
 
Additional O
plans O
will O
be O
dictated O
by O
her O
clinical O
course O
. O
 
______________________________ O
Xavier I-NAME
Alvin I-NAME
Kaufman I-NAME
, O
MD O
eScription O
document:3-6100190 O
IFFocus O
CC O
: O
Owen I-NAME
Quentin-Xiong I-NAME
M.D O
. O
 
Columbia I-LOCATION
Kingwood I-LOCATION
Medical I-LOCATION
35 I-LOCATION
Wood I-LOCATION
St I-LOCATION
North I-LOCATION
Andover I-LOCATION
, O
KY I-LOCATION
41454 I-LOCATION
DD O
: O
09/28/90 I-DATE
DT O
: O
09/28/90 I-DATE
DV O
: O
09/28/90 I-DATE
 
Record O
date O
: O
2092-05-05 I-DATE
05/05/2092 I-DATE
Spanish O
81 I-LOCATION
Wood I-LOCATION
St I-LOCATION
UHRICH O
, O
KARSON I-NAME
North I-LOCATION
Andover I-LOCATION
, O
KY I-LOCATION
41454 I-LOCATION
45630268 I-ID
( O
884 O
) O
486-9594 I-CONTACT
07/01/2091 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Uhrich I-NAME
is O
75 I-AGE
. O
 
Medical O
issues O
include O
osteopenia O
, O
hyperlipidemia O
, O
hypertension O
, O
heart O
block O
( O
pacemaker O
implanted O
) O
, O
gastritis O
, O
occasional O
joint O
pains O
. O
 
Medications O
Amitriptyline O
HCL O
25 O
MG O
( O
25MG O
TABLET O
Take O
1 O
) O
PO O
QHS O
x O
30 O
days O
# O
30 O
Tablet O
( O
s O
) O
Asa O
EC O
ONE O
TABLET O
81 I-LOCATION
MG O
PO O
qd O
# O
100 O
Tablet O
( O
s O
) O
Atenolol O
50 O
MG O
( O
50MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
60 O
Tablet O
( O
s O
) O
Calcium O
+ O
D O
( O
500 O
ELEM O
. O
 
CA O
) O
( O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
500MG O
ELEM O
CA O
) O
/ O
VIT O
D O
200 O
IU O
) O
) O
1 O
TAB O
PO O
BID O
# O
60 O
Tablet O
( O
s O
) O
Fosamax O
( O
ALENDRONATE O
) O
70 O
MG O
( O
70MG O
TABLET O
Take O
1 O
) O
PO O
Q O
month O
# O
3 O
Month O
( O
s O
) O
Supply O
Lisinopril/hydrochlorothiazide O
20MG/25MG O
1 O
TAB O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Metformin O
EXTENDED O
RELEASE O
500 O
MG O
( O
500MG O
TAB.SR O
24H O
Take O
1 O
) O
PO O
QD O
# O
90 O
TAB.SR O
Monistat O
3 O
( O
MICONAZOLE O
200MG O
VAGINAL O
SUPP O
) O
1 O
SUPP O
PV O
QHS O
x O
3 O
days O
# O
3 O
Suppositories O
Protonix O
( O
PANTOPRAZOLE O
) O
40 O
MG O
( O
40MG O
TABLET O
DR O
Take O
1 O
) O
PO O
QD O
# O
30 O
Tablet O
( O
s O
) O
Simvastatin O
20 O
MG O
( O
20MG O
TABLET O
Take O
1 O
) O
PO O
QHS O
# O
30 O
Tablet O
( O
s O
) O
Left O
arm O
pain O
has O
not O
recurred O
. O
 
When O
tested O
in O
past O
no O
cardiac O
cause O
found O
. O
 
Neurology O
examined O
her O
and O
felt O
cause O
had O
probably O
been O
impingement O
, O
no O
further O
follow O
up O
recommended O
. O
 
She O
has O
been O
pain O
free O
. O
 
She O
denies O
CP O
or O
pressure O
on O
exercise O
. O
 
No O
palpitation O
, O
no O
leg O
edema O
. O
 
Uses O
3 O
pillows O
On O
09/27/90 I-DATE
she O
was O
admitted O
to O
the O
hospital O
via O
the O
ED O
where O
she O
presented O
with O
2/1 O
heartblock O
and O
a O
ventricular O
rate O
of O
38 O
. O
 
A O
pacemeker O
was O
implanted O
and O
the O
lightheadedness O
that O
brought O
her O
to O
the O
ED O
disappeared O
. O
 
She O
is O
under O
the O
care O
of O
Dr. O
Ison I-NAME
and O
Dr. O
Ximenez I-NAME
in O
Cardiology O
. O
 
Otherwise O
she O
has O
has O
been O
well O
. O
 
She O
does O
have O
osteoarthritis O
of O
the O
knees O
Rt O
. O
 
& O
gt O
; O
Lft O
. O
 
Has O
experienced O
cramps O
in O
her O
LE O
. O
 
She O
does O
not O
drink O
much O
water O
. O
 
No O
PND O
or O
ankle O
edema O
. O
 
No O
significant O
nocturia O
( O
X1 O
or O
2 O
) O
. O
 
No O
cough O
or O
sputum O
, O
no O
chills O
or O
fever O
. O
 
She O
is O
still O
having O
trouble O
remembering O
things O
but O
problem O
is O
not O
worse O
than O
before O
. O
 
Still O
has O
occaasional O
dysuria O
; O
in O
past O
culture O
has O
been O
negative O
PHYSICAL O
EXAMINATION O
: O
Vital O
Signs O
BP O
152/79 O
, O
P O
72 O
, O
Wt O
147 O
lb O
FINGER O
BLOOD O
GLUCOSE O
118 O
She O
is O
in O
no O
distress O
. O
 
Extraocular O
movements O
are O
full O
. O
 
The O
neck O
veins O
are O
flat O
. O
 
The O
chest O
is O
clear O
to O
auscultation O
. O
 
The O
heart O
rhythm O
is O
regular O
, O
no O
rubs O
or O
gallops O
. O
 
The O
lower O
extremities O
are O
free O
of O
edema.Knees O
thickened O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
A O
75-year-old O
diabetic O
whose O
glycemic O
control O
is O
good O
. O
 
Hemoglobin O
A1 O
was O
6.8 O
, O
electrolytes O
, O
renal O
function O
, O
and O
calcium O
and O
a O
lipid O
panel O
WNL O
except O
for O
mild O
triglceride O
elevation. O
. O
She O
has O
an O
implanted O
pacemaker O
which O
if O
functioning O
well O
. O
 
Adviced O
her O
to O
continue O
to O
walk O
and O
watch O
her O
diet O
. O
 
She O
will O
keep O
appointment O
with O
Ophthalmologist O
who O
did O
her O
cataract O
surgery O
. O
 
She O
feels O
that O
her O
vision O
on O
OD O
is O
diminished O
and O
at O
times O
gets O
inflamed. O
. O
 
I O
have O
given O
her O
my O
card O
to O
give O
to O
her O
ophthalmologist O
to O
send O
me O
a O
report O
. O
 
Return O
in O
4 O
months O
or O
prn O
______________________________ O
Owen I-NAME
Quentin-Xiong I-NAME
, O
M.D O
. O
 
Results05/03/2092 O
NA O
139 O
, O
K O
4.1 O
, O
CL O
101 O
, O
CO2 O
30 O
, O
BUN O
20 O
, O
CRE O
1.09 O
, O
EGFR O
49 O
, O
GLU O
10305/03/2092 O
ANION O
805/03/2092 O
CA O
9.705/03/2092 O
ALT/SGPT O
36 O
( O
# O
) O
, O
AST/SGOT O
41 O
( O
* O
# O
) O
05/03/2092 I-DATE
CHOL O
192 O
, O
TRIG O
171 O
( O
* O
) O
, O
HDL O
42 O
( O
# O
) O
, O
LDLCAL O
116 O
, O
VLDL O
3405/03/2092 O
HGBA1C O
6.8 O
( O
* O
) O
05/03/2092 I-DATE
MALB O
0.8 O
, O
MALB/CRE O
11.805/03/2092 O
UTIME O
RANDOM05/03/2092 O
UTIME O
RANDOM O
, O
U/UCRE O
67.8 O
 
Record O
date O
: O
2087-12-05 I-DATE
Beckley I-LOCATION
Appalachian I-LOCATION
Regional I-LOCATION
Hospital I-LOCATION
040 I-LOCATION
Townsend I-LOCATION
West I-LOCATION
MOSS O
, O
DEREK I-NAME
Espanola I-LOCATION
, O
WI I-LOCATION
85976 I-LOCATION
59624156 I-ID
895-239-5445 I-CONTACT
, O
302-843-7619 I-CONTACT
12/05/2087 I-DATE
History O
of O
the O
Present O
Illness/Chief O
Complaint O
: O
The O
patient O
is O
a O
77-year-old O
man O
who O
is O
here O
with O
his O
son O
and O
daughter O
today O
, O
acutely O
ill O
with O
multiple O
acute O
medical O
problems O
. O
 
Medications O
: O
Per O
the O
list O
entered O
on O
the O
computer O
today O
, O
a O
total O
of O
28 O
medications O
and O
accessories O
. O
 
Allergies O
: O
None O
. O
 
Past O
Medical O
History O
Surgeries O
1 O
. O
 
Hip O
surgery O
. O
 
2 O
. O
 
Cholecystectomy O
. O
 
3 O
. O
 
Lumbar O
laminectomy O
. O
 
4 O
. O
 
Left O
leg O
surgery O
. O
 
5 O
. O
 
Bilateral O
cataract O
extraction O
. O
 
6 O
. O
 
Prostate O
biopsy O
2086 I-DATE
, O
Gleason O
grade O
6/10 O
. O
 
7 O
. O
 
Left O
skin O
cancer O
removal O
. O
 
Medical O
Problems O
1 O
. O
 
Septic O
arthritis O
of O
the O
left O
shoulder O
. O
 
2 O
. O
 
Dislocated O
left O
shoulder O
. O
 
3 O
. O
 
CHF O
with O
dilated O
cardiomyopathy O
. O
 
4 O
. O
 
Atrial O
fibrillation O
. O
 
5 O
. O
 
Insulin-dependent O
diabetes O
. O
 
6 O
. O
 
Parkinson O
's O
disease O
. O
 
7 O
. O
 
GI O
bleed O
. O
 
8 O
. O
 
Diffuse O
arthritis O
. O
 
9 O
. O
 
Prostatic O
cancer O
. O
 
10 O
. O
 
Prostatic O
obstruction O
. O
 
11 O
. O
 
Microcytic O
anemia O
. O
 
Family O
History O
Family O
history O
was O
reviewed O
and O
is O
notable O
for O
: O
CVD O
: O
Positive O
. O
 
Social O
History O
Living O
arrangements O
: O
He O
has O
recently O
moved O
from O
Ouagadougou I-LOCATION
. O
 
He O
is O
living O
with O
his O
son O
and O
daughter-in-law O
in O
Harrisburg I-LOCATION
. O
 
He O
has O
mostly O
been O
in O
the O
hospital O
over O
the O
last O
several O
months O
. O
 
Work O
: O
He O
is O
a O
retired O
vocational I-PROFESSION
instructor I-PROFESSION
. O
 
He O
had O
been O
with O
the O
city O
of O
Cadiz I-LOCATION
for O
32 O
years O
. O
 
Smoking O
: O
None O
. O
 
ETOH O
: O
None O
. O
 
Exercise O
: O
None O
. O
 
Diet O
: O
Minimal O
, O
poor O
appetite O
. O
 
Domestic O
Violence O
: O
None O
. O
 
Health O
Maintenance O
Seat O
belts O
: O
Always O
. O
 
Colonoscopy O
: O
Has O
had O
but O
there O
are O
no O
records O
( O
may O
have O
been O
indadequate O
exam O
) O
. O
 
Endoscopy O
in O
2087 I-DATE
showed O
gastritis O
. O
 
Immunization O
Td O
: O
Up-to-date O
. O
 
Review O
of O
Systems O
ROS O
reviewed O
in O
detail O
. O
 
General O
: O
Good O
mood O
. O
 
No O
F/S/C O
. O
 
Depressed O
with O
chronic O
illness O
, O
extremely O
fatigued O
. O
 
Skin O
: O
Multiple O
ecchymoses O
, O
extremely O
dry O
skin O
. O
 
HEENT O
: O
no O
sore O
throat O
; O
no O
change O
in O
vision O
or O
blurring O
; O
No O
change O
in O
hearing O
, O
ear O
pain O
, O
or O
tinnitus O
Cardiovascular O
: O
History O
of O
substernal O
chest O
pain O
, O
on O
longacting O
nitroglycerin O
, O
dyspnea O
on O
exertion O
, O
sleeps O
with O
the O
bed O
propped O
up O
and O
one O
pillow O
, O
chronic O
ankle O
edema O
, O
chronic O
AF O
. O
 
Respiratory O
: O
Dyspnea O
on O
exertion O
. O
 
GI O
: O
Loose O
bowel O
movements O
multiple O
times O
a O
day O
. O
 
Over O
the O
last O
week O
he O
has O
been O
having O
bright O
red O
blood O
. O
 
He O
has O
had O
melena O
in O
the O
past O
, O
most O
recently O
grape O
jelly O
like O
clots O
of O
blood O
. O
 
He O
has O
had O
anorexia O
. O
 
No O
abdominal O
pain O
, O
no O
vomiting O
. O
 
Extrem O
: O
Left O
shoulder O
pain O
, O
history O
of O
significant O
infection O
in O
the O
left O
shoulder O
, O
torn O
rotator O
cuff O
so O
that O
he O
is O
essentially O
unable O
to O
use O
the O
left O
arm O
. O
 
Endocrine O
: O
no O
polyuria O
or O
polydipsia O
; O
one O
episode O
of O
sig O
hypoglycemia O
Neurologic O
: O
no O
HA O
, O
visual O
change O
, O
seizure O
, O
or O
acute O
neurologic O
sxs O
Psychiatric O
: O
depression O
; O
acutely O
ill O
Hematologic O
: O
Significant O
bruising O
and O
bleeding O
. O
 
GU O
: O
Urinary O
hesitancy O
, O
prostatic O
obstruction O
, O
prostatic O
cancer O
. O
 
Physical O
Examination O
General/constitutional O
: O
Pleasant O
, O
alert O
, O
oriented O
, O
in O
acute O
distress O
, O
weak O
, O
has O
difficulty O
moving O
; O
nl O
affect O
Vital O
signs O
: O
Ht O
67 O
inches O
Wt O
( O
lbs O
) O
154 O
BMI O
BP O
128/68 O
Heart O
rate O
84 O
, O
irregularly O
irregular O
RR12 O
and O
comfortable O
w/out O
accessory O
muscles O
Temp O
96.3 O
. O
 
Skin O
: O
Dry O
skin O
, O
sallow O
pale O
, O
multiple O
ecchymoses O
, O
significant O
ulcer O
on O
the O
left O
shoulder O
in O
the O
subdeltoid O
bursa O
area O
with O
pus O
in O
the O
center O
and O
erythema O
surrounding O
it O
. O
 
Lymph O
nodes O
: O
no O
cervical O
, O
supraclavicular O
, O
axillary O
, O
inguinal O
lymphadenopathy O
Neck O
: O
supple O
; O
carotid O
upstroke O
good O
w/out O
bruit O
; O
no O
thyromegaly O
or O
tenderness O
HEENT O
: O
pharynx O
with O
nl O
mucosa O
w/out O
exudates O
; O
good O
dental O
care O
; O
conjunctivae O
noninjected O
; O
no O
scleralicterus O
; O
PERRLA O
; O
EOMI O
w/out O
nystagmus O
; O
pupils O
pinpoint O
, O
discs O
not O
visualized O
; O
hearing O
significantly O
reduced O
; O
TM O
nl O
; O
sinuses O
non-tender O
Chest O
: O
w/out O
chest O
wall O
tenderness O
; O
clear O
P O
& O
A O
w/out O
rales O
, O
rhonchi O
, O
or O
wheeze O
Cardiac O
: O
In O
AF O
, O
rate O
of O
80 O
, O
palpable O
, O
PMI O
laterally O
displaced O
, O
soft O
S2 O
, O
S4 O
, O
2/6 O
apical O
systolic O
murmur O
radiating O
to O
the O
left O
sternal O
border O
and O
to O
the O
axilla O
. O
 
Breast O
: O
No O
gynecomastia O
. O
 
Abdomen O
: O
nl O
BS O
, O
no O
hepatomegaly/splenomegaly O
or O
mass O
; O
no O
tenderness/G/R O
; O
abd O
aorta O
w/out O
bruit O
or O
palpable O
enlargement O
Extremities O
: O
1+ O
pretibial O
edema O
. O
 
No O
motion O
of O
the O
left O
shoulder O
ulcer O
as O
noted O
above O
. O
 
Neurologic O
: O
A O
& O
O O
; O
nl O
affect O
; O
nl O
speech O
; O
weakened O
left O
arm O
; O
reflexes O
symmetric O
; O
plantars O
flexor O
Rectal O
: O
Copious O
amounts O
of O
blood O
in O
the O
rectal O
exam O
, O
loose O
sphincter O
, O
no O
prostatic O
mass O
. O
 
Laboratory O
data O
and O
Old O
record O
reviewed O
extensive O
records O
. O
 
Impression O
: O
Acutely O
ill O
gentleman O
w/ O
GI O
Bleed O
CHF O
Hz O
L O
shoulder O
infection O
; O
currently O
w/ O
infected O
ulcer O
and O
limited O
ROM O
due O
to O
rotator O
tear O
DM O
out O
of O
control O
Multiple O
problems O
as O
above O
. O
 
Long O
discussion O
with O
the O
family O
regarding O
previous O
care O
. O
 
Acute O
problem O
today O
is O
massive O
GI O
bleed O
without O
clear O
etiology O
. O
 
History O
of O
heart O
failure O
with O
significant O
weakness O
, O
shortness O
of O
breath O
, O
recent O
chest O
pain O
, O
nonhealing O
ulcer O
on O
his O
left O
shoulder O
, O
all O
requiring O
emergency O
hospitalization O
, O
and O
he O
will O
be O
sent O
to O
the O
BARH I-LOCATION
ER O
at O
once O
. O
 
Long O
discussion O
with O
the O
family O
about O
this O
and O
his O
other O
chronic O
problems O
including O
diabetes O
and O
episodes O
of O
hypoglycemia O
. O
 
Plan O
Health O
Maintenance O
Diet O
and O
exercise O
counseling O
Further O
evaluation O
Medications O
FU O
______________________________ O
Ursula I-NAME
Yawn I-NAME
, O
MD O
eScription O
document:7-3720969 O
HFFocus O
DD O
: O
12/05/87 I-DATE
DT O
: O
12/05/87 I-DATE
DV O
: O
12/05/87 I-DATE
 
Record O
date O
: O
2088-01-20 I-DATE
Infectious O
Disease O
Consultation O
Patient O
Name O
: O
Moss I-NAME
, O
Derek I-NAME
MR O
: O
89659991 I-ID
Reason O
for O
consult O
: O
assistance O
with O
management O
of O
possible O
persistent O
L O
shoulder O
septic O
arthritis O
in O
patient O
pre-op O
for O
planned O
hip O
replacement O
Source O
: O
patient O
, O
MR O
Counsult O
requested O
by O
: O
Dr. O
Everett I-NAME
Pace I-NAME
Date O
of O
consult O
: O
1/20 I-DATE
Location O
: O
4E-66 O
__________________________________________________________________ O
HPI O
: O
Mr. O
Moss I-NAME
is O
a O
77 I-AGE
yo O
M O
with O
PmHx O
significant O
for O
DMII O
, O
CHF O
( O
EF O
20-25 O
% O
) O
, O
afib O
, O
Parkinson O
's O
, O
prostate O
cancer O
s/p O
XRT O
c/b O
proctitis O
and O
GIB O
, O
multiple O
hip O
replacements O
, O
s/p O
multiple O
knee O
surgeries O
who O
, O
recently O
treated O
for O
S. O
aureus O
L O
shoulder O
septic O
arthritis O
( O
10/87 I-DATE
) O
who O
presented O
1/19 I-DATE
s/p O
fall O
. O
 
Mr. O
Moss I-NAME
has O
experienced O
multiple O
falls O
recently O
, O
and O
was O
ultimately O
diagnosed O
with O
Parkinsons O
last O
September I-DATE
. O
 
Following O
the O
diagnosis O
, O
he O
was O
discharged O
to O
Bellaire I-LOCATION
City I-LOCATION
Hospital I-LOCATION
, O
where O
he O
continued O
to O
experience O
falls O
. O
 
After O
one O
episode O
, O
he O
was O
forcibly O
picked O
up O
, O
and O
began O
to O
have O
L O
shoulder O
pain O
thereafter O
. O
 
He O
also O
noted O
a O
cut O
over O
the O
L O
elbow O
on O
transfer O
to O
the O
NH O
that O
was O
slow O
to O
heal O
. O
 
After O
several O
weeks O
of O
worsening O
shoulder O
pain O
, O
erythema O
, O
and O
warmth O
, O
he O
was O
re-hospitalized O
at O
Ouagadougou I-LOCATION
, O
where O
he O
underwent O
L O
shoulder O
aspiration O
. O
 
MRI O
10/87 I-DATE
demonstrated O
complete O
rupture O
of O
the O
rotator O
cuff O
, O
with O
associated O
large O
joint O
effusion O
. O
 
Of O
note O
, O
he O
denied O
fevers O
, O
chills O
, O
or O
NS O
. O
 
L O
shoulder O
aspiration O
10/10/87 I-DATE
demonstrated O
purulent O
fluid O
, O
with O
2,800,000 O
WBC O
( O
97 O
% O
PMN O
) O
. O
 
Gram O
stain O
demonstrated O
GPC O
in O
clusters O
. O
 
He O
subsequently O
underwent O
L O
shoulder O
I O
& O
D O
10/12 I-DATE
, O
with O
removal O
of O
300cc O
of O
frankly O
purulent O
fluid O
. O
 
He O
was O
started O
on O
cefazolin O
. O
 
Culture O
results O
returned O
a O
pan-sensitive O
Staphylococcus O
aureus O
isolate O
( O
including O
to O
ampicillin O
, O
cefazolin O
, O
clindamycin O
, O
penicillin O
, O
rifampin O
) O
. O
 
Blood O
cultures O
were O
negative O
. O
 
He O
was O
taken O
back O
to O
the O
OR O
10/16 I-DATE
for O
arthroscopy O
, O
with O
extensive O
debridement O
. O
 
Interop O
findings O
included O
demonstration O
of O
significant O
fibrinous O
tissue O
, O
with O
no O
normal-appearing O
cartiledge O
present O
. O
 
A O
penrose O
was O
placed O
into O
a O
large O
cavity O
down O
the O
subdeltoid O
rescess O
, O
and O
a O
second O
in O
the O
subacromial O
space O
. O
 
He O
was O
transitioned O
to O
ampicillin O
2g O
q6 O
hours O
x O
2 O
weeks O
, O
and O
then O
given O
amoxicillin O
( O
either O
1g O
BID O
or O
500mg O
TID O
, O
unsure O
which O
) O
x O
2 O
weeks O
. O
 
Repeat O
R O
shoulder O
MRI O
obtained O
12/12/87 I-DATE
, O
which O
was O
reviewed O
with O
staff O
radiologist O
, O
and O
demonstrated O
again O
complete O
tear O
of O
the O
supra/infraspinatus/teres O
minor/ O
subscapularis/ O
biceps O
tendons O
, O
with O
also O
persistent O
large O
joint O
effusion O
, O
extensive O
synovitis O
, O
and O
full O
thickness O
cartiledge O
loss O
of O
glenoid O
and O
humeral O
head O
. O
 
Also O
noted O
was O
possible O
AVN O
of O
medial O
portion O
of O
the O
humeral O
head O
. O
 
Overall O
, O
was O
difficult O
to O
tell O
from O
MRI O
whether O
findings O
represented O
prior O
vs O
active O
disease O
. O
 
Mr. O
Moss I-NAME
was O
seen O
in O
the O
ID O
clinic O
1/18 I-DATE
, O
at O
which O
time O
he O
complained O
of O
a O
several O
week O
h/o O
progressively O
worsening O
L O
shoulder O
discomfort O
with O
activity O
. O
 
He O
did O
not O
experience O
shoulder O
pain O
at O
rest O
, O
and O
had O
not O
recently O
noted O
erythema O
. O
 
No O
drainage O
. O
 
Appetite O
was O
near O
baseline O
, O
though O
he O
had O
experienced O
fatigue O
. O
 
Blood O
glucoses O
had O
been O
well O
controlled O
. O
 
His O
daughter O
in O
law O
brought O
in O
extensive O
data O
on O
his O
home O
vital O
signs O
, O
which O
revealed O
absence O
of O
fever O
except O
for O
a O
single O
isolated O
temp O
of O
103 O
, O
with O
stable O
pulse/BP O
, O
and O
overall O
well O
controlled O
blood O
sugars O
. O
 
Date O
ESR O
CRP O
12/6/87 I-DATE
88 O
23 O
12/19/87 I-DATE
96 O
28 O
1/18/88 I-DATE
67 O
9.4 O
Unfortunately O
, O
Mr. O
Moss I-NAME
sustained O
a O
mechanical O
fall O
1/19 I-DATE
. O
 
Following O
the O
fall O
, O
he O
had O
significantly O
increased O
hip O
pain O
. O
 
Hip/pelvis O
films O
notable O
for O
femoral O
component O
with O
lucency O
measuring O
more O
than O
2mm O
superolaterally O
and O
along O
the O
stem O
. O
 
Orthopedic O
team O
felt O
that O
loosening O
of O
hardware O
would O
require O
another O
hip O
revision O
. O
 
ROS O
: O
as O
per O
HPI O
. O
 
Denied O
having O
R O
hip O
pain O
prior O
to O
his O
fall O
. O
 
No O
cough O
, O
sore O
throat O
, O
chest O
discomfort O
, O
abdominal O
pain O
, O
dysuria O
, O
diarrhea O
. O
 
Extensive O
ROS O
otherwise O
negative O
. O
 
PmHx O
: O
h/o O
L O
shoulder O
septic O
joint O
s/p O
I/D O
in O
10/87 I-DATE
c/b O
hemorrhage O
as O
per O
HPI O
CHF O
( O
EF O
20-25 O
% O
) O
s/p O
5 O
hip O
surgeries O
, O
s/p O
bilateral O
hip O
replacements O
. O
 
S/p O
R O
THA O
with O
revision O
x O
2 O
, O
last O
2081 I-DATE
( O
Kent I-NAME
) O
, O
s/p O
l O
THA O
with O
revision O
x O
1 O
. O
 
Afib O
, O
maintained O
on O
coumadin O
DMII O
, O
diagnosed O
~20 O
years O
ago O
. O
 
Unsure O
of O
last O
A1c O
CRI O
( O
baseline O
Cr O
~1.6-1.7 O
) O
HTN O
Parkinson O
's O
disease O
, O
prostate O
ca O
s/p O
radiation O
c/b O
radiation O
proctitis O
, O
LGIB O
, O
thought O
secondary O
to O
radiation O
proctitis O
. O
 
Was O
to O
have O
a O
colonoscopy O
this O
week O
. O
 
Admitted O
with O
GIB O
12/87 I-DATE
. O
 
s/p O
multiple O
knee O
surgeries O
GERD O
melanoma O
s/p O
excision O
s/p O
cholecystectomy O
. O
 
Meds O
on O
admission O
: O
Protonix O
, O
isosorbide O
, O
MVI O
, O
lasix O
, O
hydralazine O
, O
sucralfate O
, O
flomax O
, O
FeSo4 O
, O
senna O
, O
avodart O
, O
sinemet O
, O
coumadin O
, O
quinine O
, O
lantus/novolog O
. O
 
Current O
medications O
: O
Iron O
, O
quinine O
, O
isosorbide O
, O
lasix O
, O
hydral O
, O
insulin O
, O
sinemet O
, O
flomax O
, O
avodart O
, O
nexium O
, O
requip O
, O
sucralfate O
All/adverse O
rxn O
: O
NKDA O
Social O
history O
: O
widowed O
, O
lives O
with O
family O
, O
who O
are O
very O
involved O
in O
his O
care O
. O
 
No O
tobacco O
, O
EtOH O
, O
or O
IVDU O
. O
 
Retired O
. O
 
FHx O
: O
Noncontributory O
P.E O
. O
 
VS O
: O
97.4 O
76 O
118/97 O
18 O
98 O
% O
RA O
Gen O
: O
found O
lying O
flat O
in O
bed O
, O
in O
no O
acute O
distress O
Skin O
: O
no O
rashes O
. O
 
Multiple O
areas O
of O
ecchymoses O
, O
with O
some O
skin O
breakdown O
, O
on O
extremities O
bilaterally O
( O
he O
attributes O
this O
to O
multiple O
falls O
) O
HEENT O
: O
anicteric O
, O
conjunctiva O
uninjected O
. O
 
No O
sinus O
tenderness O
. O
 
No O
nasal O
d/c O
. O
 
No O
sores/lesions O
in O
oral O
cavity O
. O
 
No O
thrush O
Neck O
: O
supple O
, O
no O
JVD O
, O
no O
LAD O
. O
 
Cor O
: O
irregular O
rhythm O
, O
nl O
S1 O
S2 O
, O
II/VI O
SEM O
at O
RUSB O
Chest O
: O
clear O
to O
auscultation O
and O
percussion O
Abd O
: O
soft O
, O
NT/ND O
, O
+BS O
x4 O
, O
no O
hepatomegaly O
, O
no O
spleen O
tip O
palpable O
. O
 
Extr O
: O
acyanotic O
, O
nonedematous O
. O
 
Back O
: O
no O
midline O
or O
CVA O
tenderness O
Shoulder O
: O
L O
shoulder O
non-erythematous O
, O
not O
significantly O
tender O
to O
palpation O
, O
though O
does O
have O
pain O
with O
active O
motion O
. O
 
No O
exudate O
. O
 
Can O
forward O
flex O
past O
90 O
, O
abduct O
to O
45 O
. O
 
Hip O
: O
minimal O
tenderness O
to O
palpation O
of O
R O
hip O
( O
though O
just O
given O
pain O
meds O
) O
; O
unable O
to O
flex O
or O
abduct O
hip O
( O
was O
able O
to O
on O
Wednesday I-DATE
in O
clinic O
) O
. O
 
Neuro O
: O
MS O
: O
awake O
, O
alert O
, O
oriented O
to O
person O
, O
place O
, O
time O
. O
 
CN O
II-XII O
intact O
. O
 
Motor O
exam O
limited O
by O
shoulder O
pain O
, O
though O
strength O
exam O
non-focal O
when O
adjusted O
for O
injuries O
. O
 
Mildly O
shuffling O
gait O
noted O
on O
Wednesday I-DATE
in O
clinic O
, O
not O
tested O
today O
. O
 
Resting O
tremor O
, O
pill O
rolling O
. O
 
Lines O
: O
no O
erythema O
. O
 
Laboratory O
Data O
: O
SODIUM O
134 O
* O
( O
136-142 O
) O
mmol/L O
POTASSIUM O
4.1 O
( O
3.5-5.0 O
) O
mmol/L O
CHLORIDE O
95 O
* O
( O
98-108 O
) O
mmol/L O
TOTAL O
CO2 O
27 O
( O
23-32 O
) O
mmol/L O
GLUCOSE O
100 O
( O
54-118 O
) O
mg/dL O
UREA O
N O
99 O
* O
( O
9-25 O
) O
mg/dL O
CREATININE O
2.5 O
* O
( O
0.7-1.3 O
) O
mg/dL O
WBC O
8.66 O
( O
4-10 O
) O
K/uL O
HCT O
34.1 O
* O
( O
40-54 O
) O
% O
PLT O
252 O
( O
150-450 O
) O
K/uL O
POLY O
87 O
* O
( O
48-76 O
) O
% O
BAND O
4 O
* O
( O
0-3 O
) O
% O
PT O
17.9 O
* O
( O
11.8-14.6 O
) O
sec O
PTT O
33.2 O
( O
23.8-36.6 O
) O
sec O
PT O
( O
INR O
) O
1.5 O
* O
( O
0.9-1.1 O
) O
Micro O
Data O
: O
None O
recently O
Shoulder O
aspirate O
as O
per O
HPI O
( O
S O
aureus O
, O
pan O
sensitive O
) O
Imaging O
: O
Pelvis/Hip O
( O
right O
) O
films O
: O
Bilateral O
total O
hip O
arthroplasties O
without O
any O
acute O
fracture O
or O
dislocation O
. O
 
The O
acetabular O
component O
demonstrates O
vertical O
inclination O
with O
evidence O
of O
polyethylene O
wear O
. O
 
The O
femoral O
component O
demonstrates O
lucency O
measuring O
more O
than O
2mm O
superolaterally O
and O
along O
the O
stem O
consistent O
with O
granulomatous O
disease O
. O
 
There O
is O
no O
subsidence O
or O
loosening O
based O
on O
Grauer O
's O
classification O
. O
 
AP O
chest O
film O
: O
no O
acute O
pulmonary O
process O
, O
probable O
cardiomegaly O
. O
 
Assessment O
: O
77 I-AGE
yo O
M O
with O
DMII O
, O
CHF O
( O
EF O
20-25 O
% O
) O
, O
afib O
, O
Parkinson O
's O
, O
prostate O
cancer O
s/p O
XRT O
c/b O
proctitis O
and O
GIB O
, O
multiple O
hip O
replacements O
, O
recently O
treated O
for O
S. O
aureus O
L O
shoulder O
septic O
arthritis O
( O
10/87 I-DATE
- O
11/87 I-DATE
) O
who O
presented O
1/19 I-DATE
s/p O
fall O
. O
 
With O
regards O
to O
his O
shoulder O
, O
it O
is O
difficult O
to O
know O
whether O
his O
infection O
was O
cured O
by O
the O
4-week O
abx O
course O
. O
 
Though O
his O
shoulder O
does O
not O
appear O
to O
be O
grossly O
infected O
on O
exam O
, O
2 O
months O
after O
completion O
of O
his O
course O
, O
it O
is O
too O
early O
to O
determine O
sterilization O
of O
the O
shoulder O
on O
a O
clinical O
basis O
. O
 
The O
MRI O
is O
difficult O
to O
interpret O
, O
and O
may O
well O
reflect O
prior O
inflammatory O
changes O
. O
 
He O
did O
have O
persistently O
elevated O
inflammatory O
markers O
( O
though O
confounded O
by O
multiple O
comorbidities O
) O
. O
 
Given O
the O
possibility O
that O
he O
had O
cleared O
the O
infection O
, O
our O
plan O
as O
of O
the O
clinic O
visit O
Wednesday I-DATE
had O
been O
to O
observe O
him O
clinically O
, O
off O
abx O
, O
for O
signs O
of O
recurrent O
infection O
. O
 
However O
, O
given O
his O
fall O
and O
the O
possibility O
of O
new O
hardware O
placement O
, O
would O
now O
favor O
a O
more O
aggressive O
workup O
of O
his O
shoulder O
. O
 
As O
such O
, O
would O
recommend O
shoulder O
aspiration O
off O
antibiotics O
. O
 
The O
source O
for O
the O
L O
shoulder O
staph O
infection O
was O
never O
elucidated O
, O
and O
blood O
cultures O
were O
negative O
. O
 
However O
, O
such O
septic O
arthritis O
often O
results O
from O
hematogenous O
seeding O
, O
and O
there O
is O
a O
small O
change O
that O
his O
R O
hip O
may O
also O
have O
become O
infected O
. O
 
This O
could O
help O
to O
explain O
the O
prosthesis O
loosening O
. O
 
Alternatively O
, O
he O
may O
have O
had O
hardware O
mechanical O
failure O
in O
setting O
of O
falls O
, O
or O
less O
likely O
involvement O
by O
his O
prostatic O
ca O
( O
? O
read O
of O
granulomatous O
disease O
around O
the O
prosthesis O
) O
. O
 
Recommendations O
: O
-hold O
antibiotics O
, O
including O
pre-operative O
prophylactic O
antibiotics O
to O
allow O
optimal O
culture O
data O
-Aspirate O
shoulder O
. O
 
Send O
fluid O
for O
cell O
counts O
, O
Gram O
stain O
, O
aerobic/anaerobic/fungal O
cultures O
-if O
do O
not O
see O
contraindication O
to O
proceeding O
with O
planned O
hip O
replacement O
-would O
obtain O
hip O
biopsies O
in O
the O
OR O
, O
again O
off O
abx O
, O
to O
assess O
for O
possible O
hip O
infection O
-likewise O
, O
would O
send O
OR O
hip O
specimen O
to O
pathology O
to O
assess O
for O
infection O
vs. O
neoplastic O
involvement O
-check O
CK O
, O
given O
elevated O
Cr O
following O
fall O
, O
and O
possible O
rhabdo O
Thank O
you O
for O
this O
interesting O
consultation O
. O
 
We O
will O
continue O
to O
follow O
with O
you O
. O
 
___________ O
Yair I-NAME
Gillespie I-NAME
Pager O
# O
52719 I-CONTACT
Infectious O
disease O
fellow O
 
Record O
date O
: O
2088-09-04 I-DATE
Beckley I-LOCATION
Appalachian I-LOCATION
Regional I-LOCATION
Hospital I-LOCATION
315 I-LOCATION
Townsend I-LOCATION
West I-LOCATION
MOSS O
, O
DEREK I-NAME
Espanola I-LOCATION
, O
WI I-LOCATION
85976 I-LOCATION
89659991 I-ID
895-239-5445 I-CONTACT
09/04/2088 I-DATE
REASON O
FOR O
VISIT O
: O
Follow O
up O
with O
Mr. O
Derek I-NAME
Moss I-NAME
who O
is O
here O
with O
his O
son O
and O
daughter-in-law O
with O
multiple O
problems O
and O
for O
preop O
check O
of O
electrolytes O
. O
 
Mr. O
Moss I-NAME
is O
78 I-AGE
years O
old O
. O
 
MEDICAL O
PROBLEM O
LIST O
: O
1 O
. O
 
Diabetes O
mellitus O
type O
2 O
, O
insulin O
dependent O
. O
 
2 O
. O
 
Left O
shoulder O
pain O
. O
 
Scheduled O
for O
surgical O
care O
tomorrow O
. O
 
3 O
. O
 
GI O
bleeding O
, O
ongoing O
. O
 
4 O
. O
 
Parkinson O
's O
disease O
. O
 
5 O
. O
 
Fatigue O
. O
 
6 O
. O
 
BCE O
. O
 
MEDICATIONS O
: O
Medication O
list O
updated O
on O
the O
LMR O
. O
 
Major O
change O
is O
furosemide O
now O
60 O
mg O
b.i.d O
. O
 
instead O
of O
80 O
. O
 
INTERIM O
HISTORY O
: O
1 O
. O
 
Hyperkalemia O
occurred O
on O
higher O
dose O
of O
Lasix O
. O
 
Apparently O
this O
has O
been O
a O
problem O
in O
the O
past O
. O
 
He O
also O
bumped O
his O
creatinine O
to O
2.3 O
. O
 
Potassium O
rechecked O
today O
and O
is O
now O
down O
to O
5.1 O
, O
stable O
creatinine O
. O
 
2 O
. O
 
Diabetes O
. O
 
Blood O
sugars O
running O
in O
the O
80s O
in O
the O
morning O
, O
higher O
later O
in O
the O
day O
on O
16 O
units O
of O
Lantus O
sliding O
scale O
to O
cover O
other O
meals O
. O
 
Uses O
regular O
insulin O
about O
twice O
a O
day O
. O
 
3 O
. O
 
GI O
bleeding O
ongoing O
by O
Mr. O
Moss I-NAME
's O
report O
, O
still O
having O
clots O
of O
blood O
, O
no O
abdominal O
pain O
, O
has O
not O
had O
GI O
follow O
up O
recently O
, O
is O
off O
Coumadin O
prior O
to O
shoulder O
repair O
. O
 
3 O
. O
 
Skin O
lesions O
, O
one O
on O
his O
left O
leg O
, O
one O
on O
his O
right O
medial O
leg O
and O
a O
lump O
on O
his O
back O
noticed O
by O
his O
daughter O
when O
she O
was O
giving O
him O
a O
therapeutic O
massage O
. O
 
4 O
. O
 
Left O
shoulder O
pain O
. O
 
Scheduled O
for O
surgery O
in O
the O
a.m O
. O
 
PHYSICAL O
EXAMINATION O
: O
He O
is O
brighter O
, O
cheerier O
, O
acutely O
oriented O
. O
 
No O
acute O
pain O
. O
 
Vital O
Signs O
: O
Blood O
pressure O
126/57 O
, O
pulse O
66 O
and O
regular O
, O
respirations O
12 O
and O
unlabored O
, O
weight O
161 O
. O
 
Skin O
shows O
seborrheic O
keratoses O
, O
actinic O
keratoses O
on O
the O
right O
leg O
, O
papule O
with O
eschar O
on O
the O
left O
leg O
, O
a O
subcutaneous O
nodule O
on O
the O
right O
upper O
back O
. O
 
Chest O
is O
clear O
P O
& O
A O
. O
 
Cardiac O
exam O
regular O
rate O
and O
rhythm O
, O
normal O
S1 O
, O
S2 O
, O
II/IV O
apical O
systolic O
murmur O
radiating O
to O
the O
left O
sternal O
border O
. O
 
No O
gallop O
. O
 
Extremities O
, O
trace O
edema O
. O
 
Decreased O
ROM O
R O
shoulder O
. O
 
Abdomen O
soft O
. O
 
Neurologic O
, O
alert O
and O
oriented O
. O
 
IMPRESSION O
AND O
PLAN O
: O
Hyperkalemia O
resolving O
. O
 
Discussed O
importance O
of O
careful O
fluid O
balance O
, O
low-protein O
diet O
given O
azotemia O
, O
renal O
follow O
up O
, O
follow O
up O
with O
GI O
for O
GI O
bleeding O
, O
blood O
transfusions O
are O
available O
. O
 
Continue O
lower O
dose O
of O
Lasix O
. O
 
Skin O
lesions O
include O
seborrheic O
dermatitis O
, O
seborrheic O
keratoses O
, O
possible O
lipoma O
, O
although O
lump O
on O
his O
back O
is O
firm O
and O
may O
need O
a O
biopsy O
once O
he O
has O
recovered O
from O
shoulder O
surgery O
. O
 
Long O
consultation O
with O
him O
and O
his O
daughter O
regarding O
home O
care O
after O
surgery O
. O
 
______________________________ O
Ursula I-NAME
Yawn I-NAME
, O
MD O
eScription O
document:7-9274121 O
EMSSten O
Tel O
DD O
: O
09/04/88 I-DATE
DT O
: O
09/05/88 I-DATE
DV O
: O
09/04/88 I-DATE
 
Record O
date O
: O
2089-03-11 I-DATE
EDVISIT^89659991^MOSS O
, O
DEREK^03/11/89^GODFREY O
, O
XAVIER I-NAME
GEORGE I-NAME
I O
saw O
this O
patient O
with O
the O
resident O
, O
Dr. O
Louvinia I-NAME
Duvall I-NAME
. O
 
Please O
see O
her O
note O
for O
further O
details O
. O
 
I O
confirm O
that O
I O
have O
interviewed O
and O
examined O
the O
patient O
, O
reviewed O
the O
resident's O
documentation O
on O
the O
patient O
's O
chart O
, O
and O
discussed O
the O
evaluation O
, O
plan O
of O
care O
, O
and O
disposition O
with O
the O
patient O
. O
 
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
The O
patient O
is O
a O
78-year-old O
male O
with O
a O
history O
of O
diabetes O
, O
hypertension O
, O
atrial O
fibrillation O
, O
congestive O
heart O
failure O
, O
prostate O
cancer O
, O
chronic O
renal O
insufficiency O
, O
and O
Parkinson O
disease O
previously O
hospitalized O
2 O
weeks O
prior O
for O
right O
lower O
extremity O
cellulitis O
, O
which O
he O
had O
a O
PICC O
line O
placed O
, O
and O
was O
discharged O
to O
home O
on O
vancomycin O
. O
 
Since O
that O
time O
, O
he O
has O
had O
progressively O
increase O
in O
his O
creatinines O
despite O
decreasing O
doses O
of O
vancomycin O
. O
 
He O
was O
concerned O
and O
requested O
that O
the O
patient O
to O
come O
in O
for O
a O
possible O
acute O
renal O
failure O
secondary O
to O
the O
antibiotic O
. O
 
There O
is O
also O
concern O
that O
cellulitis O
had O
worsened O
, O
as O
the O
patient O
was O
experiencing O
increasing O
weakness O
. O
 
He O
is O
denying O
currently O
any O
fevers O
, O
chills O
, O
or O
constitutional O
symptoms O
. O
 
His O
baseline O
shortness O
of O
breath O
has O
been O
going O
on O
for O
months O
. O
 
No O
GI O
complaints O
. O
 
He O
has O
had O
a O
mild O
headache O
, O
but O
no O
visual O
changes O
, O
no O
focal O
motor O
or O
sensory O
loss O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
The O
systems O
reviewed O
and O
found O
to O
be O
negative O
. O
 
MEDICATIONS O
: O
He O
has O
a O
long O
list O
of O
medications O
Please O
see O
the O
chart O
. O
 
ALLERGIES O
: O
Morphine O
. O
 
SOCIAL O
HISTORY O
: O
Reviewed O
and O
found O
to O
be O
noncontributory O
. O
 
FAMILY O
HISTORY O
: O
Reviewed O
and O
found O
to O
be O
noncontributory O
. O
 
PAST O
SURGICAL O
HISTORY O
: O
Cholecystectomy O
and O
bilateral O
total O
hip O
replacement O
. O
 
PHYSICAL O
EXAMINATION O
: O
He O
is O
awake O
, O
alert O
, O
nontoxic O
appearing O
, O
and O
in O
no O
acute O
distress O
. O
 
Vital O
signs O
reviewed O
and O
found O
to O
be O
within O
normal O
limits O
. O
 
Afebrile O
at O
95.6 O
. O
 
HEENT O
exam O
is O
unremarkable O
. O
 
Mucosal O
membranes O
are O
moist O
. O
 
Neck O
is O
supple O
. O
 
Lungs O
are O
clear O
bilaterally O
. O
 
Heart O
is O
regular O
rate O
and O
rhythm O
, O
no O
murmurs O
or O
gallops O
. O
 
Abdomen O
: O
Soft O
, O
nondistended O
, O
and O
nontender O
with O
normoactive O
bowel O
sounds O
. O
 
Skin O
is O
warm O
and O
dry O
. O
 
Extremity O
exam O
: O
He O
has O
right O
lower O
extremity O
cellulitis O
with O
2 O
small O
ulcerations O
and O
serosanguineous O
drainage O
is O
minimal O
. O
 
No O
evidence O
of O
pus O
. O
 
It O
is O
about O
where O
it O
was O
at O
the O
start O
based O
on O
the O
initial O
skin O
markings O
. O
 
LABORATORY O
DATA O
: O
Hematocrit O
of O
32 O
. O
 
However O
, O
his O
BUN O
has O
been O
150 O
and O
creatinine O
of O
3 O
. O
 
This O
has O
significantly O
increased O
from O
his O
baseline O
of O
1.8-2 O
he O
has O
had O
in O
the O
past O
. O
 
Vancomycin O
level O
was O
sent O
. O
 
DIAGNOSIS O
: O
Cellulitis O
with O
acute O
renal O
insufficiency O
most O
likely O
secondary O
to O
vancomycin O
. O
 
This O
was O
discussed O
with O
his O
primary O
care O
provider O
. O
 
DISPOSITION O
: O
He O
is O
admitted O
to O
the O
Medicine O
Service O
. O
 
______________________________ O
GODFREY O
, O
XAVIER I-NAME
GEORGE I-NAME
MD O
D O
: O
03/17/89 I-DATE
T O
: O
03/17/89 I-DATE
Dictated O
By O
: O
GODFREY O
, O
XAVIER I-NAME
GEORGE I-NAME
eScription O
document:7-3638497 O
BFFocus O
* O
* O
* O
* O
* O
* O
* O
* O
Not O
reviewed O
by O
Attending O
Physician O
* O
* O
* O
* O
* O
* O
* O
* O
 
Record O
date O
: O
2090-02-18 I-DATE
Patient O
Name O
: O
MOSS O
, O
DEREK O
P I-NAME
[ O
89659991 I-ID
( O
QMC I-LOCATION
) O
] O
Date O
of O
Visit O
: O
02/18/2090 I-DATE
Problems O
Parkinsons O
disease O
Diabetes O
mellitus O
type O
2 O
Congestive O
heart O
failure O
Atrial O
fibrillation O
Pacemaker O
Gastroesophageal O
reflux O
disease O
Hyperlipidemia O
Chronic O
renal O
dysfunction O
H/O O
basal O
cell O
carcinoma O
H/O O
prostate O
cancer O
Chief O
Complaint O
Comes O
in O
for O
his O
2 O
month O
follow O
up O
visit O
History O
of O
Present O
Illness O
79 I-AGE
year O
old O
male O
comes O
in O
with O
his O
son O
for O
a O
follow O
up O
. O
 
He O
reports O
right O
LE O
swelling O
and O
redness O
increasing O
over O
the O
last O
1 O
week O
. O
 
Patient O
and O
his O
son O
also O
noted O
right O
big O
toe O
swelling O
and O
ulceration O
yesterday O
. O
 
They O
stated O
that O
the O
did O
not O
look O
at O
bilateral O
feet O
for O
the O
last O
4-5 O
days O
. O
 
The O
patient O
reports O
pain O
in O
the O
right O
foot O
as O
well O
. O
 
He O
has O
no O
h/o O
fevers O
. O
 
The O
patient O
has O
a O
VNA O
nurse O
that O
was O
dicontinued O
by O
the O
family O
1 O
week O
ago O
. O
 
Past O
Medical O
History O
Parkinson O
's O
disease O
Diabetes O
mellitus O
type O
2 O
Atrial O
fibrillation O
Hyperlipidemia O
Pacemaker O
CHF O
( O
Ischemic O
cardiomyopathy O
with O
an O
EF O
of O
25-30 O
% O
) O
Moderate O
AS/ O
moderate O
MR O
CKD O
GERD O
OA O
s/p O
bilateral O
hip O
replacements O
Prostate O
Cancer O
diagnosed O
in O
2084 I-DATE
s/p O
XRT O
in O
2085 I-DATE
with O
h/o O
radiation O
proctitis O
Basal O
cell O
carcinoma O
excision O
Past O
Surgical O
History O
Lumbar O
laminectomy O
in O
the O
2060s I-DATE
Left O
septic O
shoulder O
s/p O
placement O
of O
a O
prosthetic O
shoulder O
placement O
in O
2087 I-DATE
Bilateral O
THR O
s/p O
RH O
revision O
2/88 I-DATE
H/o O
bilateral O
knee O
surgeries O
x O
4 O
( O
2 O
surgeries O
on O
each O
side O
) O
Cholecystectomy O
for O
gall O
stones O
in O
2084 I-DATE
Social O
History O
Widowed O
in O
2081 I-DATE
Smoking-None O
Alcohol-None O
Illicit O
drug O
use-None O
Occupation-Was O
a O
vocational I-PROFESSION
instructor I-PROFESSION
Health O
care O
proxy-Yes O
, O
son O
( O
West I-NAME
) O
Allergies O
DUTASTERIDE O
- O
cough O
, O
Morphine O
- O
Mental O
Status O
Change O
Medications O
ASA O
81 O
MG O
PO O
QD O
Ferrous O
Sulfate O
325 O
MG O
( O
325 O
( O
65 O
) O
MG O
TABLET O
take O
1 O
) O
PO O
QD O
FUROSEMIDE O
80 O
MG O
( O
80MG O
TABLET O
take O
1 O
) O
PO O
BID O
x O
30 O
days O
Hydralazine O
Hcl O
10 O
MG O
( O
10MG O
TABLET O
take O
1 O
) O
PO O
TID O
Imdur O
Er O
( O
ISOSORBIDE O
Mononitrate O
( O
SR O
) O
) O
120 O
MG O
( O
120MG O
TAB.SR O
24H O
take O
1 O
) O
PO O
QD O
x O
90 O
days O
, O
pt O
needs O
increase O
in O
dose O
for O
afterload O
reduction O
for O
severe O
MR O
. O
 
Substitution O
permitted O
. O
 
Insulin O
Regular O
Human O
6 O
UNITS O
SC O
as O
directed O
based O
on O
BG O
, O
at O
meals O
pending O
BG O
levels O
Lantus O
( O
INSULIN O
Glargine O
) O
16 O
UNITS O
SC O
QHS O
, O
Lantus O
# O
3 O
vials O
3rf O
LISINOPRIL O
2.5 O
MG O
PO O
QD O
MULTIVITAMINS O
1 O
TAB O
PO O
QD O
Nitroquick O
0.3mg O
( O
NITROGLYCERIN O
1/200 O
( O
0.3 O
Mg O
) O
) O
1 O
TAB O
SL O
as O
directed O
PRN O
emergency O
Procrit O
( O
EPOETIN O
Alfa O
) O
6000 O
UNITS O
SC O
Q O
OTHER O
WEEK O
, O
Dose O
reduced O
per O
order O
Dr. O
Dunlap I-NAME
Protonix O
( O
PANTOPRAZOLE O
) O
40 O
MG O
PO O
QD O
Requip O
( O
ROPINIROLE O
) O
2 O
MG O
( O
1MG O
TABLET O
take O
2 O
) O
PO O
TID O
Silver O
Sulfadiazine O
1 O
% O
1 O
APPLICATION O
TOP O
BID O
PRN O
, O
cream O
Toprol O
Xl O
( O
METOPROLOL O
Succinate O
Extended O
Release O
) O
12.5 O
MG O
( O
25MG O
TAB.SR O
24H O
take O
0.5 O
) O
PO O
QHS O
Warfarin O
Sodium O
5 O
MG O
( O
2.5MG O
TABLET O
take O
2 O
) O
PO O
QPM O
Zocor O
( O
SIMVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
take O
1 O
) O
PO O
QHS O
Vital O
Signs O
BLOOD O
PRESSURE O
115/55 O
PULSE O
70 O
TEMPERATURE O
96.3 O
F O
WEIGHT O
152 O
lb O
Physical O
Exam O
General O
Appearance O
Alert O
, O
sitting O
, O
comfortably O
on O
the O
examination O
table O
, O
oriented O
, O
in O
no O
acute O
distress O
HEENT O
PERRL/EOMI O
, O
Nose-no O
congestion O
, O
Throat-clear O
, O
no O
lesions O
Neck O
Supple O
Cor/Cardiac O
S1 O
S2 O
+ O
, O
irregularly O
irregular O
rhythm O
, O
no O
murmurs O
Chest O
Clear O
to O
auscultation O
bilaterally O
, O
no O
wheezing O
Abdomen O
Soft O
, O
no O
organomegaly O
, O
BS O
+ O
Extremity O
No O
cyanosis O
, O
clubbing O
, O
or O
edema O
. O
 
Sleeves O
on O
all O
4 O
extremities O
covering O
dressings O
. O
 
Improvement O
in O
the O
forearm O
abrasions O
. O
 
Right O
big O
toe O
with O
a O
1.5 O
x O
1.5 O
cm O
ulcer O
with O
granulation O
tissue O
and O
surrounding O
erythema O
. O
 
Abscess O
collection O
visible O
at O
the O
lateral O
toe O
. O
 
Erythema O
, O
swelling O
, O
and O
warmth O
noted O
in O
the O
right O
LE O
up O
to O
the O
middler O
of O
the O
lower O
leg O
. O
 
Neurological O
No O
resting O
tremor O
, O
CNs O
II-XII O
intact O
, O
increased O
tone O
all O
extremities O
, O
walks O
with O
a O
walker O
, O
has O
bradykinesia O
Nodes/Lymphatic O
No O
lymphadenopathy O
Assessment O
and O
Plan O
Right O
foot O
diabetic O
ulcer O
and O
right O
LE O
cellulitis O
: O
-Advised O
to O
go O
to O
the O
QMC I-LOCATION
ER O
as O
soon O
as O
possible O
to O
start O
IV O
antibiotics O
. O
 
-Patient O
will O
needs O
debridement O
and O
incision O
and O
drainage O
of O
his O
right O
big O
toe O
ulcer O
and O
abscess O
. O
 
-Expect O
message O
left O
with O
the O
charge O
nurse O
at O
QMC I-LOCATION
. O
 
RTC O
after O
discharge O
from O
the O
hospital O
. O
 
______________________________ O
Frank I-NAME
T. I-NAME
Xuan I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2083-09-22 I-DATE
Chief O
Complaint O
Mrs O
Chapman I-NAME
is O
here O
to O
follow O
up O
on O
Back O
pain O
, O
HTN O
, O
S/P O
TAH O
and O
DM O
History O
of O
Present O
Illness O
For O
the O
past O
21 O
days O
has O
had O
back O
pain O
since O
she O
was O
involved O
in O
a O
low O
speed O
MVA O
. O
 
Was O
a O
restarined O
passanger O
in O
the O
back O
seat O
of O
a O
car O
, O
that O
was O
n't O
moving O
, O
and O
their O
car O
was O
hit O
from O
behind O
. O
 
She O
developed O
LBP O
and O
has O
had O
it O
since O
. O
 
The O
next O
day O
she O
had O
the O
TAH O
. O
 
The O
pain O
is O
constant O
, O
localized O
in O
the O
lower O
, O
with O
radiation O
to O
left O
upper O
or O
left O
lower O
extremities O
. O
 
NO O
numbness O
, O
tingling O
or O
weakness O
on O
upper O
or O
lower O
extremities O
. O
 
The O
pain O
gets O
worse O
with O
movement O
and O
changing O
positions O
. O
 
Unable O
to O
sleep O
at O
night O
with O
the O
pain O
. O
 
Denies O
any O
urinary O
incontinence O
apart O
of O
her O
usual O
, O
when O
sneezing O
or O
coughing O
or O
bowel O
incontinence O
, O
no O
fever O
, O
chills O
, O
or O
other O
joint O
aches O
. O
 
Has O
n't O
had O
similar O
symptoms O
before O
. O
 
Hasn O
been O
taking O
Tylenol O
PRN O
with O
no O
relif O
She O
has O
a O
TAH O
and O
BSO O
on O
9/2/83 I-DATE
for O
a O
pelvic O
mass O
, O
found O
to O
be O
serous O
cystadenoma O
. O
 
Feeling O
well O
, O
occasional O
wound O
discomfort O
, O
she O
was O
not O
aware O
of O
her O
uterus O
being O
removed O
. O
 
Review O
of O
Systems O
C/P O
: O
Denies O
chest O
pain O
, O
shortness O
of O
breath O
, O
PND O
, O
orthopnea O
General O
: O
Denies O
fever O
, O
chills O
, O
headache O
, O
Has O
lost O
20 O
pounds O
since O
6/83 I-DATE
GI O
: O
Denies O
nausea O
, O
vomiting O
, O
diarrhea O
GU O
: O
Denies O
dysuria O
, O
polyuria O
Neuro O
: O
denies O
headaches O
HEENT O
: O
no O
cold O
sx O
but O
stuffy O
nose O
and O
sneezing O
Psych O
: O
was O
very O
depressed O
before O
her O
surgery O
, O
was O
very O
scared O
All O
other O
systems O
negative O
Problems O
ASTHMA O
HYPERTENSION O
INSOMNIA O
SCHIZOPHRENIA O
DIABETES O
MELLITUS O
PELVIC O
MASS O
Allergies O
NKDA O
NONE O
Medications O
METAMUCIL O
( O
PSYLLIUM O
( O
METAMUCIL O
) O
SUGAR O
FREE O
) O
1TBSP O
PO O
BID O
PREMPRO O
0.625/2.5 O
PO O
QD O
LOTENSIN O
40MG O
PO O
BID O
NORVASC O
5MG O
PO O
QD O
VANCERIL O
2PUFFS O
INH O
BID O
VENTOLIN O
2PUFF O
INH O
QID O
MULTIVITAMINS O
PRENATAL O
1 O
PO O
QD O
PAXIL O
40MG O
PO O
QHS O
HALOPERIDOL O
4MG O
PO O
QD O
BENADRYL O
50MG O
PO O
QHS O
CALCIUM O
CARBONATE O
1000MG O
PO O
QD O
FIORICET O
1TAB O
PO O
Q4H O
Vital O
Signs O
Blood O
Pressure O
: O
120/80 O
Pulse O
: O
84 O
Respiratory O
Rate O
: O
14 O
Weight O
: O
212 O
Pounds O
Physical O
Exam O
Alert O
, O
in O
mild O
distress O
, O
able O
to O
sit O
and O
lye O
down O
with O
mild O
discomfort O
HEENT O
: O
oral O
mucosa O
moist O
, O
no O
lesions O
, O
Throat O
: O
clear O
, O
no O
plaques O
, O
exudates O
or O
erythema O
. O
 
Rhinoscopy O
: O
erythematous O
mucosa O
, O
no O
polyps O
Neck O
: O
supple O
, O
no O
masses O
or O
nodes O
, O
no O
JVD O
. O
 
Lungs O
: O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
, O
normal O
percussion O
. O
 
Heart O
: O
regular O
, O
. O
 
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
Abdomen O
: O
midline O
surgical O
scar O
clean O
, O
soft O
, O
no O
tenderness O
, O
no O
masses O
no O
organomegalies O
BS O
( O
+ O
) O
, O
no O
rebound O
Ext O
: O
no O
edema O
, O
normal O
skin O
Back O
exam O
: O
no O
spinal O
deformities O
, O
no O
paraspinal O
muscle O
spasm O
, O
no O
sacroiliac O
tenderness O
, O
normal O
skin O
exam O
. O
 
Bilateral O
straight O
leg O
raising O
test O
negative O
. O
 
Neurological O
: O
Strenght O
5/5 O
bilateral O
symmetrical O
, O
Sensory O
intact O
, O
DTR O
2++ O
bilateral O
symmetrical O
. O
 
No O
pathological O
reflexes O
Assessment O
1 O
. O
 
BACK O
PAIN O
No O
evidence O
of O
anatomical O
or O
neurological O
deficit O
Most O
likely O
musculoskeletal O
origin O
Naprosyn O
500 O
mg O
po O
BID O
for O
7 O
days O
and O
the O
PRN O
# O
40 O
no O
refills O
Soma O
Compound O
1 O
tb O
TID O
# O
30 O
no O
refills O
Heat O
pads O
TID O
for O
20 O
minutes O
each O
time O
Physical O
activity O
as O
tolerated O
Written O
instructions O
on O
how O
to O
avoid O
back O
pain O
and O
exercises O
to O
performed O
three O
times O
per O
week O
given O
and O
start O
the O
exercises O
in O
a O
month O
time O
Use O
a O
pillow O
under O
the O
knees O
to O
decreased O
the O
back O
pain O
2 O
. O
 
S/P O
TAH O
BSO O
Explained O
to O
her O
the O
procedure O
and O
she O
understood O
. O
 
Will O
start O
Premarin O
0.625 O
mg O
po O
QD O
# O
30 O
6 O
refills O
and O
D/C O
Prempro O
Continue O
MVI O
and O
calcium O
3 O
. O
 
ALLERGIC O
RHINITIS O
Rhinocort O
nasal O
spray O
2 O
puffs O
BID O
# O
1 O
and O
6 O
refills O
4 O
. O
 
HYPERTENSION O
Well O
controlled O
, O
continue O
same O
meds O
5 O
. O
 
DIABETES O
MELLITUS O
Prescr O
for O
Accucheck O
glucometer O
, O
strips O
and O
lancets O
Plan O
Follow O
up O
with O
me O
in O
2 O
months O
for O
flu O
shot O
or O
before O
PRN O
 
Record O
date O
: O
2086-11-17 I-DATE
Chilton I-LOCATION
County I-LOCATION
Hospital I-LOCATION
Nursing I-LOCATION
Home I-LOCATION
427 I-LOCATION
Ohio I-LOCATION
Street I-LOCATION
CHAPMAN O
, O
NOOR I-NAME
Weston I-LOCATION
, O
VT I-LOCATION
36112 I-LOCATION
45479406 I-ID
( O
324 O
) O
090-7704 I-CONTACT
11/17/86 I-DATE
REASON O
FOR O
VISIT O
: O
Ms. O
Chapman I-NAME
is O
a O
58-year-old O
woman O
who O
comes O
in O
complaining O
of O
allergy O
symptoms O
with O
nasal O
congestion O
, O
runny O
nose O
, O
sneezing O
. O
 
She O
also O
has O
a O
bit O
of O
a O
cough O
and O
trouble O
breathing O
because O
of O
the O
congestion O
and O
allergies O
. O
 
She O
has O
no O
fevers O
, O
sweats O
or O
chills O
, O
no O
chest O
pain O
. O
 
Her O
sugars O
have O
been O
in O
the O
180 O
and O
200 O
range O
at O
home O
. O
 
No O
dysuria O
. O
 
No O
abdominal O
symptoms O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Otherwise O
negative O
in O
detail O
. O
 
MEDICATIONS O
: O
Ativan O
1 O
mg O
q.d. O
, O
lisinopril O
10 O
mg O
q.d. O
, O
metformin O
500 O
mg O
b.i.d. O
, O
Serzone O
b.i.d. O
, O
Zyprexa O
q.h.s. O
, O
atenolol O
25 O
mg O
q.d. O
, O
enteric O
coated O
aspirin O
325 O
mg O
q.d. O
, O
Vanceril O
inhaler O
, O
Ventolin O
inhaler O
everyday O
and O
also O
occasionally O
at O
night O
Paxil O
40 O
mg O
q.h.s O
. O
 
She O
notes O
she O
has O
not O
used O
any O
sublingual O
nitroglycerin O
. O
 
ALLERGIES O
: O
None O
known O
. O
 
SOCIAL O
HISTORY O
: O
She O
has O
never O
smoked O
, O
used O
alcohol O
or O
street O
drugs O
. O
 
PHYSICAL O
EXAMINATION O
: O
Well O
developed O
, O
well O
nourished O
in O
no O
acute O
distress O
. O
 
Blood O
pressure O
136/72 O
, O
pulse O
84 O
, O
weight O
229 O
pounds O
, O
afebrile O
, O
pleasant O
, O
Spanish O
speaking O
woman O
. O
 
She O
has O
an O
8 O
mm O
in O
diameter O
irregular O
hyperpigmented O
nodular O
lesion O
on O
her O
right O
forefoot O
. O
 
Mouth O
and O
pharynx O
without O
erythema O
or O
exudate O
. O
 
No O
adenopathy O
or O
tenderness O
in O
the O
submandibular O
, O
cervical O
, O
posterior O
cervical O
, O
supraclavicular O
or O
axillary O
area O
. O
 
Thyroid O
is O
nontender O
and O
nonnodular O
. O
 
Neck O
: O
Supple O
. O
 
No O
spine O
or O
flank O
tenderness O
. O
 
No O
bruits O
, O
no O
stridor O
. O
 
Heart O
sounds O
: O
S1 O
and O
S2 O
regular O
rate O
and O
rhythm O
. O
 
No O
murmur O
, O
rub O
or O
gallop O
. O
 
Her O
chest O
is O
clear O
to O
auscultation O
anteriorly O
and O
posteriorly O
with O
no O
rales O
wheezes O
or O
rhonchi O
. O
 
She O
is O
clear O
to O
percussion O
. O
 
Normal O
bowel O
sounds O
. O
 
Abdomen O
is O
soft O
and O
nontender O
. O
 
No O
mass O
or O
organomegaly O
. O
 
No O
guarding O
or O
rebound O
. O
 
Extremities O
are O
without O
edema O
, O
cyanosis O
or O
clubbing O
. O
 
No O
calf O
tenderness O
. O
 
Reflexes O
are O
normal O
. O
 
Pedal O
pulses O
are O
present O
bilaterally O
. O
 
There O
is O
no O
rash O
or O
erythema O
, O
maceration O
on O
her O
feet O
. O
 
No O
lesion O
on O
her O
foot O
. O
 
LABORATORY O
STUDIES O
: O
An O
MRI O
from O
September I-DATE
18 I-DATE
showed O
a O
left O
kidney O
mass O
, O
cystic O
. O
 
Hemoglobin O
A1c O
from O
August I-DATE
was O
6.5 O
and O
the O
LDL O
was O
125 O
. O
 
IMPRESSION O
AND O
PLAN O
: O
1 O
. O
 
Diabetes O
: O
Her O
diabetes O
has O
been O
extremely O
well O
controlled O
. O
 
We O
will O
continue O
her O
current O
regimen O
. O
 
We O
will O
check O
glucose O
, O
hemoglobin O
A1c O
, O
U/A O
, O
urine O
, O
microalbuminuria O
. O
 
She O
recently O
went O
to O
the O
ophthalmologist O
. O
 
2 O
. O
 
Elevated O
cholesterol O
. O
 
Our O
goal O
is O
an O
LDL O
of O
100 O
. O
 
We O
will O
start O
Lipitor O
10 O
mg O
p.o O
. O
 
q.d O
. O
 
She O
will O
return O
in O
six O
weeks O
for O
follow O
up O
of O
this O
. O
 
3 O
. O
 
Hypertension O
. O
 
Her O
blood O
pressure O
is O
acceptable O
. O
 
We O
will O
continue O
her O
current O
regimen O
. O
 
Results O
were O
given O
as O
needed O
. O
 
4 O
. O
 
Allergy O
symptoms O
. O
 
I O
gave O
her O
Rhinocort O
AQ O
nasal O
spray O
. O
 
Explained O
how O
to O
use O
it O
. O
 
5 O
. O
 
Nodular O
hyperpigmented O
lesion O
on O
her O
forefeet O
. O
 
I O
will O
refer O
her O
to O
Dermatology O
for O
evaluation O
of O
this O
lesion O
, O
but O
the O
patient O
says O
that O
it O
has O
been O
there O
for O
as O
long O
as O
she O
can O
remember O
but O
it O
is O
quite O
atypical O
to O
my O
exam O
. O
 
6 O
. O
 
Left O
renal O
cystic O
mass O
. O
 
She O
has O
been O
scheduled O
for O
a O
follow-up O
MRI O
for O
December I-DATE
13 I-DATE
. O
 
7 O
. O
 
Asthma O
: O
She O
is O
doing O
stably O
in O
this O
regard O
and O
I O
believe O
that O
nasal O
spray O
will O
help O
substantially O
with O
her O
symptoms O
. O
 
labs O
great O
, O
letter O
sent O
______________________________ O
Sandra I-NAME
Jewell I-NAME
, O
M.D O
. O
 
Dictated O
By O
: O
Sandra I-NAME
Jewell I-NAME
eScription O
document:5-7786571 O
EMSSten O
Tel O
DD O
: O
11/18/86 I-DATE
DT O
: O
11/19/86 I-DATE
DV O
: O
11/18/86 I-DATE
 
Record O
date O
: O
2087-06-16 I-DATE
Chief O
Complaint O
Mrs O
Chapman I-NAME
is O
here O
today O
to O
follow O
up O
on O
HTN O
, O
DM O
History O
of O
Present O
Illness O
I O
saw O
her O
2/24/87 I-DATE
for O
HTN O
and O
DM O
. O
 
BP O
was O
high O
and O
increased O
Lisinopril O
to O
20 O
mg O
QD O
Restarted O
Lipitpr O
but O
she O
still O
is O
not O
taking O
it O
. O
 
The O
pharmacy O
did O
n't O
give O
it O
to O
her O
. O
 
Her O
LDL O
is O
116 O
ono O
2/87 I-DATE
and O
has O
DM O
, O
goal O
< O
100 O
. O
 
Feels O
well O
. O
 
Had O
an O
ETT O
MIBI O
few O
weeks O
ago O
and O
no O
evidence O
of O
ischemia O
. O
 
Denies O
CP O
, O
SOB O
, O
palpitations O
Started O
walking O
daily O
around O
Woodstown I-LOCATION
about O
3.5 O
miles O
and O
has O
lost O
7 O
pounds O
since O
I O
saw O
her O
. O
 
Also O
eating O
more O
vegetables O
and O
fruits O
and O
less O
carbohydrates O
. O
 
Third O
, O
she O
had O
a O
renal O
U/S O
done O
for O
hematuria O
and O
showed O
small O
left O
renal O
mass O
. O
 
Had O
a O
CT O
scan O
later O
that O
showed O
the O
same O
and O
recommended O
an O
MRI O
. O
 
She O
had O
it O
done O
few O
9/86 I-DATE
. O
 
Recommended O
to O
repeat O
it O
soon O
. O
 
Left O
lower O
pole O
renal O
lesion O
with O
MRI O
signal O
characteristics O
consistent O
with O
a O
cystic O
, O
septated O
, O
unenhancing O
renal O
lesion O
or O
bosniak O
grade O
2 O
. O
 
However O
, O
when O
compared O
to O
prior O
CT O
examination O
demonstrating O
late O
filling O
of O
this O
lesion O
, O
follow O
up O
is O
warranted O
to O
exclude O
a O
cystic O
renal O
neoplasm O
making O
this O
an O
overall O
bosniak O
grade O
2F O
. O
 
Review O
of O
Systems O
C/P O
: O
Denies O
PND O
, O
orthopnea O
. O
 
Leg O
swelling O
after O
walking O
around O
the O
pond O
General O
: O
Denies O
fever O
, O
chills O
HEENT O
: O
No O
cold O
sx O
GI O
: O
Denies O
nausea O
, O
vomiting O
, O
diarrhea O
. O
 
Psych O
: O
follow O
with O
therapist O
and O
psychiatry O
. O
 
Taking O
all O
her O
psych O
meds O
GU O
: O
Denies O
dysuria O
, O
polyuria O
Neuro O
: O
denies O
Skin O
: O
denies O
All O
other O
systems O
negative O
Problems O
ASTHMA O
HYPERTENSION O
INSOMNIA O
SCHIZOPHRENIA O
DIABETES O
MELLITUS O
10/08/85 I-DATE
R O
breast O
u/s O
with O
likely O
lipoma O
and O
simple O
cyst O
at O
8 O
o'clock O
, O
repeat O
u/s O
in O
6 O
months O
and O
mammography O
in O
01/2086 I-DATE
Renal O
mass O
OBESITY O
: O
Type O
3 O
- O
BMI O
44 O
Allergies O
NKDA O
NONE O
Medications O
Paxil O
40 O
MG O
PO O
QHS O
Ntg O
1/150 O
( O
NITROGLYCERIN O
1/150 O
( O
0.4 O
MG O
) O
) O
1 O
TAB O
SL O
Not O
taking O
it O
Ativan O
( O
LORAZEPAM O
) O
1MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
Ventolin O
2 O
PUFF O
INH O
QID O
PRN O
Shortness O
of O
breath O
, O
PRNNot O
taking O
it O
Vanceril O
2 O
PUFFS O
INH O
BID O
Not O
taking O
it O
Rhinocort O
AQUA O
( O
BUDESONIDE O
NASAL O
INHALER O
) O
2 O
SPRAY O
NAS O
qd O
Not O
taking O
it O
Zyprexa O
( O
OLANZAPINE O
) O
7.5MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Serzone O
( O
NEFAZODONE O
) O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Calcium O
CARBONATE O
1250 O
MG O
( O
1.25G O
TABLET O
) O
PO O
QD O
Multivitamins O
1 O
CAPSULE O
PO O
QD O
Not O
taking O
it O
Ecasa O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
325MG O
TABLET O
EC O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Metformin O
500MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
BID O
Lisinopril O
20MG O
TABLET O
take O
1 O
PO O
QD O
Atenolol O
50MG O
TABLET O
take O
1 O
PO O
QD O
Lipitor O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
Not O
taking O
it O
Vital O
signs O
BP O
128/88 O
, O
P O
76 O
, O
RR O
14 O
, O
Ht O
61.5 O
in O
, O
Wt O
224 O
lb O
Physical O
Exam O
Alert O
, O
in O
no O
distress O
obese O
HEENT O
: O
oral O
mucosa O
moist O
, O
no O
lesions O
, O
Throat O
: O
clear O
, O
no O
plaques O
, O
exudates O
or O
erythema O
. O
 
Neck O
: O
supple O
, O
no O
masses O
or O
nodes O
, O
no O
JVD O
. O
 
Lungs O
: O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
Heart O
: O
regular O
, O
. O
 
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
Abdomen O
: O
soft O
, O
no O
tenderness O
, O
no O
masses O
no O
organomegalies O
BS O
( O
+ O
) O
, O
no O
rebound O
Ext O
: O
no O
edema O
, O
normal O
skin O
Feet O
exam O
: O
normal O
skin O
, O
no O
lesions O
, O
normal O
DP O
, O
good O
capillary O
filling O
, O
thick O
toenails O
, O
microfilament O
test O
normal O
Assessment/Plan O
1 O
. O
 
HYPERTENSION O
Borderline O
controlled O
on O
current O
therapy O
Will O
increase O
Atenolol O
to O
100 O
mg O
QD O
# O
30 O
Increase O
Lisinopril O
to O
40 O
mg O
QD O
# O
30 O
and O
6 O
refills O
Low O
salt O
diet O
See O
me O
in O
12 O
weeks O
Congratulated O
her O
for O
exercise O
and O
weigth O
loss O
2 O
. O
 
CHEST O
PAIN O
Asymptomatic O
for O
weeks O
Negative O
ETT O
MIBI O
Needs O
to O
take O
ASA O
QD O
Already O
on O
BBlockers O
, O
ASA O
3 O
. O
 
DIABETES O
MELLITUS O
On O
Metformin O
500 O
mg O
BID O
# O
60 O
and O
6 O
refills O
Recomm O
low O
fat O
and O
low O
carb O
diet O
and O
increase O
physical O
activity O
, O
return O
to O
walking O
QD O
Wil O
check O
HbA1C O
and O
glucose O
Restart O
Lipitor O
10 O
mg O
QHS O
# O
30 O
and O
6 O
refills O
LDL O
goal O
< O
100 O
Chedck O
Lipid O
profile O
4 O
. O
 
ASTHMA O
Stable O
for O
months O
5 O
. O
 
RENAL O
MASS O
Needs O
to O
repeat O
MRI O
soon O
. O
 
Will O
schedule O
6.SCHIZOPHRENIA O
Follow O
up O
with O
Psych O
See O
me O
in O
12 O
weeks O
 
Record O
date O
: O
2088-06-24 I-DATE
Patient O
Name O
: O
CHAPMAN O
, O
NOOR O
[ O
MRN O
: O
45479406HBMC O
] O
Date O
of O
Visit O
: O
6/24/2088 I-DATE
Chief O
Complaint O
Mrs O
Chapman I-NAME
is O
here O
today O
to O
follow O
up O
on O
HTN O
, O
DM O
History O
of O
Present O
Illness O
She O
has O
been O
feeling O
well O
. O
 
Seen O
by O
orthopedics O
few O
days O
ago O
for O
shopulder O
pain O
. O
 
Offered O
steroid O
injection O
but O
she O
declined O
. O
 
Instead O
started O
NSAIDs O
and O
will O
follow O
up O
in O
4 O
weeks O
. O
 
Still O
has O
pain O
on O
her O
left O
shoulder O
. O
 
She O
is O
checking O
glucose O
sometimes O
and O
has O
been O
in O
the O
high O
90s O
. O
 
Not O
taking O
Metformin O
for O
1 O
month O
, O
was O
told O
insurance O
wo O
n't O
pay O
for O
it O
. O
 
Has O
been O
doing O
well O
overall O
. O
 
Eye O
exam O
scheduled O
for O
next O
month O
Depression O
is O
stable O
. O
 
Taking O
all O
her O
meds O
as O
directed O
Needs O
refills O
for O
meds O
Walking O
1 O
hour O
every O
day O
Review O
of O
Systems O
C/P O
: O
Denies O
PND O
, O
orthopnea O
General O
: O
Denies O
fever O
, O
chills O
HEENT O
: O
No O
cold O
sx O
GI O
: O
Denies O
nausea O
, O
vomiting O
, O
diarrhea O
. O
 
Psych O
: O
follow O
with O
therapist O
and O
psychiatry O
. O
 
Taking O
all O
her O
psych O
meds O
GU O
: O
Denies O
dysuria O
, O
polyuria O
Neuro O
: O
headaches O
Skin O
: O
no O
rashes O
All O
other O
systems O
negative O
Problems O
ASTHMA O
HYPERTENSION O
INSOMNIA O
SCHIZOPHRENIA O
DIABETES O
MELLITUS O
10/08/85 I-DATE
R O
breast O
u/s O
with O
likely O
lipoma O
and O
simple O
cyst O
at O
8 O
o'clock O
, O
repeat O
u/s O
in O
6 O
months O
and O
mammography O
in O
01/2086 I-DATE
Renal O
mass O
OBESITY O
: O
Type O
3 O
- O
BMI O
44 O
Allergies O
NKA O
Medications O
ATENOLOL O
100MG O
TABLET O
take O
1 O
PO O
QD O
ATIVAN O
( O
LORAZEPAM O
) O
1MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
CALCIUM O
CARBONATE O
1250 O
MG O
( O
1.25G O
TABLET O
) O
PO O
QD O
CLOBETASOL O
PROPIONATE O
0.05 O
% O
1 O
APPLICATION O
TOP O
BID O
ECASA O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
325MG O
TABLET O
EC O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
IBUPROFEN O
800 O
MG O
PO O
TID O
PRN O
shoulder O
pain O
LIPITOR O
( O
ATORVASTATIN O
) O
10MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QD O
LISINOPRIL O
40MG O
TABLET O
take O
1 O
PO O
QD O
METFORMIN O
500MG O
TABLET O
take O
1 O
PO O
BID O
( O
Not O
taking O
it O
) O
MULTIVITAMINS O
1 O
CAPSULE O
PO O
QD O
NASACORT O
2 O
PUFF O
NA O
QHS O
, O
2 O
puffs O
in O
each O
nostril O
QHS O
PAXIL O
40 O
MG O
PO O
QHS O
PREMARIN O
( O
CONJUGATED O
ESTROGENS O
) O
1 O
GM O
PV O
Q72H O
SERZONE O
( O
NEFAZODONE O
) O
100MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
VENTOLIN O
2 O
PUFF O
INH O
QID O
PRN O
Shortness O
of O
breath O
, O
PRN O
ZYPREXA O
( O
OLANZAPINE O
) O
7.5MG O
TABLET O
take O
1 O
Tablet O
( O
s O
) O
PO O
QHS O
Vital O
Signs O
Blood O
Pressure O
: O
-- O
140/80 O
[ O
Left O
Arm O
] O
[ O
Sitting O
] O
Pulse O
: O
-- O
68 O
[ O
Regular O
] O
[ O
Radial O
] O
Respiratory O
Rate O
: O
-- O
14 O
[ O
Regular O
] O
Weight O
: O
-- O
225 O
[ O
Pounds O
] O
Physical O
Exam O
Alert O
, O
in O
no O
distress O
obese O
HEENT O
: O
PEERL O
, O
EOMI O
, O
oral O
mucosa O
moist O
, O
no O
lesions O
, O
Throat O
: O
clear O
, O
no O
plaques O
, O
exudates O
or O
erythema O
. O
 
Neck O
: O
supple O
, O
no O
masses O
or O
nodes O
, O
no O
JVD O
. O
 
Lungs O
: O
clear O
anteriorly O
and O
posteriroly O
to O
auscultation O
, O
no O
rhonchi O
, O
crackles O
or O
wheezes O
Heart O
: O
regular O
, O
. O
 
S1S2 O
normal O
, O
no O
S3 O
or O
murmurs O
Abdomen O
: O
soft O
, O
no O
tenderness O
, O
no O
masses O
no O
organomegalies O
BS O
( O
+ O
) O
, O
no O
rebound O
Ext O
: O
no O
edema O
, O
normal O
skin O
Feet O
exam O
: O
thick O
toenails O
, O
good O
DP O
, O
good O
capillary O
filling O
, O
normal O
microfillament O
test O
Assessment/Plan O
1 O
. O
 
HYPERTENSION O
Well O
controlled O
on O
current O
therapy O
Atenolol O
to O
100 O
mg O
QD O
# O
30 O
and O
6 O
refills O
Lisinopril O
40 O
mg O
QD O
# O
30 O
and O
6 O
refills O
2 O
. O
 
DIABETES O
MELLITUS O
On O
Metformin O
500 O
mg O
BID O
# O
60 O
and O
6 O
refills O
. O
 
AllMed I-LOCATION
Insurance I-LOCATION
covers O
for O
it O
Check O
glucose O
QAM O
Recomm O
low O
fat O
and O
low O
carb O
diet O
and O
increase O
physical O
activity O
, O
continue O
walking O
QD O
Last O
HbA1C O
in O
5/88 I-DATE
7.4 O
LDL O
69 O
5/88 I-DATE
Lipitor O
10 O
mg O
QHS O
# O
30 O
and O
6 O
refills O
Needs O
eye O
exam O
3 O
. O
 
ASTHMA O
Stable O
for O
months O
See O
me O
in O
4 O
months O
______________________________ O
Cynthia I-NAME
Nancy-Nesmith I-NAME
, O
M.D O
. O
 
Record O
date O
: O
2081-03-22 I-DATE
Chief O
Complaint O
of O
: O
Nephrolithiasis O
2/28/81 I-DATE
cysto O
, O
left O
stent O
, O
ESWL O
, O
meatal O
dilatation O
History O
of O
Present O
Illness O
: O
50 I-AGE
yo O
male O
here O
for O
removal O
of O
his O
stent O
. O
 
He O
denies O
fevers O
, O
nausea O
, O
chest O
pain O
, O
shortness O
of O
breadth O
( O
at O
baseline O
) O
, O
and O
vomiting O
. O
 
Voiding O
symptoms O
: O
hesitancy O
, O
intermittency O
, O
nocturia O
x1 O
3/week O
, O
no O
frequency O
, O
and O
intermittent O
urgency O
. O
 
Reports O
erectile O
dysfunction-difficulty O
maintaining O
erections O
. O
 
Past O
Medical O
History O
: O
NIDDM O
, O
neurofibromatosis O
, O
Hodgkins O
disease-chemo O
and O
XRT O
( O
bleomycin O
, O
adriamycin O
, O
vincristine O
, O
DTIC O
) O
Past O
Surgical O
History O
: O
left O
axillary O
biopsy O
, O
pectus O
excavatum O
, O
neck O
surgery O
Medications O
: O
metformin O
, O
urocit O
K O
, O
ibuprofen O
PRN O
Allergies O
: O
he O
reports O
an O
allergy O
to O
contrast O
in O
the O
past O
but O
did O
well O
with O
his O
last O
CT O
scan O
. O
 
Social O
History O
: O
Single O
Does O
not O
smoke O
No O
alcohol O
use O
Retired O
from O
dc I-LOCATION
comics I-LOCATION
Family O
Hx O
: O
No O
history O
of O
stones O
Mother O
- O
died O
of O
sarcoma O
Father O
-died O
of O
an O
MI O
Sister O
with O
ITP O
Review O
of O
Systems O
: O
No O
interval O
change O
Genitourinary O
Review O
of O
Systems O
No O
Kidney O
stones O
in O
the O
past O
No O
Urinary O
tract O
infections O
No O
Sexually O
transmitted O
diseases O
Physical O
Examination O
: O
General O
Examination O
: O
Vital O
Signs O
: O
Morbid O
obesity O
BP O
154/82 O
cor O
RRR O
lung O
CTAB O
abd O
soft O
No O
CVAT O
LE O
no O
calf O
tenderness O
cystoscopy O
Patient O
was O
placed O
in O
the O
supine O
position O
and O
prepped O
and O
draped O
in O
the O
standard O
sterile O
fashion O
. O
 
Lidocaine O
jelly O
was O
inserted O
into O
the O
meatus O
for O
local O
anaesthesia O
. O
 
A O
flexible O
cystoscope O
was O
inserted O
into O
the O
meatus O
. O
 
The O
urethra O
was O
without O
lesions O
. O
 
The O
lateral O
lobes O
of O
the O
prostate O
coapted O
at O
the O
midline O
. O
 
The O
stent O
was O
identified O
and O
using O
alligator O
forceps O
the O
distal O
portion O
was O
grasped O
. O
 
It O
was O
removed O
intact O
. O
 
The O
patient O
tolerated O
the O
procedure O
and O
was O
discharged O
from O
the O
clinic O
after O
receiving O
ciprofloxacin O
. O
 
Laboratory O
Values O
: O
An O
independent O
review O
of O
a O
urinalysis O
shows O
: O
No O
WBC's O
+ O
RBC's O
No O
Glucose O
No O
Protein O
Nitrite O
Negative O
pH O
7.0 O
Abdomen O
Single O
22-Mar-2081 I-DATE
REPORT O
: O
History O
: O
As O
above O
. O
 
Comparison O
: O
Noncontrast O
CT O
abdomen O
and O
pelvis O
3/14/81 I-DATE
. O
 
Findings O
: O
There O
is O
a O
left O
ureteral O
stent O
. O
 
Tiny O
residual O
stones O
seen O
on O
prior O
CT O
are O
not O
identified O
on O
this O
KUB.The O
bowel O
gas O
pattern O
is O
nonobstructive O
. O
 
The O
bones O
are O
unremarkable O
in O
appearance O
. O
 
The O
visualized O
lung O
bases O
are O
unremarkable O
. O
 
IMPRESSION O
: O
LEFT O
URETERAL O
STENT O
. O
 
NO O
ABNORMAL O
CALCIFICATIONS O
IDENTIFIED O
. O
 
Impression O
: O
50 I-AGE
yo O
male O
treated O
for O
a O
1.1 O
cm O
symptomatic O
left O
renal O
stone O
. O
 
His O
post-operative O
KUB O
does O
not O
show O
any O
calcifications O
. O
 
The O
stent O
was O
removed O
intact O
without O
difficulty O
. O
 
He O
is O
to O
have O
a O
follow O
up O
CT O
in O
June I-DATE
with O
and O
without O
contrast O
for O
further O
evaluation O
of O
a O
renal O
lesion O
seen O
on O
a O
previous O
CT O
scan O
. O
 
He O
did O
have O
a O
post-operative O
CT O
that O
showed O
a O
subcapsular O
hematoma O
for O
which O
his O
blood O
pressure O
will O
be O
followed O
. O
 
That O
study O
also O
showed O
the O
stone O
which O
is O
no O
longer O
visualized O
on O
todays O
KUB O
. O
 
The O
imaging O
in O
June I-DATE
will O
again O
assess O
his O
stone O
burden O
. O
 
Plan O
: O
1 O
CT O
abd/pelvis O
I-/I+ O
in O
June I-DATE
Follow O
Up O
: O
in O
June I-DATE
Patricia I-NAME
Barajas I-NAME
, O
MD O
Urology- O
Gila I-LOCATION
Regional I-LOCATION
Hospital I-LOCATION
Please O
note O
: O
This O
email O
may O
contain O
confidential O
patient O
information O
which O
is O
legally O
protected O
by O
patient-physician O
privilege O
. O
 
If O
you O
are O
not O
the O
intended O
recipient O
, O
you O
are O
hereby O
notified O
that O
any O
disclosure O
, O
copying O
, O
or O
distribution O
of O
this O
information O
is O
strictly O
prohibited O
by O
law O
. O
 
If O
you O
have O
received O
this O
communication O
in O
error O
, O
please O
notify O
us O
by O
telephone O
at O
once O
and O
destroy O
any O
electronic O
or O
paper O
copies O
. O
 
We O
apologize O
for O
any O
inconvenience O
. O
 
cc O
: O
 
Record O
date O
: O
2084-04-28 I-DATE
Medicine O
& O
# O
8211 O
; O
Mediquik I-LOCATION
6 O
Intern O
Admission O
Note O
PATIENT O
: O
Gillespie I-NAME
, O
Patrick I-NAME
MRN O
: O
2571454 I-ID
ADMIT O
DATE O
: O
Tuesday I-DATE
4/28/84 I-DATE
PCP O
: O
Dr. O
Yakov I-NAME
Xie I-NAME
ATTENDING O
: O
Ward O
( O
Dr. O
Wiggins I-NAME
/ O
Dr. O
Stone I-NAME
) O
CONTACT O
: O
sister O
Snow I-NAME
241-904-0696 I-CONTACT
SOURCE O
: O
patient O
and O
records O
CC/ID O
: O
cough O
HPI O
Mr O
Gillespie I-NAME
is O
a O
53 I-AGE
yo O
man O
with O
a O
history O
of O
NIDDM O
and O
hypertension O
who O
presented O
to O
House I-LOCATION
Of I-LOCATION
Calvary I-LOCATION
Hospital I-LOCATION
today O
with O
a O
chief O
complaint O
of O
cough O
for O
the O
last O
5 O
days O
. O
 
He O
was O
in O
his O
usual O
state O
of O
health O
prior O
to O
that O
. O
 
Cough O
has O
been O
dry O
; O
also O
notes O
shortness O
of O
breath O
with O
exertion O
and O
diaphoresis O
. O
 
He O
notes O
intermittent O
palpitations O
and O
mild O
lightheadedness O
during O
the O
last O
few O
days O
. O
 
He O
has O
had O
pneumonia O
several O
times O
in O
the O
past O
. O
 
He O
denies O
fever O
, O
chills O
, O
SOB O
at O
rest O
, O
orthopnea O
, O
PND O
, O
chest O
pain O
, O
wheezing O
, O
hemoptysis O
, O
and O
sick O
contacts O
. O
 
He O
reports O
compliance O
with O
his O
medications O
and O
no O
recent O
change O
in O
diet O
. O
 
At O
Calvary I-LOCATION
, O
CXR O
was O
interpreted O
as O
bilateral O
pneumonia O
L O
& O
gt O
; O
R. O
EKG O
revealed O
atrial O
fibrillation O
, O
of O
which O
he O
had O
no O
known O
history O
. O
 
He O
was O
referred O
to O
the O
GRH I-LOCATION
ED O
for O
further O
evaluation O
. O
 
In O
the O
ED O
he O
was O
afebrile O
, O
HR O
130s-140s O
( O
atrial O
fibrillation O
) O
SBP O
140s O
O2 O
sat O
99-100 O
% O
. O
 
On O
exam O
he O
had O
fine O
bibasilar O
crackles O
. O
 
He O
was O
given O
levofloxacin O
750 O
mg O
po O
, O
dalteparin O
5000 O
units O
, O
diltiazem O
10 O
mg O
iv O
and O
30 O
mg O
po O
with O
lowering O
of O
HR O
to O
90s O
, O
and O
NS O
500 O
cc O
. O
 
He O
was O
admitted O
to O
Medicine O
& O
# O
8211 O
; O
Mediquik I-LOCATION
77 O
for O
further O
management O
. O
 
REVIEW O
OF O
SYSTEMS O
General O
& O
# O
8211 O
; O
+sweats O
, O
no O
weight O
loss/gain O
, O
no O
fever O
, O
no O
chills O
, O
no O
change O
in O
appetite O
HEENT O
& O
# O
8211 O
; O
no O
neck O
swelling O
, O
no O
neck O
stiffness O
, O
no O
hoarseness O
, O
no O
hearing O
loss O
Pulmonary O
& O
# O
8211 O
; O
per O
HPI O
, O
no O
hemoptysis O
, O
no O
wheezing O
Cardiac O
& O
# O
8211 O
; O
+palpitations O
, O
no O
chest O
pain/pressure O
, O
no O
PND O
Gastrointestinal O
& O
# O
8211 O
; O
no O
N/V O
, O
no O
diarrhea O
, O
no O
constipation O
, O
no O
BRBPR O
, O
no O
melena O
, O
no O
abd O
pain O
Genitourinary O
& O
# O
8211 O
; O
no O
hematuria O
, O
no O
dysuria O
, O
no O
polyuria O
, O
no O
nocturia O
Extremity O
& O
# O
8211 O
; O
no O
leg O
swelling O
Musculoskeletal O
& O
# O
8211 O
; O
no O
back O
pain O
, O
no O
neck O
pain O
, O
no O
leg O
pain O
, O
no O
arm O
pain O
, O
no O
joint O
pain O
Hematologic O
& O
# O
8211 O
; O
no O
bruising O
, O
no O
bleeding O
Neuro O
& O
# O
8211 O
; O
no O
seizures O
, O
no O
headache O
, O
no O
weakness O
, O
no O
numbness/tingling O
Skin O
& O
# O
8211 O
; O
no O
new O
concerning O
rashes O
or O
lesions O
Exposures O
& O
# O
8211 O
; O
no O
sick O
contacts O
, O
no O
recent O
travel O
PAST O
MEDICAL O
HISTORY O
NIDDM O
& O
# O
8211 O
; O
A1c O
6.4 O
last O
month O
Hypertension O
Hyperlipidemia O
Nephrolithiasis O
Neurofibromatosis O
Pectus O
excavatum O
Hodgkin O
& O
# O
8217 O
; O
s O
disease O
& O
# O
8211 O
; O
diagnosed O
in O
2070 I-DATE
; O
s/p O
XRT O
, O
chemo O
( O
bleomycin O
, O
adriamycin O
, O
vincristine O
, O
DTIC O
) O
, O
and O
surgical O
Resection O
; O
oncologist O
Dr. O
Bass I-NAME
at O
MAC I-LOCATION
Pneumonia O
& O
# O
8211 O
; O
multiple O
times O
in O
past O
PAST O
SURGICAL O
HISTORY O
Left O
axillary O
biopsy O
L O
neck/shoulder O
surgery O
( O
to O
remove O
Hodgkin O
& O
# O
8217 O
; O
s O
tumor O
) O
Surgery O
for O
pectus O
excavatum O
RECENT O
DIAGNOSTIC O
STUDIES O
Adeno-MIBI O
2082 I-DATE
: O
negative O
for O
ischemia O
, O
maybe O
a O
small O
inferior O
wall O
scar O
, O
LV O
fxn O
at O
lower O
limit O
of O
normal O
Chest O
CT O
3/25/84 I-DATE
: O
Homogeneous O
soft O
tissue O
mass O
in O
the O
right O
apical O
paraspinal O
region O
that O
is O
slightly O
fusiform O
in O
morphology O
( O
2.6 O
x O
2.6 O
cm O
x O
4 O
cm O
) O
with O
imaging O
features O
suggestive O
of O
a O
neurogenic O
tumor O
( O
ganglioneuroma O
, O
neurofibroma O
, O
schwannoma O
) O
. O
 
No O
evidence O
of O
associated O
osseous O
change O
or O
extension O
into O
the O
neural O
foramina O
. O
 
MEDICATIONS O
ON O
ADMISSION O
ASA O
81 O
mg O
daily O
Metformin O
1000 O
mg O
bid O
Lisinopril O
10 O
mg O
daily O
Simvastatin O
& O
# O
8211 O
; O
not O
sure O
of O
dose O
Flovent O
2 O
puffs O
bid O
( O
started O
1 O
month O
ago O
for O
cough O
) O
ALLERGIES/ADVERSE O
REACTIONS O
IV O
contrast O
& O
# O
8211 O
; O
SOB O
, O
nausea O
FAMILY O
HISTORY O
Mother O
& O
# O
8211 O
; O
DM O
, O
died O
of O
sarcoma O
, O
Father O
- O
died O
of O
an O
MI O
, O
Sister O
with O
ITP O
, O
Brother O
and O
Sister O
have O
neurofibromatosis O
SOCIAL O
HISTORY O
Native O
of O
Edgefield I-LOCATION
. O
 
Lives O
in O
Edgefield I-LOCATION
with O
his O
brother O
. O
 
On O
disability O
. O
 
Volunteers O
- O
animal I-PROFESSION
rescue I-PROFESSION
. O
 
No O
current O
or O
previous O
tobacco O
. O
 
Rare O
EtOH O
. O
 
No O
illicits O
. O
 
PHYSICAL O
EXAMINATION O
Vitals O
97.7 O
92 O
141/69 O
18 O
98 O
% O
3L O
General O
& O
# O
8211 O
; O
obese O
, O
breathing O
comfortably O
HEENT O
& O
# O
8211 O
; O
sclerae O
anicteric O
, O
MMM O
Neck O
& O
# O
8211 O
; O
supple O
, O
no O
LAD O
Pulmonary O
& O
# O
8211 O
; O
good O
air O
movement O
, O
no O
crackles O
or O
wheezes O
, O
decreased O
breath O
sounds O
at O
L O
base O
Cardiac O
& O
# O
8211 O
; O
irreg O
irreg O
rhythm O
, O
no O
m/g/r O
, O
nl O
LV O
heave O
; O
pectus O
excavatum O
Abdomen O
& O
# O
8211 O
; O
+BS O
, O
obese O
, O
soft O
, O
nontender O
, O
nondistended O
Extremity O
& O
# O
8211 O
; O
warm O
, O
2+ O
DP O
pulses O
bilaterally O
, O
trace O
bilateral O
lower O
extremity O
edema O
, O
no O
foot O
ulcers O
Neuro O
& O
# O
8211 O
; O
CNs O
2-12 O
grossly O
intact O
, O
normal O
sensation O
to O
light O
touch O
, O
5/5 O
strength O
bilaterally O
Skin O
& O
# O
8211 O
; O
multiple O
5mm O
elevated O
round O
vesicular O
lesions O
on O
face O
, O
chest O
, O
and O
back O
LABS O
143 O
/ O
4.3 O
/ O
100 O
/ O
32.4 O
/ O
17 O
/ O
1.07 O
/ O
117 O
8.9 O
/ O
3.6 O
/ O
1.7 O
LFTs O
wnl O
12.8 O
& O
gt O
; O
39.8 O
& O
lt O
; O
405 O
83 O
% O
polys O
INR O
1.2 O
MICROBIOLOGY O
Blood O
culture O
pending O
( O
sent O
) O
RADIOLOGICAL O
STUDIES O
CXR O
& O
# O
8211 O
; O
no O
acute O
abnormalities O
, O
severe O
pectus O
excavatum O
and O
rib O
deformities O
noted O
, O
unchanged O
from O
the O
prior O
studies O
EKG O
Atrial O
fibrillation O
, O
L O
axis O
deviation O
, O
narrow O
QRS O
, O
QTc O
438 O
, O
incomplete O
RBBB O
, O
no O
concerning O
ST O
segment O
or O
T O
wave O
changes O
ASSESSMENT O
AND O
PLAN O
53 I-AGE
yo O
man O
with O
NIDDM O
and O
HTN O
presents O
with O
5 O
days O
of O
cough O
and O
mild O
SOB O
, O
CXR O
reveals O
possible O
pneumonia O
, O
also O
noted O
to O
have O
new O
atrial O
fibrillation O
. O
 
# O
# O
# O
ATRIAL O
FIBRILLATION O
& O
# O
8211 O
; O
per O
patient O
, O
no O
history O
of O
a O
fib O
. O
 
May O
have O
been O
triggered O
by O
pneumonia O
. O
 
No O
chest O
pain O
to O
suggest O
recent O
MI O
. O
 
No O
sign O
of O
PE O
. O
 
Hemodynamically O
stable O
. O
 
CHADS2 O
score O
2 O
, O
so O
warfarin O
is O
indicated O
for O
anticoagulation O
. O
 
Unclear O
when O
this O
rhythm O
started O
, O
so O
will O
hold O
off O
on O
cardioversion O
. O
 
- O
Rate O
control O
with O
po O
diltiazem O
- O
Warfarin O
for O
anticoagulation O
; O
follow O
INR O
- O
Check O
TTE O
, O
TSH O
# O
# O
# O
PNEUMONIA O
& O
# O
8211 O
; O
afebrile O
, O
but O
has O
elevated O
WBC O
count O
; O
also O
symptomatic O
cough O
and O
SOB O
, O
and O
history O
of O
pneumonia O
several O
times O
. O
 
Will O
treat O
for O
community-acquired O
pneumonia O
. O
 
- O
Levofloxacin O
750 O
mg O
daily O
; O
plan O
for O
10 O
day O
course O
( O
4/28-5/7 O
) O
- O
Check O
sputum O
and O
blood O
cultures O
# O
# O
# O
DIABETES O
MELLITUS O
& O
# O
8211 O
; O
RISS O
, O
FSG O
; O
hold O
metformin O
# O
# O
# O
HYPERTENSION O
& O
# O
8211 O
; O
will O
switch O
lisinopril O
to O
captopril O
12.5 O
mg O
tid O
; O
also O
getting O
diltiazem O
as O
above O
# O
# O
# O
DYSLIPIDEMIA O
& O
# O
8211 O
; O
simvastatin O
20 O
mg O
daily O
( O
does O
not O
know O
home O
dose O
) O
# O
# O
# O
PROPHYLAXIS O
: O
GI O
: O
none O
DVT O
: O
dalteparin O
BOWEL O
: O
Colace/Senna O
prn O
FEN O
: O
Cardiac O
, O
ADA O
1800 O
calorie O
DISPO O
: O
to O
home O
once O
HR O
controlled O
CODE O
: O
Full O
( O
confirmed O
& O
# O
8211 O
; O
does O
not O
want O
prolonged O
intubation O
) O
___________________________________ O
Marion I-NAME
Costa I-NAME
, O
MD O
Internal O
Medicine O
PGY-1 O
Pager O
67531 I-CONTACT
 
Record O
date O
: O
2084-06-09 I-DATE
Medicine O
Attending O
Admit O
Note O
June I-DATE
9 O
, O
2084 I-DATE
1340 O
h O
I O
interviewed O
and O
examined O
the O
patient O
on O
rounds O
this O
morning O
with O
Dr. O
Lilly I-NAME
and O
with O
Team O
E O
and O
we O
reviewed O
the O
relevant O
data O
and O
discussed O
the O
case O
in O
detail O
. O
 
I O
agree O
with O
the O
findings O
and O
recommendations O
in O
Dr. O
Lilly I-NAME
's O
note O
, O
with O
any O
small O
exceptions O
or O
points O
of O
emphasis O
noted O
below O
. O
 
Please O
refer O
to O
it O
for O
details O
of O
HPI O
, O
PMH O
, O
medications O
and O
allergies O
, O
family O
and O
social O
history O
, O
laboratory O
and O
other O
data O
, O
and O
ROS O
. O
 
I O
would O
only O
add/emphasize O
the O
following O
: O
Mr. O
Gillespie I-NAME
is O
a O
53 I-AGE
year-old O
man O
with O
medical O
history O
that O
includes O
: O
h/p O
Hodgkin O
& O
# O
8217 O
; O
s O
lymphoma O
, O
2070-2071 O
, O
treated O
with O
local O
resection O
, O
bleomycin O
, O
adriamycin O
, O
and O
other O
agents O
, O
XRT O
to O
a O
wide O
chest O
field O
Atrial O
fibrillation O
- O
diagnosed O
in O
3/84 I-DATE
; O
on O
warfarin O
, O
metoprolol O
Pectus O
excavatum O
& O
# O
8211 O
; O
repair O
failed O
as O
a O
child O
Pneumonia O
several O
times O
in O
the O
past O
Central O
obesity O
& O
# O
8211 O
; O
weighs O
about O
315 O
# O
, O
down O
from O
a O
high O
of O
360 O
# O
Type O
II O
diabetes O
mellitus O
, O
last O
A1C O
6.4 O
, O
on O
metformin O
only O
, O
1000 O
mg O
BID O
Hypertension O
, O
on O
lisinopril O
10 O
mg O
, O
Toprol O
XL O
Elevated O
lipids O
- O
on O
statin O
Neurofibromatosis O
( O
Soft O
tissue O
mass O
in O
right O
apex O
noted O
on O
3/84 I-DATE
CT O
may O
be O
neurogenic O
tumor O
. O
) O
 
Kidney O
stones O
Patent O
foramen O
ovale O
He O
presents O
with O
dyspnea O
, O
orthopnea O
, O
and O
palpitations O
as O
described O
by O
Dr. O
Lilly I-NAME
, O
and O
was O
found O
to O
be O
in O
atrial O
fibrillation/flutter O
with O
rapid O
ventricular O
response O
. O
 
He O
has O
improved O
with O
heart O
rate O
control O
. O
 
Exam O
VS O
- O
as O
noted O
General O
- O
pleasant O
obese O
white O
man O
with O
severe O
pectus O
deformity O
. O
 
Breathing O
with O
abdominal O
muscles O
tensed O
on O
expiration O
. O
 
CV O
- O
heart O
with O
regular O
rhythm O
, O
normal O
S1 O
, O
prominent O
S2 O
, O
and O
no O
murmurs O
, O
rubs O
, O
or O
gallops O
Lungs O
- O
clear O
Abdomen O
- O
obese O
Extremities O
- O
minimal O
edema O
Data O
- O
reviewed O
in O
detail O
and O
are O
as O
in O
Dr. O
Lilly I-NAME
's O
note O
. O
 
Bicarb O
31 O
, O
BNP O
2050 O
, O
WBC O
15 O
, O
INR O
3.1 O
. O
 
Impression O
: O
Poorly O
tolerated O
atrial O
fibrillation/flutter O
with O
RVR O
, O
needing O
better O
rate O
control O
. O
 
Given O
the O
severe O
pectus O
deformity O
as O
well O
as O
his O
history O
of O
lung-toxic O
chemotherapy O
drugs O
and O
XRT O
, O
he O
may O
have O
some O
restrictive O
lung O
disease O
that O
would O
limit O
his O
cardiopulmonary O
reserve O
. O
 
I O
would O
not O
be O
surprised O
if O
he O
additionally O
has O
obstructive O
lung O
disease O
, O
given O
the O
`` O
belly O
breathing O
'' O
and O
the O
wheezing O
he O
had O
last O
admission O
. O
 
Recommendations O
: O
Increase O
metoprolol O
dose O
. O
 
May O
need O
Toprol O
XL O
100 O
BID O
. O
 
Best O
to O
maximize O
utility O
of O
BB O
prior O
to O
adding O
other O
agents O
. O
 
Filter O
all O
IVs O
( O
PFO O
) O
PFTs O
and O
Pulmonology O
consult O
as O
an O
outpatient O
Balance O
of O
plan O
per O
Dr. O
Lilly I-NAME
. O
 
Peter I-NAME
Wiggins I-NAME
, O
MD O
, O
PhD O
pager O
32089 I-CONTACT
 
Record O
date O
: O
2084-06-15 I-DATE
PATIENT O
: O
Patrick I-NAME
Gillespie I-NAME
MRN O
: O
2571454 I-ID
ADMIT O
DATE O
: O
6/13/84 I-DATE
TRANSFER O
DATE O
: O
6/15/84 I-DATE
ATTN O
: O
Wright I-NAME
Reason O
for O
admission/transfer O
: O
aflutter O
starting O
on O
sotalol O
HPI O
Please O
see O
admission O
note O
for O
full O
details O
. O
 
In O
brief O
, O
this O
is O
a O
54 I-AGE
y/o O
M O
hx O
neurofibromatosis O
, O
Hodgkin O
's O
lymphoma O
s/p O
chemo/XRT O
in O
the O
70s I-DATE
, O
DMII O
( O
A1c O
6.5 O
in O
03/84 I-DATE
) O
, O
HTN O
, O
obesity O
and O
new O
diagnosis O
of O
Afib O
, O
recently O
discharged O
from O
the O
Mediquik I-LOCATION
2 O
days O
prior O
to O
readmission O
6/13 I-DATE
where O
he O
was O
being O
treated O
for O
AF O
w/ O
RVR O
. O
 
His O
toprol O
was O
increased O
from O
100mg O
dily O
to O
100mg O
BID O
at O
that O
time O
. O
 
Prior O
w/u O
w/ O
fairly O
nl O
TTE O
and O
nl O
TSH O
. O
 
Now O
returned O
for O
his O
third O
admission O
with O
AF O
w/ O
RVR O
, O
rates O
into O
the O
140s O
. O
 
He O
is O
considerably O
symptomatic O
with O
the O
AF O
w/ O
palpitations O
, O
lightheadedness O
, O
dyspnea O
, O
and O
diaphoresis O
. O
 
HD O
stable O
. O
 
He O
has O
been O
on O
increasing O
doses O
of O
Toprol O
without O
effect O
given O
this O
is O
his O
third O
admission O
. O
 
MEDICAL O
HISTORY O
NIDDM O
HTN O
HL O
Neurofibromatosis O
Pectus O
excavatum O
H/o O
Hodgkin O
's O
disease O
- O
diagnosed O
in O
2070 I-DATE
; O
s/p O
XRT O
, O
chemo O
( O
bleomycin O
, O
adriamycin O
, O
vincristine O
, O
DTIC O
) O
, O
and O
surgical O
resection O
; O
oncologist O
Dr. O
Bass I-NAME
at O
MAC I-LOCATION
ALLERGIES O
: O
IV O
contrast O
For O
social O
history/ O
family O
history/ O
meds O
on O
admission O
please O
see O
admission O
note O
. O
 
HOSPITAL O
COURSE O
: O
PAF/ O
Flutter O
: O
In O
the O
Ed O
, O
he O
had O
been O
given O
IV O
lopressor O
5mg O
w/ O
25mg O
PO O
lopressor O
w/o O
improvement O
and O
then O
was O
given O
10mg O
IV O
dilt O
which O
brought O
HR O
down O
to O
90s O
. O
 
He O
was O
also O
given O
0.5mg O
digoxin O
for O
possible O
dig O
load O
. O
 
Given O
he O
was O
failing O
on O
Toprol O
100mg O
BID O
his O
medications O
were O
switched O
to O
diltiazem O
60mg O
q6hr O
to O
see O
if O
a O
different O
drug O
class O
might O
help O
. O
 
Cardiology/ O
EP O
was O
consulted O
for O
the O
possibility O
of O
ablation O
given O
this O
was O
his O
third O
admission O
and O
he O
is O
so O
symptomatic O
. O
 
EP O
decided O
to O
start O
the O
patient O
on O
sotalol O
80-mg O
BID O
with O
the O
plan O
to O
increase O
sotalol O
to O
120mg O
BID O
on O
6/15 I-DATE
if O
Qtc O
remains O
stable O
( O
& O
lt O
; O
500 O
msec O
) O
. O
 
He O
is O
planned O
to O
received O
5 O
doses O
of O
sotalol O
prior O
to O
dispo O
and O
if O
he O
remained O
in O
aflutter O
through O
6/15 I-DATE
is O
to O
get O
DCCV O
on O
6/16 I-DATE
. O
 
He O
received O
his O
first O
and O
only O
dose O
in O
the O
pm O
6/14 I-DATE
. O
 
Overnight O
he O
was O
bradycardic O
into O
the O
40s O
while O
sleeping O
. O
 
He O
had O
a O
3.5 O
second O
pause O
however O
on O
telemetry O
. O
 
His O
heart O
rates O
have O
ranged O
from O
45-60 O
in O
AFlutter O
. O
 
BPs O
90s O
systolic O
. O
 
Per O
EP O
, O
as O
pt O
asleep O
, O
will O
co O
n't O
sotalol O
. O
 
He O
is O
on O
coumadin O
for O
anticoagulation O
. O
 
INR O
goal O
2-3 O
. O
 
EP O
( O
Dr. O
Moody= O
fellow O
) O
and O
cards O
( O
PRM I-LOCATION
wright I-NAME
) O
are O
following O
. O
 
PUMP O
: O
echo O
04/84 I-DATE
which O
demonstrated O
an O
elongated O
LA O
sLVH O
, O
EF O
61 O
% O
, O
tr O
TR O
, O
RSVP O
41 O
, O
RV O
nl O
. O
 
On O
ACEI O
. O
 
PULM O
: O
CXR O
in O
ED O
with O
pulm O
edema O
. O
 
Given O
20mg O
PO O
lasix O
x1 O
for O
gentle O
diuresis O
. O
 
On O
1 O
L O
O2 O
as O
of O
am O
6/15 I-DATE
and O
lasix O
10mg O
Iv O
x O
1 O
again O
this O
am O
6/15 I-DATE
. O
 
Felt O
to O
be O
related O
to O
his O
AF O
. O
 
He O
does O
have O
a O
h/o O
repeated O
PNAs O
. O
 
On O
xopenex O
, O
flovent O
. O
 
FEN O
: O
Mild O
hyperK O
in O
the O
ED O
to O
5.3 O
. O
 
Received O
30g O
kayexelate O
. O
 
Normalized O
. O
 
NPO O
at O
midnight O
6/15 I-DATE
for O
possibel O
DCCV O
if O
still O
planned O
by O
E. O
Isabella I-NAME
Glenn I-NAME
Mathews I-NAME
, O
MD O
MSc O
, O
Pager O
43771 I-CONTACT
 
Record O
date O
: O
2071-05-31 I-DATE
Walk-in O
clinic O
Xian I-NAME
, O
Imogene I-NAME
81376761 I-ID
5-31-71 I-DATE
HPI O
: O
Ms. O
Xian I-NAME
is O
a O
74-year-old O
female O
who O
presented O
to O
clinic O
this O
evening O
for O
follow O
up O
of O
her O
diabetes O
. O
 
Patient O
was O
last O
seen O
in O
clinic O
in O
11-70 I-DATE
after O
which O
time O
she O
left O
for O
Ghana I-LOCATION
for O
the O
past O
six O
months O
. O
 
She O
returned O
this O
past O
Friday I-DATE
but O
has O
since O
run O
out O
of O
insulin O
. O
 
She O
states O
that O
she O
has O
been O
feeling O
well O
and O
has O
not O
had O
any O
problems O
but O
does O
not O
know O
the O
amount O
of O
insulin O
that O
she O
has O
been O
taking O
. O
 
It O
has O
been O
administered O
to O
her O
by O
a O
friend O
in O
Ghana I-LOCATION
. O
 
Our O
records O
show O
that O
when O
she O
left O
Ghana I-LOCATION
she O
was O
on O
a O
70/30 O
of O
Humulin O
, O
20 O
units O
per O
day O
and O
also O
600mg O
of O
Rezulin O
and O
20mg O
q.d O
. O
 
of O
Lipitor O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
Review O
of O
systems O
is O
positive O
for O
insulin O
dependent O
diabetes O
mellitus O
but O
other O
than O
that O
Ms. O
Xian I-NAME
is O
a O
fairly O
healthy O
woman O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
exam O
this O
evening O
her O
pulse O
is O
80 O
. O
 
Blood O
pressure O
was O
152/80 O
in O
her O
left O
arm O
. O
 
Blood O
sugar O
was O
262 O
. O
 
It O
should O
be O
noted O
that O
she O
has O
not O
had O
any O
insulin O
since O
Sunday I-DATE
. O
 
Her O
weight O
was O
116 O
1/2 O
which O
reflects O
a O
1/2 O
lb O
. O
 
weight O
loss O
since O
11-70 I-DATE
. O
 
Tonight O
her O
heart O
had O
a O
regular O
rate O
and O
rhythm O
at O
80 O
. O
 
Her O
neck O
veins O
were O
flat O
. O
 
Her O
lungs O
were O
clear O
to O
auscultation O
bilaterally O
and O
there O
was O
no O
evidence O
of O
peripheral O
edema O
. O
 
ASSESSMENT O
: O
Insulin O
dependent O
diabetes O
mellitus O
. O
 
PLAN O
: O
LFTs O
, O
A1C O
, O
basic O
panel O
this O
evening O
. O
 
Glucotrol O
10mg O
dispense O
No O
. O
 
60 O
with O
1 O
refill O
b.i.d O
. O
 
A O
VNA O
referral O
for O
medication O
management O
and O
patient O
was O
instructed O
to O
return O
to O
the O
clinic O
on O
Saturday I-DATE
6-05 I-DATE
for O
repeat O
blood O
sugar O
and O
also O
to O
bring O
her O
glucometer O
at O
that O
time O
so O
that O
it O
could O
be O
calibrated O
correctly O
. O
 
________________________________ O
Grace I-NAME
Vann I-NAME
, O
R.N.P O
. O
 
DG I-NAME
: O
WA:1749 O
DD:5-31-71 O
DT:6-1-71 O
DV:5-31-71 O
 
Record O
date O
: O
2072-07-30 I-DATE
SCHLESWIG I-LOCATION
COUNTY I-LOCATION
CLINIC I-LOCATION
Walk-in O
clinic O
24 I-LOCATION
Weld I-LOCATION
St I-LOCATION
Grandview I-LOCATION
, O
NE I-LOCATION
13472 I-LOCATION
Xian I-NAME
, O
Imogene I-NAME
64187177 I-ID
07/30/72 I-DATE
CHIEF O
COMPLAINT O
: O
Ms. O
Xian I-NAME
is O
a O
75-year-old O
female O
who O
presented O
to O
the O
walk-in O
clinic O
this O
evening O
as O
a O
walk-in O
with O
a O
chief O
complaint O
of O
bilateral O
foot O
pain O
especially O
in O
the O
toe O
area O
, O
and O
she O
says O
that O
this O
has O
been O
going O
on O
for O
approximately O
two O
months O
. O
 
ALLERGIES O
: O
She O
denies O
any O
known O
drug O
allergies O
. O
 
MEDICATIONS O
: O
At O
present O
, O
she O
is O
taking O
Glucophage O
500 O
mg O
one O
p.o O
. O
 
q.a.m O
, O
two O
p.o O
. O
 
q.p.m. O
, O
Avandia O
2 O
mg O
one O
p.o O
. O
 
q.a.m. O
, O
Plavix O
75 I-AGE
mg O
one O
p.o O
. O
 
q.d. O
, O
glipizide O
5 O
mg O
two O
p.o O
. O
 
q.a.m. O
, O
and O
two O
p.o O
. O
 
q.p.m. O
, O
and O
Lipitor O
20 O
mg O
q.d O
. O
 
REVIEW O
OF O
SYSTEMS O
: O
The O
patient O
states O
that O
she O
has O
had O
constant O
pain O
in O
her O
toes O
and O
at O
times O
with O
a O
feeling O
of O
tingling O
. O
 
Otherwise O
, O
she O
states O
she O
has O
been O
feeling O
well O
. O
 
She O
denies O
any O
chest O
pain O
or O
heart O
palpitation O
. O
 
She O
denies O
any O
shortness O
of O
breath O
. O
 
She O
denies O
any O
nausea O
, O
vomiting O
or O
diarrhea O
. O
 
She O
denies O
any O
frequency O
, O
dysuria O
or O
thirst O
. O
 
She O
has O
a O
history O
of O
non- O
insulin-dependent O
diabetes O
at O
this O
time O
. O
 
PHYSICAL O
EXAMINATION O
: O
Her O
temperature O
was O
98.5 O
degrees O
p.o. O
, O
her O
pulse O
was O
80 O
, O
her O
blood O
pressure O
was O
118/60 O
in O
her O
right O
arm O
. O
 
Her O
weight O
was O
117 O
pounds O
, O
which O
reflects O
a O
one-pound O
weight O
loss O
since O
her O
last O
visit O
. O
 
Her O
blood O
sugar O
, O
which O
was O
random O
, O
was O
159 O
, O
her O
last O
meal O
being O
at O
12 O
noon O
. O
 
Her O
son O
, O
who O
accompanied O
her O
states O
that O
it O
is O
questionable O
whether O
she O
is O
taking O
her O
medications O
as O
instructed O
and O
voiced O
an O
interest O
in O
having O
his O
mother O
take O
insulin O
, O
which O
she O
has O
taken O
in O
the O
past O
. O
 
Her O
heart O
had O
a O
regular O
rate O
and O
rhythm O
at O
80 O
. O
 
There O
was O
no O
evidence O
of O
any O
peripheral O
edema O
. O
 
Examination O
of O
her O
toes O
revealed O
presence O
of O
some O
tinea O
interdigitally O
. O
 
ASSESSMENT O
: O
1 O
. O
 
Non-insulin-dependent O
diabetes O
mellitus O
, O
moderate O
control O
. O
 
2 O
. O
 
Tinea O
pedis O
. O
 
PLAN O
: O
Medication O
refills O
were O
given O
for O
Glucotrol O
5 O
mg O
dispensed O
No O
. O
 
120 O
with O
two O
refills O
, O
two O
p.o O
. O
 
q.a.m. O
, O
two O
p.o O
. O
 
q.p.m. O
, O
Glucophage O
500 O
mg O
No O
. O
 
90 O
one O
p.o O
. O
 
q.a.m. O
, O
two O
p.o O
. O
 
q.p.m. O
, O
and O
Avandia O
2 O
mg O
No O
. O
 
30 O
with O
two O
refills O
one O
p.o O
. O
 
q.a.m. O
, O
and O
a O
new O
prescription O
for O
Lotrimin O
AF O
1 O
% O
cream O
dispensed O
12 O
g O
with O
one O
refill O
, O
apply O
to O
the O
affected O
area O
b.i.d O
. O
 
for O
up O
to O
four O
weeks O
. O
 
Xian I-NAME
, O
Imogene I-NAME
64187177 I-ID
07/30/72 I-DATE
Page O
2 O
The O
patient O
has O
an O
appointment O
scheduled O
with O
her O
primary O
care O
provider O
Dr. O
Paul I-NAME
Shaw I-NAME
for O
8/16/72 I-DATE
, O
and O
was O
advised O
to O
keep O
that O
appointment O
. O
 
Grace I-NAME
Vann I-NAME
, O
N.P O
. O
 
GV I-NAME
: O
arreola:06:278:08 O
; O
37-60093.doc O
; O
DD:07/30/72 O
; O
DT:08/01/72 O
; O
DV:07/30/72 O
; O
 
Record O
date O
: O
2073-05-29 I-DATE
Internal O
Medicine O
97 I-LOCATION
Weld I-LOCATION
St I-LOCATION
Xian I-NAME
, O
Imogene I-NAME
Grandview I-LOCATION
, O
NE I-LOCATION
13472 I-LOCATION
81376761 I-ID
( O
552 O
) O
598-5590 I-CONTACT
05/29/73 I-DATE
HISTORY O
OF O
PRESENT O
ILLNESS O
: O
Ms. O
Xian I-NAME
is O
75 I-AGE
years O
of O
age O
. O
 
She O
has O
adult-onset O
diabetes O
, O
which O
in O
the O
past O
has O
required O
treatment O
with O
insulin O
. O
 
She O
has O
been O
managed O
with O
oral O
hypoglycemics O
because O
of O
her O
reticence O
to O
using O
injections O
. O
 
She O
also O
has O
a O
history O
of O
CVA O
. O
 
I O
last O
saw O
her O
in O
August I-DATE
of O
last O
year O
. O
 
She O
was O
seen O
by O
Ms. O
Vann I-NAME
, O
our O
nurse O
practitioner O
in O
early O
May I-DATE
. O
 
CURRENT O
MEDICATIONS O
: O
Glipizide O
5 O
mg O
two O
in O
the O
morning O
and O
two O
in O
the O
evening O
, O
Plavix O
75 I-AGE
mg O
one O
p.o O
. O
 
q.d. O
, O
and O
Avandia O
2 O
mg O
one O
p.o O
. O
 
q.a.m O
. O
 
According O
to O
Ms. O
Vann I-NAME
's O
note O
of O
Apr I-DATE
29 O
, O
2073 I-DATE
, O
she O
is O
also O
supposed O
to O
be O
taking O
metformin O
500 O
mg O
one O
in O
the O
morning O
and O
two O
with O
the O
evening O
meal O
as O
was O
prescribed O
back O
in O
2072 I-DATE
. O
 
The O
patient O
and O
her O
son O
today O
are O
not O
sure O
that O
she O
is O
taking O
this O
medication O
. O
 
In O
fact O
, O
they O
believe O
that O
she O
is O
not O
. O
 
There O
has O
been O
moderate O
polyuria O
and O
polydipsia O
. O
 
Control O
of O
diabetes O
has O
been O
erratic O
. O
 
Hemoglobin O
A1c O
has O
been O
elevated O
. O
 
On O
Apr I-DATE
29 O
, O
2073 I-DATE
, O
blood O
glucose O
was O
274 O
, O
BUN O
was O
25 O
, O
creatinine O
1.0 O
, O
electrolytes O
within O
normal O
limits O
as O
was O
calcium O
. O
 
Cholesterol O
was O
315 O
. O
 
Hemoglobin O
A1c O
10.6 O
. O
 
The O
patient O
has O
not O
experienced O
chest O
pain O
, O
palpitations O
but O
she O
is O
moderately O
short O
of O
breath O
when O
climbing O
stairs O
. O
 
There O
has O
been O
no O
orthopnea O
and O
no O
PND O
. O
 
She O
denies O
dysuria O
and O
urgency O
and O
has O
not O
experienced O
near O
syncope O
. O
 
She O
denies O
nausea O
, O
vomiting O
, O
diarrhea O
, O
and O
constipation O
. O
 
PHYSICAL O
EXAMINATION O
: O
On O
physical O
examination O
today O
, O
she O
appears O
well O
. O
 
Blood O
pressure O
122/66 O
. O
 
The O
heart O
rate O
is O
90 O
and O
regular O
, O
weight O
113 O
pounds O
, O
approximately O
five O
pounds O
less O
than O
last O
year O
. O
 
Random O
blood O
glucose O
was O
224 O
. O
 
The O
patient O
suffered O
a O
minor O
CVA O
back O
in O
September I-DATE
2071 I-DATE
. O
 
She O
denies O
any O
recurrence O
of O
motor O
deficits O
or O
symptoms O
suggestive O
of O
TIA O
. O
 
The O
patient O
has O
a O
past O
history O
of O
hyperthyroidism O
that O
was O
treated O
with O
iodine O
131 O
. O
 
She O
has O
not O
been O
hypothyroid O
since O
then O
. O
 
In O
fact O
, O
the O
last O
TSH O
level O
was O
0.05 O
in O
August I-DATE
of O
last O
year O
, O
just O
prior O
to O
her O
departure O
to O
Ghana I-LOCATION
. O
 
She O
denies O
heat O
intolerance O
as O
well O
as O
palpitations O
. O
 
On O
physical O
examination O
, O
she O
is O
a O
small O
lady O
in O
no O
acute O
distress O
. O
 
The O
neck O
veins O
are O
flat O
. O
 
The O
extraocular O
movements O
are O
full O
. O
 
There O
are O
no O
symptoms O
of O
hyperthyroidism O
. O
 
The O
chest O
is O
clear O
to O
auscultation O
. O
 
The O
heart O
sounds O
are O
regular O
. O
 
There O
are O
no O
rubs O
or O
gallops O
. O
 
The O
lower O
extremities O
are O
free O
of O
edema O
and O
now O
her O
toes O
are O
free O
of O
fungi O
but O
the O
nails O
are O
overgrown O
and O
require O
attention O
. O
 
ASSESSMENT O
AND O
PLAN O
: O
A O
76 I-AGE
year O
old O
woman O
with O
a O
past O
history O
of O
hyperthyroidism O
, O
which O
was O
treated O
with O
I-131 O
with O
good O
results O
who O
, O
last O
year O
before O
she O
left O
the O
country O
, O
had O
a O
subnormal O
TSH O
. O
 
She O
does O
not O
have O
obvious O
symptoms O
of O
hyperthyroidism O
but O
today O
I O
have O
obtained O
a O
repeat O
TSH O
as O
well O
as O
T3 O
and O
T4 O
. O
 
Diabetes O
continues O
to O
be O
a O
problem O
. O
 
Glycemic O
control O
continues O
to O
be O
difficult O
to O
achieve O
. O
 
Today O
, O
I O
have O
reinstated O
metformin O
at O
500 O
mg O
p.o O
. O
 
q.d O
. O
 
The O
son O
is O
going O
to O
check O
on O
the O
medications O
to O
make O
certain O
that O
indeed O
she O
is O
not O
taking O
this O
medicine O
at O
this O
point O
. O
 
The O
other O
medications O
were O
continued O
. O
 
It O
is O
indeed O
possible O
that O
she O
will O
need O
insulin O
in O
the O
near O
future O
. O
 
I O
plan O
close O
followup O
and O
will O
see O
her O
again O
in O
six O
weeks O
' O
time O
. O
 
If O
she O
is O
hyperthyroid O
, O
this O
may O
also O
explain O
the O
difficulty O
in O
achieving O
glycemic O
control O
. O
 
Against O
this O
is O
the O
high O
cholesterol O
. O
 
She O
used O
to O
be O
on O
Lipitor O
, O
which O
was O
discontinued O
during O
her O
trip O
to O
Ghana I-LOCATION
. O
 
I O
have O
reinstated O
the O
Lipitor O
today O
20 O
mg O
p.o O
. O
 
q.d O
. O
 
I O
have O
also O
added O
a O
small O
dose O
of O
enalapril O
2.5 O
mg O
p.o O
. O
 
q.d O
. O
 
to O
protect O
her O
kidneys O
even O
though O
she O
is O
not O
hypertensive O
. O
 
______________________________ O
Kevin I-NAME
Shamar-Trevino I-NAME
, O
M.D O
. O
 
eScription O
document:0-389401 O
NFFocus O
DD O
: O
05/29/73 I-DATE
DT O
: O
05/30/73 I-DATE
DV O
: O
05/29/73 I-DATE
 
Record O
date O
: O
2080-06-15 I-DATE
Walk-in O
visit O
because O
of O
Pt O
of O
Dr O
Shamar I-NAME
Seen O
in O
the O
EW O
bo O
HA O
, O
work O
up O
negative O
. O
 
Basicallty O
the O
diagnosis O
was O
anxiety O
. O
 
It O
seems O
she O
's O
very O
lonely O
here O
, O
lives O
with O
son O
who O
works O
long O
hours O
. O
 
In O
the O
EW O
it O
was O
recommended O
she O
antecipates O
her O
trip O
to O
Ghana I-LOCATION
because O
she O
feels O
much O
better O
there O
. O
 
Sent O
for O
fup O
with O
pcp O
. O
 
Symtpoms O
all O
resolved O
. O
 
Son O
needs O
a O
letter O
to O
antecipate O
her O
airplane O
ticket O
She O
ahs O
no O
new O
complaints O
. O
 
Problems O
TOXIC O
NODULAR O
GOITER O
ARTHRITIS O
CVA O
: O
In O
year O
2071 I-DATE
. O
 
Hyperthyroidism O
: O
I-131 O
5 O
years O
ago O
. O
 
Insulin O
dependent O
diabetic O
Hyperlipidemia O
Hypertension O
h/o O
urosepsis O
Medications O
Actos O
( O
PIOGLITAZONE O
) O
15 O
MG O
( O
15MG O
TABLET O
Take O
1 O
) O
PO O
q.d O
. O
 
# O
90 O
Tablet O
( O
s O
) O
Calcium O
+ O
D O
( O
600 O
MG O
ELEM O
CA O
) O
( O
CALCIUM O
CARBONATE O
1500 O
MG O
( O
600 O
MG O
ELEM O
CA O
) O
/ O
VIT O
D O
200 O
IU O
) O
1 O
TAB O
PO O
BID O
# O
3 O
Month O
( O
s O
) O
Supply O
Enteric O
COATED O
ASPIRIN O
( O
ASPIRIN O
ENTERIC O
COATED O
) O
81 O
MG O
( O
81MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Insulin O
NPH O
HUMAN O
17 O
UNITS O
SC O
as O
directed O
, O
15 O
units O
in O
the O
morning O
and O
5 O
units O
at O
night O
# O
3 O
Month O
( O
s O
) O
Supply O
Lancets O
ONE O
UNIT O
( O
Take O
1 O
) O
PO O
bid O
x O
90 O
days O
# O
180 O
units O
Lipitor O
( O
ATORVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Lisinopril O
10 O
MG O
( O
20MG O
TABLET O
Take O
1 O
) O
PO O
QD O
x O
90 O
days O
# O
90 O
Tablet O
( O
s O
) O
Lopressor O
( O
METOPROLOL O
TARTRATE O
) O
25 O
MG O
( O
25MG O
TABLET O
Take O
1 O
) O
PO O
BID O
# O
3 O
Month O
( O
s O
) O
Supply O
Micronase O
5 O
MG O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Motrin O
( O
IBUPROFEN O
) O
400 O
MG O
( O
400MG O
TABLET O
Take O
1 O
) O
PO O
BID O
# O
30 O
Tablet O
( O
s O
) O
Onetocuh O
Ultra O
Soft O
Lancets O
ONE O
TOP O
As O
directed O
, O
Use O
as O
directed O
# O
1 O
Box O
( O
es O
) O
Onetouch O
Test O
Strips O
ONE O
TOP O
as O
directed O
, O
Use O
as O
directed O
# O
1 O
Box O
( O
es O
) O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Social O
history O
: O
smoking O
( O
- O
) O
ROS O
: O
Constitutional O
: O
Feels O
well O
. O
 
Energy O
: O
good O
. O
 
Wt O
: O
stable O
ENT O
: O
no O
hearing O
loss O
, O
no O
ear O
pain O
, O
no O
nasal O
discharge O
Skin O
: O
no O
rashes O
, O
itching O
CV O
: O
no O
chest O
pain O
, O
no O
SOB O
, O
PND O
, O
DOE O
, O
no O
edema O
Respir O
: O
no O
cough O
, O
no O
wheezing O
GI O
: O
no O
nausea O
, O
no O
vomiting O
, O
no O
abdominal O
pain O
, O
heart O
burn O
, O
nl O
BM O
GU O
: O
no O
dysuria O
, O
no O
frequency O
, O
no O
urgency O
. O
 
PE O
: O
Appears O
well O
. O
 
Legally O
blind O
. O
 
Vital O
Signs O
BP O
151/68 O
, O
P O
88 O
, O
Wt O
140 O
lb O
FINGER O
BLOOD O
GLUCOSE O
90 O
O2 O
sat O
99 O
HEENT O
: O
NCAT O
, O
EOMI O
Neck O
: O
no O
cervical O
adenopathy O
Lungs O
: O
clear O
bilaterally O
Heart O
: O
regular O
, O
normal O
S1 O
and O
S2 O
. O
 
Abd O
: O
Soft O
, O
non-tender O
. O
 
Extr O
: O
no O
edema O
. O
 
ASSESMENT O
AND O
PLAN O
: O
labs O
reviwed O
DM O
: O
check O
A O
! O
C O
today O
HTn O
: O
increase O
lisinopril O
to O
20 O
mg O
, O
check O
chem O
HL O
; O
check O
cho O
profile O
on O
lipitor O
. O
 
Anxxiety O
: O
letter O
to O
antecipate O
her O
trip O
 
Record O
date O
: O
2081-09-06 I-DATE
09/06/81 I-DATE
Follow O
up O
after O
long O
absence O
. O
 
Pt O
was O
seen O
last O
week O
by O
Dr.Anderson O
and O
prior O
to O
that O
she O
was O
at O
Chesterfield I-LOCATION
ED O
and O
prior O
to O
that O
her O
son O
reports O
that O
she O
had O
been O
in O
Ghanna I-LOCATION
. O
 
I O
suspect O
she O
has O
been O
under O
someone O
else O
's O
care O
since O
I O
never O
prescribed O
Glyburide O
, O
Actos O
and O
Insulin O
. O
 
The O
last O
time O
I O
saw O
her O
in O
January I-DATE
I O
discontinued O
Metformin O
because O
of O
GI O
intolerance O
and O
her O
regimen O
was O
Insulin O
only O
. O
 
She O
did O
not O
keep O
subsequent O
appointments O
. O
 
She O
was O
seen O
at O
Chesterfield I-LOCATION
ED O
because O
of O
pyelonephritis/UTI O
treated O
with O
ceftriaxone O
and O
discharged O
on O
Nitrofurantoin O
. O
 
She O
has O
now O
completed O
the O
treatment O
. O
 
She O
feels O
better O
although O
there O
is O
still O
mild O
dysuria O
, O
denies O
chills O
and O
fever O
. O
 
course O
Problems O
TOXIC O
NODULAR O
GOITER O
ARTHRITIS O
CVA O
: O
In O
year O
2071 I-DATE
. O
 
Hyperthyroidism O
: O
I-131 O
5 O
years O
ago O
. O
 
Insulin O
dependent O
diabetic O
Hyperlipidemia O
Hypertension O
h/o O
urosepsis O
Medications O
Actos O
( O
PIOGLITAZONE O
) O
15 O
MG O
( O
15MG O
TABLET O
Take O
1 O
) O
PO O
q.d O
. O
 
# O
30 O
Tablet O
( O
s O
) O
Calcium O
+ O
D O
( O
600 O
Mg O
Elem O
Ca O
) O
( O
CALCIUM O
Carbonate O
1500 O
Mg O
( O
600 O
Mg O
Elem O
Ca O
) O
/ O
Vit O
D O
200 O
Iu O
) O
1 O
TAB O
PO O
BID O
# O
3 O
Month O
( O
s O
) O
Supply O
Clotrimazole O
1 O
% O
Cream O
1 O
APPLICATION O
TOP O
BID O
, O
Apply O
between O
toes O
left O
foot O
# O
15 O
GM O
TUBE O
Enteric O
Coated O
Aspirin O
( O
ASPIRIN O
Enteric O
Coated O
) O
81 O
MG O
( O
81MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Insulin O
Nph O
Human O
17 O
UNITS O
SC O
as O
directed O
, O
15 O
units O
in O
the O
morning O
and O
5 O
units O
at O
night O
# O
3 O
Month O
( O
s O
) O
Supply O
Lancets O
ONE O
UNIT O
( O
Take O
1 O
) O
PO O
bid O
x O
90 O
days O
# O
180 O
units O
Levofloxacin O
500 O
MG O
( O
500MG O
TABLET O
Take O
1 O
) O
PO O
Q48H O
# O
3 O
Tablet O
( O
s O
) O
Lipitor O
( O
ATORVASTATIN O
) O
20 O
MG O
( O
20MG O
TABLET O
Take O
1 O
) O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Lisinopril O
20 O
MG O
( O
20MG O
TABLET O
Take O
1 O
) O
PO O
QD O
x O
90 O
days O
# O
90 O
Tablet O
( O
s O
) O
Lopressor O
( O
METOPROLOL O
Tartrate O
) O
25 O
MG O
( O
25MG O
TABLET O
Take O
1 O
) O
PO O
BID O
# O
3 O
Month O
( O
s O
) O
Supply O
Micronase O
5 O
MG O
PO O
QD O
# O
30 O
Tablet O
( O
s O
) O
Motrin O
( O
IBUPROFEN O
) O
400 O
MG O
( O
400MG O
TABLET O
Take O
1 O
) O
PO O
BID O
# O
30 O
Tablet O
( O
s O
) O
One O
Touch O
Glucometer O
1 O
( O
Take O
1 O
) O
PO O
bid O
# O
1 O
Unit O
Onetocuh O
Ultra O
Soft O
Lancets O
ONE O
TOP O
As O
directed O
, O
Use O
as O
directed O
# O
1 O
Box O
( O
es O
) O
Plavix O
( O
CLOPIDOGREL O
) O
75 O
MG O
PO O
QD O
# O
90 O
Tablet O
( O
s O
) O
Soc O
Hx O
: O
Smoking O
( O
- O
) O
ROS O
: O
all O
other O
systems O
were O
reviewed O
and O
are O
negative O
. O
 
PE O
: O
Appears O
elderly O
but O
in O
no O
distress O
.. O
Comes O
accompanied O
by O
son O
. O
 
Lungs O
: O
clear O
bilaterally O
Heart O
: O
regular O
, O
normal O
S1 O
and O
S2 O
. O
 
Abd O
: O
Soft O
, O
non-tender O
, O
no O
CVA O
tenderness O
ASSESMENT O
AND O
PLAN O
: O
UTI O
: O
Reculture O
now O
post O
Rx O
DM O
: O
she O
did O
not O
tolerate O
Metformin O
. O
 
I O
have O
DC O
Actos O
and O
kept O
her O
on O
Glyburide O
and O
current O
dose O
of O
insulin O
. O
 
Instructed O
son O
to O
call O
if O
hypoglycemic O
or O
if O
Sx O
of O
UTI O
reccur O
. O
 
Plan O
to O
see O
her O
in O
one O
week O
and O
will O
then O
DC O
Glyburide O
. O
 
Son O
denies O
taking O
her O
to O
another O
MD O
. O
 
I O
will O
obtain O
a O
second O
urine O
culture O
and O
sensitivities O
. O
 
Kevin I-NAME
P. I-NAME
Shamar I-NAME
MD O
 
Record O
date O
: O
2129-08-20 I-DATE
July I-DATE
06 O
, O
2129 I-DATE
Robert I-NAME
Trejo I-NAME
, O
M.D O
. O
 
17 I-LOCATION
Unicorn I-LOCATION
Way I-LOCATION
Suite O
353 O
Chickasha I-LOCATION
, O
NC I-LOCATION
75156 I-LOCATION
RE O
: O
Tyler I-NAME
Pearson I-NAME
WMC I-LOCATION
# O
727-19-02 I-ID
Dear O
Doctor O
Trejo I-NAME
: O
I O
had O
the O
pleasure O
of O
seeing O
our O
mutual O
patient O
, O
Mr. O
Tyler I-NAME
Pearson I-NAME
, O
in O
follow O
up O
evaluation O
in O
our O
vascular O
surgery O
clinic O
here O
today O
. O
 
As O
you O
will O
remember O
he O
recently O
underwent O
right O
carotid O
endarterectomy O
with O
Dacron O
patch O
angioplasty O
after O
treatment O
of O
a O
severe O
underlying O
pneumonia O
. O
 
He O
returns O
today O
reporting O
that O
he O
is O
doing O
well O
from O
a O
neurologic O
standpoint O
. O
 
He O
has O
had O
no O
focal O
, O
motor O
, O
sensory O
deficits O
, O
and O
no O
amaurosis O
fugax O
. O
 
A O
follow O
up O
duplex O
examination O
performed O
in O
our O
vascular O
laboratory O
reveals O
mild O
right O
ICA O
disease O
after O
his O
carotid O
endarterectomy O
with O
moderate O
left O
ICA O
stenosis O
which O
should O
be O
followed O
over O
time O
. O
 
Assessment O
and O
plan O
: O
Overall O
, O
I O
am O
extremely O
pleased O
with O
Mr. O
Pearson I-NAME
's O
outcome O
given O
his O
high O
risk O
pulmonary O
status O
. O
 
It O
would O
be O
prudent O
to O
see O
him O
again O
in O
follow O
up O
evaluation O
in O
six O
months O
' O
time O
with O
a O
repeat O
carotid O
duplex O
examination O
. O
 
I O
would O
be O
happy O
to O
assist O
in O
the O
management O
of O
this O
or O
any O
of O
your O
other O
patients O
as O
you O
deem O
necessary O
in O
the O
future O
. O
 
Thank O
you O
again O
for O
allowing O
me O
to O
assist O
in O
his O
care O
. O
 
If O
I O
can O
be O
of O
any O
further O
assistance O
, O
please O
feel O
free O
to O
contact O
either O
myself O
or O
one O
of O
my O
partners O
directly O
. O
 
Sincerely O
, O
Steven I-NAME
E. I-NAME
Land I-NAME
, O
M.D O
. O
 
SEL I-NAME
: O
kerns I-NAME
 
Record O
date O
: O
2132-05-27 I-DATE
Date O
5/27/32 I-DATE
Time O
4am O
Team O
E O
Admission O
Note O
Patient O
: O
Pearson O
, O
Tyler I-NAME
Medical O
Record O
Number O
: O
727 I-ID
19 I-ID
02 I-ID
Room O
: O
J8845I O
Date O
of O
Admission O
: O
5/26/32 I-DATE
PCP O
: O
Yale I-NAME
Triplett I-NAME
( O
Turner I-LOCATION
Clinic I-LOCATION
) O
Attending O
Physician O
: O
Arias/Wesley O
Admitting O
Intern O
: O
Jaquan I-NAME
Mahoney I-NAME
Code O
Status O
: O
FULL O
CODE O
Source O
: O
Patient O
, O
Medical O
Record O
ID/CC O
: O
87yoM O
h/o O
COPD O
, O
DM2 O
, O
CVA O
p/w O
SOB O
, O
cough O
. O
 
History O
of O
Present O
Illness O
: O
Patient O
w/ O
severe O
COPD O
( O
PFT O
not O
available O
) O
. O
 
Reports O
coughing O
x O
3wks O
, O
productive O
of O
light O
, O
white O
sputum O
. O
 
Has O
had O
intermittent O
, O
fluctuating O
symptoms O
of O
cough/DOE O
since O
then O
. O
 
10d O
prior O
, O
seen O
at O
VGH I-LOCATION
ED O
and O
was O
discharged O
w/ O
prednisone O
( O
7d O
course O
) O
. O
 
He O
reports O
that O
his O
symptoms O
never O
improved O
on O
prednisone O
. O
 
At O
baseline O
, O
he O
is O
able O
to O
walk O
40-50y O
flat O
ground O
and O
several O
flights O
of O
stairs O
; O
limited O
by O
dyspnea O
. O
 
Now O
, O
has O
dyspnea O
at O
rest O
and O
can O
not O
climb O
1 O
flight O
of O
stairs O
. O
 
Saw O
his O
PCPs O
NP O
on O
the O
day O
of O
admission O
and O
was O
referred O
to O
WMC I-LOCATION
. O
 
Denies O
clear O
precipitant O
, O
denies O
sick O
contacts O
, O
h/o O
seasonal O
allergies O
. O
 
In O
the O
ED O
, O
VS O
: O
T O
98.1 O
HR O
100-114 O
BP95/55-172/79 O
RR24-36 O
O2sat O
96 O
% O
4L O
. O
 
He O
was O
noted O
to O
be O
visibly O
dyspneic O
, O
wheezes O
on O
exam O
w/ O
an O
irregular O
heartbeat O
. O
 
He O
was O
transferred O
to O
trauma O
for O
close O
observation O
of O
respiratory O
status O
, O
although O
he O
did O
not O
require O
PPV O
or O
ABG O
. O
 
BNP O
136 O
, O
cardiac O
markers O
neg O
x O
1 O
. O
 
WBC O
returned O
at O
17.5 O
. O
 
AP O
CXR O
was O
indeterminate O
for O
clear O
PNA O
. O
 
Patient O
was O
started O
on O
albuterol/atrovent O
nebs O
, O
solumedrol O
125mg O
, O
ceftriaxone/azithromycin O
for O
possible O
PNA O
. O
 
Review O
of O
Systems O
: O
Chest O
pressure O
sensation O
, O
muscle O
tightness O
, O
L O
sided O
, O
intermittent O
lasting O
only O
minutes O
, O
nonradiating O
, O
non-exertional O
, O
nonpleuritic O
, O
non-positional O
. O
 
Patient O
denies O
the O
following O
symptoms O
. O
 
CONSTITUTIONAL O
: O
f/c/r/sweats O
, O
anorexia/weight-loss O
HEENT O
: O
h/a/ear O
pain/sore O
throat/rhinorrhea O
PULM O
: O
cough/SOB/DOE O
CV O
: O
chest O
pain/palpitations/LH O
dness/LOC/PND/LE O
swelling O
ABD O
: O
abd O
px/n/v/constipation/diarrhea/melena/BPR/ O
bloating O
GU O
: O
dysuria/frequency/urgency O
SKIN O
: O
rash O
, O
bruising O
, O
mucosal O
bleeding O
NEURO O
: O
unilateral O
weakness/paresthesia/dysphasia/dysphagia/visual O
change O
. O
 
Past O
Medical/Surgical O
History O
: O
COPD O
PFTs O
not O
in O
CAS O
Home O
O2 O
: O
2L O
at O
baseline O
( O
used O
continuously O
) O
No O
history O
of O
intubation O
Cerebrovascular O
Disease O
R O
ICA O
stenosis O
S/p O
R O
CEA O
for O
symptoms O
L O
ICA O
stenosis O
F/b O
Steven I-NAME
Land I-NAME
Avoiding O
CEA O
given O
severe O
pulmonary O
disease O
On O
ASA O
, O
suggesting O
addition O
of O
plavix O
( O
not O
currently O
on O
) O
DM2 O
BPH O
PTSD O
Lung O
CA O
S/p O
L O
lobectomy O
. O
 
Allergies O
: O
Tetracycline O
- O
unknown O
Bactrim O
- O
unknown O
Medications O
( O
on O
PCP O
note O
as O
of O
5/3/32 I-DATE
) O
: O
Tylenol O
prn O
Albuterol O
inh O
qid O
prn O
Albuterol O
neb O
qid O
ECASA O
325 O
qd O
Ca O
+ O
D O
250/125 O
bid O
Advair O
250/50 O
bid O
Lasix O
10mg O
qd O
Neurontin O
300mg O
tid O
Guaifenesin O
300mg O
tid O
Atrovent O
inhaler O
2 O
puff O
qid O
Loratidine O
10 O
qd O
Losartan O
50 O
qd O
Zantac O
150 O
bid O
Senna O
prn O
Simvastatin O
20 O
qd O
Travoprost O
0.004 O
% O
OS O
qhs O
Social O
History O
: O
Lives O
in O
North I-LOCATION
Wilkesboro I-LOCATION
w/ O
wife O
. O
 
Son O
lives O
first O
floor O
of O
same O
house O
. O
 
Wife O
and O
family O
split O
responsibilities O
for O
his O
care-taking O
. O
 
Has O
VNA O
. O
 
Former O
civil I-PROFESSION
engineer I-PROFESSION
, O
supervisor I-PROFESSION
, O
consultant I-PROFESSION
. O
 
+ O
asbestos O
exposure O
. O
 
TOB:3-4ppd O
x O
40y O
. O
 
stopped O
40y O
prior O
ETOH O
: O
social O
ILLICITS O
: O
none O
Family O
History O
: O
Denies O
colon/prostate O
CA O
, O
DM O
, O
CVD O
. O
 
Physical O
Examination O
: O
GEN O
: O
appropriate O
, O
mildly O
dyspneic O
, O
worse O
with O
standing O
up O
VS O
: O
T O
98.1 O
P O
111 O
BP O
183/90 O
RR O
28 O
O2SAT O
94 O
% O
4L O
HEENT O
: O
MMM O
, O
JVP O
base O
of O
neck O
. O
 
Conjunctiva O
clear O
. O
 
PULM O
: O
partially O
broken O
sentences O
; O
mildly-moderately O
dyspneic O
. O
 
incr O
expiratory O
: O
inspiratory O
ratio O
. O
 
Quiet O
BS O
bilaterally O
. O
 
Wheezing O
scattered O
. O
 
CV O
: O
no O
bruits O
auscultated O
. O
 
Tachy O
, O
regular O
, O
S1 O
and O
S2 O
normal O
, O
no O
murmurs O
ABD O
: O
soft O
, O
NT/ND/NM/NHSM O
. O
 
BS O
active O
EXT O
: O
no O
c/c/e O
, O
DPs O
2+ O
NEURO O
: O
MS O
A O
& O
Ox3 O
SKIN O
: O
no O
rash O
, O
good O
skin O
turgor O
Data O
: O
NA O
139 O
K O
3.6 O
CL O
101 O
CO2 O
33.9 O
( O
H O
) O
BUN O
22 O
CRE O
1.2 O
GLU O
131 O
( O
H O
) O
CA O
8.7 O
PHOS O
2.7 O
MG O
1.6 O
TBILI O
0.4 O
DBILI O
0.1 O
TP O
8.0 O
ALB O
3.3 O
GLOB O
4.7 O
( O
H O
) O
AMY O
72 O
LIPS O
2.1 O
ALT/SGPT O
25 O
AST/SGOT O
21 O
ALKP O
67 O
NT-BNP O
136 O
( O
T O
) O
CK O
30 O
( O
L O
) O
CK-MB O
2.9 O
Negative O
CKMBRI O
see O
detail O
TROP-I O
Negative O
TROP-T O
< O
0.01 O
WBC O
17.5 O
( O
H O
) O
RBC O
5.31 O
HGB O
14.8 O
HCT O
47.1 O
MCV O
89 O
MCH O
27.9 O
MCHC O
31.4 O
PLT O
332 O
RDW O
15.8 O
( O
H O
) O
DIFFR O
Received O
METHOD O
Auto O
% O
NEUT O
83 O
( O
H O
) O
% O
LYMPH O
12 O
( O
L O
) O
% O
MONO O
4 O
% O
EOS O
1 O
% O
BASO O
0 O
ANEUT O
14.77 O
( O
H O
) O
ALYMP O
2.02 O
AMONS O
0.64 O
( O
H O
) O
AEOSN O
0.08 O
( O
L O
) O
ABASOP O
0.03 O
ANISO O
None O
HYPO O
None O
MACRO O
None O
MICRO O
None O
PT O
13.6 O
( O
T O
) O
PT-INR O
1.1 O
PTT O
25.3 O
EKG O
tachycardia O
, O
at O
least O
two O
atrial O
foci O
. O
 
RBBB O
. O
 
CXR O
L O
lower O
lung O
opacity O
. O
 
Poor O
film O
. O
 
Impression/Plan O
: O
87yoM O
h/o O
COPD O
, O
vascular O
disease O
p/w O
SOB O
, O
cough O
. O
 
Likely O
COPD O
flare O
. O
 
High O
WBC O
may O
be O
steroids O
, O
but O
CXR O
too O
poor O
to O
rule O
out O
PNA O
. O
 
Otherwise O
, O
no O
clear O
precipitant O
. O
 
Failed O
steroids O
as O
outpatient O
( O
dosing O
unclear O
) O
. O
 
Given O
level O
of O
dyspnea O
, O
will O
treat O
w/ O
solumedrol O
for O
now O
, O
and O
transition O
to O
prednisone O
when O
improvement/trajectory O
is O
clear O
. O
 
Patient O
may O
need O
a O
longer O
taper O
than O
over O
10d O
. O
 
SOB O
: O
COPD O
flare O
+/- O
PNA O
. O
 
-repeat O
CXR O
in O
AM O
. O
 
-solumedrol O
125mg O
q6 O
for O
now O
. O
 
Transition O
to O
prednisone O
1mg/kg O
when O
clinically O
stable O
. O
 
Follow O
trend O
, O
decide O
on O
length O
of O
taper O
at O
later O
date O
. O
 
-advair O
, O
spiriva O
. O
 
Standing O
albuterol O
nebs O
q4 O
for O
now O
. O
 
Space O
nebs O
when O
improvement O
demonstrated O
. O
 
-keep O
O2 O
sats O
88-92 O
% O
CHEST O
PRESSURE O
: O
follow O
for O
now O
. O
 
Would O
deserve O
stress O
. O
 
Unless O
has O
more O
activity/symptoms O
while O
here O
, O
would O
defer O
to O
be O
done O
as O
outpatient O
. O
 
Does O
have O
significant O
risk O
factors O
. O
 
-ROMI O
by O
markers O
. O
 
-telemetry O
. O
 
-ASA O
, O
ARB O
, O
statin O
. O
 
-start O
low O
dose O
beta-blocker O
to O
see O
if O
he O
tolerates O
. O
 
HTN O
: O
likely O
exacerbated O
by O
steroids O
. O
 
Will O
be O
moving O
target O
in O
setting O
of O
changing O
steroid O
dose O
. O
 
-c/w O
home O
ARB O
. O
 
-start O
lopressor O
25 O
tid O
for O
now O
. O
 
-hydralazine O
25mg O
q6h O
for O
immediate O
decrease O
in O
BP O
now O
. O
 
Taper O
off O
when O
able O
. O
 
DM2 O
: O
no O
meds O
from O
home O
-RISS O
, O
FS O
qid O
. O
 
-check O
A1c O
. O
 
FEN O
: O
no O
added O
salt O
, O
low O
cholesterol/fat O
, O
no O
conc O
sweets O
PROPHY O
: O
fragmin O
, O
zantac O
. O
 
CODE O
: O
full O
code O
( O
confirmed O
w/ O
patient O
) O
DISPO O
: O
PT O
eval O
. O
 
Jaquan I-NAME
Mahoney I-NAME
, O
MD O
Pager O
: O
# O
84464 I-CONTACT
 
Record O
date O
: O
2132-06-14 I-DATE
Internal O
Medicine O
Intern O
Admission O
Note O
Name O
: O
Tyler I-NAME
Pearson I-NAME
MR O
# O
: O
7271902 I-ID
Date O
of O
admission O
: O
14 I-DATE
June I-DATE
2132 I-DATE
Admitting O
Intern O
: O
Noah I-NAME
Rosario I-NAME
Admitting O
Junior O
: O
Raymond I-NAME
Pack I-NAME
Attending O
: O
Frank I-NAME
Ash I-NAME
Chief O
Complaint O
: O
shortness O
of O
breath O
History O
of O
Present O
Illness O
: O
Mr. O
Pearson I-NAME
is O
a O
an O
87 I-AGE
year O
old O
gentleman O
with O
COPD O
on O
home O
oxygen O
, O
CVA O
, O
DM O
, O
and O
history O
of O
lung O
cancer O
s/p O
resection O
without O
chemotherapy O
who O
presented O
to O
the O
ED O
with O
acute O
shortness O
of O
breath O
. O
 
Of O
note O
, O
he O
was O
hospitalized O
from O
May I-DATE
26 I-DATE
until O
May I-DATE
29 I-DATE
for O
a O
COPD O
flare O
, O
and O
was O
discharged O
home O
at O
that O
time O
on O
a O
prednisone O
taper O
, O
which O
he O
completed O
about O
one O
week O
ago O
. O
 
He O
was O
in O
his O
usual O
state O
of O
good O
health O
and O
had O
even O
spent O
the O
past O
weekend O
with O
family O
in O
Connecticut I-LOCATION
camping O
. O
 
But O
on O
the O
evening O
of O
June I-DATE
13 I-DATE
he O
began O
to O
feel O
short O
of O
breath O
, O
without O
cough O
or O
chest O
pain O
, O
and O
the O
dyspnea O
was O
made O
worse O
with O
exertion O
. O
 
Not O
made O
worse O
with O
lying O
down O
. O
 
He O
also O
had O
a O
fever O
to O
103 O
, O
without O
mental O
status O
changes O
. O
 
EMS O
was O
called O
and O
in O
the O
field O
he O
was O
noted O
to O
be O
breathing O
at O
a O
rate O
in O
the O
40s O
; O
he O
was O
given O
a O
dose O
of O
IV O
lasix O
and O
he O
put O
out O
600cc O
of O
urine O
. O
 
He O
was O
then O
brought O
to O
the O
WMC I-LOCATION
ED O
where O
he O
continued O
to O
display O
labored O
breathing O
, O
breathing O
in O
the O
40s O
, O
afebrile O
, O
tachycardic O
to O
147bpm O
. O
 
An O
ABG O
on O
BIPAP O
showed O
7.35/53/100 O
. O
 
His O
blood O
pressure O
dropped O
from O
systolic O
130s O
to O
70/50 O
, O
and O
so O
he O
was O
subsequently O
intubated O
, O
and O
a O
central O
and O
arterial O
lines O
placed O
. O
 
He O
was O
given O
approximately O
2L O
of O
NS O
with O
resultant O
CVP O
of O
11 O
. O
 
He O
was O
also O
started O
on O
dopamine O
, O
which O
was O
eventually O
transitioned O
to O
norepinephrine O
. O
 
He O
was O
given O
vancomycin O
, O
levaquin O
, O
and O
flagyl O
, O
as O
well O
as O
a O
dose O
of O
solumedrol O
. O
 
He O
was O
then O
transferred O
to O
the O
Internal O
Medicine O
. O
 
Review O
of O
Systems O
: O
per O
HPI O
; O
no O
changes O
in O
mental O
status O
; O
no O
cough O
, O
chest O
pain O
, O
palpitations O
; O
no O
N/V/C/D O
; O
no O
BRBPR O
or O
melena O
; O
no O
sick O
contacts O
. O
 
Past O
Medical O
History O
COPD O
on O
home O
O2 O
2LNC O
at O
all O
times O
, O
never O
been O
intubated O
Cerebrovascular O
disease O
: O
s/p O
R O
CEA O
, O
and O
with O
L O
ICA O
on O
aspirin O
DM2 O
Lung O
cancer O
: O
s/p O
L O
partial O
resection O
BPH O
PTSD O
Medications O
on O
Admission O
Albuterol O
and O
atrovent O
nebulizers O
prn O
Advair O
250/50 O
2puffs O
bid O
ASA O
325mg O
po O
qd O
Calcium O
and O
vitamin O
D O
250mg O
po O
bid O
Lasix O
10mg O
po O
qd O
Neurontin O
300mg O
po O
tid O
Guaifenasin O
10mL O
tid O
Zantac O
150mg O
po O
bid O
Senna O
2tabs O
bid O
Zocor O
20mg O
po O
qhs O
Losartan O
100mg O
po O
qd O
Toprol O
XL O
100mg O
po O
qd O
Loratidine O
10mg O
po O
qd O
Allergies O
: O
bactrim O
and O
tetracycline O
, O
reactions O
unknown O
Social O
History O
: O
retired O
Civil I-PROFESSION
Engineer I-PROFESSION
, O
positive O
asbestos O
exposure O
; O
quit O
smoking O
30 O
years O
ago O
; O
no O
EtOH O
or O
illicits O
Family O
History O
: O
denies O
any O
known O
family O
history O
of O
lung O
disease O
, O
COPD O
, O
CAD O
, O
or O
cancer O
Physical O
Exam O
Gen O
: O
NAD O
, O
appears O
comfortable O
VS O
: O
T96.1 O
bp118/60 O
without O
pressors O
P93 O
CVP O
6-9 O
O2sat O
97 O
% O
on O
mechanical O
ventilation O
HEENT O
: O
R O
eye O
not O
reactive O
to O
light O
; O
L O
eye O
3 O
2mm O
with O
light O
; O
EOMI O
Neck O
: O
supple O
, O
JVP O
flat O
Pulm O
: O
ronchi O
bilaterally O
without O
wheezing O
or O
crackles O
Cor O
: O
regular O
, O
nls1s2 O
, O
no O
mumurs O
Abd O
: O
soft O
, O
NTND O
, O
+BS O
, O
no O
HSM O
Ext O
: O
trace O
lower O
edema O
bilaterally O
; O
warm O
, O
DP O
2+ O
B O
Neuro O
: O
no O
focal O
findings O
, O
pt O
appropriate O
; O
CN O
2-12 O
intact O
, O
tongue O
midlines O
, O
strength O
5/5 O
all O
extremities O
, O
toes O
downgoing O
Labs O
Date/Time O
NA O
K O
CL O
CO2 O
06/14/2132 I-DATE
4.3 O
06/14/2132 I-DATE
138 O
4.1 O
101 O
29.1 O
Date/Time O
BUN O
CRE O
GLU O
06/14/2132 I-DATE
132 O
( O
H O
) O
06/14/2132 I-DATE
30 O
( O
H O
) O
1.6 O
( O
H O
) O
123 O
( O
H O
) O
Date/Time O
CA O
PHOS O
MG O
TBILI O
06/14/2132 I-DATE
9.4 O
4.1 O
1.4 O
0.9 O
Date/Time O
DBILI O
TP O
ALB O
GLOB O
06/14/2132 I-DATE
0.0 O
6.7 O
3.4 O
3.3 O
Date/Time O
LACT O
06/14/2132 I-DATE
1.2 O
Date/Time O
TEMP O
FIO2 O
bPO2 O
bPCO2 O
06/14/2132 I-DATE
37.0 O
1.00 O
100 O
( O
H O
) O
53 O
( O
H O
) O
Date/Time O
bPH O
06/14/2132 I-DATE
7.35 O
Date/Time O
ALT/SGPT O
AST/SGOT O
ALKP O
TBILI O
06/14/2132 I-DATE
16 O
22 O
54 O
0.9 O
Date/Time O
NT-BNP O
CK-MB O
TROP-I O
06/14/2132 I-DATE
NEGATIVE O
NEGATIVE O
06/14/2132 I-DATE
325 O
Date/Time O
PT O
PT-INR O
PTT O
06/14/2132 I-DATE
12.8 O
1.0 O
26.8 O
Date/Time O
WBC O
RBC O
HGB O
HCT O
06/14/2132 I-DATE
22.9 O
( O
H O
) O
4.89 O
14.1 O
42.9 O
Date/Time O
MCV O
MCH O
MCHC O
PLT O
06/14/2132 I-DATE
88 O
28.9 O
32.9 O
190 O
Date/Time O
DIFFR O
METHOD O
% O
NEUT O
% O
LYMPH O
06/14/2132 I-DATE
RECEIVED O
Auto O
82 O
( O
H O
) O
15 O
( O
L O
) O
Date/Time O
UA-GLUC O
UA-KET O
UA-SPGR O
UA-BLD O
06/14/2132 I-DATE
NEGATIVE O
NEGATIVE O
1.015 O
NEGATIVE O
Date/Time O
UA-PH O
UA-PROT O
UA-NIT O
UA-WBC O
06/14/2132 I-DATE
5.0 O
NEGATIVE O
NEGATIVE O
NEGATIVE O
06/14/2132 I-DATE
07:10 O
CXR O
Right O
upper O
lobe O
and O
right O
middle O
lobe O
opacity O
, O
new O
since O
5/27/2132 I-DATE
, O
suspicious O
for O
pneumonia O
. O
 
Lines O
and O
tubes O
as O
described O
above O
, O
without O
evidence O
of O
pneumothorax O
following O
left O
IJ O
placement O
. O
 
EKG O
: O
sinus O
tachycardia O
at O
134bpm O
; O
right O
ventricular O
hypertrophy O
; O
0.5mm O
ST O
depression O
V6 O
Assessment O
and O
Plan O
Mr. O
Pearson I-NAME
is O
a O
pleasant O
87 I-AGE
year O
old O
gentleman O
with O
a O
history O
of O
COPD O
, O
never O
intubated O
, O
who O
presented O
with O
one O
day O
of O
dyspnea O
. O
 
He O
had O
a O
fever O
to O
103 O
, O
and O
presented O
with O
hypotension O
and O
respiratory O
distress O
requiring O
intubation O
. O
 
He O
has O
an O
elevated O
wbc O
and O
an O
increased O
creatinine O
to O
1.6 O
; O
his O
chest O
x-ray O
is O
consistent O
with O
a O
RUL O
and O
RML O
pneumonia O
, O
and O
he O
has O
a O
low O
bnp O
negative O
for O
cardiac O
stretching O
. O
 
His O
presentation O
is O
consistent O
with O
sepsis O
secondary O
to O
pneumonia O
. O
 
Sepsis O
: O
continue O
EGDT O
, O
with O
goal O
MAP O
> O
65 O
and O
goal O
CVP O
of O
8-12 O
a. O
IVF O
with O
NS O
for O
goal O
CVP O
8-12 O
b. O
pressors O
as O
needed O
( O
vasopressin O
+/- O
levophed O
) O
for O
goal O
MAP O
> O
65 O
( O
currently O
off O
pressors O
) O
c. O
monitor O
urine O
output O
d. O
measure O
central O
venous O
oxygen O
saturation O
e. O
antibiotics O
for O
pneumonia O
: O
would O
treat O
with O
vancomycin O
and O
cefepime O
, O
check O
vancomycin O
trough O
tomorrow O
am O
f. O
f/u O
all O
culture O
data O
g. O
continue O
advair O
250/50 O
h. O
no O
need O
for O
steroids O
currently O
, O
and O
will O
not O
check O
cort-stim O
in O
setting O
of O
having O
received O
solumedrol O
in O
ED O
i. O
hold O
antihypertensives O
( O
losartan O
100mg O
qd O
and O
toprol O
100mg O
qd O
) O
in O
setting O
of O
hypotension O
ARF O
: O
creatinine O
up O
to O
1.6 O
from O
baseline O
of O
1.1 O
, O
likely O
pre-renal O
etiology O
in O
setting O
of O
sepsis O
; O
will O
give O
trial O
hydration O
Ppx O
: O
ranitidine O
and O
heparin O
_______________________________ O
Noah I-NAME
G. I-NAME
Rosario I-NAME
Pager O
81251 I-CONTACT
PGY-1 O
 
Record O
date O
: O
2134-10-28 I-DATE
Team O
IV O
Attending O
Admission O
Note O
PT O
Name O
: O
Pearson I-NAME
, O
Tyler I-NAME
MR O
# O
7271902 I-ID
Date O
of O
Admission O
: O
10/28/34 I-DATE
at O
1930 O
CC O
: O
shortness O
of O
breath O
HPI O
: O
Mr. O
Pearson I-NAME
is O
a O
89 I-AGE
year O
old O
male O
with O
past O
medical O
history O
of O
COPD O
, O
s/p O
CVA O
, O
AODM O
, O
BPH O
, O
CRI O
who O
presented O
to O
WMC I-LOCATION
complaining O
about O
shortness O
of O
breath O
. O
 
The O
patient O
was O
admitted O
to O
the O
Ross I-LOCATION
Medical I-LOCATION
Center I-LOCATION
with O
pneumonia O
on O
three O
occasions O
in O
the O
last O
6 O
weeks O
. O
 
He O
was O
discharged O
home O
and O
completed O
the O
most O
recent O
course O
of O
antibiotics O
today O
. O
 
He O
has O
noted O
increasing O
shortness O
of O
breath O
, O
wheezing O
, O
decreased O
exercise O
tolerance O
prompting O
him O
to O
seek O
medical O
attention O
. O
 
The O
patient O
denied O
fever O
, O
productive O
cough O
, O
nausea O
, O
vomiting O
, O
diaphoresis O
, O
chest O
pain O
. O
 
ROS O
: O
all O
systems O
are O
negative O
in O
detail O
except O
as O
noted O
above O
PMH O
: O
COPD O
on O
home O
O2 O
2LNC O
at O
all O
times O
Cerebrovascular O
disease O
: O
s/p O
R O
CEA O
6/2129 I-DATE
L O
ICA O
stenosis O
, O
followed O
medically O
with O
serial O
ultrasound O
, O
on O
aspirin O
DM2 O
Lung O
cancer O
: O
s/p O
L O
partial O
resection O
2106 I-DATE
& O
# O
8217 O
; O
s O
BPH O
PTSD O
Artificial O
R O
eye O
( O
s/p O
trauma O
2069 I-DATE
) O
CRI O
( O
baseline O
1.1 O
& O
# O
8211 O
; O
1.3 O
) O
Medications O
( O
from O
discharge O
notes O
) O
: O
Acetylsalicylic O
Acid O
( O
Aspirin O
) O
PO O
325 O
MG O
QD O
Fluticasone O
Propionate/salmeterol O
250/50 O
( O
Advair O
Diskus O
250/50 O
) O
INH O
1 O
PUFF O
BID O
Simvastatin O
( O
Zocor O
) O
PO O
40 O
MG O
QD O
Losartan O
PO O
100 O
MG O
QD O
Ipratropium O
Nebulizer O
( O
Atrovent O
Nebulizer O
) O
NEB O
0.5 O
MG O
QID O
Calcium O
Carbonate/vitd O
( O
250mg O
Ca++/125u O
Vitd O
) O
PO O
250 O
MG O
TID O
Gabapentin O
( O
Neurontin O
) O
PO O
300 O
MG O
TID O
Albuterol O
Nebulizer O
NEB O
2.5 O
MG O
Q4H O
prn O
Metoprolol O
PO O
12.5 O
MG O
BID O
Furosemide O
( O
Lasix O
) O
PO O
10 O
MG O
QD O
Loratadine O
PO O
10 O
MG O
QD O
MVI O
Brimonidine O
one O
gtt O
OS O
BID O
Tamsulosin O
0.4 O
mg O
QHS O
Prednisone O
40 O
mg O
QD O
Allergies O
: O
Bactrim/Tetracycline O
FH O
: O
noncontributory O
SH O
: O
retired O
Civil I-PROFESSION
Engineer I-PROFESSION
; O
( O
- O
) O
ETOH O
( O
- O
) O
illicit O
drugs O
( O
+ O
) O
tobacco O
& O
# O
8211 O
; O
stopped O
30 O
years O
ago O
; O
30 O
pack O
year O
history O
Exam O
: O
VS O
: O
T=99 O
HR=112 O
BP= O
139/57 O
RR=28 O
; O
96 O
% O
after O
neb O
in O
ER O
General O
: O
well O
nourished/well O
developed O
male O
in O
no O
acute O
distress O
HEENT O
: O
NC/AT O
Neck O
: O
Supple O
; O
JVP O
flat O
Chest O
: O
diffuse O
expiratory O
wheezes O
CVS O
: O
distant O
heart O
sounds O
( O
difficult O
to O
appreciate O
over O
breath O
sounds O
) O
Abd O
: O
soft O
, O
nontender O
, O
nondistended O
, O
normoactive O
BS O
Extr O
: O
no O
C/C/E O
Neuro O
: O
nonfocal O
Skin O
: O
no O
rashes O
DATA O
: O
Chemistry O
: O
Plasma O
Sodium O
135 O
( O
135-145 O
) O
mmol/L O
Plasma O
Potassium O
4.5 O
( O
3.4-4.8 O
) O
mmol/L O
Plasma O
Chloride O
96 O
L O
( O
100-108 O
) O
mmol/L O
Plasma O
Carbon O
Dioxide O
31.5 O
( O
23.0-31.9 O
) O
mmol/L O
Plasma O
Anion O
GAP O
8 O
( O
3-15 O
) O
mmol/L O
Calcium O
9.6 O
( O
8.5-10.5 O
) O
mg/dl O
Phosphorus O
3.0 O
( O
2.6-4.5 O
) O
mg/dl O
Magnesium O
1.8 O
( O
1.4-2.0 O
) O
meq/L O
Plasma O
Urea O
Nitrogen O
15 O
( O
8-25 O
) O
mg/dl O
Plasma O
Creatinine O
1.38 O
( O
0.60-1.50 O
) O
mg/dl O
eGFR O
51 O
mL/min/1.73m2 O
Abnormal O
if O
& O
lt O
; O
60 O
mL/min/1.73m2 O
. O
 
If O
patient O
is O
African-American O
, O
multiply O
the O
result O
by O
1.21 O
. O
 
Plasma O
Glucose O
124 O
H O
( O
70-110 O
) O
mg/dl O
Creatine O
Kinase O
Isoenzymes O
NEGATIVE O
( O
NEG O
) O
Troponin-I O
NEGATIVE O
( O
NEG O
) O
NT-proBNP O
398 O
( O
0-1800 O
) O
pg/ml O
Hematology O
: O
WBC O
14.4 O
H O
( O
4.5-11.0 O
) O
th/cmm O
HCT O
36.9 O
L O
( O
41.0-53.0 O
) O
% O
HGB O
12.7 O
L O
( O
13.5-17.5 O
) O
gm/dl O
RBC O
4.07 O
L O
( O
4.50-5.90 O
) O
mil/cmm O
PLT O
354 O
( O
150-400 O
) O
th/cumm O
MCV O
91 O
( O
80-100 O
) O
fl O
MCH O
31.3 O
( O
26.0-34.0 O
) O
pg/rbc O
MCHC O
34.5 O
( O
31.0-37.0 O
) O
g/dl O
RDW O
13.7 O
( O
11.5-14.5 O
) O
% O
PT O
14.7 O
H O
( O
10.3-13.2 O
) O
sec O
PT-INR O
1.3 O
DIFFERENTIAL O
REQUEST O
RECEIVED O
Diff O
Method O
Auto O
Poly O
81 O
H O
( O
40-70 O
) O
% O
Lymphs O
11 O
L O
( O
22-44 O
) O
% O
Monos O
5 O
( O
4-11 O
) O
% O
EOS O
3 O
( O
0-8 O
) O
% O
Basos O
0 O
( O
0-3 O
) O
% O
Absolute O
Neuts O
11.75 O
H O
( O
1.8-7.7 O
) O
th/cmm O
Absolute O
Lymphs O
1.60 O
( O
1.0-4.8 O
) O
th/cmm O
Absolute O
Monos O
0.70 O
( O
0.2-1.2 O
) O
th/mm3 O
Absolute O
EOS O
0.36 O
H O
( O
0.1-0.3 O
) O
th/cmm O
Absolute O
Basos O
0.01 O
( O
0.0-0.3 O
) O
th/cmm O
Aniso O
None O
( O
None O
) O
Hypo O
None O
( O
None O
) O
Macrocytes O
None O
( O
None O
) O
Microcytes O
None O
( O
None O
) O
Chest O
x-ray O
: O
diffuse O
interstitial O
opacities O
likely O
representing O
interstitial O
fibrosis O
; O
no O
definite O
focal O
consolidation O
EKG O
: O
sinus O
tach O
at O
111 O
; O
nl O
axis O
; O
RBBB O
; O
___________________________________________ O
Impression O
: O
89 I-AGE
year O
old O
male O
with O
past O
medical O
history O
of O
COPD O
on O
home O
O2 O
, O
HTN O
, O
AODM O
, O
hyperlipidemia O
, O
remote O
CVA O
, O
CRI O
admitted O
with O
COPD O
exacerbation O
after O
recent O
admission O
to O
Ross I-LOCATION
Hospital I-LOCATION
with O
pneumonia O
. O
 
Plan O
: O
1 O
. O
 
COPD O
exacerbation O
-- O
Patient O
appears O
comfortable O
after O
nebulizer O
treatments O
in O
the O
ER O
. O
 
He O
has O
completed O
his O
course O
of O
oral O
antibiotics O
and O
remains O
on O
oral O
Prednisone O
. O
 
Will O
continue O
oral O
Prednisone O
and O
continue O
aggressive O
nebulizer O
treatments O
. O
 
He O
may O
require O
higher O
dose O
of O
oral O
steroids O
and O
subsequent O
taper O
. O
 
His O
chest O
x-ray O
does O
NOT O
demonstrate O
a O
focal O
area O
of O
consolidation O
at O
this O
time O
. O
 
2 O
. O
 
HTN O
& O
# O
8211 O
; O
continue O
Lasix O
, O
Losartan O
, O
and O
Lasix O
3. O
diabetes O
& O
# O
8211 O
; O
Patient O
reportedly O
does O
NOT O
require O
medication O
for O
management O
. O
 
Will O
check O
BS O
BID O
now O
that O
he O
is O
on O
oral O
Prednisone O
4 O
. O
 
Glaucoma O
& O
# O
8211 O
; O
continue O
Brimonidine O
BID O
______________________ O
Gennaro I-NAME
B. I-NAME
Norwood I-NAME
, O
MD O
Medical I-LOCATION
Team O
4 O
Team O
4 O
Beeper O
# O
07736 I-CONTACT
 
